PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Urusova, DV; Kinsella, RL; Salinas, ND; Haurat, MF; Feldman, MF; Tolia, NH				Urusova, Darya V.; Kinsella, Rachel L.; Salinas, Nichole D.; Haurat, M. Florencia; Feldman, Mario F.; Tolia, Niraj H.			The structure of Acinetobacter-secreted protease CpaA complexed with its chaperone CpaB reveals a novel mode of a T2SS chaperone-substrate interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structural biology; bacteria; type II secretion system (T2SS); chaperone; metalloprotease; ADAM; drug resistance; glycoprotein; virulence factor	BACTEROIDES-FRAGILIS; BAUMANNII; ENTEROTOXIN; SYSTEM; STCE	Members of the Acinetobacter baumannii-calcoaceticus complex are nosocomial pathogens frequently causing multidrug-resistant infections that are increasing at alarming rates. A. baumannii has become the Gram-negative bacterium with the highest rate of multidrug resistance. As such, it is categorized by the World Health Organization as a critical priority for the research and development of new antimicrobial therapies. The zinc-dependent metalloendopeptidase CpaA is a predominant substrate of the type II secretion system (T2SS). CpaA is also a virulence factor of medically relevant Acinetobacter strains that specifically degrade the human glycoprotein coagulation factor XII and not its deglycosylated form, but the mechanism for this specificity is unknown. CpaB is a membrane-anchored T2SS chaperone that interacts with CpaA and is required for its stability and secretion. Here, we report the crystal structure of the CpaAB complex at 2.6-angstrom resolution, revealing four glycan-binding domains in CpaA that were not predicted from its primary sequence and may explain CpaA's glycoprotein-targeting activity. The structure of the complex identified a novel mode for chaperone-protease interactions in which the protease surrounds the chaperone. The CpaAB organization was akin to zymogen inactivation, with CpaB serving as a prodomain that inhibits catalytically active CpaA. CpaB contains a C-terminal tail that appears to block access to the CpaA catalytic site, and functional experiments with truncated variants indicated that this tail is dispensable for CpaA expression and secretion. Our results provide new insight into the mechanism of CpaA secretion and may inform the future development of therapeutic strategies for managing Acinetobacter infections.	[Urusova, Darya V.; Kinsella, Rachel L.; Haurat, M. Florencia; Feldman, Mario F.; Tolia, Niraj H.] Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230, St Louis, MO 63110 USA; [Salinas, Nichole D.; Tolia, Niraj H.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tolia, NH (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	niraj.tolia@nih.gov	Haurat, M Florencia/ABA-2634-2020; Tolia, Niraj/D-2332-2014	Haurat, M Florencia/0000-0001-7569-2783; Tolia, Niraj/0000-0002-2689-1337; Salinas, Nichole/0000-0003-4105-3718	National Institutes of Health Intramural Research Program of the NIAID; Burroughs Wellcome Fund; Department of Molecular Microbiology, Washington University in St. Louis; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships-Doctoral Program (NSERC PGSD); Washington University in St. Louis Schlesinger awards	National Institutes of Health Intramural Research Program of the NIAID; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Department of Molecular Microbiology, Washington University in St. Louis; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships-Doctoral Program (NSERC PGSD)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Washington University in St. Louis Schlesinger awards	This work was supported by the National Institutes of Health Intramural Research Program of the NIAID and the Burroughs Wellcome Fund (to N. H. T.), a startup grant from the Department of Molecular Microbiology, Washington University in St. Louis (to M. F. F.), and Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships-Doctoral Program (NSERC PGSD) and Washington University in St. Louis Schlesinger awards (to R. L. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Auld D. S., 2004, HDB PROTEOLYTIC ENZY; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Elhosseiny NM, 2016, INT J MED MICROBIOL, V306, P633, DOI 10.1016/j.ijmm.2016.09.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; Harding CM, 2017, J BIOL CHEM, V292, P9075, DOI 10.1074/jbc.M117.781575; Harding CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005391; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holton John, 2008, Curr Infect Dis Rep, V10, P99, DOI 10.1007/s11908-008-0018-7; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Johnson TL, 2016, J BACTERIOL, V198, P711, DOI 10.1128/JB.00622-15; Kinsella RL, 2017, J BIOL CHEM, V292, P19628, DOI 10.1074/jbc.M117.808394; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MONCRIEF JS, 1995, INFECT IMMUN, V63, P175, DOI 10.1128/IAI.63.1.175-181.1995; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MYERS LL, 1984, INFECT IMMUN, V44, P241, DOI 10.1128/IAI.44.2.241-244.1984; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Poulikakos P, 2014, EUR J CLIN MICROBIOL, V33, P1675, DOI 10.1007/s10096-014-2124-9; Rabizadeh Shervin, 2008, Curr Infect Dis Rep, V10, P92, DOI 10.1007/s11908-008-0017-8; Rosenau F, 2004, CHEMBIOCHEM, V5, P153, DOI 10.1002/cbic.200300761; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Szabady RL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000320; Tilley D, 2014, FEMS MICROBIOL LETT, V356, P53, DOI 10.1111/1574-6968.12496; Waack U, 2018, MBIO, V9, DOI 10.1128/mBio.01606-18; Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Yu ACY, 2012, STRUCTURE, V20, P707, DOI 10.1016/j.str.2012.02.015	35	6	6	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13344	13354		10.1074/jbc.RA119.009805	http://dx.doi.org/10.1074/jbc.RA119.009805			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31320476	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000486417200012
J	Santonocito, R; Venturella, F; Dal Piaz, F; Morando, MA; Provenzano, A; Rao, E; Costa, MA; Bulone, D; San Biagio, PL; Giacomazza, D; Sicorello, A; Alfano, C; Passantino, R; Pastore, A				Santonocito, Radha; Venturella, Francesca; Dal Piaz, Fabrizio; Morando, Maria Agnese; Provenzano, Alessia; Rao, Estella; Costa, Maria Assunta; Bulone, Donatella; San Biagio, Pier Luigi; Giacomazza, Daniela; Sicorello, Alessandro; Alfano, Caterina; Passantino, Rosa; Pastore, Annalisa			Recombinant mussel protein Pvfp-5 beta: A potential tissue bioadhesive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; biomaterials; biophysics; epidermal growth factor (EGF); structural biology; adhesion proteins; EGF-like motifs; Marine proteins	ADHESIVE PROTEIN; DOPA; SURFACES	During their lifecycle, many marine organisms rely on natural adhesives to attach to wet surfaces for movement and self-defense in aqueous tidal environments. Adhesive proteins from mussels are biocompatible and elicit only minimal immune responses in humans. Therefore these proteins have received increased attention for their potential applications in medicine, biomaterials, and biotechnology. The Asian green mussel Perna viridis secretes several byssal plaque proteins, molecules that help anchoring the mussel to surfaces. Among these proteins, protein-5 beta (Pvfp-5 beta) initiates interactions with the substrate, displacing interfacial water molecules before binding to the surface. Here, we established the first recombinant expression in Escherichia coli of Pvfp-5 beta. We characterized recombinant Pvfp-5 beta, finding that despite displaying a CD spectrum consistent with features of a random coil, the protein is correctly folded as indicated by MS and NMR analyses. Pvfp-5 beta folds as a beta-sheet-rich protein as expected for an epidermal growth factor-like module. We examined the effects of Pvfp-5 beta on cell viability and adhesion capacity in NIH-3T3 and HeLa cell lines, revealing that Pvfp-5 beta has no cytotoxic effects at the protein concentrations used and provides good cell-adhesion strength on both glass and plastic plates. Our findings suggest that the adhesive properties of recombinant Pvfp-5 beta make it an efficient surface-coating material, potentially suitable for biomedical applications including regeneration of damaged tissues.	[Santonocito, Radha; Provenzano, Alessia; Rao, Estella; Costa, Maria Assunta; Bulone, Donatella; San Biagio, Pier Luigi; Giacomazza, Daniela; Passantino, Rosa] CNR, Ist Biofis, I-190146 Palermo, Italy; [Venturella, Francesca] Univ Palermo, I-190128 Palermo, Italy; [Dal Piaz, Fabrizio] Univ Salerno, I-184084 Salerno, Italy; [Venturella, Francesca; Morando, Maria Agnese; Alfano, Caterina] Fdn Ri MED, I-190133 Palermo, Italy; [Sicorello, Alessandro; Pastore, Annalisa] Kings Coll London, London SE5 9RT, England; [Sicorello, Alessandro; Pastore, Annalisa] Kings Coll London, UK Dementia Res Inst, London SE5 9RT, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Palermo; University of London; King's College London; University of London; King's College London	Passantino, R (corresponding author), CNR, Ist Biofis, I-190146 Palermo, Italy.; Alfano, C (corresponding author), Fdn Ri MED, I-190133 Palermo, Italy.	calfano@fondazionerimed.com; rosa.passantino@cnr.it	bulone, donatella/AAB-6116-2022; passantino, rosa/C-3993-2015; Giacomazza, Daniela/C-4280-2015	bulone, donatella/0000-0002-5841-9133; Costa, Maria Assunta/0000-0003-3377-6123; Alfano, Caterina/0000-0003-0374-5852; Rao, Estella/0000-0002-1202-5083; passantino, rosa/0000-0001-6598-2664; Giacomazza, Daniela/0000-0002-6667-0205; Sicorello, Alessandro/0000-0003-1407-8039	Cancer Research UK [FC001029]; UK Medical Research Council [FC001029]; Wellcome Trust [FC001029]; MRC [UKDRI-6002, MC_U117584256, MC_U117533887] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Francis Crick Institute through provision of access to the MRC Biomedical NMR Centre. The Francis Crick Institute receives its core funding from Cancer Research UK Grant FC001029, UK Medical Research Council Grant FC001029, and the Wellcome Trust Grant FC001029.	BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Cho Hyung Joon, 2008, Biotechnology Journal, V3, P631, DOI 10.1002/biot.200700258; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0; DOVE J, 1986, J AM DENT ASSOC, V112, P879; Forooshani PK, 2017, J POLYM SCI POL CHEM, V55, P9, DOI 10.1002/pola.28368; George MN, 2018, BIOFOULING, V34, P388, DOI 10.1080/08927014.2018.1453927; GRANDE DA, 1988, B HOSP JOINT DIS ORT, V48, P140; Guerette PA, 2013, NAT BIOTECHNOL, V31, P908, DOI 10.1038/nbt.2671; He YH, 2018, SOFT MATTER, V14, P7145, DOI 10.1039/c8sm00509e; Hwang DS, 2012, SOFT MATTER, V8, P5640, DOI 10.1039/c2sm25173f; Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157; INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698; Jeon EY, 2015, BIOMATERIALS, V67, P11, DOI 10.1016/j.biomaterials.2015.07.014; Jiang Z, 2012, COLLOID SURFACE B, V90, P227, DOI 10.1016/j.colsurfb.2011.10.037; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kershaw NJ, 2015, BIOCHEM J, V468, P159, DOI 10.1042/BJ20150010; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Lim S, 2009, J ADHESION, V85, P812, DOI 10.1080/00218460903291411; Maier GP, 2015, SCIENCE, V349, P628, DOI 10.1126/science.aab0556; Mirshafian R, 2016, BIOCHEMISTRY-US, V55, P743, DOI 10.1021/acs.biochem.5b01177; NARHI LO, 1992, INT J PEPT PROT RES, V39, P182; Ohkawa K, 2004, BIOFOULING, V20, P101, DOI 10.1080/08927010410001681246; Petrone L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9737; Priemel T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14539; Rahimnejad M, 2017, RSC ADV, V7, P47380, DOI 10.1039/c7ra06743g; Rodriguez NRM, 2015, BIOFOULING, V31, P221, DOI 10.1080/08927014.2015.1026337; RZEPECKI LM, 1992, BIOL BULL, V183, P123, DOI 10.2307/1542413; SAEZ C, 1991, COMP BIOCHEM PHYS B, V98, P569, DOI 10.1016/0305-0491(91)90255-C; Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x; Stewart RJ, 2011, J POLYM SCI POL PHYS, V49, P757, DOI 10.1002/polb.22256; Waite JH, 2017, J EXP BIOL, V220, P517, DOI 10.1242/jeb.134056; Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172; Weisshuhn PC, 2016, STRUCTURE, V24, P555, DOI 10.1016/j.str.2016.02.010; Wilker JJ, 2010, CURR OPIN CHEM BIOL, V14, P276, DOI 10.1016/j.cbpa.2009.11.009; Yu J, 2013, BIOMACROMOLECULES, V14, P1072, DOI 10.1021/bm301908y; Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z; Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y; Zhang W, 2017, RSC ADV, V7, P32518, DOI 10.1039/c7ra04228k; Zhang XY, 2017, APPL MATER TODAY, V7, P222, DOI 10.1016/j.apmt.2017.04.001; Zhu WZ, 2018, ACTA BIOMATER, V74, P1, DOI 10.1016/j.actbio.2018.04.034	43	11	13	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12826	12835		10.1074/jbc.RA119.009531	http://dx.doi.org/10.1074/jbc.RA119.009531			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31292195	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000484414600023
J	Huang, XX; LeDuc, RD; Fornelli, L; Schunter, AJ; Bennett, RL; Kelleher, NL; Licht, JD				Huang, Xiaoxiao; LeDuc, Richard D.; Fornelli, Luca; Schunter, Alissa J.; Bennett, Richard L.; Kelleher, Neil L.; Licht, Jonathan D.			Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone methylation; DNA damage; protein complex; proteomics; epigenetics; NSD2; PARP1; PARylation	LYSINE 36; METHYLATION; TRANSCRIPTION; REVEALS; PROTEINS; COMPLEX; GROWTH; CONTRIBUTES; INHIBITORS; REGULATOR	NSD2 is a histone methyltransferase that specifically dimethylates histone H3 lysine 36 (H3K36me2), a modification associated with gene activation. Dramatic overexpression of NSD2 in t(4;14) multiple myeloma (MM) and an activating mutation of NSD2 discovered in acute lymphoblastic leukemia are significantly associated with altered gene activation, transcription, and DNA damage repair. The partner proteins through which NSD2 may influence critical cellular processes remain poorly defined. In this study, we utilized proximity-based labeling (BioID) combined with label-free quantitative MS to identify high confidence NSD2 interacting partners in MM cells. The top 24 proteins identified were involved in maintaining chromatin structure, transcriptional regulation, RNA pre-spliceosome assembly, and DNA damage. Among these, an important DNA damage regulator, poly(ADP-ribose) polymerase 1 (PARP1), was discovered. PARP1 and NSD2 have been found to be recruited to DNA double strand breaks upon damage and H3K36me2 marks are enriched at damage sites. We demonstrate that PARP1 regulates NSD2 via PARylation upon oxidative stress. In vitro assays suggest the PARylation significantly reduces NSD2 histone methyltransferase activity. Furthermore, PARylation of NSD2 inhibits its ability to bind to nucleosomes and further get recruited at NSD2-regulated genes, suggesting PARP1 regulates NSD2 localization and H3K36me2 balance. This work provides clear evidence of cross-talk between PARylation and histone methylation and offers new directions to characterize NSD2 function in DNA damage response, transcriptional regulation, and other pathways.	[Huang, Xiaoxiao; Bennett, Richard L.; Licht, Jonathan D.] Univ Florida, Hlth Canc Ctr, Div Hematol Oncol, Gainesville, FL 32608 USA; [Huang, Xiaoxiao; LeDuc, Richard D.; Fornelli, Luca; Schunter, Alissa J.; Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Huang, Xiaoxiao; LeDuc, Richard D.; Fornelli, Luca; Schunter, Alissa J.; Kelleher, Neil L.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Huang, Xiaoxiao; LeDuc, Richard D.; Fornelli, Luca; Schunter, Alissa J.; Kelleher, Neil L.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Schunter, Alissa J.] Cell Signaling Technol, 3 Trask Lane, Danvers, MA 01923 USA	State University System of Florida; University of Florida; Northwestern University; Northwestern University; Northwestern University	Licht, JD (corresponding author), Univ Florida, Hlth Canc Ctr, Div Hematol Oncol, Gainesville, FL 32608 USA.	jdlicht@ufl.edu	Huang, Xiaoxiao/ABG-2564-2020; Bennett, Richard/ABF-9211-2021; Licht, Jonathan/AAL-9184-2020; Fornelli, Luca/K-7772-2013	Huang, Xiaoxiao/0000-0002-4623-2005; Licht, Jonathan/0000-0002-3942-1369; Fornelli, Luca/0000-0001-6334-1046; LeDuc, Richard/0000-0002-6951-2923; Bennett, Richard/0000-0002-0243-2443	National Institutes of Health [P41 GM108569, R01 CA195732]; Leukemia and Lymphoma Society Specialized Center of Excellence grant; NATIONAL CANCER INSTITUTE [R01CA195732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM108569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Specialized Center of Excellence grant(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 CA195732 (to J.D.L.), a Leukemia and Lymphoma Society Specialized Center of Excellence grant (to J.D.L.), and National Institutes of Health Grant P41 GM108569 (to N.L.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amendola PG, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006632; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett RL, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026708; Brackertz M, 2006, NUCLEIC ACIDS RES, V34, P397, DOI 10.1093/nar/gkj437; Brackertz M, 2002, J BIOL CHEM, V277, P40958, DOI 10.1074/jbc.M207467200; Brown JS, 2016, BRIT J CANCER, V114, P713, DOI 10.1038/bjc.2016.67; Cao LL, 2016, ONCOGENE, V35, P402, DOI 10.1038/onc.2015.311; Caruso Lisa B, 2018, Oncotarget, V9, P10585, DOI 10.18632/oncotarget.24291; Ciccarone F, 2017, SEMIN CELL DEV BIOL, V63, P123, DOI 10.1016/j.semcdb.2016.11.010; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Ding LW, 2017, CANCER RES, V77, P390, DOI 10.1158/0008-5472.CAN-16-1303; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Gagne JP, 2012, NUCLEIC ACIDS RES, V40, P7788, DOI 10.1093/nar/gks486; Gibson BA, 2016, SCIENCE, V353, P45, DOI 10.1126/science.aaf7865; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Hadjikyriacou A, 2015, J BIOL CHEM, V290, P16723, DOI 10.1074/jbc.M115.659433; Nguyen HV, 2017, P NATL ACAD SCI USA, V114, pE10560, DOI 10.1073/pnas.1701366114; Hajdu I, 2011, P NATL ACAD SCI USA, V108, P13130, DOI 10.1073/pnas.1110081108; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Jha DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4965; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Koh DI, 2014, P NATL ACAD SCI USA, V111, P15078, DOI 10.1073/pnas.1318780111; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Le May N, 2012, MOL CELL, V48, P785, DOI 10.1016/j.molcel.2012.09.021; Li X, 2014, P NATL ACAD SCI USA, V111, P7096, DOI 10.1073/pnas.1324036111; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Martiniano R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10326; Min DJ, 2013, LEUKEMIA, V27, P686, DOI 10.1038/leu.2012.269; Mirabella F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.9; Oyer JA, 2014, LEUKEMIA, V28, P198, DOI 10.1038/leu.2013.204; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Park JW, 2018, ONCOGENE, V37, P6212, DOI 10.1038/s41388-018-0393-y; Pei HD, 2013, J IMMUNOL, V190, P756, DOI 10.4049/jimmunol.1201811; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Roux K. J., 2013, CURR PROTOC PROTEIN, V74; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sarai N, 2013, EMBO J, V32, P2392, DOI 10.1038/emboj.2013.176; Shah MY, 2016, ONCOGENE, V35, P5905, DOI 10.1038/onc.2016.116; Swaroop A, 2019, ONCOGENE, V38, P671, DOI 10.1038/s41388-018-0474-y; Wildburger NC., 2015, EUPA OPEN PROTEOMICS, V8, P94, DOI [DOI 10.1016/J.EUPROT.2015.06.006, 10.1016/j.euprot.2015.06.006]; Wildburger NC, 2015, MOL CELL PROTEOMICS, V14, P1288, DOI 10.1074/mcp.M114.040055; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Yamaguchi H, 2018, ONCOGENE, V37, P208, DOI 10.1038/onc.2017.311; Zhang JH, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.824.824; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhen YL, 2018, BIOCHEMISTRY-US, V57, P429, DOI 10.1021/acs.biochem.7b01022; Zheng YP, 2012, P NATL ACAD SCI USA, V109, P13549, DOI 10.1073/pnas.1205707109	56	9	10	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12459	12471		10.1074/jbc.RA118.006159	http://dx.doi.org/10.1074/jbc.RA118.006159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248990	hybrid, Green Published			2022-12-28	WOS:000484402700017
J	Talmon, M; Rossi, S; Lim, D; Pollastro, F; Palattella, G; Ruffinatti, FA; Marotta, P; Boldorini, R; Genazzani, AA; Fresu, LG				Talmon, Maria; Rossi, Silvia; Lim, Dmitry; Pollastro, Federica; Palattella, Gioele; Ruffinatti, Federico A.; Marotta, Patrizia; Boldorini, Renzo; Genazzani, Armando A.; Fresu, Luigia G.			Absinthin, an agonist of the bitter taste receptor hTAS2R46, uncovers an ER-to-mitochondria Ca2+-shuttling event	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; intracellular calcium release; smooth muscle; signal transduction; mitochondria; airway smooth muscle; asthma; mitochondrial calcium; bitter taste receptors; cell signaling; type 2 taste receptor (TAS2R); bronchodilator	AIRWAY SMOOTH-MUSCLE; SESQUITERPENE LACTONES; RETICULUM INTERACTIONS; INTRACELLULAR CA2+; PLASMA-MEMBRANE; CAMP; OSCILLATIONS; COMPARTMENTS; AEQUORIN; CELLS	Type 2 taste receptors (TAS2R) are G protein-coupled receptors first described in the gustatory system, but have also been shown to have extraoral localizations, including airway smooth muscle (ASM) cells, in which TAS2R have been reported to induce relaxation. TAS2R46 is an unexplored subtype that responds to its highly specific agonist absinthin. Here, we first demonstrate that, unlike other bitter-taste receptor agonists, absinthin alone (1 mu m) in ASM cells does not induce Ca2+ signals but reduces histamine-induced cytosolic Ca2+ increases. To investigate this mechanism, we introduced into ASM cells aequorin-based Ca2+ probes targeted to the cytosol, subplasma membrane domain, or the mitochondrial matrix. We show that absinthin reduces cytosolic histamine-induced Ca2+ rises and simultaneously increases Ca2+ influx into mitochondria. We found that this effect is inhibited by the potent human TAS2R46 (hTAS2R46) antagonist 3 beta-hydroxydihydrocostunolide and is no longer evident in hTAS2R46-silenced ASM cells, indicating that it is hTAS2R46-dependent. Furthermore, these changes were sensitive to the mitochondrial uncoupler carbonyl cyanide p-(trifluoromethoxy)phenyl-hydrazone (FCCP); the mitochondrial calcium uniporter inhibitor KB-R7943 (carbamimidothioic acid); the cytoskeletal disrupter latrunculin; and an inhibitor of the exchange protein directly activated by cAMP (EPAC), ESI-09. Similarly, the beta 2 agonist salbutamol also could induce Ca2+ shuttling from cytoplasm to mitochondria, suggesting that this new mechanism might be generalizable. Moreover, forskolin and an EPAC activator mimicked this effect in HeLa cells. Our findings support the hypothesis that plasma membrane receptors can positively regulate mitochondrial Ca2+ uptake, adding a further facet to the ability of cells to encode complex Ca2+ signals.	[Talmon, Maria; Rossi, Silvia; Palattella, Gioele; Boldorini, Renzo; Fresu, Luigia G.] Univ Piemonte Orientale, Sch Med, Dept Hlth Sci, Via Solaroli 17, I-28100 Novara, Italy; [Lim, Dmitry; Pollastro, Federica; Ruffinatti, Federico A.; Marotta, Patrizia; Genazzani, Armando A.] Univ Piemonte Orientale, Dept Pharmaceut Sci, Via Bovio 6, I-28100 Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Fresu, LG (corresponding author), Univ Piemonte Orientale, Sch Med, Dept Hlth Sci, Via Solaroli 17, I-28100 Novara, Italy.; Genazzani, AA (corresponding author), Univ Piemonte Orientale, Dept Pharmaceut Sci, Via Bovio 6, I-28100 Novara, Italy.	armando.genazzani@uniupo.it; luigia.fresu@med.uniupo.it	RUFFINATTI, FEDERICO ALESSANDRO/ABA-8065-2020; Genazzani, Armando/AAI-8280-2020; BOLDORINI, Renzo Luciano/J-5330-2016	RUFFINATTI, FEDERICO ALESSANDRO/0000-0002-3084-0380; Pollastro, Federica/0000-0002-0949-2799; BOLDORINI, Renzo Luciano/0000-0003-1183-2737; Genazzani, Armando/0000-0003-1923-7430; Talmon, Maria/0000-0002-3914-5034	Regione Piemonte Grant on Autoimmunity and Allergic Diseases D.D. [195 18/07/2014]	Regione Piemonte Grant on Autoimmunity and Allergic Diseases D.D.	This work was supported by Regione Piemonte Grant on Autoimmunity and Allergic Diseases D.D. n. 195 18/07/2014 (to L.G.F.). The authors declare that they have no conflicts of interest with the contents of this article.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; An SS, 2017, CELL SIGNAL, V41, P82, DOI 10.1016/j.cellsig.2017.02.002; Bachmanov AA, 2009, AM J CLIN NUTR, V90, p756S, DOI 10.3945/ajcn.2009.27462L; Bai Y, 2016, AM J RESP CELL MOL, V54, P656, DOI 10.1165/rcmb.2015-0290MA; BEAUHAIRE J, 1980, TETRAHEDRON LETT, V21, P3191, DOI 10.1016/S0040-4039(00)77442-9; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Belvisi MG, 2011, NAT MED, V17, P776, DOI [10.1038/nm0711-776a, 10.1038/nm0711-776b]; Billington CK, 2017, HANDB EXP PHARMACOL, V237, P23, DOI 10.1007/164_2016_64; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 1999, MICROSC RES TECHNIQ, V46, P380, DOI 10.1002/(SICI)1097-0029(19990915)46:6<380::AID-JEMT6>3.0.CO;2-Y; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Brockhoff A, 2011, J NEUROSCI, V31, P14775, DOI 10.1523/JNEUROSCI.2923-11.2011; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Camoretti-Mercado B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131582; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Cieri D, 2018, CELL DEATH DIFFER, V25, P1131, DOI 10.1038/s41418-017-0033-z; Colombini M, 2016, BBA-MOL CELL RES, V1863, P2498, DOI 10.1016/j.bbamcr.2016.01.019; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dale P, 2018, CELL CALCIUM, V71, P53, DOI 10.1016/j.ceca.2017.12.002; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Devin A, 2007, AM J PHYSIOL-CELL PH, V292, pC52, DOI 10.1152/ajpcell.00208.2006; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fazal L, 2017, CIRC RES, V120, P645, DOI 10.1161/CIRCRESAHA.116.309859; Grassin-Delyle S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-134; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; He X, 2015, ARTERIOSCL THROM VAS, V35, P1623, DOI 10.1161/ATVBAHA.115.305469; Liggett SB, 2013, EXPERT OPIN THER TAR, V17, P721, DOI 10.1517/14728222.2013.782395; Lim D, 2016, CELL CALCIUM, V59, P228, DOI 10.1016/j.ceca.2016.03.001; LUSH IE, 1995, GENET RES, V66, P167, DOI 10.1017/S0016672300034510; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mishra J, 2017, HANDB EXP PHARMACOL, V240, P129, DOI 10.1007/164_2017_1; Paillard M, 2013, CIRCULATION, V128, P1555, DOI 10.1161/CIRCULATIONAHA.113.001225; Pan S, 2017, AM J PHYSIOL-LUNG C, V313, pL154, DOI 10.1152/ajplung.00106.2017; Parekh AB, 2003, NEWS PHYSIOL SCI, V18, P252, DOI 10.1152/nips.01458.2003; Pulkkinen V, 2012, AM J PHYSIOL-LUNG C, V303, pL956, DOI 10.1152/ajplung.00205.2012; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Robinett KS, 2014, AM J RESP CELL MOL, V50, P678, DOI 10.1165/rcmb.2013-0439RC; Santo-Domingo J, 2007, BRIT J PHARMACOL, V151, P647, DOI 10.1038/sj.bjp.0707260; SAUVE R, 1991, CELL CALCIUM, V12, P165, DOI 10.1016/0143-4160(91)90018-A; Szanda G, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215178; Tan XH, 2014, BRIT J PHARMACOL, V171, P646, DOI 10.1111/bph.12460; Taylor CW, 2017, CELL CALCIUM, V63, P48, DOI 10.1016/j.ceca.2016.10.005; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Wang Z, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.106; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501	50	10	10	6	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12472	12482		10.1074/jbc.RA119.007763	http://dx.doi.org/10.1074/jbc.RA119.007763			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248983	hybrid, Green Published			2022-12-28	WOS:000484402700018
J	Parakala, ML; Zhang, YH; Modgil, A; Chadchankar, J; Vien, TN; Ackley, MA; Doherty, JJ; Davies, PA; Moss, SJ				Parakala, Manasa L.; Zhang, Yihui; Modgil, Amit; Chadchankar, Jayashree; Vien, Thuy N.; Ackley, Michael A.; Doherty, James J.; Davies, Paul A.; Moss, Stephen J.			Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABA(A) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GABA receptor; phosphorylation; gamma-aminobutyric acid (GABA); progesterone; protein phosphorylation; neurosteroid; tonic inhibition; membrane protein; epilepsy; neurotransmission; neuroactive steroid; membrane progesterone receptor (mPR)	KINASE-C ACTIVITY; PROTEIN-KINASE; SYNAPTIC INHIBITION; MEMBRANE INSERTION; MODULATION; BRAIN; INVOLVEMENT; ALPHA; TRAFFICKING; EFFICACY	Neuroactive steroids (NASs) are synthesized within the brain and exert profound effects on behavior. These effects are primarily believed to arise from the activities of NASs as positive allosteric modulators (PAMs) of the GABA-type A receptor (GABA(A)R). NASs also activate a family of G protein-coupled receptors known as membrane progesterone receptors (mPRs). Here, using surface-biotinylation assays and electrophysiology techniques, we examined mPRs' role in mediating the effects of NAS on the efficacy of GABAergic inhibition. Selective mPR activation enhanced phosphorylation of Ser-408 and Ser-409 (Ser-408/9) within the GABA(A)R beta 3 subunit, which depended on the activity of cAMP-dependent protein kinase A (PKA) and protein kinase C (PKC). mPR activation did not directly modify GABA(A)R activity and had no acute effects on phasic or tonic inhibition. Instead, mPR activation induced a sustained elevation in tonic current, which was blocked by PKA and PKC inhibition. Substitution of Ser-408/9 to alanine residues also prevented the effects of mPR activation on tonic current. Furthermore, this substitution abolished the effects of sustained NAS exposure on tonic inhibition. Interestingly, the allosteric effects of NAS on GABAergic inhibition were independent of Ser-408/9 in the beta 3 subunit. Additionally, although allosteric effects of NAS on GABAergic inhibition were sensitive to a recently developed NAS antagonist, the sustained effects of NAS on tonic inhibition were not. We conclude that metabotropic effects of NAS on GABAergic inhibition are mediated by mPR-dependent modulation of GABA(A)R phosphorylation. We propose that this mechanism may contribute to the varying behavioral effects of NAS.	[Parakala, Manasa L.; Zhang, Yihui; Modgil, Amit; Chadchankar, Jayashree; Vien, Thuy N.; Davies, Paul A.; Moss, Stephen J.] Tufts Univ, Dept Neurosci, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA; [Ackley, Michael A.; Doherty, James J.] Sage Therapeut, Cambridge, MA 02142 USA; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	Tufts University; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Dept Neurosci, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	Stephen.Moss@Tufts.edu	Davies, Paul A/P-4595-2017	Davies, Paul A/0000-0002-3973-3143	NINDS, National Institutes of Health (NIH) [NS051195, NS056359, NS081735, R21NS080064, NS087662]; NIMH, NIH [MH097446]	NINDS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by NINDS, National Institutes of Health (NIH), Grants NS051195, NS056359, NS081735, R21NS080064, and NS087662 and NIMH, NIH, Grant MH097446. To whom correspondence should be addressed: Dept. of Neuroscience, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111. Tel.: 617-636-3976; Fax: 617-636-2413; E-mail:Stephen.Moss@Tufts.edu.	Abramian AM, 2014, P NATL ACAD SCI USA, V111, P7132, DOI 10.1073/pnas.1403285111; Abramian AM, 2010, J BIOL CHEM, V285, P41795, DOI 10.1074/jbc.M110.149229; Adams JM, 2015, NEUROPHARMACOLOGY, V88, P63, DOI 10.1016/j.neuropharm.2014.09.021; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brown AR, 2015, J PHYSIOL-LONDON, V593, P267, DOI 10.1113/jphysiol.2014.280263; Collier PN, 2015, J MED CHEM, V58, P517, DOI 10.1021/jm500362j; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; El Bitar F, 2014, PSYCHOPHARMACOLOGY, V231, P3293, DOI 10.1007/s00213-014-3435-3; Fernandes MS, 2008, STEROIDS, V73, P942, DOI 10.1016/j.steroids.2007.12.004; Foster H, 2010, MOL MED REP, V3, P27, DOI 10.3892/mmr_00000214; Hanson E, 2019, J NEUROSCI, V39, P3611, DOI 10.1523/JNEUROSCI.1392-18.2019; Hines RM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05481-1; Hosie AM, 2009, NEUROPHARMACOLOGY, V56, P149, DOI 10.1016/j.neuropharm.2008.07.050; Johansson M, 2018, PSYCHOPHARMACOLOGY, V235, P1533, DOI 10.1007/s00213-018-4864-1; Johansson M, 2015, AM J PHYSIOL-GASTR L, V309, pG400, DOI 10.1152/ajpgi.00073.2015; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kanes S, 2017, LANCET, V390, P480, DOI 10.1016/S0140-6736(17)31264-3; Kasubuchi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05423-9; Kelder J, 2010, STEROIDS, V75, P314, DOI 10.1016/j.steroids.2010.01.010; Kretschmannova K, 2013, J NEUROSCI, V33, P7264, DOI 10.1523/JNEUROSCI.5475-12.2013; Krietsch T, 2006, MOL ENDOCRINOL, V20, P3146, DOI 10.1210/me.2006-0129; Laverty D, 2017, NAT STRUCT MOL BIOL, V24, P977, DOI 10.1038/nsmb.3477; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Mendell AL, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00359; Mitchell EA, 2008, NEUROCHEM INT, V52, P588, DOI 10.1016/j.neuint.2007.10.007; Modgil A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00015; Modgil A, 2017, NEUROPHARMACOLOGY, V113, P314, DOI 10.1016/j.neuropharm.2016.10.010; Nakamura Y, 2015, ADV PHARMACOL, V72, P97, DOI 10.1016/bs.apha.2014.11.008; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Pang YF, 2013, ENDOCRINOLOGY, V154, P283, DOI 10.1210/en.2012-1772; Stefanits H, 2018, J COMP NEUROL, V526, P324, DOI 10.1002/cne.24337; Terunuma M, 2008, J NEUROSCI, V28, P376, DOI 10.1523/JNEUROSCI.4346-07.2008; Thomas P, 2017, MOL CELL ENDOCRINOL, V447, P23, DOI 10.1016/j.mce.2017.02.025; Thomas P, 2012, NEUROENDOCRINOLOGY, V96, P162, DOI 10.1159/000339822; Vien TN, 2016, ANESTH ANALG, V123, P1220, DOI 10.1213/ANE.0000000000001349; Vien TN, 2015, P NATL ACAD SCI USA, V112, P14805, DOI 10.1073/pnas.1514657112; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100	40	23	23	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12220	12230		10.1074/jbc.RA119.008875	http://dx.doi.org/10.1074/jbc.RA119.008875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31239352	Green Published, hybrid			2022-12-28	WOS:000484284500024
J	Bhattacharya, S; Stanley, CB; Heller, WT; Friedman, PA; Bu, ZM				Bhattacharya, Shibani; Stanley, Christopher B.; Heller, William T.; Friedman, Peter A.; Bu, Zimei			Dynamic structure of the full-length scaffolding protein NHERF1 influences signaling complex assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						scaffold protein; neutron scattering; nuclear magnetic resonance (NMR); PDZ domain; ezrin; GRK6A; NHERF1	EXCHANGER REGULATORY FACTOR; TANDEM PDZ DOMAINS; X-RAY; NEUTRON-SCATTERING; BINDING; EZRIN; ASSOCIATION; EBP50; NMR; AUTOINHIBITION	The Na+/H+ exchange regulatory cofactor 1 (NHERF1) protein modulates the assembly and intracellular trafficking of several transmembrane G protein-coupled receptors (GPCRs) and ion transport proteins with the membrane-cytoskeleton adapter protein ezrin. Here, we applied solution NMR and small-angle neutron scattering (SANS) to structurally characterize full-length NHERF1 and disease-associated variants that are implicated in impaired phosphate homeostasis. Using NMR, we mapped the modular architecture of NHERF1, which is composed of two structurally-independent PDZ domains that are connected by a flexible, disordered linker. We observed that the ultra-long and disordered C-terminal tail of NHERF1 has a type 1 PDZ-binding motif that interacts weakly with the proximal, second PDZ domain to form a dynamically autoinhibited structure. Using ensemble-optimized analysis of SANS data, we extracted the molecular size distribution of structures from the extensive conformational space sampled by the flexible chain. Our results revealed that NHERF1 is a diffuse ensemble of variable PDZ domain configurations and a disordered C-terminal tail. The joint NMR/SANS data analyses of three disease variants (L110V, R153Q, and E225K) revealed significant differences in the local PDZ domain structures and in the global conformations compared with the WT protein. Furthermore, we show that the substitutions affect the affinity and kinetics of NHERF1 binding to ezrin and to a C-terminal peptide from G protein-coupled receptor kinase 6A (GRK6A). These findings provide important insight into the modulation of the intrinsic flexibility of NHERF1 by disease-associated point mutations that alter the dynamic assembly of signaling complexes.	[Bhattacharya, Shibani] New York Struct Biol Ctr, New York, NY 10027 USA; [Stanley, Christopher B.; Heller, William T.] Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN 37830 USA; [Friedman, Peter A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Bu, Zimei] CUNY City Coll, Dept Chem & Biochem, New York, NY 10031 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; City University of New York (CUNY) System; City College of New York (CUNY)	Bhattacharya, S (corresponding author), New York Struct Biol Ctr, New York, NY 10027 USA.; Friedman, PA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.; Bu, ZM (corresponding author), CUNY City Coll, Dept Chem & Biochem, New York, NY 10031 USA.	sbhattacharya@nysbc.org; paf10@pitt.edu; zbu@ccny.cuny.edu	Heller, William/ABE-1104-2020; Stanley, Christopher/AAC-2732-2022	Heller, William/0000-0001-6456-2975; Stanley, Christopher/0000-0002-4226-7710	National Institutes of Health [P41GM111135]; Keck Foundation, New York State Assembly [P41GM066354]; United States Department of Defense; NCRR; Biomedical Technology Research Resource (BTRR); NIGMS; Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation, New York State Assembly; United States Department of Defense(United States Department of Defense); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Research Resource (BTRR); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The data collected at New York Structural Biology Center was made possible by ORIP/National Institutes of Health Facility Improvement Grants CO6RR015495 and S10OD016432 (800 MHz). The 900 MHz NMR spectrometers were purchased with funds from National Institutes of Health Grant P41GM066354, the Keck Foundation, New York State Assembly, the United States Department of Defense, and National Institutes of Health Grant 2G12 RR003060 from the NCRR to City College of New York. This study made use of NMRbox: National Center for Biomolecular NMR Data Processing and Analysis, a Biomedical Technology Research Resource (BTRR), supported by National Institutes of Health Grant P41GM111135 from NIGMS. A portion of the research conducted at ORNL's Spallation Neutron Source was sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy. We thank Carrie Gao for technical support during the SANS experiments.	Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Arnold O, 2014, NUCL INSTRUM METH A, V764, P156, DOI 10.1016/j.nima.2014.07.029; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bhattacharya S, 2005, BIOCHEMISTRY-US, V44, P9462, DOI 10.1021/bi0502689; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Borcherds W, 2017, BIOPHYS J, V112, P2038, DOI 10.1016/j.bpj.2017.04.017; Callaway DJE, 2017, J MOL BIOL, V429, P987, DOI 10.1016/j.jmb.2017.03.003; Callaway DJE, 2017, CURR OPIN STRUC BIOL, V42, P1, DOI 10.1016/j.sbi.2016.10.001; Cheng H, 2009, STRUCTURE, V17, P660, DOI 10.1016/j.str.2009.03.009; Deshmukh L, 2016, CHEMPHYSCHEM, V17, P1548, DOI 10.1002/cphc.201600212; Deshmukh L, 2013, J AM CHEM SOC, V135, P16133, DOI 10.1021/ja406246z; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Farago B, 2010, BIOPHYS J, V99, P3473, DOI 10.1016/j.bpj.2010.09.058; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; Garbett D, 2014, MOL BIOL CELL, V25, P2315, DOI 10.1091/mbc.E14-04-0878; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; Georgescu MM, 2008, CURR MOL MED, V8, P459, DOI 10.2174/156652408785748031; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Harris BZ, 2001, J CELL SCI, V114, P3219; Hertig S, 2015, BIOPHYS J, V108, P2097, DOI 10.1016/j.bpj.2015.03.051; Holcomb J, 2014, BIOCHEM BIOPH RES CO, V448, P169, DOI 10.1016/j.bbrc.2014.04.085; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jayasundar JJ, 2012, J BIOL CHEM, V287, P37119, DOI 10.1074/jbc.M112.380972; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Keller R., 2004, THESIS; Laederach A, 2003, J MOL BIOL, V329, P1011, DOI 10.1016/S0022-2836(03)00531-X; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Loureiro CA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1580; Mamonova T, 2017, BIOCHEMISTRY-US, V56, P2584, DOI 10.1021/acs.biochem.7b00078; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Nielsen JT, 2018, J BIOMOL NMR, V70, P141, DOI 10.1007/s10858-018-0166-5; Pan Y, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1616; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Perkins SJ, 2016, J APPL CRYSTALLOGR, V49, P1861, DOI 10.1107/S160057671601517X; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schwieters CD, 2018, PROTEIN SCI, V27, P26, DOI 10.1002/pro.3248; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shen Y, 2015, METHODS MOL BIOL, V1260, P17, DOI 10.1007/978-1-4939-2239-0_2; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Theillet Francois-Xavier, 2013, Intrinsically Disord Proteins, V1, pe24360, DOI 10.4161/idp.24360; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Uversky Vladimir N, 2015, Intrinsically Disord Proteins, V3, pe1027032, DOI 10.1080/21690707.2015.1027032; Uversky Vladimir N, 2013, Intrinsically Disord Proteins, V1, pe24684, DOI 10.4161/idp.24684; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022; Zhang QM, 2019, J BIOL CHEM, V294, P4546, DOI 10.1074/jbc.RA119.007421; Zhao JK, 2010, J APPL CRYSTALLOGR, V43, P1068, DOI 10.1107/S002188981002217X; Zhou HX, 2006, BIOPHYS J, V91, P3170, DOI 10.1529/biophysj.106.090258	65	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11297	11310		10.1074/jbc.RA119.008218	http://dx.doi.org/10.1074/jbc.RA119.008218			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31171716	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000478717400020
J	Nihalani, D; Solanki, AK; Arif, E; Srivastava, P; Rahman, B; Zuo, XF; Dang, YJ; Fogelgren, B; Fermin, D; Gillies, CE; Sampson, MG; Lipschutz, JH				Nihalani, Deepak; Solanki, Ashish K.; Arif, Ehtesham; Srivastava, Pankaj; Rahman, Bushra; Zuo, Xiaofeng; Dang, Yujing; Fogelgren, Ben; Fermin, Damian; Gillies, Christopher E.; Sampson, Matthew G.; Lipschutz, Joshua H.			Disruption of the exocyst induces podocyte loss and dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						trafficking; cilia; photoreceptor; podocyte; endocytosis; ciliopathy; connecting cilium; exocyst; photoreceptor; protein trafficking	DIAPHRAGM PROTEIN NEPH1; PRIMARY CILIOGENESIS; NEPHROTIC SYNDROME; SIGNALING PATHWAY; ACTIN; COMPLEX; CDC42; CYSTOGENESIS; ARCHITECTURE; NEPHROPATHY	Although the slit diaphragm proteins in podocytes are uniquely organized to maintain glomerular filtration assembly and function, little is known about the underlying mechanisms that participate in trafficking these proteins to the correct location for development and homeostasis. Identifying these mechanisms will likely provide novel targets for therapeutic intervention to preserve podocyte function following glomerular injury. Analysis of structural variation in cases of human nephrotic syndrome identified rare heterozygous deletions of EXOC4 in two patients. This suggested that disruption of the highly-conserved eight-protein exocyst trafficking complex could have a role in podocyte dysfunction. Indeed, mRNA profiling of injured podocytes identified significant exocyst down-regulation. To test the hypothesis that the exocyst is centrally involved in podocyte development/function, we generated homozygous podocyte-specific Exoc5 (a central exocyst component that interacts with Exoc4) knockout mice that showed massive proteinuria and died within 4 weeks of birth. Histological and ultrastructural analysis of these mice showed severe glomerular defects with increased fibrosis, proteinaceous casts, effaced podocytes, and loss of the slit diaphragm. Immunofluorescence analysis revealed that Neph1 and Nephrin, major slit diaphragm constituents, were mislocalized and/or lost. mRNA profiling of Exoc5 knockdown podocytes showed that vesicular trafficking was the most affected cellular event. Mapping of signaling pathways and Western blot analysis revealed significant up-regulation of the mitogen-activated protein kinase and transforming growth factor-beta pathways in Exoc5 knockdown podocytes and in the glomeruli of podocyte-specific Exoc5 KO mice. Based on these data, we propose that exocyst-based mechanisms regulate Neph1 and Nephrin signaling and trafficking, and thus podocyte development and function.	[Nihalani, Deepak; Solanki, Ashish K.; Arif, Ehtesham; Srivastava, Pankaj; Rahman, Bushra; Zuo, Xiaofeng; Dang, Yujing; Lipschutz, Joshua H.] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Fogelgren, Ben] Univ Hawaii Manoa, Dept Anat Biochem & Physiol, Honolulu, HI 96813 USA; [Fermin, Damian; Gillies, Christopher E.; Sampson, Matthew G.] Univ Michigan, Dept Pediat Nephrol, Ann Arbor, MI 48109 USA; [Sampson, Matthew G.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29401 USA	Medical University of South Carolina; University of Hawaii System; University of Hawaii Manoa; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Nihalani, D (corresponding author), Med Univ South Carolina, 96 Jonathan Lucas St,CSB 829, Charleston, SC 29425 USA.	nihalani@musc.edu	nihalani, deepak/AAK-9453-2020; Arif, Ehtesham/AAV-8272-2020; Solanki, Ashish K/F-5210-2017	Solanki, Ashish K/0000-0002-5043-1699; Nihalani, Deepak/0000-0002-7343-6169; Arif, Ehtesham/0000-0001-9638-3189	Veterans Affairs Merit Award [I01 BX000820]; National Institutes of Health [P30DK074038, R01DK087956, RO1DK108805]; South Carolina SmartState Centers of Excellence Endowment; SCTR NIH/NCATS Grant [5UL1TR001450]; Ben J. Lipps Research Fellowship from the American Society of Nephrology; Charles Woodson Clinical Research Fund; Ravitz Foundation; American Heart Association AWRP Winter 2017 Collaborative Sciences Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK117308, P30DK074038, U54DK083912, R01DK087956, R01DK108805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000820] Funding Source: NIH RePORTER	Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina SmartState Centers of Excellence Endowment; SCTR NIH/NCATS Grant; Ben J. Lipps Research Fellowship from the American Society of Nephrology; Charles Woodson Clinical Research Fund; Ravitz Foundation; American Heart Association AWRP Winter 2017 Collaborative Sciences Award(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by Veterans Affairs Merit Award I01 BX000820 (to J. H. L.), National Institutes of Health Grants P30DK074038 (to J. H. L.), R01DK087956 (to D. N.), and RO1DK108805 (to M. G. S.), South Carolina SmartState Centers of Excellence Endowment (to D. N.), SCTR NIH/NCATS Grant 5UL1TR001450 (to D. N. and E. A.), the American Heart Association AWRP Winter 2017 Collaborative Sciences Award (to J. H. L.), the Ben J. Lipps Research Fellowship from the American Society of Nephrology (to A. K. S.), the Charles Woodson Clinical Research Fund (to M. G. S.), and the Ravitz Foundation (to M. G. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal S, 2014, KIDNEY INT, V86, P1150, DOI 10.1038/ki.2014.196; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Arif E, 2011, MOL CELL BIOL, V31, P2134, DOI 10.1128/MCB.05051-11; Arif E, 2019, KIDNEY INT, V96, P139, DOI 10.1016/j.kint.2019.02.014; Arif E, 2016, MOL CELL BIOL, V36, P1639, DOI 10.1128/MCB.00020-16; Arif E, 2014, J BIOL CHEM, V289, P9502, DOI 10.1074/jbc.M113.505743; Assady S, 2017, J AM SOC NEPHROL, V28, P1707, DOI 10.1681/ASN.2017010027; Blattner SM, 2013, KIDNEY INT, V84, P920, DOI 10.1038/ki.2013.175; Choi SY, 2013, J AM SOC NEPHROL, V24, P1435, DOI 10.1681/ASN.2012121236; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Fogelgren B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129346; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Gadegbeku CA, 2013, KIDNEY INT, V83, P749, DOI 10.1038/ki.2012.428; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; George B, 2012, SEMIN NEPHROL, V32, P307, DOI 10.1016/j.semnephrol.2012.06.002; Grahammer F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86177; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hattori Seisuke, 2011, J Signal Transduct, V2011, P317852, DOI 10.1155/2011/317852; Herman-Edelstein M, 2013, CURR OPIN NEPHROL HY, V22, P93, DOI 10.1097/MNH.0b013e32835b4870; Hulkko J, 2014, NEPHRON EXTRA, V4, P146, DOI 10.1159/000365091; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Kim JH, 2003, KIDNEY INT, V64, P1715, DOI 10.1046/j.1523-1755.2003.00288.x; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lennon JC, 2016, INVEST NEW DRUG, V34, P663, DOI 10.1007/s10637-016-0366-3; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Lobo GP, 2017, J BIOL CHEM, V292, P14814, DOI 10.1074/jbc.M117.795674; Mei KR, 2018, NAT STRUCT MOL BIOL, V25, P139, DOI 10.1038/s41594-017-0016-2; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Ozkan E, 2014, CELL, V156, P482, DOI 10.1016/j.cell.2014.01.004; Perico L, 2016, NAT REV NEPHROL, V12, P692, DOI 10.1038/nrneph.2016.127; Picco A, 2017, CELL, V168, P400, DOI 10.1016/j.cell.2017.01.004; Robins R, 2015, AM J PHYSIOL-RENAL, V308, pF1207, DOI 10.1152/ajprenal.00225.2014; Sagar A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12134-8; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Solanki AK, 2018, KIDNEY INT REP, V3, P1443, DOI 10.1016/j.ekir.2018.06.003; Srivastava P, 2019, KIDNEY INT, V95, P708, DOI 10.1016/j.kint.2018.10.030; Swiatecka-Urban A, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00032; Takei R, 2018, BIOL OPEN, V7, DOI 10.1242/bio.033241; Toikkanen JH, 2003, J BIOL CHEM, V278, P20946, DOI 10.1074/jbc.M213111200; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Velez JCQ, 2017, J AM SOC NEPHROL, V28, P2119, DOI 10.1681/ASN.2016111166; Verbitsky M, 2015, J CLIN INVEST, V125, P2171, DOI 10.1172/JCI80877; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Wagner MC, 2008, J BIOL CHEM, V283, P35579, DOI 10.1074/jbc.M805507200; Yoder BK, 1995, P ASSOC AM PHYSICIAN, V107, P314; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	55	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10104	10119		10.1074/jbc.RA119.008362	http://dx.doi.org/10.1074/jbc.RA119.008362			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31073028	Green Published, hybrid			2022-12-28	WOS:000474445600006
J	dos Reis, LM; Adamoski, D; Souza, ROO; Ascencao, CFR; de Oliveira, KRS; Correa-da-Silva, F; de Sa Patroni, FM; Dias, MM; Consonni, SR; de Moraes-Vieira, PMM; Silber, AM; Dias, SMG				dos Reis, Larissa Menezes; Adamoski, Douglas; Oliveira Souza, Rodolpho Ornitz; Rodrigues Ascencao, Carolline Fernanda; Sousa de Oliveira, Krishina Ratna; Correa-da-Silva, Felipe; de Sa Patroni, Fabio Malta; Dias, Marilia Meira; Consonni, Silvio Roberto; Mendes de Moraes-Vieira, Pedro Manoel; Silber, Ariel Mariano; Gomes Dias, Sandra Martha			Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glutaminase; breast cancer; -oxidation; energy metabolism; cancer therapy; CB-839; CPT1; CPT2; etomoxir	FATTY-ACID OXIDATION; ACTIVATED PROTEIN-KINASE; TUMOR-GROWTH; METABOLISM; GLUTAMINOLYSIS; MECHANISM; HALLMARKS; PHOSPHORYLATION; EXPRESSION; PHENOTYPE	Triple-negative breast cancers (TNBCs) lack progesterone and estrogen receptors and do not have amplified human epidermal growth factor receptor 2, the main therapeutic targets for managing breast cancer. TNBCs have an altered metabolism, including an increased Warburg effect and glutamine dependence, making the glutaminase inhibitor CB-839 therapeutically promising for this tumor type. Accordingly, CB-839 is currently in phase I/II clinical trials. However, not all TNBCs respond to CB-839 treatment, and the tumor resistance mechanism is not yet fully understood. Here we classified cell lines as CB-839-sensitive or -resistant according to their growth responses to CB-839. Compared with sensitive cells, resistant cells were less glutaminolytic and, upon CB-839 treatment, exhibited a smaller decrease in ATP content and less mitochondrial fragmentation, an indicator of poor mitochondrial health. Transcriptional analyses revealed that the expression levels of genes linked to lipid metabolism were altered between sensitive and resistant cells and between breast cancer tissues (available from The Cancer Genome Atlas project) with low versus high glutaminase (GLS) gene expression. Of note, CB-839-resistant TNBC cells had increased carnitine palmitoyltransferase 2 (CPT2) protein and CPT1 activity levels. In agreement, CB-839-resistant TNBC cells mobilized more fatty acids into mitochondria for oxidation, which responded to AMP-activated protein kinase and acetyl-CoA carboxylase signaling. Moreover, chemical inhibition of both glutaminase and CPT1 decreased cell proliferation and migration of CB-839-resistant cells compared with single inhibition of each enzyme. We propose that dual targeting of glutaminase and CPT1 activities may have therapeutic relevance for managing CB-839-resistant tumors.	[dos Reis, Larissa Menezes; Adamoski, Douglas; Rodrigues Ascencao, Carolline Fernanda; Sousa de Oliveira, Krishina Ratna; de Sa Patroni, Fabio Malta; Dias, Marilia Meira; Gomes Dias, Sandra Martha] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, BR-13083970 Campinas, SP, Brazil; [dos Reis, Larissa Menezes; Adamoski, Douglas; Rodrigues Ascencao, Carolline Fernanda; Sousa de Oliveira, Krishina Ratna; Correa-da-Silva, Felipe; de Sa Patroni, Fabio Malta] Univ Estadual Campinas, Inst Biol, Grad Program Genet & Mol Biol, BR-13083970 Campinas, SP, Brazil; [Oliveira Souza, Rodolpho Ornitz; Silber, Ariel Mariano] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Lab Biochem Tryps, BR-05508000 Sao Paulo, SP, Brazil; [Correa-da-Silva, Felipe; Mendes de Moraes-Vieira, Pedro Manoel] Univ Estadual Campinas, Inst Biol, Lab Immunometab, Dept Genet Evolut Microbiol & Immunol, BR-13083970 Campinas, SP, Brazil; [Consonni, Silvio Roberto] Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, Lab Cytochem & Immunocytochem, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Dias, SMG (corresponding author), CNPEM, Lab Nacl Biociencias, Rua Giuseppe Maximo Scolfaro, BR-13083100 Campinas, SP, Brazil.	sandra.dias@lnbio.cnpem.br	Adamoski, Douglas/J-8570-2014; Consonni, Sílvio Roberto/R-9281-2019; Dias, Sandra/AAB-7042-2019; Reis, Larissa Menezes dos/T-9867-2019; Dias, Marília M/C-3014-2012; Moraes-Vieira, Pedro/C-8701-2014; Silber, Ariel/O-6951-2015	Adamoski, Douglas/0000-0001-5062-2586; Moraes-Vieira, Pedro/0000-0002-8263-786X; Souza, Rodolpho/0000-0003-1215-8553; Malta de Sa Patroni, Fabio/0000-0003-0221-8380; Dias, Marilia/0000-0003-1415-9023; Menezes dos Reis, Larissa/0000-0003-1597-0176; Consonni, Silvio Roberto/0000-0003-3149-021X; Silber, Ariel/0000-0003-4528-4732	Sao Paulo Research Foundation (FAPESP) [2014/18061-9, 2014/17820-3, 2013/23510-4, 2017/06225-5, 2014/06512-6, 2015/26059-7, 2014/15968-3, 2015/25832-4, 2016/06034-2, 2015/15626-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP) fellowships to L. M. R. (2014/18061-9), D. A. (2014/17820-3), C. F. R. A. (2013/23510-4), F. C. S. (2017/06225-5), K. R. S. O. (2014/06512-6), and F. M. S. P. (2015/26059-7) and research grants to S. M. G. D. (2014/15968-3 and 2015/25832-4), A. M. S. (2016/06034-2), and P. M. M. d. M.-V. (2015/15626-8). The authors declare that they have no conflicts of interest with the contents of this article.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; ANGERMULLER S, 1982, HISTOCHEM J, V14, P823, DOI 10.1007/BF01033631; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakal Chris, 2012, HIGH CONTENT IMAGE A; Bernardi R, 2014, CELL RES, V24, P904, DOI 10.1038/cr.2014.61; Bernt E., 1974, METHODS ENZYMATIC AN, P1704, DOI [10.1016/B978-0-12-091304-6.50017-3, DOI 10.1016/B978-0-12-091304-6.50017-3]; Blomme A, 2017, ONCOGENE, V36, P2116, DOI 10.1038/onc.2016.369; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camarda R, 2016, NAT MED, V22, P427, DOI 10.1038/nm.4055; Cao MD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-941; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Chakrabarti G, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0137-1; Cluntun AA, 2017, TRENDS CANCER, V3, P169, DOI 10.1016/j.trecan.2017.01.005; Daemen A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r110; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; Dornier E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02101-2; Farabegoli F, 2012, EUR J PHARM SCI, V47, P729, DOI 10.1016/j.ejps.2012.08.012; Garber K, 2016, NAT BIOTECHNOL, V34, P794, DOI 10.1038/nbt0816-794; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Halama A, 2018, CANCER LETT, V430, P133, DOI 10.1016/j.canlet.2018.05.017; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermanova I, 2016, LEUKEMIA, V30, P209, DOI 10.1038/leu.2015.213; Huang QQ, 2018, J BIOL CHEM, V293, P3535, DOI 10.1074/jbc.M117.810101; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Jacque N, 2015, BLOOD, V126, P1346, DOI 10.1182/blood-2015-01-621870; Kalinsky K., 2018, CANCER RES, V78, pPD3, DOI [10.1158/1538-7445.SABCS17-PD3-13, DOI 10.1158/1538-7445.SABCS17-PD3-13]; Kaplan HG, 2008, BREAST J, V14, P456, DOI 10.1111/j.1524-4741.2008.00622.x; Karlic H, 2002, J HISTOCHEM CYTOCHEM, V50, P205, DOI 10.1177/002215540205000208; Kenny J, 2003, PROTEIN EXPRES PURIF, V31, P140, DOI 10.1016/S1046-5928(03)00161-X; Lampa M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185092; Lee KH, 2011, J BIOL CHEM, V286, P39247, DOI 10.1074/jbc.M111.264598; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Lim SO, 2016, CANCER RES, V76, P1284, DOI 10.1158/0008-5472.CAN-15-2478; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Long BS, 2016, AMINO ACIDS, V48, P1297, DOI 10.1007/s00726-016-2182-7; LOPASCHUK GD, 1989, MOL CELL BIOCHEM, V88, P175; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marquez J, 2006, NEUROCHEM INT, V48, P465, DOI 10.1016/j.neuint.2005.10.015; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Momcilovic M, 2017, CELL REP, V18, P601, DOI 10.1016/j.celrep.2016.12.061; Moncada S, 2012, BIOCHEM J, V446, P1, DOI 10.1042/BJ20120427; Noh S, 2014, TUMOR BIOL, V35, P4457, DOI 10.1007/s13277-013-1588-z; O'Toole SA, 2013, J CLIN PATHOL, V66, P530, DOI 10.1136/jclinpath-2012-201361; Park JH, 2016, CELL REP, V14, P2154, DOI 10.1016/j.celrep.2016.02.004; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Perez-Gomez C, 2003, BIOCHEM J, V370, P771, DOI 10.1042/BJ20021445; Peyton KJ, 2018, BIOCHEM PHARMACOL, V156, P204, DOI 10.1016/j.bcp.2018.08.032; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Quintero M, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3726-2; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Ascencao CFR, 2018, BIOCHIMIE, V154, P69, DOI 10.1016/j.biochi.2018.07.022; Rodrigues MF, 2016, BIOCHEM J, V473, P703, DOI 10.1042/BJ20150645; Ryu J.H., 2015, P 4 CHIN KOR WORKSH, V1, P1, DOI DOI 10.1080/15384101.2015.1087620; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Shen LL, 2015, P NATL ACAD SCI USA, V112, P5425, DOI 10.1073/pnas.1501555112; Nunes JPS, 2017, BIOTECHNIQUES, V62, P175, DOI 10.2144/000114535; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Song M, 2018, CURR TOP MED CHEM, V18, P432, DOI 10.2174/1568026618666180525100830; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168907; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Turner NC, 2013, CLIN CANCER RES, V19, P6380, DOI 10.1158/1078-0432.CCR-13-0915; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; van Geldermalsen M, 2016, ONCOGENE, V35, P3201, DOI 10.1038/onc.2015.381; Varley KE, 2014, BREAST CANCER RES TR, V146, P287, DOI 10.1007/s10549-014-3019-2; Wright HJ, 2017, P NATL ACAD SCI USA, V114, pE6556, DOI 10.1073/pnas.1703791114; Yang LF, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.20134892; Yao Cong-Hui, 2018, PLoS Biol, V16, pe2003782, DOI 10.1371/journal.pbio.2003782; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	73	35	35	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9342	9357		10.1074/jbc.RA119.008180	http://dx.doi.org/10.1074/jbc.RA119.008180			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31040181	Green Published, hybrid			2022-12-28	WOS:000472713000003
J	Ying, MF; Guo, C; Hu, X				Ying, Minfeng; Guo, Cheng; Hu, Xun			The quantitative relationship between isotopic and net contributions of lactate and glucose to the tricarboxylic acid (TCA) cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose; lactic acid; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); tumor metabolism; isotope exchange; isotopic tracer; C-13 labeling; metabolic flux; net contribution	TUMOR-CELLS; METABOLISM; HYPOXIA; CANCER; INHIBITION; GLUTAMINE; GROWTH; HEAD	Whether growing cancer cells prefer lactate as a fuel over glucose or vice versa is an important but controversial issue. Labeling of tricarboxylic acid (TCA) cycle intermediates with glucose or lactate isotope tracers is often used to report the relative contributions of these two metabolites to the TCA cycle. However, this approach may not yield accurate results, as isotopic labeling may not accurately reflect net contributions of each metabolite. This may be due to isotopic exchange occurring during the conversion between pyruvate and lactate. To evaluate this quantitatively, we used an equation (C-G - C-G = C-L - C-L) assessing the relationship between isotopic labeling and net consumption measurements in vitro. C-G and C-L refer to the contributions of glucose and lactate to the TCA cycle as measured by their net consumption, whereas C-G and C-L refer to glucose's and lactate's contributions determined with isotopic labeling. We found that the isotopic labeling data overestimate the net contribution of lactate to the TCA cycle and underestimate that of glucose. The overestimated amount is equal to the isotopic exchange amount between pyruvate and lactate. After excluding the interference of isotopic exchange, the major carbon contribution (i.e. acetyl-CoA) to the TCA cycle comes from glucose rather than lactate in vitro. We propose that these relative contributions of glucose and lactate may also be present in cancer cells in vivo.	[Ying, Minfeng; Guo, Cheng; Hu, Xun] Zhejiang Univ, Sch Med,Affiliated Hosp 2, Inst Canc,Zhejiang Prov Key Lab Mol Biol Med Sci, Key Lab Canc Intervent & Prevent,China Natl Minis, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University	Hu, X (corresponding author), Zhejiang Univ, Sch Med,Affiliated Hosp 2, Inst Canc,Zhejiang Prov Key Lab Mol Biol Med Sci, Key Lab Canc Intervent & Prevent,China Natl Minis, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	huxun@zju.edu.cn	Guo, Cheng/AAU-1990-2020; Guo, Cheng/R-8316-2019	Guo, Cheng/0000-0001-6194-1232; Ying, Minfeng/0000-0001-5328-4404	China National 973 Project [2013CB911303]; China Natural Sciences Foundation [81470126]; Zhejiang Provincial Department of Sciences and Technologies Key Project [2018C03009]; Fundamental Research Funds for the Central Universities, National Ministry of Education, China	China National 973 Project(National Basic Research Program of China); China Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Department of Sciences and Technologies Key Project; Fundamental Research Funds for the Central Universities, National Ministry of Education, China	This work was supported in part by China National 973 Project Grant 2013CB911303, China Natural Sciences Foundation Project Grant 81470126, Zhejiang Provincial Department of Sciences and Technologies Key Project Grant 2018C03009, and Fundamental Research Funds for the Central Universities, National Ministry of Education, China (to X. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; DONOVAN CM, 1983, AM J PHYSIOL, V244, pE83, DOI 10.1152/ajpendo.1983.244.1.E83; Fan J, 2013, J BIOL CHEM, V288, P31363, DOI 10.1074/jbc.M113.502740; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Fujiwara S, 2013, BRIT J CANCER, V108, P170, DOI 10.1038/bjc.2012.527; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GOLDBERG RN, 1993, J PHYS CHEM REF DATA, V22, P515, DOI 10.1063/1.555939; Goodwin Matthew L, 2007, J Diabetes Sci Technol, V1, P558; HASLAM RJ, 1963, BIOCHEM J, V88, P566, DOI 10.1042/bj0880566; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; KREBS HA, 1966, BIOCHEM J, V101, P242, DOI 10.1042/bj1010242; LANDAU BR, 1986, METABOLISM, V35, P94, DOI 10.1016/0026-0495(86)90102-2; LANDAU BR, 1992, METABOLISM, V41, P457, DOI 10.1016/0026-0495(92)90199-K; Li X., 2011, DATABASE, V2011; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Midani FS, 2017, ANAL BIOCHEM, V520, P27, DOI 10.1016/j.ab.2016.12.011; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nelson D. L., 2008, LEHNINGER PRINCIPLES, P524; NOSADINI R, 1985, AM J PHYSIOL-ENDOC M, V249, pE13, DOI DOI 10.1152/AJPENDO.1985.249.2.E131; Passonneau J. V., 1993, ENZYMATIC ANAL PRACT, p[157, 272]; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; ROSENBLATT J, 1992, AM J PHYSIOL, V263, pE584, DOI 10.1152/ajpendo.1992.263.3.E584; SAHLIN K, 1987, AM J PHYSIOL-ENDOC M, V252, pE43, DOI DOI 10.1152/AJPENDO.1987.252.3.E439; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; SKINNER SA, 1990, CANCER RES, V50, P2411; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WEINMAN EO, 1957, PHYSIOL REV, V37, P252, DOI 10.1152/physrev.1957.37.2.252; Wigfield SM, 2008, BRIT J CANCER, V98, P1975, DOI 10.1038/sj.bjc.6604356; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	41	13	16	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9615	9630		10.1074/jbc.RA119.007841	http://dx.doi.org/10.1074/jbc.RA119.007841			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31040177	Green Published, hybrid			2022-12-28	WOS:000472713000026
J	Banerjee, S; Clapp, K; Tarsio, M; Kane, PM				Banerjee, Subhrajit; Clapp, Kaitlyn; Tarsio, Maureen; Kane, Patricia M.			Interaction of the late endo-lysosomal lipid PI(3,5)P2 with the Vph1 isoform of yeast V-ATPase increases its activity and cellular stress tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; vacuole; phosphatidylinositol signaling; Saccharomyces cerevisiae; proton pump; lysosome; acidification; osmoregulation; osmotic stress; phosphatidylinositol 3; 5-bisphosphate	VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; TERMINAL DOMAIN; GENE ENCODES; SUBUNIT; MUTATIONS; HOMOLOG; KINASE; PHOSPHOINOSITIDES; ACIDIFICATION	The low-level endo-lysosomal signaling lipid, phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), is required for full assembly and activity of vacuolar H+-ATPases (V-ATPases) containing the vacuolar a-subunit isoform Vph1 in yeast. The cytosolic N-terminal domain of Vph1 is also recruited to membranes in vivo in a PI(3,5)P2-dependent manner, but it is not known if its interaction with PI(3,5)P2 is direct. Here, using biochemical characterization of isolated yeast vacuolar vesicles, we demonstrate that addition of exogenous short-chain PI(3,5)P2 to Vph1-containing vacuolar vesicles activates V-ATPase activity and proton pumping. Modeling of the cytosolic N-terminal domain of Vph1 identified two membrane-oriented sequences that contain clustered basic amino acids. Substitutions in one of these sequences ((KTREYKHK)-K-231) abolished the PI(3,5)P2-dependent activation of V-ATPase without affecting basal V-ATPase activity. We also observed that vph1 mutants lacking PI(3,5)P2 activation have enlarged vacuoles relative to those in WT cells. These mutants exhibit a significant synthetic growth defect when combined with deletion of Hog1, a kinase important for signaling the transcriptional response to osmotic stress. The results suggest that PI(3,5)P2 interacts directly with Vph1, and that this interaction both activates V-ATPase activity and protects cells from stress.	[Banerjee, Subhrajit; Clapp, Kaitlyn; Tarsio, Maureen; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, 750 E Adams St, Syracuse, NY 13210 USA.	kanepm@upstate.edu	BANERJEE, SUBHRAJIT/GXF-2066-2022	BANERJEE, SUBHRAJIT/0000-0003-3594-8056; Banerjee, Subhrajit/0000-0003-1474-8864	National Institutes of Health [R01 GM50322, GM126020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM50322 and GM126020 (to P. M. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Banerjee S, 2017, MOL BIOL CELL, V28, P2518, DOI 10.1091/mbc.E17-05-0316; Baskaran S, 2012, MOL CELL, V47, P339, DOI 10.1016/j.molcel.2012.05.027; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Choy CH, 2018, J CELL SCI, V131, DOI 10.1242/jcs.213587; Collins MD, 2013, BIOPHYS J, V105, P2485, DOI 10.1016/j.bpj.2013.09.035; Compton LM, 2016, AM J PHYSIOL-CELL PH, V311, pC366, DOI 10.1152/ajpcell.00104.2016; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Duex JE, 2006, EUKARYOT CELL, V5, P723, DOI 10.1128/EC.5.4.723-731.2006; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Finnigan GC, 2012, J BIOL CHEM, V287, P19487, DOI 10.1074/jbc.M112.343814; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Ho CY, 2015, J BIOL CHEM, V290, P9919, DOI 10.1074/jbc.M114.613984; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Jin N, 2017, J CELL BIOL, V216, P2075, DOI 10.1083/jcb.201611144; Jin N, 2016, BIOCHEM SOC T, V44, P177, DOI 10.1042/BST20150174; Jin N, 2014, MOL BIOL CELL, V25, P1171, DOI 10.1091/mbc.E14-01-0021; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1992, J BIOL CHEM, V267, P447; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kartner N, 2012, CURR PROTEIN PEPT SC, V13, P164, DOI 10.2174/138920312800493179; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Li SC, 2012, EUKARYOT CELL, V11, P282, DOI 10.1128/EC.05198-11; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Marrone G, 2018, HEPATOLOGY, V68, P1140, DOI 10.1002/hep.30029; McCartney AJ, 2014, BIOESSAYS, V36, P52, DOI 10.1002/bies.201300012; McGuire C, 2017, FRONT BIOSCI-LANDMRK, V22, P609, DOI 10.2741/4506; Naufer A, 2018, J CELL BIOL, V217, P329, DOI 10.1083/jcb.201702179; Oot RA, 2017, PROTEIN SCI, V26, P896, DOI 10.1002/pro.3147; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roh SH, 2018, MOL CELL, V69, P993, DOI 10.1016/j.molcel.2018.02.006; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Schulze U, 2017, BBA-MOL CELL RES, V1864, P749, DOI 10.1016/j.bbamcr.2017.02.012; She J, 2018, NATURE, V556, P130, DOI 10.1038/nature26139; SIKORSKI RS, 1989, GENETICS, V122, P19; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Stransky L, 2016, PHYSIOL REV, V96, P1071, DOI 10.1152/physrev.00035.2015; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Wilson ZN, 2018, MOL BIOL CELL, V29, P1718, DOI 10.1091/mbc.E18-01-0015; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	64	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9161	9171		10.1074/jbc.RA119.008552	http://dx.doi.org/10.1074/jbc.RA119.008552			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31023825	Green Published, hybrid			2022-12-28	WOS:000471751600012
J	Zhao, WC; Bohleber, S; Schmidt, H; Seeher, S; Howard, MT; Braun, D; Arndt, S; Reuter, U; Wende, H; Birchmeier, C; Fradejas-Villar, N; Schweizer, U				Zhao, Wenchao; Bohleber, Simon; Schmidt, Henrik; Seeher, Sandra; Howard, Michael T.; Braun, Doreen; Arndt, Simone; Reuter, Uschi; Wende, Hagen; Birchmeier, Carmen; Fradejas-Villar, Noelia; Schweizer, Ulrich			Ribosome profiling of selenoproteins in vivo reveals consequences of pathogenic Secisbp2 missense mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						selenium; selenocysteine insertion sequence (SECIS); selenoprotein; neurobiology; neuroinflammation; translation; thyroid hormone; Sbp2; selenocysteine; thermal instability; brain; liver; deiodinase; SECIS-binding protein 2 (SECISBP2)	INSERTION-SEQUENCE-BINDING; RNA-BINDING; ELONGATION-FACTOR; PROTEIN; SELENOCYSTEINE; EXPRESSION; SBP2; TRANSLATION; AFFINITY; DOMAIN	Recoding of UGA codons as selenocysteine (Sec) codons in selenoproteins depends on a selenocysteine insertion sequence (SECIS) in the 3?-UTR of mRNAs of eukaryotic selenoproteins. SECIS-binding protein 2 (SECISBP2) increases the efficiency of this process. Pathogenic mutations in SECISBP2 reduce selenoprotein expression and lead to phenotypes associated with the reduction of deiodinase activities and selenoprotein N expression in humans. Two functions have been ascribed to SECISBP2: binding of SECIS elements in selenoprotein mRNAs and facilitation of co-translational Sec insertion. To separately probe both functions, we established here two mouse models carrying two pathogenic missense mutations in Secisbp2 previously identified in patients. We found that the C696R substitution in the RNA-binding domain abrogates SECIS binding and does not support selenoprotein translation above the level of a complete Secisbp2 null mutation. The R543Q missense substitution located in the selenocysteine insertion domain resulted in residual activity and caused reduced selenoprotein translation, as demonstrated by ribosomal profiling to determine the impact on UGA recoding in individual selenoproteins. We found, however, that the R543Q variant is thermally unstable in vitro and completely degraded in the mouse liver in vivo, while being partially functional in the brain. The moderate impairment of selenoprotein expression in neurons led to astrogliosis and transcriptional induction of genes associated with immune responses. We conclude that differential SECISBP2 protein stability in individual cell types may dictate clinical phenotypes to a much greater extent than molecular interactions involving a mutated amino acid in SECISBP2.	[Zhao, Wenchao; Bohleber, Simon; Schmidt, Henrik; Seeher, Sandra; Braun, Doreen; Arndt, Simone; Reuter, Uschi; Fradejas-Villar, Noelia; Schweizer, Ulrich] Rheinische Friedrich Wilhelms Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany; [Howard, Michael T.] Univ Utah, Dept Genet, Salt Lake City, UT 84112 USA; [Wende, Hagen; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	University of Bonn; Utah System of Higher Education; University of Utah; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Schweizer, U (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	Ulrich.schweizer@uni-bonn.de		Fradejas-Villar, Noelia/0000-0003-3418-0743; Schweizer, Ulrich/0000-0003-1380-4780; Birchmeier, Carmen/0000-0002-2041-8872; Bohleber, Simon/0000-0002-1551-9839; Wende, Hagen/0000-0002-9168-8095; Reuter, Uwe/0000-0002-8527-0725	Deutsche Forschungsgemeinschaft [Schw914/2, Schw914/5]; Universitatsklinikum Bonn; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114291] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Universitatsklinikum Bonn; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft Grants Schw914/2 and Schw914/5 and Universitatsklinikum Bonn. The authors declare that they have no conflicts of interest with the contents of this article.	Alam MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048273; Allmang C, 2002, RNA, V8, P1308, DOI 10.1017/S1355838202020034; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Azevedo MF, 2010, J CLIN ENDOCR METAB, V95, P4066, DOI 10.1210/jc.2009-2611; Bubenik JL, 2007, J BIOL CHEM, V282, P34653, DOI 10.1074/jbc.M707059200; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Carlson BA, 2009, BIOCHEM J, V418, P61, DOI 10.1042/BJ20081304; Catli G, 2018, THYROID, V28, P1221, DOI 10.1089/thy.2018.0015; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; Di Cosmo C, 2009, J CLIN ENDOCR METAB, V94, P4003, DOI 10.1210/jc.2009-0686; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donovan J, 2008, J BIOL CHEM, V283, P35129, DOI 10.1074/jbc.M806008200; Dumitrescu AM, 2010, ANTIOXID REDOX SIGN, V12, P905, DOI 10.1089/ars.2009.2892; Dumitrescu AM, 2005, NAT GENET, V37, P1247, DOI 10.1038/ng1654; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fradejas-Villar N, 2017, NUCLEIC ACIDS RES, V45, P4094, DOI 10.1093/nar/gkw1255; Gladyshev VN, 2016, J BIOL CHEM, V291, P24036, DOI 10.1074/jbc.M116.756155; Hamajima T, 2012, EUR J ENDOCRINOL, V166, P957, DOI 10.1530/EJE-11-0812e; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jo S, 2019, J CLIN INVEST, V129, P230, DOI 10.1172/JCI123176; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Kirchner S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000779; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Krueger F., 2014, TRIM GALORE WRAPPER; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Olieric V, 2009, BIOCHIMIE, V91, P1003, DOI 10.1016/j.biochi.2009.05.004; Pitts MW, 2012, NEUROSCIENCE, V208, P58, DOI 10.1016/j.neuroscience.2012.02.017; R Core Team, 2018, R LANG ENV STAT COMP; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Schweizer U, 2016, FASEB J, V30, P3669, DOI 10.1096/fj.201600424; Seeher S, 2014, ANTIOXID REDOX SIGN, V21, P835, DOI 10.1089/ars.2013.5358; Seeher S, 2014, BIOCHEM J, V462, P67, DOI 10.1042/BJ20140423; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Smith AC, 2014, J MED GENET, V51, P470, DOI 10.1136/jmedgenet-2013-102218; Squires JE, 2007, MOL CELL BIOL, V27, P7848, DOI 10.1128/MCB.00793-07; Takeuchi A, 2009, NUCLEIC ACIDS RES, V37, P2126, DOI 10.1093/nar/gkp078; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Wirth EK, 2014, BIOL TRACE ELEM RES, V158, P203, DOI 10.1007/s12011-014-9920-z; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200	56	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14185	14200		10.1074/jbc.RA119.009369	http://dx.doi.org/10.1074/jbc.RA119.009369			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31350336	hybrid, Green Published			2022-12-28	WOS:000499248200003
J	Song, CH; Orlandi, C; Sutton, LP; Martemyanov, KA				Song, Chenghui; Orlandi, Cesare; Sutton, Laurie P.; Martemyanov, Kirill A.			The signaling proteins GPR158 and RGS7 modulate excitability of L2/3 pyramidal neurons and control A-type potassium channel in the prelimbic cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); heterotrimeric G protein; ion channel; depression; regulator of G protein signaling (RGS); stress; intrinsic excitability; KV4; 2 channels; neuromodulation; orphan receptors; regulator of G protein signaling 7 (RGS7)	MEDIAL PREFRONTAL CORTEX; INTRINSIC EXCITABILITY; CAMP MODULATION; REPEATED STRESS; DELTA-FOSB; BA2+ BLOCK; K+ CHANNEL; KV4.2; BRAIN; EXPRESSION	Stress profoundly affects physiological properties of neurons across brain circuits and thereby increases the risk for depression. However, the molecular and cellular mechanisms mediating these effects are poorly understood. In this study, we report that chronic physical restraint stress in mice decreases excitability specifically in layer 2/3 of pyramidal neurons within the prelimbic subarea of the prefrontal cortex (PFC) accompanied by the induction of depressive-like behavioral states. We found that a complex between G protein-coupled receptor (GPCR) 158 (GPR158) and regulator of G protein signaling 7 (RGS7), a regulatory GPCR signaling node recently discovered to be a key modulator of affective behaviors, plays a key role in controlling stress-induced changes in excitability in this neuronal population. Deletion of GPR158 or RGS7 enhanced excitability of layer 2/3 PFC neurons and prevented the impact of stress. Investigation of the underlying molecular mechanisms revealed that the A-type potassium channel Kv4.2 subunit is a molecular target of the GPR158-RGS7 complex. We further report that GPR158 physically associates with Kv4.2 channel and promotes its function by suppressing inhibitory modulation by cAMP-protein kinase A (PKA)-mediated phosphorylation. Taken together, our observations reveal a critical mechanism that adjusts neuronal excitability in L2/3 pyramidal neurons of the PFC and may thereby modulate the effects of stress on depression.	[Song, Chenghui; Orlandi, Cesare; Sutton, Laurie P.; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Song, Chenghui] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA	Scripps Research Institute; University of Alabama System; University of Alabama Birmingham	Martemyanov, KA (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.	kirill@scripps.edu	Orlandi, Cesare/AAK-3180-2020	Orlandi, Cesare/0000-0002-4992-9350; Martemyanov, Kirill/0000-0002-9925-7599; Sutton, Laurie/0000-0002-8694-2060	National Institutes of Health [MH105482, DA026405]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants MH105482 and DA026405 (to K. A. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alagem N, 2001, J PHYSIOL-LONDON, V534, P381, DOI 10.1111/j.1469-7793.2001.00381.x; Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; BORSINI F, 1986, PHYSIOL BEHAV, V38, P385, DOI 10.1016/0031-9384(86)90110-1; Cao Y, 2012, P NATL ACAD SCI USA, V109, P7905, DOI 10.1073/pnas.1202332109; Carrasquillo Y, 2012, J PHYSIOL-LONDON, V590, P3877, DOI 10.1113/jphysiol.2012.229013; Chen CL, 2015, ACTA PHARM SIN B, V5, P55, DOI 10.1016/j.apsb.2014.12.004; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; Donati RJ, 2003, LIFE SCI, V73, P1, DOI 10.1016/S0024-3205(03)00249-2; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Ehrlich AT, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0106-7; Fan Y, 2016, BRAIN STRUCT FUNCT, V221, P3111, DOI 10.1007/s00429-015-1090-z; Fujita M, 2017, MOL PSYCHIATR, V22, P754, DOI 10.1038/mp.2016.171; Ghanemi A, 2015, SAUDI PHARM J, V23, P115, DOI 10.1016/j.jsps.2013.07.007; Golan M, 2009, CURR PHARM DESIGN, V15, P1699, DOI 10.2174/138161209788168038; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; Guan DX, 2011, J NEUROPHYSIOL, V105, P2976, DOI 10.1152/jn.00758.2010; Hammond RS, 2008, J NEUROSCI, V28, P7513, DOI 10.1523/JNEUROSCI.1951-08.2008; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Huang Z, 2009, J NEUROSCI, V29, P10979, DOI 10.1523/JNEUROSCI.1531-09.2009; Jett JD, 2017, NEUROSCIENCE, V346, P284, DOI 10.1016/j.neuroscience.2017.01.017; Kase Daisuke, 2012, J Signal Transduct, V2012, P619747, DOI 10.1155/2012/619747; Kehl SJ, 2013, AM J PHYSIOL-CELL PH, V304, pC370, DOI 10.1152/ajpcell.00267.2012; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kiselycznyk C, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-5; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Lockridge A, 2010, NEUROSCIENCE, V170, P1086, DOI 10.1016/j.neuroscience.2010.08.047; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; Magee JC, 1998, J NEUROSCI, V18, P7613; Marionneau C, 2011, SEMIN CELL DEV BIOL, V22, P145, DOI 10.1016/j.semcdb.2010.10.004; Marionneau C, 2009, CHANNELS, V3, P284; McKlveen JM, 2015, J NEUROENDOCRINOL, V27, P446, DOI 10.1111/jne.12272; Moyer James R. Jr., 2007, V38, P169; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Orlandi C, 2019, NEUROPSYCHOPHARMACOL, V44, P642, DOI 10.1038/s41386-018-0238-y; Orlandi C, 2015, J BIOL CHEM, V290, P13622, DOI 10.1074/jbc.M115.645374; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Ostrovskaya O, 2014, ELIFE, V3, DOI 10.7554/eLife.02053; Papadopoulou A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.72; Perova Z, 2015, J NEUROSCI, V35, P3201, DOI 10.1523/JNEUROSCI.2670-14.2015; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Radley JJ, 2005, AGEING RES REV, V4, P271, DOI 10.1016/j.arr.2005.03.004; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Reiach JS, 1999, J AFFECT DISORDERS, V56, P141, DOI 10.1016/S0165-0327(99)00048-8; Roberson ED, 1999, J NEUROSCI, V19, P4337; Rosenkranz JA, 2010, BIOL PSYCHIAT, V67, P1128, DOI 10.1016/j.biopsych.2010.02.008; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; Seo H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0103-4; Shrestha P, 2015, ELIFE, V4, DOI 10.7554/eLife.08752; Song CH, 2018, J NEUROSCI, V38, P7120, DOI 10.1523/JNEUROSCI.0493-18.2018; Song CH, 2018, J NEUROPHYSIOL, V119, P177, DOI 10.1152/jn.00146.2017; Song CH, 2015, J NEUROSCI, V35, P13511, DOI 10.1523/JNEUROSCI.2329-15.2015; STORM JF, 1990, PROG BRAIN RES, V83, P161; Stratinaki M, 2013, P NATL ACAD SCI USA, V110, P8254, DOI 10.1073/pnas.1214696110; Surges R, 2006, EUR J NEUROSCI, V24, P94, DOI 10.1111/j.1460-9568.2006.04880.x; Sutton LP, 2018, ELIFE, V7, DOI 10.7554/eLife.33273; Tomita Hiroaki, 2013, Frontiers in Genetics, V4, P297, DOI 10.3389/fgene.2013.00297; van Harmelen AL, 2014, SOC COGN AFFECT NEUR, V9, P2026, DOI 10.1093/scan/nsu008; Verwer RWH, 1997, HIPPOCAMPUS, V7, P397, DOI 10.1002/(SICI)1098-1063(1997)7:4<397::AID-HIPO5>3.0.CO;2-G; Vialou V, 2014, J NEUROSCI, V34, P3878, DOI 10.1523/JNEUROSCI.1787-13.2014; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Wang GQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8660; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Wang MH, 2014, J NEUROSCI, V34, P7485, DOI 10.1523/JNEUROSCI.5294-13.2014; Wilber AA, 2011, NEUROSCIENCE, V174, P115, DOI 10.1016/j.neuroscience.2010.10.070; Witkowski G, 2012, J PHYSIOL PHARMACOL, V63, P457; Wray NH, 2019, MOL PSYCHIATR, V24, P1833, DOI 10.1038/s41380-018-0083-8; Yost CS, 1999, ANESTHESIOLOGY, V90, P1186, DOI 10.1097/00000542-199904000-00035; Zhang B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03680-2; Zhong P, 2014, J NEUROSCI, V34, P6352, DOI 10.1523/JNEUROSCI.3673-13.2014	82	11	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13145	13157		10.1074/jbc.RA119.007533	http://dx.doi.org/10.1074/jbc.RA119.007533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31311860	hybrid, Green Published			2022-12-28	WOS:000486416000023
J	Vanacloig-Pedros, E; Lozano-Perez, C; Alarcon, B; Pascual-Ahuir, A; Proft, M				Vanacloig-Pedros, Elena; Lozano-Perez, Carlos; Alarcon, Benito; Pascual-Ahuir, Amparo; Proft, Markus			Live-cell assays reveal selectivity and sensitivity of the multidrug response in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						stress response; multidrug transporter; xenobiotic; gene transcription; Saccharomyces cerevisiae; transcription factor; drug resistance; ABC transporter; chemical stress; efflux pump	TRANSCRIPTION FACTOR; DRUG-RESISTANCE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; OXIDATIVE STRESS; ACTIVATION; PATHWAY; PDR1; YRR1; TRANSPORTERS	Pleiotropic drug resistance arises by the enhanced extrusion of bioactive molecules and is present in a wide range of organisms, ranging from fungi to human cells. A key feature of this adaptation is the sensitive detection of intracellular xenobiotics by transcriptional activators, activating expression of multiple drug exporters. Here, we investigated the selectivity and sensitivity of the budding yeast (Saccharomyces cerevisiae) multidrug response to better understand how differential drug recognition leads to specific activation of drug exporter genes and to drug resistance. Applying live-cell luciferase reporters, we demonstrate that the SNQ2, PDR5, PDR15, and YOR1 transporter genes respond to different mycotoxins, menadione, and hydrogen peroxide in a distinguishable manner and with characteristic amplitudes, dynamics, and sensitivities. These responses correlated with differential sensitivities of the respective transporter mutants to the specific xenobiotics. We further establish a binary vector system, enabling quantitative determination of xenobiotic-transcription factor (TF) interactions in real time. Applying this system we found that the TFs Pdr1, Pdr3, Yrr1, Stb5, and Pdr8 have largely different drug recognition patterns. We noted that Pdr1 is the most promiscuous activator, whereas Yrr1 and Stb5 are selective for ochratoxin A and hydrogen peroxide, respectively. We also show that Pdr1 is rapidly degraded after xenobiotic exposure, which leads to a desensitization of the Pdr1-specific response upon repeated activation. The findings of our work indicate that in the yeast multidrug system, several transcriptional activators with distinguishable selectivities trigger differential activation of the transporter genes.	[Vanacloig-Pedros, Elena; Pascual-Ahuir, Amparo] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, Dept Biotechnol, E-46022 Valencia, Spain; [Lozano-Perez, Carlos; Alarcon, Benito; Proft, Markus] CSIC, IBV, Dept Mol & Cellular Pathol & Therapy, Valencia 46010, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Pascual-Ahuir, A (corresponding author), Ingeniero Fausto Elio S-N, Valencia 46022, Spain.; Proft, M (corresponding author), CSIC, Inst Biomed, Jaime Roig 11, Valencia 46010, Spain.	apascual@ibmcp.upv.es; mproft@ibv.csic.es	Pascual-ahuir, Amparo/K-1338-2014	Proft, Markus/0000-0002-6788-5830; Alarcon Hernandis, Benito/0000-0002-9026-3247	Ministerio de Economia y Competitividad Grant [BFU2016-75792-R]	Ministerio de Economia y Competitividad Grant(Spanish Government)	This work was supported by Ministerio de Economia y Competitividad Grant BFU2016-75792-R. The authors declare that they have no conflicts of interest with the contents of this article.	Akache B, 2004, J BIOL CHEM, V279, P27855, DOI 10.1074/jbc.M403487200; Balzi E, 2019, YEAST, V36, P195, DOI 10.1002/yea.3354; Borecka-Melkusova S, 2008, FEMS YEAST RES, V8, P414, DOI 10.1111/j.1567-1364.2007.00352.x; Cadiere A, 2010, FEMS YEAST RES, V10, P819, DOI 10.1111/j.1567-1364.2010.00672.x; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Cavalheiro M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00995-18; Colabufo NA, 2009, CURR TOP MED CHEM, V9, P119, DOI 10.2174/156802609787521553; Cui Z, 1998, MOL MICROBIOL, V29, P1307, DOI 10.1046/j.1365-2958.1998.01027.x; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Dolz-Edo L, 2013, MOL CELL BIOL, V33, P2228, DOI 10.1128/MCB.00240-13; Fardeau V, 2007, J BIOL CHEM, V282, P5063, DOI 10.1074/jbc.M610197200; Gao C, 2004, J BIOL CHEM, V279, P42677, DOI 10.1074/jbc.M406363200; Healey KR, 2018, J FUNGI, V4, DOI 10.3390/jof4030105; Hikkel I, 2003, J BIOL CHEM, V278, P11427, DOI 10.1074/jbc.M208549200; Hong HY, 2000, ELECTROPHORESIS, V21, P841, DOI 10.1002/(SICI)1522-2683(20000301)21:5<841::AID-ELPS841>3.3.CO;2-W; Ito H, 2006, PLANT PHYSIOL, V142, P63, DOI 10.1104/pp.106.084533; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; Keeven J, 2002, CURR GENET, V41, P11, DOI 10.1007/s00294-002-0274-2; Kim MS, 2019, NUCLEIC ACIDS RES, V47, P1211, DOI 10.1093/nar/gky1188; Kodo N, 2013, BIOCHEM BIOPH RES CO, V434, P42, DOI 10.1016/j.bbrc.2013.03.069; Kren A, 2003, MOL CELL BIOL, V23, P1775, DOI 10.1128/MCB.23.5.1775-1785.2003; Larochelle M, 2006, MOL CELL BIOL, V26, P6690, DOI 10.1128/MCB.02450-05; Le Crom S, 2002, MOL CELL BIOL, V22, P2642, DOI 10.1128/MCB.22.8.2642-2649.2002; Lucau-Danila A, 2003, J BIOL CHEM, V278, P52641, DOI 10.1074/jbc.M309580200; Moye-Rowley WS, 2019, CURR GENET, V65, P103, DOI 10.1007/s00294-018-0870-4; Naar AM, 2009, GENE DEV, V23, P419, DOI 10.1101/gad.1743009; Nishida-Aoki N, 2015, CURR GENET, V61, P153, DOI 10.1007/s00294-014-0463-9; Nishikawa JL, 2016, NATURE, V530, P485, DOI 10.1038/nature16963; Noel T, 2012, J MYCOL MED, V22, P173, DOI 10.1016/j.mycmed.2012.04.004; Onda M, 2004, GENE, V332, P51, DOI 10.1016/j.gene.2004.02.003; Ouyang LM, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy091; Pascual-Ahuir A, 2019, BBA-GENE REGUL MECH, V1862, P457, DOI 10.1016/j.bbagrm.2019.02.009; Paul S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00143; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Rienzo A, 2015, MOL CELL BIOL, V35, P3669, DOI 10.1128/MCB.00729-15; Rienzo A, 2012, YEAST, V29, P219, DOI 10.1002/yea.2905; Rong-Mullins X, 2018, G3-GENES GENOM GENET, V8, P607, DOI 10.1534/g3.117.300138; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Shahi P, 2010, MOL BIOL CELL, V21, P2469, DOI 10.1091/mbc.E09-10-0899; Stavrovskaya AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P592, DOI 10.1134/S0006297908050118; Teixeira MC, 2018, NUCLEIC ACIDS RES, V46, pD348, DOI 10.1093/nar/gkx842; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Vanacloig-Pedros E, 2016, TOXINS, V8, DOI 10.3390/toxins8100273; Voth WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084092; Zhang XT, 2001, J BIOL CHEM, V276, P8812, DOI 10.1074/jbc.M010686200	46	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12933	12946		10.1074/jbc.RA119.009291	http://dx.doi.org/10.1074/jbc.RA119.009291			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296662	hybrid, Green Published			2022-12-28	WOS:000486416000007
J	Li, LZ; Martin-Levilain, J; Jimenez-Sanchez, C; Karaca, M; Foti, M; Martinou, JC; Maechler, P				Li, Lingzi; Martin-Levilain, Juliette; Jimenez-Sanchez, Cecilia; Karaca, Melis; Foti, Michelangelo; Martinou, Jean-Claude; Maechler, Pierre			In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver metabolism; mitochondria; hepatocyte; gluconeogenesis; mitochondrial metabolism; OPA1; prohibitins; liver	M-AAA PROTEASE; GLUCOSE-PRODUCTION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; HEPATIC GLYCOGENOLYSIS; PROTEOLYTIC CLEAVAGE; TCA CYCLE; LIVER; DYSFUNCTION; APOPTOSIS; FUSION	Patients with fatty liver diseases present altered mitochondrial morphology and impaired metabolic function. Mitochondrial dynamics and related cell function require the uncleaved form of the dynamin-like GTPase OPA1. Stabilization of OPA1 might then confer a protective mechanism against stress-induced tissue damages. To study the putative role of hepatic mitochondrial morphology in a sick liver, we expressed a cleavage-resistant long form of OPA1 (L-OPA1 Delta) in the liver of a mouse model with mitochondrial liver dysfunction (i.e. the hepatocyte-specific prohibitin-2 knockout (Hep-Phb2(-/-)) mice). Liver prohibitin-2 deficiency caused excessive proteolytic cleavage of L-OPA1, mitochondrial fragmentation, and increased apoptosis. These molecular alterations were associated with lipid accumulation, abolished gluconeogenesis, and extensive liver damage. Such liver dysfunction was associated with severe hypoglycemia. In prohibitin-2 knockout mice, expression of L-OPA1 Delta by in vivo adenovirus delivery restored the morphology but not the function of mitochondria in hepatocytes. In prohibitin-competent mice, elongation of liver mitochondria by expression of L-OPA1 Delta resulted in excessive glucose production associated with increased mitochondrial respiration. In conclusion, mitochondrial dynamics participates in the control of hepatic glucose production.	[Li, Lingzi; Martin-Levilain, Juliette; Jimenez-Sanchez, Cecilia; Karaca, Melis; Foti, Michelangelo; Maechler, Pierre] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1206 Geneva, Switzerland; [Li, Lingzi; Martin-Levilain, Juliette; Jimenez-Sanchez, Cecilia; Karaca, Melis; Foti, Michelangelo; Maechler, Pierre] Univ Geneva, Fac Diabet Ctr, Med Ctr, CH-1206 Geneva, Switzerland; [Martinou, Jean-Claude] Univ Geneva, Fac Sci, Cell Biol Dept, CH-1205 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Maechler, P (corresponding author), CMU, Dept Cell Physiol & Metab, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	Pierre.Maechler@unige.ch		Foti, Michelangelo/0000-0001-7199-4135; Maechler, Pierre/0000-0002-2005-1433; /0000-0002-6856-1299	Swiss National Science Foundation Sinergia [CRSII3_147637, 310030_172862]; Fundacion Alfonso Martin Escudero	Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); Fundacion Alfonso Martin Escudero	This work was supported by Swiss National Science Foundation Sinergia Grants CRSII3_147637 (to P. M. and J.-C. M.) and 310030_172862 (to M. F.) and by a fellowship from the Fundacion Alfonso Martin Escudero (to C. J. S). The authors declare that they have no conflicts of interest with the contents of this article.	Adam M, 2018, FASEB J, V32, P3434, DOI 10.1096/fj.201700914R; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; EXTON JH, 1972, METABOLISM, V21, P945, DOI 10.1016/0026-0495(72)90028-5; Farese RV, 2005, EXP BIOL MED, V230, P593; Foti M, 1997, MOL BIOL CELL, V8, P1377, DOI 10.1091/mbc.8.7.1377; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Garcia-Ruiz I, 2010, J PROTEOME RES, V9, P2450, DOI 10.1021/pr9011427; Grimaldi M, 2017, HUM MOL GENET, V26, P3453, DOI 10.1093/hmg/ddx213; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Holmstrom MH, 2013, METABOLISM, V62, P1258, DOI 10.1016/j.metabol.2013.04.001; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Karaca M, 2018, DIABETES, V67, P1949, DOI 10.2337/db17-1561; Korwitz A, 2016, J CELL BIOL, V212, P157, DOI 10.1083/jcb.201507022; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; Lane M, 2016, J INHERIT METAB DIS, V39, P427, DOI 10.1007/s10545-016-9927-z; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; MCCLUNG JK, 1995, EXP GERONTOL, V30, P99, DOI 10.1016/0531-5565(94)00069-7; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003021; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Park M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030494; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Parvez S, 2006, TOXICOLOGY, V225, P109, DOI 10.1016/j.tox.2006.05.009; Petersen KF, 1996, AM J PHYSIOL-ENDOC M, V270, pE186, DOI 10.1152/ajpendo.1996.270.1.E186; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Ross JA, 2017, ONCOTARGET, V8, P65445, DOI 10.18632/oncotarget.18920; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Stark R, 2014, BBA-GEN SUBJECTS, V1840, P1313, DOI 10.1016/j.bbagen.2013.10.033; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tietge UJF, 1999, J LIPID RES, V40, P2134; von Wilamowitz-Moellendorff A, 2013, DIABETES, V62, P4070, DOI 10.2337/db13-0880; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Wang LX, 2015, DIABETOLOGIA, V58, P2371, DOI 10.1007/s00125-015-3704-7; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	64	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12581	12598		10.1074/jbc.RA119.007601	http://dx.doi.org/10.1074/jbc.RA119.007601			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31285263	Green Published, hybrid			2022-12-28	WOS:000484414600003
J	Liang, X; Samways, DSK; Cox, J; Egan, TM				Liang, Xin; Samways, Damien S. K.; Cox, Jane; Egan, Terrance M.			Ca2+ flux through splice variants of the ATP-gated ionotropic receptor P2X7 is regulated by its cytoplasmic N terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; purinergic receptor; calcium transport; patch clamp; permeability; calcium channel; fractional calcium current; ligand-gated; P2X 7 (P2X7) P2RX7; patch-clamp fluorometry; splice variant	AMINO-TERMINUS; CATION PERMEABILITY; PORE; DESENSITIZATION; PHYSIOLOGY; RESIDUES; REGIONS; INNATE	Activation of ionotropic P2X receptors increases free intracellular Ca2+ ([Ca2+](i)) by initiating a transmembrane cation flux. We studied the a and k splice variants of the rat purinergic P2X7 receptor (rP2X7aR and rP2X7kR) to exhibit a significant difference in Ca2+ flux through this channel. This difference is surprising because the variants share absolute sequence identity in the area of the pore that defines ionic selectivity. Here, we used patch-clamp fluorometry and chimeric receptors to show that the fraction of the total current carried by Ca2+ is a function of the primary sequence of the cytoplasmic N terminus. Using scanning mutagenesis, we identified five sites within the N terminus that respond to mutagenesis with a decrease in fractional calcium current and an increase in permeability to the polyatomic cation, N-methyl-d-glucamine (NMDG(+)), relative to Na+ (P-NMDG/P-Na). We tested the hypothesis that these sites line the permeation pathway by measuring the ability of thiol-reactive MTSET+ to alter the current of cysteine-substituted variants, but we detected no effect. Finally, we studied the homologous sites of the rat P2X2 receptor (rP2X2R) and observed that substitutions at Glu(17) significantly reduced the fractional calcium current. Taken together, our results suggest that a change in the structure of the N terminus alters the ability of an intra-pore Ca2+ selectivity filter to discriminate among permeating cations. These results are noteworthy for two reasons: they identify a previously unknown outcome of mutagenesis of the N-terminal domain, and they suggest caution when assigning structure to function for truncated P2X receptors that lack a part of the N terminus.	[Liang, Xin] Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Guangdong, Peoples R China; [Samways, Damien S. K.] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA; [Cox, Jane; Egan, Terrance M.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol, 1402 South Grand Blvd, St Louis, MO 63104 USA; [Cox, Jane; Egan, Terrance M.] St Louis Univ, Sch Med, Henry & Amelia Nasrallah Ctr Neurosci, St Louis, MO 63104 USA	Sun Yat Sen University; Clarkson University; Saint Louis University; Saint Louis University	Egan, TM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol, 1402 South Grand Blvd, St Louis, MO 63104 USA.	terrance.egan@health.slu.edu		Egan, Terrance/0000-0002-7249-3161	National Institutes of Health [1R01GM112188]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01GM112188. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adinolfi E, 2018, BIOCHEM PHARMACOL, V151, P234, DOI 10.1016/j.bcp.2017.12.021; Allsopp RC, 2015, J BIOL CHEM, V290, P14556, DOI 10.1074/jbc.M115.642033; Allsopp RC, 2013, J BIOL CHEM, V288, P21412, DOI 10.1074/jbc.M113.464651; Allsopp RC, 2011, J BIOL CHEM, V286, P44691, DOI 10.1074/jbc.M111.303917; Allsopp RC, 2010, J BIOL CHEM, V285, P32770, DOI 10.1074/jbc.M110.148940; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Di Virgilio F, 2018, CURR OPIN IMMUNOL, V52, P51, DOI 10.1016/j.coi.2018.03.026; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Di Virgilio F, 2015, CURR MED CHEM, V22, P866; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Fryatt AG, 2019, J GEN PHYSIOL, V151, P146, DOI 10.1085/jgp.201812108; He ML, 2003, AM J PHYSIOL-CELL PH, V285, pC467, DOI 10.1152/ajpcell.00042.2003; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hille B., 2001, ION CHANNELS EXCITAB, P13; Janks L, 2019, J IMMUNOL, V202, P883, DOI 10.4049/jimmunol.1801101; Jimenez-Mateos EM, 2019, BRAIN RES BULL, V151, P153, DOI 10.1016/j.brainresbull.2018.12.008; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Lalo U, 2011, J BIOL CHEM, V286, P30591, DOI 10.1074/jbc.M111.253153; Li MF, 2015, NAT NEUROSCI, V18, P1577, DOI 10.1038/nn.4120; Liang X, 2015, J BIOL CHEM, V290, P7930, DOI 10.1074/jbc.M114.627810; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nicke A., 2018, OXFORD HDB NEURONAL, P1; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Pippel A, 2017, P NATL ACAD SCI USA, V114, pE2156, DOI 10.1073/pnas.1610414114; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Samways DSK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00006; Savio LEB, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00052; Schmid R, 2019, ANNU REV PHYSIOL, V81, P43, DOI 10.1146/annurev-physiol-020518-114259; Schwarz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041269; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Sluyter R, 2017, ADV EXP MED BIOL, V1051, P17, DOI 10.1007/5584_2017_59; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; Sperlagh B, 2014, TRENDS PHARMACOL SCI, V35, P537, DOI 10.1016/j.tips.2014.08.002; Stojilkovic SS, 2005, ANN NY ACAD SCI, V1048, P116, DOI 10.1196/annals.1342.011; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Taylor SRJ, 2008, J IMMUNOL, V180, P300, DOI 10.4049/jimmunol.180.1.300; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wen HR, 2009, J NEUROCHEM, V108, P331, DOI 10.1111/j.1471-4159.2008.05761.x; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Yan ZH, 2010, J NEUROSCI, V30, P14213, DOI 10.1523/JNEUROSCI.2390-10.2010; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458	51	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12521	12533		10.1074/jbc.RA119.009666	http://dx.doi.org/10.1074/jbc.RA119.009666			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248985	hybrid, Green Published			2022-12-28	WOS:000484402700022
J	Gottesman, S				Gottesman, Susan			Trouble is coming: Signaling pathways that regulate general stress responses in bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Hfq protein; RNA; RNA polymerase; prokaryotic signal-transduction; proteolysis; Escherichia coli (E; coli); anti-adaptor; ClpXP; general stress response; RpoS	PHASE SIGMA-FACTOR; TRANSFER-RNA MODIFICATION; CELL-ENVELOPE STRESS; ESCHERICHIA-COLI; STATIONARY-PHASE; BIOFILM FORMATION; RPOS TRANSLATION; SIGMA(S)-DEPENDENT GENES; BINDING PROTEIN; HOST FACTOR	Bacteria can rapidly and reversibly respond to changing environments via complex transcriptional and post-transcriptional regulatory mechanisms. Many of these adaptations are specific, with the regulatory output tailored to the inducing signal (for instance, repairing damage to cell components or improving acquisition and use of growth-limiting nutrients). However, the general stress response, activated in bacterial cells entering stationary phase or subjected to nutrient depletion or cellular damage, is unique in that its common, broad output is induced in response to many different signals. In many different bacteria, the key regulator for the general stress response is a specialized sigma factor, the promoter specificity subunit of RNA polymerase. The availability or activity of the sigma factor is regulated by complex regulatory circuits, the majority of which are post-transcriptional. In Escherichia coli, multiple small regulatory RNAs, each made in response to a different signal, positively regulate translation of the general stress response sigma factor RpoS. Stability of RpoS is regulated by multiple anti-adaptor proteins that are also synthesized in response to different signals. In this review, the modes of signaling to and levels of regulation of the E. coli general stress response are discussed. They are also used as a basis for comparison with the general stress response in other bacteria with the aim of extracting key principles that are common among different species and highlighting important unanswered questions.	[Gottesman, Susan] NCI, Lab Mol Biol, Ctr Canc Res, NIH, Bldg 37,Rm 5132, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gottesman, S (corresponding author), NCI, Lab Mol Biol, Ctr Canc Res, NIH, Bldg 37,Rm 5132, Bethesda, MD 20892 USA.	gottesms@mail.nih.gov			Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011203] Funding Source: NIH RePORTER	Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Amores G., 2017, THESIS; Amores GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17114-6; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Aubee JI, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7020039; Aubee JI, 2016, RNA, V22, P729, DOI 10.1261/rna.053165.115; BARTH M, 1995, J BACTERIOL, V177, P3455, DOI 10.1128/jb.177.12.3455-3464.1995; Battesti A, 2012, J BACTERIOL, V194, P2470, DOI 10.1128/JB.00132-12; Battesti A, 2015, P NATL ACAD SCI USA, V112, P5159, DOI 10.1073/pnas.1504639112; Battesti A, 2013, GENE DEV, V27, P2722, DOI 10.1101/gad.229617.113; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Becker G, 2000, MOL MICROBIOL, V35, P657, DOI 10.1046/j.1365-2958.2000.01736.x; Bertani I, 2003, ARCH MICROBIOL, V180, P264, DOI 10.1007/s00203-003-0586-8; Bouche S, 1998, MOL MICROBIOL, V27, P787, DOI 10.1046/j.1365-2958.1998.00725.x; Bougdour A, 2004, J BIOL CHEM, V279, P19540, DOI 10.1074/jbc.M314145200; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Bougdour A, 2008, MOL MICROBIOL, V68, P298, DOI 10.1111/j.1365-2958.2008.06146.x; Bougdour A, 2007, P NATL ACAD SCI USA, V104, P12896, DOI 10.1073/pnas.0705561104; Bouillet S, 2018, ENV MICROBIOL REP, V10, P127, DOI 10.1111/1758-2229.12620; Bouillet S, 2017, J BIOL CHEM, V292, P14921, DOI 10.1074/jbc.M117.781443; Bouillet S, 2016, J BIOL CHEM, V291, P26151, DOI 10.1074/jbc.M116.751933; Brown L, 1997, J BACTERIOL, V179, P656, DOI 10.1128/jb.179.3.656-662.1997; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; Chen JD, 2017, GENE DEV, V31, P1382, DOI 10.1101/gad.302547.117; Colland F, 2002, GENES CELLS, V7, P233, DOI 10.1046/j.1365-2443.2002.00517.x; Cronan J., 2005, ECOSAL PLUS, DOI [10.1128/ecosalplus.3.5.2, DOI 10.1128/ECOSALPLUS.3.5.2]; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; De Mets F, 2019, P NATL ACAD SCI USA, V116, P1043, DOI 10.1073/pnas.1815288116; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; Dorich V, 2019, GENE DEV, V33, P718, DOI 10.1101/gad.320168.118; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; Fan YQ, 2015, NUCLEIC ACIDS RES, V43, P1740, DOI 10.1093/nar/gku1404; Feklistov A, 2014, ANNU REV MICROBIOL, V68, P357, DOI 10.1146/annurev-micro-092412-155737; Francez-Charlot A, 2015, TRENDS MICROBIOL, V23, P164, DOI 10.1016/j.tim.2014.12.006; FUJITA M, 1994, MOL MICROBIOL, V13, P1071, DOI 10.1111/j.1365-2958.1994.tb00498.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gebhardt MJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00066-17; Girard ME, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00463-17; Gourse RL, 2018, ANNU REV MICROBIOL, V72, P163, DOI 10.1146/annurev-micro-090817-062444; Guo MY, 2015, J BACTERIOL, V197, P3317, DOI 10.1128/JB.00291-15; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Hamdallah I, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00520-18; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Helmann JD, 2019, MOL MICROBIOL, V112, P335, DOI 10.1111/mmi.14309; Hirsch M, 2005, J BACTERIOL, V187, P7204, DOI 10.1128/JB.187.21.7204-7213.2005; Hryckowian AJ, 2014, MBIO, V5, DOI 10.1128/mBio.01043-14; Nguyen HTB, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02488; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; Jorgensen F, 1999, MICROBIOL-UK, V145, P835, DOI 10.1099/13500872-145-4-835; KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; Keseler IM, 2017, NUCLEIC ACIDS RES, V45, pD543, DOI 10.1093/nar/gkw1003; Klauck E, 1997, MOL MICROBIOL, V25, P559, DOI 10.1046/j.1365-2958.1997.4911852.x; Klauck G, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180066; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Kuhlmann NJ, 2017, CURR OPIN MICROBIOL, V36, P118, DOI 10.1016/j.mib.2017.03.013; Kurylo CM, 2018, CELL REP, V25, P236, DOI 10.1016/j.celrep.2018.08.093; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; LANGE R, 1994, MOL MICROBIOL, V13, P733, DOI 10.1111/j.1365-2958.1994.tb00466.x; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Lease RA, 1998, P NATL ACAD SCI USA, V95, P12456, DOI 10.1073/pnas.95.21.12456; LI C, 1992, P NATL ACAD SCI USA, V89, P9885, DOI 10.1073/pnas.89.20.9885; Lori C, 2018, MBIO, V9, DOI 10.1128/mBio.00809-18; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Majdalani N, 2002, MOL MICROBIOL, V46, P813, DOI 10.1046/j.1365-2958.2002.03203.x; Majdalani N, 2001, MOL MICROBIOL, V39, P1382, DOI 10.1111/j.1365-2958.2001.02329.x; Mandel MJ, 2005, J BACTERIOL, V187, P434, DOI 10.1128/JB.187.2.434-442.2005; Mandin P, 2010, EMBO J, V29, P3094, DOI 10.1038/emboj.2010.179; MCCANN MP, 1993, J BACTERIOL, V175, P2143, DOI 10.1128/JB.175.7.2143-2149.1993; Melamed S, 2016, MOL CELL, V63, P884, DOI 10.1016/j.molcel.2016.07.026; Merrikh H, 2009, J BACTERIOL, V191, P7436, DOI 10.1128/JB.00412-09; Merrikh H, 2009, P NATL ACAD SCI USA, V106, P611, DOI 10.1073/pnas.0803665106; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; Mika F, 2014, RNA BIOL, V11, P494, DOI 10.4161/rna.28867; Mika F, 2013, INT J MOL SCI, V14, P4560, DOI 10.3390/ijms14034560; Mika F, 2012, MOL MICROBIOL, V84, P51, DOI 10.1111/j.1365-2958.2012.08002.x; Monteiro C, 2012, RNA BIOL, V9, P489, DOI 10.4161/rna.19682; Moon K, 2011, MOL MICROBIOL, V82, P1545, DOI 10.1111/j.1365-2958.2011.07907.x; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Muffler A, 1996, EMBO J, V15, P1333, DOI 10.1002/j.1460-2075.1996.tb00475.x; MULVEY MR, 1988, GENE, V73, P337, DOI 10.1016/0378-1119(88)90498-2; Nadezhdin EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025418; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Papenfort K, 2009, MOL MICROBIOL, V74, P139, DOI 10.1111/j.1365-2958.2009.06857.x; Park H, 2017, MBIO, V8, DOI 10.1128/mBio.01355-17; Parker A, 2017, MOL MICROBIOL, V105, P309, DOI 10.1111/mmi.13702; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Paulander W, 2009, GENETICS, V183, P539, DOI 10.1534/genetics.109.106104; Peano C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10469; Peterson CN, 2012, GENE DEV, V26, P548, DOI 10.1101/gad.183517.111; Peterson CN, 2004, J BACTERIOL, V186, P7403, DOI 10.1128/JB.186.21.7403-7410.2004; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Pratt LA, 1996, P NATL ACAD SCI USA, V93, P2488, DOI 10.1073/pnas.93.6.2488; Ranquet C, 2007, J BACTERIOL, V189, P4872, DOI 10.1128/JB.01838-06; Repoila F, 2003, J BACTERIOL, V185, P6609, DOI 10.1128/JB.185.22.6609-6614.2003; Repoila F, 2001, J BACTERIOL, V183, P4012, DOI 10.1128/JB.183.13.4012-4023.2001; Roberts J. W., 2019, J MOL BIOL, V2019; Romeo T, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0009-2017; Sanchez-Vazquez P, 2019, P NATL ACAD SCI USA, V116, P8310, DOI 10.1073/pnas.1819682116; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Sedlyarova N, 2016, CELL, V167, P111, DOI 10.1016/j.cell.2016.09.004; Simm R, 2014, FUTURE MICROBIOL, V9, P1261, DOI [10.2217/FMB.14.88, 10.2217/fmb.14.88]; Singh K, 2016, ANNU REV MICROBIOL, V70, P199, DOI 10.1146/annurev-micro-102215-095301; SLEDJESKI D, 1995, P NATL ACAD SCI USA, V92, P2003, DOI 10.1073/pnas.92.6.2003; Sledjeski DD, 1996, EMBO J, V15, P3993, DOI 10.1002/j.1460-2075.1996.tb00773.x; Sledjeski DD, 2001, J BACTERIOL, V183, P1997, DOI 10.1128/JB.183.6.1997-2005.2001; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TAKAYANAGI Y, 1994, MOL GEN GENET, V243, P525, DOI 10.1007/BF00284200; Thompson KM, 2014, J BACTERIOL, V196, P754, DOI 10.1128/JB.01013-13; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629; Updegrove TB, 2016, CURR OPIN MICROBIOL, V30, P133, DOI 10.1016/j.mib.2016.02.003; Wall E, 2018, ANNU REV MICROBIOL, V72, P111, DOI 10.1146/annurev-micro-090817-062640; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Wassarman KM, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0019-2018; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wong GT, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00755-16; Yoshida H, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00057-18; Zhang AX, 1998, EMBO J, V17, P6061, DOI 10.1093/emboj/17.20.6061; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	134	86	86	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11685	11700		10.1074/jbc.REV119.005593	http://dx.doi.org/10.1074/jbc.REV119.005593			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31197038	hybrid, Green Published			2022-12-28	WOS:000486127800006
J	Andrews, SS; Schaefer-Ramadan, S; Al-Thani, NM; Ahmed, I; Mohamoud, YA; Malek, JA				Andrews, Simeon S.; Schaefer-Ramadan, Stephanie; Al-Thani, Nayra M.; Ahmed, Ikhlak; Mohamoud, Yasmin A.; Malek, Joel A.			High-resolution protein-protein interaction mapping using all-versus-all sequencing (AVA-Seq)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; Helicobacter pylori; functional genomics; structure-function; molecular genetics; interactome; next generation sequencing; two-hybrid	P53 TUMOR-SUPPRESSOR; CRYSTAL-STRUCTURE; COMPLEXES; SYSTEM	Two-hybrid systems can be used for investigating protein-protein interactions and may provide important information about gene products with unknown function. Despite their success in mapping protein interactions, two-hybrid systems have remained mostly untouched by improvements in next-generation DNA sequencing. The two-hybrid systems rely on one-versus-all methods in which each bait is sequentially screened against an entire library. Here, we developed a screening method that joins both bait and prey as a convergent fusion into one bacterial plasmid vector that can then be amplified and paired-end sequencing by next-generation sequencing (NGS). Our method enables all-versus-all sequencing (AVA-Seq) and utilizes NGS to remove multiple bottlenecks of the two-hybrid system. AVA-Seq allows for high-resolution protein-protein interaction mapping of a small set of proteins and has the potential for lower-resolution mapping of entire proteomes. Features of the system include ORF selection to improve efficiency, high bacterial transformation efficiency, a convergent fusion vector to allow paired-end sequencing of interactors, and the use of protein fragments rather than full-length proteins to better resolve specific protein contact points. We demonstrate the system's strengths and limitations on a set of proteins known to interact in humans and provide a framework for future large-scale projects.	[Andrews, Simeon S.; Schaefer-Ramadan, Stephanie; Al-Thani, Nayra M.; Ahmed, Ikhlak; Malek, Joel A.] Weill Cornell Med Qatar, Dept Genet Med, Doha 24144, Qatar; [Mohamoud, Yasmin A.; Malek, Joel A.] Weill Cornell Med Qatar, Genom Lab, Doha 24144, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Malek, JA (corresponding author), Weill Cornell Med Qatar, Dept Genet Med, Doha 24144, Qatar.	jom2042@qatar-med.cornell.edu	Ramadan, Stephanie/AAX-4548-2020	Ramadan, Stephanie/0000-0001-9650-1472; Malek, Joel/0000-0002-1516-8477	Qatar Foundation Biomedical Research Program (BMRP) grant; Weill Cornell Medicine in Qatar pilot grant	Qatar Foundation Biomedical Research Program (BMRP) grant(Qatar National Research Fund (QNRF)); Weill Cornell Medicine in Qatar pilot grant	This work was supported by a Qatar Foundation Biomedical Research Program (BMRP) grant and a Weill Cornell Medicine in Qatar pilot grant. The authors declare that they have no conflicts of interest with the contents of this article.	Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Di Niro R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq052; Dove Simon L, 2004, Methods Mol Biol, V261, P231; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Goldsmith M, 2007, PROTEIN ENG DES SEL, V20, P315, DOI 10.1093/protein/gzm026; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lewis JD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-8; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin ML, 1996, MOL CELL BIOL, V16, P2110; Meng X, 2014, CANCER RES, V74, P7161, DOI 10.1158/0008-5472.CAN-14-1446; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; SCOTT JD, 1990, J BIOL CHEM, V265, P21561; Suter B, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00346; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yachie N, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156660	18	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11549	11558		10.1074/jbc.RA119.008792	http://dx.doi.org/10.1074/jbc.RA119.008792			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31182485	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000478717600017
J	Nambi, S; Gupta, K; Bhattacharyya, M; Ramakrishnan, P; Ravikumar, V; Siddiqui, N; Thomas, AT; Visweswariah, SS				Nambi, Subhalaxmi; Gupta, Kallol; Bhattacharyya, Moitrayee; Ramakrishnan, Parvathy; Ravikumar, Vaishnavi; Siddiqui, Nida; Thomas, Ann Terene; Visweswariah, Sandhya S.			Cyclic AMP-dependent protein lysine acylation in mycobacteria regulates fatty acid and propionate metabolism (vol 288, pg 14114, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Gupta, Kallol/0000-0002-3557-3242; Visweswariah, Sandhya/0000-0003-2786-7344				Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					11046	11046		10.1074/jbc.AAC119.009859	http://dx.doi.org/10.1074/jbc.AAC119.009859			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31300591	Green Published, hybrid			2022-12-28	WOS:000478717200025
J	Froula, JM; Castellana-Cruz, M; Anabtawi, NM; Camino, JD; Chen, SW; Thrasher, DR; Freire, J; Yazdi, AA; Fleming, S; Dobson, CM; Kumita, JR; Cremades, N; Volpicelli-Daley, LA				Froula, Jessica M.; Castellana-Cruz, Marta; Anabtawi, Nadia M.; Camino, Jose D.; Chen, Serene W.; Thrasher, Drake R.; Freire, Jennifer; Yazdi, Allen A.; Fleming, Sheila; Dobson, Christopher M.; Kumita, Janet R.; Cremades, Nunilo; Volpicelli-Daley, Laura A.			Defining alpha-synuclein species responsible for Parkinson's disease phenotypes in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein; Parkinson's disease; amyloid; protein aggregation; neurodegenerative disease; cytotoxicity; fibril; Lewy body; motor-behavior defect; oligomer	ANTIPARALLEL BETA-SHEET; LEWY BODY; OLIGOMERS; FIBRILS; SEEDS; NEURODEGENERATION; TRANSMISSION; PROPAGATION; DYSFUNCTION; AGGREGATION	Parkinson's disease (PD) is a neurodegenerative disorder characterized by fibrillar neuronal inclusions composed of aggregated alpha-synuclein (alpha-syn). These inclusions are associated with behavioral and pathological PD phenotypes. One strategy for therapeutic interventions is to prevent the formation of these inclusions to halt disease progression. alpha-Synuclein exists in multiple structural forms, including disordered, nonamyloid oligomers, ordered amyloid oligomers, and fibrils. It is critical to understand which conformers contribute to specific PD phenotypes. Here, we utilized a mouse model to explore the pathological effects of stable beta-amyloid-sheet oligomers compared with those of fibrillar alpha-synuclein. We biophysically characterized these species with transmission EM, atomic-force microscopy, CD spectroscopy, FTIR spectroscopy, analytical ultracentrifugation, and thioflavin T assays. We then injected these different alpha-synuclein forms into the mouse striatum to determine their ability to induce PD-related phenotypes. We found that beta-sheet oligomers produce a small but significant loss of dopamine neurons in the substantia nigra pars compacta (SNc). Injection of small beta-sheet fibril fragments, however, produced the most robust phenotypes, including reduction of striatal dopamine terminals, SNc loss of dopamine neurons, and motor-behavior defects. We conclude that although the beta-sheet oligomers cause some toxicity, the potent effects of the short fibrillar fragments can be attributed to their ability to recruit monomeric alpha-synuclein and spread in vivo and hence contribute to the development of PD-like phenotypes. These results suggest that strategies to reduce the formation and propagation of beta-sheet fibrillar species could be an important route for therapeutic intervention in PD and related disorders.	[Froula, Jessica M.; Thrasher, Drake R.; Freire, Jennifer; Yazdi, Allen A.; Volpicelli-Daley, Laura A.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA; [Anabtawi, Nadia M.; Camino, Jose D.; Cremades, Nunilo] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit BIFI IQFR CSIC, Zaragoza 50018, Spain; [Castellana-Cruz, Marta; Chen, Serene W.; Dobson, Christopher M.; Kumita, Janet R.] Univ Cambridge, Ctr Misfolding Dis, Dept Chem, Cambridge CB2 1EW, England; [Fleming, Sheila] Northeast Ohio Med Univ, Dept Pharmaceut Sci, Rootstown, OH 44272 USA	University of Alabama System; University of Alabama Birmingham; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Cambridge; Northeast Ohio Medical University (NEOMED)	Volpicelli-Daley, LA (corresponding author), Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA.; Cremades, N (corresponding author), Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit BIFI IQFR CSIC, Zaragoza 50018, Spain.	ncc@unizar.es; lvolpicellidaley@uabmc.edu	Camino, José Daniel/AFR-1589-2022; Kumita, Janet/AAO-5254-2021; Cremades, Nunilo/F-9634-2015	Yazdi, Allen/0000-0002-4536-7346; Chen, Serene W/0000-0001-7084-5621; Cremades, Nunilo/0000-0002-9138-6687; Freire, Jennifer/0000-0002-6811-7438; Froula, Jessica/0000-0003-0738-904X	Michael J. Fox Foundation; Alabama Udall Center [P50NS108675]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS108675] Funding Source: NIH RePORTER	Michael J. Fox Foundation; Alabama Udall Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Michael J. Fox Foundation (to L.V.-D. and N.C.) and Grant P50NS108675 (Alabama Udall Center). The authors declare that they have no conflicts of interest with the contents of this article.	Abdelmotilib H, 2017, NEUROBIOL DIS, V105, P84, DOI 10.1016/j.nbd.2017.05.014; Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Angelova PR, 2016, J CELL SCI, V129, P1792, DOI 10.1242/jcs.180737; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chang E, 2008, ANAL BIOCHEM, V373, P330, DOI 10.1016/j.ab.2007.09.015; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Cremades N, 2018, NEUROBIOL DIS, V109, P178, DOI 10.1016/j.nbd.2017.07.009; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Deas E, 2016, ANTIOXID REDOX SIGN, V24, P376, DOI 10.1089/ars.2015.6343; Dettmer U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8314; Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634; Dirr ER, 2018, BEHAV BRAIN RES, V343, P41, DOI 10.1016/j.bbr.2018.01.029; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Fusco G, 2017, SCIENCE, V358, P1440, DOI 10.1126/science.aan6160; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Hersch SM, 1997, J COMP NEUROL, V388, P211; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Karpowicz RJ, 2017, J BIOL CHEM, V292, P13482, DOI 10.1074/jbc.M117.780296; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kuusisto E, 2003, J NEUROPATH EXP NEUR, V62, P1241, DOI 10.1093/jnen/62.12.1241; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Luk KC, 2016, CELL REP, V16, P3373, DOI 10.1016/j.celrep.2016.08.053; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Masuda-Suzukake M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0088-8; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Melki R, 2018, NEUROBIOL DIS, V109, P201, DOI 10.1016/j.nbd.2017.03.011; Mor DE, 2017, NAT NEUROSCI, V20, P1560, DOI 10.1038/nn.4641; OGAWA N, 1985, RES COMMUN CHEM PATH, V50, P435; Osterberg VR, 2015, CELL REP, V10, P1252, DOI 10.1016/j.celrep.2015.01.060; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Paumier KL, 2015, NEUROBIOL DIS, V82, P185, DOI 10.1016/j.nbd.2015.06.003; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Polinski NK, 2018, J PARKINSON DIS, V8, P303, DOI 10.3233/JPD-171248; Popova B, 2015, BIOMOLECULES, V5, P617, DOI 10.3390/biom5020617; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Rey NL, 2016, J EXP MED, V213, P1759, DOI 10.1084/jem.20160368; Rutherford NJ, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0357-9; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shrivastava AN, 2015, EMBO J, V34, P2408, DOI 10.15252/embj.201591397; Celej MS, 2012, BIOCHEM J, V443, P719, DOI 10.1042/BJ20111924; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tarutani A, 2016, J BIOL CHEM, V291, P18675, DOI 10.1074/jbc.M116.734707; Vargas KJ, 2017, CELL REP, V18, P161, DOI 10.1016/j.celrep.2016.12.023; Volpicelli-Daley Laura, 2018, Handb Clin Neurol, V153, P321, DOI 10.1016/B978-0-444-63945-5.00017-9; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Volpicelli-Daley Laura A, 2004, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0102s25; Weihofen A, 2019, NEUROBIOL DIS, V124, P276, DOI 10.1016/j.nbd.2018.10.016; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xu GL, 2002, ALZ DIS ASSOC DIS, V16, P191, DOI 10.1097/00002093-200207000-00010; Zharikov AD, 2015, J CLIN INVEST, V125, P2721, DOI 10.1172/JCI64502	58	58	58	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10392	10406		10.1074/jbc.RA119.007743	http://dx.doi.org/10.1074/jbc.RA119.007743			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31142553	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000478717100002
J	Zhao, PS; Pattison, LA; Jensen, DD; Jimenez-Vargas, NN; Latorre, R; Lieu, T; Jaramillo, JO; Lopez-Lopez, C; Poole, DP; Vanner, SJ; Schmidt, BL; Bunnett, NW				Zhao, Peishen; Pattison, Luke A.; Jensen, Dane D.; Jimenez-Vargas, Nestor N.; Latorre, Rocco; Lieu, TinaMarie; Jaramillo, Josue O.; Lopez-Lopez, Cintya; Poole, Daniel P.; Vanner, Stephen J.; Schmidt, Brian L.; Bunnett, Nigel W.			Protein kinase D and G beta gamma mediate sustained nociceptive signaling by biased agonists of protease-activated receptor-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); Golgi; pain; protease; protein kinase D (PKD); signal transduction; trafficking; F2R-like trypsin receptor; nociception; proteinase-activated receptor-2; G beta gamma	ARRESTIN-DEPENDENT ENDOCYTOSIS; G(Q)-COUPLED RECEPTORS; MEMBRANE-PROTEIN; LOOP SER(744); GOLGI; DOMAIN; TRANSLOCATION; STIMULATION; TRAFFICKING; SELECTIVITY	Proteases sustain hyperexcitability and pain by cleaving protease-activated receptor-2 (PAR(2)) on nociceptors through distinct mechanisms. Whereas trypsin induces PAR(2) coupling to G alpha(q), G alpha(s), and beta-arrestins, cathepsin-S (CS) and neutrophil elastase (NE) cleave PAR(2) at distinct sites and activate it by biased mechanisms that induce coupling to G alpha(s), but not to G alpha(q) or beta-arrestins. Because proteases activate PAR(2) by irreversible cleavage, and activated PAR(2) is degraded in lysosomes, sustained extracellular protease-mediated signaling requires mobilization of intact PAR(2) from the Golgi apparatus or de novo synthesis of new receptors by incompletely understood mechanisms. We found here that trypsin, CS, and NE stimulate PAR(2)-dependent activation of protein kinase D (PKD) in the Golgi of HEK293 cells, in which PKD regulates protein trafficking. The proteases stimulated translocation of the PKD activator G beta gamma to the Golgi, coinciding with PAR(2) mobilization from the Golgi. Proteases also induced translocation of a photoconverted PAR(2)-Kaede fusion protein from the Golgi to the plasma membrane of KNRK cells. After incubation of HEK293 cells and dorsal root ganglia neurons with CS, NE, or trypsin, PAR(2) responsiveness initially declined, consistent with PAR(2) cleavage and desensitization, and then gradually recovered. Inhibitors of PKD, G beta gamma, and protein translation inhibited recovery of PAR(2) responsiveness. PKD and G beta gamma inhibitors also attenuated protease-evoked mechanical allodynia in mice. We conclude that proteases that activate PAR(2) by canonical and biased mechanisms stimulate PKD in the Golgi; PAR(2) mobilization and de novo synthesis repopulate the cell surface with intact receptors and sustain nociceptive signaling by extracellular proteases.	[Zhao, Peishen; Pattison, Luke A.; Lieu, TinaMarie; Poole, Daniel P.; Bunnett, Nigel W.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Zhao, Peishen; Pattison, Luke A.; Lieu, TinaMarie; Poole, Daniel P.; Bunnett, Nigel W.] Monash Univ, Australian Res Council Ctr Excellence Convergent, Parkville, Vic 3052, Australia; [Jensen, Dane D.; Latorre, Rocco] Columbia Univ, Vagelos Coll Phys & Surg, Dept Surg, New York, NY 10032 USA; [Jensen, Dane D.; Latorre, Rocco] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Jimenez-Vargas, Nestor N.; Jaramillo, Josue O.; Lopez-Lopez, Cintya; Vanner, Stephen J.] Queens Univ, Div Gastroenterol, Gastrointestinal Dis Res Unit, Kingston, ON K7L 3N6, Canada; [Schmidt, Brian L.] NYU, Bluestone Ctr Clin Res, Coll Dent, New York, NY 10010 USA	Monash University; Monash University; Columbia University; Columbia University; Queens University - Canada; New York University	Bunnett, NW (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, 21 Audubon Av,Rm 209, New York, NY 10032 USA.	nb2733@cumc.columbia.edu	Zhao, Peishen/AFQ-6840-2022; Poole, Daniel/AET-6645-2022; Lieu, TinaMarie/AAM-7691-2020; Polanco, Josue O Jaramillo/Q-3718-2016	Poole, Daniel/0000-0002-6168-8422; Polanco, Josue O Jaramillo/0000-0002-4444-6149; Jensen, Dane D./0000-0001-6540-2375; Jimenez-Vargas, Nestor N/0000-0001-6595-1884; Bunnett, Nigel W./0000-0003-3367-0644; Zhao, Peishen/0000-0003-0185-0595; Pattison, Luke/0000-0001-8571-3314	National Institutes of Health [NS102722, DE026806, DK118971]; Department of Defense [W81XWH1810431]; National Health and Medical Research Council [63303, 1049682, 1031886]; Takeda Pharmaceuticals Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE026806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Takeda Pharmaceuticals Inc.(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants NS102722, DE026806, and DK118971; Department of Defense Grant W81XWH1810431 (to N. W. B. and B. L. S.); and National Health and Medical Research Council Grants 63303, 1049682, and 1031886) (to N. W. B.). Nigel Bunnett is a founding scientist of Endosome Therapeutics Inc. Research in Nigel Bunnett's laboratory was funded in part by Takeda Pharmaceuticals Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Amadesi S, 2009, J COMP NEUROL, V516, P141, DOI 10.1002/cne.22104; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banting G, 1997, BBA-MOL CELL RES, V1355, P209, DOI 10.1016/S0167-4889(96)00146-2; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jensen DD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3447; Jensen DD, 2016, J BIOL CHEM, V291, P11285, DOI 10.1074/jbc.M115.710681; Jimenez-Vargas NN, 2018, P NATL ACAD SCI USA, V115, pE7438, DOI 10.1073/pnas.1721891115; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Muniz M, 1997, P NATL ACAD SCI USA, V94, P14461, DOI 10.1073/pnas.94.26.14461; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Poole DP, 2008, AM J PHYSIOL-GASTR L, V294, pG1245, DOI 10.1152/ajpgi.00521.2007; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Coria AS, 2014, BIOL CELL, V106, P30, DOI 10.1111/boc.201300052; von Zastrow M, 2003, CURR OPIN NEUROBIOL, V13, P348, DOI 10.1016/S0959-4388(03)00069-2; Waldron RT, 2012, CELL SIGNAL, V24, P914, DOI 10.1016/j.cellsig.2011.12.014; Yarwood RE, 2017, P NATL ACAD SCI USA, V114, P12309, DOI 10.1073/pnas.1706656114; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736; Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712	43	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10649	10662		10.1074/jbc.RA118.006935	http://dx.doi.org/10.1074/jbc.RA118.006935			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31142616	Green Published, hybrid			2022-12-28	WOS:000478717100023
J	Wang, XP; Im, SJ; Balchak, DM; Montalbetti, N; Carattino, MD; Ray, EC; Kashlan, OB				Wang, Xue-Ping; Im, Seohyun Janice; Balchak, Deidra M.; Montalbetti, Nicolas; Carattino, Marcelo D.; Ray, Evan C.; Kashlan, Ossama B.			Murine epithelial sodium (Na+) channel regulation by biliary factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); bile acid; protein palmitoylation; allosteric regulation; proteolysis; renal physiology; bililrubin; cholic acid; degenerin family; kidney tubule; physico-chemical properties; trimeric cation channel	BILE CAST NEPHROPATHY; GAMMA-SUBUNIT; NUCLEAR RECEPTOR; ACID METABOLISM; DISTAL NEPHRON; ALPHA-SUBUNIT; DOMINANT ROLE; ENAC; ACTIVATION; PALMITOYLATION	The epithelial sodium channel (ENaC) mediates Na+ transport in several epithelia, including the aldosterone-sensitive distal nephron, distal colon, and biliary epithelium. Numerous factors regulate ENaC activity, including extracellular ligands, post-translational modifications, and membrane-resident lipids. However, ENaC regulation by bile acids and conjugated bilirubin, metabolites that are abundant in the biliary tree and intestinal tract and are sometimes elevated in the urine of individuals with advanced liver disease, remains poorly understood. Here, using a Xenopus oocyte-based system to express and functionally study ENaC, we found that, depending on the bile acid used, bile acids both activate and inhibit mouse ENaC. Whether bile acids were activating or inhibiting was contingent on the position and orientation of specific bile acid moieties. For example, a hydroxyl group at the 12-position and facing the hydrophilic side (12 alpha-OH) was activating. Taurine-conjugated bile acids, which have reduced membrane permeability, affected ENaC activity more strongly than did their more membrane-permeant unconjugated counterparts, suggesting that bile acids regulate ENaC extracellularly. Bile acid-dependent activation was enhanced by amino acid substitutions in ENaC that depress open probability and was precluded by proteolytic cleavage that increases open probability, consistent with an effect of bile acids on ENaC open probability. Bile acids also regulated ENaC in a cortical collecting duct cell line, mirroring the results in Xenopus oocytes. We also show that bilirubin conjugates activate ENaC. These results indicate that ENaC responds to compounds abundant in bile and that their ability to regulate this channel depends on the presence of specific functional groups.	[Wang, Xue-Ping; Im, Seohyun Janice; Balchak, Deidra M.; Montalbetti, Nicolas; Carattino, Marcelo D.; Ray, Evan C.; Kashlan, Ossama B.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, 5828B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol & Mol Physiol, Pittsburgh, PA 15261 USA; [Kashlan, Ossama B.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kashlan, OB (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, 5828B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	obk2@pitt.edu	Montalbetti, Nicolas/T-4212-2019; Wang, Xueping/AAF-2215-2020	Montalbetti, Nicolas/0000-0003-2897-9540; Ray, Evan/0000-0003-1491-4869; Wang, Xueping/0000-0003-1102-0392	NIDDK, National Institutes of Health [P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK098204] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Pittsburgh Center for Kidney Research was supported by NIDDK, National Institutes of Health, Grant P30 DK079307.	Ahn YJ, 1999, AM J PHYSIOL-RENAL, V277, pF121, DOI 10.1152/ajprenal.1999.277.1.F121; Balchak DM, 2018, J BIOL CHEM, V293, P16217, DOI 10.1074/jbc.RA118.004362; Bohnert BN, 2018, KIDNEY INT, V93, P159, DOI 10.1016/j.kint.2017.07.023; Boscardin E, 2016, BRIT J PHARMACOL, V173, P2671, DOI 10.1111/bph.13533; Brandl K, 2018, J HEPATOL, V69, P396, DOI 10.1016/j.jhep.2018.03.031; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Cavanaugh C, 2019, AM J KIDNEY DIS, V73, P258, DOI 10.1053/j.ajkd.2018.07.012; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Enright EF, 2017, MOL PHARMACEUT, V14, P1251, DOI 10.1021/acs.molpharmaceut.6b01155; Frindt G, 2018, J PHYSIOL-LONDON, V596, P3585, DOI 10.1113/JP275988; Frindt G, 2017, AM J PHYSIOL-RENAL, V313, pF62, DOI 10.1152/ajprenal.00668.2016; Frindt G, 2015, AM J PHYSIOL-RENAL, V308, pF572, DOI 10.1152/ajprenal.00585.2014; Ghosh A, 2015, CELL MOL LIFE SCI, V72, P3637, DOI 10.1007/s00018-015-1946-7; Hernaez R, 2017, GUT, V66, P541, DOI 10.1136/gutjnl-2016-312670; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ilyaskin AV, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13132; Ilyaskin AV, 2016, J BIOL CHEM, V291, P19835, DOI 10.1074/jbc.M116.726471; Jiao N, 2018, GUT, V67, P1881, DOI 10.1136/gutjnl-2017-314307; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kashlan OB, 2012, J BIOL CHEM, V287, P20720, DOI 10.1074/jbc.M112.358218; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Koyama K, 1999, AM J PHYSIOL-GASTR L, V276, pG975, DOI 10.1152/ajpgi.1999.276.4.G975; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lapidus A, 2006, WORLD J GASTROENTERO, V12, P70, DOI 10.3748/wjg.v12.i1.70; Li Q, 2016, HEPATOLOGY, V63, P538, DOI 10.1002/hep.28301; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Memon N, 2016, PEDIATR RES, V79, P378, DOI 10.1038/pr.2015.247; Miura R, 2011, HEPATOL RES, V41, P358, DOI 10.1111/j.1872-034X.2011.00779.x; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; Mukherjee A, 2017, J BIOL CHEM, V292, P4152, DOI 10.1074/jbc.M117.776146; Mukherjee A, 2014, J BIOL CHEM, V289, P14351, DOI 10.1074/jbc.M113.526020; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Patel J, 2016, WORLD J GASTROENTERO, V22, P6328, DOI 10.3748/wjg.v22.i27.6328; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; RODA A, 1990, J LIPID RES, V31, P1433; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Schlattjan JH, 2003, NEPHRON PHYSIOL, V95, P49, DOI DOI 10.1159/000074330; Schmidt A, 2018, BIOPHYS J, V114, P1321, DOI 10.1016/j.bpj.2018.01.028; Schmidt A, 2016, J BIOL CHEM, V291, P24551, DOI 10.1074/jbc.M116.756437; Sequeira A, 2015, HEMODIAL INT, V19, P132, DOI 10.1111/hdi.12169; Simko V, 1998, HEPATO-GASTROENTEROL, V45, P1706; Singal AK, 2018, AM J GASTROENTEROL, V113, P175, DOI 10.1038/ajg.2017.469; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; SOLER NG, 1976, GUT, V17, P152, DOI 10.1136/gut.17.2.152; Stockand JD, 2010, J AM SOC NEPHROL, V21, P1903, DOI 10.1681/ASN.2010040377; Sullivan JI, 2017, CURR OPIN GASTROEN, V33, P164, DOI 10.1097/MOG.0000000000000354; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Toney GM, 2012, CURR OPIN NEPHROL HY, V21, P52, DOI 10.1097/MNH.0b013e32834db4a0; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wensing G, 1997, HEPATOLOGY, V26, P1149; Wiemuth D, 2014, PFLUG ARCH EUR J PHY, V466, P1725, DOI 10.1007/s00424-013-1403-0; Wiemuth D, 2014, CHANNELS, V8, P29, DOI 10.4161/chan.27493; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; WONG F, 1994, HEPATOLOGY, V20, P873, DOI 10.1002/hep.1840200415; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Yang L, 2018, AM J PHYSIOL-RENAL, V315, pF1032, DOI 10.1152/ajprenal.00117.2018	70	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10182	10193		10.1074/jbc.RA119.007394	http://dx.doi.org/10.1074/jbc.RA119.007394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31092599	hybrid, Green Published			2022-12-28	WOS:000474445600012
J	Haroth, S; Feussner, K; Kelly, AA; Zienkiewicz, K; Shaikhqasem, A; Herrfurth, C; Feussner, I				Haroth, Sven; Feussner, Kirstin; Kelly, Amelie A.; Zienkiewicz, Krzysztof; Shaikhqasem, Alaa; Herrfurth, Cornelia; Feussner, Ivo			The glycosyltransferase UGT76E1 significantly contributes to 12-O-glucopyranosyl-jasmonic acid formation in wounded Arabidopsis thaliana leaves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; glycosyltransferase; phytohormone; plant defense; CRISPR; Cas; oxylipin	SALICYLIC-ACID; VACUOLAR LOCALIZATION; STRESS-RESPONSE; JASMONIC ACID; L-ISOLEUCINE; GUIDE RNA; CRISPR-P; GLUCOSYLTRANSFERASE; IDENTIFICATION; METABOLISM	Jasmonoyl-isoleucine (JA-Ile) is a phytohormone that orchestrates plant defenses in response to wounding, feeding insects, or necrotrophic pathogens. JA-Ile metabolism has been studied intensively, but its catabolism as a potentially important mechanism for the regulation of JA-Ile-mediated signaling is not well-understood. Especially the enzyme(s) responsible for specifically glycosylating 12-hydroxy-jasmonic acid (12-OH-JA) and thereby producing 12-O-glucopyranosyl-jasmonic acid (12-O-Glc-JA) is still elusive. Here, we used co-expression analyses of available Arabidopsis thaliana transcriptomic data, identifying four UDP-dependent glycosyltransferase (UGT) genes as wound-induced and 12-OH-JA-related, namely, UGT76E1, UGT76E2, UGT76E11, and UGT76E12. We heterologously expressed and purified the corresponding proteins to determine their individual substrate specificities and kinetic parameters. We then used an ex vivo metabolite-fingerprinting approach to investigate these proteins in conditions as close as possible to their natural environment, with an emphasis on greatly extending the range of potential substrates. As expected, we found that UGT76E1 and UGT76E2 are 12-OH-JA-UGTs, with UGT76E1 contributing a major in vivo UGT activity, as deduced from Arabidopsis mutants with abolished or increased UGT gene expression. In contrast, recombinant UGT76E11 acted on an unidentified compound and also glycosylated two other oxylipins, 11-hydroxy-7,9,13-hexadecatrienoic acid (11-HHT) and 13-hydroxy-9,11,15-octadecatrienoic acid (13-HOT), which were also accepted by recombinant UGT76E1, UGT76E2, and UGT76E12 enzymes. UGT76E12 glycosylated 12-OH-JA only to a low extent, but also accepted an artificial hydroxylated fatty acid and low amounts of kaempferol. In conclusion, our findings have elucidated the missing step in the wound-induced synthesis of 12-O-glucopyranosyl-jasmonic acid in A. thaliana.	[Haroth, Sven; Feussner, Kirstin; Kelly, Amelie A.; Zienkiewicz, Krzysztof; Shaikhqasem, Alaa; Herrfurth, Cornelia; Feussner, Ivo] Univ Goettingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Justus von Liebig Weg 11, D-37077 Gottingen, Germany; [Feussner, Kirstin; Herrfurth, Cornelia] Univ Goettingen, Serv Unit Metabol & Lipid, Goettingen Ctr Mol Biosci GZMB, D-37077 Gottingen, Germany; [Feussner, Ivo] Univ Goettingen, Dept Plant Biochem, Goettingen Ctr Mol Biosci GZMB, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Feussner, I (corresponding author), Univ Goettingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	ifeussn@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003	Deutsche Forschungsgemeinschaft (DFG) [IRTG 2172, ZUK 45/2010, INST 186/822-1]; Gottingen Graduate School of Neuroscience and Molecular Biology (GGNB)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gottingen Graduate School of Neuroscience and Molecular Biology (GGNB)	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants IRTG 2172 "PRoTECT", ZUK 45/2010, and INST 186/822-1 and the "PRoTECT" program of the Gottingen Graduate School of Neuroscience and Molecular Biology (GGNB) (to S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreou AZ, 2009, LIPIDS, V44, P207, DOI 10.1007/s11745-008-3264-4; Augustin JM, 2012, PLANT PHYSIOL, V160, P1881, DOI 10.1104/pp.112.202747; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Brown C, 2012, NAT PROTOC, V7, P1634, DOI 10.1038/nprot.2012.089; Bruckhoff V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159875; Caarls L, 2017, P NATL ACAD SCI USA, V114, P6388, DOI 10.1073/pnas.1701101114; Chini A, 2018, NAT CHEM BIOL, V14, P171, DOI [10.1038/NCHEMBIO.2540, 10.1038/nchembio.2540]; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dean JV, 2005, PLANTA, V221, P287, DOI 10.1007/s00425-004-1430-3; Dean JV, 2003, PHYSIOL PLANTARUM, V118, P328, DOI 10.1034/j.1399-3054.2003.00117.x; Ding YD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00703; GERWICK WH, 1991, ARCH BIOCHEM BIOPHYS, V290, P436, DOI 10.1016/0003-9861(91)90563-X; Gidda SK, 2003, J BIOL CHEM, V278, P17895, DOI 10.1074/jbc.M211943200; Guo Q, 2018, CURR OPIN PLANT BIOL, V44, P72, DOI 10.1016/j.pbi.2018.02.009; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Hillwig MS, 2008, MOL GENET GENOMICS, V280, P249, DOI 10.1007/s00438-008-0360-3; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Huang FC, 2015, J BIOTECHNOL, V216, P100, DOI 10.1016/j.jbiotec.2015.10.011; Ito T, 2002, PLANT PHYSIOL, V129, P1695, DOI 10.1104/pp.002774; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaever A, 2015, METABOLOMICS, V11, P764, DOI 10.1007/s11306-014-0734-y; Kaever A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089297; Kai K, 2010, PHYTOCHEMISTRY, V71, P1168, DOI 10.1016/j.phytochem.2010.04.015; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kitaoka N, 2014, PHYTOCHEMISTRY, V99, P6, DOI 10.1016/j.phytochem.2013.12.019; Kitaoka N, 2011, PLANT CELL PHYSIOL, V52, P1757, DOI 10.1093/pcp/pcr110; Konig S, 2012, NEW PHYTOL, V196, P1086, DOI 10.1111/j.1469-8137.2012.04351.x; Koo AJ, 2018, PHYTOCHEM REV, V17, P51, DOI 10.1007/s11101-017-9510-8; Koo AJ, 2014, J BIOL CHEM, V289, P29728, DOI 10.1074/jbc.M114.603084; Koo AJK, 2011, P NATL ACAD SCI USA, V108, P9298, DOI 10.1073/pnas.1103542108; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kuromori T, 2004, PLANT J, V37, P897, DOI 10.1111/j.1365.313X.2004.02009.x; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Lim EK, 2004, BIOTECHNOL BIOENG, V87, P623, DOI 10.1002/bit.20154; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Lim EK, 2001, J BIOL CHEM, V276, P4344, DOI 10.1074/jbc.M007263200; Liu H, 2017, MOL PLANT, V10, P530, DOI 10.1016/j.molp.2017.01.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Miersch O, 2008, NEW PHYTOL, V177, P114, DOI 10.1111/j.1469-8137.2007.02252.x; Montillet JL, 2004, PLANT J, V40, P439, DOI 10.1111/j.1365-313X.2004.02223.x; Mosblech A, 2008, MOL PLANT, V1, P249, DOI 10.1093/mp/ssm028; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakamura Y, 2011, PLANT PHYSIOL, V155, P1226, DOI 10.1104/pp.110.168617; Obayashi T, 2018, PLANT CELL PHYSIOL, V59, DOI 10.1093/pcp/pcx191; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Rehman HM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19535-3; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Seto Y, 2009, PHYTOCHEMISTRY, V70, P370, DOI 10.1016/j.phytochem.2009.01.004; Smirnova E, 2017, MOL PLANT, V10, P1159, DOI 10.1016/j.molp.2017.07.010; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki H, 2007, BIOCHEM BIOPH RES CO, V361, P980, DOI 10.1016/j.bbrc.2007.07.147; Swiatek A, 2004, PLANT PHYSIOL, V135, P161, DOI 10.1104/pp.104.040501; Thompson AMG, 2017, SCI REP-UK, V7, DOI 10.1038/srep46629; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; von Saint Paul V, 2011, PLANT CELL, V23, P4124, DOI 10.1105/tpc.111.088443; Wakuta S, 2010, PHYTOCHEMISTRY, V71, P1280, DOI 10.1016/j.phytochem.2010.04.025; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wasternack C, 2018, ANNU REV PLANT BIOL, V69, P363, DOI 10.1146/annurev-arplant-042817-040440; Weichert H, 1999, FEBS LETT, V464, P133, DOI 10.1016/S0014-5793(99)01697-X; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Widemann E, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5010004; Widemann Emilie, 2013, J Biol Chem, V288, P31701, DOI 10.1074/jbc.M113.499228; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yang M, 2018, NAT CHEM BIOL, V14, P1109, DOI 10.1038/s41589-018-0154-9; Zhang T, 2016, J EXP BOT, V67, P2107, DOI 10.1093/jxb/erv521	70	19	19	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9858	9872		10.1074/jbc.RA119.007600	http://dx.doi.org/10.1074/jbc.RA119.007600			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31072871	Green Published, hybrid			2022-12-28	WOS:000473277900018
J	Shao, YJ; Wang, LR; Guo, NN; Wang, SF; Yang, L; Li, YJ; Wang, MS; Yin, SM; Han, HH; Zeng, L; Zhang, LD; Hui, LJ; Ding, QR; Zhang, JQ; Geng, HQ; Liu, MY; Li, DL				Shao, Yanjiao; Wang, Liren; Guo, Nana; Wang, Shengfei; Yang, Lei; Li, Yajing; Wang, Mingsong; Yin, Shuming; Han, Honghui; Zeng, Li; Zhang, Ludi; Hui, Lijian; Ding, Qiurong; Zhang, Jiqin; Geng, Hongquan; Liu, Mingyao; Li, Dali			Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats (vol 293, pg 6883, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Wang, liren/GQQ-5391-2022	Shao, Yanjiao/0000-0001-7204-3534	Shanghai Municipal Commission for Science and Technology [14140901600, 17140901600]	Shanghai Municipal Commission for Science and Technology	There was an error in the grant footnote. "The Shanghai Municipal Commission for Science and Technology Grant 14140901600" should read as "The Shanghai Municipal Commission for Science and Technology Grant 17140901600."	Shao YJ, 2018, J BIOL CHEM, V293, P6883, DOI 10.1074/jbc.RA117.000347	1	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8348	8348		10.1074/jbc.AAC119.009120	http://dx.doi.org/10.1074/jbc.AAC119.009120			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	31127060	Green Published, hybrid			2022-12-28	WOS:000471108200003
J	Ciccone, DN; Namiki, Y; Chen, CF; Morshead, KB; Wood, AL; Johnston, CM; Morris, JW; Wang, YQ; Sadreyev, R; Corcoran, AE; Matthews, AGW; Oettinger, MA				Ciccone, David N.; Namiki, Yuka; Chen, Changfeng; Morshead, Katrina B.; Wood, Andrew L.; Johnston, Colette M.; Morris, John W.; Wang, Yanqun; Sadreyev, Ruslan; Corcoran, Anne E.; Matthews, Adam G. W.; Oettinger, Marjorie A.			The murine IgH locus contains a distinct DNA sequence motif for the chromatin regulatory factor CTCF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA recombination; chromatin; cellular immune response; chromatin immunoprecipitation (ChIP); chromatin regulation; adaptive immunity; antigen receptor; CCTC-binding factor (CTCF); DNA binding; V(D)J	ENHANCER-BLOCKING ACTIVITY; INSULATOR PROTEIN CTCF; B-CELL DEVELOPMENT; V(D)J RECOMBINATION; BINDING SITES; ZINC FINGERS; H19 GENE; TRANSCRIPTION; ELEMENTS; GENOME	Antigen receptor assembly in lymphocytes involves stringently-regulated coordination of specific DNA rearrangement events across several large chromosomal domains. Previous studies indicate that transcription factors such as paired box 5 (PAX5), Yin Yang 1 (YY1), and CCCTC-binding factor (CTCF) play a role in regulating the accessibility of the antigen receptor loci to the V(D)J recombinase, which is required for these rearrangements. To gain clues about the role of CTCF binding at the murine immunoglobulin heavy chain (IgH) locus, we utilized a computational approach that identified 144 putative CTCF-binding sites within this locus. We found that these CTCF sites share a consensus motif distinct from other CTCF sites in the mouse genome. Additionally, we could divide these CTCF sites into three categories: intergenic sites remote from any coding element, upstream sites present within 8 kb of the V-H-leader exon, and recombination signal sequence (RSS)-associated sites characteristically located at a fixed distance (similar to 18 bp) downstream of the RSS. We noted that the intergenic and upstream sites are located in the distal portion of the V-H locus, whereas the RSS-associated sites are located in the D-H-proximal region. Computational analysis indicated that the prevalence of CTCF-binding sites at the IgH locus is evolutionarily conserved. In all species analyzed, these sites exhibit a striking strand-orientation bias, with >98% of the murine sites being present in one orientation with respect to V-H gene transcription. Electrophoretic mobility shift and enhancer-blocking assays and ChIP-chip analysis confirmed CTCF binding to these sites both in vitro and in vivo.	[Ciccone, David N.; Namiki, Yuka; Chen, Changfeng; Morshead, Katrina B.; Morris, John W.; Wang, Yanqun; Sadreyev, Ruslan; Matthews, Adam G. W.; Oettinger, Marjorie A.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ciccone, David N.; Namiki, Yuka; Chen, Changfeng; Morshead, Katrina B.; Morris, John W.; Wang, Yanqun; Sadreyev, Ruslan; Matthews, Adam G. W.; Oettinger, Marjorie A.] Harvard Med Sch, Dept Genet, Boston, MA 02114 USA; [Wood, Andrew L.; Johnston, Colette M.; Corcoran, Anne E.] Babraham Inst, Lymphocyte Signalling & Dev, Babraham Res Campus, Cambridge CB22 3AT, England; [Matthews, Adam G. W.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02481 USA; [Matthews, Adam G. W.] Wellesley Coll, Program Biochem, Wellesley, MA 02481 USA; [Ciccone, David N.] Merck, Boston, MA 02115 USA; [Chen, Changfeng] BioSciences Inc, Beijing 100053, Peoples R China; [Morshead, Katrina B.] Genentech Inc, San Francisco, CA 94080 USA; [Wood, Andrew L.] Kymab Ltd, Babraham Res Campus, Cambridge CB22 3AT, England; [Johnston, Colette M.] Crescendo Biol, Babraham Res Campus, Cambridge CB22 3AT, England; [Morris, John W.] Synopsys Inc, Burlington, MA 01803 USA; [Wang, Yanqun] Novartis Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellesley College; Wellesley College; Merck & Company; Roche Holding; Genentech; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Synopsys Inc; Novartis	Oettinger, MA (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Oettinger, MA (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02114 USA.	Oettinger@molbio.mgh.harvard.edu		Morris, John W/0000-0001-9476-181X; Corcoran, Anne/0000-0002-9577-5313	Biotechnological and Biological Scientific Research Council [BB/F012217/1]; National Institutes of Health [GM48026]; BBSRC; BBSRC [BBS/E/B/000C0404, BB/F012217/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	Biotechnological and Biological Scientific Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Biotechnological and Biological Scientific Research Council Grant BB/F012217/1 (to A. E. C.) and National Institutes of Health Grant GM48026 (to M. A. O). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a BBSRC Ph.D. studentship. Present address: Kymab Ltd., Babraham Research Campus, Cambridge CB22 3AT, United Kingdom.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Benner C, 2015, P NATL ACAD SCI USA, V112, P12776, DOI 10.1073/pnas.1512995112; Bolland DJ, 2016, CELL REP, V15, P2475, DOI 10.1016/j.celrep.2016.05.020; Carico Z, 2015, ADV IMMUNOL, V128, P307, DOI 10.1016/bs.ai.2015.07.005; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Ciccone DN, 2004, METHOD ENZYMOL, V376, P334; Cuomo CA, 1996, MOL CELL BIOL, V16, P5683; de Almeida CR, 2011, IMMUNITY, V35, P501, DOI 10.1016/j.immuni.2011.07.014; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Gerasimova T, 2015, GENE DEV, V29, P1683, DOI 10.1101/gad.263871.115; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grundy GJ, 2009, MOL CELL, V35, P217, DOI 10.1016/j.molcel.2009.06.022; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kleiman E, 2016, P NATL ACAD SCI USA, V113, pE3911, DOI 10.1073/pnas.1606297113; Kumari G, 2015, ADV IMMUNOL, V128, P41, DOI 10.1016/bs.ai.2015.08.001; Lin SG, 2015, P NATL ACAD SCI USA, V112, P1815, DOI 10.1073/pnas.1424936112; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Lucas JS, 2011, CURR OPIN CELL BIOL, V23, P318, DOI 10.1016/j.ceb.2010.11.007; Majumder K, 2015, ADV IMMUNOL, V128, P273, DOI 10.1016/bs.ai.2015.07.001; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Montefiori L, 2016, CELL REP, V14, P896, DOI 10.1016/j.celrep.2015.12.083; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; Osipovich O, 2007, NAT IMMUNOL, V8, P809, DOI 10.1038/ni1481; Osipovich OA, 2009, J IMMUNOL, V183, P1509, DOI 10.4049/jimmunol.0900896; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Proudhon C, 2015, ADV IMMUNOL, V128, P123, DOI 10.1016/bs.ai.2015.07.003; Pulivarthy SR, 2016, P NATL ACAD SCI USA, V113, pE6427, DOI 10.1073/pnas.1605543113; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Shih HY, 2012, P NATL ACAD SCI USA, V109, pE3493, DOI 10.1073/pnas.1214131109; Stubbington MJT, 2013, CURR OPIN GENET DEV, V23, P81, DOI 10.1016/j.gde.2013.01.001; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Volpi SA, 2012, J IMMUNOL, V188, P2556, DOI 10.4049/jimmunol.1102763; Xiao TJ, 2011, MOL CELL BIOL, V31, P2174, DOI 10.1128/MCB.05093-11; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao LJ, 2016, J EXP MED, V213, P1921, DOI 10.1084/jem.20160670; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	64	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13580	13592		10.1074/jbc.RA118.007348	http://dx.doi.org/10.1074/jbc.RA118.007348			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31285261	hybrid, Green Published			2022-12-28	WOS:000486418600006
J	Dai, Y; Schlanger, S; Haque, MM; Misra, S; Stuehr, DJ				Dai, Yue; Schlanger, Simon; Haque, Mohammad Mahfuzul; Misra, Saurav; Stuehr, Dennis J.			Heat shock protein 90 regulates soluble guanylyl cyclase maturation by a dual mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heat shock protein 90 (HSP90); chaperone; heme; structural model; protein-protein interaction; protein folding; cell signaling; client protein	NITRIC-OXIDE; THERAPEUTIC TARGET; CRYSTAL-STRUCTURE; BAY 58-2667; HEME; HSP90; BINDING; DOMAIN; ACTIVATION; KINASE	The enzyme soluble guanylyl cyclase (sGC) is a heterodimer composed of an alpha subunit and a heme-containing beta subunit. It participates in signaling by generating cGMP in response to nitric oxide (NO). Heme insertion into the beta 1 subunit of sGC (sGC beta) is critical for function, and heat shock protein 90 (HSP90) associates with heme-free sGC beta (apo-sGC beta) to drive its heme insertion. Here, we tested the accuracy and relevance of a modeled apo-sGC beta-HSP90 complex by constructing sGC beta variants predicted to have an impaired interaction with HSP90. Using site-directed mutagenesis, purified recombinant proteins, mammalian cell expression, and fluorescence approaches, we found that (i) three regions in apo-sGC beta predicted by the model mediate direct complex formation with HSP90 both in vitro and in mammalian cells; (ii) such HSP90 complex formation directly correlates with the extent of heme insertion into apo-sGC beta and with cyclase activity; and (iii) apo-sGC beta mutants possessing an HSP90-binding defect instead bind to sGC alpha in cells and form inactive, heme-free sGC heterodimers. Our findings uncover the molecular features of the cellular apo-sGC beta-HSP90 complex and reveal its dual importance in enabling heme insertion while preventing inactive heterodimer formation during sGC maturation.	[Dai, Yue; Schlanger, Simon; Haque, Mohammad Mahfuzul; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA; [Misra, Saurav] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Haque, Mohammad Mahfuzul] Jamia Millia Islamia, Dept Biotechnol, New Delhi, India	Cleveland Clinic Foundation; Kansas State University; Jamia Millia Islamia	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Dai, Yue/AAD-9906-2019	Dai, Yue/0000-0001-9368-7769; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [P01HL081064, P01HL103453]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064, P01HL103453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants P01HL081064 and P01HL103453 (to D. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beuve A, 2017, ANTIOXID REDOX SIGN, V26, P137, DOI 10.1089/ars.2015.6591; Dasgupta A, 2015, CLIN PHARMACOL THER, V97, P88, DOI 10.1002/cpt.10; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Dupont LL, 2014, PULM PHARMACOL THER, V29, P1, DOI 10.1016/j.pupt.2014.07.004; Fernhoff NB, 2012, J BIOL CHEM, V287, P43053, DOI 10.1074/jbc.M112.393892; Foerster J, 1996, EUR J BIOCHEM, V240, P380, DOI 10.1111/j.1432-1033.1996.0380h.x; Ghosh A, 2018, P NATL ACAD SCI USA, V115, pE1117, DOI 10.1073/pnas.1717993115; Ghosh A, 2017, ANTIOXID REDOX SIGN, V26, P182, DOI 10.1089/ars.2016.6690; Ghosh A, 2016, P NATL ACAD SCI USA, V113, pE2355, DOI 10.1073/pnas.1524398113; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Harris MB, 2008, EUR J APPL PHYSIOL, V104, P795, DOI 10.1007/s00421-008-0833-4; Hoffmann LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023596; IGNARRO LJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P49, DOI 10.1016/0304-4165(82)90008-3; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Kollau A, 2018, BIOCHEM PHARMACOL, V156, P168, DOI 10.1016/j.bcp.2018.08.009; Krieg T, 2009, EUR HEART J, V30, P1607, DOI 10.1093/eurheartj/ehp143; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Lucas KA, 2000, PHARMACOL REV, V52, P375; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; Martin E, 2005, METHOD ENZYMOL, V396, P478, DOI 10.1016/S0076-6879(05)96040-0; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Montfort WR, 2017, ANTIOXID REDOX SIGN, V26, P107, DOI 10.1089/ars.2016.6693; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Nedvetsky PI, 2008, FEBS LETT, V582, P327, DOI 10.1016/j.febslet.2007.12.025; Nossaman B, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/290805; Pan J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43112; Papapetropoulos A, 2005, MOL PHARMACOL, V68, P1133, DOI 10.1124/mol.105.012682; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Potter LR, 2011, CELL SIGNAL, V23, P1921, DOI 10.1016/j.cellsig.2011.09.001; Purohit R, 2013, PROTEIN SCI, V22, P1439, DOI 10.1002/pro.2331; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Sarkar A, 2015, J BIOL CHEM, V290, P21615, DOI 10.1074/jbc.M115.645515; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schmidt PM, 2004, J BIOL CHEM, V279, P3025, DOI 10.1074/jbc.M310141200; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Tabima DM, 2012, FREE RADICAL BIO MED, V52, P1970, DOI 10.1016/j.freeradbiomed.2012.02.041; Thoonen R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9482; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; Wagenaar GTM, 2015, AM J PHYSIOL-LUNG C, V309, pL1037, DOI 10.1152/ajplung.00333.2015; West AR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00055; Yetik-Anacak G, 2006, AM J PHYSIOL-HEART C, V291, pH260, DOI 10.1152/ajpheart.01027.2005	47	11	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12880	12891		10.1074/jbc.RA119.009016	http://dx.doi.org/10.1074/jbc.RA119.009016			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31311859	hybrid, Green Published			2022-12-28	WOS:000486416000002
J	Varden, FA; Saitoh, H; Yoshino, K; Franceschetti, M; Kamoun, S; Terauchi, R; Banfield, MJ				Varden, Freya A.; Saitoh, Hiromasa; Yoshino, Kae; Franceschetti, Marina; Kamoun, Sophien; Terauchi, Ryohei; Banfield, Mark J.			Cross-reactivity of a rice NLR immune receptor to distinct effectors from the rice blast pathogen Magnaporthe oryzae provides partial disease resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant defense; protein structure; plant biochemistry; host-pathogen interaction; Nod-like receptor (NLR); effector; plant immunity; rice; rice blast disease	AVR-PIA; AVIRULENCE PROTEIN; PLANT; FUNGAL; GENES; RECOGNITION; DOMAINS	Unconventional integrated domains in plant intracellular immune receptors of the nucleotide-binding leucine-rich repeat (NLRs) type can directly bind translocated effector proteins from pathogens and thereby initiate an immune response. The rice (Oryza sativa) immune receptor pairs Pik-1/Pik-2 and RGA5/RGA4 both use integrated heavy metal-associated (HMA) domains to bind the effectors AVR-Pik and AVR-Pia, respectively, from the rice blast fungal pathogen Magnaporthe oryzae. These effectors both belong to the MAX effector family and share a core structural fold, despite being divergent in sequence. How integrated domains in NLRs maintain specificity of effector recognition, even of structurally similar effectors, has implications for understanding plant immune receptor evolution and function. Here, using plant cell death and pathogenicity assays and protein-protein interaction analyses, we show that the rice NLR pair Pikp-1/Pikp-2 triggers an immune response leading to partial disease resistance toward the mis-matched effector AVR-Pia in planta and that the Pikp-HMA domain binds AVR-Pia in vitro. We observed that the HMA domain from another Pik-1 allele, Pikm, cannot bind AVR-Pia, and it does not trigger a plant response. The crystal structure of Pikp-HMA bound to AVR-Pia at 1.9 angstrom resolution revealed a binding interface different from those formed with AVR-Pik effectors, suggesting plasticity in integrated domain-effector interactions. The results of our work indicate that a single NLR immune receptor can bait multiple pathogen effectors via an integrated domain, insights that may enable engineering plant immune receptors with extended disease resistance profiles.	[Varden, Freya A.; Franceschetti, Marina; Banfield, Mark J.] Norwich Res Pk, John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Saitoh, Hiromasa; Yoshino, Kae] Tokyo Univ Agr, Fac Life Sci, Dept Mol Microbiol, Lab Plant Symbiot & Parasit Microbes, Tokyo 1568502, Japan; [Kamoun, Sophien] Univ East Anglia, Norwich Res Pk, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Div Genom & Breeding, Kitakami, Iwate 0240003, Japan; [Terauchi, Ryohei] Kyoto Univ, Grad Sch Agr, Lab Crop Evolut, Kyoto 6068501, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Tokyo University of Agriculture; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; Iwate Biotechnology Research Center; Kyoto University	Banfield, MJ (corresponding author), Norwich Res Pk, John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	mark.banfield@jic.ac.uk	Kamoun, Sophien/B-3529-2009; Banfield, Mark/C-7453-2013; Terauchi, Ryohei/Y-2992-2019	Kamoun, Sophien/0000-0002-0290-0315; Banfield, Mark/0000-0001-8921-3835; Terauchi, Ryohei/0000-0002-0095-4651; Varden, Freya/0000-0003-4224-2326	Biotechnology and Biological Sciences Research Council (United Kingdom) [BB/P012574, BB/M02198X]; European Research Council [743165]; John Innes Foundation; Gatsby Charitable Foundation; JSPS KAKENHI [15H05779, 18K05657]; BBSRC [BBS/E/J/000PR9798, BB/M022315/1, BBS/E/J/000PR9795, BB/M02198X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); John Innes Foundation; Gatsby Charitable Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (United Kingdom) Grants BB/P012574 and BB/M02198X, European Research Council Proposal 743165, the John Innes Foundation, the Gatsby Charitable Foundation, and JSPS KAKENHI Grants 15H05779 and 18K05657. The authors declare that they have no conflicts of interest with the contents of this article.	Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Bebber DP, 2015, FUNGAL GENET BIOL, V74, P62, DOI 10.1016/j.fgb.2014.10.012; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bialas A, 2018, MOL PLANT MICROBE IN, V31, P34, DOI 10.1094/MPMI-08-17-0196-FI; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Cesari S, 2018, NEW PHYTOL, V219, P17, DOI 10.1111/nph.14877; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Guillen K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005228; De la Concepcion JC, 2018, NAT PLANTS, V4, P576, DOI 10.1038/s41477-018-0194-x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fernandez J, 2018, TRENDS MICROBIOL, V26, P582, DOI 10.1016/j.tim.2017.12.007; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Franceschetti M, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00066-16, 10.1128/mmbr.00066-16]; Guo LW, 2018, P NATL ACAD SCI USA, V115, P11637, DOI 10.1073/pnas.1810705115; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Kanzaki H, 2002, THEOR APPL GENET, V105, P809, DOI 10.1007/s00122-001-0817-9; Kanzaki H, 2012, PLANT J, V72, P894, DOI 10.1111/j.1365-313X.2012.05110.x; Kourelis J, 2018, PLANT CELL, V30, P285, DOI 10.1105/tpc.17.00579; Krissinel E, 2015, NUCLEIC ACIDS RES, V43, pW314, DOI 10.1093/nar/gkv314; Kroj T, 2016, NEW PHYTOL, V210, P618, DOI 10.1111/nph.13869; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Maqbool A, 2015, ELIFE, V4, DOI 10.7554/eLife.08709; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Ortiz D, 2017, PLANT CELL, V29, P156, DOI 10.1105/tpc.16.00435; Ose T, 2015, J BIOMOL NMR, V63, P229, DOI 10.1007/s10858-015-9979-7; R Core Team, 2019, R LANG ENV STAT COMP; Sarris PF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0228-7; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takano Y, 2001, MOL PLANT MICROBE IN, V14, P1149, DOI 10.1094/MPMI.2001.14.10.1149; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wu CH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00134; Yoshida K, 2009, PLANT CELL, V21, P1573, DOI 10.1105/tpc.109.066324; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zhang X, 2018, PLANT J, V96, P133, DOI 10.1111/tpj.14023; Zhang ZM, 2013, J BIOMOL NMR, V55, P219, DOI 10.1007/s10858-012-9695-5	46	13	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13006	13016		10.1074/jbc.RA119.007730	http://dx.doi.org/10.1074/jbc.RA119.007730			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296569	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-28	WOS:000486416000012
J	Hu, YM; Boehm, DM; Chung, H; Wilson, S; Bird, AJ				Hu, Ya-Mei; Boehm, Derek M.; Chung, Hak; Wilson, Stevin; Bird, Amanda J.			Zinc-dependent activation of the Pho8 alkaline phosphatase in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						yeast genetics; transport metal; protein stability; protein processing; gene expression; cation diffusion facilitator; hypophosphatemia; metal homeostasis; transition metal; zinc transport	GENE-EXPRESSION; IRON-DEFICIENCY; TRANSPORTERS; HOMEOSTASIS; COPPER; METAL; PROTEINS; TURNOVER; BINDING; LOZ1	Genome-wide analyses have revealed that during metal ion starvation, many cells undergo programmed changes in their transcriptome or proteome that lower the levels of abundant metalloproteins, conserving metal ions for more critical functions. Here we investigated how changes in cellular zinc status affect the expression and activity of the zinc-requiring Pho8 alkaline phosphatase from fission yeast (Schizosaccharomyces pombe). In S. pombe, Pho8 is a membrane-tethered and processed glycoprotein that resides in the vacuole. Using alkaline phosphatase activity assays along with various biochemical analyses, we found that Pho8 is active when zinc is plentiful and inactive when zinc is limited. Although Pho8 activity depended on zinc, we also found that higher levels of pho8 mRNAs and Pho8 protein accumulate in zinc-deficient cells. To gain a better understanding of the inverse relationship between pho8 mRNA levels and Pho8 activity, we examined the effects of zinc on the stability and processing of the Pho8 protein. We show that Pho8 is processed regardless of zinc status and that mature Pho8 accumulates under all conditions. We also noted that alkaline phosphatase activity is rapidly restored when zinc is resupplied to cells, even in the presence of the protein synthesis inhibitor cycloheximide. Our results suggest that S. pombe cells maintain inactive pools of Pho8 proteins under low-zinc conditions and that these pools facilitate rapid restoration of Pho8 activity when zinc ions become available.	[Hu, Ya-Mei; Bird, Amanda J.] Ohio State Univ, Dept Human Nutr, 1787 Neil Ave, Columbus, OH 43210 USA; [Boehm, Derek M.; Wilson, Stevin; Bird, Amanda J.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Chung, Hak] Ohio State Univ, Interdisciplinary Nutr Program, Columbus, OH 43210 USA; [Bird, Amanda J.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bird, AJ (corresponding author), Ohio State Univ, Dept Human Nutr, 1787 Neil Ave, Columbus, OH 43210 USA.	bird.96@osu.edu	Bird, Amanda Jane/ABD-2295-2021	Bird, Amanda Jane/0000-0002-1846-7050; Hu, Ya-Mei/0000-0002-2575-1770; Wilson, Stevin/0000-0002-9662-5501	National Institutes of Health [RO1 GM105695]; Office of the Director of the National Institutes of Health [S10OD023582]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105695] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant RO1 GM105695 (to A. J. B.) and by the Office of the Director of the National Institutes of Health under Award S10OD023582. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bird AJ, 2015, J NUTR BIOCHEM, V26, P1103, DOI 10.1016/j.jnutbio.2015.08.002; Boch A, 2008, FEMS YEAST RES, V8, P883, DOI 10.1111/j.1567-1364.2008.00414.x; Camaschella C, 2015, NEW ENGL J MED, V372, P1832, DOI 10.1056/NEJMra1401038; Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Choi S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007262; Christiano R, 2014, CELL REP, V9, P1959, DOI 10.1016/j.celrep.2014.10.065; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Corkins ME, 2013, P NATL ACAD SCI USA, V110, P15371, DOI 10.1073/pnas.1300853110; Ehrensberger KM, 2014, J BIOL CHEM, V289, P18087, DOI 10.1074/jbc.M114.551333; Ehrensberger KM, 2013, J BIOL CHEM, V288, P759, DOI 10.1074/jbc.M112.406165; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Fujimoto S, 2016, BIOCHEM J, V473, P2611, DOI 10.1042/BCJ20160324; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gupta A, 2009, FUTURE MED CHEM, V1, P1125, DOI 10.4155/FMC.09.84; Idiris A, 2006, APPL MICROBIOL BIOT, V73, P404, DOI 10.1007/s00253-006-0489-0; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kropat J, 2015, P NATL ACAD SCI USA, V112, P2644, DOI 10.1073/pnas.1422492112; Li M, 2015, J CELL BIOL, V211, P639, DOI 10.1083/jcb.201505062; Lock A, 2019, NUCLEIC ACIDS RES, V47, pD821, DOI 10.1093/nar/gky961; Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200; MacDiarmid CW, 2013, J BIOL CHEM, V288, P31313, DOI 10.1074/jbc.M113.512384; Mann KJ, 2001, BIOCHEMISTRY-US, V40, P1205, DOI 10.1021/bi0024512; Martinez-Pastor M, 2013, MOL CELL BIOL, V33, P2178, DOI 10.1128/MCB.01458-12; MERCHANT S, 1987, EMBO J, V6, P2531, DOI 10.1002/j.1460-2075.1987.tb02540.x; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Mornet E, 2001, J BIOL CHEM, V276, P31171, DOI 10.1074/jbc.M102788200; Mukaiyama H, 2011, APPL MICROBIOL BIOT, V90, P203, DOI 10.1007/s00253-010-3031-3; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Nunez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121059; Palm-Espling ME, 2012, BBA-MOL CELL RES, V1823, P1594, DOI 10.1016/j.bbamcr.2012.01.013; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Petrovic N, 1996, J BIOL CHEM, V271, P28331, DOI 10.1074/jbc.271.45.28331; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Qiao W, 2009, MOL MICROBIOL, V72, P320, DOI 10.1111/j.1365-2958.2009.06644.x; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; SAMBROOK J, 2000, MOL CLONING LAB MANU; Smith AD, 2017, ANNU REV MICROBIOL, V71, P597, DOI 10.1146/annurev-micro-030117-020444; Solovyov A, 2004, PROTEIN SCI, V13, P1902, DOI 10.1110/ps.04716104; Wang YR, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00269j; Wilson S, 2016, ARCH BIOCHEM BIOPHYS, V611, P30, DOI 10.1016/j.abb.2016.02.031	41	3	3	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12392	12404		10.1074/jbc.RA119.007371	http://dx.doi.org/10.1074/jbc.RA119.007371			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31239353	Green Published, hybrid			2022-12-28	WOS:000484402700012
J	Yu, QF; Gratzke, C; Wang, RX; Li, BS; Kuppermann, P; Herlemann, A; Tamalunas, A; Wang, YM; Rutz, B; Ciotkowska, A; Wang, XL; Strittmatter, F; Waidelich, R; Stief, CG; Hennenberg, M				Yu, Qingfeng; Gratzke, Christian; Wang, Ruixiao; Li, Bingsheng; Kuppermann, Paul; Herlemann, Annika; Tamalunas, Alexander; Wang, Yiming; Rutz, Beata; Ciotkowska, Anna; Wang, Xiaolong; Strittmatter, Frank; Waidelich, Raphaela; Stief, Christian G.; Hennenberg, Martin			A NAV2729-sensitive mechanism promotes adrenergic smooth muscle contraction and growth of stromal cells in the human prostate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						smooth muscle; pharmacology; molecular pharmacology; adrenergic receptor; small GTPase; ADP ribosylation factor (ARF); benign prostatic hyperplasia; lower urinary tract symptoms; prostate; NAV2729; smooth muscle contraction; benign prostatic hyperplasia (BPH); lower urinary tract symptoms (LUTS)	RHO-KINASE; G-PROTEINS; ARF6; INHIBITION; HYPERPLASIA; ACTIVATION; RAC1; PROLIFERATION; THERAPY; GTPASE	Voiding symptoms in benign prostatic hyperplasia (BPH) are driven by prostate smooth muscle contraction and prostate growth. Smooth muscle contraction in the prostate and other organs critically depends on activation of the small monomeric GTPase RhoA and probably Rac1. A role of another GTPase, ADP-ribosylation factor 6 (ARF6), for smooth muscle contraction has been recently suggested by indirect evidence but remains to be proven for any organ. Here, we report effects of NAV2729, an inhibitor with assumed specificity for ARF6, in human prostate tissues and cultured prostate stromal cells (WPMY-1). NAV2729 (5 mu m) inhibited neurogenic and alpha(1)-adrenergic contractions of human prostate tissues. Contractions induced by endothelin-1, by the thromboxane A(2) agonist U46619, or by high molar KCl were not inhibited. Correlation analyses suggested up-regulation of prostatic ARF6 expression with increasing degree of BPH, as ARF6 expression increased with the content of prostate-specific antigen (PSA) of prostate tissues. NAV2729 inhibited ARF6 activity but not other GTPases (ARF1, RhoA, Rac1) in prostate tissues and in WPMY-1 cells. Proliferation of WPMY-1 cells was inhibited concentration-dependently by NAV2726, as reflected by decreased viability, 5-ethynyl-2 '-deoxyuridine (EdU) assay, colony formation assay, and expression of Ki-67. Silencing of ARF6 expression mimicked effects of NAV2729 on viability and in the EdU assay. Effects of NAV2729 on viability and proliferation were attenuated in cells with silenced ARF6 expression. Our findings suggest that a NAV2729-sensitive mechanism promotes adrenergic contraction and stromal cell growth in the human prostate, which is probably ARF6-mediated. Similar actions in other organs and urodynamic effects of NAV2729 appear possible.	[Yu, Qingfeng; Gratzke, Christian; Wang, Ruixiao; Li, Bingsheng; Kuppermann, Paul; Herlemann, Annika; Tamalunas, Alexander; Wang, Yiming; Rutz, Beata; Ciotkowska, Anna; Wang, Xiaolong; Strittmatter, Frank; Waidelich, Raphaela; Stief, Christian G.; Hennenberg, Martin] Ludwig Maximilians Univ Munchen, Dept Urol, Univ Hosp, D-81377 Munich, Germany; [Yu, Qingfeng] Guangzhou Med Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510230, Guangdong, Peoples R China; [Yu, Qingfeng] Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Key Lab Urol, Guangzhou 510230, Guangdong, Peoples R China; [Gratzke, Christian] Univ Freiburg, Dept Urol, D-79106 Freiburg, Germany	University of Munich; Guangzhou Medical University; Guangzhou Medical University; University of Freiburg	Hennenberg, M (corresponding author), Urol Forschungslab, Feodor Lynen Str 19, D-81377 Munich, Germany.	martin.hennenberg@med.uni-muenchen.de	li, bing/GWQ-9617-2022; Tamalunas, Alexander/AAW-3850-2021	Tamalunas, Alexander/0000-0002-4659-2262; Stief, Christian/0000-0003-3291-9460	Deutsche Forschungsgemeinschaft [HE 5825/2-1, GR 3333/2-1]; Chinese Scholarship Council (CSC); Friedrich-Baur-Stiftung [71/16]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chinese Scholarship Council (CSC)(China Scholarship Council); Friedrich-Baur-Stiftung	This work was supported by Deutsche Forschungsgemeinschaft Grants HE 5825/2-1 and GR 3333/2-1, the Chinese Scholarship Council (CSC), and Friedrich-Baur-Stiftung Grant 71/16. The authors declare that they have no conflicts of interest with the contents of this article.	Alcaraz A, 2009, EUR UROL, V55, P864, DOI 10.1016/j.eururo.2008.11.011; Andre-Gregoire G, 2018, J ALLERGY CLIN IMMUN, V142, P824, DOI 10.1016/j.jaci.2017.09.049; Benabdi S, 2017, BIOCHEMISTRY-US, V56, P5125, DOI 10.1021/acs.biochem.7b00706; Bond M, 2008, CARDIOVASC RES, V80, P290, DOI 10.1093/cvr/cvn188; Bourmoum M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148097; Charles R, 2016, J BIOL CHEM, V291, P3967, DOI 10.1074/jbc.M115.684357; Chiba Y, 2010, J PHARMACOL SCI, V114, P239, DOI 10.1254/jphs.10R03CR; Christ GJ, 2007, NEUROUROL URODYNAM, V26, P948, DOI 10.1002/nau.20475; Chughtai B, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.31; Cindolo L, 2015, EUR UROL, V68, P418, DOI 10.1016/j.eururo.2014.11.006; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; Dahma P, 2017, EUR UROL, V71, P570, DOI 10.1016/j.eururo.2016.09.032; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Hennenberg M, 2017, PROSTATE, V77, P697, DOI 10.1002/pros.23293; Hennenberg M, 2014, NEUROUROL URODYNAM, V33, P1074, DOI 10.1002/nau.22467; Hennenberg M, 2013, AM J PHYSIOL-RENAL, V305, pF1383, DOI 10.1152/ajprenal.00380.2013; Herlemann A, 2018, AM J PHYSIOL-RENAL, V314, pF47, DOI 10.1152/ajprenal.00125.2017; Hongu Tsunaki, 2014, Advances in Biological Regulation, V54, P59, DOI 10.1016/j.jbior.2013.09.014; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Koumakpayi IH, 2011, MOL CARCINOGEN, V50, P901, DOI 10.1002/mc.20766; Levitt Jonathan M, 2007, Curr Urol Rep, V8, P269, DOI 10.1007/s11934-007-0072-y; Li R, 2017, LIFE SCI, V182, P80, DOI 10.1016/j.lfs.2017.06.008; Loirand Gervaise, 2014, Small GTPases, V5, P1, DOI 10.4161/sgtp.28846; Madersbacher S, 2007, EUR UROL, V51, P1522, DOI 10.1016/j.eururo.2007.03.034; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Orsted DD, 2013, NAT REV UROL, V10, P49, DOI 10.1038/nrurol.2012.192; Pradidarcheep Wisuit, 2011, Handb Exp Pharmacol, P117, DOI 10.1007/978-3-642-16499-6_7; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Rattan S, 2010, GASTROENTEROLOGY, V138, P13, DOI 10.1053/j.gastro.2009.11.016; Rees RW, 2003, J UROLOGY, V170, P2517, DOI 10.1097/01.ju.0000085024.47406.6c; Sakai H, 2018, EUR J PHARMACOL, V818, P74, DOI 10.1016/j.ejphar.2017.10.032; Shaikhibrahim Z, 2012, MOL MED REP, V5, P313, DOI 10.3892/mmr.2011.647; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Strand DW, 2017, DIFFERENTIATION, V96, P49, DOI 10.1016/j.diff.2017.07.005; Ventura S, 2011, BRIT J PHARMACOL, V163, P891, DOI 10.1111/j.1476-5381.2011.01332.x; Wang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107593; Wang Y, 2015, BRIT J PHARMACOL, V172, P2905, DOI 10.1111/bph.13099; Wang YM, 2016, BRIT J PHARMACOL, V173, P3342, DOI 10.1111/bph.13623; Yamauchi Yohei, 2017, Advances in Biological Regulation, V63, P115, DOI 10.1016/j.jbior.2016.10.004; Yoo JH, 2019, CANCER RES, V79, P2892, DOI 10.1158/0008-5472.CAN-18-3026; Yoo JH, 2016, CANCER CELL, V29, P889, DOI 10.1016/j.ccell.2016.04.015	42	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12231	12249		10.1074/jbc.RA119.007958	http://dx.doi.org/10.1074/jbc.RA119.007958			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31243101	hybrid, Green Published			2022-12-28	WOS:000484284500025
J	Ikeda, KN; Freeman, M				Ikeda, Kyojiro N.; Freeman, Matthew			Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoproteomics; rhomboid protease; intramembrane proteolysis; proteostasis; protein-protein interaction; polyubiquitin chain; tyrosine-protein phosphatase (tyrosine phosphatase); endoplasmic-reticulum-associated protein degradation (ERAD); BioID; Lys(63)-linked ubiquitin; PTP1B PTP1N; rhomboid-like protein 4 (RHBDL4); VCP p97	GENE-FUNCTION; PHYSIOLOGICAL FUNCTIONS; ER; RECEPTOR; ACTIVATION; FAMILY; IDENTIFICATION; PANTHER; STRESS; GOLGI	Rhomboid-like proteins are evolutionarily conserved, ubiquitous polytopic membrane proteins, including the canonical rhomboid intramembrane serine proteases and also others that have lost protease activity during evolution. We still have much to learn about their cellular roles, and evidence suggests that some may have more than one function. For example, RHBDL4 (rhomboid-like protein 4) is an endoplasmic reticulum (ER)-resident protease that forms a ternary complex with ubiquitinated substrates and p97/VCP (valosin-containing protein), a major driver of ER-associated degradation (ERAD). RHBDL4 is required for ERAD of some substrates, such as the pre-T-cell receptor alpha chain (pT alpha) and has also been shown to cleave amyloid precursor protein to trigger its secretion. In another case, RHBDL4 enables the release of full-length transforming growth factor alpha in exosomes. Using the proximity proteomic method BioID, here we screened for proteins that interact with or are in close proximity to RHBDL4. Bioinformatics analyses revealed that BioID hits of RHBDL4 overlap with factors related to protein stress at the ER, including proteins that interact with p97/VCP. PTP1B (protein-tyrosine phosphatase nonreceptor type 1, also called PTPN1) was also identified as a potential proximity factor and interactor of RHBDL4. Analysis of RHBDL4 peptides highlighted the presence of tyrosine phosphorylation at the cytoplasmic RHBDL4 C terminus. Site-directed mutagenesis targeting these tyrosine residues revealed that their phosphorylation modifies binding of RHBDL4 to p97/VCP and Lys(63)-linked ubiquitinated proteins. Our work lays a critical foundation for future mechanistic studies of the roles of RHBDL4 in ERAD and other important cellular pathways.	[Ikeda, Kyojiro N.; Freeman, Matthew] Univ Oxford, Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England; [Ikeda, Kyojiro N.] Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Dr Bohr Gasse 9-4, A-1030 Vienna, Austria	University of Oxford; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Ikeda, KN; Freeman, M (corresponding author), Univ Oxford, Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England.; Ikeda, KN (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Dr Bohr Gasse 9-4, A-1030 Vienna, Austria.	kyojiro.ikeda@univie.ac.at; matthew.freeman@path.ox.ac.uk		Freeman, Matthew/0000-0003-0410-5451; Ikeda, Kyojiro/0000-0002-4962-0767	Wellcome Trust [101035/Z/13/Z]; Marie Sklodowska-Curie Actions Individual Fellowship from the European Commission [R36414/AA001 RHOMBioID]; Wolfson College, University of Oxford	Wellcome Trust(Wellcome TrustEuropean Commission); Marie Sklodowska-Curie Actions Individual Fellowship from the European Commission; Wolfson College, University of Oxford	This work was supported by Wellcome Trust Investigator Award 101035/Z/13/Z (to M. F.); and Marie Sklodowska-Curie Actions Individual Fellowship R36414/AA001 RHOMBioID from the European Commission and a Junior Research Fellowship from Wolfson College, University of Oxford (to K. N. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Odeh M, 2014, J BIOL CHEM, V289, P8865, DOI 10.1074/jbc.M113.506790; Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Boubekeur S, 2011, J BIOL CHEM, V286, P19373, DOI 10.1074/jbc.M111.222984; Cavadas M, 2017, CELL REP, V21, P745, DOI 10.1016/j.celrep.2017.09.074; Christova Y, 2013, EMBO REP, V14, P884, DOI 10.1038/embor.2013.128; Coyaud E, 2015, MOL CELL PROTEOMICS, V14, P1781, DOI 10.1074/mcp.M114.045658; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Eden ER, 2016, DEV CELL, V37, P473, DOI 10.1016/j.devcel.2016.05.005; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fogeron ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2517; Freeman M, 2016, BIOCHEM SOC T, V44, P945, DOI 10.1042/BST20160035; Freeman M, 2014, ANNU REV CELL DEV BI, V30, P235, DOI 10.1146/annurev-cellbio-100913-012944; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Grieve AG, 2017, ELIFE, V6, DOI 10.7554/eLife.23968; Haque A, 2011, CELL, V147, P185, DOI 10.1016/j.cell.2011.08.036; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Huang B, 2017, MOL PHARMACOL, V91, P307, DOI 10.1124/mol.116.106716; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Krishnan N, 2015, TRENDS NEUROSCI, V38, P462, DOI 10.1016/j.tins.2015.06.006; Lastun VL, 2016, SEMIN CELL DEV BIOL, V60, P10, DOI 10.1016/j.semcdb.2016.07.033; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Lim JJ, 2016, BIOCHEM J, V473, P2863, DOI 10.1042/BCJ20160237; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Lin A, 2010, GENOME RES, V20, P1122, DOI 10.1101/gr.104216.109; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; McAllaster MR, 2015, MOL BIOL CELL, V26, P3013, DOI 10.1091/mbc.E15-04-0219; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Meissner C, 2015, AUTOPHAGY, V11, P1484, DOI 10.1080/15548627.2015.1063763; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Montojo Jason, 2014, F1000Res, V3, P153, DOI 10.12688/f1000research.4572.1; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; Paschkowsky S, 2018, J BIOL CHEM, V293, P15556, DOI 10.1074/jbc.RA118.002640; Paschkowsky S, 2016, J BIOL CHEM, V291, P21903, DOI 10.1074/jbc.M116.753582; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Popov D, 2012, BIOCHEM BIOPH RES CO, V422, P535, DOI 10.1016/j.bbrc.2012.05.048; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Raman M, 2015, NAT CELL BIOL, V17, P1356, DOI 10.1038/ncb3238; Recinto SJ, 2018, BIOL CHEM, V399, P1399, DOI 10.1515/hsz-2018-0259; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Song W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9022; Srinivasan P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000262; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tomar D, 2013, BBA-MOL CELL RES, V1833, P3134, DOI 10.1016/j.bbamcr.2013.08.021; Tomar D, 2012, BBA-MOL CELL RES, V1823, P316, DOI 10.1016/j.bbamcr.2011.11.015; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Trudgian DC, 2012, J PROTEOME RES, V11, P6282, DOI 10.1021/pr300694b; Trudgian DC, 2011, PROTEOMICS, V11, P2790, DOI 10.1002/pmic.201000800; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wunderle L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27342; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	72	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11486	11497		10.1074/jbc.RA118.007074	http://dx.doi.org/10.1074/jbc.RA118.007074			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31177093	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000478717600012
J	Deep, SN; Mitra, S; Rajagopal, S; Paul, S; Poddar, R				Deep, Satya Narayan; Mitra, Sumonto; Rajagopal, Sathyanarayanan; Paul, Surojit; Poddar, Ranjana			GluN2A-NMDA receptor-mediated sustained Ca2+ influx leads to homocysteine-induced neuronal cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						homocysteine; N-methyl-D-aspartate receptor (NMDA receptor; NMDAR); glutamate; calcium; extracellular-signal-regulated kinase (ERK); calcium homeostasis; GluN2A-NMDA receptor subunit; hyperhomocysteinemia; kinase signaling; neurotoxicity	METABOTROPIC GLUTAMATE RECEPTORS; EXCITATORY AMINO-ACIDS; ISCHEMIC BRAIN-INJURY; NMDA RECEPTOR; PLASMA HOMOCYSTEINE; DIFFERENTIAL ROLES; TYROSINE PHOSPHATASE; NR2A SUBUNIT; RISK-FACTOR; IN-VITRO	Homocysteine, a metabolite of the methionine cycle, is a known agonist of N-methyl-d-aspartate receptor (NMDAR), a glutamate receptor subtype and is involved in NMDAR-mediated neurotoxicity. Our previous findings have shown that homocysteine-induced, NMDAR-mediated neurotoxicity is facilitated by a sustained increase in phosphorylation and activation of extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK MAPK). In the current study, we investigated the role GluN1/GluN2A-containing functional NMDAR (GluN2A-NMDAR) and GluN1/GluN2B-containing functional NMDAR (GluN2B-NMDAR) in homocysteine-induced neurotoxicity. Our findings revealed that exposing primary cortical neuronal cultures to homocysteine leads to a sustained low-level increase in intracellular Ca2+. We also showed that pharmacological inhibition of GluN2A-NMDAR or genetic deletion of the GluN2A subunit attenuates homocysteine-induced increase in intracellular Ca2+. Our results further established the role of GluN2A-NMDAR in homocysteine-mediated sustained ERK MAPK phosphorylation and neuronal cell death. Of note, the preferential role of GluN2A-NMDAR in homocysteine-induced neurotoxicity was distinctly different from glutamate-NMDAR-induced excitotoxic cell death that involves overactivation of GluN2B-NMDAR and is independent of ERK MAPK activation. These findings indicate a critical role of GluN2A-NMDAR-mediated signaling in homocysteine-induced neurotoxicity.	[Deep, Satya Narayan; Mitra, Sumonto; Rajagopal, Sathyanarayanan; Paul, Surojit; Poddar, Ranjana] Univ New Mexico, Dept Neurol, Hlth Sci Ctr, 1 Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Poddar, R (corresponding author), Univ New Mexico, Dept Neurol, Hlth Sci Ctr, 1 Univ New Mexico, Albuquerque, NM 87131 USA.	rpoddar@salud.unm.edu	Sumonto, Mitra/H-2083-2013	Sumonto, Mitra/0000-0001-6381-5344	National Institutes of Health [RO1 NS083914, RO1 NS059962]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083914, R01NS059962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health Grants RO1 NS083914 (to R. P.) and RO1 NS059962 (to S. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ansari R, 2014, J CLIN NEUROL, V10, P281, DOI 10.3988/jcn.2014.10.4.281; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Austin RC, 2004, CELL DEATH DIFFER, V11, pS56, DOI 10.1038/sj.cdd.4401451; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Cheng CL, 1999, BRAIN RES, V849, P97, DOI 10.1016/S0006-8993(99)01995-2; Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; DAXHELET GA, 1989, ANAL BIOCHEM, V179, P401, DOI 10.1016/0003-2697(89)90152-8; DEERAUSQUIN GA, 1990, P NATL ACAD SCI USA, V87, P8017, DOI 10.1073/pnas.87.20.8017; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Dingledine R, 1999, PHARMACOL REV, V51, P7; GLAUM SR, 1990, J PHARMACOL EXP THER, V253, P1293; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hankey GJ, 2001, CURR OPIN NEUROL, V14, P95, DOI 10.1097/00019052-200102000-00015; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hyrc K, 1997, J NEUROSCI, V17, P6669; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jara-Prado A, 2003, NEUROTOX RES, V5, P237, DOI 10.1007/BF03033381; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai TW, 2011, TRENDS MOL MED, V17, P266, DOI 10.1016/j.molmed.2010.12.008; Lazarewicz JW, 2003, NEUROCHEM RES, V28, P259, DOI 10.1023/A:1022329317218; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; LINDGREN A, 1995, STROKE, V26, P795, DOI 10.1161/01.STR.26.5.795; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lynch DR, 2002, J PHARMACOL EXP THER, V300, P717, DOI 10.1124/jpet.300.3.717; Mao LM, 2004, EUR J NEUROSCI, V19, P1207, DOI 10.1111/j.1460-9568.2004.03223.x; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; Martin HGS, 2010, CELL, V140, P174, DOI 10.1016/j.cell.2010.01.014; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; Morikawa E, 1998, J NEUROSCI, V18, P9727; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2010, J NEUROCHEM, V114, P1107, DOI 10.1111/j.1471-4159.2010.06835.x; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; Poddar R, 2017, J NEUROCHEM, V142, P560, DOI 10.1111/jnc.14078; Poddar R, 2013, J NEUROCHEM, V124, P558, DOI 10.1111/jnc.12102; Poddar R, 2009, J NEUROCHEM, V110, P1095, DOI 10.1111/j.1471-4159.2009.06207.x; RANDALL RD, 1992, J NEUROSCI, V12, P1882; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Riccio A, 2002, NAT NEUROSCI, V5, P389, DOI 10.1038/nn0502-389; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Sharma M, 2015, BASIC CLIN PHARMACOL, V117, P287, DOI 10.1111/bcpt.12424; Shi Q, 2003, J PHARMACOL EXP THER, V305, P131, DOI 10.1124/jpet.102.047092; Sibarov DA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00246; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Terasaki Y, 2010, J CEREBR BLOOD F MET, V30, P1441, DOI 10.1038/jcbfm.2010.18; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tymianski M, 1996, ADV NEUROL, V71, P85; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhou XJ, 2013, J BIOL CHEM, V288, P24151, DOI 10.1074/jbc.M113.482000; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367; Zieminska E, 2003, NEUROCHEM INT, V43, P481, DOI 10.1016/S0197-0186(03)00038-X; Zoccolella S, 2010, AMYOTROPH LATERAL SC, V11, P140, DOI 10.3109/17482960902919360; Zoccolella Stefano, 2006, Current Vascular Pharmacology, V4, P237, DOI 10.2174/157016106777698414	69	23	26	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11154	11165		10.1074/jbc.RA119.008820	http://dx.doi.org/10.1074/jbc.RA119.008820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167782	Green Published, hybrid			2022-12-28	WOS:000478717400009
J	Duan, YR; Guo, QG; Zhang, TR; Meng, Y; Sun, D; Luo, GZ; Liu, Y				Duan, Yuran; Guo, Qingguo; Zhang, Tianrui; Meng, Yuan; Sun, Dong; Luo, Guangzuo; Liu, Ying			Cyclin-dependent kinase-mediated phosphorylation of the exocyst subunit Exo84 in late G(1) phase suppresses exocytic secretion and cell growth in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; exocytosis; G(1); S cyclin; cell growth; cyclin-dependent kinase (CDK); mitosis; membrane trafficking; cell wall remodeling; exocyst; exocytic secretion; G(1); S transition; membrane tethering	PLASMA-MEMBRANE; SUBSTRATE-SPECIFICITY; PROTEIN COMPLEXES; SIZE HOMEOSTASIS; GOLGI-APPARATUS; INHIBITOR; DIVISION; PATHWAY; CDK1; TARGETS	In eukaryotic cells, the growth rate is strictly regulated for proper progression of the cell cycle. In the budding yeast Saccharomyces cerevisiae, it was previously shown that cell growth dramatically slows down when the cells start budding at the G(1)/S transition. However, the molecular mechanism for this G(1)/S-associated growth arrest is unclear. In this study, using exocytic secretion, cyclin-dependent kinase (CDK) assay, immunoprecipitation, and microscopy, we demonstrate that the exocyst subunit Exo84, which is known to be phosphorylated in mitosis, can also be phosphorylated directly by Cdk1 in the late G(1) phase. Of note, we found that the Cdk1-mediated Exo84 phosphorylation impairs exocytic secretion in the late G(1) phase. Using conditional cdc mutants and phosphodeficient and phosphomimetic exo84 mutants, we further observed that Cdk1-phosphoryated Exo84 inhibits the exocyst complex assembly, exocytic secretion, and cell growth, which may be important for proper execution of the G(1)/S-phase transition before commitment to a complete cell cycle. Our results suggest that the direct Cdk1-mediated regulation of the exocyst complex critically contributes to the coordination of cell growth and cell cycle progression.	[Duan, Yuran; Guo, Qingguo; Zhang, Tianrui; Meng, Yuan; Liu, Ying] China Med Univ, Dept Biochem & Mol Biol, Shenyang 110122, Liaoning, Peoples R China; [Sun, Dong; Luo, Guangzuo] China Med Univ, Inst Translat Med, Shenyang 110122, Liaoning, Peoples R China	China Medical University; China Medical University	Liu, Y (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Shenyang 110122, Liaoning, Peoples R China.; Luo, GZ (corresponding author), China Med Univ, Inst Translat Med, Shenyang 110122, Liaoning, Peoples R China.	gzluo@cmu.edu.cn; liuying@cmu.edu.cn		Luo, Guangzuo/0000-0002-8518-5766	National Natural Science Foundation of China [31570819]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 31570819. The authors declare that they have no conflicts of interest with the contents of this article.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bjorklund M, 2019, BBA-MOL CELL RES, V1866, P409, DOI 10.1016/j.bbamcr.2018.10.002; Boucrot E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001477; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Brennwald P, 2013, CURR BIOL, V23, pR838, DOI 10.1016/j.cub.2013.08.007; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; ERICKSON CA, 1976, EXP CELL RES, V99, P375, DOI 10.1016/0014-4827(76)90595-4; Garmendia-Torres C, 2018, ELIFE, V7, DOI 10.7554/eLife.34025; Garrett S, 2001, MOL CELL BIOL, V21, P88, DOI 10.1128/MCB.21.1.88-99.2001; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goranov AI, 2010, CURR OPIN CELL BIOL, V22, P795, DOI 10.1016/j.ceb.2010.06.004; Goranov AI, 2009, GENE DEV, V23, P1408, DOI 10.1101/gad.1777309; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Inagaki M, 1999, MOL CELL BIOL, V19, P8344; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Koivomagi M, 2011, MOL CELL, V42, P610, DOI 10.1016/j.molcel.2011.05.016; KREINER T, 1990, CELL REGUL, V1, P415, DOI 10.1091/mbc.1.5.415; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LEAF DS, 1990, DEV BIOL, V141, P1, DOI 10.1016/0012-1606(90)90097-3; Liu JL, 2012, PROTOPLASMA, V249, P587, DOI 10.1007/s00709-011-0330-1; Liu Y, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0295-x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Lowe M, 1998, TRENDS CELL BIOL, V8, P40, DOI 10.1016/S0962-8924(97)01189-6; LUCOCQ JM, 1987, EMBO J, V6, P3239, DOI 10.1002/j.1460-2075.1987.tb02641.x; Luo GG, 2014, MOL BIOL CELL, V25, P3813, DOI 10.1091/mbc.E14-04-0907; Luo GZ, 2013, J CELL BIOL, V202, P97, DOI 10.1083/jcb.201211093; MAKAROW M, 1988, EMBO J, V7, P1475, DOI 10.1002/j.1460-2075.1988.tb02965.x; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; McCusker D, 2012, CURR OPIN CELL BIOL, V24, P845, DOI 10.1016/j.ceb.2012.10.008; MITCHISON JM, 1985, J CELL SCI, V75, P357; Mitchison JM, 2003, INT REV CYTOL, V226, P165, DOI 10.1016/S0074-7696(03)01004-0; Moseley JB, 2009, CURR OPIN CELL BIOL, V21, P82, DOI 10.1016/j.ceb.2008.12.005; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nelson WJ, 2001, TRENDS CELL BIOL, V11, P483, DOI 10.1016/S0962-8924(01)02145-6; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; NUGROHO TT, 1994, MOL CELL BIOL, V14, P3320, DOI 10.1128/MCB.14.5.3320; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Polgar N, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a031401; Rancati G, 2007, CURR BIOL, V17, pR600, DOI 10.1016/j.cub.2007.05.065; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soma S, 2014, MICROB CELL, V1, P256, DOI 10.15698/mic2014.08.160; Son S, 2012, NAT METHODS, V9, P910, DOI 10.1038/nmeth.2133; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wiederkehr A, 2003, MOL BIOL CELL, V14, P4770, DOI 10.1091/mbc.E03-04-0229; Wu B, 2015, J CELL SCI, V128, P2957, DOI 10.1242/jcs.156398; Zhang XY, 2005, J BIOL CHEM, V280, P20356, DOI 10.1074/jbc.M500511200; Zheng XD, 2007, EMBO J, V26, P3760, DOI 10.1038/sj.emboj.7601814	68	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11323	11332		10.1074/jbc.RA119.008591	http://dx.doi.org/10.1074/jbc.RA119.008591			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31171719	Green Published, hybrid			2022-12-28	WOS:000478717400022
J	Yadav, PK; Vitvitsky, V; Kim, H; White, A; Cho, US; Banerjee, R				Yadav, Pramod K.; Vitvitsky, Victor; Kim, Hanseong; White, Andrew; Cho, Uhn-Soo; Banerjee, Ruma			S-3-Carboxypropyl-l-cysteine specifically inhibits cystathionine gamma-lyase-dependent hydrogen sulfide synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; crystal structure; pyridoxal phosphate; hydrogen sulfide; enzyme inhibitor; chemical screen; cystathionine gamma-lyase; cysteine catabolism; PLP enzyme; propargylglycine; transsulfuration pathway	BETA-SYNTHASE; L-AMINOETHOXYVINYLGLYCINE; TRANSSULFURATION PATHWAY; CYSTEINE PERSULFIDES; INDUCED INFLAMMATION; REDOX REGULATION; HEME; AMINOTRANSFERASE; GLUTATHIONE; LIVER	Hydrogen sulfide (H2S) is a gaseous signaling molecule, which modulates a wide range of mammalian physiological processes. Cystathionine gamma-lyase (CSE) catalyzes H2S synthesis and is a potential target for modulating H2S levels under pathophysiological conditions. CSE is inhibited by propargylglycine (PPG), a widely used mechanism-based inhibitor. In this study, we report that inhibition of H2S synthesis from cysteine, but not the canonical cystathionine cleavage reaction catalyzed by CSE in vitro, is sensitive to preincubation of the enzyme with PPG. In contrast, the efficacy of S-3-carboxpropyl-l-cysteine (CPC) a new inhibitor described herein, was not dependent on the order of substrate/inhibitor addition. We observed that CPC inhibited the gamma-elimination reaction of cystathionine and H2S synthesis from cysteine by human CSE with K-i values of 50 +/- 3 and 180 +/- 15 mu m, respectively. We noted that CPC spared the other enzymes involved either directly (cystathionine beta-synthase and mercaptopyruvate sulfurtransferase) or indirectly (cysteine aminotransferase) in H2S biogenesis. CPC also targeted CSE in cultured cells, inhibiting transsulfuration flux by 80-90%, as monitored by the transfer of radiolabel from [S-35]methionine to GSH. The 2.5 angstrom resolution crystal structure of human CSE in complex with the CPC-derived aminoacrylate intermediate provided a structural framework for the molecular basis of its inhibitory effect. In summary, our study reveals a previously unknown confounding effect of PPG, widely used to inhibit CSE-dependent H2S synthesis, and reports on an alternative inhibitor, CPC, which could be used as a scaffold to develop more potent H2S biogenesis inhibitors.	[Yadav, Pramod K.; Vitvitsky, Victor; Kim, Hanseong; Cho, Uhn-Soo; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Sch, Ann Arbor, MI 48109 USA; [White, Andrew] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Sch, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010; Vitvitsky, Victor/ABA-2967-2021	Yadav, Pramod K./0000-0003-0026-1684; Vitvitsky, Victor/0000-0001-6251-6115; cho, uhn-soo/0000-0002-6992-2455; Kim, Hanseong/0000-0001-7518-6936	National Institutes of Health [HL58984, DK111465]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants HL58984 (to R. B.) and DK111465 (to U.-S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABELES RH, 1973, J AM CHEM SOC, V95, P6124, DOI 10.1021/ja00799a053; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKAGI R, 1982, ACTA MED OKAYAMA, V36, P187; Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Banerjee R, 2017, CURR OPIN CHEM BIOL, V37, P115, DOI 10.1016/j.cbpa.2017.02.021; BAXTER CF, 1961, J BIOL CHEM, V236, P3287; BEATTY PW, 1980, ARCH BIOCHEM BIOPHYS, V204, P80, DOI 10.1016/0003-9861(80)90009-0; Capitani G, 2002, J BIOL CHEM, V277, P49735, DOI 10.1074/jbc.M208427200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Clausen T, 1997, BIOCHEMISTRY-US, V36, P12633, DOI 10.1021/bi970630m; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Kabil O, 2016, J BIOL CHEM, V291, P16418, DOI 10.1074/jbc.C116.742213; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; KAWAJI A, 1990, Journal of Toxicological Sciences, V15, P145; LAUINGER C, 1970, BIOCHIM BIOPHYS ACTA, V198, P316, DOI 10.1016/0005-2744(70)90064-1; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Nagahara N, 2007, J BIOL CHEM, V282, P1561, DOI 10.1074/jbc.M605931200; Ohta J, 1997, BBA-GEN SUBJECTS, V1334, P240, DOI 10.1016/S0304-4165(96)00100-6; REJ R, 1977, CLIN CHEM, V23, P1508; Roman HB, 2013, ANTIOXID REDOX SIGN, V19, P1321, DOI 10.1089/ars.2012.5010; SHINOZUKA S, 1982, EUR J BIOCHEM, V124, P377; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Steegborn C, 1999, J BIOL CHEM, V274, P12675, DOI 10.1074/jbc.274.18.12675; Sun QX, 2009, J BIOL CHEM, V284, P3076, DOI 10.1074/jbc.M805459200; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Vitvitsky V, 2015, METHOD ENZYMOL, V554, P111, DOI 10.1016/bs.mie.2014.11.013; Vitvitsky V, 2013, MECH AGEING DEV, V134, P321, DOI 10.1016/j.mad.2013.05.004; Wang J, 2003, HUM GENET, V112, P404, DOI 10.1007/s00439-003-0906-8; Whiteman M, 2011, CLIN SCI, V121, P459, DOI 10.1042/CS20110267; Whiteman M, 2010, ANN NY ACAD SCI, V1203, P146, DOI 10.1111/j.1749-6632.2010.05556.x; Yadav PK, 2016, J AM CHEM SOC, V138, P289, DOI 10.1021/jacs.5b10494; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yadav PK, 2012, J BIOL CHEM, V287, P43464, DOI 10.1074/jbc.M112.414722; Yadav PK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414706; Yamagata S, 2003, J BIOCHEM, V134, P607, DOI 10.1093/jb/mvg179; Yan YL, 2013, RES VET SCI, V94, P590, DOI 10.1016/j.rvsc.2012.10.009; Zhang L, 2010, MOL MED, V16, P417, DOI 10.2119/molmed.2010.00027; Zhu WD, 2008, BIOCHEMISTRY-US, V47, P6226, DOI 10.1021/bi800351a	48	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					11011	11022		10.1074/jbc.RA119.009047	http://dx.doi.org/10.1074/jbc.RA119.009047			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31160338	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000478717200022
J	Huang, CY; Chen, YC; Wu-Hsieh, BA; Fang, JM; Chang, ZF				Huang, Chang-Yu; Chen, Yee-Chun; Wu-Hsieh, Betty A.; Fang, Jim-Min; Chang, Zee-Fen			The Ca-loop in thymidylate kinase is critical for growth and contributes to pyrimidine drug sensitivity of Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; drug resistance; nucleoside; nucleotide analogue; DNA damage; substrate specificity; thymidylate kinase	CELL-DIVISION CYCLE; SACCHAROMYCES-CEREVISIAE; GENETIC-CONTROL; 5-FLUOROURACIL; MECHANISMS; RESISTANCE; EXPRESSION; INSIGHTS; SYSTEM; AZOLES	The yeast Candida albicans is the most prevalent opportunistic fungal pathogen in humans. Drug resistance among C. albicans isolates poses a common challenge, and overcoming this resistance represents an unmet need in managing this common pathogen. Here, we investigated CDC8, encoding thymidylate kinase (TMPK), as a potential drug target for the management of C. albicans infections. We found that the region spanning amino acids 106-123, namely the Ca-loop of C. albicans TMPK (CaTMPK), contributes to the hyperactivity of this enzyme compared with the human enzyme (hTMPK) and to the utilization of deoxyuridine monophosphate (dUMP)/deoxy-5-fluorouridine monophosphate (5-FdUMP) as a substrate. Notably, expression of CaTMPK, but not of hTMPK, produced dUTP/5-FdUTP-mediated DNA toxicity in budding yeast (Saccharomyces cerevisiae). CRISPR-mediated deletion of this Ca-loop in C. albicans revealed that the Ca-loop is critical for fungal growth and susceptibility to 5-fluorouridine (5-FUrd). Of note, pathogenic and drug-resistant C. albicans clones were similarly sensitive to 5-FUrd, and we also found that CaTMPK is essential for the growth of C. albicans. In conclusion, these findings not only identified a target site for the development of CaTMPK-selective drugs, but also revealed that 5-FUrd may have potential utility as drug for managing C. albicans infections.	[Huang, Chang-Yu; Chang, Zee-Fen] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Linong St, Taipei 11221, Taiwan; [Huang, Chang-Yu; Chang, Zee-Fen] Natl Taiwan Univ, Coll Med, Inst Mol Med, Jen Ai Rd, Taipei 10051, Taiwan; [Chen, Yee-Chun] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Taipei 10002, Taiwan; [Chen, Yee-Chun] Natl Taiwan Univ, Coll Med, Taipei 10002, Taiwan; [Chen, Yee-Chun; Chang, Zee-Fen] Natl Taiwan Univ, Coll Med, Ctr Precis Med, Taipei 10002, Taiwan; [Wu-Hsieh, Betty A.] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Jen Ai Rd, Taipei 10051, Taiwan; [Fang, Jim-Min] Natl Taiwan Univ, Dept Chem, Taipei 10612, Taiwan; [Chang, Zee-Fen] 1,Sect 1,Jen Ai Rd, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Chang, ZF (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, Jen Ai Rd, Taipei 10051, Taiwan.; Chang, ZF (corresponding author), 1,Sect 1,Jen Ai Rd, Taipei 100, Taiwan.	zfchang@ntu.edu.tw		Huang, Chang Yu/0000-0001-7430-2085	"Center of PrecisionMedicine" from the Fea-of CaTMPK within Ministry of Education (MOE) in Taiwan; Ministry of Science and Technology, Taiwan [MOST 108-3017-F-002-004, MOST 107-2321-B-002-041, MOST 106-2113-M-002-021-MY3]	"Center of PrecisionMedicine" from the Fea-of CaTMPK within Ministry of Education (MOE) in Taiwan; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the "Center of PrecisionMedicine" from the Fea-of CaTMPK from C. albicans in antifungal drug development. tured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan and by Grants MOST 108-3017-F-002-004, MOST 107-2321-B-002-041, and MOST 106-2113-M-002-021-MY3 from the Ministry of Science and Technology, Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Albertson GD, 1996, ANTIMICROB AGENTS CH, V40, P2835, DOI 10.1128/AAC.40.12.2835; Alexander B. D., 2017, M27 CLSI, P1; Belenky P, 2013, CELL REP, V3, P350, DOI 10.1016/j.celrep.2012.12.021; BIRKENMEYER LG, 1984, MOL CELL BIOL, V4, P583, DOI 10.1128/MCB.4.4.583; Chen YC, 2017, MYCOSES, V60, P89, DOI 10.1111/myc.12553; Chen YH, 2016, J MED CHEM, V59, P9906, DOI 10.1021/acs.jmedchem.6b01280; Cui Q, 2013, CURR MED CHEM, V20, P1286, DOI 10.2174/0929867311320100006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ford CB, 2015, ELIFE, V4, DOI 10.7554/eLife.00662; Gabriel F, 2014, ANTIMICROB AGENTS CH, V58, P4476, DOI 10.1128/AAC.00009-14; HARTWELL LH, 1971, J MOL BIOL, V59, P183, DOI 10.1016/0022-2836(71)90420-7; HARTWELL LH, 1973, GENETICS, V74, P267; Hope WW, 2004, ANTIMICROB AGENTS CH, V48, P4377, DOI 10.1128/AAC.48.11.4377-4386.2004; Hu CM, 2012, CANCER CELL, V22, P36, DOI 10.1016/j.ccr.2012.04.038; Hu R, 2005, ANTIMICROB AGENTS CH, V49, P2044, DOI 10.1128/AAC.49.5.2044-2049.2005; Lai WC, 2016, CURR GENET, V62, P213, DOI 10.1007/s00294-015-0526-6; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lockhart S. R., 2016, M59 CLSI, P1; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Martel CM, 2010, ANTIMICROB AGENTS CH, V54, P3578, DOI 10.1128/AAC.00303-10; Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000; Nett JE, 2010, ANTIMICROB AGENTS CH, V54, P3505, DOI 10.1128/AAC.00227-10; Ostermann N, 2000, STRUCTURE, V8, P629, DOI 10.1016/S0969-2126(00)00149-0; POLAK A, 1979, J MED MICROBIOL, V12, P83, DOI 10.1099/00222615-12-1-83; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; Shor E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004668; Sinha K, 2017, BIOCHEMISTRY-US, V56, P4360, DOI 10.1021/acs.biochem.7b00498; Su H, 2018, J ANTIBIOT, V71, P978, DOI 10.1038/s41429-018-0100-9; SU JY, 1991, NUCLEIC ACIDS RES, V19, P823, DOI 10.1093/nar/19.4.823; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Toussaint M, 2005, NUCLEIC ACIDS RES, V33, P704, DOI 10.1093/nar/gki219; Turner SA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019778; Vickers MF, 2000, J BIOL CHEM, V275, P25931, DOI 10.1074/jbc.M000239200; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092	38	3	3	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10686	10697		10.1074/jbc.RA118.006798	http://dx.doi.org/10.1074/jbc.RA118.006798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31152062	Green Published, hybrid			2022-12-28	WOS:000478717100026
J	McGlinchey, RP; Lacy, SM; Huffer, KE; Tayebi, N; Sidransky, E; Lee, JC				McGlinchey, Ryan P.; Lacy, Shannon M.; Huffer, Katherine E.; Tayebi, Nahid; Sidransky, Ellen; Lee, Jennifer C.			C-terminal -synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; alpha-synuclein (-synuclein); lysosome; mass spectrometry (MS); electron microscopy (EM); transmission electron microscopy; Lewy body; cysteine cathepsin; proteolytic processing; protein aggregation	ALPHA-SYNUCLEIN; LEWY BODIES; POSTTRANSLATIONAL MODIFICATIONS; GLUCOCEREBROSIDASE MUTATIONS; PATHOLOGICAL FORMS; A-SYNUCLEIN; BETA-SHEET; AGGREGATION; DEGRADATION; DEMENTIA	A pathological feature of Parkinson's disease (PD) is Lewy bodies (LBs) composed of -synuclein (-syn) amyloid fibrils. -Syn is a 140 amino acids-long protein, but truncated -syn is enriched in LBs. The proteolytic processes that generate these truncations are not well-understood. On the basis of our previous work, we propose that these truncations could originate from lysosomal activity attributable to cysteine cathepsins (Cts). Here, using a transgenic SNCA(A53T) mouse model, overexpressing the PD-associated -syn variant A53T, we compared levels of -syn species in purified brain lysosomes from nonsymptomatic mice with those in age-matched symptomatic mice. In the symptomatic mice, antibody epitope mapping revealed enrichment of C-terminal truncations, resulting from CtsB, CtsL, and asparagine endopeptidase. We did not observe changes in individual cathepsin activities, suggesting that the increased levels of C-terminal -syn truncations are because of the burden of aggregated -syn. Using LC-MS and purified -syn, we identified C-terminal truncations corresponding to amino acids 1-122 and 1-90 from the SNCA(A53T) lysosomes. Feeding rat dopaminergic N27 cells with exogenous -syn fibrils confirmed that these fragments originate from incomplete fibril degradation in lysosomes. We mimicked these events in situ by asparagine endopeptidase degradation of -syn fibrils. Importantly, the resulting C-terminally truncated fibrils acted as superior seeds in stimulating -syn aggregation compared with that of the full-length fibrils. These results unequivocally show that C-terminal -syn truncations in LBs are linked to Cts activities, promote amyloid formation, and contribute to PD pathogenesis.	[McGlinchey, Ryan P.; Lacy, Shannon M.; Huffer, Katherine E.; Lee, Jennifer C.] NHLBI, Lab Prot Conformat & Dynam, Biochem & Biophys Ctr, Bldg 10, Bethesda, MD 20892 USA; [Tayebi, Nahid; Sidransky, Ellen] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Lee, JC (corresponding author), NHLBI, Lab Prot Conformat & Dynam, Biochem & Biophys Ctr, Bldg 10, Bethesda, MD 20892 USA.	leej4@nhlbi.nih.gov		Huffer, Katherine/0000-0001-5003-3140	Intramural Research Program at the NHLBI, National Institutes of Health; Intramural Research Program at the NHGRI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006144] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200336] Funding Source: NIH RePORTER	Intramural Research Program at the NHLBI, National Institutes of Health; Intramural Research Program at the NHGRI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by the Intramural Research Program at the NHLBI and NHGRI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abounit S, 2016, EMBO J, V35, P2120, DOI 10.15252/embj.201593411; Aflaki E, 2016, J NEUROSCI, V36, P7441, DOI 10.1523/JNEUROSCI.0636-16.2016; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; APFFEL A, 1995, J CHROMATOGR A, V712, P177, DOI 10.1016/0021-9673(95)00175-M; Baba M, 1998, AM J PATHOL, V152, P879; Bae EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5755; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Clarkson ED, 1998, P NATL ACAD SCI USA, V95, P1265, DOI 10.1073/pnas.95.3.1265; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Diepenbroek M, 2014, HUM MOL GENET, V23, P3975, DOI 10.1093/hmg/ddu112; Ding QX, 2018, NEUROSCI LETT, V678, P131, DOI 10.1016/j.neulet.2018.05.022; Domert J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168700; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; Flavin WP, 2017, ACTA NEUROPATHOL, V134, P629, DOI 10.1007/s00401-017-1722-x; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; Guerrero-Ferreira R, 2018, ELIFE, V7, DOI 10.7554/eLife.36402; Hoffmann AC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35811-8; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jiang PZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08149-w; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Karpowicz RJ, 2017, J BIOL CHEM, V292, P13482, DOI 10.1074/jbc.M117.780296; Kasai T, 2008, NEUROSCI LETT, V436, P52, DOI 10.1016/j.neulet.2008.02.057; Kellie JF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05797; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Levitan K, 2011, J MOL BIOL, V411, P329, DOI 10.1016/j.jmb.2011.05.046; Li BS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05971-2; Li LY, 2011, NEUROSCI LETT, V489, P62, DOI 10.1016/j.neulet.2010.11.068; Li YW, 2018, CELL RES, V28, P897, DOI 10.1038/s41422-018-0075-x; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Mahul-Mellier A.-L., 2018, MAKING LEWY BODY ROL, DOI [10.1101/500058, DOI 10.1101/500058]; Mazzulli JR, 2016, J NEUROSCI, V36, P7693, DOI 10.1523/JNEUROSCI.0628-16.2016; McGlinchey RP, 2017, BIOCHEMISTRY-US, V56, P3881, DOI 10.1021/acs.biochem.7b00360; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; McGlinchey RP, 2013, BIOCHEM SOC T, V41, P1509, DOI 10.1042/BST20130158; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; Moors T, 2016, MOVEMENT DISORD, V31, P791, DOI 10.1002/mds.26562; Muntane G, 2012, NEUROSCIENCE, V200, P106, DOI 10.1016/j.neuroscience.2011.10.042; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nalls MA, 2013, JAMA NEUROL, V70, P727, DOI 10.1001/jamaneurol.2013.1925; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Sardi SP, 2013, P NATL ACAD SCI USA, V110, P3537, DOI 10.1073/pnas.1220464110; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Sato H, 2013, REV NEUROSCIENCE, V24, P115, DOI 10.1515/revneuro-2012-0071; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid AW, 2013, MOL CELL PROTEOMICS, V12, P3543, DOI 10.1074/mcp.R113.032730; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Taggart C, 2000, J BIOL CHEM, V275, P27258; Tayebi N, 2017, MOL GENET METAB, V122, P198, DOI 10.1016/j.ymgme.2017.11.001; Terada M, 2018, J BIOL CHEM, V293, P13910, DOI 10.1074/jbc.RA118.001862; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Tsujimura A, 2015, NEUROBIOL DIS, V73, P244, DOI 10.1016/j.nbd.2014.10.011; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; van der Wateren IM, 2018, CHEM SCI, V9, P5506, DOI 10.1039/c8sc01109e; vanderStappen JWJ, 1996, INT J CANCER, V67, P547, DOI 10.1002/(SICI)1097-0215(19960807)67:4<547::AID-IJC14>3.0.CO;2-4; Wang W, 2016, P NATL ACAD SCI USA, V113, P9587, DOI 10.1073/pnas.1610099113; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wong E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a006734; Xiang W, 2013, MOL CELL NEUROSCI, V54, P71, DOI 10.1016/j.mcn.2013.01.004; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Yap TL, 2015, J BIOL CHEM, V290, P744, DOI 10.1074/jbc.M114.610584; Yap TL, 2013, MOL GENET METAB, V108, P56, DOI 10.1016/j.ymgme.2012.11.010; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859; Zhang ZT, 2017, NAT STRUCT MOL BIOL, V24, P632, DOI 10.1038/nsmb.3433	71	30	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9973	9984		10.1074/jbc.RA119.008930	http://dx.doi.org/10.1074/jbc.RA119.008930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31092553	Green Published, hybrid			2022-12-28	WOS:000473277900027
J	Duan, L; Perez, RE; Lai, X; Chen, L; Maki, CG				Duan, Lei; Perez, Ricardo E.; Lai, Xin; Chen, Ling; Maki, Carl G.			The histone demethylase JMJD2B is critical for p53-mediated autophagy and survival in Nutlin-treated cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; p53; histone demethylase; mouse double minute 2 homolog (MDM2); histone methylation; ATG16L1; ULK1; Jumonji domain containing protein 2B (JMJD2B); nutlin; cancer; epigenetic regulation; chromatin regulation; MDM2 proto-oncogene	P53; APOPTOSIS; MECHANISMS; ROLES	Autophagy promotes cancer cell survival in response to p53 activation by the anticancer agent Nutlin-3a (Nutlin). We reported previously that Nutlin kills MDM2-amplified cancer cells and that this killing is associated with an inhibition of glucose metabolism, reduced -ketoglutarate (-KG) levels, and reduced autophagy. In the current report, using SJSA1, U2OS, A549, and MHM cells, we found that Nutlin alters histone methylation in an MDM2 proto-oncogene-dependent manner and that this, in turn, regulates autophagy-related gene (ATG) expression and cell death. In MDM2-amplified cells, Nutlin increased histone (H) 3 lysine (K) 9 and K36 trimethylation (me3) coincident with reduced autophagy and increased apoptosis. Blocking histone methylation restored autophagy and rescued these cells from Nutlin-induced killing. In MDM2-nonamplified cells, H3K9me3 and H3K36me3 levels were either reduced or not changed by the Nutlin treatment, and this coincided with increased autophagy and cell survival. Blocking histone demethylation reduced autophagy and sensitized these cells to Nutlin-induced killing. Further experiments suggested that MDM2 amplification increases histone methylation in Nutlin-treated cells by causing depletion of the histone demethylase Jumonji domain-containing protein 2B (JMJD2B). Finally, JMJD2B knockdown or inhibition increased H3K9/K36me3 levels, decreased ATG gene expression and autophagy, and sensitized MDM2-nonamplified cells to apoptosis. Together, these results support a model in which MDM2- and JMJD2B-regulated histone methylation levels modulate ATG gene expression, autophagy, and cell fate in response to the MDM2 antagonist Nutlin-3a.	[Duan, Lei; Perez, Ricardo E.; Maki, Carl G.] Rush Univ, Dept Cell & Mol Med, Med Ctr, Chicago, IL 60612 USA; [Lai, Xin] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Ctr, Chengdu, Sichuan, Peoples R China; [Chen, Ling] Hubei Univ Med, Taihe Hosp, Dept Lab Med, Shiyan 442000, Hubei, Peoples R China	Rush University; University of Electronic Science & Technology of China; Hubei University of Medicine	Maki, CG (corresponding author), 600 S Paulina,AcFac 507, Chicago, IL 60612 USA.	Carl_Maki@rush.edu			National Cancer Institute, National Institutes of Health [1 R21 CA185036-01A1]; Swim Across America Foundation; NATIONAL CANCER INSTITUTE [R21CA185036] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swim Across America Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute, National Institutes of Health Grant 1 R21 CA185036-01A1 (to C. G. M) and by a Swim Across America Foundation Grant (to C. G. M). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biga PR, 2017, BIOL OPEN, V6, P1720, DOI 10.1242/bio.029090; Broz DK, 2013, AUTOPHAGY, V9, P1440, DOI 10.4161/auto.25833; Castellini L, 2017, NUCLEIC ACIDS RES, V45, P3674, DOI 10.1093/nar/gkw1281; Chen LH, 2010, EMBO J, V29, P2538, DOI 10.1038/emboj.2010.140; Ci Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.506; de Narvajas AAM, 2013, MOL CELL BIOL, V33, P3983, DOI 10.1128/MCB.00813-13; Duan L, 2019, CANCER BIOL THER, V20, P252, DOI 10.1080/15384047.2018.1523858; Duan L, 2018, J MOL CELL BIOL, V10, P331, DOI 10.1093/jmcb/mjx051; Duan L, 2015, ONCOTARGET, V6, P23135, DOI 10.18632/oncotarget.5218; Duan L, 2014, CANCER LETT, V353, P290, DOI 10.1016/j.canlet.2014.07.031; Fitzwalter BE, 2018, DEV CELL, V44, P555, DOI 10.1016/j.devcel.2018.02.014; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; Johansson C, 2014, EPIGENOMICS-UK, V6, P89, DOI 10.2217/epi.13.79; Kim TD, 2012, J CELL BIOCHEM, V113, P1368, DOI 10.1002/jcb.24009; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rubinsztein DC, 2012, EMBO REP, V13, P173, DOI 10.1038/embor.2012.5; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Tang XH, 2004, ONCOGENE, V23, P5759, DOI 10.1038/sj.onc.1207706; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wesselborg S, 2015, CELL MOL LIFE SCI, V72, P4721, DOI 10.1007/s00018-015-2034-8; White E, 2015, CLIN CANCER RES, V21, P5037, DOI 10.1158/1078-0432.CCR-15-0490; Wienken M, 2016, MOL CELL, V61, P68, DOI 10.1016/j.molcel.2015.12.008; Xie P, 2008, CELL SIGNAL, V20, P1671, DOI 10.1016/j.cellsig.2008.05.012; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zheng H, 2014, ONCOGENE, V33, P734, DOI 10.1038/onc.2013.6	32	6	6	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9186	9197		10.1074/jbc.RA118.007122	http://dx.doi.org/10.1074/jbc.RA118.007122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31036564	Green Published, hybrid			2022-12-28	WOS:000471751600014
J	Li, WQ; Zhu, TQ; Guan, KL				Li, Weiquan; Zhu, Tianqing; Guan, Kun-Liang			RETRACTION: Transformation potential of Ras isoforms correlates with activation of phosphatidylinositol 3-kinase but not ERK. (Retraction of Vol 279, Pg 37398, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Guan, Kun-Liang/ADK-7088-2022					Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200	1	2	2	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8310	8310		10.1074/jbc.W119.009032	http://dx.doi.org/10.1074/jbc.W119.009032			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	31101660	Green Published, hybrid			2022-12-28	WOS:000470656500027
J	Ho, RXY; Tahboub, R; Amraei, R; Meyer, RD; Varongchayakul, N; Grinstaff, M; Rahimi, N				Ho, Rachel Xi-Yeen; Tahboub, Rawan; Amraei, Razie; Meyer, Rosana D.; Varongchayakul, Nitinun; Grinstaff, Mark; Rahimi, Nader			The cell adhesion molecule IGPR-1 is activated by and regulates responses of endothelial cells to shear stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; adherens junction; cardiovascular; endothelial cell; serine; threonine protein kinase; shear stress; signal transduction; IGPR-1; immunoglobulin and proline-rich receptor-1; mechanotransduction; shear stress; transmembrane and immunoglobulin domain-containing 2 (TMIGD2)	FLUID SHEAR; STIMULATES PHOSPHORYLATION; ELASTIC-MODULUS; ACTIN; ADHERENS; MECHANOTRANSDUCTION; EXPRESSION; MICROSCOPY; JUNCTIONS; VINCULIN	Vascular endothelial cells respond to blood flow-induced shear stress. However, the mechanisms through which endothelial cells transduce mechanical signals to cellular responses remain poorly understood. In this report, using tensile-force assays, immunofluorescence and atomic force microscopy, we demonstrate that immunoglobulin and proline-rich receptor-1 (IGPR-1) responds to mechanical stimulation and increases the stiffness of endothelial cells. We observed that IGPR-1 is activated by shear stress and tensile force and that flow shear stress-mediated IGPR-1 activation modulates remodeling of endothelial cells. We found that under static conditions, IGPR-1 is present at the cell-cell contacts; however, under shear stress, it redistributes along the cell borders into the flow direction. IGPR-1 activation stimulated actin stress fiber assembly and cross-linking with vinculin. Moreover, we noted that IGPR-1 stabilizes cell-cell junctions of endothelial cells as determined by staining of cells with ZO1. Mechanistically, shear stress stimulated activation of AKT Ser/Thr kinase 1 (AKT1), leading to phosphorylation of IGPR-1 at Ser-220. Inhibition of this phosphorylation prevented shear stress-induced actin fiber assembly and endothelial cell remodeling. Our findings indicate that IGPR-1 is an important player in endothelial cell mechanosensing, insights that have important implications for the pathogenesis of common maladies, including ischemic heart diseases and inflammation.	[Ho, Rachel Xi-Yeen; Tahboub, Rawan; Amraei, Razie; Meyer, Rosana D.; Rahimi, Nader] Boston Univ Med Campus, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Varongchayakul, Nitinun; Grinstaff, Mark] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Varongchayakul, Nitinun; Grinstaff, Mark] Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA; [Varongchayakul, Nitinun; Grinstaff, Mark] Boston Univ, Dept Med, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Boston University	Rahimi, N (corresponding author), Boston Univ Med Campus, Dept Pathol, Boston, MA 02118 USA.	nrahimi@bu.edu	Amraei, Razie/AAO-8769-2021; Grinstaff, Mark/U-2829-2017	Ho, Rachel/0000-0002-8346-2328; Grinstaff, Mark/0000-0002-5453-3668; Rahimi, Nader/0000-0002-6745-1725	NCI, National Institutes of Health [R21CA191970, R21CA193958]; Clinical and Translational Science Institute [1UL1TR001430]; NATIONAL CANCER INSTITUTE [R21CA191970] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001430] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by NCI, National Institutes of Health Grants R21CA191970 and R21CA193958 and Clinical and Translational Science Institute Grant 1UL1TR001430 (to N. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baeyens N, 2016, J CLIN INVEST, V126, P821, DOI 10.1172/JCI83083; Bays JL, 2014, J CELL BIOL, V205, P251, DOI 10.1083/jcb.201309092; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; dela Paz NG, 2012, J CELL SCI, V125, P831, DOI 10.1242/jcs.084301; dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; DiRenzo J, 2002, CANCER RES, V62, P89; Dokukin ME, 2013, BIOPHYS J, V104, P2123, DOI [10.1016/j.bpj.2013.04.019, 10.1016/j.bpj.2013.03.019]; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Heinisch JJ, 2012, J CELL SCI, V125, P4189, DOI 10.1242/jcs.106005; Malek AM, 1996, J CELL SCI, V109, P713; Marjoram RJ, 2016, METHODS, V94, P19, DOI 10.1016/j.ymeth.2015.09.025; Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6; Noria S, 1999, CIRC RES, V85, P504, DOI 10.1161/01.RES.85.6.504; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Paszkowiak Jacek J, 2003, Vasc Endovascular Surg, V37, P47, DOI 10.1177/153857440303700107; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rahimi N, 2012, MOL BIOL CELL, V23, P1646, DOI 10.1091/mbc.E11-11-0934; Schaefer A, 2015, J CELL SCI, V128, P2221, DOI 10.1242/jcs.163055; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Sokolov I, 2013, METHODS, V60, P202, DOI 10.1016/j.ymeth.2013.03.037; Steward R, 2015, AM J PHYSIOL-CELL PH, V308, pC657, DOI 10.1152/ajpcell.00363.2014; Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225; Tornavaca O, 2015, J CELL BIOL, V208, P821, DOI 10.1083/jcb.201404140; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Wang WY, 2010, BLOOD, V115, P2971, DOI 10.1182/blood-2009-05-224824; Wang YHW, 2016, J MOL BIOL, V428, P5019, DOI 10.1016/j.jmb.2016.11.003; Woolf N, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.77; Zeller KS, 2010, CELL SIGNAL, V22, P1838, DOI 10.1016/j.cellsig.2010.07.011	41	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13671	13680		10.1074/jbc.RA119.008548	http://dx.doi.org/10.1074/jbc.RA119.008548			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31341021	hybrid, Green Published			2022-12-28	WOS:000486418600013
J	Grotjahn, DA; Lander, GC				Grotjahn, Danielle A.; Lander, Gabriel C.			Setting the dynein motor in motion: New insights from electron tomography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						dynein; cryo-electron microscopy; molecular motor; electron tomography; cell motility	LIGHT INTERMEDIATE CHAIN; INTRAFLAGELLAR TRANSPORT IFT; CYTOPLASMIC DYNEIN; MICROTUBULE-BINDING; HEAVY-CHAIN; BICAUDAL-D; CRYOELECTRON TOMOGRAPHY; IN-VIVO; TUBULIN TYROSINATION; DYNACTIN RECRUITS	Dyneins are ATP-fueled macromolecular machines that power all minus-end microtubule-based transport processes of molecular cargo within eukaryotic cells and play essential roles in a wide variety of cellular functions. These complex and fascinating motors have been the target of countless structural and biophysical studies. These investigations have elucidated the mechanism of ATP-driven force production and have helped unravel the conformational rearrangements associated with the dynein mechanochemical cycle. However, despite decades of research, it remains unknown how these molecular motions are harnessed to power massive cellular reorganization and what are the regulatory mechanisms that drive these processes. Recent advancements in electron tomography imaging have enabled researchers to visualize dynein motors in their transport environment with unprecedented detail and have led to exciting discoveries regarding dynein motor function and regulation. In this review, we will highlight how these recent structural studies have fundamentally propelled our understanding of the dynein motor and have revealed some unexpected, unifying mechanisms of regulation.	[Grotjahn, Danielle A.; Lander, Gabriel C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Lander, GC (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	glander@scripps.edu		Grotjahn, Danielle/0000-0001-5908-7882; Lander, Gabriel C./0000-0003-4921-1135	Pew Scholarship in the Biomedical Sciences from the Pew Charitable Trust; National Institutes of Health [DP2EB020402]	Pew Scholarship in the Biomedical Sciences from the Pew Charitable Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Pew Scholarship in the Biomedical Sciences from the Pew Charitable Trust and by National Institutes of Health Grant DP2EB020402. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alper JD, 2014, BIOPHYS J, V107, P2872, DOI 10.1016/j.bpj.2014.10.061; AMOS LA, 1989, J CELL SCI, V93, P19; Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197; Bader JR, 2011, J BIOL CHEM, V286, P20769, DOI 10.1074/jbc.M111.226605; Bhabha G, 2014, CELL, V159, P857, DOI 10.1016/j.cell.2014.10.018; Bleck CKE, 2010, J MICROSC-OXFORD, V237, P23, DOI 10.1111/j.1365-2818.2009.03299.x; Blocker A, 1997, J CELL BIOL, V137, P113, DOI 10.1083/jcb.137.1.113; Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003; Buisson J, 2013, J CELL SCI, V126, P327, DOI 10.1242/jcs.117069; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2013, J CELL SCI, V126, P705, DOI 10.1242/jcs.120725; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Chien A, 2017, ELIFE, V6, DOI 10.7554/eLife.28606; Cho C, 2012, BBA-MOL CELL RES, V1823, P182, DOI 10.1016/j.bbamcr.2011.10.009; Chowdhury S, 2015, NAT STRUCT MOL BIOL, V22, P345, DOI 10.1038/nsmb.2996; Cianfrocco MA, 2015, ANNU REV CELL DEV BI, V31, P83, DOI 10.1146/annurev-cellbio-100814-125438; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dai W, 2014, NAT PROTOC, V9, P2630, DOI 10.1038/nprot.2014.176; Danev R, 2017, ELIFE, V6, DOI 10.7554/eLife.23006; de Boer P, 2015, NAT METHODS, V12, P503, DOI 10.1038/nmeth.3400; Dienstbier M, 2009, BIOCHEM SOC T, V37, P1066, DOI 10.1042/BST0371066; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Eschbach J, 2011, PHARMACOL THERAPEUT, V130, P348, DOI 10.1016/j.pharmthera.2011.03.004; Gagnon JA, 2011, CRIT REV BIOCHEM MOL, V46, P229, DOI 10.3109/10409238.2011.572861; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; GIBBONS IR, 1960, J BIOPHYS BIOCHEM CY, V7, P697, DOI 10.1083/jcb.7.4.697; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GIBBONS IR, 1965, SCIENCE, V149, P424, DOI 10.1126/science.149.3682.424; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Gokhale A, 2009, J CELL BIOL, V186, P817, DOI 10.1083/jcb.200906168; GOODENOUGH U, 1984, J MOL BIOL, V180, P1083, DOI 10.1016/0022-2836(84)90272-9; GOODENOUGH UW, 1982, J CELL BIOL, V95, P798, DOI 10.1083/jcb.95.3.798; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Grotjahn DA, 2018, NAT STRUCT MOL BIOL, V25, P203, DOI 10.1038/s41594-018-0027-7; Habura A, 1999, J BIOL CHEM, V274, P15447, DOI 10.1074/jbc.274.22.15447; Harrell JM, 2004, J BIOL CHEM, V279, P54647, DOI 10.1074/jbc.M406863200; Hayashi S, 2008, J CELL SCI, V121, P2833, DOI 10.1242/jcs.031195; Heuser T, 2012, P NATL ACAD SCI USA, V109, pE2067, DOI 10.1073/pnas.1120690109; Himes BA, 2018, NAT METHODS, V15, P955, DOI 10.1038/s41592-018-0167-z; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Hou YQ, 2004, MOL BIOL CELL, V15, P4382, DOI 10.1091/mbc.E04-05-0377; Hsu MT, 2015, DEV CELL, V35, P418, DOI 10.1016/j.devcel.2015.10.018; Ishikawa Takashi, 2015, Cilia, V4, P3, DOI 10.1186/s13630-014-0012-7; Johnson KA, 1998, J CELL SCI, V111, P313; Jordan MA, 2018, NAT CELL BIOL, V20, P1250, DOI 10.1038/s41556-018-0213-1; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kamiya R, 2014, ZOOL SCI, V31, P633, DOI 10.2108/zs140066; Kempeneers C, 2018, PEDIATR PULM, V53, P1122, DOI 10.1002/ppul.24078; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SM, 2018, CYTOSKELETON, V75, P372, DOI 10.1002/cm.21483; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lin JF, 2018, SCIENCE, V360, DOI 10.1126/science.aar1968; Lin JF, 2014, NAT CELL BIOL, V16, P479, DOI 10.1038/ncb2939; Liu Y, 2013, GENE DEV, V27, P1233, DOI 10.1101/gad.212381.112; Lucic V, 2013, J CELL BIOL, V202, P407, DOI 10.1083/jcb.201304193; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; McKenney RJ, 2016, EMBO J, V35, P1175, DOI 10.15252/embj.201593071; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; MITCHELL DR, 1985, J CELL BIOL, V100, P1228, DOI 10.1083/jcb.100.4.1228; Mitchison TJ, 2010, NATURE, V463, P308, DOI 10.1038/463308a; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Mizuno N, 2012, J MOL BIOL, V422, P163, DOI 10.1016/j.jmb.2012.05.040; Moore JK, 2008, TRAFFIC, V9, P510, DOI 10.1111/j.1600-0854.2008.00710.x; Moore JK, 2009, P NATL ACAD SCI USA, V106, P5147, DOI 10.1073/pnas.0810828106; Movassagh T, 2010, NAT STRUCT MOL BIOL, V17, P761, DOI 10.1038/nsmb.1832; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nicastro D, 2009, METHOD CELL BIOL, V91, P1, DOI 10.1016/S0091-679X(08)91001-3; Nirschl JJ, 2016, CELL REP, V14, P2637, DOI 10.1016/j.celrep.2016.02.046; Oda T, 2015, MOL BIOL CELL, V26, P294, DOI 10.1091/mbc.E14-09-1367; Oikonomou CM, 2017, ANNU REV BIOCHEM, V86, P873, DOI 10.1146/annurev-biochem-061516-044741; OKAGAKI T, 1986, J CELL BIOL, V103, P1895, DOI 10.1083/jcb.103.5.1895; Olenick MA, 2016, J BIOL CHEM, V291, P18239, DOI 10.1074/jbc.M116.738211; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pigino G, 2009, J CELL BIOL, V187, P135, DOI 10.1083/jcb.200905103; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qiu RD, 2013, J BIOL CHEM, V288, P2271, DOI 10.1074/jbc.M112.412403; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Raaijmakers JA, 2014, CHROMOSOMA, V123, P407, DOI 10.1007/s00412-014-0468-7; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Rai A, 2016, CELL, V164, P722, DOI 10.1016/j.cell.2015.12.054; Reck J, 2016, MOL BIOL CELL, V27, P2404, DOI 10.1091/mbc.E16-03-0191; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; Roberts AJ, 2012, STRUCTURE, V20, P1670, DOI 10.1016/j.str.2012.07.003; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Rogowski M, 2013, METHOD ENZYMOL, V524, P243, DOI 10.1016/B978-0-12-397945-2.00014-7; SALE WS, 1977, P NATL ACAD SCI USA, V74, P2045, DOI 10.1073/pnas.74.5.2045; SALE WS, 1986, J CELL BIOL, V102, P2042, DOI 10.1083/jcb.102.6.2042; SALE WS, 1985, J CELL BIOL, V101, P1400, DOI 10.1083/jcb.101.4.1400; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schlager MA, 2014, CELL REP, V8, P1248, DOI 10.1016/j.celrep.2014.07.052; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schmidt H, 2016, BIOPOLYMERS, V105, P557, DOI 10.1002/bip.22856; Schmidt H, 2015, NATURE, V518, P435, DOI 10.1038/nature14023; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Schroeder CM, 2016, J CELL BIOL, V214, P309, DOI 10.1083/jcb.201604002; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Shah JV, 2000, MOL BIOL CELL, V11, P3495, DOI 10.1091/mbc.11.10.3495; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; SMITH EF, 1992, SCIENCE, V257, P1557, DOI 10.1126/science.1387971; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Stepanek L, 2017, METHOD CELL BIOL, V140, P1, DOI 10.1016/bs.mcb.2017.03.003; Stepanek L, 2016, SCIENCE, V352, P721, DOI 10.1126/science.aaf4594; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; TAKAHASHI M, 1978, J BIOCHEM-TOKYO, V84, P1339, DOI 10.1093/oxfordjournals.jbchem.a132256; TAMM SL, 1984, J CELL BIOL, V99, P1364, DOI 10.1083/jcb.99.4.1364; Tan SC, 2011, MOL BIOL CELL, V22, P467, DOI 10.1091/mbc.E10-02-0129; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Toropova K, 2017, NAT STRUCT MOL BIOL, V24, P461, DOI 10.1038/nsmb.3391; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Urnavicius L, 2018, NATURE, V554, P202, DOI 10.1038/nature25462; Urnavicius L, 2015, SCIENCE, V347, P1441, DOI 10.1126/science.aaa4080; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; VALE RD, 1989, J CELL BIOL, V108, P2327, DOI 10.1083/jcb.108.6.2327; VALLEE RB, 1988, NATURE, V332, P561, DOI 10.1038/332561a0; Vancoillie G, 2000, BRIT J DERMATOL, V143, P298, DOI 10.1046/j.1365-2133.2000.03654.x; Vannuccini E, 2016, J CELL SCI, V129, P2064, DOI 10.1242/jcs.183244; WAISSTEIDER J, 1979, J SUPRAMOL STR CELL, V11, P339, DOI 10.1002/jss.400110309; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; WARNER FD, 1978, J CELL BIOL, V76, P261, DOI 10.1083/jcb.76.2.261; Wren KN, 2013, CURR BIOL, V23, P2463, DOI 10.1016/j.cub.2013.10.044; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Yu I, 2015, J BIOL CHEM, V290, P17163, DOI 10.1074/jbc.R115.637447; Zhang K, 2017, CELL, V169, P1303, DOI 10.1016/j.cell.2017.05.025	146	9	9	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13202	13217		10.1074/jbc.REV119.003095	http://dx.doi.org/10.1074/jbc.REV119.003095			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31285262	Green Published, hybrid			2022-12-28	WOS:000486417200001
J	Peess, C; Scholz, C; Casagolda, D; Dufel, H; Gerg, M; Kowalewsky, F; Bocola, M; von Proff, L; Goller, S; Kloppel-Swarlik, H; Hoppe, A; Schraml, M				Peess, Carmen; Scholz, Christian; Casagolda, David; Duefel, Hartmut; Gerg, Michael; Kowalewsky, Frank; Bocola, Marco; von Proff, Leopold; Goller, Sabine; Kloeppel-Swarlik, Heidi; Hoppe, Alessandra; Schraeml, Michael			A novel epitope-presenting thermostable scaffold for the development of highly specific insulin-like growth factor-1/2 antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; antigen presentation; chaperone; insulin-like growth factor (IGF); protein engineering; antigen mimic; FK-506 binding protein; FKBP domain; immunogen	I IGF-I; PROLYL-ISOMERASE; STRUCTURAL HOMOLOGY; CRYSTAL-STRUCTURE; FORCE-FIELD; DOMAIN; SLYD; PROTEINS; POLYPEPTIDES; INSERTIONS	High sequence and structural homology between mature human insulin-like growth factors IGF-1 and IGF-2 makes serological discrimination by immunodiagnostic IGF tests a challenging task. There is an urgent need for highly specific IGF-1 and IGF-2 antibodies, yet only a short sequence element, i.e. the IGF loop, provides enough difference in sequence to discriminate between the two molecules. We sought to address this unmet demand by investigating novel chimeric immunogens as carriers for recombinant peptide motif grafting. We found Thermus thermophilus sensitive to lysis D (SlyD) and Thermococcus gammatolerans SlyD FK-506-binding protein (FKBP) domains suitable for presentation of the predefined epitopes, namely the IGF-1 and IGF-2 loops. Chimeric SlyD-IGF proteins allowed for the development of exceptionally specific IGF-1 and IGF-2 monoclonal antibodies. The selected antibodies bound with high affinity to the distinct IGF epitopes displayed on the protein scaffolds, as well as on the mature human IGF isoforms. The respective SlyD scaffolds display favorable engineering properties in that they are small, monomeric, and cysteine-free and can be produced in high yields in a prokaryotic host, such as Escherichia coli. In conclusion, FKBP domains from thermostable SlyD proteins are highly suitable as a generic scaffold platform for epitope grafting.	[Peess, Carmen; Duefel, Hartmut; Gerg, Michael; Kowalewsky, Frank] Roche Diagnost GmbH, Antibody Dev, D-82377 Penzberg, Germany; [Scholz, Christian] Roche Diagnost GmbH, Prot Design, D-82377 Penzberg, Germany; [Casagolda, David; von Proff, Leopold; Goller, Sabine; Schraeml, Michael] Roche Diagnost GmbH, Enzyme & Prot Technol, Nonnenwald 2, D-82377 Penzberg, Germany; [Kloeppel-Swarlik, Heidi; Hoppe, Alessandra] Roche Diagnost GmbH, Endocrinol Dis 3, D-82377 Penzberg, Germany; [Bocola, Marco] Rhein Westfal TH Aachen, Lehrstuhl Biotechnol, D-52074 Aachen, Germany	Roche Holding; Roche Holding; Roche Holding; Roche Holding; RWTH Aachen University	Schraml, M (corresponding author), Roche Diagnost GmbH, Enzyme & Prot Technol, Nonnenwald 2, D-82377 Penzberg, Germany.	michael.schraeml@roche.com			Roche Diagnostics GmbH; Deutscher Akademischer Austauschdienst	Roche Diagnostics GmbH; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by funding from Roche Diagnostics GmbH. David Casagolda received funding from the Deutscher Akademischer Austauschdienst and is employed by Roche Diagnostics GmbH. Carmen Peess, Hartmut Dufel, Michael Gerg, Frank Kowalewsky, Christian Scholz, Leopold von Proff, Sabine Goller, Heidi Kloppel-Swarlik, Alessandra Hoppe, and Michael Schraml are employed by Roche Diagnostics GmbH. Marco Bocola has no conflicts of interest within the contents of this article.	Aroul-Selvam R, 2004, J MOL BIOL, V338, P633, DOI 10.1016/j.jmb.2004.03.039; Backeljauw P, 2010, J PEDIATR ENDOCR MET, V23, P3; Bidlingmaier M, 2014, J CLIN ENDOCR METAB, V99, P1712, DOI 10.1210/jc.2013-3059; BLUNDELL TL, 1978, P NATL ACAD SCI USA, V75, P180, DOI 10.1073/pnas.75.1.180; Bruchim I, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00076; Collinet B, 2000, J BIOL CHEM, V275, P17428, DOI 10.1074/jbc.M000666200; Dasch James R, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.prot093856; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Feng Y, 2006, MOL CANCER THER, V5, P114, DOI 10.1158/1535-7163.MCT-05-0252; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geitner AJ, 2012, J MOL BIOL, V420, P335, DOI 10.1016/j.jmb.2012.04.018; Goya M, 2004, CANCER RES, V64, P6252, DOI 10.1158/0008-5472.CAN-04-0919; Ha JH, 2006, J MOL BIOL, V357, P1058, DOI 10.1016/j.jmb.2006.01.073; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hottenrott S, 1997, J BIOL CHEM, V272, P15697, DOI 10.1074/jbc.272.25.15697; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakob RP, 2009, P NATL ACAD SCI USA, V106, P20282, DOI 10.1073/pnas.0909544106; Jolivet E, 2003, INT J SYST EVOL MICR, V53, P847, DOI 10.1099/ijs.0.02503-0; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Knappe TA, 2007, J MOL BIOL, V368, P1458, DOI 10.1016/j.jmb.2007.02.097; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Low C, 2010, J MOL BIOL, V398, P375, DOI 10.1016/j.jmb.2010.03.014; Manes S, 1997, J ENDOCRINOL, V154, P293, DOI 10.1677/joe.0.1540293; Manes S, 1997, ENDOCRINOLOGY, V138, P905, DOI 10.1210/en.138.3.905; Martino L, 2009, FEBS J, V276, P4529, DOI 10.1111/j.1742-4658.2009.07159.x; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; O'Dell SD, 1998, INT J BIOCHEM CELL B, V30, P767, DOI 10.1016/S1357-2725(98)00048-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Peess C. M., 2015, THESIS; Quistgaard EM, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0300-3; Radley TL, 2003, J MOL BIOL, V332, P529, DOI 10.1016/S0022-2836(03)00925-2; Ramm K, 2001, J MOL BIOL, V310, P485, DOI 10.1006/jmbi.2001.4747; Ramm K, 2000, J BIOL CHEM, V275, P17106, DOI 10.1074/jbc.M910234199; Reinstein J, 2013, J MOL BIOL, V425, P4065, DOI 10.1016/j.jmb.2013.07.031; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; RINDERKNECHT E, 1976, P NATL ACAD SCI USA, V73, P4379, DOI 10.1073/pnas.73.12.4379; SATO A, 1993, INT J PEPT PROT RES, V41, P433; SCHAGGER H, 1988, ANAL BIOCHEM, V173, P201, DOI 10.1016/0003-2697(88)90179-0; Scholz C, 2006, BIOCHEMISTRY-US, V45, P20, DOI 10.1021/bi051922n; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Schraml Michael, 2012, Methods Mol Biol, V901, P171, DOI 10.1007/978-1-61779-931-0_11; Schubert C, 2007, J BIOL CHEM, V282, P4094, DOI 10.1074/jbc.M608183200; Weininger U, 2009, J MOL BIOL, V387, P295, DOI 10.1016/j.jmb.2009.01.034; Zoldak G, 2009, J MOL BIOL, V386, P1138, DOI 10.1016/j.jmb.2008.12.052	48	2	2	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13434	13444		10.1074/jbc.RA119.007654	http://dx.doi.org/10.1074/jbc.RA119.007654			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31337703	Green Published, hybrid			2022-12-28	WOS:000486417200019
J	Tripathi, V; Kaur, E; Kharat, SS; Hussain, M; Damodaran, AP; Kulshrestha, S; Sengupta, S				Tripathi, Vivek; Kaur, Ekjot; Kharat, Suhas Sampat; Hussain, Mansoor; Damodaran, Arun Prasath; Kulshrestha, Swati; Sengupta, Sagar			Abrogation of FBW7 alpha-dependent p53 degradation enhances p53's function as a tumor suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin ligase; p53; E3 ubiquitin ligase; tumor suppressor gene; ubiquitylation (ubiquitination); DNA damage; Fbw7; p53; SCFFbw7 complex	UBIQUITIN-INDEPENDENT DEGRADATION; HOT-SPOT MUTANTS; HUMAN-CELLS; CYCLIN-E; LIGASE; FBW7; PHOSPHORYLATION; RESTORATION; INACTIVATION; CROSSROADS	The gene encoding the tumor suppressor p53 is mutated in most cancers. p53 expression is known to be tightly controlled by several E3 ligases. Here, we show that F-box and WD repeat domain-containing 7 alpha (FBW7 alpha), the substrate-recognition component of the SCFFBW7 multiprotein E3 ligase complex, targets both WT and tumor-derived mutants of p53 for proteasomal degradation in multiple human cancer cell lines (HCT116 and U2OS). We found that lack of FBW7 alpha stabilizes p53 levels, thereby increasing its half-life. p53 ubiquitylation and subsequent degradation require the F-box and the C-terminal WD40 repeats in FBW7 alpha. The polyubiquitylation of p53 occurred via Lys-48 linkage and involved phosphorylation on p53 at Ser-33 and Ser-37 by glycogen synthase kinase 3 beta (GSK3 beta) and DNA-dependent protein kinase (DNA-PK), respectively. These phosphorylation events created a phosphodegron that enhanced p53 binding to FBW7 alpha, allowing for the attachment of polyubiquitin moieties at Lys-132 in p53. FBW7 alpha-dependent p53 polyubiquitylation apparently occurred during and immediately after DNA double-strand breaks induced by either doxorubicin or ionizing radiation. Accordingly, in cells lacking FBW7 alpha, p53 induction was enhanced after DNA damage. Phosphodegron-mediated polyubiquitylation of p53 on Lys-132 had functional consequences, with cells in which FBW7 alpha-mediated p53 degradation was abrogated exhibiting enhancement of their tumorigenic potential. We conclude that p53, which previously has been reported to transactivate FBW7, is also targeted by the same E3 ligase for degradation, suggesting the presence of a regulatory feedback loop that controls p53 levels and functions during DNA damage.	[Tripathi, Vivek; Kaur, Ekjot; Kharat, Suhas Sampat; Hussain, Mansoor; Damodaran, Arun Prasath; Kulshrestha, Swati; Sengupta, Sagar] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sengupta, S (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	sagar@nii.ac.in	Hussain, Mansoor/GQI-2915-2022; Kharat, Suhas/V-2129-2019; Sengupta, Sagar/AGR-1063-2022	Kharat, Suhas/0000-0003-2283-7429; Sengupta, Sagar/0000-0002-6365-1770; Hussain, Mansoor/0000-0003-4260-2256; Kaur, Ekjot/0000-0002-7937-6646	National Institute of Immunology core funds; Department of Biotechnology India (DBT) [BT/MED/30/SP11263/2015, BT/PR23545/BRB/10/1593/2017]; Council of Scientific and Industrial Research (CSIR) India [37(1699)/17/EMR-11]; Science and Engineering Research Board (SERB) India [EMR/2017/000541]; J. C. Bose Fellowship by Science and Engineering Research Board (SERB) India [JCB/2018/000013]; Department of Science and Technology [DST/INSPIRE/04/2017/000088]	National Institute of Immunology core funds; Department of Biotechnology India (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India); Science and Engineering Research Board (SERB) India(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); J. C. Bose Fellowship by Science and Engineering Research Board (SERB) India; Department of Science and Technology(Department of Science & Technology (India))	This work was supported by National Institute of Immunology core funds; Department of Biotechnology India (DBT) Grants BT/MED/30/SP11263/2015 and BT/PR23545/BRB/10/1593/2017; Council of Scientific and Industrial Research (CSIR) India Grants 37(1699)/17/EMR-11; Science and Engineering Research Board (SERB) India Grant EMR/2017/000541; and J. C. Bose Fellowship by Science and Engineering Research Board (SERB) India Grant JCB/2018/000013 (to S. S.) and Department of Science and Technology Grant DST/INSPIRE/04/2017/000088 for the INSPIRE Faculty Award (to E. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali A, 2017, BIOCHEM J, V474, P1653, DOI 10.1042/BCJ20160304; Asher G, 2003, P NATL ACAD SCI USA, V100, P15065, DOI 10.1073/pnas.2436329100; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Bunz F, 2002, CANCER RES, V62, P1129; Calcagno DQ, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-141; Cao J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002496; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Dai XP, 2014, ONCOTARGET, V5, P3307, DOI 10.18632/oncotarget.1939; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Galanis E, 2005, GENE THER, V12, P437, DOI 10.1038/sj.gt.3302436; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Grim JE, 2012, MOL CELL BIOL, V32, P2160, DOI 10.1128/MCB.00305-12; Gupta S, 2014, CARCINOGENESIS, V35, P34, DOI 10.1093/carcin/bgt315; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jain AK, 2014, MOL CELL BIOL, V34, P2695, DOI 10.1128/MCB.01705-12; Kharat SS, 2016, ONCOGENE, V35, P1025, DOI 10.1038/onc.2015.157; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Li Z, 2015, MOL CANCER RES, V13, P584, DOI 10.1158/1541-7786.MCR-14-0277-T; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Minella AC, 2007, ONCOGENE, V26, P6948, DOI 10.1038/sj.onc.1210518; Monke G, 2017, SCI REP-UK, V7, DOI 10.1038/srep46571; Nemunaitis J, 2007, CANCER GENE THER, V14, P885, DOI 10.1038/sj.cgt.7701080; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Perez-Losada J, 2005, CANCER RES, V65, P6488, DOI 10.1158/0008-5472.CAN-05-1294; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sengupta S, 2005, ONCOGENE, V24, P1738, DOI 10.1038/sj.onc.1208380; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Spruck CH, 2002, CANCER RES, V62, P4535; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tan MJ, 2011, DEV CELL, V21, P1062, DOI 10.1016/j.devcel.2011.09.014; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang WS, 2007, J BIOL CHEM, V282, P3273, DOI 10.1074/jbc.M610793200; Yeh CH, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0857-2; Yokobori T, 2009, CANCER RES, V69, P3788, DOI 10.1158/0008-5472.CAN-08-2846	53	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13224	13232		10.1074/jbc.AC119.008483	http://dx.doi.org/10.1074/jbc.AC119.008483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31346036	hybrid, Green Published			2022-12-28	WOS:000486417200003
J	Saeki, T; Suzuki, Y; Yamamura, H; Takeshima, H; Imaizumi, Y				Saeki, Takanori; Suzuki, Yoshiaki; Yamamura, Hisao; Takeshima, Hiroshi; Imaizumi, Yuji			A junctophilin-caveolin interaction enables efficient coupling between ryanodine receptors and BKCa channels in the Ca2+ microdomain of vascular smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vascular smooth muscle cells; calcium channel; potassium channel; calcium imaging; molecular imaging; single-molecule biophysics; patch clamp; fluorescence resonance energy transfer (FRET); caveolin; blood pressure	TRANSIENT OUTWARD CURRENTS; K+ CHANNELS; T-TUBULE; CELLS; EXPRESSION; PROTEINS; MUTATION; RELEASE; BINDING; SPARKS	Functional coupling between large-conductance Ca2+-activated K+ (BKCa) channels in the plasma membrane (PM) and ryanodine receptors (RyRs) in the sarcoplasmic reticulum (SR) is an essential mechanism for regulating mechanical force in most smooth muscle (SM) tissues. Spontaneous Ca2+ release through RyRs (Ca2+ sparks) and subsequent BKCa channel activation occur within the PM-SR junctional sites. We report here that a molecular interaction of caveolin-1 (Cav1), a caveola-forming protein, with junctophilin-2 (JP2), a bridging protein between PM and SR, positions BKCa channels near RyRs in SM cells (SMCs) and thereby contributes to the formation of a molecular complex essential for Ca2+ microdomain function. Approximately half of all Ca2+ sparks occurred within a close distance (<400 nm) from fluorescently labeled JP2 or Cav1 particles, when they were moderately expressed in primary SMCs from mouse mesenteric artery. The removal of caveolae by genetic Cav1 ablation or methyl-beta-cyclodextrin treatments significantly reduced coupling efficiency between Ca2+ sparks and BKCa channel activity in SMCs, an effect also observed after JP2 knockdown in SMCs. A 20-amino acid-long region in JP2 appeared to be essential for the observed JP2-Cav1 interaction, and we also observed an interaction between JP2 and the BKCa channel. It can be concluded that the JP2-Cav1 interaction provides a structural and functional basis for the Ca2+ microdomain at PM-SR junctions and mediates cross-talk between RyRs and BKCa channels, converts local Ca2+ sparks into membrane hyperpolarization, and contributes to stabilizing resting tone in SMCs.	[Saeki, Takanori; Suzuki, Yoshiaki; Yamamura, Hisao; Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Nagoya, Aichi 4678603, Japan; [Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan	Nagoya City University; Kyoto University	Imaizumi, Y (corresponding author), 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan.	yimaizum@phar.nagoya-cu.ac.jp	Suzuki, Yoshiaki/ABH-5320-2020; Imaizumi, Yuji/AAF-6585-2020	Suzuki, Yoshiaki/0000-0002-7879-6059; Yamamura, Hisao/0000-0001-8909-176X; Takeshima, Hiroshi/0000-0003-4525-3725; Imaizumi, Yuji/0000-0001-9431-688X	Japan Society for the Promotion of Science KAKENHI [26293021, 16K15128, 15H01408, 18KK0218, 16K08278, 17H05537, 19K07125, 16H06215, 16K15127, 19H03381, 18J15415]; Takeda Science Foundation; Salt Science Research Foundation [1637]; Nakatomi Foundation; Uehara Memorial Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Salt Science Research Foundation; Nakatomi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 26293021, 16K15128, 15H01408, and 18KK0218 (to Y. I.), 16K08278, 17H05537, and 19K07125 (to H. Y.), 16H06215, 16K15127, and 19H03381 (to Y. S.), and 18J15415 (to T. S.). This work was also supported by Grants-in-Aid from the Takeda Science Foundation (to Y. S.), Salt Science Research Foundation Grant 1637 (to Y. S.), the Nakatomi Foundation (to Y. S.), and the Uehara Memorial Foundation (to Y. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abriel H, 2015, CIRC RES, V116, P1971, DOI 10.1161/CIRCRESAHA.116.305017; Alioua A, 2008, J BIOL CHEM, V283, P4808, DOI 10.1074/jbc.M709802200; Baddeley D, 2009, P NATL ACAD SCI USA, V106, P22275, DOI 10.1073/pnas.0908971106; Bao R, 2008, J GEN PHYSIOL, V132, P145, DOI 10.1085/jgp.200709933; Beavers DL, 2013, J AM COLL CARDIOL, V62, P2010, DOI 10.1016/j.jacc.2013.06.052; Bennett HJ, 2013, BIOCHEM J, V456, P205, DOI 10.1042/BJ20130591; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bolton TB, 1996, CELL CALCIUM, V20, P141, DOI 10.1016/S0143-4160(96)90103-7; Caldwell JL, 2014, CIRC RES, V115, P986, DOI 10.1161/CIRCRESAHA.116.303448; Chen BY, 2013, CARDIOVASC RES, V100, P54, DOI 10.1093/cvr/cvt180; Cheng XY, 2006, AM J PHYSIOL-HEART C, V290, pH2309, DOI 10.1152/ajpheart.01226.2005; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Golini L, 2011, J BIOL CHEM, V286, P43717, DOI 10.1074/jbc.M111.292755; Guo A, 2014, P NATL ACAD SCI USA, V111, P12240, DOI 10.1073/pnas.1412729111; Hotta S, 2007, J PHARMACOL SCI, V103, P121, DOI 10.1254/jphs.SC0060213; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Jayasinghe ID, 2012, BIOPHYS J, V102, pL9, DOI 10.1016/j.bpj.2012.01.034; Jiang M, 2016, HEART RHYTHM, V13, P743, DOI 10.1016/j.hrthm.2015.10.037; Landstrom AP, 2014, TRENDS MOL MED, V20, P353, DOI 10.1016/j.molmed.2014.02.004; Li L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.179; Lifshitz LM, 2011, J GEN PHYSIOL, V138, P195, DOI 10.1085/jgp.201110626; Matsuki K, 2018, AM J PHYSIOL-CELL PH, V315, pC1, DOI 10.1152/ajpcell.00006.2018; Matsushita Y, 2007, J HUM GENET, V52, P543, DOI 10.1007/s10038-007-0149-y; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Nakada T, 2018, P NATL ACAD SCI USA, V115, P4507, DOI 10.1073/pnas.1716649115; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nishi M, 2000, BIOCHEM BIOPH RES CO, V273, P920, DOI 10.1006/bbrc.2000.3011; Nishi M, 2003, MOL BRAIN RES, V118, P102, DOI 10.1016/S0169-328X(03)00341-3; Ohi Y, 2001, J PHYSIOL-LONDON, V534, P313, DOI 10.1111/j.1469-7793.2001.t01-3-00313.x; Phimister AJ, 2007, J BIOL CHEM, V282, P8667, DOI 10.1074/jbc.M609936200; Poburko D, 2004, TRENDS PHARMACOL SCI, V25, P8, DOI 10.1016/j.tips.2003.10.011; Popescu LM, 2006, J CELL MOL MED, V10, P960, DOI 10.1111/j.1582-4934.2006.tb00539.x; Prakash YS, 2007, AM J PHYSIOL-LUNG C, V293, pL1118, DOI 10.1152/ajplung.00136.2007; Pritchard HAT, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan2694; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Suzuki Y, 2016, J BIOL CHEM, V291, P24247, DOI 10.1074/jbc.M116.743302; Suzuki Y, 2013, J BIOL CHEM, V288, P36750, DOI 10.1074/jbc.M113.511485; Suzuki Y, 2013, BIOCHEM BIOPH RES CO, V430, P1169, DOI 10.1016/j.bbrc.2012.12.015; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H, 2015, CELL CALCIUM, V58, P349, DOI 10.1016/j.ceca.2015.01.007; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Veluthakal R, 2005, DIABETES, V54, P2576, DOI 10.2337/diabetes.54.9.2576; Wagner E, 2012, CIRC RES, V111, P402, DOI 10.1161/CIRCRESAHA.112.274530; Wang W, 2014, AM J PHYSIOL-HEART C, V307, pH1317, DOI 10.1152/ajpheart.00413.2014; Wong J, 2013, BIOPHYS J, V104, pL22, DOI 10.1016/j.bpj.2013.02.059; Woo JS, 2009, MOL CELL BIOCHEM, V328, P25, DOI 10.1007/s11010-009-0070-0; Wray S, 2010, PHYSIOL REV, V90, P113, DOI 10.1152/physrev.00018.2008; Yamamura H, 2012, BIOCHEM BIOPH RES CO, V427, P54, DOI 10.1016/j.bbrc.2012.08.145; Yamamura H, 2012, AM J PHYSIOL-CELL PH, V302, pC1257, DOI 10.1152/ajpcell.00191.2011; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Yamazawa T, 1996, EMBO J, V15, P6172, DOI 10.1002/j.1460-2075.1996.tb01005.x; ZhuGe R, 2002, J GEN PHYSIOL, V120, P15, DOI 10.1085/jgp.20028571; ZhuGe RH, 2004, AM J PHYSIOL-CELL PH, V287, pC1577, DOI 10.1152/ajpcell.00153.2004	60	15	15	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13093	13105		10.1074/jbc.RA119.008342	http://dx.doi.org/10.1074/jbc.RA119.008342			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31308177	hybrid, Green Published			2022-12-28	WOS:000486416000019
J	Jia, Y; Reddy, MA; Das, S; Oh, HJ; Abdollahi, M; Yuan, H; Zhang, EL; Lanting, LD; Wang, M; Natarajan, R				Jia, Ye; Reddy, Marpadga A.; Das, Sadhan; Oh, Hyung Jung; Abdollahi, Maryam; Yuan, Hang; Zhang, Erli; Lanting, Linda; Wang, Mei; Natarajan, Rama			Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-beta 1-induced gene expression in mesangial cells and diabetic kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibrosis; inflammation; diabetic nephropathy; epigenetics; microRNA (miRNA); transforming growth factor beta (TGF-beta); diabetic nephropathy; Ezh2; H3K27me3; histone modifications; mesangial cells; histone methylation; histone demethylases	TGF-BETA; EPIGENETIC CHANGES; RENAL FIBROSIS; MECHANISMS; EZH2; TRANSCRIPTION; NEPHROPATHY; METHYLATION; 12/15-LIPOXYGENASE; INHIBITION	Transforming growth factor-beta 1 (TGF-beta)-induced fibrotic and inflammatory genes in renal mesangial cells (MCs) play important roles in glomerular dysfunction associated with diabetic nephropathy (DN). TGF-beta regulates gene expression in MCs by altering key chromatin histone modifications at target gene promoters. However, the role of the repressive histone H3 lysine 27 trimethylation (H3K27me3) modification is unclear. Here we show that TGF-beta reduces H3K27me3 at the Ctgf, Serpine1, and Ccl2 gene promoters in rat MCs (RMCs) and reciprocally up-regulates the expression of these pro-fibrotic and inflammatory genes. In parallel, TGF-beta down-regulates Enhancer of Zeste homolog 2 (Ezh2), an H3K27me3 methyltransferase, and decreases its recruitment at Ctgf and Ccl2 but not Serpine1 promoters. Ezh2 knockdown with siRNAs enhances TGF-beta-induced expression of these genes, supporting its repressive function. Mechanistically, Ezh2 down-regulation is mediated by TGF-beta-induced microRNA, miR-101b, which targets Ezh2 3 '-UTR. TGF-beta also up-regulates Jmjd3 and Utx in RMCs, suggesting a key role for these H3K27me3 demethylases in H3K27me3 inhibition. In RMCs, Utx knockdown inhibits hypertrophy, a key event in glomerular dysfunction. The H3K27me3 regulators are similarly altered in human and mouse MCs. High glucose inhibits Ezh2 and increases miR-101b in a TGF-beta-dependent manner. Furthermore, in kidneys from rodent models of DN, fibrotic genes, miR-101b, and H3K27me3 demethylases are up-regulated, whereas Ezh2 protein levels as well as enrichment of Ezh2 and H3K27me3 at target genes are decreased, demonstrating in vivo relevance. These results suggest that H3K27me3 inhibition by TGF-beta via dysregulation of related histone-modifying enzymes and miRNAs augments pathological genes mediating glomerular mesangial dysfunction and DN.	[Jia, Ye; Reddy, Marpadga A.; Das, Sadhan; Oh, Hyung Jung; Abdollahi, Maryam; Yuan, Hang; Zhang, Erli; Lanting, Linda; Wang, Mei; Natarajan, Rama] City Hope Natl Med Ctr, Dept Diabet Complicat & Metab, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Jia, Ye; Yuan, Hang] Jilin Univ, Hosp 1, Div Nephrol, Changchun 130021, Jilin, Peoples R China; [Oh, Hyung Jung] Ewha Womans Univ, Ewha Inst Convergence Med, Mokdong Hosp, Seoul 07985, South Korea; [Zhang, Erli] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Dept Cardiol, Beijing 100037, Peoples R China	City of Hope; Beckman Research Institute of City of Hope; Jilin University; Ewha Womans University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Reddy, MA; Natarajan, R (corresponding author), City Hope Natl Med Ctr, Dept Diabet Complicat & Metab, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91010 USA.	mreddy@coh.org; rnatarajan@coh.org	Das, Sadhan/O-1423-2017	Das, Sadhan/0000-0002-7153-9519; Reddy, Marpadga A/0000-0001-9259-7243	NCI, National Institutes of Health [P30CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073, R01DK081705, R01DK058191] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication included work performed in the DNA/RNA Synthesis Core supported by NCI, National Institutes of Health, under Grant P30CA33572.	Arcipowski KM, 2016, CURR OPIN GENET DEV, V36, P59, DOI 10.1016/j.gde.2016.03.010; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen H, 2019, J PHYSIOL-LONDON, V597, P1643, DOI 10.1113/JP277367; Chen JG, 2014, AM J PHYSIOL-RENAL, V306, pF916, DOI 10.1152/ajprenal.00697.2012; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Chen Z, 2016, P NATL ACAD SCI USA, V113, pE3002, DOI 10.1073/pnas.1603712113; Das S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01629-7; Decleves AE, 2014, NAT REV NEPHROL, V10, P257, DOI 10.1038/nrneph.2014.31; Huntington disease, 2015, NAT REV DIS PRIMERS, V1, P15052, DOI [10.1038/nrdp.2015.52, DOI 10.1038/NRDP.2015.18]; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kato M, 2014, NAT REV NEPHROL, V10, P517, DOI 10.1038/nrneph.2014.116; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Khan S, 2015, BIOCHIMIE, V110, P1, DOI 10.1016/j.biochi.2014.12.015; Komers R, 2013, LAB INVEST, V93, P543, DOI 10.1038/labinvest.2013.47; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Majumder S, 2018, J CLIN INVEST, V128, P483, DOI 10.1172/JCI95946; McClelland AD, 2014, CLIN SCI, V126, P95, DOI 10.1042/CS20130079; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Naito M, 2009, J AM SOC NEPHROL, V20, P1787, DOI 10.1681/ASN.2009010118; Naito M, 2009, AM J PATHOL, V174, P54, DOI 10.2353/ajpath.2009.080602; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Reddy MA, 2015, KIDNEY INT, V88, P250, DOI 10.1038/ki.2015.148; Reddy MA, 2015, DIABETOLOGIA, V58, P443, DOI 10.1007/s00125-014-3462-y; Reddy MA, 2014, KIDNEY INT, V85, P362, DOI 10.1038/ki.2013.387; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Sakurai T, 2012, BIOCHEM BIOPH RES CO, V422, P607, DOI 10.1016/j.bbrc.2012.05.035; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; Shanmugam N, 2008, J BIOL CHEM, V283, P36221, DOI 10.1074/jbc.M806322200; Siddiqi FS, 2016, J AM SOC NEPHROL, V27, P2021, DOI 10.1681/ASN.2014090898; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Trionfini P, 2017, J AM SOC NEPHROL, V28, P1686, DOI 10.1681/ASN.2016101117; Van Beneden K, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-1; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang AB, 2013, J IMMUNOL, V191, P4908, DOI 10.4049/jimmunol.1300433; Xu HH, 2015, J AM SOC NEPHROL, V26, P1648, DOI 10.1681/ASN.2014070678; Yang Hai-Chun, 2010, Drug Discov Today Dis Models, V7, P13, DOI 10.1016/j.ddmod.2010.08.002; Yuan H, 2008, AM J PHYSIOL-RENAL, V295, pF605, DOI 10.1152/ajprenal.90268.2008; Yuan H, 2016, ANTIOXID REDOX SIGN, V24, P361, DOI 10.1089/ars.2015.6372; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zeybel M, 2017, MOL THER, V25, P218, DOI 10.1016/j.ymthe.2016.10.004; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457	45	34	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12695	12707		10.1074/jbc.RA119.007575	http://dx.doi.org/10.1074/jbc.RA119.007575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31266808	hybrid, Green Published			2022-12-28	WOS:000484414600012
J	Wang, YD; Palmfeldt, J; Gregersen, N; Makhov, AM; Conway, JF; Wang, MC; McCalley, SP; Basu, S; Alharbi, H; St Croix, C; Calderon, MJ; Watkins, S; Vockley, J				Wang, Yudong; Palmfeldt, Johan; Gregersen, Niels; Makhov, Alexander M.; Conway, James F.; Wang, Meicheng; McCalley, Stephen P.; Basu, Shrabani; Alharbi, Hana; St Croix, Claudette; Calderon, Michael J.; Watkins, Simon; Vockley, Jerry			Mitochondrial fatty acid oxidation and the electron transport chain comprise a multifunctional mitochondrial protein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid oxidation; mitochondrial respiratory chain complex; mitochondrial metabolism; protein structure; proteomics; electron microscopy (EM); primary metabolism; stimulated emission depletion microscopy (STED); supercomplex; trifunctional protein (TFP)	BETA-OXIDATION; SYNERGISTIC HETEROZYGOSITY; ENZYMES; SUPERCOMPLEXES; ARCHITECTURE; OXIDASE; IV	Three mitochondrial metabolic pathways are required for efficient energy production in eukaryotic cells: the electron transfer chain (ETC), fatty acid beta-oxidation (FAO), and the tricarboxylic acid cycle. The ETC is organized into inner mitochondrial membrane supercomplexes that promote substrate channeling and catalytic efficiency. Although previous studies have suggested functional interaction between FAO and the ETC, their physical interaction has never been demonstrated. In this study, using blue native gel and two-dimensional electrophoreses, nano-LC-MS/MS, immunogold EM, and stimulated emission depletion microscopy, we show that FAO enzymes physically interact with ETC supercomplexes at two points. We found that the FAO trifunctional protein (TFP) interacts with the NADH-binding domain of complex I of the ETC, whereas the electron transfer enzyme flavoprotein dehydrogenase interacts with ETC complex III. Moreover, the FAO enzyme very-long-chain acyl-CoA dehydrogenase physically interacted with TFP, thereby creating a multifunctional energy protein complex. These findings provide a first view of an integrated molecular architecture for the major energy-generating pathways in mitochondria that ensures the safe transfer of unstable reducing equivalents from FAO to the ETC. They also offer insight into clinical ramifications for individuals with genetic defects in these pathways.	[Wang, Yudong; Wang, Meicheng; Basu, Shrabani; Alharbi, Hana; Vockley, Jerry] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Makhov, Alexander M.; Conway, James F.] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15261 USA; [Palmfeldt, Johan; Gregersen, Niels] Aarhus Univ Hosp, Res Unit Mol Med, DK-8200 Aarhus, Denmark; [McCalley, Stephen P.; Vockley, Jerry] Univ Pittsburgh, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [St Croix, Claudette] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Calderon, Michael J.; Watkins, Simon; Vockley, Jerry] UPMC Childrens Hosp Pittsburgh, Ctr Rare Dis Therapy, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aarhus University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vockley, J (corresponding author), UPMC Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	gerard.vockley@chp.edu	Wang, Yudong/ABG-1086-2021; Vockley, Jerry/AAF-8523-2020; Watkins, Simon/ABG-2590-2021; Vockley, Jerry/B-5210-2016; St Croix, Claudette/AAA-3338-2022; Alharbi, Hana/GXG-0806-2022; Conway, James/A-2296-2010	Wang, Yudong/0000-0003-3224-4555; Vockley, Jerry/0000-0002-8180-6457; Watkins, Simon/0000-0003-4092-1552; Vockley, Jerry/0000-0002-8180-6457; Alharbi, Hana/0000-0002-6139-2816; Palmfeldt, Johan/0000-0001-5585-639X; Basu, Shrabani/0000-0001-5096-5490; Conway, James/0000-0002-6581-4748	National Institutes of Health [S10OD021540, 1S10OD025009-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078775] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021540, S10OD025009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant 1S10OD025009-01 (to J.F.C.) and in part by National Institutes of Health Grant S10OD021540 (to S.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; BERRY EA, 1985, J BIOL CHEM, V260, P2458; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Hua JF, 2017, MBIO, V8, DOI 10.1128/mBio.01579-17; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Kuhlbrandt W, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0201-x; Liang K, 2018, P NATL ACAD SCI USA, V115, P7039, DOI 10.1073/pnas.1801252115; Lobo-Jarne T, 2018, SEMIN CELL DEV BIOL, V76, P179, DOI 10.1016/j.semcdb.2017.07.021; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Neumann Daniel, 2010, PMC Biophys, V3, P4, DOI 10.1186/1757-5036-3-4; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Parker A, 2000, BIOCHEM J, V345, P429, DOI 10.1042/0264-6021:3450429; Reifschneider NH, 2006, J PROTEOME RES, V5, P1117, DOI 10.1021/pr0504440; Sahebekhtiari N, 2016, PROTEOMICS, V16, P1166, DOI 10.1002/pmic.201500336; Saydmohammed M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05866-2; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schuler AM, 2005, MOL GENET METAB, V85, P7, DOI 10.1016/j.ymgme.2004.09.006; Shingler KL, 2015, J VIROL, V89, P1900, DOI 10.1128/JVI.03098-14; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; SUMEGI B, 1984, J BIOL CHEM, V259, P8748; SUMEGI B, 1991, BIOCHIM BIOPHYS ACTA, V1081, P121, DOI 10.1016/0005-2760(91)90016-B; Tao J, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224568; Van Laar VS, 2018, J NEUROSCI, V38, P7505, DOI 10.1523/JNEUROSCI.0541-18.2018; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; Vockley J., 2016, ONLINE METABOLIC MOL; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Xia CW, 2019, P NATL ACAD SCI USA, V116, P6069, DOI 10.1073/pnas.1816317116; Zhang J, 2006, P NATL ACAD SCI USA, V103, P16212, DOI 10.1073/pnas.0604567103; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	37	37	37	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12380	12391		10.1074/jbc.RA119.008680	http://dx.doi.org/10.1074/jbc.RA119.008680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31235473	Green Published, hybrid			2022-12-28	WOS:000484402700011
J	Sun, R; Cheng, ED; Velasquez, C; Chang, Y; Moore, PS				Sun, Rui; Cheng, Erdong; Velasquez, Celestino; Chang, Yuan; Moore, Patrick S.			Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eukaryotic translation initiation factor 4E (eIF4E); eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1); eukaryotic translation initiation factor 4G (eIF4G); eukaryotic translation initiation; cell cycle; mitosis; protein phosphorylation; mammalian target of rapamycin (mTOR); cyclin-dependent kinase 1 (CDK1); PHAS-I	FACTOR 4E-BINDING PROTEIN-1; MESSENGER-RNA TRANSLATION; CAP-DEPENDENT TRANSLATION; P70 S6 KINASE; PHAS-I; MAMMALIAN TARGET; BINDING; RAPAMYCIN; INSULIN; REGULATOR	Eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) inhibits cap-dependent translation in eukaryotes by competing with eIF4G for an interaction with eIF4E. Phosphorylation at Ser-83 of 4E-BP1 occurs during mitosis through the activity of cyclin-dependent kinase 1 (CDK1)/cyclin B rather than through canonical mTOR kinase activity. Here, we investigated the interaction of eIF4E with 4E-BP1 or eIF4G during interphase and mitosis. We observed that 4E-BP1 and eIF4G bind eIF4E at similar levels during interphase and mitosis. The most highly phosphorylated mitotic 4E-BP1 isoform (delta) did not interact with eIF4E, whereas a distinct 4E-BP1 phospho-isoform, EB-gamma, phosphorylated at Thr-70, Ser-83, and Ser-101, bound to eIF4E during mitosis. Two-dimensional gel electrophoretic analysis corroborated the identity of the phosphorylation marks on the eIF4E-bound 4E-BP1 isoforms and uncovered a population of phosphorylated 4E-BP1 molecules lacking Thr-37/Thr-46-priming phosphorylation. Moreover, proximity ligation assays for phospho-4E-BP1 and eIF4E revealed different in situ interactions during interphase and mitosis. The eIF4E:eIF4G interaction was not inhibited but rather increased in mitotic cells, consistent with active translation initiation during mitosis. Phosphodefective substitution of 4E-BP1 at Ser-83 did not change global translation or individual mRNA translation profiles as measured by single-cell nascent protein synthesis and eIF4G RNA immunoprecipitation sequencing. Mitotic 5 '-terminal oligopyrimidine RNA translation was active and, unlike interphase translation, resistant to mTOR inhibition. Our findings reveal the phosphorylation profiles of 4E-BP1 isoforms and their interactions with eIF4E throughout the cell cycle and indicate that 4E-BP1 does not specifically inhibit translation initiation during mitosis.	[Sun, Rui; Cheng, Erdong; Velasquez, Celestino; Moore, Patrick S.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Chang, Yuan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Sun, Rui; Cheng, Erdong; Velasquez, Celestino; Chang, Yuan; Moore, Patrick S.] UPMC Hillman Canc Ctr, Canc Virol Program, Pittsburgh, PA 15213 USA; [Cheng, Erdong] Univ Pittsburgh, Dept Urol, Pittsburgh, PA 15232 USA; [Velasquez, Celestino] Oral Roberts Univ, Dept Biol & Chem, Tulsa, OK 74171 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chang, Y; Moore, PS (corresponding author), UPMC Hillman Canc Ctr, Canc Virol Program, Pittsburgh, PA 15213 USA.	yc70@pitt.edu; psm9@pitt.edu	Chang, Yuan/F-4146-2011; Moore, Patrick/GVR-8294-2022; Moore, Patrick/F-3960-2011	Chang, Yuan/0000-0003-1125-4041; Sun, Rui/0000-0003-2571-1012; Moore, Patrick/0000-0002-8132-858X	National Institutes of Health [R35 CA197463, CA232604]; Pennsylvania Department of Health; Pittsburgh Foundation; UPMC Foundation; NATIONAL CANCER INSTITUTE [R35CA197463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Pittsburgh Foundation; UPMC Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R35 CA197463 (to P.S.M.) and CA232604 (to Y.C.). This work was also funded, in part, under a grant with the Pennsylvania Department of Health, the Pittsburgh Foundation (to P. S. M.), and UPMC Foundation (to Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Author's Choice-Final version open access under the terms of the Creative Commons CC-BY license.	Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Brunn GJ, 1997, J BIOL CHEM, V272, P32547, DOI 10.1074/jbc.272.51.32547; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Choi SH, 2019, GENE DEV, V33, P418, DOI 10.1101/gad.322339.118; Coldwell MJ, 2013, CELL CYCLE, V12, P3615, DOI 10.4161/cc.26588; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dobrikov MI, 2014, MOL CELL BIOL, V34, P439, DOI 10.1128/MCB.01046-13; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Fadden P, 1997, J BIOL CHEM, V272, P10240; FAN H, 1970, J MOL BIOL, V50, P655, DOI 10.1016/0022-2836(70)90091-4; Ferguson G, 2003, J BIOL CHEM, V278, P47459, DOI 10.1074/jbc.M307949200; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; Gruner S, 2018, NUCLEIC ACIDS RES, V46, P6893, DOI 10.1093/nar/gky542; Gruner S, 2016, MOL CELL, V64, P467, DOI 10.1016/j.molcel.2016.09.020; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; Heesom KJ, 1998, BIOCHEM J, V336, P39, DOI 10.1042/bj3360039; HU CB, 1994, P NATL ACAD SCI USA, V91, P3730, DOI 10.1073/pnas.91.9.3730; Igreja C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5790; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Karim MM, 2001, J BIOL CHEM, V276, P20750, DOI 10.1074/jbc.M011068200; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Livingstone Mark, 2012, F1000Res, V1, P4, DOI 10.12688/f1000research.1-4.v1; Lukhele S, 2013, STRUCTURE, V21, P2186, DOI 10.1016/j.str.2013.08.030; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Miloslavski R, 2014, J MOL CELL BIOL, V6, P255, DOI 10.1093/jmcb/mju008; Mizuno A, 2008, FEBS LETT, V582, P3439, DOI 10.1016/j.febslet.2008.09.003; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Musa J, 2016, ONCOGENE, V35, P4675, DOI 10.1038/onc.2015.515; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; Park JE, 2016, MOL CELL, V62, P462, DOI 10.1016/j.molcel.2016.04.007; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Peter D, 2015, MOL CELL, V57, P1074, DOI 10.1016/j.molcel.2015.01.017; Ptushkina M, 1999, EMBO J, V18, P4068, DOI 10.1093/emboj/18.14.4068; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Sekiyama N, 2015, P NATL ACAD SCI USA, V112, pE4036, DOI 10.1073/pnas.1512118112; Shah OJ, 2003, J BIOL CHEM, V278, P16433, DOI 10.1074/jbc.M300435200; Shuda M, 2015, P NATL ACAD SCI USA, V112, P5875, DOI 10.1073/pnas.1505787112; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Sousa MML, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-45; Tanenbaum ME, 2015, ELIFE, V4, DOI 10.7554/eLife.07957; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Velasquez C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00713; Velasquez C, 2016, P NATL ACAD SCI USA, V113, P8466, DOI 10.1073/pnas.1607768113; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 2003, MOL CELL BIOL, V23, P1546, DOI 10.1128/MCB.23.5.1546-1557.2003; Yamashita R, 2008, NUCLEIC ACIDS RES, V36, P3707, DOI 10.1093/nar/gkn248; Yang DQ, 1999, FEBS LETT, V453, P387, DOI 10.1016/S0014-5793(99)00762-0; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	57	13	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11840	11852		10.1074/jbc.RA119.008512	http://dx.doi.org/10.1074/jbc.RA119.008512			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31201269	Green Published, hybrid			2022-12-28	WOS:000486127800020
J	Sharma, G; Huo, AN; Kimura, T; Shiozawa, S; Kobayashi, R; Sahara, N; Ishibashi, M; Ishigaki, S; Saito, T; Ando, K; Murayama, S; Hasegawa, M; Sobue, G; Okano, H; Hisanaga, S				Sharma, Govinda; Huo, Anni; Kimura, Taeko; Shiozawa, Seiji; Kobayashi, Reona; Sahara, Naruhiko; Ishibashi, Minaka; Ishigaki, Shinsuke; Saito, Taro; Ando, Kanae; Murayama, Shigeo; Hasegawa, Masato; Sobue, Gen; Okano, Hideyuki; Hisanaga, Shin-ichi			Tau isoform expression and phosphorylation in marmoset brains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tau protein (tau); FTLD-tau; Alzheimer disease; alternative splicing; phosphorylation; mammal; phylogenetics; neurodegenerative disease; development; marmoset; non-human primate; MAPT; isoform; neurodegeneration	MICROTUBULE-BINDING; ALZHEIMERS-DISEASE; COMMON MARMOSET; FETAL-TAU; PROTEIN; MOUSE; FTDP-17; HYPERPHOSPHORYLATION; DEPHOSPHORYLATION; GENERATION	Tau is a microtubule-associated protein expressed in neuronal axons. Hyperphosphorylated tau is a major component of neurofibrillary tangles, a pathological hallmark of Alzheimer's disease (AD). Hyperphosphorylated tau aggregates are also found in many neurodegenerative diseases, collectively referred to as tauopathies, and tau mutations are associated with familial frontotemporal lobar degeneration (FTLD). Previous studies have generated transgenic mice with mutant tau as tauopathy models, but nonhuman primates, which are more similar to humans, may be a better model to study tauopathies. For example, the common marmoset is poised as a nonhuman primate model for investigating the etiology of age-related neurodegenerative diseases. However, no biochemical studies of tau have been conducted in marmoset brains. Here, we investigated several important aspects of tau, including expression of different tau isoforms and its phosphorylation status, in the marmoset brain. We found that marmoset tau does not possess the primate-unique motif in its N-terminal domain. We also discovered that the tau isoform expression pattern in marmosets is more similar to that of mice than that of humans, with adult marmoset brains expressing only four-repeat tau isoforms as in adult mice but unlike in adult human brains. Of note, tau in brains of marmoset newborns was phosphorylated at several sites associated with AD pathology. However, in adult marmoset brains, much of this phosphorylation was lost, except for Ser-202 and Ser-404 phosphorylation. These results reveal key features of tau expression and phosphorylation in the marmoset brain, a potentially useful nonhuman primate model of neurodegenerative diseases.	[Sharma, Govinda; Huo, Anni; Kimura, Taeko; Saito, Taro; Ando, Kanae; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Fac Sci, Lab Mol Neurosci, Hachioji, Tokyo 1920397, Japan; [Kimura, Taeko; Sahara, Naruhiko] Natl Inst Radiol Sci, Dept Funct Brain Imaging Res, 4-9-1 Anagawa, Chiba, Chiba 2638555, Japan; [Shiozawa, Seiji; Kobayashi, Reona; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Kobayashi, Reona; Okano, Hideyuki] RIKEN, Lab Marmoset Neural Architecture, Ctr Brain Sci, Wako, Saitama 3510198, Japan; [Ishibashi, Minaka; Ishigaki, Shinsuke; Sobue, Gen] Nagoya Univ, Grad Sch Med, Res Div Dementia & Neurodegenerat Dis, Nagoya, Aichi 4668550, Japan; [Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo 1730015, Japan; [Hasegawa, Masato; Hisanaga, Shin-ichi] Tokyo Metropolitan Inst Med Sci, Setagaya Ku, Tokyo 1568506, Japan; [Sharma, Govinda] Univ Calgary, Fac Vet Med, Calgary, AB T2N 1N4, Canada	Tokyo Metropolitan University; National Institutes for Quantum Science & Technology; Keio University; RIKEN; Nagoya University; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Medical Science; University of Calgary	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sc, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp	Okano, Hideyuki/I-7584-2019; Okano, Hideyuki/X-9131-2019; ISHIGAKI, Shinsuke/I-7305-2014; Shiozawa, Seiji/L-1248-2013	Okano, Hideyuki/0000-0001-7482-5935; Ishigaki, Shinsuke/0000-0002-9555-0659; Shiozawa, Seiji/0000-0002-3504-5415	MEXT of Japan [26117004]; MEXT [16K07060, 60748820]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a MEXT Grant-in-aid project, Scientific Research on Innovation Area (Brain Protein Aging and Dementia Control) of Japan 26117004 (to S. H.), and by MEXT Grants-in-aid 16K07060 (to S. H.) and 60748820 (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Bullmann T, 2010, J COMP NEUROL, V518, P2538, DOI 10.1002/cne.22351; COUCHIE D, 1992, P NATL ACAD SCI USA, V89, P4378, DOI 10.1073/pnas.89.10.4378; D'Souza I, 2000, J BIOL CHEM, V275, P17700, DOI 10.1074/jbc.M909470199; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forrest SL, 2018, BRAIN, V141, P521, DOI 10.1093/brain/awx328; Geula C, 2002, ACTA NEUROPATHOL, V103, P48, DOI 10.1007/s004010100429; GOEDERT M, 1992, P NATL ACAD SCI USA, V89, P1983, DOI 10.1073/pnas.89.5.1983; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Gratuze M, 2017, NEUROBIOL DIS, V98, P1, DOI 10.1016/j.nbd.2016.10.004; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Holzer M, 2004, GENE, V341, P313, DOI 10.1016/j.gene.2004.07.013; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Ishigaki S, 2017, CELL REP, V18, P1118, DOI 10.1016/j.celrep.2017.01.013; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; Kimura T, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00044; Kimura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33479; Kimura T, 2016, AM J PATHOL, V186, P398, DOI 10.1016/j.ajpath.2015.10.009; Kimura T, 2013, J BIOL CHEM, V288, P7968, DOI 10.1074/jbc.M112.433326; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kobayashi R, 2016, NEUROSCI RES, V106, P55, DOI 10.1016/j.neures.2015.11.006; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; Mashiko H, 2012, J NEUROSCI, V32, P5039, DOI 10.1523/JNEUROSCI.4788-11.2012; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Meredith RW, 2011, MOL PHYLOGENET EVOL, V60, P183, DOI 10.1016/j.ympev.2011.03.026; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Murayama S, 2004, NEUROPATHOLOGY, V24, P254, DOI 10.1111/j.1440-1789.2004.00571.x; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Qian W, 2014, NEUROSCI BULL, V30, P367, DOI 10.1007/s12264-013-1411-2; Rodriguez-Callejas JD, 2016, FRONT AGING NEUROSCI, V8, DOI [10.3389/fnagi.2016.00375, 10.3389/fnagi.2016.00315]; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Schoch KM, 2016, NEURON, V90, P941, DOI 10.1016/j.neuron.2016.04.042; Sharma G, 2016, GENES CELLS, V21, P1080, DOI 10.1111/gtc.12404; Shiarli AM, 2006, NEUROPATH APPL NEURO, V32, P374, DOI 10.1111/j.1365-2990.2006.00736.x; Shimozawa A, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0413-0; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stefanoska K, 2018, J BIOL CHEM, V293, P3710, DOI 10.1074/jbc.RA118.001784; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Tuerde D, 2018, J BIOL CHEM, V293, P1781, DOI 10.1074/jbc.M117.798918; Wang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15709; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WATANABE A, 1993, J BIOL CHEM, V268, P25712; Whittington RA, 2013, PROG NEURO-PSYCHOPH, V47, P147, DOI 10.1016/j.pnpbp.2013.03.004; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042; Yotsumoto K, 2009, J BIOL CHEM, V284, P16840, DOI 10.1074/jbc.M109.003277; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x; Yun Jun-Won, 2015, Lab Anim Res, V31, P155, DOI 10.5625/lar.2015.31.4.155; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	60	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11433	11444		10.1074/jbc.RA119.008415	http://dx.doi.org/10.1074/jbc.RA119.008415			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31171723	hybrid, Green Published			2022-12-28	WOS:000478717600008
J	Stone, JK; Kim, JH; Vukadin, L; Richard, A; Giannini, HK; Lim, STS; Tan, M; Ahn, EYE				Stone, Joshua K.; Kim, Jung-Hyun; Vukadin, Lana; Richard, Alexander; Giannini, Hannah K.; Lim, Ssang-Taek Steve; Tan, Ming; Ahn, Eun-Young Erin			Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia; long noncoding RNA (long ncRNA; lncRNA); chromatin structure; histone modification; breast cancer; MALAT1	LONG NONCODING RNA; CHROMOSOME CONFORMATION CAPTURE; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; METASTASIS; REGULATOR; SIGNATURE; ENHANCERS; ELEMENTS; MEDIATOR	Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a long noncoding RNA overexpressed in various cancers that promotes cell growth and metastasis. Although hypoxia has been shown to up-regulate MALAT1, only hypoxia-inducible factors (HIFs) have been implicated in activation of the MALAT1 promoter in specific cell types and other molecular mechanisms associated with hypoxia-mediated MALAT1 up-regulation remain largely unknown. Here, we demonstrate that hypoxia induces cancer cell-specific chromatin-chromatin interactions between newly identified enhancer-like cis-regulatory elements present at the MALAT1 locus. We show that hypoxia-mediated up-regulation of MALAT1 as well as its antisense strand TALAM1 occurs in breast cancer cells, but not in nontumorigenic mammary epithelial cells. Our analyses on the MALAT1 genomic locus discovered three novel putative enhancers that are located upstream and downstream of the MALAT1 gene body. We found that parts of these putative enhancers are epigenetically modified to a more open chromatin state under hypoxia in breast cancer cells. Furthermore, our chromosome conformation capture experiment demonstrated that noncancerous cells and breast cancer cells exhibit different interaction profiles under both normoxia and hypoxia, and only breast cancer cells gain specific chromatin interactions under hypoxia. Although the HIF-2 alpha protein can enhance the interaction between the promoter and the putative 3 ' enhancer, the gain of chromatin interactions associated with other upstream elements, such as putative -7 and -20 kb enhancers, were HIF-independent events. Collectively, our study demonstrates that cancer cell-specific chromatin-chromatin interactions are formed at the MALAT1 locus under hypoxia, implicating a novel mechanism of MALAT1 regulation in cancer.	[Stone, Joshua K.; Kim, Jung-Hyun; Vukadin, Lana; Richard, Alexander; Giannini, Hannah K.; Tan, Ming; Ahn, Eun-Young Erin] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Lim, Ssang-Taek Steve; Tan, Ming; Ahn, Eun-Young Erin] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama	Ahn, EYE (corresponding author), Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA.	eahn@health.southalabama.edu	Tan, Ming/ABD-5847-2021; Kim, Jung-Hyun/AAK-8795-2021	Tan, Ming/0000-0003-2007-9898; Kim, Jung-Hyun/0000-0001-7176-409X; Ahn, Eun-Young Erin/0000-0001-8795-7734; Lim, Steve/0000-0003-0323-8607	Mitchell Cancer Institute; National Institutes of Health [R21 CA185818, R01 CA190688, R01 CA149646, R01 HL136432]; NATIONAL CANCER INSTITUTE [R21CA185818, R01CA190688] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136432] Funding Source: NIH RePORTER	Mitchell Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Mitchell Cancer Institute (to E. Y. E. A.) and National Institutes of Health Grants R21 CA185818 (to E. Y. E. A.), R01 CA190688 (to E. Y. E. A.), R01 CA149646 (to M. T.), and R01 HL136432 (to S. T. S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Andersson R, 2015, TRENDS GENET, V31, P426, DOI 10.1016/j.tig.2015.05.007; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Chan HL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05728-x; Chang S, 2016, FEBS LETT, V590, P3407, DOI 10.1002/1873-3468.12375; Choudhry H, 2014, EMBO REP, V15, P70, DOI 10.1002/embr.201337642; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Favaro E, 2011, GENOME MED, V3, DOI 10.1186/gm271; Gheldof N, 2012, METHODS MOL BIOL, V786, P211, DOI 10.1007/978-1-61779-292-2_13; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Huang ZL, 2015, ONCOL REP, V34, P2403, DOI 10.3892/or.2015.4259; Jeffers Liesl K, 2013, J Cancer Ther, V4, DOI 10.4236/jct.2013.43094; Jen JY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0674-z; Jiao F, 2015, INT J MOL SCI, V16, P6677, DOI 10.3390/ijms16046677; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Kim JH, 2016, MOL CELL, V61, P859, DOI 10.1016/j.molcel.2016.02.024; Kirmes I, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0802-2; Lawrence M, 2016, TRENDS GENET, V32, P42, DOI 10.1016/j.tig.2015.10.007; Lelli A, 2015, HYPOXIA, V3, P45, DOI 10.2147/HP.S90555; Li SF, 2015, J CANCER RES CLIN, V141, P1909, DOI 10.1007/s00432-015-1951-0; Luo F, 2016, ONCOTARGET, V7, P5769, DOI 10.18632/oncotarget.6806; Ma XY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1881-x; Medina-Rivera A, 2018, TRENDS BIOCHEM SCI, V43, P452, DOI 10.1016/j.tibs.2018.03.004; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Mikhaylichenko O, 2018, GENE DEV, V32, P42, DOI 10.1101/gad.308619.117; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Niskanen H, 2018, NUCLEIC ACIDS RES, V46, P1724, DOI 10.1093/nar/gkx1214; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Platt JL, 2016, EMBO REP, V17, P1410, DOI 10.15252/embr.201642198; Prickaerts P, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0086-0; Salle-Lefort S, 2016, INT J ONCOL, V49, P1731, DOI 10.3892/ijo.2016.3630; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sexton T, 2012, NAT PROTOC, V7, P1335, DOI 10.1038/nprot.2012.071; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Singh KK, 2016, INT J VASC MED, V2016, DOI 10.1155/2016/2459687; Stiehl DP, 2012, ONCOGENE, V31, P2283, DOI 10.1038/onc.2011.417; Tee AE, 2016, ONCOTARGET, V7, P8663, DOI 10.18632/oncotarget.6675; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Wu YS, 2015, INT J ONCOL, V46, P2586, DOI 10.3892/ijo.2015.2976; Wu YT, 2015, TOXICOL APPL PHARM, V289, P163, DOI 10.1016/j.taap.2015.09.028; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yoshimoto R, 2016, BBA-GENE REGUL MECH, V1859, P192, DOI 10.1016/j.bbagrm.2015.09.012; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zeitz MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073974; Zhang RR, 2017, ENDOCR PATHOL, V28, P7, DOI 10.1007/s12022-016-9453-4; Zhao G, 2016, FEBS LETT, V590, P2884, DOI 10.1002/1873-3468.12315; Zhao Y, 2014, CANCER RES, V74, P5103, DOI 10.1158/0008-5472.CAN-14-0427; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942; Zong XY, 2016, NUCLEIC ACIDS RES, V44, P2898, DOI 10.1093/nar/gkw047; Zou A, 2016, NEOPLASMA, V63, P865, DOI 10.4149/neo_2016_605	59	24	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11213	11224		10.1074/jbc.RA118.006889	http://dx.doi.org/10.1074/jbc.RA118.006889			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167784	hybrid, Green Published			2022-12-28	WOS:000478717400013
J	Zhong, G; Hogarth, C; Snyder, J; Palau, L; Topping, T; Huang, WZ; Czuba, LC; Lafrance, J; Ghiaur, G; Isoherranen, N				Zhong, Guo; Hogarth, Cathryn; Snyder, Jessica; Palau, Laura; Topping, Traci; Huang, Weize; Czuba, Lindsay C.; Lafrance, Jeffrey; Ghiaur, Gabriel; Isoherranen, Nina			The retinoic acid hydroxylase Cyp26a1 has minor effects on postnatal vitamin A homeostasis, but is required for exogenous atRA clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retinoic acid; retinoid; retinol; cytochrome P450; vitamin A; cytochrome; hematopoiesis	INHIBITION; METABOLISM; DIFFERENTIATION; EXPRESSION; ENZYMES; CANCER; ROLES	The all-trans-retinoic acid (atRA) hydroxylase Cyp26a1 is essential for embryonic development and may play a key role in regulating atRA clearance also in adults. We hypothesized that loss of Cyp26a1 activity via inducible knockout in juvenile or adult mice would result in decreased atRA clearance and increased tissue atRA concentrations and atRA-related adverse effects. To test these hypotheses, Cyp26a1 was knocked out in juvenile and adult male and female Cyp26a1 floxed mice using standard Cre-Lox technology and tamoxifen injections. Biochemical and histological methods were used to study the effects of global Cyp26a1 knockout. The Cyp26a1 knockout did not result in consistent histopathological changes in any major organs. Cyp26a1(-/-) mice gained weight normally and exhibited no adverse phenotypes for up to 1 year after loss of Cyp26a1 expression. Similarly, atRA concentrations were not increased in the liver, testes, spleen, or serum of these mice, and the Cyp26a1 knockout did not cause compensatory induction of lecithin:retinol acetyltransferase (Lrat) or retinol dehydrogenase 11 (Rdh11) mRNA or a decrease in aldehyde dehydrogenase 1a1 (Aldh1a1) mRNA in the liver compared with tamoxifen-treated controls. However, the Cyp26a1(-/-) mice showed increased bone marrow cellularity and decreased frequency of erythroid progenitor cells in the bone marrow consistent with a retinoid-induced myeloid skewing of hematopoiesis. In addition, the Cyp26a1 knockout decreased clearance of exogenous atRA by 70% and increased atRA half-life 6-fold. These findings demonstrate that despite lacking a major impact on endogenous atRA signaling, Cyp26a1 critically contributes as a barrier for exogenous atRA exposure.	[Zhong, Guo; Huang, Weize; Czuba, Lindsay C.; Lafrance, Jeffrey; Isoherranen, Nina] Univ Washington, Dept Pharmaceut, Sch Pharm, Hlth Sci Bldg,Rm H-272M,Box 357610, Seattle, WA 98195 USA; [Snyder, Jessica] Univ Washington, Dept Comparat Med, Sch Pharm, Seattle, WA 98195 USA; [Hogarth, Cathryn; Topping, Traci] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Palau, Laura; Ghiaur, Gabriel] Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington State University; Johns Hopkins University	Isoherranen, N (corresponding author), Univ Washington, Dept Pharmaceut, Sch Pharm, Hlth Sci Bldg,Rm H-272M,Box 357610, Seattle, WA 98195 USA.	ni2@uw.edu	Czuba, Lindsay/AAB-2320-2020	Huang, Weize/0000-0001-5903-721X; Ghiaur, Gabriel/0000-0002-3955-7944; Hogarth, Cathryn/0000-0003-2744-7323; Zhong, Guo/0000-0002-6056-9472; Czuba, Lindsay/0000-0001-9142-5706; Isoherranen, Nina/0000-0002-9548-3126	National Institutes of Health [R01GM111772, K08HL127269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL127269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants increases tissue atRA concentrations and retinoid signaling R01GM111772 (to N. I. and C. H.) and K08HL127269 (to G. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Alonso S, 2017, EXP HEMATOL, V54, P17, DOI 10.1016/j.exphem.2017.07.004; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Amory JK, 2011, J ANDROL, V32, P111, DOI 10.2164/jandrol.110.010751; Arnold SLM, 2015, BIOCHEM PHARMACOL, V95, P177, DOI 10.1016/j.bcp.2015.03.001; Beedle MT, 2019, BIOL REPROD, V100, P547, DOI 10.1093/biolre/ioy200; Chenery A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072308; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; GEELEN JAG, 1979, CRC CR REV TOXICOL, V6, P351, DOI 10.3109/10408447909043651; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; Grizotte-Lake M, 2018, IMMUNITY, V49, P1103, DOI 10.1016/j.immuni.2018.11.018; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hogarth CA, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129718; Hogarth CA, 2013, CURR OPIN ENDOCRINOL, V20, P217, DOI 10.1097/MED.0b013e32836067cf; Jing J, 2017, J PHARMACOL EXP THER, V361, P246, DOI 10.1124/jpet.117.240523; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; KISTLER A, 1986, BIOCHEM SOC T, V14, P936, DOI 10.1042/bst0140936; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz JD, 2009, BIOCHEM PHARMACOL, V77, P258, DOI 10.1016/j.bcp.2008.10.012; McCaffery PJ, 2003, EUR J NEUROSCI, V18, P457, DOI 10.1046/j.1460-9568.2003.02765.x; Morton JEV, 2016, AM J MED GENET A, V170, P2706, DOI 10.1002/ajmg.a.37804; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nelson CH, 2016, FEBS LETT, V590, P2527, DOI 10.1002/1873-3468.12303; Nelson CH, 2013, CURR TOP MED CHEM, V13, P1402; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Nilsson O, 2016, HORM METAB RES, V48, P737, DOI 10.1055/s-0042-114038; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Shirakami Y, 2012, BBA-MOL CELL BIOL L, V1821, P124, DOI 10.1016/j.bbalip.2011.06.023; Stevison F, 2017, DRUG METAB DISPOS, V45, P846, DOI 10.1124/dmd.117.075341; Stoppie P, 2000, J PHARMACOL EXP THER, V293, P304; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; Tay S, 2010, MOL PHARMACOL, V77, P218, DOI 10.1124/mol.109.059071; Thatcher JE, 2011, MOL PHARMACOL, V80, P228, DOI 10.1124/mol.111.072413; Thatcher JE, 2010, BIOCHEM PHARMACOL, V80, P903, DOI 10.1016/j.bcp.2010.05.023; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Treuting Piper M, 2015, Curr Protoc Mouse Biol, V5, P223, DOI 10.1002/9780470942390.mo140296; Wen J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-100; Zhong G, 2019, J PHARMACOL EXP THER, V370, P92, DOI 10.1124/jpet.119.258517; Zhong G, 2018, MOL PHARMACOL, V93, P489, DOI 10.1124/mol.117.111039	47	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11166	11179		10.1074/jbc.RA119.009023	http://dx.doi.org/10.1074/jbc.RA119.009023			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167781	Green Published, hybrid			2022-12-28	WOS:000478717400010
J	Das, F; Maity, S; Ghosh-Choudhury, N; Kasinath, BS; Choudhury, GG				Das, Falguni; Maity, Soumya; Ghosh-Choudhury, Nandini; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh			Deacetylation of S6 kinase promotes high glucose-induced glomerular mesangial cell hypertrophy and matrix protein accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone deacetylase 1 (HDAC1); S6 kinase; signal transduction; diabetic nephropathy; extracellular matrix; diabetic renal hypertrophy; matrix expansion; mTORC1	MESSENGER-RNA TRANSLATION; DIABETIC-NEPHROPATHY; GROWTH-FACTOR; MAMMALIAN TARGET; MTOR; ACTIVATION; REGULATOR; RAPTOR; SIZE; PHOSPHORYLATION	S6 kinase acts as a driver for renal hypertrophy and matrix accumulation, two key pathologic signatures of diabetic nephropathy. As a post-translational modification, S6 kinase undergoes acetylation at the C terminus. The role of this acetylation to regulate kidney glomerular cell hypertrophy and matrix expansion is not known. In mesangial cells, high glucose decreased the acetylation and enhanced phosphorylation of S6 kinase and its substrates rps6 and eEF2 kinase that lead to dephosphorylation of eEF2. To determine the mechanism of S6 kinase deacetylation, we found that trichostatin A, a pan-histone deacetylase (HDAC) inhibitor, blocked all high glucose-induced effects. Furthermore, high glucose increased the expression and association of HDAC1 with S6 kinase. HDAC1 decreased the acetylation of S6 kinase and mimicked the effects of high glucose, resulting in mesangial cell hypertrophy and expression of fibronectin and collagen I (2). In contrast, siRNA against HDAC1 inhibited these effects by high glucose. A C-terminal acetylation-mimetic mutant of S6 kinase suppressed high glucose-stimulated phosphorylation of S6 kinase, rps6 and eEF2 kinase, and inhibited the dephosphorylation of eEF2. Also, the acetylation mimetic attenuated the mesangial cell hypertrophy and fibronectin and collagen I (2) expression. Conversely, an S6 kinase acetylation-deficient mutant induced all the above effects of high glucose. Finally, in the renal glomeruli of diabetic rats, the acetylation of S6 kinase was significantly reduced concomitant with increased HDAC1 and S6 kinase activity. In aggregate, our data uncovered a previously unrecognized role of S6 kinase deacetylation in high glucose-induced mesangial cell hypertrophy and matrix protein expression.	[Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Das, Falguni; Maity, Soumya; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] UT Hlth, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini] UT Hlth, Dept Pathol, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Choudhury, GG (corresponding author), UT Hlth, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu		Maity, Soumya/0000-0002-3407-1734	Department of Veterans Affairs Biomedical Laboratory Research and Development Service Merit Review Award [2I01 BX000926]; Veterans Affairs Merit Review Grant [I01 BX001340]; San Antonio Area Foundation; Department of Veterans Affairs Biomedical Laboratory Research and Development Service Research Career Scientist Award [IK6BX00361]; Veterans Affairs [I01BX000926] Funding Source: NIH RePORTER	Department of Veterans Affairs Biomedical Laboratory Research and Development Service Merit Review Award; Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); San Antonio Area Foundation; Department of Veterans Affairs Biomedical Laboratory Research and Development Service Research Career Scientist Award(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Department of Veterans Affairs Biomedical Laboratory Research and Development Service Merit Review Award 2I01 BX000926 (to G. G. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Veterans Affairs Merit Review Grant I01 BX001340.; Recipient of a research grant from the San Antonio Area Foundation.; Recipient of Department of Veterans Affairs Biomedical Laboratory Research and Development Service Research Career Scientist Award IK6BX00361.	Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Awazu M, 2003, J AM SOC NEPHROL, V14, P699, DOI 10.1097/01.ASN.0000051726.41601.C0; Bera A, 2017, AM J PHYSIOL-CELL PH, V313, pC430, DOI 10.1152/ajpcell.00081.2017; Caramori ML, 2003, CURR OPIN NEPHROL HY, V12, P273, DOI 10.1097/00041552-200305000-00008; Chen JK, 2009, AM J PHYSIOL-RENAL, V297, pF585, DOI 10.1152/ajprenal.00186.2009; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Choundhury GG, 1999, J BIOL CHEM, V274, P10897; Das F, 2018, CELL SIGNAL, V42, P44, DOI 10.1016/j.cellsig.2017.09.017; Das F, 2016, AM J PHYSIOL-CELL PH, V310, pC583, DOI 10.1152/ajpcell.00266.2015; Das F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109608; Das F, 2013, J BIOL CHEM, V288, P7756, DOI 10.1074/jbc.M113.455782; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Drummond K, 2002, DIABETES, V51, P1580, DOI 10.2337/diabetes.51.5.1580; Eckschlager T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071414; Eid AA, 2013, DIABETES, V62, P2935, DOI 10.2337/db12-1504; Fenton TR, 2010, INT J BIOCHEM CELL B, V42, P359, DOI 10.1016/j.biocel.2009.11.022; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Fenton TR, 2010, BIOCHEM BIOPH RES CO, V398, P400, DOI 10.1016/j.bbrc.2010.06.081; FERRARI S, 1992, P NATL ACAD SCI USA, V89, P7282, DOI 10.1073/pnas.89.15.7282; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Ghosh C, 2004, CELL SIGNAL, V16, P31, DOI DOI 10.1016/S0898-6568(03)00094-9; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Gwalter I, 2009, INT J BIOCHEM CELL B, V41, P828, DOI 10.1016/j.biocel.2008.08.018; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hong SK, 2014, J BIOL CHEM, V289, P13132, DOI 10.1074/jbc.M113.520734; Ibrahim HN, 1997, J AM SOC NEPHROL, V8, P487; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Inoki K, 2008, DIABETES RES CLIN PR, V82, pS59, DOI 10.1016/j.diabres.2008.09.028; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kato M, 2014, NAT REV NEPHROL, V10, P517, DOI 10.1038/nrneph.2014.116; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Komorowsky C, 2009, J CELL MOL MED, V13, P2353, DOI 10.1111/j.1582-4934.2009.00674.x; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Lehmann R, 2000, CLIN CHIM ACTA, V297, P135, DOI 10.1016/S0009-8981(00)00240-0; Liu N, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00121; Livingstone M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/021001; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Maity S, 2018, EXP CELL RES, V364, P5, DOI 10.1016/j.yexcr.2018.01.021; Manson SR, 2014, J UROLOGY, V191, P242, DOI 10.1016/j.juro.2013.06.110; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2011, AM J PHYSIOL-RENAL, V300, pF219, DOI 10.1152/ajprenal.00207.2010; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; MOGENSEN CE, 1973, DIABETES, V22, P706, DOI 10.2337/diab.22.9.706; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Satriano J, 2007, AMINO ACIDS, V33, P331, DOI 10.1007/s00726-007-0529-9; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sfakianos AP, 2018, CELL DEATH DIFFER, V25, P1766, DOI 10.1038/s41418-018-0076-9; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; SHULTZ PJ, 1988, AM J PHYSIOL, V255, pF674, DOI 10.1152/ajprenal.1988.255.4.F674; VanLint C, 1996, GENE EXPRESSION, V5, P245; Wakino S, 2015, KIDNEY INT, V88, P691, DOI 10.1038/ki.2015.157; Wang XJ, 2014, KIDNEY INT, V86, P712, DOI 10.1038/ki.2014.111; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; WENG QP, 1995, MOL CELL BIOL, V15, P2333; White KE, 2000, J AM SOC NEPHROL, V11, P1667, DOI 10.1681/ASN.V1191667; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Zhang JJ, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1052; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	78	12	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9440	9460		10.1074/jbc.RA118.007023	http://dx.doi.org/10.1074/jbc.RA118.007023			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31028173	Green Published, hybrid			2022-12-28	WOS:000472713000014
J	Feng, K; Deng, F; Hu, ZH; Wang, HL; Ning, YJ				Feng, Kuan; Deng, Fei; Hu, Zhihong; Wang, Hualin; Ning, Yun-Jia			Heartland virus antagonizes type I and III interferon antiviral signaling by inhibiting phosphorylation and nuclear translocation of STAT2 and STAT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; infectious disease; innate immunity; interferon; virus; signal transducers and activators of transcription 1 (STAT1); Heartland virus; nonstructural protein; phlebovirus; STAT2; phosphorylation; nuclear translocation	THROMBOCYTOPENIA SYNDROME VIRUS; SEVERE FEVER; BUNYAVIRIDAE PHLEBOVIRUS; IDENTIFICATION; INFECTION; HIJACKING; PROTEIN	Heartland virus (HRTV) is a pathogenic phlebovirus recently identified in the United States and related to severe fever with thrombocytopenia syndrome virus (SFTSV) emerging in Asia. We previously reported that SFTSV disrupts host antiviral responses directed by interferons (IFNs) and their downstream regulators, signal transducer and activator of transcription (STAT) proteins. However, whether HRTV infection antagonizes the IFN-STAT signaling axis remains unclear. Here, we show that, similar to SFTSV, HRTV also inhibits IFN-- and IFN--mediated antiviral responses. As expected, the nonstructural protein (NSs) of HRTV (HNSs) robustly antagonized both type I and III IFN signaling. Protein interaction analyses revealed that a common component downstream of type I and III IFN signaling, STAT2, is the target of HNSs. Of note, the DNA-binding and linker domains of STAT2 were required for an efficient HNSs-STAT2 interaction. Unlike the NSs of SFTSV (SNSs), which blocks both STAT2 and STAT1 nuclear accumulation, HNSs specifically blocked IFN-triggered nuclear translocation only of STAT2. However, upon HRTV infection, IFN-induced nuclear translocation of both STAT2 and STAT1 was suppressed, suggesting that STAT1 is an additional HRTV target for IFN antagonism. Consistently, despite HNSs inhibiting phosphorylation only of STAT2 and not STAT1, HRTV infection diminished both STAT2 and STAT1 phosphorylation. These results suggest that HRTV antagonizes IFN antiviral signaling by dampening both STAT2 and STAT1 activities. We propose that HNSs-specific targeting of STAT2 likely plays an important role but is not all of the tactics of HRTV in its immune evasion.	[Feng, Kuan; Deng, Fei; Hu, Zhihong; Wang, Hualin; Ning, Yun-Jia] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China; [Feng, Kuan] Univ Chinese Acad Sci, Beijing 101408, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ning, YJ (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China.	nyj@wh.iov.cn	Hu, Zhihong/AAS-2215-2020	Hu, Zhihong/0000-0002-1560-0928	National Natural Science Foundation of China [31621061, 31600144]; National Key Research and Development Program of China [2018YFA0507202, 2016YFC1200400, 2016YFE0113500]; European Union [653316]; Chinese Academy of Sciences [XDPB0301]; "One-Three-Five" Research Program of the Wuhan Institute of Virology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; European Union(European Commission); Chinese Academy of Sciences(Chinese Academy of Sciences); "One-Three-Five" Research Program of the Wuhan Institute of Virology	This work was supported by National Natural Science Foundation of China Grants 31621061 and 31600144; National Key Research and Development Program of China Grants 2018YFA0507202, 2016YFC1200400, and 2016YFE0113500; the European Union's Horizon 2020 project European Virus Archive Goes Global (EVAg; Grant 653316); the strategic priority research program of the Chinese Academy of Sciences (Grant XDPB0301); and the "One-Three-Five" Research Program of the Wuhan Institute of Virology. The authors declare that they have no conflicts of interest with the contents of this article.	Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10; Bosco-Lauth AM, 2016, EMERG INFECT DIS, V22, P2070, DOI 10.3201/eid2212.160472; Bosco-Lauth AM, 2015, AM J TROP MED HYG, V92, P1163, DOI 10.4269/ajtmh.14-0702; Charoenthongtrakul S, 2011, J VIROL, V85, P6955, DOI 10.1128/JVI.00007-11; Chaudhary V, 2015, J GEN VIROL, V96, P3204, DOI 10.1099/jgv.0.000280; Cheng HJ, 2013, ADV MATH PHYS, V2013, DOI 10.1155/2013/187217; Chow KT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.12.008; Egli A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.51; Elliott RM, 2014, CURR OPIN VIROL, V5, P50, DOI 10.1016/j.coviro.2014.01.011; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Hemann EA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01707; Ho J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000117; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Li H, 2018, LANCET INFECT DIS, V18, P1127, DOI 10.1016/S1473-3099(18)30293-7; Liu Y, 2014, J VIROL, V88, P1781, DOI 10.1128/JVI.02277-13; Mansfield KL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00298; Matsuno K, 2015, J VIROL, V89, P594, DOI 10.1128/JVI.02704-14; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mourya DT, 2014, J VIROL, V88, P3605, DOI 10.1128/JVI.02617-13; Muehlenbachs A, 2014, CLIN INFECT DIS, V59, P845, DOI 10.1093/cid/ciu434; Najjar I, 2010, BIOCHIMIE, V92, P425, DOI 10.1016/j.biochi.2010.02.009; Nan YC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01758; Ning YJ, 2018, PROTEIN CELL, V9, P389, DOI 10.1007/s13238-017-0471-x; Ning YJ, 2017, J BIOL CHEM, V292, P16722, DOI 10.1074/jbc.M117.805127; Ning YJ, 2015, J VIROL, V89, P4227, DOI 10.1128/JVI.00154-15; Ning YJ, 2014, J MOL CELL BIOL, V6, DOI 10.1093/jmcb/mju015; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Rezelj VV, 2017, MSPHERE, V2, DOI [10.1128/msphere.00234-17, 10.1128/mSphere.00234-17]; Santiago FW, 2014, J VIROL, V88, P4572, DOI 10.1128/JVI.03021-13; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Shen S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0093-2; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Sun LJ, 2010, CELL, V140, P436, DOI 10.1016/j.cell.2010.01.041; Sun YP, 2018, PROTEIN CELL, V9, P832, DOI 10.1007/s13238-017-0503-6; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Wang J, 2014, EMERG INFECT DIS, V20, P1040, DOI 10.3201/eid2006.140003; Westover JB, 2017, VIROLOGY, V511, P175, DOI 10.1016/j.virol.2017.08.004; Wu XD, 2014, J VIROL, V88, P3067, DOI 10.1128/JVI.03510-13; Wuerth JD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060174; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Xu ZC, 2016, CHIN HERB MED, V8, P3, DOI 10.1016/S1674-6384(16)60002-3; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209	49	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9503	9517		10.1074/jbc.RA118.006563	http://dx.doi.org/10.1074/jbc.RA118.006563			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31040183	Green Published, hybrid			2022-12-28	WOS:000472713000018
J	Wagstaff, B; Rejzek, M; Kuhaudomlarp, S; Hill, L; Mascia, I; Nepogodiev, SA; Dorfmueller, HC; Field, RA				Wagstaff, Ben A.; Rejzek, Martin; Kuhaudomlarp, Sakonwan; Hill, Lionel; Mascia, Ilaria; Nepogodiev, Sergey A.; Dorfmueller, Helge C.; Field, Robert A.			Discovery of an RmlC/D fusion protein in the microalga Prymnesium parvum and its implications for NDP-beta-l-rhamnose biosynthesis in microalgae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; carbohydrate biosynthesis; bioinformatics; carbohydrate processing; glycobiology; enzyme; pathway evolution; Prymnesium parvum; rhamnose; sugar nucleotides	DTDP-D-GLUCOSE; SEROVAR TYPHIMURIUM; 2ND ENZYME; NUCLEOTIDE; CARBOHYDRATE; PURIFICATION; REDUCTASE; PATHWAY; POLYSACCHARIDE; IDENTIFICATION	The 6-deoxy sugar l-rhamnose (l-Rha) is found widely in plant and microbial polysaccharides and natural products. The importance of this and related compounds in host-pathogen interactions often means that l-Rha plays an essential role in many organisms. l-Rha is most commonly biosynthesized as the activated sugar nucleotide uridine 5-diphospho--l-rhamnose (UDP--l-Rha) or thymidine 5-diphospho--l-rhamnose (TDP--l-Rha). Enzymes involved in the biosynthesis of these sugar nucleotides have been studied in some detail in bacteria and plants, but the activated form of l-Rha and the corresponding biosynthetic enzymes have yet to be explored in algae. Here, using sugar-nucleotide profiling in two representative algae, Euglena gracilis and the toxin-producing microalga Prymnesium parvum, we show that levels of UDP- and TDP-activated l-Rha differ significantly between these two algal species. Using bioinformatics and biochemical methods, we identified and characterized a fusion of the RmlC and RmlD proteins, two bacteria-like enzymes involved in TDP--l-Rha biosynthesis, from P. parvum. Using this new sequence and also others, we explored l-Rha biosynthesis among algae, finding that although most algae contain sequences orthologous to plant-like l-Rha biosynthesis machineries, instances of the RmlC-RmlD fusion protein identified here exist across the Haptophyta and Gymnodiniaceae families of microalgae. On the basis of these findings, we propose potential routes for the evolution of nucleoside diphosphate -l-Rha (NDP--l-Rha) pathways among algae.	[Wagstaff, Ben A.; Rejzek, Martin; Kuhaudomlarp, Sakonwan; Hill, Lionel; Mascia, Ilaria; Nepogodiev, Sergey A.; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Dorfmueller, Helge C.] Univ Dundee, Sch Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland; [Kuhaudomlarp, Sakonwan] Univ Grenoble Alpes, CNRS, CERMAV, F-38000 Grenoble, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Dundee; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Field, RA (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	rob.field@jic.ac.uk	Kuhaudomlarp, Sakonwan/AAO-1251-2021	Rejzek, Martin/0000-0002-5091-544X; Kuhaudomlarp, Sakonwan/0000-0003-4415-3781; Field, Rob/0000-0001-8574-0275	UK Biotechnological and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant "Molecules from Nature-Products and Pathways" [BBS/E/J/000PR9790]; John Innes Foundation; Wellcome Trust [109357/Z/15/Z]; Royal Society; BBSRC [BB/L014130/1, BBS/E/J/000PR9790, BBS/E/J/000C0618] Funding Source: UKRI	UK Biotechnological and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant "Molecules from Nature-Products and Pathways"(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnological and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant "Molecules from Nature-Products and Pathways" BBS/E/J/000PR9790 and the John Innes Foundation. This work was also supported by Grant 109357/Z/15/Z from Wellcome Trust and Royal Society (to H. C. D.)." The authors declare that they have no conflicts of interest with the contents of this article.	Allard STM, 2000, ACTA CRYSTALLOGR D, V56, P222, DOI 10.1107/S0907444999016200; Allard STM, 2001, J MOL BIOL, V307, P283, DOI 10.1006/jmbi.2000.4470; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARRAS DR, 1965, BIOCHEM J, V97, pP14; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Blankenfeldt W, 2002, STRUCTURE, V10, P773, DOI 10.1016/S0969-2126(02)00770-0; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; COGBURN JN, 1984, J PHYCOL, V20, P533, DOI 10.1111/j.0022-3646.1984.00533.x; Dong C, 2003, BIOCHEM SOC T, V31, P532, DOI 10.1042/BST0310532; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Feng LK, 2016, BIOCHEM J, V473, P1507, DOI 10.1042/BCJ20160142; Gabrielsen TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019132; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; Graham LE, 2000, ALGAE; Han XD, 2015, BBA-PROTEINS PROTEOM, V1854, P1476, DOI 10.1016/j.bbapap.2015.06.007; JIANG XM, 1991, MOL MICROBIOL, V5, P695, DOI 10.1111/j.1365-2958.1991.tb00741.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; LIU HW, 1994, ANNU REV MICROBIOL, V48, P223, DOI 10.1146/annurev.micro.48.1.223; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; Maki M, 2004, GLYCOBIOLOGY, V14, p1R, DOI 10.1093/glycob/cwh040; MARKER AFH, 1965, J MAR BIOL ASSOC UK, V45, P755, DOI 10.1017/S002531540001657X; Martinez V, 2012, J BIOL CHEM, V287, P879, DOI 10.1074/jbc.M111.287367; McNaught AD, 1996, PURE APPL CHEM, V68, P1919, DOI 10.1351/pac199668101919; Mistou MY, 2016, FEMS MICROBIOL REV, V40, P464, DOI 10.1093/femsre/fuw006; Morden CW, 2002, P NATL ACAD SCI USA, V99, P11558, DOI 10.1073/pnas.192456999; Nakano Y, 2000, J BIOL CHEM, V275, P6806, DOI 10.1074/jbc.275.10.6806; NAKANO Y, 1987, J BIOCHEM, V102, P1053, DOI 10.1093/oxfordjournals.jbchem.a122143; O'Neill E. C., 2015, PERSPECTIVES SCI, V6, P84, DOI DOI 10.1016/J.PISC.2015.07.002; O'Neill EC, 2015, MOL BIOSYST, V11, P2808, DOI 10.1039/c5mb00319a; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Pabst M, 2010, ANAL CHEM, V82, P9782, DOI 10.1021/ac101975k; Pettolino F, 2009, FEBS J, V276, P4122, DOI 10.1111/j.1742-4658.2009.07086.x; Piacente F, 2015, INT J MOL SCI, V16, P29315, DOI 10.3390/ijms161226169; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Rejzek M, 2007, CARBOHYD RES, V342, P460, DOI 10.1016/j.carres.2006.10.016; Rejzek M, 2017, METHOD ENZYMOL, V597, P209, DOI 10.1016/bs.mie.2017.06.005; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; SABESAN S, 1992, CARBOHYD RES, V223, P169, DOI 10.1016/0008-6215(92)80015-S; Santhanam P, 2017, MOL PLANT PATHOL, V18, P347, DOI 10.1111/mpp.12401; Schwartzbach S. D., 2017, EUGLENA BIOCH CELL M; Singh S, 2012, NAT PROD REP, V29, P1201, DOI 10.1039/c2np20039b; Stern RJ, 1999, MICROBIOL-UK, V145, P663, DOI 10.1099/13500872-145-3-663; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Teramoto M., 2012, ADV APPL BIOTECHNOLO, DOI [10.5772/29196, DOI 10.5772/29196]; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; van der Beek SL, 2015, MOL MICROBIOL, V98, P946, DOI 10.1111/mmi.13169; Wagstaff BA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030040; Wagstaff BA, 2015, CARBOHYD RES, V404, P17, DOI 10.1016/j.carres.2014.12.005; Yamashita Y, 1999, J BACTERIOL, V181, P6556, DOI 10.1128/JB.181.20.6556-6559.1999; Yin YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027995; Yoo HG, 2011, BIOORG MED CHEM LETT, V21, P3914, DOI 10.1016/j.bmcl.2011.05.030	55	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9172	9185		10.1074/jbc.RA118.006440	http://dx.doi.org/10.1074/jbc.RA118.006440			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31010825	hybrid, Green Published			2022-12-28	WOS:000471751600013
J	Kim, JS; He, XY; Liu, J; Duan, ZJ; Kim, T; Gerard, J; Kim, B; Pillai, MM; Lane, WS; Noble, WS; Budnik, B; Waldman, T				Kim, Jung-Sik; He, Xiaoyuan; Liu, Jie; Duan, Zhijun; Kim, Taeyeon; Gerard, Julia; Kim, Brian; Pillai, Manoj M.; Lane, William S.; Noble, William S.; Budnik, Bogdan; Waldman, Todd			Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding protein; cell cycle; mitosis; RNA splicing; protein-protein interaction; cell division; genome structure; CKAP5; cohesin; gene editing; MGA; STAG2	SISTER-CHROMATID COHESION; CELL-DIVISION; COMPLEXES; GENOME; IDENTIFICATION; TRANSCRIPTION; ASSOCIATION; SPLICEOSOME; MUTATIONS; SORORIN	The cohesin complex regulates sister chromatid cohesion, chromosome organization, gene expression, and DNA repair. Cohesin is a ring complex composed of four core subunits and seven regulatory subunits. In an effort to comprehensively identify additional cohesin-interacting proteins, we used gene editing to introduce a dual epitope tag into the endogenous allele of each of 11 known components of cohesin in cultured human cells, and we performed MS analyses on dual-affinity purifications. In addition to reciprocally identifying all known components of cohesin, we found that cohesin interacts with a panoply of splicing factors and RNA-binding proteins (RBPs). These included diverse components of the U4/U6.U5 tri-small nuclear ribonucleoprotein complex and several splicing factors that are commonly mutated in cancer. The interaction between cohesin and splicing factors/RBPs was RNA- and DNA-independent, occurred in chromatin, was enhanced during mitosis, and required RAD21. Furthermore, cohesin-interacting splicing factors and RBPs followed the cohesin cycle and prophase pathway of cell cycle-regulated interactions with chromatin. Depletion of cohesin-interacting splicing factors and RBPs resulted in aberrant mitotic progression. These results provide a comprehensive view of the endogenous human cohesin interactome and identify splicing factors and RBPs as functionally significant cohesin-interacting proteins.	[Kim, Jung-Sik; He, Xiaoyuan; Kim, Taeyeon; Gerard, Julia; Kim, Brian; Waldman, Todd] Georgetown Univ, Sch Med, Dept Oncol, Washington, DC 20057 USA; [Kim, Jung-Sik; He, Xiaoyuan; Kim, Taeyeon; Gerard, Julia; Kim, Brian; Waldman, Todd] Georgetown Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20057 USA; [Liu, Jie; Noble, William S.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Duan, Zhijun] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Duan, Zhijun] Univ Washington, Div Hematol, Seattle, WA 98195 USA; [Pillai, Manoj M.] Yale Univ, Sch Med, Sect Hematol, Yale Canc Ctr, 333 Cedar St, New Haven, CT 06510 USA; [Lane, William S.; Budnik, Bogdan] Harvard Univ, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA	Georgetown University; Georgetown University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Yale University; Harvard University	Waldman, T (corresponding author), Georgetown Univ, Sch Med, Dept Oncol, Washington, DC 20057 USA.; Waldman, T (corresponding author), Georgetown Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20057 USA.	waldmant@georgetown.edu	Budnik, Bogdan/AAH-9987-2019; Budnik, Bogdan/AGG-8824-2022	Budnik, Bogdan/0000-0003-3622-2003	National Institutes of Health [P30CA51008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Mass spectrometry and bioinformatics analysis was conducted at the Mass Spectrometry and Proteomics Resource Laboratory, FAS Division of Science, Harvard University. The Lombardi Comprehensive Cancer Center was supported by National Institutes of Health Grant P30CA51008. We thank Peter Johnson and Shannon White for assistance with live-cell imaging	Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Anczukow O, 2016, RNA, V22, P1285, DOI 10.1261/rna.057919.116; Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gaj T, 2016, MOL THER, V24, P458, DOI 10.1038/mt.2015.151; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Hill VK, 2016, BBA-REV CANCER, V1866, P1, DOI 10.1016/j.bbcan.2016.05.002; Hofmann JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074851; Hofmann JC, 2010, NUCLEUS-PHILA, V1, P447, DOI 10.4161/nucl.1.6.13328; Huen MSY, 2010, CELL CYCLE, V9, P2679, DOI 10.4161/cc.9.13.12151; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Karamysheva Z, 2015, CELL CYCLE, V14, P1873, DOI 10.1080/15384101.2015.1039209; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kim JS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005865; Kim JS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn566; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; McCracken S, 2005, J BIOL CHEM, V280, P42227, DOI 10.1074/jbc.M507410200; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Oka Y, 2014, EMBO REP, V15, P956, DOI 10.15252/embr.201438679; Paulo Joao A, 2016, J Biol Methods, V3; Peters JM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011130; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Sundaramoorthy S, 2014, EMBO J, V33, P2623, DOI 10.15252/embj.201488244; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; van der Lelij P, 2014, EMBO J, V33, P2643, DOI 10.15252/embj.201488202; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Watrin E, 2014, EMBO REP, V15, P948, DOI 10.15252/embr.201438640; Zakari M, 2015, WIRES DEV BIOL, V4, P489, DOI 10.1002/wdev.190; Zheng G, 2018, ELIFE, V7, DOI 10.7554/eLife.33920	40	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8760	8772		10.1074/jbc.RA119.007832	http://dx.doi.org/10.1074/jbc.RA119.007832			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31010829	hybrid, Green Published			2022-12-28	WOS:000470971100012
J	Ng, J; Kaur, H; Collier, T; Chang, K; Brooks, AES; Allison, JR; Brimble, MA; Hickey, A; Birch, NP				Ng, Jin; Kaur, Harveen; Collier, Thomas; Chang, Kevin; Brooks, Anna E. S.; Allison, Jane R.; Brimble, Margaret A.; Hickey, Anthony; Birch, Nigel P.			Site-specific glycation of A1-42 affects fibril formation and is neurotoxic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid- (A); glycation; fibril; protein aggregation; mitochondria; neurodegeneration; advanced glycated end product (AGE); N-E-(carboxyethyl)lysine (CEL)	END-PRODUCTS; AMYLOID-BETA; MITOCHONDRIAL DYSFUNCTION; ALZHEIMERS-DISEASE; MAILLARD REACTION; OXIDATIVE STRESS; CHEMICAL-MODIFICATION; MONTE-CARLO; FORCE-FIELD; FREE-ENERGY	A1-42 is involved in Alzheimer's disease (AD) pathogenesis and is prone to glycation, an irreversible process where proteins accumulate advanced glycated end products (AGEs). N-E-(Carboxyethyl)lysine (CEL) is a common AGE associated with AD patients and occurs at either Lys-16 or Lys-28 of A1-42. Methyglyoxal is commonly used for the unspecific glycation of A1-42, which results in a complex mixture of AGE-modified peptides and makes interpretation of a causative AGE at a specific amino acid residue difficult. We address this issue by chemically synthesizing defined CEL modifications on A1-42 at Lys-16 (A-CEL16), Lys-28 (A-CEL28), and Lys-16 and -28 (A-CEL16&28). We demonstrated that double-CEL glycations at Lys-16 and Lys-28 of A1-42 had the most profound impact on the ability to form amyloid fibrils. In silico predictions indicated that A-CEL16&28 had a substantial decrease in free energy change, which contributes to fibril destabilization, and a increased aggregation rate. Single-CEL glycations at Lys-28 of A1-42 had the least impact on fibril formation, whereas CEL glycations at Lys-16 of A1-42 delayed fibril formation. We also tested these peptides for neuronal toxicity and mitochondrial function on a retinoic acid-differentiated SH-SY5Y human neuroblastoma cell line (RA-differentiated SH-SY5Y). Only A-CEL16 and A-CEL28 were neurotoxic, possibly through a nonmitochondrial pathway, whereas A-CEL16&28 showed no neurotoxicity. Interestingly, A-CEL16&28 had depolarized the mitochondrial membrane potential, whereas A-CEL16 had increased mitochondrial respiration at complex II. These results may indicate mitophagy or an alternate route of metabolism, respectively. Therefore, our results provides insight into potential therapeutic approaches against neurotoxic CEL-glycated A1-42.	[Ng, Jin; Kaur, Harveen; Brooks, Anna E. S.; Allison, Jane R.; Brimble, Margaret A.; Hickey, Anthony; Birch, Nigel P.] Univ Auckland, Sch Biol Sci, 3A Symonds St, Auckland 1010, New Zealand; [Kaur, Harveen; Brimble, Margaret A.] Univ Auckland, Sch Chem Sci, Auckland 1010, New Zealand; [Chang, Kevin] Univ Auckland, Ctr Stat Consulting, Dept Stat, Auckland 1010, New Zealand; [Collier, Thomas] Massey Univ, Ctr Theoret Chem & Phys, Inst Nat & Math Sci, Auckland 0632, New Zealand; [Ng, Jin; Brimble, Margaret A.; Birch, Nigel P.] Brain Res New Zealand Rangahau Roro Aotearoa, Auckland 1010, New Zealand; [Ng, Jin; Brimble, Margaret A.; Birch, Nigel P.] Ctr Brain Res, Auckland 1010, New Zealand; [Collier, Thomas; Brooks, Anna E. S.; Allison, Jane R.; Brimble, Margaret A.] Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand	University of Auckland; University of Auckland; University of Auckland; Massey University; University of Auckland	Ng, J; Hickey, A (corresponding author), Univ Auckland, Sch Biol Sci, 3A Symonds St, Auckland 1010, New Zealand.; Ng, J (corresponding author), Brain Res New Zealand Rangahau Roro Aotearoa, Auckland 1010, New Zealand.; Ng, J (corresponding author), Ctr Brain Res, Auckland 1010, New Zealand.	jin.ng@auckland.ac.nz; a.hickey@auckland.ac.nz		Brooks, Anna/0000-0003-3551-6982; Brimble, Margaret/0000-0002-7086-4096; Ng, Jin Yang/0000-0003-0516-7208	Brain Research New Zealand Rangahau Roro Aotearoa; University of Auckland Faculty Research Development Fund; Lottery Grants Board	Brain Research New Zealand Rangahau Roro Aotearoa; University of Auckland Faculty Research Development Fund; Lottery Grants Board	This work was supported by grants from Brain Research New Zealand Rangahau Roro Aotearoa, the University of Auckland Faculty Research Development Fund, the Lottery Grants Board. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Ahmed N, 2005, J NEUROCHEM, V92, P255, DOI 10.1111/j.1471-4159.2004.02864.x; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Case D. A., 2012, AMBER 12; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Castellani RJ, 2001, FREE RADICAL BIO MED, V31, P175, DOI 10.1016/S0891-5849(01)00570-6; Cheignon C, 2018, REDOX BIOL, V14, P450, DOI 10.1016/j.redox.2017.10.014; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Emendato A, 2018, J BIOL CHEM, V293, P13100, DOI 10.1074/jbc.RA118.002275; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9; Fica-Contreras SM, 2017, J BIOL INORG CHEM, V22, P1211, DOI 10.1007/s00775-017-1497-5; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Grimm A, 2017, J NEUROCHEM, V143, P418, DOI 10.1111/jnc.14037; Gruber P, 2005, J PEPT RES, V66, P111, DOI 10.1111/j.1399-3011.2005.00279.x; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaur H, 2016, ACCOUNTS CHEM RES, V49, P2199, DOI 10.1021/acs.accounts.6b00366; Kerr JS, 2017, TRENDS NEUROSCI, V40, P151, DOI 10.1016/j.tins.2017.01.002; Kimura T, 1996, NEUROSCI LETT, V208, P53, DOI 10.1016/0304-3940(96)12537-4; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; Kuhla B, 2005, ANN NY ACAD SCI, V1043, P211, DOI 10.1196/annals.1333.026; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lemkul JA, 2010, J PHYS CHEM B, V114, P1652, DOI 10.1021/jp9110794; Li XH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.180; Lin CY, 2018, CLIN BIOCHEM, V56, P75, DOI 10.1016/j.clinbiochem.2018.04.009; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Martinez-Vicente M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00064; Meisl G, 2017, CHEM SCI, V8, P7087, DOI 10.1039/c7sc01965c; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mungarro-Menchaca X, 2002, J NEUROSCI RES, V68, P89, DOI 10.1002/jnr.10193; Nash A, 2018, J MOL MODEL, V24, DOI 10.1007/s00894-017-3530-6; Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200; Pamplona R, 2002, FREE RADICAL RES, V36, P47, DOI 10.1080/10715760210165; PATEY GN, 1973, CHEM PHYS LETT, V21, P297, DOI 10.1016/0009-2614(73)80139-3; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Ryan TM, 2013, PEERJ, V1, DOI 10.7717/peerj.73; Sasaki N, 1998, AM J PATHOL, V153, P1149, DOI 10.1016/S0002-9440(10)65659-3; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P473, DOI 10.1021/cn3000247; SMITH MA, 1994, P NATL ACAD SCI USA, V91, P5710, DOI 10.1073/pnas.91.12.5710; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Takeda T, 2009, J PHYS CHEM B, V113, P6692, DOI 10.1021/jp9016773; Takeuchi M, 2008, CURR PHARM DESIGN, V14, P973, DOI 10.2174/138161208784139693; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Valente T, 2010, NEUROBIOL DIS, V37, P67, DOI 10.1016/j.nbd.2009.09.008; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766	63	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8806	8818		10.1074/jbc.RA118.006846	http://dx.doi.org/10.1074/jbc.RA118.006846			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30996005	hybrid, Green Published			2022-12-28	WOS:000470971100016
J	Morris, MC; Mery, J; Heitz, F; Goody, RS; Divita, G				Morris, May C.; Mery, Jean; Heitz, Frederic; Goody, Roger S.; Divita, Gilles			A new potent HIV-1 reverse transcriptase inhibitor: A synthetic peptide derived from the interface subunit domains (vol 274, pg 24941, 1999)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													MORRIS, May/ABB-2629-2021; DIVITA, GILLES/AAV-9214-2021	MORRIS, May/0000-0001-8106-9728; 				Morris MC, 1999, J BIOL CHEM, V274, P24941, DOI 10.1074/jbc.274.35.24941	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6658	6658		10.1074/jbc.AAC119.008640	http://dx.doi.org/10.1074/jbc.AAC119.008640			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	31075755	hybrid, Green Published			2022-12-28	WOS:000468402000039
J	Admiraal, SJ; Eyler, DE; Baldwin, MR; Brines, EM; Lohans, CT; Schofield, CJ; O'Brien, PJ				Admiraal, Suzanne J.; Eyler, Daniel E.; Baldwin, Michael R.; Brines, Emily M.; Lohans, Christopher T.; Schofield, Christopher J.; O'Brien, Patrick J.			Expansion of base excision repair compensates for a lack of DNA repair by oxidative dealkylation in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						base excision repair (BER); DNA repair; Saccharomyces cerevisiae; translation regulation; DNA damage; hydroxylase; AlkA; AlkB; Mag1; oxidative dealkylation; Tpa1	SACCHAROMYCES-CEREVISIAE TPA1; ESCHERICHIA-COLI; 3-METHYLADENINE DNA; TRANSLATION TERMINATION; CONTROLS SENSITIVITY; GLYCOSYLASE; ALKB; GENE; 1,N-6-ETHENOADENINE; PROTEIN	The Mag1 and Tpa1 proteins from budding yeast (Saccharomyces cerevisiae) have both been reported to repair alkylation damage in DNA. Mag1 initiates the base excision repair pathway by removing alkylated bases from DNA, and Tpa1 has been proposed to directly repair alkylated bases as does the prototypical oxidative dealkylase AlkB from Escherichia coli. However, we found that in vivo repair of methyl methanesulfonate (MMS)-induced alkylation damage in DNA involves Mag1 but not Tpa1. We observed that yeast strains without tpa1 are no more sensitive to MMS than WT yeast, whereas mag1-deficient yeast are similar to 500-fold more sensitive to MMS. We therefore investigated the substrate specificity of Mag1 and found that it excises alkylated bases that are known AlkB substrates. In contrast, purified recombinant Tpa1 did not repair these alkylated DNA substrates, but it did exhibit the prolyl hydroxylase activity that has also been ascribed to it. A comparison of several of the kinetic parameters of Mag1 and its E. coli homolog AlkA revealed that Mag1 catalyzes base excision from known AlkB substrates with greater efficiency than does AlkA, consistent with an expanded role of yeast Mag1 in repair of alkylation damage. Our results challenge the proposal that Tpa1 directly functions in DNA repair and suggest that Mag1-initiated base excision repair compensates for the absence of oxidative dealkylation of alkylated nucleobases in budding yeast. This expanded role of Mag1, as compared with alkylation repair glycosylases in other organisms, could explain the extreme sensitivity of Mag1-deficient S. cerevisiae toward alkylation damage.	[Admiraal, Suzanne J.; Eyler, Daniel E.; Baldwin, Michael R.; Brines, Emily M.; O'Brien, Patrick J.] Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Lohans, Christopher T.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England; [Eyler, Daniel E.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Oxford; University of Michigan System; University of Michigan	O'Brien, PJ (corresponding author), Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA.	pjobrien@umich.edu		Brines, Emily/0000-0001-6754-3470; Admiraal, Suzanne/0000-0003-3334-2499; Lohans, Christopher/0000-0003-1094-0349; Schofield, Christopher/0000-0002-0290-6565	National Science Foundation [MCB-1615586]; Wellcome Trust; Cancer Research UK; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Science Foundation Grant MCB-1615586 (to P. J. O.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Wellcome Trust and Cancer Research UK.	Aamodt RM, 2004, J BIOL CHEM, V279, P13601, DOI 10.1074/jbc.M314277200; Adhikary S, 2011, EMBO REP, V12, P1286, DOI 10.1038/embor.2011.189; Admiraal SJ, 2015, BIOCHEMISTRY-US, V54, P1849, DOI 10.1021/bi501491z; [Anonymous], 2000, GENOME BIOL, DOI DOI 10.1186/GB-2000-1-4-RESEARCH0007; Baldwin MR, 2012, NUCLEIC ACIDS RES, V40, P11638, DOI 10.1093/nar/gks952; BERDAL KG, 1990, EMBO J, V9, P4563, DOI 10.1002/j.1460-2075.1990.tb07909.x; Bjelland S, 1996, FEBS LETT, V397, P127, DOI 10.1016/S0014-5793(96)01166-0; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Brachmann CB, 1998, YEAST, V14, P115; CHEN J, 1989, P NATL ACAD SCI USA, V86, P7961, DOI 10.1073/pnas.86.20.7961; CHEN J, 1990, EMBO J, V9, P4569, DOI 10.1002/j.1460-2075.1990.tb07910.x; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Fedeles BI, 2015, J BIOL CHEM, V290, P20734, DOI 10.1074/jbc.R115.656462; Fersht A., 1999, STRUCTURE MECH PROTE, P103; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hedderich R, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P1050, DOI 10.1007/0-387-30742-7_34; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Henri J, 2010, J BIOL CHEM, V285, P30767, DOI 10.1074/jbc.M110.106864; Holland PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008680; Horita S, 2015, STRUCTURE, V23, P639, DOI 10.1016/j.str.2015.01.014; Iyer LM, 2001, GENOME BIOL, V2; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Keeling KM, 2006, MOL CELL BIOL, V26, P5237, DOI 10.1128/MCB.02448-05; Kim HS, 2010, NUCLEIC ACIDS RES, V38, P2099, DOI 10.1093/nar/gkp1151; Leiros I, 2007, EMBO J, V26, P2206, DOI 10.1038/sj.emboj.7601662; Lhomme J, 1999, BIOPOLYMERS, V52, P65, DOI 10.1002/1097-0282(1999)52:2<65::AID-BIP1>3.0.CO;2-U; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Lutsenko E, 1999, J BIOL CHEM, V274, P31034, DOI 10.1074/jbc.274.43.31034; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Moe E, 2012, ACTA CRYSTALLOGR D, V68, P703, DOI 10.1107/S090744491200947X; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shi RX, 2018, EMBO J, V37, P63, DOI 10.15252/embj.201797833; Shivange G, 2014, J BIOL CHEM, V289, P35939, DOI 10.1074/jbc.M114.590216; Singer B., 1983, MOL BIOL MUTAGENS CA, P45; Singleton RS, 2014, P NATL ACAD SCI USA, V111, P4031, DOI 10.1073/pnas.1314482111; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tang Q, 2017, ACS OMEGA, V2, P8205, DOI 10.1021/acsomega.7b01482; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; van den Born E, 2009, NUCLEIC ACIDS RES, V37, P7124, DOI 10.1093/nar/gkp774; VOLKERT MR, 1991, MOL GEN GENET, V229, P319, DOI 10.1007/BF00272173; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; YAMAMOTO Y, 1978, J BACTERIOL, V135, P144, DOI 10.1128/JB.135.1.144-152.1978; Zdzalik D, 2015, DNA REPAIR, V30, P1, DOI 10.1016/j.dnarep.2015.02.021	50	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13629	13637		10.1074/jbc.RA119.009813	http://dx.doi.org/10.1074/jbc.RA119.009813			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31320474	hybrid, Green Published			2022-12-28	WOS:000486418600010
J	Cuevasanta, E; Reyes, AM; Zeida, A; Mastrogiovanni, M; De Armas, MI; Radi, R; Alvarez, B; Trujillo, M				Cuevasanta, Ernesto; Reyes, Anibal M.; Zeida, Ari; Mastrogiovanni, Mauricio; Ines De Armas, Maria; Radi, Rafael; Alvarez, Beatriz; Trujillo, Madia			Kinetics of formation and reactivity of the persulfide in the one-cysteine peroxiredoxin from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen sulfide; Mycobacterium tuberculosis; peroxiredoxin; antioxidant; enzyme kinetics; alkyl hydroperoxide reductase E; hydrodisulfide; persulfide; signaling compound; sulfenic acid	HYDROGEN-SULFIDE METABOLISM; SULFENIC ACID; MECHANISTIC INSIGHTS; OXIDATIVE STRESS; SULFUR; PEROXIDE; PEROXYNITRITE; THIOL; HYDROPEROXIDE; MYCOTHIOL	Hydrogen sulfide (H2S) participates in prokaryotic metabolism and is associated with several physiological functions in mammals. H2S reacts with oxidized thiol derivatives (i.e. disulfides and sulfenic acids) and thereby forms persulfides, which are plausible transducers of the H2S-mediated signaling effects. The one-cysteine peroxiredoxin alkyl hydroperoxide reductase E from Mycobacterium tuberculosis (MtAhpE-SH) reacts fast with hydroperoxides, forming a stable sulfenic acid (MtAhpE-SOH), which we chose here as a model to study the interactions between H2S and peroxiredoxins (Prx). MtAhpE-SOH reacted with H2S, forming a persulfide (MtAhpE-SSH) detectable by mass spectrometry. The rate constant for this reaction was (1.4 +/- 0.2) x 10(3) M-1 s(-1) (pH 7.4, 25 degrees C), six times higher than that reported for the reaction with the main low-molecular-weight thiol in M. tuberculosis, mycothiol. H2S was able to complete the catalytic cycle of MtAhpE and, according to kinetic considerations, it could represent an alternative substrate in M. tuberculosis. MtAhpE-SSH reacted 43 times faster than did MtAhpE-SH with the unspecific electrophile 4,4 '-dithiodipyridine, a disulfide that exhibits no preferential reactivity with peroxidatic cysteines, but MtAhpE-SSH was less reactive toward specific Prx substrates such as hydrogen peroxide and peroxynitrite. According to molecular dynamics simulations, this loss of specific reactivity could be explained by alterations in the MtAhpE active site. MtAhpE-SSH could transfer its sulfane sulfur to a low-molecular-weight thiol, a process likely facilitated by the low pK(a) of the leaving thiol MtAhpE-SH, highlighting the possibility that Prx participates in transpersulfidation. The findings of our study contribute to the understanding of persulfide formation and reactivity.	[Cuevasanta, Ernesto; Alvarez, Beatriz] Univ Republica, Lab Enzimol, Inst Quim Biol, Montevideo, Uruguay; [Cuevasanta, Ernesto] Univ Republica, Unidad Bioquim Analit, Ctr Invest Nucl, Fac Ciencias, Montevideo, Uruguay; [Reyes, Anibal M.; Zeida, Ari; Mastrogiovanni, Mauricio; Ines De Armas, Maria; Radi, Rafael; Trujillo, Madia] Univ Republica, Dept Bioquim, Fac Med, Montevideo 11800, Uruguay; [Cuevasanta, Ernesto; Reyes, Anibal M.; Zeida, Ari; Mastrogiovanni, Mauricio; Ines De Armas, Maria; Radi, Rafael; Alvarez, Beatriz; Trujillo, Madia] Univ Republica, Ctr Invest Biomed CEINBIO, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Reyes, AM (corresponding author), Univ Republica, Dept Bioquim, Fac Med, Montevideo 11800, Uruguay.; Cuevasanta, E (corresponding author), Univ Republica, Inst Quim Biol, Lab Enzimol, Fac Ciencias, Montevideo 11400, Uruguay.	ecuevasanta@fcien.edu.uy; marceloreyes@fmed.edu.uy		Alvarez, Beatriz/0000-0001-6911-3132; Trujillo, Madia/0000-0003-2087-017X; Zeida, Ari/0000-0003-0938-287X; Reyes, Anibal M./0000-0003-3911-4649	Comision Sectorial de Investigacion Cientifica (CSIC); CSIC I + [D2016]; Fondo Vaz Ferreira MEC; PEDECIBA; Comision Academica de Posgrado (CAP, Universidad de la Republica); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA, Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII); Universidad de la Republica	Comision Sectorial de Investigacion Cientifica (CSIC); CSIC I +; Fondo Vaz Ferreira MEC; PEDECIBA; Comision Academica de Posgrado (CAP, Universidad de la Republica); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA, Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII); Universidad de la Republica	This work was supported in part by grants from Comision Sectorial de Investigacion Cientifica (CSIC, Universidad de la Republica) CSIC-Iniciacion 2015 (to E. C. and A. M. R.), CSIC I + D2016 (to B. A.), CSIC I + D2016 (to M. T.), CSIC Grupos 2014 and 2018 (to E. C. and B. A.), CSIC Grupos 2014 and 2018 (to R. R.), CSIC Centros Interdisciplinarios 2015 (to R. R.), Fondo Vaz Ferreira MEC, I/FVF2017/069 (to E. C.), and I/FVF2017/185 (to A. Z.), and by funding from PEDECIBA. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of fellowships from Comision Academica de Posgrado (CAP, Universidad de la Republica) and Programa de Desarrollo de las Ciencias Basicas (PEDECIBA, Uruguay).; Recipient of postdoctoral fellowship funding from Agencia Nacional de Investigacion e Innovacion (ANII) and Universidad de la Republica.	Abe K, 1996, J NEUROSCI, V16, P1066; Abhishek S, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00330; Alvarez B, 2004, FREE RADICAL BIO MED, V37, P813, DOI 10.1016/j.freeradbiomed.2004.06.006; Artaud I, 2014, CHEMBIOCHEM, V15, P2361, DOI 10.1002/cbic.201402312; Bailey TS, 2014, J AM CHEM SOC, V136, P10573, DOI 10.1021/ja505371z; Bestetti S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5770; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Bibli SI, 2018, REDOX BIOL, V18, P295, DOI 10.1016/j.redox.2018.07.016; BOHLE DS, 1994, J AM CHEM SOC, V116, P7423, DOI 10.1021/ja00095a062; Bonanata J, 2017, FREE RADICAL BIO MED, V108, P952, DOI 10.1016/j.freeradbiomed.2017.04.021; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Chen W, 2013, CHEM SCI, V4, P2892, DOI 10.1039/c3sc50754h; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Cuevasanta E, 2017, ARCH BIOCHEM BIOPHYS, V617, P9, DOI 10.1016/j.abb.2016.09.018; Cuevasanta E, 2015, J BIOL CHEM, V290, P26866, DOI 10.1074/jbc.M115.672816; Cuevasanta E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034562; Cumming BM, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0019-2013; Doka E, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500968; Espenson J. H., 1995, CHEM KINETICS REACTI, P46; EVERETT SA, 1994, FREE RADICAL RES, V20, P387, DOI 10.3109/10715769409145638; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; Flohe L, 2002, ARCH BIOCHEM BIOPHYS, V397, P324, DOI 10.1006/abbi.2001.2688; Francoleon NE, 2011, ARCH BIOCHEM BIOPHYS, V516, P146, DOI 10.1016/j.abb.2011.09.015; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; Greiner R, 2013, ANTIOXID REDOX SIGN, V19, P1749, DOI 10.1089/ars.2012.5041; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hall A, 2010, J MOL BIOL, V402, P194, DOI 10.1016/j.jmb.2010.07.022; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; HOFFMANN MR, 1977, ENVIRON SCI TECHNOL, V11, P61, DOI 10.1021/es60124a004; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Hughes MN, 2009, FREE RADICAL BIO MED, V47, P1346, DOI 10.1016/j.freeradbiomed.2009.09.018; Hugo M, 2014, J BIOL CHEM, V289, P5228, DOI 10.1074/jbc.M113.510248; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; JENCKS WP, 1960, J BIOL CHEM, V235, P3608; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; Kumar A, 2017, BBA-GEN SUBJECTS, V1861, P2354, DOI 10.1016/j.bbagen.2017.05.007; Kumar A, 2016, FREE RADICAL BIO MED, V97, P588, DOI 10.1016/j.freeradbiomed.2016.07.007; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Li S, 2005, J MOL BIOL, V346, P1035, DOI 10.1016/j.jmb.2004.12.046; Libiad M, 2018, J BIOL CHEM, V293, P2675, DOI 10.1074/jbc.RA117.000826; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Loumaye E, 2011, ARCH BIOCHEM BIOPHYS, V514, P1, DOI 10.1016/j.abb.2011.07.002; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Nagahara N, 2012, ANTIOXID REDOX SIGN, V16, P747, DOI 10.1089/ars.2011.4468; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Nambi S, 2015, CELL HOST MICROBE, V17, P829, DOI 10.1016/j.chom.2015.05.008; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Alvarez MN, 2011, J BIOL CHEM, V286, P6627, DOI 10.1074/jbc.M110.167247; Nzungize L, 2019, J DRUG TARGET, V27, P1004, DOI 10.1080/1061186X.2019.1579820; Pal VK, 2018, IUBMB LIFE, V70, P393, DOI 10.1002/iub.1740; Pan J, 2013, ACS CHEM BIOL, V8, P1110, DOI 10.1021/cb4001052; Peshenko IV, 2001, FREE RADICAL BIO MED, V31, P292, DOI 10.1016/S0891-5849(01)00579-2; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Piacenza L, 2019, J EXP MED, V216, P501, DOI 10.1084/jem.20181886; Poole Leslie B., 2007, V44, P61; Portillo-Ledesma S, 2018, BIOCHEMISTRY-US, V57, P3416, DOI 10.1021/acs.biochem.8b00188; Portillo-Ledesma S, 2014, BIOCHEMISTRY-US, V53, P6113, DOI 10.1021/bi500389m; Randall LM, 2013, METHOD ENZYMOL, V527, P41, DOI 10.1016/B978-0-12-405882-8.00003-9; Reyes AM, 2016, FREE RADICAL BIO MED, V101, P249, DOI 10.1016/j.freeradbiomed.2016.10.005; Reyes AM, 2011, FREE RADICAL BIO MED, V51, P464, DOI 10.1016/j.freeradbiomed.2011.04.023; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Soito L, 2011, NUCLEIC ACIDS RES, V39, pD332, DOI 10.1093/nar/gkq1060; Toohey JI, 2011, ANAL BIOCHEM, V413, P1, DOI 10.1016/j.ab.2011.01.044; Trujillo M, 2008, ANTIOXID REDOX SIGN, V10, P1607, DOI 10.1089/ars.2008.2060; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Ubuka T, 2002, J CHROMATOGR B, V781, P227, DOI 10.1016/S1570-0232(02)00623-2; van Bergen LAH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30369; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wedmann R, 2016, CHEM SCI, V7, P3414, DOI 10.1039/c5sc04818d; Wheeler PR, 2005, J BIOL CHEM, V280, P8069, DOI 10.1074/jbc.M412540200; Wilkins MR, 1999, METH MOL B, V112, P531; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wright CM, 2006, CHEM COMMUN, P3104, DOI 10.1039/b604040c; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Zeida A, 2015, BIOCHEMISTRY-US, V54, P7237, DOI 10.1021/acs.biochem.5b00758; Zeida A, 2014, CHEM COMMUN, V50, P10070, DOI 10.1039/c4cc02899f; Zhang DH, 2014, ANGEW CHEM INT EDIT, V53, P575, DOI 10.1002/anie.201305876	95	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13593	13605		10.1074/jbc.RA119.008883	http://dx.doi.org/10.1074/jbc.RA119.008883			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31311857	Green Published, hybrid			2022-12-28	WOS:000486418600007
J	Tan, SY; Li, JQ; Cheng, HY; Li, ZF; Lan, Y; Zhang, TT; Yang, ZC; Li, WJ; Qi, T; Qiu, YR; Chen, ZP; Li, L; Liu, SW				Tan, Suiyi; Li, Jin-Qing; Cheng, Hongyan; Li, Zhaofeng; Lan, Yan; Zhang, Ting-Ting; Yang, Zi-Chao; Li, Wenjuan; Qi, Tao; Qiu, Yu-Rong; Chen, Zhipeng; Li, Lin; Liu, Shu-wen			The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); amyloid; antiviral agent; inhibitor; fibril; ADS-J1; semen; semen-derived enhancer of viral infection (SEVI); sexual transmission; suramin	MEDIATED ENHANCEMENT; GENITAL INFLAMMATION; HIGH-THROUGHPUT; VIRUS TYPE-1; BINDING; MICROBICIDE; ACQUISITION; ANTAGONIST; PROTEINS; GP120	Seminal amyloid fibrils are made up of naturally occurring peptide fragments and are key targets for the development of combination microbicides or antiviral drugs. Previously, we reported that the polysulfonic compound ADS-J1 is a potential candidate microbicide that not only inhibits HIV-1 entry, but also seminal fibrils. However, the carcinogenic azo moieties in ADS-J1 preclude its clinical application. Here, we screened several ADS-J1-like analogs and found that the antiparasitic drug suramin most potently inhibited seminal amyloid fibrils. Using various biochemical methods, including Congo red staining, CD analysis, transmission EM, viral infection assays, surface plasmon resonance imaging, and molecular dynamics simulations, we investigated suramin's inhibitory effects and its putative mechanism of action. We found that by forming a multivalent interaction, suramin binds to proteolytic peptides and mature fibrils, thereby inhibiting seminal fibril formation and blocking fibril-mediated enhancement of viral infection. Of note, suramin exhibited potent anti-HIV activities, and combining suramin with several antiretroviral drugs produced synergistic effects against HIV-1 in semen. Suramin also displayed a good safety profile for vaginal application. Moreover, suramin inhibited the semen-derived enhancer of viral infection (SEVI)/semen-mediated enhancement of HIV-1 transcytosis through genital epithelial cells and the subsequent infection of target cells. Collectively, suramin has great potential for further development as a combination microbicide to reduce the spread of the AIDS pandemic by targeting both viral and host factors involved in HIV-1 sexual transmission.	[Tan, Suiyi; Li, Jin-Qing; Cheng, Hongyan; Li, Zhaofeng; Lan, Yan; Zhang, Ting-Ting; Yang, Zi-Chao; Li, Wenjuan; Chen, Zhipeng; Li, Lin; Liu, Shu-wen] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Guangdong, Peoples R China; [Qi, Tao; Qiu, Yu-Rong] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Liu, SW (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Guangdong, Peoples R China.	liusw@smu.edu.cn	LI, LI/GVS-5344-2022; Li, Wenjuan/GRR-3618-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022	Li, Wenjuan/0000-0002-2231-7338; Liu, Shuwen/0000-0001-6346-5006	Pearl River S&T Nova Program of Guangzhou Grant [201610010132]; Program for Outstanding Young Teacher in Guangdong Province [YQ2015039]; Natural Science Foundation of China [81772194, 81773787]; Natural Science Foundation of Guangdong Province [2017A030313598, 2015A030313241]	Pearl River S&T Nova Program of Guangzhou Grant; Program for Outstanding Young Teacher in Guangdong Province; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by Pearl River S&T Nova Program of Guangzhou Grant 201610010132, the Program for Outstanding Young Teacher in Guangdong Province Grant YQ2015039, Natural Science Foundation of China Grants 81772194 (to S. T.) and 81773787 (to S. L.), and Natural Science Foundation of Guangdong Province Grants 2017A030313598 and 2015A030313241. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar JS, 1999, VIROLOGY, V258, P141, DOI 10.1006/viro.1999.9723; Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016; Alexandre KB, 2016, VIROLOGY, V497, P69, DOI 10.1016/j.virol.2016.07.004; Anderson DJ, 2014, J INFECT DIS, V210, pS648, DOI 10.1093/infdis/jiu537; Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11; Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Capule CC, 2012, J AM CHEM SOC, V134, P905, DOI 10.1021/ja210931b; CHESON BD, 1987, JAMA-J AM MED ASSOC, V258, P1347, DOI 10.1001/jama.258.10.1347; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DECLERCQ E, 1979, CANCER LETT, V8, P9, DOI 10.1016/0304-3835(79)90017-X; Dupre TV, 2016, AM J PHYSIOL-RENAL, V310, pF248, DOI 10.1152/ajprenal.00433.2015; Henss L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0607-2; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kohli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098077; Koval A, 2016, BIOCHEM J, V473, P371, DOI 10.1042/BJ20150913; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Li HP, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0196-y; Liu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036194; LoRicco JG, 2016, J BIOL CHEM, V291, P14045, DOI 10.1074/jbc.M116.718684; Lump E, 2015, ELIFE, V4, DOI 10.7554/eLife.05397; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; McKinnon LR, 2018, NAT MED, V24, P491, DOI 10.1038/nm.4506; MITSUYA H, 1984, SCIENCE, V226, P172, DOI 10.1126/science.6091268; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Nanga RPR, 2009, J AM CHEM SOC, V131, P17972, DOI 10.1021/ja908170s; Naviaux RK, 2017, ANN CLIN TRANSL NEUR, V4, P491, DOI 10.1002/acn3.424; Olsen JS, 2010, J BIOL CHEM, V285, P35488, DOI 10.1074/jbc.M110.163659; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ren PJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42902; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Sahu D, 2017, EUR J PHARM SCI, V101, P125, DOI 10.1016/j.ejps.2017.02.013; SCHOLS D, 1990, VIROLOGY, V175, P556, DOI 10.1016/0042-6822(90)90440-3; Smith-McCune K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129769; Tan SY, 2014, LAB INVEST, V94, P777, DOI 10.1038/labinvest.2014.72; Tan SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059777; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Usmani SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4508; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Xu W, 2014, JAIDS-J ACQ IMM DEF, V67, P1, DOI 10.1097/QAI.0000000000000265; Xun TR, 2015, ANTIMICROB AGENTS CH, V59, P5123, DOI 10.1128/AAC.00385-15; YAHI N, 1994, J BIOL CHEM, V269, P24349; Yang J, 2012, AIDS RES HUM RETROV, V28, P1498, DOI [10.1089/AID.2012.0084, 10.1089/aid.2012.0084]; Zhao Q, 2002, AIDS RES HUM RETROV, V18, P989, DOI 10.1089/08892220260235353; Zirafi O, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009634	47	4	6	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13740	13754		10.1074/jbc.RA118.006797	http://dx.doi.org/10.1074/jbc.RA118.006797			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31346035	hybrid, Green Published			2022-12-28	WOS:000486418600019
J	Dutta, S; Aoki, K; Doungkamchan, K; Tiemeyer, M; Bovin, N; Miller, DJ				Dutta, Sudipta; Aoki, Kazuhiro; Doungkamchan, Kankanit; Tiemeyer, Michael; Bovin, Nicolai; Miller, David J.			Sulfated Lewis A trisaccharide on oviduct membrane glycoproteins binds bovine sperm and lengthens sperm lifespan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; lectin; sperm; fertilization; glycomics; cell adhesion; cell death; Lewis structure; oviduct; receptors	SEMINAL PLASMA-PROTEINS; PORCINE SPERM; ESTROUS-CYCLE; MOUSE SPERM; BULL SPERM; IN-VITRO; TRANSPORT; SPERMATOZOA; STORAGE; CELL	A fraction of sperm deposited at mating or insemination reaches the oviduct isthmus, where sperm are retained and thereby form a reservoir. This reservoir delays capacitation, prevents polyspermy, selects a fertile population of sperm, and, foremost, increases sperm lifespan. The molecular interactions underlying the formation of a sperm reservoir are becoming clearer in mammals. Sperm lectins bind to oviductal glycans to form the reservoir. Herein, we found that the highest percentage of bovine sperm bound to the 3'-O-sulfated form of Lewis A (suLe(A)) trisaccharide and sialylated Lewis A and that fluoresceinated versions of each localized to receptors on the anterior head of the sperm. Following capacitation, binding to suLe(A) decreased significantly, a potential explanation for sperm release from the reservoir. MS and immunohistochemistry analyses indicated that suLe(A) motifs were present predominantly on O-linked glycans initiated by GalNAc residues, but no sialylated Lewis A was detected. To determine whether sperm binding to isolated suLe(A) in vitro could mimic in vivo sperm binding to oviduct cells and increase sperm longevity, we immobilized suLe(A) and incubated it with sperm. Using free-swimming sperm and sperm bound to immobilized laminin as controls, we observed that over 96 h, the viability of free-swimming sperm decreased to 10%, and that of sperm bound to immobilized laminin decreased to about 50%, whereas viability of sperm bound to immobilized suLe(A) was highest throughout the incubation and 60% at 96 h. These results indicate that bovine sperm binding to oviduct suLe(A) retains sperm for reservoir formation and extends sperm lifespan.	[Dutta, Sudipta; Doungkamchan, Kankanit; Miller, David J.] Univ Illinois, Dept Anim Sci, 1207 W Gregory Dr, Urbana, IL 61801 USA; [Aoki, Kazuhiro; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Bovin, Nicolai] Shemyakin Inst Bioorgan Chem, Moscow 117997, Russia; [Dutta, Sudipta] Univ Nebraska Med Ctr, Dept Obstet & Gynecol, Omaha, NE 68198 USA	University of Illinois System; University of Illinois Urbana-Champaign; University System of Georgia; University of Georgia; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of Nebraska System; University of Nebraska Medical Center	Miller, DJ (corresponding author), Univ Illinois, Dept Anim Sci, 1207 W Gregory Dr, Urbana, IL 61801 USA.	djmille@illinois.edu	Bovin, Nicolai/P-2948-2017; Miller, David J/ABC-2156-2020	Bovin, Nicolai/0000-0001-8669-4477; Miller, David J/0000-0001-7147-5546; dutta, sudipta/0000-0001-5272-288X; Aoki, Kazuhiro/0000-0003-0029-4291	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture [2015-67015-23228]; National Science Foundation [1450227]; National Institutes of Health (NIH) [R21AI129873]; NIGMS, NIH [P41GM103490]; Russian Science Foundation [14-50-00131]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI129873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by Agriculture and Food Research Initiative Competitive Grant 2015-67015-23228 from the United States Department of Agriculture National Institute of Food and Agriculture and National Science Foundation Grant 1450227 (to D. J. M.); National Institutes of Health (NIH) Common Fund Grant R21AI129873 (to K. A.); NIGMS, NIH, Grant P41GM103490 (to M. T.); and Russian Science Foundation Grant 14-50-00131 (to N. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMANN RP, 1974, J DAIRY SCI, V57, P212, DOI 10.3168/jds.S0022-0302(74)84862-9; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Astorgues-Xerri L, 2014, CANCER TREAT REV, V40, P307, DOI 10.1016/j.ctrv.2013.07.007; Bao R, 2013, P NATL ACAD SCI USA, V110, P1065, DOI 10.1073/pnas.1212431110; Belardi B, 2012, J AM CHEM SOC, V134, P9549, DOI 10.1021/ja301694s; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Boccuto L, 2014, HUM MOL GENET, V23, P418, DOI 10.1093/hmg/ddt434; Chang HX, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096578; Clark GF, 2006, J BIOL CHEM, V281, P13853, DOI 10.1074/jbc.R600001200; Curtis MP, 2012, J THEOR BIOL, V309, P1, DOI 10.1016/j.jtbi.2012.05.035; Damerell David, 2015, Methods Mol Biol, V1273, P3, DOI 10.1007/978-1-4939-2343-4_1; DEMOTT RP, 1995, BIOL REPROD, V52, P1395, DOI 10.1095/biolreprod52.6.1395; ELLINGTON JE, 1993, ARCH ANDROLOGY, V31, P79, DOI 10.3109/01485019308988384; Elliott RMA, 2009, REPRODUCTION, V137, P191, DOI 10.1530/REP-08-0298; Fan JJ, 2006, GENE, V375, P63, DOI 10.1016/j.gene.2006.02.025; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Galanina O, 2001, SPECTROCHIM ACTA A, V57, P2285, DOI 10.1016/S1386-1425(01)00478-4; Galanina OE, 1998, ANAL BIOCHEM, V265, P282, DOI 10.1006/abio.1998.2859; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; Gwathmey TM, 2006, BIOL REPROD, V75, P501, DOI 10.1095/biolreprod.106.053306; HARPER MJK, 1973, BIOL REPROD, V8, P441, DOI 10.1093/biolreprod/8.4.441; Holt WV, 2016, ANNU REV ANIM BIOSCI, V4, P291, DOI 10.1146/annurev-animal-021815-111350; Holt WV, 2005, REPROD FERT DEVELOP, V17, P683, DOI 10.1071/RD05070; HUNTER RHF, 1981, J REPROD FERTIL, V63, P109, DOI 10.1530/jrf.0.0630109; HUNTER RHF, 1984, REPROD NUTR DEV, V24, P597, DOI 10.1051/rnd:19840508; HUNTER RHF, 1983, J EXP ZOOL, V228, P121, DOI 10.1002/jez.1402280113; HUNTER RHF, 1971, J REPROD FERTIL, V24, P233, DOI 10.1530/jrf.0.0240233; Ignotz GG, 2001, BIOL REPROD, V64, P1806, DOI 10.1095/biolreprod64.6.1806; IRELAND JJ, 1980, J DAIRY SCI, V63, P155, DOI 10.3168/jds.S0022-0302(80)82901-8; IRELAND JJ, 1979, J ANIM SCI, V49, P1261, DOI 10.2527/jas1979.4951261x; Jaiswal RS, 2004, BIOL REPROD, V71, P1244, DOI 10.1095/biolreprod.104.030726; Kadirvel G, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103879; Kawakami E, 2001, ANIM REPROD SCI, V68, P121, DOI 10.1016/S0378-4320(01)00135-X; Kumagai T, 2013, ANAL CHEM, V85, P8692, DOI 10.1021/ac4015935; LEFEBVRE R, 1995, BIOL REPROD, V53, P1066, DOI 10.1095/biolreprod53.5.1066; Lefebvre R, 1997, BIOL REPROD, V56, P1198, DOI 10.1095/biolreprod56.5.1198; Machado SA, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119503; MANJUNATH P, 1987, BIOSCIENCE REP, V7, P231, DOI 10.1007/BF01124794; Miles EL, 2013, P NATL ACAD SCI USA, V110, P6334, DOI 10.1073/pnas.1220910110; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Nix DB, 2014, JOVE-J VIS EXP, DOI 10.3791/51840; OVERSTREET JW, 1978, BIOL REPROD, V19, P115, DOI 10.1095/biolreprod19.1.115; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Patnode ML, 2013, GLYCOBIOLOGY, V23, P381, DOI 10.1093/glycob/cws166; POLLARD JW, 1991, BIOL REPROD, V44, P102, DOI 10.1095/biolreprod44.1.102; Rodriguez-Martinez H, 2007, THERIOGENOLOGY, V68, pS138, DOI 10.1016/j.theriogenology.2007.03.018; Rodriguez-Martinez H, 2005, THERIOGENOLOGY, V63, P514, DOI 10.1016/j.theriogenology.2004.09.028; Sabeur K, 2007, ANIM REPROD SCI, V101, P74, DOI 10.1016/j.anireprosci.2006.08.028; Seppo A, 2000, EUR J BIOCHEM, V267, P3549, DOI 10.1046/j.1432-1327.2000.01383.x; SUAREZ S, 1991, BIOL REPROD, V44, P998, DOI 10.1095/biolreprod44.6.998; Suarez SS, 2001, CELLS TISSUES ORGANS, V168, P105, DOI 10.1159/000016811; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 1998, BIOL REPROD, V59, P39, DOI 10.1095/biolreprod59.1.39; SUAREZ SS, 1987, J EXP ZOOL, V244, P331, DOI 10.1002/jez.1402440218; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Suarez SS, 2016, CELL TISSUE RES, V363, P185, DOI 10.1007/s00441-015-2244-2; Teijeiro JM, 2011, BIOL RES, V44, P329, DOI /S0716-97602011000400003; Teijeiro JM, 2012, REPRODUCTION, V143, P773, DOI 10.1530/REP-11-0314; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Topfer-Petersen E, 2008, INT J DEV BIOL, V52, P717, DOI 10.1387/ijdb.072536et; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Waberski D, 2006, REPRODUCTION, V131, P311, DOI 10.1530/rep.1.00814; Wagner A, 2002, MOL REPROD DEV, V61, P249, DOI 10.1002/mrd.1154; Wells L, 2013, MOL CELL PROTEOMICS, V12, P833, DOI 10.1074/mcp.E113.027904; Williams E, 2016, TRANSFUSION, V56, P325, DOI 10.1111/trf.13384; YANAGIMACHI R, 1963, J REPROD FERTIL, V6, P413, DOI 10.1530/jrf.0.0060413; York WS, 2014, GLYCOBIOLOGY, V24, P402, DOI 10.1093/glycob/cwu018	69	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13445	13463		10.1074/jbc.RA119.007695	http://dx.doi.org/10.1074/jbc.RA119.007695			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31337705	hybrid, Green Published			2022-12-28	WOS:000486417200020
J	Namekata, K; Guo, XL; Kimura, A; Arai, N; Harada, C; Harada, T				Namekata, Kazuhiko; Guo, Xiaoli; Kimura, Atsuko; Arai, Nobutaka; Harada, Chikako; Harada, Takayuki			DOCK8 is expressed in microglia, and it regulates microglial activity during neurodegeneration in murine disease models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microglia; guanine nucleotide exchange factor (GEF); phagocytosis; retina; neurodegeneration; multiple sclerosis; Rho (Rho GTPase); migration; DOCK8; glaucoma	MULTIPLE-SCLEROSIS; CELL-MIGRATION; AXONAL OUTGROWTH; RHO-GTPASES; MOUSE MODEL; MINOCYCLINE; ACTIVATION; DEGENERATION; INSIGHTS; SURVIVAL	Dedicator of cytokinesis 8 (DOCK8) is a guanine nucleotide exchange factor whose loss of function results in immunodeficiency, but its role in the central nervous system (CNS) has been unclear. Microglia are the resident immune cells of the CNS and are implicated in the pathogenesis of various neurodegenerative diseases, including multiple sclerosis (MS) and glaucoma, which affects the visual system. However, the exact roles of microglia in these diseases remain unknown. Herein, we report that DOCK8 is expressed in microglia but not in neurons or astrocytes and that its expression is increased during neuroinflammation. To define the role of DOCK8 in microglial activity, we focused on the retina, a tissue devoid of infiltrating T cells. The retina is divided into distinct layers, and in a disease model of MS/optic neuritis, DOCK8-deficient mice exhibited a clear reduction in microglial migration through these layers. Moreover, neuroinflammation severity, indicated by clinical scores, visual function, and retinal ganglion cell (RGC) death, was reduced in the DOCK8-deficient mice. Furthermore, using a glaucoma disease model, we observed impaired microglial phagocytosis of RGCs in DOCK8-deficient mice. Our data demonstrate that DOCK8 is expressed in microglia and regulates microglial activity in disease states. These findings contribute to a better understanding of the molecular pathways involved in microglial activation and implicate a role of DOCK8 in several neurological diseases.	[Namekata, Kazuhiko; Guo, Xiaoli; Kimura, Atsuko; Harada, Chikako; Harada, Takayuki] Tokyo Metropolitan Inst Med Sci, Visual Res Project, Tokyo 1568506, Japan; [Arai, Nobutaka] Tokyo Metropolitan Inst Med Sci, Brain Pathol Res Ctr, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science	Harada, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Visual Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	harada-tk@igakuken.or.jp		Harada, Takayuki/0000-0001-6167-0997	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16K08635, JP16K07076, JP17K07123, JP19K09943, JP15H04999, JP18K19625]; Taiju Life Social Welfare Foundation; Takeda Science Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Taiju Life Social Welfare Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants-in-aid for Scientific Research JP16K08635 (to K. N.), JP16K07076 (to X. G.), JP17K07123 (to A. K.), JP19K09943 (to C. H.), and JP15H04999 and JP18K19625 (to T. H.); the Taiju Life Social Welfare Foundation (to T. H.); and the Takeda Science Foundation (to T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Akaiwa K, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.341; Baeten DLP, 2013, NAT MED, V19, P824, DOI 10.1038/nm.3268; Baptiste DC, 2005, NEUROSCIENCE, V134, P575, DOI 10.1016/j.neuroscience.2005.04.011; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Crawford G, 2013, BLOOD, V122, P2052, DOI 10.1182/blood-2013-02-482331; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Forabosco P, 2013, NEUROBIOL AGING, V34, P2699, DOI 10.1016/j.neurobiolaging.2013.05.001; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Goldmann T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/208093; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; Guo X, 2007, NEUROSCI RES, V59, P457, DOI 10.1016/j.neures.2007.08.014; Guo XL, 2017, AM J PATHOL, V187, P2876, DOI 10.1016/j.ajpath.2017.08.012; Guo XL, 2011, INVEST OPHTH VIS SCI, V52, P2696, DOI 10.1167/iovs.10-6015; Guo XL, 2010, EMBO MOL MED, V2, P504, DOI 10.1002/emmm.201000103; Guo XL, 2009, NEUROSCI LETT, V462, P281, DOI 10.1016/j.neulet.2009.07.028; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Harada C, 2006, AM J PATHOL, V168, P261, DOI 10.2353/ajpath.2006.050765; Harada C, 2015, AM J PATHOL, V185, P3238, DOI 10.1016/j.ajpath.2015.08.005; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hilla AM, 2017, J NEUROSCI, V37, P6113, DOI 10.1523/JNEUROSCI.0584-17.2017; Inoue K, 2018, NAT REV NEUROSCI, V19, P138, DOI 10.1038/nrn.2018.2; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Janssen E, 2016, J CLIN INVEST, V126, P3837, DOI 10.1172/JCI85774; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Katome T, 2013, CELL DEATH DIFFER, V20, P270, DOI 10.1038/cdd.2012.122; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Korn T, 2008, J NEUROL, V255, P2, DOI 10.1007/s00415-008-6001-2; Krishnaswamy JK, 2015, P NATL ACAD SCI USA, V112, P3056, DOI 10.1073/pnas.1501554112; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Metz LM, 2017, NEW ENGL J MED, V376, P2122, DOI 10.1056/NEJMoa1608889; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Namekata K, 2014, PROG RETIN EYE RES, V43, P1, DOI 10.1016/j.preteyeres.2014.06.005; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Neher JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00027; Neniskyte U, 2014, FEBS LETT, V588, P2952, DOI 10.1016/j.febslet.2014.05.046; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Noro T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.93; Orlic-Milacic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091742; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Randall KL, 2011, J EXP MED, V208, P2305, DOI 10.1084/jem.20110345; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Rasmussen S, 2007, BRAIN, V130, P2816, DOI 10.1093/brain/awm219; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Ruusala A, 2004, FEBS LETT, V572, P159, DOI 10.1016/j.febslet.2004.06.095; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Sanagi T, 2010, J NEUROSCI RES, V88, P2736, DOI 10.1002/jnr.22424; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schramm A, 2015, NAT GENET, V47, P872, DOI 10.1038/ng.3349; Shimazawa M, 2005, BRAIN RES, V1053, P185, DOI 10.1016/j.brainres.2005.06.053; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Su HC, 2011, ANN NY ACAD SCI, V1246, P26, DOI 10.1111/j.1749-6632.2011.06295.x; Sutter EE, 1999, VISION RES, V39, P419, DOI 10.1016/S0042-6989(98)00161-8; THANOS S, 1991, EUR J NEUROSCI, V3, P1189, DOI 10.1111/j.1460-9568.1991.tb00054.x; Tirosh O, 2018, NAT MED, V24, P1815, DOI 10.1038/s41591-018-0211-7; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Vinci G, 2007, MOL HUM REPROD, V13, P685, DOI 10.1093/molehr/gam045; Weiner HL, 2004, ARCH NEUROL-CHICAGO, V61, P1613, DOI 10.1001/archneur.61.10.1613; Xu XY, 2017, J EXP MED, V214, P209, DOI 10.1084/jem.20160068; Yamamura K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13946; Yang HW, 2016, NAT CELL BIOL, V18, P191, DOI 10.1038/ncb3292; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Zhang Q, 2014, J EXP MED, V211, P2549, DOI 10.1084/jem.20141307; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	85	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13421	13433		10.1074/jbc.RA119.007645	http://dx.doi.org/10.1074/jbc.RA119.007645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31337702	Green Published, hybrid			2022-12-28	WOS:000486417200018
J	Choi, SH; Koh, DI; Cho, SY; Kim, MK; Kim, KS; Hur, MW				Choi, Seo-Hyun; Koh, Dong-In; Cho, Su-Yeon; Kim, Min-Kyeong; Kim, Kyung-Sup; Hur, Man-Wook			Temporal and differential regulation of KAISO-controlled transcription by phosphorylated and acetylated p53 highlights a crucial regulatory role of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; apoptosis; gene transcription; transcription factor; DNA damage; post-translational modification (PTM); DNA damage response; KAISO; mutant p53; p53QRQ; transcriptional regulation; DNA damage response (DDR); zinc finger and BTB domain-containing 33 (ZBTB33); stress response	DAMAGE-INDUCED PHOSPHORYLATION; POSTTRANSLATIONAL MODIFICATIONS; BINDING-PROTEIN; DNA-BINDING; ACTIVATION; ATM; DEACETYLATION; CANCER; UBIQUITINATION; INHIBITION	Transcriptional regulator KAISO plays a critical role in cell cycle arrest and apoptosis through modulation of p53 acetylation by histone acetyltransferase p300. KAISO potently stimulates apoptosis in cells expressing WT p53, but not in p53-mutant or p53-null cells. Here, we investigated how KAISO transcription is regulated by p53, finding four potential p53-binding sites (p53-responsive DNA elements; p53REs) located in a distal 5'-upstream regulatory element, intron 1, exon 2 coding sequence, and a 3'-UTR region. Transient transcription assays of pG5-p53RE-Luc constructs with various p53REs revealed that p53 activates KAISO (ZBTB33) transcription by acting on p53RE1 (-4326 to -4227) of the 5'-upstream region and on p53RE3 (+2929 to +2959) of the exon 2 coding region during early DNA damage responses (DDRs). ChIP and oligonucleotide pulldown assays further disclosed that p53 binds to the p53RE1 and p53RE3 sites. Moreover, ataxia telangiectasia mutated (ATM) or ATM-Rad3-related (ATR) kinase-mediated p53 phosphorylation at Ser-15 or Ser-37 residues activated KAISO transcription by binding its p53RE1 or p53RE3 sites during early DDR. p53RE1 uniquely contained three p53-binding half-sites, a structural feature important for transcriptional activation by phosphorylated p53 Ser-15.Ser-37. During the later DDR phase, a KAISO-mediated acetylated p53 form (represented by a p53QRQ acetyl-mimic) robustly activated transcription by acting on p53RE1 in which this structural feature is not significant, but it provided sufficient KAISO levels to confer a p53 "apoptotic code." These results suggest that the critical apoptosis regulator KAISO is a p53 target gene that is differently regulated by phosphorylated p53 or acetylated p53, depending on DDR stage.	[Choi, Seo-Hyun; Koh, Dong-In; Cho, Su-Yeon; Kim, Min-Kyeong; Kim, Kyung-Sup; Hur, Man-Wook] Yonsei Univ, Brain Korea 21 Plus Project Med Sci, Dept Biochem & Mol Biol, Severance Biomed Res Inst,Sch Med, 50-1 Yonsei Ro, Seoul 03722, South Korea	Yonsei University	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, 134 ShinChon Dong, Seoul 120752, South Korea.	mwhur2@yuhs.ac		Hur, Man-Wook/0000-0002-3416-1334; Kim, Kyung-sup/0000-0001-8483-8537	National Research Foundation of Korea (NRF) of the Korean Government (MSIP) [2016R1E1A1A02921938, 2011-0028817, 2011-0030086]	National Research Foundation of Korea (NRF) of the Korean Government (MSIP)	This work was supported by JeonRack-HooSok Grant 2016R1E1A1A02921938 (to M.-W. H.), Do-Yak Research Grant 2011-0028817 (to M.-W. H.), and Medical Research Center Grant 2011-0030086 (to M.-W. H.) from the National Research Foundation of Korea (NRF) of the Korean Government (MSIP). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen JJ, 2017, J CELL PHYSIOL, V232, P2308, DOI 10.1002/jcp.25669; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Dohoney KM, 2004, ONCOGENE, V23, P49, DOI 10.1038/sj.onc.1207005; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Koh DI, 2015, BBA-GENE REGUL MECH, V1849, P1170, DOI 10.1016/j.bbagrm.2015.07.008; Koh DI, 2014, P NATL ACAD SCI USA, V111, P15078, DOI 10.1073/pnas.1318780111; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang H, 2008, J BIOL CHEM, V283, P2564, DOI 10.1074/jbc.M702454200; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; ZAMBETTI GP, 1993, FASEB J, V7, P855, DOI 10.1096/fasebj.7.10.8344485; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	49	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12957	12974		10.1074/jbc.RA119.008100	http://dx.doi.org/10.1074/jbc.RA119.008100			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296660	Green Published, hybrid			2022-12-28	WOS:000486416000009
J	Malfatti, MC; Henneke, G; Balachander, S; Koh, KD; Newnam, G; Uehara, R; Crouch, RJ; Storici, F; Tell, G				Malfatti, Matilde Clarissa; Henneke, Ghislaine; Balachander, Sathya; Koh, Kyung Duk; Newnam, Gary; Uehara, Ryo; Crouch, Robert J.; Storici, Francesca; Tell, Gianluca			Unlike the Escherichia coli counterpart, archaeal RNase HII cannot process ribose monophosphate abasic sites and oxidized ribonucleotides embedded in DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribonuclease; bacteria; Escherichia coli (E coli); archaea; oxidative stress; abasic-ribose; oxidized-ribonucleotides; Pyrococcus abyssi; Type 2 RNase H	CRYSTAL-STRUCTURES; REPAIR; H2; MECHANISM; GENOME; IMPACT	The presence of ribonucleoside monophosphates (rNMPs) in nuclear DNA decreases genome stability. To ensure survival despite rNMP insertions, cells have evolved a complex network of DNA repair mechanisms, in which the ribonucleotide excision repair pathway, initiated by type 2 RNase H (RNase HII/2), plays a major role. We recently demonstrated that eukaryotic RNase H2 cannot repair damage, that is, ribose monophosphate abasic (both apurinic or apyrimidinic) site (rAP) or oxidized rNMP embedded in DNA. Currently, it remains unclear why RNase H2 is unable to repair these modified nucleic acids having either only a sugar moiety or an oxidized base. Here, we compared the endoribonuclease specificity of the RNase HII enzymes from the archaeon Pyrococcus abyssi and the bacterium Escherichia coli, examining their ability to process damaged rNMPs embedded in DNA in vitro. We found that E. coli RNase HII cleaves both rAP and oxidized rNMP sites. In contrast, like the eukaryotic RNase H2, P. abyssi RNase HII did not display any rAP or oxidized rNMP incision activities, even though it recognized them. Notably, the archaeal enzyme was also inactive on a mismatched rNMP, whereas the E. coli enzyme displayed a strong preference for the mispaired rNMP over the paired rNMP in DNA. On the basis of our biochemical findings and also structural modeling analyses of RNase HII/2 proteins from organisms belonging to all three domains of life, we propose that RNases HII/2's dual roles in ribonucleotide excision repair and RNA/DNA hydrolysis result in limited acceptance of modified rNMPs embedded in DNA.	[Malfatti, Matilde Clarissa; Tell, Gianluca] Univ Udine, Dept Med, Lab Mol Biol & DNA Repair, Piazzale M Kolbe 4, I-33100 Udine, Italy; [Henneke, Ghislaine] Univ Brest, CNRS, IFREMER, Lab Microbiol Environm Extremes, F-29280 Plouzane, France; [Balachander, Sathya; Koh, Kyung Duk; Newnam, Gary; Storici, Francesca] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Uehara, Ryo] Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan; [Crouch, Robert J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Koh, Kyung Duk] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA	University of Udine; Centre National de la Recherche Scientifique (CNRS); Ifremer; Universite de Bretagne Occidentale; University System of Georgia; Georgia Institute of Technology; Ritsumeikan University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Francisco	Tell, G (corresponding author), Univ Udine, Dept Med, Lab Mol Biol & DNA Repair, Piazzale M Kolbe 4, I-33100 Udine, Italy.	gianluca.tell@uniud.it		Henneke, Ghislaine/0000-0002-2985-5526; Uehara, Ryo/0000-0002-7534-599X; Tell, Gianluca/0000-0001-8845-6448; MALFATTI, MATILDE CLARISSA/0000-0002-8101-568X	Associazione Italiana per la Ricerca sul Cancro Grant [IG19862]; NIEHS, National Institutes of Health [1R01ES026243-01]; Howard Hughes Medical Institute Faculty Scholar Grant [55108574]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026243] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Howard Hughes Medical Institute Faculty Scholar Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Associazione Italiana per la Ricerca sul Cancro Grant IG19862 (to G. T.), by NIEHS, National Institutes of Health Grant 1R01ES026243-01 (to F. S.), and Howard Hughes Medical Institute Faculty Scholar Grant 55108574 (to F. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Caldecott KW, 2014, SCIENCE, V343, P260, DOI 10.1126/science.1248234; Cerritelli SM, 2016, TRENDS BIOCHEM SCI, V41, P434, DOI 10.1016/j.tibs.2016.02.005; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chiu HC, 2014, NANOSCALE, V6, P10009, DOI 10.1039/c4nr01794c; Chon H, 2013, NUCLEIC ACIDS RES, V41, P3130, DOI 10.1093/nar/gkt027; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Cilli P, 2015, J BIOL CHEM, V290, P26259, DOI 10.1074/jbc.M115.679209; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; Cohen GN, 2003, MOL MICROBIOL, V47, P1495, DOI 10.1046/j.1365-2958.2003.03381.x; Crespan E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10805; Dalgaard JZ, 2012, TRENDS GENET, V28, P592, DOI 10.1016/j.tig.2012.07.008; EGLI M, 1993, BIOCHEMISTRY-US, V32, P3221, DOI 10.1021/bi00064a004; El Hage A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004716; Evich M, 2016, CHEMBIOCHEM, V17, P1968, DOI 10.1002/cbic.201600385; Figiel M, 2011, J BIOL CHEM, V286, P10540, DOI 10.1074/jbc.M110.181974; GASPARUTTO D, 1992, NUCLEIC ACIDS RES, V20, P5159, DOI 10.1093/nar/20.19.5159; Heider MR, 2017, J BIOL CHEM, V292, P8835, DOI 10.1074/jbc.M117.783472; Henneke G, 2012, BIOCHEM J, V447, P271, DOI 10.1042/BJ20120959; Huang SYN, 2015, J BIOL CHEM, V290, P14068, DOI 10.1074/jbc.M115.653345; Koh KD, 2015, NAT METHODS, V12, P251, DOI [10.1038/NMETH.3259, 10.1038/nmeth.3259]; Le Laz S, 2010, J BACTERIOL, V192, P3689, DOI 10.1128/JB.00268-10; Lemor M, 2018, J MOL BIOL, V430, P4908, DOI 10.1016/j.jmb.2018.10.004; Lindsey-Boltz LA, 2015, J BIOL CHEM, V290, P29801, DOI 10.1074/jbc.M115.695254; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Malfatti MC, 2017, NUCLEIC ACIDS RES, V45, P11193, DOI 10.1093/nar/gkx723; Morelra PI, 2008, FREE RADICAL BIO MED, V44, P1493, DOI 10.1016/j.freeradbiomed.2008.01.002; Muroya A, 2001, PROTEIN SCI, V10, P707, DOI 10.1110/ps.48001; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; Potenski CJ, 2014, NUCLEIC ACIDS RES, V42, P10226, DOI 10.1093/nar/gku773; RANDERATH K, 1992, MUTAT RES, V275, P355, DOI 10.1016/0921-8734(92)90038-Q; Reijns MAM, 2011, J BIOL CHEM, V286, P10530, DOI 10.1074/jbc.M110.177394; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Sassa A, 2019, GENES ENVIRON, V41, DOI 10.1186/s41021-019-0118-7; Sassa A, 2016, J BIOL CHEM, V291, P24314, DOI 10.1074/jbc.M116.738732; Shen Y, 2012, NAT STRUCT MOL BIOL, V19, P98, DOI 10.1038/nsmb.2176; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x; Williams JS, 2016, NAT REV MOL CELL BIO, V17, P350, DOI 10.1038/nrm.2016.37	40	9	9	4	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13061	13072		10.1074/jbc.RA119.009493	http://dx.doi.org/10.1074/jbc.RA119.009493			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31300556	Green Published, hybrid			2022-12-28	WOS:000486416000017
J	Wittenborn, EC; Cohen, SE; Merrouch, M; Leger, C; Fourmond, V; Dementin, S; Drennan, CL				Wittenborn, Elizabeth C.; Cohen, Steven E.; Merrouch, Meriem; Leger, Christophe; Fourmond, Vincent; Dementin, Sebastien; Drennan, Catherine L.			Structural insight into metallocofactor maturation in carbon monoxide dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nickel; iron-sulfur protein; metalloenzyme; one-carbon metabolism; oxidation-reduction (redox); X-ray crystallography; bioremediation catalyst; carbon monoxide dehydrogenase (CODH); heterometallic cofactor	RHODOSPIRILLUM-RUBRUM; CO-DEHYDROGENASE; ACETYL-COA; CLOSTRIDIUM-THERMOACETICUM; NICKEL INSERTION; ACTIVE-SITE; CLUSTER; PROTEIN; MECHANISM; INTERCONVERSIONS	The nickel-dependent carbon monoxide dehydrogenase (CODH) employs a unique heterometallic nickel-iron-sulfur cluster, termed the C-cluster, to catalyze the interconversion of CO and CO2. Like other complex metalloenzymes, CODH requires dedicated assembly machinery to form the fully intact and functional C-cluster. In particular, nickel incorporation into the C-cluster depends on the maturation factor CooC; however, the mechanism of nickel insertion remains poorly understood. Here, we compare X-ray structures (1.50-2.48 angstrom resolution) of CODH from Desulfovibrio vulgaris (DvCODH) heterologously expressed in either the absence (DvCODH(-CooC)) or presence (DvCODH(+CooC)) of co-expressed CooC. We find that the C-cluster of DvCODH(-CooC) is fully loaded with iron but does not contain any nickel. Interestingly, the so-called unique iron ion (Fe-u) occupies both its canonical site (80% occupancy) and the nickel site (20% occupancy), with addition of reductant causing further mismetallation of the nickel site (60% iron occupancy). We also demonstrate that a DvCODH variant that lacks a surface-accessible iron-sulfur cluster (the D-cluster) has a C-cluster that is also replete in iron but lacks nickel, despite co-expression with CooC. In this variant, all Fe-u is in its canonical location, and the nickel site is empty. This D-cluster-deficient CODH is inactive despite attempts to reconstitute it with nickel. Taken together, these results suggest that an empty nickel site is not sufficient for nickel incorporation. Based on our findings, we propose a model for C-cluster assembly that requires both CooC and a functioning D-cluster, involves precise redox-state control, and includes a two-step nickel-binding process.	[Wittenborn, Elizabeth C.; Cohen, Steven E.; Drennan, Catherine L.] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Merrouch, Meriem; Leger, Christophe; Fourmond, Vincent; Dementin, Sebastien] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, Lab Bioenerget & Ingn Prot, Marseille, France; [Drennan, Catherine L.] Canadian Inst Adv Res, Bioinspired Solar Energy Program, Toronto, ON M5G 1M1, Canada; [Wittenborn, Elizabeth C.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Canadian Institute for Advanced Research (CIFAR); University of California System; University of California Berkeley	Drennan, CL (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Dementin, S (corresponding author), Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, Lab Bioenerget & Ingn Prot, Marseille, France.	dementin@imm.cnrs.fr; cdrennan@mit.edu	Fourmond, Vincent/K-1706-2014; Leger, Christophe/C-7230-2016	Fourmond, Vincent/0000-0001-9837-6214; Dementin, Sebastien/0000-0001-6168-5371; Drennan, Catherine/0000-0001-5486-2755; Leger, Christophe/0000-0002-8871-6059; Merrouch, Meriem/0000-0001-6948-0135; Cohen, Steven/0000-0002-3193-0740	National Institutes of Health [T32 GM008334, R01 GM069857, R35 GM126982]; French Agence Nationale de la Recherche [ANR-15-CE05-0020, ANR-17-CE11-0027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, T32GM008334, R01GM069857, R35GM126982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants T32 GM008334 (to E.C.W. and S.E.C.) and R01 GM069857 and R35 GM126982 (to C.L.D.) and the work in Marseille was funded by the French Agence Nationale de la Recherche (ANR-15-CE05-0020 and ANR-17-CE11-0027). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfano M, 2018, J BIOL INORG CHEM, V23, P809, DOI 10.1007/s00775-018-1576-2; Alfano M., 2019, J BIOL CHEM; ANDERSON ME, 1994, BIOCHEMISTRY-US, V33, P8702, DOI 10.1021/bi00195a011; BARTHOLOMEW GW, 1979, APPL ENVIRON MICROB, V37, P932, DOI 10.1128/AEM.37.5.932-937.1979; Can M, 2014, CHEM REV, V114, P4149, DOI 10.1021/cr400461p; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CONOVER RC, 1990, J AM CHEM SOC, V112, P4562, DOI 10.1021/ja00167a074; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; DeRose VJ, 1998, J AM CHEM SOC, V120, P8767, DOI 10.1021/ja9731480; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENSIGN SA, 1990, BIOCHEMISTRY-US, V29, P2162, DOI 10.1021/bi00460a029; Hadj-Said J, 2015, BBA-BIOENERGETICS, V1847, P1574, DOI 10.1016/j.bbabio.2015.08.002; Hu ZG, 1996, J AM CHEM SOC, V118, P830, DOI 10.1021/ja9528386; Inoue T, 2013, BIOCHEM BIOPH RES CO, V441, P13, DOI 10.1016/j.bbrc.2013.09.143; Jeon WB, 2005, J BIOL INORG CHEM, V10, P903, DOI 10.1007/s00775-005-0043-z; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Jeoung JH, 2007, SCIENCE, V318, P1461, DOI 10.1126/science.1148481; Jeoung JH, 2014, BIOL CHEM, V395, P545, DOI 10.1515/hsz-2013-0290; Jeoung JH, 2010, J MOL BIOL, V396, P1165, DOI 10.1016/j.jmb.2009.12.062; Jeoung JH, 2009, BIOCHEMISTRY-US, V48, P11505, DOI 10.1021/bi901443z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KENT TA, 1982, P NATL ACAD SCI-BIOL, V79, P1096, DOI 10.1073/pnas.79.4.1096; Kerby RL, 1997, J BACTERIOL, V179, P2259, DOI 10.1128/jb.179.7.2259-2266.1997; Kim EJ, 2004, BIOCHEMISTRY-US, V43, P5728, DOI 10.1021/bi036062u; KUMAR M, 1993, J AM CHEM SOC, V115, P11646, DOI 10.1021/ja00077a093; Kung Y, 2009, BIOCHEMISTRY-US, V48, P7432, DOI 10.1021/bi900574h; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merrouch M, 2018, J BIOL INORG CHEM, V23, P613, DOI 10.1007/s00775-018-1541-0; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; MOURA JJG, 1982, J BIOL CHEM, V257, P6259; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Spangler NJ, 1998, J BIOL CHEM, V273, P4059, DOI 10.1074/jbc.273.7.4059; Staples CR, 1999, J AM CHEM SOC, V121, P11034, DOI 10.1021/ja990396i; SVETLICHNY VA, 1991, SYST APPL MICROBIOL, V14, P254, DOI 10.1016/S0723-2020(11)80377-2; Svetlitchnyi V, 2001, J BACTERIOL, V183, P5134, DOI 10.1128/JB.183.17.5134-5144.2001; Timm J, 2017, METALLOMICS, V9, P575, DOI 10.1039/c7mt00063d; UFFEN RL, 1976, P NATL ACAD SCI USA, V73, P3298, DOI 10.1073/pnas.73.9.3298; Watt RK, 1998, J BIOL CHEM, V273, P10019, DOI 10.1074/jbc.273.16.10019; Wittenborn EC, 2018, ELIFE, V7, DOI 10.7554/eLife.39451; Zhou J, 1997, J AM CHEM SOC, V119, P6242, DOI 10.1021/ja9704186	46	11	11	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13017	13026		10.1074/jbc.RA119.009610	http://dx.doi.org/10.1074/jbc.RA119.009610			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296570	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000486416000013
J	Denisov, SS; Ippel, JH; Heinzmann, ACA; Koenen, RR; Ortega-Gomez, M; Soehnlein, O; Hackeng, TM; Dijkgraaf, I				Denisov, Stepan S.; Ippel, Johannes H.; Heinzmann, Alexandra C. A.; Koenen, Rory R.; Ortega-Gomez, Mudena; Soehnlein, Oliver; Hackeng, Tilman M.; Dijkgraaf, Ingrid			Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 interactions with glycosaminoglycans and CXCR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; peptide chemical synthesis; nuclear magnetic resonance (NMR); protein structure; protein-protein interaction; C-X-C motif chemokine ligand (CXCL)	CHEMOKINE-BINDING-PROTEINS; CYSTINE KNOT; WEB SERVER; MONOCLONAL-ANTIBODY; RECEPTOR CXCR1; XPLOR-NIH; INTERLEUKIN-8; RECOGNITION; SELECTIVITY; STABILITY	Chemokines are a group of chemotaxis proteins that regulate cell trafficking and play important roles in immune responses and inflammation. Ticks are blood-sucking parasites that secrete numerous immune-modulatory agents in their saliva to evade host immune responses. Evasin-3 is a small salivary protein that belongs to a class of chemokine-binding proteins isolated from the brown dog tick, Rhipicephalus sanguineus. Evasin-3 has been shown to have a high affinity for chemokines CXCL1 and CXCL8 and to diminish inflammation in mice. In the present study, solution NMR spectroscopy was used to investigate the structure of Evasin-3 and its CXCL8-Evasin-3 complex. Evasin-3 is found to disrupt the glycosaminoglycan-binding site of CXCL8 and inhibit the interaction of CXCL8 with CXCR2. Structural data were used to design two novel CXCL8-binding peptides. The linear tEv3 17-56 and cyclic tcEv3 16-56 dPG Evasin-3 variants were chemically synthesized by solid-phase peptide synthesis. The affinity of these newly synthesized variants to CXCL8 was measured by surface plasmon resonance biosensor analysis. The K-d values of tEv3 17-56 and tcEv3 16-56 dPG were 27 and 13 nm, respectively. Both compounds effectively inhibited CXCL8-induced migration of polymorphonuclear neutrophils. The present results suggest utility of synthetic Evasin-3 variants as scaffolds for designing and fine-tuning new chemokine-binding agents that suppress immune responses and inflammation.	[Denisov, Stepan S.; Ippel, Johannes H.; Heinzmann, Alexandra C. A.; Koenen, Rory R.; Hackeng, Tilman M.; Dijkgraaf, Ingrid] Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, Univ Singel 50, NL-6229 ER Maastricht, Netherlands; [Ortega-Gomez, Mudena; Soehnlein, Oliver] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, D-80336 Munich, Germany; [Soehnlein, Oliver] German Ctr Cardiovasc Res, D-13316 Berlin, Germany; [Soehnlein, Oliver] Partner Site Munich Heart Alliance, D-80802 Munich, Germany; [Soehnlein, Oliver] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Soehnlein, Oliver] Karolinska Inst, Dept Med, SE-17177 Stockholm, Sweden	Maastricht University; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Karolinska Institutet; Karolinska Institutet	Dijkgraaf, I (corresponding author), Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, Univ Singel 50, NL-6229 ER Maastricht, Netherlands.	i.dijkgraaf@maastrichtuniversity.nl	Koenen, Rory/H-4172-2012; Denisov, Stepan/AAJ-4022-2020; Ortega-Gomez, Almudena/AAA-9572-2020	Koenen, Rory/0000-0002-9955-9730; Ortega-Gomez, Almudena/0000-0002-3762-6934; Hackeng, Tilman/0000-0003-0142-0843; Dijkgraaf, Ingrid/0000-0003-4586-3646; Ippel, Hans/0000-0001-6589-6678; Denisov, Stepan S./0000-0001-5460-940X	Netherlands Organisation for Scientific Research [VIDI 723.013.009, Aspasia 015.010.005]; Landsteiner Foundation for Blood Transfusion Research [1638]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Landsteiner Foundation for Blood Transfusion Research	This work was supported in part by Netherlands Organisation for Scientific Research Grants VIDI 723.013.009 and Aspasia 015.010.005 (to I. D.). Further financial support for the appointment of A.C.A.H. was from Landsteiner Foundation for Blood Transfusion Research Grant 1638 (to R.R.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Akcan M, 2015, BIOPOLYMERS, V104, P682, DOI 10.1002/bip.22699; Bao ZY, 2010, INT IMMUNOPHARMACOL, V10, P259, DOI 10.1016/j.intimp.2009.11.005; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Berkamp S, 2017, J BIOMOL NMR, V69, P111, DOI 10.1007/s10858-017-0128-3; Bonvin P, 2014, J BIOL CHEM, V289, P31846, DOI 10.1074/jbc.M114.599233; Brinkmann V., 2010, JOVE-J VIS EXP, V36, P1724, DOI [10.3791/1724, DOI 10.3791/1724/J0VE.C0M/VIDE0/1724]; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Chand KK, 2016, SCI REP-UK, V6, DOI 10.1038/srep29446; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Denisov SS, 2019, CHEM COMMUN, V55, P1374, DOI 10.1039/c8cc08777f; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Deruaz M, 2013, FEBS J, V280, P4876, DOI 10.1111/febs.12463; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Eaton JRO, 2018, J BIOL CHEM, V293, P6134, DOI 10.1074/jbc.RA117.000487; Espinosa JF, 2000, ANGEW CHEM INT EDIT, V39, P2330, DOI 10.1002/1521-3773(20000703)39:13<2330::AID-ANIE2330>3.0.CO;2-C; Ezerzer C, 2009, PEPTIDES, V30, P1296, DOI 10.1016/j.peptides.2009.03.016; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gonzalez-Motos V, 2016, CYTOKINE GROWTH F R, V30, P71, DOI 10.1016/j.cytogfr.2016.02.007; Ha H, 2017, THERANOSTICS, V7, P1543, DOI 10.7150/thno.15625; Hafsa NE, 2015, NUCLEIC ACIDS RES, V43, pW370, DOI 10.1093/nar/gkv494; Heidarieh H, 2015, VIRUS RES, V209, P67, DOI 10.1016/j.virusres.2015.02.028; Herzig V, 2015, TOXINS, V7, P4366, DOI 10.3390/toxins7104366; Hughes CE, 2018, FEBS J, V285, P2944, DOI 10.1111/febs.14466; Joseph PRB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170168; Joseph PRB, 2015, BIOCHEM J, V472, P121, DOI 10.1042/BJ20150059; Joseph PRB, 2013, BIOPHYS J, V105, P1491, DOI 10.1016/j.bpj.2013.08.008; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mahler DA, 2004, CHEST, V126, P926, DOI 10.1378/chest.126.3.926; Mamik MK, 2016, CURR DRUG TARGETS, V17, P111, DOI 10.2174/1389450116666150626124544; Mikolka P, 2018, EXP LUNG RES, V44, P40, DOI 10.1080/01902148.2017.1420272; Miles LA, 2002, J BIOL CHEM, V277, P43033, DOI 10.1074/jbc.M206690200; Montecucco F, 2010, ARTERIOSCL THROM VAS, V30, P1371, DOI 10.1161/ATVBAHA.110.206011; Ning Y, 2012, EXPERT OPIN THER TAR, V16, P491, DOI 10.1517/14728222.2012.677440; Park SH, 2011, J MOL BIOL, V414, P194, DOI 10.1016/j.jmb.2011.08.025; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Proudfoot AEI, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10030070; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; RAJARATHNAM K, 1995, BIOCHEMISTRY-US, V34, P12983, DOI 10.1021/bi00040a008; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Ryu H, 2016, BIOINFORMATICS, V32, P611, DOI 10.1093/bioinformatics/btv595; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Singh K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05204-4; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; Tanaka K, 2001, J AM CHEM SOC, V123, P2530, DOI 10.1021/ja0035708; Tsai YC, 2017, THER ADV MUSCULOSKEL, V9, P277, DOI 10.1177/1759720X17735756; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vink S, 2014, TOXICON, V90, P308, DOI 10.1016/j.toxicon.2014.08.068; von Hundelshausen P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6650; Wang X, 2013, PROG MOL BIOL TRANSL, V117, P531, DOI 10.1016/B978-0-12-386931-9.00020-9; Weber C, 2006, TRENDS IMMUNOL, V27, P268, DOI 10.1016/j.it.2006.04.002; Zheng Y, 2017, IMMUNITY, V46, P1005, DOI 10.1016/j.immuni.2017.05.002	57	13	13	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12370	12379		10.1074/jbc.RA119.008902	http://dx.doi.org/10.1074/jbc.RA119.008902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31235521	Green Published, hybrid			2022-12-28	WOS:000484402700010
J	Tecle, E; Reynoso, HS; Wang, RX; Gagneux, P				Tecle, Eillen; Reynoso, Hector Sequoyah; Wang, Ruixuan; Gagneux, Pascal			The female reproductive tract contains multiple innate sialic acid-binding immunoglobulin-like lectins (Siglecs) that facilitate sperm survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						spermatozoa; sialic acid; reproduction; innate immunity; lectin; glycan; sialic acid-binding immunoglobulin-like lectins (Siglec)	LEUKOCYTIC REACTION; EXPRESSION; IMMUNITY; CAPACITATION; NEUTROPHILS; RECEPTORS; RESPONSES; ROLES; CELLS; CD24	A sperm that fertilizes an egg has successfully survived multiple checkpoints within the female reproductive tract, termed pre-fertilization events. The leukocytic response is a pre-fertilization event in which sperm trigger an immune response that promotes homing of circulating leukocytes to the uterine lumen to destroy most sperm. Various glycoconjugates decorate the sperm surface, including sialic acids, which are abundant at the sperm surface where they cap most glycan chains and regulate sperm migration through cervical mucus, formation of the sperm oviductal reservoir, and sperm capacitation. However, the role of sperm-associated sialic acids in the leukocytic reaction remains unknown. The cognate endogenous binding partners of sialic acids, sialic acid-binding immunoglobulin-like lectins (Siglecs) play a pivotal role in regulating many immune responses. Here we investigated whether sperm-associated sialic acids inhibit activation of neutrophils, one of the major immune cells involved in the leukocytic reaction. We used in vitro interactions between sperm and neutrophils as well as binding assays between sperm and recombinant Siglec-Fc chimeric proteins to measure interactions. Moreover, we examined whether Siglecs are expressed on human and mouse endometria, which have a role in initiating the leukocytic reaction. Surprisingly less sialylated, capacitated, sperm did not increase neutrophil activation in vitro. However, we observed expression of several Siglecs on the endometrium and that these receptors interact with sialylated sperm. Our results indicate that sperm sialic acids may interact with endometrial Siglecs and that these interactions facilitate sperm survival in the face of female immunity.	[Tecle, Eillen; Reynoso, Hector Sequoyah; Wang, Ruixuan; Gagneux, Pascal] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Pathol, San Diego, CA 92093 USA	University of California System; University of California San Diego	Gagneux, P (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Pathol, San Diego, CA 92093 USA.	pgagneux@ucsds.edu		Tecle, Eillen/0000-0003-4253-1128; Gagneux, Pascal/0000-0001-9599-9838	 [P30 NS047101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ajit Varki for the Siglec-Fc chimera plasmids, Nissi Varki for the frozen human samples, Anel Lizcano and Ross Corriden for guidance with neutrophil isolation, and Stevan Springer for critical feedback. We gratefully acknowledge the University of California, San Diego, Neuroscience Microscopy Facility supported by Grant P30 NS047101.	Aitken RJ, 2015, ASIAN J ANDROL, V17, P633, DOI 10.4103/1008-682X.153850; Ali SR, 2014, J EXP MED, V211, P1231, DOI 10.1084/jem.20131853; Anderson MJ, 2007, AM J PHYS ANTHROPOL, V134, P274, DOI 10.1002/ajpa.20674; Angata T, 2000, J BIOL CHEM, V275, P22127, DOI 10.1074/jbc.M002775200; Ardighieri L, 2014, INT J GYNECOL PATHOL, V33, P581, DOI 10.1097/PGP.0000000000000095; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Boehme K, 2009, TOXICOL APPL PHARM, V236, P85, DOI 10.1016/j.taap.2009.01.006; Bokers S, 2014, J IMMUNOL, V192, P2994, DOI 10.4049/jimmunol.1303367; Brandtzaeg P, 1997, J REPROD IMMUNOL, V36, P23, DOI 10.1016/S0165-0378(97)00061-2; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2008, BIOCHEM SOC T, V36, P1467, DOI 10.1042/BST0361467; Guseva NV, 2005, MICROBES INFECT, V7, P1469, DOI 10.1016/j.micinf.2005.05.004; Huo LJ, 2002, THERIOGENOLOGY, V58, P1349, DOI 10.1016/S0093-691X(02)00953-6; Katila T, 2012, REPROD DOMEST ANIM, V47, P31, DOI 10.1111/j.1439-0531.2012.02120.x; Lamb FS, 2012, J BIOL CHEM, V287, P12395, DOI 10.1074/jbc.M111.306530; Lee SK, 2015, IMMUNE NETW, V15, P16, DOI 10.4110/in.2015.15.1.16; Lizcano A, 2017, BLOOD, V129, P3100, DOI 10.1182/blood-2016-11-751636; Ma F, 2016, J BIOL CHEM, V291, P18222, DOI 10.1074/jbc.M116.739169; Ma F, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380584; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; MUNNE S, 1993, HUM REPROD, V8, P581, DOI 10.1093/oxfordjournals.humrep.a138100; Nasu K, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/976024; Nitschke L, 2015, ANN NY ACAD SCI, V1362, P117, DOI 10.1111/nyas.12826; Okabe M, 2015, ASIAN J ANDROL, V17, P646, DOI 10.4103/1008-682X.153299; PANDYA IJ, 1985, FERTIL STERIL, V43, P417; Razi N, 1999, GLYCOBIOLOGY, V9, P1225, DOI 10.1093/glycob/9.11.1225; Sammar M, 2017, HISTOCHEM CELL BIOL, V147, P565, DOI 10.1007/s00418-016-1531-7; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Springer SA, 2013, J BIOL CHEM, V288, P6904, DOI 10.1074/jbc.R112.424523; SRIVASTAVA PN, 1977, BIOCHEM J, V161, P193, DOI 10.1042/bj1610193; Suarez SS, 2016, CELL TISSUE RES, V363, P185, DOI 10.1007/s00441-015-2244-2; Tamm-Rosenstein K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068907; Tecle E, 2015, MOL REPROD DEV, V82, P635, DOI 10.1002/mrd.22500; THOMPSON LA, 1992, AM J REPROD IMMUNOL, V28, P85, DOI 10.1111/j.1600-0897.1992.tb00765.x; Tollner TL, 2012, NAT REV UROL, V9, P365, DOI [10.1038/nrurol.2012.109, 10.1038/nruro1.2012.109]; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A., 2017, ESSENTIALS GLYCOBIOL, V3, P179; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Varki A, 2011, GLYCOBIOLOGY, V21, P1121, DOI 10.1093/glycob/cwr087; Viles K, 2013, ANIM REPROD SCI, V143, P57, DOI 10.1016/j.anireprosci.2013.11.002; Wang XX, 2012, MOL BIOL EVOL, V29, P2073, DOI 10.1093/molbev/mss077; Wira CR, 2011, AM J REPROD IMMUNOL, V65, P196, DOI 10.1111/j.1600-0897.2011.00970.x; Yang Q, 2012, ARCH GYNECOL OBSTET, V286, P481, DOI 10.1007/s00404-012-2305-7; Zandieh Z, 2015, ANDROLOGIA, V47, P1120, DOI 10.1111/and.12391	48	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11910	11919		10.1074/jbc.RA119.008729	http://dx.doi.org/10.1074/jbc.RA119.008729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31201275	Green Published, hybrid			2022-12-28	WOS:000486127800025
J	Du, H; Wang, PC; Li, L; Wang, YS				Du, Hua; Wang, Pengcheng; Li, Lin; Wang, Yinsheng			Repair and translesion synthesis of O-6-alkylguanine DNA lesions in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA replication; mutagenesis; mutagenesis mechanism; carcinogenesis; DNA adduct; MS; O-6-alkylguanine lesion; translesion synthesis	ERROR-FREE BYPASS; Y-FAMILY; ALKYLTRANSFERASE ACTIVITY; POLYMERASE-KAPPA; MAMMALIAN-CELLS; N-NITROSOUREA; POL-KAPPA; RAT-LIVER; B-FAMILY; REPLICATION	O-6-alkyl-2 '-deoxyguanosine (O-6-alkyl-dG) lesions are among the most mutagenic and prevalent alkylated DNA lesions that are associated with cancer initiation and progression. In this study, using a shuttle vector-based strand-specific PCR-competitive replication and adduct bypass assay in conjunction with tandem MS for product identification, we systematically assessed the repair and replicative bypass of a series of O-6-alkyl-dG lesions, with the alkyl group being a Me, Et, nPr, iPr, nBu, iBu, or sBu, in several human cell lines. We found that the extent of replication-blocking effects of these lesions is influenced by the size of the alkyl groups situated on the O-6 position of the guanine base. We also noted involvement of distinct DNA repair pathways and translesion synthesis polymerases (Pols) in ameliorating the replication blockage effects elicited by the straight- and branched-chain O-6-alkyl-dG lesions. We observed that O-6-methylguanine DNA methyltransferase is effective in removing the smaller alkyl groups from the O-6 position of guanine, whereas repair of the branched-chain lesions relied on nucleotide excision repair. Moreover, these lesions were highly mutagenic during cellular replication and exclusively directed G -> A mutations; Pol eta and Pol zeta participated in error-prone bypass of the straight-chain lesions, whereas Pol kappa preferentially incorporated the correct dCMP opposite the branched-chain lesions. Together, these results uncover key cellular proteins involved in repair and translesion synthesis of O-6-alkyl-dG lesions and provide a better understanding of the roles of these types of lesions in the etiology of human cancer.	[Du, Hua; Wang, Pengcheng; Li, Lin; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022	Wang, Pengcheng/0000-0003-4581-983X	National Institutes of Health [R01 ES025121]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant R01 ES025121. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIROLDI L, 1994, CARCINOGENESIS, V15, P2297, DOI 10.1093/carcin/15.10.2297; Bauer NC, 2015, NUCLEIC ACIDS RES, V43, P10083, DOI 10.1093/nar/gkv1136; Berti M, 2016, NAT STRUCT MOL BIOL, V23, P103, DOI 10.1038/nsmb.3163; Bignami M, 2000, MUTAT RES-REV MUTAT, V462, P71, DOI 10.1016/S1383-5742(00)00016-8; BOYLE JM, 1987, J CELL SCI, P147; BRONSTEIN SM, 1992, CANCER RES, V52, P2008; BRONSTEIN SM, 1991, CANCER RES, V51, P5188; CHITTENDEN T, 1991, J VIROL, V65, P5944, DOI 10.1128/JVI.65.11.5944-5951.1991; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; CHUEH LL, 1992, CARCINOGENESIS, V13, P837; DOLAN ME, 1985, CANCER RES, V45, P6413; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; Du H, 2018, J BIOL CHEM, V293, P11100, DOI 10.1074/jbc.RA118.003477; ELLISON KS, 1989, MUTAT RES, V220, P93, DOI 10.1016/0165-1110(89)90014-6; ELLISON KS, 1989, P NATL ACAD SCI USA, V86, P8620, DOI 10.1073/pnas.86.22.8620; Esteller M, 1999, CANCER RES, V59, P793; Friedberg E. C., 2006, DNA REPAIR MUTAGENES, P1; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Groth P, 2010, J MOL BIOL, V402, P70, DOI 10.1016/j.jmb.2010.07.010; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Hendel A, 2008, DNA REPAIR, V7, P1636, DOI 10.1016/j.dnarep.2008.06.008; Jalal S, 2011, CLIN CANCER RES, V17, P6973, DOI 10.1158/1078-0432.CCR-11-0761; Jeggo PA, 2016, NAT REV CANCER, V16, P35, DOI 10.1038/nrc.2015.4; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P10466, DOI 10.1073/pnas.0503859102; Johnson RE, 2003, GENE DEV, V17, P77, DOI 10.1101/gad.1048303; Johnson RE, 2006, MOL CELL BIOL, V26, P6435, DOI 10.1128/MCB.00851-06; KAINA B, 1991, CARCINOGENESIS, V12, P1857; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kirouac KN, 2011, P NATL ACAD SCI USA, V108, P3210, DOI 10.1073/pnas.1013909108; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; Lupari E, 2012, DNA REPAIR, V11, P579, DOI 10.1016/j.dnarep.2012.03.004; Meikrantz W, 1998, CARCINOGENESIS, V19, P369, DOI 10.1093/carcin/19.2.369; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; MORIMOTO K, 1985, CARCINOGENESIS, V6, P1027, DOI 10.1093/carcin/6.7.1027; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; ORTLIEB H, 1980, CARCINOGENESIS, V1, P849, DOI 10.1093/carcin/1.10.849; Pauly GT, 2001, CHEM RES TOXICOL, V14, P894, DOI 10.1021/tx010032f; PEGG AE, 1992, FASEB J, V6, P2302, DOI 10.1096/fasebj.6.6.1544541; PEGG AE, 1990, MUTAT RES, V233, P165, DOI 10.1016/0027-5107(90)90160-6; PEGG AE, 1984, CANCER RES, V44, P3806; PEGG AE, 1990, CANCER RES, V50, P6119; PEGG AE, 1985, ENVIRON HEALTH PERSP, V62, P109, DOI 10.2307/3430101; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Perrino FW, 2003, CHEM RES TOXICOL, V16, P1616, DOI 10.1021/tx034164f; Peterson LA, 2001, CANCER RES, V61, P5757; PETERSON LA, 1991, CANCER RES, V51, P5557; Raz MH, 2016, CHEM RES TOXICOL, V29, P1493, DOI 10.1021/acs.chemrestox.6b00168; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Samson L, 1997, CARCINOGENESIS, V18, P919, DOI 10.1093/carcin/18.5.919; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; SOULIOTIS VL, 1989, CANCER RES, V49, P6997; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Takenaka K, 2006, J BIOL CHEM, V281, P2000, DOI 10.1074/jbc.M506153200; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Wang PC, 2018, J BIOL CHEM, V293, P15033, DOI 10.1074/jbc.RA118.004676; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Williams HL, 2012, MOL CELL, V47, P140, DOI 10.1016/j.molcel.2012.05.001; Wu J, 2018, J BIOL CHEM, V293, P8638, DOI 10.1074/jbc.RA118.003133; Wu J, 2016, NUCLEIC ACIDS RES, V44, P9256, DOI 10.1093/nar/gkw662; Xu-Welliver M, 2002, CARCINOGENESIS, V23, P823, DOI 10.1093/carcin/23.5.823; Yang W, 2018, ANNU REV BIOCHEM, V87, P239, DOI 10.1146/annurev-biochem-062917-012405; Yoon JH, 2015, GENE DEV, V29, P2588, DOI 10.1101/gad.272229.115; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; Yousefzadeh MJ, 2013, DNA REPAIR, V12, P1, DOI 10.1016/j.dnarep.2012.10.004; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b	77	13	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11144	11153		10.1074/jbc.RA119.009054	http://dx.doi.org/10.1074/jbc.RA119.009054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167778	Green Published, hybrid			2022-12-28	WOS:000478717400008
J	Plateau, P; Moch, C; Blanquet, S				Plateau, Pierre; Moch, Clara; Blanquet, Sylvain			Spermidine strongly increases the fidelity of Escherichia coli CRISPR Cas1-Cas2 integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; integrase; polyamine; DNA-protein interaction; genomic instability; integration host factor (IHF)	SPACER ACQUISITION; HOST FACTOR; TRANSCRIPTIONAL ACTIVITY; FOREIGN DNA; POLYAMINES; PROTEIN; ADAPTATION; PURIFICATION; PAM; IHF	Site-selective CRISPR array expansion at the origin of bacterial adaptive immunity relies on recognition of sequence-dependent DNA structures by the conserved Cas1-Cas2 integrase. Off-target integration of a new spacer sequence outside canonical CRISPR arrays has been described in vitro. However, this nonspecific integration activity is rare in vivo. Here, we designed gel assays to monitor fluorescently labeled protospacer insertion in a supercoiled 3-kb plasmid harboring a minimal CRISPR locus derived from the Escherichia coli type I-E system. This assay enabled us to distinguish and quantify target and off-target insertion events catalyzed by E. coli Cas1-Cas2 integrase. We show that addition of the ubiquitous polyamine spermidine or of another polyamine, spermine, significantly alters the ratio between target and off-target insertions. Notably, addition of 2 mm spermidine quenched the off-target spacer insertion rate by a factor of 20-fold, and, in the presence of integration host factor, spermidine also increased insertion at the CRISPR locus 1.5-fold. The observation made in our in vitro system that spermidine strongly decreases nonspecific activity of Cas1-Cas2 integrase outside the leader-proximal region of a CRISPR array suggests that this polyamine plays a potential role in the fidelity of the spacer integration also in vivo.	[Plateau, Pierre; Moch, Clara; Blanquet, Sylvain] IP Paris, Ecole Polytech, CNRS, BIOC, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris	Plateau, P (corresponding author), Ecole Polytech, BIOC, F-91128 Palaiseau, France.	pierre.plateau@polytechnique.edu		Moch, Clara/0000-0002-8674-3440	Centre National de la Recherche Scientifique (CNRS); Ecole polytechnique	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ecole polytechnique	This work was supported by the Centre National de la Recherche Scientifique (CNRS) and Ecole polytechnique. The authors declare that they have no conflicts of interest with the contents of this article.	Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Ando T, 2016, J PHYS CHEM B, V120, P11856, DOI 10.1021/acs.jpcb.6b06243; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bloomfield VA, 1996, CURR OPIN STRUC BIOL, V6, P334, DOI 10.1016/S0959-440X(96)80052-2; Boldt JL, 2007, NUCLEIC ACIDS RES, V35, P716, DOI 10.1093/nar/gkl1078; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; CHALMERS RM, 1994, J BIOL CHEM, V269, P8029; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dillard KE, 2018, CELL, V175, P934, DOI 10.1016/j.cell.2018.09.039; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Drabavicius G, 2018, EMBO REP, V19, DOI 10.15252/embr.201745543; Fagerlund RD, 2017, P NATL ACAD SCI USA, V114, pE5122, DOI 10.1073/pnas.1618421114; FEUERSTEIN BG, 1990, NUCLEIC ACIDS RES, V18, P1271, DOI 10.1093/nar/18.5.1271; FISHER PA, 1979, J BIOL CHEM, V254, P1033; FRIEDMAN DI, 1988, CELL, V55, P545, DOI 10.1016/0092-8674(88)90213-9; Garcia-Martinez J, 2018, MICROB CELL, V5, P262, DOI 10.15698/mic2018.06.634; GOOSEN N, 1995, MOL MICROBIOL, V16, P1, DOI 10.1111/j.1365-2958.1995.tb02386.x; GUERON M, 1980, BIOPOLYMERS, V19, P353, DOI 10.1002/bip.1980.360190212; HAFNER EW, 1979, J BIOL CHEM, V254, P2419; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Hu LI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207563; Jackson SA, 2017, SCIENCE, V356, DOI 10.1126/science.aal5056; Kanemura A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193595; Kieper SN, 2018, CELL REP, V22, P3377, DOI 10.1016/j.celrep.2018.02.103; KRASNOW MA, 1982, J BIOL CHEM, V257, P2687; Lee H, 2019, ELIFE, V8, DOI 10.7554/eLife.44248; Lee H, 2018, MOL CELL, V70, P48, DOI 10.1016/j.molcel.2018.03.003; Luckel F, 2005, FEBS LETT, V579, P5119, DOI 10.1016/j.febslet.2005.07.095; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marchfelder A, 2013, RNA BIOL, V10, P655, DOI 10.4161/rna.24687; Michael AJ, 2016, J BIOL CHEM, V291, P14896, DOI 10.1074/jbc.R116.734780; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; Moch C, 2017, NUCLEIC ACIDS RES, V45, P2714, DOI 10.1093/nar/gkw1309; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; NASH HA, 1981, J BIOL CHEM, V256, P9246; Nivala J, 2018, NAT MICROBIOL, V3, P310, DOI 10.1038/s41564-017-0097-z; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; OSLAND A, 1978, BIOCHIM BIOPHYS ACTA, V520, P317, DOI 10.1016/0005-2787(78)90230-7; Parekh BS, 1996, J BIOL CHEM, V271, P20258, DOI 10.1074/jbc.271.34.20258; Phengchat R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38281; PINGOUD A, 1984, BIOCHEMISTRY-US, V23, P5697, DOI 10.1021/bi00319a006; PINGOUD A, 1985, EUR J BIOCHEM, V147, P105, DOI 10.1111/j.1432-1033.1985.tb08725.x; Radovcic M, 2018, NUCLEIC ACIDS RES, V46, P10173, DOI 10.1093/nar/gky799; RICHET E, 1986, CELL, V46, P1011, DOI 10.1016/0092-8674(86)90700-2; Rollie C, 2018, NUCLEIC ACIDS RES, V46, P1007, DOI 10.1093/nar/gkx1232; Rollie C, 2015, ELIFE, V4, DOI [10.7554/eLife.08716, 10.7554/eLife.08716.001]; Rouzina I, 1998, BIOPHYS J, V74, P3152, DOI 10.1016/S0006-3495(98)78021-X; RUBIN RL, 1977, J BACTERIOL, V129, P916, DOI 10.1128/JB.129.2.916-925.1977; RUBINCHIK S, 1995, J BIOL CHEM, V270, P20059, DOI 10.1074/jbc.270.34.20059; Sarkar T, 2009, BIOCHEMISTRY-US, V48, P667, DOI 10.1021/bi8019965; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shiimori M, 2018, MOL CELL, V70, P814, DOI 10.1016/j.molcel.2018.05.002; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; SVAREN J, 1987, NUCLEIC ACIDS RES, V15, P8739, DOI 10.1093/nar/15.21.8739; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TABOR H, 1980, J BACTERIOL, V144, P952, DOI 10.1128/JB.144.3.952-956.1980; Tsumoto K, 2003, BIOPHYS CHEM, V106, P23, DOI 10.1016/S0301-4622(03)00138-8; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; WANG ZG, 1994, P NATL ACAD SCI USA, V91, P699, DOI 10.1073/pnas.91.2.699; Wei YZ, 2016, MOL CELL, V62, P803, DOI 10.1016/j.molcel.2016.06.004; WEMMER DE, 1985, BIOCHEMISTRY-US, V24, P5745, DOI 10.1021/bi00342a009; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Wright AV, 2017, SCIENCE, V357, P1113, DOI 10.1126/science.aao0679; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Xiao YB, 2017, NATURE, V550, P137, DOI 10.1038/nature24020; Yamada A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1937990; Yoganand KNR, 2017, NUCLEIC ACIDS RES, V45, P367, DOI 10.1093/nar/gkw1151; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	82	2	3	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11311	11322		10.1074/jbc.RA119.007619	http://dx.doi.org/10.1074/jbc.RA119.007619			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31171718	hybrid, Green Published			2022-12-28	WOS:000478717400021
J	Spiering, MJ				Spiering, Martin J.			On the trail of steroid aromatase: The work of Kenneth J. Ryan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CONVERSION; CYTOCHROME-P-450; AROMATIZATION; PURIFICATION					mspiering@asbmb.org		Spiering, Martin/0000-0002-9160-5296				KELLIS JT, 1987, J BIOL CHEM, V262, P4413; MENDELSON CR, 1985, ARCH BIOCHEM BIOPHYS, V243, P480, DOI 10.1016/0003-9861(85)90525-9; MEYER AS, 1955, BIOCHIM BIOPHYS ACTA, V17, P441, DOI 10.1016/0006-3002(55)90395-4; MEYER AS, 1955, ACTA ENDOCRINOL-COP, V18, P148, DOI 10.1530/acta.0.0180148; OSAWA Y, 1987, Steroids, V50, P11, DOI 10.1016/0039-128X(83)90058-2; RYAN KJ, 1958, ENDOCRINOLOGY, V63, P392, DOI 10.1210/endo-63-3-392; RYAN KJ, 1959, J BIOL CHEM, V234, P2006; RYAN KJ, 1959, J BIOL CHEM, V234, P268; RYAN KJ, 1957, J BIOL CHEM, V225, P103; Schiff I, 2002, FERTIL STERIL, V78, P1136, DOI 10.1016/S0015-0282(02)04235-8; Steinach E, 1937, LANCET, V2, P845; Yoshimoto FK, 2014, J AM CHEM SOC, V136, P15016, DOI 10.1021/ja508185d	12	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10743	10745		10.1074/jbc.CL119.009620	http://dx.doi.org/10.1074/jbc.CL119.009620			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31300589	Green Published, hybrid			2022-12-28	WOS:000478717200001
J	Tiwari, P; Gosain, TP; Singh, M; Sankhe, GD; Arora, G; Kidwai, S; Agarwal, S; Chugh, S; Saini, DK; Singh, R				Tiwari, Prabhakar; Gosain, Tannu Priya; Singh, Mamta; Sankhe, Gaurav D.; Arora, Garima; Kidwai, Saqib; Agarwal, Sakshi; Chugh, Saurabh; Saini, Deepak K.; Singh, Ramandeep			Inorganic polyphosphate accumulation suppresses the dormancy response and virulence in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microbiology; microbial pathogenesis; molecular biology; Mycobacterium tuberculosis; mycobacteria; inorganic polyphosphate homeostasis; virulence; exopolyphosphatases; dormancy-associated genes; biofilm; stress adaptation; bacterial pathogenesis; hypoxia	ESCHERICHIA-COLI; EXOPOLYPHOSPHATASE PPX; BIOFILM FORMATION; HYPOXIC RESPONSE; STRESS; KINASE; GROWTH; SURVIVAL; MOTILITY; GENE	Stringent response pathways involving inorganic polyphosphate (PolyP) play an essential role in bacterial stress adaptation and virulence. The intracellular levels of PolyP are modulated by the activities of polyphosphate kinase-1 (PPK1), polyphosphate kinase-2 (PPK2), and exopolyphosphatases (PPXs). The genome of Mycobacterium tuberculosis encodes two functional PPXs, and simultaneous deletion of ppx1 and ppx2 results in a defect in biofilm formation. We demonstrate here that these PPXs cumulatively contribute to the ability of M. tuberculosis to survive in nutrient-limiting, low-oxygen growth conditions and also in macrophages. Characterization of single (Delta ppx2) and double knockout (dkppx) strains of M. tuberculosis indicated that PPX-mediated PolyP degradation is essential for establishing bacterial infection in guinea pigs. RNA-Seq-based transcriptional profiling revealed that relative to the parental strain, the expression levels of DosR regulon-regulated dormancy genes were significantly reduced in the dkppx mutant strain. In concordance, we also provide evidence that PolyP inhibits the autophosphorylation activities associated with DosT and DosS sensor kinases. The results in this study uncover that enzymes involved in PolyP homeostasis play a critical role in M. tuberculosis physiology and virulence and are attractive targets for developing more effective therapeutic interventions.	[Tiwari, Prabhakar; Gosain, Tannu Priya; Singh, Mamta; Arora, Garima; Kidwai, Saqib; Agarwal, Sakshi; Chugh, Saurabh; Singh, Ramandeep] Translat Hlth Sci & Technol Inst, TB Res Lab, Vaccine & Infect Dis Res Ctr, Pali 121001, Haryana, India; [Sankhe, Gaurav D.; Saini, Deepak K.] Indian Inst Sci, Ctr BioSyst Sci & Engn, Bangalore 560012, Karnataka, India; [Saini, Deepak K.] Indian Inst Sci, Dept Mol Reprod Dev & Genet Biol Sci Bldg, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Singh, R (corresponding author), Translat Hlth Sci & Technol Inst, TB Res Lab, Vaccine & Infect Dis Res Ctr, Pali 121001, Haryana, India.	ramandeep@thsti.res.in			Department of Biotechnology, India [BT/PR17357/MED/29/1019/2016, BT/PR5600/MED/29/543/2012, BT/COE/34/15219/2015]; Translational Health Science and Technology Institute; Ramalingaswami Fellowship [BT/HRD/35/02/18/2009]; National Bioscience Award [BT/HRD/NBA/37/01/2014]	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Translational Health Science and Technology Institute; Ramalingaswami Fellowship; National Bioscience Award	Supported by Department of Biotechnology, India, Grant BT/PR17357/MED/29/1019/2016.; Supported by the Translational Health Science and Technology Institute and Department of Biotechnology, India Grants BT/PR5600/MED/29/543/2012 and BT/COE/34/15219/2015. Recipient of Ramalingaswami Fellowship BT/HRD/35/02/18/2009 and National Bioscience Award BT/HRD/NBA/37/01/2014.	Agrawal R, 2015, BIOCHEM J, V469, P121, DOI 10.1042/BJ20150268; AHN KH, 1990, J BIOL CHEM, V265, P11734; Albeldas C, 2018, J PROTEOMICS, V180, P1, DOI 10.1016/j.jprot.2017.10.006; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bolesch DG, 2000, J BIOL CHEM, V275, P33814, DOI 10.1074/jbc.M002039200; Chavez FP, 2004, APPL ENVIRON MICROB, V70, P3064, DOI 10.1128/AEM.70.5.3064-3072.2004; Choi MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042561; Chuang YM, 2015, MBIO, V6, DOI 10.1128/mBio.02428-14; Chuang YM, 2013, MBIO, V4, DOI 10.1128/mBio.00039-13; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Diaz JM, 2010, ENVIRON SCI TECHNOL, V44, P4665, DOI 10.1021/es100191h; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Feng JA, 2011, ANAL BIOCHEM, V409, P144, DOI 10.1016/j.ab.2010.10.025; Gangaiah D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012142; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Grillo-Puertas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050368; Gupta S, 2005, IUBMB LIFE, V57, P149, DOI 10.1080/15216540500090611; Hu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020958; Ishige K, 2002, P NATL ACAD SCI USA, V99, P16684, DOI 10.1073/pnas.262655299; Jahid IK, 2006, APPL ENVIRON MICROB, V72, P7043, DOI 10.1128/AEM.00924-06; Kidwai S, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00969-17, 10.1128/aac.00969-17]; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; Kim MJ, 2010, J BACTERIOL, V192, P4868, DOI 10.1128/JB.00550-10; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Kristensen O, 2008, J MOL BIOL, V375, P1469, DOI 10.1016/j.jmb.2007.11.073; KULAEV IS, 1975, REV PHYSIOL BIOCH P, V73, P131, DOI 10.1007/BFb0034661; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Kumble KD, 1996, J BIOL CHEM, V271, P27146, DOI 10.1074/jbc.271.43.27146; Kundu M, 2018, IUBMB LIFE, V70, P710, DOI 10.1002/iub.1872; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lindner SN, 2009, APPL ENVIRON MICROB, V75, P3161, DOI 10.1128/AEM.02705-08; Malde A, 2014, VIRULENCE, V5, P521, DOI 10.4161/viru.28311; Marino N, 2011, INORG CHEM, V50, P378, DOI 10.1021/ic1020884; O'Toole R, 2003, RES MICROBIOL, V154, P387, DOI 10.1016/S0923-2508(03)00081-0; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Ojha Anil K, 2015, Methods Mol Biol, V1285, P215, DOI 10.1007/978-1-4939-2450-9_12; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rashid MH, 2000, J BACTERIOL, V182, P225, DOI 10.1128/JB.182.1.225-227.2000; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Rodrigues CO, 2002, J BIOL CHEM, V277, P50899, DOI 10.1074/jbc.M208940200; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi TY, 2011, CURR MICROBIOL, V63, P470, DOI 10.1007/s00284-011-0004-4; Shi XB, 2004, P NATL ACAD SCI USA, V101, P17061, DOI 10.1073/pnas.0407787101; Shiba T, 1997, P NATL ACAD SCI USA, V94, P11210, DOI 10.1073/pnas.94.21.11210; Singh M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26900; Singh R, 2013, J BACTERIOL, V195, P2839, DOI 10.1128/JB.00038-13; Sureka K, 2009, MOL MICROBIOL, V74, P1187, DOI 10.1111/j.1365-2958.2009.06925.x; Taneja NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010860; Thayil SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028076; Tiwari P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7059; Wright CC, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00131-17; Yang ZX, 2010, MOL MICROBIOL, V77, P618, DOI 10.1111/j.1365-2958.2010.07233.x; Zhang HY, 2005, P NATL ACAD SCI USA, V102, P13416, DOI 10.1073/pnas.0506520102; Zhang QA, 2010, J BIOL CHEM, V285, P34259, DOI 10.1074/jbc.M110.154393	70	9	9	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10819	10832		10.1074/jbc.RA119.008370	http://dx.doi.org/10.1074/jbc.RA119.008370			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31113860	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000478717200008
J	Naldiga, S; Ji, SF; Thomforde, J; Nicolae, CM; Lee, M; Zhang, ZT; Moldovan, GL; Tretyakova, NY; Basu, AK				Naldiga, Spandana; Ji, Shaofei; Thomforde, Jenna; Nicolae, Claudia M.; Lee, Marietta; Zhang, Zhongtao; Moldovan, George-Lucian; Tretyakova, Natalia Y.; Basu, Ashis K.			Error-prone replication of a 5-formylcytosine-mediated DNA-peptide cross-link in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA damage response; DNA polymerase; mutagenesis; mutagenesis mechanism; 5-formylcytosine; DNA-peptide cross-link; translesion synthesis	REPAIR; ROLES; POLYMERASES; MECHANISM; THYMINE; MUTAGENICITY; MUTAGENESIS; INDUCTION; PROTEINS; REVEALS	DNA-protein cross-links can interfere with chromatin architecture, block DNA replication and transcription, and interfere with DNA repair. Here we synthesized a DNA 23-mer containing a site-specific DNA-peptide cross-link (DpC) by cross-linking an 11-mer peptide to the DNA epigenetic mark 5-formylcytosine in synthetic DNA and used it to generate a DpC-containing plasmid construct. Upon replication of the DpC-containing plasmid in HEK 293T cells, approximately 9% of progeny plasmids contained targeted mutations and 5% semitargeted mutations. Targeted mutations included C -> T transitions and C deletions, whereas semitargeted mutations included several base substitutions and deletions near the DpC lesion. To identify DNA polymerases involved in DpC bypass, we comparatively studied translesion synthesis (TLS) efficiency and mutagenesis of the DpC in a series of cell lines with TLS polymerase knockouts or knockdowns. Knockdown of either hPol iota or hPol zeta reduced the mutation frequency by nearly 50%. However, the most significant reduction in mutation frequency (50%-70%) was observed upon simultaneous knockout of hPol eta and hPol kappa with knockdown of hPol zeta, suggesting that these TLS polymerases play a critical role in error-prone DpC bypass. Because TLS efficiency of the DpC construct was not significantly affected in TLS polymerase-deficient cells, we examined a possible role of replicative DNA polymerases in their bypass and determined that hPol delta and hPol E can accurately bypass the DpC. We conclude that both replicative and TLS polymerases can bypass this DpC lesion in human cells but that mutations are induced mainly by TLS polymerases.	[Naldiga, Spandana; Basu, Ashis K.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Ji, Shaofei] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Thomforde, Jenna; Tretyakova, Natalia Y.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Thomforde, Jenna; Tretyakova, Natalia Y.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Nicolae, Claudia M.; Moldovan, George-Lucian] Penn State Univ, Coll Med, Hershey, PA 17033 USA; [Lee, Marietta; Zhang, Zhongtao] New York Med Coll, Valhalla, NY 10595 USA	University of Connecticut; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; New York Medical College	Basu, AK (corresponding author), Univ Connecticut, Dept Chem, Storrs, CT 06269 USA.	ashis.basu@uconn.edu	Ji, Shaofei/K-3555-2019	Ji, Shaofei/0000-0003-0013-0617; Naldiga, Spandana/0000-0003-1289-2897; zhang, zhongtao/0000-0002-1910-4753; George-Lucian, Moldovan/0000-0003-3825-149X	NIEHS, National Institutes of Health [R01 ES-023350, R01 ES-026184]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023350, R01ES026184] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NIEHS, National Institutes of Health Grants R01 ES-023350 (to N. Y. T. and A. K. B.) and R01 ES-026184 (to G-L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachman M, 2015, NAT CHEM BIOL, V11, P555, DOI 10.1038/nchembio.1848; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Basu AK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040970; Chesner LN, 2018, DNA REPAIR, V62, P18, DOI 10.1016/j.dnarep.2018.01.004; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; COHEN MD, 1992, MUTAT RES, V269, P141, DOI 10.1016/0027-5107(92)90169-3; CRAFT TR, 1987, MUTAT RES, V176, P147, DOI 10.1016/0027-5107(87)90262-4; DIZDAROGLU M, 1989, BIOCHEMISTRY-US, V28, P3625, DOI 10.1021/bi00434a071; DIZDAROGLU M, 1989, CANCER RES, V49, P3463; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Izzotti A, 1999, MUTAT RES-GEN TOX EN, V446, P215, DOI 10.1016/S1383-5718(99)00189-8; Ji SF, 2018, NUCLEIC ACIDS RES, V46, P6455, DOI 10.1093/nar/gky444; Ji SF, 2017, ANGEW CHEM INT EDIT, V56, P14130, DOI 10.1002/anie.201708286; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Li FC, 2017, J AM CHEM SOC, V139, P10617, DOI 10.1021/jacs.7b05495; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Merk O, 1998, ENVIRON MOL MUTAGEN, V32, P260, DOI 10.1002/(SICI)1098-2280(1998)32:3<260::AID-EM9>3.0.CO;2-M; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Minko IG, 2008, MUTAT RES-FUND MOL M, V637, P161, DOI 10.1016/j.mrfmmm.2007.08.001; NACKERDIEN Z, 1991, BIOCHEMISTRY-US, V30, P4873, DOI 10.1021/bi00234a006; Pande P, 2017, CHEM RES TOXICOL, V30, P669, DOI 10.1021/acs.chemrestox.6b00397; Pande P, 2014, BIOCHEMISTRY-US, V53, P5323, DOI 10.1021/bi5007805; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Sanchez AM, 2003, CHEM RES TOXICOL, V16, P1019, DOI 10.1021/tx034066u; Singer B., 1981, MOLECULAR BIOLOGY OF; SMITH KC, 1966, BIOCHIM BIOPHYS ACTA, V114, P1, DOI 10.1016/0005-2787(66)90248-6; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Speit G, 2000, MUTAGENESIS, V15, P85, DOI 10.1093/mutage/15.1.85; Stingele J, 2017, NAT REV MOL CELL BIO, V18, P563, DOI 10.1038/nrm.2017.56; Stingele J, 2016, MOL CELL, V64, P688, DOI 10.1016/j.molcel.2016.09.031; Tretyakova NY, 2015, ACCOUNTS CHEM RES, V48, P1631, DOI 10.1021/acs.accounts.5b00056; Tretyakova NY, 2013, BIOCHEMISTRY-US, V52, P3171, DOI 10.1021/bi400273m; Vaisman A, 2017, CRIT REV BIOCHEM MOL, V52, P274, DOI 10.1080/10409238.2017.1291576; Voitkun V, 1999, MUTAT RES-FUND MOL M, V424, P97, DOI 10.1016/S0027-5107(99)00011-1; Wickramaratne S, 2016, J BIOL CHEM, V291, P23589, DOI 10.1074/jbc.M116.745257; Wickramaratne S, 2015, J BIOL CHEM, V290, P775, DOI 10.1074/jbc.M114.613638; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; Wu FY, 2002, CANCER EPIDEM BIOMAR, V11, P287; Wu FY, 2002, MUTAT RES-FUND MOL M, V501, P69, DOI 10.1016/S0027-5107(02)00006-4; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yeo JE, 2014, ACS CHEM BIOL, V9, P1860, DOI 10.1021/cb5001795; ZWELLING LA, 1979, MUTAT RES, V67, P271, DOI 10.1016/0165-1218(79)90021-1	48	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10619	10627		10.1074/jbc.RA119.008879	http://dx.doi.org/10.1074/jbc.RA119.008879			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138652	hybrid, Green Published			2022-12-28	WOS:000478717100020
J	Inabe, K; Kondo, K; Yoshida, K; Wakabayashis, K; Hisabori, T				Inabe, Kosuke; Kondo, Kumiko; Yoshida, Keisuke; Wakabayashis, Ken-ichi; Hisabori, Toru			The N-terminal region of the E subunit from cyanobacterial ATP synthase alone can inhibit ATPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; cyanobacteria; F1FO-ATPase; ADP; ATPase; ADP-inhibition; epsilon subunit; epsilon-inhibition; ATP synthase	EPSILON-SUBUNIT; ESCHERICHIA-COLI; GAMMA-SUBUNIT; ADENOSINE-TRIPHOSPHATASE; THIOL MODULATION; REDOX REGULATION; F-1 MOTOR; F-1-ATPASE; ACTIVATION; ROTATION	ATP hydrolysis activity catalyzed by chloroplast and proteobacterial ATP synthase is inhibited by their E subunits. To clarify the function of the E subunit from phototrophs, here we analyzed the E subunit-mediated inhibition (E-inhibition) of cyanobacterial F-1-ATPase, a subcomplex of ATP synthase obtained from the thermophilic cyanobacterium Thermosynechococcus elongatus BP-1. We generated three C-terminal alpha-helix null E-mutants; one lacked the C-terminal alpha-helices, and in the other two, the C-terminal conformation could be locked by a disulfide bond formed between two alpha-helices or an alpha-helix and a beta-sandwich structure. All of these E-mutants maintained ATPase-inhibiting competency. We then used single-molecule observation techniques to analyze the rotary motion of F-1-ATPase in the presence of these E-mutants. The stop angular position of the gamma subunit in the presence of the E-mutant was identical to that in the presence of the WT E. Using magnetic tweezers, we examined recovery from the inhibited rotation and observed restoration of rotation by 80 degrees forcing of the gamma subunit in the case of the ADP-inhibited form, but not when the rotation was inhibited by the E-mutants or by the WT E subunit. These results imply that the C-terminal alpha-helix domain of the E subunit of cyanobacterial enzyme does not directly inhibit ATP hydrolysis and that its N-terminal domain alone can inhibit the hydrolysis activity. Notably, this property differed from that of the proteobacterial E, which could not tightly inhibit rotation. We conclude that phototrophs and heterotrophs differ in the E subunit-mediated regulation of ATP synthase.	[Inabe, Kosuke; Kondo, Kumiko; Yoshida, Keisuke; Wakabayashis, Ken-ichi; Hisabori, Toru] Tokyo Inst Technol, Lab Chem & Life Sci, Midori Ku, Nagatsuta Cho 4259-R1-8, Yokohama, Kanagawa 2268503, Japan; [Inabe, Kosuke; Wakabayashis, Ken-ichi; Hisabori, Toru] Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Nagatsuta Cho 4259, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Hisabori, T (corresponding author), Tokyo Inst Technol, Lab Chem & Life Sci, Midori Ku, Nagatsuta Cho 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Yoshida, Keisuke/E-5231-2014; Wakabayashi, Ken-ichi/D-2440-2015; Hisabori, Toru/E-5205-2014	Yoshida, Keisuke/0000-0001-6542-6254; Wakabayashi, Ken-ichi/0000-0002-1025-9249; Hisabori, Toru/0000-0003-2046-0277	MEXT-KAKENHI [16H06556]	MEXT-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT-KAKENHI Grant 16H06556 (to T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bald D, 2001, J BIOL CHEM, V276, P39505, DOI 10.1074/jbc.C100436200; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Ferguson SA, 2016, P NATL ACAD SCI USA, V113, P10860, DOI 10.1073/pnas.1612035113; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hahn A, 2018, SCIENCE, V360, P620, DOI 10.1126/science.aat4318; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hisabori T, 2013, ANTIOXID REDOX SIGN, V19, P1846, DOI 10.1089/ars.2012.5044; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Imashimizu M, 2011, J BIOL CHEM, V286, P26595, DOI 10.1074/jbc.M111.234138; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Johnson EA, 2002, BIOCHEMISTRY-US, V41, P2446, DOI 10.1021/bi011939f; Kato-Yamada Y, 2003, J BIOL CHEM, V278, P36013, DOI 10.1074/jbc.M306140200; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Keis S, 2006, J BACTERIOL, V188, P3796, DOI 10.1128/JB.00040-06; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim Y, 2011, J BIOL CHEM, V286, P9071, DOI 10.1074/jbc.M110.200584; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Konno H, 2012, PLANT CELL PHYSIOL, V53, P626, DOI 10.1093/pcp/pcs018; Konno H, 2011, J BIOL CHEM, V286, P13423, DOI 10.1074/jbc.M110.155986; Krah A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177907; LAGET PP, 1979, ARCH BIOCHEM BIOPHYS, V197, P83, DOI 10.1016/0003-9861(79)90222-4; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; Mukherjee S, 2017, PHOTOSYNTH RES, V134, P1, DOI 10.1007/s11120-017-0411-x; Murakami S, 2018, BIOCHEM J, V475, P2925, DOI 10.1042/BCJ20180481; NALIN CM, 1984, J BIOL CHEM, V259, P7275; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Nowak KF, 2002, BIOCHEMISTRY-US, V41, P15130, DOI 10.1021/bi026594v; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; RICHTER ML, 1985, BIOCHEMISTRY-US, V24, P5755, DOI 10.1021/bi00342a011; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruhle T, 2015, BBA-BIOENERGETICS, V1847, P849, DOI 10.1016/j.bbabio.2015.02.005; Schwarz O, 1997, J BIOL CHEM, V272, P16924, DOI 10.1074/jbc.272.27.16924; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Shah NB, 2013, J BIOL CHEM, V288, P9383, DOI 10.1074/jbc.M113.451583; Shirakihara Y, 2015, FEBS J, V282, P2895, DOI 10.1111/febs.13329; Sielaff H, 2018, BBA-BIOENERGETICS, V1859, P775, DOI 10.1016/j.bbabio.2018.06.013; Stiggall D L, 1979, Methods Enzymol, V55, P308; Stiggall DL, 1979, METHOD ENZYMOL, V55, P819; Stumpp MT, 1999, BIOCHEM J, V341, P157, DOI 10.1042/0264-6021:3410157; Sunamura E, 2012, J BIOL CHEM, V287, P38695, DOI 10.1074/jbc.M112.395053; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; VASILYEVA EA, 1980, BIOCHEM J, V188, P807, DOI 10.1042/bj1880807; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; XIE DL, 1993, BIOCHIM BIOPHYS ACTA, V1172, P267, DOI 10.1016/0167-4781(93)90213-W; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yagi H, 2010, BIOCHEM J, V425, P85, DOI 10.1042/BJ20091247; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; YOSHIDA M, 1979, J BIOL CHEM, V254, P9525; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	55	3	3	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10094	10103		10.1074/jbc.RA118.007131	http://dx.doi.org/10.1074/jbc.RA118.007131			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31068416	Green Published, hybrid			2022-12-28	WOS:000474445600005
J	Koyano, F; Yamano, K; Kosako, H; Tanaka, K; Matsuda, N				Koyano, Fumika; Yamano, Koji; Kosako, Hidetaka; Tanaka, Keiji; Matsuda, Noriyuki			Parkin recruitment to impaired mitochondria for nonselective ubiquitylation is facilitated by MITOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						parkin; Parkinson disease; mitophagy; ubiquitin; ubiquitin ligase	UBIQUITIN LIGASE MARCH5; PHOSPHORYLATED UBIQUITIN; MITOFUSIN 2; E3 LIGASE; PINK1; DEGRADATION; MITOPHAGY; TRANSLOCATION; PROTEASOME; DRP1	PINK1 (PARK6) and PARKIN (PARK2) are causal genes of recessive familial Parkinson's disease. Parkin is a ubiquitin ligase E3 that conjugates ubiquitin to impaired mitochondrial proteins for organelle degradation. PINK1, a Ser/Thr kinase that accumulates only on impaired mitochondria, phosphorylates two authentic substrates, the ubiquitin-like domain of Parkin and ubiquitin. Our group and others have revealed that both the subcellular localization and ligase activity of Parkin are regulated through interactions with phosphorylated ubiquitin. Once PINK1 localizes on impaired mitochondria, PINK1-catalyzed phosphoubiquitin recruits and activates Parkin. Parkin then supplies a ubiquitin chain to PINK1 for phosphorylation. The amplified ubiquitin functions as a signal for the sequestration and degradation of the damaged mitochondria. Although a bewildering variety of Parkin substrates have been reported, the basis for Parkin substrate specificity remains poorly understood. Moreover, the mechanism underlying initial activation and translocation of Parkin onto mitochondria remains unclear, because the presence of ubiquitin on impaired mitochondria is thought to be a prerequisite for the initial PINK1 phosphorylation process. Here, we show that artificial mitochondria-targeted proteins are ubiquitylated by Parkin, suggesting that substrate specificity of Parkin is not determined by its amino acid sequence. Moreover, recruitment and activation of Parkin are delayed following depletion of the mitochondrial E3, MITOL/March5. We propose a model in which the initial step in Parkin recruitment and activation requires protein ubiquitylation by MITOL/March5 with subsequent PINK1-mediated phosphorylation. Because PINK1 and Parkin amplify the ubiquitin signal via a positive feedback loop, the low substrate specificity of Parkin might facilitate this amplification process.	[Koyano, Fumika; Yamano, Koji; Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Ubiquitin Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Kosako, Hidetaka] Tokushima Univ, Fujii Mem Inst Med Sci, Div Cell Signaling, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokushima University	Matsuda, N (corresponding author), Tokyo Metropolitan Inst Med Sci, Ubiquitin Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	matsuda-nr@igakuken.or.jp	Matsuda, Noriyuki/AAI-3156-2020	Matsuda, Noriyuki/0000-0001-8199-952X	JSPS KAKENHI [JP17K08635, JP18H02443, JP26000014, JP15K19037, JP18K14708, JP16K18545, JP18K06237]; Chieko Iwanaga Fund for Parkinson's Disease Research; Joint Usage and Joint Research Programs of the Institute of Advanced Medical Sciences of Tokushima University; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Chieko Iwanaga Fund for Parkinson's Disease Research; Joint Usage and Joint Research Programs of the Institute of Advanced Medical Sciences of Tokushima University; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by JSPS KAKENHI Grant JP18H02443, the Chieko Iwanaga Fund for Parkinson's Disease Research, and the Joint Usage and Joint Research Programs of the Institute of Advanced Medical Sciences of Tokushima University (to N. M.); by JSPS KAKENHI Grant JP26000014 (to K. T.); by JSPS KAKENHI Grants JP15K19037 and JP18K14708 (to F. K.); by JSPS KAKENHI Grants JP16K18545 and JP18K06237 (to K. Y.); by JSPS KAKENHI Grant JP17K08635 (to H. K.); and by the Takeda Science Foundation (to K. T. and N. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Cherok E, 2017, MOL BIOL CELL, V28, P396, DOI 10.1091/mbc.E16-04-0208; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gladkova C, 2018, NATURE, V559, P411, DOI 10.1038/s41586-018-0224-x; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Kazlauskaite A, 2015, EMBO REP, V16, P939, DOI 10.15252/embr.201540352; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Matsuda N, 2016, J BIOCHEM, V159, P379, DOI 10.1093/jb/mvv125; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050; Okatsu K, 2015, J CELL SCI, V128, P964, DOI 10.1242/jcs.161000; Okatsu K, 2012, BIOCHEM BIOPH RES CO, V428, P197, DOI 10.1016/j.bbrc.2012.10.041; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Pawlyk AC, 2003, J BIOL CHEM, V278, P48120, DOI 10.1074/jbc.M306889200; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Prudent J, 2015, MOL CELL, V59, P941, DOI 10.1016/j.molcel.2015.08.001; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Rose CM, 2016, CELL SYST, V3, P395, DOI 10.1016/j.cels.2016.08.009; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sauve V, 2018, NAT STRUCT MOL BIOL, V25, P623, DOI 10.1038/s41594-018-0088-7; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Uversky VN, 2004, CELL TISSUE RES, V318, P225, DOI 10.1007/s00441-004-0937-z; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Xiao B, 2017, J BIOL CHEM, V292, P16697, DOI 10.1074/jbc.M117.787739; Xu S, 2016, MOL BIOL CELL, V27, P349, DOI 10.1091/mbc.E15-09-0678; Yamano K, 2018, ELIFE, V7, DOI 10.7554/eLife.31326; Yamano K, 2016, EMBO REP, V17, P300, DOI 10.15252/embr.201541486; Yamano K, 2015, J BIOL CHEM, V290, P25199, DOI 10.1074/jbc.M115.671446; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Yun JN, 2014, ELIFE, V3, DOI 10.7554/eLife.01958; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	51	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10300	10314		10.1074/jbc.RA118.006302	http://dx.doi.org/10.1074/jbc.RA118.006302			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31110043	Green Published, hybrid			2022-12-28	WOS:000474445600020
J	Sun, L; Pan, XM; Wada, J; Haas, CS; Wuthrich, RP; Danesh, FR; Chugh, SS; Kanwar, YS				Sun, Lin; Pan, Xiaomin; Wada, Jun; Haas, Christian S.; Wuthrich, Rudolf P.; Danesh, Farhad R.; Chugh, Sumant S.; Kanwar, Yashpal S.			RETRACTION: Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy (Retraction of Vol 277, Pg 29953, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													; Wada, Jun/B-2023-2011	Danesh, Farhad/0000-0001-6849-5239; Wada, Jun/0000-0003-1468-5170				Sun L, 2002, J BIOL CHEM, V277, P29953, DOI 10.1074/jbc.M204665200	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10382	10382		10.1074/jbc.W119.009588	http://dx.doi.org/10.1074/jbc.W119.009588			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31253690	Green Published, hybrid			2022-12-28	WOS:000474445600029
J	Hillman, GA; Henry, MF				Hillman, Gabrielle A.; Henry, Michael F.			The yeast protein Mam33 functions in the assembly of the mitochondrial ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; chaperone; ribosome assembly; RNA helicase; mitochondrial respiratory chain complex; complement C1q-binding protein (C1QBP); COX1; protein misfolding; synthetic lethality	CYTOCHROME-C-OXIDASE; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; LARGE SUBUNIT; TRANSLATIONAL REGULATION; GENE-EXPRESSION; P-32 PROTEIN; MATRIX; COX1; MAINTENANCE	Mitochondrial ribosomes are functionally specialized for the synthesis of several essential inner membrane proteins of the respiratory chain. Although remarkable progress has been made toward understanding the structure of mitoribosomes, the pathways and factors that facilitate their biogenesis remain largely unknown. The long unstructured domains of unassembled ribosomal proteins are highly prone to misfolding and often require dedicated chaperones to prevent aggregation. To date, chaperones that ensure safe delivery to the assembling ribosome have not been identified in the mitochondrion. In this study, a respiratory synthetic lethality screen revealed a role for an evolutionarily conserved mitochondrial matrix protein called Mam33 in Saccharomyces cerevisiae mitoribosome biogenesis. We found that the absence of Mam33 results in misassembled, aggregated ribosomes and a respiratory lethal phenotype in combination with other ribosome-assembly mutants. Using sucrose gradient sedimentation, native affinity purifications, in vitro binding assays, and SILAC-based quantitative proteomics, we found that Mam33 does not associate with the mature mitoribosome, but directly binds a subset of unassembled large subunit proteins. Based on these data, we propose that Mam33 binds specific mitoribosomal proteins to ensure proper assembly.	[Hillman, Gabrielle A.; Henry, Michael F.] Rowan Univ, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA; [Hillman, Gabrielle A.; Henry, Michael F.] Rowan Univ, Grad Sch Biomed Sci, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rowan University	Henry, MF (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA.; Henry, MF (corresponding author), Rowan Univ, Grad Sch Biomed Sci, Stratford, NJ 08084 USA.	henrymf@rowan.edu		Hillman, Gabrielle/0000-0003-1354-9994; Henry, Michael/0000-0002-8754-9463	NIGMS National Institutes of Health [GM117483]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM117483] Funding Source: NIH RePORTER	NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS National Institutes of Health Grant GM117483 (to M. F. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Biswas TK, 1999, BIOCHEMISTRY-US, V38, P13042, DOI 10.1021/bi990058u; Bogenhagen DF, 2018, CELL REP, V22, P1935, DOI 10.1016/j.celrep.2018.01.066; Box JM, 2017, MOL BIOL CELL, V28, P3489, DOI 10.1091/mbc.E17-04-0239; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Chowdhury AR, 2008, EXP CELL RES, V314, P651, DOI 10.1016/j.yexcr.2007.10.033; De Silva D, 2017, NUCLEIC ACIDS RES, V45, P6628, DOI 10.1093/nar/gkx426; De Silva D, 2015, CELL CYCLE, V14, P2226, DOI 10.1080/15384101.2015.1053672; De Silva D, 2013, CELL METAB, V18, P712, DOI 10.1016/j.cmet.2013.10.007; DECOSTER E, 1990, MOL GEN GENET, V224, P111, DOI 10.1007/BF00259457; Desai N, 2017, SCIENCE, V355, P528, DOI 10.1126/science.aal2415; DEZAMAROCZY M, 1986, GENE, V47, P155, DOI 10.1016/0378-1119(86)90060-0; Eisinger DP, 1997, MOL CELL BIOL, V17, P5146, DOI 10.1128/MCB.17.9.5146; FEARON K, 1988, MOL CELL BIOL, V8, P3636, DOI 10.1128/MCB.8.9.3636; FEARON K, 1992, J BIOL CHEM, V267, P5162; Feichtinger RG, 2017, AM J HUM GENET, V101, P525, DOI 10.1016/j.ajhg.2017.08.015; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; Frenois F, 2016, ACTA CRYSTALLOGR F, V72, P59, DOI 10.1107/S2053230X15024097; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GRAACK HR, 1995, GENE, V152, P107, DOI 10.1016/0378-1119(94)00633-4; GRAACK HR, 1988, FEBS LETT, V242, P4, DOI 10.1016/0014-5793(88)80975-X; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Henry MF, 1996, MOL CELL BIOL, V16, P3668; Herrmann JM, 2013, BBA-MOL CELL RES, V1833, P286, DOI 10.1016/j.bbamcr.2012.03.007; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Jia LX, 2009, EUKARYOT CELL, V8, P1792, DOI 10.1128/EC.00219-09; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055; Kehrein K, 2015, CELL REP, V10, P843, DOI 10.1016/j.celrep.2015.01.012; Kim HJ, 2017, SEMIN CANCER BIOL, V47, P67, DOI 10.1016/j.semcancer.2017.04.004; Koepp DM, 1996, J CELL BIOL, V133, P1163, DOI 10.1083/jcb.133.6.1163; KRANZ JE, 1990, P NATL ACAD SCI USA, V87, P6629, DOI 10.1073/pnas.87.17.6629; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Meenakshi J, 2003, BIOCHEM BIOPH RES CO, V300, P686, DOI 10.1016/S0006-291X(02)02788-2; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Pausch P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8494; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Pillet B, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600153; Prestele M, 2009, MOL BIOL CELL, V20, P2615, DOI 10.1091/mbc.E08-12-1162; Pu YG, 2011, J STRUCT BIOL, V175, P469, DOI 10.1016/j.jsb.2011.05.005; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Roloff GA, 2015, MOL BIOL CELL, V26, P2885, DOI 10.1091/mbc.E15-04-0222; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; Saha Paramita, 2018, Oncotarget, V9, P10784, DOI 10.18632/oncotarget.24082; Saha P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078131; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Schmidt U, 2002, FEMS YEAST RES, V2, P267, DOI 10.1016/S1567-1356(02)00109-5; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Seytter T, 1998, YEAST, V14, P303, DOI 10.1002/(SICI)1097-0061(19980315)14:4<303::AID-YEA217>3.0.CO;2-N; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; SIKORSKI RS, 1989, GENETICS, V122, P19; Singh R, 2014, MITOCHONDRION, V16, P50, DOI 10.1016/j.mito.2013.10.005; Sotgia F, 2017, ONCOTARGET, V8, P67117, DOI 10.18632/oncotarget.19962; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Soto IC, 2012, CELL METAB, V16, P801, DOI 10.1016/j.cmet.2012.10.018; Sprehe M, 2010, J BIOL CHEM, V285, P18899, DOI 10.1074/jbc.M109.066597; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Ting YH, 2017, J BIOL CHEM, V292, P585, DOI 10.1074/jbc.M116.747634; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.bi.55.070186.001341; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; Zambrano A, 2007, MOL BIOL CELL, V18, P523, DOI 10.1091/mbc.E06-09-0803; Zeng R, 2018, CELL METAB, V27, P645, DOI 10.1016/j.cmet.2018.01.012	83	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9813	9829		10.1074/jbc.RA119.008476	http://dx.doi.org/10.1074/jbc.RA119.008476			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31053642	hybrid, Green Published			2022-12-28	WOS:000473277900015
J	Sun, NY; Uda, Y; Azab, E; Kochen, A; Santos, RNCE; Shi, C; Kobayashi, T; Wein, MN; Pajevic, PD				Sun, Ningyuan; Uda, Yuhei; Azab, Ehab; Kochen, Alejandro; Santos, Roberto Nunes Campos E.; Shi, Chao; Kobayashi, Tokio; Wein, Marc N.; Pajevic, Paola Divieti			Effects of histone deacetylase inhibitor Scriptaid and parathyroid hormone on osteocyte functions and metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						parathyroid hormone; histone deacetylase (HDAC); osteocyte; glucose transporter type 4 (GLUT4); bone; cell metabolism; MEF2; Scriptaid; SOST	BONE-FORMATION; GLUCOSE-UPTAKE; SCLEROSTIN; WNT; DIFFERENTIATION; RUNX2; HDAC	Bone is a highly metabolic organ that undergoes continuous remodeling to maintain its structural integrity. During development, bones, in particular osteoblasts, rely on glucose uptake. However, the role of glucose metabolism in osteocytes is unknown. Osteocytes are terminally differentiated osteoblasts orchestrating bone modeling and remodeling. In these cells, parathyroid hormone (PTH) suppresses Sost/sclerostin expression (a potent inhibitor of bone formation) by promoting nuclear translocation of class IIa histone deacetylase (HDAC) 4 and 5 and the repression of myocyte enhancer factor 2 (MEF2) type C. Recently, Scriptaid, an HDAC complex co-repressor inhibitor, has been shown to induce MEF2 activation and exercise-like adaptation in mice. In muscles, Scriptaid disrupts the HDAC4/5 co-repressor complex, increases MEF2C function, and promotes cell respiration. We hypothesized that Scriptaid, by affecting HDAC4/5 localization and MEF2C activation, might affect osteocyte functions. Treatment of the osteocytic Ocy454-12H cells with Scriptaid increased metabolic gene expression, cell respiration, and glucose uptake. Similar effects were also seen upon treatment with PTH, suggesting that both Scriptaid and PTH can promote osteocyte metabolism. Similar to PTH, Scriptaid potently suppressed Sost expression. Silencing of HDAC5 in Ocy454-12H cells abolished Sost suppression but not glucose transporter type 4 (Glut4) up-regulation induced by Scriptaid. These results demonstrate that Scriptaid increases osteocyte respiration and glucose uptake by mechanisms independent of HDAC complex inhibition. In osteocytes, Scriptaid, similar to PTH, increases binding of HDAC5 to Mef2c with suppression of Sost but only partially increases receptor activator of NF-B ligand (Rankl) expression, suggesting a potential bone anabolic effect.	[Sun, Ningyuan; Uda, Yuhei; Azab, Ehab; Kochen, Alejandro; Santos, Roberto Nunes Campos E.; Shi, Chao; Kobayashi, Tokio; Pajevic, Paola Divieti] Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA; [Shi, Chao] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Orthoped, Jinan 250014, Shandong, Peoples R China; [Wein, Marc N.] Harvard Med Sch, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Azab, Ehab] Umm Al Qura Univ, Mecca 21421, Mecca Province, Saudi Arabia	Boston University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Umm Al Qura University	Pajevic, PD (corresponding author), Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA.	pdivieti@bu.edu	Uda, Yuhei/AAZ-4978-2021; Azab, Ehab/F-5269-2019; Azab, Ehab/GQH-9122-2022	Uda, Yuhei/0000-0003-4705-6215; Azab, Ehab/0000-0002-1122-3942; Divieti Pajevic, Paola/0000-0001-9853-9837	National Institutes of Health [RO1-AR06221-05, AR067285, DK116716]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR067285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK116716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants RO1-AR06221-05 (to P. D. P.) and AR067285 and DK116716 (to M. N. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Cain CJ, 2012, J BONE MINER RES, V27, P1451, DOI 10.1002/jbmr.1608; Cantley MD, 2017, BONE, V95, P162, DOI 10.1016/j.bone.2016.11.028; Chang E, 2009, MOL CELL ENDOCRINOL, V307, P77, DOI 10.1016/j.mce.2009.03.024; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Esen E, 2015, J BONE MINER RES, V30, P1959, DOI 10.1002/jbmr.2556; Fulzele K, 2017, J BONE MINER RES, V32, P373, DOI 10.1002/jbmr.3001; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Gaur V, 2017, DIABETES OBES METAB, V19, P936, DOI 10.1111/dom.12896; Gaur V, 2016, CELL REP, V16, P2802, DOI 10.1016/j.celrep.2016.08.005; Henriksson E, 2015, J CELL SCI, V128, P472, DOI 10.1242/jcs.153932; Hernandez P, 2014, BIOCHEM BIOPH RES CO, V446, P1108, DOI 10.1016/j.bbrc.2014.03.079; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; Pajevic PD, 2009, IBMS BONEKEY, V6, P63, DOI DOI 10.1138/20090363; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Shi C, 2018, FASEB J, V32, P440, DOI 10.1096/fj.201700485RR; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Ukita M, 2016, J CELL BIOCHEM, V117, P1419, DOI 10.1002/jcb.25432; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wei JW, 2015, CELL, V161, P1576, DOI 10.1016/j.cell.2015.05.029; Wein MN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13176; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	31	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9722	9733		10.1074/jbc.RA118.007312	http://dx.doi.org/10.1074/jbc.RA118.007312			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31068415	hybrid, Green Published			2022-12-28	WOS:000473277900008
J	[Anonymous]				[Anonymous]			Protein kinase C-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells (Expression of Concern of Vol 283, Pg 12446, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200	1	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					10026	10026		10.1074/jbc.EC119.009572	http://dx.doi.org/10.1074/jbc.EC119.009572			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31227631	Green Published, hybrid			2022-12-28	WOS:000473277900039
J	Tien, AH; Sadar, MD				Tien, Amy H.; Sadar, Marianne D.			Keys to unlock androgen receptor translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							IDENTIFICATION; GENE	The androgen receptor (AR) is tightly linked to prostate cancer, but the mechanisms by which AR transactivation is dysregulated during cancer progression are not fully explored. Dagar et al. examined AR translocation to the nucleus to identify a link between heat shock protein 90 (HSP90) and protein kinase A (PKA). Their findings provide a potential mechanism of the initiation of AR transactivation and potential targets for developing and refining treatments for prostate cancer.	[Tien, Amy H.; Sadar, Marianne D.] Canadas Michael Smith Genome Sci Ctr, BC Canc, Vancouver, BC V5Z 1L3, Canada		Sadar, MD (corresponding author), Canadas Michael Smith Genome Sci Ctr, BC Canc, Vancouver, BC V5Z 1L3, Canada.	msadar@bcgsc.ca	Sadar, Marianne/E-9136-2012	Sadar, Marianne/0000-0003-0599-9215	NCI, National Institutes of Health [R01 CA105304]; NATIONAL CANCER INSTITUTE [R01CA105304] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health, Grant R01 CA105304. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Dagar M, 2019, J BIOL CHEM, V294, P8699, DOI 10.1074/jbc.RA119.007420; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; LINDZEY J, 1993, MOL ENDOCRINOL, V7, P1530, DOI 10.1210/me.7.12.1530; Liu WY, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.6_suppl.285; Moen LV, 2017, UROL ONCOL-SEMIN ORI, V35, DOI 10.1016/j.urolonc.2016.10.002; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Sarwar M, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2012.08.019; Sunkel B, 2016, NUCLEIC ACIDS RES, V44, P4105, DOI 10.1093/nar/gkv1528; Wang G, 2006, ONCOGENE, V25, P7311, DOI 10.1038/sj.onc.1209715; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605	10	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8711	8712		10.1074/jbc.H119.009180	http://dx.doi.org/10.1074/jbc.H119.009180			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31152093	Green Published, hybrid			2022-12-28	WOS:000470971100004
J	Luna, EJ				Luna, Elizabeth J.			Unconventional myosins muscle into myofibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							18A	Myosin is famous as a component of muscle fibrils, but the majority of myosin family members act elsewhere with roles unrelated to muscle contraction. The biological functions of a relatively new family of these unconventional myosins, myosins 18A and 18B, are poorly understood. New research from Horsthemke et al. describes a new isoform (Myo18A) that is essential for heart function and viability in mice. Their findings both support and contradict other work in the field and raise new questions about the roles of myosin 18 proteins in vivo.	[Luna, Elizabeth J.] Univ Massachusetts, Sch Med, Dept Radiol, Div Cell Biol & Imaging, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Luna, EJ (corresponding author), Univ Massachusetts, Sch Med, Dept Radiol, Div Cell Biol & Imaging, Worcester, MA 01655 USA.	Elizabeth.Luna@umassmed.edu		Luna, Elizabeth/0000-0002-0779-3379	NIAMS, National Institutes of Health [R01 AR068660]	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health, Grant R01 AR068660 (to E. R. Barton and E. J. L.). The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Billington N, 2015, CURR BIOL, V25, P942, DOI 10.1016/j.cub.2015.02.012; Bruun K, 2017, CYTOSKELETON, V74, P205, DOI 10.1002/cm.21364; Buschman Matthew D., 2018, Advances in Biological Regulation, V67, P84, DOI 10.1016/j.jbior.2017.09.005; Cao JM, 2014, J GENET GENOMICS, V41, P417, DOI 10.1016/j.jgg.2014.06.008; Horsthemke M, 2019, J BIOL CHEM, V294, P7202, DOI 10.1074/jbc.RA118.004560; Jiu YM, 2019, CURR BIOL, V29, P81, DOI 10.1016/j.cub.2018.11.045; Kendrick-Jones J, 2016, TRAFFIC, V17, P819, DOI 10.1111/tra.12405; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Salamon M, 2003, J MOL BIOL, V326, P137, DOI 10.1016/S0022-2836(02)01335-9	9	2	2	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7219	7220		10.1074/jbc.H119.008784	http://dx.doi.org/10.1074/jbc.H119.008784			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	31053679	Green Published, hybrid			2022-12-28	WOS:000468402900011
J	Li, L; Guan, KL				Li, Li; Guan, Kun-Liang			Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) is a negative regulator of the mammalian target of rapamycin complex 1 (mTORC1) (vol 288, pg 703, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Guan, Kun-Liang/ADK-7088-2022					Li L, 2013, J BIOL CHEM, V288, P703, DOI 10.1074/jbc.C112.396903	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5810	5810		10.1074/jbc.AAC119.008438	http://dx.doi.org/10.1074/jbc.AAC119.008438			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30979852	Green Published, hybrid			2022-12-28	WOS:000465077500011
J	Zhang, T; Huang, K; Zhu, YL; Wang, TY; Shan, YL; Long, B; Li, YH; Chen, QY; Wang, PT; Zhao, SY; Li, DW; Wu, CM; Kang, BQ; Gu, JM; Mai, YC; Wang, Q; Li, JB; Zhang, YQ; Liang, ZC; Guo, L; Wu, F; Su, SQ; Wang, JW; Gao, MH; Zhong, XF; Liao, BJ; Chen, JK; Zhang, X; Shu, XD; Pei, DQ; Nie, JF; Pan, GJ				Zhang, Tian; Huang, Ke; Zhu, Yanling; Wang, Tianyu; Shan, Yongli; Long, Bing; Li, Yuhang; Chen, Qianyu; Wang, Pengtao; Zhao, Shaoyang; Li, Dongwei; Wu, Chuman; Kang, Baoqiang; Gu, Jiaming; Mai, Yuchan; Wang, Qing; Li, Jinbing; Zhang, Yanqi; Liang, Zechuan; Guo, Lin; Wu, Fang; Su, Shuquan; Wang, Junwei; Gao, Minghui; Zhong, Xiaofen; Liao, Baojian; Chen, Jiekai; Zhang, Xiao; Shu, Xiaodong; Pei, Duanqing; Nie, Jinfu; Pan, Guangjin			Vitamin C-dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hematopoiesis; zebrafish; vitamin C; hematopoietic stem cells; cell differentiation; epigenetics; chromatin regulation; H3K27me3; human pluripotent stem cells; lysine demethylase 6 (KDM6)	STEM-CELLS; ACCESSIBILITY DYNAMICS; GENERATION; DIFFERENTIATION; PROGENITORS; IDENTIFICATION; EMERGENCE; JMJD3; UTX	Hematopoietic stem cells (HSCs)/progenitor cells (HPCs) are generated from hemogenic endothelial cells (HECs) during the endothelial-to-hematopoietic transition (EHT); however, the underlying mechanism remains poorly understood. Here, using an array of approaches, including CRSPR/Cas9 gene knockouts, RNA-Seq, ChIP-Seq, ATAC-Seq etc., we report that vitamin C (Vc) is essential in HPC generation during human pluripotent stem cell (hPSC) differentiation in defined culture conditions. Mechanistically, we found that the endothelial cells generated in the absence of Vc fail to undergo the EHT because of an apparent failure in opening up genomic loci essential for hematopoiesis. Under Vc deficiency, these loci exhibited abnormal accumulation of histone H3 trimethylation at Lys-27 (H3K27me3), a repressive histone modification that arose because of lower activities of demethylases that target H3K27me3. Consistently, deletion of the two H3K27me3 demethylases, Jumonji domain-containing 3 (JMJD3 or KDM6B) and histone demethylase UTX (UTX or KDM6A), impaired HPC generation even in the presence of Vc. Furthermore, we noted that Vc and jmjd3 are also important for HSC generation during zebrafish development. Together, our findings reveal an essential role for Vc in the EHT for hematopoiesis, and identify KDM6-mediated chromatin demethylation as an important regulatory mechanism in hematopoietic cell differentiation.	[Zhang, Tian; Huang, Ke; Zhu, Yanling; Wang, Tianyu; Shan, Yongli; Li, Yuhang; Chen, Qianyu; Wang, Pengtao; Zhao, Shaoyang; Li, Dongwei; Wu, Chuman; Kang, Baoqiang; Gu, Jiaming; Mai, Yuchan; Wang, Qing; Li, Jinbing; Zhang, Yanqi; Liang, Zechuan; Guo, Lin; Wu, Fang; Su, Shuquan; Wang, Junwei; Gao, Minghui; Zhong, Xiaofen; Liao, Baojian; Chen, Jiekai; Zhang, Xiao; Shu, Xiaodong; Pei, Duanqing; Nie, Jinfu; Pan, Guangjin] Guangzhou Med Univ, Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol,Joint Sch Life Sci, Guangzhou 510530, Guangdong, Peoples R China; [Zhang, Tian; Zhu, Yanling; Shan, Yongli; Gu, Jiaming; Li, Jinbing] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Tian; Huang, Ke; Zhu, Yanling; Wang, Tianyu; Shan, Yongli; Li, Yuhang; Chen, Qianyu; Wang, Pengtao; Zhao, Shaoyang; Li, Dongwei; Wu, Chuman; Kang, Baoqiang; Gu, Jiaming; Mai, Yuchan; Wang, Qing; Li, Jinbing; Zhang, Yanqi; Liang, Zechuan; Guo, Lin; Wu, Fang; Su, Shuquan; Wang, Junwei; Gao, Minghui; Zhong, Xiaofen; Liao, Baojian; Chen, Jiekai; Zhang, Xiao; Shu, Xiaodong; Pei, Duanqing; Nie, Jinfu; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Zhang, Tian; Huang, Ke; Liao, Baojian; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Hefei Inst Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Zhang, Tian; Huang, Ke] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China; [Zhang, Tian; Huang, Ke; Pan, Guangjin] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou 510005, Guangdong, Peoples R China; [Long, Bing] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou 510630, Guangdong, Peoples R China; [Nie, Jinfu] Chinese Acad Sci, Hefei Inst Phys Sci, Ctr Med Phys & Technol, Anhui Prov Key Lab Med Phys & Technol, Hefei 230031, Anhui, Peoples R China; [Nie, Jinfu] Chinese Acad Sci, Hefei Canc Hosp, Hefei 230031, Anhui, Peoples R China; [Pan, Guangjin] Shandong First Med Univ, Shandong Med Biotechnol Ctr, Jinan 250012, Shandong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Sun Yat Sen University; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Shandong First Medical University & Shandong Academy of Medical Sciences	Pan, GJ (corresponding author), Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave,Sci Pk, Guangzhou 510530, Guangdong, Peoples R China.	pan_guangjin@gibh.ac.cn	Wang, Tianyu/ABC-4758-2021; Liao, Baojian/AAI-6286-2021	Wang, Tianyu/0000-0003-4169-8268; Zhang, Yanqi/0000-0001-6896-8657; Su, Shuquan/0000-0003-3957-6325; Zhu, Yanling/0000-0003-4728-5421; Pan, Guangjin/0000-0002-2378-7198	National Key Research and Development Program of China, Stem Cell and Translational Research Grant [2017YFA0102601]; Strategic Priority Research Program of Chinese Academy of Sciences [XDA16030504]; Science and Technology Planning Project of Guangdong Province, China [2014B030301058]; Key Technology Innovation Special Grant from the Department of Science and Technology of Guangdong Province [2014B020225006, 2014B020225002, 2014B050504008, 2015B020228003, 2016B030230002, 2016B030229008]; Natural Science Foundation of Guangdong Province, China [2016A030313167]; National Basic Research Program of China, 973 Program of China [2015CB964900]; International Science and Technology Cooperation Program of China [2014DFA30180]; National Natural Science Foundation of China [31371514, 31421004, 31801225, 81571238, 81700149]; Natural Science Foundation of Guangdong Province [2014A030313801, 2014A030312012, 2015A030310229, 2015A030310254, 2017A030310376]; Science and Information Technology of Guangzhou Key Project [201508020258, 201506010092]; Guangzhou Science and Technology Program General project [201804010339]; Guangdong Province Special Program for Elite Scientists in Science and Technology Innovation [2015TX01R203]; Innovative Team Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory Grant [2018GZR110104005]	National Key Research and Development Program of China, Stem Cell and Translational Research Grant; Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Planning Project of Guangdong Province, China; Key Technology Innovation Special Grant from the Department of Science and Technology of Guangdong Province; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China, 973 Program of China(National Basic Research Program of China); International Science and Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Information Technology of Guangzhou Key Project; Guangzhou Science and Technology Program General project; Guangdong Province Special Program for Elite Scientists in Science and Technology Innovation; Innovative Team Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory Grant	This work was supported by National Key Research and Development Program of China, Stem Cell and Translational Research Grant 2017YFA0102601, Strategic Priority Research Program of Chinese Academy of Sciences Grant XDA16030504, Science and Technology Planning Project of Guangdong Province, China Grant 2017B030314056, Frontier and Key Technology Innovation Special Grant from the Department of Science and Technology of Guangdong Province Grants 2014B020225006, 2014B020225002, 2014B050504008, 2015B020228003, 2016B030230002, and 2016B030229008, Natural Science Foundation of Guangdong Province, China Grant 2016A030313167, the National Basic Research Program of China, 973 Program of China Grant 2015CB964900, International Science and Technology Cooperation Program of China Grant 2014DFA30180, National Natural Science Foundation of China Grants 31371514, 31421004, 31801225, 81571238, and 81700149 Cooperation Grant of Natural Science Foundation of Guangdong Province Grants 2014A030313801, 2014A030312012, 2015A030310229, 2015A030310254, and 2017A030310376, Science and Information Technology of Guangzhou Key Project Grants 201508020258 and 201506010092, Guangzhou Science and Technology Program General project Grant 201804010339, Science and Technology Planning Project of Guangdong Province, China Grant 2014B030301058, the Guangdong Province Special Program for Elite Scientists in Science and Technology Innovation Grant 2015TX01R203 (to G. P.), and Innovative Team Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory Grant 2018GZR110104005. The authors declare that they have no conflicts of interest with the contents of this article.	Ackermann M, 2015, EMBO MOL MED, V7, P1388, DOI 10.15252/emmm.201505301; Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cao ST, 2018, CELL STEM CELL, V22, P529, DOI 10.1016/j.stem.2018.03.005; Chanda B, 2013, CELL, V155, P215, DOI 10.1016/j.cell.2013.08.055; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Daniel MG, 2016, TRENDS CELL BIOL, V26, P202, DOI 10.1016/j.tcb.2015.10.002; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Ditadi A, 2017, NAT REV MOL CELL BIO, V18, P56, DOI 10.1038/nrm.2016.127; Ditadi A, 2015, NAT CELL BIOL, V17, P580, DOI 10.1038/ncb3161; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; He XB, 2015, STEM CELLS, V33, P1320, DOI 10.1002/stem.1932; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huang K, 2016, STEM CELL REP, V7, P854, DOI 10.1016/j.stemcr.2016.09.008; Huang Ke, 2015, Cell Regen, V4, P4, DOI 10.1186/s13619-015-0018-7; Hutchins AP, 2015, SCI REP-UK, V5, DOI 10.1038/srep09100; Hutchins Andrew Paul, 2014, Cell Regen, V3, P1, DOI 10.1186/2045-9769-3-1; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kirkwood JS, 2012, J BIOL CHEM, V287, P3833, DOI 10.1074/jbc.M111.316018; Li DW, 2017, CELL STEM CELL, V21, P819, DOI 10.1016/j.stem.2017.10.012; Li Z, 2013, J GENET GENOMICS, V40, P557, DOI 10.1016/j.jgg.2013.09.001; Liu J, 2015, NAT CELL BIOL, V17, P1228, DOI 10.1038/ncb3235; Loh KM, 2016, CELL, V166, P451, DOI 10.1016/j.cell.2016.06.011; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Miller GW, 2012, J NUTR BIOCHEM, V23, P478, DOI 10.1016/j.jnutbio.2011.02.002; Mingay M, 2018, LEUKEMIA, V32, P11, DOI 10.1038/leu.2017.171; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Shan YL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00668-4; Sharma S, 2016, INT J STEM CELLS, V9, P36, DOI 10.15283/ijsc.2016.9.1.36; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI 10.1038/nbt.2915; Sturgeon CM, 2013, NAT BIOTECHNOL, V31, P416, DOI 10.1038/nbt.2571; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vo LT, 2018, NATURE, V553, P506, DOI 10.1038/nature25435; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wang CY, 2012, CELL RES, V22, P194, DOI 10.1038/cr.2011.138; Wang HT, 2018, STEM CELL REP, V10, P447, DOI 10.1016/j.stemcr.2017.12.017; Wang WQ, 2017, FASEB J, V31, P1130, DOI 10.1096/fj.201600782R; Wei YL, 2014, BLOOD, V124, P1578, DOI 10.1182/blood-2013-11-541391; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573; Yu SH, 2018, BBA-GENE REGUL MECH, V1861, P106, DOI 10.1016/j.bbagrm.2017.12.009	48	26	26	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13657	13670		10.1074/jbc.RA119.009757	http://dx.doi.org/10.1074/jbc.RA119.009757			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31341023	hybrid, Green Published			2022-12-28	WOS:000486418600012
J	Agrotis, A; von Chamier, L; Oliver, H; Kiso, K; Singh, T; Ketteler, R				Agrotis, Alexander; von Chamier, Lucas; Oliver, Harriet; Kiso, Koshiro; Singh, Tanya; Ketteler, Robin			Human ATG4 autophagy proteases counteract attachment of ubiquitin-like LC3/GABARAP proteins to other cellular proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; cysteine protease; deubiquitylation (deubiquitination); post-translational modification; ubiquitin-conjugating enzyme (E2 enzyme); ATG4B; Atg8; deconjugation; GABARAPL2; LC3ylation	CONJUGATION SYSTEM; ATG8-PE DECONJUGATION; E2 ENZYME; LC3; GABARAP; GATE-16; HOMOLOG; COMPLEX; PHOSPHATIDYLETHANOLAMINE; DEGRADATION	Microtubule-associated protein 1 light chain 3 alpha (LC3)/GABA type A receptor-associated protein (GABARAP) comprises a family of ubiquitin-like proteins involved in (macro)autophagy, an important intracellular degradation pathway that delivers cytoplasmic material to lysosomes via double-membrane vesicles called autophagosomes. The only currently known cellular molecules covalently modified by LC3/GABARAP are membrane phospholipids such as phosphatidylethanolamine in the autophagosome membrane. Autophagy-related 4 cysteine peptidase (ATG4) proteases process inactive pro-LC3/GABARAP before lipidation, and the same proteases can also deconjugate LC3/GABARAP from lipids. To determine whether LC3/GABARAP has other molecular targets, here we generated a pre-processed LC3B mutant (Q116P) that is resistant to ATG4-mediated deconjugation. Upon expression in human cells and when assessed by immunoblotting under reducing and denaturing conditions, deconjugation-resistant LC3B accumulated in multiple forms and at much higher molecular weights than free LC3B. We observed a similar accumulation when pre-processed versions of all mammalian LC3/GABARAP isoforms were expressed in ATG4-deficient cell lines, suggesting that LC3/GABARAP can attach also to other larger molecules. We identified ATG3, the E2-like enzyme involved in LC3/GABARAP lipidation, as one target of conjugation with multiple copies of LC3/GABARAP. We show that LC3B-ATG3 conjugates are distinct from the LC3B-ATG3 thioester intermediate formed before lipidation, and we biochemically demonstrate that ATG4B can cleave LC3B-ATG3 conjugates. Finally, we determined ATG3 residue Lys-243 as an LC3B modification site. Overall, we provide the first cellular evidence that mammalian LC3/GABARAP post-translationally modifies proteins akin to ubiquitination (LC3ylation), with ATG4 proteases acting like deubiquitinating enzymes to counteract this modification (deLC3ylation).	[Agrotis, Alexander; von Chamier, Lucas; Oliver, Harriet; Kiso, Koshiro; Singh, Tanya; Ketteler, Robin] UCL, MRC, Lab Mol Cell Biol, London WC1E 6BT, England	University of London; University College London	Ketteler, R (corresponding author), UCL, MRC, Lab Mol Cell Biol, London WC1E 6BT, England.	r.ketteler@ucl.ac.uk	Agrotis, Alexander/AAW-8562-2021	Agrotis, Alexander/0000-0002-4875-4499; Kiso, Koshiro/0000-0002-0908-6723; Oliver, Harriet/0000-0003-3640-3453	UK Medical Research Council [MC_U12266B]; MRC Dementia Platform Grant UK [MR/M02492X/1]; Wellcome Trust [105604/Z/14/Z]; BBSRC [BB/J015881/1] Funding Source: UKRI; MRC [MR/M02492X/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Dementia Platform Grant UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by UK Medical Research Council core funding to the MRC-UCL University Unit Grant Ref MC_U12266B, MRC Dementia Platform Grant UK MR/M02492X/1, and Wellcome Trust Grant 105604/Z/14/Z. The authors declare that they have no conflicts of interest with the contents of this article.	Agrotis A, 2019, AUTOPHAGY, V15, P976, DOI 10.1080/15548627.2019.1569925; Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Bai H, 2012, ONCOGENE, V31, P4397, DOI 10.1038/onc.2011.613; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bekes M, 2013, CELL REP, V5, P826, DOI 10.1016/j.celrep.2013.10.008; Bekes M, 2011, J BIOL CHEM, V286, P10238, DOI 10.1074/jbc.M110.205153; Berger AH, 2016, CANCER CELL, V30, P214, DOI 10.1016/j.ccell.2016.06.022; Costa JR, 2016, ONCOTARGET, V7, P41203, DOI 10.18632/oncotarget.9754; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fass E, 2007, AUTOPHAGY, V3, P48, DOI 10.4161/auto.3417; Frudd K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02352-z; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hanada T, 2009, FEBS LETT, V583, P1078, DOI 10.1016/j.febslet.2009.03.009; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Ketteler R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r64; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Legesse-Miller A, 2000, J BIOL CHEM, V275, P32966, DOI 10.1074/jbc.M000917200; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Murrow L, 2015, NAT CELL BIOL, V17, P300, DOI 10.1038/ncb3112; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Ngu M, 2015, J BIOL CHEM, V290, P8146, DOI 10.1074/jbc.M114.626952; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pengo N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00303-2; Petschnigg J, 2014, NAT METHODS, V11, P585, DOI [10.1038/NMETH.2895, 10.1038/nmeth.2895]; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Sanchez-Wandelmer J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00302-3; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Scherz-Shouval R, 2003, J BIOL CHEM, V278, P14053, DOI 10.1074/jbc.M212108200; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tanida I, 2006, FEBS J, V273, P2553, DOI 10.1111/j.1742-4658.2006.05260.x; Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074222; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yang ZF, 2015, J BIOL CHEM, V290, P26549, DOI 10.1074/jbc.M115.658088; Yu ZQ, 2012, AUTOPHAGY, V8, P883, DOI 10.4161/auto.19652	70	23	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12610	12621		10.1074/jbc.AC119.009977	http://dx.doi.org/10.1074/jbc.AC119.009977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31315929	Green Published, hybrid			2022-12-28	WOS:000484414600005
J	Sengupta, R; Coppo, L; Mishra, P; Holmgren, A				Sengupta, Rajib; Coppo, Lucia; Mishra, Pradeep; Holmgren, Arne			Glutathione-glutaredoxin is an efficient electron donor system for mammalian p53R2-R1-dependent ribonucleotide reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thioredoxin; ribonucleotide reductase; DNA replication; DNA repair; enzyme kinetics; antioxidant system; cell cycle; deoxyribonucleotide; glutaredoxin; Glutathione	ESCHERICHIA-COLI; ALLOSTERIC REGULATION; RECOMBINANT MOUSE; DNA-DAMAGE; THIOREDOXIN; MITOCHONDRIAL; SUBUNIT; DEOXYRIBONUCLEOTIDES; PURIFICATION; RESIDUES	Deoxyribonucleotides are DNA building blocks and are produced de novo by reduction of ribose to deoxyribose. This reduction is catalyzed by ribonucleotide reductase (RNR), a heterodimeric tetramer enzyme in mammalian cells, having one of two free radical-containing subunits called R2 and p53R2. R2 is S-phase specific and used for DNA replication, whereas p53R2 functions in DNA repair and mitochondrial DNA synthesis. The larger RNR subunit, R1, has catalytically active cysteine thiols in its buried active site and a C-terminal swinging arm, with a Cys-Leu-Met-Cys sequence suggested to act as a shuttle dithiol/disulfide for electron transport. After each catalytic cycle the active site contains a disulfide, which has to be reduced for turnover. Thioredoxin (Trx) and glutaredoxin (Grx) systems have been implicated as electron donors for the RNR disulfide reduction via the swinging arm. Using mouse R1-R2 and R1-p53R2 complexes, we found here that the catalytic efficiency of the GSH-Grx system is 4-6 times higher than that of the Trx1 system. For both complexes, the V-max values for Grx are strongly depended on GSH concentrations. The GSH disulfide resulting from the Grx reaction was reduced by NADPH and GSH reductase and this enzyme was essential because reaction with GSH alone yielded only little activity. These results indicate that C-terminal shuttle dithiols of mammalian R1 have a crucial catalytic role and that the GSH-Grx system favors the R1-p53R2 enzyme for DNA replication in hypoxic conditions, mitochondrial DNA synthesis, and in DNA repair outside the S-phase.	[Sengupta, Rajib; Coppo, Lucia; Mishra, Pradeep; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden	Karolinska Institutet	Holmgren, A (corresponding author), Karolinska Inst, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se	SENGUPTA, RAJIB/AGY-3587-2022	SENGUPTA, RAJIB/0000-0002-9665-8784; Holmgren, Arne/0000-0001-5046-1815; COPPO, LUCIA/0000-0001-6902-6346	Swedish Cancer Society [961]; Swedish Research Council Medicine Grant [13X-3529]; K& A Wallenberg Foundation; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council Medicine Grant; K& A Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet)	This work was supported by Swedish Cancer Society Grant 961, Swedish Research Council Medicine Grant 13X-3529, the K& A Wallenberg Foundation, and grants from Karolinska Institutet. The authors declare that they have no conflicts of interest with the contents of this article.	ABERG A, 1989, J BIOL CHEM, V264, P12249; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Bucurenci N, 1996, J BIOL CHEM, V271, P2856, DOI 10.1074/jbc.271.5.2856; Coppo L, 2016, ANAL BIOCHEM, V499, P24, DOI 10.1016/j.ab.2016.01.012; DAVIS R, 1994, J BIOL CHEM, V269, P23171; DETHLEFSEN LA, 1988, RADIAT RES, V114, P215, DOI 10.2307/3577219; Du YT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392225; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Foskolou IP, 2017, MOL CELL, V66, P206, DOI 10.1016/j.molcel.2017.03.005; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; Holmgren A, 2010, FREE RADICAL BIO MED, V49, P1617, DOI 10.1016/j.freeradbiomed.2010.09.005; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Johansson C, 2011, BIOCHEM J, V433, P303, DOI 10.1042/BJ20101286; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LIN ANI, 1987, BIOCHEMISTRY-US, V26, P6905, DOI 10.1021/bi00396a006; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Mandal PK, 2010, CANCER RES, V70, P9505, DOI 10.1158/0008-5472.CAN-10-1509; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Markovic J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006413; Montano SJ, 2014, ANAL BIOCHEM, V449, P139, DOI 10.1016/j.ab.2013.12.025; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Prigge JR, 2017, CELL REP, V19, P2771, DOI 10.1016/j.celrep.2017.06.019; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rollins MF, 2010, J CELL SCI, V123, P2402, DOI 10.1242/jcs.068106; Sengupta Rajib, 2014, World J Biol Chem, V5, P68, DOI 10.4331/wjbc.v5.i1.68; Stubbe J, 2000, CURR OPIN STRUC BIOL, V10, P731, DOI 10.1016/S0959-440X(00)00153-6; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Yang F, 2018, J PROTEOME RES, V17, P1091, DOI 10.1021/acs.jproteome.7b00761; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P2217, DOI 10.1073/pnas.0611095104	45	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12708	12716		10.1074/jbc.RA119.008752	http://dx.doi.org/10.1074/jbc.RA119.008752			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31266802	Green Published, hybrid			2022-12-28	WOS:000484414600013
J	Chen, PYT; DeColli, AA; Meyers, CLF; Drennan, CL				Chen, Percival Yang-Ting; DeColli, Alicia A.; Meyers, Caren L. Freel; Drennan, Catherine L.			X-ray crystallography-based structural elucidation of enzyme-bound intermediates along the 1-deoxy-d-xylulose 5-phosphate synthase reaction coordinate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; pyruvate; decarboxylase; crystallography; bacterial metabolism; 1-deoxy-D-xylulose 5-phosphate synthase (DXPS); conformational dynamics; DXP synthase; methylerythritol phosphate (MEP) pathway; thiamine diphosphate (ThDP)	THIAMIN DIPHOSPHATE; PYRUVATE-DEHYDROGENASE; CRYSTAL-STRUCTURE; RATE CONSTANTS; DXP SYNTHASE; OXIDOREDUCTASE; BIOSYNTHESIS; INHIBITION; COMPLEX; BINDING	1-Deoxy-d-xylulose 5-phosphate synthase (DXPS) uses thiamine diphosphate (ThDP) to convert pyruvate and d-glyceraldehyde 3-phosphate (d-GAP) into 1-deoxy-d-xylulose 5-phosphate (DXP), an essential bacterial metabolite. DXP is not utilized by humans; hence, DXPS has been an attractive antibacterial target. Here, we investigate DXPS from Deinococcus radiodurans (DrDXPS), showing that it has similar kinetic parameters K-m(d-GAP) andK(m)(pyruvate) (54 +/- 3 and 11 +/- 1 mu m, respectively) and comparable catalytic activity (k(cat) = 45 +/- 2 min(-1)) with previously studied bacterial DXPS enzymes and employing it to obtain missing structural data on this enzyme family. In particular, we have determined crystallographic snapshots of DrDXPS in two states along the reaction coordinate: a structure of DrDXPS bound to C2 alpha-phosphonolactylThDP (PLThDP), mimicking the native pre-decarboxylation intermediate C2 alpha-lactylThDP (LThDP), and a native post-decarboxylation state with a bound enamine intermediate. The 1.94-angstrom-resolution structure of PLThDP-bound DrDXPS delineates how two active-site histidine residues stabilize the LThDP intermediate. Meanwhile, the 2.40-angstrom-resolution structure of an enamine intermediate-bound DrDXPS reveals how a previously unknown 17-angstrom conformational change removes one of the two histidine residues from the active site, likely triggering LThDP decarboxylation to form the enamine intermediate. These results provide insight into how the bi-substrate enzyme DXPS limits side reactions by arresting the reaction on the less reactive LThDP intermediate when its cosubstrate is absent. They also offer a molecular basis for previous low-resolution experimental observations that correlate decarboxylation of LThDP with protein conformational changes.	[Chen, Percival Yang-Ting; Drennan, Catherine L.] MIT, Dept Chem, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [DeColli, Alicia A.; Meyers, Caren L. Freel] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Johns Hopkins University	Drennan, CL (corresponding author), MIT, Dept Chem, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Dept Biol, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA.; Meyers, CLF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	cmeyers@jhmi.edu; cdrennan@mit.edu		Drennan, Catherine/0000-0001-5486-2755; Chen, Percival Yang-Ting/0000-0001-7362-9801	National Institutes of Health [R35 GM126982, R01 GM084998]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM124165, T32GM008763, R01GM084998, R35GM126982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35 GM126982 (to C. L. D.) and R01 GM084998 (C. L. F. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Balakrishnan A, 2012, J AM CHEM SOC, V134, P18644, DOI 10.1021/ja3062375; Bartee D, 2018, ACCOUNTS CHEM RES, V51, P2546, DOI 10.1021/acs.accounts.8b00321; Bartee D, 2018, BIOCHEMISTRY-US, V57, P4349, DOI 10.1021/acs.biochem.8b00548; Basta LAB, 2014, FEBS J, V281, P2820, DOI 10.1111/febs.12823; Battistini MR, 2016, PROTEIN EXPRES PURIF, V120, P16, DOI 10.1016/j.pep.2015.12.003; Brammer LA, 2011, J BIOL CHEM, V286, P36522, DOI 10.1074/jbc.M111.259747; Brammer LA, 2009, ORG LETT, V11, P4748, DOI 10.1021/ol901961q; Chen PYT, 2019, JOULE, V3, P595, DOI 10.1016/j.joule.2018.12.006; Chen PYT, 2018, P NATL ACAD SCI USA, V115, P3846, DOI 10.1073/pnas.1722329115; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Costelloe SJ, 2008, J MOL EVOL, V66, P36, DOI 10.1007/s00239-007-9056-2; DeColli AA, 2018, J BIOL CHEM, V293, P10857, DOI 10.1074/jbc.RA118.001980; Du QL, 2011, INT J BIOL SCI, V7, P41, DOI 10.7150/ijbs.7.41; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eubanks LM, 2003, BIOCHEMISTRY-US, V42, P1140, DOI 10.1021/bi0205303; Gibson MI, 2016, CURR OPIN STRUC BIOL, V41, P54, DOI 10.1016/j.sbi.2016.05.011; Gibson MI, 2016, P NATL ACAD SCI USA, V113, P320, DOI 10.1073/pnas.1518537113; Handa Sumit, 2018, Biochem Mol Biol J, V4, DOI 10.21767/2471-8084.100051; Jordan F, 2005, BIOORG CHEM, V33, P190, DOI 10.1016/j.bioorg.2005.02.001; Jordan F, 2002, BIOORG CHEM, V30, P188, DOI 10.1006/bioo.2002.1249; Jordan F, 2014, BIOORG CHEM, V57, P251, DOI 10.1016/j.bioorg.2014.08.002; Kale S, 2007, J BIOL CHEM, V282, P28106, DOI 10.1074/jbc.M704326200; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon S, 1996, BIOCHEMISTRY-US, V35, P15814, DOI 10.1021/bi9615598; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morris F, 2013, CHEMBIOCHEM, V14, P1309, DOI 10.1002/cbic.201300187; Mukherjee T, 2011, BBA-PROTEINS PROTEOM, V1814, P1585, DOI 10.1016/j.bbapap.2011.06.018; Nemeria N, 2004, BIOCHEMISTRY-US, V43, P6565, DOI 10.1021/bi049549r; Nemeria NS, 2016, BIOCHEMISTRY-US, V55, P1135, DOI 10.1021/acs.biochem.5b01300; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; OBRIEN TA, 1980, BIOCHIM BIOPHYS ACTA, V613, P10, DOI 10.1016/0005-2744(80)90186-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel H, 2014, BIOCHEMISTRY-US, V53, P2145, DOI 10.1021/bi4015743; Patel H, 2012, J AM CHEM SOC, V134, P18374, DOI 10.1021/ja307315u; Querol-Audi J., 2014, CATALYTICALLY IMPORT; Reed GH, 2012, BBA-PROTEINS PROTEOM, V1824, P1291, DOI 10.1016/j.bbapap.2011.11.010; Sanders S, 2017, ACS INFECT DIS, V3, P467, DOI 10.1021/acsinfecdis.6b00168; Smith JM, 2014, J ANTIBIOT, V67, P77, DOI 10.1038/ja.2013.105; Smith JM, 2012, MEDCHEMCOMM, V3, P65, DOI 10.1039/c1md00233c; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; TURANO A, 1982, J AM CHEM SOC, V104, P3089, DOI 10.1021/ja00375a024; Wang X, 2018, ACS INFECT DIS, V4, P278, DOI 10.1021/acsinfecdis.7b00176; White JK, 2016, J PHYS CHEM B, V120, P9922, DOI 10.1021/acs.jpcb.6b07248; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200; Zhou JY, 2017, P NATL ACAD SCI USA, V114, P9355, DOI 10.1073/pnas.1619981114	50	12	12	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12405	12414		10.1074/jbc.RA119.009321	http://dx.doi.org/10.1074/jbc.RA119.009321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31239351	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000484402700013
J	Tam, SW; Feng, R; Lau, WKW; Law, ACK; Yeung, PKK; Chung, SK				Tam, Sze-Wah; Feng, Rui; Lau, Way Kwok-Wai; Law, Andrew Chi-Kin; Yeung, Patrick Ka-Kit; Chung, Sookja Kim			Endothelin type B receptor promotes cofilin rod formation and dendritic loss in neurons by inducing oxidative stress and cofilin activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cofilin; dendrite; NADPH oxidase; oxidative stress; neurodegeneration; Alzheimer's disease; endothelin type B receptor; endothelin-1	ACTIN REORGANIZATION; ALZHEIMERS-DISEASE; NADPH OXIDASE; EXPRESSION; PROLIFERATION; DYSFUNCTION; ASTROCYTES; SLINGSHOT; IMMUNOREACTIVITY; MITOCHONDRIAL	Endothelin-1 (ET-1) is a neuroactive peptide produced by neurons, reactive astrocytes, and endothelial cells in the brain. Elevated levels of ET-1 have been detected in the post-mortem brains of individuals with Alzheimer's disease (AD). We have previously demonstrated that overexpression of astrocytic ET-1 exacerbates memory deficits in aged mice or in APP(K670/M671) mutant mice. However, the effects of ET-1 on neuronal dysfunction remain elusive. ET-1 has been reported to mediate superoxide formation in the vascular system via NADPH oxidase (NOX) and to regulate the actin cytoskeleton of cancer cell lines via the cofilin pathway. Interestingly, oxidative stress and cofilin activation were both reported to mediate one of the AD histopathologies, cofilin rod formation in neurons. This raises the possibility that ET-1 mediates neurodegeneration via oxidative stress- or cofilin activation-driven cofilin rod formation. Here, we demonstrate that exposure to 100 nm ET-1 or to a selective ET type B receptor (ETB) agonist (IRL1620) induces cofilin rod formation in dendrites of primary hippocampal neurons, accompanied by a loss of distal dendrites and a reduction in dendritic length. The 100 nm IRL1620 exposure induced superoxide formation and cofilin activation, which were abolished by pretreatment with a NOX inhibitor (5 mu m VAS2870). Moreover, IRL1620-induced cofilin rod formation was partially abolished by pretreatment with a calcineurin inhibitor (100 nm FK506), which suppressed cofilin activation. In conclusion, our findings suggest a role for ETB in neurodegeneration by promoting cofilin rod formation and dendritic loss via NOX-driven superoxide formation and cofilin activation.	[Tam, Sze-Wah; Feng, Rui; Yeung, Patrick Ka-Kit; Chung, Sookja Kim] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Tam, Sze-Wah; Lau, Way Kwok-Wai; Law, Andrew Chi-Kin] Univ Hong Kong, Dept Psychiat, Hong Kong, Peoples R China; [Chung, Sookja Kim] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Peoples R China; [Chung, Sookja Kim] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Peoples R China; [Lau, Way Kwok-Wai] Educ Univ Hong Kong, Dept Special Educ & Counseling, Hong Kong, Peoples R China; [Law, Andrew Chi-Kin] Perdana Univ, Dept Psychiat, Royal Coll Surg Ireland, Selangor, Malaysia	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Education University of Hong Kong (EdUHK); Perdana University; Royal College of Surgeons - Ireland	Tam, SW (corresponding author), Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China.; Tam, SW (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Peoples R China.; Chung, SK (corresponding author), Univ Hong Kong, Fac Med, Sch Biomed Sci, Pokfulam, 21 Sassoon Rd, Hong Kong, Peoples R China.	cathy_tsw@connect.hku.hk; skchung@hku.hk		Lau, Way/0000-0003-1493-5002	University Grants Council of Hong Kong on "Molecular Neuroscience: Basic Research and Drug Discovery" [AoE/B-15/01]; University of Hong Kong	University Grants Council of Hong Kong on "Molecular Neuroscience: Basic Research and Drug Discovery"; University of Hong Kong(University of Hong Kong)	This work was supported by a generous donation from the Henderson Warmth Foundation and Chow Tai Fook Charity Foundation for dementia research (to A. C.-K. L.), the Research Grants Council and the University Grants Council of Hong Kong on "Molecular Neuroscience: Basic Research and Drug Discovery" (Grant AoE/B-15/01), and University of Hong Kong matching funds for the State Key Laboratory of Pharmaceutical Biotechnology (to S. K. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Briyal S, 2015, NEUROSCIENCE, V301, P1, DOI 10.1016/j.neuroscience.2015.05.044; Briyal S, 2014, PHARMACOL BIOCHEM BE, V120, P65, DOI 10.1016/j.pbb.2014.02.008; Briyal S, 2011, J ALZHEIMERS DIS, V23, P491, DOI 10.3233/JAD-2010-101245; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Dong F, 2005, BRIT J PHARMACOL, V145, P323, DOI 10.1038/sj.bjp.0706193; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Grimm A, 2018, ISCIENCE, V6, P114, DOI 10.1016/j.isci.2018.07.015; Heneka MT, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-22; Hung K. L. V., 2008, THESIS, DOI [10.5353/th_b4218198, DOI 10.5353/TH_B4218198]; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Koizumi K, 2016, CELL MOL NEUROBIOL, V36, P155, DOI 10.1007/s10571-015-0256-9; Koyama Y, 1996, GLIA, V16, P342, DOI 10.1002/(SICI)1098-1136(199604)16:4<342::AID-GLIA6>3.0.CO;2-1; Li JJ, 2010, NEUROSCIENCE, V167, P665, DOI 10.1016/j.neuroscience.2010.02.062; Li LX, 2003, CIRCULATION, V107, P1053, DOI 10.1161/01.CIR.0000051459.74466.46; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Loomis ED, 2005, J PHARMACOL EXP THER, V315, P1058, DOI 10.1124/jpet.105.091728; MINAMI M, 1995, PROG NEURO-PSYCHOPH, V19, P509, DOI 10.1016/0278-5846(95)00031-P; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Minton AZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043199; Morigi M, 2006, AM J PATHOL, V169, P1965, DOI 10.2353/ajpath.2006.051331; Naidoo V, 2004, J CHEM NEUROANAT, V27, P87, DOI 10.1016/j.jchemneu.2003.12.002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Palmer JC, 2012, J ALZHEIMERS DIS, V29, P853, DOI 10.3233/JAD-2012-111760; Panettieri RA, 1996, BRIT J PHARMACOL, V118, P191, DOI 10.1111/j.1476-5381.1996.tb15385.x; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Rahman T, 2014, J ALZHEIMERS DIS, V42, P1443, DOI 10.3233/JAD-140393; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sato Y, 2000, AM J RESP CELL MOL, V23, P404, DOI 10.1165/ajrcmb.23.3.4057; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Semprucci E, 2016, ONCOGENE, V35, P3432, DOI 10.1038/onc.2015.403; Walsh KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095995; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Woo JA, 2015, CELL DEATH DIFFER, V22, P921, DOI 10.1038/cdd.2015.5; ZHANG WW, 1994, J NEUROL SCI, V122, P90, DOI 10.1016/0022-510X(94)90057-4	43	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12495	12506		10.1074/jbc.RA118.005155	http://dx.doi.org/10.1074/jbc.RA118.005155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248984	hybrid, Green Published			2022-12-28	WOS:000484402700020
J	Doden, HL; Pollet, RM; Mythen, SM; Wawrzaki, Z; Devendran, S; Cann, I; Koropatkin, NM; Ridlon, JM				Doden, Heidi L.; Pollet, Rebecca M.; Mythen, Sean M.; Wawrzaki, Zdzislaw; Devendran, Saravanan; Cann, Isaac; Koropatkin, Nicole M.; Ridlon, Jason M.			Structural and biochemical characterization of 20 beta-hydroxysteroid dehydrogenase from Bifidobacterium adolescentis strain L2-32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microbiome; probiotic; androgen; glucocorticoid; oxidation-reduction (redox); 20 beta-hydroxysteroid dehydrogenase; Bifidobacteria; C-20 reduction; cortisol; Steroid-17; 20-desmolase	3-ALPHA,20-BETA-HYDROXYSTEROID DEHYDROGENASE; URINARY-EXCRETION; 21-DEHYDROXYLASE; CORTICOSTEROIDS; DESMOLANS; BACTERIUM; CORTISOL; FEATURES; PLASMA	Anaerobic bacteria inhabiting the human gastrointestinal tract have evolved various enzymes that modify host-derived steroids. The bacterial steroid-17,20-desmolase pathway cleaves the cortisol side chain, forming pro-androgens predicted to impact host physiology. Bacterial 20 beta-hydroxysteroid dehydrogenase (20 beta-HSDH) regulates cortisol side-chain cleavage by reducing the C-20 carboxyl group on cortisol, yielding 20 beta-dihydrocortisol. Recently, the gene encoding 20 beta-HSDH in Butyricicoccus desmolans ATCC 43058 was reported, and a nonredundant protein search yielded a candidate 20 beta-HSDH gene in Bifidobacterium adolescentis strain L2-32. B. adolescentis 20 beta-HSDH could regulate cortisol side-chain cleavage by limiting pro-androgen formation in bacteria such as Clostridium scindens and 21-dehydroxylation by Eggerthella lenta. Here, the putative B. adolescentis 20 beta-HSDH was cloned, overexpressed, and purified. 20 beta-HSDH activity was confirmed through whole-cell and pure enzymatic assays, and it is specific for cortisol. Next, we solved the structures of recombinant 20 beta-HSDH in both the apo- and holo-forms at 2.0-2.2 angstrom resolutions, revealing close overlap except for rearrangements near the active site. Interestingly, the structures contain a large, flexible N-terminal region that was investigated by gel-filtration chromatography and CD spectroscopy. This extended N terminus is important for protein stability because deletions of varying lengths caused structural changes and reduced enzymatic activity. A nonconserved extended N terminus was also observed in several short-chain dehydrogenase/reductase family members. B. adolescentis strains capable of 20 beta-HSDH activity could alter glucocorticoid metabolism in the gut and thereby serve as potential probiotics for the management of androgen-dependent diseases.	[Doden, Heidi L.; Mythen, Sean M.; Devendran, Saravanan; Cann, Isaac; Ridlon, Jason M.] Carl R Woese Inst Genom Biol, Microbiome Metab Engn Theme, Urbana, IL 61801 USA; [Doden, Heidi L.; Mythen, Sean M.; Devendran, Saravanan; Cann, Isaac; Ridlon, Jason M.] Univ Illinois, Dept Anim Sci, 1207 Gregory Dr, Urbana, IL 61801 USA; [Cann, Isaac] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Ridlon, Jason M.] Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA; [Ridlon, Jason M.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Pollet, Rebecca M.; Koropatkin, Nicole M.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Wawrzaki, Zdzislaw] Northwestern Univ, Northwestern Synchrotron Res Ctr LS CAT, Argonne, IL 60439 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan; Northwestern University	Ridlon, JM (corresponding author), Univ Illinois, Dept Anim Sci, 1207 Gregory Dr, Urbana, IL 61801 USA.	jmridlon@illinois.edu	Devendran, Saravanan/D-5140-2013	Devendran, Saravanan/0000-0002-1540-5241; Doden, Heidi/0000-0002-9282-5645	new faculty Start-up Grant Hatch through the Department of Animal Sciences, University of Illinois at Urbana-Champaign [ILLU-538-916]	new faculty Start-up Grant Hatch through the Department of Animal Sciences, University of Illinois at Urbana-Champaign	This work was supported by new faculty Start-up Grant Hatch ILLU-538-916 through the Department of Animal Sciences, University of Illinois at Urbana-Champaign (to J.M.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BOKKENHEUSER VD, 1984, J INFECT DIS, V149, P489, DOI 10.1093/infdis/149.4.489; BOKKENHEUSER VD, 1986, APPL ENVIRON MICROB, V52, P1153, DOI 10.1128/AEM.52.5.1153-1156.1986; Cho HJ, 2009, ANAL CHIM ACTA, V632, P101, DOI 10.1016/j.aca.2008.10.059; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; D'Errico I, 2008, CELL MOL LIFE SCI, V65, P1523, DOI 10.1007/s00018-008-7552-1; Devendran S, 2018, J LIPID RES, V59, P1005, DOI 10.1194/jlr.M083949; Devendran S, 2017, J LIPID RES, V58, P916, DOI 10.1194/jlr.M074914; Devlin AS, 2015, NAT CHEM BIOL, V11, P685, DOI [10.1038/NCHEMBIO.1864, 10.1038/nchembio.1864]; EDENHARDER R, 1985, APPL ENVIRON MICROB, V49, P964, DOI 10.1128/AEM.49.4.964-968.1985; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEIGHNER SC, 1980, J LIPID RES, V21, P585; FEIGHNER SD, 1979, BIOCHIM BIOPHYS ACTA, V574, P154, DOI 10.1016/0005-2760(79)90094-8; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; GHOSH D, 1994, STRUCTURE, V2, P973, DOI 10.1016/S0969-2126(94)00099-9; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; KORNEL L, 1975, J CLIN ENDOCR METAB, V40, P949, DOI 10.1210/jcem-40-6-949; KRIEGER DT, 1971, J CLIN ENDOCR METAB, V32, P266, DOI 10.1210/jcem-32-2-266; Latif SA, 2005, MOL CELL ENDOCRINOL, V243, P43, DOI 10.1016/j.mce.2005.08.006; Lee JH, 2010, MICROBIOL MOL BIOL R, V74, P378, DOI 10.1128/MMBR.00004-10; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morgan RA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10410-1; Morris DJ, 2017, STEROIDS, V125, P1, DOI 10.1016/j.steroids.2017.06.002; Mythen SM, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02475-17; O'Toole PW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.57; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281; Pretorius E, 2017, MOL CELL ENDOCRINOL, V441, P76, DOI 10.1016/j.mce.2016.08.014; Pretorius E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159867; Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483; Ridlon JM, 2013, J LIPID RES, V54, P2437, DOI 10.1194/jlr.M038869; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROMANOFF LP, 1959, J CLIN ENDOCR METAB, V19, P819, DOI 10.1210/jcem-19-7-819; ROSSMANN MG, 1972, J MOL BIOL, V64, P237, DOI 10.1016/0022-2836(72)90332-4; SCHONESHOFER M, 1983, CLIN CHEM, V29, P385; Storbeck KH, 2013, MOL CELL ENDOCRINOL, V377, P135, DOI 10.1016/j.mce.2013.07.006; Takeshita D, 2014, AMB EXPRESS, V4, DOI 10.1186/2191-0855-4-6; Tickle I.J., 2018, STARANISO; Tissier H, 1900, THESIS; Tokarz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054851; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WINTER J, 1982, J STEROID BIOCHEM, V17, P661, DOI 10.1016/0022-4731(82)90568-4; YOSHIOKA H, 1991, BIFIDOBACTERIA MICRO, V10, P11, DOI DOI 10.12938/bifidus1982.10.1_11; Zhang RZ, 2008, PROTEIN SCI, V17, P1412, DOI 10.1110/ps.035089.108	49	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12040	12053		10.1074/jbc.RA119.009390	http://dx.doi.org/10.1074/jbc.RA119.009390			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31209107	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000484284500009
J	Gross, AS; Zimmermann, A; Pendl, T; Schroeder, S; Schoenlechner, H; Knittelfelder, O; Lamplmayr, L; Santiso, A; Aufschnaiter, A; Waltenstorfer, D; Lara, SO; Stryeck, S; Kast, C; Ruckenstuhl, C; Hofer, SJ; Michelitsch, B; Woelflingseder, M; Muller, R; Carmona-Gutierrez, D; Madl, T; Buttner, S; Frohlich, KU; Shevchenko, A; Eisenberg, T				Gross, Angelina S.; Zimmermann, Andreas; Pendl, Tobias; Schroeder, Sabrina; Schoenlechner, Hannes; Knittelfelder, Oskar; Lamplmayr, Laura; Santiso, Ana; Aufschnaiter, Andreas; Waltenstorfer, Daniel; Lara, Sandra Ortonobes; Stryeck, Sarah; Kast, Christina; Ruckenstuhl, Christoph; Hofer, Sebastian J.; Michelitsch, Birgit; Woelflingseder, Martina; Mueller, Rolf; Carmona-Gutierrez, Didac; Madl, Tobias; Buettner, Sabrina; Froehlich, Kai-Uwe; Shevchenko, Andrej; Eisenberg, Tobias			Acetyl-CoA carboxylase 1-dependent lipogenesis promotes autophagy downstream of AMPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); acetate; aging; autophagy; lipid metabolism; yeast; Acc1; acetyl-CoA carboxylase 1; AMPK; oleate; Snf1; lipogenesis	FATTY-ACID SYNTHESIS; BUDDING YEAST LIFE; CHEMICAL INHIBITION; DIETARY RESTRICTION; METABOLIC-CONTROL; STRESS-RESPONSE; VACUOLE FUSION; CELL-DEATH; PROTEIN; HOMEOSTASIS	Autophagy, a membrane-dependent catabolic process, ensures survival of aging cells and depends on the cellular energetic status. Acetyl-CoA carboxylase 1 (Acc1) connects central energy metabolism to lipid biosynthesis and is rate-limiting for the de novo synthesis of lipids. However, it is unclear how de novo lipogenesis and its metabolic consequences affect autophagic activity. Here, we show that in aging yeast, autophagy levels highly depend on the activity of Acc1. Constitutively active Acc1 (acc1(S/A)) or a deletion of the Acc1 negative regulator, Snf1 (yeast AMPK), shows elevated autophagy levels, which can be reversed by the Acc1 inhibitor soraphen A. Vice versa, pharmacological inhibition of Acc1 drastically reduces cell survival and results in the accumulation of Atg8-positive structures at the vacuolar membrane, suggesting late defects in the autophagic cascade. As expected, acc1(S/A) cells exhibit a reduction in acetate/acetyl-CoA availability along with elevated cellular lipid content. However, concomitant administration of acetate fails to fully revert the increase in autophagy exerted by acc1(S/A). Instead, administration of oleate, while mimicking constitutively active Acc1 in WT cells, alleviates the vacuolar fusion defects induced by Acc1 inhibition. Our results argue for a largely lipid-dependent process of autophagy regulation downstream of Acc1. We present a versatile genetic model to investigate the complex relationship between acetate metabolism, lipid homeostasis, and autophagy and propose Acc1-dependent lipogenesis as a fundamental metabolic path downstream of Snf1 to maintain autophagy and survival during cellular aging.	[Gross, Angelina S.; Zimmermann, Andreas; Pendl, Tobias; Schroeder, Sabrina; Schoenlechner, Hannes; Lamplmayr, Laura; Santiso, Ana; Aufschnaiter, Andreas; Waltenstorfer, Daniel; Lara, Sandra Ortonobes; Kast, Christina; Ruckenstuhl, Christoph; Hofer, Sebastian J.; Michelitsch, Birgit; Woelflingseder, Martina; Carmona-Gutierrez, Didac; Buettner, Sabrina; Froehlich, Kai-Uwe; Eisenberg, Tobias] Karl Franzens Univ Graz, Inst Mol Biosci, NAWI Graz, A-8010 Graz, Austria; [Zimmermann, Andreas; Eisenberg, Tobias] Karl Franzens Univ Graz, Cent Lab Gracia, NAWI Graz, A-8010 Graz, Austria; [Schroeder, Sabrina; Hofer, Sebastian J.; Madl, Tobias; Eisenberg, Tobias] BioTechMed Graz, A-8010 Graz, Austria; [Knittelfelder, Oskar; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Aufschnaiter, Andreas; Buettner, Sabrina] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-11419 Stockholm, Sweden; [Stryeck, Sarah; Madl, Tobias] Med Univ Graz, Inst Mol Biol & Biochem, Gottfried Schatz Res Ctr Cell Signaling Metab & A, A-8036 Graz, Austria; [Michelitsch, Birgit] Med Univ Graz, Div Plast Aesthet & Reconstruct Surg, Dept Surg, A-8036 Graz, Austria; [Mueller, Rolf] Helmholtz Inst Pharmaceut Res Saarland, D-66123 Saarbrucken, Germany	University of Graz; University of Graz; Max Planck Society; Stockholm University; Medical University of Graz; Medical University of Graz; Helmholtz Association; Helmholtz-Center for Infection Research	Eisenberg, T (corresponding author), Karl Franzens Univ Graz, Inst Mol Biosci, NAWI Graz, A-8010 Graz, Austria.	tobias.eisenberg@uni-graz.at	Madl, Tobias/B-1682-2012; Eisenberg, Tobias/AAV-7806-2021; Aufschnaiter, Andreas/GRR-7117-2022; Müller, Rolf/B-1559-2008; Aufschnaiter, Andreas/ABC-7709-2021; Hofer, Sebastian J./AAG-6974-2021	Madl, Tobias/0000-0002-9725-5231; Müller, Rolf/0000-0002-1042-5665; Aufschnaiter, Andreas/0000-0001-6571-2162; Hofer, Sebastian J./0000-0002-0756-0014; Stryeck, Sarah/0000-0001-7524-6038; Santiso, Ana/0000-0003-3436-8121; Gross, Angelina Sarah/0000-0002-8096-0831; Ruckenstuhl, Christoph/0000-0002-4338-4679; Zimmermann, Andreas/0000-0003-2249-944X; Knittelfelder, Oskar/0000-0002-1565-7238; Buttner, Sabrina/0000-0002-2786-8542; Eisenberg, Tobias/0000-0003-3559-1130; Carmona-Gutierrez, Didac/0000-0001-7548-7771	University of Graz; APART program of the Austrian Academy of Sciences (OAW); Austrian Science Fund (FWF) [P27183-B24, P28854, I3792, W1226]; Austrian Research Promotion Agency (FFG) [864690, 870454]; Integrative Metabolism Research Center Graz; BioTechMed-Graz; Styrian government (Zukunftsfonds); Swedish Research Council Vetenskapsradet [2015-05468]; Ake Wiberg Stiftelse [M16-0130]; Carl Tryggers Stiftelse [CTS16:85]; Austrian Infrastructure Program	University of Graz; APART program of the Austrian Academy of Sciences (OAW); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG); Integrative Metabolism Research Center Graz; BioTechMed-Graz; Styrian government (Zukunftsfonds); Swedish Research Council Vetenskapsradet(Swedish Research Council); Ake Wiberg Stiftelse; Carl Tryggers Stiftelse; Austrian Infrastructure Program	This work was supported by the University of Graz and a grant from the APART program of the Austrian Academy of Sciences (OAW) (to T.E.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Austrian Science Fund (FWF) Grants P28854, I3792, DK-MCD, and W1226; Austrian Research Promotion Agency (FFG) Grants 864690 and 870454; the Integrative Metabolism Research Center Graz; the Austrian Infrastructure Program 2016/2017; BioTechMed-Graz; and the Styrian government (Zukunftsfonds).; Supported by Austrian Science Fund (FWF) Grant P27183-B24, Swedish Research Council Vetenskapsradet Grant 2015-05468, Ake Wiberg Stiftelse Grant M16-0130, and Carl Tryggers Stiftelse Grant CTS16:85.	Alvers AL, 2009, AUTOPHAGY, V5, P847, DOI 10.4161/auto.8824; Aufschnaiter A, 2019, BBA-MOL CELL RES, V1866, P957, DOI 10.1016/j.bbamcr.2019.02.011; Aufschnaiter A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00207; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Brooks T, 2006, 20062654 AIAA, DOI [10.2514/6.2006-2654, DOI 10.2514/6.2006-2654]; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; Callegari S, 2010, FEMS YEAST RES, V10, P188, DOI 10.1111/j.1567-1364.2009.00593.x; Carmona-Gutierrez D, 2018, MICROB CELL, V5, P4, DOI 10.15698/mic2018.01.607; Carmona-Gutierrez D, 2014, YEAST, V31, P289, DOI 10.1002/yea.3020; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; CHIRALA SS, 1994, NUCLEIC ACIDS RES, V22, P412, DOI 10.1093/nar/22.3.412; Coccetti P, 2018, MICROB CELL, V5, P482, DOI 10.15698/mic2018.11.655; Coonrod EM, 2013, DEV CELL, V27, P462, DOI 10.1016/j.devcel.2013.10.014; Corominas-Faja B, 2014, ONCOTARGET, V5, P8306, DOI 10.18632/oncotarget.2059; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031; Delorme-Axford E, 2018, J BIOL CHEM, V293, P5396, DOI 10.1074/jbc.R117.804641; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; Eisenberg T, 2014, FEMS YEAST RES, V14, P179, DOI 10.1111/1567-1364.12105; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; GERTH K, 1994, J ANTIBIOT, V47, P23, DOI 10.7164/antibiotics.47.23; Gossing M, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy096; Graef M, 2018, FEBS LETT, V592, P1291, DOI 10.1002/1873-3468.12996; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Han S, 2017, NATURE, V544, P185, DOI 10.1038/nature21686; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Herzog R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029851; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hofbauer HF, 2014, DEV CELL, V29, P729, DOI 10.1016/j.devcel.2014.04.025; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Johansson P, 2008, P NATL ACAD SCI USA, V105, P12803, DOI 10.1073/pnas.0805827105; Kainz K, 2017, METHOD ENZYMOL, V588, P367, DOI 10.1016/bs.mie.2016.09.086; Kao CF, 2003, METHODS, V31, P59, DOI 10.1016/S1046-2023(03)00088-4; Katewa SD, 2012, CELL METAB, V16, P97, DOI 10.1016/j.cmet.2012.06.005; Kimmelman AC, 2017, CELL METAB, V25, P1037, DOI 10.1016/j.cmet.2017.04.004; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klug L, 2014, FEMS YEAST RES, V14, P369, DOI 10.1111/1567-1364.12141; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Lees ND, 1999, CRIT REV BIOCHEM MOL, V34, P33; Li D, 2015, FEBS LETT, V589, P269, DOI 10.1016/j.febslet.2014.11.050; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Maciejak A, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-68; Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005; Miner GE, 2017, TRAFFIC, V18, P315, DOI 10.1111/tra.12479; Niso-Santano M, 2015, EMBO J, V34, P1025, DOI 10.15252/embj.201489363; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Nwadike C, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00023-18; Orlandi I, 2012, FRONT ONCOL, V2, P1, DOI [10.3380/fonc.2012.00067, 10.3389/fonc.2012.00067]; Postnikoff SDL, 2017, MICROB CELL, V4, P368, DOI 10.15698/mic2017.11.597; Prokesch A, 2017, FASEB J, V31, P732, DOI 10.1096/fj.201600845R; Radovic B, 2016, DIABETOLOGIA, V59, P1743, DOI 10.1007/s00125-016-3968-6; Regnacq M, 2016, BIOCHEM BIOPH RES CO, V477, P33, DOI 10.1016/j.bbrc.2016.06.017; RIEZMAN H, 1983, EMBO J, V2, P2161, DOI 10.1002/j.1460-2075.1983.tb01717.x; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sales S, 2017, METHODS MOL BIOL, V1619, P203, DOI 10.1007/978-1-4939-7057-5_16; Sales S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27710; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sauvat A, 2018, EBIOMEDICINE, V30, P261, DOI 10.1016/j.ebiom.2018.03.028; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroeder S, 2014, MICROB CELL, V1, P110, DOI 10.15698/mic2014.04.142; Schroeder S, 2014, AUTOPHAGY, V10, P1335, DOI 10.4161/auto.28919; Schuhmann K, 2017, ANAL CHEM, V89, P7046, DOI 10.1021/acs.analchem.7b00794; Schuhmann K, 2012, J MASS SPECTROM, V47, P96, DOI 10.1002/jms.2031; Seo AY, 2017, ELIFE, V6, DOI 10.7554/eLife.21690; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Shepard BD, 2009, WORLD J GASTROENTERO, V15, P1219, DOI 10.3748/wjg.15.1219; Shi SB, 2014, MBIO, V5, DOI 10.1128/mBio.01130-14; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Shpilka T, 2015, EMBO J, V34, P2117, DOI 10.15252/embj.201490315; Solinas G, 2015, MOL METAB, V4, P367, DOI 10.1016/j.molmet.2015.03.004; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Svensson RU, 2016, NAT MED, V22, P1108, DOI 10.1038/nm.4181; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; VAHLENSIECK HF, 1994, CURR GENET, V25, P95, DOI 10.1007/BF00309532; van Zutphen T, 2014, MOL BIOL CELL, V25, P290, DOI 10.1091/mbc.E13-08-0448; Velazquez AP, 2016, AUTOPHAGY, V12, P1409, DOI 10.1080/15548627.2016.1190074; Velazquez AR, 2016, J CELL BIOL, V212, P621, DOI 10.1083/jcb.201508102; Wang CW, 2014, J CELL BIOL, V206, P357, DOI 10.1083/jcb.201404115; Wei JW, 2012, AMINO ACIDS, V42, P2031, DOI 10.1007/s00726-011-0924-0; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; Wolinski Heimo, 2015, Methods Mol Biol, V1270, P289, DOI 10.1007/978-1-4939-2309-0_21; WOODS A, 1994, J BIOL CHEM, V269, P19509; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546; Zhang M, 2013, MOL CELL BIOL, V33, P4701, DOI 10.1128/MCB.00198-13; Zimmermann A, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy020; Zou SS, 2017, MOL CELLS, V40, P643, DOI 10.14348/molcells.2017.0030	103	16	18	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12020	12039		10.1074/jbc.RA118.007020	http://dx.doi.org/10.1074/jbc.RA118.007020			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31209110	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000484284500008
J	Kelly, SD; Clarke, BR; Ovchinnikova, OG; Sweeney, RP; Williamson, ML; Lowary, TL; Whitfield, C				Kelly, Steven D.; Clarke, Bradley R.; Ovchinnikova, Olga G.; Sweeney, Ryan P.; Williamson, Monica L.; Lowary, Todd L.; Whitfield, Chris			Klebsiella pneumoniae O1 and O2ac antigens provide prototypes for an unusual strategy for polysaccharide antigen diversification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gram-negative bacteria; Klebsiella pneumonia; lipopolysaccharide (LPS); glycosyltransferase; polysaccharide; antigenic diversity; cell surface; enzyme complex; O-antigen; serotyping	D-GALACTAN-I; ESCHERICHIA-COLI; CHAIN-LENGTH; SEROTYPE O1-K20; LIPOPOLYSACCHARIDE; BINDING; BIOSYNTHESIS; PROTEIN; IDENTIFICATION; MEMBRANE	A limited range of different structures is observed in O-antigenic polysaccharides (OPSs) from Klebsiella pneumoniae lipopolysaccharides. Among these, several are based on modifications of a conserved core element of serotype O2a OPS, which has a disaccharide repeat structure [-> 3)-alpha-d-Galp-(1 -> 3)-beta-d-Galf-(1 ->]. Here, we describe the enzymatic pathways for a highly unusual modification strategy involving the attachment of a second glycan repeat-unit structure to the nonreducing terminus of O2a. This occurs by the addition of the O1 [-> 3)-alpha-d-Galp-(1 -> 3)-beta-d-Galp-(1 ->] or O2c [-> 3)-beta-d-GlcpNAc-(1 -> 5)-beta-d-Galf-(1 ->] antigens. The organization of the enzyme activities performing these modifications differs, with the enzyme WbbY possessing two glycosyltransferase catalytic sites solely responsible for O1 antigen polymerization and forming a complex with the O2a glycosyltransferase WbbM. In contrast, O2c polymerization requires glycosyltransferases WbmV and WbmW, which interact with one another but apparently not with WbbM. Using defined synthetic acceptors and site-directed mutants to assign the activities of the WbbY catalytic sites, we found that the C-terminal WbbY domain is a UDP-Galp-dependent GT-A galactosyltransferase adding beta-(1 -> 3)-linked d-Galp, whereas the WbbY N terminus includes a GT-B enzyme adding alpha-(1 -> 3)-linked d-Galp. These activities build the O1 antigen on a terminal Galp in the O2a domain. Using similar approaches, we identified WbmV as the UDP-GlcNAc transferase and noted that WbmW represents a UDP-Galf-dependent enzyme and that both are GT-A members. WbmVW polymerizes the O2c antigen on a terminal Galf. Our results provide mechanistic and conceptual insights into an important strategy for polysaccharide antigen diversification in bacteria.	[Kelly, Steven D.; Clarke, Bradley R.; Ovchinnikova, Olga G.; Williamson, Monica L.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Sweeney, Ryan P.; Lowary, Todd L.] Univ Alberta, Alberta Glycom Ctr, Edmonton, AB T6G 2G2, Canada; [Sweeney, Ryan P.; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Guelph; University of Alberta; University of Alberta	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Lowary, Todd L/F-9608-2019	Lowary, Todd L/0000-0002-8331-8211; Sweeney, Ryan/0000-0003-4022-3041; Whitfield, Chris/0000-0002-5267-7027; Kelly, Steven/0000-0003-1250-7055	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (to T. L. L. and C. W.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 2013, ANT RES THREATS; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRONNER D, 1994, MOL MICROBIOL, V14, P505, DOI 10.1111/j.1365-2958.1994.tb02185.x; Chua TK, 2008, PLANT CELL, V20, P1059, DOI 10.1105/tpc.107.051193; CLARKE BR, 1995, J BACTERIOL, V177, P5411, DOI 10.1128/jb.177.19.5411-5418.1995; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; CLARKE BR, 1992, J BACTERIOL, V174, P4614, DOI 10.1128/JB.174.14.4614-4621.1992; Clarke BR, 2018, J BIOL CHEM, V293, P4666, DOI 10.1074/jbc.RA117.000646; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Follador R, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000073; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Guachalla LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06682-2; Guan S, 2001, J BACTERIOL, V183, P3318, DOI 10.1128/JB.183.11.3318-3327.2001; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Hagelueken G, 2015, NAT STRUCT MOL BIOL, V22, P50, DOI 10.1038/nsmb.2935; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Hegerle N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203143; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hsieh PF, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00608; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KELLY RF, 1995, J ENDOTOXIN RES, V0002; KELLY RF, 1993, MOL MICROBIOL, V10, P615, DOI 10.1111/j.1365-2958.1993.tb00933.x; KOL O, 1992, CARBOHYD RES, V236, P339, DOI 10.1016/0008-6215(92)85028-X; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Kos V, 2010, J BIOL CHEM, V285, P19668, DOI 10.1074/jbc.M110.122598; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; Kubler-Kielb J, 2013, CARBOHYD RES, V378, P144, DOI 10.1016/j.carres.2013.03.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Liston SD, 2017, BBA-MOL CELL BIOL L, V1862, P1394, DOI 10.1016/j.bbalip.2016.10.008; Mann E, 2016, J BIOL CHEM, V291, P9748, DOI 10.1074/jbc.M116.719344; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; MCCALLUM KL, 1989, INFECT IMMUN, V57, P3816, DOI 10.1128/IAI.57.12.3816-3822.1989; Miller J. H., 1972, EXPT MOL GENETICS, P432; Mostowy RJ, 2018, TRENDS MICROBIOL, V26, P1008, DOI 10.1016/j.tim.2018.06.006; Okuda S, 2016, NAT REV MICROBIOL, V14, P337, DOI 10.1038/nrmicro.2016.25; Ovchinnikova OG, 2016, J BIOL CHEM, V291, P21519, DOI 10.1074/jbc.M116.751115; Paczosa MK, 2016, MICROBIOL MOL BIOL R, V80, P629, DOI 10.1128/MMBR.00078-15; Pan YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15573; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Stojkovic K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00684; Szijarto V, 2017, VIRULENCE, V8, P1203, DOI 10.1080/21505594.2017.1279778; Szijarto V, 2016, INT J MED MICROBIOL, V306, P89, DOI 10.1016/j.ijmm.2015.12.002; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; Thomason Lynn C, 2014, Curr Protoc Mol Biol, V106, DOI 10.1002/0471142727.mb0116s106; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trautmann M, 1997, CLIN DIAGN LAB IMMUN, V4, P550, DOI 10.1128/CDLI.4.5.550-555.1997; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Williams DM, 2017, P NATL ACAD SCI USA, V114, pE1215, DOI 10.1073/pnas.1613609114; Yates LE, 2021, ADV BIOCHEM ENG BIOT, V175, P167, DOI 10.1007/10_2018_72	58	9	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10863	10876		10.1074/jbc.RA119.008969	http://dx.doi.org/10.1074/jbc.RA119.008969			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31138653	Green Published, hybrid			2022-12-28	WOS:000478717200011
J	Li, YT; Deng, S; Peng, JT; Wang, XH; Essandoh, K; Mu, XJ; Peng, TQ; Meng, ZX; Fan, GC				Li, Yutian; Deng, Shan; Peng, Jiangtong; Wang, Xiaohong; Essandoh, Kobina; Mu, Xingjiang; Peng, Tianqing; Meng, Zhuo-Xian; Fan, Guo-Chang			MicroRNA-223 is essential for maintaining functional beta-cell mass during diabetes through inhibiting both FOXO1 and SOX6 pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin; diabetes; beta cell (B-cell); cell proliferation; microRNA (miRNA); microRNA-223; beta-cell proliferation; metabolic disorder; gene regulation; forkhead box O1 (FOXO1); SRY-box 6 (SOX6)	INSULIN-SECRETION; MIR-223; EXPRESSION; PROLIFERATION	The initiation and development of diabetes are mainly ascribed to the loss of functional beta-cells. Therapies designed to regenerate beta-cells provide great potential for controlling glucose levels and thereby preventing the devastating complications associated with diabetes. This requires detailed knowledge of the molecular events and underlying mechanisms in this disorder. Here, we report that expression of microRNA-223 (miR-223) is up-regulated in islets from diabetic mice and humans, as well as in murine Min6 beta-cells exposed to tumor necrosis factor alpha (TNF alpha) or high glucose. Interestingly, miR-223 knockout (KO) mice exhibit impaired glucose tolerance and insulin resistance. Further analysis reveals that miR-223 deficiency dramatically suppresses beta-cell proliferation and insulin secretion. Mechanistically, using luciferase reporter gene assays, histological analysis, and immunoblotting, we demonstrate that miR-223 inhibits both forkhead box O1 (FOXO1) and SRY-box 6 (SOX6) signaling, a unique bipartite mechanism that modulates expression of several beta-cell markers (pancreatic and duodenal homeobox 1 (PDX1), NK6 homeobox 1 (NKX6.1), and urocortin 3 (UCN3)) and cell cycle-related genes (cyclin D1, cyclin E1, and cyclin-dependent kinase inhibitor P27 (P27)). Importantly, miR-223 overexpression in beta-cells could promote beta-cell proliferation and improve beta-cell function. Taken together, our results suggest that miR-223 is a critical factor for maintaining functional beta-cell mass and adaptation during metabolic stress.	[Li, Yutian; Deng, Shan; Wang, Xiaohong; Essandoh, Kobina; Mu, Xingjiang; Fan, Guo-Chang] Univ Cincinnati, Dept Pharmacol & Syst Physiol, Coll Med, Cincinnati, OH 45267 USA; [Deng, Shan; Peng, Jiangtong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, Wuhan 430074, Hubei, Peoples R China; [Peng, Tianqing] Lawson Hlth Res Inst, Crit Illness Res, London, ON N6C 2R5, Canada; [Meng, Zhuo-Xian] Zhejiang Univ, Key Lab Precis Diag & Treatment Hepatobiliary & P, Affiliated Hosp 1, Dept Pathol & Pathophysiol,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China	University System of Ohio; University of Cincinnati; Huazhong University of Science & Technology; Western University (University of Western Ontario); Zhejiang University	Fan, GC (corresponding author), Univ Cincinnati, Dept Pharmacol & Syst Physiol, Coll Med, Cincinnati, OH 45267 USA.; Meng, ZX (corresponding author), Zhejiang Univ, Key Lab Precis Diag & Treatment Hepatobiliary & P, Affiliated Hosp 1, Dept Pathol & Pathophysiol,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.	zxmeng@zju.edu.cn; fangg@ucmail.uc.edu	Fan, Guo-Chang/E-1153-2012; Peng, Tianqing/G-3340-2011	Fan, Guo-Chang/0000-0002-0439-8277; Li, Yutian/0000-0002-5118-0916	American Heart Association (AHA) Established Investigator Award [17EIA33400063]; National Institutes of Health [GM-112930, GM-126061]; National Key Research and Development Programme of China [2016YFC1305303]; Fundamental Research Funds for the Central Universities; National Natural Science Foundation of China [81670740, 81722012, 81600616]; Thousand Young Talents Plan of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126061, R01GM132149, R01GM112930] Funding Source: NIH RePORTER	American Heart Association (AHA) Established Investigator Award(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Research and Development Programme of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Young Talents Plan of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association (AHA) Established Investigator Award 17EIA33400063 and National Institutes of Health Grants GM-112930 and GM-126061 (to G.-C.F.);National Key Research and Development Programme of China 2016YFC1305303, the Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China Grants 81670740 and 81722012, and the Thousand Young Talents Plan of China (to Z.X.M.); and National Natural Science Foundation of China Grant 81600616 (to S.D.).	Bar Y, 2012, J BIOL CHEM, V287, P17269, DOI 10.1074/jbc.M111.319152; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Cheng CW, 2017, CELL, V168, P775, DOI 10.1016/j.cell.2017.01.040; Chuang TY, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/943659; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fang DH, 2012, MOL MED REP, V5, P233, DOI 10.3892/mmr.2011.607; Filios SR, 2015, DIABETES, V64, P3631, DOI 10.2337/db15-0831; Iguchi H, 2005, J BIOL CHEM, V280, P37669, DOI 10.1074/jbc.M505392200; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kim-Muller JY, 2014, CELL METAB, V20, P593, DOI 10.1016/j.cmet.2014.08.012; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Lenz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112914; Lopez YON, 2017, MOL BIOSYST, V13, P106, DOI 10.1039/c6mb00596a; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Osmai M, 2016, DIABETES-METAB RES, V32, P334, DOI 10.1002/dmrr.2719; Plaisance V, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/618652; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Sintov E, 2015, SCI REP-UK, V5, DOI 10.1038/srep13024; Song MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30321; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Vickers KC, 2014, P NATL ACAD SCI USA, V111, P14518, DOI 10.1073/pnas.1215767111; Wang J, 2015, INT J MOL SCI, V16, P24965, DOI 10.3390/ijms161024965; Wang P, 2015, NAT REV ENDOCRINOL, V11, P201, DOI 10.1038/nrendo.2015.9; Wang XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13721; White MG, 2013, DIABETES CARE, V36, P3818, DOI 10.2337/dc13-0705; Yang LW, 2016, J BIOL CHEM, V291, P15700, DOI 10.1074/jbc.M116.715805; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhao Y, 2017, INT J CLIN EXP PATHO, V10, P2950; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	38	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10438	10448		10.1074/jbc.RA119.007755	http://dx.doi.org/10.1074/jbc.RA119.007755			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31118273	Green Published, hybrid			2022-12-28	WOS:000478717100006
J	Liu, ZY; Zhang, WC; Zhang, M; Zhu, HP; Moriasi, C; Zou, MH				Liu, Zhaoyu; Zhang, Wencheng; Zhang, Miao; Zhu, Huaiping; Moriasi, Cate; Zou, Ming-Hui			Liver kinase B1 suppresses lipopolysaccharide-induced nuclear factor kappa Beta (NF-kappa Beta) activation in macrophages (vol 290, pg 2312, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													liu, zhao/GXV-6141-2022					Liu ZY, 2015, J BIOL CHEM, V290, P2312, DOI 10.1074/jbc.M114.616441	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10737	10737		10.1074/jbc.AAC119.009646	http://dx.doi.org/10.1074/jbc.AAC119.009646			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31278156	hybrid, Green Published			2022-12-28	WOS:000478717100030
J	Picciano, AL; Crane, BR				Picciano, Angela L.; Crane, Brian R.			A nitric oxide synthase-like protein from Synechococcus produces NO/NO- from l-arginine and NAPDH in a tetrahydrobiopterin- and Ca2+-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; cyanobacteria; cytochrome P450; nitric-oxide synthase; multifunctional enzyme; reactive nitrogen species (RNS); dioxygenase; denitrification; flavohemoglobin; nitrogen assimilation; nitrogen utilization	ESCHERICHIA-COLI; PROXIMAL LIGAND; AMINO-ACIDS; CALCIUM; NO; BINDING; DOMAIN; FLAVOHEMOGLOBIN; INHIBITION; SEAWATER	Nitric oxide synthases (NOSs) are heme-based monooxygenases that convert l-Arg to l-citrulline and nitric oxide (NO), a key signaling molecule and cytotoxic agent in mammals. Bacteria also contain NOS proteins, but the role of NO production within these organisms, where understood, differs considerably from that of mammals. For example, a NOS protein in the marine cyanobacterium Synechococcus sp. PCC 7335 (syNOS) has recently been proposed to function in nitrogen assimilation from l-Arg. syNOS retains the oxygenase (NOSox) and reductase (NOSred) domains present in mammalian NOS enzymes (mNOSs), but also contains an N-terminal globin domain (NOSg) homologous to bacterial flavohemoglobin proteins. Herein, we show that syNOS functions as a dimer and produces NO from l-Arg and NADPH in a tetrahydrobiopterin (H4B)-dependent manner at levels similar to those produced by other NOSs but does not require Ca2+-calmodulin, which regulates NOSred-mediated NOSox reduction in mNOSs. Unlike other bacterial NOSs, syNOS cannot function with tetrahydrofolate and requires high Ca2+ levels (>200 mu m) for its activation. NOSg converts NO to NO 3- in the presence of O-2 and NADPH; however, NOSg did not protect Escherichia coli strains against nitrosative stress, even in a mutant devoid of NO-protective flavohemoglobin. We also found that syNOS does not have NOS activity in E. coli (which lacks H4B) and that the recombinant protein does not confer growth advantages on l-Arg as a nitrogen source. Our findings indicate that syNOS has both NOS and NO oxygenase activities, requires H4B, and may play a role in Ca2+-mediated signaling.	[Picciano, Angela L.; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	bc69@cornell.edu		Picciano, Angela/0000-0002-3041-1498	National Institutes of Health [R35GM122535]; National Science Foundation [MCB1715233]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R35GM122535 and National Science Foundation Grant MCB1715233. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agapie T, 2009, P NATL ACAD SCI USA, V106, P16221, DOI 10.1073/pnas.0908443106; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bonamore A, 2008, IUBMB LIFE, V60, P19, DOI 10.1002/iub.9; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Chachlaki K, 2017, NAT REV ENDOCRINOL, V13, P521, DOI 10.1038/nrendo.2017.69; Chaudhari SS, 2017, MBIO, V8, DOI 10.1128/mBio.00887-17; Choudhari SK, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-118; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CLARK ME, 1972, LIMNOL OCEANOGR, V17, P749, DOI 10.4319/lo.1972.17.5.0749; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; Correa-Aragunde N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30889-6; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Crane BR, 2010, ANNU REV BIOCHEM, V79, P445, DOI 10.1146/annurev-biochem-062608-103436; Daff S, 2003, BIOCHEM SOC T, V31, P502, DOI 10.1042/bst0310502; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; Davydov R, 2009, J AM CHEM SOC, V131, P14493, DOI 10.1021/ja906133h; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Domingos P, 2015, MOL PLANT, V8, P506, DOI 10.1016/j.molp.2014.12.010; Dominguez DC, 2015, CELL CALCIUM, V57, P151, DOI 10.1016/j.ceca.2014.12.006; Foresi N, 2010, PLANT CELL, V22, P3816, DOI 10.1105/tpc.109.073510; Fujimoto K, 2001, CHEM-BIOL INTERACT, V130, P825, DOI 10.1016/S0009-2797(00)00238-6; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gau AE, 2007, Z NATURFORSCH C, V62, P273; Gupta S, 2012, J BIOL CHEM, V287, P16435, DOI 10.1074/jbc.M111.329920; Gupta S, 2011, IUBMB LIFE, V63, P337, DOI 10.1002/iub.460; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; Gusarov I, 2018, MOL CELL, V69, P351, DOI 10.1016/j.molcel.2018.01.022; Hansell DA, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P597, DOI 10.1016/B978-0-12-372522-6.00013-X; Hobbs AJ, 1999, ANNU REV PHARMACOL, V39, P191, DOI 10.1146/annurev.pharmtox.39.1.191; HUBBERTEN U, 1994, MAR CHEM, V45, P121, DOI 10.1016/0304-4203(94)90096-5; Huisman A, 2002, FASEB J, V16, P1135, DOI 10.1096/fj.01-0890fje; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Kaiser K, 2009, MAR CHEM, V113, P63, DOI 10.1016/j.marchem.2008.12.004; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Kim SO, 1999, FEBS LETT, V445, P389, DOI 10.1016/S0014-5793(99)00157-X; Kinkel TL, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.224; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; Lechauve C, 2018, J CLIN INVEST, V128, P5073, DOI 10.1172/JCI99933; Leganes F, 2009, MICROBIOL-SGM, V155, P25, DOI 10.1099/mic.0.022251-0; Li HY, 1999, J BIOL CHEM, V274, P21276, DOI 10.1074/jbc.274.30.21276; MEDINA A, 1957, BIOCHIM BIOPHYS ACTA, V23, P440, DOI 10.1016/0006-3002(57)90355-4; Membrillo-Hernandez J, 1999, J BIOL CHEM, V274, P748, DOI 10.1074/jbc.274.2.748; Moreau M, 2004, J INORG BIOCHEM, V98, P1200, DOI 10.1016/j.jinorgbio.2004.03.015; PALMER RMJ, 1989, BIOCHEM BIOPH RES CO, V158, P348, DOI 10.1016/S0006-291X(89)80219-0; Patel BA, 2009, P NATL ACAD SCI USA, V106, P18183, DOI 10.1073/pnas.0907262106; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Pfeiffer S, 1996, BRIT J PHARMACOL, V118, P1433, DOI 10.1111/j.1476-5381.1996.tb15557.x; Plate L, 2013, TRENDS BIOCHEM SCI, V38, P566, DOI 10.1016/j.tibs.2013.08.008; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Rao MX, 2015, MBIO, V6, DOI 10.1128/mBio.00206-15; Reitzer Larry, 2005, EcoSal Plus, V1, DOI 10.1128/ecosalplus.3.4.7; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; RIPPKA R, 1977, FEMS MICROBIOL LETT, V2, P83, DOI 10.1111/j.1574-6968.1977.tb00913.x; Sabat J, 2009, J AM CHEM SOC, V131, P12186, DOI 10.1021/ja901016a; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Schneider BL, 1998, J BACTERIOL, V180, P4278, DOI 10.1128/JB.180.16.4278-4286.1998; Schriek S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-437; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Singh SP, 2011, WORLD J MICROB BIOT, V27, P1225, DOI 10.1007/s11274-010-0571-8; Sohn OS, 2000, ANAL BIOCHEM, V279, P202, DOI 10.1006/abio.1999.4471; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Tejero J, 2013, IUBMB LIFE, V65, P358, DOI 10.1002/iub.1136; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Vannini F, 2015, REDOX BIOL, V6, P334, DOI 10.1016/j.redox.2015.08.009; Walter J, 2016, J EXP BOT, V67, P3997, DOI 10.1093/jxb/erw112; Wang HC, 2011, MICROBIOL-SGM, V157, P3059, DOI 10.1099/mic.0.051847-0; Wang ZQ, 2016, J INORG BIOCHEM, V158, P122, DOI 10.1016/j.jinorgbio.2016.03.002; Wang ZQ, 2004, J BIOL CHEM, V279, P19018, DOI 10.1074/jbc.M311663200; Watanabe M, 2000, J OCEANOGR, V56, P553, DOI [10.1023/A:1011153111688, DOI 10.1023/A:1011153111688]; Yamamoto K, 2003, METAB ENG, V5, P246, DOI 10.1016/S1096-7176(03)00046-6; YUI Y, 1991, J BIOL CHEM, V266, P3369; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	78	13	13	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10708	10719		10.1074/jbc.RA119.008399	http://dx.doi.org/10.1074/jbc.RA119.008399			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31113865	Green Published, hybrid			2022-12-28	WOS:000478717100028
J	[Anonymous]				[Anonymous]			Thromboxane A(2) receptor activates a Rho-associated kinase/LKB1/PTEN pathway to attenuate endothelium insulin signaling (Expression of Concern of Vol 284, Pg 17120, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Song P, 2009, J BIOL CHEM, V284, P17120, DOI 10.1074/jbc.M109.012583	1	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					10020	10020		10.1074/jbc.EC119.009566	http://dx.doi.org/10.1074/jbc.EC119.009566			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31227625	Green Published, hybrid			2022-12-28	WOS:000473277900033
J	[Anonymous]				[Anonymous]			Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin-in vivo-Role of mitochondrial reactive nitrogen species (Expression of Concern of Vol 279, Pg 43940, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	1	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					10024	10024		10.1074/jbc.EC119.009570	http://dx.doi.org/10.1074/jbc.EC119.009570			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31227629	Green Published, hybrid			2022-12-28	WOS:000473277900037
J	Chen, W; Zhou, Y; Yang, Q				Chen, Wei; Zhou, Yong; Yang, Qing			Structural dissection reveals a general mechanistic principle for group II chitinase (ChtII) inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; inhibitor; inhibition mechanism; insect; protein crystallization; Asian corn borer (Ostrinia furnacalis); ecdysis; group II chitinase; inhibitor design; X-ray crystallography	INSECT CHITINASE; CATALYSIS; INSIGHTS; DIFFRACTION	Small-molecule inhibitors of insect chitinases have potential applications for controlling insect pests. Insect group II chitinase (ChtII) is the most important chitinase in insects and functions throughout all developmental stages. However, the possibility of inhibiting ChtII by small molecules has not been explored yet. Here, we report the structural characteristics of four molecules that exhibited similar levels of inhibitory activity against OfChtII, a group II chitinase from the agricultural pest Asian corn borer Ostrinia furnacalis. These inhibitors were chitooctaose ((GlcN)(8)), dipyrido-pyrimidine derivative (DP), piperidine-thienopyridine derivative (PT), and naphthalimide derivative (NI). The crystal structures of the OfChtII catalytic domain complexed with each of the four inhibitors at 1.4-2.0 resolutions suggested they all exhibit similar binding modes within the substrate-binding cleft; specifically, two hydrophobic groups of the inhibitor interact with +1/+2 tryptophan and a -1 hydrophobic pocket. The structure of the (GlcN)(8) complex surprisingly revealed that the oligosaccharide chain of the inhibitor is orientated in the opposite direction to that previously observed in complexes with other chitinases. Injection of the inhibitors into 4th instar O. furnacalis larvae led to defects in development and pupation. The results of this study provide insights into a general mechanistic principle that confers inhibitory activity against ChtII, which could facilitate rational design of agrochemicals that target ecdysis of insect pests.	[Chen, Wei; Yang, Qing] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, 2 West Yuanmingyuan Rd, Beijing 100193, Peoples R China; [Zhou, Yong; Yang, Qing] Dalian Univ Technol, Sch Biotechnol, 2 Linggong Rd, Dalian 116024, Peoples R China; [Zhou, Yong; Yang, Qing] Dalian Univ Technol, Sch Software, 2 Linggong Rd, Dalian 116024, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Dalian University of Technology; Dalian University of Technology	Yang, Q (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, 2 West Yuanmingyuan Rd, Beijing 100193, Peoples R China.; Yang, Q (corresponding author), Dalian Univ Technol, Sch Biotechnol, 2 Linggong Rd, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Dalian Univ Technol, Sch Software, 2 Linggong Rd, Dalian 116024, Peoples R China.	qingyang@dlut.edu.cn	Yang, Qing/GZK-2526-2022	Yang, Qing/0000-0001-8623-7532	National Key Research and Development Project of China [2017YFD0200502, 2017YFD0201207]; Program for National Natural Science Funds for Distinguished Young Scholar [31425021]	National Key Research and Development Project of China; Program for National Natural Science Funds for Distinguished Young Scholar	This work was supported by National Key Research and Development Project of China Grants 2017YFD0200502 and 2017YFD0201207 and the Program for National Natural Science Funds for Distinguished Young Scholar Grant 31425021. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen OA, 2008, CHEM BIOL, V15, P295, DOI 10.1016/j.chembiol.2008.02.015; ARAI N, CHEM PHARM B TOKYO, V48, P1442; ARAI N, J ANTIBIOT TOKYO, V53, P609; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; Brameld KA, 1998, J MOL BIOL, V280, P913, DOI 10.1006/jmbi.1998.1890; Cederkvist FH, 2008, CARBOHYD POLYM, V74, P41, DOI 10.1016/j.carbpol.2008.01.020; Chen L, 2014, J BIOL CHEM, V289, P17932, DOI 10.1074/jbc.M114.564534; Chen W, 2018, J BIOL CHEM, V293, P2652, DOI 10.1074/jbc.RA117.000119; Duan YW, 2018, J BIOL CHEM, V293, P15429, DOI [10.1074/jbc.RA118.004351, 10.1074/jbc.ra118.004351]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fadel F, 2015, ACTA CRYSTALLOGR D, V71, P1455, DOI 10.1107/S139900471500783X; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; Garner AL, 2011, J MED CHEM, V54, P3963, DOI 10.1021/jm200364n; Gloeckner C, 2010, P NATL ACAD SCI USA, V107, P3424, DOI 10.1073/pnas.0915125107; Gouda H, 2009, BIOORG MED CHEM LETT, V19, P2630, DOI 10.1016/j.bmcl.2009.04.013; He BC, 2013, ADV MATER, V25, P4580, DOI 10.1002/adma.201301201; Hirose T, 2010, P JPN ACAD B-PHYS, V86, P85, DOI 10.2183/pjab.86.85; Honda Y, 2004, FEBS LETT, V567, P307, DOI 10.1016/j.febslet.2004.05.002; ISOGAI A, 1989, AGR BIOL CHEM TOKYO, V53, P2825, DOI 10.1080/00021369.1989.10869709; Jiang X, 2016, J CHEM INF MODEL, V56, P2413, DOI 10.1021/acs.jcim.6b00615; KATO T, 1995, TETRAHEDRON LETT, V36, P2133, DOI 10.1016/0040-4039(95)00194-H; KRAMER KJ, 1986, INSECT BIOCHEM, V16, P851, DOI 10.1016/0020-1790(86)90059-4; Liu T, 2017, J BIOL CHEM, V292, P2080, DOI [10.1074/jbc.M116.755330, 10.1074/jbc.m116.755330]; Liu T, 2014, CURR PHARM DESIGN, V20, P754, DOI 10.2174/138161282005140214164730; Lu YM, 2002, INSECT BIOCHEM MOLEC, V32, P1369, DOI 10.1016/S0965-1748(02)00057-7; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Pan Y, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.15001; Pantoom S, 2011, J BIOL CHEM, V286, P24312, DOI 10.1074/jbc.M110.183376; Rao FV, 2005, CHEM BIOL, V12, P973, DOI 10.1016/j.chembiol.2005.07.009; Rao FV, 2005, CHEM BIOL, V12, P65, DOI 10.1016/j.chembiol.2004.10.013; Royer W, 2002, BIOCHEM J, V366, P921, DOI 10.1042/bj20011764; Schuttelkopf AW, 2011, ACS MED CHEM LETT, V2, P428, DOI 10.1021/ml200008b; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P27278, DOI 10.1074/jbc.M604048200; SHAHABUDDIN M, 1993, P NATL ACAD SCI USA, V90, P4266, DOI 10.1073/pnas.90.9.4266; Su C, 2016, INSECT MOL BIOL, V25, P401, DOI 10.1111/imb.12227; Tabudravu JN, 2002, BIOORGAN MED CHEM, V10, P1123, DOI 10.1016/S0968-0896(01)00372-8; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Zhu Q, 2008, INSECT BIOCHEM MOLEC, V38, P467, DOI 10.1016/j.ibmb.2007.06.011; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105	42	9	13	4	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9358	9364		10.1074/jbc.RA119.007812	http://dx.doi.org/10.1074/jbc.RA119.007812			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31053640	Green Published, hybrid			2022-12-28	WOS:000472713000004
J	Varghese, F; Kabasakal, BV; Cotton, CAR; Schumacher, J; Rutherford, AW; Fantuzzi, A; Murray, JW				Varghese, Febin; Kabasakal, Burak Veli; Cotton, Charles A. R.; Schumacher, Jorg; Rutherford, A. William; Fantuzzi, Andrea; Murray, James W.			A low-potential terminal oxidase associated with the iron-only nitrogenase from the nitrogen-fixing bacterium Azotobacter vinelandii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nitrogen fixation; nitrogenase; dioxygenase; enzyme structure; oxidase	CYTOCHROME-C-OXIDASE; ALTERNATIVE NITROGENASE; ELECTRON-TRANSFER; REDOX PROPERTIES; NITRIC-OXIDE; HEME; FIXATION; SEQUENCE; COMPLEX; PROTEIN	The biological route for nitrogen gas entering the biosphere is reduction to ammonia by the nitrogenase enzyme, which is inactivated by oxygen. Three types of nitrogenase exist, the least-studied of which is the iron-only nitrogenase. The Anf3 protein in the bacterium Rhodobacter capsulatus is essential for diazotrophic (i.e. nitrogen-fixing) growth with the iron-only nitrogenase, but its enzymatic activity and function are unknown. Here, we biochemically and structurally characterize Anf3 from the model diazotrophic bacterium Azotobacter vinelandii. Determining the Anf3 crystal structure to atomic resolution, we observed that it is a dimeric flavocytochrome with an unusually close interaction between the heme and the FAD cofactors. Measuring the reduction potentials by spectroelectrochemical redox titration, we observed values of -420 +/- 10 and -330 +/- 10 mV for the two FAD potentials and -340 +/- 1 mV for the heme. We further show that Anf3 accepts electrons from spinach ferredoxin and that Anf3 consumes oxygen without generating superoxide or hydrogen peroxide. We predict that Anf3 protects the iron-only nitrogenase from oxygen inactivation by functioning as an oxidase in respiratory protection, with flavodoxin or ferredoxin as the physiological electron donors.	[Varghese, Febin; Kabasakal, Burak Veli; Cotton, Charles A. R.; Schumacher, Jorg; Rutherford, A. William; Fantuzzi, Andrea; Murray, James W.] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Kabasakal, Burak Veli] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Cotton, Charles A. R.] Max Planck Inst Mol Plant Physiol, Muhlenberg 1, D-14476 Potsdam, Germany	Imperial College London; University of Bristol; Max Planck Society	Fantuzzi, A; Murray, JW (corresponding author), Imperial Coll London, Dept Life Sci, London SW7 2AZ, England.	a.fantuzzi@imperial.ac.uk; j.w.murray@imperial.ac.uk	Kabasakal, Burak Veli/M-8009-2017; Rutherford, Alfred W/A-7831-2019	Kabasakal, Burak Veli/0000-0003-3001-9282; Rutherford, Alfred W/0000-0002-3124-154X; Murray, James/0000-0002-8897-0161	Biotechnology and Biological Sciences Research Council/National Science Foundation Nitrogen Ideas Lab: Oxygen-Tolerant Nitrogenase [BB/L011468/1]; BBSRC [BB/N003608/1, BB/L011468/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council/National Science Foundation Nitrogen Ideas Lab: Oxygen-Tolerant Nitrogenase; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Grant BB/L011468/1 from the Biotechnology and Biological Sciences Research Council/National Science Foundation Nitrogen Ideas Lab: Oxygen-Tolerant Nitrogenase. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADDISON AW, 1985, BIOCHIM BIOPHYS ACTA, V828, P362, DOI 10.1016/0167-4838(85)90317-6; Ahmed FH, 2015, J MOL BIOL, V427, P3554, DOI 10.1016/j.jmb.2015.09.021; Al-Attar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27631; ALIVERTI A, 1995, FEBS LETT, V368, P220, DOI 10.1016/0014-5793(95)00648-S; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Case CL, 2009, MICROBIOL-SGM, V155, P69, DOI 10.1099/mic.0.024265-0; CHISNELL JR, 1988, J BACTERIOL, V170, P27, DOI 10.1128/jb.170.1.27-33.1988; COLETTA M, 1991, EUR J BIOCHEM, V202, P1101, DOI 10.1111/j.1432-1033.1991.tb16476.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ermakova M, 2014, P NATL ACAD SCI USA, V111, P11205, DOI 10.1073/pnas.1407327111; GALLON JR, 1992, NEW PHYTOL, V122, P571; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Hoffmann MC, 2016, J BACTERIOL, V198, P633, DOI 10.1128/JB.00750-15; Hunter CL, 1997, BIOCHEMISTRY-US, V36, P1010, DOI 10.1021/bi961385u; IISMAA SE, 1991, J BIOL CHEM, V266, P21563; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kareyeva AV, 2011, FEBS LETT, V585, P385, DOI 10.1016/j.febslet.2010.12.019; Klipp W., 1995, Nitrogen fixation: fundamentals and applications. Proceedings of the 10th International Congress on Nitrogen Fixation, St. Petersburg, Russia, May 28-June 3 1995., P201; Kurtz DM, 2007, DALTON T, P4115, DOI 10.1039/b710047g; Lewis D F, 2001, ScientificWorldJournal, V1, P151; Lopez-Torrejon G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11426; MacKellar D, 2016, SCI REP-UK, V6, DOI 10.1038/srep20086; Maier RJ, 2000, J BACTERIOL, V182, P3854, DOI 10.1128/JB.182.13.3854-3857.2000; Masepohl B, 1996, ARCH MICROBIOL, V165, P80, DOI 10.1007/s002030050301; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRose DL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00267; Melin F, 2016, BBA-BIOENERGETICS, V1857, P1892, DOI 10.1016/j.bbabio.2016.09.009; Michoux F, 2010, BIOCHEMISTRY-US, V49, P7411, DOI 10.1021/bi1011145; MOSHIRI F, 1994, MOL MICROBIOL, V14, P101, DOI 10.1111/j.1365-2958.1994.tb01270.x; Mowat CG, 2010, ARCH BIOCHEM BIOPHYS, V493, P37, DOI 10.1016/j.abb.2009.10.005; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; Oldroyd GED, 2014, CURR OPIN BIOTECH, V26, P19, DOI 10.1016/j.copbio.2013.08.006; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PAU RN, 1993, BIOCHEM J, V293, P101, DOI 10.1042/bj2930101; Pessanha M, 2009, BBA-BIOENERGETICS, V1787, P113, DOI 10.1016/j.bbabio.2008.11.007; Rauhamaki V, 2009, J BIOL CHEM, V284, P11301, DOI 10.1074/jbc.M808839200; Rich PR, 2017, BIOCHEM SOC T, V45, P813, DOI 10.1042/BST20160139; ROBSON RL, 1979, BIOCHEM J, V181, P569, DOI 10.1042/bj1810569; Safo MK, 2001, J MOL BIOL, V310, P817, DOI 10.1006/jmbi.2001.4734; Schejter A, 2006, PROTEIN SCI, V15, P234, DOI 10.1110/ps.051825906; Segal HM, 2017, PROTEIN SCI, V26, P1984, DOI 10.1002/pro.3236; Setubal JC, 2009, J BACTERIOL, V191, P4534, DOI 10.1128/JB.00504-09; Sharma V, 2015, P NATL ACAD SCI USA, V112, P2040, DOI 10.1073/pnas.1409543112; Sicking C, 2005, J BACTERIOL, V187, P92, DOI 10.1128/JB.187.1.92-98.2005; Swoboda M, 2012, ACS NANO, V6, P6364, DOI 10.1021/nn301895c; Turner KL, 1999, BIOCHEMISTRY-US, V38, P3302, DOI 10.1021/bi9826308; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; YAMAMOTO Y, 1986, BIOCHEMISTRY-US, V25, P5288, DOI 10.1021/bi00366a045; Yang JG, 2014, P NATL ACAD SCI USA, V111, pE3718, DOI 10.1073/pnas.1411185111; Yoshimura H, 2006, BIOCHEMISTRY-US, V45, P8301, DOI 10.1021/bi060315c; Zanetti G., 1980, METHODS ENZYMOL, V69, P250	54	11	11	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9367	9376		10.1074/jbc.RA118.007285	http://dx.doi.org/10.1074/jbc.RA118.007285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31043481	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000472713000007
J	Guo, YJ; Lei, I; Tian, S; Gao, WB; Hacer, K; Li, YB; Wang, SM; Liu, L; Wang, Z				Guo, Yijing; Lei, Ienglam; Tian, Shuo; Gao, Wenbin; Hacer, Karatas; Li, Yangbing; Wang, Shaomeng; Liu, Liu; Wang, Zhong			Chemical suppression of specific C-C chemokine signaling pathways enhances cardiac reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small molecule; cellular immune response; myocardial infarction; cardiomyocyte; regeneration; reprogramming; cardiovascular disease; fibrosis; cardiomyopathy; cell signaling; C-C chemokine; cardiac reprogramming; heart regeneration; immune response	MOUSE FIBROBLASTS; IN-VITRO; CARDIOMYOCYTES; INDUCTION; MYOCYTES; REPAIR; MEF2C	Reprogramming of fibroblasts into induced cardiomyocytes (iCMs) is a potentially promising strategy for regenerating a damaged heart. However, low fibroblast-cardiomyocyte conversion rates remain a major challenge in this reprogramming. To this end, here we conducted a chemical screen and identified four agents, insulin-like growth factor-1, Mll1 inhibitor MM589, transforming growth factor- inhibitor A83-01, and Bmi1 inhibitor PTC-209, termed IMAP, which coordinately enhanced reprogramming efficiency. Using -muscle heavy chain-GFP-tagged mouse embryo fibroblasts as a starting cell type, we observed that the IMAP treatment increases iCM formation 6-fold. IMAP stimulated higher cardiac troponin T and -actinin expression and increased sarcomere formation, coinciding with up-regulated expression of many cardiac genes and down-regulated fibroblast gene expression. Furthermore, IMAP promoted higher spontaneous beating and calcium transient activities of iCMs derived from neonatal cardiac fibroblasts. Intriguingly, we also observed that the IMAP treatment repressed many genes involved in immune responses, particularly those in specific C-C chemokine signaling pathways. We therefore investigated the roles of C-C motif chemokine ligand 3 (CCL3), CCL6, and CCL17 in cardiac reprogramming and observed that they inhibited iCM formation, whereas inhibitors of C-C motif chemokine receptor 1 (CCR1), CCR4, and CCR5 had the opposite effect. These results indicated that the IMAP treatment directly suppresses specific C-C chemokine signaling pathways and thereby enhances cardiac reprogramming. In conclusion, a combination of four chemicals, named here IMAP, suppresses specific C-C chemokine signaling pathways and facilitates Mef2c/Gata4/Tbx5 (MGT)-induced cardiac reprogramming, providing a potential means for iCM formation in clinical applications.	[Guo, Yijing; Lei, Ienglam; Tian, Shuo; Gao, Wenbin; Liu, Liu; Wang, Zhong] Univ Michigan, Dept Cardiac Surg, Frankel Cardiovasc Ctr, Ann Arbor, MI 48109 USA; [Guo, Yijing] Cent S Univ, Xiangya Hosp, Xiangya Spinal Surg Ctr, Dept Spine Surg, Changsha 410008, Hunan, Peoples R China; [Lei, Ienglam] Univ Macau, Fac Hlth Sci, Ave Univ, Taipa, Macau, Peoples R China; [Gao, Wenbin] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou 510405, Guangdong, Peoples R China; [Hacer, Karatas; Li, Yangbing; Wang, Shaomeng] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hacer, Karatas; Li, Yangbing; Wang, Shaomeng] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Hacer, Karatas; Li, Yangbing; Wang, Shaomeng] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Central South University; University of Macau; Guangzhou University of Chinese Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Liu, L; Wang, Z (corresponding author), Univ Michigan, Dept Cardiac Surg, Frankel Cardiovasc Ctr, Ann Arbor, MI 48109 USA.	luvul@med.umich.edu; zhongw@med.umich.edu	gao, wenbin/AAA-4665-2022; Lei, IENG LAM/AAT-8216-2020	gao, wenbin/0000-0001-9268-8823; Lei, IENG LAM/0000-0002-0248-6871; Tian, Shuo/0000-0001-9883-2961; Wang, Shaomeng/0000-0002-8782-6950	National Institutes of Health [HL109054]; Joint Institute of University of Michigan Health System; Peking University Health Science Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Institute of University of Michigan Health System; Peking University Health Science Center(Peking University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grant HL109054 and a Pilot Award from the Joint Institute of University of Michigan Health System and Peking University Health Science Center (to Z. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abad M, 2017, STEM CELL REP, V8, P548, DOI 10.1016/j.stemcr.2017.01.025; Addis RC, 2013, J MOL CELL CARDIOL, V60, P97, DOI 10.1016/j.yjmcc.2013.04.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bektik E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183000; Belperio JA, 2004, J IMMUNOL, V173, P4692, DOI 10.4049/jimmunol.173.7.4692; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bouzaffour M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005824; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Cahill TJ, 2017, NAT REV DRUG DISCOV, V16, P699, DOI 10.1038/nrd.2017.106; Cao N, 2016, SCIENCE, V352, P1216, DOI 10.1126/science.aaf1502; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Cavalera M, 2014, CURR PHARM DESIGN, V20, P1971, DOI 10.2174/13816128113199990449; Ceholski DK, 2017, STEM CELL RES, V23, P77, DOI 10.1016/j.scr.2017.06.015; Chong SW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-54; Christoforou N, 2017, SCI REP-UK, V7, DOI 10.1038/srep40285; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063577; Dal-Pra S, 2017, CIRC RES, V120, P1403, DOI 10.1161/CIRCRESAHA.116.308741; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Fu YB, 2015, CELL RES, V25, P1013, DOI 10.1038/cr.2015.99; Ghosh MC, 2009, BLOOD, V114, P1366, DOI 10.1182/blood-2008-08-175869; GRAVES DT, 1995, CRIT REV ORAL BIOL M, V6, P109, DOI 10.1177/10454411950060020101; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ifkovits JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089678; Jayawardena TM, 2015, CIRC RES, V116, P418, DOI 10.1161/CIRCRESAHA.116.304510; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jozefczuk J, 2012, JOVE-J VIS EXP, DOI 10.3791/3854; Kim BS, 2015, INT J CARDIOL, V197, P2, DOI 10.1016/j.ijcard.2015.06.017; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Liu WR, 2011, WIRES SYST BIOL MED, V3, P191, DOI 10.1002/wsbm.112; Liu ZQ, 2017, NATURE, V551, P100, DOI 10.1038/nature24454; Mah N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024351; Mohamed TMA, 2017, CIRCULATION, V135, P978, DOI 10.1161/CIRCULATIONAHA.116.024692; Muraoka N, 2014, EMBO J, V33, P1565, DOI 10.15252/embj.201387605; Pignatti P, 2006, AM J RESP CRIT CARE, V173, P310, DOI 10.1164/rccm.200502-244OC; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Umei TC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081805; Velecela V, 2013, HUM MOL GENET, V22, P5083, DOI 10.1093/hmg/ddt358; Wada R, 2013, P NATL ACAD SCI USA, V110, P12667, DOI 10.1073/pnas.1304053110; Wang HX, 2014, CELL REP, V6, P951, DOI 10.1016/j.celrep.2014.01.038; Wang L, 2015, JOVE-J VIS EXP, DOI 10.3791/53426; Wang L, 2015, CIRC RES, V116, P237, DOI 10.1161/CIRCRESAHA.116.305547; Yamakawa H, 2015, STEM CELL REP, V5, P1128, DOI 10.1016/j.stemcr.2015.10.019; Yang CS, 2011, STEM CELLS, V29, P1528, DOI 10.1002/stem.717; Zhao YB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9243; Zhou HY, 2017, GENE DEV, V31, P1770, DOI 10.1101/gad.305482.117; Zhou HY, 2015, P NATL ACAD SCI USA, V112, P11864, DOI 10.1073/pnas.1516237112; Zhou Y, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/3814747; Zhou Y, 2016, CELL STEM CELL, V18, P382, DOI 10.1016/j.stem.2016.02.003	50	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9134	9146		10.1074/jbc.RA118.006000	http://dx.doi.org/10.1074/jbc.RA118.006000			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31023824	hybrid, Green Published			2022-12-28	WOS:000471751600010
J	Cejas, RB; Lorenz, V; Garay, YC; Irazoqui, FJ				Cejas, Romina B.; Lorenz, Virginia; Garay, Yohana C.; Irazoqui, Fernando J.			Biosynthesis of O-N-acetylgalactosamine glycans in the human cell nucleus (vol 294, pg 2997, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Cejas RB, 2019, J BIOL CHEM, V294, P2997, DOI 10.1074/jbc.RA118.005524	1	0	0	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7967	7967		10.1074/jbc.AAC119.008943	http://dx.doi.org/10.1074/jbc.AAC119.008943			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	31076524	Green Published, hybrid			2022-12-28	WOS:000470153300035
J	Sha, Z; Blyszcz, T; Gonzalez-Prieto, R; Vertegaal, ACO; Goldberg, AL				Sha, Zhe; Blyszcz, Tamara; Gonzalez-Prieto, Roman; Vertegaal, Alfred C. O.; Goldberg, Alfred L.			Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; proteasome; ubiquitylation (ubiquitination); small ubiquitin-like modifier (SUMO); sumoylation; nuclear body; promyelocytic leukemia (PML); SUMO-conjugating enzyme UBC9; TAK243; ubiquitin-activating enzyme (UAE; E1))	ACUTE PROMYELOCYTIC LEUKEMIA; NF-KAPPA-B; TRANSCRIPTIONAL ACTIVITY; HEAT-SHOCK; E3 LIGASE; COMPUTATIONAL PLATFORM; SUMO-1 MODIFICATION; STRUCTURAL BASIS; REVEALS; DEGRADATION	Protein ubiquitination and SUMOylation are required for the maintenance of cellular protein homeostasis, and both increase in proteotoxic conditions (e.g. heat shock or proteasome inhibition). However, we found that when ubiquitination was blocked in several human cell lines by inhibiting the ubiquitin-activating enzyme with TAK243, there was an unexpected, large accumulation of proteins modified by SUMO2/3 chains or SUMO1, but not by several other ubiquitin-like proteins. This buildup of SUMOylated proteins was evident within 3?4 h. It required the small ubiquitin-like modifier (SUMO)-conjugating enzyme, UBC9, and the promyelocytic leukemia protein (PML) and thus was not due to nonspecific SUMO conjugation by ubiquitination enzymes. The SUMOylated proteins accumulated predominantly bound to chromatin and were localized to PML nuclear bodies. Because blocking protein synthesis with cycloheximide prevented the buildup of SUMOylated proteins, they appeared to be newly-synthesized proteins. The proteins SUMOylated after inhibition of ubiquitination were purified and analyzed by MS. In HeLa and U2OS cells, there was a cycloheximide-sensitive increase in a similar set of SUMOylated proteins (including transcription factors and proteins involved in DNA damage repair). Surprisingly, the inhibition of ubiquitination also caused a cycloheximide-sensitive decrease in a distinct set of SUMOylated proteins (including proteins for chromosome modification and mRNA splicing). More than 80% of the SUMOylated proteins whose levels rose or fell upon inhibiting ubiquitination inhibition underwent similar cycloheximide-sensitive increases or decreases upon proteasome inhibition. Thus, when nuclear substrates of the ubiquitin?proteasome pathway are not efficiently degraded, many become SUMO-modified and accumulate in PML bodies.	[Sha, Zhe; Goldberg, Alfred L.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Blyszcz, Tamara; Gonzalez-Prieto, Roman; Vertegaal, Alfred C. O.] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Sha, Zhe] 3 Preston Ct, Bedford, MA 01730 USA	Harvard University; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Goldberg, AL (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Vertegaal, ACO (corresponding author), Leiden Univ, Dept Cell & Chem Biol, Med Ctr, NL-2333 ZA Leiden, Netherlands.	vertegaal@lumc.nl; alfred_goldberg@hms.harvard.edu	Gonzalez Prieto, Roman/O-4132-2014; Vertegaal, Alfred/ABG-8141-2021	Gonzalez Prieto, Roman/0000-0001-8997-2321; Vertegaal, Alfred/0000-0002-7989-0493	National Institutes of Health Grant from NIGMS [RO1 GM51923-23]; Muscular Dystrophy Association; Cure Alzheimers Foundation, Project ALS; European Research Council (ERC) [310913]; Netherlands Organisation for Scientific Research (NWO) VICI Grant [724.016.003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Muscular Dystrophy Association(Muscular Dystrophy Association); Cure Alzheimers Foundation, Project ALS; European Research Council (ERC)(European Research Council (ERC)); Netherlands Organisation for Scientific Research (NWO) VICI Grant(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM51923-23 from NIGMS (to A. L. G.); the Muscular Dystrophy Association; the Cure Alzheimers Foundation, Project ALS (to A. L. G.); the European Research Council (ERC) Grant 310913 (to A. C. O. V.), and Netherlands Organisation for Scientific Research (NWO) VICI Grant 724.016.003 (to A. C. O. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablain J, 2014, NAT MED, V20, P167, DOI 10.1038/nm.3441; Bailey D, 2005, BIOCHEM J, V392, P271, DOI 10.1042/BJ20050873; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Barghout SH, 2019, LEUKEMIA, V33, P37, DOI 10.1038/s41375-018-0167-0; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chen H, 2010, BIOCHEM J, V429, P95, DOI 10.1042/BJ20100193; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; de The H, 2017, CANCER CELL, V32, P552, DOI 10.1016/j.ccell.2017.10.002; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dundr M, 2012, CURR OPIN CELL BIOL, V24, P415, DOI 10.1016/j.ceb.2012.03.010; Eisenhardt N, 2015, NAT STRUCT MOL BIOL, V22, P959, DOI 10.1038/nsmb.3114; Erker Y, 2013, MOL CELL BIOL, V33, P2163, DOI 10.1128/MCB.01019-12; Ferbeyre G, 2000, GENE DEV, V14, P2015; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Guo LL, 2014, MOL CELL, V55, P15, DOI 10.1016/j.molcel.2014.04.030; He XY, 2017, NAT CHEM BIOL, V13, P1164, DOI [10.1038/nchembio.2463, 10.1038/NCHEMBIO.2463]; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Hendriks IA, 2016, METHODS MOL BIOL, V1475, P171, DOI 10.1007/978-1-4939-6358-4_13; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Hendriks IA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8289; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Hou X, 2017, BIOCHEM BIOPH RES CO, V494, P446, DOI 10.1016/j.bbrc.2017.10.103; Hsu KS, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0204-8; Hyer ML, 2018, NAT MED, V24, P186, DOI 10.1038/nm.4474; Imoto S, 2008, BIOCHEM BIOPH RES CO, V370, P359, DOI 10.1016/j.bbrc.2008.03.116; Kumar R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01900-x; Lallemand-Breitenbach V, 2018, CURR OPIN CELL BIOL, V52, P154, DOI 10.1016/j.ceb.2018.03.011; Liebelt F, 2019, CELL REP, V26, P236, DOI 10.1016/j.celrep.2018.12.027; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lomonte P, 2016, MICROB CELL, V3, P438, DOI 10.15698/mic2016.11.541; Long JY, 2004, BIOCHEM J, V379, P23, DOI 10.1042/BJ20031867; Maghames CM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06365-0; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Myatt SS, 2014, ONCOGENE, V33, P4316, DOI 10.1038/onc.2013.546; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Rao HBDP, 2017, SCIENCE, V355, P403, DOI 10.1126/science.aaf6407; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rott R, 2017, P NATL ACAD SCI USA, V114, P13176, DOI 10.1073/pnas.1704351114; Sahin U, 2014, J PATHOL, V234, P289, DOI 10.1002/path.4426; Sahin U, 2014, J CELL BIOL, V204, P931, DOI 10.1083/jcb.201305148; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143; Sha Z, 2018, J CELL BIOL, V217, P1757, DOI 10.1083/jcb.201708168; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Xiao ZY, 2015, MOL CELL PROTEOMICS, V14, P1419, DOI 10.1074/mcp.O114.044792; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112; Zilio N, 2017, ADV EXP MED BIOL, V963, P51, DOI 10.1007/978-3-319-50044-7_4	74	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15218	15234		10.1074/jbc.RA119.009147	http://dx.doi.org/10.1074/jbc.RA119.009147			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31285264	Green Published, hybrid			2022-12-28	WOS:000499248700003
J	Shen, Z; Wang, G; Yang, YL; Shi, JL; Fang, LR; Li, F; Xiao, SB; Fu, ZF; Peng, GQ				Shen, Zhou; Wang, Gang; Yang, Yiling; Shi, Jiale; Fang, Liurong; Li, Fang; Xiao, Shaobo; Fu, Zhen F.; Peng, Guiqing			A conserved region of nonstructural protein 1 from alphacoronaviruses inhibits host gene expression and is critical for viral virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein motif; pathogenesis; crystal structure; virulence factor; virus; coronavirus; host gene expression; immune evasion; nonstructural protein 1 (nsp1); transmissible gastroenteritis virus (TGEV)	RESPIRATORY SYNDROME CORONAVIRUS; EPIDEMIC DIARRHEA VIRUS; RATIONAL DESIGN; BINDING PROTEIN; NSP1 PROTEINS; I INTERFERON; PATHOGENESIS; REPLICATION; RNA; IMMUNIZATION	Coronaviruses are enveloped, single-stranded RNA viruses that are distributed worldwide. They include transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhea virus (PEDV), and the human coronaviruses severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), many of which seriously endanger human health and well-being. Only alphacoronaviruses and betacoronaviruses harbor nonstructural protein 1 (nsp1), which performs multiple functions in inhibiting antiviral host responses. The role of the C terminus of betacoronavirus nsp1 in virulence has been characterized, but the location of the alphacoronavirus nsp1 region that is important for virulence remains unclear. Here, using TGEV nsp1 as a model to explore the function of this protein in alphacoronaviruses, we demonstrate that alphacoronavirus nsp1 inhibits host gene expression. Solving the crystal structure of full-length TGEV at 1.85-angstrom resolution and conducting several biochemical analyses, we observed that a specific motif (amino acids 91-95) of alphacoronavirus nsp1 is a conserved region that inhibits host protein synthesis. Using a reverse-genetics system based on CRISPR/Cas9 technology to construct a recombinant TGEV in which this specific nsp1 motif was altered, we found that this mutation does not affect virus replication in cell culture but significantly reduces TGEV pathogenicity in pigs. Taken together, our findings suggest that alphacoronavirus nsp1 is an essential virulence determinant, providing a potential paradigm for the development of a new attenuated vaccine based on modified nsp1.	[Shen, Zhou; Wang, Gang; Yang, Yiling; Shi, Jiale; Fang, Liurong; Xiao, Shaobo; Fu, Zhen F.; Peng, Guiqing] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China; [Shen, Zhou; Wang, Gang; Yang, Yiling; Shi, Jiale; Fang, Liurong; Xiao, Shaobo; Fu, Zhen F.; Peng, Guiqing] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Hubei, Peoples R China; [Li, Fang] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Fu, Zhen F.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Peng, Guiqing] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University; University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; University of Georgia; Huazhong Agricultural University	Peng, GQ (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China.	penggq@mail.hzau.edu.cn		Xiao, Shaobo/0000-0003-0023-9188; Shen, Zhou/0000-0001-8772-2978	National Natural Science Foundation of China [31873020, 31722056]; National Key Research and Development Plan of China [2018YFD0500102]; Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation Program [2662017PY028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan of China; Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation Program	This work was supported by National Natural Science Foundation of China Grants 31873020 and 31722056, National Key Research and Development Plan of China Grant 2018YFD0500102, and Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation Program 2662017PY028. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Almeida MS, 2006, J BIOMOL NMR, V36, P46, DOI 10.1007/s10858-006-9018-9; Cai H, 2016, J VIROL, V90, P7323, DOI 10.1128/JVI.00755-16; De Diego ML, 2014, VIRUS RES, V194, P124, DOI 10.1016/j.virusres.2014.07.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1; Fett C, 2013, J VIROL, V87, P6551, DOI 10.1128/JVI.00087-13; Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143; Grell L, 2006, BIOCHEM MOL BIOL EDU, V34, P402, DOI 10.1002/bmb.2006.494034062672; Guan BJ, 2012, J VIROL, V86, P4631, DOI 10.1128/JVI.06265-11; Gustin KM, 2009, J VIROL, V83, P6087, DOI 10.1128/JVI.00160-09; Huang C, 2011, J VIROL, V85, P638, DOI 10.1128/JVI.01806-10; Jansson AM, 2013, J VIROL, V87, P2949, DOI 10.1128/JVI.03163-12; Jimenez-Guardeno JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004320; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Lamirande EW, 2008, J VIROL, V82, P7721, DOI 10.1128/JVI.00304-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061166; Liu YF, 2016, FEBS J, V283, P899, DOI 10.1111/febs.13642; Lloyd RE, 2006, VIRUS RES, V119, P76, DOI 10.1016/j.virusres.2005.10.016; Lokugamage KG, 2015, J VIROL, V89, P10970, DOI 10.1128/JVI.01352-15; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Netland J, 2010, VIROLOGY, V399, P120, DOI 10.1016/j.virol.2010.01.004; Nicolodi C, 2019, VACCINE, V37, P3722, DOI 10.1016/j.vaccine.2019.05.013; Park HS, 2018, J VIROL, V92, DOI [10.1128/JVI.00022-18, 10.1128/jvi.00022-18]; Pasieka TJ, 2008, J VIROL, V82, P5527, DOI 10.1128/JVI.02047-07; Patnaik S, 2019, BIOORG MED CHEM LETT, V29, P1113, DOI 10.1016/j.bmcl.2019.02.027; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Shen Z, 2018, J VIROL, V92, DOI 10.1128/JVI.01896-17; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; Tohya Y, 2009, J VIROL, V83, P5282, DOI 10.1128/JVI.02485-08; Wang G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040313; Wang YJ, 2010, INFECT GENET EVOL, V10, P919, DOI 10.1016/j.meegid.2010.05.014; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2; Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803; Zhang QZ, 2017, VIROLOGY, V510, P111, DOI 10.1016/j.virol.2017.07.009; Zhang QZ, 2016, VIROLOGY, V489, P252, DOI 10.1016/j.virol.2015.12.010; Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	46	35	38	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13606	13618		10.1074/jbc.RA119.009713	http://dx.doi.org/10.1074/jbc.RA119.009713			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31350335	hybrid, Green Published			2022-12-28	WOS:000486418600008
J	Jiang, M; Hu, JP; White, FKH; Williamson, J; Klymchenko, AS; Murthy, A; Workman, SW; Tseng, GN				Jiang, Min; Hu, Junping; White, Frances K. H.; Williamson, Judy; Klymchenko, Andrey S.; Murthy, Akshay; Workman, Samuel W.; Tseng, Gea-Ny			S-Palmitoylation of junctophilin-2 is critical for its role in tethering the sarcoplasmic reticulum to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); post-translational modification; lipid raft; plasma membrane; excitation-contraction coupling (E-C coupling); ER-PM junction; palmitoylation	PROTEINS; JUNCTIONS; PROBES; TOOLS	Junctophilins (JPH1-JPH4) are expressed in excitable and nonexcitable cells, where they tether endoplasmic/sarcoplasmic reticulum (ER/SR) and plasma membranes (PM). These ER/SR-PM junctions bring Ca-release channels in the ER/SR and Ca as well as Ca-activated K channels in the PM to within 10-25 nm. Such proximity is critical for excitation-contraction coupling in muscles, Ca modulation of excitability in neurons, and Ca homeostasis in nonexcitable cells. JPHs are anchored in the ER/SR through the C-terminal transmembrane domain (TMD). Their N-terminal Membrane-Occupation-Recognition-Nexus (MORN) motifs can bind phospholipids. Whether MORN motifs alone are sufficient to stabilize JPH-PM binding is not clear. We investigate whether S-palmitoylation of cysteine (Cys), a critical mechanism controlling peripheral protein binding to PM, occurs in JPHs. We focus on JPH2 that has four Cys residues: three flanking the MORN motifs and one in the TMD. Using palmitate-alkyne labeling, Cu(I)-catalyzed alkyne-azide cycloaddition reaction with azide-conjugated biotin, immunoblotting, proximity-ligation-amplification, and various imaging techniques, we show that JPH2 is S-palmitoylatable, and palmitoylation is essential for its ER/SR-PM tether function. Palmitoylated JPH2 binds to lipid-raft domains in PM, whereas palmitoylation of TMD-located Cys stabilizes JPH2's anchor in the ER/SR membrane. Binding to lipid-raft domains protects JPH2 from depalmitoylation. Unpalmitoylated JPH2 is largely excluded from lipid rafts and loses the ability to form stable ER/SR-PM junctions. In adult ventricular myocytes, native JPH2 is S-palmitoylatable, and palmitoylated JPH2 forms distinct PM puncta. Sequence alignment reveals that the palmitoylatable Cys residues in JPH2 are conserved in other JPHs, suggesting that palmitoylation may also enhance ER/SR-PM tethering by these proteins.	[Jiang, Min; Hu, Junping; Murthy, Akshay; Workman, Samuel W.; Tseng, Gea-Ny] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [White, Frances K. H.; Williamson, Judy] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Jiang, Min] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Jiang, Min] Peking Union Med Coll, Beijing 100050, Peoples R China; [Klymchenko, Andrey S.] Univ Strasbourg, CNRS, UMR 7021, Lab Bioimagerie & Pathol, F-67401 Illkirch Graffenstaden, France	Virginia Commonwealth University; Virginia Commonwealth University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tseng, GN (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA.	gtseng@vcu.edu			National Institutes of Health from NHLBI [RO1 HL128610, RO1 HL96962]; American Heart Association/Mid-Atlantic Affiliate [16GRNT29920012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096962, R01HL128610] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association/Mid-Atlantic Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants RO1s HL128610 and HL96962 from NHLBI and by Grant-in-aid 16GRNT29920012 from American Heart Association/Mid-Atlantic Affiliate (to G. -N. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chamberlain LH, 2004, FEBS LETT, V559, P1, DOI 10.1016/S0014-5793(04)00050-X; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Darwich Z, 2013, METHODS APPL FLUORES, V1, DOI 10.1088/2050-6120/1/2/025002; Fox PD, 2015, J CELL SCI, V128, P2096, DOI 10.1242/jcs.166009; Fukata Y, 2016, CURR TOP MEMBR, V77, P97, DOI 10.1016/bs.ctm.2015.10.003; Gao XX, 2014, J AM CHEM SOC, V136, P4544, DOI 10.1021/ja410068g; Guo A, 2015, J BIOL CHEM, V290, P17946, DOI 10.1074/jbc.M115.652396; Guo A, 2014, P NATL ACAD SCI USA, V111, P12240, DOI 10.1073/pnas.1412729111; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Jiang M, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005084; Jiang M, 2016, HEART RHYTHM, V13, P743, DOI 10.1016/j.hrthm.2015.10.037; Klymchenko AS, 2014, CHEM BIOL, V21, P97, DOI 10.1016/j.chembiol.2013.11.009; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Li L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.179; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Morgan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053785; Quick AP, 2017, CIRC RES, V120, P110, DOI 10.1161/CIRCRESAHA.116.309977; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H, 2015, CELL CALCIUM, V58, P349, DOI 10.1016/j.ceca.2015.01.007; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Wang YH, 2014, HEART RHYTHM, V11, P2064, DOI 10.1016/j.hrthm.2014.07.022; Woo JS, 2016, P NATL ACAD SCI USA, V113, P2762, DOI 10.1073/pnas.1524229113; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014	33	15	15	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13487	13501		10.1074/jbc.RA118.006772	http://dx.doi.org/10.1074/jbc.RA118.006772			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31337710	Green Published, hybrid			2022-12-28	WOS:000486417200023
J	Wang, X; Obeidat, M; Li, LJ; Pasarj, P; Aburahess, S; Holmes, CFB; Ballermann, BJ				Wang, Xin; Obeidat, Marya; Li, Laiji; Pasarj, Phuwadet; Aburahess, Salah; Holmes, Charles F. B.; Ballermann, Barbara J.			TIMAP inhibits endothelial myosin light chain phosphatase by competing with MYPT1 for the catalytic protein phosphatase 1 subunit PP1c beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoprotein phosphatase 1 (PP1); myosin; endothelial cell; inhibitor; angiogenesis; microcystin; myosin phosphatase; MYPT1	TARGETING SUBUNIT; CRYSTAL-STRUCTURE; SMOOTH-MUSCLE; STRUCTURAL BASIS; DOCKING MOTIF; OKADAIC ACID; PHOSPHORYLATION; SPECIFICITY; BARRIER; BETA	Transforming growth factor-beta membrane associated protein (TIMAP) is an endothelial cell (EC)-predominant PP1 regulatory subunit and a member of the myosin phosphatase target (MYPT) protein family. The MYPTs preferentially bind the catalytic protein phosphatase 1 subunit PP1c beta, forming myosin phosphatase holoenzymes. We investigated whether TIMAP/PP1c beta could also function as a myosin phosphatase. Endogenous PP1c beta, myosin light chain 2 (MLC2), and myosin IIA heavy chain coimmunoprecipitated from EC lysates with endogenous TIMAP, and endogenous MLC2 colocalized with TIMAP in EC projections. Purified recombinant GST-TIMAP interacted directly with purified recombinant His-MLC2. However, TIMAP overexpression in EC enhanced MLC2 phosphorylation, an effect not observed with a TIMAP mutant that does not bind PP1c beta. Conversely, MLC2 phosphorylation was reduced in lung lysates from TIMAP-deficient mice and upon silencing of endogenous TIMAP expression in ECs. Ectopically expressed TIMAP slowed the rate of MLC2 dephosphorylation, an effect requiring TIMAP-PP1c beta interaction. The association of MYPT1 with PP1c beta was profoundly reduced in the presence of excess TIMAP, leading to proteasomal MYPT1 degradation. In the absence of TIMAP, MYPT1-associated PP1c beta readily bound immobilized microcystin-LR, an active-site inhibitor of PP1c. By contrast, TIMAP-associated PP1c beta did not interact with microcystin-LR, indicating that the active site of PP1c beta is blocked when it is bound to TIMAP. Thus, TIMAP inhibits myosin phosphatase activity in ECs by competing with MYPT1 for PP1c beta and blocking the PP1c beta active site.	[Wang, Xin; Obeidat, Marya; Li, Laiji; Aburahess, Salah; Ballermann, Barbara J.] Univ Alberta, Dept Med, Clin Sci Bldg 13-103,11350 83rd Ave NW, Edmonton, AB T6G 2G3, Canada; [Pasarj, Phuwadet; Holmes, Charles F. B.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2G3, Canada; [Wang, Xin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Key Nephrol Lab,China Minist Hlth, Guangzhou 510080, Guangdong, Peoples R China; [Obeidat, Marya] Jordan Univ Sci & Technol, Fac Appl Med Sci, Dept Med Lab Sci, POB 3030, Irbid 22110, Jordan	University of Alberta; University of Alberta; Sun Yat Sen University; Jordan University of Science & Technology	Ballermann, BJ (corresponding author), Univ Alberta, Dept Med, Clin Sci Bldg 13-103,11350 83rd Ave NW, Edmonton, AB T6G 2G3, Canada.	barbara.ballermann@ualberta.ca	Wang, Xin/GQQ-5679-2022; Ballermann, Barbara/G-5349-2016	WANG, XIN/0000-0002-5016-6653; Ballermann, Barbara/0000-0002-8220-6381	Heart and Stroke Foundation of Canada; Kidney Foundation of Canada; Canadian Cancer Society; China Scholarship Council; Division of Nephrology, Dept. of Medicine, University of Alberta; Libyan-North American Scholarship Program	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Kidney Foundation of Canada; Canadian Cancer Society(Canadian Cancer Society (CCS)); China Scholarship Council(China Scholarship Council); Division of Nephrology, Dept. of Medicine, University of Alberta; Libyan-North American Scholarship Program	This work was supported by grants from the Heart and Stroke Foundation of Canada and from the Kidney Foundation of Canada (to B. J. B.) and by a research innovation grant from the Canadian Cancer Society (to C. F. B. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the China Scholarship Council.; Supported by the Division of Nephrology, Dept. of Medicine, University of Alberta.; Supported by the Libyan-North American Scholarship Program.	ALESSI DR, 1993, EUR J BIOCHEM, V213, P1055, DOI 10.1111/j.1432-1033.1993.tb17853.x; Bagu JR, 1997, J BIOL CHEM, V272, P5087, DOI 10.1074/jbc.272.8.5087; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Boratko A, 2017, IUBMB LIFE, V69, P918, DOI 10.1002/iub.1695; Boratko A, 2017, BBA-MOL CELL RES, V1864, P431, DOI 10.1016/j.bbamcr.2016.12.001; Boratko A, 2017, INT J BIOCHEM CELL B, V82, P10, DOI 10.1016/j.biocel.2016.11.010; Cao JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02373-8; Cao WS, 2002, AM J PHYSIOL-CELL PH, V283, pC327, DOI 10.1152/ajpcell.00442.2001; Chatterjee J, 2013, CURR OPIN CHEM BIOL, V17, P361, DOI 10.1016/j.cbpa.2013.04.008; Csortos C, 2008, AM J PHYSIOL-LUNG C, V295, pL440, DOI 10.1152/ajplung.00325.2007; Czikora I, 2011, BIOCHIMIE, V93, P1139, DOI 10.1016/j.biochi.2011.03.011; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; Eto M, 2012, IUBMB LIFE, V64, P732, DOI 10.1002/iub.1067; Gailly P, 1996, EUR J BIOCHEM, V239, P326, DOI 10.1111/j.1432-1033.1996.0326u.x; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Heinzel K, 2007, EUR J IMMUNOL, V37, P2562, DOI 10.1002/eji.200637474; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448; Kelker MS, 2009, J MOL BIOL, V385, P11, DOI 10.1016/j.jmb.2008.10.053; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kim K, 2005, BIOCHEM BIOPH RES CO, V338, P1327, DOI 10.1016/j.bbrc.2005.10.089; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kita A, 2002, STRUCTURE, V10, P715, DOI 10.1016/S0969-2126(02)00764-5; Korrodi-Gregorio L, 2014, TRANSL RES, V164, P366, DOI 10.1016/j.trsl.2014.07.001; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P3536, DOI 10.1073/pnas.94.8.3536; Li L, 2007, J BIOL CHEM, V282, P25960, DOI 10.1074/jbc.M703532200; Ma HJ, 2010, AM J PHYSIOL-LUNG C, V299, pL117, DOI 10.1152/ajplung.00340.2009; MacDonald Justin A., 2018, Cardiovascular & Hematological Disorders - Drug Targets, V18, P4, DOI 10.2174/1871529X18666180326120638; Magdaleno Susan, 2002, Brain Res Gene Expr Patterns, V1, P143; Matsuzawa F, 2005, J BIOCHEM, V137, P633, DOI 10.1093/jb/mvi077; Maynes JT, 2001, J BIOL CHEM, V276, P44078, DOI 10.1074/jbc.M107656200; Maynes JT, 2004, J BIOL CHEM, V279, P43198, DOI 10.1074/jbc.M407184200; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; MOORHEAD G, 1994, FEBS LETT, V356, P46, DOI 10.1016/0014-5793(94)01232-6; MOORHEAD G, 1995, FEBS LETT, V362, P101, DOI 10.1016/0014-5793(95)00197-H; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Obeidat M., 2015, THESIS; Obeidat M, 2014, AM J PHYSIOL-RENAL, V307, pF623, DOI 10.1152/ajprenal.00070.2014; Poirier C, 2011, RESP PHYSIOL NEUROBI, V179, P334, DOI 10.1016/j.resp.2011.08.012; Schnittler H, 2016, HISTOCHEM CELL BIOL, V146, P651, DOI 10.1007/s00418-016-1501-0; Scotto-Lavino E, 2010, J BIOL CHEM, V285, P6419, DOI 10.1074/jbc.M109.074773; Shopik MJ, 2013, BIOCHEM BIOPH RES CO, V435, P567, DOI 10.1016/j.bbrc.2013.05.012; Skinner JA, 2001, BIOCHEM J, V356, P257, DOI 10.1042/0264-6021:3560257; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Twomey E, 2010, EXP CELL RES, V316, P68, DOI 10.1016/j.yexcr.2009.09.001; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Wittkopper K, 2011, CARDIOVASC RES, V91, P392, DOI 10.1093/cvr/cvr058; Wu Y, 2005, J MUSCLE RES CELL M, V26, P123, DOI 10.1007/s10974-005-2579-5; Yang J, 2017, J MOL MED, V95, P273, DOI 10.1007/s00109-016-1479-z; Yong J, 2006, J BIOL CHEM, V281, P31202, DOI 10.1074/jbc.M607287200	58	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13280	13291		10.1074/jbc.RA118.006075	http://dx.doi.org/10.1074/jbc.RA118.006075			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31315927	hybrid, Green Published			2022-12-28	WOS:000486417200007
J	Chandler, KB; Leon, DR; Kuang, J; Meyer, RD; Rahimi, N; Costello, CE				Chandler, Kevin Brown; Leon, Deborah R.; Kuang, Jenevieve; Meyer, Rosana D.; Rahimi, Nader; Costello, Catherine E.			N-Glycosylation regulates ligand-dependent activation and signaling of vascular endothelial growth factor receptor 2 (VEGFR2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; receptor tyrosine kinase; angiogenesis; endothelial cell; sialic acid; N-linked glycosylation; vascular endothelial growth factor (VEGF); angiogenic signaling; cytokine signaling; endothelial signaling; N-glycan; vascular endothelial growth factor receptor 2 (VEGFR2)	TUMOR VESSEL NORMALIZATION; KINASE-ACTIVITY; E-CADHERIN; CANCER; ANGIOGENESIS; GLYCANS; ADHESION; CELLS; SIALYLATION; AUTOPHOSPHORYLATION	The tumor microenvironment and proinflammatory signals significantly alter glycosylation of cell-surface proteins on endothelial cells. By altering the N-glycosylation machinery in the endoplasmic reticulum and Golgi, proinflammatory cytokines promote the modification of endothelial glycoproteins such as vascular endothelial growth factor receptor 2 (VEGFR2) with sialic acid-capped N-glycans. VEGFR2 is a highly N-glycosylated receptor tyrosine kinase involved in pro-angiogenic signaling in physiological and pathological contexts, including cancer. Here, using glycoside hydrolase and kinase assays and immunoprecipitation and MS-based analyses, we demonstrate that N-linked glycans at the Asn-247 site in VEGFR2 hinder VEGF ligand-mediated receptor activation and signaling in endothelial cells. We provide evidence that cell surface-associated VEGFR2 displays sialylated N-glycans at Asn-247 and, in contrast, that the nearby sites Asn-145 and Asn-160 contain lower levels of sialylated N-glycans and higher levels of high-mannose N-glycans, respectively. Furthermore, we report that VEGFR2 Asn-247-linked glycans capped with sialic acid oppose ligand-mediated VEGFR2 activation, whereas the uncapped asialo-glycans favor activation of this receptor. We propose that N-glycosylation, specifically the capping of N-glycans at Asn-247 by sialic acid, tunes ligand-dependent activation and signaling of VEGFR2 in endothelial cells.	[Chandler, Kevin Brown; Leon, Deborah R.; Kuang, Jenevieve; Costello, Catherine E.] Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA; [Kuang, Jenevieve; Costello, Catherine E.] Boston Univ, Dept Chem, Boston, MA 02118 USA; [Meyer, Rosana D.; Rahimi, Nader] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Costello, CE (corresponding author), Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, 670 Albany St,Rm 511, Boston, MA 02118 USA.	cecmsms@bu.edu	Chandler, Kevin/AAA-4334-2020	Chandler, Kevin/0000-0001-5514-9652; Rahimi, Nader/0000-0002-6745-1725; Costello, Catherine/0000-0003-1594-5122	National Institutes of Health [F32 CA196157, R21 CA191970, R21 CA193958, P41 GM104603, S10 OD021728]; NATIONAL CANCER INSTITUTE [F32CA196157, R21CA191970, R21CA193958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104603] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants F32 CA196157 (to K. B. C.), R21 CA191970 and R21 CA193958 (to N. R.), and P41 GM104603 and S10 OD021728 (to C. E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe Y, 1999, J IMMUNOL, V163, P2867; Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Banerjee A, 2011, J BIOL CHEM, V286, P29127, DOI 10.1074/jbc.M110.169771; Chandler KB, 2019, MOL CELL PROTEOMICS, V18, P686, DOI 10.1074/mcp.RA118.001185; Chandler KB, 2017, J PROTEOME RES, V16, P677, DOI 10.1021/acs.jproteome.6b00738; Chiodelli P, 2017, ONCOGENE, V36, P6531, DOI 10.1038/onc.2017.243; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; Croci DO, 2018, HANDB EXP PHARMACOL, V249, P31, DOI 10.1007/164_2017_29; Croci DO, 2014, GLYCOBIOLOGY, V24, P1283, DOI 10.1093/glycob/cwu083; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; De Palma M, 2017, IMMUNITY, V46, P773, DOI 10.1016/j.immuni.2017.04.015; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Dudley AC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006536; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fernandes H, 2001, J BIOL CHEM, V276, P5375, DOI 10.1074/jbc.M005599200; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Franses JW, 2013, INT J CANCER, V133, P1334, DOI 10.1002/ijc.28146; Ganss R, 2017, IMMUNOL CELL BIOL, V95, P497, DOI 10.1038/icb.2017.30; Hall MK, 2014, FEBS OPEN BIO, V4, P892, DOI 10.1016/j.fob.2014.10.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kendall RL, 1999, J BIOL CHEM, V274, P6453, DOI 10.1074/jbc.274.10.6453; Khatri K, 2014, J PROTEOME RES, V13, P4347, DOI 10.1021/pr500506z; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; LI W, 1991, MOL CELL BIOL, V11, P3756, DOI 10.1128/MCB.11.7.3756; Liang W, 2016, CANCER IMMUNOL RES, V4, P83, DOI 10.1158/2326-6066.CIR-15-0313; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Lopez-Sambrooks C, 2016, NAT CHEM BIOL, V12, P1023, DOI 10.1038/nchembio.2194; Maishi N, 2017, CANCER SCI, V108, P1921, DOI 10.1111/cas.13336; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; MATTHEWS W, 1991, P NATL ACAD SCI USA, V88, P9026, DOI 10.1073/pnas.88.20.9026; Meyer RD, 2006, J BIOL CHEM, V281, P8620, DOI 10.1074/jbc.M512309200; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; Meyer RD, 2011, MOL CELL BIOL, V31, P2010, DOI 10.1128/MCB.01006-10; Nacev BA, 2011, J BIOL CHEM, V286, P44045, DOI 10.1074/jbc.M111.278754; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pinho SS, 2013, BBA-GEN SUBJECTS, V1830, P2690, DOI 10.1016/j.bbagen.2012.10.021; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Rahimi N, 1999, MOL BIOL CELL, V10, P3401, DOI 10.1091/mbc.10.10.3401; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; Sambrooks CL, 2018, CANCER RES, V78, P5094, DOI 10.1158/0008-5472.CAN-18-0505; Scott DW, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000263; Scott DW, 2013, GLYCOBIOLOGY, V23, P622, DOI 10.1093/glycob/cwt014; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Shade KTC, 2015, J EXP MED, V212, P457, DOI 10.1084/jem.20142182; Stanley P., 2015, ESSENTIALS GLYCOBIOL, P101; Tian L, 2017, NATURE, V544, P250, DOI 10.1038/nature21724; Varelas X, 2014, GLYCOBIOLOGY, V24, P579, DOI 10.1093/glycob/cwu031; Varki A, 2015, ESSENTIALS GLYCOBIOL, DOI DOI 10.1101/GLYCOBIOLOGY.3E.047; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yen HY, 2015, P NATL ACAD SCI USA, V112, P6955, DOI 10.1073/pnas.1507329112; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x	67	23	23	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13117	13130		10.1074/jbc.RA119.008643	http://dx.doi.org/10.1074/jbc.RA119.008643			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31308178	hybrid, Green Published			2022-12-28	WOS:000486416000021
J	Gospe, SM; Travis, AM; Kolesnikov, AV; Klingeborn, M; Wang, LY; Kefalov, VJ; Arshaysky, VY				Gospe, Sidney M., III; Travis, Amanda M.; Kolesnikov, Alexander, V; Klingeborn, Mikael; Wang, Luyu; Kefalov, Vladimir J.; Arshaysky, Vadim Y.			Photoreceptors in a mouse model of Leigh syndrome are capable of normal light-evoked signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retina; photoreceptor; gene knockout; transgenic mice; phototransduction; neurological disease; NADH:ubiquinone oxidoreductase subunit S4 (NDUFS4); optic atrophy	HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL; TRANSDUCIN; GLUCOSE; CELLS; MICE; TRANSLOCATION; CHILDREN	Mitochondrial dysfunction is an important cause of heritable vision loss. Mutations affecting mitochondrial bioenergetics may lead to isolated vision loss or life-threatening systemic disease, depending on a mutation's severity. Primary optic nerve atrophy resulting from death of retinal ganglion cells is the most prominent ocular manifestation of mitochondrial disease. However, dysfunction of other retinal cell types has also been described, sometimes leading to a loss of photoreceptors and retinal pigment epithelium that manifests clinically as pigmentary retinopathy. A popular mouse model of mitochondrial disease that lacks NADH:ubiquinone oxidoreductase subunit S4 (NDUFS4), a subunit of mitochondrial complex I, phenocopies many traits of the human disease Leigh syndrome, including the development of optic atrophy. It has also been reported that ndufs4(-/-) mice display diminished light responses at the level of photoreceptors or bipolar cells. By conducting electroretinography (ERG) recordings in live ndufs4(-/-) mice, we now demonstrate that this defect occurs at the level of retinal photoreceptors. We found that this deficit does not arise from retinal developmental anomalies, photoreceptor degeneration, or impaired regeneration of visual pigment. Strikingly, the impairment of ndufs4(-/-) photoreceptor function was not observed in ex vivo ERG recordings from isolated retinas, indicating that photoreceptors with complex I deficiency are intrinsically capable of normal signaling. The difference in electrophysiological phenotypes in vivo and ex vivo suggests that the energy deprivation associated with severe mitochondrial impairment in the outer retina renders ndufs4(-/-) photoreceptors unable to maintain the homeostatic conditions required to operate at their normal capacity.	[Gospe, Sidney M., III; Klingeborn, Mikael; Wang, Luyu; Arshaysky, Vadim Y.] Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA; [Travis, Amanda M.; Arshaysky, Vadim Y.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Kolesnikov, Alexander, V; Kefalov, Vladimir J.] Washington Univ, Dept Ophthalmol & Visual Sci, Sch Med, St Louis, MO 63110 USA; [Travis, Amanda M.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA	Duke University; Duke University; Washington University (WUSTL); University of Michigan System; University of Michigan	Gospe, SM (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA.	sid.gospe@duke.edu	Klingeborn, Mikael/AAC-2471-2019; Kolesnikov, Alexander V/O-1840-2016	Klingeborn, Mikael/0000-0003-2907-0371; Kefalov, Vladimir/0000-0002-1659-008X; Gospe III, Sidney/0000-0003-2838-7983	NEI, National Institutes of Health [EY028610, EY022959, EY025696, EY027387, EY005722, EY002687]; Duke University School of Medicine Strong Start award; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022959, R01EY019312, R01EY027387, P30EY002687, K08EY028610, P30EY005722, R01EY025696] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Duke University School of Medicine Strong Start award; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI, National Institutes of Health Grants EY028610 (to S.M.G.), EY022959 (to V.Y.A.), EY025696 and EY027387 (to V.J.K.), and Core Grants EY005722 (to Duke University) and EY002687 (to Washington University) as well as a Duke University School of Medicine Strong Start award (to S.M.G.) and an unrestricted Research to Prevent Blindness grant (to Duke Eye Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akebrand R, 2016, ACTA OPHTHALMOL, V94, P609, DOI 10.1111/aos.12983; BORGULA GA, 1989, VISION RES, V29, P1069, DOI 10.1016/0042-6989(89)90054-0; BOWNDS D, 1971, J GEN PHYSIOL, V58, P225, DOI 10.1085/jgp.58.3.225; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chinchore Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25946; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P; Contreras L, 2016, MOL VIS, V22, P1198; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002; Gospe SM, 2010, J CELL SCI, V123, P3639, DOI 10.1242/jcs.072389; Gronlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187; Herrmann R, 2010, J NEUROSCI, V30, P3239, DOI 10.1523/JNEUROSCI.4775-09.2010; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Kirches E, 2011, CURR GENOMICS, V12, P44, DOI 10.2174/138920211794520150; KNOSPE V, 1988, CURR EYE RES, V7, P1137, DOI 10.3109/02713688809001885; Kolesnikov AV, 2012, JOVE-J VIS EXP, DOI 10.3791/3424; Korsten A, 2010, BBA-BIOENERGETICS, V1797, P197, DOI 10.1016/j.bbabio.2009.10.003; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551; Lefevere E, 2017, MITOCHONDRION, V36, P66, DOI 10.1016/j.mito.2017.03.006; Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; Ogilvie JM, 2007, P NATL ACAD SCI USA, V104, P8514, DOI 10.1073/pnas.0702899104; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Philp NJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1319, DOI 10.1152/ajpcell.2001.280.5.C1319; Sadun Alfredo A, 2006, Trans Am Ophthalmol Soc, V104, P51; Sadun Alfredo A, 2002, Semin Ophthalmol, V17, P29, DOI 10.1076/soph.17.1.29.10290; Salomao SR, 2004, DOC OPHTHALMOL, V108, P147, DOI 10.1023/B:DOOP.0000036829.37053.31; SCHNETKAMP PPM, 1995, BIOCHEMISTRY-US, V34, P7282, DOI 10.1021/bi00021a045; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Smith BJ, 2017, NEUROSCIENCE, V340, P279, DOI 10.1016/j.neuroscience.2016.10.054; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Song LY, 2017, BRAIN RES, V1657, P232, DOI 10.1016/j.brainres.2016.12.019; TAKATA K, 1992, INVEST OPHTH VIS SCI, V33, P377; Travis AM, 2018, J NEUROSCI, V38, P723, DOI 10.1523/JNEUROSCI.1994-17.2017; Vinberg F, 2015, HUM MOL GENET, V24, P5915, DOI 10.1093/hmg/ddv319; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Wallace DC, 2011, COLD SH Q B, V76, P1, DOI 10.1101/sqb.2011.76.010462; Yu AK, 2015, HUM MOL GENET, V24, P2848, DOI 10.1093/hmg/ddv045	45	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12432	12443		10.1074/jbc.RA119.007945	http://dx.doi.org/10.1074/jbc.RA119.007945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248988	Green Published, hybrid			2022-12-28	WOS:000484402700015
J	Bowin, CF; Inoue, A; Schulte, G				Bowin, Carl-Fredrik; Inoue, Asuka; Schulte, Gunnar			WNT-3A-induced beta-catenin signaling does not require signaling through heterotrimeric G proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); WNT pathway; cell signaling; CRISPR; Cas; beta-catenin; conformational selection; Frizzled (FZD); WNT signaling; WNT-3A	WNT/BETA-CATENIN; GROWTH; INHIBITION; ACTIVATION; COMPLEX	The network of Wingless/Int-1 (WNT)-induced signaling pathways includes beta-catenin-dependent and -independent pathways. beta-Catenin regulates T cell factor/lymphoid enhancer-binding factor (TCF/LEF)-mediated gene transcription, and in response to WNTs, beta-catenin signaling is initiated through engagement of a Frizzled (FZD)/LDL receptor-related protein 5/6 (LRP5/6) receptor complex. FZDs are G protein-coupled receptors, but the question of whether heterotrimeric G proteins are involved in WNT/beta-catenin signaling remains unanswered. Here, we investigate whether acute activation of WNT/beta-catenin signaling by purified WNT-3A requires functional signaling through heterotrimeric G proteins. Using genome editing, we ablated expression of G(s)/G(olf)/G(q)/G(11)/G(12)/G(13)/G(z) in HEK293 (Delta G7) cells, leaving the expression of pertussis toxin (PTX)-sensitive G(i/o) proteins unchanged, to assess whether WNT-3A activates WNT/beta-catenin signaling in WT and Delta G7 cells devoid of functional G protein signaling. We monitored WNT-3A-induced activation by detection of phosphorylation of LDL receptor-related protein 6 (LRP6), electrophoretic mobility shift of the phosphoprotein Dishevelled (DVL), beta-catenin stabilization and dephosphorylation, and TCF-dependent transcription. We found that purified, recombinant WNT-3A efficiently induces WNT/beta-catenin signaling in Delta G7 cells in both the absence and presence of G(i/o)-blocking PTX. Furthermore, cells completely devoid of G protein expression, so called G alpha-depleted HEK293 cells, maintain responsiveness to WNT-3A with regard to the hallmarks of WNT/beta-catenin signaling. These findings corroborate the concept that heterotrimeric G proteins are not required for this FZD- and DVL-mediated signaling branch. Our observations agree with previous results arguing for FZD conformation-dependent functional selectivity between DVL and heterotrimeric G proteins. In conclusion, WNT/beta-catenin signaling through FZDs does not require the involvement of heterotrimeric G proteins.	[Bowin, Carl-Fredrik; Schulte, Gunnar] Karolinska Inst, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, Biomed 6D,Solnavagen 9, SE-17165 Stockholm, Sweden; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan	Karolinska Institutet; Tohoku University	Schulte, G (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sec Receptor Biol & Signaling, S-17177 Stockholm, Sweden.	gunnar.schulte@ki.se		Schulte, Gunnar/0000-0002-2700-7013; Bowin, Carl-Fredrik/0000-0001-9090-9493	Karolinska Institutet; Swedish Research Council [2017-04676]; Swedish Cancer Society [CAN2017/561]; Novo Nordisk Foundation [NNF17OC0026940]; Stiftelsen Olle Engkvist Byggmastare [2016/193]; Emil and Wera Cornells Stiftelse	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Emil and Wera Cornells Stiftelse	This work was supported by a grant from the Karolinska Institutet, Swedish Research Council Grant 2017-04676, Swedish Cancer Society Grant CAN2017/561, Novo Nordisk Foundation Grant NNF17OC0026940, Stiftelsen Olle Engkvist Byggmastare Grant 2016/193, and the Emil and Wera Cornells Stiftelse.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Arthofer E, 2016, MOL PHARMACOL, V90, P447, DOI 10.1124/mol.116.104919; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; DeBruine ZJ, 2017, BRIT J PHARMACOL, V174, P4564, DOI 10.1111/bph.14048; Driehuis E, 2017, BRIT J PHARMACOL, V174, P4547, DOI 10.1111/bph.13758; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Fujino H, 2001, J BIOL CHEM, V276, P12489, DOI 10.1074/jbc.C100039200; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Halleskog C, 2013, CELL SIGNAL, V25, P822, DOI 10.1016/j.cellsig.2012.12.006; Hisano Y, 2019, J EXP MED, V216, P1582, DOI 10.1084/jem.20181895; Hot B, 2017, CELL SIGNAL, V32, P93, DOI 10.1016/j.cellsig.2017.01.023; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kilander MBC, 2011, ACTA PHYSIOL, V203, P363, DOI 10.1111/j.1748-1716.2011.02324.x; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Koval A, 2016, BIOCHEM J, V473, P371, DOI 10.1042/BJ20150913; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; Malbon Craig C, 2011, Biochem J, V433, pe3, DOI 10.1042/BJ20102111; Milligan G, 2018, TRENDS PHARMACOL SCI, V39, P481, DOI 10.1016/j.tips.2018.02.005; Nag JK, 2018, CANCER METAST REV, V37, P147, DOI 10.1007/s10555-017-9711-z; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2018, TRENDS PHARMACOL SCI, V39, P828, DOI 10.1016/j.tips.2018.07.001; SUNYER T, 1989, MOL ENDOCRINOL, V3, P1115, DOI 10.1210/mend-3-7-1115; Valnohova J, 2018, J BIOL CHEM, V293, P17875, DOI 10.1074/jbc.RA118.004763; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright SC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08630-2; Wu CL, 2000, DEVELOPMENT, V127, P2773	33	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11677	11684		10.1074/jbc.AC119.009412	http://dx.doi.org/10.1074/jbc.AC119.009412			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31235524	Green Published, hybrid			2022-12-28	WOS:000486127800005
J	Boyko, S; Qi, X; Chen, TH; Surewicz, K; Surewicz, WK				Boyko, Solomiia; Qi, Xu; Chen, Tien-Hao; Surewicz, Krystyna; Surewicz, Witold K.			Liquid-liquid phase separation of tau protein: The crucial role of electrostatic interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Tau protein (Tau); protein misfolding; tauopathy; neurodegenerative disease; protein-protein interaction; intrinsically disordered protein; liquid-liquid phase separation (LLPS); Alzheimer's disease; neurodegeneration; protein aggregation	C-TERMINAL DOMAIN	Recent studies have indicated that tau, a protein involved in Alzheimer's disease and other neurodegenerative disorders, has a propensity to undergo liquid-liquid phase separation (LLPS). However, the mechanism of this process remains unknown. Here, we demonstrate that tau LLPS is largely driven by intermolecular electrostatic interactions between the negatively charged N-terminal and positively charged middle/C-terminal regions, whereas hydrophobic interactions play a surprisingly small role. Furthermore, our results reveal that, in contrast to previous suggestions, phosphorylation is not required for tau LLPS. These findings provide a foundation for understanding the mechanism by which phosphorylation and other posttranslational modifications could modulate tau LLPS in the context of specific physiological functions as well as pathological interactions.	[Boyko, Solomiia; Qi, Xu; Chen, Tien-Hao; Surewicz, Krystyna; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu			National Institutes of Health [RF1 AG061797]; Department of Physiology and Biophysics, Case Western Reserve University; NATIONAL INSTITUTE ON AGING [RF1AG061797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Physiology and Biophysics, Case Western Reserve University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant RF1 AG061797 (to W. K. S.) and a Department of Physiology and Biophysics, Case Western Reserve University, Pilot Project Grant (to W. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Babinchak WM, 2019, J BIOL CHEM, V294, P6306, DOI 10.1074/jbc.RA118.007222; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Barghorn Stefan, 2004, V299, P35; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Despres C, 2017, P NATL ACAD SCI USA, V114, P9080, DOI 10.1073/pnas.1708448114; Elbaum-Garfinkle S, 2019, J BIOL CHEM, V294, P7160, DOI 10.1074/jbc.REV118.001188; Ferreon JC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051360; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Gomes E, 2019, J BIOL CHEM, V294, P7115, DOI 10.1074/jbc.TM118.001192; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Holehouse AS, 2017, BIOPHYS J, V112, P16, DOI 10.1016/j.bpj.2016.11.3200; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Li HR, 2018, BBA-PROTEINS PROTEOM, V1866, P214, DOI 10.1016/j.bbapap.2017.10.001; Lin YX, 2019, ELIFE, V8, DOI 10.7554/eLife.42571; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Mair W, 2016, ANAL CHEM, V88, P3704, DOI 10.1021/acs.analchem.5b04509; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Martin EW, 2018, BIOCHEMISTRY-US, V57, P2478, DOI 10.1021/acs.biochem.8b00008; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nedelsky NB, 2019, NAT REV NEUROL, V15, P272, DOI 10.1038/s41582-019-0157-5; Quiroz FG, 2015, NAT MATER, V14, P1164, DOI [10.1038/nmat4418, 10.1038/NMAT4418]; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Uversky VN, 2017, ADV COLLOID INTERFAC, V239, P97, DOI 10.1016/j.cis.2016.05.012; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183; Zhu SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120416	33	90	90	12	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11054	11059		10.1074/jbc.AC119.009198	http://dx.doi.org/10.1074/jbc.AC119.009198			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31097543	Green Published, hybrid			2022-12-28	WOS:000478717400001
J	Rosell-Garcia, T; Paradela, A; Bravo, G; Dupont, L; Bekhouche, M; Colige, A; Rodriguez-Pascual, F				Rosell-Garcia, Tamara; Paradela, Alberto; Bravo, Gema; Dupont, Laura; Bekhouche, Mourad; Colige, Alain; Rodriguez-Pascual, Fernando			Differential cleavage of lysyl oxidase by the metalloproteinases BMP1 and ADAMTS2/14 regulates collagen binding through a tyrosine sulfate domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; collagen; lysyl oxidase; proteolysis; post-translational modification (PTM); connective tissue; ADAMTS; tyrosine sulfation; metalloproteinase	CROSS-LINKING; ENZYME-ACTIVITY; PROTEIN; IDENTIFICATION; BIOSYNTHESIS; ACCUMULATION; ORGANIZATION; INSIGHTS; MUTATION; FIBRILS	Collagens are the main structural component of the extracellular matrix and provide biomechanical properties to connective tissues. A critical step in collagen fibril formation is the proteolytic removal of N- and C-terminal propeptides from procollagens by metalloproteinases of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) and BMP1 (bone morphogenetic protein 1)/Tolloid-like families, respectively. BMP1 also cleaves and activates the lysyl oxidase (LOX) precursor, the enzyme catalyzing the initial step in the formation of covalent collagen cross-links, an essential process for fibril stabilization. In this study, using murine skin fibroblasts and HEK293 cells, along with immunoprecipitation, LOX enzymatic activity, solid-phase binding assays, and proteomics analyses, we report that the LOX precursor is proteolytically processed by the procollagen N-proteinases ADAMTS2 and ADAMTS14 between Asp-218 and Tyr-219, 50 amino acids downstream of the BMP1 cleavage site. We noted that the LOX sequence between the BMP1- and ADAMTS-processing sites contains several conserved tyrosine residues, of which some are post-translationally modified by tyrosine O-sulfation and contribute to binding to collagen. Taken together, these findings unravel an additional level of regulation in the formation of collagen fibrils. They point to a mechanism that controls the binding of LOX to collagen and is based on differential BMP1- and ADAMTS2/14-mediated cleavage of a tyrosine-sulfated domain.	[Rosell-Garcia, Tamara; Rodriguez-Pascual, Fernando] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severn Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain; [Paradela, Alberto; Bravo, Gema] Univ Autonoma Madrid, Prote Facil, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Dupont, Laura; Bekhouche, Mourad; Colige, Alain] Univ Liege, Lab Connect Tissues Biol, GIGA, B-4000 Sart Taman, Belgium	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Liege	Rodriguez-Pascual, F (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severn Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain.	frodriguez@cbm.csic.es	Bekhouche, Mourad/ABA-6557-2020; Bekhouche, Mourad/ABA-7355-2020; Rosell-Garcia, Tamara/E-7212-2015; Paradela, Alberto/H-2113-2015	Bekhouche, Mourad/0000-0003-3786-2563; Rosell-Garcia, Tamara/0000-0001-8784-2769; Rodriguez-Pascual, Fernando/0000-0002-9765-9578; Paradela, Alberto/0000-0001-6837-7056	 [PT17/0019]		We thank Victor L. Ruiz-Perez (Instituto de Investigaciones Biomedicas "Alberto Sols," Madrid, Spain) for providing the plasmid pBabe-BMP1. Proteomic analysis was carried out at the CBMSO and CNB Protein Chemistry Facilities, which belong to the Spanish Proteomics Network ProteoRed, PRB3-ISCIII, supported by Grant PT17/0019.	Atsawasuwan P, 2011, CONNECT TISSUE RES, V52, P479, DOI 10.3109/03008207.2011.564337; Bekhouche M, 2016, FASEB J, V30, P1741, DOI 10.1096/fj.15-279869; Bekhouche M, 2015, MATRIX BIOL, V44-46, P46, DOI 10.1016/j.matbio.2015.04.001; Blouin S., 2010, BONE, V47, pS80, DOI [10.1016/j.bone.2010.04.159, DOI 10.1016/J.BONE.2010.04.159]; BOAK AM, 1994, AM J RESP CELL MOL, V11, P751, DOI 10.1165/ajrcmb.11.6.7946403; Busnadiego O, 2013, MOL CELL BIOL, V33, P2388, DOI 10.1128/MCB.00036-13; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; CRONLUND AL, 1985, CONNECT TISSUE RES, V14, P109, DOI 10.3109/03008208509015017; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; Dupont L, 2018, MATRIX BIOL, V70, P140, DOI 10.1016/j.matbio.2018.04.002; Engel J, 2011, BIOL EXTRACELL MATR, P1, DOI 10.1007/978-3-642-16555-9_1; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Grau-Bove X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10568; Guo DC, 2016, CIRC RES, V118, P928, DOI 10.1161/CIRCRESAHA.115.307130; Hunt SE, 2018, DATABASE-OXFORD, DOI [10.1093/database/bay119, 10.1186/1471-2164-11-293]; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; KAGAN HM, 1984, J BIOL CHEM, V259, P1203; KAGAN HM, 1979, BIOCHEM J, V177, P203, DOI 10.1042/bj1770203; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kanan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105409; Kehoe JW, 2000, CHEM BIOL, V7, pR57, DOI 10.1016/S1074-5521(00)00093-4; KUIVANIEMI H, 1985, BIOCHEM J, V230, P639, DOI 10.1042/bj2300639; Le Goff C, 2006, DEVELOPMENT, V133, P1587, DOI 10.1242/dev.02308; Lee VS, 2016, P NATL ACAD SCI USA, V113, P8759, DOI 10.1073/pnas.1601442113; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Marini JC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.52; Martinez-Glez V, 2012, HUM MUTAT, V33, P343, DOI 10.1002/humu.21647; Moali C, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P539; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Mould A. Paul, 2009, V522, P195, DOI 10.1007/978-1-59745-413-1_13; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Puig M, 2015, MOL CANCER RES, V13, P161, DOI 10.1158/1541-7786.MCR-14-0155; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rodriguez-Pascual F, 2003, CIRC RES, V92, P1288, DOI 10.1161/01.RES.0000078491.79697.7F; Rodriguez-Pascual Fernando, 2018, J Glaucoma, V27 Suppl 1, pS15, DOI 10.1097/IJG.0000000000000910; Rodriguez-Pascual F, 2016, SCI REP-UK, V6, DOI 10.1038/srep37374; Rosini S, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar2566; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIEGEL RC, 1974, P NATL ACAD SCI USA, V71, P4826, DOI 10.1073/pnas.71.12.4826; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Tillgren V, 2016, J BIOL CHEM, V291, P23744, DOI 10.1074/jbc.M116.730325; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Uzel MI, 2000, J BONE MINER RES, V15, P1189, DOI 10.1359/jbmr.2000.15.6.1189; VIDAL GP, 1975, BIOCHEM BIOPH RES CO, V64, P989, DOI 10.1016/0006-291X(75)90145-X; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang YS, 2015, MOLECULES, V20, P2138, DOI 10.3390/molecules20022138; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]	55	25	25	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11087	11100		10.1074/jbc.RA119.007806	http://dx.doi.org/10.1074/jbc.RA119.007806			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31152061	Green Published, hybrid			2022-12-28	WOS:000478717400004
J	Samson, SC; Elliott, A; Mueller, BD; Kim, Y; Carney, KR; Bergman, JP; Blenis, J; Mendoza, MC				Samson, Shiela C.; Elliott, Andrew; Mueller, Brian D.; Kim, Yung; Carney, Keith R.; Bergman, Jared P.; Blenis, John; Mendoza, Michelle C.			p90 ribosomal S6 kinase (RSK) phosphorylates myosin phosphatase and thereby controls edge dynamics during cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular-signal-regulated kinase (ERK); myosin; cell migration; cell signaling; cytoskeleton; cell motility; myosin phosphatase targeting subunit (MYPT1); p90 ribosomal S6 kinase (RSK); Rho kinase (ROCK)	REGULATORY SUBUNIT; SERINE PHOSPHORYLATION; ADHESION DYNAMICS; ACTIVATES RAF-1; DISTINCT ROLES; ERK ACTIVATION; RAS-ERK; F-ACTIN; RHO; PROTRUSION	Cell migration is essential to embryonic development, wound healing, and cancer cell dissemination. Cells move via leading-edge protrusion, substrate adhesion, and retraction of the cell's rear. The molecular mechanisms by which extracellular cues signal to the actomyosin cytoskeleton to control these motility mechanics are poorly understood. The growth factor-responsive and oncogenically activated protein extracellular signal-regulated kinase (ERK) promotes motility by signaling in actin polymerization-mediated edge protrusion. Using a combination of immunoblotting, co-immunoprecipitation, and myosin-binding experiments and cell migration assays, we show here that ERK also signals to the contractile machinery through its substrate, p90 ribosomal S6 kinase (RSK). We probed the signaling and migration dynamics of multiple mammalian cell lines and found that RSK phosphorylates myosin phosphatase-targeting subunit 1 (MYPT1) at Ser-507, which promotes an interaction of Rho kinase (ROCK) with MYPT1 and inhibits myosin targeting. We find that by inhibiting the myosin phosphatase, ERK and RSK promote myosin II-mediated tension for lamella expansion and optimal edge dynamics for cell migration. These findings suggest that ERK activity can coordinately amplify both protrusive and contractile forces for optimal cell motility.	[Samson, Shiela C.; Elliott, Andrew; Mueller, Brian D.; Kim, Yung; Carney, Keith R.; Bergman, Jared P.; Mendoza, Michelle C.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Blenis, John; Mendoza, Michelle C.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Blenis, John] Weill Cornell Med Coll, Meyer Canc Ctr, 1300 York Ave,F-113, New York, NY 10065 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Cornell University	Mendoza, MC (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	Michelle.Mendoza@hci.utah.edu		Kim, Yung/0000-0002-5732-3017; Mendoza, Michelle/0000-0002-6490-1794; Mueller, Brian/0000-0002-6525-7101	National Institutes of Health [K01CA168850, R01CA046595]; American Lung Association Research Grant; American Cancer Society [RSG CSM130435]; NATIONAL CANCER INSTITUTE [F32CA236428, K01CA168850, R01CA046595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association Research Grant; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants K01CA168850 (to M. C. M.) and R01CA046595 (to J. B.), an American Lung Association Research Grant (to M. C. M.), and American Cancer Society Grant RSG CSM130435 (to M. C. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JC, 1997, MOL BIOL CELL, V8, P2345, DOI 10.1091/mbc.8.11.2345; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Anderson TW, 2008, MOL BIOL CELL, V19, P5006, DOI 10.1091/mbc.E08-01-0034; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Aronchik I, 2014, MOL CANCER RES, V12, P803, DOI 10.1158/1541-7786.MCR-13-0595; Artamonov M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058703; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; BAZZI MD, 1989, BIOCHEMISTRY-US, V28, P3577, DOI 10.1021/bi00434a064; BAZZI MD, 1988, BIOCHEMISTRY-US, V27, P7589, DOI 10.1021/bi00420a003; Boeckeler K, 2010, J CELL SCI, V123, P2725, DOI 10.1242/jcs.062299; Bos CL, 2004, INT J BIOCHEM CELL B, V36, P1187, DOI 10.1016/j.biocel.2003.08.006; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; Cell Signalling Technology, 2019, PHOSPH MYPT1 SER668; Chao A, 2012, J PROTEOMICS, V75, P3342, DOI 10.1016/j.jprot.2012.03.043; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Galan JA, 2014, P NATL ACAD SCI USA, V111, pE2918, DOI 10.1073/pnas.1405601111; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gawecka JE, 2012, J BIOL CHEM, V287, P43424, DOI 10.1074/jbc.M112.423046; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang JS, 2004, CELL SIGNAL, V16, P521, DOI 10.1016/j.cellsig.2003.10.008; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Khasnis M, 2014, BIOCHEMISTRY-US, V53, P2701, DOI 10.1021/bi5001728; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Krens SFG, 2008, DEV BIOL, V319, P370, DOI 10.1016/j.ydbio.2008.04.032; Lara R, 2011, ONCOGENE, V30, P3513, DOI 10.1038/onc.2011.61; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Li D, 2013, J BIOL CHEM, V288, P32528, DOI 10.1074/jbc.M113.500561; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Markwardt ML, 2018, CELL REP, V24, P1060, DOI 10.1016/j.celrep.2018.06.088; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Melak M, 2017, J CELL SCI, V130, P525, DOI 10.1242/jcs.189068; Mendoza MC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa8859; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Pang HA, 2005, AM J PHYSIOL-CELL PH, V289, pC352, DOI 10.1152/ajpcell.00111.2005; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Sayyad WA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07842; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shi GX, 2018, P NATL ACAD SCI USA, V115, pE190, DOI 10.1073/pnas.1708584115; Shutova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040814; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Sommese RF, 2016, J BIOL CHEM, V291, P21963, DOI 10.1074/jbc.M116.737601; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weiser DC, 2009, DEVELOPMENT, V136, P2375, DOI 10.1242/dev.034892; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Yuen S, 2011, J BIOL CHEM, V286, P37274, DOI 10.1074/jbc.M111.282905; Zhang XM, 2014, J PROTEOMICS, V109, P63, DOI 10.1016/j.jprot.2014.06.010; Zhou Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8679	92	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10846	10862		10.1074/jbc.RA119.007431	http://dx.doi.org/10.1074/jbc.RA119.007431			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31138649	hybrid, Green Published			2022-12-28	WOS:000478717200010
J	Tao, T; Sun, J; Peng, YJ; Li, YQ; Wang, P; Chen, X; Zhao, W; Zheng, YY; Wei, LS; Wang, W; Zhou, YW; Liu, JH; Shi, YS; Zhu, MS				Tao, Tao; Sun, Jie; Peng, Yajing; Li, Yeqiong; Wang, Pei; Chen, Xin; Zhao, Wei; Zheng, Yan-Yan; Wei, Lisha; Wang, Wei; Zhou, Yuwei; Liu, Jianghuai; Shi, Yun Stone; Zhu, Min-Sheng			Golgi-resident TRIO regulates membrane trafficking during neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurite outgrowth; membrane trafficking; neurodevelopment; guanine nucleotide exchange factor (GEF); Rho (Rho GTPase); Rab; signal transduction	RHO-GTPASES; INTELLECTUAL DISABILITY; RAB GTPASES; ACTIVATION; TRANSPORT; KINASE; CELL; IDENTIFICATION; POLARIZATION; MUTATIONS	Neurite outgrowth requires coordinated cytoskeletal rearrangements in the growth cone and directional membrane delivery from the neuronal soma. As an essential Rho guanine nucleotide exchange factor (GEF), TRIO is necessary for cytoskeletal dynamics during neurite outgrowth, but its participation in the membrane delivery is unclear. Using co-localization studies, live-cell imaging, and fluorescence recovery after photobleaching analysis, along with neurite outgrowth assay and various biochemical approaches, we here report that in mouse cerebellar granule neurons, TRIO protein pools at the Golgi and regulates membrane trafficking by controlling the directional maintenance of both RAB8 (member RAS oncogene family 8)- and RAB10-positive membrane vesicles. We found that the spectrin repeats in Golgi-resident TRIO confer RAB8 and RAB10 activation by interacting with and activating the RAB GEF RABIN8. Constitutively active RAB8 or RAB10 could partially restore the neurite outgrowth of TRIO-deficient cerebellar granule neurons, suggesting that TRIO-regulated membrane trafficking has an important functional role in neurite outgrowth. Our results also suggest cross-talk between Rho GEF and Rab GEF in controlling both cytoskeletal dynamics and membrane trafficking during neuronal development. They further highlight how protein pools localized to specific organelles regulate crucial cellular activities and functions. In conclusion, our findings indicate that TRIO regulates membrane trafficking during neurite outgrowth in coordination with its GEF-dependent function in controlling cytoskeletal dynamics via Rho GTPases.	[Tao, Tao; Sun, Jie; Li, Yeqiong; Wang, Pei; Chen, Xin; Zhao, Wei; Zheng, Yan-Yan; Wei, Lisha; Wang, Wei; Zhou, Yuwei; Liu, Jianghuai; Shi, Yun Stone; Zhu, Min-Sheng] Nanjing Univ, Med Sch, Affiliated Nanjing Drum Tower Hosp,Dept Neurol, Model Anim Res Ctr State,Key Lab Pharmaceut Biote, Nanjing 210061, Jiangsu, Peoples R China; [Peng, Yajing] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	Nanjing University; University of Wisconsin System; University of Wisconsin Madison	Zhu, MS (corresponding author), Nanjing Univ, Med Sch, Affiliated Nanjing Drum Tower Hosp,Dept Neurol, Model Anim Res Ctr State,Key Lab Pharmaceut Biote, Nanjing 210061, Jiangsu, Peoples R China.	zhums@nju.edu.cn	Shi, Yun S/T-8845-2018; Shi, Yun/B-5623-2009	Shi, Yun/0000-0002-8842-9818; Chen, Xin/0000-0003-3304-8943; Liu, Jianghuai/0000-0002-2382-9140	National Natural Science Foundation of China [31272311, 31330034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31272311 and 31330034 (to M.-S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Ba W, 2016, HUM MOL GENET, V25, P892, DOI 10.1093/hmg/ddv618; Backer S, 2007, J NEUROSCI, V27, P10323, DOI 10.1523/JNEUROSCI.1102-07.2007; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bateman J, 2001, J CELL SCI, V114, P1973; Beck KA, 2005, BBA-MOL CELL RES, V1744, P374, DOI 10.1016/j.bbamcr.2005.04.008; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Campa CC, 2018, NAT CHEM BIOL, V14, P801, DOI 10.1038/s41589-018-0086-4; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Deng CY, 2014, J NEUROSCI, V34, P1710, DOI 10.1523/JNEUROSCI.4496-13.2014; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Franco I, 2014, DEV CELL, V28, P647, DOI 10.1016/j.devcel.2014.01.022; Gartner A, 2014, J CELL SCI, V127, P4409, DOI 10.1242/jcs.149815; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Herring BE, 2016, P NATL ACAD SCI USA, V113, P2264, DOI 10.1073/pnas.1600179113; Homma Y, 2016, MOL BIOL CELL, V27, P2107, DOI 10.1091/mbc.E16-02-0091; HUBER LA, 1995, MOL CELL BIOL, V15, P918; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Katrancha SM, 2017, HUM MOL GENET, V26, P4728, DOI 10.1093/hmg/ddx355; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; McPherson CE, 2005, GENE, V347, P125, DOI 10.1016/j.gene.2004.12.028; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neumann S, 2017, TRAFFIC, V18, P71, DOI 10.1111/tra.12456; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Pellegrin S., 2008, RHO GTPASE ACTIVATIO; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; Pengelly RJ, 2016, J MED GENET, V53, P735, DOI 10.1136/jmedgenet-2016-103942; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Portales-Casamar E, 2006, BIOL CELL, V98, P183, DOI 10.1042/BC20050009; Qi Yaoyao, 2015, Methods Mol Biol, V1298, P259, DOI 10.1007/978-1-4939-2569-8_22; Sadybekov A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00472-0; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Tahirovic S, 2010, J NEUROSCI, V30, P6930, DOI 10.1523/JNEUROSCI.5395-09.2010; Tojima T, 2015, DEV GROWTH DIFFER, V57, P291, DOI 10.1111/dgd.12218; Ultanir SK, 2012, NEURON, V73, P1127, DOI 10.1016/j.neuron.2012.01.019; Villarroel-Campos D, 2016, CYTOSKELETON, V73, P498, DOI 10.1002/cm.21303; Wang JF, 2015, P NATL ACAD SCI USA, V112, P148, DOI 10.1073/pnas.1412089112; Wang T, 2011, DEV CELL, V21, P431, DOI 10.1016/j.devcel.2011.07.007; Wojnacki J, 2016, DEV NEUROBIOL, V76, P1185, DOI 10.1002/dneu.22390; Zeitvogel F., 2016, J OPEN RES SOFTWARE, V4, pe5, DOI DOI 10.5334/J0RS.89; Zheng CY, 2011, JOVE-J VIS EXP, DOI 10.3791/2568; Zheng CG, 2016, P NATL ACAD SCI USA, V113, P6973, DOI 10.1073/pnas.1607179113; Zong W, 2015, BRAIN RES, V1608, P82, DOI 10.1016/j.brainres.2015.02.040	59	14	15	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10954	10968		10.1074/jbc.RA118.007318	http://dx.doi.org/10.1074/jbc.RA118.007318			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31152060	Green Published, hybrid			2022-12-28	WOS:000478717200018
J	Hossain, F; Moghal, MMR; Islam, MZ; Moniruzzaman, M; Yamazaki, M				Hossain, Farzana; Moghal, Md Mizanur Rahman; Islam, Md Zahidul; Moniruzzaman, Md; Yamazaki, Masahito			Membrane potential is vital for rapid permeabilization of plasma membranes and lipid bilayers by the antimicrobial peptide lactoferricin B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); membrane biophysics; Escherichia coli (E; coli); lipid vesicle; lipid bilayer; giant unilamellar vesicle; lactoferricin B; leakage; pore formation; spheroplast	2-INDUCED PORE FORMATION; BACTERIAL SPHEROPLASTS; CYTOPLASMIC MEMBRANE; ELEMENTARY PROCESSES; INTERNAL CONTENTS; CELL; MECHANISMS; CHANNEL; VESICLE; DERIVATIVES	Lactoferricin B (LfcinB) is a cationic antimicrobial peptide, and its capacity to damage the bacterial plasma membrane is suggested to be a main factor in LfcinB's antimicrobial activity. However, the specific processes and mechanisms in LfcinB-induced membrane damage are unclear. In this report, using confocal laser-scanning microscopy, we examined the interaction of LfcinB with single Escherichia coli cells and spheroplasts containing the water-soluble fluorescent probe calcein in the cytoplasm. LfcinB induced rapid calcein leakage from single E. coli cells and from single spheroplasts, indicating that LfcinB interacts directly with the plasma membrane and induces its rapid permeabilization. The proton ionophore carbonyl cyanide m-chlorophenylhydrazone suppressed this leakage. Next, we used the single giant unilamellar vesicle (GUV) method to examine LfcinB's interaction with GUVs comprising polar lipid extracts of E. coli containing a water-soluble fluorescent probe, Alexa Fluor 647 hydrazide (AF647). We observed that LfcinB stochastically induces local rupture in single GUVs, causing rapid AF647 leakage; however, higher LfcinB concentrations were required for AF647 leakage from GUVs than from E. coli cells and spheroplasts. To identify the reason for this difference, we examined the effect of membrane potential on LfcinB-induced pore formation, finding that the rate of LfcinB-induced local rupture in GUVs increases greatly with increasing negative membrane potential. These results indicate that membrane potential plays an important role in LfcinB-induced local rupture of lipid bilayers and rapid permeabilization of E. coli plasma membranes. On the basis of these results, we discuss the mode of action of LfcinB's antimicrobial activity.	[Hossain, Farzana; Moghal, Md Mizanur Rahman; Islam, Md Zahidul; Moniruzzaman, Md; Yamazaki, Masahito] Shizuoka Univ, Grad Sch Sci & Technol, Integrated Biosci Sect, Shizuoka 4228529, Japan; [Yamazaki, Masahito] Shizuoka Univ, Res Inst Elect, Nanomat Res Div, Shizuoka 4228529, Japan; [Yamazaki, Masahito] Shizuoka Univ, Grad Sch Sci, Dept Phys, Shizuoka 4228529, Japan; [Islam, Md Zahidul] Jahangirnagar Univ, Dept Biotechnol & Genet Engn, Dhaka 1342, Bangladesh	Shizuoka University; Shizuoka University; Shizuoka University; Jahangirnagar University	Yamazaki, M (corresponding author), Shizuoka Univ, Inst Elect, Nanomat Res Div, Suruga Ku, 836 Oya, Shizuoka 4228529, Japan.	yamazaki.masahito@shizuoka.ac.jp	Yamazaki, Masahito/F-6122-2011	Yamazaki, Masahito/0000-0002-5959-9914; Moniruzzaman, Mohammad/0000-0001-9956-6036	Japan Society for the Promotion of Science (JSPS) [15H04361, 19H03193]; Cooperative Research Project of Research Center for Biomedical Engineering	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cooperative Research Project of Research Center for Biomedical Engineering	This work was supported in part by Grant-in-Aid for Scientific Research (B) numbers 15H04361 and 19H03193 from the Japan Society for the Promotion of Science (JSPS) (to M.Y.) and the Cooperative Research Project of Research Center for Biomedical Engineering.	Alam JM, 2012, BIOCHEMISTRY-US, V51, P5160, DOI 10.1021/bi300448g; ANDERSEN OS, 1983, BIOPHYS J, V41, P135, DOI 10.1016/S0006-3495(83)84415-4; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; DANIELS CJ, 1981, P NATL ACAD SCI-BIOL, V78, P5396, DOI 10.1073/pnas.78.9.5396; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; FELLE H, 1980, BIOCHEMISTRY-US, V19, P3585, DOI 10.1021/bi00556a026; FINKELSTEIN A, 1981, J MEMBRANE BIOL, V59, P155, DOI 10.1007/BF01875422; Fulda S, 1998, J BIOL CHEM, V273, P33942, DOI 10.1074/jbc.273.51.33942; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hasan M, 2019, ADV EXP MED BIOL, V1117, P17, DOI 10.1007/978-981-13-3588-4_3; Hasan M, 2018, LANGMUIR, V34, P3349, DOI 10.1021/acs.langmuir.7b04219; Hille B., 1992, IONIC CHANNELS EXCIT; Hwang PM, 1998, BIOCHEMISTRY-US, V37, P4288, DOI 10.1021/bi972323m; Hwang PM, 1998, BIOCHEM CELL BIOL, V76, P235, DOI 10.1139/bcb-76-2-3-235; Ishihara Y, 2006, J BIOL CHEM, V281, P6726, DOI 10.1074/jbc.M510382200; Islam MZ, 2014, PHYS CHEM CHEM PHYS, V16, P15752, DOI 10.1039/c4cp00717d; Islam MZ, 2014, BIOCHEMISTRY-US, V53, P386, DOI 10.1021/bi401406p; Kang JH, 1996, INT J PEPT PROT RES, V48, P357; Karal MA, 2015, LANGMUIR, V31, P3391, DOI 10.1021/la503318z; Kiviet DJ, 2014, NATURE, V514, P376, DOI 10.1038/nature13582; Kuwata H, 1998, BBA-PROTEIN STRUCT M, V1429, P129, DOI 10.1016/S0167-4838(98)00224-6; Maki N, 2000, J BACTERIOL, V182, P4337, DOI 10.1128/JB.182.15.4337-4342.2000; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Moniruzzaman M, 2015, BIOCHEMISTRY-US, V54, P5802, DOI 10.1021/acs.biochem.5b00594; Moniruzzarnan M, 2017, BIOCHEMISTRY-US, V56, P4419, DOI 10.1021/acs.biochem.6b01274; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nguyen LT, 2005, J PEPT SCI, V11, P379, DOI 10.1002/psc.629; Osella M, 2017, TRENDS MICROBIOL, V25, P250, DOI 10.1016/j.tim.2016.12.005; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; ROLINSON GN, 1980, J GEN MICROBIOL, V120, P317; RUTHE HJ, 1985, BIOCHIM BIOPHYS ACTA, V819, P105, DOI 10.1016/0005-2736(85)90200-7; Schibli DJ, 2002, BIOCHEM CELL BIOL, V80, P667, DOI 10.1139/O02-147; SHAPIRO HM, 1994, METHOD CELL BIOL, V41, P121; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Strom MB, 2002, BIOCHEM CELL BIOL, V80, P65, DOI 10.1139/o01-236; Sun Y, 2016, BIOPHYS J, V111, P132, DOI 10.1016/j.bpj.2016.05.037; Tamba Y, 2005, BIOCHEMISTRY-US, V44, P15823, DOI 10.1021/bi051684w; Tamba Y, 2011, CHEM PHYS LIPIDS, V164, P351, DOI 10.1016/j.chemphyslip.2011.04.003; Tamba Y, 2010, J PHYS CHEM B, V114, P12018, DOI 10.1021/jp104527y; Tamba Y, 2009, J PHYS CHEM B, V113, P4846, DOI 10.1021/jp8109622; Tomita Mamoru, 1994, Acta Paediatrica Japonica, V36, P585; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403; Wakabayashi H, 1999, ANTIMICROB AGENTS CH, V43, P1267, DOI 10.1128/AAC.43.5.1267; Wakabayashi H, 2003, CURR PHARM DESIGN, V9, P1277, DOI 10.2174/1381612033454829; Wei L, 2016, ANTIMICROB AGENTS CH, V60, P6350, DOI 10.1128/AAC.01008-16; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; YAMAUCHI K, 1993, INFECT IMMUN, V61, P719, DOI 10.1128/IAI.61.2.719-728.1993; Yamazaki M, 2008, ADV PLANAR LIP BILAY, V7, P121, DOI 10.1016/S1554-4516(08)00005-7; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	54	18	19	2	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10449	10462		10.1074/jbc.RA119.007762	http://dx.doi.org/10.1074/jbc.RA119.007762			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31118274	Green Published, hybrid			2022-12-28	WOS:000478717100007
J	Falconer, AMD; Chan, CM; Gray, J; Nagashima, I; Holland, RA; Shimizu, H; Pickford, AR; Rowan, AD; Wilkinson, DJ				Falconer, Adrian M. D.; Chan, Chun Ming; Gray, Joseph; Nagashima, Izuru; Holland, Robert A.; Shimizu, Hiroki; Pickford, Andrew R.; Rowan, Andrew D.; Wilkinson, David J.			Collagenolytic matrix metalloproteinases antagonize proteinase-activated receptor-2 activation, providing insights into extracellular matrix turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						matrix metalloproteinase (MMP); cell signaling; proteolysis; chondrocyte; arthritis; extracellular matrix; inflammation; collagenase; proteinase-activated receptor-2 (PAR2)	HUMAN FIBROBLAST; TETHERED LIGAND; ONCOSTATIN-M; CARTILAGE; PROTEASE; EXPRESSION; RELEASE; DEGRADATION; COLLAGENASE; MATRIPTASE	The collagenase subfamily of matrix metalloproteinases (MMPs) have important roles in the remodeling of collagenous matrices. The proteinase-activated receptor (PAR) family has a unique mechanism of activation requiring proteolysis of an extracellular domain forming a neo-N terminus that acts as a tethered ligand, a process that has been associated with the development of arthritis. Canonical PAR2 activation typically occurs via a serine proteinase at Arg(36)-Ser(37), but other proteinases can cleave PARs downstream of the tethered ligand and disarm the receptor. To identify additional cleavage sites within PAR2, we synthesized a 42-amino-acid peptide corresponding to the extracellular region. We observed that all three soluble MMP collagenases, MMP-1, MMP-8, and MMP-13, cleave PAR2 and discovered a novel cleavage site (Ser(37)-Leu(38)). Metalloproteinases from resorbing bovine nasal cartilage and recombinant human collagenases could cleave a quenched fluorescent peptide mimicking the canonical PAR2 activation region, and kinetic constants were determined. In PAR2-overexpressing SW1353 chondrocytes, we demonstrated that the activator peptide SLIGKV-NH2 induces rapid calcium flux, inflammatory gene expression (including MMP1 and MMP13), and the phosphorylation of extracellular signal-regulated kinase (ERK) and p38 kinase. The corresponding MMP cleavage-derived peptide (LIGKVD-NH2) exhibited no canonical activation; however, we observed phosphorylation of ERK, providing evidence of biased agonism. Importantly, we demonstrated that preincubation with active MMP-1 reduced downstream PAR2 activation by a canonical activator, matriptase, but not SLIGKV-NH2. These results support a role for collagenases as proteinases capable of disarming PAR2, revealing a mechanism that suppresses PAR2-mediated inflammatory responses.	[Falconer, Adrian M. D.; Chan, Chun Ming; Rowan, Andrew D.; Wilkinson, David J.] Newcastle Univ, Inst Genet Med, Skeletal Res Grp, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Gray, Joseph] Newcastle Univ, Inst Cell & Mol Biosdences, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Nagashima, Izuru; Shimizu, Hiroki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Dept Life Sci & Biotechnol, Biomat Engn Res Grp, Sapporo, Hokkaido 0628517, Japan; [Holland, Robert A.; Pickford, Andrew R.] Univ Portsmouth, Ctr Enzyme Innovat, Sch Biol Sci, King Henry Bldg,King Henry I St, Portsmouth PO1 2DY, Hants, England; [Holland, Robert A.; Pickford, Andrew R.] Univ Portsmouth, Inst Biol & Biomed Sci, King Henry Bldg,King Henry I St, Portsmouth PO1 2DY, Hants, England	Newcastle University - UK; Newcastle University - UK; National Institute of Advanced Industrial Science & Technology (AIST); University of Portsmouth; University of Portsmouth	Wilkinson, DJ (corresponding author), Newcastle Univ, Inst Genet Med, Skeletal Res Grp, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	david.wilkinson@newcastle.ac.uk	Pickford, Andy/AGB-6901-2022	Wilkinson, David/0000-0002-6262-3575; Pickford, Andy/0000-0002-7237-0030; Holland, Rob/0000-0001-6879-0043; Falconer, Adrian/0000-0001-7362-0313	Fight Arthritis in the North East (FARNE); JGW Patterson Foundation; Arthritis Research UK [20199]	Fight Arthritis in the North East (FARNE); JGW Patterson Foundation; Arthritis Research UK(Versus Arthritis)	This work was supported by Fight Arthritis in the North East (FARNE), the JGW Patterson Foundation, and Arthritis Research UK Grant 20199. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Ani B, 2004, MOL PHARMACOL, V65, P149, DOI 10.1124/mol.65.1.149; Al-Ani B, 2002, J PHARMACOL EXP THER, V302, P1046, DOI 10.1124/jpet.302.3.1046; Amiable N, 2011, J RHEUMATOL, V38, P911, DOI 10.3899/jrheum.100710; Arnold LH, 2011, J BIOL CHEM, V286, P45073, DOI 10.1074/jbc.M111.285213; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P3244, DOI 10.1002/art.22167; BARRETT AJ, 1986, BIOCHEM J, V237, P935, DOI 10.1042/bj2370935; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Boileau C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2329; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; CAWSTON TE, 1995, BIOCHEM BIOPH RES CO, V215, P377, DOI 10.1006/bbrc.1995.2476; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chan CM, 2017, J BIOL CHEM, V292, P1625, DOI 10.1074/jbc.M116.756601; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1992, MATRIX, V12, P475, DOI 10.1016/S0934-8832(11)80092-2; Cowell J, 2017, CHEMBIOCHEM, V18, P1688, DOI 10.1002/cbic.201700214; Das K, 2018, BIOMED PHARMACOTHER, V105, P395, DOI 10.1016/j.biopha.2018.05.155; Davidson RK, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2013; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Ferrell WR, 2010, ANN RHEUM DIS, V69, P2051, DOI 10.1136/ard.2010.130336; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544; Huesa C, 2016, ANN RHEUM DIS, V75, P1989, DOI 10.1136/annrheumdis-2015-208268; Jackson MT, 2014, ARTHRITIS RHEUMATOL, V66, P3337, DOI 10.1002/art.38876; Jaffre F, 2012, CIRCULATION, V125, P2993, DOI 10.1161/CIRCULATIONAHA.111.066787; Kelso EB, 2006, J PHARMACOL EXP THER, V316, P1017, DOI 10.1124/jpet.105.093807; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; LAZARUS GS, 1968, J CLIN INVEST, V47, P2622, DOI 10.1172/JCI105945; Li XL, 2014, MOL CARCINOGEN, V53, P659, DOI 10.1002/mc.22020; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Nagase H, 2011, BIOL EXTRACELL MATR, P95, DOI 10.1007/978-3-642-16861-1_5; NETZELARNETT S, 1991, J BIOL CHEM, V266, P6747; Oikonomopoulou K, 2018, NAT REV RHEUMATOL, V14, P170, DOI 10.1038/nrrheum.2018.17; Pan SL, 2008, SHOCK, V30, P496, DOI 10.1097/SHK.0b013e3181673233; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Suen JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013809; Swingler TE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2741; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V377, P622, DOI 10.1016/j.bbrc.2008.10.018; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Ugalde AP, 2010, METHODS MOL BIOL, V622, P3, DOI 10.1007/978-1-60327-299-5_1; Ungefroren H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122776; Vliagoftis A, 2000, J ALLERGY CLIN IMMUN, V106, P537, DOI 10.1067/mai.2000.109058; Wilkinson DJ, 2019, BRIT J PHARMACOL, V176, P38, DOI 10.1111/bph.14173; Wilkinson DJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17028-3; Wilkinson DJ, 2017, ARTHRITIS RHEUMATOL, V69, P1601, DOI 10.1002/art.40133; WILLENBROCK F, 1993, BIOCHEMISTRY-US, V32, P4330, DOI 10.1021/bi00067a023; Xiang Y, 2006, OSTEOARTHR CARTILAGE, V14, P1163, DOI 10.1016/j.joca.2006.04.015; Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712; Zhao PS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00067	55	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10266	10277		10.1074/jbc.RA119.006974	http://dx.doi.org/10.1074/jbc.RA119.006974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31110047	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000474445600017
J	Shehat, MG; Cardona, OA; Aranjuez, GF; Jewett, MW; Tigno-Aranjuez, JT				Shehat, Michael G.; Cardona, Omar A.; Aranjuez, George F.; Jewett, Mollie W.; Tigno-Aranjuez, Justine T.			RIP2 promotes Fc gamma R-mediated reactive oxygen species production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fc-gamma receptor; reactive oxygen species (ROS); Src; inflammation; Fc receptor; signal transduction; receptor interacting protein 2 (RIP2)	HOST RECOGNITION; IMMUNE-RESPONSES; KINASE; NOD1; INNATE; ACTIVATION; RECEPTORS; PROTEIN; IDENTIFICATION; ASSOCIATION	Receptor-interacting protein 2 (RIP2) is a kinase that mediates signaling downstream of the bacterial peptidoglycan sensors NOD1 and NOD2. Genetic loss or pharmaceutical inhibition of RIP2 has been shown to be beneficial in multiple inflammatory disease models with the effects largely attributed to reducing proinflammatory signaling downstream of peptidoglycan recognition. However, given the widespread expression of this kinase and its reported interactions with numerous other proteins, it is possible that RIP2 may also function in roles outside of peptidoglycan sensing. In this work, we show that RIP2 undergoes tyrosine phosphorylation and activation in response to engagement of the Fc gamma receptor (Fc gamma R). Using bone marrow-derived macrophages from WT and RIP2-KO mice, we show that loss of RIP2 leads to deficient Fc gamma R signaling and reactive oxygen species (ROS) production upon Fc gamma R cross-linking without affecting cytokine secretion, phagocytosis, or nitrate/nitrite production. The Fc gamma R-induced ROS response was still dependent on NOD2, as macrophages deficient in this receptor showed similar defects. Mechanistically, we found that different members of the Src family kinases (SFKs) can promote RIP2 tyrosine phosphorylation and activation. Altogether, our findings suggest that RIP2 is functionally important in pathways outside of bacterial peptidoglycan sensing and that involvement in such pathways may depend on the actions of SFKs. These findings will have important implications for future therapies designed to target this kinase.	[Shehat, Michael G.; Cardona, Omar A.; Aranjuez, George F.; Jewett, Mollie W.; Tigno-Aranjuez, Justine T.] Univ Cent Florida, Burnett Sch Biomed Sci, Immun & Pathogenesis Div, Coll Med, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Tigno-Aranjuez, JT (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	justine.tigno-aranjuez@ucf.edu		Shehat, Michael/0000-0002-0418-456X; Tigno-Aranjuez, Justine/0000-0002-6843-7490	NHLBI, National Institutes of Health [R00HL122365]; University of Central Florida; NIAID, National Institutes of Health [R01AI099094]; Deborah and Mark Blackman-Global Lyme Alliance postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL122365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099094] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Central Florida; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Deborah and Mark Blackman-Global Lyme Alliance postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by NHLBI, National Institutes of Health Grant R00HL122365 and University of Central Florida start-up funds (to J. T. T.-A.); NIAID, National Institutes of Health Grant R01AI099094 (to M. W. J.); and a Deborah and Mark Blackman-Global Lyme Alliance postdoctoral fellowship (to G. F. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Conde C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041005; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Frutuoso MS, 2010, MICROBES INFECT, V12, P819, DOI 10.1016/j.micinf.2010.05.006; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goncharov T, 2018, MOL CELL, V69, P551, DOI 10.1016/j.molcel.2018.01.016; Haile PA, 2016, J MED CHEM, V59, P4867, DOI 10.1021/acs.jmedchem.6b00211; Hall HTL, 2008, EUR J IMMUNOL, V38, P64, DOI 10.1002/eji.200737393; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Kisiswa L, 2018, CELL REP, V24, P1013, DOI 10.1016/j.celrep.2018.06.098; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Li J, 2012, MUTAGENESIS, V27, P319, DOI 10.1093/mutage/ger081; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Meinzer U, 2012, CELL HOST MICROBE, V11, P337, DOI 10.1016/j.chom.2012.02.009; Miller MH, 2018, J LEUKOCYTE BIOL, V104, P447, DOI 10.1002/JLB.4HI0118-017RR; Nachbur U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7442; Nakashima Kazuko, 2006, Allergol Int, V55, P77, DOI 10.2332/allergolint.55.77; Nembrini C, 2008, MICROBES INFECT, V10, P522, DOI 10.1016/j.micinf.2008.01.016; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pauls SD, 2017, EUR J IMMUNOL, V47, P932, DOI 10.1002/eji.201646795; Rego ROM, 2011, J BACTERIOL, V193, P1161, DOI 10.1128/JB.01176-10; Rhodes DA, 2007, MOL IMMUNOL, V44, P2406, DOI 10.1016/j.molimm.2006.10.013; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Salla M, 2018, J PHARMACOL EXP THER, V365, P354, DOI 10.1124/jpet.117.247163; Shimada K, 2018, IMMUNITY, V49, P873, DOI 10.1016/j.immuni.2018.08.022; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Tigno-Aranjuez JT, 2014, J BIOL CHEM, V289, P29651, DOI 10.1074/jbc.M114.591388; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vieira SM, 2012, J IMMUNOL, V188, P5116, DOI 10.4049/jimmunol.1004190; Zurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041255	40	5	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10365	10378		10.1074/jbc.RA118.007218	http://dx.doi.org/10.1074/jbc.RA118.007218			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31113864	hybrid, Green Published			2022-12-28	WOS:000474445600025
J	Liu, SY; Ando, F; Fujita, Y; Liu, JJ; Maeda, T; Shen, XF; Kikuchi, K; Matsumoto, A; Yokomori, M; Tanabe-Fujimura, C; Shimokata, H; Michikawa, M; Komano, H; Zou, K				Liu, Shuyu; Ando, Fujiko; Fujita, Yu; Liu, Junjun; Maeda, Tomoji; Shen, Xuefeng; Kikuchi, Kota; Matsumoto, Aoi; Yokomori, Mirai; Tanabe-Fujimura, Chiaki; Shimokata, Hiroshi; Michikawa, Makoto; Komano, Hiroto; Zou, Kun			A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (AB); amyloid precursor protein (APP); neurodegeneration; amyloid; ACE inhibitor; Angiotensin-converting enzyme (ACE); dementia; IQ decline; neurotoxicity	AMYLOID-BETA-PROTEIN; BLOOD-PRESSURE; HEART-FAILURE; BRAIN; INDIVIDUALS; ASSOCIATION; DEPOSITION; A-BETA-42; SURVIVAL; GENDER	Inhibition of angiotensin-converting enzyme (ACE) is a strategy used worldwide for managing hypertension. In addition to converting angiotensin I to angiotensin II, ACE also converts neurotoxic -amyloid protein 42 (A42) to A40. Because of its neurotoxicity, A42 is believed to play a causative role in the development of Alzheimer's disease (AD), whereas A40 has neuroprotective effects against A42 aggregation and also against metal-induced oxidative damage. Whether ACE inhibition enhances A42 aggregation or impairs human cognitive ability are very important issues for preventing AD onset and for optimal hypertension management. In an 8-year longitudinal study, we found here that the mean intelligence quotient of male, but not female, hypertensive patients taking ACE inhibitors declined more rapidly than that of others taking no ACE inhibitors. Moreover, the sera of all AD patients exhibited a decrease in A42-to-A40-converting activity compared with sera from age-matched healthy individuals. Using human amyloid precursor protein transgenic mice, we found that a clinical dose of an ACE inhibitor was sufficient to increase brain amyloid deposition. We also generated human amyloid precursor protein/ACE(+/-) mice and found that a decrease in ACE levels promoted A42 deposition and increased the number of apoptotic neurons. These results suggest that inhibition of ACE activity is a risk factor for impaired human cognition and for triggering AD onset.	[Liu, Shuyu; Fujita, Yu; Liu, Junjun; Maeda, Tomoji; Shen, Xuefeng; Kikuchi, Kota; Matsumoto, Aoi; Yokomori, Mirai; Tanabe-Fujimura, Chiaki; Komano, Hiroto; Zou, Kun] Iwate Med Univ, Sch Pharm, Dept Neurosci, Yahaba, Iwate 0283694, Japan; [Liu, Shuyu] Shenyang Med Coll, Liaoning Prov Key Lab Behav & Cognit Neurosci, Shenyang 110034, Liaoning, Peoples R China; [Ando, Fujiko] Aichi Shukutoku Univ, Fac Hlth & Med Sci, Nagakute, Aichi 4801146, Japan; [Shimokata, Hiroshi] Nagoya Univ Arts & Sci, Grad Sch Nutr Sci, Nisshin 4700196, Japan; [Michikawa, Makoto; Zou, Kun] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem, Nagoya, Aichi 4678601, Japan	Iwate Medical University; Shenyang Medical College; Aichi Shukutoku University; Nagoya City University	Komano, H; Zou, K (corresponding author), Iwate Med Univ, Sch Pharm, Dept Neurosci, Yahaba, Iwate 0283694, Japan.; Michikawa, M; Zou, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Biochem, Nagoya, Aichi 4678601, Japan.	michi@med.nagoya-cu.ac.jp; hkomano@iwate-med.ac.jp; kunzou@med.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Daiko Foundation; Hirose International Scholarship Foundation; Doctoral Startup Foundation of Liaoning Province, China [201601227];  [22700399];  [24700383];  [26430057];  [19K07846];  [S1491001]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiko Foundation(Daiko Foundation); Hirose International Scholarship Foundation; Doctoral Startup Foundation of Liaoning Province, China; ; ; ; ; 	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Young Scientists (B) 22700399 and 24700383; Grants-in-Aid for Scientific Research (C) 26430057 and 19K07846; Grant-in-Aid for Strategic Medical Science Research S1491001; and funds from the Daiko Foundation and the Hirose International Scholarship Foundation and from the Doctoral Startup Foundation of Liaoning Province 201601227, China. The authors declare that they have no conflicts of interest with the contents of this article.	Allegri Ricardo F., 2010, Dement. neuropsychol., V4, P28, DOI 10.1590/S1980-57642010DN40100005; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bevilacqua M, 1996, J CARDIOVASC PHARM, V28, P494, DOI 10.1097/00005344-199610000-00003; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; de Oliveira FF, 2018, CURR ALZHEIMER RES, V15, P386, DOI 10.2174/1567205014666171016101816; Dubois B, 2018, LANCET NEUROL, V17, P335, DOI 10.1016/S1474-4422(18)30029-2; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; Fazal K, 2017, BJPSYCH OPEN, V3, P158, DOI 10.1192/bjpo.bp.116.004184; Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865; Hemming ML, 2007, NEUROBIOL DIS, V26, P273, DOI 10.1016/j.nbd.2007.01.004; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hooper NM, 2003, NAT STRUCT BIOL, V10, P155, DOI 10.1038/nsb0303-155; Kehoe PG, 1999, NAT GENET, V21, P71, DOI 10.1038/5009; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Kilander L, 1998, HYPERTENSION, V31, P780, DOI 10.1161/01.HYP.31.3.780; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lehmann DJ, 2005, AM J EPIDEMIOL, V162, P305, DOI 10.1093/aje/kwi202; Liu JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12059; Liu SY, 2014, J NEUROSCI RES, V92, P1178, DOI 10.1002/jnr.23404; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Mazure CM, 2016, LANCET NEUROL, V15, P451, DOI 10.1016/S1474-4422(16)00067-3; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Ohi K, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00293; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Regenold WT, 2017, AM J ALZHEIMERS DIS, V32, P347, DOI 10.1177/1533317517707288; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Sacks CA, 2017, NEW ENGL J MED, V376, P1706, DOI 10.1056/NEJMp1701047; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shimokata H, 2000, J Epidemiol, V10, pS1; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Zapater P, 2004, J CARDIOVASC PHARM, V43, P737, DOI 10.1097/00005344-200405000-00018; Zou K, 2003, J NEUROCHEM, V87, P609, DOI 10.1046/j.1471-4159.2003.02018.x; Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002; Zou K, 2007, J NEUROSCI, V27, P8628, DOI 10.1523/JNEUROSCI.1549-07.2007; Zou K, 2013, AM J PATHOL, V182, P2322, DOI 10.1016/j.ajpath.2013.01.053; Zou K, 2009, J BIOL CHEM, V284, P31914, DOI 10.1074/jbc.M109.011437; Zou K, 2008, REV NEUROSCIENCE, V19, P203	48	18	18	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9760	9770		10.1074/jbc.RA118.006420	http://dx.doi.org/10.1074/jbc.RA118.006420			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31072831	Green Published, hybrid			2022-12-28	WOS:000473277900011
J	Wang, XH; Ji, C; Zhang, HH; Shan, Y; Ren, YJ; Hu, YW; Shi, LR; Guo, LC; Zhu, WD; Xia, YJ; Liu, BJ; Rong, ZY; Wu, BL; Ming, ZJ; Ren, XC; Song, JX; Yang, JM; Zhang, Y				Wang, XiaoHui; Ji, Cheng; Zhang, HongHan; Shan, Yu; Ren, YiJie; Hu, YanWei; Shi, LiangRong; Guo, LingChuan; Zhu, WeiDong; Xia, YuJuan; Liu, BeiJia; Rong, ZiYun; Wu, BiLian; Ming, ZhiJun; Ren, XingCong; Song, JianXun; Yang, JinMing; Zhang, Yi			Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer therapy; transcription target gene; protein targeting; inhibitor; cancer biology; combination therapy; dimerization; inhibitor; NAC1	NF-KAPPA-B; TRANSCRIPTION FACTORS; TUMOR RECURRENCE; OVARIAN-CANCER; PLURIPOTENCY; RESISTANCE; TARGETS; STAT3; ACTIVATION; PACLITAXEL	Nucleus accumbens-associated protein-1 (NAC1) is a transcriptional repressor encoded by the NACC1 gene, which is amplified and overexpressed in various human cancers and plays critical roles in tumor development, progression, and drug resistance. NAC1 has therefore been explored as a potential therapeutic target for managing malignant tumors. However, effective approaches for effective targeting of this nuclear protein remain elusive. In this study, we identified a core unit consisting of Met(7) and Leu(90) in NAC1's N-terminal domain (amino acids 1-130), which is critical for its homodimerization and stability. Furthermore, using a combination of computational analysis of the NAC1 dimerization interface and high-throughput screening (HTS) for small molecules that inhibit NAC1 homodimerization, we identified a compound (NIC3) that selectively binds to the conserved Leu-90 of NAC1 and prevents its homodimerization, leading to proteasomal NAC1 degradation. Moreover, we demonstrate that NIC3-mediated down-regulation of NAC1 protein sensitizes drug-resistant tumor cells to conventional chemotherapy and enhances the antimetastatic effect of the antiangiogenic agent bevacizumab both in vitro and in vivo. These results suggest that small-molecule inhibitors of NAC1 homodimerization may effectively sensitize cancer cells to some anticancer agents and that NAC1 homodimerization could be further explored as a potential therapeutic target in the development of antineoplastic agents.	[Wang, XiaoHui; Zhang, HongHan; Ren, YiJie; Hu, YanWei; Guo, LingChuan; Zhu, WeiDong; Xia, YuJuan; Liu, BeiJia; Rong, ZiYun; Wu, BiLian; Ming, ZhiJun; Zhang, Yi] Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Ji, Cheng] Soochow Univ, Affiliated Hosp 1, Dept Resp Med, Suzhou 215000, Jiangsu, Peoples R China; [Shan, Yu] Inst Bot, Nanjing, Jiangsu, Peoples R China; [Shan, Yu] Chinese Acad Sci, Nanjing 210014, Jiangsu, Peoples R China; [Shi, LiangRong] Cent S Univ, Xiangya Hosp, Dept Radiol, Radiol Intervent Ctr, Changsha 410013, Hunan, Peoples R China; [Song, JianXun] Texas A&M Univ, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA; [Ren, XingCong; Yang, JinMing] Univ Kentucky, Coll Med, Dept Canc Biol & Toxicol, Markey Canc Ctr, Lexington, KY 40506 USA	Soochow University - China; Soochow University - China; Chinese Academy of Sciences; Central South University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Kentucky	Zhang, Y (corresponding author), Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.; Yang, JM (corresponding author), Univ Kentucky, Coll Med, Dept Canc Biol & Toxicol, Markey Canc Ctr, Lexington, KY 40506 USA.	jyang@uky.edu; zhangyi@suda.edu.cn	Xiaohui, Wang/AFS-7746-2022		National Natural Sciences Foundation of China [81473240, 81773749]; Natural Science Foundation of Jiangsu Province of China [BK20151209]; Qing Lan Project - Priority Academic Program Development of the Jiangsu Higher Education Institutes (PAPD)	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Qing Lan Project - Priority Academic Program Development of the Jiangsu Higher Education Institutes (PAPD)	This work was supported by National Natural Sciences Foundation of China Grants 81473240 and 81773749 (to Y. Z.) and Natural Science Foundation of Jiangsu Province of China Grant BK20151209 (to C. J.) and sponsored by the Qing Lan Project (to Y. Z.) and by a project funded by the Priority Academic Program Development of the Jiangsu Higher Education Institutes (PAPD). The authors declare that they have no conflicts of interest with the contents of this article.	AGASHE VR, 1995, NATURE, V377, P754, DOI 10.1038/377754a0; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Brown N, 2014, MOL INFORM, V33, P458, DOI 10.1002/minf.201400037; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Dang CV, 2017, NAT REV CANCER, V17, P502, DOI 10.1038/nrc.2017.36; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Denhardt DT, 1996, CRIT REV ONCOGENESIS, V7, P261, DOI 10.1615/CritRevOncog.v7.i3-4.70; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; Grimley E, 2017, ACS CHEM BIOL, V12, P724, DOI 10.1021/acschembio.6b00782; Ishibashi M, 2008, CLIN CANCER RES, V14, P3149, DOI 10.1158/1078-0432.CCR-07-4358; Jinawath N, 2009, ONCOGENE, V28, P1941, DOI 10.1038/onc.2009.37; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; LINS L, 1995, FASEB J, V9, P535, DOI 10.1096/fasebj.9.7.7737462; Majerciak V, 2015, J VIROL, V89, P3256, DOI 10.1128/JVI.03721-14; Malleshaiah M, 2016, CELL REP, V14, P1181, DOI 10.1016/j.celrep.2015.12.101; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Nakayama K, 2007, CANCER RES, V67, P8058, DOI 10.1158/0008-5472.CAN-07-1357; Nakayama K, 2006, P NATL ACAD SCI USA, V103, P18739, DOI 10.1073/pnas.0604083103; Nakayama K, 2010, GYNECOL ONCOL, V119, P469, DOI 10.1016/j.ygyno.2010.08.031; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Overman J, 2017, ELIFE, V6, DOI 10.7554/eLife.21221; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Piunti A, 2017, NAT MED, V23, P493, DOI 10.1038/nm.4296; Qi J, 2016, CANCER RES, V76, P453, DOI 10.1158/0008-5472.CAN-15-1874; Rath KS, 2014, CANCER RES, V74, P2316, DOI 10.1158/0008-5472.CAN-13-2433; Shih IM, 2011, MODERN PATHOL, V24, P638, DOI 10.1038/modpathol.2010.230; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Turkson J, 2005, J BIOL CHEM, V280, P32979, DOI 10.1074/jbc.M502694200; Ueda SM, 2010, J ONCOL, V2010, DOI 10.1155/2010/285191; Vilaboa N, 2017, NUCLEIC ACIDS RES, V45, P5797, DOI 10.1093/nar/gkx194; Wu T, 2018, BIOORG CHEM, V80, P1, DOI 10.1016/j.bioorg.2018.05.024; Xu L, 2013, BIOORGAN MED CHEM, V21, P540, DOI 10.1016/j.bmc.2012.10.051; Yap KL, 2012, CANCER RES, V72, P4085, DOI 10.1158/0008-5472.CAN-12-0302; Yeasmin S, 2012, HUM PATHOL, V43, P506, DOI 10.1016/j.humpath.2011.05.021; Zhang Y, 2017, ONCOGENE, V36, P4171, DOI 10.1038/onc.2017.51; Zhang Y, 2012, ONCOGENE, V31, P1055, DOI 10.1038/onc.2011.290; Zhang Y, 2012, CANCER RES, V72, P4262, DOI 10.1158/0008-5472.CAN-12-0139	44	9	9	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					10006	10017		10.1074/jbc.RA119.007664	http://dx.doi.org/10.1074/jbc.RA119.007664			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31101655	Green Published, hybrid			2022-12-28	WOS:000473277900030
J	Ricketts, MD; Dasgupta, N; Fan, JY; Han, J; Gerace, M; Tang, Y; Black, B; Adams, PD; Marmorstein, R				Ricketts, M. Daniel; Dasgupta, Nirmalya; Fan, Jiayi; Han, Joseph; Gerace, Morgan; Tang, Yong; Black, Ben E.; Adams, Peter D.; Marmorstein, Ronen			The HIRA histone chaperone complex subunit UBN1 harbors H3/H4-and DNA-binding activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone chaperone; histone; chromatin; DNA-binding protein; epigenetics	STRUCTURAL BASIS; CHROMATIN; H3.3; H3-H4; ASF1; DIMERIZATION; HETERODIMER; DEPOSITION; MECHANISM; PROTEIN	The HIRA histone chaperone complex is composed of the proteins HIRA, UBN1, and CABIN1 and cooperates with the histone chaperone ASF1a to specifically bind and deposit H3.3/H4 into chromatin. We recently reported that the UBN1 Hpc2-related domain (HRD) specifically binds to H3.3/H4 over H3.1/H4. However, the mechanism for HIRA complex deposition of H3.3/H4 into nucleosomes remains unclear. Here, we characterize a central region of UBN1 (UBN1 middle domain) that is evolutionarily conserved and predicted to have helical secondary structure. We report that the UBN1 middle domain has dimer formation activity and binds to H3/H4 in a manner that does not discriminate between H3.1 and H3.3. We additionally identify a nearby DNA-binding domain in UBN1, located between the UBN1 HRD and middle domain, which binds DNA through electrostatic contacts involving several conserved lysine residues. Together, these observations suggest a mechanism for HIRA-mediated H3.3/H4 deposition whereby UBN1 associates with DNA and dimerizes to mediate formation of an (H3.3/H4)(2) heterotetramer prior to chromatin deposition.	[Ricketts, M. Daniel; Fan, Jiayi; Han, Joseph; Gerace, Morgan; Black, Ben E.; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Black, Ben E.; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA; [Han, Joseph; Marmorstein, Ronen] Univ Penn, Dept Chem, Grad Grp, Philadelphia, PA 19104 USA; [Ricketts, M. Daniel; Marmorstein, Ronen] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Tang, Yong; Marmorstein, Ronen] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Dasgupta, Nirmalya; Adams, Peter D.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Tang, Yong] Relay Therapeut, 215 First St, Cambridge, MA 02142 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute; Sanford Burnham Prebys Medical Discovery Institute	Marmorstein, R (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	marmor@upenn.edu	Dasgupta, Nirmalya/GSD-9997-2022	Dasgupta, Nirmalya/0000-0002-0289-5712; Adams, Peter/0000-0002-0684-1770	National Institutes of Health [AG031862, GM082989]; American Heart Association Predoctoral Fellowship [12PRE12030157]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG031862 (to R. M.) and GM082989 (to B. E. B.) and American Heart Association Predoctoral Fellowship 12PRE12030157 (to M. D. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Banumathy G, 2009, MOL CELL BIOL, V29, P758, DOI 10.1128/MCB.01047-08; Bonnefoy E, 2007, PLOS GENET, V3, P1991, DOI 10.1371/journal.pgen.0030182; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Chen SD, 2015, GENE DEV, V29, P1326, DOI 10.1101/gad.261115.115; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Domsic JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003672; Donham DC, 2011, NUCLEIC ACIDS RES, V39, P5449, DOI 10.1093/nar/gkr097; Duarte LF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6210; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Fazly A, 2012, J BIOL CHEM, V287, P10753, DOI 10.1074/jbc.M112.347450; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Huang HD, 2015, NAT STRUCT MOL BIOL, V22, P618, DOI 10.1038/nsmb.3055; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mattiroli F, 2017, ELIFE, V6, DOI 10.7554/eLife.22799; Mattiroli F, 2015, EMBO REP, V16, P1454, DOI 10.15252/embr.201540840; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Quivy JP, 2001, EMBO J, V20, P2015, DOI 10.1093/emboj/20.8.2015; Rai TS, 2011, MOL CELL BIOL, V31, P4107, DOI 10.1128/MCB.05546-11; Ray-Gallet D, 2007, CHROMOSOMA, V116, P487, DOI 10.1007/s00412-007-0112-x; Ray-Gallet D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05581-y; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Richet N, 2015, NUCLEIC ACIDS RES, V43, P1905, DOI 10.1093/nar/gkv021; Ricketts MD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8711; Safina A, 2017, NUCLEIC ACIDS RES, V45, P1925, DOI 10.1093/nar/gkw1366; Sauer PV, 2017, ELIFE, V6, DOI 10.7554/eLife.23474; Schneiderman JI, 2012, P NATL ACAD SCI USA, V109, P19721, DOI 10.1073/pnas.1206629109; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tang Y, 2012, BIOCHEMISTRY-US, V51, P2366, DOI 10.1021/bi300050b; Wang H, 2015, PROTEIN CELL, V6, P693, DOI 10.1007/s13238-015-0190-0; WEINER MP, 1994, PCR METH APPL, V4, pS131; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; Zasadzinska E, 2013, EMBO J, V32, P2113, DOI 10.1038/emboj.2013.142; Zhang K, 2016, NUCLEIC ACIDS RES, V44, P5083, DOI 10.1093/nar/gkw106; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Zhu RB, 2017, CELL STRUCT FUNCT, V42, P37, DOI 10.1247/csf.17001	46	3	3	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9239	9259		10.1074/jbc.RA119.007480	http://dx.doi.org/10.1074/jbc.RA119.007480			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31040182	hybrid, Green Published			2022-12-28	WOS:000471751600018
J	Tandon, H; Sharma, A; Wadhwa, S; Varadarajan, R; Singh, R; Srinivasan, N; Sandhya, S				Tandon, Himani; Sharma, Arun; Wadhwa, Saruchi; Varadarajan, Raghavan; Singh, Ramandeep; Srinivasan, Narayanaswamy; Sandhya, Sankaran			Bioinformatic and mutational studies of related toxin-antitoxin pairs in Mycobacterium tuberculosis predict and identify key functional residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; structure-function; molecular modeling; protein evolution; bioinformatics; phylogenetics; protein sequence; genome analysis; homology; pathogenesis; toxin-antitoxin; VapBC	CRYSTAL-STRUCTURE; INTERACTION SPECIFICITY; ACTIVE-SITE; PROTEIN; SYSTEMS; DATABASE; SEQUENCE; COMPLEX; DIVERSITY; EVOLUTION	Mycobacterium tuberculosis possesses an unusually large representation of type II toxin-antitoxin (TA) systems, whose functions and targets are mostly unknown. To better understand the basis of their unique expansion and to probe putative functional similarities among these systems, here we computationally and experimentally investigated their sequence relationships. Bioinformatic and phylogenetic investigations revealed that 51 sequences of the VapBC toxin family group into paralogous sub-clusters. On the basis of conserved sequence fingerprints within paralogues, we predicted functional residues and residues at the putative TA interface that are useful to evaluate TA interactions. Substitution of these likely functional residues abolished the toxin's growth-inhibitory activity. Furthermore, conducting similarity searches in 101 mycobacterial and approximate to 4500 other prokaryotic genomes, we assessed the relative conservation of the M. tuberculosis TA systems and found that most TA orthologues are well-conserved among the members of the M. tuberculosis complex, which cause tuberculosis in animal hosts. We found that soil-inhabiting, free-living Actinobacteria also harbor as many as 12 TA pairs. Finally, we identified five novel putative TA modules in M. tuberculosis. For one of them, we demonstrate that overexpression of the putative toxin, Rv2514c, induces bacteriostasis and that co-expression of the cognate antitoxin Rv2515c restores bacterial growth. Taken together, our findings reveal that toxin sequences are more closely related than antitoxin sequences in M. tuberculosis. Furthermore, the identification of additional TA systems reported here expands the known repertoire of TA systems in M. tuberculosis.	[Tandon, Himani; Varadarajan, Raghavan; Srinivasan, Narayanaswamy; Sandhya, Sankaran] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Sharma, Arun; Wadhwa, Saruchi; Singh, Ramandeep] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, TB Res Lab, NCR Biotech Sci Cluster, 3rd Milestone,P.OB 4, Faridabad 121001, Haryana, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Srinivasan, N; Sandhya, S (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@iisc.ac.in; sandhyas@iisc.ac.in		Tandon, Himani/0000-0002-3469-8449; Sandhya, Sankaran/0000-0003-0055-302X; Singh, Ramandeep/0000-0003-2705-3826; WADHWA, SARUCHI/0000-0001-7271-0421	Ministry of Human Resource Development (MHRD) of the Government of India; Department of Science and Technology-Fund for improvement of S&T infrastructure (DST-FIST) of the Government of India; University Grants Commission (UGC) Center for Advanced Study of the Government of India; Mathematical Biology Program of the Department of Science and Technology of the Government of India; Department of Biotechnology-Indian Institute of Science (DBT-IISc) Partnership Program of the Government of India	Ministry of Human Resource Development (MHRD) of the Government of India; Department of Science and Technology-Fund for improvement of S&T infrastructure (DST-FIST) of the Government of India; University Grants Commission (UGC) Center for Advanced Study of the Government of India(University Grants Commission, India); Mathematical Biology Program of the Department of Science and Technology of the Government of India; Department of Biotechnology-Indian Institute of Science (DBT-IISc) Partnership Program of the Government of India	We thank members of R. V., R. S., and N. S. labs for their inputs. We acknowledge funding for infrastructural support from the following agencies or programs of the Government of India, Ministry of Human Resource Development (MHRD), Department of Science and Technology-Fund for improvement of S&T infrastructure (DST-FIST), University Grants Commission (UGC) Center for Advanced Study, Mathematical Biology Program of the Department of Science and Technology, and the Department of Biotechnology-Indian Institute of Science (DBT-IISc) Partnership Program.	Aakre CD, 2015, CELL, V163, P594, DOI 10.1016/j.cell.2015.09.055; Aakre CD, 2013, MOL CELL, V52, P617, DOI 10.1016/j.molcel.2013.10.014; Agarwal S, 2018, J INFECT DIS, V217, P1809, DOI 10.1093/infdis/jiy109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Averina O, 2015, ANAEROBE, V35, P59, DOI 10.1016/j.anaerobe.2015.07.007; Bordes P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13339; Coray DS, 2017, RNA BIOL, V14, P275, DOI 10.1080/15476286.2016.1272747; Cruz JW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8480; Das U, 2014, J STRUCT BIOL, V188, P249, DOI 10.1016/j.jsb.2014.10.002; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Fiebig A, 2010, MOL MICROBIOL, V77, P236, DOI 10.1111/j.1365-2958.2010.07207.x; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017962; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Ghodbane R, 2014, MICROBIOL-SGM, V160, P496, DOI 10.1099/mic.0.073379-0; Gupta A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06003-7; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Jardim P, 2016, BIOCHEM BIOPH RES CO, V478, P1370, DOI 10.1016/j.bbrc.2016.08.130; Jin GZ, 2015, J BACTERIOL, V197, P1197, DOI 10.1128/JB.02508-14; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Kedzierska B, 2016, MOLECULES, V21, DOI 10.3390/molecules21060790; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klimina KM, 2013, ANAEROBE, V22, P82, DOI 10.1016/j.anaerobe.2013.05.007; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee IG, 2015, NUCLEIC ACIDS RES, V43, P7624, DOI 10.1093/nar/gkv689; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McKenzie JL, 2012, J BACTERIOL, V194, P2189, DOI 10.1128/JB.06790-11; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Miele V, 2012, BIOINFORMATICS, V28, P1078, DOI 10.1093/bioinformatics/bts098; Min AB, 2012, PROTEIN SCI, V21, P1754, DOI 10.1002/pro.2161; Mishra S, 2012, PROTEIN EXPRES PURIF, V86, P58, DOI 10.1016/j.pep.2012.08.020; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pandurangan AP, 2019, NUCLEIC ACIDS RES, V47, pD490, DOI 10.1093/nar/gky1130; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pertea M, 2009, NUCLEIC ACIDS RES, V37, pD479, DOI 10.1093/nar/gkn784; Prozorov AA, 2010, MICROBIOLOGY+, V79, P129, DOI 10.1134/S0026261710020013; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romero D, 1997, ANNU REV GENET, V31, P91, DOI 10.1146/annurev.genet.31.1.91; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Soo VWC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04807; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tandon H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37473-y; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; THOMAS JH, 1993, TRENDS GENET, V9, P395, DOI 10.1016/0168-9525(93)90140-D; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wei YX, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03232-16; Wen YR, 2014, PATHOG DIS, V70, P240, DOI 10.1111/2049-632X.12145; Winther K, 2016, NUCLEIC ACIDS RES, V44, P9860, DOI 10.1093/nar/gkw781; Winther KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3796; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; World Health Organization, 2018, WHO GLOB TUB REP 201, DOI [10.1016/j.pharep.2017.02.021, DOI 10.1016/J.PHAREP.2017.02.021]; Yamaguchi Y., 2016, STRESS ENV REGULATIO, P97; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhu L, 2010, J BIOL CHEM, V285, P39732, DOI 10.1074/jbc.M110.163105	73	16	17	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9048	9063		10.1074/jbc.RA118.006814	http://dx.doi.org/10.1074/jbc.RA118.006814			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31018964	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000471751600004
J	Chepurny, OG; Matsuokas, MT; Liapakis, G; Leech, CA; Milliken, BT; Doyle, RP; Holz, GG				Chepurny, Oleg G.; Matsuokas, Minos-Timotheos; Liapakis, George; Leech, Colin A.; Milliken, Brandon T.; Doyle, Robert P.; Holz, George G.			Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP (vol 294, pg 3514, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Doyle, Robert P/W-1921-2018	Holz, George/0000-0002-1781-3580				Chepurny OG, 2019, J BIOL CHEM, V294, P3514, DOI 10.1074/jbc.RA118.005682	1	2	2	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8714	8714		10.1074/jbc.AAC119.009193	http://dx.doi.org/10.1074/jbc.AAC119.009193			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31152095	Green Published, hybrid			2022-12-28	WOS:000470971100006
J	Solorzano-Vargas, RS; Bjerknes, M; Wu, SV; Wang, JF; Stelzner, M; Dunn, JCY; Dhawan, S; Cheng, H; Georgia, S; Martin, M				Solorzano-Vargas, R. Sergio; Bjerknes, Matthew; Wu, S. Vincent; Wang, Jiafang; Stelzner, Matthias; Dunn, James C. Y.; Dhawan, Sangeeta; Cheng, Hazel; Georgia, Senta; Martin, Martin			The cellular regulators PTEN and BMI1 help mediate NEUROGENIN-3?induced cell cycle arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocrinology; neuroendocrinology; basic helix-loop-helix transcription factor (bHLH); pancreatic islet; intestinal epithelium	PROLIFERATION; EXPRESSION; LINEAGE; PROTEIN; PHOSPHORYLATION; DIFFERENTIATION; PROGENITORS; REPRESSION; PATHWAY; ASSAY	Neurogenin-3 (NEUROG3) is a helix-loop-helix (HLH) transcription factor involved in the production of endocrine cells in the intestine and pancreas of humans and mice. However, the human NEUROG3 loss-of-function phenotype differs subtly from that in mice, but the reason for this difference remains poorly understood. Because NEUROG3 expression precedes exit of the cell cycle and the expression of endocrine cell markers during differentiation, we investigated the effect of lentivirus-mediated overexpression of the human NEUROG3 gene on the cell cycle of BON4 cells and various human nonendocrine cell lines. NEUROG3 overexpression induced a reversible cell cycle exit, whereas expression of a neuronal lineage homolog, NEUROG1, had no such effect. In endocrine lineage cells, the cellular quiescence induced by short-term NEUROG3 expression required cyclin-dependent kinase inhibitor 1A (CDKN1A)/p21(CIP1) expression. Expression of endocrine differentiation markers required sustained NEUROG3 expression in the quiescent, but not in the senescent, state. Inhibition of the phosphatase and tensin homolog (PTEN) pathway reversed quiescence by inducing cyclin-dependent kinase 2 (CDK2) and reducing p21(CIP1) and NEUROG3 protein levels in BON4 cells and human enteroids. We discovered that NEUROG3 expression stimulates expression of CDKN2a/p16(INK4a) and BMI1 proto-oncogene polycomb ring finger (BMI1), with the latter limiting expression of the former, delaying the onset of CDKN2a/p16(INK4a)-driven cellular senescence. Furthermore, NEUROG3 bound to the promoters of both CDKN1a/p21(CIP1) and BMI1 genes, and BMI1 attenuated NEUROG3 binding to the CDKN1a/p21CIP1 promoter. Our findings reveal how human NEUROG3 integrates inputs from multiple signaling pathways and thereby mediates cell cycle exit at the onset of differentiation.	[Solorzano-Vargas, R. Sergio; Wang, Jiafang; Martin, Martin] Univ Calif Los Angeles, Mattel Childrens Hosp, Div Gastroenterol & Nutr, Dept Pediat, Los Angeles, CA 90095 USA; [Solorzano-Vargas, R. Sergio; Wang, Jiafang; Martin, Martin] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bjerknes, Matthew; Cheng, Hazel] Univ Toronto, Dept Med, Med Sci Bldg, Toronto, ON M5S 1A8, Canada; [Wu, S. Vincent] Univ Calif Los Angeles, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Wu, S. Vincent] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90073 USA; [Stelzner, Matthias] Univ Calif Los Angeles, Dept Surg, Div Gen Surg, Los Angeles, CA 90095 USA; [Dunn, James C. Y.] Stanford Univ, Dept Surg, Div Pediat Surg, Sch Med, Stanford, CA 94305 USA; [Dhawan, Sangeeta] City Hope Natl Med Ctr, Dept Translat Res & Cellular Therapeut, Duarte, CA 91010 USA; [Georgia, Senta] Univ Southern Calif, Childrens Hosp Los Angeles, Dept Pediat, Div Endocrinol, Los Angeles, CA 90027 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Stanford University; City of Hope; Children's Hospital Los Angeles; University of Southern California	Martin, M (corresponding author), Univ Calif Los Angeles, Mattel Childrens Hosp, Div Gastroenterol & Nutr, Dept Pediat, Los Angeles, CA 90095 USA.; Martin, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	mmartin@mednet.ucla.edu	Solorzano-Vargas, R Sergio/D-4869-2016; Georgia, Senta/AAP-1971-2020	Georgia, Senta/0000-0002-2016-7866; Dunn, James/0000-0002-6826-7065	National Institutes of Health NIDDK [DK083762, DK41301]; National Institutes of Health NIAID [U01DK085535]	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health NIDDK Grants DK083762 and DK41301, and NIAID Grant U01DK085535. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Azzarelli R, 2017, DEV CELL, V41, P274, DOI 10.1016/j.devcel.2017.04.004; Beucher A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036449; Bjerknes M, 2006, DEV BIOL, V300, P722, DOI 10.1016/j.ydbio.2006.07.040; Brandmaier A, 2017, J MOL BIOL, V429, P2265, DOI 10.1016/j.jmb.2017.06.004; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; Farah MH, 2000, DEVELOPMENT, V127, P693; Gimm O, 2000, HUM MOL GENET, V9, P1633, DOI 10.1093/hmg/9.11.1633; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hlobilkova A, 2006, ANTICANCER RES, V26, P1015; Itahana Koji, 2013, Methods Mol Biol, V965, P143, DOI 10.1007/978-1-62703-239-1_8; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Krentz NAJ, 2017, DEV CELL, V41, P129, DOI 10.1016/j.devcel.2017.02.006; Miyatsuka T, 2011, P NATL ACAD SCI USA, V108, P185, DOI 10.1073/pnas.1004842108; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Mutoh H, 1998, GENE DEV, V12, P820, DOI 10.1101/gad.12.6.820; Pauerstein PT, 2015, DIABETES, V64, P3037, DOI 10.2337/db15-0042; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Richmond CA, 2015, CELL REP, V13, P2403, DOI 10.1016/j.celrep.2015.11.035; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Tschen SI, 2011, MOL ENDOCRINOL, V25, P2134, DOI 10.1210/me.2011-1119; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Yan KS, 2017, CELL STEM CELL, V21, P78, DOI 10.1016/j.stem.2017.06.014; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Zou D, 2004, DEVELOPMENT, V131, P5561, DOI 10.1242/dev.01437	34	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					15182	15192		10.1074/jbc.RA119.008926	http://dx.doi.org/10.1074/jbc.RA119.008926			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31341016	Green Published, hybrid			2022-12-28	WOS:000499253400032
J	Dujardin, M; Madan, V; Gandhi, NS; Cantrelle, FX; Launay, H; Huvent, I; Bartenschlager, R; Lippens, G; Hanoulle, X				Dujardin, Marie; Madan, Vanesa; Gandhi, Neha S.; Cantrelle, Francois-Xavier; Launay, Helene; Huvent, Isabelle; Bartenschlager, Ralf; Lippens, Guy; Hanoulle, Xavier			Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intrinsically disordered protein; nuclear magnetic resonance (NMR); prolyl isomerase; hepatitis C virus (HCV); cyclophilin; allosteric regulation; conformer ensemble; nonstructural protein 5A (NS5A); RNA replication	HEPATITIS-C-VIRUS; NONSTRUCTURAL PROTEIN 5A; CRYSTAL-STRUCTURE; INTRINSIC DISORDER; ISOMERASE ACTIVITY; VIRAL REPLICATION; CYCLOSPORINE-A; BINDING-SITE; AMBER; IDENTIFICATION	Implicated in numerous human diseases, intrinsically disordered proteins (IDPs) are dynamic ensembles of interconverting conformers that often contain many proline residues. Whether and how proline conformation regulates the functional aspects of IDPs remains an open question, however. Here, we studied the disordered domain 2 of nonstructural protein 5A (NS5A-D2) of hepatitis C virus (HCV). NS5A-D2 comprises a short structural motif (PW-turn) embedded in a proline-rich sequence, whose interaction with the human prolyl isomerase cyclophilin A (CypA) is essential for viral RNA replication. Using NMR, we show here that the PW-turn motif exists in a conformational equilibrium between folded and disordered states. We found that the fraction of conformers in the NS5A-D2 ensemble that adopt the structured motif is allosterically modulated both by the cis/trans isomerization of the surrounding prolines that are CypA substrates and by substitutions conferring resistance to cyclophilin inhibitor. Moreover, we noted that this fraction is directly correlated with HCV RNA replication efficiency. We conclude that CypA can fine-tune the dynamic ensemble of the disordered NS5A-D2, thereby regulating viral RNA replication efficiency.	[Dujardin, Marie; Cantrelle, Francois-Xavier; Launay, Helene; Huvent, Isabelle; Lippens, Guy; Hanoulle, Xavier] Univ Lille, CNRS, UMR 8576, UGSF, Campus CNRS Haute Borne,50 Ave Halley, F-59000 Lille, France; [Madan, Vanesa; Bartenschlager, Ralf] Heidelberg Univ, Mol Virol, Dept Infect Dis, D-69120 Heidelberg, Germany; [Gandhi, Neha S.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4000, Australia; [Gandhi, Neha S.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4000, Australia; [Dujardin, Marie] Univ Lyon, CNRS, UMR 5086, MMSB, F-69367 Lyon, France; [Madan, Vanesa] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Launay, Helene] Univ Aix Marseille, CNRS, UMR 7281, BIP, F-13402 Marseille, France; [Lippens, Guy] Univ Toulouse, CNRS, INRA, INSA,Lab Ingn Syst Biol & Procedes, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Ruprecht Karls University Heidelberg; Queensland University of Technology (QUT); Queensland University of Technology (QUT); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); MRC Laboratory Molecular Biology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Hanoulle, X (corresponding author), Univ Lille, CNRS, UMR 8576, UGSF, Campus CNRS Haute Borne,50 Ave Halley, F-59000 Lille, France.	xavier.hanoulle@univ-lille.fr	HANOULLE, Xavier/HHN-4815-2022; Gandhi, Neha S/E-7688-2010; Hanoulle, Xavier/AAK-7236-2021; Gandhi, Neha S./AAX-9592-2021	Gandhi, Neha S/0000-0003-3119-6731; Hanoulle, Xavier/0000-0002-3755-2680; Gandhi, Neha S./0000-0003-3119-6731; cantrelle, francois-xavier/0000-0002-3413-5443; Lippens, Guy/0000-0002-8236-0901; Launay, Helene/0000-0003-0639-2642; Huvent, Isabelle/0000-0002-7241-0290	French National Agency for Research (ANR) [ANR-11-JSV8-005]; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) [A02014-2]; Lille University; Deutsche Forschungsgemeinschaft (German Research Foundation) [112927078-TRR 83]; Research Federation "structural and functional biochemistry of BIOmolecular Assemblies" (CNRS) [FR-3688]	French National Agency for Research (ANR)(French National Research Agency (ANR)); French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); Lille University; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Research Federation "structural and functional biochemistry of BIOmolecular Assemblies" (CNRS)	This work was supported by French National Agency for Research (ANR) Grant ANR-11-JSV8-005 and French National Agency for Research on AIDS and Viral Hepatitis (ANRS) Grant A02014-2, a fellowship from Lille University (to M. D.), Deutsche Forschungsgemeinschaft (German Research Foundation) Project Grant 112927078-TRR 83 (to V. M. and R. B.), and by Research Federation "structural and functional biochemistry of BIOmolecular Assemblies" (CNRS, FR-3688). The authors declare that they have no conflicts of interest with the contents of this article.	Aberham C, 1996, J VIROL, V70, P3536, DOI 10.1128/JVI.70.6.3536-3544.1996; Ahmed-Belkacem A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12777; Ahn J, 2004, J BIOCHEM MOL BIOL, V37, P741; Ahuja P, 2016, J MOL BIOL, V428, P79, DOI 10.1016/j.jmb.2015.11.023; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Bessa LM, 2017, J BIOL CHEM, V292, P18024, DOI 10.1074/jbc.M117.813766; Borgia A, 2018, NATURE, V555, P61, DOI 10.1038/nature25762; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Changeux JP, 2013, NAT REV MOL CELL BIO, V14, P819, DOI 10.1038/nrm3695; Chatterji U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159511; Chatterji U, 2015, ANTIMICROB AGENTS CH, V59, P2496, DOI 10.1128/AAC.04958-14; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Chung HY, 2014, J VIROL, V88, P11022, DOI 10.1128/JVI.01582-14; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dujardin M, 2015, J BIOL CHEM, V290, P19104, DOI 10.1074/jbc.M115.644419; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; Feuerstein S, 2012, J MOL BIOL, V420, P310, DOI 10.1016/j.jmb.2012.04.023; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Garcia-Rivera JA, 2012, ANTIMICROB AGENTS CH, V56, P5113, DOI 10.1128/AAC.00919-12; Goto K, 2009, CANCER SCI, V100, P1943, DOI 10.1111/j.1349-7006.2009.01263.x; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Grise H, 2012, J VIROL, V86, P4811, DOI 10.1128/JVI.06641-11; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hanoulle X, 2010, PROTEIN PEPTIDE LETT, V17, P1012, DOI 10.2174/092986610791498920; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Ilizaliturri-Flores I, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-2940-1; Jensen MR, 2009, STRUCTURE, V17, P1169, DOI 10.1016/j.str.2009.08.001; Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162; Kosol S, 2013, MOLECULES, V18, P10802, DOI 10.3390/molecules180910802; Lambert SM, 2014, PROTEIN SCI, V23, P723, DOI 10.1002/pro.2456; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10714; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Lu MM, 2015, P NATL ACAD SCI USA, V112, P14617, DOI 10.1073/pnas.1516920112; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Madan V, 2014, GASTROENTEROLOGY, V146, P1361, DOI 10.1053/j.gastro.2014.01.055; Miao YL, 2015, J CHEM THEORY COMPUT, V11, P3584, DOI 10.1021/acs.jctc.5b00436; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Nevers Q, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00126-18, 10.1128/aac.00126-18]; Ngure M, 2016, ACS INFECT DIS, V2, P839, DOI 10.1021/acsinfecdis.6b00143; O'Boyle DR, 2013, VIROLOGY, V444, P343, DOI 10.1016/j.virol.2013.06.032; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Quinn CM, 2018, P NATL ACAD SCI USA, V115, P11519, DOI 10.1073/pnas.1800796115; Roe DR, 2018, J COMPUT CHEM, V39, P2110, DOI 10.1002/jcc.25382; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rosnoblet C, 2012, J BIOL CHEM, V287, P44249, DOI 10.1074/jbc.M112.392209; Saleh T, 2016, NAT CHEM BIOL, V12, P117, DOI [10.1038/NCHEMBIO.1981, 10.1038/nchembio.1981]; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Schrodinger  LLC, 2015, THE PYMOL MOLECULAR; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Stollar EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051282; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Theillet Francois-Xavier, 2013, Intrinsically Disord Proteins, V1, pe24360, DOI 10.4161/idp.24360; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Verdegem D, 2008, J BIOMOL NMR, V42, P11, DOI 10.1007/s10858-008-9262-2; Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118; Ylinen LMJ, 2009, J VIROL, V83, P2044, DOI 10.1128/JVI.01876-08; Zhou JH, 2018, J MOL BIOL, V430, P2342, DOI 10.1016/j.jmb.2018.03.028; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y	101	7	7	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13171	13185		10.1074/jbc.RA119.009537	http://dx.doi.org/10.1074/jbc.RA119.009537			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31315928	hybrid, Green Published			2022-12-28	WOS:000486416000025
J	Deuss, FA; Watson, GM; Goodall, KJ; Leece, I; Chatterjee, S; Fu, ZH; Thaysen-Andersen, M; Andrews, DM; Rossjohn, J; Berry, R				Deuss, Felix A.; Watson, Gabrielle M.; Goodall, Katharine J.; Leece, Isobel; Chatterjee, Sayantani; Fu, Zhihui; Thaysen-Andersen, Morten; Andrews, Daniel M.; Rossjohn, Jamie; Berry, Richard			Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						natural killer cells (NK cells); protein structure; immunology; immunoglobulin fold; cell adhesion; cancer immunotherapy; CD226 molecule; DNAX accessory molecule-1 (DNAM-1); nectin-like protein-5 (NECL-5); PVR cell adhesion molecule	CRYSTAL-STRUCTURE; CELL IMMUNOGLOBULIN; CUTTING EDGE; NK CELLS; T-CELLS; CD226; CYTOTOXICITY; ADHESION; SUSCEPTIBILITY; GLYCOSYLATION	Nectin and nectin-like (Necl) adhesion molecules are broadly overexpressed in a wide range of cancers. By binding to these adhesion molecules, the immunoreceptors DNAX accessory molecule-1 (DNAM-1), CD96 molecule (CD96), and T-cell immunoreceptor with Ig and ITIM domains (TIGIT) play a crucial role in regulating the anticancer activities of immune effector cells. However, within this axis, it remains unclear how DNAM-1 recognizes its cognate ligands. Here, we determined the structure of human DNAM-1 in complex with nectin-like protein-5 (Necl-5) at 2.8 angstrom resolution. Unexpectedly, we found that the two extracellular domains (D1-D2) of DNAM-1 adopt an unconventional collapsed arrangement that is markedly distinct from those in other immunoglobulin-based immunoreceptors. The DNAM-1/Necl-5 interaction was underpinned by conserved lock-and-key motifs located within their respective D1 domains, but also included a distinct interface derived from DNAM-1 D2. Mutation of the signature DNAM-1 key motif within the D1 domain attenuated Necl-5 binding and natural killer cell-mediated cytotoxicity. Altogether, our results have implications for understanding the binding mode of an immune receptor family that is emerging as a viable candidate for cancer immunotherapy.	[Deuss, Felix A.; Watson, Gabrielle M.; Fu, Zhihui; Rossjohn, Jamie; Berry, Richard] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Deuss, Felix A.; Watson, Gabrielle M.; Fu, Zhihui; Rossjohn, Jamie; Berry, Richard] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Watson, Gabrielle M.; Rossjohn, Jamie; Berry, Richard] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Goodall, Katharine J.; Leece, Isobel] Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic 3800, Australia; [Chatterjee, Sayantani; Thaysen-Andersen, Morten; Andrews, Daniel M.] Macquarie Univ, Fac Sci & Engn, Dept Mol Sci, Sydney, NSW 2109, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; Monash University; Monash University; Macquarie University; Cardiff University	Rossjohn, J; Berry, R (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Rossjohn, J; Berry, R (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Rossjohn, J; Berry, R (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	jamie.rossjohn@monash.edu; richard.berty@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Andrews, Dan/0000-0002-5896-7885; Chatterjee, Sayantani/0000-0002-7007-0333; Watson, Gabrielle/0000-0003-0056-7528; Thaysen-Andersen, Morten/0000-0001-8327-6843	Macquarie University Research Seeding grant; International Macquarie University Research Excellence Scholarship iMQRES [2017152]; Australian Research Council [FL160100049]; Career Development Fellowship from the National Health and Medical Research Council of Australia [APP1109901]	Macquarie University Research Seeding grant; International Macquarie University Research Excellence Scholarship iMQRES; Australian Research Council(Australian Research Council); Career Development Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Macquarie University Research Seeding grant (to M.T.-A.), International Macquarie University Research Excellence Scholarship iMQRES 2017152 (to S.C.), Australian Research Council Laureate Fellowship FL160100049 (to J.R.), and by Career Development Fellowship APP1109901 from the National Health and Medical Research Council of Australia (to R.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar OA, 2017, CELL, V169, P58, DOI 10.1016/j.cell.2017.03.002; Ashwood C, 2018, J AM SOC MASS SPECTR, V29, P1194, DOI 10.1007/s13361-018-1932-z; Balaji GR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06989-2; Berry R, 2014, IMMUNOL CELL BIOL, V92, P214, DOI 10.1038/icb.2013.100; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; Borrego F, 2006, IMMUNOL RES, V35, P263, DOI 10.1385/IR:35:3:263; Burshtyn DN, 2016, J IMMUNOL, V196, P947, DOI 10.4049/jimmunol.1501937; Campbell KS, 2011, IMMUNOLOGY, V132, P315, DOI 10.1111/j.1365-2567.2010.03398.x; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Cho D, 2010, CLIN CANCER RES, V16, P3901, DOI 10.1158/1078-0432.CCR-10-0735; Deuss FA, 2019, STRUCTURE, V27, P219, DOI 10.1016/j.str.2018.10.023; Deuss FA, 2017, J BIOL CHEM, V292, P11413, DOI 10.1074/jbc.M117.786483; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Everest-Dass AV, 2012, GLYCOBIOLOGY, V22, P1465, DOI 10.1093/glycob/cws112; Foster CE, 2003, J BIOL CHEM, V278, P46081, DOI 10.1074/jbc.M308491200; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Harrison OJ, 2012, NAT STRUCT MOL BIOL, V19, P906, DOI 10.1038/nsmb.2366; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Kirkham CL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00214; Kurtulus S, 2015, J CLIN INVEST, V125, P4053, DOI 10.1172/JCI81187; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P10483, DOI 10.1073/pnas.0804453105; Liu S, 2013, CELL DEATH DIFFER, V20, P456, DOI 10.1038/cdd.2012.141; Lofgren SE, 2010, ARTHRITIS RHEUM-US, V62, P3404, DOI 10.1002/art.27677; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Meyer D, 2009, J BIOL CHEM, V284, P2235, DOI 10.1074/jbc.M807698200; Mohammed F, 2017, ONCOTARGET, V8, P54160, DOI 10.18632/oncotarget.16952; Mysling S, 2010, ANAL CHEM, V82, P5598, DOI 10.1021/ac100530w; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Oshima T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-60; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Ramsbottom KM, 2014, J IMMUNOL, V192, P553, DOI 10.4049/jimmunol.1302197; Reinards THCM, 2015, ANN RHEUM DIS, V74, P2193, DOI 10.1136/annrheumdis-2013-205138; Sansom DM, 2000, IMMUNOLOGY, V101, P169, DOI 10.1046/j.1365-2567.2000.00121.x; Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stengel KF, 2012, P NATL ACAD SCI USA, V109, P5399, DOI 10.1073/pnas.1120606109; Sumer-Bayraktar Z, 2012, PROTEOMICS, V12, P3315, DOI 10.1002/pmic.201200354; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Verhoeven DHJ, 2008, MOL IMMUNOL, V45, P3917, DOI 10.1016/j.molimm.2008.06.016; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Wang H, 2019, P NATL ACAD SCI USA, V116, P988, DOI 10.1073/pnas.1815716116; Zhang Q, 2018, NAT IMMUNOL, V19, P723, DOI 10.1038/s41590-018-0132-0	53	8	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12534	12546		10.1074/jbc.RA119.009261	http://dx.doi.org/10.1074/jbc.RA119.009261			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31253644	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000484402700023
J	Gunal, S; Hardman, R; Kopriva, S; Mueller, JW				Guenal, Sueleyman; Hardman, Rebecca; Kopriva, Stanislav; Mueller, Jonathan Wolf			Sulfation pathways from red to green	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						sulfotransferase; sulfur; Arabidopsis thaliana; steroid hormone; human; secondary metabolism; 3 '-phosphoadenosine 5 '-phosphosulfate (PAPS) synthase; adenosine 5 '-phosphosulfate kinase; ATP sulfurylase; glucosinolates; sulfate activation	FORMYLGLYCINE-GENERATING ENZYME; ADENOSINE 5'-PHOSPHOSULFATE REDUCTASE; INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; CYTOSOLIC SULFOTRANSFERASE 1A1; ATP SULFURYLASE; STEROID SULFATASE; ARABIDOPSIS-THALIANA; NATURAL VARIATION; STRUCTURAL BASIS; PHOSPHOADENOSINE 5'-PHOSPHOSULFATE	Sulfur is present in the amino acids cysteine and methionine and in a large range of essential coenzymes and cofactors and is therefore essential for all organisms. It is also a constituent of sulfate esters in proteins, carbohydrates, and numerous cellular metabolites. The sulfation and desulfation reactions modifying a variety of different substrates are commonly known as sulfation pathways. Although relatively little is known about the function of most sulfated metabolites, the synthesis of activated sulfate used in sulfation pathways is essential in both animal and plant kingdoms. In humans, mutations in the genes encoding the sulfation pathway enzymes underlie a number of developmental aberrations, and in flies and worms, their loss-of-function is fatal. In plants, a lower capacity for synthesizing activated sulfate for sulfation reactions results in dwarfism, and a complete loss of activated sulfate synthesis is also lethal. Here, we review the similarities and differences in sulfation pathways and associated processes in animals and plants, and we point out how they diverge from bacteria and yeast. We highlight the open questions concerning localization, regulation, and importance of sulfation pathways in both kingdoms and the ways in which findings from these red and green experimental systems may help reciprocally address questions specific to each of the systems.	[Guenal, Sueleyman; Kopriva, Stanislav] Univ Cologne, Cluster Excellence Plant Sci CEPLAS, Bot Inst, D-50674 Cologne, Germany; [Hardman, Rebecca; Mueller, Jonathan Wolf] Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England; [Mueller, Jonathan Wolf] Birmingham Hlth Partners, CEDAM, Birmingham B15 2TH, W Midlands, England	University of Cologne; University of Birmingham	Kopriva, S (corresponding author), Univ Cologne, Cluster Excellence Plant Sci CEPLAS, Bot Inst, D-50674 Cologne, Germany.; Mueller, JW (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England.; Mueller, JW (corresponding author), Birmingham Hlth Partners, CEDAM, Birmingham B15 2TH, W Midlands, England.	skopriva@uni-koeln.de; j.w.mueller@bham.ac.uk	Kopriva, Stanislav/C-7401-2013; Mueller, Jonathan Wolf/D-1632-2010	Kopriva, Stanislav/0000-0002-7416-6551; Mueller, Jonathan Wolf/0000-0003-1212-189X	Deutsche Forschungsgemeinschaft (DFG) under Germany's Excellence Strategy [EXC 2048/1, 390686111]; DFG Project [KO2065/13-1]; European Commission Marie Curie Fellowship [SUPA-HD 625451]; Wellcome Trust (ISSF Award); Medical Research Council UK	Deutsche Forschungsgemeinschaft (DFG) under Germany's Excellence Strategy(German Research Foundation (DFG)); DFG Project(German Research Foundation (DFG)); European Commission Marie Curie Fellowship(European Commission); Wellcome Trust (ISSF Award)(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) under Germany's Excellence Strategy-EXC 2048/1, Project 390686111 (to the S. K. laboratory), DFG Project KO2065/13-1 (to S. G.), European Commission Marie Curie Fellowship SUPA-HD 625451, Wellcome Trust (ISSF Award), and the Medical Research Council UK (Proximity-to-Discovery) (to the J. W. M. laboratory). The authors declare that they have no conflicts of interest with the contents of this article.	Abayev M, 2018, FEBS J, V285, P1988, DOI 10.1111/febs.14460; Ahmad M, 1998, AM J MED GENET, V78, P468; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; Appel MJ, 2019, P NATL ACAD SCI USA, V116, P5370, DOI 10.1073/pnas.1818274116; Ashykhmina N, 2019, PLANT CELL, V31, P231, DOI 10.1105/tpc.18.00512; Baek D, 2010, PLANT CELL ENVIRON, V33, P1383, DOI 10.1111/j.1365-3040.2010.02156.x; Barbosa ACS, 2019, EXPERT OPIN DRUG MET, V15, P329, DOI 10.1080/17425255.2019.1588884; Bedini E, 2017, CARBOHYD POLYM, V174, P1224, DOI 10.1016/j.carbpol.2017.07.017; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Beinert H, 2000, EUR J BIOCHEM, V267, P5657, DOI 10.1046/j.1432-1327.2000.01637.x; Berger I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026794; Besset S, 2000, FASEB J, V14, P345, DOI 10.1096/fasebj.14.2.345; Bick JA, 2001, BIOCHEMISTRY-US, V40, P9040, DOI 10.1021/bi010518v; Bohrer AS, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00751; Bohrer AS, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00750; Borghei A, 2006, J BIOL CHEM, V281, P9423, DOI 10.1074/jbc.M513768200; Brachi B, 2015, P NATL ACAD SCI USA, V112, P4032, DOI 10.1073/pnas.1421416112; Bruce JW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000207; Brylski O, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00031; Calderwood A, 2014, NITRIC OXIDE-BIOL CH, V41, P72, DOI 10.1016/j.niox.2014.02.005; Capulli M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213660; Carroll KS, 2005, PLOS BIOL, V3, P1418, DOI 10.1371/journal.pbio.0030250; Chan KX, 2019, J EXP BOT, V70, P4237, DOI 10.1093/jxb/erz119; Chan KX, 2016, P NATL ACAD SCI USA, V113, pE4567, DOI 10.1073/pnas.1604936113; Chan KX, 2013, TRENDS PLANT SCI, V18, P18, DOI 10.1016/j.tplants.2012.07.005; Chao DY, 2014, PLANT PHYSIOL, V166, P1593, DOI 10.1104/pp.114.247825; Chen GM, 2018, J AM SOC MASS SPECTR, V29, P455, DOI 10.1007/s13361-017-1854-1; Chen H, 2010, PLANT CELL ENVIRON, V33, P2180, DOI 10.1111/j.1365-3040.2010.02218.x; Cook I, 2013, J BIOL CHEM, V288, P34494, DOI 10.1074/jbc.M113.510974; Coughtrie MWH, 2016, CHEM-BIOL INTERACT, V259, P2, DOI 10.1016/j.cbi.2016.05.005; Cumming M, 2007, FEBS LETT, V581, P4139, DOI 10.1016/j.febslet.2007.07.062; Danan LM, 2010, J AM SOC MASS SPECTR, V21, P1633, DOI 10.1016/j.jasms.2010.03.037; Darrah K, 2019, J BIOL CHEM, V294, P2293, DOI 10.1074/jbc.RA118.006511; Dias IHK, 2019, CHEM PHYS LIPIDS, V221, P53, DOI 10.1016/j.chemphyslip.2019.03.009; Dick G, 2015, GLYCOBIOLOGY, V25, P30, DOI 10.1093/glycob/cwu084; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; El-Gamal MI, 2016, BIOORGAN MED CHEM, V24, P2762, DOI 10.1016/j.bmc.2016.04.040; Erickson AI, 2015, BIOCHEMISTRY-US, V54, P6830, DOI 10.1021/acs.biochem.5b01000; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Feldman-Salit A, 2019, NEW PHYTOL, V222, P1392, DOI 10.1111/nph.15704; FOSTER BA, 1994, J BIOL CHEM, V269, P19777; Foster PA, 2018, J MOL ENDOCRINOL, V61, pT271, DOI 10.1530/JME-18-0086; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Fuda H, 2002, BIOCHEM J, V365, P497, DOI 10.1042/BJ20020044; Ganeshapillai D, 2018, ACS OMEGA, V3, P10748, DOI 10.1021/acsomega.8b01383; Garcia PL, 2018, DRUG METAB DISPOS, V46, P41, DOI 10.1124/dmd.117.077560; Gay SC, 2009, ACTA CRYSTALLOGR D, V65, P1021, DOI 10.1107/S0907444909026547; Geu-Flores F, 2009, NAT CHEM BIOL, V5, P575, DOI 10.1038/nchembio.185; Gidda SK, 2003, J BIOL CHEM, V278, P17895, DOI 10.1074/jbc.M211943200; Gigolashvili T, 2012, PLANT CELL, V24, P4187, DOI 10.1105/tpc.112.101964; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; Gill DM, 2019, CHEM COMMUN, V55, P4319, DOI 10.1039/c9cc01057b; Glaser K, 2014, PLANT J, V77, P31, DOI 10.1111/tpj.12359; Goettsch S, 2006, J MOL BIOL, V361, P436, DOI 10.1016/j.jmb.2006.06.023; Greaves RF, 2014, CLIN BIOCHEM, V47, P5, DOI 10.1016/j.clinbiochem.2014.07.017; Gromes R, 2008, PLANT J, V54, P1063, DOI 10.1111/j.1365-313X.2008.03477.x; Grum D, 2010, BIOCHEM BIOPH RES CO, V395, P420, DOI 10.1016/j.bbrc.2010.04.039; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Harenberg J, 2016, INT J CARDIOL, V212, pS10, DOI 10.1016/S0167-5273(16)12003-0; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; Hartmann K, 2016, HISTOCHEM CELL BIOL, V146, P737, DOI 10.1007/s00418-016-1503-y; Hartmann-Fatu C, 2016, CHEM-BIOL INTERACT, V259, P17, DOI 10.1016/j.cbi.2016.04.006; Hashiguchi T, 2013, BIOCHEM BIOPH RES CO, V434, P829, DOI 10.1016/j.bbrc.2013.04.022; He DN, 2006, DRUG METAB DISPOS, V34, P1749, DOI 10.1124/dmd.106.011114; Hernandez-Guzman FG, 2003, J BIOL CHEM, V278, P22989, DOI 10.1074/jbc.M211497200; Herrmann J, 2014, J BIOL CHEM, V289, P10919, DOI 10.1074/jbc.M113.540401; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Hirsch J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016724; Hirschmann F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04539-2; Hirschmann F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00556; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; Hudson BH, 2018, P NATL ACAD SCI USA, V115, P3000, DOI 10.1073/pnas.1715302115; Hudson Benjamin H., 2014, Advances in Biological Regulation, V54, P208, DOI 10.1016/j.jbior.2013.11.002; Hudson BH, 2013, P NATL ACAD SCI USA, V110, P5040, DOI 10.1073/pnas.1205001110; Hudson Benjamin H, 2012, Adv Biol Regul, V52, P229; Idkowiak J, 2016, J CLIN ENDOCR METAB, V101, P2545, DOI 10.1210/jc.2015-4101; Jaszczuk I, 2017, MOL GENET METAB, V121, P252, DOI 10.1016/j.ymgme.2017.05.013; Jez JM, 2016, CHEM-BIOL INTERACT, V259, P31, DOI 10.1016/j.cbi.2016.02.017; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Kawashima CG, 2011, PLANT J, V66, P863, DOI 10.1111/j.1365-313X.2011.04547.x; Kehoe JW, 2000, CHEM BIOL, V7, pR57, DOI 10.1016/S1074-5521(00)00093-4; Kertesz MA, 2004, J EXP BOT, V55, P1939, DOI 10.1093/jxb/erh176; Kim BH, 2009, PLANT J, V58, P208, DOI 10.1111/j.1365-313X.2008.03770.x; Kim MS, 2004, AM J PHYSIOL-ENDOC M, V287, pE731, DOI 10.1152/ajpendo.00130.2004; Kimura H, 2014, NITRIC OXIDE-BIOL CH, V41, P4, DOI 10.1016/j.niox.2014.01.002; Klein M, 2006, FEBS J, V273, P122, DOI 10.1111/j.1742-4658.2005.05048.x; Klein M, 2004, J EXP BOT, V55, P1809, DOI 10.1093/jxb/erh183; Klein M, 2009, PHYSIOL PLANTARUM, V135, P140, DOI 10.1111/j.1399-3054.2008.01182.x; Kleinenkuhnen N, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00885; Kliebenstein D, 2002, GENETICS, V161, P325; KLONUS D, 1994, PLANT J, V6, P105, DOI 10.1046/j.1365-313X.1994.6010105.x; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kopriva S, 2004, J EXP BOT, V55, P1775, DOI 10.1093/jxb/erh185; Kopriva S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00163; Koprivova A, 2016, CHEM-BIOL INTERACT, V259, P23, DOI 10.1016/j.cbi.2016.05.021; Koprivova A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00589; Koprivova A, 2013, PLANT PHYSIOL, V163, P1133, DOI 10.1104/pp.113.225748; Kozinska A, 2019, J APPL GENET, V60, P103, DOI 10.1007/s13353-019-00482-2; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Kruger T, 2019, BIOL CHEM, V400, P289, DOI 10.1515/hsz-2018-0358; KU MSB, 1991, PLANT PHYSIOL, V96, P518, DOI 10.1104/pp.96.2.518; Langford R, 2017, J GENET GENOMICS, V44, P7, DOI 10.1016/j.jgg.2016.08.001; Lansdon EB, 2004, BIOCHEMISTRY-US, V43, P4356, DOI 10.1021/bi049827m; Lappartient AG, 1999, PLANT J, V18, P89, DOI 10.1046/j.1365-313X.1999.00416.x; Lappartient AG, 1996, PLANT PHYSIOL, V111, P147, DOI 10.1104/pp.111.1.147; Lee BR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039425, 10.1371/journal.pone.0048744]; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; LEYH TS, 1992, J BIOL CHEM, V267, P542; LEYH TS, 1993, CRIT REV BIOCHEM MOL, V28, P515, DOI 10.3109/10409239309085137; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; LIPMANN F, 1958, SCIENCE, V128, P575, DOI 10.1126/science.128.3324.575; Litthauer S, 2018, PLANT PHYSIOL, V176, P3120, DOI 10.1104/pp.17.01611; Lopez-Coronado JM, 1999, J BIOL CHEM, V274, P16034, DOI 10.1074/jbc.274.23.16034; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Malojcic G, 2014, BIOCHEMISTRY-US, V53, P1870, DOI 10.1021/bi401725j; Manmathan H, 2013, J EXP BOT, V64, P1381, DOI 10.1093/jxb/ert003; Marcello MR, 2011, J BIOL CHEM, V286, P13060, DOI 10.1074/jbc.M110.175463; Marsolais F, 2007, PLANTA, V225, P1233, DOI 10.1007/s00425-006-0413-y; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; Meisel JD, 2016, CURR BIOL, V26, P1922, DOI 10.1016/j.cub.2016.05.050; Miki TS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006313; Mithen R, 2003, THEOR APPL GENET, V106, P727, DOI 10.1007/s00122-002-1123-x; Mohamed MF, 2013, BBA-PROTEINS PROTEOM, V1834, P417, DOI 10.1016/j.bbapap.2012.07.015; Moldrup ME, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-12; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Moolman WJA, 2014, BIOCHEM SOC T, V42, P1080, DOI 10.1042/BST20140131; Mougous JD, 2006, MOL CELL, V21, P109, DOI 10.1016/j.molcel.2005.10.034; Mueller JW, 2018, J MOL ENDOCRINOL, V61, pE5, DOI 10.1530/JME-18-0109; Mueller JW, 2018, J BIOL CHEM, V293, P9724, DOI 10.1074/jbc.RA118.002248; Mueller JW, 2015, ENDOCR REV, V36, P526, DOI 10.1210/er.2015-1036; Mueller JW, 2013, FEBS J, V280, P3050, DOI 10.1111/febs.12252; Mugford SG, 2011, PLANT J, V65, P96, DOI 10.1111/j.1365-313X.2010.04410.x; Mugford SG, 2010, FEBS LETT, V584, P119, DOI 10.1016/j.febslet.2009.11.014; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; Nakayama T, 2017, SCIENCE, V355, P284, DOI 10.1126/science.aai9057; Namdeo S, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.166272; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nishitsuji K, 2018, GLYCOCONJUGATE J, V35, P387, DOI 10.1007/s10719-018-9833-8; Nizon M, 2012, AM J MED GENET A, V158A, P2183, DOI 10.1002/ajmg.a.35504; Noordam C, 2009, NEW ENGL J MED, V360, P2310, DOI 10.1056/NEJMoa0810489; Okamoto N, 2018, DEV CELL, V47, P294, DOI 10.1016/j.devcel.2018.09.012; Oostdijk W, 2015, J CLIN ENDOCR METAB, V100, pE672, DOI 10.1210/jc.2014-3556; Ouyang YB, 2002, J BIOL CHEM, V277, P23781, DOI 10.1074/jbc.M202420200; Parris TZ, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.8; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; PENG ZH, 1995, J BIOL CHEM, V270, P29105, DOI 10.1074/jbc.270.49.29105; Petrotchenko EV, 2001, FEBS LETT, V490, P39, DOI 10.1016/S0014-5793(01)02129-9; Pornsiriwong W, 2017, ELIFE, V6, DOI [10.7554/eLife.23361, 10.7554/elife.23361]; Pozo OJ, 2018, J MOL ENDOCRINOL, V61, pM1, DOI 10.1530/JME-17-0286; Pranata A, 2019, STEROIDS, V143, P25, DOI 10.1016/j.steroids.2018.11.017; Prioretti L, 2016, BIOCHEM BIOPH RES CO, V478, P1555, DOI 10.1016/j.bbrc.2016.08.151; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; Rainey WE, 2004, SEMIN REPROD MED, V22, P327, DOI 10.1055/s-2004-861549; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; RENSDOMIANO SS, 1987, J NEUROCHEM, V48, P1411, DOI 10.1111/j.1471-4159.1987.tb05679.x; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Rizner TL, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00030; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Rodriguez VM, 2010, PLANT PHYSIOL, V152, P1335, DOI 10.1104/pp.109.150474; Rohn-Glowacki KJ, 2014, HORM MOL BIOL CLIN I, V20, P81, DOI 10.1515/hmbci-2014-0028; Ronaghi M, 1999, ANAL BIOCHEM, V267, P65, DOI 10.1006/abio.1998.2978; Rotte C, 2000, PLANT PHYSIOL, V124, P715, DOI 10.1104/pp.124.2.715; Scheerer U, 2010, J EXP BOT, V61, P609, DOI 10.1093/jxb/erp327; Schlotawa L, 2018, CELL REP, V24, P27, DOI 10.1016/j.celrep.2018.06.016; Schlotawa L, 2013, EUR J HUM GENET, V21, P1020, DOI 10.1038/ejhg.2012.291; Schlotawa L, 2011, EUR J HUM GENET, V19, P253, DOI 10.1038/ejhg.2010.219; Schroder E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029559; Shabbir RMK, 2018, J MED GENET, V55, P489, DOI 10.1136/jmedgenet-2017-105003; Shaltiel G, 2009, J NEURAL TRANSM, V116, P1543, DOI 10.1007/s00702-009-0298-6; Shinohara H, 2016, P NATL ACAD SCI USA, V113, P3897, DOI 10.1073/pnas.1522639113; Sonoda J, 2002, P NATL ACAD SCI USA, V99, P13801, DOI 10.1073/pnas.212494599; Spiegelberg BD, 1999, J BIOL CHEM, V274, P13619, DOI 10.1074/jbc.274.19.13619; Sun MH, 2006, BIOCHEMISTRY-US, V45, P11304, DOI 10.1021/bi060421e; Swann J, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0491-9; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Tanaka S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07141-8; Teramoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2593; THOMAS D, 1990, J BIOL CHEM, V265, P15518; Thomas MP, 2013, J STEROID BIOCHEM, V137, P27, DOI 10.1016/j.jsbmb.2012.12.014; Tibbs ZE, 2015, DRUG METAB PHARMACOK, V30, P3, DOI 10.1016/j.dmpk.2014.10.004; Traka M, 2009, PHYTOCHEM REV, V8, P269, DOI 10.1007/s11101-008-9103-7; TSANG MLS, 1976, ANAL BIOCHEM, V74, P623, DOI 10.1016/0003-2697(76)90249-9; van den Boom J, 2012, J BIOL CHEM, V287, P17645, DOI 10.1074/jbc.M111.325498; VARIN L, 1986, Z NATURFORSCH C, V41, P813; VARIN L, 1992, P NATL ACAD SCI USA, V89, P1286, DOI 10.1073/pnas.89.4.1286; Vauclare P, 2002, PLANT J, V31, P729, DOI 10.1046/j.1365-313X.2002.01391.x; Vijzelaar R, 2018, PHARMACOGENOMICS, V19, P761, DOI 10.2217/pgs-2018-0047; Vissers LELM, 2011, AM J HUM GENET, V88, P608, DOI 10.1016/j.ajhg.2011.04.002; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Weigel D, 2012, PLANT PHYSIOL, V158, P2, DOI 10.1104/pp.111.189845; Weitzner B, 2009, PROTEINS, V75, P289, DOI 10.1002/prot.22347; WILLEMSEN R, 1988, HISTOCHEM J, V20, P41, DOI 10.1007/BF01745968; Xiong LM, 2004, PLANT J, V40, P536, DOI 10.1111/j.1365-313X.2004.02225.x; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhao CC, 2019, P NATL ACAD SCI USA, V116, P5015, DOI 10.1073/pnas.1812092116; Zito E, 2016, EMBO REP, V17, P1901, DOI 10.15252/embr.201570010	208	48	48	4	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12293	12312		10.1074/jbc.REV119.007422	http://dx.doi.org/10.1074/jbc.REV119.007422			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31270211	Green Published, hybrid			2022-12-28	WOS:000484402700003
J	Theilmann, MC; Fredslund, F; Svensson, B; Lo Leggio, L; Abou Hachem, M				Theilmann, Mia Christine; Fredslund, Folmer; Svensson, Birte; Lo Leggio, Leila; Abou Hachem, Maher			Substrate preference of an ABC importer corresponds to selective growth on beta-(1,6)-galactosides in Bifidobacterium animalis subsp. lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; surface plasmon resonance (SPR); isothermal titration calorimetry (ITC); crystal structure; actinobacteria; protein evolution; microbiome; probiotic; evolution; enzyme kinetics; bifidobacteria; galactooligosaccharides (GOS); human gut microbiota; human milk oligosaccharides (HMO); prebiotics	STRUCTURE REFINEMENT; GALACTOOLIGOSACCHARIDES; OLIGOSACCHARIDES; GALACTOSIDASE; SPECIFICITIES; CONSUMPTION; MICROBIOTA; PROTEINS; BEAMLINE; PECTIN	Bifidobacteria are exposed to substantial amounts of dietary beta-galactosides. Distinctive preferences for growth on different beta-galactosides are observed within Bifidobacterium members, but the basis of these preferences remains unclear. We previously described the first beta-(1,6)/(1,3)-galactosidase from Bifidobacterium animalis subsp. lactis Bl-04. This enzyme is relatively promiscuous, exhibiting only 5-fold higher efficiency on the preferred beta-(1,6)-galactobiose than the beta-(1,4) isomer. Here, we characterize the solute-binding protein (Bal6GBP) that governs the specificity of the ABC transporter encoded by the same beta-galactoside utilization locus. We observed that although Bal6GBP recognizes both beta-(1,6)- and beta-(1,4)-galactobiose, Bal6GBP has a 1630-fold higher selectivity for the former, reflected in dramatic differences in growth, with several hours lag on less preferred beta-(1,4)- and beta-(1,3)-galactobiose. Experiments performed in the presence of varying proportions of beta-(1,4)/beta-(1,6)-galactobioses indicated that the preferred substrate was preferentially depleted from the culture supernatant. This established that the poor growth on the nonpreferred beta-(1,4) was due to inefficient uptake. We solved the structure of Bal6GBP in complex with beta-(1,6)-galactobiose at 1.39 angstrom resolution, revealing the structural basis of this strict selectivity. Moreover, we observed a close evolutionary relationship with the human milk disaccharide lacto-N-biose-binding protein from Bifidobacterium longum, indicating that the recognition of the nonreducing galactosyl is essentially conserved, whereas the adjacent position is diversified to fit different glycosidic linkages and monosaccharide residues. These findings indicate that oligosaccharide uptake has a pivotal role in governing selectivity for distinct growth substrates and have uncovered evolutionary trajectories that shape the diversification of sugar uptake proteins within Bifidobacterium.	[Theilmann, Mia Christine; Svensson, Birte; Abou Hachem, Maher] Tech Univ Denmark, Dept Biotechnol & Biomed, Bldg 224,Off 222, DK-2800 Lyngby, Denmark; [Fredslund, Folmer; Lo Leggio, Leila] Univ Copenhagen, Dept Chem, Univ Pk 5, DK-2100 Copenhagen, Denmark; [Fredslund, Folmer] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Bldg 220, Lyngby, Denmark	Technical University of Denmark; University of Copenhagen; Technical University of Denmark	Abou Hachem, M (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Bldg 224,Off 222, DK-2800 Lyngby, Denmark.	maha@bio.dtu.dk	Fredslund, Folmer/ABH-5821-2020; Abou Hachem, Maher/M-4772-2019	Fredslund, Folmer/0000-0003-0881-1927; Abou Hachem, Maher/0000-0001-8250-1842; Svensson, Birte/0000-0002-2993-8196	Carlsberg Foundation [2011-01-0598]	Carlsberg Foundation(Carlsberg Foundation)	We acknowledge the Carlsberg Foundation for Instrument Grant 2011-01-0598 (to M. A. H.) to fund the isothermal titration calorimeter. We also thank Professor Mads Hartvig Clausen (Department of Chemistry, Technical University of Denmark), Dr. Motomitsu Kitaoka (National Food Research Institute, Tsukuba, Japan), and Assistant Professor Wataru Saburi (Faculty of Agriculture, Hokkaido University, Sapporo, Japan) for generous gifts of oligosaccharides and Professor Tine Rask Licht and technician Bodil Madsen (National Food Institute, Technical University of Denmark) for help regarding bifidobacterial growth. We thank the MAX IV Laboratory and Maria Hakonsson (MAX IV Laboratory, Lund University) for use of the Mosquito robot and help during crystallization and Tobias Tandrup (Department of Chemistry, University of Copenhagen) for doing the Oryx8 crystallization setup. Mickael Blaise (currently at Institut de Recherche en Infectiologie de Montpellier, CNRS) and Tobias Tandrup and Jens-Christian Navarro Poulsen (both from the Department of Chemistry, University of Copenhagen) are thanked for help during data collection. The ESRF and the MAX IV Laboratory are thanked for beamtime.	Abe K, 2018, J BIOL CHEM, V293, P8812, DOI 10.1074/jbc.RA117.001536; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Akiyama T, 2015, BIOSCI BIOTECH BIOCH, V79, P664, DOI 10.1080/09168451.2014.987204; Andersen JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-312; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Canfora EE, 2017, GASTROENTEROLOGY, V153, P87, DOI 10.1053/j.gastro.2017.03.051; Cockburn DW, 2016, J MOL BIOL, V428, P3230, DOI 10.1016/j.jmb.2016.06.021; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; Ejby M, 2016, J BIOL CHEM, V291, P20220, DOI 10.1074/jbc.M116.746529; Ejby M, 2013, MOL MICROBIOL, V90, P1100, DOI 10.1111/mmi.12419; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Garrido D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017315; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Ichinose H, 2008, APPL ENVIRON MICROB, V74, P2379, DOI 10.1128/AEM.01733-07; Ichinose H, 2006, BIOSCI BIOTECH BIOCH, V70, P2745, DOI 10.1271/bbb.60365; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Knoch E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00198; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Leth ML, 2018, NAT MICROBIOL, V3, P570, DOI 10.1038/s41564-018-0132-8; Li W, 2015, J FUNCT FOODS, V13, P158, DOI 10.1016/j.jff.2014.12.044; Matsuki T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11939; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Milani C, 2016, APPL ENVIRON MICROB, V82, P980, DOI 10.1128/AEM.03500-15; Milani C, 2014, APPL ENVIRON MICROB, V80, P6290, DOI 10.1128/AEM.02308-14; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Motherway MO, 2013, MICROB BIOTECHNOL, V6, P67, DOI 10.1111/1751-7915.12011; O'Callaghan A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00925; Peacock KS, 2013, J AGR FOOD CHEM, V61, P12612, DOI 10.1021/jf403789r; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Shigehisa A, 2015, MICROBIOL-SGM, V161, P1463, DOI 10.1099/mic.0.000100; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Sotoya H, 2017, MICROBIOL-SGM, V163, P1420, DOI 10.1099/mic.0.000517; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Takahashi K, 2016, DIGESTION, V93, P59, DOI 10.1159/000441768; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Turroni F, 2011, INT J FOOD MICROBIOL, V149, P37, DOI 10.1016/j.ijfoodmicro.2010.12.010; Urashima T, 2013, BIOSCI BIOTECH BIOCH, V77, P455, DOI 10.1271/bbb.120810; Urashima T, 2012, ADV NUTR, V3, p473S, DOI 10.3945/an.111.001412; Ursby T, 2013, J SYNCHROTRON RADIAT, V20, P648, DOI 10.1107/S0909049513011734; van Leeuwen SS, 2016, CARBOHYD RES, V425, P48, DOI 10.1016/j.carres.2016.03.006; Viborg AH, 2014, GLYCOBIOLOGY, V24, P208, DOI 10.1093/glycob/cwt104; Viborg AH, 2014, MOL MICROBIOL, V94, P1024, DOI 10.1111/mmi.12815; Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330	55	13	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11701	11711		10.1074/jbc.RA119.008843	http://dx.doi.org/10.1074/jbc.RA119.008843			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31186348	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000486127800007
J	Margittai, M				Margittai, Martin			Driving tau into phase-separated liquid droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Liquid-liquid phase separation of tau protein has been implicated in normal biological function as well as neurodegenerative diseases, including Alzheimer's. However, knowledge about these links is still scant, and the mechanisms driving tau into liquid droplets are poorly understood. A simplified in vitro system that uses unmodified human tau protein now suggests electrostatic interactions provide the basic instructions underlying liquid droplet formation.	[Margittai, Martin] Univ Denver, Dept Chem & Biochem, 2190 East Iliff Ave, Denver, CO 80208 USA	University of Denver	Margittai, M (corresponding author), Univ Denver, Dept Chem & Biochem, 2190 East Iliff Ave, Denver, CO 80208 USA.	martin.margittai@du.edu	Margittai, Martin/D-5039-2014	Margittai, Martin/0000-0003-1903-5927	NIA, National Institutes of Health [R01AG061566]	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIA, National Institutes of Health, Grant R01AG061566. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Boyko S, 2019, J BIOL CHEM, V294, P11054, DOI 10.1074/jbc.AC119.009198; Despres C, 2017, P NATL ACAD SCI USA, V114, P9080, DOI 10.1073/pnas.1708448114; Dinkel PD, 2015, BIOCHEMISTRY-US, V54, P4731, DOI 10.1021/acs.biochem.5b00453; Elbaum-Garfinkle S, 2019, J BIOL CHEM, V294, P7160, DOI 10.1074/jbc.REV118.001188; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Lin YX, 2019, ELIFE, V8, DOI 10.7554/eLife.42571; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183	10	1	1	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11060	11061		10.1074/jbc.H119.009703	http://dx.doi.org/10.1074/jbc.H119.009703			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31324714	hybrid, Green Published			2022-12-28	WOS:000478717400002
J	Yoo, W; Cho, EB; Kim, S; Yoon, JB				Yoo, Wonjin; Cho, Eun-Bee; Kim, Sungjoo; Yoon, Jong-Bok			The E3 ubiquitin ligase MARCH2 regulates ERGIC3-dependent trafficking of secretory proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; protein degradation; intracellular trafficking; ubiquitin; protein secretion; alpha 1-antitrypsin; cargo receptor; endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3); haptoglobin; membrane-associated ring-CH-type finger 2 (MARCH2)	GOLGI INTERMEDIATE COMPARTMENT; ENDOPLASMIC-RETICULUM; TRANSPORT; COMPLEX; DEGRADATION; RECEPTOR; ERV41P; EXIT; ER	The E3 ubiquitin ligase membrane-associated ring-CH-type finger 2 (MARCH2) is known to be involved in intracellular vesicular trafficking, but its role in the early secretory pathway between the endoplasmic reticulum (ER) and Golgi compartments is largely unknown. Human ER-Golgi intermediate compartment protein 2 (ERGIC2) and ERGIC3 are orthologs of Erv41 and Erv46 in yeast, proteins that form a heteromeric complex, cycle between the ER and Golgi, and function as cargo receptors in both anterograde and retrograde protein trafficking. Here, we report that MARCH2 directs ubiquitination and subsequent degradation of ERGIC3 and that MARCH2 depletion increases endogenous ERGIC3 levels. We provide evidence that the lysine residues at positions 6 and 8 of ERGIC3 are the major sites of MARCH2-mediated ubiquitination. Of note, MARCH2 did not significantly decrease the levels of an ERGIC3 variant with lysine-to-arginine substitutions at residues 6 and 8. We also show that ERGIC3 binds to itself or to ERGIC2, whereas ERGIC2 is unable to interact with itself. Our results indicate that alpha(1)-antitrypsin and haptoglobin are likely to be cargo proteins of ERGIC3. We further observed that alpha(1)-antitrypsin and haptoglobin specifically bind to ERGIC3 and that ERGIC3 depletion decreases their secretion. Moreover, MARCH2 reduced secretion of alpha(1)-antitrypsin and haptoglobin, and coexpression of the ubiquitination-resistant ERGIC3 variant largely restored their secretion, suggesting that MARCH2-mediated ERGIC3 ubiquitination is the major cause of the decrease in trafficking of ERGIC3-binding secretory proteins. Our findings provide detailed insights into the regulation of the early secretory pathway by MARCH2 and into ERGIC3 function.	[Yoo, Wonjin; Yoon, Jong-Bok] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea; [Cho, Eun-Bee; Kim, Sungjoo] Catholic Univ Korea, Dept Med Lifesci, Seoul 06591, South Korea	Yonsei University; Catholic University of Korea	Yoon, JB (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea.	yoonj@yonsei.ac.kr		Yoo, Wonjin/0000-0002-3779-4348; Kim, Sungjoo/0000-0003-2497-729X	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT (MSIT)) [NRF-2019R1A2C1010777, NRF-2018R1A2B6003455]; Brain Korea 21 (BK21) PLUS Program	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT (MSIT)); Brain Korea 21 (BK21) PLUS Program	This work was supported by the National Research Foundation of Korea (NRF) Grants NRF-2019R1A2C1010777 and NRF-2018R1A2B6003455 funded by the Korea government (Ministry of Science and ICT (MSIT)) and the Brain Korea 21 (BK21) PLUS Program (to J.-B. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Barlowe C, 2016, ANNU REV CELL DEV BI, V32, P197, DOI 10.1146/annurev-cellbio-111315-125016; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Biterova EI, 2013, J MOL BIOL, V425, P2208, DOI 10.1016/j.jmb.2013.03.024; Breuza L, 2004, J BIOL CHEM, V279, P47242, DOI 10.1074/jbc.M406644200; Cao ZF, 2008, CELL SIGNAL, V20, P73, DOI 10.1016/j.cellsig.2007.08.019; Cheng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068001; Cho EB, 2018, BBA-MOL BASIS DIS, V1864, P2199, DOI 10.1016/j.bbadis.2018.04.001; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Deshar R, 2019, NUCLEIC ACIDS RES, V47, P762, DOI 10.1093/nar/gky1166; Deshar R, 2016, FEBS J, V283, P4583, DOI 10.1111/febs.13947; Geva Y, 2014, CURR BIOL, V24, pR130, DOI 10.1016/j.cub.2013.12.008; Gomez-Navarro N, 2016, J CELL BIOL, V215, P769, DOI 10.1083/jcb.201610031; Guo YS, 2014, ANNU REV CELL DEV BI, V30, P169, DOI 10.1146/annurev-cellbio-100913-013012; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Lee H, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143107; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Nakamura N, 2005, MOL BIOL CELL, V16, P1696, DOI 10.1091/mbc.E04-03-0216; Noda Y, 2014, BIOL OPEN, V3, P209, DOI 10.1242/bio.20146312; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Orci L, 2003, P NATL ACAD SCI USA, V100, P4586, DOI 10.1073/pnas.0730885100; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Shibuya A, 2015, J CELL BIOL, V208, P197, DOI 10.1083/jcb.201408024; Xia D, 2016, AUTOPHAGY, V12, P1614, DOI 10.1080/15548627.2016.1192752; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	25	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10900	10912		10.1074/jbc.RA119.007435	http://dx.doi.org/10.1074/jbc.RA119.007435			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31142615	Green Published, hybrid			2022-12-28	WOS:000478717200014
J	Chen, Y; Cramer, P				Chen, Ying; Cramer, Patrick			Structure of the super-elongation complex subunit AFF4 C-terminal homology domain reveals requirements for AFF homo- and heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription elongation factor; phosphorylation; X-ray crystallography; dimerization; RNA polymerase II; gene regulation; AF4; FMR2 family member 4 (AFF4); C-terminal homology domain (CHD); super elongation complex	LIGATION-INDEPENDENT CLONING; POISSON-BOLTZMANN EQUATION; RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION; PHOSPHORYLATION SITES; SEC FAMILY; P-TEFB; KINASE; GPS; ACTIVATION	AF4/FMR2 family member 4 (AFF4) is the scaffold protein of the multisubunit super-elongation complex, which plays key roles in the release of RNA polymerase II from promoter-proximal pausing and in the transactivation of HIV-1 transcription. AFF4 consists of an intrinsically disordered N-terminal region that interacts with other super-elongation complex subunits and a C-terminal homology domain (CHD) that is conserved among AF4/FMR2 family proteins, including AFF1, AFF2, AFF3, and AFF4. Here, we solved the X-ray crystal structure of the CHD in human AFF4 (AFF4-CHD) to 2.2 angstrom resolution and characterized its biochemical properties. The structure disclosed that AFF4-CHD folds into a novel domain that consists of eight helices and is distantly related to tetratrico peptide repeat motifs. Our analyses further revealed that AFF4-CHD mediates the formation of an AFF4 homodimer or an AFF1-AFF4 heterodimer. Results from fluorescence anisotropy experiments suggested that AFF4-CHD interacts with both RNA and DNA in vitro. Furthermore, we identified a surface loop region in AFF4-CHD as a substrate for the P-TEFb kinase cyclin-dependent kinase 9, which triggers release of polymerase II from promoter-proximal pausing sites. In conclusion, the AFF-CHD structure and biochemical analyses reported here reveal the molecular basis for the homo- and heterodimerization of AFF proteins and implicate the AFF4-CHD in nucleic acid interactions. The high conservation of the CHD among several other proteins suggests that our results are also relevant for understanding other CHD-containing proteins and their dimerization behavior.	[Chen, Ying; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany	Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de			Deutsche Forschungsgemeinschaft [SFB860, SPP1935]; European Research Council Advanced Investigator Grant TRANSREGULON [693023]; Volkswagen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Advanced Investigator Grant TRANSREGULON; Volkswagen Foundation(Volkswagen)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB860 and SPP1935, by European Research Council Advanced Investigator Grant TRANSREGULON under Agreement 693023, and by the Volkswagen Foundation (to P. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; ASLANIDIS C, 1994, PCR METH APPL, V4, P172; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chou S, 2013, P NATL ACAD SCI USA, V110, pE123, DOI 10.1073/pnas.1216971110; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Gu JY, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28756; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; He NH, 2011, J NEUROIMMUNE PHARM, V6, P260, DOI 10.1007/s11481-011-9267-6; Hill CP, 2013, ELIFE, V2, DOI 10.7554/eLife.00577; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kuzmina A, 2017, TRANSCR-AUSTIN, V8, P133, DOI 10.1080/21541264.2017.1295831; Leach BI, 2013, STRUCTURE, V21, P176, DOI 10.1016/j.str.2012.11.011; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lu HS, 2015, NUCLEIC ACIDS RES, V43, P5868, DOI 10.1093/nar/gkv541; Lu HS, 2014, P NATL ACAD SCI USA, V111, pE15, DOI 10.1073/pnas.1318503111; Lu XD, 2016, NUCLEIC ACIDS RES, V44, P6853, DOI 10.1093/nar/gkw571; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Melko M, 2011, HUM MOL GENET, V20, P1873, DOI 10.1093/hmg/ddr069; Muck F, 2016, AM J BLOOD RES, V6, P28; OBEROI H, 1993, BIOPHYS J, V65, P48, DOI 10.1016/S0006-3495(93)81032-4; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Okuda H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9869; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Pan Z, 2013, STRUCTURE, V21, P1007, DOI 10.1016/j.str.2013.04.005; Qi SQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14076; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Schulze-Gahmen U, 2018, P NATL ACAD SCI USA, V115, P12973, DOI 10.1073/pnas.1806438115; Schulze-Gahmen U, 2016, ELIFE, V5, DOI 10.7554/eLife.15910; Schulze-Gahmen U, 2014, ELIFE, V3, DOI 10.7554/eLife.02375; Schulze-Gahmen U, 2013, ELIFE, V2, DOI 10.7554/eLife.00327; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Smidova A, 2018, FEBS J, V285, P4196, DOI 10.1111/febs.14670; Stevers LM, 2018, J AM CHEM SOC, V140, P14498, DOI 10.1021/jacs.8b09618; Vos SM, 2018, NATURE, V560, P607, DOI 10.1038/s41586-018-0440-4; Vos SM, 2018, NATURE, V560, P601, DOI 10.1038/s41586-018-0442-2; Vos SM, 2016, ELIFE, V5, DOI 10.7554/eLife.14981; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winters AC, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00004; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zhang SY, 2016, NATURE, V533, P260, DOI 10.1038/nature17973; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	68	16	17	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10663	10673		10.1074/jbc.RA119.008577	http://dx.doi.org/10.1074/jbc.RA119.008577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31147444	hybrid, Green Published			2022-12-28	WOS:000478717100024
J	Liu, YP; Lan, WX; Wang, CX; Cao, CY				Liu, Yaping; Lan, Wenxian; Wang, Chunxi; Cao, Chunyang			A putative G-quadruplex structure in the proximal promoter of VEGFR-2 has implications for drug design to inhibit tumor angiogenesis (vol 293, pg 8947, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															National Key R&D Program of China [2017YFE0108200]	National Key R&D Program of China	The project number 2017YFE0108200 supported by the National Key R&D Program of China	Liu YP, 2018, J BIOL CHEM, V293, P8947, DOI 10.1074/jbc.RA118.002666	1	0	0	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10740	10740		10.1074/jbc.AAC119.009662	http://dx.doi.org/10.1074/jbc.AAC119.009662			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31278159	Green Published, hybrid			2022-12-28	WOS:000478717100033
J	Terzyan, SS; Shen, T; Liu, X; Huang, QL; Teng, P; Zhou, M; Hilberg, F; Cai, JF; Mooers, BHM; Wu, J				Terzyan, Simon S.; Shen, Tao; Liu, Xuan; Huang, Qingling; Teng, Peng; Zhou, Mi; Hilberg, Frank; Cai, Jianfeng; Mooers, Blaine H. M.; Wu, Jie			Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tyrosine-protein kinase (tyrosine kinase); inhibitor; cancer biology; cancer therapy; lung cancer; structural biology; mutant; thyroid; KIF5B-RET; RET	CELL LUNG-CANCER; OPEN-LABEL; EMERGENCE; CARCINOMA; KNOWLEDGE; PHASE-2; TOOL	RET is a transmembrane growth factor receptor. Aberrantly activated RET is found in several types of human cancer and is a target for treating RET aberration-associated cancer. Multiple clinically relevant RET protein-tyrosine kinase inhibitors (TKIs) have been identified, but how TKIs bind to RET is unknown except for vandetanib. Nintedanib is a RET TKI that inhibits the vandetanib-resistant RET(G810A) mutant. Here, we determined the X-ray co-crystal structure of RET kinase domain-nintedanib complex to 1.87 angstrom resolution and a RET(G810A) kinase domain crystal structure to 1.99 angstrom resolution. We also identified a vandetanib-resistant RET(L881V) mutation previously found in familial medullary thyroid carcinoma. Drug-sensitivity profiling of RET(L881V) revealed that it remains sensitive to nintedanib. The RET-nintedanib co-crystal structure disclosed that Leu-730 in RET engages in hydrophobic interactions with the piperazine, anilino, and phenyl groups of nintedanib, providing a structural basis for explaining that the p.L730V mutation identified in nine independently isolated cell lines resistant to nintedanib. Comparisons of RET-nintedanib, RET(G810A), and RET-vandetanib crystal structures suggested that the solvent-front Ala-810 makes hydrophobic contacts with a methyl group and aniline in nintedanib and blocks water access to two oxygen atoms of vandetanib, resulting in an energetic penalty for burying polar groups. Of note, even though the p.L881V mutation did not affect sensitivity to nintedanib, RET(L881V) was resistant to nintedanib analogs lacking a phenyl group. These results provide structural insights into resistance of RET mutants against the TKIs nintedanib and vandetanib.	[Terzyan, Simon S.; Mooers, Blaine H. M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, 975 NE 10th St,BRC 466, Oklahoma City, OK 73104 USA; [Shen, Tao; Liu, Xuan; Wu, Jie] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Terzyan, Simon S.; Mooers, Blaine H. M.] Univ Oklahoma, Hlth Sci Ctr, Lab Biomol Struct & Funct, Oklahoma City, OK 73104 USA; [Shen, Tao; Liu, Xuan; Mooers, Blaine H. M.; Wu, Jie] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St,BRC 413, Oklahoma City, OK 73104 USA; [Huang, Qingling; Wu, Jie] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Teng, Peng; Zhou, Mi; Cai, Jianfeng] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Hilberg, Frank] Boehringer Ingelheim GmbH & Co KG, Dept Pharmacol, A-1121 Vienna, Austria	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Boehringer Ingelheim	Mooers, BHM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, 975 NE 10th St,BRC 466, Oklahoma City, OK 73104 USA.; Wu, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St,BRC 413, Oklahoma City, OK 73104 USA.	blaine-mooers@ouhsc.edu; jie-wu@ouhsc.edu	Mooers, Blaine/S-4383-2017; Wu, Jie/R-2404-2019	Mooers, Blaine/0000-0001-8181-8987; Wu, Jie/0000-0002-2864-1606; Huang, Qingling/0000-0002-0538-8249	Presbyterian Health Foundation Team Science Grant; National Institute of Health [R01CA17456, R21CA175603, R01AG056569]; Boehringer Ingelheim International GmbH; NIGMS, National Institutes of Health [P20GM103640, P41GM103393, P20GM103639]; U.S. Department of Energy Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NCI, National Institutes of Health [P30CA225520]; NATIONAL CANCER INSTITUTE [P30CA225520, R01CA178456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103639, P20GM103640, P41GM103393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG056569] Funding Source: NIH RePORTER	Presbyterian Health Foundation Team Science Grant; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim International GmbH(Boehringer Ingelheim); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Presbyterian Health Foundation Team Science Grant (to B.H.M.M. and J.W.); National Institute of Health Grants R01CA17456 (to J.W.), R21CA175603 (to J.W.), and R01AG056569 (to J.C.); and a Boehringer Ingelheim International GmbH research agreement. Use of the University of Oklahoma Health Sciences Center Laboratory of Structure and Function was supported by NIGMS, National Institutes of Health Grant P20GM103640. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory is supported by U.S. Department of Energy Office of Basic Energy Sciences Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the NIGMS, National Institutes of Health (including Grant P41GM103393). The shared resources at the University of Oklahoma Health Sciences Center were supported by NIGMS, National Institutes of Health Grant P20GM103639, and NCI, National Institutes of Health Grant P30CA225520. F.H. is an employee of Boehringer Ingelheim. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barratt E, 2006, J MOL BIOL, V362, P994, DOI 10.1016/j.jmb.2006.07.067; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Dagogo-Jack I, 2018, J THORAC ONCOL, V13, pE226, DOI 10.1016/j.jtho.2018.06.021; Drilon A, 2016, ANN ONCOL, V27, P920, DOI 10.1093/annonc/mdw042; Drilon A, 2016, LANCET ONCOL, V17, P1653, DOI 10.1016/S1470-2045(16)30562-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gainor JF, 2017, JCO PRECIS ONCOL, V1; Gainor JF, 2013, J CLIN ONCOL, V31, P3987, DOI 10.1200/JCO.2012.45.2029; Gainor JF, 2013, ONCOLOGIST, V18, P865, DOI 10.1634/theoncologist.2013-0095; Gautschi O, 2017, J CLIN ONCOL, V35, P1403, DOI 10.1200/JCO.2016.70.9352; Hilberg F, 2018, J PHARMACOL EXP THER, V364, P494, DOI 10.1124/jpet.117.244129; Huang QL, 2016, MOL CANCER THER, V15, P2521, DOI 10.1158/1535-7163.MCT-16-0258; Iams WT, 2018, CANCER DISCOV, V8, P797, DOI 10.1158/2159-8290.CD-18-0489; Katayama R, 2015, CLIN CANCER RES, V21, P2227, DOI 10.1158/1078-0432.CCR-14-2791; Kato S, 2017, CLIN CANCER RES, V23, P1988, DOI 10.1158/1078-0432.CCR-16-1679; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liao JJL, 2007, J MED CHEM, V50, P409, DOI 10.1021/jm0608107; Liu X, 2018, BRIT J PHARMACOL, V175, P3504, DOI 10.1111/bph.14395; Nakaoku T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02994-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ou SHI, 2017, LUNG CANCER, V108, P228, DOI 10.1016/j.lungcan.2017.04.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roskoski R, 2016, PHARMACOL RES, V103, P26, DOI 10.1016/j.phrs.2015.10.021; Sabari JK, 2017, ONCOTARGETS THER, V10, P1983, DOI 10.2147/OTT.S109295; Schrodinger L., 2018, PYMOL MOL GRAPHICS S; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott LM, 2011, BIOORG MED CHEM LETT, V21, P730, DOI 10.1016/j.bmcl.2010.11.117; Shen T, 2017, ONCOTARGET, V8, P60975, DOI 10.18632/oncotarget.17689; Subbiah V, 2018, ANN ONCOL, V29, P1869, DOI 10.1093/annonc/mdy137; Subbiah V, 2018, CANCER DISCOV, V8, P836, DOI 10.1158/2159-8290.CD-18-0338; Tang ZH, 2018, CANCER LETT, V420, P242, DOI 10.1016/j.canlet.2018.02.004; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Linden OPJ, 2014, J MED CHEM, V57, P249, DOI 10.1021/jm400378w; Wells SA, 2013, J CLIN ENDOCR METAB, V98, P3149, DOI 10.1210/jc.2013-1204; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040; Yoh K, 2017, LANCET RESP MED, V5, P42, DOI 10.1016/S2213-2600(16)30322-8	41	22	22	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10428	10437		10.1074/jbc.RA119.007682	http://dx.doi.org/10.1074/jbc.RA119.007682			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31118272	Green Published, hybrid			2022-12-28	WOS:000478717100005
J	Wu, Y; Song, P; Xu, J; Zhang, M; Zou, MH				Wu, Yong; Song, Ping; Xu, Jian; Zhang, Miao; Zou, Ming-Hui			RETRACTION: Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase (Retraction of Vol 282, Pg 9777, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200	1	1	1	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10741	10741		10.1074/jbc.W119.009747	http://dx.doi.org/10.1074/jbc.W119.009747			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31278160	Green Published, hybrid			2022-12-28	WOS:000478717100034
J	Butler, AA; Zhang, JS; Price, CA; Stevens, JR; Graham, JL; Stanhope, KL; King, S; Krauss, RM; Bremer, AA; Havel, PJ				Butler, Andrew A.; Zhang, Jinsong; Price, Candice A.; Stevens, Joseph R.; Graham, James L.; Stanhope, Kimber L.; King, Sarah; Krauss, Ronald M.; Bremer, Andrew A.; Havel, Peter J.			Low plasma adropin concentrations increase risks of weight gain and metabolic dysregulation in response to a high-sugar diet in male nonhuman primates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; circadian; type 2 diabetes; epigenetics; glucose metabolism; insulin resistance; leptin; dyslipidemia; obesity; nutrition	APOLIPOPROTEIN A-IV; INSULIN-RESISTANCE; DIABETES-MELLITUS; RHESUS-MONKEYS; ION MOBILITY; FOOD-INTAKE; RESTRICTION; EXPRESSION; ELEMENTS; FAT	Mouse studies linking adropin, a peptide hormone encoded by the energy homeostasis-associated (ENHO) gene, to biological clocks and to glucose and lipid metabolism suggest a potential therapeutic target for managing diseases of metabolism. However, adropin's roles in human metabolism are unclear. In silico expression profiling in a nonhuman primate diurnal transcriptome atlas (GSE98965) revealed a dynamic and diurnal pattern of ENHO expression. ENHO expression is abundant in brain, including ventromedial and lateral hypothalamic nuclei regulating appetite and autonomic function. Lower ENHO expression is present in liver, lung, kidney, ileum, and some endocrine glands. Hepatic ENHO expression associates with genes involved in glucose and lipid metabolism. Unsupervised hierarchical clustering identified 426 genes co-regulated with ENHO in liver, ileum, kidney medulla, and lung. Gene Ontology analysis of this cluster revealed enrichment for epigenetic silencing by histone H3K27 trimethylation and biological processes related to neural function. Dietary intervention experiments with 59 adult male rhesus macaques indicated low plasma adropin concentrations were positively correlated with fasting glucose, plasma leptin, and apolipoprotein C3 (APOC3) concentrations. During consumption of a high-sugar (fructose) diet, which induced 10% weight gain, animals with low adropin had larger increases of plasma leptin and more severe hyperglycemia. Declining adropin concentrations were correlated with increases of plasma APOC3 and triglycerides. In summary, peripheral ENHO expression associates with pathways related to epigenetic and neural functions, and carbohydrate and lipid metabolism, suggesting co-regulation in nonhuman primates. Low circulating adropin predicts increased weight gain and metabolic dysregulation during consumption of a high-sugar diet.	[Butler, Andrew A.; Zhang, Jinsong; Stevens, Joseph R.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol, 1402 S Grand Blvd, St Louis, MO 63104 USA; [Butler, Andrew A.; Zhang, Jinsong] St Louis Univ, Henry & Amelia Nasrallah Ctr Neurosci, St Louis, MO 63104 USA; [Price, Candice A.; Graham, James L.; Stanhope, Kimber L.; Havel, Peter J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Price, Candice A.; Graham, James L.; Stanhope, Kimber L.; Havel, Peter J.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [King, Sarah; Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA; [Bremer, Andrew A.] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA	Saint Louis University; Saint Louis University; University of California System; University of California Davis; University of California System; University of California Davis; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Vanderbilt University	Butler, AA (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol, 1402 S Grand Blvd, St Louis, MO 63104 USA.; Havel, PJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.; Havel, PJ (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	andrew.butler@health.slu.edu; pjhavel@ucdavis.edu		Havel, Peter/0000-0003-3652-8301; Graham, James/0000-0001-6507-8149; Zhang, Jinsong/0000-0002-8798-7316; Stanhope, Kimber/0000-0002-2474-0914; Butler, Andrew/0000-0001-7196-0170	National Institutes of Health [R21NS108138, AT250099, AT003645]; American Diabetes Association; California National Primate Research Center Base Grant [OD-0111107]; UC Davis Clinical and Translational Science Center [UL1 RR024146]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS108138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); California National Primate Research Center Base Grant; UC Davis Clinical and Translational Science Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grants R21NS108138, AT250099, and AT003645, the American Diabetes Association, California National Primate Research Center Base Grant OD-0111107, and UC Davis Clinical and Translational Science Center Grant UL1 RR024146. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams AC, 2016, CELL METAB, V23, P227, DOI 10.1016/j.cmet.2016.01.013; Akcilar R, 2016, BRATISL MED J, V117, P100, DOI 10.4149/BLL_2016_020; Akcilar R, 2016, IRAN J BASIC MED SCI, V19, P245; Bass J, 2016, RES PERSPECT END INT, P25, DOI 10.1007/978-3-319-27069-2_3; Begg DP, 2013, NAT REV ENDOCRINOL, V9, P584, DOI 10.1038/nrendo.2013.136; Beigi A, 2015, GYNECOL ENDOCRINOL, V31, P939, DOI 10.3109/09513590.2015.1081681; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; Bremer AA, 2014, J NUTR, V144, P5, DOI 10.3945/jn.113.178061; Bremer AA, 2011, CTS-CLIN TRANSL SCI, V4, P243, DOI 10.1111/j.1752-8062.2011.00298.x; Bushkofsky JR, 2016, ARCH BIOCHEM BIOPHYS, V597, P30, DOI 10.1016/j.abb.2016.03.030; Butler AA, 2019, J LIPID RES, V60, P805, DOI 10.1194/jlr.M089508; Butler AA, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00128; Butler AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep14691; Butler AA, 2012, J CLIN ENDOCR METAB, V97, P3783, DOI 10.1210/jc.2012-2194; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; Celik E, 2013, J PERINAT MED, V41, P375, DOI 10.1515/jpm-2012-0227; Chang JB, 2018, OBES RES CLIN PRACT, V12, P101, DOI 10.1016/j.orcp.2017.03.001; Chen S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.362; Conway E, 2015, CURR OPIN CELL BIOL, V37, P42, DOI 10.1016/j.ceb.2015.10.003; Cox LA, 2017, ILAR J, V58, P235, DOI 10.1093/ilar/ilx025; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Gao S, 2015, MOL METAB, V4, P310, DOI 10.1016/j.molmet.2015.01.005; Gao S, 2014, DIABETES, V63, P3242, DOI 10.2337/db14-0388; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Ghoshal S, 2018, MOL METAB, V8, P51, DOI 10.1016/j.molmet.2017.12.002; HANSEN BC, 1986, DIABETOLOGIA, V29, P713, DOI 10.1007/BF00870281; Havel PJ, 2017, ILAR J, V58, P251, DOI 10.1093/ilar/ilx031; Holoch D, 2017, TRENDS BIOCHEM SCI, V42, P531, DOI 10.1016/j.tibs.2017.04.003; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Jamaiyar A, 2017, PHARMACOL THERAPEUT, V175, P28, DOI 10.1016/j.pharmthera.2017.02.032; Khetarpal SA, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0609-y; Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kuhla A, 2014, J GERONTOL A-BIOL, V69, P915, DOI 10.1093/gerona/glt160; Kumar KG, 2012, OBESITY, V20, P1394, DOI 10.1038/oby.2012.31; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Larsen MC, 2015, ARCH BIOCHEM BIOPHYS, V571, P21, DOI 10.1016/j.abb.2015.02.010; Lazar MA, 2016, RES PERSPECT END INT, P63, DOI 10.1007/978-3-319-27069-2_7; Li S, 2015, DIABETES OBES METAB, V17, P33, DOI 10.1111/dom.12520; Liu M, 2004, ENDOCRINOLOGY, V145, P3232, DOI 10.1210/en.2003-1554; Matikainen N, 2014, OBESITY, V22, P1854, DOI 10.1002/oby.20781; Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063; Mora S, 2015, CIRCULATION, V132, P2220, DOI 10.1161/CIRCULATIONAHA.115.016857; Morrison CD, 2015, TRENDS ENDOCRIN MET, V26, P256, DOI 10.1016/j.tem.2015.02.008; Mure LS, 2018, SCIENCE, V359, P1232, DOI 10.1126/science.aao0318; Nordestgaard BG, 2018, NAT REV CARDIOL, V15, P261, DOI 10.1038/nrcardio.2018.3; Orsso CE, 2019, PEDIATR OBES, V14, DOI 10.1111/ijpo.12493; Partridge CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-99; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Ramms B, 2018, CURR OPIN LIPIDOL, V29, P171, DOI 10.1097/MOL.0000000000000502; Reinke H, 2016, GASTROENTEROLOGY, V150, P574, DOI 10.1053/j.gastro.2015.11.043; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Sacks FM, 2015, CURR OPIN LIPIDOL, V26, P56, DOI 10.1097/MOL.0000000000000146; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Sato K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051293; Sergushichev A., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Shen L, 2005, AM J PHYSIOL-GASTR L, V288, pG48, DOI 10.1152/ajpgi.00064.2004; Shen L, 2009, BRAIN RES, V1273, P66, DOI 10.1016/j.brainres.2009.04.004; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; St-Onge MP, 2014, OBESITY, V22, P1056, DOI 10.1002/oby.20631; Stevens JR, 2016, OBESITY, V24, P1731, DOI 10.1002/oby.21557; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thapa D, 2019, J MOL CELL CARDIOL, V129, P174, DOI 10.1016/j.yjmcc.2019.02.012; Thapa D, 2018, REDOX BIOL, V18, P25, DOI 10.1016/j.redox.2018.06.003; Thomas EL, 2012, OBESITY, V20, P76, DOI 10.1038/oby.2011.142; Tuna BG, 2017, NUTR CANCER, V69, P1003, DOI 10.1080/01635581.2017.1359314; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van der Klaauw AA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13055; Wagner JD, 2006, ILAR J, V47, P259, DOI 10.1093/ilar.47.3.259; Wang F, 2015, J LIPID RES, V56, P1403, DOI 10.1194/jlr.R052753; Wong CM, 2014, J BIOL CHEM, V289, P25976, DOI 10.1074/jbc.M114.576058; Yang CJ, 2018, AGING DIS, V9, P322, DOI 10.14336/AD.2017.0523; Yang CJ, 2016, PEPTIDES, V81, P29, DOI 10.1016/j.peptides.2016.03.009; Zang HH, 2018, ENDOCR J, V65, P685, DOI 10.1507/endocrj.EJ18-0060	75	31	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9706	9719		10.1074/jbc.RA119.007528	http://dx.doi.org/10.1074/jbc.RA119.007528			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	30988006	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000473277900006
J	Ozaslan, D; Wang, S; Ahmed, BA; Kocabas, AM; McCastlain, JC; Bene, A; Kilic, F				Ozaslan, Deniz; Wang, Sophie; Ahmed, Billow A.; Kocabas, Arif M.; McCastlain, John C.; Bene, Anca; Kilic, Fusun			Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter: a specific role for sialic acid residues (Withdrawal of Vol 278, Pg 43991, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal																		OZASLAN D, 2003, THE JOURNAL OF BIOLO, V278, P43991	1	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9657	9657		10.1074/jbc.W119.009466	http://dx.doi.org/10.1074/jbc.W119.009466			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31201245	hybrid, Green Published			2022-12-28	WOS:000472713000031
J	Pajed, L; Wagner, C; Taschler, U; Schreiber, R; Kolleritsch, S; Fawzy, N; Pototschnig, I; Schoiswohl, G; Pusch, LM; Wieser, BI; Vesely, P; Hoefler, G; Eichmann, TO; Zimmermann, R; Lass, A				Pajed, Laura; Wagner, Carina; Taschler, Ulrike; Schreiber, Renate; Kolleritsch, Stephanie; Fawzy, Nermeen; Pototschnig, Isabella; Schoiswohl, Gabriele; Pusch, Lisa-Maria; Wieser, Beatrix I.; Vesely, Paul; Hoefler, Gerald; Eichmann, Thomas O.; Zimmermann, Robert; Lass, Achim			Hepatocyte-specific deletion of lysosomal acid lipase leads to cholesteryl ester but not triglyceride or retinyl ester accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid metabolism; liver; lysosome; vitamin A; cholesterol; triglyceride; hepatocytes; hyperlipidemia; metabolic disorder; lysosomal acid lipase; neutral lipid ester metabolism	RAT-LIVER; STORAGE DISEASE; DEFICIENT MICE; METABOLISM; CELLS; PURIFICATION; HYDROLYSIS; ENZYME; INFLAMMATION; RECOGNITION	Lysosomal acid lipase (LAL) hydrolyzes cholesteryl ester (CE) and retinyl ester (RE) and triglyceride (TG). Mice globally lacking LAL accumulate CE most prominently in the liver. The severity of the CE accumulation phenotype progresses with age and is accompanied by hepatomegaly and hepatic cholesterol crystal deposition. In contrast, hepatic TG accumulation is much less pronounced in these mice, and hepatic RE levels are even decreased. To dissect the functional role of LAL for neutral lipid ester mobilization in the liver, we generated mice specifically lacking LAL in hepatocytes (hep-LAL-ko). On a standard chow diet, hep-LAL-ko mice exhibited increased hepatic CE accumulation but unaltered TG and RE levels. Feeding the hep-LAL-ko mice a vitamin A excess/high-fat diet (VitA/HFD) further increased hepatic cholesterol levels, but hepatic TG and RE levels in these mice were lower than in control mice. Performing in vitro activity assays with lysosome-enriched fractions from livers of mice globally lacking LAL, we detected residual acid hydrolytic activities against TG and RE. Interestingly, this non-LAL acid TG hydrolytic activity was elevated in lysosome-enriched fractions from livers of hep-LAL-ko mice upon VitA/HFD feeding. In conclusion, the neutral lipid ester phenotype in livers from hep-LAL-ko mice indicates that LAL is limiting for CE turnover, but not for TG and RE turnovers. Furthermore, in vitro hydrolase activity assays revealed the existence of non-LAL acid hydrolytic activities for TG and RE. The corresponding acid lipase(s) catalyzing these reactions remains to be identified.	[Pajed, Laura; Wagner, Carina; Taschler, Ulrike; Schreiber, Renate; Kolleritsch, Stephanie; Fawzy, Nermeen; Pototschnig, Isabella; Schoiswohl, Gabriele; Pusch, Lisa-Maria; Eichmann, Thomas O.; Zimmermann, Robert; Lass, Achim] Karl Franzens Univ Graz, NAWI Graz, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria; [Wieser, Beatrix I.; Vesely, Paul; Hoefler, Gerald] Med Univ Graz, Inst Pathol, Diagnost & Res Ctr Mol BioMed, A-8010 Graz, Austria; [Eichmann, Thomas O.] BioTechMed Graz, Ctr Explorat Lipid, A-8010 Graz, Austria; [Hoefler, Gerald; Zimmermann, Robert; Lass, Achim] BioTechMed Graz, A-8010 Graz, Austria	University of Graz; Medical University of Graz	Lass, A (corresponding author), Karl Franzens Univ Graz, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria.	achim.lass@uni-graz.at	Lass, Achim/C-3332-2008; Pajed, Laura/GZL-5233-2022; Vesely, Paul/AAO-1286-2020; Hoefler, Gerald/H-1796-2016	Lass, Achim/0000-0002-8190-7151; Taschler, Ulrike/0000-0001-9000-1602; Zimmermann, Robert/0000-0002-7354-870X; Schoiswohl, Gabriele/0000-0002-7346-2834; Wagner, Carina/0000-0002-0146-702X; Hoefler, Gerald/0000-0002-9056-3063; Schreiber, Renate/0000-0002-3475-157X; Eichmann, Thomas O./0000-0002-8521-2795; Vesely, Paul Willibald/0000-0003-3608-1060	Leuchtturm Projekt/Flagship Project "Lipases and Lipid Signaling" - BioTechMed-Graz [I3535, P28882-B21]; DK Molecular Enzymology Grant - Austrian Science Fund (FWF) [FWF/W9]; Fondation Leducq Transatlantic Network Grant [12CVD04]	Leuchtturm Projekt/Flagship Project "Lipases and Lipid Signaling" - BioTechMed-Graz; DK Molecular Enzymology Grant - Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Fondation Leducq Transatlantic Network Grant	This work was supported by the Leuchtturm Projekt/Flagship Project "Lipases and Lipid Signaling" (to A. L. and R. Z.) funded by BioTechMed-Graz, Grants I3535 (to A. L.) and P28882-B21 (to G. S.) and DK Molecular Enzymology Grant FWF/W9 (to R. Z.) funded by the Austrian Science Fund (FWF), and by the Fondation Leducq Transatlantic Network Grant 12CVD04. The authors declare that they have no conflicts of interest with the contents of this article.	Aguisanda Francis, 2017, Curr Chem Genom Transl Med, V11, P1, DOI 10.2174/2213988501711010001; Aqul A, 2014, AM J PHYSIOL-GASTR L, V307, pG836, DOI 10.1152/ajpgi.00243.2014; Bernstein DL, 2013, J HEPATOL, V58, P1230, DOI 10.1016/j.jhep.2013.02.014; BLOMHOFF R, 1985, J BIOL CHEM, V260, P3566; BROWN WJ, 1980, BIOCHIM BIOPHYS ACTA, V617, P305, DOI 10.1016/0005-2760(80)90173-3; D'Souza K, 2018, J LIPID RES, V59, P1805, DOI 10.1194/jlr.M082008; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146/annurev-genom-090711-163739; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Du H, 2005, AM J HUM GENET, V77, P1061, DOI 10.1086/498652; Du H, 2001, J LIPID RES, V42, P489; Du H, 2001, HUM MOL GENET, V10, P1639, DOI 10.1093/hmg/10.16.1639; Du H, 2008, J LIPID RES, V49, P1646, DOI 10.1194/jlr.M700482-JLR200; Du H, 2015, AM J PATHOL, V185, P2379, DOI 10.1016/j.ajpath.2015.05.021; Erwin AL, 2017, THER ADV GASTROENTER, V10, P553, DOI 10.1177/1756283X17705775; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fouchier SW, 2013, CURR OPIN LIPIDOL, V24, P332, DOI 10.1097/MOL.0b013e328361f6c6; GROOT PHE, 1981, METABOLISM, V30, P792, DOI 10.1016/0026-0495(81)90025-1; Grumet L, 2016, J BIOL CHEM, V291, P17977, DOI 10.1074/jbc.M116.724054; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hagen E, 1999, J LIPID RES, V40, P309; HARRISON EH, 1993, BIOCHIM BIOPHYS ACTA, V1170, P99, DOI 10.1016/0005-2760(93)90058-H; HARRISON EH, 1995, J LIPID RES, V36, P1498; Hullin-Matsuda F, 2009, PROSTAG LEUKOTR ESS, V81, P313, DOI 10.1016/j.plefa.2009.09.006; Iglesias J, 2016, J LIPID RES, V57, P131, DOI 10.1194/jlr.D058438; Jaeger D, 2015, J HEPATOL, V63, P437, DOI 10.1016/j.jhep.2015.02.035; JOUTTI A, 1981, CHEM PHYS LIPIDS, V29, P235, DOI 10.1016/0009-3084(81)90054-2; Knittelfelder OL, 2014, J CHROMATOGR B, V951, P119, DOI 10.1016/j.jchromb.2014.01.011; Krishna Murli, 2013, Clin Liver Dis (Hoboken), V2, pS8, DOI 10.1002/cld.148; LARSSON B, 1983, BIOCHIM BIOPHYS ACTA, V751, P474, DOI 10.1016/0005-2760(83)90309-0; Leopold C, 2019, BBA-MOL CELL BIOL L, V1864, P500, DOI 10.1016/j.bbalip.2019.01.007; Li JJ, 2013, CARDIOVASC RES, V99, P674, DOI 10.1093/cvr/cvt139; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; LIPPIELLO PM, 1985, BIOCHEM J, V232, P395, DOI 10.1042/bj2320395; MERCIER M, 1994, BBA-LIPID LIPID MET, V1212, P176, DOI 10.1016/0005-2760(94)90251-8; Palacios LE, 2005, J AM OIL CHEM SOC, V82, P571, DOI 10.1007/s11746-005-1111-4; Pericleous M, 2017, LANCET GASTROENTEROL, V2, P670, DOI 10.1016/S2468-1253(17)30052-3; Porto AF, 2014, PEDIATR ENDOCR REV P, V12, P125; Radovic B, 2016, DIABETOLOGIA, V59, P1743, DOI 10.1007/s00125-016-3968-6; RHODES DN, 1957, BIOCHEM J, V65, P526, DOI 10.1042/bj0650526; Rosenbaum AI, 2010, J MED CHEM, V53, P5281, DOI 10.1021/jm100499s; SANDO GN, 1985, J BIOL CHEM, V260, P5186; SANDO GN, 1990, CELL REGUL, V1, P661, DOI 10.1091/mbc.1.9.661; SANDO GN, 1982, J LIPID RES, V23, P114; SCHIFF L, 1968, AM J MED, V44, P538, DOI 10.1016/0002-9343(68)90054-5; Shteyer E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030312; Shu J., 2019, MIDAS J; Sun Y, 2014, MOL GENET METAB, V112, P229, DOI 10.1016/j.ymgme.2014.04.006; Taschler U, 2015, BBA-MOL CELL BIOL L, V1851, P937, DOI 10.1016/j.bbalip.2015.02.017; Tuohetahuntila M, 2017, J BIOL CHEM, V292, P12436, DOI 10.1074/jbc.M117.778472; Valayannopoulos V, 2014, J HEPATOL, V61, P1135, DOI 10.1016/j.jhep.2014.06.022; VANDIJK MCM, 1992, EUR J BIOCHEM, V205, P775, DOI 10.1111/j.1432-1033.1992.tb16842.x; WOLMAN M, 1961, PEDIATRICS, V28, P742	52	9	9	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9118	9133		10.1074/jbc.RA118.007201	http://dx.doi.org/10.1074/jbc.RA118.007201			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31023823	Green Published, hybrid			2022-12-28	WOS:000471751600009
J	Dagar, M; Singh, JP; Dagar, G; Tyagi, RK; Bagchi, G				Dagar, Manisha; Singh, Julie Pratibha; Dagar, Gunjan; Tyagi, Rakesh K.; Bagchi, Gargi			Phosphorylation of HSP90 by protein kinase A is essential for the nuclear translocation of androgen receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase A (PKA); androgen receptor; heat shock protein 90 (HSP90); androgen; prostate cancer; castration-resistant prostate cancer (CRPC); cell signaling; kinase signaling; hormone-responsive tumor; endocrine disorder	PROSTATE-CANCER; STEROID-RECEPTORS; ACTIVATION; ALPHA; PROGRESSION; CAMP	The androgen receptor (AR) is often activated in prostate cancer patients undergoing androgen-ablative therapy because of the activation of cellular pathways that stimulate the AR despite low androgen levels. In many of these tumors, the cAMP-dependent protein kinase A (PKA) pathway is activated. Previous studies have shown that PKA can synergize with low levels of androgen to enhance androgen signaling and consequent cell proliferation, leading to castration-resistant prostate cancer. However, the mechanism by which PKA causes AR stimulation in the presence of low/no androgen is not established yet. Here, using immunofluorescence immunoblotting assays, co-immunoprecipitation, siRNA-mediated gene silencing, and reporter gene assays, we demonstrate that PKA activation is necessary for the phosphorylation of heat shock protein (HSP90) that binds to unliganded AR in the cytoplasm, restricting its entry into the nucleus. We also found that PKA-mediated phosphorylation of the Thr(89) residue in HSP90 releases AR from HSP90, enabling AR binding to HSP27 and its migration into the nucleus. Substitution of the Thr(89) in HSP90 prevented its phosphorylation by PKA and significantly reduced AR transactivation and cellular proliferation. We further observed that the transcription of AR target genes, such as prostate-specific antigen (PSA), is also lowered in the HSP90 Thr(89) variant. These results suggest that using a small-molecule inhibitor against the HSP90 Thr(89) residue in conjunction with existing androgen-ablative therapy may be more effective than androgen-ablative therapy alone in the treatment of prostate cancer patients.	[Dagar, Manisha; Singh, Julie Pratibha; Dagar, Gunjan; Bagchi, Gargi] Amity Univ Haryana, Amity Inst Biotechnol, Gurgaon 122413, India; [Tyagi, Rakesh K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Bagchi, G (corresponding author), Amity Univ Haryana, Amity Inst Biotechnol, Gurgaon 122413, India.	gbagchi@ggn.amity.edu			Department of Biotechnology Bio Care Project, New Delhi	Department of Biotechnology Bio Care Project, New Delhi	This work was supported by funds from the Department of Biotechnology Bio Care Project, New Delhi (to G. B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Bagchi G, 2008, CANCER RES, V68, P3225, DOI 10.1158/0008-5472.CAN-07-5026; Cheung J, 2000, MOL ENDOCRINOL, V14, P939, DOI 10.1210/me.14.7.939; Chin KV, 2002, ANN NY ACAD SCI, V968, P49, DOI 10.1111/j.1749-6632.2002.tb04326.x; Denis LJ, 2000, SEMIN SURG ONCOL, V18, P52, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<52::AID-SSU8>3.0.CO;2-6; Eder IE, 2013, INT J MOL SCI, V14, P11942, DOI 10.3390/ijms140611942; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Gartner EM, 2012, BREAST CANCER RES TR, V131, P933, DOI 10.1007/s10549-011-1866-7; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gobinet J, 2002, MOL CELL ENDOCRINOL, V198, P15, DOI 10.1016/S0303-7207(02)00364-7; He SQ, 2014, INVEST NEW DRUG, V32, P577, DOI 10.1007/s10637-014-0095-4; Huggins C, 1941, CANCER RES, V1, P293; IKONEN T, 1994, ENDOCRINOLOGY, V135, P1359, DOI 10.1210/en.135.4.1359; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; Kasbohm EA, 2005, J BIOL CHEM, V280, P11583, DOI 10.1074/jbc.M414423200; Khor LY, 2008, INT J RADIAT ONCOL, V71, P1309, DOI 10.1016/j.ijrobp.2007.12.010; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kumar S, 2006, MOL CELL ENDOCRINOL, V246, P147, DOI 10.1016/j.mce.2005.11.028; Lei HT, 2007, J BIOL CHEM, V282, P9364, DOI 10.1074/jbc.M608985200; Leung JK, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00002; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Sadar MD, 1999, ENDOCR-RELAT CANCER, V6, P487, DOI 10.1677/erc.0.0060487; Sarwar M, 2011, J CANC SCI THER S, VS5, P3, DOI [10.4172/1948-5956.S5-003, DOI 10.4172/1948-5956.S5-003]; Shafi AA, 2013, STEROIDS, V78, P548, DOI 10.1016/j.steroids.2012.12.013; Soroka J, 2012, MOL CELL, V45, P517, DOI 10.1016/j.molcel.2011.12.031; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	29	18	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8699	8710		10.1074/jbc.RA119.007420	http://dx.doi.org/10.1074/jbc.RA119.007420			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30992362	hybrid, Green Published			2022-12-28	WOS:000470971100003
J	Xu, S; Uddin, MJ; Banerjee, S; Duggan, K; Musee, J; Kiefer, JR; Ghebreselasie, K; Rouzer, CA; Marnett, LJ				Xu, Shu; Uddin, Md. Jashim; Banerjee, Surajit; Duggan, Kelsey; Musee, Joel; Kiefer, James R.; Ghebreselasie, Kebreab; Rouzer, Carol A.; Marnett, Lawrence J.			Fluorescent indomethacin-dansyl conjugates utilize the membrane-binding domain of cyclooxygenase-2 to block the opening to the active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclooxygenase (COX); enzyme structure; protein drug interaction; X-ray crystallography; enzyme kinetics; anticancer drug; inflammation; chemotherapy; prostaglandin endoperoxide synthase	TIME-DEPENDENT INHIBITION; OXYGENATION; PROSTAGLANDINS; DESIGN; CANCER; ESTERS; AMIDES; PHENIX	Many indomethacin amides and esters are cyclooxygenase-2 (COX-2)-selective inhibitors, providing a framework for the design of COX-2-targeted imaging and cancer chemotherapeutic agents. Although previous studies have suggested that the amide or ester moiety of these inhibitors binds in the lobby region, a spacious alcove within the enzyme's membrane-binding domain, structural details have been lacking. Here, we present observations on the crystal complexes of COX-2 with two indomethacin-dansyl conjugates (compounds 1 and 2) at 2.22-angstrom resolution. Both compounds are COX-2-selective inhibitors with IC50 values of 0.76 and 0.17 m, respectively. Our results confirmed that the dansyl moiety is localized in and establishes hydrophobic interactions and several hydrogen bonds with the lobby of the membrane-binding domain. We noted that in both crystal structures, the linker tethering indomethacin to the dansyl moiety passes through the constriction at the mouth of the COX-2 active site, resulting in displacement and disorder of Arg-120, located at the opening to the active site. Both compounds exhibited higher inhibitory potency against a COX-2 R120A variant than against the WT enzyme. Inhibition kinetics of compound 2 were similar to those of the indomethacin parent compound against WT COX-2, and the R120A substitution reduced the time dependence of COX inhibition. These results provide a structural basis for the further design and optimization of conjugated COX reagents for imaging of malignant or inflammatory tissues containing high COX-2 levels.	[Xu, Shu; Uddin, Md. Jashim; Duggan, Kelsey; Musee, Joel; Ghebreselasie, Kebreab; Rouzer, Carol A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Dept Biochem, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Vanderb, Nashville, TN 37212 USA; [Xu, Shu; Uddin, Md. Jashim; Duggan, Kelsey; Musee, Joel; Ghebreselasie, Kebreab; Rouzer, Carol A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Dept Chem, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Vanderb, Nashville, TN 37212 USA; [Xu, Shu; Uddin, Md. Jashim; Duggan, Kelsey; Musee, Joel; Ghebreselasie, Kebreab; Rouzer, Carol A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Dept Pharmacol, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Vanderb, Nashville, TN 37212 USA; [Banerjee, Surajit] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Banerjee, Surajit] Argonne Natl Lab, Northeastern Collaborat Access Team, 9700 S Cass Ave, Argonne, IL 60439 USA; [Kiefer, James R.] Genentech Inc, San Francisco, CA 94080 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Roche Holding; Genentech	Marnett, LJ (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu	Xu, Shu/O-6667-2019	Xu, Shu/0000-0002-6876-7991; Rouzer, Carol/0000-0001-6827-1534	NIGMS, National Institutes of Health [P30 GM124165, S10 RR029205]; United States DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM124165, P41GM103403] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	X-ray diffraction was conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by NIGMS, National Institutes of Health Grants P30 GM124165 and S10 RR029205. We thank Life Science Collaborative Access Team beamlines at Advanced Photon Source for the earlier assistance with data collection of the COX-2compound 2 complex. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by United States DOE under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Blobaum AL, 2015, J BIOL CHEM, V290, P12793, DOI 10.1074/jbc.M114.635987; Cekanova M, 2013, CANCER PREV RES, V6, P466, DOI 10.1158/1940-6207.CAPR-12-0358; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garavito RM, 2003, ANNU REV BIOPH BIOM, V32, P183, DOI 10.1146/annurev.biophys.32.110601.141906; Harman CA, 2007, J BIOL CHEM, V282, P28096, DOI 10.1074/jbc.M701335200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; Kalgutkar AS, 2000, J MED CHEM, V43, P2860, DOI 10.1021/jm000004e; Kingsley PJ, 2005, ANAL BIOCHEM, V343, P203, DOI 10.1016/j.ab.2005.05.005; Konkle ME, 2016, BIOCHEMISTRY-US, V55, P348, DOI 10.1021/acs.biochem.5b01222; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Marnett L. J., 2012, U. S. Patent, Patent No. [8, 143, 302, 8143302]; Marnett LJ, 1999, TRENDS PHARMACOL SCI, V20, P465, DOI 10.1016/S0165-6147(99)01385-1; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; Prusakiewicz JJ, 2004, BIOCHEMISTRY-US, V43, P15439, DOI 10.1021/bi048534q; Ra HJ, 2015, NEOPLASIA, V17, P201, DOI 10.1016/j.neo.2014.12.009; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; ROME LH, 1975, P NATL ACAD SCI USA, V72, P4863, DOI 10.1073/pnas.72.12.4863; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Timofeevski SL, 2002, BIOCHEMISTRY-US, V41, P9654, DOI 10.1021/bi0203637; Uddin MJ, 2016, ACS CHEM BIOL, V11, P3052, DOI 10.1021/acschembio.6b00560; Uddin MJ, 2013, BIOCONJUGATE CHEM, V24, P712, DOI 10.1021/bc300693w; Uddin MJ, 2010, CANCER RES, V70, P3618, DOI 10.1158/0008-5472.CAN-09-2664; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu S, 2014, J BIOL CHEM, V289, P6799, DOI 10.1074/jbc.M113.517987	38	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8690	8698		10.1074/jbc.RA119.007405	http://dx.doi.org/10.1074/jbc.RA119.007405			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31000626	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000470971100002
J	Feng, Y; Xie, Y; Xu, MS; Li, LH; Selce, KW; Oberly, PJ; Poloyac, SM; Wang, HB; Li, CJ; Dong, FQ; Yu, CH; Xie, W				Feng, Ye; Xie, Yang; Xu, Meishu; Li, Linhao; Selce, Kyle W.; Oberly, Patrick J.; Poloyac, Samuel M.; Wang, Hongbing; Li, Chengjiang; Dong, Fengqin; Yu, Chaohui; Xie, Wen			Hepatic steroid sulfatase critically determines estrogenic activities of conjugated equine estrogens in human cells in vitro and in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						steroid hormone; metabolism; sulfotransferase; estrogen; gene regulation; conjugated equine estrogens; hormone replacement therapy (HRT); inflammation; menopause; steroid sulfatase (STS)	PREGNANE-X-RECEPTOR; HORMONE REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; BINDING; HEALTH; BREAST; ACTIVATION; GROWTH; PROTEIN-1; ELEMENT	Conjugated equine estrogens (CEEs), whose brand name is Premarin, are widely used as a hormone-replacement therapy (HRT) drug to manage postmenopausal symptoms in women. Extracted from pregnant mare urine, CEEs are composed of nearly a dozen estrogens existing in an inactive sulfated form. To determine whether the hepatic steroid sulfatase (STS) is a key contributor to the efficacy of CEEs in HRT, we performed estrogen-responsive element (ERE) reporter gene assay, real-time PCR, and UPLC-MS/MS to assess the STS-dependent and inflammation-responsive estrogenic activity of CEEs in HepG2 cells and human primary hepatocytes. Using liver-specific STS-expressing transgenic mice, we also evaluated the effect of STS on the estrogenic activity of CEEs in vivo. We observed that CEEs induce activity of the ERE reporter gene in an STS-dependent manner and that genetic or pharmacological inhibition of STS attenuates CEE estrogenic activity. In hepatocytes, inflammation enhanced CEE estrogenic activity by inducing STS gene expression. The inflammation-responsive estrogenic activity of CEEs, in turn, attenuated inflammation through the anti-inflammatory activity of the active estrogens. In vivo, transgenic mice with liver-specific STS expression exhibited markedly increased sensitivity to CEE-induced estrogenic activity in the uterus resulting from increased levels of liver-derived and circulating estrogens. Our results reveal a critical role of hepatic STS in mediating the hormone-replacing activity of CEEs. We propose that caution needs to be applied when Premarin is used in patients with chronic inflammatory liver diseases because such patients may have heightened sensitivity to CEEs due to the inflammatory induction of STS activity.	[Feng, Ye; Xie, Yang; Xu, Meishu; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Feng, Ye; Xie, Yang; Xu, Meishu; Oberly, Patrick J.; Poloyac, Samuel M.; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Feng, Ye; Li, Chengjiang; Dong, Fengqin] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Endocrinol & Metab Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Linhao; Wang, Hongbing] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA; [Selce, Kyle W.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Yu, Chaohui] Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Wen] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Zhejiang University; University System of Maryland; University of Maryland Baltimore; Duquesne University; Zhejiang University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xie, W (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA.; Xie, W (corresponding author), Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.; Yu, CH (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	zyyyych@zju.edu.cn; wex6@pitt.edu	Xie, Wen/M-1768-2016	Xie, Yang/0000-0002-2190-6966	National Institutes of Health [DK083952, ES023438, GM121550]; University of Pittsburgh School of Pharmacy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Pharmacy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants DK083952, ES023438 (to W.X.), and GM121550 (to H.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the Joseph Koslow Endowed Professorship from the University of Pittsburgh School of Pharmacy.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; Barkhem T, 2002, MOL PHARMACOL, V61, P1273, DOI 10.1124/mol.61.6.1273; Bhavnani BR, 2014, J STEROID BIOCHEM, V142, P16, DOI 10.1016/j.jsbmb.2013.10.011; Cardim HJP, 2001, FERTIL STERIL, V75, P282, DOI 10.1016/S0015-0282(00)01691-5; Christopoulos PF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0291-7; Della Torre S, 2011, ENDOCRINOLOGY, V152, P2256, DOI 10.1210/en.2011-0173; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Faucette SR, 2007, J PHARMACOL EXP THER, V320, P72, DOI 10.1124/jpet.106.112136; Ferrante P, 2002, EUR J HUM GENET, V10, P813, DOI 10.1038/sj.ejhg.5200887; Gong HB, 2007, MOL ENDOCRINOL, V21, P1781, DOI 10.1210/me.2007-0187; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Jiang MX, 2016, J HEPATOL, V64, P44, DOI 10.1016/j.jhep.2015.07.022; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lee YJ, 2003, ARCH PHARM RES, V26, P58, DOI 10.1007/BF03179933; Li JY, 2016, J STEROID BIOCHEM, V163, P113, DOI 10.1016/j.jsbmb.2016.04.013; Lobo RA, 2016, ATHEROSCLEROSIS, V254, P282, DOI 10.1016/j.atherosclerosis.2016.10.005; Miller VM, 2017, AM J PHYSIOL-HEART C, V313, pH1013, DOI 10.1152/ajpheart.00383.2017; Mu Y, 2006, J PHARMACOL EXP THER, V316, P1369, DOI 10.1124/jpet.105.094342; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; PAN CC, 1985, J CLIN ENDOCR METAB, V61, P499, DOI 10.1210/jcem-61-3-499; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Selcer KW, 2012, STEROIDS, V77, P696, DOI 10.1016/j.steroids.2012.02.024; Sengupta S, 2010, HORM MOL BIOL CLIN I, V2, P235, DOI 10.1515/HMBCI.2010.025; Stanway SJ, 2006, CLIN CANCER RES, V12, P1585, DOI 10.1158/1078-0432.CCR-05-1996; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Stuenkel CA, 2012, MENOPAUSE, V19, P846, DOI 10.1097/gme.0b013e31826226f2; Suwanvesh N, 2017, MENOPAUSE, V24, P210, DOI 10.1097/GME.0000000000000742; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	30	3	3	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12112	12121		10.1074/jbc.RA119.009181	http://dx.doi.org/10.1074/jbc.RA119.009181			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31217279	hybrid, Green Published			2022-12-28	WOS:000484284500015
J	McCann, JL; Klein, MM; Leland, EM; Law, EK; Brown, WL; Salamango, DJ; Harris, RS				McCann, Jennifer L.; Klein, Madeline M.; Leland, Evelyn M.; Law, Emily K.; Brown, William L.; Salamango, Daniel J.; Harris, Reuben S.			The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA viruses; cell cycle; virus; proteomics; retrovirus; APOBEC3B; cancer mutagenesis; CDK4; innate antiviral immunity	SUBCELLULAR-LOCALIZATION; STRUCTURAL BASIS; SUBSTRATE-SPECIFICITY; MUTATIONAL SIGNATURES; THERAPEUTIC TARGET; CYTOSINE DEAMINASE; CRYSTAL-STRUCTURE; FAMILY PROTEINS; MESSENGER-RNA; UP-REGULATION	Apolipoprotein B mRNA editing enzyme catalytic subunit-like protein 3B (APOBEC3B or A3B), as other APOBEC3 members, is a single-stranded (ss)DNA cytosine deaminase with antiviral activity. A3B is also overexpressed in multiple tumor types, such as carcinomas of the bladder, cervix, lung, head/neck, and breast. A3B generates both dispersed and clustered C-to-T and C-to-G mutations in intrinsically preferred trinucleotide motifs (TCA/TCG/TCT). A3B-catalyzed mutations are likely to promote tumor evolution and cancer progression and, as such, are associated with poor clinical outcomes. However, little is known about cellular processes that regulate A3B. Here, we used a proteomics approach involving affinity purification coupled to MS with human 293T cells to identify cellular proteins that interact with A3B. This approach revealed a specific interaction with cyclin-dependent kinase 4 (CDK4). We validated and mapped this interaction by co-immunoprecipitation experiments. Functional studies and immunofluorescence microscopy experiments in multiple cell lines revealed that A3B is not a substrate for CDK4-Cyclin D1 phosphorylation nor is its deaminase activity modulated. Instead, we found that A3B is capable of disrupting the CDK4-dependent nuclear import of Cyclin D1. We propose that this interaction may favor a more potent antiviral response and simultaneously facilitate cancer mutagenesis.	[McCann, Jennifer L.; Klein, Madeline M.; Leland, Evelyn M.; Law, Emily K.; Brown, William L.; Salamango, Daniel J.; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [McCann, Jennifer L.; Law, Emily K.; Brown, William L.; Salamango, Daniel J.; Harris, Reuben S.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [McCann, Jennifer L.; Law, Emily K.; Brown, William L.; Salamango, Daniel J.; Harris, Reuben S.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [McCann, Jennifer L.; Law, Emily K.; Brown, William L.; Salamango, Daniel J.; Harris, Reuben S.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Harris, Reuben S.] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	Salamango, DJ (corresponding author), 2231 6th St SE,4-230B, Minneapolis, MN 55455 USA.	dsalaman@umn.edu	Brown, William/GXN-2777-2022	Harris, Reuben/0000-0002-9034-9112	University of Minnesota Masonic Cancer Center, Academic Health Center, and College of Biological Sciences; National Science Foundation [00039202]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER	University of Minnesota Masonic Cancer Center, Academic Health Center, and College of Biological Sciences; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Minnesota Masonic Cancer Center, Academic Health Center, and College of Biological Sciences and in part by National Science Foundation Graduate Research Fellowship Grant 00039202 (to J.L.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Ayaz P, 2016, ACS CHEM BIOL, V11, P1710, DOI 10.1021/acschembio.6b00074; Baker Stacey J, 2012, Genes Cancer, V3, P658, DOI 10.1177/1947601913478972; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Bertucci F, 2019, NATURE, V569, P560, DOI 10.1038/s41586-019-1056-z; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Bransteitter R, 2009, CELL MOL LIFE SCI, V66, P3137, DOI 10.1007/s00018-009-0070-y; Brown W., 2019, RABBIT MONOCLONAL AN, DOI [10.1101/513341, DOI 10.1101/513341]; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Carpenter MA, 2019, METHODS, V156, P79, DOI 10.1016/j.ymeth.2018.12.006; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chen HB, 2017, J BIOL CHEM, V292, P10131, DOI 10.1074/jbc.M116.773226; Cheng AZ, 2019, NAT MICROBIOL, V4, P78, DOI 10.1038/s41564-018-0284-6; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Davy CE, 2005, J VIROL, V79, P3998, DOI 10.1128/JVI.79.7.3998-4011.2005; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Dhar KK, 1999, BRIT J CANCER, V81, P1174, DOI 10.1038/sj.bjc.6690826; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fanourakis G, 2016, EXP MOL PATHOL, V101, P314, DOI 10.1016/j.yexmp.2016.11.001; Feng YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00450; Grafstrom RH, 1999, CARCINOGENESIS, V20, P193, DOI 10.1093/carcin/20.2.193; Harris RS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0498-3; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Holland TA, 2001, INT J CANCER, V95, P302, DOI 10.1002/1097-0215(20010920)95:5<302::AID-IJC1052>3.0.CO;2-#; Hoopes JI, 2016, CELL REP, V14, P1273, DOI 10.1016/j.celrep.2016.01.021; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Italiano A, 2009, CLIN CANCER RES, V15, P5696, DOI 10.1158/1078-0432.CCR-08-3185; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kouno T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15024; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Lackey L, 2013, CELL CYCLE, V12, P762, DOI 10.4161/cc.23713; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Land AM, 2013, J BIOL CHEM, V288, P17253, DOI 10.1074/jbc.M113.458661; Law EK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601737; Lee CR, 2019, J MICROBIOL, V57, P93, DOI 10.1007/s12275-019-9021-y; Lefebvre C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002201; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Ma W, 2019, MOL CARCINOGEN, V58, P643, DOI 10.1002/mc.22956; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martin LG, 1998, J VIROL, V72, P975, DOI 10.1128/JVI.72.2.975-985.1998; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; McNamara RP, 2013, CELL REP, V5, P1256, DOI 10.1016/j.celrep.2013.11.003; Middlebrooks CD, 2016, NAT GENET, V48, P1330, DOI 10.1038/ng.3670; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nascimento R, 2009, ARCH VIROL, V154, P1143, DOI 10.1007/s00705-009-0420-y; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nigg E A, 1991, Semin Cell Biol, V2, P261; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nikkila J, 2017, BRIT J CANCER, V117, P113, DOI 10.1038/bjc.2017.133; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohba K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097787; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Paladino P, 2014, J VIROL, V88, P4480, DOI 10.1128/JVI.00059-14; Pan WJ, 1998, CARCINOGENESIS, V19, P765, DOI 10.1093/carcin/19.5.765; Parker GA, 1996, ONCOGENE, V13, P2541; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Refsland EW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004761; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Salamango DJ, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00356-18; Salamango DJ, 2018, J MOL BIOL, V430, P2695, DOI 10.1016/j.jmb.2018.04.044; Sheppard KE, 2013, CLIN CANCER RES, V19, P5320, DOI 10.1158/1078-0432.CCR-13-0259; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Sieuwerts AM, 2014, MOL ONCOL, V8, P1679, DOI 10.1016/j.molonc.2014.07.003; Starrett GJ, 2019, MBIO, V10, DOI 10.1128/mBio.02690-18; Stavrou S, 2015, J IMMUNOL, V195, P4565, DOI 10.4049/jimmunol.1501504; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stevenson-Lindert LM, 2003, J BIOL CHEM, V278, P50956, DOI 10.1074/jbc.M306546200; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Tokunaga E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168090; Tsuboi M, 2016, BREAST CANCER-TOKYO, V23, P780, DOI 10.1007/s12282-015-0641-8; Ullah I, 2018, J CLIN INVEST, V128, P1355, DOI 10.1172/JCI96149; Venkatesan S, 2018, ANN ONCOL, V29, P563, DOI 10.1093/annonc/mdy003; Verhalen B, 2016, J VIROL, V90, P6379, DOI 10.1128/JVI.00771-16; Vieira VC, 2014, MBIO, V5, DOI 10.1128/mBio.02234-14; Wagner JR, 2019, J CHEM INF MODEL, V59, P2264, DOI 10.1021/acs.jcim.8b00427; Walker BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7997; Warren CJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080233; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; Xiao X, 2017, NUCLEIC ACIDS RES, V45, P7494, DOI 10.1093/nar/gkx362; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yim Eun-Kyoung, 2005, Cancer Res Treat, V37, P319, DOI 10.4143/crt.2005.37.6.319	99	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12099	12111		10.1074/jbc.RA119.008443	http://dx.doi.org/10.1074/jbc.RA119.008443			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31217276	Green Published, hybrid			2022-12-28	WOS:000484284500014
J	Sayed, ME; Cheng, A; Yadav, GP; Ludlow, AT; Shay, JW; Wright, WE; Jiang, QX				Sayed, Mohammed E.; Cheng, Ao; Yadav, Gaya P.; Ludlow, Andrew T.; Shay, Jerry W.; Wright, Woodring E.; Jiang, Qiu-Xing			Catalysis-dependent inactivation of human telomerase and its reactivation by intracellular telomerase-activating factors (iTAFs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; thermodynamics; cellular regulation; cancer biology; cellular senescence; catalysis-dependent control; ddTRAP; hTERT; single-run catalysis; telomerase reactivation	SINGLE-MOLECULE; LENGTH REGULATION; HUMAN CANCER; RNA; PROTEIN; END; MECHANISM; YEAST; TETRAHYMENA; SHELTERIN	Human telomerase maintains genome stability by adding telomeric repeats to the ends of linear chromosomes. Although previous studies have revealed profound insights into telomerase functions, the low cellular abundance of functional telomerase and the difficulties in quantifying its activity leave its thermodynamic and kinetic properties only partially characterized. Employing a stable cell line overexpressing both the human telomerase RNA component and the N-terminally biotinylated human telomerase reverse transcriptase and using a newly developed method to count individual extension products, we demonstrate here that human telomerase holoenzymes contain fast- and slow-acting catalytic sites. Surprisingly, both active sites became inactive after two consecutive rounds of catalysis, named single-run catalysis. The fast active sites turned off similar to 40-fold quicker than the slow ones and exhibited higher affinities to DNA substrates. In a dimeric enzyme, the two active sites work in tandem, with the faster site functioning before the slower one, and in the monomeric enzyme, the active sites also perform single-run catalysis. Interestingly, inactive enzymes could be reactivated by intracellular telomerase-activating factors (iTAFs) from multiple cell types. We conclude that the single-run catalysis and the iTAF-triggered reactivation serve as an unprecedented control circuit for dynamic regulation of telomerase. They endow native telomerase holoenzymes with the ability to match their total number of active sites to the number of telomeres they extend. We propose that the exquisite kinetic control of telomerase activity may play important roles in both cell division and cell aging.	[Sayed, Mohammed E.; Cheng, Ao; Yadav, Gaya P.; Ludlow, Andrew T.; Shay, Jerry W.; Wright, Woodring E.; Jiang, Qiu-Xing] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Sayed, Mohammed E.; Ludlow, Andrew T.] Univ Michigan, Sch Kinesiol, Integrat Mol Genet Lab, Ann Arbor, MI 48109 USA; [Cheng, Ao] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Yadav, Gaya P.; Jiang, Qiu-Xing] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of Florida	Jiang, QX (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	qxjiang@ufl.edu	Jiang, Qiu-Xing/AAI-8579-2020; Yadav, Gaya P/F-3720-2019; Jiang, Qiu-Xing/ABF-1143-2021; yadav, gaya/AAA-3576-2021	Yadav, Gaya P/0000-0002-4514-4679; Ludlow, Andrew/0000-0003-0423-4800; Shay, Jerry W./0000-0001-5052-0627	National Institutes of Health [C06RR30414]; NATIONAL CANCER INSTITUTE [K99CA197672, R00CA197672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111367, R21GM131231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to members of the Jiang laboratory and those of the Shay/Wright laboratory. Three members of the Ph.D. thesis committee for M. E. S., Drs. Hamid Mirazei, Robert Eberhart, and Michael Cho, provided insightful advice and comments. Drs Sixue Chen and Jin Koh in the Proteomics Core at the Interdisciplinary Center of Biotechnology Research (ICBR) of University of Florida offered technical support. Some experiments reported here were performed in a laboratory constructed with support from National Institutes of Health Grant C06RR30414.	Alves D, 2008, NAT CHEM BIOL, V4, P287, DOI 10.1038/nchembio.82; Armanios M, 2009, AM J HUM GENET, V85, P823, DOI 10.1016/j.ajhg.2009.10.028; Armstrong CA, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160338; Armstrong CA, 2014, CURR BIOL, V24, P2006, DOI 10.1016/j.cub.2014.07.035; Beattie TL, 1998, CURR BIOL, V8, P177, DOI 10.1016/S0960-9822(98)70067-3; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Blackburn E H, 2000, Keio J Med, V49, P59; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2005, MOL CANCER RES, V3, P477, DOI 10.1158/1541-7786.MCR-05-0147; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blackburn EH, 2010, ANGEW CHEM INT EDIT, V49, P7405, DOI 10.1002/anie.201002387; Blackburn EH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003558; Boukamp P, 2007, EXP DERMATOL, V16, P71, DOI 10.1111/j.1600-0625.2006.00517.x; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Cohen SB, 2008, NAT METHODS, V5, P355, DOI 10.1038/NMETH.F.209; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Corey DR, 2009, CHEM BIOL, V16, P1219, DOI 10.1016/j.chembiol.2009.12.001; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Folini M, 2011, EXPERT OPIN THER TAR, V15, P579, DOI 10.1517/14728222.2011.556621; Forstemann K, 2005, EMBO REP, V6, P361, DOI 10.1038/sj.embor.7400374; Gardano L, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1243; Greider CW, 2006, COLD SPRING HARB SYM, V71, P225, DOI 10.1101/sqb.2006.71.063; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Hengesbach M, 2012, ANGEW CHEM INT EDIT, V51, P5876, DOI 10.1002/anie.201200526; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; Holmstrom ED, 2014, J PHYS CHEM B, V118, P3853, DOI 10.1021/jp501893c; Hsu M, 2007, P NATL ACAD SCI USA, V104, P11682, DOI 10.1073/pnas.0700327104; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Jiang QX, 2002, EMBO J, V21, P3575, DOI 10.1093/emboj/cdf380; Jurczyluk J, 2011, NUCLEIC ACIDS RES, V39, P1774, DOI 10.1093/nar/gkq1083; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku439; Maine GN, 2010, NAT PROTOC, V5, P1447, DOI 10.1038/nprot.2010.109; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Mender I, 2015, CANCER DISCOV, V5, P82, DOI 10.1158/2159-8290.CD-14-0609; Montanaro L, 2010, J PATHOL, V222, P345, DOI 10.1002/path.2777; Morrish TA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000357; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Parks JW, 2017, ANNU REV BIOPHYS, V46, P357, DOI 10.1146/annurev-biophys-062215-011256; Pongracz K, 2003, NUCLEOS NUCLEOT NUCL, V22, P1627, DOI 10.1081/NCN-120023085; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; Sandin S, 2014, CURR OPIN STRUC BIOL, V25, P104, DOI 10.1016/j.sbi.2014.02.003; Sauerwald A, 2013, NAT STRUCT MOL BIOL, V20, P454, DOI 10.1038/nsmb.2530; Shore D, 2009, EMBO J, V28, P2309, DOI 10.1038/emboj.2009.195; Skvortsov DA, 2011, ACTA NATURAE, V3, P48, DOI 10.32607/20758251-2011-3-1-48-68; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Nguyen THD, 2018, NATURE, V557, P190, DOI 10.1038/s41586-018-0062-x; Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319; Trahan C, 2009, RNA, V15, P235, DOI 10.1261/rna.1354009; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wallweber G, 2003, BIOCHEMISTRY-US, V42, P589, DOI 10.1021/bi026914a; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Wu RA, 2017, ANNU REV BIOCHEM, V86, P439, DOI 10.1146/annurev-biochem-061516-045019; Wu RA, 2015, ELIFE, V4, DOI 10.7554/eLife.08363; Yadav GP, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800139; Zhang JY, 2017, J GEN PHYSIOL, V149, P355, DOI 10.1085/jgp.201611664; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648	66	3	3	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11579	11596		10.1074/jbc.RA118.007234	http://dx.doi.org/10.1074/jbc.RA118.007234			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31186347	Green Published, hybrid			2022-12-28	WOS:000478717600020
J	Cao, QJ; Zhang, N; Zhou, R; Yao, LL; Li, XD				Cao, Qing-Juan; Zhang, Ning; Zhou, Rui; Yao, Lin-Lin; Li, Xiang-dong			The cargo adaptor proteins RILPL2 and melanophilin co-regulate myosin-5a motor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; molecular motor; allosteric regulation; actin; organelle; Rab; small GTPase; melanophilin; melanosome; myosin-5a; Rab36; vesicle transport	GLOBULAR TAIL DOMAIN; STRUCTURAL BASIS; LINKS RAB27A; VA; CALCIUM; ACTIVATION; RECEPTOR; COMPLEX; SLAC2-A/MELANOPHILIN; IDENTIFICATION	Vertebrate myosin-5a is an ATP-utilizing processive motor associated with the actin network and responsible for the transport and localization of several vesicle cargoes. To transport cargo efficiently and prevent futile ATP hydrolysis, myosin-5a motor function must be tightly regulated. The globular tail domain (GTD) of myosin-5a not only functions as the inhibitory domain but also serves as the binding site for a number of cargo adaptor proteins, including melanophilin (Mlph) and Rab-interacting lysosomal protein-like 2 (RILPL2). In this study, using various biochemical approaches, including ATPase, single-molecule motility, GST pulldown assays, and analytical ultracentrifugation, we demonstrate that the binding of both Mlph and RILPL2 to the GTD of myosin-5a is required for the activation of myosin-5a motor function under physiological ionic conditions. We also found that this activation is regulated by the small GTPase Rab36, a binding partner of RILPL2. In summary, our results indicate that RILPL2 is required for Mlph-mediated activation of Myo5a motor activity under physiological conditions and that Rab36 promotes this activation. We propose that Rab36 stimulates RILPL2 to interact with the myosin-5a GTD; this interaction then induces exposure of the Mlph-binding site in the GTD, enabling Mlph to interact with the GTD and activate myosin-5a motor activity.	[Cao, Qing-Juan; Zhang, Ning; Zhou, Rui; Yao, Lin-Lin; Li, Xiang-dong] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Grp Cell Motil & Muscle Contract, Beijing 100101, Peoples R China; [Zhou, Rui; Li, Xiang-dong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, XD (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Grp Cell Motil & Muscle Contract, Beijing 100101, Peoples R China.; Li, XD (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	lixd@ioz.ac.cn			National Natural Science Foundation of China [31672359, 31470791, 31171367]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31672359, 31470791, and 31171367. The authors declare that they have no conflicts of interest with the contents of this article.	Chen L, 2010, MOL MEMBR BIOL, V27, P23, DOI 10.3109/09687680903417470; Fukuda M, 2004, J BIOL CHEM, V279, P22314, DOI 10.1074/jbc.401791200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Geething NC, 2007, J BIOL CHEM, V282, P21518, DOI 10.1074/jbc.M701932200; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Ikebe M, 2008, BIOCHEM BIOPH RES CO, V369, P157, DOI 10.1016/j.bbrc.2008.01.057; Ji HH, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181252; Ji HH, 2015, BIOCHEM J, V469, P135, DOI 10.1042/BJ20141330; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lise MF, 2009, J CELL SCI, V122, P3810, DOI 10.1242/jcs.050344; Lu ZK, 2014, J BIOL CHEM, V289, P18535, DOI 10.1074/jbc.M114.569087; Matsui T, 2012, J BIOL CHEM, V287, P28619, DOI 10.1074/jbc.M112.370544; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nagashima K, 2002, FEBS LETT, V517, P233, DOI 10.1016/S0014-5793(02)02634-0; Pylypenko O, 2016, ELIFE, V5, DOI [10.7554/elife.17523, 10.7554/eLife.17523]; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Sckolnick M, 2013, J BIOL CHEM, V288, P29313, DOI 10.1074/jbc.M113.476929; Sellers JR, 2008, BIOCHEM BIOPH RES CO, V369, P176, DOI 10.1016/j.bbrc.2007.11.109; Shen M, 2016, P NATL ACAD SCI USA, V113, pE5812, DOI 10.1073/pnas.1607702113; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Trivedi DV, 2015, P NATL ACAD SCI USA, V112, P14593, DOI 10.1073/pnas.1517566112; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang TL, 2004, MOL BIOL CELL, V15, P815, DOI 10.1091/mbc.E03-06-0413; Wei ZY, 2013, P NATL ACAD SCI USA, V110, P11314, DOI 10.1073/pnas.1306768110; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yao LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10874; Zhang N, 2018, CELL MOL LIFE SCI, V75, P261, DOI 10.1007/s00018-017-2599-5; Zhang WB, 2016, J BIOL CHEM, V291, P13571, DOI 10.1074/jbc.M116.724328	40	5	6	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11333	11341		10.1074/jbc.RA119.007384	http://dx.doi.org/10.1074/jbc.RA119.007384			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31175157	Green Published, hybrid			2022-12-28	WOS:000478717400023
J	Delfarah, A; Parrish, S; Junge, JA; Yang, J; Seo, F; Li, S; Mac, J; Wang, P; Fraser, SE; Graham, NA				Delfarah, Alireza; Parrish, Sydney; Junge, Jason A.; Yang, Jesse; Seo, Frances; Li, Si; Mac, John; Wang, Pin; Fraser, Scott E.; Graham, Nicholas A.			Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						systems biology; metabolomics; nucleoside; nucleotide biosynthesis; epithelial cell; cellular senescence; aging; cell stress; growth arrest; ribonucleotide reductase regulatory subunit M2 (RRM2)	PLASMINOGEN-ACTIVATOR INHIBITOR-1; CELLULAR SENESCENCE; INCREASED GLYCOLYSIS; DNA-DAMAGE; METABOLISM; P53; STRESS; METABOLOMICS; HOMEOSTASIS; EXPRESSION	Cellular senescence is a mechanism by which cells permanently withdraw from the cell cycle in response to stresses including telomere shortening, DNA damage, or oncogenic signaling. Senescent cells contribute to both age-related degeneration and hyperplastic pathologies, including cancer. In culture, normal human epithelial cells enter senescence after a limited number of cell divisions, known as replicative senescence. Here, to investigate how metabolic pathways regulate replicative senescence, we used LC-MS-based metabolomics to analyze senescent primary human mammary epithelial cells (HMECs). We did not observe significant changes in glucose uptake or lactate secretion in senescent HMECs. However, analysis of intracellular metabolite pool sizes indicated that senescent cells exhibit depletion of metabolites from nucleotide synthesis pathways. Furthermore, stable isotope tracing with C-13-labeled glucose or glutamine revealed a dramatic blockage of flux of these two metabolites into nucleotide synthesis pathways in senescent HMECs. To test whether cellular immortalization would reverse these observations, we expressed telomerase in HMECs. In addition to preventing senescence, telomerase expression maintained metabolic flux from glucose into nucleotide synthesis pathways. Finally, we investigated whether inhibition of nucleotide synthesis in proliferating HMECs is sufficient to induce senescence. In proliferating HMECs, both pharmacological and genetic inhibition of ribonucleotide reductase regulatory subunit M2 (RRM2), a rate-limiting enzyme in dNTP synthesis, induced premature senescence with concomitantly decreased metabolic flux from glucose into nucleotide synthesis. Taken together, our results suggest that nucleotide synthesis inhibition plays a causative role in the establishment of replicative senescence in HMECs.	[Delfarah, Alireza; Parrish, Sydney; Yang, Jesse; Seo, Frances; Li, Si; Mac, John; Wang, Pin; Graham, Nicholas A.] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Junge, Jason A.; Fraser, Scott E.] Univ Southern Calif, Translat Imaging Ctr, Mol & Computat Biol, Los Angeles, CA 90089 USA; [Graham, Nicholas A.] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Graham, NA (corresponding author), Univ Southern Calif, 3710 McClintock Ave,RTH 509, Los Angeles, CA 90089 USA.	nagraham@usc.edu	Graham, Nicholas/GYD-5066-2022; Delfarah, Alireza/AAN-2110-2020; Graham, Nicholas A./X-2738-2019	Graham, Nicholas/0000-0002-6811-1941; Graham, Nicholas A./0000-0002-6811-1941; Fraser, Scott/0000-0002-5377-0223; Delfarah, Alireza/0000-0002-3192-5941; Yang, Jesse/0000-0002-6487-1652; Junge, Jason/0000-0002-9886-1751	Rose Hills Foundation; University of Southern California (USC) Provost's Office; USC Translational Imaging Center; Viterbi School of Engineering	Rose Hills Foundation; University of Southern California (USC) Provost's Office; USC Translational Imaging Center; Viterbi School of Engineering	This work was supported by the Rose Hills Foundation, the University of Southern California (USC) Provost's Office, the USC Translational Imaging Center, and the Viterbi School of Engineering. The authors declare that they have no conflicts of interest with the contents of this article.	Aird KM, 2015, CELL REP, V11, P893, DOI 10.1016/j.celrep.2015.04.014; Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; BITTLES AH, 1984, BIOSCIENCE REP, V4, P751, DOI 10.1007/BF01128816; Buescher JM, 2015, CURR OPIN BIOTECH, V34, P189, DOI 10.1016/j.copbio.2015.02.003; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chen QM, 2000, J CELL SCI, V113, P4087; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cordes T, 2016, CURR OPIN CHEM ENG, V14, P72, DOI 10.1016/j.coche.2016.08.019; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dikovskaya D, 2015, CELL REP, V12, P1483, DOI 10.1016/j.celrep.2015.07.055; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Eren M, 2014, SEMIN THROMB HEMOST, V40, P645, DOI 10.1055/s-0034-1387883; Foskolou IP, 2017, MOL CELL, V66, P206, DOI 10.1016/j.molcel.2017.03.005; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Garbe JC, 2014, CELL CYCLE, V13, P3423, DOI 10.4161/15384101.2014.954456; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Graham NA, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167159; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hsu CW, 2017, J CANCER, V8, P1378, DOI 10.7150/jca.17478; James EL, 2015, J PROTEOME RES, V14, P1854, DOI 10.1021/pr501221g; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kim J, 2017, NATURE, V546, P168, DOI 10.1038/nature22359; Knecht H, 2009, LEUKEMIA, V23, P565, DOI 10.1038/leu.2008.314; Kondoh H, 2005, CANCER RES, V65, P177; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kuo ML, 2012, SCI REP-UK, V2, DOI 10.1038/srep00822; Lamm N, 2015, EMBO MOL MED, V7, P1138, DOI 10.15252/emmm.201404824; Leikam C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.71; Li MX, 2013, PROTEOMICS, V13, P2585, DOI 10.1002/pmic.201200298; Mannava S, 2013, AM J PATHOL, V182, P142, DOI 10.1016/j.ajpath.2012.09.011; Mazurek S, 2001, ONCOGENE, V20, P6891, DOI 10.1038/sj.onc.1204792; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Mirzayans R, 2018, CANCERS, V10, DOI 10.3390/cancers10040118; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Moseley HNB, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-139; Pai CC, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020057; Popovic-Bijelic A, 2011, J INORG BIOCHEM, V105, P1422, DOI 10.1016/j.jinorgbio.2011.07.003; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stampfer MR, 2013, CELL MOL BIOL BREAST, P323, DOI [10.1007/978-1-62703-634-4_15, DOI 10.1007/978-1-62703-634-4_15]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Vaughan DE, 2017, ARTERIOSCL THROM VAS, V37, P1446, DOI 10.1161/ATVBAHA.117.309451; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Wiley CD, 2016, CELL METAB, V23, P1013, DOI 10.1016/j.cmet.2016.05.010; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816	61	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10564	10578		10.1074/jbc.RA118.005806	http://dx.doi.org/10.1074/jbc.RA118.005806			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138644	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000478717100016
J	Johnson, K; Learn, BA; Estrella, MA; Bailey, S				Johnson, Kaitlin; Learn, Brian A.; Estrella, Michael A.; Bailey, Scott			Target sequence requirements of a type III-B CRISPR-Cas immune system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR-Cas; CRISPR-RNA; crRNA; deoxyribonuclease (DNase); ribonuclease; RNA; DNA; bacterial immunity; Cmr effector complex; nucleotide mismatch; sequence similarity	RNA CLEAVAGE; DNA CLEAVAGE; CMR COMPLEX; DUAL-RNA; REPEATS; MECHANISM; DEFENSE; BACTERIOPHAGE; TRANSCRIPTION; ENDONUCLEASE	CRISPR-Cas systems are RNA-based immune systems that protect many prokaryotes from invasion by viruses and plasmids. Type III CRISPR systems are unique, as their targeting mechanism requires target transcription. Upon transcript binding, DNA cleavage by type III effector complexes is activated. Type III systems must differentiate between invader and native transcripts to prevent autoimmunity. Transcript origin is dictated by the sequence that flanks the 3 ' end of the RNA target site (called the PFS). However, how the PFS is recognized may vary among different type III systems. Here, using purified proteins and in vitro assays, we define how the type III-B effector from the hyperthermophilic bacterium Thermotoga maritima discriminates between native and invader transcripts. We show that native transcripts are recognized by base pairing at positions -2 to -5 of the PFS and by a guanine at position -1, which is not recognized by base pairing. We also show that mismatches with the RNA target are highly tolerated in this system, except for those nucleotides adjacent to the PFS. These findings define the target requirement for the type III-B system from T. maritima and provide a framework for understanding the target requirements of type III systems as a whole.	[Johnson, Kaitlin; Learn, Brian A.; Estrella, Michael A.; Bailey, Scott] Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Bailey, Scott] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Bailey, S (corresponding author), Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.; Bailey, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	scott.bailey@jhu.edu		Bailey, Scott/0000-0003-1953-7089; Estrella, Michael/0000-0002-1721-9418	National Institutes of Health [GM097330]; Ruth L. Kirschstein National Institutes of Health F31 fellowship [GM105364]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Institutes of Health F31 fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM097330 (to S. B.) and Ruth L. Kirschstein National Institutes of Health F31 fellowship GM105364 (to M. A. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Benda C, 2014, MOL CELL, V56, P43, DOI 10.1016/j.molcel.2014.09.002; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han WY, 2018, NUCLEIC ACIDS RES, V46, P10319, DOI 10.1093/nar/gky844; Han WY, 2017, NUCLEIC ACIDS RES, V45, P1983, DOI 10.1093/nar/gkw1274; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Jia N, 2019, MOL CELL, V73, P264, DOI 10.1016/j.molcel.2018.11.007; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kazlauskiene M, 2017, SCIENCE, V357, P605, DOI 10.1126/science.aao0100; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Liu TY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170552; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Maniv I, 2016, J BACTERIOL, V198, P941, DOI 10.1128/JB.00897-15; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Meeske AJ, 2018, MOL CELL, V71, P791, DOI 10.1016/j.molcel.2018.07.013; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Niewoehner O, 2017, NATURE, V548, P543, DOI 10.1038/nature23467; Park KH, 2017, EMBO REP, V18, P826, DOI 10.15252/embr.201643700; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pyenson NC, 2017, CELL HOST MICROBE, V22, P343, DOI 10.1016/j.chom.2017.07.016; Pyenson NC, 2017, CURR OPIN MICROBIOL, V37, P150, DOI 10.1016/j.mib.2017.08.003; Ramia NF, 2014, CELL REP, V9, P1610, DOI 10.1016/j.celrep.2014.11.007; Rouillon C, 2018, ELIFE, V7, DOI 10.7554/eLife.36734; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Silas S, 2017, ELIFE, V6, DOI 10.7554/eLife.27601; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; Terns MP, 2018, MOL CELL, V72, P404, DOI 10.1016/j.molcel.2018.09.018; Walker FC, 2017, NUCLEIC ACIDS RES, V45, P2112, DOI 10.1093/nar/gkw891; Wang L, 2019, MOL CELL, V73, P278, DOI 10.1016/j.molcel.2018.11.008; Wei WJ, 2019, FASEB J, V33, P1496, DOI 10.1096/fj.201800557RR; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; You LL, 2019, CELL, V176, P239, DOI 10.1016/j.cell.2018.10.052; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang J, 2016, NUCLEIC ACIDS RES, V44, P1789, DOI 10.1093/nar/gkw020; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013; Zhu X, 2015, NUCLEIC ACIDS RES, V43, P1257, DOI 10.1093/nar/gku1355	59	13	13	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10290	10299		10.1074/jbc.RA119.008728	http://dx.doi.org/10.1074/jbc.RA119.008728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31110048	Green Published, hybrid			2022-12-28	WOS:000474445600019
J	Wang, KX; Sturt-Gillespie, B; Hittle, JC; Macdonald, D; Chan, GK; Yen, TJ; Liu, ST				Wang, Kexi; Sturt-Gillespie, Brianne; Hittle, James C.; Macdonald, Dawn; Chan, Gordon K.; Yen, Tim J.; Liu, Song-Tao			Thyroid hormone receptor interacting protein 13 (TRIP13) AAA-ATPase is a novel mitotic checkpoint-silencing protein (vol 289, pg 23928, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Chan, Gordon/AAN-7784-2020	Chan, Gordon/0000-0003-0497-9407				Wang KX, 2014, J BIOL CHEM, V289, P23928, DOI 10.1074/jbc.M114.585315	1	1	1	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					10019	10019		10.1074/jbc.AAC119.009554	http://dx.doi.org/10.1074/jbc.AAC119.009554			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31227624	Green Published, hybrid			2022-12-28	WOS:000473277900032
J	Pandey, S; Li, XX; Srivastava, A; Baidya, M; Kumari, P; Dwivedi, H; Chaturvedi, M; Ghosh, E; Woodruff, TM; Shukla, AK				Pandey, Shubhi; Li, Xaria X.; Srivastava, Ashish; Baidya, Mithu; Kumari, Punita; Dwivedi, Hemlata; Chaturvedi, Madhu; Ghosh, Eshan; Woodruff, Trent M.; Shukla, Arun K.			Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-protein-coupled receptor (GPCR); arrestin; complement; cell signaling; signal transduction	BETA-ARRESTIN; ANAPHYLATOXIN; DISCOVERY	The human complement component, C5a, binds two different seven-transmembrane receptors termed C5aR1 and C5aR2. C5aR1 is a prototypical G-protein-coupled receptor that couples to the G(i) subfamily of heterotrimeric G-proteins and -arrestins (arrs) following C5a stimulation. Peptide fragments derived from the C terminus of C5a can still interact with the receptor, albeit with lower affinity, and can act as agonists or antagonists. However, whether such fragments might display ligand bias at C5aR1 remains unexplored. Here, we compare C5a and a modified C-terminal fragment of C5a, C5a(pep), in terms of G-protein coupling, arr recruitment, endocytosis, and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase activation at the human C5aR1. We discover that C5a(pep) acts as a full agonist for G(i) coupling as measured by cAMP response and extracellular signal-regulated kinase 1/2 phosphorylation, but it displays partial agonism for arr recruitment and receptor endocytosis. Interestingly, C5a(pep) exhibits full-agonist efficacy with respect to inhibiting lipopolysaccharide-induced interleukin-6 secretion in human macrophages, but its ability to induce human neutrophil migration is substantially lower compared with C5a, although both these responses are sensitive to pertussis toxin treatment. Taken together, our data reveal that compared with C5a, C5a(pep) exerts partial efficacy for arr recruitment, receptor trafficking, and neutrophil migration. Our findings therefore uncover functional bias at C5aR1 and also provide a framework that can potentially be extended to chemokine receptors, which also typically interact with chemokines through a biphasic mechanism.	[Pandey, Shubhi; Srivastava, Ashish; Baidya, Mithu; Kumari, Punita; Dwivedi, Hemlata; Chaturvedi, Madhu; Ghosh, Eshan; Shukla, Arun K.] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Li, Xaria X.; Woodruff, Trent M.] Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld 4072, Australia	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; University of Queensland	Shukla, AK (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.; Woodruff, TM (corresponding author), Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	t.woodruff@uq.edu.au; arshukla@iitk.ac.in	Li, Xaria X/ABG-7342-2020; Woodruff, Trent/AAS-4629-2020; Woodruff, Trent M/B-4861-2009; Baidya, Mithu/AAA-2984-2021	Li, Xaria X/0000-0001-5924-2977; Woodruff, Trent/0000-0003-1382-911X; Woodruff, Trent M/0000-0003-1382-911X; Srivastava, Ashish/0000-0002-1587-1859; Ghosh, Eshan/0000-0003-4532-1329; Baidya, Mithu/0000-0002-4255-244X; shukla, arun/0000-0003-2910-8288	DBT Wellcome Trust India Alliance Intermediate Fellowship [IA/I/14/1/501285]; Department of Biotechnology of the Government of India Innovative Young Biotechnologist Award [BT/08/IYBA/2014-3]; LADY TATA Memorial Trust Young Researcher Award; Science and Engineering Research Board [SB/SO/BB-121/2013]; National Health and Medical Research Council of Australia [1082271]; National Health and Medical Research Council Career Development Fellowship [1105420]; Council of Scientific and Industrial Research Grant [37[1637]14/EMR-II]	DBT Wellcome Trust India Alliance Intermediate Fellowship; Department of Biotechnology of the Government of India Innovative Young Biotechnologist Award; LADY TATA Memorial Trust Young Researcher Award; Science and Engineering Research Board; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Council of Scientific and Industrial Research Grant	This work was supported by DBT Wellcome Trust India Alliance Intermediate Fellowship IA/I/14/1/501285 (to A. K. S.), Department of Biotechnology of the Government of India Innovative Young Biotechnologist Award BT/08/IYBA/2014-3 (to A. K. S.), a LADY TATA Memorial Trust Young Researcher Award (to A. K. S.), Science and Engineering Research Board Grant SB/SO/BB-121/2013, Council of Scientific and Industrial Research Grant 37[1637]14/EMR-II, and National Health and Medical Research Council of Australia Project Grant 1082271. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Health and Medical Research Council Career Development Fellowship 1105420.	Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Braun L, 2003, J BIOL CHEM, V278, P4277, DOI 10.1074/jbc.M210120200; Croker DE, 2016, IMMUNOL CELL BIOL, V94, P787, DOI 10.1038/icb.2016.43; Croker DE, 2013, IMMUNOL CELL BIOL, V91, P625, DOI 10.1038/icb.2013.48; Dwivedi H, 2018, CURR BIOL, V28, pR324, DOI 10.1016/j.cub.2018.02.027; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Gundry J, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00017; Gurevich Vsevolod V, 2018, World J Biol Chem, V9, P25, DOI 10.4331/wjbc.v9.i3.25; Gutkind JS, 2018, NAT REV MOL CELL BIO, V19, P615, DOI 10.1038/s41580-018-0041-y; Ho JH, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar4309; KAWAI M, 1992, J MED CHEM, V35, P220, DOI 10.1021/jm00080a004; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; KONTEATIS ZD, 1994, J IMMUNOL, V153, P4200; Kumar BA, 2017, METHOD CELL BIOL, V142, P27, DOI 10.1016/bs.mcb.2017.07.012; Kumari P, 2019, METHOD CELL BIOL, V149, P141, DOI 10.1016/bs.mcb.2018.09.015; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Liu H, 2018, NAT STRUCT MOL BIOL, V25, P472, DOI 10.1038/s41594-018-0067-z; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; Milligan G, 2018, TRENDS PHARMACOL SCI, V39, P481, DOI 10.1016/j.tips.2018.02.005; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Pandey S, 2019, METHOD CELL BIOL, V149, P131, DOI 10.1016/bs.mcb.2018.09.014; Ranjan R, 2017, TRENDS CELL BIOL, V27, P861, DOI 10.1016/j.tcb.2017.05.008; Robertson N, 2018, NATURE, V553, P111, DOI 10.1038/nature25025; Schatz-Jakobsen JA, 2014, ACTA CRYSTALLOGR D, V70, P1704, DOI 10.1107/S139900471400844X; Seow V, 2016, SCI REP-UK, V6, DOI 10.1038/srep24575; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214; Srivastava A, 2015, TRENDS ENDOCRIN MET, V26, P628, DOI 10.1016/j.tem.2015.09.001; Sumichika H, 2002, J BIOL CHEM, V277, P49403, DOI 10.1074/jbc.M209672200; van Lith LHC, 2009, J BIOMOL SCREEN, V14, P1067, DOI 10.1177/1087057109341407; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wang J, 2017, CELL DEATH DIS, V8, P1, DOI DOI 10.1038/S41467-017-01855-Z]; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269	34	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9416	9429		10.1074/jbc.RA119.007485	http://dx.doi.org/10.1074/jbc.RA119.007485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31036565	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000472713000012
J	Subramanian, C; Frank, MW; Batte, JL; Whaley, SG; Rock, CO				Subramanian, Chitra; Frank, Matthew W.; Batte, Justin L.; Whaley, Sarah G.; Rock, Charles O.			Oleate hydratase from Staphylococcus aureus protects against palmitoleic acid, the major antimicrobial fatty acid produced by mammalian skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Staphylococcus aureus (S; aureus); fatty acid metabolism; bacterial metabolism; host defense; host-pathogen interaction; innate immunity; antimicrobial fatty acid; FAD; hydroxy fatty acid; oleate hydratase; sebum	GUT MICROBIAL METABOLITE; DOUBLE-BOND HYDRATASE; 10-HYDROXY-CIS-12-OCTADECENOIC ACID; LINOLEIC-ACID; PPAR-GAMMA; OLEIC-ACID; BACTERIA; PATHWAY; IDENTIFICATION; HOMEOSTASIS	Oleate hydratases (OhyAs) belong to a large family of bacterial proteins catalyzing the hydration or isomerization of double bonds in unsaturated fatty acids. A Staphylococcus aureus gene (Sa0102) is predicted to encode an OhyA. Here, we recombinantly expressed and purified SaOhyA and found that it forms a homodimer that requires FAD for activity. SaOhyA hydrates only unsaturated fatty acids containing cis-9 double bonds, but not fatty acids with trans-9 double bonds or cis double bonds at other positions. SaOhyA products were not detected in S. aureus phospholipids and were released into the growth medium. S. aureus does not synthesize unsaturated fatty acids, and the SaOhyA substrates are derived from infection sites. Palmitoleate (16:1(9Z)) is a major mammalian skin-produced antimicrobial fatty acid that protects against S. aureus infection, and we observed that it is an SaOhyA substrate and that its hydroxylated derivative is not antimicrobial. Treatment of S. aureus with 24 m 16:1(9Z) immediately arrested growth, followed by growth resumption after a lag period of 2 h. The ohyA mutant strain did not recover from the 16:1(9Z) challenge, and increasing SaOhyA expression using a plasmid system prevented the initial growth arrest. Challenging S. aureus with sapienic acid (16:1(6Z)), an antimicrobial fatty acid produced only by human skin, arrested growth without recovery in WT, ohyA, and SaOhyA-overexpressing strains. We conclude that SaOhyA protects S. aureus from palmitoleic acid, the antimicrobial unsaturated fatty acid produced by most mammals, and that sapienic acid, uniquely produced by humans, counters the OhyA-dependent bacterial defense mechanism.	[Subramanian, Chitra; Frank, Matthew W.; Batte, Justin L.; Whaley, Sarah G.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Subramanian, Chitra/N-9210-2018; Rock, Charles/N-2256-2018	Subramanian, Chitra/0000-0003-1101-5307; Whaley, Sarah/0000-0001-5851-0490; Rock, Charles/0000-0001-8648-4189	National Institutes of Health [GM034496]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM034496, Cancer Center Support Grant CA21765, and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alnaseri H, 2015, J BACTERIOL, V197, P1893, DOI 10.1128/JB.02607-14; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bergamo P, 2014, J FUNCT FOODS, V11, P192, DOI 10.1016/j.jff.2014.10.007; Bevers LE, 2009, J BACTERIOL, V191, P5010, DOI 10.1128/JB.00306-09; Bose JL, 2013, APPL ENVIRON MICROB, V79, P2218, DOI 10.1128/AEM.00136-13; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Demming RM, 2018, CURR OPIN CHEM BIOL, V43, P43, DOI 10.1016/j.cbpa.2017.10.030; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; Engleder M, 2015, CHEMBIOCHEM, V16, P1730, DOI 10.1002/cbic.201500269; Ericson ME, 2017, MBIO, V8, DOI 10.1128/mBio.00988-17; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Ge L, 2003, J INVEST DERMATOL, V120, P707, DOI 10.1046/j.1523-1747.2003.12123.x; Georgel P, 2005, INFECT IMMUN, V73, P4512, DOI 10.1128/IAI.73.8.4512-4521.2005; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kidani Y, 2012, IMMUNOL REV, V249, P72, DOI 10.1111/j.1600-065X.2012.01153.x; Kim KR, 2013, BIOTECHNOL ADV, V31, P1473, DOI 10.1016/j.biotechadv.2013.07.004; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Kishino S, 2011, BIOCHEM BIOPH RES CO, V416, P188, DOI 10.1016/j.bbrc.2011.11.022; Marion-Letellier R, 2016, EUR J PHARMACOL, V785, P44, DOI 10.1016/j.ejphar.2015.11.004; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Miyamoto J, 2015, J BIOL CHEM, V290, P2902, DOI 10.1074/jbc.M114.610733; MORTIMER CE, 1974, J BIOL CHEM, V249, P2833; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Schmid J., 2017, J MOL CATAL B, V133, pS243, DOI [10.1016/j.molcatb.2017.01.010, DOI 10.1016/J.MOLCATB.2017.01.010]; Takigawa H, 2005, DERMATOLOGY, V211, P240, DOI 10.1159/000087018; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Truong-Bolduc QC, 2014, J INFECT DIS, V209, P1485, DOI 10.1093/infdis/jit660; Volkov A, 2013, ACTA CRYSTALLOGR D, V69, P648, DOI 10.1107/S0907444913000991; Volkov A, 2010, J BIOL CHEM, V285, P10353, DOI 10.1074/jbc.M109.081851; WALLEN LL, 1962, ARCH BIOCHEM BIOPHYS, V99, P249, DOI 10.1016/0003-9861(62)90006-1; Wille JJ, 2003, SKIN PHARMACOL APPL, V16, P176, DOI 10.1159/000069757; Zhang LS, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0296-x; Zorn K, 2016, PROG LIPID RES, V63, P153, DOI 10.1016/j.plipres.2016.06.001	38	21	21	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9285	9294		10.1074/jbc.RA119.008439	http://dx.doi.org/10.1074/jbc.RA119.008439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31018965	Green Published, hybrid			2022-12-28	WOS:000471751600021
J	Brody, MJ; Vanhoutte, D; Bakshi, CV; Liu, RJ; Correll, RN; Sargent, MA; Molkentin, JD				Brody, Matthew J.; Vanhoutte, Davy; Bakshi, Chinmay V.; Liu, Ruije; Correll, Robert N.; Sargent, Michelle A.; Molkentin, Jeffery D.			Disruption of valosin-containing protein activity causes cardiomyopathy and reveals pleiotropic functions in cardiac homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; cardiomyopathy; cardiomyocyte; protein aggregation; endoplasmic reticulum-associated protein degradation (ERAD); RNA turnover	RETICULUM-ASSOCIATED DEGRADATION; INCLUSION-BODY MYOPATHY; INNER NUCLEAR-MEMBRANE; ENDOPLASMIC-RETICULUM; AAA-ATPASE; PAGET-DISEASE; FRONTOTEMPORAL DEMENTIA; QUALITY-CONTROL; MULTISYSTEM PROTEINOPATHY; RIBOSOME BIOGENESIS	Valosin-containing protein (VCP), also known as p97, is an ATPase with diverse cellular functions, although the most highly characterized is targeting of misfolded or aggregated proteins to degradation pathways, including the endoplasmic reticulum-associated degradation (ERAD) pathway. However, how VCP functions in the heart has not been carefully examined despite the fact that human mutations in VCP cause Paget disease of bone and frontotemporal dementia, an autosomal dominant multisystem proteinopathy that includes disease in the heart, skeletal muscle, brain, and bone. Here we generated heart-specific transgenic mice overexpressing WT VCP or a VCPK524A mutant with deficient ATPase activity. Transgenic mice overexpressing WT VCP exhibit normal cardiac structure and function, whereas mutant VCP-overexpressing mice develop cardiomyopathy. Mechanistically, mutant VCP-overexpressing hearts up-regulate ERAD complex components and have elevated levels of ubiquitinated proteins prior to manifestation of cardiomyopathy, suggesting dysregulation of ERAD and inefficient clearance of proteins targeted for proteasomal degradation. The hearts of mutant VCP transgenic mice also exhibit profound defects in cardiomyocyte nuclear morphology with increased nuclear envelope proteins and nuclear lamins. Proteomics revealed overwhelming interactions of endogenous VCP with ribosomal, ribosome-associated, and RNA-binding proteins in the heart, and impairment of cardiac VCP activity resulted in aggregation of large ribosomal subunit proteins. These data identify multifactorial functions and diverse mechanisms whereby VCP regulates cardiomyocyte protein and RNA quality control that are critical for cardiac homeostasis, suggesting how human VCP mutations negatively affect the heart.	[Brody, Matthew J.; Vanhoutte, Davy; Bakshi, Chinmay V.; Liu, Ruije; Correll, Robert N.; Sargent, Michelle A.; Molkentin, Jeffery D.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, 240 Albert Sabin Way,MLC7020, Cincinnati, OH 45229 USA; [Molkentin, Jeffery D.] Howard Hughes Med Inst, 240 Albert Sabin Way,MLC7020, Cincinnati, OH 45229 USA; [Liu, Ruije] Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA; [Correll, Robert N.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; Grand Valley State University; University of Alabama System; University of Alabama Tuscaloosa	Molkentin, JD (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, 240 Albert Sabin Way,MLC7020, Cincinnati, OH 45229 USA.; Molkentin, JD (corresponding author), Howard Hughes Med Inst, 240 Albert Sabin Way,MLC7020, Cincinnati, OH 45229 USA.	Jeff.Molkentin@cchmc.org	Vanhoutte, Davy/F-8071-2017	Vanhoutte, Davy/0000-0002-8147-6953; Molkentin, Jeffery/0000-0002-3558-6529; liu, ruijie/0000-0002-2468-0579; Brody, Matthew/0000-0003-4904-7670	NIH [F32HL124698, K99HL136695, R01HL105924]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL124698, R01HL105924, K99HL136695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants F32HL124698 and K99HL136695 (to M.J.B.) and R01HL105924 (to J.D.M.) and grants from the Howard Hughes Medical Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht M, 2004, EUR J BIOCHEM, V271, P3155, DOI 10.1111/j.1432-1033.2004.04245.x; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; An H, 2018, NAT CELL BIOL, V20, P135, DOI 10.1038/s41556-017-0007-x; Aulas A, 2015, J CELL BIOL, V209, P73, DOI 10.1083/jcb.201408092; Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183; Bernasconi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013008; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brody MJ, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00114-18; Brody MJ, 2016, AM J PHYSIOL-HEART C, V310, pH269, DOI 10.1152/ajpheart.00717.2014; Brody MJ, 2016, MOL CELL BIOL, V36, P2, DOI 10.1128/MCB.00607-15; Brody MJ, 2013, J MOL CELL CARDIOL, V62, P237, DOI 10.1016/j.yjmcc.2013.05.020; Brody MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051621; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Chu A, 1998, FEBS LETT, V441, P165, DOI 10.1016/S0014-5793(98)01534-8; Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050; Defenouillere Q, 2016, J BIOL CHEM, V291, P12245, DOI 10.1074/jbc.M116.722264; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Doroudgar S, 2015, CIRC RES, V117, P536, DOI 10.1161/CIRCRESAHA.115.306993; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Grubb S, 2012, MOL BIOL CELL, V23, P520, DOI 10.1091/mbc.E11-08-0704; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Iida Y, 2011, J BIOL CHEM, V286, P16929, DOI 10.1074/jbc.M110.215871; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jeon H., 2016, SCI REP-UK, V6, P1; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Kobayashi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36780; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Leitman J, 2014, MOL BIOL CELL, V25, P1050, DOI 10.1091/mbc.E13-06-0350; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Maric M, 2014, SCIENCE, V346, P440, DOI 10.1126/science.1253596; Matsubara S, 2016, NEUROMUSCULAR DISORD, V26, P436, DOI 10.1016/j.nmd.2016.05.001; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Mehta SG, 2013, CLIN GENET, V83, P422, DOI 10.1111/cge.12000; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Pantazopoulou M, 2016, J CELL SCI, V129, P3770, DOI 10.1242/jcs.189332; Paredes F, 2016, FREE RADICAL BIO MED, V90, P206, DOI 10.1016/j.freeradbiomed.2015.11.024; Partridge JJ, 2003, MOL BIOL CELL, V14, P4221, DOI 10.1091/mbc.E03-02-0111; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Quan HY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23289-3; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Raman M, 2015, NAT CELL BIOL, V17, P1356, DOI 10.1038/ncb3238; Sakoh-Nakatogawa M, 2009, J BIOL CHEM, V284, P11815, DOI 10.1074/jbc.M900813200; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Shih YT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11020; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Song CC, 2015, BBA-MOL CELL RES, V1853, P222, DOI 10.1016/j.bbamcr.2014.10.019; Stroud MJ, 2014, CIRC RES, V114, P538, DOI 10.1161/CIRCRESAHA.114.301236; Sun SY, 2014, P NATL ACAD SCI USA, V111, pE582, DOI 10.1073/pnas.1318114111; Taylor JP, 2015, NEUROLOGY, V85, P658, DOI 10.1212/WNL.0000000000001862; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Zhou HL, 2013, GENE DEV, V27, P1046, DOI 10.1101/gad.215681.113; Zhou N, 2017, AGING CELL, V16, P1168, DOI 10.1111/acel.12653	78	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8918	8929		10.1074/jbc.RA119.007585	http://dx.doi.org/10.1074/jbc.RA119.007585			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31006653	Green Published, hybrid			2022-12-28	WOS:000470971100025
J	Charafeddine, RA; Cortopassi, WA; Lak, P; Tan, R; McKenney, RJ; Jacobson, MP; Barber, DL; Wittmann, T				Charafeddine, Rabab A.; Cortopassi, Wilian A.; Lak, Parnian; Tan, Ruensern; McKenney, Richard J.; Jacobson, Matthew P.; Barber, Diane L.; Wittmann, Torsten			Tau repeat regions contain conserved histidine residues that modulate microtubule-binding in response to changes in pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microtubule; histidine; molecular dynamics; cancer biology; neurobiology; Tau protein (Tau); microtubule-associated protein (MAP); intrinsically disordered protein; neurodegeneration; protein-protein interaction; intracellular pH; neuronal cytoskeleton; pH sensing	CATION-PI INTERACTIONS; NA+/H+-EXCHANGER NHE1; DYSREGULATED PH; ACIDIFICATION; PROTEINS; DYNAMICS; DOMAIN; NBCN1; ENDS; MAP2	Tau, a member of the MAP2/tau family of microtubule-associated proteins, stabilizes and organizes axonal microtubules in healthy neurons. In neurodegenerative tauopathies, tau dissociates from microtubules and forms neurotoxic extracellular aggregates. MAP2/tau family proteins are characterized by three to five conserved, intrinsically disordered repeat regions that mediate electrostatic interactions with the microtubule surface. Here, we used molecular dynamics, microtubule-binding experiments, and live-cell microscopy, revealing that highly-conserved histidine residues near the C terminus of each microtubule-binding repeat are pH sensors that can modulate tau-microtubule interaction strength within the physiological intracellular pH range. We observed that at low pH (<7.5), these histidines are positively charged and interact with phenylalanine residues in a hydrophobic cleft between adjacent tubulin dimers. At higher pH (>7.5), tau deprotonation decreased binding to microtubules both in vitro and in cells. Electrostatic and hydrophobic characteristics of histidine were both required for tau-microtubule binding, as substitutions with constitutively and positively charged nonaromatic lysine or uncharged alanine greatly reduced or abolished tau-microtubule binding. Consistent with these findings, tau-microtubule binding was reduced in a cancer cell model with increased intracellular pH but was rapidly restored by decreasing the pH to normal levels. These results add detailed insights into the intracellular regulation of tau activity that may be relevant in both normal and pathological conditions.	[Charafeddine, Rabab A.; Barber, Diane L.; Wittmann, Torsten] Univ Calif San Francisco, Dept Cell & Tissue Biol, 513 Parnassus Ave, San Francisco, CA 94143 USA; [Cortopassi, Wilian A.; Lak, Parnian; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Tan, Ruensern; McKenney, Richard J.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Wittmann, T (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	torsten.wittmann@ucsf.edu	Jacobson, Matthew/Y-5161-2018; Cortopassi, Wilian/P-3136-2014; Wittmann, Torsten/F-9833-2013	Jacobson, Matthew/0000-0001-6262-655X; Tan, Ruensern/0000-0002-6165-5938; Cortopassi, Wilian/0000-0001-8038-7847; Wittmann, Torsten/0000-0001-9134-691X	Paul G. Allen Frontiers grant; National Institutes of Health from NIGMS [R01GM116384, R35 GM124889]; National Institutes of Health from NINDS [R01 NS107480]; NATIONAL CANCER INSTITUTE [R01CA197855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124889, R01GM116384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS107480] Funding Source: NIH RePORTER	Paul G. Allen Frontiers grant; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health from NINDS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Paul G. Allen Frontiers grant (to D. L. B., M. P. J., and T. W.), by National Institutes of Health Grants R01GM116384 (to D. L. B.) and R35 GM124889 (to R. J. M.) from NIGMS, and by National Institutes of Health Grant R01 NS107480 (to T. W.) from NINDS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Bouziad N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01575-4; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Biswas S, 2018, J NEUROSCI, V38, P291, DOI 10.1523/JNEUROSCI.2281-17.2017; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Chau MF, 1998, BIOCHEMISTRY-US, V37, P17692, DOI 10.1021/bi9812118; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Choi CH, 2013, J CELL BIOL, V202, P849, DOI 10.1083/jcb.201302131; Dehmelt L, 2005, GENOME BIOL, V6; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Ettinger A, 2016, CURR BIOL, V26, P1549, DOI 10.1016/j.cub.2016.04.020; Ettinger A, 2014, METHOD CELL BIOL, V123, P77, DOI 10.1016/B978-0-12-420138-5.00005-7; Flinck M, 2018, CELL CYCLE, V17, P1056, DOI 10.1080/15384101.2018.1464850; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Goedert M, 2018, FEBS LETT, V592, P2383, DOI 10.1002/1873-3468.13108; Grillo-Hill BK, 2015, ELIFE, V4, DOI 10.7554/eLife.03270; Harguindey S, 2017, SEMIN CANCER BIOL, V43, P157, DOI 10.1016/j.semcancer.2017.02.003; Hayashi H, 2008, AM J PHYSIOL-CELL PH, V294, pC526, DOI 10.1152/ajpcell.00219.2007; He WT, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0950-3; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; Kadavath H, 2015, P NATL ACAD SCI USA, V112, P7501, DOI 10.1073/pnas.1504081112; Kellogg EH, 2018, SCIENCE, V360, P1242, DOI 10.1126/science.aat1780; Kimura T, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00044; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kumar K, 2018, CHEM SCI, V9, P2655, DOI 10.1039/c7sc04905f; Lauritzen G, 2012, CANCER LETT, V317, P172, DOI 10.1016/j.canlet.2011.11.023; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Ludwig FT, 2013, J CELL PHYSIOL, V228, P1351, DOI 10.1002/jcp.24293; Majdi A, 2016, J NEUROSCI RES, V94, P879, DOI 10.1002/jnr.23757; Martinho M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32096-9; Matlashov ME, 2015, BBA-GEN SUBJECTS, V1850, P2318, DOI 10.1016/j.bbagen.2015.08.002; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Meima ME, 2009, J BIOL CHEM, V284, P26666, DOI 10.1074/jbc.M109.019448; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Qiang L, 2006, J NEUROSCI, V26, P3120, DOI 10.1523/JNEUROSCI.5392-05.2006; Ramirez-Rios S, 2016, MOL BIOL CELL, V27, P2924, DOI 10.1091/mbc.E16-01-0029; Ramkumar A, 2018, DEV DYNAM, V247, P138, DOI 10.1002/dvdy.24599; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Ross JL, 2016, BIOPHYS J, V111, P909, DOI 10.1016/j.bpj.2016.07.037; Schonichen A, 2013, ANNU REV BIOPHYS, V42, P289, DOI 10.1146/annurev-biophys-050511-102349; Schwiening CJ, 2002, J PHYSIOL-LONDON, V538, P371, DOI 10.1113/jphysiol.2001.013055; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shigematsu H, 2018, J CELL BIOL, V217, P4155, DOI 10.1083/jcb.201711182; Smoter M, 2011, CANCER CHEMOTH PHARM, V68, P553, DOI 10.1007/s00280-011-1696-7; Srivastava J, 2008, P NATL ACAD SCI USA, V105, P14436, DOI 10.1073/pnas.0805163105; Stehbens S, 2012, METHOD ENZYMOL, V504, P293, DOI 10.1016/B978-0-12-391857-4.00015-X; Steinbrecher T, 2012, J CHEM THEORY COMPUT, V8, P4405, DOI 10.1021/ct300613v; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Webb BA, 2016, J BIOL CHEM, V291, P24096, DOI 10.1074/jbc.M116.736215; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; White KA, 2018, J CELL BIOL, V217, P3965, DOI 10.1083/jcb.201712041; White KA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam9931; White KA, 2017, J CELL SCI, V130, P663, DOI 10.1242/jcs.195297; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008	58	10	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8779	8790		10.1074/jbc.RA118.007004	http://dx.doi.org/10.1074/jbc.RA118.007004			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30992364	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000470971100014
J	Hoffman, AM; Chen, Q; Zheng, TL; Nicchitta, CV				Hoffman, Alyson M.; Chen, Qiang; Zheng, Tianli; Nicchitta, Christopher V.			y Heterogeneous translational landscape of the endoplasmic reticulum revealed by ribosome proximity labeling and transcriptome analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); ribosome; mRNA; RNA-binding protein; membrane structure; BioID proximity labeling; proteomics; ribosome receptor; Sec translocon	PROTEIN TRANSLOCATION; MESSENGER-RNAS; SCALE IDENTIFICATION; BOUND RIBOSOMES; IN-VITRO; BINDING; ER; ORGANIZATION; COMPLEX; YEAST	The endoplasmic reticulum (ER) is a nexus for mRNA localization and translation, and recent studies have demonstrated that ER-bound ribosomes also play a transcriptome-wide role in regulating proteome composition. The Sec61 translocon (SEC61) serves as the receptor for ribosomes that translate secretory/integral membrane protein-encoding mRNAs, but whether SEC61 also serves as a translation site for cytosolic protein-encoding mRNAs remains unknown. Here, using a BioID proximity-labeling approach in HEK293T Flp-In cell lines, we examined interactions between ER-resident proteins and ribosomes in vivo. Using in vitro analyses, we further focused on bona fide ribosome interactors (i.e. SEC61) and ER proteins (ribophorin I, leucine-rich repeat-containing 59 (LRRC59), and SEC62) previously implicated in associating with ribosomes. We observed labeling of ER-bound ribosomes with the SEC61 and LRRC59 BioID reporters, comparatively modest labeling with the ribophorin I reporter, and no labeling with the SEC62 reporter. A biotin pulse-chase/subcellular fractionation approach to examine ribosome exchange at the SEC61 and LRRC59 sites revealed that, at steady state, ribosomes at these sites comprise both rapid- and slow-exchanging pools. Global translational initiation arrest elicited by the inhibitor harringtonine accelerated SEC61 reporter-labeled ribosome exchange. RNA-Seq analyses of the mRNAs associated with SEC61- and LRRC59-labeled ribosomes revealed both site-enriched and shared mRNAs and further established that the ER has a transcriptome-wide role in regulating proteome composition. These results provide evidence that ribosomes interact with the ER membrane via multiple modes and suggest regulatory mechanisms that control global proteome composition via ER membrane-bound ribosomes.	[Hoffman, Alyson M.; Nicchitta, Christopher V.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Chen, Qiang; Zheng, Tianli; Nicchitta, Christopher V.] Duke Univ, Sch Med, Dept Cell Biol, Box 3709, Durham, NC 27710 USA	Duke University; Duke University	Nicchitta, CV (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Box 3709, Durham, NC 27710 USA.	christopher.nicchitta@duke.edu			NIGMS, National Institutes of Health [GM101533-A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118630, R01GM101533] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant GM101533-A1 (to C.V.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Alvear D, 2018, ELIFE, V7, DOI 10.7554/eLife.43036; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Armenteros JJA, 2017, BIOINFORMATICS, V33, P3387, DOI 10.1093/bioinformatics/btx431; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Benedix J, 2010, J BIOL CHEM, V285, P36427, DOI 10.1074/jbc.M110.143263; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blau M, 2005, NAT STRUCT MOL BIOL, V12, P1015, DOI 10.1038/nsmb998; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braunger K, 2018, SCIENCE, V360, P215, DOI 10.1126/science.aar7899; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cui KY, 2000, J BIOL CHEM, V275, P7591, DOI 10.1074/jbc.275.11.7591; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Diehn M, 2006, PLOS GENET, V2, P39, DOI 10.1371/journal.pgen.0020011; English AR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013227; Fawcett D. W., 1966, ATLAS FINE STRUCTURE, P303; Firat-Karalar EN, 2015, METHOD CELL BIOL, V129, P153, DOI 10.1016/bs.mcb.2015.03.016; Gilbert WV, 2011, TRENDS BIOCHEM SCI, V36, P127, DOI 10.1016/j.tibs.2010.12.002; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Hsu J. C.-C., 2018, ELS, DOI [10.1002/9780470015902.a0005718, DOI 10.1002/9780470015902.A0005718]; Hsu JCC, 2018, RNA, V24, P688, DOI 10.1261/rna.063313.117; Hudder A, 2003, MOL CELL BIOL, V23, P9318, DOI 10.1128/MCB.23.24.9318-9326.2003; Hung V, 2017, ELIFE, V6, DOI 10.7554/eLife.24463; ICHIMURA T, 1993, FEBS LETT, V326, P241, DOI 10.1016/0014-5793(93)81799-6; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jagannathan S, 2011, METHODS MOL BIOL, V714, P301, DOI 10.1007/978-1-61779-005-8_19; Jan CH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8299; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Jing J, 2015, NAT CELL BIOL, V17, P1339, DOI 10.1038/ncb3234; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KREIBICH G, 1978, J CELL BIOL, V77, P488, DOI 10.1083/jcb.77.2.488; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Levy R, 2001, J BIOL CHEM, V276, P2340, DOI 10.1074/jbc.M004867200; Lin PJ, 2011, J CELL BIOL, V195, P55, DOI 10.1083/jcb.201103118; Lingappa V R, 1980, Recent Prog Horm Res, V36, P451; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynes EM, 2011, BBA-MOL CELL RES, V1813, P1893, DOI 10.1016/j.bbamcr.2011.06.011; MATASOVA NB, 1991, ANAL BIOCHEM, V198, P219, DOI 10.1016/0003-2697(91)90416-Q; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; MIGLIACCIO G, 1992, J CELL BIOL, V117, P15, DOI 10.1083/jcb.117.1.15; MUECKLER MM, 1981, J CELL BIOL, V90, P495, DOI 10.1083/jcb.90.2.495; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; Nikonov AV, 2002, J CELL BIOL, V158, P497, DOI 10.1083/jcb.200201116; OHSUMI T, 1993, BIOCHEM J, V294, P465, DOI 10.1042/bj2940465; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9403; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Potter MD, 2000, J BIOL CHEM, V275, P2037, DOI 10.1074/jbc.275.3.2037; Potter MD, 2001, TRENDS CELL BIOL, V11, P112, DOI 10.1016/S0962-8924(00)01905-X; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; Reid DW, 2015, NAT REV MOL CELL BIO, V16, P221, DOI 10.1038/nrm3958; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Shi Z, 2017, MOL CELL, V67, P71, DOI 10.1016/j.molcel.2017.05.021; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; Stephens SB, 2007, METHOD ENZYMOL, V431, P47, DOI 10.1016/S0076-6879(07)31004-5; TAZAWA S, 1991, J BIOCHEM-TOKYO, V109, P89; Ueno T, 2012, NUCLEIC ACIDS RES, V40, P3006, DOI 10.1093/nar/gkr1197; Uezu A, 2016, SCIENCE, V353, P1123, DOI 10.1126/science.aag0821; Valm AM, 2017, NATURE, V546, P162, DOI 10.1038/nature22369; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Voigt F, 2017, CELL REP, V21, P3740, DOI 10.1016/j.celrep.2017.12.008; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108870; Wild R, 2018, SCIENCE, V359, P545, DOI 10.1126/science.aar5140; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Wu B, 2016, SCIENCE, V352, P1430, DOI 10.1126/science.aaf1084; Youn JY, 2018, MOL CELL, V69, P517, DOI 10.1016/j.molcel.2017.12.020; Zhang Y, 2013, J BIOL CHEM, V288, P33697, DOI 10.1074/jbc.M113.508283	90	14	14	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8942	8958		10.1074/jbc.RA119.007996	http://dx.doi.org/10.1074/jbc.RA119.007996			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31004035	Green Published, hybrid			2022-12-28	WOS:000470971100027
J	Meng, R; Gu, L; Lu, YY; Zhao, K; Wu, JF; Wang, HC; Han, JH; Tang, YT; Lu, B				Meng, Ran; Gu, Lan; Lu, Yanyan; Zhao, Kai; Wu, Jianfeng; Wang, Haichao; Han, Jiahuai; Tang, Yiting; Lu, Ben			High mobility group box 1 enables bacterial lipids to trigger receptor-interacting protein kinase 3 (RIPK3)-mediated necroptosis and apoptosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; inflammasome; tumor necrosis factor (TNF); bacteria; lipid A; damage-associated molecular patterns; HMGB1; necroptosis; RIPK3	MIXED LINEAGE KINASE; CELL-DEATH; INFLAMMASOME ACTIVATION; PROGRAMMED NECROSIS; HMGB1; RIPK1; LIPOPOLYSACCHARIDE; RELEASE; BINDING; PHOSPHORYLATION	Receptor-interacting protein kinase 3 (RIPK3) is a key regulator of programmed cell death and inflammation during viral infection or sterile tissue injury. Whether and how bacterial infection also activates RIPK3-dependent immune responses remains poorly understood. Here we show that bacterial lipids (lipid IVa or lipid A) form a complex with high mobility group box 1 (HMGB1), released by activated immune cells or damaged tissue during bacterial infection, and that this complex triggers RIPK3- and TIR domain-containing adapter-inducing IFN- (TRIF)-dependent immune responses. We found that these responses lead to macrophage death, interleukin (IL)-1 release, and IL-1 maturation. In an air-pouch inflammatory infiltration model, genetic deletion of Ripk3, Trif, or IL-1 receptor (Il-1R), or monoclonal antibody-mediated HMGB1 neutralization uniformly attenuated inflammatory responses induced by Gram-negative bacteria that release lipid IVa and lipid A. These findings uncover a previously unrecognized mechanism by which host factors and bacterial components work in concert to orchestrate immune responses.	[Meng, Ran; Gu, Lan; Lu, Yanyan; Zhao, Kai; Tang, Yiting; Lu, Ben] Cent S Univ, Dept Hematol, Xiangya Hosp 3, Changsha 410000, Hunan, Peoples R China; [Meng, Ran; Gu, Lan; Lu, Yanyan; Zhao, Kai; Tang, Yiting; Lu, Ben] Cent S Univ, Key Lab Nonresolving Inflammat & Tumor, Xiangya Hosp 3, Changsha 410000, Hunan, Peoples R China; [Meng, Ran] Cent S Univ, Postdoctoral Res Stn Clin Med, Xiangya Hosp 3, Changsha 410000, Hunan, Peoples R China; [Gu, Lan; Lu, Yanyan; Zhao, Kai; Lu, Ben] Cent S Univ, Key Lab Med Genet, Sch Biol Sci & Technol, Changsha 410000, Hunan, Peoples R China; [Wu, Jianfeng; Han, Jiahuai] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Signaling Network, Xiamen 361005, Fujian, Peoples R China; [Wang, Haichao] Northwell Hlth, Dept Emergency Med, North Shore Univ Hosp, Manhasset, NY 11030 USA; [Tang, Yiting] Cent S Univ, Dept Physiol, Sch Basic Med Sci, Changsha 410000, Hunan, Peoples R China; [Lu, Ben] Cent S Univ, Key Lab Sepsis Translat Med Hunan, Changsha 410000, Hunan, Peoples R China; [Lu, Ben] Jinan Univ, Dept Pathophysiol, Sch Basic Med Sci, Guangzhou 510632, Guangdong, Peoples R China	Central South University; Central South University; Central South University; Central South University; Xiamen University; Northwell Health; North Shore University Hospital; Central South University; Central South University; Jinan University	Tang, YT (corresponding author), Cent S Univ, Dept Physiol, Sch Basic Med Sci, 168 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.; Lu, B (corresponding author), Cent S Univ, Dept Hematol, Xiangya Hosp 3, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.	yitingtang@csu.edu.cn; xybenlu@csu.edu.cn	Lu, Ben/AAN-1068-2021; Wang, Haichao/AAU-2237-2021	Lu, Ben/0000-0002-8597-0406; Wang, Haichao/0000-0002-0211-9000; Meng, Ran/0000-0002-5267-5662	National Key Scientific Project Grant [2015CB910700]; National Natural Science Foundation of China [81422027, 81400149, 81470345]	National Key Scientific Project Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Scientific Project Grant 2015CB910700 (to B.L.) and National Natural Science Foundation of China Grants 81422027 (to B.L.), 81400149 (to Y.T.), and 81470345 (to B.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Bianchi C, 2016, ADV MATER TECHNOL-US, V1, DOI 10.1002/admt.201600077; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Huebener P, 2015, J CLIN INVEST, V125, P539, DOI 10.1172/JCI76887; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Jarvis BW, 1997, INFECT IMMUN, V65, P3011, DOI 10.1128/IAI.65.8.3011-3016.1997; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8515; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kim SJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.238; Kutuzova GD, 2001, J IMMUNOL, V167, P482, DOI 10.4049/jimmunol.167.1.482; Lin J, 2016, NATURE, V540, P124, DOI 10.1038/nature20558; Lu B, 2014, EXPERT REV CLIN IMMU, V10, P713, DOI 10.1586/1744666X.2014.909730; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46; Newton K, 2016, NATURE, V540, P129, DOI 10.1038/nature20559; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Qu Y, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.54; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang YT, 2016, ANTIOXID REDOX SIGN, V24, P620, DOI 10.1089/ars.2015.6409; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tirone M, 2018, J EXP MED, V215, P303, DOI 10.1084/jem.20160217; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.274; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Youn JH, 2011, EUR J IMMUNOL, V41, P2753, DOI 10.1002/eji.201141391; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang T, 2016, NAT MED, V22, P175, DOI 10.1038/nm.4017	52	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8872	8884		10.1074/jbc.RA118.007040	http://dx.doi.org/10.1074/jbc.RA118.007040			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31000631	hybrid, Green Published			2022-12-28	WOS:000470971100021
J	Claes, Z; Jonkhout, M; Crespillo-Casado, A; Bollen, M				Claes, Zander; Jonkhout, Marloes; Crespillo-Casado, Ana; Bollen, Mathieu			The antibiotic robenidine exhibits guanabenz-like cytoprotective properties by a mechanism independent of protein phosphatase PP1:PPP1R15A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein phosphatase; bioluminescence; biosensor; cell proliferation; drug action; endoplasmic reticulum stress (ER stress); enzyme inhibitor; eIF2; neurodegenerative disease; guanabenz; protein phosphatase 1 (PP1); protein phosphatase 1 regulatory subunit 15A (PPP1R15A); robenidine; unfolded protein response (UPR)	PLASMODIUM-FALCIPARUM; SELECTIVE-INHIBITION; CELLS	The aminoguanidine compound robenidine is widely used as an antibiotic for the control of coccidiosis, a protozoal infection in poultry and rabbits. Interestingly, robenidine is structurally similar to guanabenz (analogs), which are currently undergoing clinical trials as cytoprotective agents for the management of neurodegenerative diseases. Here we show that robenidine and guanabenz protect cells from a tunicamycin-induced unfolded protein response to a similar degree. Both compounds also reduced the tumor necrosis factor alpha-induced activation of NF-kappa B. The cytoprotective effects of guanabenz (analogs) have been explained previously by their ability to maintain eIF2 alpha phosphorylation by allosterically inhibiting protein phosphatase PP1:PPP1R15A. However, using a novel split-luciferase-based protein-protein interaction assay, we demonstrate here that neither robenidine nor guanabenz disrupt the interaction between PPP1R15A and either PP1 or eIF2 alpha in intact cells. Moreover, both drugs also inhibited the unfolded protein response in cells that expressed a nonphosphorylatable mutant (S51A) of eIF2 alpha. Our results identify robenidine as a PP1: PPP1R15A-independent cytoprotective compound that holds potential for the management of protein misfolding-associated diseases.	[Claes, Zander; Jonkhout, Marloes; Bollen, Mathieu] Univ Leuven, KU Leuven, Dept Cellular & Mol Med, Lab Biosignaling & Therapeut, B-3000 Leuven, Belgium; [Crespillo-Casado, Ana] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	KU Leuven; University of Cambridge	Bollen, M (corresponding author), Katholieke Univ Leuven, Campus Gasthuisberg,Herestr 49,O&N1,PB901, B-3000 Leuven, Belgium.	Mathieu.Bollen@kuleuven.be		Claes, Zander/0000-0002-9905-0555	Bijzonder Onderzoeksfonds [BOF-GOA 15/016]; Research Foundation Flanders (FWO)	Bijzonder Onderzoeksfonds; Research Foundation Flanders (FWO)(FWO)	This work was supported by the Bijzonder Onderzoeksfonds (BOF-GOA 15/016). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a PhD grant of the Research Foundation Flanders (FWO).	Botte CY, 2012, CHEM REV, V112, P1269, DOI 10.1021/cr200258w; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Carrara M, 2017, NAT STRUCT MOL BIOL, V24, P708, DOI 10.1038/nsmb.3443; Chambers JE, 2015, ELIFE, V4, DOI 10.7554/eLife.04872; Chen RM, 2015, ELIFE, V4, DOI 10.7554/eLife.04871; Crespillo-Casado A, 2018, J BIOL CHEM, V293, P7766, DOI 10.1074/jbc.RA118.002325; Crespillo-Casado A, 2017, ELIFE, V6, DOI 10.7554/eLife.26109; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; Dooves S, 2018, NEUROPATH APPL NEURO, V44, P391, DOI 10.1111/nan.12411; Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149; KANTOR S, 1970, SCIENCE, V168, P373, DOI 10.1126/science.168.3929.373; Krzyzosiak A, 2018, CELL, V174, P1216, DOI 10.1016/j.cell.2018.06.030; McCollum AM, 2006, J INFECT DIS, V194, P189, DOI 10.1086/504687; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nakajima S, 2015, BIOL PHARM BULL, V38, P1368, DOI 10.1248/bpb.b15-00312; Ogunniyi AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183457; Perego J, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam8104; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Nguyen PH, 2014, ACS CHEM NEUROSCI, V5, P1075, DOI 10.1021/cn5001588; Saczewski F, 2013, EXPERT OPIN THER PAT, V23, P965, DOI 10.1517/13543776.2013.788645; Schneider K, 2015, J CELL SCI, V128, P3861, DOI 10.1242/jcs.173047; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sundaram JR, 2017, BIOCHEM SOC T, V45, P101, DOI 10.1042/BST20160157; TRIBOUILLARDTAN.D, 2008, PLOS ONE, V0003; Tsaytler P, 2013, FEBS J, V280, P766, DOI 10.1111/j.1742-4658.2012.08535.x; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; TULLIEZ JE, 1982, J AGR FOOD CHEM, V30, P1071, DOI 10.1021/jf00114a016; Van Dessel N, 2010, NUCLEIC ACIDS RES, V38, P7500, DOI 10.1093/nar/gkq643; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Way SW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7532; 2011, EFSA J, V9, P2102, DOI DOI 10.2903/j.efsa.2011.2102	32	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13478	13486		10.1074/jbc.RA119.008857	http://dx.doi.org/10.1074/jbc.RA119.008857			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31337709	hybrid, Green Published			2022-12-28	WOS:000486417200022
J	Gonzalez-Lopez, O; DeCotiis, J; Goyeneche, C; Mello, H; Vicente-Ortiz, BA; Shin, HJ; Driscoll, KE; Du, PC; Palmeri, D; Lukac, DM				Gonzalez-Lopez, Olga; DeCotiis, Jennifer; Goyeneche, Corey; Mello, Helena; Vicente-Ortiz, Bryan Alexis; Shin, Hye Jin; Driscoll, Kyla E.; Du, Peicheng; Palmeri, Diana; Lukac, David M.			A herpesvirus transactivator and cellular POU proteins extensively regulate DNA binding of the host Notch signaling protein RBP-J kappa to the virus genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Notch pathway; DNA viruses; herpesvirus; viral DNA; DNA-binding protein; chromatin immunoprecipitation (ChiP); tumor virus; KSHV; Oct-1; POU2F1; Rta	SARCOMA-ASSOCIATED HERPESVIRUS; LYTIC SWITCH PROTEIN; POLYADENYLATED NUCLEAR-RNA; DELAYED-EARLY PROMOTER; READING FRAME 50; KAPOSIS-SARCOMA; GENE-EXPRESSION; TRANSCRIPTION FACTORS; VIRAL GENE; RTA	Reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) from latency requires the viral transactivator Rta to contact the host protein J kappa recombination signal-binding protein (RBP-J kappa or CSL). RBP-J kappa normally binds DNA sequence-specifically to determine the transcriptional targets of the Notch-signaling pathway, yet Notch alone cannot reactivate KSHV. We previously showed that Rta stimulates RBP-J kappa DNA binding to the viral genome. On a model viral promoter, this function requires Rta to bind to multiple copies of an Rta DNA motif (called "CANT" or Rta-c) proximal to an RBP-J kappa motif. Here, high-resolution ChIP/deep sequencing from infected primary effusion lymphoma cells revealed that RBP-J kappa binds nearly exclusively to different sets of viral genome sites during latency and reactivation. RBP-J kappa bound DNA frequently, but not exclusively, proximal to Rta bound to single, but not multiple, Rta-c motifs. To discover additional regulators of RBP-J kappa DNA binding, we used bioinformatics to identify cellular DNA-binding protein motifs adjacent to either latent or reactivation-specific RBP-J kappa-binding sites. Many of these cellular factors, including POU class homeobox (POU) proteins, have known Notch or herpesvirus phenotypes. Among a set of Rta- and RBP-J kappa-bound promoters, Rta transactivated only those that also contained POU motifs in conserved positions. On some promoters, POU factors appeared to inhibit RBP-J kappa DNA binding unless Rta bound to a proximal Rta-c motif. Moreover, POU2F1/Oct-1 expression was induced during KSHV reactivation, and POU2F1 knockdown diminished infectious virus production. Our results suggest that Rta and POU proteins broadly regulate DNA binding of RBP-J kappa during KSHV reactivation.	[Gonzalez-Lopez, Olga; DeCotiis, Jennifer; Goyeneche, Corey; Mello, Helena; Vicente-Ortiz, Bryan Alexis; Shin, Hye Jin; Driscoll, Kyla E.; Palmeri, Diana; Lukac, David M.] Rutgers State Univ, New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Gonzalez-Lopez, Olga; DeCotiis, Jennifer; Goyeneche, Corey; Mello, Helena; Shin, Hye Jin; Lukac, David M.] Rutgers State Univ, New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Grad Sch Biomed Sci, Newark, NJ 07103 USA; [Du, Peicheng] Rutgers State Univ, New Jersey Med Sch, Rutgers Biomed & Hlth Sci, High Performance & Res Comp, Newark, NJ 07103 USA; [Gonzalez-Lopez, Olga] Univ N Carolina, Chapel Hill, NC 27514 USA; [Shin, Hye Jin] Korea Res Inst Chem Technol, Daejeon 305600, South Korea; [Driscoll, Kyla E.] Eli Lilly & Co, New York, NY 10016 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Korea Research Institute of Chemical Technology (KRICT); Eli Lilly	Lukac, DM (corresponding author), 225 Warren St,ICPH Rm E350C, Newark, NJ 07103 USA.	Lukacdm@njms.rutgers.edu			National Institutes of Health [AI 078138, AI 117127]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants AI 078138 and AI 117127. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aquila Giorgio, 2013, Glob Cardiol Sci Pract, V2013, P364, DOI 10.5339/gscp.2013.44; Arias C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003847; Aster JC, 2014, J PATHOL, V232, P1, DOI 10.1002/path.4291; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bu W, 2008, J VIROL, V82, P10709, DOI 10.1128/JVI.01012-08; Bu W, 2007, J VIROL, V81, P5788, DOI 10.1128/JVI.00140-07; Carbone A, 1998, BLOOD, V91, P747; Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5279; Carroll KD, 2007, J VIROL, V81, P8451, DOI 10.1128/JVI.00265-07; Carroll KD, 2006, J VIROL, V80, P9697, DOI 10.1128/JVI.00746-06; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Chang HS, 2005, J VIROL, V79, P14371, DOI 10.1128/JVI.79.22.14371-14382.2005; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; Chen JG, 2009, VIROLOGY, V386, P290, DOI 10.1016/j.virol.2009.01.031; Curry CL, 2005, ONCOGENE, V24, P6333, DOI 10.1038/sj.onc.1208783; DeCotiis JL, 2017, J VIROL METHODS, V247, P99, DOI [10.1016/j.jviromet.2017.04.019, 10.1016/j.jviro]; Di Bartolo DL, 2009, J VIROL, V83, P4308, DOI 10.1128/JVI.02196-08; Ellison TJ, 2009, VIROLOGY, V387, P76, DOI 10.1016/j.virol.2009.02.016; Gasperini P, 2012, CANCER RES, V72, P1157, DOI 10.1158/0008-5472.CAN-11-3067; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gramolelli S, 2015, J PATHOL, V235, P368, DOI 10.1002/path.4441; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Guito J, 2014, J VIROL, V88, P547, DOI 10.1128/JVI.02877-13; Guito Jonathan, 2012, Front Microbiol, V3, P30, DOI 10.3389/fmicb.2012.00030; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Kamath BM, 2013, NAT REV NEPHROL, V9, P409, DOI 10.1038/nrneph.2013.102; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Kulakovskiy IV, 2013, NUCLEIC ACIDS RES, V41, pD195, DOI 10.1093/nar/gks1089; Lan K, 2007, P NATL ACAD SCI USA, V104, P16287, DOI 10.1073/pnas.0703508104; Lan K, 2006, J VIROL, V80, P6411, DOI 10.1128/JVI.00239-06; Lan K, 2009, CANCER BIOL THER, V8, P2136, DOI 10.4161/cbt.8.22.9743; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang YY, 2003, P NATL ACAD SCI USA, V100, P8490, DOI 10.1073/pnas.1432843100; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Liao W, 2003, J VIROL, V77, P9399, DOI 10.1128/JVI.77.17.9399-9411.2003; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Lu J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002479; Lu M, 2004, J VIROL, V78, P13637, DOI 10.1128/JVI.78.24.13637-13652.2004; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Lukac DM, 2001, J VIROL, V75, P6786, DOI 10.1128/JVI.75.15.6786-6799.2001; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Neumann CJ, 1998, SCIENCE, V281, P409, DOI 10.1126/science.281.5375.409; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osada N, 2014, DNA RES, V21, P673, DOI 10.1093/dnares/dsu029; Palmeri D, 2011, J VIROL, V85, P11901, DOI 10.1128/JVI.05479-11; Pankratova Elizaveta V, 2018, Oncotarget, V9, P29892, DOI 10.18632/oncotarget.25648; Papp B, 2019, J VIROL, V93, DOI 10.1128/JVI.01978-18; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Persson LM, 2010, J VIROL, V84, P1334, DOI 10.1128/JVI.01301-09; Robinson AR, 2011, J VIROL, V85, P8940, DOI 10.1128/JVI.00569-11; Roizman B, 2013, ANNU REV MICROBIOL, V67, P355, DOI 10.1146/annurev-micro-092412-155654; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Scholz BA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003336; Shin HJ, 2014, J VIROL, V88, P1281, DOI 10.1128/JVI.02665-13; Song MJ, 2004, J VIROL, V78, P12940, DOI 10.1128/JVI.78.23.12940-12950.2004; Song MJ, 2003, J VIROL, V77, P9451, DOI 10.1128/JVI.77.17.9451-9462.2003; Song MJ, 2002, J VIROL, V76, P5000, DOI 10.1128/JVI.76.10.5000-5013.2002; Song MJ, 2001, J VIROL, V75, P3129, DOI 10.1128/JVI.75.7.3129-3140.2001; Spadavecchia S, 2010, J VIROL, V84, P10488, DOI 10.1128/JVI.00894-10; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Tantin D, 2013, DEVELOPMENT, V140, P2857, DOI 10.1242/dev.095927; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Thurber AE, 2011, ONCOGENE, V30, P3036, DOI 10.1038/onc.2011.33; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wang Y, 2007, VIROLOGY, V359, P19, DOI 10.1016/j.virol.2006.09.032; Wang Y, 2006, J VIROL, V80, P12171, DOI 10.1128/JVI.00990-06; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Xu YY, 2010, J VIROL, V84, P5465, DOI 10.1128/JVI.02705-09; Xu YY, 2005, J VIROL, V79, P3479, DOI 10.1128/JVI.79.6.3479-3487.2005; Zhang LM, 2014, J VIROL, V88, P6873, DOI 10.1128/JVI.00283-14; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao FQ, 2013, FRONT BIOSCI-LANDMRK, V18, P1051, DOI 10.2741/4162; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999	85	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13073	13092		10.1074/jbc.RA118.007331	http://dx.doi.org/10.1074/jbc.RA118.007331			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31308175	Green Published, hybrid			2022-12-28	WOS:000486416000018
J	Ghosh, S; Wicks, SE; Vandanmagsar, B; Mendoza, TM; Bayless, DS; Salbaum, JM; Dearth, SP; Campagna, SR; Mynatt, RL; Noland, RC				Ghosh, Sujoy; Wicks, Shawna E.; Vandanmagsar, Bolormaa; Mendoza, Tamra M.; Bayless, David S.; Salbaum, J. Michael; Dearth, Stephen P.; Campagna, Shawn R.; Mynatt, Randall L.; Noland, Robert C.			Extensive metabolic remodeling after limiting mitochondrial lipid burden is consistent with an improved metabolic health profile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						skeletal muscle metabolism; fatty acid metabolism; lipid oxidation; glucose metabolism; mitochondria; peroxisome; genomics; metabolomics; proteomics; systems biology	FATTY-ACID OXIDATION; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; COENZYME-A; MUSCLE; INHIBITION; EXPRESSION; ETOMOXIR; GENES; SUBSTRATE	Mitochondrial lipid overload in skeletal muscle contributes to insulin resistance, and strategies limiting this lipid pressure improve glucose homeostasis; however, comprehensive cellular adaptations that occur in response to such an intervention have not been reported. Herein, mice with skeletal muscle-specific deletion of carnitine palmitoyltransferase 1b (Cpt1b(M-/-)), which limits mitochondrial lipid entry, were fed a moderate fat (25%) diet, and samples were subjected to a multimodal analysis merging transcriptomics, proteomics, and nontargeted metabolomics to characterize the coordinated multilevel cellular responses that occur when mitochondrial lipid burden is mitigated. Limiting mitochondrial fat entry predictably improves glucose homeostasis; however, remodeling of glucose metabolism pathways pales compared with adaptations in amino acid and lipid metabolism pathways, shifts in nucleotide metabolites, and biogenesis of mitochondria and peroxisomes. Despite impaired fat utilization, Cpt1b(M-/-) mice have increased acetyl-CoA (14-fold) and NADH (2-fold), indicating metabolic shifts yield sufficient precursors to meet energy demand; however, this does not translate to enhance energy status as Cpt1b(M-/-) mice have low ATP and high AMP levels, signifying energy deficit. Comparative analysis of transcriptomic data with disease-associated gene-sets not only predicted reduced risk of glucose metabolism disorders but was also consistent with lower risk for hepatic steatosis, cardiac hypertrophy, and premature death. Collectively, these results suggest induction of metabolic inefficiency under conditions of energy surfeit likely contributes to improvements in metabolic health when mitochondrial lipid burden is mitigated. Moreover, the breadth of disease states to which mechanisms induced by muscle-specific Cpt1b inhibition may mediate health benefits could be more extensive than previously predicted.	[Ghosh, Sujoy] Pennington Biomed Res Ctr, Lab Computat Biol, Baton Rouge, LA 70808 USA; [Wicks, Shawna E.; Vandanmagsar, Bolormaa; Mendoza, Tamra M.; Bayless, David S.; Mynatt, Randall L.] Pennington Biomed Res Ctr, Gene Nutrient Interact Lab, Baton Rouge, LA 70808 USA; [Salbaum, J. Michael] Pennington Biomed Res Ctr, Genom Core Facil, Baton Rouge, LA 70808 USA; [Mynatt, Randall L.] Pennington Biomed Res Ctr, Transgen Core Facil, Baton Rouge, LA 70808 USA; [Noland, Robert C.] Pennington Biomed Res Ctr, Skeletal Muscle Metab Lab, Baton Rouge, LA 70808 USA; [Ghosh, Sujoy] Duke Natl Univ Singapore, Program Cardiovasc & Metab Disorders, Med Sch, Singapore 169857, Singapore; [Ghosh, Sujoy] Duke Natl Univ Singapore, Ctr Computat Biol, Med Sch, Singapore 169857, Singapore; [Wicks, Shawna E.] Talaria Antibodies Inc, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Dearth, Stephen P.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; National University of Singapore; National University of Singapore; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Tennessee System; University of Tennessee Knoxville	Noland, RC (corresponding author), 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	robert.noland@pbrc.edu	Ghosh, Sujoy/I-3729-2017	Ghosh, Sujoy/0000-0002-7601-165X; Noland, Robert/0000-0001-5543-3450	National Institutes of Health [3P30-GM118430, 1R01-DK103860, 1R01-DK089641, T32 AT004094]; American Diabetes Association [1-10-BS-129]; National Institutes of Health from the NIGMS - Louisiana Clinical and Translational Science Center [2U54 GM104940]; National Institutes of Health Pilot and Feasibility Grant from NORC [2P30-DK072476]; Botanicals and Dietary Supplements Research Center from National Institutes of Health [P50 AT002776]; National Center for Complementary & Integrative Health [P50AT002776, T32AT004094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R01DK103860, R01DK098687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118430, U54GM104940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Institutes of Health from the NIGMS - Louisiana Clinical and Translational Science Center; National Institutes of Health Pilot and Feasibility Grant from NORC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Botanicals and Dietary Supplements Research Center from National Institutes of Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants 3P30-GM118430 (to R. C. N.) and 1R01-DK103860 (to R. C. N.), American Diabetes Association Grant 1-10-BS-129 (to R. L. M.), and National Institutes of Health Grant 1R01-DK089641 (to R. L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health Grant 2U54 GM104940 from the NIGMS, which funds the Louisiana Clinical and Translational Science Center.; Supported by National Institutes of Health Fellowship T32 AT004094 and recipient of National Institutes of Health Pilot and Feasibility Grant 2P30-DK072476 from NORC.; Supported in part by a Botanicals and Dietary Supplements Research Center Grant P50 AT002776 from National Institutes of Health.	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; BARNETT M, 1992, HORM METAB RES, V24, P360, DOI 10.1055/s-2007-1003335; Cai L, 2011, COLD SH Q B, V76, P195, DOI 10.1101/sqb.2011.76.010769; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; CHASE JFA, 1972, BIOCHEM J, V129, P55, DOI 10.1042/bj1290055; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Davies MN, 2016, CELL REP, V14, P243, DOI 10.1016/j.celrep.2015.12.030; Deems RO, 1998, AM J PHYSIOL-REG I, V274, pR524, DOI 10.1152/ajpregu.1998.274.2.R524; Dobbins RL, 2001, DIABETES, V50, P123, DOI 10.2337/diabetes.50.1.123; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hubinger A, 1997, HORM METAB RES, V29, P436, DOI 10.1055/s-2007-979072; Jackowski S, 2014, BIOCHEM SOC T, V42, P1118, DOI 10.1042/BST20140156; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Keung W, 2013, DIABETES, V62, P711, DOI 10.2337/db12-0259; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; LOPASCHUK GD, 1989, MOL CELL BIOCHEM, V88, P175; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; MARTIN C, 1991, METABOLISM, V40, P420, DOI 10.1016/0026-0495(91)90154-O; Matsumura H, 2015, METHODS MOL BIOL, V1236, P181, DOI 10.1007/978-1-4939-1743-3_14; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE986, DOI 10.1152/ajpendo.00399.2006; Noland RC, 2015, PROG MOL BIOL TRANSL, V135, P39, DOI 10.1016/bs.pmbts.2015.06.017; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; RATHEISER K, 1991, METABOLISM, V40, P1185, DOI 10.1016/0026-0495(91)90214-H; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Salbaum JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16917; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Timmers S, 2012, P NATL ACAD SCI USA, V109, P11711, DOI 10.1073/pnas.1206868109; TUTWILER GF, 1985, P SOC EXP BIOL MED, V178, P288; Vandanmagsar B, 2016, CELL REP, V15, P1686, DOI 10.1016/j.celrep.2016.04.057; Wang ZM, 2000, AM J PHYSIOL-ENDOC M, V279, pE539, DOI 10.1152/ajpendo.2000.279.3.E539; Warfel JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188850; White AT, 2012, AM J PHYSIOL-ENDOC M, V303, pE308, DOI 10.1152/ajpendo.00054.2012; Wicks SE, 2015, P NATL ACAD SCI USA, V112, pE3300, DOI 10.1073/pnas.1418560112; WOLF HPO, 1985, EUR J BIOCHEM, V146, P359, DOI 10.1111/j.1432-1033.1985.tb08661.x	49	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12313	12327		10.1074/jbc.RA118.006074	http://dx.doi.org/10.1074/jbc.RA118.006074			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31097541	Green Published, hybrid			2022-12-28	WOS:000484402700004
J	Cong, XY; Yuan, ZL; Du, YJ; Wu, B; Lu, DF; Wu, XJ; Zhang, YJ; Li, F; Wei, B; Li, J; Wu, JQ; Xu, SJ; Wang, JB; Qi, J; Shang, GJ; Gu, LC				Cong, Xiaoyan; Yuan, Zenglin; Du, Yijun; Wu, Bo; Lu, Defen; Wu, Xiangju; Zhang, Youjia; Li, Feng; Wei, Bin; Li, Jun; Wu, Jiaqiang; Xu, Sujuan; Wang, Jinbao; Qi, Jing; Shang, Guijun; Gu, Lichuan			Crystal structures of porcine STING(CBD)-CDN complexes reveal the mechanism of ligand recognition and discrimination of STING proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signaling; pathogen-associated molecular pattern (PAMP); pattern recognition receptor (PRR); cyclic diadenosine monophosphate (c-di-AMP); interferon	CYCLIC DI-GMP; ENDOGENOUS 2ND-MESSENGER; AMP; RECEPTORS; TRANSLOCATION; ACTIVATION; BINDING	The cyclic dinucleotide (CDN)-stimulator of interferon genes (STING) pathway plays an important role in the detection of viral and bacterial pathogens in animals. Previous studies have shown that the metazoan second messenger cyclic [G(2 ',5 ')pA(3 ',5 ')p] (2 ',3 '-cGAMP) generated by cyclic GMP-AMP synthase cGAS binds STING with high affinity compared with bacterial CDNs such as c-di-GMP, c-di-AMP, and 3 ',3 '-cGAMP. Despite recent progress indicating that the CDN-binding domain (CBD) of dimeric STING binds asymmetric 2 ',3 '-cGAMP preferentially over symmetric 3 ',3 '-CDNs, it remains an open question whether STING molecules, such as human STING, adopt a symmetric dimeric conformation to efficiently engage its asymmetric ligand. Here, structural studies of the CBD from porcine STING (STING(CBD)) in complex with CDNs at 1.76-2.6 angstrom resolution revealed that porcine STING(CBD), unlike its human and mouse counterparts, can adopt an asymmetric ligand-binding pocket to accommodate the CDNs. We observed that the extensive interactions and shape complementarity between asymmetric 2 ',3 '-cGAMP and the ligand-binding pocket make it the most preferred ligand for porcine STING and that geometry constraints limit the binding between symmetric 3 ',3 '-CDN and porcine STING. The ligand-discrimination mechanism of porcine STING observed here expands our understanding of how the CDN-STING pathway is activated and of its role in antiviral defense.	[Cong, Xiaoyan; Yuan, Zenglin; Lu, Defen; Xu, Sujuan; Wang, Jinbao; Shang, Guijun; Gu, Lichuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Cong, Xiaoyan; Du, Yijun; Wu, Xiangju; Li, Jun; Wu, Jiaqiang; Qi, Jing] Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Shandong Key Lab Anim Dis Control & Breeding, Sangyuan Rd 8, Jinan 250100, Shandong, Peoples R China; [Wu, Bo; Zhang, Youjia] Chinese Acad Sci, Hefei Inst Phys Sci, Magnet Field Lab, Key Lab High Magnet Field & Ion Beam Phys Biol, Hefei 230026, Anhui, Peoples R China; [Li, Feng] South Dakota State Univ, Dept Biol & Microbiol, Dept Vet & Biomed Sci, Brookings, SD 57007 USA; [Wei, Bin] Shandong Asia Pacific Highharve Organisms Sci & T, 1 Jinneng Rd, Qihe 251100, Shandong, Peoples R China	Shandong University; Shandong Academy of Agricultural Sciences; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; South Dakota State University	Shang, GJ; Gu, LC (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.; Qi, J (corresponding author), Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Shandong Key Lab Anim Dis Control & Breeding, Sangyuan Rd 8, Jinan 250100, Shandong, Peoples R China.	qj-happy2008@163.com; gjshang@gmail.com; lcgu@sdu.edu.cn	; Yuan, Zenglin/M-8378-2016	Wu, Bo/0000-0003-4556-0477; Yuan, Zenglin/0000-0003-0517-8249; Du, Yijun/0000-0001-9215-4637	National Natural Science Foundation of China [31470732, 31502051, 31672609, 21673244]; National Key Research and Development Program of China [2016YFD0501505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation of China Grants 31470732 (to L. G.), 31502051 (to X. C.), 31672609 (to J. Q.) and 21673244 (to Bo. W.) and the National Key Research and Development Program of China Grant 2016YFD0501505 (to Y. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chin KH, 2013, ACTA CRYSTALLOGR D, V69, P352, DOI 10.1107/S0907444912047269; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Denessiouk KA, 2001, PROTEINS, V44, P282, DOI 10.1002/prot.1093; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jenal U, 2017, NAT REV MICROBIOL, V15, P271, DOI 10.1038/nrmicro.2016.190; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Masliah G, 2013, CELL MOL LIFE SCI, V70, P1875, DOI 10.1007/s00018-012-1119-x; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shi HP, 2015, P NATL ACAD SCI USA, V112, P8947, DOI 10.1073/pnas.1507317112; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Walsh D, 2013, CYTOKINE GROWTH F R, V24, P91, DOI 10.1016/j.cytogfr.2012.09.003; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang H, 2015, SCI REP-UK, V5, DOI 10.1038/srep18035; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	36	14	14	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11420	11432		10.1074/jbc.RA119.007367	http://dx.doi.org/10.1074/jbc.RA119.007367			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31167783	Green Published, hybrid			2022-12-28	WOS:000478717600007
J	Hashimoto, N; Ito, S; Tsuchida, A; Bhuiyan, RH; Okajima, T; Yamamoto, A; Furukawa, K; Ohmi, Y; Furukawa, K				Hashimoto, Noboru; Ito, Shizuka; Tsuchida, Akiko; Bhuiyan, Robiul H.; Okajima, Tetsuya; Yamamoto, Akihito; Furukawa, Keiko; Ohmi, Yuhsuke; Furukawa, Koichi			The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ganglioside; glycolipid structure; fatty acid; ceramide; membrane; cancer-associated carbohydrate; glycosphingolipid; hydroxylation; immunity; silica acid-binding Ig-like lectin 7 (Siglec-7)	GANGLIOSIDE G(D2); EXPRESSION; GROWTH; ACTIVATION; SYNTHASE; RECEPTOR; COMPLEX; LIGAND	To analyze the binding specificity of a sialic acid-recognizing lectin, sialic acid-binding Ig-like lectin 7 (SIGLEC7), to disialyl gangliosides (GD3s), here we established GD3-expressing cells by introducing GD3 synthase (GD3S or ST8SIA1) cDNA into a colon cancer cell line, DLD-1, that expresses no ligands for the recombinant protein SIGLEC7-Fc. SIGLEC7-Fc did not recognize newly-expressed GD3 on DLD-1 cells, even though GD3 was highly expressed, as detected by an anti-GD3 antibody. Because milk-derived GD3 could be recognized by this fusion protein when incorporated onto the surface of DLD-1 cells, we compared the ceramides in DLD-1-generated and milk-derived GD3s to identify the SIGLEC7-specific GD3 structures on the cell membrane, revealing that SIGLEC7 recognizes only GD3-containing regular ceramides but not phytoceramides. This was confirmed by knockdown/knockout of the sphingolipid delta(4)-desaturase/C4-monooxygenase (DES2) gene, involved in phytoceramide synthesis, disclosing that DES2 inhibition confers SIGLEC7 binding. Furthermore, knocking out fatty acid 2-hydroxylase also resulted in the emergence of SIGLEC7 binding to the cell surface. To analyze the effects of binding between SIGLEC7 and various GD3 species on natural killer function, we investigated cytotoxicity of peripheral blood mononuclear cells from healthy donors toward GD3S-transfected DLD-1 (DLD-1-GD3S) cells and DLD-1-GD3S cells with modified ceramides. We found that cytotoxicity is suppressed in DLD-1-GD3S cells with dehydroxylated GD3s. These results indicate that the ceramide structures in glycosphingolipids affect SIGLEC7 binding and distribution on the cell surface and influence cell sensitivity to killing by SIGLEC7-expressing effector cells.	[Hashimoto, Noboru; Ito, Shizuka; Tsuchida, Akiko; Bhuiyan, Robiul H.; Okajima, Tetsuya; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan; [Bhuiyan, Robiul H.; Furukawa, Keiko; Ohmi, Yuhsuke; Furukawa, Koichi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, 1200 Matsumoto, Kasugai, Aichi 4878501, Japan; [Hashimoto, Noboru; Yamamoto, Akihito] Tokushima Univ, Grad Sch Biomed Sci, Dept Tissue Regenerat, 3-18-5 Kuramoto Cho, Tokushima 7708504, Japan	Nagoya University; Chubu University; Tokushima University	Furukawa, K (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, 1200 Matsumoto, Kasugai, Aichi 4878501, Japan.	koichi@isc.chubu.ac.jp		Furukawa, Koichi/0000-0002-3321-9784	Ministry of Education, Culture, Sports and Technology of Japan (MEXT) [15H04696, 15K15080, 25670141, 24390078, 26860320]; Yokoyama Rinsho Yakuri Foundation	Ministry of Education, Culture, Sports and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokoyama Rinsho Yakuri Foundation(Yokoyama Foundation for Clinical Pharmacology)	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports and Technology of Japan (MEXT) 15H04696, 15K15080, 25670141, and 24390078, Grant-in-aid for Young Scientists (B) 26860320, and by a grant from Yokoyama Rinsho Yakuri Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Attrill H, 2006, J BIOL CHEM, V281, P32774, DOI 10.1074/jbc.M601714200; Cazet A, 2012, GLYCOBIOLOGY, V22, P806, DOI 10.1093/glycob/cws049; Crocker PR, 1996, BIOCHEM SOC T, V24, P150, DOI 10.1042/bst0240150; Dan P, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-84; Furukawa K, 2008, J NEUROCHEM, V105, P1057, DOI 10.1111/j.1471-4159.2008.05232.x; Furukawa K, 2012, GLYCOCONJUGATE J, V29, P579, DOI 10.1007/s10719-012-9423-0; Guo L, 2010, J BIOL CHEM, V285, P25438, DOI 10.1074/jbc.M110.119933; HAKOMORI S, 1984, ANNU REV IMMUNOL, V2, P103, DOI 10.1146/annurev.iy.02.040184.000535; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Iwabuchi Kazuhisa, 2008, Glycoconj J, V25, P357, DOI 10.1007/s10719-007-9084-6; Kaneko K, 2016, J BIOL CHEM, V291, P16630, DOI 10.1074/jbc.M115.708834; Karlsson KA, 1998, ACTA BIOCHIM POL, V45, P429, DOI 10.18388/abp.1998_4237; Kawasaki Y, 2015, TOHOKU J EXP MED, V236, P1, DOI 10.1620/tjem.236.1; Kondo Y, 2013, P NATL ACAD SCI USA, V110, P4714, DOI 10.1073/pnas.1218508110; Kota Venkatesh, 2014, Advances in Biological Regulation, V54, P223, DOI 10.1016/j.jbior.2013.09.012; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Mito M, 2016, METHODS, V98, P158, DOI 10.1016/j.ymeth.2015.11.007; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Nicoll G, 2003, EUR J IMMUNOL, V33, P1642, DOI 10.1002/eji.200323693; O'Reilly MK, 2010, METHOD ENZYMOL, V478, P343, DOI 10.1016/S0076-6879(10)78017-4; Ohkawa Y, 2015, J BIOL CHEM, V290, P16043, DOI 10.1074/jbc.M114.635755; Peracaula R, 2008, DIS MARKERS, V25, P207, DOI 10.1155/2008/797629; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Yeh SC, 2016, P NATL ACAD SCI USA, V113, P5592, DOI 10.1073/pnas.1604721113; Yoshida S, 2001, CANCER RES, V61, P4244	27	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10833	10845		10.1074/jbc.RA118.007083	http://dx.doi.org/10.1074/jbc.RA118.007083			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31138648	hybrid, Green Published			2022-12-28	WOS:000478717200009
J	Park, EJ; Kwon, YM; Lee, JW; Kang, HY; Oh, JI				Park, Eun-Jin; Kwon, Yu-Mi; Lee, Jin-Won; Kang, Ho-Young; Oh, Jeong-Il			Dual control of RegX3 transcriptional activity by SenX3 and PknB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mycobacteria; Mycobacterium smegmatis; Mycobacterium tuberculosis; serine; threonine protein kinase; signal transduction; transcription regulation; SenX3-RegX3; two-component system	MYCOBACTERIUM-TUBERCULOSIS PKNB; 2-COMPONENT REGULATORY SYSTEM; SERINE/THREONINE KINASES; RESPONSE REGULATOR; GENE-REGULATION; HISTIDINE KINASES; PROTEIN-PHOSPHORYLATION; STAPHYLOCOCCUS-AUREUS; CONSERVED ASPARTATE; SIGNAL-TRANSDUCTION	The mycobacterial SenX3-RegX3 two-component system consists of the SenX3 sensor histidine kinase and its cognate RegX3 response regulator. This system is a phosphorelay-based regulatory system involved in sensing environmental P-i levels and induction of genes required for P-i acquisition under P-i-limiting conditions. Here we demonstrate that overexpression of the kinase domain of Mycobacterium tuberculosis PknB (PknB-KDMtb) inhibits the transcriptional activity of RegX3 of both M. tuberculosis and Mycobacterium smegmatis (RegX3(Mtb) and RegX3(Ms), respectively). Mass spectrometry results, along with those of in vitro phosphorylation and complementation analyses, revealed that PknB kinase activity inhibits the transcriptional activity of RegX3(Mtb) through phosphorylation events at Thr-100, Thr-191, and Thr-217. Electrophoretic mobility shift assays disclosed that phosphorylation of Thr-191 and Thr-217 abolishes the DNA-binding ability of RegX3(Mtb) and that Thr-100 phosphorylation likely prevents RegX3(Mtb) from being activated through conformational changes induced by SenX3-mediated phosphorylation. We propose that the convergence of the PknB and SenX3-RegX3 signaling pathways might enable mycobacteria to integrate environmental P-i signals with the cellular replication state to adjust gene expression in response to P-i availability.	[Park, Eun-Jin; Kang, Ho-Young; Oh, Jeong-Il] Pusan Natl Univ, Dept Microbiol, Busan 46241, South Korea; [Kwon, Yu-Mi] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 02792, South Korea; [Kwon, Yu-Mi; Lee, Jin-Won] Hanyang Univ, Dept Life Sci & Res Inst Nat Sci, Seoul 04763, South Korea	Pusan National University; Korea Institute of Science & Technology (KIST); Hanyang University	Oh, JI (corresponding author), Pusan Natl Univ, Dept Microbiol, Busan 46241, South Korea.	joh@pusan.ac.kr		Oh, Jeong-Il/0000-0002-9250-2627; Kwon, Yumi/0000-0003-0523-6197	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [NRF-2014R1A2A1A11051572]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (NRF-2014R1A2A1A11051572). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal S, 2012, INFECT IMMUN, V80, P1361, DOI 10.1128/IAI.06311-11; Agarwal S, 2011, J BIOL CHEM, V286, P41368, DOI 10.1074/jbc.M111.286690; Bae HJ, 2017, MOL CELLS, V40, P632, DOI 10.14348/molcells.2017.0076; Baek JH, 2007, FEMS MICROBIOL LETT, V277, P254, DOI 10.1111/j.1574-6968.2007.00965.x; Baer CE, 2014, J BIOL CHEM, V289, P20422, DOI 10.1074/jbc.M114.559054; Barthe P, 2010, STRUCTURE, V18, P606, DOI 10.1016/j.str.2010.02.013; BOURRET RB, 1990, P NATL ACAD SCI USA, V87, P41, DOI 10.1073/pnas.87.1.41; Brokaw AM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02523; Canova MJ, 2014, BIOCHEM BIOPH RES CO, V447, P165, DOI 10.1016/j.bbrc.2014.03.128; Carette X, 2018, MBIO, V9, DOI 10.1128/mBio.02333-17; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cousin C, 2013, FEMS MICROBIOL LETT, V346, P11, DOI 10.1111/1574-6968.12189; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Fridman M, 2013, BIOCHEMISTRY-US, V52, P7975, DOI 10.1021/bi401177n; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gardner SG, 2014, J BACTERIOL, V196, P1741, DOI 10.1128/JB.00029-14; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; Graves JD, 1999, PHARMACOL THERAPEUT, V82, P111, DOI 10.1016/S0163-7258(98)00056-4; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; Horstmann N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004088; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Khan MZ, 2018, IUBMB LIFE, V70, P889, DOI 10.1002/iub.1871; Kim MJ, 2010, J BACTERIOL, V192, P4868, DOI 10.1128/JB.00550-10; Kriakov J, 2003, J BACTERIOL, V185, P4983, DOI 10.1128/JB.185.16.4983-4991.2003; Kundu M, 2018, IUBMB LIFE, V70, P710, DOI 10.1002/iub.1872; Lee HN, 2018, MOL MICROBIOL, V108, P661, DOI 10.1111/mmi.13956; Lee HN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111680; Lee HN, 2012, J MICROBIOL, V50, P270, DOI 10.1007/s12275-012-2050-4; Lefevre P, 1997, J BACTERIOL, V179, P2900, DOI 10.1128/jb.179.9.2900-2906.1997; Libby EA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005275; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; Manuse S, 2016, FEMS MICROBIOL REV, V40, P41, DOI 10.1093/femsre/fuv041; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Mouncey NJ, 1998, J BACTERIOL, V180, P5612, DOI 10.1128/JB.180.21.5612-5618.1998; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Namugenyi SB, 2017, MBIO, V8, DOI 10.1128/mBio.00494-17; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Ogawara H, 2016, J ANTIBIOT, V69, P660, DOI 10.1038/ja.2015.138; Oh JI, 1999, BIOCHEMISTRY-US, V38, P2688, DOI 10.1021/bi9825100; Ortega C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001746; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Parish T, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0010-2013; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Richard-Greenblatt M, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0005-2015; Rickman L, 2004, BIOCHEM BIOPH RES CO, V314, P259, DOI 10.1016/j.bbrc.2003.12.082; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh N, 2015, ANTIOXID REDOX SIGN, V22, P603, DOI 10.1089/ars.2014.6020; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Sridhar R, 2000, PHARM RES-DORDR, V17, P1345, DOI 10.1023/A:1007507224529; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Tischler AD, 2013, INFECT IMMUN, V81, P317, DOI 10.1128/IAI.01136-12; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; White DW, 2018, MBIO, V9, DOI 10.1128/mBio.00778-18; Wright DP, 2014, VIRULENCE, V5, P863, DOI 10.4161/21505594.2014.983404; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	73	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					11023	11034		10.1074/jbc.RA119.008232	http://dx.doi.org/10.1074/jbc.RA119.008232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31160336	Green Published, hybrid			2022-12-28	WOS:000478717200023
J	Khumukcham, SS; Samanthapudi, VSK; Penugurti, V; Kumari, A; Kesavan, PS; Velatooru, LR; Kotla, SR; Mazumder, A; Manavathi, B				Khumukcham, Saratchandra Singh; Samanthapudi, Venkata Subramanyam Kumar; Penugurti, Vasudevarao; Kumari, Anita; Kesavan, P. S.; Velatooru, Loka Reddy; Kotla, Siva Reddy; Mazumder, Aprotim; Manavathi, Bramanandam			Hematopoietic PBX-interacting protein is a substrate and an inhibitor of the APC/C-Cdc20 complex and regulates mitosis by stabilizing cyclin B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitosis; cell cycle; cell biology; molecular cell biology; cell division; cytokinesis; APC-C complex; chromosome segregation; Hematopoietic PBX-interacting protein (HPIP); PBX homeobox interacting protein 1 (PBXIP1); post-translational modification; spindle assembly checkpoint (SAC)	ANAPHASE-PROMOTING COMPLEX; EPITHELIAL-MESENCHYMAL TRANSITION; SPINDLE ASSEMBLY CHECKPOINT; CELL-CYCLE; STRUCTURAL INSIGHTS; APC/C ACTIVATION; CANCER; HPIP; PROMETAPHASE; MAD2	Proper cell division relies on the coordinated regulation between a structural component, the mitotic spindle, and a regulatory component, anaphase-promoting complex/cyclosome (APC/C). Hematopoietic PBX-interacting protein (HPIP) is a microtubule-associated protein that plays a pivotal role in cell proliferation, cell migration, and tumor metastasis. Here, using HEK293T and HeLa cells, along with immunoprecipitation and immunoblotting, live-cell imaging, and protein-stability assays, we report that HPIP expression oscillates throughout the cell cycle and that its depletion delays cell division. We noted that by utilizing its D box and IR domain, HPIP plays a dual role both as a substrate and inhibitor, respectively, of the APC/C complex. We observed that HPIP enhances the G(2)/M transition of the cell cycle by transiently stabilizing cyclin B1 by preventing APC/C-Cdc20-mediated degradation, thereby ensuring timely mitotic entry. We also uncovered that HPIP associates with the mitotic spindle and that its depletion leads to the formation of multiple mitotic spindles and chromosomal abnormalities, results in defects in cytokinesis, and delays mitotic exit. Our findings uncover HPIP as both a substrate and an inhibitor of APC/C-Cdc20 that maintains the temporal stability of cyclin B1 during the G(2)/M transition and thereby controls mitosis and cell division.	[Khumukcham, Saratchandra Singh; Samanthapudi, Venkata Subramanyam Kumar; Penugurti, Vasudevarao; Kumari, Anita; Velatooru, Loka Reddy; Kotla, Siva Reddy; Manavathi, Bramanandam] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500046, India; [Kesavan, P. S.; Mazumder, Aprotim] Tata Inst Fundamental Res Hyderabad, Ctr Interdisciplinary Sci, Hyderabad 500107, Telangana, India	University of Hyderabad; Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad	Manavathi, B (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500046, India.	manavbrahma@gmail.com	PENUGURTI, VASUDEVARAO/L-7757-2016; khumukcham, saratchandra singh/AAN-6413-2021; Khumukcham, Saratchandra Singh/GQQ-2407-2022	PENUGURTI, VASUDEVARAO/0000-0003-4742-8867; khumukcham, saratchandra singh/0000-0001-5632-3341; Manavathi, Bramanandam/0000-0002-1797-398X; Mazumder, Aprotim/0000-0002-3443-3010; P.S., Kesavan/0000-0003-3618-5046	Department of Biotechnology, India [BT/PR7672/BRB/10/1173/2013, BT/Med/30/SP11273/2015, BT/PR8764/MED/97/104/2013]; Department of Science and Technology, India [SB/SO/BB/013/2013]	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported by Department of Biotechnology, India Grants BT/PR7672/BRB/10/1173/2013, BT/Med/30/SP11273/2015, and BT/PR8764/MED/97/104/2013 and Department of Science and Technology, India Grant SB/SO/BB/013/2013 (to B. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramovich C, 2002, ONCOGENE, V21, P6766, DOI 10.1038/sj.onc.1205784; Bajar BT, 2016, NAT METHODS, V13, P993, DOI [10.1038/NMETH.4045, 10.1038/nmeth.4045]; Barford D, 2011, PHILOS T R SOC B, V366, P3605, DOI 10.1098/rstb.2011.0069; Bertalan Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141305; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Bhat A, 2015, CELL CYCLE, V14, P3929, DOI 10.1080/15384101.2015.1120922; Boekhout M, 2015, J CELL SCI, V128, P1639, DOI 10.1242/jcs.163279; Bugide S, 2015, ONCOGENE, V34, P4601, DOI 10.1038/onc.2014.389; Bugide S, 2017, CELL ONCOL, V40, P133, DOI 10.1007/s13402-016-0308-2; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Champion L, 2017, TRENDS CELL BIOL, V27, P26, DOI 10.1016/j.tcb.2016.07.004; Chen B, 2016, ONCOL REP, V36, P3664, DOI 10.3892/or.2016.5157; Choi HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024312; Chow C, 2012, ONCOGENE, V31, P1975, DOI 10.1038/onc.2011.372; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dionne LK, 2015, CURR OPIN CELL BIOL, V35, P51, DOI 10.1016/j.ceb.2015.04.010; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fry AM, 2006, CELL CYCLE, V5, P1487, DOI 10.4161/cc.5.14.3003; Fujimitsu K, 2016, SCIENCE, V352, P1121, DOI 10.1126/science.aad3925; Gajulapalli VNR, 2016, BIOCHEM J, V473, P1047, DOI 10.1042/BCJ20160019; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gilberto S, 2017, J CELL BIOL, V216, P2259, DOI 10.1083/jcb.201703170; Gilkerson J., 2016, BIO-PROTOCOL, V6, pe1919; Gilkerson J, 2015, PLANT PHYSIOL, V168, P708, DOI 10.1104/pp.15.00402; Hein JB, 2014, EMBO REP, V15, P264, DOI 10.1002/embr.201337496; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; HWANG A, 1995, J BIOL CHEM, V270, P28419; Kabeche L, 2013, NATURE, V502, P110, DOI 10.1038/nature12507; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; Lischetti T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970484; Malmanche N, 2006, FEBS LETT, V580, P2888, DOI 10.1016/j.febslet.2006.03.081; Manavathi B, 2006, P NATL ACAD SCI USA, V103, P15981, DOI 10.1073/pnas.0607445103; Manavathi B, 2012, J BIOL CHEM, V287, P5600, DOI 10.1074/jbc.M111.289843; Matheson CJ, 2016, TRENDS PHARMACOL SCI, V37, P872, DOI 10.1016/j.tips.2016.06.006; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Pan J, 2016, BIOMED PHARMACOTHER, V77, P176, DOI 10.1016/j.biopha.2015.12.012; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Qiao RP, 2016, P NATL ACAD SCI USA, V113, pE2570, DOI 10.1073/pnas.1604929113; Reece J. B., 2011, THE CELL CYCLE; Reid RO, 2013, JAMA-J AM MED ASSOC, V309, P267, DOI 10.1001/jama.2012.173925; Robbins JA, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-23; Roh M, 2005, J BIOL CHEM, V280, P40568, DOI 10.1074/jbc.M509369200; Sedgwick GG, 2013, EMBO J, V32, P303, DOI 10.1038/emboj.2012.335; Sivakumar S, 2015, NAT REV MOL CELL BIO, V16, P82, DOI 10.1038/nrm3934; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Song YM, 2008, CARCINOGENESIS, V29, P307, DOI 10.1093/carcin/bgm269; Strauss B, 2018, J CELL BIOL, V217, P179, DOI 10.1083/jcb.201612147; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Wang DL, 2016, TUMOR BIOL, V37, P5897, DOI 10.1007/s13277-015-4453-4; Wang X, 2017, CONNECT TISSUE RES, V1, P1, DOI DOI 10.1080/00207543.2017.1401239; Wang XH, 2008, BBA-MOL CELL RES, V1783, P1220, DOI 10.1016/j.bbamcr.2008.01.026; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Xu XJ, 2013, IUBMB LIFE, V65, P873, DOI 10.1002/iub.1202; Zhang SY, 2016, NATURE, V533, P260, DOI 10.1038/nature17973	66	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10236	10252		10.1074/jbc.RA118.006733	http://dx.doi.org/10.1074/jbc.RA118.006733			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31101654	Green Published, hybrid			2022-12-28	WOS:000474445600015
J	Wang, C; Jiang, SZ; Ke, LR; Zhang, LY; Li, DF; Liang, J; Narita, YH; Hou, I; Chen, CH; Wang, LW; Zhong, Q; Ling, YH; Lv, X; Xiang, YQ; Guo, X; Teng, MX; Tsao, SW; Gewurz, BE; Zeng, MS; Zhao, B				Wang, Chong; Jiang, Sizun; Ke, Liangru; Zhang, Luyao; Li, Difei; Liang, Jun; Narita, Yohei; Hou, Isabella; Chen, Chen-hao; Wang, Liangwei; Zhong, Qian; Ling, Yihong; Lv, Xing; Xiang, Yanqun; Guo, Xiang; Teng, Mingxiang; Tsao, Sai-Wah; Gewurz, Benjamin E.; Zeng, Mu-Sheng; Zhao, Bo			Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; CRISPR; Cas; glucose; purine; NF-B; CRISPR screen; essential genes; MYST family proteins; nasopharyngeal carcinoma	EPSTEIN-BARR-VIRUS; NF-KAPPA-B; ROLES; ACETYLTRANSFERASES; CHEMOTHERAPY; METASTASIS; EXPRESSION; FAMILY; P53	Early diagnosis of nasopharyngeal carcinoma (NPC) is difficult because of a lack of specific symptoms. Many patients have advanced disease at diagnosis, and these patients respond poorly to treatment. New treatments are therefore needed to improve the outcome of NPC. To better understand the molecular pathogenesis of NPC, here we used an NPC cell line in a genome-wide CRISPR-based knockout screen to identify the cellular factors and pathways essential for NPC (i.e. dependence factors). This screen identified the Moz, Ybf2/Sas3, Sas2, Tip60 histone acetyl transferase complex, NF-B signaling, purine synthesis, and linear ubiquitination pathways; and MDM2 proto-oncogene as NPC dependence factors/pathways. Using gene knock out, complementary DNA rescue, and inhibitor assays, we found that perturbation of these pathways greatly reduces the growth of NPC cell lines but does not affect growth of SV40-immortalized normal nasopharyngeal epithelial cells. These results suggest that targeting these pathways/proteins may hold promise for achieving better treatment of patients with NPC.	[Wang, Chong; Jiang, Sizun; Zhang, Luyao; Li, Difei; Liang, Jun; Narita, Yohei; Hou, Isabella; Wang, Liangwei; Zhong, Qian; Gewurz, Benjamin E.; Zhao, Bo] Brigham & Womens Hosp, Dept Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA; [Wang, Chong; Jiang, Sizun; Zhang, Luyao; Li, Difei; Liang, Jun; Narita, Yohei; Hou, Isabella; Wang, Liangwei; Zhong, Qian; Gewurz, Benjamin E.; Zhao, Bo] Harvard Med Sch, Boston, MA 02115 USA; [Ke, Liangru; Zhong, Qian; Ling, Yihong; Lv, Xing; Xiang, Yanqun; Guo, Xiang; Zeng, Mu-Sheng] Sun Yat Sen Univ, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Chen, Chen-hao] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Chen, Chen-hao] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Chen, Chen-hao] Harvard Sch Publ Hlth, Boston, MA 02115 USA; [Teng, Mingxiang] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA; [Tsao, Sai-Wah] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China; [Tsao, Sai-Wah] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Hong Kong, Peoples R China; [Jiang, Sizun] Stanford Univ, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; State Key Lab Oncology South China; Sun Yat Sen University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; H Lee Moffitt Cancer Center & Research Institute; University of Hong Kong; University of Hong Kong; Stanford University	Zeng, MS (corresponding author), Sun Yat Sen Univ, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.; Zhao, B (corresponding author), Brigham & Womens Hosp, Dept Med, 181 Longwood Ave, Boston, MA 02115 USA.	zengmsh@sysucc.org.cn; bzhao@bwh.harvard.edu	liang, jun/ABA-2727-2020; Wang, Liang Wei/GXI-0143-2022; Jiang, Sizun/AAO-2333-2020	Wang, Liang Wei/0000-0002-0324-8744; Jiang, Sizun/0000-0001-6149-3142; Teng, Mingxiang/0000-0002-8536-8941	National Institute of Health [AI123420, CA047006, P30CA076292, AI137337]; National Natural Science Foundation of China [81830090, 81520108022]; Burroughs Wellcome career award; NATIONAL CANCER INSTITUTE [R01CA047006, P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI137337, R01AI123420] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Burroughs Wellcome career award(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institute of Health Grants AI123420 and CA047006 (to B. Z.), P30CA076292 (to M. T.), AI137337 (to B. E. G.), and National Natural Science Foundation of China Grants 81830090 and 81520108022 (to M. Z.). B. E. G. is a Burroughs Wellcome career award in medical sciences recipient. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Baell JB, 2018, NATURE, V560, P253, DOI 10.1038/s41586-018-0387-5; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Cai LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8353; Chen CH, 2018, BIOINFORMATICS, V34, P4095, DOI 10.1093/bioinformatics/bty450; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Dai W, 2016, P NATL ACAD SCI USA, V113, P3317, DOI 10.1073/pnas.1523436113; Fotheringham JA, 2012, J VIROL, V86, P10308, DOI 10.1128/JVI.00853-12; French CA, 2016, ADV CANCER RES, V131, P21, DOI 10.1016/bs.acr.2016.04.001; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Hrdinka M, 2017, MOL CELL, V68, P265, DOI 10.1016/j.molcel.2017.09.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ke LR, 2017, P NATL ACAD SCI USA, V114, P9683, DOI 10.1073/pnas.1705236114; Kwong DLW, 2004, J CLIN ONCOL, V22, P2643, DOI 10.1200/JCO.2004.05.173; Li HM, 2004, ONCOGENE, V23, P4488, DOI 10.1038/sj.onc.1207580; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Li YY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14121; Lin DC, 2014, NAT GENET, V46, P866, DOI 10.1038/ng.3006; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Ma YJ, 2017, CELL HOST MICROBE, V21, P580, DOI 10.1016/j.chom.2017.04.005; Miller WE, 1998, ONCOGENE, V16, P1869, DOI 10.1038/sj.onc.1201696; PATHMANATHAN R, 1995, NEW ENGL J MED, V333, P693, DOI 10.1056/NEJM199509143331103; PATHMANATHAN R, 1995, AM J PATHOL, V146, P1355; Perez-Salvia M, 2017, EPIGENETICS-US, V12, P323, DOI 10.1080/15592294.2016.1265710; Raab-Traub N, 2015, CURR TOP MICROBIOL, V390, P339, DOI 10.1007/978-3-319-22822-8_14; Raab-Traub N, 2012, CURR OPIN VIROL, V2, P453, DOI 10.1016/j.coviro.2012.07.001; Rodriguez-Galindo C, 2005, CANCER-AM CANCER SOC, V103, P850, DOI 10.1002/cncr.20823; Sasaki K, 2015, IMMUNOL REV, V266, P175, DOI 10.1111/imr.12308; Siu LL, 1998, J CLIN ONCOL, V16, P2514, DOI 10.1200/JCO.1998.16.7.2514; Sommermann TG, 2011, CANCER RES, V71, P7291, DOI 10.1158/0008-5472.CAN-11-1715; Tang XR, 2018, LANCET ONCOL, V19, P382, DOI 10.1016/S1470-2045(18)30080-9; Thomas T, 2007, CELL CYCLE, V6, P696, DOI 10.4161/cc.6.6.4013; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yan KZ, 2017, AM J HUM GENET, V100, P91, DOI 10.1016/j.ajhg.2016.11.011; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yip YL, 2018, LAB INVEST, V98, P1093, DOI 10.1038/s41374-018-0034-7; Yuan J, 2017, CANCER RES, V77, P6614, DOI 10.1158/0008-5472.CAN-17-1143; Zhang J, 2017, J VIROL, V91, DOI 10.1128/JVI.02168-16; Zheng H, 2016, P NATL ACAD SCI USA, V113, P11283, DOI 10.1073/pnas.1607606113	41	5	5	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9734	9745		10.1074/jbc.RA119.008793	http://dx.doi.org/10.1074/jbc.RA119.008793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31073033	Green Published, hybrid			2022-12-28	WOS:000473277900009
J	Guo, L; Guo, YY; Li, BY; Peng, WQ; Tang, QQ				Guo, Liang; Guo, Ying-Ying; Li, Bai-Yu; Peng, Wan-Qiu; Tang, Qi-Qun			Histone demethylase KDM5A is transactivated by the transcription factor C/EBP and promotes preadipocyte differentiation by inhibiting Wnt/-catenin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipogenesis; CCAAT; enhancer-binding protein (C; EBP); histone demethylase; Wnt signaling; beta-catenin (B-catenin); epigenetics; post-translational modification (PTM); obesity; chromatin immunoprecipitation (ChiP); 3T3-L1 preadipocyte; adipogenesis; C; EBPbeta; lysine demethylase 5A (KDM5A); Wnt; beta-catenin pathway; fat cell; ChIP-on-chip	MITOTIC CLONAL EXPANSION; ADIPOCYTE DIFFERENTIATION; GAMMA EXPRESSION; BETA; ADIPOGENESIS; OBESITY; ACTIVATION; RBP2; CELL; G9A	beta-Catenin signaling is triggered by WNT proteins and is an important pathway that negatively regulates adipogenesis. However, the mechanisms controlling the expression of WNT proteins during adipogenesis remain incompletely understood. Lysine demethylase 5A (KDM5A) is a histone demethylase that removes trimethyl (me3) marks from lysine 4 of histone 3 (H3K4) and serves as a general transcriptional corepressor. Here, using the murine 3T3-L1 preadipocyte differentiation model and an array of biochemical approaches, including ChIP, immunoprecipitation, RT-qPCR, and immunoblotting assays, we show that Kdm5a is a target gene of CCAAT/enhancer-binding protein (C/EBP), an important early transcription factor required for adipogenesis. We found that C/EBP binds to the Kdm5a gene promoter and transactivates its expression. We also found that siRNA-mediated KDM5A down-regulation inhibits 3T3-L1 preadipocyte differentiation. The KDM5A knockdown significantly up-regulates the negative regulator of adipogenesis Wnt6, having increased levels of the H3K4me3 mark on its promoter. We further observed that WNT6 knockdown significantly rescues adipogenesis inhibited by the KDM5A knockdown. Moreover, we noted that C/EBP negatively regulates Wnt6 expression by binding to the Wnt6 gene promoter and repressing Wnt6 transcription. Further experiments indicated that KDM5A interacts with C/EBP and that their interaction cooperatively inhibits Wnt6 transcription. Of note, C/EBP knockdown impaired the recruitment of KDM5A to the Wnt6 promoter, which had higher H3K4me3 levels. Our results suggest a mechanism involving C/EBP and KDM5A activities that down-regulates the Wnt/-catenin pathway during 3T3-L1 preadipocyte differentiation.	[Guo, Liang; Guo, Ying-Ying; Li, Bai-Yu; Peng, Wan-Qiu; Tang, Qi-Qun] Fudan Univ, Key Lab Metab & Mol Med, Minist Educ, Dept Biochem & Mol Biol,Sch Basic Med Sci, Shanghai 200032, Peoples R China; [Guo, Liang; Guo, Ying-Ying; Li, Bai-Yu; Peng, Wan-Qiu; Tang, Qi-Qun] Fudan Univ, Dept Endocrinol & Metab, Zhongshan Hosp, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Guo, L; Tang, QQ (corresponding author), Fudan Univ, Key Lab Metab & Mol Med, Minist Educ, Dept Biochem & Mol Biol,Sch Basic Med Sci, Shanghai 200032, Peoples R China.	liangguo@fudan.edu.cn; qqtang@shmu.edu.cn		Guo, Liang/0000-0001-7353-8336	National Natural Science Foundation (NSFC) [31871435, 31370027, 81730021, 31571471]; Ministry of Science and Technology of the People's Republic of China (MOST) [2013CB530601]; 985 Project [985 III-YFX0302]	National Natural Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China); 985 Project(Jilin UniversityXiamen University)	This study was supported by National Natural Science Foundation (NSFC) Grants 31871435 and 31370027 (to L. G.), 81730021 and 31571471 (to Q.-Q. T.), and Ministry of Science and Technology of the People's Republic of China (MOST) Grant 2013CB530601 (to Q.-Q. T). The department is supported by 985 Project 985 III-YFX0302. The authors declare that they have no conflicts of interest with the contents of this article.	Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Beshiri ML, 2012, P NATL ACAD SCI USA, V109, P18499, DOI 10.1073/pnas.1216724109; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chicas A, 2012, P NATL ACAD SCI USA, V109, P8971, DOI 10.1073/pnas.1119836109; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cristancho AG, 2013, EMBO J, V32, P4, DOI 10.1038/emboj.2012.320; D'Urso A, 2014, TRENDS GENET, V30, P230, DOI 10.1016/j.tig.2014.04.004; Dentesano G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-165; Dimitrova E, 2015, EMBO REP, V16, P1620, DOI 10.15252/embr.201541113; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grundy SM, 2016, J INVEST MED, V64, P1082, DOI 10.1136/jim-2016-000155; Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75; Guo L, 2017, J CLIN INVEST, V127, P4449, DOI 10.1172/JCI96324; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Guo L, 2013, MOL CELL BIOL, V33, P3180, DOI 10.1128/MCB.00193-13; Jack BHA, 2010, J BIOL CHEM, V285, P32405, DOI 10.1074/jbc.M110.141317; Jiang Y, 2014, J PROTEOME RES, V13, P1307, DOI 10.1021/pr401292p; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kong SY, 2018, FASEB J, V32, P1108, DOI 10.1096/fj.201700780R; Li SF, 2013, AM J PHYSIOL-ENDOC M, V304, pE990, DOI 10.1152/ajpendo.00608.2012; Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108; Liu Y, 2018, J BIOL CHEM, V293, P14012, DOI 10.1074/jbc.RA118.004401; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Plch J, 2019, INT J CANCER, V144, P221, DOI 10.1002/ijc.31881; Price BD, 2017, J CELL BIOL, V216, P1871, DOI 10.1083/jcb.201705005; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Schilling T, 2007, MOL CELL ENDOCRINOL, V271, P1, DOI 10.1016/j.mce.2007.03.004; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shukla AP, 2015, J CARDIOPULM REHABIL, V35, P81, DOI 10.1097/HCR.0000000000000112; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Sugimura R, 2010, J MOL CELL BIOL, V2, P61, DOI 10.1093/jmcb/mjp030; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Varaljai R, 2015, GENE DEV, V29, P1817, DOI 10.1101/gad.264036.115; Verhoog N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110702; Arcidiacono MV, 2015, NEPHROL DIAL TRANSPL, V30, P423, DOI 10.1093/ndt/gfu311; Wang CD, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.238; Wang LF, 2013, EMBO J, V32, P45, DOI 10.1038/emboj.2012.306; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yang Y, 2017, MOL CELL ENDOCRINOL, V450, P43, DOI 10.1016/j.mce.2017.04.015; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zhang YongJie, 2012, Mycology - An International Journal on Fungal Biology, V3, P2; Zhang YY, 2011, MOL BIOL CELL, V22, P2165, DOI 10.1091/mbc.E10-11-0912; Zhao DZ, 2016, CELL REP, V15, P288, DOI 10.1016/j.celrep.2016.03.035	58	21	23	1	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9642	9654		10.1074/jbc.RA119.008419	http://dx.doi.org/10.1074/jbc.RA119.008419			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31061100	hybrid, Green Published			2022-12-28	WOS:000472713000028
J	Meyer, MB; Benkusky, NA; Kaufmann, M; Lee, SM; Redfield, RR; Jones, G; Pike, JW				Meyer, Mark B.; Benkusky, Nancy A.; Kaufmann, Martin; Lee, Seong Min; Redfield, Robert R.; Jones, Glenville; Pike, J. Wesley			Targeted genomic deletions identify diverse enhancer functions and generate a kidney-specific, endocrine-deficient Cyp27b1 pseudo-null mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; CRISPR; Cas; ChIP-sequencing (ChIP-Seq); vitamin D; gene regulation; parathyroid hormone; fibroblast growth factor 23 (FGF23); 1; 25-dihydroxyvitamin D3; 1--hydroxylase; Cyp24a1; Cyp27b1; Cyp27b1-KO; Cyp24a1; parathyroid hormone (PTH)	25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE GENE; MINERAL ION HOMEOSTASIS; HUMAN OSTEOCALCIN GENE; VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; MULTIPLE-SCLEROSIS; HIGH-CALCIUM; ACTIVATION; EXPRESSION; RECEPTOR	Vitamin D-3 is terminally bioactivated in the kidney to 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) via cytochrome P450 family 27 subfamily B member 1 (CYP27B1), whose gene is regulated by parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), and 1,25(OH)(2)D-3. Our recent genomic studies in the mouse have revealed a complex kidney-specific enhancer module within the introns of adjacent methyltransferase-like 1 (Mettl1) and Mettl21b that mediate basal and PTH-induced expression of Cyp27b1 and FGF23- and 1,25(OH)(2)D-3-mediated repression. Gross deletion of these segments in mice has severe effects on Cyp27b1 regulation and skeletal phenotype but does not affect Cyp27b1 expression in nonrenal target cells (NRTCs). Here, we report a bimodal activity in the Mettl1 intronic enhancer with components responsible for PTH-mediated Cyp27b1 induction and 1,25(OH)(2)D-3-mediated repression and additional activities, including FGF23 repression, within the Mettl21b enhancers. Deletion of both submodules eliminated basal Cyp27b1 expression and regulation in the kidney, leading to systemic and skeletal phenotypes similar to those of Cyp27b1-null mice. However, basal expression and lipopolysaccharide-induced regulation of Cyp27b1 in NRTCs was unperturbed. Importantly, dietary normalization of calcium, phosphate, PTH, and FGF23 rescued the skeletal phenotype of this mutant mouse, creating an ideal in vivo model to study nonrenal 1,25(OH)(2)D-3 production in health and disease. Finally, we confirmed a conserved chromatin landscape in human kidney that is similar to that in mouse. These findings define a finely balanced homeostatic mechanism involving PTH and FGF23 together with protection from 1,25(OH)(2)D-3 toxicity that is responsible for both adaptive vitamin D metabolism and mineral regulation.	[Meyer, Mark B.; Benkusky, Nancy A.; Lee, Seong Min; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Kaufmann, Martin; Jones, Glenville] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Kaufmann, Martin] Queens Univ, Dept Surg, Kingston, ON K7L 3N6, Canada; [Redfield, Robert R.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Queens University - Canada; Queens University - Canada; University of Wisconsin System; University of Wisconsin Madison	Meyer, MB (corresponding author), Univ Wisconsin, Dept Biochem, Hector F DeLuca Biochem Labs, Rm 543D,433 Babcock Dr, Madison, WI 53706 USA.	markmeyer@wisc.edu		Meyer, Mark/0000-0001-6612-7491	Department of Biochemistry, University of Wisconsin (Madison, WI); University of Wisconsin Carbone Cancer Center Grant P30; NIDDK, National Institutes of Health [R01-DK117475]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK117475] Funding Source: NIH RePORTER	Department of Biochemistry, University of Wisconsin (Madison, WI); University of Wisconsin Carbone Cancer Center Grant P30; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Department of Biochemistry, University of Wisconsin (Madison, WI); University of Wisconsin Carbone Cancer Center Support Grant P30; and NIDDK, National Institutes of Health, Grant R01-DK117475 (to J. W. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JS, 2014, J STEROID BIOCHEM, V144, P22, DOI 10.1016/j.jsbmb.2013.12.009; Alcina A, 2013, J MED GENET, V50, P25, DOI 10.1136/jmedgenet-2012-101085; Bahr A, 1999, GENOMICS, V57, P424, DOI 10.1006/geno.1999.5780; Bikle Daniel D, 2018, Bone Rep, V8, P255, DOI 10.1016/j.bonr.2018.02.004; Brenza HL, 2000, ARCH BIOCHEM BIOPHYS, V381, P143, DOI 10.1006/abbi.2000.1970; CHANDLER JS, 1984, J BIOL CHEM, V259, P2214; Christakos S, 2012, ARCH BIOCHEM BIOPHYS, V523, P73, DOI 10.1016/j.abb.2011.12.020; Dardenne O, 2003, BONE, V32, P332, DOI 10.1016/S8756-3282(03)00023-1; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; DELUCA HF, 1974, FED PROC, V33, P2211; Haussler M R, 1980, Prog Biochem Pharmacol, V17, P134; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Karaky M, 2016, MULT SCLER J, V22, P999, DOI 10.1177/1352458515610208; Kaufmann M, 2017, J BONE MINER RES, V32, P1589, DOI 10.1002/jbmr.3135; Kaufmann M, 2015, ENDOCRINOLOGY, V156, P4388, DOI 10.1210/en.2015-1664; Kaufmann M, 2014, J CLIN ENDOCR METAB, V99, P2567, DOI 10.1210/jc.2013-4388; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; Lee SM, 2015, J BIOL CHEM, V290, P18199, DOI 10.1074/jbc.M115.665794; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Meyer MB, 2017, J BIOL CHEM, V292, P17541, DOI 10.1074/jbc.M117.806901; Meyer MB, 2015, J BIOL CHEM, V290, P11093, DOI 10.1074/jbc.M115.648394; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Onal M, 2016, J BONE MINER RES, V31, P416, DOI 10.1002/jbmr.2698; OZONO K, 1990, J BIOL CHEM, V265, P21881; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498; PIKE JW, 1982, P NATL ACAD SCI-BIOL, V79, P7719, DOI 10.1073/pnas.79.24.7719; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Ramagopalan SV, 2011, ANN NEUROL, V70, P881, DOI 10.1002/ana.22678; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shinki T, 1999, P NATL ACAD SCI USA, V96, P8253, DOI 10.1073/pnas.96.14.8253; Sundqvist E, 2010, EUR J HUM GENET, V18, P1349, DOI 10.1038/ejhg.2010.113; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; ZIEROLD C, 1995, J BIOL CHEM, V270, P1675, DOI 10.1074/jbc.270.4.1675	42	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9518	9535		10.1074/jbc.RA119.008760	http://dx.doi.org/10.1074/jbc.RA119.008760			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31053643	Green Published, hybrid			2022-12-28	WOS:000472713000019
J	He, XB; Wang, YF; Yang, FY; Wang, B; Xie, HH; Gu, LK; Zhao, TY; Liu, XX; Zhang, DB; Ren, QW; Liu, XY; Liu, Y; Gao, CX; Gu, F				He, Xiubin; Wang, Yufei; Yang, Fayu; Wang, Bang; Xie, Haihua; Gu, Lingkai; Zhao, Tianyuan; Liu, Xiexie; Zhang, Dingbo; Ren, Qianwen; Liu, Xiaoyu; Liu, Yong; Gao, Caixia; Gu, Feng			Boosting activity of high-fidelity CRISPR/Cas9 variants using a tRNA(Gln)-processing system in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; tRNA; gene therapy; genetic disease; homologous recombination; CRISPR; Cas9; high-fidelity enzyme; off-target effects; tRNA processing	CAS9; NUCLEASES	CRISPR/Cas9 nucleases are widely used for genome editing but can induce unwanted off-target mutations. High-fidelity Cas9 variants have been identified; however, they often have reduced activity, constraining their utility, which presents a major challenge for their use in research applications and therapeutics. Here we developed a tRNA(Gln)-processing system to restore the activity of multiple high-fidelity Cas9 variants in human cells, including SpCas9-HF1, eSpCas9, and xCas9. Specifically, acting on previous observations that small guide RNAs (sgRNAs) harboring an extra A or G (A/G) in the first 5 nucleotide greatly affect the activity of high-fidelity Cas9 variants and that tRNA-sgRNA fusions improve Cas9 activity, we investigated whether a GN(20) sgRNA fused to different tRNAs (G-tRNA-N-20) could restore the activity of SpCas9 variants in human cells. Using flow cytometry, a T7E1 assay, deep sequencing-based DNA cleavage activity assays, and HEK-293 cells, we observed that a tRNA(Gln)-sgRNA fusion system enhanced the activity of Cas9 variants, which could be harnessed for efficient correction of a pathogenic mutation in the retinoschisin 1 (RS1) gene, resulting in 6- to 8-fold improved Cas9 activity. We propose that the tRNA-processing system developed here specifically for human cells could facilitate high-fidelity Cas9-mediated human genome-editing applications.	[He, Xiubin; Wang, Yufei; Yang, Fayu; Wang, Bang; Xie, Haihua; Gu, Lingkai; Zhao, Tianyuan; Liu, Xiexie; Ren, Qianwen; Liu, Xiaoyu; Liu, Yong; Gu, Feng] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou 325027, Zhejiang, Peoples R China; [He, Xiubin; Wang, Yufei; Yang, Fayu; Wang, Bang; Xie, Haihua; Gu, Lingkai; Zhao, Tianyuan; Liu, Xiexie; Ren, Qianwen; Liu, Xiaoyu; Liu, Yong; Gu, Feng] Minist Hlth, State Key Lab, Wenzhou 325027, Zhejiang, Peoples R China; [He, Xiubin; Wang, Yufei; Yang, Fayu; Wang, Bang; Xie, Haihua; Gu, Lingkai; Zhao, Tianyuan; Liu, Xiexie; Ren, Qianwen; Liu, Xiaoyu; Liu, Yong; Gu, Feng] Minist Hlth, Key Lab Vis Sci, Wenzhou 325027, Zhejiang, Peoples R China; [He, Xiubin; Wang, Yufei; Yang, Fayu; Wang, Bang; Xie, Haihua; Gu, Lingkai; Zhao, Tianyuan; Liu, Xiexie; Ren, Qianwen; Liu, Xiaoyu; Liu, Yong; Gu, Feng] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou 325027, Zhejiang, Peoples R China; [Zhang, Dingbo; Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China; [Zhang, Dingbo; Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Genome Editing, Beijing 100101, Peoples R China; [Zhang, Dingbo] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Wenzhou Medical University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gu, F (corresponding author), Wenzhou Med Univ, Hosp Eye, 270 Xueyuan West Rd, Wenzhou 325027, Zhejiang, Peoples R China.	gufenguw@gmail.com	Yang 杨发誉, Fayu/GZL-9086-2022	Yang 杨发誉, Fayu/0000-0003-1591-182X; Liu, Yong/0000-0001-6932-583X; Zhang, Dingbo/0000-0002-4860-1097; Wang, Bang/0000-0003-4223-3040; Gu, Feng/0000-0002-9600-8407; Gu, Feng/0000-0002-9019-2960	National Key R&D Program of China [2018YFA0107304]; Natural Science Foundation of China [81201181]; Zhejiang Provincial and Ministry of Health Research Fund for Medical Sciences [WKJ2013-2-023]; Science Technology Project of Zhejiang Province [2017C37176]; Wenzhou City [Y20140633]; Wenzhou Medical University [QTJ12011]; Eye Hospital at Wenzhou Medical University Grant [YNZD201602]	National Key R&D Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial and Ministry of Health Research Fund for Medical Sciences; Science Technology Project of Zhejiang Province; Wenzhou City; Wenzhou Medical University; Eye Hospital at Wenzhou Medical University Grant	Funding was provided by National Key R&D Program of China Grant 2018YFA0107304 (to Y. L.), Natural Science Foundation of China Grant 81201181 (to F. G.), Zhejiang Provincial and Ministry of Health Research Fund for Medical Sciences Grant WKJ2013-2-023 (to F. G.), Science Technology Project of Zhejiang Province Grant 2017C37176 (to F. G.), Wenzhou City Grant Y20140633 (to F. G.), Wenzhou Medical University Grant QTJ12011 (to F. G.), and Eye Hospital at Wenzhou Medical University Grant YNZD201602 (to F. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Casini A, 2018, NAT BIOTECHNOL, V36, P265, DOI 10.1038/nbt.4066; Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Jain PK, 2016, ANGEW CHEM INT EDIT, V55, P12440, DOI 10.1002/anie.201606123; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim K, 2017, GENOME RES, V27, P419, DOI 10.1101/gr.219089.116; Kim S, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1355-3; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lee JK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05477-x; Lin L, 2018, MOL THER, V26, P2650, DOI 10.1016/j.ymthe.2018.08.021; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wu H, 2018, CELL MOL LIFE SCI, V75, P3593, DOI 10.1007/s00018-018-2810-3; Yang FY, 2018, J GENET GENOMICS, V45, P329, DOI 10.1016/j.jgg.2018.02.009; Zhang DB, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1325-9; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405	24	14	16	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9308	9315		10.1074/jbc.RA119.007791	http://dx.doi.org/10.1074/jbc.RA119.007791			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31010827	hybrid, Green Published			2022-12-28	WOS:000471751600023
J	Huang, XY; Feng, T; Jiang, Z; Meng, JF; Kou, S; Lu, ZK; Chen, WZ; Lin, CP; Zhou, B; Zhang, H				Huang, Xinyan; Feng, Teng; Jiang, Zhen; Meng, Jufeng; Kou, Shan; Lu, Zhengkai; Chen, Weize; Lin, Chao-Po; Zhou, Bin; Zhang, Hui			Dual lineage tracing identifies intermediate mesenchymal stage for endocardial contribution to fibroblasts, coronary mural cells, and adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heart development; endothelial cell; adipocyte; vascular smooth muscle cells; fibroblast; Endocardium; Mesenchymal cells; pericyte	TRANSCRIPTION FACTOR; CARDIAC FIBROBLASTS; NF-ATC; FATE; TRANSITION; VALVES; RECOMBINASE; PROGENITORS; PATHWAY; ORIGIN	Early embryonic endocardium undergoes endothelial-to-mesenchymal transition to form cardiac cushion mesenchymal cells (MCs). Embryonic endocardium also gives rise to fibroblasts, intramyocardial adipocytes, and coronary mural cells, including smooth muscle cells and pericytes, in development. Whether endocardial cells directly differentiate into fibroblasts, coronary mural cells, and adipocytes or indirectly via an intermediate stage of endocardial-derived cushion MCs remains unknown. In addition to endocardium, epicardium and neural crest also contribute to cardiac cushion MCs. Given the developmental heterogeneity of cushion MCs and the lack of specific markers for endocardial-derived cushion MCs, conventional genetic lineage tracing utilizing Cre recombinase driven by one specific regulatory element is not sufficient to examine the fates of endocardial-derived cushion MCs. Intersectional genetic targeting approaches, which combine regulatory elements from two or more genes, have been employed to increase the specificity of cell targeting. Here, we developed a dual-recombinase intersectional targeting approach using Nfatc1-Dre, Sox9-CreER, and Cre/Dre double-dependent reporter Ai66 to specifically label endocardial-derived cushion MCs. Taking advantage of intersectional lineage tracing, we found that a subset of cardiac cells including fibroblasts, coronary mural cells, and intramyocardial adipocytes in adult hearts were derived from endocardial-derived cushion MCs. Our study suggests that embryonic endocardium contributes to cushion MCs first, and then endocardial-derived cushion MCs migrate into myocardium and differentiate into fibroblasts, coronary mural cells, and adipocytes in development. Understanding developmental origins of cardiac cell lineages will provide us more insights into cardiac development, regeneration, and diseases.	[Huang, Xinyan; Feng, Teng; Jiang, Zhen; Meng, Jufeng; Kou, Shan; Lu, Zhengkai; Chen, Weize; Lin, Chao-Po; Zhou, Bin; Zhang, Hui] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Huang, Xinyan; Feng, Teng; Jiang, Zhen; Kou, Shan; Lu, Zhengkai; Zhou, Bin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhou, Bin] Chinese Acad Sci, State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci, Inst Biochem & Cell Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Zhou, Bin] Jinan Univ, Key Lab Regenerat Med, Inst Aging & Regenerat Med, Minist Educ, Guangzhou 510632, Guangdong, Peoples R China	ShanghaiTech University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Jinan University	Zhang, H (corresponding author), 393 Middle Huaxia Rd,L Bldg B328, Shanghai 201210, Peoples R China.	zhanghui1@shanghaitech.edu.cn		Lin, Chao-Po/0000-0002-1457-1635; Zhou, Bin/0000-0001-5278-5522; Jiang, Zhen/0000-0001-7607-5955	National Key R&D Program of China [2018YFA0108100]; National Science Foundation of China [31871474, 31822034, 81861128023]; Shuguang Program Grant - Shanghai Education Development Foundation [17SG54]; Shanghai Municipal Commission; ShanghaiTech University start-up fund	National Key R&D Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shuguang Program Grant - Shanghai Education Development Foundation; Shanghai Municipal Commission; ShanghaiTech University start-up fund	This work was supported by National Key R&D Program of China Grant 2018YFA0108100; National Science Foundation of China Grants 31871474, 31822034, and 81861128023; Shuguang Program Grant 17SG54, supported by the Shanghai Education Development Foundation and Shanghai Municipal Commission; and the ShanghaiTech University start-up fund. The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Ali SR, 2014, CIRC RES, V115, P625, DOI 10.1161/CIRCRESAHA.115.303794; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chen Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12422; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; Garside VC, 2015, DEVELOPMENT, V142, P4340, DOI 10.1242/dev.125252; He LJ, 2017, NAT MED, V23, P1488, DOI 10.1038/nm.4437; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu K, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167775; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Pillai ICL, 2017, CELL STEM CELL, V20, P218, DOI 10.1016/j.stem.2016.10.005; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Snarr BS, 2008, DEV DYNAM, V237, P2804, DOI 10.1002/dvdy.21725; Volz KS, 2015, ELIFE, V4, DOI 10.7554/eLife.10036; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Xu ZJ, 2015, ELIFE, V4, DOI 10.7554/eLife.10567; Yamaguchi Y, 2015, P NATL ACAD SCI USA, V112, P2070, DOI 10.1073/pnas.1417232112; Zhang H, 2018, CIRC RES, V122, P774, DOI 10.1161/CIRCRESAHA.117.312136; Zhang H, 2017, CELL RES, V27, P1157, DOI 10.1038/cr.2017.103; Zhang H, 2016, CIRC RES, V118, P1880, DOI 10.1161/CIRCRESAHA.116.308749; Zhang H, 2016, NAT GENET, V48, P537, DOI 10.1038/ng.3536; Zhang H, 2016, CIRC RES, V118, P254, DOI 10.1161/CIRCRESAHA.115.307202; Zhang H, 2014, J BIOL CHEM, V289, P18681, DOI 10.1074/jbc.M114.554584	35	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8894	8906		10.1074/jbc.RA118.006994	http://dx.doi.org/10.1074/jbc.RA118.006994			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31010826	Green Published, hybrid			2022-12-28	WOS:000470971100023
J	Wang, QM; Yang, YT; Wang, YR; Gao, B; Xi, XG; Hou, XM				Wang, Qing-Man; Yang, Yan-Tao; Wang, Yi-Ran; Gao, Bo; Xi, Xuguang; Hou, Xi-Miao			Human replication protein A induces dynamic changes in single-stranded DNA and RNA structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA binding protein; DNA-protein interaction; DNA structure; single-molecule biophysics; enzyme mechanism; molecular dynamics; fluorescence resonance energy transfer (FRET); DNA recombination; DNA replication; replication protein A	BINDING; RPA; SSDNA; MECHANISM; SUBUNIT; DOMAINS; PRIMER; ARCHITECTURE; HELICASE; POLARITY	Replication protein A (RPA) is the major eukaryotic ssDNA-binding protein and has essential roles in genome maintenance. RPA binds to ssDNA through multiple modes, and recent studies have suggested that the RPA-ssDNA interaction is dynamic. However, how RPA alternates between different binding modes and modifies ssDNA structures in this dynamic interaction remains unknown. Here, we used single-molecule FRET to systematically investigate the interaction between human RPA and ssDNA. We show that RPA can adopt different types of binding complexes with ssDNAs of different lengths, leading to the straightening or bending of the ssDNAs, depending on both the length and structure of the ssDNA substrate and the RPA concentration. Importantly, we noted that some of the complexes are highly dynamic, whereas others appear relatively static. On the basis of the above observations, we propose a model explaining how RPA dynamically engages with ssDNA. Of note, fluorescence anisotropy indicated that RPA can also associate with RNA but with a lower binding affinity than with ssDNA. At the single-molecule level, we observed that RPA is undergoing rapid and repetitive associations with and dissociation from the RNA. This study may provide new insights into the rich dynamics of RPA binding to ssDNA and RNA.	[Wang, Qing-Man; Yang, Yan-Tao; Wang, Yi-Ran; Gao, Bo; Xi, Xuguang; Hou, Xi-Miao] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Wang, Qing-Man; Yang, Yan-Tao; Wang, Yi-Ran; Gao, Bo; Xi, Xuguang; Hou, Xi-Miao] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Xi, Xuguang] Ecole Normale Super, CNRS, Lab Biol & Pharmacol Appl, 61 Ave President Wilson, F-94235 Cachan, France	Northwest A&F University - China; Northwest A&F University - China; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Hou, XM (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Hou, XM (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	houximiao@nwsuaf.edu.cn	Wang, Yin/HCI-9352-2022; Wang, Yixuan/GZK-6559-2022; Hou, Xi-Miao/AAA-7919-2021; Wang, Yu/GZL-9655-2022; wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; Xi, Xu Guang/AAK-4511-2020; wang, yixuan/GXW-2866-2022		Chinese Universities Scientific Fund [Z109021718]; National Natural Science Foundation of China [11574252]	Chinese Universities Scientific Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Universities Scientific Fund Grant Z109021718 and National Natural Science Foundation of China Grant 11574252. The authors declare that they have no conflicts of interest with the contents of this article.	Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Bain FE, 2018, METHOD ENZYMOL, V600, P439, DOI 10.1016/bs.mie.2017.11.016; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Bhat KP, 2018, NAT STRUCT MOL BIOL, V25, P446, DOI 10.1038/s41594-018-0075-z; Blackwell LJ, 1996, MOL CELL BIOL, V16, P4798; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Brosey CA, 2013, NUCLEIC ACIDS RES, V41, P2313, DOI 10.1093/nar/gks1332; Brosey CA, 2009, J AM CHEM SOC, V131, P6346, DOI 10.1021/ja9013634; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09296; Chen R, 2016, NUCLEIC ACIDS RES, V44, P5758, DOI 10.1093/nar/gkw339; Chen R, 2014, BIOESSAYS, V36, P1156, DOI 10.1002/bies.201400107; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Iftode C, 2000, BIOCHEMISTRY-US, V39, P11970, DOI 10.1021/bi0005761; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kaniecki K, 2018, NAT REV GENET, V19, P191, DOI 10.1038/nrg.2017.92; Kemmerich FE, 2016, NUCLEIC ACIDS RES, V44, P5837, DOI 10.1093/nar/gkw187; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Kolpashchikov DM, 2001, NUCLEIC ACIDS RES, V29, P373, DOI 10.1093/nar/29.2.373; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Lavrik OI, 1999, NUCLEIC ACIDS RES, V27, P4235, DOI 10.1093/nar/27.21.4235; Liu Y, 2011, MOL CELL BIOL, V31, P4298, DOI 10.1128/MCB.05737-11; Ma CJ, 2017, NUCLEIC ACIDS RES, V45, P749, DOI 10.1093/nar/gkw1125; Nguyen B, 2014, J MOL BIOL, V426, P3246, DOI 10.1016/j.jmb.2014.07.014; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Pestryakov PE, 2004, NUCLEIC ACIDS RES, V32, P1894, DOI 10.1093/nar/gkh346; Pestryakov PE, 2003, J BIOL CHEM, V278, P17515, DOI 10.1074/jbc.M301265200; Pokhrel N, 2017, NUCLEIC ACIDS RES, V45, P9413, DOI 10.1093/nar/gkx598; Pretto DI, 2010, BIOCHEMISTRY-US, V49, P2880, DOI 10.1021/bi9019934; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Salas TR, 2009, NUCLEIC ACIDS RES, V37, P38, DOI 10.1093/nar/gkn895; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sugitani N, 2015, PROG BIOPHYS MOL BIO, V117, P206, DOI 10.1016/j.pbiomolbio.2014.12.001; Witosch J, 2014, NUCLEIC ACIDS RES, V42, P12912, DOI 10.1093/nar/gku960; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yates LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07883-7; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	50	13	13	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13915	13927		10.1074/jbc.RA119.009737	http://dx.doi.org/10.1074/jbc.RA119.009737			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31350334	Green Published, hybrid			2022-12-28	WOS:000490729800007
J	Dizhoor, AM; Olshevskaya, EV; Peshenko, IV				Dizhoor, Alexander M.; Olshevskaya, Elena V.; Peshenko, Igor V.			Retinal guanylyl cyclase activation by calcium sensor proteins mediates photoreceptor degeneration in an rd3 mouse model of congenital human blindness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vision; guanylate cyclase (guanylyl cyclase); phototransduction; calcium-binding protein; eye; retinal degeneration; GCAP; RD3; RetGC	1 RETGC1; CRYSTAL-STRUCTURE; ROD; GCAPS; SENSITIVITY; EXPRESSION; CLONING; PHOTOTRANSDUCTION; LOCALIZATION; TRAFFICKING	Deficiency of RD3 (retinal degeneration 3) protein causes recessive blindness and photoreceptor degeneration in humans and in the rd3 mouse strain, but the disease mechanism is unclear. Here, we present evidence that RD3 protects photoreceptors from degeneration by competing with guanylyl cyclase-activating proteins (GCAPs), which are calcium sensor proteins for retinal membrane guanylyl cyclase (RetGC). RetGC activity in rd3/rd3 retinas was drastically reduced but stimulated by the endogenous GCAPs at low Ca2+ concentrations. RetGC activity completely failed to accelerate in rd3/rd3GCAPs(-/-) hybrid photoreceptors, whose photoresponses remained drastically suppressed compared with the WT. However, similar to 70% of the hybrid rd3/rd3GCAPs(-/-) photoreceptors survived past 6 months, in stark contrast to <5% in the nonhybrid rd3/rd3 retinas. GFP-tagged human RD3 inhibited GCAP-dependent activation of RetGC in vitro similarly to the untagged RD3. When transgenically expressed in rd3/rd3 mouse retinas under control of the rhodopsin promoter, the RD3GFP construct increased RetGC levels to near normal levels, restored dark-adapted photoresponses, and rescued rods from degeneration. The fluorescence of RD3GFP in rd3/rd3RD3GFP(+) retinas was mostly restricted to the rod photoreceptor inner segments, whereas GCAP1 immunofluorescence was concentrated predominantly in the outer segment. However, RD3GFP became distributed to the outer segments when bred into a GCAPs(-/-) genetic background. These results support the hypothesis that an essential biological function of RD3 is competition with GCAPs that inhibits premature cyclase activation in the inner segment. Our findings also indicate that the fast rate of degeneration in RD3-deficient photoreceptors results from the lack of this inhibition.	[Dizhoor, Alexander M.; Olshevskaya, Elena V.; Peshenko, Igor V.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Salus Univ, Res S416,8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY011522]; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY011522 and by the Pennsylvania Department of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; Dizhoor AM, 2016, J BIOL CHEM, V291, P24504, DOI 10.1074/jbc.M116.755553; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Horton R. M., 1991, PRACTICAL APPROACH, P217; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2019, J BIOL CHEM, V294, P3476, DOI 10.1074/jbc.RA118.006180; Peshenko IV, 2019, J BIOL CHEM, V294, P2318, DOI 10.1074/jbc.RA118.006106; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2015, J BIOL CHEM, V290, P19584, DOI 10.1074/jbc.M115.661371; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sato S, 2018, J NEUROSCI, V38, P2990, DOI 10.1523/JNEUROSCI.2985-17.2018; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Wimberg H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00052; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	48	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13729	13739		10.1074/jbc.RA119.009948	http://dx.doi.org/10.1074/jbc.RA119.009948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31346032	hybrid, Green Published			2022-12-28	WOS:000486418600018
J	Matos, AM; Pinto, FR; Barros, P; Amaral, MD; Pepperkok, R; Matos, P				Matos, Ana M.; Pinto, Francisco R.; Barros, Patricia; Amaral, Margarida D.; Pepperkok, Rainer; Matos, Paulo			Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); chloride channel; plasma membrane; epithelial cell; Calpain 1; interactome; Phe508del-CFTR	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MACROMOLECULAR COMPLEXES; TEZACAFTOR-IVACAFTOR; CFTR POTENTIATOR; HALF-LIFE; PROTEIN; EZRIN	Cystic fibrosis (CF) is a genetic disease caused by mutations in the gene encoding CF transmembrane conductance regulator (CFTR), a chloride channel normally expressed at the surface of epithelial cells. The most frequent mutation, resulting in Phe-508 deletion, causes CFTR misfolding and its premature degradation. Low temperature or pharmacological correctors can partly rescue the Phe508del-CFTR processing defect and enhance trafficking of this channel variant to the plasma membrane (PM). Nevertheless, the rescued channels have an increased endocytosis rate, being quickly removed from the PM by the peripheral protein quality-control pathway. We previously reported that rescued Phe508del-CFTR (rPhe508del) can be retained at the cell surface by stimulating signaling pathways that coax the adaptor molecule ezrin (EZR) to tether rPhe508del-Na+/H+-exchange regulatory factor-1 complexes to the actin cytoskeleton, thereby averting the rapid internalization of this channel variant. However, the molecular basis for why rPhe508del fails to recruit active EZR to the PM remains elusive. Here, using a proteomics approach, we characterized and compared the core components of wt-CFTR- or rPhe508del-containing macromolecular complexes at the surface of human bronchial epithelial cells. We identified calpain 1 (CAPN1) as an exclusive rPhe508del interactor that prevents active EZR recruitment, impairs rPhe508del anchoring to actin, and reduces its stability in the PM. We show that either CAPN1 down-regulation or its chemical inhibition dramatically improves the functional rescue of Phe508del-CFTR in airway cells. These observations suggest that CAPN1 constitutes an appealing target for pharmacological intervention, as part of CF combination therapies restoring Phe508del-CFTR function.	[Matos, Ana M.; Barros, Patricia; Matos, Paulo] Natl Hlth Inst Doutor Ricardo Jorge, Dept Human Genet, Av Padre Cruz, P-1649016 Lisbon, Portugal; [Matos, Ana M.; Pinto, Francisco R.; Barros, Patricia; Amaral, Margarida D.; Matos, Paulo] Univ Lisbon, BioISI Biosyst & Integrat Sci Inst, Fac Sci, P-1749016 Lisbon, Portugal; [Pepperkok, Rainer] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Pepperkok, Rainer] European Mol Biol Lab, Adv Light Microscopy Facil, D-69117 Heidelberg, Germany	Instituto Nacional de Saude Dr. Ricardo Jorge; BIOISI; Universidade de Lisboa; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Matos, P (corresponding author), Natl Hlth Inst Doutor Ricardo Jorge, Dept Human Genet, Av Padre Cruz, P-1649016 Lisbon, Portugal.	paulo.matos@insa.min-saude.pt	Pinto, Francisco/A-7443-2008; Matos, Ana MFP/U-5810-2017; Barros, Patrícia/Q-1759-2015; Barros, Patrícia/AFQ-8459-2022; Amaral, Margarida D/E-5748-2012; Matos, Paulo/F-5245-2012	Pinto, Francisco/0000-0002-4217-0054; Matos, Ana MFP/0000-0002-0160-256X; Barros, Patrícia/0000-0001-5063-5766; Amaral, Margarida D/0000-0002-0828-8630; Matos, Paulo/0000-0002-9379-9696	Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/94322/2013, PTDC/BIA-CEL/28408/2017, UID/MULTI/04046/2019, IF2012]; BioSYS Ph.D. Program - Fundacao para a Ciencia e a Tecnologia [SFRH/BD/52490/2014, PD65-2012]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); BioSYS Ph.D. Program - Fundacao para a Ciencia e a Tecnologia	This work was supported by Grants PTDC/BIA-CEL/28408/2017 and IF2012 (to P. M.) and Center Grant UID/MULTI/04046/2019 to BioISI, both from the Fundacao para a Ciencia e a Tecnologia. This work was also supported by Fellowship SFRH/BD/52490/2014 from BioSYS Ph.D. Program PD65-2012 (to A. M. M.), and Fellowship SFRH/BPD/94322/2013 (to P. B.), both funded by the Fundacao para a Ciencia e a Tecnologia. The authors declare that they have no conflicts of interest with the contents of this article.	Abbattiscianni AC, 2016, J CELL SCI, V129, P1128, DOI 10.1242/jcs.177907; Almaca J, 2011, METHODS MOL BIOL, V742, P249, DOI 10.1007/978-1-61779-120-8_15; Antigny F, 2008, CELL CALCIUM, V43, P175, DOI 10.1016/j.ceca.2007.05.002; Antigny F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-70; Averna M, 2011, BBA-MOL BASIS DIS, V1812, P1649, DOI 10.1016/j.bbadis.2011.09.013; Bell SC, 2015, PHARMACOL THERAPEUT, V145, P19, DOI 10.1016/j.pharmthera.2014.06.005; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; Botelho HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09038; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Bronsveld I, 2000, GASTROENTEROLOGY, V119, P32, DOI 10.1053/gast.2000.8524; Caputo A, 2009, J PHARMACOL EXP THER, V330, P783, DOI 10.1124/jpet.109.154146; Carvalho-Oliveira I, 2004, J HISTOCHEM CYTOCHEM, V52, P193, DOI 10.1177/002215540405200207; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Davies JC, 2018, NEW ENGL J MED, V379, P1599, DOI 10.1056/NEJMoa1807119; De Boeck K, 2014, J CYST FIBROS, V13, P403, DOI 10.1016/j.jcf.2013.12.003; Donaldson SH, 2018, AM J RESP CRIT CARE, V197, P214, DOI 10.1164/rccm.201704-0717OC; Donkor IO, 2015, EXPERT OPIN THER PAT, V25, P17, DOI 10.1517/13543776.2014.982534; Donkor IO, 2011, EXPERT OPIN THER PAT, V21, P601, DOI 10.1517/13543776.2011.568480; Elborn JS, 2016, LANCET RESP MED, V4, P617, DOI 10.1016/S2213-2600(16)30121-7; Farinha CM, 2017, CELL MOL LIFE SCI, V74, P39, DOI 10.1007/s00018-016-2387-7; Farinha CM, 2013, FEBS J, V280, P4396, DOI 10.1111/febs.12392; Farinha CM, 2013, CHEM BIOL, V20, P943, DOI 10.1016/j.chembiol.2013.06.004; Fukuda R, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01100; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Grasemann H, 2017, NEW ENGL J MED, V377, P2085, DOI 10.1056/NEJMe1712335; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Hoskin V, 2015, MOL BIOL CELL, V26, P3464, DOI 10.1091/mbc.E14-12-1584; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutt DM, 2018, J BIOL CHEM, V293, P13477, DOI 10.1074/jbc.RA118.003192; Johansson J, 2014, CYTOM PART A, V85A, P611, DOI 10.1002/cyto.a.22456; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; Keating D, 2018, NEW ENGL J MED, V379, P1612, DOI 10.1056/NEJMoa1807120; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Kunzelmann K, 2001, NEWS PHYSIOL SCI, V16, P167; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Loureiro CA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1580; Matos A. M., 2018, J LUNG HLTH DIS, V2, P9, DOI DOI 10.29245/2689-999X/2017/1.1113; Matos AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31514-2; Moniz S, 2013, ACS CHEM BIOL, V8, P432, DOI 10.1021/cb300484r; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2017, NEW ENGL J MED, V377, P2024, DOI 10.1056/NEJMoa1709847; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shcherbina A, 1999, FEBS LETT, V443, P31, DOI 10.1016/S0014-5793(98)01674-3; SHENOY AM, 1991, CELL IMMUNOL, V138, P24, DOI 10.1016/0008-8749(91)90129-Y; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Taylor-Cousar JL, 2017, NEW ENGL J MED, V377, P2013, DOI 10.1056/NEJMoa1709846; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; van Meegen M. A., 2009, J CYST FIBROS, V8, pS56, DOI [10.1016/S1569-1993(09)60221-6, DOI 10.1016/S1569-1993(09)60221-6]; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wang SS, 2001, PFLUG ARCH EUR J PHY, V443, pS62, DOI 10.1007/s004240100646; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; YAO XB, 1993, AM J PHYSIOL, V265, pC36, DOI 10.1152/ajpcell.1993.265.1.C36	70	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13396	13410		10.1074/jbc.RA119.008738	http://dx.doi.org/10.1074/jbc.RA119.008738			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31324722	Green Published, hybrid			2022-12-28	WOS:000486417200016
J	Saline, M; Badertscher, L; Wolter, M; Lau, R; Gunnarsson, A; Jacso, T; Norris, T; Ottmann, C; Snijder, A				Saline, Maria; Badertscher, Lukas; Wolter, Madita; Lau, Roxanne; Gunnarsson, Anders; Jacso, Tomas; Norris, Tyrrell; Ottmann, Christian; Snijder, Arjan			AMPK and AKT protein kinases hierarchically phosphorylate the N-terminus of the FOXO1 transcription factor, modulating interactions with 14-3-3 proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FOXO; 14-3-3 protein; AMP-activated kinase (AMPK); Akt PKB; gene transcription; crystal structure; posttranslational modification (PTM); protein phosphorylation; NMR; 14-3-3 interaction; energy homeostasis; FOXO1 transcription factor; kinase signaling	DIETARY RESTRICTION; FORKHEAD; FKHR; ACTIVATION; BINDING; EXPRESSION; REVEALS; ROLES; SITES	Forkhead box protein O1 (FOXO1) is a transcription factor involved in various cellular processes such as glucose metabolism, development, stress resistance, and tumor suppression. FOXO1's transcriptional activity is controlled by different environmental cues through a myriad of posttranslational modifications. In response to growth factors, the serine/threonine kinase AKT phosphorylates Thr(24) and Ser(256) in FOXO1 to stimulate binding of 14-3-3 proteins, causing FOXO1 inactivation. In contrast, low nutrient and energy levels induce FOXO1 activity. AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis, partly mediates this effect through phosphorylation of Ser(383) and Thr(649) in FOXO1. In this study, we identified Ser(22) as an additional AMPK phosphorylation site in FOXO1's N terminus, with Ser(22) phosphorylation preventing binding of 14-3-3 proteins. The crystal structure of a FOXO1 peptide in complex with 14-3-3 sigma at 2.3 angstrom resolution revealed that this is a consequence of both steric hindrance and electrostatic repulsion. Furthermore, we found that AMPK-mediated Ser(22) phosphorylation impairs Thr(24) phosphorylation by AKT in a hierarchical manner. Thus, numerous mechanisms maintain FOXO1 activity via AMPK signaling. AMPK-mediated Ser(22) phosphorylation directly and indirectly averts binding of 14-3-3 proteins, whereas phosphorylation of Ser(383) and Thr(649) complementarily stimulates FOXO1 activity. Our results shed light on a mechanism that integrates inputs from both AMPK and AKT signaling pathways in a small motif to fine-tune FOXO1 transcriptional activity.	[Saline, Maria; Badertscher, Lukas; Gunnarsson, Anders; Jacso, Tomas; Norris, Tyrrell; Snijder, Arjan] AstraZeneca, R&D, Discovery Biol, Discovery Sci, Gothenburg, Sweden; [Wolter, Madita; Lau, Roxanne; Ottmann, Christian] Eindhoven Univ Technol, Dept Biomed Engn, Lab Chem Biol, POB 513, NL-5600 MB Eindhoven, Netherlands; [Wolter, Madita; Lau, Roxanne; Ottmann, Christian] Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands; [Saline, Maria] Chalmers Univ Technol, S-41296 Gothenburg, Sweden; [Saline, Maria; Badertscher, Lukas] AstraZeneca, Postdoctoral Program, Gothenburg, Sweden; [Jacso, Tomas] Nuevolution AS, Ronnegade 8, DK-2100 Copenhagen, Denmark	AstraZeneca; Eindhoven University of Technology; Eindhoven University of Technology; Chalmers University of Technology; AstraZeneca	Snijder, A (corresponding author), AstraZeneca, R&D, Discovery Biol, Discovery Sci, Gothenburg, Sweden.	arjan.snijder@astrazeneca.com		Ottmann, Christian/0000-0001-7315-0315; Wolter, Madita/0000-0003-1430-9589; Snijder, Arjan/0000-0003-2829-3098				Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Awad H, 2014, PEDIATR PULM, V49, P885, DOI 10.1002/ppul.22919; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Beaven R, 2017, J CELL BIOL, V216, P3029, DOI 10.1083/jcb.201704120; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen BL, 2010, ACTA PHARMACOL SIN, V31, P798, DOI 10.1038/aps.2010.73; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Kunzelmann S, 2010, ACS CHEM BIOL, V5, P415, DOI 10.1021/cb9003173; Leclerc Gilles M, 2010, J Mol Signal, V5, P15, DOI 10.1186/1750-2187-5-15; Lee JW, 2011, J BIOL CHEM, V286, P6423, DOI 10.1074/jbc.M110.180661; Lee K, 2015, BIOCHEM BIOPH RES CO, V466, P289, DOI 10.1016/j.bbrc.2015.08.126; Marin TL, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0156-0; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mitrea DM, 2014, P NATL ACAD SCI USA, V111, P4466, DOI 10.1073/pnas.1321007111; Molzan M, 2010, MOL CELL BIOL, V30, P4698, DOI 10.1128/MCB.01636-09; Ning YZ, 2015, J TOXICOL SCI, V40, P637, DOI 10.2131/jts.40.637; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Pezze PD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13254; Reimer U, 2002, BIOPHYS CHEM, V96, P203, DOI 10.1016/S0301-4622(02)00013-3; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Rosenlow J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096199; Safaei J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S6; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Singh P, 2017, J STRUCT BIOL, V198, P54, DOI 10.1016/j.jsb.2017.02.006; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Trinh DL, 2013, BLOOD, V121, P3666, DOI 10.1182/blood-2013-01-479865; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Yun H, 2014, FEBS J, V281, P4421, DOI 10.1111/febs.12949; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013; Zhou JC, 2015, J NEUROSCI, V35, P2624, DOI 10.1523/JNEUROSCI.3051-14.2015; Zou JF, 2016, CANCER SCI, V107, P1806, DOI 10.1111/cas.13083	51	43	44	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13106	13116		10.1074/jbc.RA119.008649	http://dx.doi.org/10.1074/jbc.RA119.008649			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31308176	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000486416000020
J	Tembo, M; Wozniak, KL; Bainbridge, RE; Carlson, AE				Tembo, Maiwase; Wozniak, Katherine L.; Bainbridge, Rachel E.; Carlson, Anne E.			Phosphatidylinositol 4,5-bisphosphate (PIP2) and Ca2+ are both required to open the Cl- channel TMEM16A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; phospholipid; calcium; patch clamp; oocyte; Xenopus; signal transduction; anion channel; transmembrane member 16A (TMEM16A)	POTASSIUM CHANNELS; INDEPENDENT ACTIVATION; K+ CHANNEL; CALCIUM; PROTEINS; PHOSPHOINOSITIDES; MECHANISM; EXCHANGE; RUNDOWN; BINDING	Transmembrane member 16A (TMEM16A) is a widely expressed Ca2+-activated Cl- channel with various physiological functions ranging from mucosal secretion to regulating smooth muscle contraction. Understanding how TMEM16A controls these physiological processes and how its dysregulation may cause disease requires a detailed understanding of how cellular processes and second messengers alter TMEM16A channel gating. Here we assessed the regulation of TMEM16A gating by recording Ca2+-evoked Cl- currents conducted by endogenous TMEM16A channels expressed in Xenopus laevis oocytes, using the inside-out configuration of the patch clamp technique. During continuous application of Ca2+, we found that TMEM16A-conducted currents decay shortly after patch excision. Such current rundown is common among channels regulated by phosphatidylinositol 4,5-bisphosphate (PIP2). Thus, we sought to investigate a possible role of PIP2 in TMEM16A gating. Consistently, synthetic PIP2 rescued the current after rundown, and the application of PIP2 modulating agents altered the speed kinetics of TMEM16A current rundown. First, two PIP2 sequestering agents, neomycin and anti-PIP2, applied to the intracellular surface of excised patches sped up TMEM16A current rundown to nearly twice as fast. Conversely, rephosphorylation of phosphatidylinositol (PI) derivatives into PIP2 using Mg-ATP or inhibiting dephosphorylation of PIP2 using beta-glycerophosphate slowed rundown by nearly 3-fold. Our results reveal that TMEM16A regulation is more complicated than it initially appeared; not only is Ca2+ necessary to signal TMEM16a opening, but PIP2 is also required. These findings improve our understanding of how the dysregulation of these pathways may lead to disease and suggest that targeting these pathways could have utility for potential therapies.	[Tembo, Maiwase; Wozniak, Katherine L.; Bainbridge, Rachel E.; Carlson, Anne E.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carlson, AE (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	acarlson@pitt.edu	Carlson, Anne/I-9495-2019	Carlson, Anne/0000-0003-2724-1325; Wozniak, Katherine/0000-0002-3797-2116; Bainbridge, Rachel/0000-0002-6014-2030	American Heart Association Predoctoral Fellowship [18PRE33960391]; National Institutes of Health [R01GM125638]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125638] Funding Source: NIH RePORTER	American Heart Association Predoctoral Fellowship(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Predoctoral Fellowship 18PRE33960391 (to M.T.) and National Institutes of Health Grant R01GM125638 (to A. E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Boskey AL, 1996, J BONE MINER RES, V11, P1694; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Bulley S, 2012, CIRC RES, V111, P1027, DOI 10.1161/CIRCRESAHA.112.277145; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; COLLINS A, 1992, J PHYSIOL-LONDON, V454, P27, DOI 10.1113/jphysiol.1992.sp019253; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; De Jesus-Perez JJ, 2018, BBA-MOL CELL BIOL L, V1863, P299, DOI 10.1016/j.bbalip.2017.12.009; Doignon F, 2016, MOL CELL BIOL, V36, P765, DOI 10.1128/MCB.00843-15; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; EGAN TM, 1992, J NEUROSCI, V12, P1964; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hasani HJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191905; Heinze C, 2014, J CLIN INVEST, V124, P675, DOI 10.1172/JCI70025; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Hughes TET, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06753-6; Jeng G, 2016, J GEN PHYSIOL, V148, P393, DOI 10.1085/jgp.201611651; Lim NK, 2016, J GEN PHYSIOL, V148, P375, DOI 10.1085/jgp.201611650; Mall MA, 2015, J CYST FIBROS, V14, P561, DOI 10.1016/j.jcf.2015.06.002; ONO K, 1992, J PHYSIOL-LONDON, V454, P673, DOI 10.1113/jphysiol.1992.sp019286; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Peters CJ, 2018, NEURON, V97, P1063, DOI 10.1016/j.neuron.2018.01.048; Pritchard HAT, 2014, BRIT J PHARMACOL, V171, P4311, DOI 10.1111/bph.12778; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P5361, DOI 10.1113/jphysiol.2009.180331; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Ta CM, 2017, BRIT J PHARMACOL, V174, P2984, DOI 10.1111/bph.13913; Tang QY, 2015, J BIOL CHEM, V290, P16517, DOI 10.1074/jbc.M115.640409; Tembo M, 2019, J GEN PHYSIOL, V151, P404, DOI 10.1085/jgp.201912320; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wozniak KL, 2018, J GEN PHYSIOL, V150, P1239, DOI 10.1085/jgp.201812069; Wozniak KL, 2018, J GEN PHYSIOL, V150, P1249, DOI 10.1085/jgp.201812071; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Xie LH, 2008, J PHYSIOL-LONDON, V586, P1833, DOI 10.1113/jphysiol.2007.147868; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Ye WL, 2018, P NATL ACAD SCI USA, V115, pE1667, DOI 10.1073/pnas.1718728115; Zawieja SD, 2019, J GEN PHYSIOL, V151, P532, DOI 10.1085/jgp.201812294; Zhang Guohui, 2018, Cold Spring Harb Protoc, V2018, DOI 10.1101/pdb.prot099051; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	51	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12556	12564		10.1074/jbc.RA118.007128	http://dx.doi.org/10.1074/jbc.RA118.007128			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31266809	hybrid, Green Published			2022-12-28	WOS:000484402700026
J	Duncan, PJ; Bi, DL; McClafferty, H; Chen, L; Tian, LJ; Shipston, MJ				Duncan, Peter J.; Bi, Danlei; McClafferty, Heather; Chen, Lie; Tian, Lijun; Shipston, Michael J.			S-Acylation controls functional coupling of BK channel pore-forming alpha-subunits and beta 1-subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein acylation; acyltransferase; protein palmitoylation; potassium channel; ion channel; post-translational modification (PTM); Kcnma1; Kcnmb1; lipid modification; protein trafficking	CONTROL SURFACE EXPRESSION; CA2+-ACTIVATED K+ CHANNEL; POTASSIUM CHANNEL; BETA-1 SUBUNIT; BLOOD-PRESSURE; SMOOTH-MUSCLE; VOLTAGE; PALMITOYLATION; MODULATION; PHYSIOLOGY	The properties and physiological function of pore-forming alpha-subunits of large conductance calcium- and voltage-activated potassium (BK) channels are potently modified by their functional coupling with regulatory subunits in many tissues. However, mechanisms that might control functional coupling are very poorly understood. Here we show that S-acylation, a dynamic post-translational lipid modification of proteins, of the intracellular S0-S1 loop of the BK channel pore-forming alpha-subunit controls functional coupling to regulatory beta 1-subunits. In HEK293 cells, alpha-subunits that cannot be S-acylated show attenuated cell surface expression, but expression was restored by co-expression with the beta 1-subunit. However, we also found that nonacylation of the S0-S1 loop reduces functional coupling between alpha- and beta 1-subunits by attenuating the beta 1-subunit-induced left shift in the voltage for half-maximal activation. In mouse vascular smooth muscle cells expressing both alpha- and beta 1-subunits, BK channel alpha-subunits were endogenously S-acylated. We further noted that S-acylation is significantly reduced in mice with a genetic deletion of the palmitoyl acyltransferase (Zdhhc23) that controls S-acylation of the S0-S1 loop. Genetic deletion of Zdhhc23 or broad-spectrum pharmacological inhibition of S-acylation attenuated endogenous BK channel currents independently of changes in cell surface expression of the alpha-subunit. We conclude that functional effects of S-acylation on BK channels depend on the presence of beta 1-subunits. In the absence of beta 1-subunits, S-acylation promotes cell surface expression, whereas in its presence, S-acylation controls functional coupling. S-Acylation thus provides a mechanism that dynamically regulates the functional coupling with beta 1-subunits, enabling an additional level of conditional, cell-specific control of ion-channel physiology.	[Duncan, Peter J.; Bi, Danlei; McClafferty, Heather; Chen, Lie; Tian, Lijun; Shipston, Michael J.] Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh Med Sch Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland; [Bi, Danlei] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China; [Chen, Lie] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, BE-1410 Gadong, Brunei	University of Edinburgh; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University Brunei Darussalam	Shipston, MJ (corresponding author), Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh Med Sch Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk		Duncan, Peter/0000-0001-5201-6272	Wellcome Trust; British Heart Foundation; MRC [MR/R010668/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was generously supported by grants from the Wellcome Trust and British Heart Foundation (to M.J.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Carvalho-De-Souza JL, 2013, AGING DIS, V4, P38; Castillo JP, 2016, P NATL ACAD SCI USA, V113, pE3231, DOI 10.1073/pnas.1606381113; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Chen L, 2017, J BIOL CHEM, V292, P8694, DOI 10.1074/jbc.M116.769505; Contreras GF, 2013, CHANNELS, V7, P442, DOI 10.4161/chan.26242; Contreras GF, 2012, P NATL ACAD SCI USA, V109, P18991, DOI 10.1073/pnas.1216953109; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Holtzclaw JD, 2011, CURR OPIN NEPHROL HY, V20, P512, DOI 10.1097/MNH.0b013e3283488889; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4816, DOI 10.1073/pnas.1221997110; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4822, DOI 10.1073/pnas.1222003110; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; Lanyon-Hogg T, 2017, TRENDS BIOCHEM SCI, V42, P566, DOI 10.1016/j.tibs.2017.04.004; Latorre R, 2017, PHYSIOL REV, V97, P39, DOI 10.1152/physrev.00001.2016; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Leo MD, 2014, P NATL ACAD SCI USA, V111, P2361, DOI 10.1073/pnas.1317527111; Liu GX, 2008, P NATL ACAD SCI USA, V105, P10727, DOI 10.1073/pnas.0805212105; Liu GX, 2010, J GEN PHYSIOL, V135, P449, DOI 10.1085/jgp.201010417; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Petkov GV, 2014, AM J PHYSIOL-REG I, V307, pR571, DOI 10.1152/ajpregu.00142.2014; Rana MS, 2018, SCIENCE, V359, P176, DOI 10.1126/science.aao6326; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Tao X, 2017, NATURE, V541, P46, DOI 10.1038/nature20608; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061	35	6	6	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12066	12076		10.1074/jbc.RA119.009065	http://dx.doi.org/10.1074/jbc.RA119.009065			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31213527	Green Published, hybrid			2022-12-28	WOS:000484284500011
J	Newcomer, ME				Newcomer, Marcia E.			Chloride to the rescue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								On the fiftieth anniversary of the discovery of the Ser-His-Asp catalytic triad, perhaps the most unusual variation on the textbook classic is described: An incomplete catalytic triad in a hydrolase is rescued by a chloride ion (Fig. 1). Structural and functional data provide compelling evidence that the active site of a phospholipase from Vibrio vulnificus employs the anion in place of the commonly observed Asp, reminding us that even well-trodden scientific ground has surprises in store.	[Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu						BLOW D, 1990, NATURE, V343, P694, DOI 10.1038/343694a0; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Kumar P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas8667; Maurus R, 2005, PROTEIN SCI, V14, P743, DOI 10.1110/ps.041079305; Shinada NK, 2019, J MED CHEM, V62, P9341, DOI 10.1021/acs.jmedchem.8b01453; Wan Y, 2019, J BIOL CHEM, V294, P11391, DOI 10.1074/jbc.RA119.008280; WRIGHT CS, 1969, NATURE, V221, P235, DOI 10.1038/221235a0	7	1	1	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11402	11403		10.1074/jbc.H119.009687	http://dx.doi.org/10.1074/jbc.H119.009687			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31350284	Green Published, hybrid			2022-12-28	WOS:000478717600005
J	Ong, JY; Torres, JZ				Ong, Joseph Y.; Torres, Jorge Z.			Dissecting the mechanisms of cell division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cell cycle; cell division; cancer; chemical biology; computational biology; genomics; proteomics; protein structure; post-translational modification (PTM); classical genetics	SPINDLE CHECKPOINT PROTEIN; ANAPHASE-PROMOTING COMPLEX; CYCLIN-A; TYROSINE PHOSPHORYLATION; ASSEMBLY CHECKPOINT; CRYSTAL-STRUCTURE; MITOTIC SPINDLE; GENETIC-CONTROL; BIOTIN LIGASE; CDC2 PROTEIN	Cell division is a highly regulated and carefully orchestrated process. Understanding the mechanisms that promote proper cell division is an important step toward unraveling important questions in cell biology and human health. Early studies seeking to dissect the mechanisms of cell division used classical genetics approaches to identify genes involved in mitosis and deployed biochemical approaches to isolate and identify proteins critical for cell division. These studies underscored that post-translational modifications and cyclin-kinase complexes play roles at the heart of the cell division program. Modern approaches for examining the mechanisms of cell division, including the use of high-throughput methods to study the effects of RNAi, cDNA, and chemical libraries, have evolved to encompass a larger biological and chemical space. Here, we outline some of the classical studies that established a foundation for the field and provide an overview of recent approaches that have advanced the study of cell division.	[Ong, Joseph Y.; Torres, Jorge Z.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Torres, Jorge Z.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Torres, Jorge Z.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Torres, JZ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Torres, JZ (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Torres, JZ (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	torres@chem.ucla.edu		Torres, Jorge/0000-0002-2158-889X	National Institutes of Health NIGMS [R01GM117475]; Ruth L. Kirschstein National Institutes of Health NRSA Award [GM007185]; National Science Foundation [DGE-1650604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117475, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth L. Kirschstein National Institutes of Health NRSA Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grant R01GM117475 (to J. Z. T.), Ruth L. Kirschstein National Institutes of Health NRSA Award GM007185 (UCLA Cellular and Molecular Biology Training Program), and National Science Foundation Graduate Research Fellowship DGE-1650604 (to J. Y. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allard CAH, 2019, ELIFE, V8, DOI 10.7554/eLife.46003; Ayati M, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006678; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharjya S, 2013, CELL DEATH DIFFER, V20, P430, DOI 10.1038/cdd.2012.135; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; Bjerregaard VA, 2018, P NATL ACAD SCI USA, V115, P13003, DOI 10.1073/pnas.1808377115; Bonacci T, 2018, EMBO J, V37, DOI 10.15252/embj.201798701; Bradley M, 2016, JOVE-J VIS EXP, DOI 10.3791/54870; Branon TC, 2018, NAT BIOTECHNOL, V36, P880, DOI 10.1038/nbt.4201; Brown NG, 2016, CELL, V165, P1440, DOI 10.1016/j.cell.2016.05.037; Cai Y, 2018, NATURE, V561, P411, DOI 10.1038/s41586-018-0518-z; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Cheung K, 2016, MOL CELL PROTEOMICS, V15, P1658, DOI 10.1074/mcp.M115.056465; CHOU YH, 1991, J BIOL CHEM, V266, P7325; Civelekoglu-Scholey G, 2006, BIOPHYS J, V90, P3966, DOI 10.1529/biophysj.105.078691; CONRAD MN, 1983, MOL CELL BIOL, V3, P1000, DOI 10.1128/MCB.3.6.1000; Davey NE, 2016, MOL CELL, V64, P12, DOI 10.1016/j.molcel.2016.09.006; Deretic J, 2019, MOL BIOL CELL, V30, P312, DOI 10.1091/mbc.E18-08-0495; DESSEV G, 1991, J CELL BIOL, V112, P523, DOI 10.1083/jcb.112.4.523; Dimitrova YN, 2016, CELL, V167, P1014, DOI 10.1016/j.cell.2016.10.011; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; FANTES P, 1979, NATURE, V279, P428, DOI 10.1038/279428a0; Fernandez C, 2004, EXP CELL RES, V300, P109, DOI 10.1016/j.yexcr.2004.06.029; Firat-Karalar EN, 2014, CURR BIOL, V24, P664, DOI 10.1016/j.cub.2014.01.067; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; Gholkar AA, 2016, CELL REP, V14, P180, DOI 10.1016/j.celrep.2015.12.035; Gholkar AA, 2015, CELL CYCLE, V14, P1116, DOI 10.4161/15384101.2014.985066; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gonen S, 2012, NAT STRUCT MOL BIOL, V19, P925, DOI 10.1038/nsmb.2358; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Hamasaki M, 2014, CHEM BIOL, V21, P1707, DOI 10.1016/j.chembiol.2014.11.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; Hara M, 2015, P NATL ACAD SCI USA, V112, P11252, DOI 10.1073/pnas.1512197112; HARTWELL LH, 1973, GENETICS, V74, P267; Henze R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04218-2; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; HINDLEY J, 1984, GENE, V31, P129, DOI 10.1016/0378-1119(84)90203-8; Hinshaw SM, 2019, ELIFE, V8, DOI 10.7554/eLife.44239; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Hung CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189324; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Hwang WL, 2014, NAT CELL BIOL, V16, P268, DOI 10.1038/ncb2910; Jeong AL, 2014, J BIOL CHEM, V289, P28, DOI 10.1074/jbc.M113.507954; Jia LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10818; Kim DI, 2016, MOL BIOL CELL, V27, P1188, DOI 10.1091/mbc.E15-12-0844; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kotak S, 2014, EMBO J, V33, P1815, DOI 10.15252/embj.201488147; Kriegel AJ, 2018, J BIOL CHEM, V293, P14080, DOI 10.1074/jbc.RA117.001705; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; Lacroix B, 2018, DEV CELL, V45, P496, DOI 10.1016/j.devcel.2018.04.022; Lammer C, 1998, J CELL SCI, V111, P2445; LEE MS, 1992, MOL BIOL CELL, V3, P73, DOI 10.1091/mbc.3.1.73; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li HC, 2010, P NATL ACAD SCI USA, V107, P14633, DOI 10.1073/pnas.1006615107; Lo YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11508-2; Lo YC, 2016, ACS CHEM BIOL, V11, P2244, DOI 10.1021/acschembio.6b00253; Lo YC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004153; LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Luo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047914; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Macedo JC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05258-6; Maki-Jouppila JHE, 2015, MOL ONCOL, V9, P1056, DOI 10.1016/j.molonc.2015.01.005; Mapa CE, 2018, MOL BIOL CELL, V29, P2821, DOI 10.1091/mbc.E18-07-0425; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; McKinley KL, 2017, DEV CELL, V40, P405, DOI 10.1016/j.devcel.2017.01.012; McNamara DE, 2015, PROTEIN SCI, V24, P1164, DOI 10.1002/pro.2704; Mistry HB, 2008, P NATL ACAD SCI USA, V105, P20215, DOI 10.1073/pnas.0810706106; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Ng CT, 2019, J CELL BIOL, V218, P455, DOI 10.1083/jcb.201809088; NOVAK B, 1993, J CELL SCI, V106, P1153; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Ong J. Y., 2019, E3 UBIQUITIN LIGASES, DOI [10.5772/intechopen.82883, DOI 10.5772/INTECHOPEN.82883]; Patterson JC, 2019, CELL SYST, V8, P163, DOI 10.1016/j.cels.2019.01.005; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Potchanant EAS, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00500-16; Pruikkonen S, 2017, BRIT J CANCER, V116, P1451, DOI 10.1038/bjc.2017.110; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Roy S, 2018, GASTROENTEROLOGY, V155, P1951, DOI 10.1053/j.gastro.2018.08.032; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schopp IM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15690; Senese S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.420; Senese S, 2015, MOL BIOL CELL, V26, P440, DOI 10.1091/mbc.E14-03-0829; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shi W, 2010, INT J CANCER, V126, P2036, DOI 10.1002/ijc.24880; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Song JN, 2017, SCI REP-UK, V7, DOI [10.1038/srep42521, 10.1038/s41598-017-07199-4]; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Stein P, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005013; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Takacs CM, 2016, DEV BIOL, V409, P442, DOI 10.1016/j.ydbio.2015.11.016; TOMKINS DJ, 1984, AM J HUM GENET, V36, P1332; Torres Jorge Z, 2012, Bioarchitecture, V2, P19; Torres JZ, 2011, CELL, V147, P1309, DOI 10.1016/j.cell.2011.11.020; Torres JZ, 2010, MOL BIOL CELL, V21, P897, DOI 10.1091/mbc.E09-07-0598; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; Tuncay H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9128; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; Wang Z., 2016, FIXED POINT THEORY A, V2016, DOI DOI 10.1038/srep26818; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Xia XY, 2019, ACS CHEM BIOL, V14, P994, DOI 10.1021/acschembio.9b00173; Xia XY, 2015, CELL CYCLE, V14, P1938, DOI 10.1080/15384101.2015.1026487; Yamaguchi M, 2016, MOL CELL, V63, P593, DOI 10.1016/j.molcel.2016.07.003; YAMASHIRO S, 1991, NATURE, V349, P169, DOI 10.1038/349169a0; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang Y, 2006, J NEUROSCI, V26, P775, DOI 10.1523/JNEUROSCI.3707-05.2006; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010; Zheng P, 2013, J CELL SCI, V126, P715, DOI 10.1242/jcs.118042	136	4	5	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11382	11390		10.1074/jbc.AW119.008149	http://dx.doi.org/10.1074/jbc.AW119.008149			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31175154	hybrid, Green Published			2022-12-28	WOS:000478717600003
J	Buceta, PMR; Romanelli-Cedrez, L; Babcock, SJ; Xun, HL; VonPaige, ML; Higley, TW; Schlatter, TD; Davis, DC; Drexelius, JA; Culver, JC; Carrera, I; Shepherd, JN; Salinas, G				Buceta, Paloma M. Roberts; Romanelli-Cedrez, Laura; Babcock, Shannon J.; Xun, Helen; VonPaige, Miranda L.; Higley, Thomas W.; Schlatter, Tyler D.; Davis, Dakota C.; Drexelius, Julia A.; Culver, John C.; Carrera, Ines; Shepherd, Jennifer N.; Salinas, Gustavo			The kynurenine pathway is essential for rhodoquinone biosynthesis in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; electron transport; Caenorhabditis elegans (C; elegans); hypoxia; ubiquinone; anthranilic acid; facultative anaerobe; helminths; kynureninase (kynu-1); rhodoquinone	FUMARATE REDUCTASE; COMPLEX-II; C-ELEGANS; IDENTIFICATION; UBIQUINONE; HELMINTH	A key metabolic adaptation of some species that face hypoxia as part of their life cycle involves an alternative electron transport chain in which rhodoquinone (RQ) is required for fumarate reduction and ATP production. RQ biosynthesis in bacteria and protists requires ubiquinone (Q) as a precursor. In contrast, Q is not a precursor for RQ biosynthesis in animals such as parasitic helminths, and most details of this pathway have remained elusive. Here, we used Caenorhabditis elegans as a model animal to elucidate key steps in RQ biosynthesis. Using RNAi and a series of C. elegans mutants, we found that arylamine metabolites from the kynurenine pathway are essential precursors for RQ biosynthesis de novo. Deletion of kynu-1, encoding a kynureninase that converts l-kynurenine (KYN) to anthranilic acid (AA) and 3-hydroxykynurenine (3HKYN) to 3-hydroxyanthranilic acid (3HAA), completely abolished RQ biosynthesis but did not affect Q levels. Deletion of kmo-1, which encodes a kynurenine 3-monooxygenase that converts KYN to 3HKYN, drastically reduced RQ but not Q levels. Knockdown of the Q biosynthetic genes coq-5 and coq-6 affected both Q and RQ levels, indicating that both biosynthetic pathways share common enzymes. Our study reveals that two pathways for RQ biosynthesis have independently evolved. Unlike in bacteria, where amination is the last step in RQ biosynthesis, in worms the pathway begins with the arylamine precursor AA or 3HAA. Because RQ is absent in mammalian hosts of helminths, inhibition of RQ biosynthesis may have potential utility for targeting parasitic infections that cause important neglected tropical diseases.	[Buceta, Paloma M. Roberts; Babcock, Shannon J.; Xun, Helen; VonPaige, Miranda L.; Higley, Thomas W.; Schlatter, Tyler D.; Davis, Dakota C.; Drexelius, Julia A.; Culver, John C.; Shepherd, Jennifer N.] Gonzaga Univ, Dept Chem & Biochem, 502 E Boone Ave, Spokane, WA 99258 USA; [Romanelli-Cedrez, Laura; Carrera, Ines; Salinas, Gustavo] Univ Republica, Inst Pasteur Montevideo, Fac Quim, Lab Biol Gusanos,Unidad Mixta,Dept Biociencia, Mataojo 2020,11400 Montevideo, Montevideo 11400, Uruguay; [Babcock, Shannon J.] Oregon Hlth & Sci Univ, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97239 USA; [Xun, Helen] Johns Hopkins Univ, Sch Med, 733 N Broadway, Baltimore, MD 21205 USA; [Schlatter, Tyler D.] Multicare Allenmore Hosp, 1901 S Union Ave, Tacoma, WA 98405 USA	Gonzaga University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Oregon Health & Science University; Johns Hopkins University	Shepherd, JN (corresponding author), Gonzaga Univ, Dept Chem & Biochem, 502 E Boone Ave, Spokane, WA 99258 USA.; Salinas, G (corresponding author), Univ Republica, Inst Pasteur Montevideo, Fac Quim, Lab Biol Gusanos,Unidad Mixta,Dept Biociencia, Mataojo 2020,11400 Montevideo, Montevideo 11400, Uruguay.	shepherd@gonzaga.edu; gsalin@fq.edu.uy		Salinas, Gustavo/0000-0003-3350-3002; Carrera, Ines/0000-0003-0903-4672; Xun, Helen/0000-0002-0412-4356	National Institutes of Health Office of Research Infrastructure Program [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Hugo Bisio, Cecilia Martinez, Gaston Risi, Drs. Lucia Otero, and Jorge Porfido (Laboratorio de Biologia de Gusanos) for helpful discussions on RQ biosynthesis, as well as Drs. Jeff Cronk and Kirk Anders from Gonzaga University, Dr. Catherine Clarke (UCLA), Drs. Andrew Roger, Courtney Stairs, and David Langelaan (Dalhousie University, Nova Scotia, Canada), and Dr. Gilles Basset and Ann Bernert (University of Florida, Gainesville). We thank Dr. Jennifer Watts (Washington State University) for RNAi clones and Alex Poppel and Fair Niven for their high school summer volunteer work at Gonzaga University. The Caenorhabditis Genetics Center is funded by National Institutes of Health Office of Research Infrastructure Program: P40 OD010440.	ALLEN PC, 1973, EXP PARASITOL, V34, P211, DOI 10.1016/0014-4894(73)90080-5; Awad AM, 2018, ESSAYS BIOCHEM, V62, P361, DOI 10.1042/EBC20170106; Bernert AC, 2019, BBA-MOL CELL BIOL L, V1864, P1226, DOI 10.1016/j.bbalip.2019.05.007; Brajcich BC, 2010, J BACTERIOL, V192, P436, DOI 10.1128/JB.01040-09; BRENNER S, 1974, GENETICS, V77, P71; Burglin TR, 1998, INT J PARASITOL, V28, P395, DOI 10.1016/S0020-7519(97)00208-7; Campbell ARM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217281; Coburn Cassandra, 2013, Frontiers in Genetics, V4, P151, DOI 10.3389/fgene.2013.00151; Corsi AK, 2015, GENETICS, V200, P387, DOI 10.1534/genetics.115.176099; Del Borrello S., 2019, BIORXIV, DOI [10.1101/627737, DOI 10.1101/627737]; ERABI T, 1975, J BIOCHEM-TOKYO, V78, P795, DOI 10.1093/oxfordjournals.jbchem.a130968; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Iwata F, 2008, PARASITOL INT, V57, P54, DOI 10.1016/j.parint.2007.08.002; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Kawamukai M, 2018, BIOSCI BIOTECH BIOCH, V82, P963, DOI 10.1080/09168451.2018.1433020; Lee PT, 1997, J BACTERIOL, V179, P1748, DOI 10.1128/jb.179.5.1748-1754.1997; Lonjers ZT, 2012, J BACTERIOL, V194, P965, DOI 10.1128/JB.06319-11; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; McReynolds MR, 2017, J BIOL CHEM, V292, P11147, DOI 10.1074/jbc.C117.795344; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Stairs CW, 2018, ELIFE, V7, DOI 10.7554/eLife.34292; Takamiya S, 1999, ARCH BIOCHEM BIOPHYS, V371, P284, DOI 10.1006/abbi.1999.1465; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; van der Goot AT, 2012, P NATL ACAD SCI USA, V109, P14912, DOI 10.1073/pnas.1203083109; van Hellemond JJ, 2003, PHILOS T ROY SOC B, V358, P205, DOI 10.1098/rstb.2002.1182; VanHellemond JJ, 1995, J BIOL CHEM, V270, P31065, DOI 10.1074/jbc.270.52.31065; Vohra M, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002032; Yamashita T, 2004, BBA-BIOENERGETICS, V1608, P97, DOI 10.1016/j.bbabio.2003.10.006	32	9	9	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					11047	11053		10.1074/jbc.AC119.009475	http://dx.doi.org/10.1074/jbc.AC119.009475			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31177094	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000478717200026
J	Guo, LS; Carraro, M; Carrer, A; Minervini, G; Urbani, A; Masgras, I; Tosatto, SCE; Szabo, I; Bernardi, P; Lippe, G				Guo, Lishu; Carraro, Michela; Carrer, Andrea; Minervini, Giovanni; Urbani, Andrea; Masgras, Ionica; Tosatto, Silvio C. E.; Szabo, Ildiko; Bernardi, Paolo; Lippe, Giovanna			Arg-8 of yeast subunit e contributes to the stability of F-ATP synthase dimers and to the generation of the full-conductance mitochondrial megachannel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; ATP synthase; yeast; dimerization; mitochondrial permeability transition (MPT); molecular motor; high-conductance channel; megachannel	MEMBRANE-SPANNING SEGMENT; PERMEABILITY TRANSITION; F1F0-ATP SYNTHASE; SACCHAROMYCES-CEREVISIAE; CHANNEL FORMATION; GXXXG MOTIF; IDENTIFICATION; RESOLUTION; F1-ATPASE; COMPLEX	The mitochondrial F-ATP synthase is a complex molecular motor arranged in V-shaped dimers that is responsible for most cellular ATP synthesis in aerobic conditions. In the yeast F-ATP synthase, subunits e and g of the F-O sector constitute a lateral domain, which is required for dimer stability and cristae formation. Here, by using site-directed mutagenesis, we identified Arg-8 of subunit e as a critical residue in mediating interactions between subunits e and g, most likely through an interaction with Glu-83 of subunit g. Consistent with this hypothesis, (i) the substitution of Arg-8 in subunit e (eArg-8) with Ala or Glu or of Glu-83 in subunit g (gGlu-83) with Ala or Lys destabilized the digitonin-extracted F-ATP synthase, resulting in decreased dimer formation as revealed by blue-native electrophoresis; and (ii) simultaneous substitution of eArg-8 with Glu and of gGlu-83 with Lys rescued digitonin-stable F-ATP synthase dimers. When tested in lipid bilayers for generation of Ca2+-dependent channels, WT dimers displayed the high-conductance channel activity expected for the mitochondrial megachannel/permeability transition pore, whereas dimers obtained at low digitonin concentrations from the Arg-8 variants displayed currents of strikingly small conductance. Remarkably, double replacement of eArg-8 with Glu and of gGlu-83 with Lys restored high-conductance channels indistinguishable from those seen in WT enzymes. These findings suggest that the interaction of subunit e with subunit g is important for generation of the full-conductance megachannel from F-ATP synthase.	[Guo, Lishu; Carraro, Michela; Carrer, Andrea; Minervini, Giovanni; Urbani, Andrea; Masgras, Ionica; Tosatto, Silvio C. E.; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Szabo, Ildiko; Bernardi, Paolo] Univ Padua, Dept Biol, Padua, Italy; [Tosatto, Silvio C. E.; Szabo, Ildiko] Consiglio Nazl Ric Inst Neurosci, I-35131 Padua, Italy; [Lippe, Giovanna] Univ Udine, Dept Agr Food Environm & Anim Sci, I-33100 Udine, Italy	University of Padua; University of Padua; University of Udine	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.; Lippe, G (corresponding author), Univ Udine, Dept Agr Food Environm & Anim Sci, I-33100 Udine, Italy.	bernardi@bio.unipd.it; giovanna.lippe@uniud.it	Tosatto, Silvio/B-2840-2009; Masgras, Ionica/ABG-9245-2021; Szabo, Ildiko/AAW-5972-2021; Bernardi, Paolo/C-3656-2008; Minervini, Giovanni/D-1200-2013	Tosatto, Silvio/0000-0003-4525-7793; Masgras, Ionica/0000-0002-9768-460X; Szabo, Ildiko/0000-0002-3637-3947; Bernardi, Paolo/0000-0001-9187-3736; Minervini, Giovanni/0000-0001-7013-5785; Urbani, Andrea/0000-0002-3935-6907	AIRC [IG17067]; Fondation Leducq Grant [16CVD04]	AIRC(Fondazione AIRC per la ricerca sul cancro); Fondation Leducq Grant(Leducq Foundation)	This work was supported in part by AIRC Grant IG17067 (to P. B.) and Fondation Leducq Grant 16CVD04 (to P. B.). This work is in partial fulfillment of the requirements for the Ph.D. at the Department of Biomedical Sciences, University of Padova (L. G.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Anselmi C, 2018, J GEN PHYSIOL, V150, P763, DOI 10.1085/jgp.201812033; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arnold I, 1997, FEBS LETT, V411, P195, DOI 10.1016/S0014-5793(97)00691-1; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Bernardi P, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01543; Bernardi P, 2018, CURR OPIN PHYSIOL, V3, P1, DOI 10.1016/j.cophys.2017.12.006; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Bradshaw PC, 2013, YEAST, V30, P471, DOI 10.1002/yea.2984; Bustos DM, 2005, J BIOL CHEM, V280, P29004, DOI 10.1074/jbc.M502140200; Carraro M, 2018, CELL PHYSIOL BIOCHEM, V50, P1840, DOI 10.1159/000494864; Carraro M, 2014, J BIOL CHEM, V289, P15980, DOI 10.1074/jbc.C114.559633; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Everard-Gigot V, 2005, EUKARYOT CELL, V4, P346, DOI 10.1128/EC.4.2.346-355.2005; Giorgio V, 2018, CELL CALCIUM, V70, P56, DOI 10.1016/j.ceca.2017.05.004; Giorgio V, 2017, EMBO REP, V18, P1065, DOI 10.15252/embr.201643354; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815; Guo LS, 2018, J BIOL CHEM, V293, P14632, DOI 10.1074/jbc.RA118.004495; Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017; Hahn A, 2016, MOL CELL, V63, P445, DOI 10.1016/j.molcel.2016.05.037; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; Klusch N, 2017, ELIFE, V6, DOI 10.7554/eLife.33274; Kuhlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903; Lau WCY, 2008, J MOL BIOL, V382, P1256, DOI 10.1016/j.jmb.2008.08.014; Neginskaya MA, 2019, CELL REP, V26, P11, DOI 10.1016/j.celrep.2018.12.033; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Saddar S, 2005, J BIOL CHEM, V280, P24435, DOI 10.1074/jbc.M502804200; Soubannier V, 1999, BIOCHEMISTRY-US, V38, P15017, DOI 10.1021/bi9916067; Soubannier V, 2002, J BIOL CHEM, V277, P10739, DOI 10.1074/jbc.M111882200; Srivastava AP, 2018, SCIENCE, V360, DOI 10.1126/science.aas9699; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Velours J, 2011, J BIOL CHEM, V286, P35477, DOI 10.1074/jbc.M111.275776; von Stockum S, 2015, J BIOL CHEM, V290, P4537, DOI 10.1074/jbc.C114.629766; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2008, MOL CELL PROTEOMICS, V7, P995, DOI 10.1074/mcp.M700465-MCP200; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	45	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10987	10997		10.1074/jbc.RA119.008775	http://dx.doi.org/10.1074/jbc.RA119.008775			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31160339	Green Published, hybrid			2022-12-28	WOS:000478717200020
J	Yang, XJ; Zhu, H; Mu, SR; Wei, WJ; Yuan, X; Wang, M; Liu, YC; Hui, JY; Huang, Y				Yang, Xiao-Juan; Zhu, Hong; Mu, Shi-Rong; Wei, Wen-Juan; Yuan, Xun; Wang, Meng; Liu, Yanchao; Hui, Jingyi; Huang, Ying			Crystal structure of a Y-box binding protein 1 (YB-1)-RNA complex reveals key features and residues interacting with RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; post-transcriptional regulation; gene expression; structural biology; cancer; oncogene; cold shock domain (CSD); single-stranded RNA binding; splicing regulation; Y-box binding protein 1 (YB-1)	COLD-SHOCK DOMAIN; SINGLE STRANDS BIND; MESSENGER-RNA; BREAST-CANCER; TRANSLATIONAL ACTIVATION; YB-1 PROMOTES; DNA-BINDING; GROWTH; RECOGNITION; ASSOCIATION	The Y-box binding protein 1 (YB-1) is a member of the cold shock domain (CSD) protein family and is recognized as an oncogenic factor in several solid tumors. By binding to RNA, YB-1 participates in several steps of posttranscriptional regulation of gene expression, including mRNA splicing, stability, and translation; microRNA processing; and stress granule assembly. However, the mechanisms in YB-1-mediated regulation of RNAs are unclear. Previously, we used both systematic evolution of ligands by exponential enrichment (SELEX) and individual-nucleotide resolution UV cross-linking and immunoprecipitation coupled RNA-Seq (iCLIP-Seq) analyses, which defined the RNA-binding consensus sequence of YB-1 as CA(U/C)C. We also reported that through binding to its core motif CAUC in primary transcripts, YB-1 regulates the alternative splicing of a CD44 variable exon and the biogenesis of miR-29b-2 during both Drosha and Dicer steps. To elucidate the molecular basis of the YB-1-RNA interactions, we report high-resolution crystal structures of the YB-1 CSD in complex with different RNA oligos at 1.7 angstrom resolution. The structure revealed that CSD interacts with RNA mainly through pi-pi stacking interactions assembled by four highly conserved aromatic residues. Interestingly, YB-1 CSD forms a homodimer in solution, and we observed that two residues, Tyr-99 and Asp-105, at the dimer interface are important for YB-1 CSD dimerization. Substituting these two residues with Ala reduced CSD's RNA-binding activity and abrogated the splicing activation of YB-1 targets. The YB-1 CSD-RNA structures presented here at atomic resolution provide mechanistic insights into gene expression regulated by CSD-containing proteins.	[Yang, Xiao-Juan; Zhu, Hong; Mu, Shi-Rong; Wei, Wen-Juan; Wang, Meng; Hui, Jingyi] CAS Ctr Excellence Mol Cell Sci, Shanghai 200031, Peoples R China; [Yang, Xiao-Juan; Zhu, Hong; Mu, Shi-Rong; Wei, Wen-Juan; Yuan, Xun; Wang, Meng; Liu, Yanchao; Hui, Jingyi; Huang, Ying] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Yang, Xiao-Juan; Yuan, Xun; Liu, Yanchao; Huang, Ying] Shanghai Key Lab Mol Androl, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Hui, JY; Huang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	jyhui@sibcb.ac.cn; huangy@sibcb.ac.cn	Huang, Ying/AFM-0838-2022	Huang, Ying/0000-0002-2806-2874; , Yanchao/0000-0002-6647-8491; Hui, Jingyi/0000-0002-1999-4776	National Natural Science Foundation of China [91640102, 31870741, 31570820, 31661143035, 31770881]; National Key Research and Development Program of China [2017YFA0504400]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010202, XDB19000000]; Chinese Academy of Sciences Facility-based Open Research Program; State Key Laboratory of Molecular Biology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences Facility-based Open Research Program; State Key Laboratory of Molecular Biology	This work was supported by National Natural Science Foundation of China Grants 91640102 and 31870741 (to Y. H.) and 31570820, 31661143035, and 31770881 (to J. H.), National Key Research and Development Program of China Grant 2017YFA0504400 (to J. H.), Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDB08010202 (to Y. H.) and XDB19000000 (to J. H.), the Chinese Academy of Sciences Facility-based Open Research Program, and the State Key Laboratory of Molecular Biology. The authors declare that they have no conflicts of interest with the contents of this article.	Abrakhi S, 2017, ACS NANO, V11, P7189, DOI 10.1021/acsnano.7b03071; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allemand E, 2007, NAT STRUCT MOL BIOL, V14, P630, DOI 10.1038/nsmb1257; Astanehe A, 2009, ONCOGENE, V28, P2406, DOI 10.1038/onc.2009.81; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; BOUVET P, 1995, J BIOL CHEM, V270, P28297; Chen CY, 2000, GENE DEV, V14, P1236; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; EVDOKIMOVA VM, 1995, J BIOL CHEM, V270, P3186, DOI 10.1074/jbc.270.7.3186; Feracci M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10355; Ferreira AR, 2017, J BONE ONCOL, V6, P16, DOI 10.1016/j.jbo.2017.01.002; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; Guryanov SG, 2013, BBA-PROTEINS PROTEOM, V1834, P559, DOI 10.1016/j.bbapap.2012.11.007; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hinze F, 2018, RNA BIOL, V15, P359, DOI 10.1080/15476286.2017.1384120; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; Kosnopfel C, 2014, EUR J CELL BIOL, V93, P61, DOI 10.1016/j.ejcb.2013.11.007; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lindquist JA, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0274-6; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Manival X, 2001, NUCLEIC ACIDS RES, V29, P2223, DOI 10.1093/nar/29.11.2223; Matsumoto K, 1996, J BIOL CHEM, V271, P22706, DOI 10.1074/jbc.271.37.22706; Maurya PK, 2017, J CANCER, V8, P1900, DOI 10.7150/jca.17689; Max KEA, 2007, FEBS J, V274, P1265, DOI 10.1111/j.1742-4658.2007.05672.x; Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044; Mayr F, 2012, NUCLEIC ACIDS RES, V40, P7492, DOI 10.1093/nar/gks355; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Ohga T, 1998, J BIOL CHEM, V273, P5997, DOI 10.1074/jbc.273.11.5997; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Rohr I, 2016, CYTOKINE, V85, P157, DOI 10.1016/j.cyto.2016.06.021; Sachs R, 2012, RNA, V18, P65, DOI 10.1261/rna.02809212; Shurtleff MJ, 2017, P NATL ACAD SCI USA, V114, pE8987, DOI 10.1073/pnas.1712108114; Shurtleff MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19276; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; To K, 2010, CANCER RES, V70, P2840, DOI 10.1158/0008-5472.CAN-09-3155; van Zalen S, 2012, BLOOD, V119, P1045, DOI 10.1182/blood-2011-10-387316; Wei WJ, 2012, NUCLEIC ACIDS RES, V40, P8622, DOI 10.1093/nar/gks579; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Wu SL, 2015, NUCLEIC ACIDS RES, V43, P8516, DOI 10.1093/nar/gkv779	52	31	31	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10998	11010		10.1074/jbc.RA119.007545	http://dx.doi.org/10.1074/jbc.RA119.007545			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31160337	Green Published, hybrid			2022-12-28	WOS:000478717200021
J	Banerjee, S; Sangwan, V; McGinn, O; Chugh, R; Dudeja, V; Vickers, SM; Saluja, AK				Banerjee, Sulagna; Sangwan, Veena; McGinn, Olivia; Chugh, Rohit; Dudeja, Vikas; Vickers, Selwyn M.; Saluja, Ashok K.			Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1 (vol 288, pg 33927, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Banerjee S, 2013, J BIOL CHEM, V288, P33927, DOI 10.1074/jbc.M113.500983	1	2	2	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10739	10739		10.1074/jbc.AAC119.009844	http://dx.doi.org/10.1074/jbc.AAC119.009844			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31278158	Green Published, hybrid			2022-12-28	WOS:000478717100032
J	Ubonprasert, S; Jaroensuk, J; Pornthanakasem, W; Kamonsutthipaijit, N; Wongpituk, P; Mee-udorn, P; Rungronnongkol, T; Ketchart, O; Chitnumsub, P; Leartsakulpanich, U; Chaiyen, P; Maenpuen, S				Ubonprasert, Sakunrat; Jaroensuk, Juthamas; Pornthanakasem, Wichai; Kamonsutthipaijit, Nuntaporn; Wongpituk, Peerapong; Mee-udorn, Pitchayathida; Rungronnongkol, Thanyada; Ketchart, Onuma; Chitnumsub, Penchit; Leartsakulpanich, Ubolsree; Chaiyen, Pimchai; Maenpuen, Somchart			A flap motif in human serine hydroxymethyltransferase is important for structural stabilization, ligand binding, and control of product release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structure-function; pyridoxal phosphate; folate; protein structure; enzyme kinetics; molecular dynamics; small-angle X-ray scattering (SAXS); analytical ultracentrifugation; oligomerization; nucleoside; nucleotide biosynthesis; dTMP synthesis cycle; flap motif; flexible loop; PLP-dependent enzymes; serine hydroxymethyl transferase; tetrahydrofolate-dependent reactions	SMALL-ANGLE SCATTERING; CRYSTAL-STRUCTURE; PLASMODIUM-VIVAX; FOLYLPOLYGLUTAMATE SYNTHETASE; ANTIFOLATE RESISTANCE; ANGSTROM RESOLUTION; TERNARY COMPLEX; INHIBITORS; GLYCINE; MECHANISM	Human cytosolic serine hydroxymethyltransferase (hcSHMT) is a promising target for anticancer chemotherapy and contains a flexible flap motif whose function is yet unknown. Here, using size-exclusion chromatography, analytical ultracentrifugation, small-angle X-ray scattering (SAXS), molecular dynamics (MD) simulations, and ligand-binding and enzyme-kinetic analyses, we studied the functional roles of the flap motif by comparing WT hcSHMT with a flap-deleted variant (hcSHMT/Delta flap). We found that deletion of the flap results in a mixture of apo-dimers and holo-tetramers, whereas the WT was mostly in the tetrameric form. MD simulations indicated that the flap stabilizes structural compactness and thereby enhances oligomerization. The hcSHMT/Delta flap variant exhibited different catalytic properties in (6S)-tetrahydrofolate (THF)-dependent reactions compared with the WT but had similar activity in THF-independent aldol cleavage of beta-hydroxyamino acid. hcSHMT/Delta flap was less sensitive to THF inhibition than the WT (K-i of 0.65 and 0.27 mm THF at pH 7.5, respectively), and the THF dissociation constant of the WT was also 3-fold lower than that of hcSHMT/Delta flap, indicating that the flap is important for THF binding. hcSHMT/Delta flap did not display the burst kinetics observed in the WT. These results indicate that, upon removal of the flap, product release is no longer the rate-limiting step, implying that the flap is important for controlling product release. The findings reported here improve our understanding of the functional roles of the flap motif in hcSHMT and provide fundamental insight into how a flexible loop can be involved in controlling the enzymatic reactions of hcSHMT and other enzymes.	[Ubonprasert, Sakunrat; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Ubonprasert, Sakunrat; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok 10400, Thailand; [Jaroensuk, Juthamas; Chaiyen, Pimchai] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Rayong 21210, Thailand; [Pornthanakasem, Wichai; Chitnumsub, Penchit; Leartsakulpanich, Ubolsree] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Biomol Anal & Applicat Lab, Pathum Thani 12120, Thailand; [Ketchart, Onuma] Natl Sci & Technol Dev Agcy, Natl Nanotechnol Ctr NANOTEC, Pathum Thani 12120, Thailand; [Kamonsutthipaijit, Nuntaporn] Synchrotron Light Res Inst Publ Org, Nakhon Ratchasima 30000, Thailand; [Wongpituk, Peerapong] Chulalongkorn Univ, Grad Sch, Dept Chem, CECC, Bangkok 10330, Thailand; [Rungronnongkol, Thanyada] Chulalongkorn Univ, Grad Sch, Dept Biochem, Biocatalyst & Environm Biotechnol Res Unit,Fac Sc, Bangkok 10330, Thailand; [Mee-udorn, Pitchayathida; Rungronnongkol, Thanyada] Chulalongkorn Univ, Grad Sch, Bioinformat & Computat Biol Program, Bangkok 10330, Thailand; [Maenpuen, Somchart] Burapha Univ, Fac Sci, Dept Biochem, 169 Long Hard Bangsaen Rd, Chon Buri 20131, Thailand	Mahidol University; Mahidol University; Vidyasirimedhi Institute of Science & Technology; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Nanotechnology Center (NANOTEC); Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Burapha University	Maenpuen, S (corresponding author), Burapha Univ, Fac Sci, Dept Biochem, 169 Long Hard Bangsaen Rd, Chon Buri 20131, Thailand.	somchart@go.buu.ac.th		Maenpuen, Somchart/0000-0001-7770-4178; Rungrotmongkol, Thanyada/0000-0002-7402-3235	Thailand Research Fund [RTA5980001, MRG5980001, RDG6050101]; Faculty of Science, Mahidol University; School of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology; Faculty of Science, Burapha University; Cluster Program and Management Office, National Science and Technology Development Agency, Thailand [CPMO-P-13-00835]; Thailand Graduate Institute of Science and Technology Scholarship [TG-22-14-59-031M]; Synchrotron Light Research Institute-Public Organization Grant [1-2561, 3212]; Science Achievement Scholarship of Thailand	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; School of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology; Faculty of Science, Burapha University; Cluster Program and Management Office, National Science and Technology Development Agency, Thailand; Thailand Graduate Institute of Science and Technology Scholarship; Synchrotron Light Research Institute-Public Organization Grant; Science Achievement Scholarship of Thailand	This work was supported by Thailand Research Fund Grants RTA5980001 (to P. Chaiyen), MRG5980001 (to S.M.), and RDG6050101 (to P. Chaiyen and S.M.); the Faculty of Science, Mahidol University and School of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (to P. Chaiyen and J.J.); the Faculty of Science, Burapha University (to S.M.); Cluster Program and Management Office, National Science and Technology Development Agency, Thailand Grant CPMO-P-13-00835 (to U.L., W.P., P. Chitnumsub, P. Chaiyen, and S.M.); Thailand Graduate Institute of Science and Technology Scholarship Grant TG-22-14-59-031M (to S.U.); Synchrotron Light Research Institute-Public Organization Grant 1-2561/Project I.D. 3212 (to S.M. and S.U.); and a Science Achievement Scholarship of Thailand (to P.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Alfadhli S, 2000, MOL BIOCHEM PARASIT, V110, P283, DOI 10.1016/S0166-6851(00)00282-6; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Amornwatcharapong W, 2017, ARCH BIOCHEM BIOPHYS, V630, P91, DOI 10.1016/j.abb.2017.07.017; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Case D. A., 2016, AMBER 2016; Chitnumsub P, 2014, ACTA CRYSTALLOGR D, V70, P3177, DOI 10.1107/S1399004714023128; Chitnumsub P, 2014, ACTA CRYSTALLOGR D, V70, P1517, DOI 10.1107/S1399004714005598; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Ducker GS, 2017, P NATL ACAD SCI USA, V114, P11404, DOI 10.1073/pnas.1706617114; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jaturontakul K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06653-7; Kaiyawet N, 2013, J CHEM INF MODEL, V53, P1315, DOI 10.1021/ci400131y; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Leartsakulpanich U, 2008, PARASITOL INT, V57, P223, DOI 10.1016/j.parint.2007.11.001; Maenpuen S, 2015, J BIOL CHEM, V290, P8656, DOI 10.1074/jbc.M114.612275; Maenpuen S, 2009, MOL BIOCHEM PARASIT, V168, P63, DOI 10.1016/j.molbiopara.2009.06.010; Mahalapbutr P, 2017, J MOL LIQ, V247, P374, DOI 10.1016/j.molliq.2017.10.021; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Marani M, 2016, ONCOTARGET, V7, P4570, DOI 10.18632/oncotarget.6726; McGillewie L, 2017, PROTEIN J, V36, P385, DOI 10.1007/s10930-017-9735-9; Montioli R, 2017, PROTEIN J, V36, P174, DOI 10.1007/s10930-017-9710-5; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Nirmalan N, 2002, MOL MICROBIOL, V46, P179, DOI 10.1046/j.1365-2958.2002.03148.x; Pahari S, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz024; Paiardini A, 2016, BBA-PROTEINS PROTEOM, V1864, P1506, DOI 10.1016/j.bbapap.2016.08.010; Paiardini A, 2015, CHEMMEDCHEM, V10, P490, DOI 10.1002/cmdc.201500028; Pinthong C, 2014, FEBS J, V281, P2570, DOI 10.1111/febs.12803; Pornthanakasem W, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-387; Rao NA, 2000, INT J BIOCHEM CELL B, V32, P405; Renwick SB, 1998, STRUCTURE, V6, P1105, DOI 10.1016/S0969-2126(98)00112-9; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Scarsdale JN, 2000, J MOL BIOL, V296, P155, DOI 10.1006/jmbi.1999.3453; Scarsdale JN, 1999, BIOCHEMISTRY-US, V38, P8347, DOI 10.1021/bi9904151; SCHIRCH L, 1982, ADV ENZYMOL RAMB, V53, P83; Schirch V, 2005, CURR OPIN CHEM BIOL, V9, P482, DOI 10.1016/j.cbpa.2005.08.017; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwertz G, 2017, CHEM-EUR J, V23, P14345, DOI 10.1002/chem.201703244; Schwertz G, 2017, J MED CHEM, V60, P4840, DOI 10.1021/acs.jmedchem.7b00008; Snell K, 2000, ADV ENZYME REGUL, V40, P353, DOI 10.1016/S0065-2571(99)00035-7; Sopitthummakhun K, 2009, FEBS J, V276, P4023, DOI 10.1111/j.1742-4658.2009.07111.x; Stark M, 2009, BLOOD, V113, P4362, DOI 10.1182/blood-2008-08-173799; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; THORNDIKE J, 1979, CANCER RES, V39, P3435; Trewhella J, 2017, ACTA CRYSTALLOGR D, V73, P710, DOI 10.1107/S2059798317011597; Trivedi V, 2002, J BIOL CHEM, V277, P17161, DOI 10.1074/jbc.M111976200; USHA R, 1992, J BIOL CHEM, V267, P9289; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang B, 2017, CLIN NEUROL NEUROSUR, V154, P28, DOI 10.1016/j.clineuro.2017.01.005; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Witschel MC, 2015, J MED CHEM, V58, P3117, DOI 10.1021/jm501987h; Wojtuszkiewicz A, 2016, INT J CANCER, V138, P1645, DOI 10.1002/ijc.29919; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921	61	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10490	10502		10.1074/jbc.RA119.007454	http://dx.doi.org/10.1074/jbc.RA119.007454			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31118236	Green Published, hybrid			2022-12-28	WOS:000478717100010
J	Chattopadhyay, M; Chowdhury, AR; Feng, T; Assenmacher, CA; Radaelli, E; Guengerich, FP; Avadhani, NG				Chattopadhyay, Mrittika; Chowdhury, Anindya Roy; Feng, Ting; Assenmacher, Charles-Antoine; Radaelli, Enrico; Guengerich, F. Peter; Avadhani, Narayan G.			Mitochondrially targeted cytochrome P450 2D6 is involved in monomethylamine-induced neuronal damage in mouse models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug metabolism; neurotoxin; mitochondria; complex I; cytochrome P450; Parkinson's disease; monomethylamines; neurodegeneration; substantia nigra; tyrosine hydroxylase	BETA-CARBOLINES NORHARMAN; PARKINSONS-DISEASE; N-METHYLATION; MPTP; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; METABOLISM; BRAIN; ACTIVATION; INHIBITION; SUBSTRATE	Parkinson's disease (PD) is a major human disease associated with degeneration of the central nervous system. Evidence suggests that several endogenously formed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mimicking chemicals that are metabolic conversion products, especially beta-carbolines and isoquinolines, act as neurotoxins that induce PD or enhance progression of the disease. We have demonstrated previously that mitochondrially targeted human cytochrome P450 2D6 (CYP2D6), supported by mitochondrial adrenodoxin and adrenodoxin reductase, can efficiently catalyze the conversion of MPTP to the toxic 1-methyl-4-phenylpyridinium ion. In this study, we show that the mitochondrially targeted CYP2D6 can efficiently catalyze MPTP-mimicking compounds, i.e. 2-methyl-1,2,3,4-tetrahydroisoquinoline, 2-methyl-1,2,3,4-tetrahydro-beta-carboline, and 9-methyl-norharmon, suspected to induce PD in humans. Our results reveal that activity and respiration in mouse brain mitochondrial complex I are significantly affected by these toxins in WT mice but remain unchanged in Cyp2d6 locus knockout mice, indicating a possible role of CYP2D6 in the metabolism of these compounds both in vivo and in vitro. These metabolic effects were minimized in the presence of two CYP2D6 inhibitors, quinidine and ajmalicine. Neuro-2a cells stably expressing predominantly mitochondrially targeted CYP2D6 were more sensitive to toxin-mediated respiratory dysfunction and complex I inhibition than cells expressing predominantly endoplasmic reticulum-targeted CYP2D6. Exposure to these toxins also induced the autophagic marker Parkin and the mitochondrial fission marker Dynamin-related protein 1 (Drp1) in differentiated neurons expressing mitochondrial CYP2D6. Our results show that monomethylamines are converted to their toxic cationic form by mitochondrially directed CYP2D6 and result in neuronal degradation in mice.	[Chattopadhyay, Mrittika; Chowdhury, Anindya Roy; Feng, Ting; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Biomed Sci, 189E Old Vet, Philadelphia, PA 19104 USA; [Assenmacher, Charles-Antoine; Radaelli, Enrico] Univ Penn, Sch Vet Med, Dept Pathobiol, MJR VHUP, Philadelphia, PA 19104 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Feng, Ting] Univ Nevada, Dept Neurosci, Reno, NV 89557 USA	University of Pennsylvania; University of Pennsylvania; Vanderbilt University; Nevada System of Higher Education (NSHE); University of Nevada Reno	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Biomed Sci, 189E Old Vet, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu	Assenmacher, Charley/ABQ-6382-2022	Feng, Ting/0000-0001-6734-0462	National Institutes of Health [R01 GM118122, RO1 GM034883]; Harriet Ellison Woodward trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883, R01GM118122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harriet Ellison Woodward trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant RO1 GM034883 and an endowment from the Harriet Ellison Woodward trust (to N. G. A.) and National Institutes of Health Grant R01 GM118122 (to F. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Bajpai P, 2013, J BIOL CHEM, V288, P4436, DOI 10.1074/jbc.M112.402123; Bezard E, 1999, EXP NEUROL, V155, P268, DOI 10.1006/exnr.1998.6995; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bjorklund A, 2010, PROG BRAIN RES, V184, P133, DOI 10.1016/S0079-6123(10)84007-5; Cannon JR, 2013, NEUROBIOL DIS, V57, P38, DOI 10.1016/j.nbd.2012.06.025; CHIBA K, 1984, BIOCHEM BIOPH RES CO, V120, P574, DOI 10.1016/0006-291X(84)91293-2; Coleman T, 1996, J PHARMACOL EXP THER, V277, P685; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Ghosh J, 2018, TOXICOL SCI, V166, P428, DOI 10.1093/toxsci/kfy206; Gilham DE, 1997, XENOBIOTICA, V27, P111, DOI 10.1080/004982597240802; Guengerich F. P., 2015, CYTOCHROME P450 STRU, V4th; Herraiz T, 2004, FOOD ADDIT CONTAM, V21, P1041, DOI 10.1080/02652030400019844; Herraiz T, 2006, TOXICOL APPL PHARM, V216, P387, DOI 10.1016/j.taap.2006.06.003; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kieburtz K, 2013, MOVEMENT DISORD, V28, P8, DOI 10.1002/mds.25150; Kohutnicka M, 1998, IMMUNOPHARMACOLOGY, V39, P167, DOI 10.1016/S0162-3109(98)00022-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lew M, 2007, PHARMACOTHERAPY, V27, p155S, DOI 10.1592/phco.27.12part2.155S; Lorenc-Koci E, 2006, BEHAV PHARMACOL, V17, P463, DOI 10.1097/00008877-200609000-00012; Louis ED, 2014, NEUROTOXICOLOGY, V40, P52, DOI 10.1016/j.neuro.2013.11.005; Matsubara K, 1998, J NEUROCHEM, V70, P727; MATSUBARA K, 1993, BRAIN RES, V610, P90, DOI 10.1016/0006-8993(93)91221-D; Matsubara K, 2002, NEUROTOXICOL TERATOL, V24, P593, DOI 10.1016/S0892-0362(02)00212-X; MATSUBARA K, 1992, J NEUROCHEM, V59, P511, DOI 10.1111/j.1471-4159.1992.tb09400.x; Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023; Modi S, 1997, BIOCHEMISTRY-US, V36, P4461, DOI 10.1021/bi962633p; MYERS RD, 1989, EXPERIENTIA, V45, P436, DOI 10.1007/BF01952025; Nagatsu T, 2007, J NEURAL TRANSM-SUPP, P113; Nagatsu T, 1997, NEUROSCI RES, V29, P99, DOI 10.1016/S0168-0102(97)00083-7; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; Onderwater RCA, 1999, CHEM RES TOXICOL, V12, P555, DOI 10.1021/tx980248q; Ostergren A, 2006, J NEURAL TRANSM, V113, P313, DOI 10.1007/s00702-005-0334-0; Pfau W, 2004, J CHROMATOGR B, V802, P115, DOI 10.1016/j.jchromb.2003.10.044; Porras G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009308; RAMSAY RR, 1986, LIFE SCI, V39, P581, DOI 10.1016/0024-3205(86)90037-8; RAMSAY RR, 1987, ARCH BIOCHEM BIOPHYS, V259, P645, DOI 10.1016/0003-9861(87)90531-5; ROMMELSPACHER H, 1991, ALCOHOL CLIN EXP RES, V15, P553, DOI 10.1111/j.1530-0277.1991.tb00559.x; Sangar MC, 2010, EXPERT OPIN DRUG MET, V6, P1231, DOI 10.1517/17425255.2010.503955; Sangar MC, 2009, FEBS J, V276, P3440, DOI 10.1111/j.1742-4658.2009.07067.x; Scheer N, 2012, MOL PHARMACOL, V81, P63, DOI 10.1124/mol.111.075192; SMITH L, 1955, Methods Biochem Anal, V2, P427, DOI 10.1002/9780470110188.ch13; STROBL GR, 1993, J MED CHEM, V36, P1136, DOI 10.1021/jm00061a004; Uehara S, 2015, DRUG METAB DISPOS, V43, P735, DOI 10.1124/dmd.115.063594; Usia T, 2005, BIOL PHARM BULL, V28, P1021, DOI 10.1248/bpb.28.1021; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yu AM, 2004, DRUG METAB REV, V36, P243, DOI 10.1081/DMR-120034000; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2	50	5	5	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10336	10348		10.1074/jbc.RA119.008848	http://dx.doi.org/10.1074/jbc.RA119.008848			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31113867	hybrid, Green Published			2022-12-28	WOS:000474445600023
J	Singh, S; Goswami, N; Tyagi, AK; Khare, G				Singh, Swati; Goswami, Nikita; Tyagi, Anil K.; Khare, Garima			Unraveling the role of the transcriptional regulator VirS in low pH-induced responses of Mycobacterium tuberculosis and identification of VirS inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; gene microarray; transcription factor; tuberculosis; inhibitor; AraC; XylS type transcription factor; immune evasion; site-directed mutagenesis; VirS; virtual screening	MICROTITER ASSAY PLATE; DNA-BINDING DOMAIN; INTRAPHAGOSOMAL SURVIVAL; 3-DIMENSIONAL STRUCTURES; GENE-EXPRESSION; PROTEIN MODELS; MYMA OPERON; ACID; SEQUENCE; REVEALS	The ability of Mycobacterium tuberculosis to respond and adapt to various stresses such as oxygen/nitrogen radicals and low pH inside macrophages is critical for the persistence of this human pathogen inside its host. We have previously shown that an AraC/XylS-type transcriptional regulator, VirS, which is induced in low pH, is involved in remodeling the architecture of the bacterial cell envelope. However, how VirS influences gene expression to coordinate these pH responses remains unclear. Here, using a genetic biosensor of cytoplasmic pH, we demonstrate that VirS is required for the intracellular pH maintenance in response to acidic stress and inside acidified macrophages. Furthermore, we observed that VirS plays an important role in blocking phagosomal-lysosomal fusions. Transcriptomics experiments revealed that VirS affects the expression of genes encoding metabolic enzymes, cell-wall envelope proteins, efflux pumps, ion transporters, detoxification enzymes, and transcriptional regulators expressed under low-pH stress. Employing electrophoretic mobility-shift assays, DNA footprinting, and in silico analysis, we identified a DNA sequence to which VirS binds and key residues in VirS required for its interaction with DNA. A significant role of VirS in M. tuberculosis survival in adverse conditions suggested it as a potential anti-mycobacterial drug target. To that end, we identified VirS inhibitors in a virtual screen; the top hit compounds inhibited its DNA-binding activity and also M. tuberculosis growth in vitro and inside macrophages. Our findings establish that VirS mediates M. tuberculosis responses to acidic stress and identify VirS-inhibiting compounds that may form the basis for developing more effective anti-mycobacterial agents.	[Singh, Swati; Goswami, Nikita; Tyagi, Anil K.; Khare, Garima] Univ Delhi South Campus, Dept Biochem, Benito Juarez Rd, New Delhi 110021, India; [Tyagi, Anil K.] Guru Gobind Singh Indraprastha Univ, Sect 16-C, New Delhi 110078, India	University of Delhi; GGS Indraprastha University	Tyagi, AK; Khare, G (corresponding author), Univ Delhi South Campus, Dept Biochem, Benito Juarez Rd, New Delhi 110021, India.	aniltyagi@south.du.ac.in; garima1822@yahoo.co.in			Department of Biotechnology, Government of India [BT/01/COE/05/06-II, BT/07/IYBA/2013-5]; Department of Science and Technology, Government of India, J.C. Bose Fellowship [SR/S2/JCB-39/2009]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India, J.C. Bose Fellowship	This work was supported by Department of Biotechnology, Government of India, Grant BT/01/COE/05/06-II (to A.K.T.); Department of Science and Technology, Government of India, J.C. Bose Fellowship SR/S2/JCB-39/2009 (to A.K.T.), and Department of Biotechnology, Government of India, Innovative Young Bio-technologist Award BT/07/IYBA/2013-5 (to G.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Athmann C, 2000, J CLIN INVEST, V106, P339, DOI 10.1172/JCI9351; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Baker JJ, 2014, MOL MICROBIOL, V94, P56, DOI 10.1111/mmi.12688; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Chauhan S, 2009, FEBS J, V276, P3428, DOI 10.1111/j.1742-4658.2009.07066.x; Cholo MC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/608682; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dangi B, 2004, MOL MICROBIOL, V54, P45, DOI 10.1111/j.1365-2958.2004.04250.x; Dassault Systemes, 2016, BIOVIA DISC STUD MOD; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Desriac N, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00284; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Golby P, 2007, MICROBIOL-SGM, V153, P3323, DOI 10.1099/mic.0.2007/009894-0; Gupta S, 1999, FEMS MICROBIOL LETT, V172, P137, DOI 10.1016/S0378-1097(99)00028-2; GUPTA S, 1993, GENE, V126, P157, DOI 10.1016/0378-1119(93)90607-5; Healy C, 2016, TUBERCULOSIS, V97, P154, DOI 10.1016/j.tube.2015.10.003; Khare G, 2013, SCI REP-UK, V3, DOI 10.1038/srep03527; Khare G, 2013, ANTIMICROB AGENTS CH, V57, P6372, DOI 10.1128/AAC.01444-13; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Lopez M, 2018, ARCH MICROBIOL, V200, P483, DOI 10.1007/s00203-017-1465-z; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marcus EA, 2013, HELICOBACTER, V18, P363, DOI 10.1111/hel.12055; Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003; Martin-Galiano AJ, 2001, MOL MICROBIOL, V41, P1327, DOI 10.1046/j.1365-2958.2001.02597.x; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Mols M, 2010, ENVIRON MICROBIOL, V12, P873, DOI 10.1111/j.1462-2920.2009.02132.x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ni L, 2013, NUCLEIC ACIDS RES, V41, P1998, DOI 10.1093/nar/gks1207; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Raimunda D, 2012, MOL MICROBIOL, V84, P1139, DOI 10.1111/j.1365-2958.2012.08082.x; Raynaud C, 2002, MOL MICROBIOL, V46, P191, DOI 10.1046/j.1365-2958.2002.03152.x; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Rodgers ME, 2009, PROTEINS, V77, P202, DOI 10.1002/prot.22431; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rohilla A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04748-9; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7; Singh S, 2018, DRUG DES DEV THER, V12, P1065, DOI 10.2147/DDDT.S144240; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; Stincone A, 2011, NUCLEIC ACIDS RES, V39, P7512, DOI 10.1093/nar/gkr338; Talaat AM, 2007, J BACTERIOL, V189, P4265, DOI 10.1128/JB.00011-07; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilks JC, 2009, APPL ENVIRON MICROB, V75, P981, DOI 10.1128/AEM.01652-08; Yao MD, 2013, J BIOL CHEM, V288, P31019, DOI 10.1074/jbc.M113.473611	59	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10055	10075		10.1074/jbc.RA118.005312	http://dx.doi.org/10.1074/jbc.RA118.005312			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31126988	Green Published, hybrid			2022-12-28	WOS:000474445600003
J	Yam, M; Engel, AL; Wang, YK; Zhu, SY; Hauer, A; Zhang, R; Lohner, D; Huang, JC; Dinterman, M; Zhao, C; Chao, JR; Du, JH				Yam, Michelle; Engel, Abbi L.; Wang, Yekai; Zhu, Siyan; Hauer, Allison; Zhang, Rui; Lohner, Daniel; Huang, Jiancheng; Dinterman, Marlee; Zhao, Chen; Chao, Jennifer R.; Du, Jianhai			Proline mediates metabolic communication between retinal pigment epithelial cells and the retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retinal metabolism; amino acid; mitochondrial metabolism; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); cell metabolism; age-related macular degeneration (AMD); glucose metabolism; oxidative stress; visual function; proline; retinal pigment epithelium; retina	ORNITHINE CYTOTOXICITY; MOLECULAR SIGNATURE; GYRATE ATROPHY; SODIUM IODATE; MOUSE RETINA; DIFFERENTIATION; TRANSPORT; PATHWAYS; MODEL; DEGENERATION	The retinal pigment epithelium (RPE) is a monolayer of pigmented cells between the choroid and the retina. RPE dysfunction underlies many retinal degenerative diseases, including age-related macular degeneration, the leading cause of age-related blindness. To perform its various functions in nutrient transport, phagocytosis of the outer segment, and cytokine secretion, the RPE relies on an active energy metabolism. We previously reported that human RPE cells prefer proline as a nutrient and transport proline-derived metabolites to the apical, or retinal, side. In this study, we investigated how RPE utilizes proline in vivo and why proline is a preferred substrate. By using [C-13]proline labeling both ex vivo and in vivo, we found that the retina rarely uses proline directly, whereas the RPE utilizes it at a high rate, exporting proline-derived mitochondrial intermediates for use by the retina. We observed that in primary human RPE cell culture, proline is the only amino acid whose uptake increases with cellular maturity. In human RPE, proline was sufficient to stimulate de novo serine synthesis, increase reductive carboxylation, and protect against oxidative damage. Blocking proline catabolism in RPE impaired glucose metabolism and GSH production. Notably, in an acute model of RPE-induced retinal degeneration, dietary proline improved visual function. In conclusion, proline is an important nutrient that supports RPE metabolism and the metabolic demand of the retina.	[Yam, Michelle; Wang, Yekai; Zhu, Siyan; Hauer, Allison; Zhang, Rui; Lohner, Daniel; Huang, Jiancheng; Dinterman, Marlee; Du, Jianhai] West Virginia Univ, Dept Ophthalmol, Morgantown, WV 26506 USA; [Yam, Michelle; Wang, Yekai; Zhu, Siyan; Hauer, Allison; Lohner, Daniel; Dinterman, Marlee; Du, Jianhai] West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Engel, Abbi L.; Chao, Jennifer R.] Univ Washington, Dept Ophthalmol, Seattle, WA 98109 USA; [Zhang, Rui] Univ Sydney, Save Sight Inst, 8 Macquarie St, Sydney, NSW, Australia; [Huang, Jiancheng; Zhao, Chen] Fudan Univ, Shanghai Med Coll, Eye Inst, Eye & ENT Hosp, Shanghai 200031, Peoples R China; [Huang, Jiancheng] Nanjing Med Univ, Affiliated Hosp 1, State Key Lab Reprod Med, Dept Ophthalmol, Nanjing 210029, Jiangsu, Peoples R China	West Virginia University; West Virginia University; University of Washington; University of Washington Seattle; University of Sydney; Fudan University; Nanjing Medical University	Chao, JR (corresponding author), 750 Republican St,Box 358058, Seattle, WA 98109 USA.; Du, JH (corresponding author), WVU Eye Inst, One Med Ctr Dr,POB 9193, Morgantown, WV 26505 USA.	jrchao@uw.edu; jianhai.du@wvumedicine.org		Chao, Jennifer/0000-0002-6859-5552; Yam, Michelle/0000-0001-5250-994X	National Institutes of Health [EY026030]; BrightFocus Foundation; Retina Research Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY026030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation(BrightFocus Foundation); Retina Research Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY026030 (to J. R. C. and J. D.), the BrightFocus Foundation (to J. D. and J. R. C.), the Retina Research Foundation (to J. D.), and an unrestricted grant from Research to Prevent Blindness (to J. R. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi R, 2017, BIOCHEM BIOPH RES CO, V488, P393, DOI 10.1016/j.bbrc.2017.05.064; Adijanto J, 2014, EXP EYE RES, V126, P77, DOI 10.1016/j.exer.2014.01.015; Agathocleous M, 2013, TRENDS CELL BIOL, V23, P484, DOI 10.1016/j.tcb.2013.05.004; Ahmado A, 2011, INVEST OPHTH VIS SCI, V52, P7148, DOI 10.1167/iovs.10-6374; Allmann S, 2013, J BIOL CHEM, V288, P18494, DOI 10.1074/jbc.M113.462978; Ando A, 2000, EXP EYE RES, V70, P89, DOI 10.1006/exer.1999.0750; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Ben Rejeb K, 2014, PLANT PHYSIOL BIOCH, V80, P278, DOI 10.1016/j.plaphy.2014.04.007; Bennis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141597; Buchholz DE, 2013, STEM CELL TRANSL MED, V2, P384, DOI 10.5966/sctm.2012-0163; Bui BV, 2009, J NEUROCHEM, V111, P589, DOI 10.1111/j.1471-4159.2009.06354.x; BURSELL E, 1973, T ROY SOC TROP MED H, V67, P296, DOI 10.1016/0035-9203(73)90222-8; Chao JR, 2017, J BIOL CHEM, V292, P12895, DOI 10.1074/jbc.M117.788422; Chowers G, 2017, INVEST OPHTH VIS SCI, V58, P2239, DOI 10.1167/iovs.16-21255; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Du JH, 2016, P NATL ACAD SCI USA, V113, P14710, DOI 10.1073/pnas.1604572113; Du JH, 2015, METHOD ENZYMOL, V561, P149, DOI 10.1016/bs.mie.2015.04.002; Du JH, 2013, P NATL ACAD SCI USA, V110, P18501, DOI 10.1073/pnas.1311193110; Edwards C, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0167-2; Elia I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15267; Eswarappa SM, 2018, J BIOL CHEM, V293, P19148, DOI 10.1074/jbc.RA118.004276; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fisher CR, 2018, INVEST OPHTH VIS SCI, V59, pAMD41, DOI 10.1167/iovs.18-24289; Fronk AH, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731416650838; Gao XR, 2019, HUM MOL GENET, V28, P1162, DOI 10.1093/hmg/ddy422; Gu HW, 2015, ANALYST, V140, P2726, DOI 10.1039/c4an02386b; Hancock CN, 2016, AMINO ACIDS, V48, P859, DOI 10.1007/s00726-015-2134-7; Hillenkamp J, 2004, INVEST OPHTH VIS SCI, V45, P1493, DOI 10.1167/iovs.03-0765; Hirabayashi Y, 2008, PROG LIPID RES, V47, P188, DOI 10.1016/j.plipres.2008.01.003; HIRATA A, 1992, INVEST OPHTH VIS SCI, V33, P2079; Hu CA, 1999, J BIOL CHEM, V274, P6754, DOI 10.1074/jbc.274.10.6754; Hu J, 2001, MOL VIS, V7, P14; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Hwang IY, 2016, CELL METAB, V24, P494, DOI 10.1016/j.cmet.2016.06.014; Iacovelli J, 2016, INVEST OPHTH VIS SCI, V57, P1038, DOI 10.1167/iovs.15-17758; Kigasawa Kazuteru, 1998, Tokai Journal of Experimental and Clinical Medicine, V23, P147; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; LI W, 1984, EXP EYE RES, V38, P291, DOI 10.1016/0014-4835(84)90167-2; Liang XW, 2013, ANTIOXID REDOX SIGN, V19, P998, DOI 10.1089/ars.2012.5074; Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341; Liu LK, 2017, ARCH BIOCHEM BIOPHYS, V632, P142, DOI 10.1016/j.abb.2017.07.005; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Marmorstein LY, 2007, HUM MOL GENET, V16, P2423, DOI 10.1093/hmg/ddm199; McDonald AE, 2018, COMP BIOCHEM PHYS B, V224, P185, DOI 10.1016/j.cbpb.2017.11.006; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/PREACCEPT-1418491035586234, 10.1186/gm315]; Nita M, 2014, MED SCI MONITOR, V20, P1003, DOI 10.12659/MSM.889887; ODONNELL JJ, 1978, SCIENCE, V200, P200, DOI 10.1126/science.635581; Phang JM, 2008, AMINO ACIDS, V35, P681, DOI 10.1007/s00726-008-0063-4; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Radeke MJ, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0183-x; REICHENBACH A, 1992, CAN J PHYSIOL PHARM, V70, pS239, DOI 10.1139/y92-267; de Pouplana LR, 2018, J BIOL CHEM, V293, P19157, DOI 10.1074/jbc.H118.006600; Schroeder EA, 2012, CELL METAB, V15, P417, DOI 10.1016/j.cmet.2012.03.011; Seiler Nikolaus, 2000, Current Drug Targets, V1, P119, DOI 10.2174/1389450003349254; Sinha T, 2018, J NUTR BIOCHEM, V62, P123, DOI 10.1016/j.jnutbio.2018.09.003; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Ueda M, 1998, INVEST OPHTH VIS SCI, V39, P820; Wang JM, 2014, INVEST OPHTH VIS SCI, V55, P1941, DOI 10.1167/iovs.13-13075; Wang T, 1996, J CLIN INVEST, V97, P2753, DOI 10.1172/JCI118730; WANG T, 1995, NAT GENET, V11, P185, DOI 10.1038/ng1095-185; Wang YK, 2018, NEUROBIOL AGING, V71, P223, DOI 10.1016/j.neurobiolaging.2018.07.024; Whitmore SS, 2014, EXP EYE RES, V129, P93, DOI 10.1016/j.exer.2014.11.001; Wolthuis DFGJ, 2014, EUR J PAEDIATR NEURO, V18, P511, DOI 10.1016/j.ejpn.2014.01.003; Xiong GF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-1; Xu L, 2018, P NATL ACAD SCI USA, V115, P10475, DOI 10.1073/pnas.1802724115; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhang L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00552; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]; Zhu SY, 2018, EXP EYE RES, V174, P113, DOI 10.1016/j.exer.2018.05.032	70	40	42	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10278	10289		10.1074/jbc.RA119.007983	http://dx.doi.org/10.1074/jbc.RA119.007983			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31110046	Green Published, hybrid			2022-12-28	WOS:000474445600018
J	Hu, J; Li, S; Sun, XZ; Fang, ZQ; Wang, LN; Xiao, F; Shao, M; Ge, LX; Tang, F; Gu, JJ; Yu, HY; Guo, YS; Guo, XJ; Liao, B; Jin, Y				Hu, Jing; Li, Shuang; Sun, Xiaozhi; Fang, Zhuoqing; Wang, Lina; Xiao, Feng; Shao, Min; Ge, Laixiang; Tang, Fan; Gu, Junjie; Yu, Hongyao; Guo, Yueshuai; Guo, Xuejiang; Liao, Bing; Jin, Ying			Stk40 deletion elevates c-JUN protein level and impairs mesoderm differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; protein degradation; development; protein complex; Wnt pathway; c-JUN; COP1; mesoderm differentiation; protein stability; STK40	EMBRYONIC STEM-CELLS; UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; BETA-CATENIN; AP-1; INDUCTION; COMPLEX; COP1; WNT; SPECIFICATION	Mesoderm development is a finely tuned process initiated by the differentiation of pluripotent epiblast cells. Serine/threonine kinase 40 (STK40) controls the development of several mesoderm-derived cell types, its overexpression induces differentiation of mouse embryonic stem cells (mESCs) toward the extraembryonic endoderm, and Stk40 knockout (KO) results in multiple organ failure and is lethal at the perinatal stage in mice. However, molecular mechanisms underlying the physiological functions of STK40 in mesoderm differentiation remain elusive. Here, we report that Stk40 ablation impairs mesoderm differentiation both in vitro and in vivo. Mechanistically, STK40 interacts with both the E3 ubiquitin ligase mammalian constitutive photomorphogenesis protein 1 (COP1) and the transcriptional regulator proto-oncogene c-Jun (c-JUN), promoting c-JUN protein degradation. Consequently, Stk40 knockout leads to c-JUN protein accumulation, which, in turn, apparently suppresses WNT signaling activity and impairs the mesoderm differentiation process. Overall, this study reveals that STK40, together with COP1, represents a previously unknown regulatory axis that modulates the c-JUN protein level within an appropriate range during mesoderm differentiation from mESCs. Our findings provide critical insights into the molecular mechanisms regulating the c-JUN protein level and may have potential implications for managing cellular disorders arising from c-JUN dysfunction.	[Hu, Jing; Li, Shuang; Sun, Xiaozhi; Wang, Lina; Ge, Laixiang; Tang, Fan; Gu, Junjie; Yu, Hongyao; Liao, Bing; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Basic Clin Res Ctr, Renji Hosp, 227 South Chongqing Rd, Shanghai 200025, Peoples R China; [Hu, Jing; Li, Shuang; Sun, Xiaozhi; Wang, Lina; Ge, Laixiang; Tang, Fan; Gu, Junjie; Yu, Hongyao; Liao, Bing; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Reprod Med, Dept Histoembryol Genet & Dev Biol, 227 South Chongqing Rd, Shanghai 200025, Peoples R China; [Fang, Zhuoqing; Xiao, Feng; Shao, Min; Jin, Ying] Univ Chinese Acad Sci, CAS Key Lab Tissue Microenvironm & Tumor, CAS Ctr Excellence Mol Cell Sci,Chinese Acad Sci, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200032, Peoples R China; [Jin, Ying] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China; [Guo, Yueshuai; Guo, Xuejiang] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Nanjing Medical University	Liao, B; Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Basic Clin Res Ctr, Renji Hosp, 227 South Chongqing Rd, Shanghai 200025, Peoples R China.; Liao, B; Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Reprod Med, Dept Histoembryol Genet & Dev Biol, 227 South Chongqing Rd, Shanghai 200025, Peoples R China.; Jin, Y (corresponding author), Univ Chinese Acad Sci, CAS Key Lab Tissue Microenvironm & Tumor, CAS Ctr Excellence Mol Cell Sci,Chinese Acad Sci, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200032, Peoples R China.; Jin, Y (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.	liaobing@shsmu.edu.cn; yjin@sibs.ac.cn	Fang, Zhuoqing/AGG-2150-2022; Fang, Zhuoqing/AGF-7360-2022; Guo, Xuejiang/J-9600-2014	Fang, Zhuoqing/0000-0002-7418-1313; Yu, Hongyao/0000-0003-3752-8442; Guo, Yueshuai/0000-0002-2719-1244; Guo, Xuejiang/0000-0002-0475-5705; Xiao, Feng/0000-0002-9084-9328; Liao, Bing/0000-0003-1279-1682	National Natural Science Foundation of China [31871373, 31730055, 31301015, 31200980]; Ministry of Science and Technology of China [2016YFA0100100]; Chinese Academy of Sciences [XDB19020100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 31871373, 31730055, 31301015, and 31200980; Ministry of Science and Technology of China Grant 2016YFA0100100; and Strategic Priority Research Program Grant XDB19020100 of the Chinese Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Baert JL, 2010, ONCOGENE, V29, P1810, DOI 10.1038/onc.2009.471; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chal J, 2015, NAT BIOTECHNOL, V33, P962, DOI 10.1038/nbt.3297; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Durzynska I, 2017, STRUCTURE, V25, P287, DOI 10.1016/j.str.2016.12.008; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gouti M, 2017, DEV CELL, V41, P243, DOI 10.1016/j.devcel.2017.04.002; Hartl M, 2003, CURR CANCER DRUG TAR, V3, P41, DOI 10.2174/1568009033333781; He K, 2017, J BIOL CHEM, V292, P351, DOI 10.1074/jbc.M116.719849; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kojima Y, 2014, SEMIN CELL DEV BIOL, V34, P65, DOI 10.1016/j.semcdb.2014.06.010; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Li S, 2018, STEM CELL REP, V11, P973, DOI 10.1016/j.stemcr.2018.09.001; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu J, 2015, NAT CELL BIOL, V17, P856, DOI 10.1038/ncb3193; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Migliorini D, 2011, J CLIN INVEST, V121, P1329, DOI 10.1172/JCI45784; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Uljon S, 2016, STRUCTURE, V24, P687, DOI 10.1016/j.str.2016.03.002; Vitari AC, 2011, NATURE, V474, P403, DOI 10.1038/nature10005; Wang LN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.148; Wang L, 2016, J MOL BIOL, V428, P1409, DOI 10.1016/j.jmb.2015.06.013; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wen FP, 2016, AUTOPHAGY, V12, P671, DOI 10.1080/15548627.2016.1149659; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Xia Y, 2007, MOL CELL BIOL, V27, P510, DOI 10.1128/MCB.01355-06; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu HY, 2015, J CELL SCI, V128, P2881, DOI 10.1242/jcs.170282; Yu HY, 2013, J BIOL CHEM, V288, P5342, DOI 10.1074/jbc.M112.409433	51	4	4	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9959	9972		10.1074/jbc.RA119.007840	http://dx.doi.org/10.1074/jbc.RA119.007840			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31092598	Green Published, hybrid			2022-12-28	WOS:000473277900026
J	Chavali, SS; Bonn-Breach, R; Wedekind, JE				Chavali, Sai Shashank; Bonn-Breach, Rachel; Wedekind, Joseph E.			Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						RNA-protein interaction; drug discovery; drug development; structural model; structural biology; structure-function; RNA virus; RNA structure; RNA-binding protein; arginine-sandwich motif; HIV TAR RNA; RNA-drug interaction; super-elongation complex; viral transactivation	HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; SMALL-MOLECULE INHIBITORS; CARBOXYL-TERMINAL DOMAIN; P-TEFB; CRYSTAL-STRUCTURE; HIGH-AFFINITY; TRANSCRIPTIONAL ACTIVATION; ELONGATION COMPLEX; GENE-REGULATION	Small molecules and short peptides that potently and selectively bind RNA are rare, making the molecular structures of these complexes highly exceptional. Accordingly, several recent investigations have provided unprecedented structural insights into how peptides and proteins recognize the HIV-1 transactivation response (TAR) element, a 59-nucleotide-long, noncoding RNA segment in the 5 long terminal repeat region of viral transcripts. Here, we offer an integrated perspective on these advances by describing earlier progress on TAR binding to small molecules, and by drawing parallels to recent successes in the identification of compounds that target the hepatitis C virus internal ribosome entry site (IRES) and the flavin-mononucleotide riboswitch. We relate this work to recent progress that pinpoints specific determinants of TAR recognition by: (i) viral Tat proteins, (ii) an innovative lab-evolved TAR-binding protein, and (iii) an ultrahigh-affinity cyclic peptide. New structural details are used to model the TAR-Tat-super-elongation complex (SEC) that is essential for efficient viral transcription and represents a focal point for antiviral drug design. A key prediction is that the Tat transactivation domain makes modest contacts with the TAR apical loop, whereas its arginine-rich motif spans the entire length of the TAR major groove. This expansive interface has significant implications for drug discovery and design, and it further suggests that future lab-evolved proteins could be deployed to discover steric restriction points that block Tat-mediated recruitment of the host SEC to HIV-1 TAR.	Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Ctr AIDS Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Wedekind, JE (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.; Wedekind, JE (corresponding author), Univ Rochester, Med Ctr, Ctr RNA Biol, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	joseph.wedekind@rochester.edu		Chavali, Sai Shashank/0000-0002-3467-2257; Wedekind, Joseph/0000-0002-4269-4229	NIAID NIH HHS [R01 AI150463, P30 AI078498] Funding Source: Medline; NIGMS NIH HHS [R01 GM063162, R01 GM123864] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI150463, P30AI078498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123864, R01GM063162] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AboulEla F, 1996, NUCLEIC ACIDS RES, V24, P3974, DOI 10.1093/nar/24.20.3974; ABOULELA F, 1995, J MOL BIOL, V253, P313, DOI 10.1006/jmbi.1995.0555; Abulwerdi FA, 2016, J MED CHEM, V59, P11148, DOI 10.1021/acs.jmedchem.6b01450; Anand K, 2008, NAT STRUCT MOL BIOL, V15, P1287, DOI 10.1038/nsmb.1513; Athanassiou Z, 2004, J AM CHEM SOC, V126, P6906, DOI 10.1021/ja0497680; Athanassiou Z, 2007, BIOCHEMISTRY-US, V46, P741, DOI 10.1021/bi0619371; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Belashov IA, 2018, NUCLEIC ACIDS RES, V46, P6401, DOI 10.1093/nar/gky529; Blanchet C, 2011, NUCLEIC ACIDS RES, V39, pW68, DOI 10.1093/nar/gkr316; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Blount KF, 2015, ANTIMICROB AGENTS CH, V59, P5736, DOI 10.1128/AAC.01282-15; Borkar AN, 2016, P NATL ACAD SCI USA, V113, P7171, DOI 10.1073/pnas.1521349113; Breaker RR, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032797; Brodsky AS, 1997, J MOL BIOL, V267, P624, DOI 10.1006/jmbi.1996.0879; Calabro V, 2005, P NATL ACAD SCI USA, V102, P6849, DOI 10.1073/pnas.0409282102; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chan CW, 2013, WIRES RNA, V4, P507, DOI 10.1002/wrna.1175; CHEN L, 1994, BIOCHEMISTRY-US, V33, P2708, DOI 10.1021/bi00175a046; Chen Y, 2013, FEBS J, V280, P3734, DOI 10.1111/febs.12375; Chittapragada M, 2009, PERSPECT MED CHEM, V3, P21; CHURCHER MJ, 1993, J MOL BIOL, V230, P90, DOI 10.1006/jmbi.1993.1128; Connelly CM, 2016, CELL CHEM BIOL, V23, P1077, DOI 10.1016/j.chembiol.2016.05.021; CORDINGLEY MG, 1990, P NATL ACAD SCI USA, V87, P8985, DOI 10.1073/pnas.87.22.8985; Crawford DW, 2016, ACS CHEM BIOL, V11, P2206, DOI 10.1021/acschembio.6b00145; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P1; D'Orso I, 2012, MOL CELL BIOL, V32, P4780, DOI 10.1128/MCB.00206-12; Dahabieh MS, 2015, ANNU REV MED, V66, P407, DOI 10.1146/annurev-med-092112-152941; Davidson A, 2011, J MOL BIOL, V410, P984, DOI 10.1016/j.jmb.2011.03.039; Davidson A, 2011, NUCLEIC ACIDS RES, V39, P248, DOI 10.1093/nar/gkq713; Davidson A, 2009, P NATL ACAD SCI USA, V106, P11931, DOI 10.1073/pnas.0900629106; Davis B, 2004, J MOL BIOL, V336, P343, DOI 10.1016/j.jmb.2003.12.046; Davis Darrell R., 2011, Antiviral Chemistry & Chemotherapy, V21, P117, DOI 10.3851/IMP1693; DELLING U, 1992, J VIROL, V66, P3018, DOI 10.1128/JVI.66.5.3018-3025.1992; Dethoff EA, 2008, BIOPHYS J, V95, P3906, DOI 10.1529/biophysj.108.140285; Dethoff EA, 2012, NATURE, V491, P724, DOI 10.1038/nature11498; Dibrov SM, 2012, P NATL ACAD SCI USA, V109, P5223, DOI 10.1073/pnas.1118699109; Dieffenbach CW, 2011, ANN INTERN MED, V154, P766, DOI 10.7326/0003-4819-154-11-201106070-00345; DINGWALL C, 1989, P NATL ACAD SCI USA, V86, P6925, DOI 10.1073/pnas.86.18.6925; DINGWALL C, 1990, EMBO J, V9, P4145, DOI 10.1002/j.1460-2075.1990.tb07637.x; Disney MD, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a034769; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Du ZH, 2002, CHEM BIOL, V9, P707, DOI 10.1016/S1074-5521(02)00151-5; Durney MA, 2010, J MOL BIOL, V404, P555, DOI 10.1016/j.jmb.2010.08.042; Faber C, 2000, J BIOL CHEM, V275, P20660, DOI 10.1074/jbc.M000920200; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Ferner J, 2009, CHEMBIOCHEM, V10, P1490, DOI 10.1002/cbic.200900220; Foley B., 2018, HIV SEQUENCE COMPEND; Freire E, 2009, CHEM BIOL DRUG DES, V74, P468, DOI 10.1111/j.1747-0285.2009.00880.x; Ghosh AK, 2012, ANGEW CHEM INT EDIT, V51, P1778, DOI 10.1002/anie.201102762; Greenbaum NL, 1996, STRUCTURE, V4, P5, DOI 10.1016/S0969-2126(96)00003-2; Gu JY, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28756; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hendrix DK, 2005, Q REV BIOPHYS, V38, P221, DOI 10.1017/S0033583506004215; Hermann T, 2000, COMB CHEM HIGH T SCR, V3, P219; Hilimire TA, 2017, ACS CHEM BIOL, V12, P1674, DOI 10.1021/acschembio.7b00052; Hiller DA, 2011, PHILOS T R SOC B, V366, P2929, DOI 10.1098/rstb.2011.0143; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Howe JA, 2016, RNA BIOL, V13, P946, DOI 10.1080/15476286.2016.1216304; Howe JA, 2015, NATURE, V526, P672, DOI 10.1038/nature15542; Huber W, 2005, J MOL RECOGNIT, V18, P273, DOI 10.1002/jmr.744; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; Isel C, 1999, J MOL BIOL, V290, P929, DOI 10.1006/jmbi.1999.2933; JAKOBOVITS A, 1988, MOL CELL BIOL, V8, P2555, DOI 10.1128/MCB.8.6.2555; Kessing CF, 2017, CELL REP, V21, P600, DOI 10.1016/j.celrep.2017.09.080; Kim YK, 2002, MOL CELL BIOL, V22, P4622, DOI 10.1128/MCB.22.13.4622-4637.2002; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulinski T, 2003, J BIOL CHEM, V278, P38892, DOI 10.1074/jbc.M301939200; Lalonde MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002038; Lawrence CF, 2016, J BIOL CHEM, V291, P15473, DOI 10.1074/jbc.M116.732180; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee ER, 2009, RNA BIOL, V6, P187, DOI 10.4161/rna.6.2.7727; Lee MM, 2009, J AM CHEM SOC, V131, P17464, DOI 10.1021/ja906877y; Leeper TC, 2005, BIOCHEMISTRY-US, V44, P12362, DOI 10.1021/bi0510532; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Liberman JA, 2011, CURR OPIN STRUC BIOL, V21, P327, DOI 10.1016/j.sbi.2011.03.016; Lilley DMJ, 2014, BBA-GENE REGUL MECH, V1839, P995, DOI 10.1016/j.bbagrm.2014.04.020; Lind KE, 2002, CHEM BIOL, V9, P185, DOI 10.1016/S1074-5521(02)00106-0; LONG KS, 1995, BIOCHEMISTRY-US, V34, P8885, DOI 10.1021/bi00027a041; Lu JX, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00054; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Matsui M, 2017, NAT REV DRUG DISCOV, V16, P167, DOI 10.1038/nrd.2016.117; McCown PJ, 2017, RNA, V23, P995, DOI 10.1261/rna.061234.117; McNamara RP, 2013, CELL REP, V5, P1256, DOI 10.1016/j.celrep.2013.11.003; Mei HY, 1997, BIOORGAN MED CHEM, V5, P1173, DOI 10.1016/S0968-0896(97)00064-3; Mei HY, 1998, BIOCHEMISTRY-US, V37, P14204, DOI 10.1021/bi981308u; Merriman DK, 2016, BIOCHEMISTRY-US, V55, P4445, DOI 10.1021/acs.biochem.6b00285; Mousseau G, 2017, CURR PHARM DESIGN, V23, P4079, DOI 10.2174/1381612823666170622104355; Mousseau G, 2015, CURR TOP MICROBIOL, V389, P121, DOI 10.1007/82_2015_435; Mousseau Guillaume, 2012, Biology (Basel), V1, P668, DOI 10.3390/biology1030668; Mousseau G, 2012, CELL HOST MICROBE, V12, P97, DOI 10.1016/j.chom.2012.05.016; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; Murchie AIH, 2004, J MOL BIOL, V336, P625, DOI 10.1016/j.jmb.2003.12.028; Narayan V, 2011, J MOL BIOL, V410, P972, DOI 10.1016/j.jmb.2011.04.013; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; OTANI S, 1974, J ANTIBIOT, V27, P88, DOI 10.7164/antibiotics.27.88; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Palacino J, 2015, NAT CHEM BIOL, V11, P511, DOI [10.1038/NCHEMBIO.1837, 10.1038/nchembio.1837]; Parsons J, 2009, NAT CHEM BIOL, V5, P823, DOI 10.1038/nchembio.217; Patwardhan NN, 2017, MEDCHEMCOMM, V8, P1022, DOI [10.1039/C6MD00729E, 10.1039/c6md00729e]; Paulsen RB, 2010, P NATL ACAD SCI USA, V107, P7263, DOI 10.1073/pnas.0911896107; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Peselis A, 2014, WIRES RNA, V5, P803, DOI 10.1002/wrna.1247; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Pham VV, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06591-6; Pintar A, 2002, BIOINFORMATICS, V18, P980, DOI 10.1093/bioinformatics/18.7.980; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; PUGLISI JD, 1993, P NATL ACAD SCI USA, V90, P3680, DOI 10.1073/pnas.90.8.3680; PUGLISI JD, 1995, SCIENCE, V270, P1200, DOI 10.1126/science.270.5239.1200; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Richter S, 2004, ANTIMICROB AGENTS CH, V48, P1895, DOI 10.1128/AAC.48.5.1895-1899.2004; Richter S, 2002, BIOCHEMISTRY-US, V41, P6391, DOI 10.1021/bi0159579; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; Saenger W., 1984, PRINCIPLES NUCL ACID, P1; Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200; Schulze-Gahmen U, 2018, P NATL ACAD SCI USA, V115, P12973, DOI 10.1073/pnas.1806438115; Schulze-Gahmen U, 2016, ELIFE, V5, DOI 10.7554/eLife.15910; Schulze-Gahmen U, 2014, ELIFE, V3, DOI 10.7554/eLife.02375; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Seth PP, 2005, J MED CHEM, V48, P7099, DOI 10.1021/jm050815o; Sherwood AV, 2016, ANNU REV MICROBIOL, V70, P361, DOI 10.1146/annurev-micro-091014-104306; Shi ZD, 2013, CANCER RES, V73, P5519, DOI 10.1158/0008-5472.CAN-13-0280; Shortridge MD, 2019, NUCLEIC ACIDS RES, V47, P1523, DOI 10.1093/nar/gky1197; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Stelzer AC, 2011, NAT CHEM BIOL, V7, P553, DOI [10.1038/NCHEMBIO.596, 10.1038/nchembio.596]; Sudarsan N, 2005, CHEM BIOL, V12, P1325, DOI 10.1016/j.chembiol.2005.10.007; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; TAO JS, 1993, P NATL ACAD SCI USA, V90, P1571, DOI 10.1073/pnas.90.4.1571; TAO JS, 1992, P NATL ACAD SCI USA, V89, P2723, DOI 10.1073/pnas.89.7.2723; Tok JBH, 2001, BIOORG MED CHEM LETT, V11, P43, DOI 10.1016/S0960-894X(00)00591-6; Vicens Q, 2003, CHEMBIOCHEM, V4, P1018, DOI 10.1002/cbic.200300684; Vicens Q, 2018, ACS CHEM BIOL, V13, P2908, DOI 10.1021/acschembio.8b00533; Wan ZT, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0088-6; Wang H, 2017, CELL CHEM BIOL, V24, P576, DOI 10.1016/j.chembiol.2017.03.014; Wang ZY, 2001, BIOCHEMISTRY-US, V40, P6458, DOI 10.1021/bi0028744; Warf MB, 2009, P NATL ACAD SCI USA, V106, P18551, DOI 10.1073/pnas.0903234106; Warner KD, 2018, NAT REV DRUG DISCOV, V17, P547, DOI 10.1038/nrd.2018.93; Wedekind JE, 2017, J BIOL CHEM, V292, P9441, DOI 10.1074/jbc.R117.787713; WEEKS KM, 1990, SCIENCE, V249, P1281, DOI 10.1126/science.2205002; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Ye XM, 1995, CHEM BIOL, V2, P827, DOI 10.1016/1074-5521(95)90089-6; ZACHARIAS M, 1995, P NATL ACAD SCI USA, V92, P6052, DOI 10.1073/pnas.92.13.6052; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	155	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9326	9341		10.1074/jbc.REV119.006860	http://dx.doi.org/10.1074/jbc.REV119.006860			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31080171	Green Published, hybrid			2022-12-28	WOS:000472713000002
J	Best, RL; LaPointe, NE; Liang, JH; Ruan, K; Shade, MF; Wilson, L; Feinstein, SC				Best, Rebecca L.; LaPointe, Nichole E.; Liang, Jiahao; Ruan, Kevin; Shade, Madeleine F.; Wilson, Leslie; Feinstein, Stuart C.			Tau isoform-specific stabilization of intermediate states during microtubule assembly and disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tau protein (tau); microtubule; microtubule-associated protein (MAP); tauopathy; neurodegeneration; neurodegenerative disease; Alzheimer disease; cytoskeleton; neurofibrillary tangle; neuronal protein	ALPHA-BETA-TUBULIN; SLOWLY HYDROLYZABLE ANALOG; DYNAMIC INSTABILITY; NEURITE OUTGROWTH; GTP HYDROLYSIS; DEPOLYMERIZATION PRODUCTS; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; STRUCTURAL TRANSITIONS; FTDP-17 MUTATIONS	The microtubule (MT)-associated protein tau regulates the critical growing and shortening behaviors of MTs, and its normal activity is essential for neuronal development and maintenance. Accordingly, aberrant tau action is tightly associated with Alzheimer's disease and is genetically linked to several additional neurodegenerative diseases known as tauopathies. Although tau is known to promote net MT growth and stability, the precise mechanistic details governing its regulation of MT dynamics remain unclear. Here, we have used the slowly-hydrolyzable GTP analog, guanylyl-(alpha,beta)-methylene-diphosphonate (GMPCPP), to examine the structural effects of tau at MT ends that may otherwise be too transient to observe. The addition of both four-repeat (4R) and three-repeat (3R) tau isoforms to pre-formed GMPCPP MTs resulted in the formation of extended, multiprotofilament-wide projections at MT ends. Furthermore, at temperatures too low for assembly of bona fide MTs, both tau isoforms promoted the formation of long spiral ribbons from GMPCPP tubulin heterodimers. In addition, GMPCPP MTs undergoing cold-induced disassembly in the presence of 4R tau (and to a much lesser extent 3R tau) also formed spirals. Finally, three pathological tau mutations known to cause neurodegeneration and dementia were differentially compromised in their abilities to stabilize MT disassembly intermediates. Taken together, we propose that tau promotes the formation/stabilization of intermediate states in MT assembly and disassembly by promoting both longitudinal and lateral tubulin-tubulin contacts. We hypothesize that these activities represent fundamental aspects of tau action that normally occur at the GTP-rich ends of GTP/GDP MTs and that may be compromised in neurodegeneration-causing tau variants.	[Best, Rebecca L.; LaPointe, Nichole E.; Liang, Jiahao; Ruan, Kevin; Shade, Madeleine F.; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA; [Best, Rebecca L.; LaPointe, Nichole E.; Liang, Jiahao; Ruan, Kevin; Shade, Madeleine F.; Wilson, Leslie] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Liang, Jiahao] Univ Calif San Francisco, Dept Pharmaceut Chem, 1700 4th St, San Francisco, CA 94158 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California San Francisco	Feinstein, SC (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA.	feinstei@lifesci.ucsb.edu		Ruan, Kevin/0000-0002-8319-3092; Best, Rebecca/0000-0001-7183-879X; Feinstein, Stuart/0000-0002-1662-6759; Liang, Jiahao/0000-0002-6701-4808	UCSB Academic Senate Research Grant; National Science Foundation [1650114]	UCSB Academic Senate Research Grant; National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by UCSB Academic Senate Research Grant 2017-2018 (to S.C.F.) and National Science Foundation Grant 1650114 (to R.L.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Best RL, 2017, METHOD CELL BIOL, V141, P3, DOI 10.1016/bs.mcb.2017.06.001; Breuzard G, 2013, J CELL SCI, V126, P2810, DOI 10.1242/jcs.120832; Brouhard GJ, 2014, J CELL BIOL, V207, P323, DOI 10.1083/jcb.201407095; Brunden KR, 2017, NEUROBIOL DIS, V105, P328, DOI 10.1016/j.nbd.2016.12.021; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Caudron N, 2002, J BIOL CHEM, V277, P50973, DOI 10.1074/jbc.M209753200; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Combs B, 2012, BIOCHEMISTRY-US, V51, P8597, DOI 10.1021/bi3010818; DeTure M, 2000, BRAIN RES, V853, P5, DOI 10.1016/S0006-8993(99)02124-1; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Duan AR, 2017, J MOL BIOL, V429, P1424, DOI 10.1016/j.jmb.2017.03.018; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; ERICKSON H P, 1974, Journal of Supramolecular Structure, V2, P393, DOI 10.1002/jss.400020228; ERICKSON HP, 1986, ANN NY ACAD SCI, V466, P552, DOI 10.1111/j.1749-6632.1986.tb38432.x; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; FRIGON RP, 1975, BIOCHEMISTRY-US, V14, P4559, DOI 10.1021/bi00692a001; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Goedert M, 2000, BBA-MOL BASIS DIS, V1502, P110, DOI 10.1016/S0925-4439(00)00037-5; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Guesdon A, 2016, NAT CELL BIOL, V18, P1102, DOI 10.1038/ncb3412; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; Hoog JL, 2011, J CELL SCI, V124, P693, DOI 10.1242/jcs.072967; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Janning D, 2014, MOL BIOL CELL, V25, P3541, DOI 10.1091/mbc.E14-06-1099; Janosi IM, 2002, BIOPHYS J, V83, P1317, DOI 10.1016/S0006-3495(02)73902-7; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1986, J MOL BIOL, V187, P61, DOI 10.1016/0022-2836(86)90406-7; Kadavath H, 2015, P NATL ACAD SCI USA, V112, P7501, DOI 10.1073/pnas.1504081112; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; KARR TL, 1980, J BIOL CHEM, V255, P8560; Kellogg EH, 2018, SCIENCE, V360, P1242, DOI 10.1126/science.aat1780; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; KIM H, 1986, ANN NY ACAD SCI, V466, P218, DOI 10.1111/j.1749-6632.1986.tb38396.x; KIRSCHNER M W, 1974, Journal of Supramolecular Structure, V2, P412, DOI 10.1002/jss.400020229; KIRSCHNER MW, 1975, ANN NY ACAD SCI, V253, P90, DOI 10.1111/j.1749-6632.1975.tb19195.x; KIRSCHNER MW, 1974, P NATL ACAD SCI USA, V71, P1159, DOI 10.1073/pnas.71.4.1159; KIRSCHNER MW, 1975, J MOL BIOL, V99, P263, DOI 10.1016/S0022-2836(75)80144-6; KIRSCHNER MW, 1986, NATURE, V324, P621, DOI 10.1038/324621a0; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Kutter S, 2016, J MOL BIOL, V428, P1742, DOI 10.1016/j.jmb.2016.03.010; Leboeuf AC, 2008, J BIOL CHEM, V283, P36406, DOI 10.1074/jbc.M803519200; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Li XH, 2017, BIOPHYS J, V112, P2567, DOI 10.1016/j.bpj.2017.05.006; Li XH, 2015, J AM CHEM SOC, V137, P9218, DOI 10.1021/jacs.5b04561; Liu CWA, 1999, CELL MOTIL CYTOSKEL, V43, P232, DOI 10.1002/(SICI)1097-0169(1999)43:3<232::AID-CM6>3.0.CO;2-7; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Margolin G, 2012, MOL BIOL CELL, V23, P642, DOI 10.1091/mbc.E11-08-0688; Martinho M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32096-9; Maurer SP, 2014, CURR BIOL, V24, P372, DOI 10.1016/j.cub.2013.12.042; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; Miller HP, 2010, METHOD CELL BIOL, V95, P3, DOI 10.1016/S0091-679X(10)95001-2; Mozziconacci J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003821; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nagiec EE, 2001, J NEUROSCI RES, V63, P268, DOI 10.1002/1097-4547(20010201)63:3<268::AID-JNR1020>3.0.CO;2-E; Odde DJ, 1999, J CELL SCI, V112, P3283; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Roostalu J, 2017, NAT REV MOL CELL BIO, V18, P702, DOI 10.1038/nrm.2017.75; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; SANDOVAL IV, 1980, J BIOL CHEM, V255, P8952; SANDOVAL IV, 1981, J BIOL CHEM, V256, P8795; SANDOVAL IV, 1978, P NATL ACAD SCI USA, V75, P3178, DOI 10.1073/pnas.75.7.3178; SANDOVAL IV, 1977, P NATL ACAD SCI USA, V74, P4881, DOI 10.1073/pnas.74.11.4881; SANDOVAL IV, 1980, J BIOL CHEM, V255, P6966; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Sept D, 2003, PROTEIN SCI, V12, P2257, DOI 10.1110/ps.03187503; SINGER WD, 1989, MOL PHARMACOL, V36, P366; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Spillantini MG, 2000, NEUROGENETICS, V2, P193, DOI 10.1007/s100480050065; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Stumpff Jason, 2007, Methods Mol Biol, V392, P37; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tran PT, 1997, J CELL BIOL, V138, P105, DOI 10.1083/jcb.138.1.105; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Vorobjev IA, 1997, J CELL SCI, V110, P2635; VOTER WA, 1984, J BIOL CHEM, V259, P430; Wang HW, 2005, CELL CYCLE, V4, P1157, DOI 10.4161/cc.4.9.2042; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WatermanStorer CM, 1997, CURR BIOL, V7, pR369, DOI 10.1016/S0960-9822(06)00177-1; WEINGARTEN MD, 1974, BIOCHEMISTRY-US, V13, P5529, DOI 10.1021/bi00724a012; WILSON L, 1982, J MOL BIOL, V159, P125, DOI 10.1016/0022-2836(82)90035-3; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012	118	5	5	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12265	12280		10.1074/jbc.RA119.009124	http://dx.doi.org/10.1074/jbc.RA119.009124			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31266806	Green Published, hybrid			2022-12-28	WOS:000484402700001
J	Liang, S; Zhong, ZY; Kim, SY; Uchiyama, R; Roh, YS; Matsushita, H; Gottlieb, RA; Seki, E				Liang, Shuang; Zhong, Zhenyu; Kim, So Yeon; Uchiyama, Ryosuke; Roh, Yoon Seok; Matsushita, Hiroshi; Gottlieb, Roberta A.; Seki, Ekihiro			Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alcohol; inflammasome; macrophage; autophagy; chemokine; Toll-like receptor 4 (TLR4); cytokine; alcoholic liver disease; CC-chemokine ligand 10; CC-chemokine ligand 5; dysbiosis; innate immunity	INFLAMMASOME ACTIVATION; INNATE IMMUNITY; STEATOHEPATITIS; DISEASE; CONTRIBUTE; CROSSTALK; CELLS	Excessive alcohol consumption induces intestinal dysbiosis of the gut microbiome and reduces gut epithelial integrity. This often leads to portal circulation-mediated translocation of gut-derived microbial products, such as lipopolysaccharide (LPS), to the liver, where these products engage Toll-like receptor 4 (TLR4) and initiate hepatic inflammation, which promotes alcoholic liver disease (ALD). Although the key self-destructive process of autophagy has been well-studied in hepatocytes, its role in macrophages during ALD pathogenesis remains elusive. Using WT and myeloid cell-specific autophagy-related 7 (Atg7) knockout (Atg7(Delta Mye)) mice, we found that chronic ethanol feeding for 6 weeks plus LPS injection enhances serum alanine aminotransferase and IL-1 beta levels and augments hepatic C-C motif chemokine ligand 5 (CCL5) and C-X-C motif chemokine ligand 10 (CXCL10) expression in WT mice, a phenotype that was further exacerbated in Atg7(Delta Mye) mice. Atg7(Delta Mye) macrophages exhibited defective mitochondrial respiration and displayed elevated mitochondrial reactive oxygen species production and inflammasome activation relative to WT cells. Interestingly, compared with WT cells, Atg7(Delta Mye) macrophages also had a drastically increased abundance and nuclear translocation of interferon regulatory factor 1 (IRF1) after LPS stimulation. Mechanistically, LPS induced co-localization of IRF1 with the autophagy adaptor p62 and the autophagosome, resulting in subsequent IRF1 degradation. However, upon p62 silencing or Atg7 deletion, IRF1 started to accumulate in autophagy-deficient macrophages and translocated into the nucleus, where it induced CCL5 and CXCL10 expression. In conclusion, macrophage autophagy protects against ALD by promoting IRF1 degradation and removal of damaged mitochondria, limiting macrophage activation and inflammation.	[Liang, Shuang] Univ Calif San Diego, Dept Med, Div Gastroenterol, Sch Med, La Jolla, CA 92093 USA; [Kim, So Yeon; Uchiyama, Ryosuke; Roh, Yoon Seok; Matsushita, Hiroshi; Seki, Ekihiro] Cedars Sinai Med Ctr, Dept Med, Div Digest & Liver Dis, Los Angeles, CA 90048 USA; [Gottlieb, Roberta A.; Seki, Ekihiro] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Gottlieb, Roberta A.] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Liang, Shuang; Zhong, Zhenyu] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Roh, Yoon Seok] Chungbuk Natl Univ, Dept Pharm, Coll Pharm, Cheongju 28160, Chungbuk, South Korea	University of California System; University of California San Diego; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chungbuk National University	Seki, E (corresponding author), Cedars Sinai Med Ctr, Davis Bldg 2099,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	Ekihiro.Seki@cshs.org	Seki, Ekihiro/K-2481-2016	Seki, Ekihiro/0000-0002-9472-6085; Zhong, Zhenyu/0000-0002-9441-7645	National Institute on Alcohol Abuse and Alcoholism [R01AA027036, R21AA025841]; NIDDK, National Institutes of Health [R01DK085252]; American Liver Foundation Congressman John Joseph Moakley postdoctoral research fellowship; National Research Foundation of Korea [2017R1C1B2004423]; Cedars-Sinai Medical Center Winnick Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA027036, R21AA025841] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Liver Foundation Congressman John Joseph Moakley postdoctoral research fellowship; National Research Foundation of Korea(National Research Foundation of Korea); Cedars-Sinai Medical Center Winnick Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institute on Alcohol Abuse and Alcoholism Grants R01AA027036 and R21AA025841 (to E.S.); NIDDK, National Institutes of Health Grant R01DK085252 (to E.S.); an American Liver Foundation Congressman John Joseph Moakley postdoctoral research fellowship (to Y.S.R.); National Research Foundation of Korea Grant 2017R1C1B2004423 (to Y.S.R.); and a Cedars-Sinai Medical Center Winnick Research Award (to E.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Enomoto N, 2001, ALCOHOL CLIN EXP RES, V25, P1360, DOI 10.1111/j.1530-0277.2001.tb02359.x; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Ilyas G, 2016, J HEPATOL, V64, P118, DOI 10.1016/j.jhep.2015.08.019; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Li Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/498491; Liu K, 2015, AUTOPHAGY, V11, P271, DOI 10.1080/15548627.2015.1009787; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Mandal P, 2010, WORLD J GASTROENTERO, V16, P1330, DOI 10.3748/wjg.v16.i11.1330; Mandrekar P, 2009, J IMMUNOL, V183, P1320, DOI 10.4049/jimmunol.0803206; Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Petrasek J, 2011, HEPATOLOGY, V53, P649, DOI 10.1002/hep.24059; Roh YS, 2015, AM J PHYSIOL-GASTR L, V309, pG30, DOI 10.1152/ajpgi.00031.2015; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Szabo G, 2012, DIGEST DIS, V30, P55, DOI 10.1159/000341126; Thomes PG, 2015, ALCOHOL CLIN EXP RES, V39, P2354, DOI 10.1111/acer.12904; Tsutsui H, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/641865; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; von Haefen C, 2011, ALCOHOL CLIN EXP RES, V35, P1381, DOI 10.1111/j.1530-0277.2011.01473.x; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057	32	16	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12359	12369		10.1074/jbc.RA119.007409	http://dx.doi.org/10.1074/jbc.RA119.007409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31235522	Green Published, hybrid			2022-12-28	WOS:000484402700009
J	Jaroensuk, J; Intasian, P; Kiattisewee, C; Munkajohnpon, P; Chunthaboon, P; Buttranon, S; Trisrivirat, D; Wongnate, T; Maenpuen, S; Tinikul, R; Chaiyen, P				Jaroensuk, Juthamas; Intasian, Pattarawan; Kiattisewee, Cholpisit; Munkajohnpon, Pobthum; Chunthaboon, Paweenapon; Buttranon, Supacha; Trisrivirat, Duangthip; Wongnate, Thanyaporn; Maenpuen, Somchart; Tinikul, Ruchanok; Chaiyen, Pimchai			Addition of formate dehydrogenase increases the production of renewable alkane from an engineered metabolic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dehydrogenase; biofuel; metabolic engineering; synthetic biology; bioenergy; enzyme; aldehyde deformylating oxygenase; alkane; formate dehydrogenase; hydrocarbon; renewables; substrate inhibition	ALDEHYDE-DEFORMYLATING OXYGENASE; CYANOBACTERIAL ALDEHYDE; REDUCTASE; ENZYME; FERREDOXIN; FLAVODOXIN; PH; BIOSYNTHESIS; CONFORMATION; CONVERSION	An engineered metabolic pathway consisting of reactions that convert fatty acids to aldehydes and eventually alkanes would provide a means to produce biofuels from renewable energy sources. The enzyme aldehyde-deformylating oxygenase (ADO) catalyzes the conversion of aldehydes and oxygen to alkanes and formic acid and uses oxygen and a cellular reductant such as ferredoxin (Fd) as co-substrates. In this report, we aimed to increase ADO-mediated alkane production by converting an unused by-product, formate, to a reductant that can be used by ADO. We achieved this by including the gene (fdh), encoding formate dehydrogenase from Xanthobacter sp. 91 (XaFDH), into a metabolic pathway expressed in Escherichia coli. Using this approach, we could increase bacterial alkane production, resulting in a conversion yield of similar to 50%, the highest yield reported to date. Measuring intracellular nicotinamide concentrations, we found that E. coli cells harboring XaFDH have a significantly higher concentration of NADH and a higher NADH/NAD(+) ratio than E. coli cells lacking XaFDH. In vitro analysis disclosed that ferredoxin (flavodoxin):NADP(+) oxidoreductase could use NADH to reduce Fd and thus facilitate ADO-mediated alkane production. As formic acid can decrease the cellular pH, the addition of formate dehydrogenase could also maintain the cellular pH in the neutral range, which is more suitable for alkane production. We conclude that this simple, dual-pronged approach of increasing NAD(P)H and removing extra formic acid is efficient for increasing the production of renewable alkanes via synthetic biology-based approaches.	[Jaroensuk, Juthamas; Intasian, Pattarawan; Kiattisewee, Cholpisit; Munkajohnpon, Pobthum; Buttranon, Supacha; Wongnate, Thanyaporn; Chaiyen, Pimchai] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Wangchan Valley 21210, Rayong, Thailand; [Munkajohnpon, Pobthum; Chunthaboon, Paweenapon; Trisrivirat, Duangthip; Tinikul, Ruchanok] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 14000, Thailand; [Munkajohnpon, Pobthum; Chunthaboon, Paweenapon; Trisrivirat, Duangthip; Tinikul, Ruchanok] Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok 14000, Thailand; [Maenpuen, Somchart] Burapha Univ, Fac Sci, Dept Biochem, Chon Buri 20131, Thailand	Vidyasirimedhi Institute of Science & Technology; Mahidol University; Mahidol University; Burapha University	Chaiyen, P (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Wangchan Valley 21210, Rayong, Thailand.	pimchai.chaiyen@vistec.ac.th		Trisrivirat, Duangthip/0000-0003-0079-4739; Kiattisewee, Cholpisit/0000-0002-6351-7352; Maenpuen, Somchart/0000-0001-7770-4178; Intasian, Pattarawan/0000-0001-6623-8108	Thailand Research Fund [RTA5980001, MRG6180151, MRG6080234, MRG5980001]; Vidyasirimedhi Institute of Science and Technology (VISTEC)	Thailand Research Fund(Thailand Research Fund (TRF)); Vidyasirimedhi Institute of Science and Technology (VISTEC)	This work was supported by Thailand Research Fund Grants RTA5980001 (to P. Chaiyen), MRG6180151 (to R. T.), MRG6080234 (to T. W.), and MRG5980001 (to S. M.) and a grant from Vidyasirimedhi Institute of Science and Technology (VISTEC) (to J. J., P. I., C. K., S. B., T. W., and P. Chaiyen). Patent Application No. TH1801003340 (alkane production using the engineered metabolic pathway) was filed to the Department of Intellectual Property, Thailand.	Akhtar MK, 2013, P NATL ACAD SCI USA, V110, P87, DOI 10.1073/pnas.1216516110; Alpdagtas S, 2018, BIOTECHNOL LETT, V40, P1135, DOI 10.1007/s10529-018-2568-6; Andre C, 2013, P NATL ACAD SCI USA, V110, P3191, DOI 10.1073/pnas.1218769110; ASANO Y, 1988, J BACTERIOL, V170, P3189, DOI 10.1128/jb.170.7.3189-3193.1988; Bao LY, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0596-9; Bhatt AN, 2005, PROTEIN SCI, V14, P980, DOI 10.1110/ps.041162705; Bommarius AS, 1995, TETRAHEDRON-ASYMMETR, V6, P2851, DOI 10.1016/0957-4166(95)00377-0; BOTTIN H, 1992, BIOCHIM BIOPHYS ACTA, V1101, P48, DOI 10.1016/0167-4838(92)90465-P; Cao YX, 2015, METAB ENG, V29, P113, DOI 10.1016/j.ymben.2015.03.005; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536; CLARK DP, 1989, FEMS MICROBIOL LETT, V63, P223, DOI 10.1111/j.1574-6968.1989.tb03398.x; Coursolle D, 2015, MOL BIOSYST, V11, P2464, DOI 10.1039/c5mb00268k; Eser BE, 2011, BIOCHEMISTRY-US, V50, P10743, DOI 10.1021/bi2012417; Fillet S, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2099-z; Galkin A, 1995, APPL MICROBIOL BIOT, V44, P479, DOI 10.1007/BF00169947; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Harger M, 2013, ACS SYNTH BIOL, V2, P59, DOI 10.1021/sb300061x; Hatrongjit R, 2010, ENZYME MICROB TECH, V46, P557, DOI 10.1016/j.enzmictec.2010.03.002; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Ho DP, 2014, BIORESOURCE TECHNOL, V169, P742, DOI 10.1016/j.biortech.2014.07.022; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Kallio P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5731; Khara B, 2013, CHEMBIOCHEM, V14, P1204, DOI 10.1002/cbic.201300307; Leadbeater C, 2000, BIOCHEM J, V352, P257, DOI 10.1042/0264-6021:3520257; Lee SY, 2019, NAT CATAL, V2, P18, DOI 10.1038/s41929-018-0212-4; Lee YH, 2007, J BIOL CHEM, V282, P5959, DOI 10.1074/jbc.M608417200; Li N, 2011, J AM CHEM SOC, V133, P6158, DOI 10.1021/ja2013517; Liao JC, 2016, NAT REV MICROBIOL, V14, P288, DOI 10.1038/nrmicro.2016.32; Lu K, 2014, MATERIALS IN ENERGY CONVERSION, HARVESTING, AND STORAGE, P1; Lynd LR, 2017, NAT BIOTECHNOL, V35, P912, DOI 10.1038/nbt.3976; Menon N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0231-1; Mesentsev AV, 1997, BIOCHEM J, V321, P475, DOI 10.1042/bj3210475; Nozzi NE, 2014, METAB ENG, V25, P174, DOI 10.1016/j.ymben.2014.07.007; Pandelia ME, 2013, J AM CHEM SOC, V135, P15801, DOI 10.1021/ja405047b; Patrikainen Pekka, 2017, Metab Eng Commun, V5, P9, DOI 10.1016/j.meteno.2017.05.001; Paul B, 2013, J AM CHEM SOC, V135, P5234, DOI 10.1021/ja3115949; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Rajakovich LJ, 2015, J AM CHEM SOC, V137, P11695, DOI 10.1021/jacs.5b06345; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200; Sheil D., 2009, IMPACTS OPPORTUNITIE, DOI [10.17528/cifor/002792, DOI 10.17528/CIFOR/002792]; Tishkov VI, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1252, DOI 10.1007/s10541-005-0071-x; TISHKOV VI, 1993, BIOCHEM BIOPH RES CO, V192, P976, DOI 10.1006/bbrc.1993.1511; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; van den Heuvel RHH, 2003, J MOL BIOL, V330, P113, DOI 10.1016/S0022-2836(03)00522-9; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x; Waugh MW, 2014, BIOCHEMISTRY-US, V53, P5537, DOI 10.1021/bi5005766; Wiener MC, 2011, P NATL ACAD SCI USA, V108, P10929, DOI 10.1073/pnas.1106927108; Willis RM, 2011, BIOCHEMISTRY-US, V50, P10550, DOI 10.1021/bi2008646; Yeom J, 2012, BMB REP, V45, P476, DOI 10.5483/BMBRep.2012.45.8.071; Zhou YJ, 2018, NAT ENERGY, V3, P925, DOI 10.1038/s41560-018-0197-x	52	12	12	6	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11536	11548		10.1074/jbc.RA119.008246	http://dx.doi.org/10.1074/jbc.RA119.008246			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31182484	Green Published, hybrid			2022-12-28	WOS:000478717600016
J	Pestoni, JC; Plati, SK; Camacho, ODV; Fuse, MA; Onatunde, M; Sparrow, NA; Karajannis, MA; Fernandez-Valle, C; Franco, MC				Pestoni, Jeanine C.; Plati, Stephani Klingeman; Camacho, Oliver D. Valdivia; Fuse, Marisa A.; Onatunde, Maria; Sparrow, Nicklaus A.; Karajannis, Matthias A.; Fernandez-Valle, Cristina; Franco, Maria Clara			Peroxynitrite supports a metabolic reprogramming in merlin-deficient Schwann cells and promotes cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Schwann cells; redox signaling; bioenergetics; energy metabolism; tumor metabolism; merlin; neurofibromatosis; nitration; peroxynitrite; schwannoma	NITRIC-OXIDE SYNTHASE; TYROSINE NITRATION; SIGNALING PATHWAYS; INDUCED APOPTOSIS; CANCER; EXPRESSION; SUPEROXIDE; PROTEIN; GROWTH; GENE	Neurofibromatosis type 2 (NF2) is an autosomal-dominant disorder characterized by the development of bilateral vestibular schwannomas. The NF2 gene encodes the tumor suppressor merlin, and loss of merlin activity promotes tumorigenesis and causes NF2. Cellular redox signaling has been implicated in different stages of tumor development. Among reactive nitrogen species, peroxynitrite is the most powerful oxidant produced by cells. We recently showed that peroxynitrite-mediated tyrosine nitration down-regulates mitochondrial metabolism in tumor cells. However, whether peroxynitrite supports a metabolic shift that could be exploited for therapeutic development is unknown. Here, we show that vestibular schwannomas from NF2 patients and human, merlin-deficient (MD) Schwann cells have high levels of endogenous tyrosine nitration, indicating production of peroxynitrite. Furthermore, scavenging or inhibiting peroxynitrite formation significantly and selectively decreased survival of human and mouse MD-Schwann cells. Using multiple complementary methods, we also found that merlin deficiency leads to a reprogramming of energy metabolism characterized by a peroxynitrite-dependent decrease of oxidative phosphorylation and increased glycolysis and glutaminolysis. In MD-Schwann cells, scavenging of peroxynitrite increased mitochondrial oxygen consumption and membrane potential, mediated by the up-regulation of the levels and activity of mitochondrial complex IV. This increase in mitochondrial activity correlated with a decrease in the glycolytic rate and glutamine dependence. This is the first demonstration of a peroxynitrite-dependent reprogramming of energy metabolism in tumor cells. Oxidized proteins constitute a novel target for therapeutic development not only for the treatment of NF2 schwannomas but also other tumors in which peroxynitrite plays a regulatory role.	[Pestoni, Jeanine C.; Camacho, Oliver D. Valdivia; Franco, Maria Clara] Oregon State Univ, Coll Sci, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Plati, Stephani Klingeman; Fuse, Marisa A.; Onatunde, Maria; Sparrow, Nicklaus A.; Fernandez-Valle, Cristina] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Karajannis, Matthias A.] NYU, Langone Hlth, Dept Pediat & Otolaryngol, 550 1St Ave, New York, NY 10016 USA; [Karajannis, Matthias A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA	Oregon State University; State University System of Florida; University of Central Florida; New York University; Memorial Sloan Kettering Cancer Center	Franco, MC (corresponding author), Oregon State Univ, 2011 ALS Bldg, Corvallis, OR 97331 USA.	maria.franco@oregonstate.edu	Karajannis, Matthias A/H-8845-2019	Karajannis, Matthias A/0000-0002-7151-6528	Office of the Assistant Secretary of Defense for Health Affairs, through the Neurofibromatosis Research Program (NRP) [W81XWH-17-1-0409, W81XWH-15-1-0446]; NINDS, National Institutes of Health [R01NS102479]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102479] Funding Source: NIH RePORTER	Office of the Assistant Secretary of Defense for Health Affairs, through the Neurofibromatosis Research Program (NRP); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Neurofibromatosis Research Program (NRP), New Investigator Award (NIA) W81XWH-17-1-0409 (to M. C. F.), Investigator Initiated Research Award (IIRA) W81XWH-15-1-0446 (to C. F. V.), and NINDS, National Institutes of Health Grant R01NS102479 (to M. C. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and Department of Defense.	Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Ammoun S, 2010, NEURO-ONCOLOGY, V12, P834, DOI 10.1093/neuonc/noq012; Asthagiri AR, 2009, LANCET, V373, P1974, DOI 10.1016/S0140-6736(09)60259-2; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; BORRELLO S, 1993, MOL ASPECTS MED, V14, P253, DOI 10.1016/0098-2997(93)90012-3; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Chiasson-MacKenzie C, 2015, J CELL BIOL, V211, P391, DOI 10.1083/jcb.201503081; Cobbs CS, 2001, ARCH BIOCHEM BIOPHYS, V394, P167, DOI 10.1006/abbi.2001.2540; Corbet C, 2017, BBA-REV CANCER, V1868, P7, DOI 10.1016/j.bbcan.2017.01.002; Diaz B, 2012, FREE RADICAL BIO MED, V52, P247, DOI 10.1016/j.freeradbiomed.2011.09.016; DIONISI O, 1975, BIOCHIM BIOPHYS ACTA, V403, P292, DOI 10.1016/0005-2744(75)90059-5; Domazou AS, 2012, FREE RADICAL BIO MED, V52, P1929, DOI 10.1016/j.freeradbiomed.2012.02.045; Ekmekcioglu S, 2006, INT J CANCER, V119, P861, DOI 10.1002/ijc.21767; Feichtinger RG, 2016, NEURO-ONCOLOGY, V18, P184, DOI 10.1093/neuonc/nov105; Feng S, 2018, P NATL ACAD SCI USA, V115, P10094, DOI 10.1073/pnas.1800695115; Ferrer-Sueta G, 2018, CHEM REV, V118, P462, DOI 10.1021/acs.chemrev.7b00568; Finocchietto P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001749; Franco MC, 2015, J BIOL CHEM, V290, P19055, DOI 10.1074/jbc.M115.663278; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Franco MC, 2006, J BIOL CHEM, V281, P4779, DOI 10.1074/jbc.M512080200; Gochman E, 2012, ACTA HISTOCHEM, V114, P827, DOI 10.1016/j.acthis.2012.02.004; Gow A, 1996, ARCH BIOCHEM BIOPHYS, V333, P42, DOI 10.1006/abbi.1996.0362; Guerrant W, 2016, CANCER RES, V76, P3507, DOI 10.1158/0008-5472.CAN-15-1144; HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607; Hermann B, 2005, ARCH SURG-CHICAGO, V140, P1204, DOI 10.1001/archsurg.140.12.1204; Houshmandi SS, 2009, MOL CELL BIOL, V29, P1472, DOI 10.1128/MCB.01392-08; Ino D, 2017, CELL MOL LIFE SCI, V74, P827, DOI 10.1007/s00018-016-2364-1; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Klotz T, 1998, CANCER, V82, P1897, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1897::AID-CNCR12>3.0.CO;2-O; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; MacMillan-Crow LA, 2000, ARCH BIOCHEM BIOPHYS, V377, P350, DOI 10.1006/abbi.2000.1799; McAninch EA, 2015, ENDOCRINOLOGY, V156, P4325, DOI 10.1210/en.2015-1221; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Nakamura Y, 2006, CLIN CANCER RES, V12, P1201, DOI 10.1158/1078-0432.CCR-05-1269; Oberley LW, 2001, ANTIOXID REDOX SIGN, V3, P461, DOI 10.1089/15230860152409095; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Pannunzio ME, 2005, J NEUROSCI METH, V149, P74, DOI 10.1016/j.jneumeth.2005.05.004; Petrilli A, 2014, ONCOGENE, V33, P3571, DOI 10.1038/onc.2013.320; Petrilli AM, 2016, ONCOGENE, V35, P537, DOI 10.1038/onc.2015.125; Petrilli AM, 2018, METHODS MOL BIOL, V1739, P161, DOI 10.1007/978-1-4939-7649-2_11; Petrilli AM, 2017, ONCOTARGET, V8, P31666, DOI 10.18632/oncotarget.15912; Petrilli AM, 2014, AM J TRANSL RES, V6, P471; Pinzar E, 2005, FEBS LETT, V579, P5100, DOI 10.1016/j.febslet.2005.08.019; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Schulz A, 2016, ACTA NEUROPATHOL, V132, P289, DOI 10.1007/s00401-016-1583-8; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1506, DOI 10.1038/sj.cdd.4401831; Squadrito GL, 2000, ARCH BIOCHEM BIOPHYS, V376, P333, DOI 10.1006/abbi.2000.1721; Srinivasan S, 2016, ONCOGENE, V35, P1585, DOI 10.1038/onc.2015.227; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Stepanova DS, 2017, CANCER RES, V77, P5026, DOI 10.1158/0008-5472.CAN-16-2834; Still ER, 2017, BRIT J CANCER, V116, P1375, DOI 10.1038/bjc.2017.113; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Teng RJ, 2002, FREE RADICAL BIO MED, V33, P1243, DOI 10.1016/S0891-5849(02)01020-1; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Vakkala M, 2000, CLIN CANCER RES, V6, P2408; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; Viader A, 2011, J NEUROSCI, V31, P10128, DOI 10.1523/JNEUROSCI.0884-11.2011; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200; Ye YZ, 1996, METHOD ENZYMOL, V269, P201; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang W, 2011, HUM PATHOL, V42, P1275, DOI 10.1016/j.humpath.2010.09.020	70	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11354	11368		10.1074/jbc.RA118.007152	http://dx.doi.org/10.1074/jbc.RA118.007152			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31171721	hybrid, Green Published			2022-12-28	WOS:000478717600001
J	Wan, Y; Liu, CS; Ma, QJ				Wan, Ye; Liu, Changshui; Ma, Qingjun			Structural analysis of a Vibrio phospholipase reveals an unusual Ser-His-chloride catalytic triad	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phospholipase; virulence factor; enzyme mechanism; bacterial pathogenesis; glycerophospholipid; catalytic triad; chloride; SGNH hydrolase superfamily; thermolabile hemolysin; Vibrio	CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; PHOTOSYSTEM-II; UNIQUE FOLD; STRUCTURE REFINEMENT; BOVINE TRYPSIN; PROTEASE FOLD; ACTIVE-SITE; ENZYME; FAMILY	Phospholipases can disrupt host membranes and are important virulence factors in many pathogens. VvPlpA is a phospholipase A(2) secreted by Vibrio vulnificus and essential for virulence. Its homologs, termed thermolabile hemolysins (TLHs), are widely distributed in Vibrio bacteria, but no structural information for this virulence factor class is available. Herein, we report the crystal structure of VvPlpA to 1.4-angstrom resolution, revealing that VvPlpA contains an N-terminal domain of unknown function and a C-terminal phospholipase domain and that these two domains are packed closely together. The phospholipase domain adopts a typical SGNH hydrolase fold, containing the four conserved catalytic residues Ser, Gly, Asn, and His. Interestingly, the structure also disclosed that the phospholipase domain accommodates a chloride ion near the catalytic His residue. The chloride is five-coordinated in a distorted bipyramid geometry, accepting hydrogen bonds from a water molecule and the amino groups of surrounding residues. This chloride substitutes for the most common Asp/Glu residue and forms an unusual Ser-His-chloride catalytic triad in VvPlpA. The chloride may orient the catalytic His and stabilize the charge on its imidazole ring during catalysis. Indeed, VvPlpA activity depended on chloride concentration, confirming the important role of chloride in catalysis. The VvPlpA structure also revealed a large hydrophobic substrate-binding pocket that is capable of accommodating a long-chain acyl group. Our results provide the first structure of the TLH family and uncover an unusual Ser-His-chloride catalytic triad, expanding our knowledge on the biological role of chloride.	[Wan, Ye; Liu, Changshui; Ma, Qingjun] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Shandong, Peoples R China; [Wan, Ye; Liu, Changshui; Ma, Qingjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Shandong, Peoples R China; [Wan, Ye; Ma, Qingjun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Ma, Qingjun] Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao 266071, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Ma, QJ (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Shandong, Peoples R China.; Ma, QJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Shandong, Peoples R China.; Ma, QJ (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Ma, QJ (corresponding author), Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao 266071, Shandong, Peoples R China.	qma@qdio.ac.cn		Liu, Changshui/0000-0002-1210-6043	1000 Talents Program; "100 Talents Program" of the Chinese Academy of Sciences; "AoShan Talents Program" of Qingdao National Laboratory for Marine Science and Technology [2015ASTP]; Qingdao Innovation Leadership Program [18-1-2-12-zhc]	1000 Talents Program; "100 Talents Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); "AoShan Talents Program" of Qingdao National Laboratory for Marine Science and Technology; Qingdao Innovation Leadership Program	This work was supported by the "1000 Talents Program," "100 Talents Program" of the Chinese Academy of Sciences, "AoShan Talents Program" of Qingdao National Laboratory for Marine Science and Technology (Grant 2015ASTP), and "Qingdao Innovation Leadership Program" (Grant 18-1-2-12-zhc). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Asler IL, 2017, ACS CHEM BIOL, V12, P1928, DOI 10.1021/acschembio.6b01140; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Berend K, 2012, EUR J INTERN MED, V23, P203, DOI 10.1016/j.ejim.2011.11.013; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Carugo O, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0019-8; Chen P, 1996, CELL, V86, P835, DOI 10.1016/S0092-8674(00)80157-9; Comellas-Bigler M, 2002, STRUCTURE, V10, P865, DOI 10.1016/S0969-2126(02)00772-4; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; CRITCHLEY C, 1985, BIOCHIM BIOPHYS ACTA, V811, P33, DOI 10.1016/0304-4173(85)90004-7; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Stasio E, 2004, BIOPHYS CHEM, V112, P245, DOI 10.1016/j.bpc.2004.07.026; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller G, 1996, J BIOL CHEM, V271, P23836, DOI 10.1074/jbc.271.39.23836; FELLER G, 1994, EUR J BIOCHEM, V222, P441, DOI 10.1111/j.1432-1033.1994.tb18883.x; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Fiore AE, 1997, INFECT IMMUN, V65, P3112, DOI 10.1128/IAI.65.8.3112-3117.1997; Flores-Diaz M, 2016, MICROBIOL MOL BIOL R, V80, P597, DOI 10.1128/MMBR.00082-15; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hakansson K, 2000, P NATL ACAD SCI USA, V97, P14097, DOI 10.1073/pnas.260376797; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; HUBER R, 1974, J MOL BIOL, V89, P73, DOI 10.1016/0022-2836(74)90163-6; Ishida T, 2004, J AM CHEM SOC, V126, P7111, DOI 10.1021/ja030405u; Jang KK, 2017, J BIOL CHEM, V292, P17129, DOI 10.1074/jbc.M117.791657; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee JH, 2002, BIOCHEM BIOPH RES CO, V298, P269, DOI 10.1016/S0006-291X(02)02434-8; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Li L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-271; Liu XF, 2001, J BIOL CHEM, V276, P33518, DOI 10.1074/jbc.M101495200; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; Masuyer G, 2014, BIOL CHEM, V395, P1135, DOI 10.1515/hsz-2014-0157; MATTHEWS BW, 1967, NATURE, V214, P652, DOI 10.1038/214652a0; Maurus R, 2005, PROTEIN SCI, V14, P743, DOI 10.1110/ps.041079305; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Murray JW, 2008, PHOTOSYNTH RES, V98, P523, DOI 10.1007/s11120-008-9366-2; Nachon F, 2005, BIOCHEMISTRY-US, V44, P1154, DOI 10.1021/bi048238d; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Pokhrel R, 2011, BIOCHEMISTRY-US, V50, P2725, DOI 10.1021/bi2000388; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Qiu XY, 1996, NATURE, V383, P275, DOI 10.1038/383275a0; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHRAG JD, 1991, NATURE, V351, P761, DOI 10.1038/351761a0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shieh HS, 1996, NATURE, V383, P279, DOI 10.1038/383279a0; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Siegbahn PEM, 2009, DALTON T, P10063, DOI 10.1039/b909470a; Sitkiewicz I, 2006, P NATL ACAD SCI USA, V103, P16009, DOI 10.1073/pnas.0607669103; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; STROUD RM, 1974, J MOL BIOL, V83, P185, DOI 10.1016/0022-2836(74)90387-8; Sun BG, 2007, J BACTERIOL, V189, P2575, DOI 10.1128/JB.01650-06; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tong L, 1996, NATURE, V383, P272, DOI 10.1038/383272a0; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wang ZJ, 2016, J SYNCHROTRON RADIAT, V23, P1323, DOI 10.1107/S160057751601451X; Wilson CS, 2019, NEUROSCI LETT, V689, P33, DOI 10.1016/j.neulet.2018.01.012; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wlodawer A, 2001, NAT STRUCT BIOL, V8, P442, DOI 10.1038/87610; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172; Zhong YB, 2006, INFECT IMMUN, V74, P6001, DOI 10.1128/IAI.00512-06	77	17	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11391	11401		10.1074/jbc.RA119.008280	http://dx.doi.org/10.1074/jbc.RA119.008280			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31073025	hybrid, Green Published			2022-12-28	WOS:000478717600004
J	Bradberry, MM; Bao, H; Lou, XC; Chapman, ER				Bradberry, Mazdak M.; Bao, Huan; Lou, Xiaochu; Chapman, Edwin R.			Phosphatidylinositol 4,5-bisphosphate drives Ca2+-independent membrane penetration by the tandem C2 domain proteins synaptotagmin-1 and Doc2 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						synaptotagmin; synapse; exocytosis; calcium-binding protein; membrane biophysics; membrane protein; calcium sensor; phosphatidylinositol (4; 5)-bisphosphate (PIP2); poly-anionic phospholipid; tandem C2 domain protein	CA2+ SENSOR; SECRETION; DOC2B; EXOCYTOSIS; INCREASES; AFFINITY; RELEASE; FUSION; DEPTH; CELLS	Exocytosis mediates the release of neurotransmitters and hormones from neurons and neuroendocrine cells. Tandem C2 domain proteins in the synaptotagmin (syt) and double C2 domain (Doc2) families regulate exocytotic membrane fusion via direct interactions with Ca2+ and phospholipid bilayers. Syt1 is a fast-acting, low-affinity Ca2+ sensor that penetrates membranes upon binding Ca2+ to trigger synchronous vesicle fusion. The closely related Doc2 beta is a slow-acting, high-affinity Ca2+ sensor that triggers spontaneous and asynchronous vesicle fusion, but whether it also penetrates membranes is unknown. Both syt1 and Doc2 beta bind the dynamically regulated plasma membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2), but it is unclear whether PIP2 serves only as a membrane contact or enables specialized membrane-binding modes by these Ca2+ sensors. Furthermore, it has been shown that PIP2 uncaging can trigger rapid, syt1-dependent exocytosis in the absence of Ca2+ influx, suggesting that current models for the action of these Ca2+ sensors are incomplete. Here, using a series of steady-state and time-resolved fluorescence measurements, we show that Doc2 beta, like syt1, penetrates membranes in a Ca2+-dependent manner. Unexpectedly, we observed that PIP2 can drive membrane penetration by both syt1 and Doc2 beta in the absence of Ca2+, providing a plausible mechanism for Ca2+-independent, PIP2-dependent exocytosis. Quantitative measurements of penetration depth revealed that, in the presence of Ca2+, PIP2 drives Doc2 beta, but not syt1, substantially deeper into the membrane, defining a biophysical regulatory mechanism specific to this high-affinity Ca2+ sensor. Our results provide evidence of a novel role for PIP2 in regulating, and under some circumstances triggering, exocytosis.	[Bradberry, Mazdak M.; Bao, Huan; Lou, Xiaochu; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Bradberry, Mazdak M.; Bao, Huan; Lou, Xiaochu; Chapman, Edwin R.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53706 USA; [Bradberry, Mazdak M.] Univ Wisconsin, Sch Med & Publ Hlth, Med Scientist Training Program, Madison, WI 53705 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Dept Neurosci, 1111 Highland Ave, Madison, WI 53705 USA.; Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1111 Highland Ave, Madison, WI 53705 USA.	chapman@wisc.edu		Bao, Huan/0000-0002-4301-4627	National Institute of Mental Health [R01 MH061876, R35 NS097362, F30 MH116580]; Howard Hughes Medical Institute investigator grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH116580, R01MH061876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097362] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute investigator grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Mental Health Grants R01 MH061876, R35 NS097362 (to E. R. C.), and F30 MH116580 (to M. M. B.) and a Howard Hughes Medical Institute investigator grant (to E. R. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAMS FS, 1993, BIOCHEMISTRY-US, V32, P10826, DOI 10.1021/bi00091a038; Bai H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10971; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; COTMAN C, 1969, BIOCHEMISTRY-US, V8, P4606, DOI 10.1021/bi00839a056; Courtney NA, 2018, NEURON, V98, P977, DOI 10.1016/j.neuron.2018.04.022; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; Evans CS, 2015, J NEUROSCI, V35, P11769, DOI 10.1523/JNEUROSCI.1694-15.2015; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giladi M, 2013, J MOL BIOL, V425, P4629, DOI 10.1016/j.jmb.2013.08.017; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Groffen AJA, 2006, J NEUROCHEM, V97, P818, DOI 10.1111/j.1471-4159.2006.03755.x; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hille B, 1999, J PHYSIOL-LONDON, V520, P23, DOI 10.1111/j.1469-7793.1999.00023.x; Houy S, 2017, ELIFE, V6, DOI 10.7554/eLife.27000; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Hui EF, 2011, NAT STRUCT MOL BIOL, V18, P813, DOI 10.1038/nsmb.2075; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; Kochubey O, 2011, NEURON, V69, P736, DOI 10.1016/j.neuron.2011.01.013; Kyrychenko A, 2013, J PHYS CHEM B, V117, P5875, DOI 10.1021/jp4026706; Li J, 2014, DIABETOLOGIA, V57, P2173, DOI 10.1007/s00125-014-3312-y; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Michaeli L, 2017, TRAFFIC, V18, P825, DOI 10.1111/tra.12528; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Perez-Lara A, 2016, ELIFE, V5, DOI 10.7554/eLife.15886; Pinheiro PS, 2013, J NEUROSCI, V33, P16459, DOI 10.1523/JNEUROSCI.2656-13.2013; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; van den Bogaart G, 2012, J BIOL CHEM, V287, P16447, DOI 10.1074/jbc.M112.343418; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Vyleta NP, 2011, J NEUROSCI, V31, P4593, DOI 10.1523/JNEUROSCI.6398-10.2011; Waltert AM, 2017, ELIFE, V6, DOI 10.7554/eLife.30203; Wang P, 2005, MOL CELL BIOL, V25, P8693, DOI 10.1128/MCB.25.19.8693-8702.2005; Wang Z, 2011, J CELL BIOL, V195, P1159, DOI 10.1083/jcb.201104079; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Xue RH, 2018, P NATL ACAD SCI USA, V115, pE5605, DOI 10.1073/pnas.1802104115; Yao J, 2011, CELL, V147, P666, DOI 10.1016/j.cell.2011.09.046	54	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10942	10953		10.1074/jbc.RA119.007929	http://dx.doi.org/10.1074/jbc.RA119.007929			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31147445	Green Published, hybrid			2022-12-28	WOS:000478717200017
J	Lin, L; Shi, CW; Sun, ZR; Le, NT; Abe, JI; Hu, KB				Lin, Ling; Shi, Chaowen; Sun, Zhaorui; Le, Nhat-Tu; Abe, Jun-Ichi; Hu, Kebin			The Ser/Thr kinase p90RSK promotes kidney fibrosis by modulating fibroblast-epithelial crosstalk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RSK; kidney; fibrosis; FOXO; beta-catenin (-catenin); reactive oxygen species (ROS); 90 kDa ribosomal protein S6 kinase 1 (p90RSK); cell-cell crosstalk; fibroblast-epithelial communication; forkhead box class O1 (FOXO1); RPS6KA1; chronic kidney disease (CKD)	RIBOSOMAL S6 KINASE; PLASMINOGEN-ACTIVATOR; OXIDATIVE STRESS; RSK FAMILY; BETA; FOXO1; MYOFIBROBLASTS; MECHANISMS; PROTEINS; ROLES	Healthy kidney structure and environment rely on epithelial integrity and interactions between epithelial cells and other kidney cells. The Ser/Thr kinase 90 kDa ribosomal protein S6 kinase 1 (p90RSK) belongs to a protein family that regulates many cellular processes, including cell motility and survival. p90RSK is predominantly expressed in the kidney, but its possible role in chronic kidney disease (CKD) remains largely unknown. Here, we found that p90RSK expression is dramatically activated in a classic mouse obstructive chronic kidney disease model, largely in the interstitial FSP-1-positive fibroblasts. We generated FSP-1-specific p90RSK transgenic mouse (RSK-Tg) and discovered that these mice, after obstructive injury, display significantly increased fibrosis and enhanced tubular epithelial damage compared with their wt littermates (RSK-wt), indicating a role of p90RSK in fibroblast-epithelial communication. We established an in vitro fibroblast-epithelial coculture system with primary kidney fibroblasts from RSK-Tg and RSK-wt mice and found that RSK-Tg fibroblasts consistently produce excessive H2O2 causing epithelial oxidative stress and inducing nuclear translocation of the signaling protein -catenin. Epithelial accumulation of -catenin, in turn, promoted epithelial apoptosis by activating the transcription factor forkhead box class O1 (FOXO1). Of note, blockade of reactive oxygen species (ROS) or -catenin or FOXO1 activity abolished fibroblast p90RSK-mediated epithelial apoptosis. These results make it clear that p90RSK promotes kidney fibrosis by inducing fibroblast-mediated epithelial apoptosis through ROS-mediated activation of -catenin/FOXO1 signaling pathway.	[Lin, Ling; Shi, Chaowen; Sun, Zhaorui; Hu, Kebin] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Le, Nhat-Tu; Abe, Jun-Ichi] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Div Internal Med, Houston, TX 77030 USA; [Hu, Kebin] Penn State Univ, Coll Med, Dept Med, Div Nephrol, Hershey, PA 17033 USA; [Le, Nhat-Tu] Houston Methodist Res Inst, Dept Cardiovasc Sci, Ctr Cardiovasc Regenerat, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; The Methodist Hospital System; The Methodist Hospital - Houston	Hu, KB (corresponding author), H166,500 Univ Dr, Hershey, PA 17033 USA.	kebinhu@pennstatehealth.psu.edu	Hu, Kebin/AAT-7840-2021	Hu, Kebin/0000-0002-0829-4256; Lin, Ling/0000-0001-5527-0575	National Institutes of Health [DK102624]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK102624 (to K. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe J, 2014, ARTERIOSCL THROM VAS, V34, P2378, DOI 10.1161/ATVBAHA.114.303428; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; BOHLE A, 1994, EXP NEPHROL, V2, P205; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Coughlan MT, 2016, KIDNEY INT, V90, P272, DOI 10.1016/j.kint.2016.02.043; Damayanti Dini Sri, 2017, In Silico Pharmacology, V5, P3, DOI 10.1007/s40203-017-0023-3; Dang LTH, 2017, BIOMATERIALS, V141, P314, DOI 10.1016/j.biomaterials.2017.07.010; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; El-Achkar TM, 2015, AM J PHYSIOL-RENAL, V308, pF1317, DOI 10.1152/ajprenal.00030.2015; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Hameedaldeen A, 2014, INT J MOL SCI, V15, P16257, DOI 10.3390/ijms150916257; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Hu K, 2008, FRONT BIOSCI, V13, P5174, DOI 10.2741/3073; Hu KB, 2008, J AM SOC NEPHROL, V19, P503, DOI 10.1681/ASN.2007030300; Hu K, 2007, J CLIN INVEST, V117, P3821, DOI 10.1172/JCI32301; Inoue T, 2010, J AM SOC NEPHROL, V21, P2047, DOI 10.1681/ASN.2010010003; Kaissling B, 2008, HISTOCHEM CELL BIOL, V130, P247, DOI 10.1007/s00418-008-0452-5; Kandula V, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0361-1; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Lin L, 2017, ONCOTARGET, V8, P88094, DOI 10.18632/oncotarget.21510; Lin L, 2015, J BIOL CHEM, V290, P7910, DOI 10.1074/jbc.M114.599688; Lin L, 2014, AM J PATHOL, V184, P2757, DOI 10.1016/j.ajpath.2014.06.013; Lin L, 2010, AM J PATHOL, V177, P1687, DOI 10.2353/ajpath.2010.100213; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Morikawa Y, 2019, NEPHRON, V141, P177, DOI 10.1159/000495217; Muller GA, 2000, NEPHROL DIAL TRANSPL, V15, P76, DOI 10.1093/ndt/15.suppl_6.76; Nakagawa N, 2012, KIDNEY INT, V82, P158, DOI 10.1038/ki.2012.115; Neilson EG, 2006, NAT CLIN PRACT NEPHR, V2, P101, DOI 10.1038/ncpneph0093; Le NT, 2013, CIRCULATION, V127, P486, DOI 10.1161/CIRCULATIONAHA.112.116988; Norambuena-Soto I, 2017, BIOSCI TRENDS, V11, P154, DOI 10.5582/bst.2017.01017; Osterreicher CH, 2011, P NATL ACAD SCI USA, V108, P308, DOI 10.1073/pnas.1017547108; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Sauer H, 2001, FASEB J, V15, P2539, DOI 10.1096/fj.01-0360fje; Schiessl IM, 2018, J AM SOC NEPHROL, V29, P1383, DOI 10.1681/ASN.2017101069; Singh MV, 2019, CIRCULATION, V139, P1199, DOI 10.1161/CIRCULATIONAHA.118.036232; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Takeishi Y, 1999, CIRC RES, V85, P1164; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Tsuchiya K, 2017, J DIABETES INVEST, V8, P726, DOI 10.1111/jdi.12651; Tsutsumi R, 2009, J BONE MINER RES, V24, P1753, DOI [10.1359/JBMR.090412, 10.1359/jbmr.090412]; Vivar R, 2016, BBA-MOL CELL RES, V1863, P128, DOI 10.1016/j.bbamcr.2015.10.019; Zeisberg M, 2000, J NEPHROL, V13, pS111; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	49	7	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9901	9910		10.1074/jbc.RA119.007904	http://dx.doi.org/10.1074/jbc.RA119.007904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31076505	Green Published, hybrid			2022-12-28	WOS:000473277900021
J	Pitera, AP; Asuni, AA; O'Connor, V; Deinhardt, K				Pitera, Aleksandra P.; Asuni, Ayodeji A.; O'Connor, Vincent; Deinhardt, Katrin			Pathogenic tau does not drive activation of the unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuron; Tau protein; tauopathy; transgenic mice; unfolded protein response (UPR); neurodegenerative disease; protein misfolding; frontotemporal dementia; primary hippocampal neuron	ENDOPLASMIC-RETICULUM STRESS; ALZHEIMERS-DISEASE; MOUSE MODEL; PATHWAY; NEURODEGENERATION; DYSFUNCTION; NEURONS	The unfolded protein response (UPR) is commonly associated with a range of neurodegenerative diseases, and targeting UPR components has been suggested as a therapeutic strategy. The UPR surveys protein folding within the endoplasmic reticulum. However, many of the misfolded proteins that accumulate in neurodegeneration are localized so that they do not directly cause endoplasmic reticulum triggers that activate this pathway. Here, using a transgenic mouse model and primary cell cultures along with quantitative PCR, immunoblotting, and immunohistochemistry, we tested whether the UPR is induced in in vivo and in vitro murine models of tauopathy that are based on expression of mutant tau(P301L). We found no evidence for the UPR in the rTg4510 mouse model, in which mutant tau is transgenically expressed under the control of tetracycline-controlled transactivator protein. This observation was supported by results from acute experiments in which neuronal cultures expressed mutant tau and accumulated misfolded cytoplasmic tau aggregates but exhibited no UPR activation. These results suggest that the UPR is not induced as a response to tau misfolding and aggregation despite clear evidence for progressive cellular dysfunction and degeneration. We propose that caution is needed when evaluating the implied significance of the UPR as a critical determinant across major neurodegenerative diseases.	[Pitera, Aleksandra P.; O'Connor, Vincent; Deinhardt, Katrin] Univ Southampton, Biol Sci, Southampton SO17 1BJ, Hants, England; [Asuni, Ayodeji A.] H Lundbeck & Co AS, Syst Biol Symptoms, DK-2500 Valby, Denmark	University of Southampton; Lundbeck Corporation	Deinhardt, K (corresponding author), Univ Southampton, Biol Sci, Southampton SO17 1BJ, Hants, England.	K.Deinhardt@soton.ac.uk	Asuni, Ayodeji/F-4285-2011	Asuni, Ayodeji/0000-0003-3488-6893; Pitera, Aleksandra/0000-0001-7004-1615; Deinhardt, Katrin/0000-0002-6473-5298; O'Connor, Vincent/0000-0003-3185-5709	Alzheimer's Society; Healthcare Management Trust [AS-PhD-2015-029]	Alzheimer's Society; Healthcare Management Trust	This work was funded by the Alzheimer's Society with support from the Healthcare Management Trust (AS-PhD-2015-029 to A.P.P.). A.A.A. is a full-time employee of H. Lundbeck A/S, Denmark.	Abisambra JF, 2013, J NEUROSCI, V33, P9498, DOI 10.1523/JNEUROSCI.5397-12.2013; Asuni AA, 2014, J BIOL CHEM, V289, P4532, DOI 10.1074/jbc.M113.502690; Blair LJ, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0186-2; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Deinhardt K, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002060; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Halliday M, 2017, BRAIN, V140, P1768, DOI 10.1093/brain/awx074; Han HJ, 2012, J NEUROSCI, V32, P10574, DOI 10.1523/JNEUROSCI.0893-12.2012; Hashimoto S, 2018, J BIOL CHEM, V293, P3118, DOI 10.1074/jbc.M117.811315; Helboe L, 2017, BRAIN RES, V1665, P22, DOI 10.1016/j.brainres.2017.04.002; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Lee JH, 2010, EXP MOL MED, V42, P386, DOI 10.3858/emm.2010.42.5.040; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; McCloskey DT, 2005, PHYSIOL GENOMICS, V22, P118, DOI 10.1152/physiolgenomics.00016.2005; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Radford H, 2015, ACTA NEUROPATHOL, V130, P633, DOI 10.1007/s00401-015-1487-z; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Rojas-Rivera D, 2017, CELL DEATH DIFFER, V24, P1100, DOI 10.1038/cdd.2017.58; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Smith HL, 2016, BRAIN, V139, P2113, DOI 10.1093/brain/aww101; Spatara ML, 2010, J NEUROSCI RES, V88, P1951, DOI 10.1002/jnr.22359; Tacik P, 2017, NEUROPATH APPL NEURO, V43, P200, DOI 10.1111/nan.12367; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wes PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106050	35	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9679	9688		10.1074/jbc.RA119.008263	http://dx.doi.org/10.1074/jbc.RA119.008263			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31053641	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000473277900003
J	Ahmed, BA; Jeffus, BC; Bukhari, SIA; Harney, JT; Unal, R; Lupashin, VV; van der Sluijs, P; Kilic, F				Ahmed, Billow A.; Jeffus, Brandon C.; Bukhari, Syed I. A.; Harney, Justin T.; Unal, Resat; Lupashin, Vladimir V.; van der Sluijs, Peter; Kilic, Fusun			Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter. (Withdrawal of Vol 283, Pg 9388, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal																		Ahmed BA, 2008, J BIOL CHEM, V283, P9388, DOI 10.1074/jbc.M706367200	1	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9658	9658		10.1074/jbc.W119.009467	http://dx.doi.org/10.1074/jbc.W119.009467			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31201246	Green Published, hybrid			2022-12-28	WOS:000472713000032
J	Mays, CE; Armijo, E; Morales, R; Kramm, C; Flores, A; Tiwari, A; Bian, JF; Telling, GC; Pandita, TK; Hunt, CR; Soto, C				Mays, Charles E.; Armijo, Enrique; Morales, Rodrigo; Kramm, Carlos; Flores, Andrea; Tiwari, Anjana; Bian, Jifeng; Telling, Glenn C.; Pandita, Tej K.; Hunt, Clayton R.; Soto, Claudio			Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; prion disease; protein aggregation; protein folding; endoplasmic reticulum stress (ER stress); heat shock protein (HSP); molecular chaperone; neurodegeneration; bovine spongiform encephalopathy; Creutzfeldt-Jakob disease; scrapie	CREUTZFELDT-JAKOB-DISEASE; CYCLIC AMPLIFICATION; CYTOSOLIC HSP70; PROTEIN; PROPAGATION; CELLS; DISAGGREGATION; REPLICATION; DEGRADATION; CONVERSION	Prion diseases are a group of incurable neurodegenerative disorders that affect humans and animals via infection with proteinaceous particles called prions. Prions are composed of PrPSc, a misfolded version of the cellular prion protein (PrPC). During disease progression, PrPSc replicates by interacting with PrPC and inducing its conversion to PrPSc. As PrPSc accumulates, cellular stress mechanisms are activated to maintain cellular proteostasis, including increased protein chaperone levels. However, the exact roles of several of these chaperones remain unclear. Here, using various methodologies to monitor prion replication (i.e. protein misfolding cyclic amplification and cellular and animal infectivity bioassays), we studied the potential role of the molecular chaperone heat shock protein 70 (HSP70) in prion replication in vitro and in vivo. Our results indicated that pharmacological induction of the heat shock response in cells chronically infected with prions significantly decreased PrPSc accumulation. We also found that HSP70 alters prion replication in vitro. More importantly, prion infection of mice lacking the genes encoding stress-induced HSP70 exhibited accelerated prion disease progression compared with WT mice. In parallel with HSP70 being known to respond to endogenous and exogenous stressors such as heat, infection, toxicants, and ischemia, our results indicate that HSP70 may also play an important role in suppressing or delaying prion disease progression, opening opportunities for therapeutic intervention.	[Mays, Charles E.; Armijo, Enrique; Morales, Rodrigo; Kramm, Carlos; Flores, Andrea; Soto, Claudio] Univ Texas Houston, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, McGovern Med Sch, Houston, TX 77030 USA; [Armijo, Enrique; Kramm, Carlos; Soto, Claudio] Univ Los Andes, Fac Med, Ave San Carlos Apoquindo, Santiago 2200, Chile; [Tiwari, Anjana; Pandita, Tej K.; Hunt, Clayton R.] Houston Methodist Res Inst, Dept Radiat Oncol, Houston, TX 77030 USA; [Bian, Jifeng; Telling, Glenn C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University of Texas System; University of Texas Health Science Center Houston; Universidad de los Andes - Chile; The Methodist Hospital System; The Methodist Hospital - Houston; Colorado State University	Mays, CE; Soto, C (corresponding author), Univ Texas Houston, Med Sch, 6431 Fannin St, Houston, TX 77030 USA.	Charles.E.Mays@uth.tmc.edu; Claudio.Soto@uth.tmc.edu	Morales, Rodrigo/K-7173-2015; Pandita, Tej K/AAM-9188-2020; Bian, Jifeng/AAE-6262-2019	Bian, Jifeng/0000-0001-6838-9938	NIAID, National Institutes of Health [P01 IA106705, P01 IA077774]; NIGMS, National Institutes of Health [GM109768]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106705, P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109768] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIAID, National Institutes of Health Grants P01 IA106705 and P01 IA077774 (to C. S.) and NIGMS, National Institutes of Health Grant GM109768 (to T. K. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benbrook D. M., 2012, Experimental Oncology, V34, P286; Bian JF, 2017, P NATL ACAD SCI USA, V114, P1141, DOI 10.1073/pnas.1611891114; Bian JF, 2014, P NATL ACAD SCI USA, V111, P6028, DOI 10.1073/pnas.1322377111; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chernova TA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023663; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Dandoy-Dron F, 2006, NEUROSCI LETT, V405, P181, DOI 10.1016/j.neulet.2006.05.066; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Fernandez-Funez P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000507; Giaccone G, 2000, BRAIN PATHOL, V10, P31, DOI 10.1111/j.1750-3639.2000.tb00240.x; Halliday M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.49; Herbst M, 2007, NEURODEGENER DIS, V4, P254, DOI 10.1159/000101849; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Jin TC, 2000, J BIOL CHEM, V275, P38699, DOI 10.1074/jbc.M005543200; Jung G, 2000, GENETICS, V156, P559; KENWARD N, 1994, J NEUROCHEM, V62, P1870; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kovacs GG, 2001, NEUROBIOL DIS, V8, P881, DOI 10.1006/nbdi.2001.0418; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Lyon A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41055-x; Mays CE, 2016, BRAIN RES, V1648, P553, DOI 10.1016/j.brainres.2016.04.009; Mays CE, 2015, J VIROL, V89, P12418, DOI 10.1128/JVI.02142-15; Mays CE, 2012, BIOMATERIALS, V33, P6808, DOI 10.1016/j.biomaterials.2012.06.004; Morales R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006323; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Neale MH, 2010, J VIROL, V84, P2444, DOI 10.1128/JVI.01855-09; Park KW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44723; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner Stanley B., 2004, VVolume 41, P143; Puig B, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007520; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; Roberts BT, 2004, YEAST, V21, P107, DOI 10.1002/yea.1062; Sabirzhanov B, 2012, J NEUROCHEM, V123, P542, DOI 10.1111/j.1471-4159.2012.07927.x; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sharma D, 2008, GENETICS, V179, P1301, DOI 10.1534/genetics.108.089458; Sharma D, 2009, GENETICS, V181, P129, DOI 10.1534/genetics.108.098699; Shyu WC, 2000, J NEUROL, V247, P929, DOI 10.1007/s004150070048; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Steele AD, 2008, P NATL ACAD SCI USA, V105, P13626, DOI 10.1073/pnas.0806319105; TATZELT J, 1995, P NATL ACAD SCI USA, V92, P2944, DOI 10.1073/pnas.92.7.2944; Torres M, 2015, J BIOL CHEM, V290, P23631, DOI 10.1074/jbc.M114.635565; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Wang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038221; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Zhu CH, 2019, J EXP MED, V216, P743, DOI 10.1084/jem.20171885	60	16	17	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13619	13628		10.1074/jbc.RA118.006186	http://dx.doi.org/10.1074/jbc.RA118.006186			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31320473	hybrid, Green Published			2022-12-28	WOS:000486418600009
J	Xia, ZX; Wu, SY; Wei, X; Liao, YF; Yi, P; Liu, Y; Liu, JM; Liu, JF				Xia, Zhixiong; Wu, Shiyong; Wei, Xin; Liao, Yifei; Yi, Ping; Liu, Yong; Liu, Jianmiao; Liu, Jianfeng			Hypoxic ER stress suppresses beta-catenin expression and promotes cooperation between the transcription factors XBP1 and HIF1 alpha for cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); cancer biology; hypoxia-inducible factor (HIF); X-box-binding protein 1 (XBP1); Wnt signaling	UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; NEGATIVE BREAST-CANCER; ANTITUMOR IMMUNITY; INDUCIBLE FACTORS; TUMOR HYPOXIA; WNT; PATHWAY; TUMORIGENESIS; MECHANISMS	Hypoxia occurs in many human solid tumors and activates multiple cellular adaptive-response pathways, including the unfolded protein response (UPR) in the endoplasmic reticulum (ER). Wnt/beta-catenin signaling plays a critical role in tumorigenesis, and beta-catenin has been shown to enhance hypoxia-inducible factor 1 alpha (HIF1 alpha)-activated gene expression, thereby supporting cell survival during hypoxia. However, the molecular interplay between hypoxic ER stress, Wnt/beta-catenin signaling, and HIF1 alpha-mediated gene regulation during hypoxia remains incompletely understood. Here, we report that hypoxic ER stress reduces beta-catenin stability, which, in turn, enhances the activity of spliced X-box-binding protein 1 (XBP1s), a transcription factor and signal transducer of the UPR, in HIF1 alpha-mediated hypoxic responses. We observed that in the RKO colon cancer cell line, which possesses a Wnt-stimulated beta-catenin signaling cascade, increased ER stress during hypoxia is accompanied by a reduction in low-density lipoprotein receptor-related protein 6 (LRP6), and this reduction in LRP6 decreased beta-catenin accumulation and impaired Wnt/beta-catenin signaling. Of note, beta-catenin interacted with both XBP1s and HIF1 alpha, suppressing XBP1s-mediated augmentation of HIF1 alpha target gene expression. Furthermore, Wnt stimulation or beta-catenin overexpression blunted XBP1s-mediated cell survival under hypoxia. Together, these results reveal an unanticipated role for the Wnt/beta-catenin pathway in hindering hypoxic UPR-mediated responses that increase cell survival. Our findings suggest that the molecular cross-talks between hypoxic ER stress, LRP6/beta-catenin signaling, and the HIF1 alpha pathway may represent an unappreciated mechanism that enables some tumor subtypes to survive and grow in hypoxic conditions.	[Xia, Zhixiong; Wu, Shiyong; Wei, Xin; Liao, Yifei; Yi, Ping; Liu, Jianmiao; Liu, Jianfeng] Huazhong Univ Sci & Technol, Key Lab Mol Biophys MOE, Int Res Ctr Sensory Biol & Technol MOST, Cellular Signaling Lab, Wuhan 430074, Hubei, Peoples R China; [Xia, Zhixiong; Wu, Shiyong; Wei, Xin; Liao, Yifei; Yi, Ping; Liu, Jianmiao; Liu, Jianfeng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Liu, Yong] Wuhan Univ, Inst Adv Studies, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University	Liu, JM; Liu, JF (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys MOE, Int Res Ctr Sensory Biol & Technol MOST, Cellular Signaling Lab, Wuhan 430074, Hubei, Peoples R China.; Liu, JM; Liu, JF (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	jmliu@mail.hust.edu.cn; jfliu@mail.hust.edu.cn		Yi, Ping/0000-0002-6954-102X	National Natural Science Foundation of China [91539107, 91739303, 31420103909, 81720108031, 31721002, 81872945]; Ministry of Science and Technology of China [2018YFA0507003]; Program for Introducing Talents of Discipline to the Universities of the Ministry of Education Grant [B08029]; Merieux Research Grants Program of the Institut Merieux	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Program for Introducing Talents of Discipline to the Universities of the Ministry of Education Grant; Merieux Research Grants Program of the Institut Merieux	This work was supported by National Natural Science Foundation of China Grants 91539107 and 91739303 (to Jianmiao Liu) and Grants 31420103909, 81720108031, 31721002, and 81872945 (to Jianfeng Liu), Ministry of Science and Technology of China Grant 2018YFA0507003, and Program for Introducing Talents of Discipline to the Universities of the Ministry of Education Grant B08029, and the Merieux Research Grants Program of the Institut Merieux. The authors declare that they have no conflicts of interest with the contents of this article.	Bernardi R, 2014, CELL RES, V24, P904, DOI 10.1038/cr.2014.61; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Canive JM, 1996, PSYCHOPHARMACOL BULL, V32, P741; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; He X, 2003, DEV CELL, V4, P791, DOI 10.1016/S1534-5807(03)00165-5; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Lhomond S, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201707929; Li XX, 2017, ONCOGENE, V36, P6738, DOI 10.1038/onc.2017.284; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mohamed E, 2017, CANCER IMMUNOL IMMUN, V66, P1069, DOI 10.1007/s00262-017-2019-6; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Sheng X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08152-3; Sim JW, 2015, CANCER DISCOV, V5, P584, DOI 10.1158/2159-8290.CD-15-0480; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Uppala JK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03940-1; Verras M, 2008, MOL CELL BIOL, V28, P7212, DOI 10.1128/MCB.00947-08; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wu Y, 2018, HEPATOLOGY, V68, P533, DOI 10.1002/hep.29871; Xie H, 2018, J CLIN INVEST, V128, P1300, DOI 10.1172/JCI95864; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhao N, 2018, J CLIN INVEST, V128, P1283, DOI 10.1172/JCI95873	51	27	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13811	13821		10.1074/jbc.RA119.008353	http://dx.doi.org/10.1074/jbc.RA119.008353			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31350332	Green Published, hybrid			2022-12-28	WOS:000486418600025
J	Xin, LY; Zeng, YK; Sheng, S; Chea, RA; Liu, Q; Li, HY; Yang, L; Xu, LH; Chiam, KH; Liang, ZX				Xin, Lingyi; Zeng, Yukai; Sheng, Shuo; Chea, Rachel Andrea; Liu, Qiong; Li, Hoi Yeung; Yang, Liang; Xu, Linghui; Chiam, Keng-Hwee; Liang, Zhao-Xun			Regulation of flagellar motor switching by c-di-GMP phosphodiesterases in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic di-GMP (c-di-GMP); Pseudomonas aeruginosa (P aeruginosa); cell motility; phosphodiesterases; chemotaxis; adaptor protein; flagellum; methyltransferase; molecular motor	BIOFILM FORMATION; SWARMING MOTILITY; CYSTIC-FIBROSIS; MUTANT LIBRARY; MECHANISM; DISPERSION; REVEALS; TIME; FLEQ; PATHOGENESIS	The second messenger cyclic diguanylate (c-di-GMP) plays a prominent role in regulating flagellum-dependent motility in the single-flagellated pathogenic bacterium Pseudomonas aeruginosa. The c-di-GMP-mediated signaling pathways and mechanisms that control flagellar output remain to be fully unveiled. Studying surface-tethered and free-swimming P. aeruginosa PAO1 cells, we found that the overexpression of an exogenous diguanylate cyclase (DGC) raises the global cellular c-di-GMP concentration and thereby inhibits flagellar motor switching and decreases motor speed, reducing swimming speed and reversal frequency, respectively. We noted that the inhibiting effect of c-di-GMP on flagellar motor switching, but not motor speed, is exerted through the c-di-GMP-binding adaptor protein MapZ and associated chemotactic pathways. Among the 22 putative c-di-GMP phosphodiesterases, we found that three of them (DipA, NbdA, and RbdA) can significantly inhibit flagellar motor switching and swimming directional reversal in a MapZ-dependent manner. These results disclose a network of c-di-GMP-signaling proteins that regulate chemotactic responses and flagellar motor switching in P. aeruginosa and establish MapZ as a key signaling hub that integrates inputs from different c-di-GMP-signaling pathways to control flagellar output and bacterial motility. We rationalized these experimental findings by invoking a model that postulates the regulation of flagellar motor switching by subcellular c-di-GMP pools.	[Xin, Lingyi; Chea, Rachel Andrea; Li, Hoi Yeung; Yang, Liang; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Yang, Liang] Nanyang Technol Univ, Interdisciplinary Grad Sch, Singapore 637551, Singapore; [Yang, Liang; Liang, Zhao-Xun] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Zeng, Yukai; Chiam, Keng-Hwee] ASTAR, Bioinformat Inst, 30 Biopolis St,07-01, Singapore 138671, Singapore; [Sheng, Shuo; Liu, Qiong; Xu, Linghui] South China Agr Univ, Integrat Microbiol Res Ctr, Guangdong Innovat & Entrepreneurial Res Team Soci, Guangzhou 510642, Guangdong, Peoples R China; [Xu, Linghui] South China Agr Univ, Key Lab Biopesticide Innovat & Applicat Guangdong, Guangzhou 510642, Guangdong, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); South China Agricultural University; South China Agricultural University	Liang, ZX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.; Chiam, KH (corresponding author), ASTAR, Bioinformat Inst, 30 Biopolis St,07-01, Singapore 138671, Singapore.	zxliang@ntu.edu.sg; zxliang@ntu.edu.sg	Liang, Zhao-Xun/A-2191-2011; Yang, Liang/C-8487-2011	Yang, Liang/0000-0002-2362-0128; Liang, Zhao-Xun/0000-0002-3128-1330; Li, Hoi Yeung/0000-0002-8603-1953	ARC Tier II Grant from the Ministry of Education of Singapore [MOE2015-T2-2-026]; National Basic Research Program of China Program 973 Grant [2015CB150600]; Guangdong technological innovation strategy of special funds key areas of research and development program [2018B020205003]	ARC Tier II Grant from the Ministry of Education of Singapore(Ministry of Education, Singapore); National Basic Research Program of China Program 973 Grant(National Basic Research Program of China); Guangdong technological innovation strategy of special funds key areas of research and development program	This work was supported by ARC Tier II Grant MOE2015-T2-2-026 (to Z.-X. L.) from the Ministry of Education of Singapore. The research is also supported by National Basic Research Program of China Program 973 Grant number 2015CB150600 (to L. X.) and Guangdong technological innovation strategy of special funds key areas of research and development program Grant 2018B020205003. The authors declare that they have no conflicts of interest with the contents of this article.	Alicia TGG, 2016, LAB CHIP, V16, P368, DOI 10.1039/c5lc01137j; Amiel E, 2010, INFECT IMMUN, V78, P2937, DOI 10.1128/IAI.00144-10; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Baker AE, 2016, J BACTERIOL, V198, P1837, DOI 10.1128/JB.00196-16; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Bellini D, 2014, MOL MICROBIOL, V91, P26, DOI 10.1111/mmi.12447; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Cheang QW, 2019, BIOCHEM SOC T, V47, P381, DOI 10.1042/BST20180543; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Chen YC, 2015, ENV MICROBIOL REP, V7, P498, DOI 10.1111/1758-2229.12278; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; Dotsch A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-234; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Fong J, 2017, J MED CHEM, V60, P215, DOI 10.1021/acs.jmedchem.6b01025; Gjermansen M, 2006, FEMS MICROBIOL LETT, V265, P215, DOI 10.1111/j.1574-6968.2006.00493.x; Ha DG, 2014, APPL ENVIRON MICROB, V80, P3384, DOI 10.1128/AEM.00299-14; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jenal U, 2017, NAT REV MICROBIOL, V15, P271, DOI 10.1038/nrmicro.2016.190; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Kulasekara BR, 2013, ELIFE, V2, DOI 10.7554/eLife.01402; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Li Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004168; Li Y, 2013, J BACTERIOL, V195, P3531, DOI 10.1128/JB.01156-12; Liu C, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00515-17; Long ZC, 2014, ANALYST, V139, P5254, DOI 10.1039/c4an00877d; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL698, DOI 10.1152/ajplung.00319.2013; Lowe D. G., 2000, INT J COMPUT VISION, V60, P91; LUZAR MA, 1985, INFECT IMMUN, V50, P577, DOI 10.1128/IAI.50.2.577-582.1985; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Massie JP, 2012, P NATL ACAD SCI USA, V109, P12746, DOI 10.1073/pnas.1115663109; Matsuyama BY, 2016, P NATL ACAD SCI USA, V113, pE209, DOI 10.1073/pnas.1523148113; Mattingly AE, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01674-18; McCarter LL, 2015, J BACTERIOL, V197, P406, DOI 10.1128/JB.02483-14; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; Morgan R, 2006, J BACTERIOL, V188, P7335, DOI 10.1128/JB.00599-06; Nair HAS, 2017, J BIOL CHEM, V292, P477, DOI 10.1074/jbc.M116.746743; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ortega DR, 2017, P NATL ACAD SCI USA, V114, P12809, DOI 10.1073/pnas.1708842114; Petrova OE, 2017, METHODS MOL BIOL, V1657, P33, DOI 10.1007/978-1-4939-7240-1_4; Petrova OE, 2012, P NATL ACAD SCI USA, V109, P16690, DOI 10.1073/pnas.1207832109; Qian C, 2013, APPL ENVIRON MICROB, V79, P4734, DOI 10.1128/AEM.01027-13; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Romling U, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00790-16; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Roy Ankita Basu, 2013, Bio Protoc, V3; Roy AB, 2012, J BACTERIOL, V194, P2904, DOI 10.1128/JB.05346-11; Rybtke MT, 2012, APPL ENVIRON MICROB, V78, P5060, DOI 10.1128/AEM.00414-12; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sampedro I, 2015, FEMS MICROBIOL REV, V39, P17, DOI 10.1111/1574-6976.12081; Sanchez-Torres V, 2011, APPL MICROBIOL BIOT, V90, P651, DOI 10.1007/s00253-010-3074-5; Sarenko O, 2017, MBIO, V8, DOI 10.1128/mBio.01639-17; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sheng S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00067; Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wang CJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002449; Wang TT, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00152-19; Xu LH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7584; Yan XF, 2018, J BIOL CHEM, V293, P100, DOI 10.1074/jbc.M117.815704	66	14	15	7	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13789	13799		10.1074/jbc.RA119.009009	http://dx.doi.org/10.1074/jbc.RA119.009009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31350333	hybrid, Green Published			2022-12-28	WOS:000486418600023
J	Zhang, XY; Tu, HJ; Yang, YZ; Jiang, XY; Hu, XL; Luo, QD; Li, J				Zhang, Xiaoyan; Tu, Huaijun; Yang, Yazhi; Jiang, Xiaoyan; Hu, Xianliang; Luo, Qidong; Li, Jian			Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell death; chronic myelogenous leukemia (CML); mesenchymal stem cells (MSCs); drug resistance; cytokine; cancer; kinase cascade; myeloproliferative disease	COLONY-STIMULATING FACTOR; IMATINIB MESYLATE; CHRONIC-PHASE; MOLECULAR RESPONSE; POOR RESPONSE; IL-7; MUTATIONS; STEM; CML; MICROENVIRONMENT	Chronic myeloid leukemia (CML) is caused by the fusion of the BCR activator of RhoGEF and GTPase activating protein (BCR) and ABL proto-oncogene, the nonreceptor tyrosine kinase (ABL) genes. Although the tyrosine kinase inhibitors (TKIs) imatinib (IM) and nilotinib (NI) have remarkable efficacy in managing CML, the malignancies in some patients become TKI-resistant. Here, we isolated bone marrow (BM)-derived mesenchymal stem cells (MSCs) from several CML patients by Ficoll-Hypaque density-gradient centrifugation for coculture with K562 and BV173 cells with or without TKIs. We used real-time quantitative PCR to assess the level of interleukin 7 (IL-7) expression in the MSCs and employed immunoblotting to monitor protein expression in the BCR/ABL, phosphatidylinositol 3-kinase (PI3K)/AKT, and JAK/STAT signaling pathways. We also used a xenograft tumor model to examine the in vivo effect of different MSCs on CML cells. MSCs from patients with IM-resistant CML protected K562 and BV173 cells against IM- or NI-induced cell death, and this protection was due to increased IL-7 secretion from the MSCs. Moreover, IL-7 levels in the BM of patients with IM-resistant CML were significantly higher than in healthy donors or IM-sensitive CML patients. IL-7 elicited IM and NI resistance via BCR/ABL-independent activation of JAK1/STAT5 signaling, but not of JAK3/STAT5 or PI3K/AKT signaling. IL-7 or JAK1 gene knockdown abrogated IL-7-mediated STAT5 phosphorylation and IM resistance in vitro and in vivo. Because high IL-7 levels in the BM mediate TKI resistance via BCR/ABL-independent activation of JAK1/STAT5 signaling, combining TKIs with IL-7/JAK1/STAT5 inhibition may have significant utility for managing CML.	[Zhang, Xiaoyan; Yang, Yazhi; Jiang, Xiaoyan; Hu, Xianliang; Luo, Qidong; Li, Jian] Nanchang Univ, Dept Hematol, Key Lab Hematol Jiangxi Prov, Affiliated Hosp 2, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China; [Zhang, Xiaoyan] Nanchang Univ, Sch Basic Med Sci, Lab Infect & Immunol, Nanchang 330006, Jiangxi, Peoples R China; [Tu, Huaijun] Nanchang Univ, Dept Neurol, Affiliated Hosp 2, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China; [Zhang, Xiaoyan; Yang, Yazhi; Jiang, Xiaoyan; Hu, Xianliang; Luo, Qidong] Nanchang Univ, Grad Sch Med, 465 Bayi Rd, Nanchang 330006, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University; Nanchang University	Li, J (corresponding author), Nanchang Univ, Affiliated Hosp 2, Key Lab Hematol Jiangxi Prov, Nanchang 330006, Jiangxi, Peoples R China.	ndefy03048@ncu.edu.cn	HU, XIAN LIANG/GPX-5936-2022	HU, XIAN LIANG/0000-0001-6373-638X	Major Basic Research Projects of Jiangxi Province [20143ACB20005]; National Natural Science Foundation of China [81260231, 81760033]; Graduate Student Innovation Fund of Jiangxi Province [YC2014-B023]; Jiangxi Provincial Health and Family Planning Commission Science and Technology Program [20155645]	Major Basic Research Projects of Jiangxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Innovation Fund of Jiangxi Province; Jiangxi Provincial Health and Family Planning Commission Science and Technology Program	This work was supported by Major Basic Research Projects of Jiangxi Province Grant 20143ACB20005, National Natural Science Foundation of China Grants 81260231 and 81760033, Graduate Student Innovation Fund of Jiangxi Province Grant YC2014-B023, and Jiangxi Provincial Health and Family Planning Commission Science and Technology Program Grant 20155645. The authors declare that they have no conflicts of interest with the contents of this article.	Albajar M, 2011, MOL CANCER RES, V9, P564, DOI 10.1158/1541-7786.MCR-10-0356; Baba T, 2016, BLOOD, V127, P2607, DOI 10.1182/blood-2015-10-673087; Balciunaite G, 2005, EUR J IMMUNOL, V35, P1292, DOI 10.1002/eji.200425822; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Bortolin MT, 2012, CYTOKINE, V60, P90, DOI 10.1016/j.cyto.2012.06.022; Cheng Y, 2016, J CLIN INVEST, V126, P1267, DOI 10.1172/JCI81468; Chomel JC, 2016, ONCOTARGET, V7, P35293, DOI 10.18632/oncotarget.9182; Chu S, 2005, BLOOD, V105, P2093, DOI 10.1182/blood-2004-03-1114; DIGEL W, 1991, BLOOD, V78, P753; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Eide CA, 2015, CURR HEMATOL MALIG R, V10, P158, DOI 10.1007/s11899-015-0248-3; Gonzalez-Garcia S, 2012, CURR TOP MICROBIOL, V360, P47, DOI 10.1007/82_2012_231; Held SAE, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1065368; Hochhaus A, 2016, LEUKEMIA, V30, P1044, DOI 10.1038/leu.2016.5; Hughes TP, 2015, LEUKEMIA, V29, P1832, DOI 10.1038/leu.2015.168; Jabbour E, 2006, LEUKEMIA, V20, P1767, DOI 10.1038/sj.leu.2404318; Jiang XY, 2007, J NATL CANCER I, V99, P680, DOI 10.1093/jnci/djk150; Jiang XY, 1999, P NATL ACAD SCI USA, V96, P12804, DOI 10.1073/pnas.96.22.12804; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Khorashad JS, 2013, BLOOD, V121, P489, DOI 10.1182/blood-2012-05-431379; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Melo JV, 2007, CANCER LETT, V249, P121, DOI 10.1016/j.canlet.2006.07.010; Mumprecht S, 2010, EUR J IMMUNOL, V40, P2720, DOI 10.1002/eji.201040404; Nair RR, 2010, BIOCHEM PHARMACOL, V80, P602, DOI 10.1016/j.bcp.2010.04.003; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Okada M, 2018, CL LYMPH MYELOM LEUK, V18, P353, DOI 10.1016/j.clml.2018.03.004; Parker WT, 2012, BLOOD, V119, P2234, DOI 10.1182/blood-2011-08-375535; Peterson LF, 2011, LEUKEMIA, V25, P761, DOI 10.1038/leu.2011.7; Quintarelli C, 2014, LEUKEMIA RES, V38, P236, DOI 10.1016/j.leukres.2013.11.006; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Ross DM, 2010, LEUKEMIA, V24, P1719, DOI 10.1038/leu.2010.185; Sasaki K, 2016, CANCER-AM CANCER SOC, V122, P238, DOI 10.1002/cncr.29745; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shahrabi S, 2014, TUMOR BIOL, V35, P10627, DOI 10.1007/s13277-014-2610-9; Silva A, 2011, LEUKEMIA, V25, P960, DOI 10.1038/leu.2011.56; Singh H, 2014, J BIOMOL SCREEN, V19, P158, DOI 10.1177/1087057113501081; Tabe Y, 2012, LEUKEMIA, V26, P883, DOI 10.1038/leu.2011.291; Vianello F, 2010, HAEMATOL-HEMATOL J, V95, P1081, DOI 10.3324/haematol.2009.017178; Wang Y, 2007, BLOOD, V109, P2147, DOI 10.1182/blood-2006-08-040022; Weisberg E, 2008, MOL CANCER THER, V7, P1121, DOI 10.1158/1535-7163.MCT-07-2331; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Zhang B, 2013, BLOOD, V121, P1824, DOI 10.1182/blood-2012-02-412890; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018	49	14	15	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12167	12179		10.1074/jbc.RA119.008037	http://dx.doi.org/10.1074/jbc.RA119.008037			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31235520	Green Published, hybrid			2022-12-28	WOS:000484284500020
J	Broeker, NK; Roske, Y; Valleriani, A; Stephan, MS; Andres, D; Koetz, J; Heinemann, U; Barbirz, S				Broeker, Nina K.; Roske, Yvette; Valleriani, Angelo; Stephan, Mareike S.; Andres, Dorothee; Koetz, Joachim; Heinemann, Udo; Barbirz, Stefanie			Time-resolved DNA release from an O-antigen-specific Salmonella bacteriophage with a contractile tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteriophage; lipopolysaccharide (YLPS); structural biology; DNA viruses; glycobiology; fluorescence; Salmonella enterica; contractile tail; DNA ejection; O-antigen specificity; Salmonella myovirus; tailspike protein; molecular machine	BROAD-HOST-RANGE; TAILSPIKE PROTEIN; CRYSTAL-STRUCTURE; IN-VITRO; PHAGE; LIPOPOLYSACCHARIDE; EJECTION; DELIVERY; RECEPTOR; MACHINES	Myoviruses, bacteriophages with T4-like architecture, must contract their tails prior to DNA release. However, quantitative kinetic data on myovirus particle opening are lacking, although they are promising tools in bacteriophage-based antimicrobial strategies directed against Gram-negative hosts. For the first time, we show time-resolved DNA ejection from a bacteriophage with a contractile tail, the multi-O-antigen-specific Salmonella myovirus Det7. DNA release from Det7 was triggered by lipopolysaccharide (LPS) O-antigen receptors and notably slower than in noncontractile-tailed siphoviruses. Det7 showed two individual kinetic steps for tail contraction and particle opening. Our in vitro studies showed that highly specialized tailspike proteins (TSPs) are necessary to attach the particle to LPS. A P22-like TSP confers specificity for the Salmonella Typhimurium O-antigen. Moreover, crystal structure analysis at 1.63 angstrom resolution confirmed that Det7 recognized the Salmonella Anatum O-antigen via an E15-like TSP, DettilonTSP. DNA ejection triggered by LPS from either host showed similar velocities, so particle opening is thus a process independent of O-antigen composition and the recognizing TSP. In Det7, at permissive temperatures TSPs mediate O-antigen cleavage and couple cell surface binding with DNA ejection, but no irreversible adsorption occurred at low temperatures. This finding was in contrast to short-tailed Salmonella podoviruses, illustrating that tailed phages use common particle-opening mechanisms but have specialized into different infection niches.	[Broeker, Nina K.; Stephan, Mareike S.; Andres, Dorothee; Barbirz, Stefanie] Univ Potsdam, Dept Phys Biochem, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany; [Koetz, Joachim] Univ Potsdam, Kolloidchem, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany; [Roske, Yvette; Heinemann, Udo] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Valleriani, Angelo] Max Planck Inst Colloids & Interfaces, Muhlenberg 1, D-14476 Potsdam, Germany; [Heinemann, Udo] Freie Univ, Inst Chem & Biochem, Takustr 6, D-14195 Berlin, Germany	University of Potsdam; University of Potsdam; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; Free University of Berlin	Barbirz, S (corresponding author), Univ Potsdam, Phys Biochem, Karl Liebknecht Str 24-25, D-14476 Golm, Germany.	barbirz@uni-potsdam.de	Heinemann, Udo/AAH-4766-2019; Barbirz, Stefanie/S-9158-2019; Heinemann, Udo/S-3379-2016	Heinemann, Udo/0000-0002-8191-3850; Barbirz, Stefanie/0000-0001-6101-9862; Heinemann, Udo/0000-0002-8191-3850; Stephan, Mareike/0000-0002-4958-7979	Deutsche Forschungsgemeinschaft [BA 4046/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant BA 4046/1-2 (to S. B.).	Ackermann HW, 2012, ARCH VIROL, V157, P1843, DOI 10.1007/s00705-012-1383-y; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres D, 2013, GLYCOBIOLOGY, V23, P486, DOI 10.1093/glycob/cws224; Andres D, 2012, MOL MICROBIOL, V83, P1244, DOI 10.1111/j.1365-2958.2012.08006.x; Andres D, 2010, J BIOL CHEM, V285, P36768, DOI 10.1074/jbc.M110.169003; Arnaud CA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02049-3; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Bono LM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1932; BOULANGER P, 1988, J BIOL CHEM, V263, P9767; BRANDENBURG K, 1990, EUR J BIOCHEM, V191, P229, DOI 10.1111/j.1432-1033.1990.tb19114.x; Broeker NK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060289; Broeker NK, 2017, MOL MICROBIOL, V105, P353, DOI 10.1111/mmi.13729; Buth SA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080427; Casjens SR, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00279-15; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Chaban Y, 2015, P NATL ACAD SCI USA, V112, P7009, DOI 10.1073/pnas.1504039112; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; Chiaruttini N, 2010, BIOPHYS J, V99, P447, DOI 10.1016/j.bpj.2010.04.048; Chiaruttini N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084376; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Davidson AR, 2012, ADV EXP MED BIOL, V726, P115, DOI 10.1007/978-1-4614-0980-9_6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evilevitch A, 2018, ELIFE, V7, DOI 10.7554/eLife.37345; Fernandes S, 2016, VIROLOGY, V495, P79, DOI 10.1016/j.virol.2016.05.004; Freeman KG, 2016, J PHYS CHEM B, V120, P6421, DOI 10.1021/acs.jpcb.6b04172; GARCIA LR, 1995, J BACTERIOL, V177, P4066, DOI 10.1128/jb.177.14.4066-4076.1995; Gebhart D, 2017, VIROLOGY, V507, P263, DOI 10.1016/j.virol.2017.02.025; Goldberg Edward, 1994, P347; Golomidova AK, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010026; Gonzalez-Garcia VA, 2015, J BIOL CHEM, V290, P10038, DOI 10.1074/jbc.M114.614222; Gonzalez-Huici V, 2004, MOL MICROBIOL, V52, P529, DOI 10.1111/j.1365-2958.2004.03993.x; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; Habann M, 2014, MOL MICROBIOL, V92, P84, DOI 10.1111/mmi.12539; Hu B, 2015, P NATL ACAD SCI USA, V112, pE4919, DOI 10.1073/pnas.1501064112; Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887; JESAITIS MA, 1955, J EXP MED, V102, P733, DOI 10.1084/jem.102.6.733; Kang Y, 2016, J AM CHEM SOC, V138, P9109, DOI 10.1021/jacs.6b00240; Kropinski AM, 2007, VIROLOGY, V369, P234, DOI 10.1016/j.virol.2007.07.027; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Lander GC, 2009, STRUCTURE, V17, P789, DOI 10.1016/j.str.2009.04.006; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Lhuillier S, 2009, P NATL ACAD SCI USA, V106, P8507, DOI 10.1073/pnas.0812407106; Marti R, 2013, MOL MICROBIOL, V87, P818, DOI 10.1111/mmi.12134; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Nobrega FL, 2018, NAT REV MICROBIOL, V16, P760, DOI 10.1038/s41579-018-0070-8; Novacek J, 2016, P NATL ACAD SCI USA, V113, P9351, DOI 10.1073/pnas.1605883113; Pan YJ, 2017, J VIROL, V91, DOI 10.1128/JVI.02457-16; Parent KN, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020067; Pires DP, 2016, APPL MICROBIOL BIOT, V100, P2141, DOI 10.1007/s00253-015-7247-0; Prokhorov NS, 2017, MOL MICROBIOL, V105, P385, DOI 10.1111/mmi.13710; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raspaud E, 2007, BIOPHYS J, V93, P3999, DOI 10.1529/biophysj.107.111435; Richter W, 2011, INNATE IMMUN-LONDON, V17, P427, DOI 10.1177/1753425910372434; ROBBINS PW, 1962, BIOCHEMISTRY-US, V1, P323, DOI 10.1021/bi00908a020; Sao-Jose C, 2007, J MOL BIOL, V374, P346, DOI 10.1016/j.jmb.2007.09.045; Scholl D, 2001, J VIROL, V75, P2509, DOI 10.1128/JVI.75.6.2509-2515.2001; Schwarzer D, 2012, J VIROL, V86, P10384, DOI 10.1128/JVI.00801-12; Seul A, 2014, ACTA CRYSTALLOGR D, V70, P1336, DOI 10.1107/S1399004714002685; Silva JB, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw002; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; Tavares P, 2012, ADV EXP MED BIOL, V726, P585, DOI 10.1007/978-1-4614-0980-9_25; Taylor NMI, 2016, NATURE, V533, P346, DOI 10.1038/nature17971; Tu JG, 2017, VIROLOGY, V507, P206, DOI 10.1016/j.virol.2017.04.017; Van Valen D, 2012, CURR BIOL, V22, P1339, DOI 10.1016/j.cub.2012.05.023; Walter M, 2008, J VIROL, V82, P2265, DOI 10.1128/JVI.01641-07; Wang CY, 2019, NAT MICROBIOL, V4, P1049, DOI 10.1038/s41564-019-0403-z; Washizaki A, 2016, MICROBIOLOGYOPEN, V5, P1003, DOI 10.1002/mbo3.384; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Wu D, 2010, BIOPHYS J, V99, P1101, DOI 10.1016/j.bpj.2010.06.024; Yap ML, 2016, P NATL ACAD SCI USA, V113, P2654, DOI 10.1073/pnas.1601654113; Yosef I, 2017, MOL CELL, V66, P721, DOI 10.1016/j.molcel.2017.04.025; Zaccheus MV, 2012, CARBOHYD RES, V357, P118, DOI 10.1016/j.carres.2012.05.022	73	15	15	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11751	11761		10.1074/jbc.RA119.008133	http://dx.doi.org/10.1074/jbc.RA119.008133			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31189652	hybrid, Green Published			2022-12-28	WOS:000486127800012
J	Furusawa, K; Takasugi, T; Chiu, YW; Hori, Y; Tomita, T; Fukuda, M; Hisanaga, S				Furusawa, Kotaro; Takasugi, Toshiyuki; Chiu, Yung-Wen; Hori, Yukiko; Tomita, Taisuke; Fukuda, Mitsunori; Hisanaga, Shin-ichi			CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid precursor protein (APP); Rab; endosome; membrane trafficking; protein degradation; Alzheimer disease; CD2AP; CIN85; Rab7	ALZHEIMERS-DISEASE; COMMON VARIANTS; CAPPING PROTEIN; TRAFFICKING; ASSOCIATION; LOCALIZATION; DISABLED-1; AUTOPHAGY; SECRETASE; INTERACT	A hallmark of Alzheimer's disease (AD) pathology is the appearance of senile plaques, which are composed of beta-amyloid (A beta) peptides. A beta is produced by sequential cleavages of amyloid precursor protein (APP) by beta- and gamma-secretases. These cleavages take place in endosomes during intracellular trafficking of APP through the endocytic and recycling pathways. Genome-wide association studies have identified several risk factors for late-onset AD, one of which is CD2-associated protein (CD2AP), an adaptor molecule that regulates membrane trafficking. Although CD2AP's involvement in APP trafficking has recently been reported, how APP trafficking is regulated remains unclear. We sought to address this question by investigating the effect of CD2AP overexpression or knockdown on the intracellular APP distribution and degradation of APP in cultured COS-7 and HEK293 cells. We found that overexpression of CD2AP increases the localization of APP to Rab7-positive late endosomes, and decreases its localization to Rab5-positive early endosomes. CD2AP overexpression accelerated the onset of APP degradation without affecting its degradation rate. Furthermore, nutrient starvation increased the localization of APP to Rab7-positive late endosomes, and CD2AP overexpression stimulated starvation-induced lysosomal APP degradation. Moreover, the effect of CD2AP on the degradation of APP was confirmed by CD2AP overexpression and knockdown in primary cortical neurons from mice. We conclude that CD2AP accelerates the transfer of APP from early to late endosomes. This transfer in localization stimulates APP degradation by reducing the amount of time before degradation initiation. Taken together, these results may explain why impaired CD2AP function is a risk factor for AD.	[Furusawa, Kotaro; Takasugi, Toshiyuki; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Chiu, Yung-Wen; Hori, Yukiko; Tomita, Taisuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Integrat Life Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Furusawa, Kotaro] Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan	Tokyo Metropolitan University; University of Tokyo; Tohoku University; University of Tokyo	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp	Fukuda, MItsunori/I-1511-2015; Tomita, Taisuke/L-5427-2015	Fukuda, MItsunori/0000-0002-8620-5853; Hisanaga, Shin-ichi/0000-0002-7572-472X; Tomita, Taisuke/0000-0002-0075-5943	MEXT of Japan [26117004]; MEXT [16K07060, 18J01378]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by MEXT Grant-in-aid project, Scientific Research on Innovation Area (Brain Protein Aging and Dementia Control) of Japan Grant 26117004 (to S. H.) and MEXT Grant-in-aid numbers 16K07060 (to S. H.) and 18J01378 (to K. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Colacurcio DJ, 2018, FREE RADICAL BIO MED, V114, P40, DOI 10.1016/j.freeradbiomed.2017.10.001; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; DETER RL, 1967, J CELL BIOL, V33, P437, DOI 10.1083/jcb.33.2.437; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Eggert S, 2018, CELL MOL LIFE SCI, V75, P301, DOI 10.1007/s00018-017-2625-7; Fuchigami T, 2013, GENES CELLS, V18, P410, DOI 10.1111/gtc.12045; Furusawa K, 2017, J NEUROSCI, V37, P790, DOI 10.1523/JNEUROSCI.2197-16.2016; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hernandez-Valladares M, 2010, NAT STRUCT MOL BIOL, V17, P497, DOI 10.1038/nsmb.1792; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Jaeger PA, 2010, ARCH NEUROL-CHICAGO, V67, P1181, DOI 10.1001/archneurol.2010.258; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kuchitsu Y, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215442; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Lambert JC, 2013, MOL PSYCHIATR, V18, P461, DOI 10.1038/mp.2012.14; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Lefebvre C, 2018, SEMIN CELL DEV BIOL, V74, P21, DOI 10.1016/j.semcdb.2017.08.014; Liao F, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0006-y; Minami SS, 2011, J NEUROCHEM, V118, P879, DOI 10.1111/j.1471-4159.2011.07296.x; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Musardo S, 2013, EUR J PHARMACOL, V719, P84, DOI 10.1016/j.ejphar.2013.07.019; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nakagawa K, 2006, J NEUROCHEM, V96, P924, DOI 10.1111/j.1471-4159.2005.03595.x; Naumann N, 2010, HIPPOCAMPUS, V20, P971, DOI 10.1002/hipo.20693; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nizzari M, 2007, J BIOL CHEM, V282, P13833, DOI 10.1074/jbc.M610146200; Orhon I, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6030020; Quast T, 2003, FASEB J, V17, P1739, DOI 10.1096/fj.02-1059fje; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Rouka E, 2015, J BIOL CHEM, V290, P25275, DOI 10.1074/jbc.M115.637207; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Sato Y, 2007, GENES CELLS, V12, P1315, DOI 10.1111/j.1365-2443.2007.01139.x; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shulman JM, 2013, JAMA NEUROL, V70, P1150, DOI 10.1001/jamaneurol.2013.2815; Siemes C, 2006, EXP CELL RES, V312, P1939, DOI 10.1016/j.yexcr.2006.02.025; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Sullivan SE, 2014, J BIOL CHEM, V289, P15374, DOI 10.1074/jbc.M113.541003; Tanabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092291; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Toh WH, 2017, TRAFFIC, V18, P159, DOI 10.1111/tra.12465; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Ubelmann F, 2017, EMBO REP, V18, P102, DOI 10.15252/embr.201642738; Wang X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00294; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376; Yoon SY, 2008, J NEUROSCI RES, V86, P3230, DOI 10.1002/jnr.21760; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; Zhao JP, 2013, MOL CELL BIOL, V33, P38, DOI 10.1128/MCB.00734-12	57	18	18	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10886	10899		10.1074/jbc.RA118.005385	http://dx.doi.org/10.1074/jbc.RA118.005385			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31138646	hybrid, Green Published			2022-12-28	WOS:000478717200013
J	Hurst, S; Baggett, A; Csordas, G; Sheu, SS				Hurst, Stephen; Baggett, Ariele; Csordas, Gyorgy; Sheu, Shey-Shing			SPG7 targets the m-AAA protease complex to process MCU for uniporter assembly, Ca2+ influx, and regulation of mitochondrial permeability transition pore opening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial permeability transition (MPT); calcium; cyclophilin D; protein turnover; protein processing; mitochondrial calcium uniporter; spastic paraplegia 7	F-ATP SYNTHASE; CYCLOSPORINE-A; PROTEINS; SENSITIVITY; INHIBITION; DEFICIENCY; CHANNEL; STRESS	The mitochondrial matrix ATPase associated with diverse cellular activities (m-AAA) protease spastic paraplegia 7 (SPG7) has been recently implicated as either a negative or positive regulatory component of the mitochondrial permeability transition pore (mPTP) by two research groups. To address this controversy, we investigated possible mechanisms that explain the discrepancies between these two studies. We found that loss of the SPG7 gene increased resistance to Ca2+-induced mPTP opening. However, this occurs independently of cyclophilin D (cyclosporine A insensitive) rather it is through decreased mitochondrial Ca2+ concentrations and subsequent adaptations mediated by impaired formation of functional mitochondrial Ca2+ uniporter complexes. We found that SPG7 directs the m-AAA complex to favor association with the mitochondrial Ca2+ uniporter (MCU) and MCU processing regulates higher order MCU-complex formation. The results suggest that SPG7 does not constitute a core component of the mPTP but can modulate mPTP through regulation of the basal mitochondrial Ca2+ concentration.	[Hurst, Stephen; Baggett, Ariele; Sheu, Shey-Shing] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Ctr Translat Med, Dept Med, Philadelphia, PA 19107 USA; [Csordas, Gyorgy] Thomas Jefferson Univ, Mitocare Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Sheu, SS (corresponding author), 1020 Locust St,Suite 543D, Philadelphia, PA 19107 USA.	shey-shing.sheu@jefferson.edu	; Sheu, Shey-Shing/Y-4009-2019	Hurst, Stephen/0000-0002-9333-4629; Baggett, Ariele/0000-0001-9623-4052; Sheu, Shey-Shing/0000-0003-3838-3601; Csordas, Gyorgy/0000-0003-3156-1460	National Institutes of Health [2R01HL093671, 1R01HL122124, 1RO1114760, T32AA007463]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122124, R01HL137266, R01HL093671, R01HL142864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants 2R01HL093671, 1R01HL122124, and 1RO1114760 (to S.-S.S.) and T32AA007463 (to S.H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Antoniel M, 2014, INT J MOL SCI, V15, P7513, DOI 10.3390/ijms15057513; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00320; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chaudhuri D, 2016, P NATL ACAD SCI USA, V113, pE1872, DOI 10.1073/pnas.1602264113; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Consolato F, 2018, J CELL SCI, V131, DOI 10.1242/jcs.213546; CROMPTON M, 1988, BIOCHEM J, V255, P357; Ding Y, 2015, J MOL MED, V93, P1119, DOI 10.1007/s00109-015-1278-y; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; Giorgio V, 2017, EMBO REP, V18, P1065, DOI 10.15252/embr.201643354; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Glynn SE, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00034; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; Konig T, 2016, MOL CELL, V64, P148, DOI 10.1016/j.molcel.2016.08.020; Lee SK, 2016, CELL CHEM BIOL, V23, P1157, DOI 10.1016/j.chembiol.2016.07.012; Martin LJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00433; Parks RJ, 2019, CARDIOVASC RES, V115, P385, DOI 10.1093/cvr/cvy218; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shanmughapriya S, 2015, MOL CELL, V60, P47, DOI 10.1016/j.molcel.2015.08.009; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; Teixeira PF, 2013, BBA-MOL CELL RES, V1833, P360, DOI 10.1016/j.bbamcr.2012.03.012; Tomar D, 2016, CELL REP, V15, P1673, DOI 10.1016/j.celrep.2016.04.050; Tsai CW, 2017, P NATL ACAD SCI USA, V114, P4388, DOI 10.1073/pnas.1702938114	32	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10807	10818		10.1074/jbc.RA118.006443	http://dx.doi.org/10.1074/jbc.RA118.006443			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31097542	Green Published, hybrid			2022-12-28	WOS:000478717200007
J	Li, J; Jia, YH; Lin, AY; Hanna, M; Chelico, L; Xiao, W; Moore, SA				Li, Jia; Jia, Yunhua; Lin, Aiyang; Hanna, Michelle; Chelico, Linda; Xiao, Wei; Moore, Stanley A.			Structure of Ddi2, a highly inducible detoxifying metalloenzyme from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallography; enzyme structure; enzyme mechanism; metalloenzyme; yeast physiology; active site; cyanamide; HD domain; hydratase; urea	ALDEHYDE DEHYDROGENASE; CYANAMIDE HYDRATION; NATURAL CYANAMIDE; CRYSTAL-STRUCTURE; MECHANISM; REVEALS; PROTEIN; INHIBITION; ENZYME	Cyanamide (H2N-CN) is used to break bud dormancy in woody plants and to deter alcohol use in humans. The biological effects of cyanamide in both these cases require the enzyme catalase. We previously demonstrated that Saccharomyces cerevisiae exposed to cyanamide resulted in strong induction of DDI2 gene expression. Ddi2 enzymatically hydrates cyanamide to urea and belongs to the family of HD-domain metalloenzymes (named after conserved active-site metal-binding His and Asp residues). Here, we report the X-ray structure of yeast Ddi2 to 2.6 angstrom resolution, revealing that Ddi2 is a dimeric zinc metalloenzyme. We also confirm that Ddi2 shares structural similarity with other known HD-domain proteins. HD residues His-55, His-88, and Asp-89 coordinate the active-site zinc, and the fourth zinc ligand is a water/hydroxide molecule. Other HD domain enzymes have a second aspartate metal ligand, but in Ddi2 this residue (Thr-157) does not interact with the zinc ion. Several Ddi2 active-site point mutations exhibited reduced catalytic activity. We kinetically and structurally characterized H137N and T157V mutants of Ddi2. A cyanamide soak of the Ddi2-T157V enzyme revealed cyanamide bound directly to the Zn2+ ion, having displaced the zinc-bound water molecule. The mode of cyanamide binding to Ddi2 resembles cyanamide binding to the active-site zinc of carbonic anhydrase, a known cyanamide hydratase. Finally, we observed that the sensitivity of ddi2 Delta ddi3 Delta to cyanamide was not rescued by plasmids harboring ddi2-H137N or ddi2-TI57V variants, demonstrating that yeast cells require a functioning cyanamide hydratase to overcome cyanamide-induced growth defects.	[Li, Jia; Jia, Yunhua; Lin, Aiyang; Hanna, Michelle; Chelico, Linda; Xiao, Wei; Moore, Stanley A.] Univ Saskatchewan, Dept Biochem Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada; [Lin, Aiyang; Xiao, Wei] Capital Normal Univ, Coll Life Sci, Beijing Key Lab DNA Damage Responses, Beijing 100048, Peoples R China	University of Saskatchewan; Capital Normal University	Xiao, W; Moore, SA (corresponding author), Univ Saskatchewan, Dept Biochem Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada.; Xiao, W (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing Key Lab DNA Damage Responses, Beijing 100048, Peoples R China.	wei.xiao@usask.ca; stan.moore@usask.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04580, RGPIN-2019-05604, RGPIN-2011-262138, MOP-126155]; Canadian Institutes for Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grants RGPIN-2014-04580 and RGPIN-2019-05604 (to W.X.) and RGPIN-2011-262138 (to S.A.M.) and by Operating Grant MOP-126155 from the Canadian Institutes for Health Research (to S.A.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bellini D, 2014, MOL MICROBIOL, V91, P26, DOI 10.1111/mmi.12447; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; Briganti F, 1999, J BIOL INORG CHEM, V4, P528, DOI 10.1007/s007750050375; Buijnsters P, 2014, ACS MED CHEM LETT, V5, P1049, DOI 10.1021/ml500262u; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; DEMASTER EG, 1984, BIOCHEM BIOPH RES CO, V122, P358, DOI 10.1016/0006-291X(84)90483-2; DeMaster EG, 1998, BIOCHEM PHARMACOL, V55, P2007, DOI 10.1016/S0006-2952(98)00080-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Guerri A, 2000, BIOCHEMISTRY-US, V39, P12391, DOI 10.1021/bi000937c; Halaly T, 2008, PLANTA, V228, P79, DOI 10.1007/s00425-008-0720-6; Ionescu IA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01233; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jeon YJ, 2016, J STRUCT BIOL, V195, P113, DOI 10.1016/j.jsb.2016.04.002; Kamo T, 2003, J CHEM ECOL, V29, P275, DOI 10.1023/A:1022621709486; Kamo T, 2008, PHYTOCHEMISTRY, V69, P1166, DOI 10.1016/j.phytochem.2007.11.004; Kamo T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10527; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li J, 2015, J BIOL CHEM, V290, P12664, DOI 10.1074/jbc.M115.645408; MAIERGREINER UH, 1991, P NATL ACAD SCI USA, V88, P4260, DOI 10.1073/pnas.88.10.4260; Maninang JS, 2015, NAT PROD COMMUN, V10, P743; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez FJ, 2005, J PLANT PHYSIOL, V162, P301, DOI 10.1016/j.jplph.2004.07.011; Rinaldo S, 2015, J BACTERIOL, V197, P1525, DOI 10.1128/JB.02606-14; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shirota FN, 1996, BIOCHEM PHARMACOL, V52, P141, DOI 10.1016/0006-2952(96)00174-8; Singh D, 2015, J BIOL CHEM, V290, P10418, DOI 10.1074/jbc.M115.636936; Tamames B, 2007, PROTEINS, V69, P466, DOI 10.1002/prot.21536; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thorsell AG, 2008, J BIOL CHEM, V283, P15209, DOI 10.1074/jbc.M800348200; van Staalduinen LM, 2014, P NATL ACAD SCI USA, V111, P5171, DOI 10.1073/pnas.1320039111; Weeks JT, 2000, CROP SCI, V40, P1749, DOI 10.2135/cropsci2000.4061749x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu X, 2014, METHODS MOL BIOL, V1163, P183, DOI 10.1007/978-1-4939-0799-1_13; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	44	4	4	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10674	10685		10.1074/jbc.RA118.006394	http://dx.doi.org/10.1074/jbc.RA118.006394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31152065	hybrid, Green Published			2022-12-28	WOS:000478717100025
J	Ren, H; Xin, GW; Jia, MK; Zhu, SC; Lin, QY; Wang, XY; Jiang, Q; Zhang, CM				Ren, He; Xin, Guangwei; Jia, Mingkang; Zhu, Shicong; Lin, Qiaoyu; Wang, Xiangyang; Jiang, Qing; Zhang, Chuanmao			Postmitotic annulate lamellae assembly contributes to nuclear envelope reconstitution in daughter cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; nuclear envelope; nuclear pore; endoplasmic reticulum (ER); nuclear membrane; chromatin; AL pore complex (ALPC); annulate lamellae; Drosophila; intracellular membrane; nucleoporin	IMPORTIN-BETA; PORE; COMPLEX; SIZE; MEMBRANES; RAN; PHOSPHORYLATION; PROTEINS; DNA	In higher eukaryotic cells, the nuclear envelope (NE) is composed of double nuclear membranes studded with nuclear pore complexes (NPCs) and undergoes dynamic disassembly and reassembly during the cell cycle. However, how the NE and NPC reassemble remains largely unclear. Here, using HeLa, HEK293, and Drosophila cells, along with immunofluorescence microscopy and transmission EM methods, we found that postmitotic annulate lamellae (AL) assembly contributes to NE and NPC assembly. We observed that the AL are parallel membrane-pair stacks and possess regularly spaced AL pore complexes (ALPCs) that are morphologically similar to the NPCs. We found that the AL assemble in the cytoplasm during mitotic exit simultaneously with NE re-formation in daughter cells. Then, the assembled AL either bound the decondensing chromatin to directly transform into the NE or bound and fused with the outer nuclear membrane to join the assembling NE. The AL did not colocalize with sheet and tubular endoplasmic reticulum (ER) marker proteins on the ER or the lamin B receptor-localized membrane in the cytoplasm, suggesting that postmitotic AL assembly occurs independently of the chromatin and ER. Collectively, our results indicate that postmitotic AL assembly is a common cellular event and an intermediate step in NE and NPC assembly and in NE expansion in higher eukaryotic cells.	[Ren, He; Xin, Guangwei; Jia, Mingkang; Zhu, Shicong; Lin, Qiaoyu; Wang, Xiangyang; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Coll Life Sci, Beijing 100871, Peoples R China; [Ren, He; Xin, Guangwei; Jia, Mingkang; Zhu, Shicong; Lin, Qiaoyu; Wang, Xiangyang; Jiang, Qing; Zhang, Chuanmao] Peking Univ, State Key Lab Membrane Biol, Coll Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University	Zhang, CM (corresponding author), Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Coll Life Sci, Beijing 100871, Peoples R China.	zhangcm@pku.edu.cn		Zhang, Chuanmao/0000-0003-1359-6475; Ren, He/0000-0003-0660-3657	Ministry of Science and Technology of China; National Natural Science Foundation of China [31520103906, 2016YFA0500201, 2016YFA0100501, 31430051]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China and National Natural Science Foundation of China Grants 31520103906, 2016YFA0500201, 2016YFA0100501, and 31430051. The authors declare that they have no conflicts of interest with the contents of this article.	Blow JJ, 2016, INT J DEV BIOL, V60, P202, DOI 10.1387/ijdb.160142jb; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Bodoor K, 1999, J CELL SCI, V112, P2253; Boulware MJ, 2008, J PHYSIOL-LONDON, V586, P2873, DOI 10.1113/jphysiol.2008.153379; CHEN TY, 1988, J CELL BIOL, V107, P1299, DOI 10.1083/jcb.107.4.1299; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Goldberg MW, 1997, J CELL SCI, V110, P409; Good MC, 2015, DEV CELL, V33, P496, DOI 10.1016/j.devcel.2015.05.015; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hampoelz B, 2016, CELL, V166, P664, DOI 10.1016/j.cell.2016.06.015; Hara Y, 2015, DEV CELL, V33, P562, DOI 10.1016/j.devcel.2015.04.016; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; HUTCHISON CJ, 1987, EMBO J, V6, P2003, DOI 10.1002/j.1460-2075.1987.tb02464.x; Jevtic P, 2015, CURR BIOL, V25, P45, DOI 10.1016/j.cub.2014.10.051; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; KESSEL RG, 1992, INT REV CYTOL, V133, P43, DOI 10.1016/S0074-7696(08)61858-6; Kosinski J, 2016, SCIENCE, V352, P363, DOI 10.1126/science.aaf0643; LaJoie D, 2017, CURR OPIN CELL BIOL, V46, P39, DOI 10.1016/j.ceb.2016.12.008; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Lenart P, 2003, CURR OPIN CELL BIOL, V15, P88, DOI 10.1016/S0955-0674(02)00011-X; Levy DL, 2010, CELL, V143, P288, DOI 10.1016/j.cell.2010.09.012; Lu QL, 2012, CELL RES, V22, P1562, DOI 10.1038/cr.2012.113; Lu XL, 2010, J BIOL CHEM, V285, P33281, DOI 10.1074/jbc.M110.102368; Lusk CP, 2016, CELL, V166, P534, DOI 10.1016/j.cell.2016.07.011; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; Raghunayakula S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144508; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Rotem A, 2009, MOL BIOL CELL, V20, P4031, DOI 10.1091/mbc.E09-02-0150; Schooley A, 2012, CHROMOSOMA, V121, P539, DOI 10.1007/s00412-012-0388-3; STAFSTROM JP, 1984, J CELL BIOL, V98, P699, DOI 10.1083/jcb.98.2.699; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 1996, J CELL SCI, V109, P2275; Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288; Zhang CM, 2002, CURR BIOL, V12, P498, DOI 10.1016/S0960-9822(02)00714-5	38	5	5	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10383	10391		10.1074/jbc.AC119.008171	http://dx.doi.org/10.1074/jbc.AC119.008171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31152066	Green Published, hybrid			2022-12-28	WOS:000478717100001
J	Montecinos-Franjola, F; Chaturvedi, SK; Schuck, P; Sackett, DL				Montecinos-Franjola, Felipe; Chaturvedi, Sumit K.; Schuck, Peter; Sackett, Dan L.			All tubulins are not alike: Heterodimer dissociation differs among different biological sources	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tubulin; dimerization; analytical ultracentrifugation; fluorescence; protein conformation; cytoskeleton; dissociation constant; heterologous dimerization; monomer; non-interacting surface (NIS)	BETA-TUBULIN; ANALYTICAL ULTRACENTRIFUGATION; SEDIMENTATION-VELOCITY; DIMER DISSOCIATION; BINDING-AFFINITY; ALPHA-TUBULIN; PROTEIN; ISOTYPES; EXPRESSION; ACTIN	Tubulin, the subunit of microtubules, is a noncovalent heterodimer composed of one alpha- and one beta-tubulin monomer. Both tubulins are encoded by multiple genes or composed of different isotypes, which are differentially expressed in different tissues and in development. Tubulin alpha beta dimers are found throughout the eukaryotes and, although very similar, are known to differ among organisms. We seek to investigate tubulins from different tissues and different organisms for a basic physical characteristic: heterodimer stability and monomer exchange between heterodimers. We previously showed that mammalian brain tubulin heterodimers reversibly dissociate, following the mass action law. Dissociation yields native monomers that can exchange with added tubulin to form new heterodimers. Here, we compared the dissociation of tubulins from multiple sources, including mammalian (rat) brain, cultured human cells (HeLa cells), chicken brain, chicken erythrocytes, and the protozoan Leishmania. We used fluorescence-detected analytical ultracentrifugation to measure tubulin dissociation over a >1000-fold range in concentration and found that tubulin heterodimers from different biological sources differ in K-d by as much as 150-fold under the same conditions. Furthermore, when fluorescent tracer tubulins from various sources were titrated with unlabeled tubulin from a single source (rat brain tubulin), heterologous dimerization occurred, exhibiting similar affinities, in some cases binding even more strongly than with autologous tubulin. These results provide additional insight into the regulation of heterodimer formation of tubulin from different biological sources, revealing that monomer exchange appears to contribute to the sorting of alpha- and beta-tubulin monomers that associate following tubulin folding.	[Montecinos-Franjola, Felipe; Sackett, Dan L.] NICHD, Div Basic & Translat Biophys, Bethesda, MD 20892 USA; [Chaturvedi, Sumit K.; Schuck, Peter] NIBIB, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA; [Montecinos-Franjola, Felipe] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Case Western Reserve University	Sackett, DL (corresponding author), NICHD, Div Basic & Translat Biophys, Bethesda, MD 20892 USA.	sackettd@mail.nih.gov	Schuck, Peter/AAA-6888-2020; Chaturvedi, Sumit K/P-5052-2014; Franjola, Felipe A Montecinos/R-3907-2017; Montecinos, Felipe/HHS-7232-2022	Schuck, Peter/0000-0002-8859-6966; Chaturvedi, Sumit K/0000-0003-3600-8883; Franjola, Felipe A Montecinos/0000-0002-1823-103X; Montecinos, Felipe/0000-0002-1823-103X	NIBIB; NICHD, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000008] Funding Source: NIH RePORTER	NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the intramural research programs of the NIBIB and NICHD, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; BAKER HN, 1990, J CELL BIOL, V110, P97, DOI 10.1083/jcb.110.1.97; BAUM P, 1978, P NATL ACAD SCI USA, V75, P4962, DOI 10.1073/pnas.75.10.4962; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Caplow M, 2002, MOL BIOL CELL, V13, P2120, DOI 10.1091/mbc.E01-10-0089; Chakraborti S, 2016, CYTOSKELETON, V73, P521, DOI 10.1002/cm.21290; Chaturvedi SK, 2017, NAT PROTOC, V12, P1777, DOI 10.1038/nprot.2017.064; Findeisen P, 2014, GENOME BIOL EVOL, V6, P2274, DOI 10.1093/gbe/evu187; Francis JW, 2017, J MOL BIOL, V429, P3696, DOI 10.1016/j.jmb.2017.09.016; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Hoyle HD, 2001, MOL BIOL CELL, V12, P2185, DOI 10.1091/mbc.12.7.2185; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Joachimiak LA, 2014, CELL, V159, P1042, DOI 10.1016/j.cell.2014.10.042; JOHNSON ML, 1992, ANAL BIOCHEM, V206, P215, DOI 10.1016/0003-2697(92)90356-C; Kastritis PL, 2014, J MOL BIOL, V426, P2632, DOI 10.1016/j.jmb.2014.04.017; Kastritis PL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0835; LEWIS SA, 1985, J CELL BIOL, V101, P852, DOI 10.1083/jcb.101.3.852; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Luduena RF, 2013, INT REV CEL MOL BIO, V302, P41, DOI 10.1016/B978-0-12-407699-0.00002-9; MEJILLANO MR, 1989, BIOCHEMISTRY-US, V28, P6518, DOI 10.1021/bi00441a053; MELKI R, 1993, J CELL BIOL, V122, P1301, DOI 10.1083/jcb.122.6.1301; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; MILLER FD, 1987, J CELL BIOL, V105, P3065, DOI 10.1083/jcb.105.6.3065; Montecinos-Franjola F, 2016, BIOPHYS J, V110, p26A, DOI 10.1016/j.bpj.2015.11.207; Montecinos-Franjola F, 2016, J BIOL CHEM, V291, P9281, DOI 10.1074/jbc.M115.699728; Montecinos-Franjola F, 2012, BIOPHYS J, V102, P2176, DOI 10.1016/j.bpj.2012.03.064; Monterroso B, 2013, METHODS, V59, P349, DOI 10.1016/j.ymeth.2012.12.014; Nithianantham S, 2015, ELIFE, V4, DOI 10.7554/eLife.08811; Pamula MC, 2016, J CELL BIOL, V213, P425, DOI 10.1083/jcb.201603050; PANDA D, 1992, BIOCHEMISTRY-US, V31, P9709, DOI 10.1021/bi00155a026; Rommelaere H, 2001, J BIOL CHEM, V276, P41023, DOI 10.1074/jbc.M106591200; Sackett D L, 1991, Protein Expr Purif, V2, P390, DOI 10.1016/1046-5928(91)90099-5; Sackett DL, 2010, METHOD CELL BIOL, V95, P17, DOI 10.1016/S0091-679X(10)95002-4; SACKETT DL, 1991, BIOCHEMISTRY-US, V30, P3511, DOI 10.1021/bi00228a023; SACKETT DL, 1995, ANAL BIOCHEM, V228, P343, DOI 10.1006/abio.1995.1361; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P., 2017, SEDIMENTATION VELOCI; Serna M., 2016, ELS, P1, DOI [10.1002/9780470015902.a0026333, DOI 10.1002/9780470015902.A0026333]; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P885, DOI 10.1021/bi00170a006; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; SLABAS AR, 1980, FEBS LETT, V110, P77, DOI 10.1016/0014-5793(80)80027-5; Sontag CA, 2005, J CELL BIOL, V169, P233, DOI 10.1083/jcb.200410027; Sontag CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007253; Tian GL, 2013, METHOD CELL BIOL, V115, P155, DOI 10.1016/B978-0-12-407757-7.00011-6; Verdier-Pinard P, 2003, BIOCHEMISTRY-US, V42, P12019, DOI 10.1021/bi0350147; Wang YQ, 2006, J BIOL CHEM, V281, P13628, DOI 10.1074/jbc.M513730200; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; YAFFE MB, 1988, J BIOL CHEM, V263, P16023; YAFFE MB, 1988, BIOCHEMISTRY-US, V27, P1869, DOI 10.1021/bi00406a012; Zhao HY, 2017, ELIFE, V6, DOI 10.7554/eLife.32056; Zhao HY, 2014, ANAL CHEM, V86, P3181, DOI 10.1021/ac500093m; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083439	53	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10315	10324		10.1074/jbc.RA119.007973	http://dx.doi.org/10.1074/jbc.RA119.007973			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31110044	hybrid, Green Published			2022-12-28	WOS:000474445600021
J	Anderson, NS; Barlowe, C				Anderson, Nadine S.; Barlowe, Charles			Conserved juxtamembrane domains in the yeast golgin Coy1 drive assembly of a megadalton-sized complex and mediate binding to tethering and SNARE proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intracellular trafficking; protein trafficking (Golgi); SNARE proteins; oligomerization; protein-protein interaction	MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; COILED COILS; COG COMPLEX; TRANSPORT; FUSION; VESICLES; ER	The architecture and organization of the Golgi complex depend on a family of coiled-coil proteins called golgins. Golgins are thought to form extended homodimers that are C-terminally anchored to Golgi membranes, whereas their N termini extend into the cytoplasm to initiate vesicle capture. Previously, we reported that the Saccharomyces cerevisiae golgin Coy1 contributes to intra-Golgi retrograde transport and binds to the conserved oligomeric Golgi (COG) complex and multiple retrograde Golgi Q-SNAREs (where SNARE is soluble NSF-attachment protein receptor). Here, using various engineered yeast strains, membrane protein extraction and fractionation methods, and in vitro binding assays, we mapped the Coy1 regions responsible for these activities. We also report that Coy1 assembles into a megadalton-size complex and that assembly of this complex depends on the most C-terminal coiled-coil and a conserved region between this coiled-coil and the transmembrane domain of Coy1. We found that this conserved region is necessary and sufficient for binding the SNARE protein Sed5 and the COG complex. Mutagenesis of conserved arginine residues within the C-terminal coiled-coil disrupted oligomerization, binding, and function of Coy1. Our findings indicate that the stable incorporation of Coy1 into a higher-order oligomer is required for its interactions and role in maintaining Golgi homeostasis. We propose that Coy1 assembles into a docking platform that directs COG-bound vesicles toward cognate SNAREs on the Golgi membrane.	[Anderson, Nadine S.; Barlowe, Charles] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA	Dartmouth College	Barlowe, C (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA.	charles.barlowe@dartmouth.edu		Anderson, Nadine/0000-0001-9764-7991	National Institutes of Health [GM052549]; BioMT COBRE Grant [P20 GM113132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052549, P20GM113132, R01GM052549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioMT COBRE Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM052549 and BioMT COBRE Grant P20 GM113132. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson NS, 2017, MOL BIOL CELL, V28, P2686, DOI 10.1091/mbc.E17-03-0137; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; Ballew N, 2005, MOL BIOL CELL, V16, P1839, DOI 10.1091/mbc.E04-08-0725; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; Bello OD, 2018, P NATL ACAD SCI USA, V115, pE7624, DOI 10.1073/pnas.1808792115; Brachmann CB, 1998, YEAST, V14, P115; Burgess NK, 2008, METHOD CELL BIOL, V84, P181, DOI 10.1016/S0091-679X(07)84007-6; Cheung PYP, 2015, ELIFE, V4, DOI 10.7554/eLife.12790; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; D'Agostino M, 2017, NATURE, V551, P634, DOI 10.1038/nature24469; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Dubuke ML, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00042; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; DUDEN R, 1994, J BIOL CHEM, V269, P24486; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fisher P, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00015; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; Gillingham AK, 2018, BIOCHEM SOC T, V46, P43, DOI 10.1042/BST20170188; Gillingham AK, 2016, TRENDS CELL BIOL, V26, P399, DOI 10.1016/j.tcb.2016.02.005; Glick BS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005215; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gupta K, 2017, NATURE, V541, P421, DOI 10.1038/nature20820; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hopper JTS, 2013, NAT METHODS, V10, P1206, DOI [10.1038/nmeth.2691, 10.1038/NMETH.2691]; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kim DW, 1999, MOL BIOL CELL, V10, P3317, DOI 10.1091/mbc.10.10.3317; Kim DW, 2003, BIOCHEM BIOPH RES CO, V303, P370, DOI 10.1016/S0006-291X(03)00341-3; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lees JA, 2010, NAT STRUCT MOL BIOL, V17, P1292, DOI 10.1038/nsmb.1917; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Lupas AN, 2017, TRENDS BIOCHEM SCI, V42, P130, DOI 10.1016/j.tibs.2016.10.007; Magdeleine M, 2016, ELIFE, V5, DOI 10.7554/eLife.16988; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Malsam J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005249; Miller VJ, 2013, J BIOL CHEM, V288, P4229, DOI 10.1074/jbc.M112.426767; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Munro S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005256; Orr A, 2017, MOL BIOL CELL, V28, P975, DOI 10.1091/mbc.E16-10-0743; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; Shin JJH, 2017, NAT CELL BIOL, V19, P1424, DOI 10.1038/ncb3627; Simm D, 2015, BIOINFORMATICS, V31, P767, DOI 10.1093/bioinformatics/btu700; Siniossoglou S, 2005, METHOD ENZYMOL, V403, P599, DOI 10.1016/S0076-6879(05)03052-1; Siniossoglou S, 2001, EMBO J, V20, P5991, DOI 10.1093/emboj/20.21.5991; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Slubowski CJ, 2015, YEAST, V32, P379, DOI 10.1002/yea.3065; Sun L, 2014, NATURE, V505, P432, DOI 10.1038/nature12816; Suvorova ES, 2002, J CELL BIOL, V157, P631, DOI 10.1083/jcb.200111081; Tsui MMK, 2000, J CELL SCI, V113, P145; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; VanRheenen SM, 1999, J CELL BIOL, V147, P729, DOI 10.1083/jcb.147.4.729; Wang J, 2017, ELIFE, V6, DOI 10.7554/eLife.27441; Wang J, 2014, P NATL ACAD SCI USA, V111, P13966, DOI 10.1073/pnas.1415849111; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Weill U, 2018, TRAFFIC, V19, P370, DOI 10.1111/tra.12560; Welsh LM, 2006, J CELL SCI, V119, P4730, DOI 10.1242/jcs.03250; Willett R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2535; Wilson JD, 2010, J BIOL CHEM, V285, P18252, DOI 10.1074/jbc.M109.080382; Wong M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0345-3; Wong M, 2014, SCIENCE, V346, P601, DOI 10.1126/science.1256898; Xu Zhidong, 2003, Methods Mol Biol, V235, P203; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Yuan H, 2017, P NATL ACAD SCI USA, V114, pE8637, DOI 10.1073/pnas.1708394114; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	84	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9690	9705		10.1074/jbc.RA119.008107	http://dx.doi.org/10.1074/jbc.RA119.008107			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31073031	hybrid, Green Published			2022-12-28	WOS:000473277900005
J	Lubbers, ER; Murphy, NP; Musa, H; Huang, CYM; Gupta, R; Price, MV; Han, M; Daoud, G; Gratz, D; El Refaey, M; Xu, XY; Hoeflinger, NK; Friel, EL; Lancione, P; Wallace, MJ; Cavus, O; Simmons, SL; Williams, JL; Skaf, M; Koenig, SN; Janssen, PML; Rasband, MN; Hund, TJ; Mohler, PJ				Lubbers, Ellen R.; Murphy, Nathaniel P.; Musa, Hassan; Huang, Claire Yu-Mei; Gupta, Rohan; Price, Morgan V.; Han, Mei; Daoud, Georges; Gratz, Daniel; El Refaey, Mona; Xu, Xianyao; Hoeflinger, Nicole K.; Friel, Emma L.; Lancione, Peter; Wallace, Michael J.; Cavus, Omer; Simmons, Samantha L.; Williams, Jordan L.; Skaf, Michel; Koenig, Sara N.; Janssen, Paul M. L.; Rasband, Matthew N.; Hund, Thomas J.; Mohler, Peter J.			Defining new mechanistic roles for II spectrin in cardiac function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heart; heart failure; adaptor protein; ion channel; cardiovascular disease; cytoskeleton; spectrin; ankryin	AXON INITIAL SEGMENTS; BREAKDOWN PRODUCTS; STRUCTURAL PLATFORM; BRAIN-INJURY; ANKYRIN-G; PROTEIN; CYTOSKELETAL; EXCITABILITY; CELLS; MODEL	Spectrins are cytoskeletal proteins essential for membrane biogenesis and regulation and serve critical roles in protein targeting and cellular signaling. II spectrin (SPTAN1) is one of two spectrin genes and II spectrin dysfunction is linked to alterations in axon initial segment formation, cortical lamination, and neuronal excitability. Furthermore, human II spectrin loss-of-function variants cause neurological disease. As global II spectrin knockout mice are embryonic lethal, the in vivo roles of II spectrin in adult heart are unknown and untested. Here, based on pronounced alterations in II spectrin regulation in human heart failure we tested the in vivo roles of II spectrin in the vertebrate heart. We created a mouse model of cardiomyocyte-selective II spectrin-deficiency (cKO) and used this model to define the roles of II spectrin in cardiac function. II spectrin cKO mice displayed significant structural, cellular, and electrical phenotypes that resulted in accelerated structural remodeling, fibrosis, arrhythmia, and mortality in response to stress. At the molecular level, we demonstrate that II spectrin plays a nodal role for global cardiac spectrin regulation, as II spectrin cKO hearts exhibited remodeling of I spectrin and altered -spectrin expression and localization. At the cellular level, II spectrin deficiency resulted in altered expression, targeting, and regulation of cardiac ion channels Na(V)1.5 and K(V)4.3. In summary, our findings define critical and unexpected roles for the multifunctional II spectrin protein in the heart. Furthermore, our work provides a new in vivo animal model to study the roles of II spectrin in the cardiomyocyte.	[Lubbers, Ellen R.; Murphy, Nathaniel P.; Musa, Hassan; Gupta, Rohan; Price, Morgan V.; Han, Mei; Daoud, Georges; Gratz, Daniel; El Refaey, Mona; Xu, Xianyao; Hoeflinger, Nicole K.; Friel, Emma L.; Lancione, Peter; Wallace, Michael J.; Cavus, Omer; Simmons, Samantha L.; Williams, Jordan L.; Skaf, Michel; Koenig, Sara N.; Janssen, Paul M. L.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH USA; [Lubbers, Ellen R.; Murphy, Nathaniel P.; Musa, Hassan; Gupta, Rohan; Price, Morgan V.; Han, Mei; Daoud, Georges; Gratz, Daniel; El Refaey, Mona; Xu, Xianyao; Hoeflinger, Nicole K.; Friel, Emma L.; Lancione, Peter; Wallace, Michael J.; Cavus, Omer; Simmons, Samantha L.; Williams, Jordan L.; Skaf, Michel; Koenig, Sara N.; Janssen, Paul M. L.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Coll Med, Frick Ctr Heart Failure & Arrhythmia, Columbus, OH USA; [Lubbers, Ellen R.; Murphy, Nathaniel P.] Ohio State Univ, Coll Med, Med Scientist Training Program, Columbus, OH USA; [Lubbers, Ellen R.; Murphy, Nathaniel P.; Janssen, Paul M. L.; Mohler, Peter J.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH USA; [Janssen, Paul M. L.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med, Columbus, OH USA; Wexner Med Ctr, Columbus, OH USA; [Huang, Claire Yu-Mei; Rasband, Matthew N.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Huang, Claire Yu-Mei; Rasband, Matthew N.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Gratz, Daniel; Hund, Thomas J.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Baylor College of Medicine; Baylor College of Medicine; University System of Ohio; Ohio State University	Mohler, PJ (corresponding author), 110G DHLRI,473 West 12th Ave, Columbus, OH 43210 USA.	Peter.Mohler@osumc.edu	Musa, Hassan/AAQ-1548-2021; Cavus, Omer/Z-4264-2019; Koenig, Sara/AAN-4417-2020	Koenig, Sara/0000-0002-5416-8621; El Refaey, Mona/0000-0003-3989-0920; Lubbers, Ellen/0000-0002-0357-5681; Daoud, Georges/0000-0003-3354-957X	National Institutes of Health [HL135754, HL134824, HL139348, HL135096, HL114383, HL114893, HL137331, HL137325]; Ohio State University Graduate School University Fellowship; Medical Scientist Training Program; Ohio State JB Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL137325, R01HL114893, R01HL139348, R01HL134824, R35HL135754, F30HL137331, R01HL135096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Graduate School University Fellowship; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State JB Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL135754, HL134824, HL139348, HL135096, and HL114383 (to P. J. M.), HL135096, HL134824, and HL114893 (to T. J. H.), HL137331 (to E. R. L.), and HL137325 (to N. P. M.), an Ohio State University Graduate School University Fellowship, Medical Scientist Training Program, and the Ohio State JB Project. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baines AJ, 2005, FRONT BIOSCI, V10, P3020, DOI 10.2741/1759; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Bennett PM, 2004, J MUSCLE RES CELL M, V25, P119, DOI 10.1023/B:JURE.0000035892.77399.51; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Centers for Disease Control and Prevention and Statistics N C, 2015, FH HLTH US 2014; Chen QC, 2018, ENVIRON SCI POLLUT R, V25, P12981, DOI 10.1007/s11356-018-1584-3; CLARKE M, 1971, BIOCHEM BIOPH RES CO, V45, P1063, DOI 10.1016/0006-291X(71)90445-1; Curran J, 2015, ANNU REV PHYSIOL, V77, P505, DOI 10.1146/annurev-physiol-021014-071838; Derbala MH, 2018, LIFE SCI, V192, P278, DOI 10.1016/j.lfs.2017.11.009; Deschenes I, 2008, J MOL CELL CARDIOL, V45, P336, DOI 10.1016/j.yjmcc.2008.05.001; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; El Refaey M, 2019, CIRC RES, V124, P737, DOI 10.1161/CIRCRESAHA.118.314350; ELGSAETER A, 1986, SCIENCE, V234, P1217, DOI 10.1126/science.3775380; Glynn P, 2014, LIFE SCI, V111, P1, DOI 10.1016/j.lfs.2014.07.005; Hamdan FF, 2012, EUR J HUM GENET, V20, P796, DOI 10.1038/ejhg.2011.271; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Huang CYM, 2017, J NEUROSCI, V37, P11323, DOI 10.1523/JNEUROSCI.2113-17.2017; Huang CYM, 2017, J NEUROSCI, V37, P11311, DOI 10.1523/JNEUROSCI.2112-17.2017; Hund TJ, 2008, J MOL CELL CARDIOL, V45, P420, DOI 10.1016/j.yjmcc.2008.06.007; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Jain P, 2014, PEDIATR CRIT CARE ME, V15, P229, DOI 10.1097/PCC.0000000000000059; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Li JD, 2007, CHANNELS, V1, P387, DOI 10.4161/chan.5449; Lou Q, 2015, J PHYSIOL-LONDON, V593, P1443, DOI 10.1113/jphysiol.2014.280784; Machnicka B, 2014, BBA-BIOMEMBRANES, V1838, P620, DOI 10.1016/j.bbamem.2013.05.002; Makara MA, 2018, JACC-BASIC TRANSL SC, V3, P675, DOI 10.1016/j.jacbts.2018.07.008; Makara MA, 2014, CIRC RES, V115, P929, DOI 10.1161/CIRCRESAHA.115.305154; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; McMahon LW, 2009, BIOCHEM BIOPH RES CO, V381, P288, DOI 10.1016/j.bbrc.2009.02.038; Musa H, 2016, HEART RHYTHM, V13, P1932, DOI 10.1016/j.hrthm.2016.06.012; Nonoda Y, 2013, BRAIN DEV-JPN, V35, P280, DOI 10.1016/j.braindev.2012.05.002; Onal B, 2017, AM J PHYSIOL-HEART C, V313, pH1227, DOI 10.1152/ajpheart.00185.2017; Onal B, 2016, METHODSX, V3, P589, DOI 10.1016/j.mex.2016.11.002; Perkins E, 2016, J PHYSIOL-LONDON, V594, P4661, DOI 10.1113/JP271195; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Ponce-Balbuena D, 2018, CIRC RES, V122, P1501, DOI 10.1161/CIRCRESAHA.117.311872; Portero V, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00178; Salomao M, 2006, P NATL ACAD SCI USA, V103, P643, DOI 10.1073/pnas.0507661103; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith SA, 2016, AM J PHYSIOL-HEART C, V310, pH1583, DOI 10.1152/ajpheart.00875.2015; Sridharan D, 2003, J CELL SCI, V116, P823, DOI 10.1242/jcs.00294; Stankewich MC, 2011, J CELL SCI, V124, P3956, DOI 10.1242/jcs.080374; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Tohyama J, 2015, J HUM GENET, V60, P167, DOI 10.1038/jhg.2015.5; Uemoto Y, 2007, J BIOL CHEM, V282, P6548, DOI 10.1074/jbc.M609223200; Ursitti JA, 2007, J MOL CELL CARDIOL, V42, P572, DOI 10.1016/j.yjmcc.2006.11.018; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Wang Y, 2018, J CLIN INVEST, V128, P760, DOI 10.1172/JCI95743; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Zhang R, 2013, SCI CHINA LIFE SCI, V56, P1076, DOI 10.1007/s11427-013-4575-0; Zhang YH, 2010, J MOL CELL CARDIOL, V48, P1050, DOI 10.1016/j.yjmcc.2010.01.001	53	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9576	9591		10.1074/jbc.RA119.007714	http://dx.doi.org/10.1074/jbc.RA119.007714			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31064843	Green Published, hybrid			2022-12-28	WOS:000472713000023
J	Machacek, M; Saunders, H; Zhang, Z; Tan, EP; Li, JB; Li, TG; Villar, MT; Artigues, A; Lydic, T; Cork, G; Slawson, C; Fields, PE				Machacek, Miranda; Saunders, Harmony; Zhang, Zhen; Tan, Ee Phie; Li, Jibiao; Li, Tiangang; Villar, Maria T.; Artigues, Antonio; Lydic, Todd; Cork, Gentry; Slawson, Chad; Fields, Patrick E.			Elevated O-GlcNAcylation enhances pro-inflammatory Th17 function by altering the intracellular lipid microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						obesity; type 2 diabetes; inflammation; O-linked N-acetylglucosamine (O-GlcNAc); T helper cells; acetyl-CoA carboxylase (ACC); RAR-related orphan receptor gamma t variant; Th17; lipid metabolism	T-CELL-ACTIVATION; ROR-GAMMA-T; ADIPOSE-TISSUE; N-ACETYLGLUCOSAMINE; INSULIN-RESISTANCE; DIFFERENTIATION; NUCLEAR; PHOSPHORYLATION; CHOLINE; GLUCOSE	Chronic, low-grade inflammation increases the risk for atherosclerosis, cancer, and autoimmunity in diseases such as obesity and diabetes. Levels of CD4(+) T helper 17 (Th17) cells, which secrete interleukin 17A (IL-17A), are increased in obesity and contribute to the inflammatory milieu; however, the relationship between signaling events triggered by excess nutrient levels and IL-17A-mediated inflammation is unclear. Here, using cytokine, quantitative real-time PCR, immunoprecipitation, and ChIP assays, along with lipidomics and MS-based approaches, we show that increased levels of the nutrient-responsive, post-translational protein modification, O-GlcNAc, are present in naive CD4(+) T cells from a diet-induced obesity murine model and that elevated O-GlcNAc levels increase IL-17A production. We also found that increased binding of the Th17 master transcription factor RAR-related orphan receptor t variant (RORt) at the IL-17 gene promoter and enhancer, as well as significant alterations in the intracellular lipid microenvironment, elevates the production of ligands capable of increasing RORt transcriptional activity. Importantly, the rate-limiting enzyme of fatty acid biosynthesis, acetyl-CoA carboxylase 1 (ACC1), is O-GlcNAcylated and necessary for production of these RORt-activating ligands. Our results suggest that increased O-GlcNAcylation of cellular proteins may be a potential link between excess nutrient levels and pathological inflammation.	[Machacek, Miranda; Saunders, Harmony; Cork, Gentry; Fields, Patrick E.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Machacek, Miranda; Saunders, Harmony; Zhang, Zhen; Tan, Ee Phie; Villar, Maria T.; Artigues, Antonio; Cork, Gentry; Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Li, Jibiao; Li, Tiangang] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Lydic, Todd] Michigan State Univ, Dept Physiol, Collaborat Mass Spectrometry Core, E Lansing, MI 48824 USA; [Zhang, Zhen] Univ Penn, Dept Cell Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhang, Zhen] Univ Penn, Dept Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tan, Ee Phie] Sanford Burnham Prebys Med Discovery Inst, Program Dev Aging & Regenerat, La Jolla, CA 92037 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Michigan State University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Sanford Burnham Prebys Medical Discovery Institute	Fields, PE (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA.; Slawson, C (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	cslawson@kumc.edu; pfields@kumc.edu	Lydic, Todd A./ADB-0177-2022; Li, Jibiao/A-5627-2017; Fields, Patrick E/G-4878-2012; Tan, Ee Phie/AAC-8378-2021	Saunders, Harmony/0000-0002-4417-717X; Fields, Patrick/0000-0002-6797-4139	Molecular Regulation of Cell Development and Differentiation COBRE [P30GM122731]; University of Kansas Medical Center Biomedical Research Training Program grant; NATIONAL CANCER INSTITUTE [P30CA168524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK117965, R01DK102487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM122731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG035982] Funding Source: NIH RePORTER	Molecular Regulation of Cell Development and Differentiation COBRE; University of Kansas Medical Center Biomedical Research Training Program grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Molecular Regulation of Cell Development and Differentiation COBRE P30GM122731 (to P.E.F. and C.S.) and a University of Kansas Medical Center Biomedical Research Training Program grant (to M.M.).	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chehimi M, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070068; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Chuang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5602; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Cox MA, 2019, SCIENCE, V363, P639, DOI 10.1126/science.aau9072; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Eljaafari A, 2015, DIABETES, V64, P2477, DOI 10.2337/db15-0162; Endo Y, 2015, CELL REP, V12, P1042, DOI 10.1016/j.celrep.2015.07.014; Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Geginat J, 2013, SEMIN IMMUNOL, V25, P252, DOI 10.1016/j.smim.2013.10.012; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Glatzel DK, 2018, J LIPID RES, V59, P298, DOI 10.1194/jlr.M080101; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Gwinn DM, 2010, ENZYMES, V28, P49, DOI 10.1016/S1874-6047(10)28003-4; HA J, 1994, J BIOL CHEM, V269, P22162; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hewagama A, 2013, J AUTOIMMUN, V41, P60, DOI 10.1016/j.jaut.2012.12.006; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; KEARSE KP, 1991, ARCH BIOCHEM BIOPHYS, V290, P543, DOI 10.1016/0003-9861(91)90579-8; Kidani Y, 2017, CURR OPIN IMMUNOL, V46, P121, DOI 10.1016/j.coi.2017.03.012; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Liu RQ, 2017, J IMMUNOL, V198, P2626, DOI 10.4049/jimmunol.1601727; Lund PJ, 2016, J IMMUNOL, V197, P3086, DOI 10.4049/jimmunol.1502031; Lydic TA, 2015, METHODS, V87, P83, DOI 10.1016/j.ymeth.2015.04.014; Lydic TA, 2014, J LIPID RES, V55, P1797, DOI 10.1194/jlr.D050302; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; McDonald JG, 2007, METHOD ENZYMOL, V432, P145, DOI 10.1016/S0076-6879(07)32006-5; McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; NIKAWA J, 1979, FEBS LETT, V102, P223, DOI 10.1016/0014-5793(79)80005-8; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; RIECKEHOFF IG, 1980, NUTR REV, V38, P247; RINNER I, 1993, J NEUROSCI RES, V35, P188, DOI 10.1002/jnr.490350209; Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004; Scheffel MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15791-x; Schindler TI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01543; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Shen Y, 2008, BIOCHEMISTRY-US, V47, P5767, DOI 10.1021/bi800314m; Shen Y, 2017, NAT IMMUNOL, V18, P1025, DOI 10.1038/ni.3808; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Soroosh P, 2014, P NATL ACAD SCI USA, V111, P12163, DOI 10.1073/pnas.1322807111; Stadhouders R, 2018, J AUTOIMMUN, V87, P1, DOI 10.1016/j.jaut.2017.12.007; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Wei J, 2015, NATURE, V526, P723, DOI 10.1038/nature15375; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206	69	23	24	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8973	8990		10.1074/jbc.RA119.008373	http://dx.doi.org/10.1074/jbc.RA119.008373			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31010828	Green Published, hybrid			2022-12-28	WOS:000470971100029
J	Ivanov, A; Shuvalova, E; Egorova, T; Shuvalov, A; Sokolova, E; Bizyaev, N; Shatsky, I; Terenin, I; Alkalaeva, E				Ivanov, Alexandr; Shuvalova, Ekaterina; Egorova, Tatiana; Shuvalov, Alexey; Sokolova, Elizaveta; Bizyaev, Nikita; Shatsky, Ivan; Terenin, Ilya; Alkalaeva, Elena			Polyadenylate-binding protein-interacting proteins PAIP1 and PAIP2 affect translation termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribosome; translation release factor; translation control; translation; protein complex; eRF3a; PABP; PAIP1; PAIP2; stop codon readthrough	STOP CODON RECOGNITION; EUKARYOTIC TRANSLATION; MESSENGER-RNA; POLY(A)-BINDING PROTEIN; FACTOR ERF1; INITIATION-FACTOR; CRYSTAL-STRUCTURE; RELEASE FACTORS; EIF4G; PABP	Polyadenylate-binding protein (PABP) stimulates translation termination via interaction of its C-terminal domain with eukaryotic polypeptide chain release factor, eRF3. Additionally, two other proteins, poly(A)-binding protein-interacting proteins 1 and 2 (PAIP1 and PAIP2), bind the same domain of PABP and regulate its translation-related activity. To study the biochemistry of eRF3 and PAIP1/2 competition for PABP binding, we quantified the effects of PAIPs on translation termination in the presence or absence of PABP. Our results demonstrated that both PAIP1 and PAIP2 prevented translation termination at the premature termination codon, by controlling PABP activity. Moreover, PAIP1 and PAIP2 inhibited the activity of free PABP on translation termination in vitro. However, after binding the poly(A) tail, PABP became insensitive to suppression by PAIPs and efficiently activated translation termination in the presence of eRF3a. Additionally, we revealed that PAIP1 binds eRF3 in solution, which stabilizes the post-termination complex. These results indicated that PAIP1 and PAIP2 participate in translation termination and are important regulators of readthrough at the premature termination codon.	[Ivanov, Alexandr; Shuvalova, Ekaterina; Egorova, Tatiana; Shuvalov, Alexey; Sokolova, Elizaveta; Bizyaev, Nikita; Alkalaeva, Elena] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Ivanov, Alexandr] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119234, Russia; [Shatsky, Ivan; Terenin, Ilya] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119234, Russia; [Terenin, Ilya] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow 119146, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University; Lomonosov Moscow State University; Sechenov First Moscow State Medical University	Alkalaeva, E (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia.; Terenin, I (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119234, Russia.; Terenin, I (corresponding author), Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow 119146, Russia.	terenin@genebee.msu.ru; alkalaeva@eimb.ru	Ivanov, Alexander V/Q-9672-2017; Shuvalov, Alexey/ABG-3217-2021; Egorova, Tatiana/P-9982-2017; Alkalaeva, Elena/ABC-3888-2021; SOKOLOVA, ELIZAVETA/F-2461-2019; Shuvalova, Ekaterina/F-2469-2019; Ivanov, Alexandr/AAM-6231-2021; Terenin, Ilya/Q-6470-2019; Biziaev, Nikita/ABF-5694-2021	Ivanov, Alexander V/0000-0002-0000-0401; Shuvalov, Alexey/0000-0002-0346-3794; Alkalaeva, Elena/0000-0003-2078-7261; Ivanov, Alexandr/0000-0002-0000-0401; Terenin, Ilya/0000-0002-4459-0781; Biziaev, Nikita/0000-0001-5587-5398; Shuvalova, Ekaterina/0000-0003-2379-4328; SOKOLOVA, ELIZAVETA/0000-0002-5324-0070	Russian Science Foundation [14-14-00487]; Russian Foundation for Basic Research [15-04-08174, 16-04-01628]; Program of Fundamental Research for State Academies [1201363822]; Russian Science Foundation [17-14-00106] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program of Fundamental Research for State Academies; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation Grant 14-14-00487, Russian Foundation for Basic Research Grants 15-04-08174 and 16-04-01628; and Program of Fundamental Research for State Academies Grant 1201363822. The authors declare that they have no conflicts of interest with the contents of this article.	Alkalaeva E, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600213; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Andreev DE, 2009, NUCLEIC ACIDS RES, V37, P6135, DOI 10.1093/nar/gkp665; Borman AM, 2000, NUCLEIC ACIDS RES, V28, P4068, DOI 10.1093/nar/28.21.4068; Brown A, 2015, NATURE, V524, P493, DOI 10.1038/nature14896; Costello J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0559-z; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; des Georges A, 2014, NUCLEIC ACIDS RES, V42, P3409, DOI 10.1093/nar/gkt1279; Dubovaya VI, 2006, MOL BIOL+, V40, P310; Eliseev B, 2011, NUCLEIC ACIDS RES, V39, P599, DOI 10.1093/nar/gkq759; Eliseeva IA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1377, DOI 10.1134/S0006297913130014; Feng T, 2014, MOL CELL, V53, P645, DOI 10.1016/j.molcel.2013.12.028; Heaphy SM, 2016, MOL BIOL EVOL, V33, P2885, DOI 10.1093/molbev/msw166; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Ivanov A, 2016, NUCLEIC ACIDS RES, V44, P7766, DOI 10.1093/nar/gkw635; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; Kozlov G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010169; Kryuchkova P, 2013, NUCLEIC ACIDS RES, V41, P4573, DOI 10.1093/nar/gkt113; Lee SH, 2014, NUCLEIC ACIDS RES, V42, P2697, DOI 10.1093/nar/gkt1170; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; Mikhailova T, 2017, NUCLEIC ACIDS RES, V45, P1307, DOI 10.1093/nar/gkw1239; Preis A, 2014, CELL REP, V8, P59, DOI 10.1016/j.celrep.2014.04.058; Rajkowitsch L, 2004, J MOL BIOL, V335, P71, DOI 10.1016/j.jmb.2003.10.049; Roy G, 2002, MOL CELL BIOL, V22, P3769, DOI 10.1128/MCB.22.11.3769-3782.2002; Shirokikh NE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1025; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Susorov D, 2015, NUCLEIC ACIDS RES, V43, P3332, DOI 10.1093/nar/gkv171; Swart EC, 2016, CELL, V166, P691, DOI 10.1016/j.cell.2016.06.020; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Zahonova K, 2016, CURR BIOL, V26, P2364, DOI 10.1016/j.cub.2016.06.064; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	39	12	12	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8630	8639		10.1074/jbc.RA118.006856	http://dx.doi.org/10.1074/jbc.RA118.006856			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30992367	hybrid, Green Published			2022-12-28	WOS:000471108200029
J	Agnew, C; Liu, LJ; Liu, S; Xu, W; You, L; Yeung, W; Kannan, N; Jablons, D; Jura, N				Agnew, Christopher; Liu, Lijun; Liu, Shu; Xu, Wei; You, Liang; Yeung, Wayland; Kannan, Natarajan; Jablons, David; Jura, Natalia			The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serine; threonine protein kinase; fibrosis; cancer; DYRK1A; structural biology; neurodegenerative disease; inhibitor; CMGC superfamily; homeodomain-interacting protein kinase 2 (HIPK2)	ACTIVATION-LOOP; SUBCELLULAR-LOCALIZATION; CATALYTIC-ACTIVITY; HOMEODOMAIN; INHIBITOR; CK2; AUTOPHOSPHORYLATION; SPECIFICITY; DYRK1A; IDENTIFICATION	The homeodomain-interacting protein kinase (HIPK) family is comprised of four nuclear protein kinases, HIPK1-4. HIPK proteins phosphorylate a diverse range of transcription factors involved in cell proliferation, differentiation, and apoptosis. HIPK2, thus far the best-characterized member of this largely understudied family of protein kinases, plays a role in the activation of p53 in response to DNA damage. Despite this tumor-suppressor function, HIPK2 is also found overexpressed in several cancers, and its hyperactivation causes chronic fibrosis. There are currently no structures of HIPK2 or of any other HIPK kinase. Here, we report the crystal structure of HIPK2's kinase domain bound to CX-4945, a casein kinase 2 alpha (CK2 alpha) inhibitor currently in clinical trials against several cancers. The structure, determined at 2.2 angstrom resolution, revealed that CX-4945 engages the HIPK2 active site in a hybrid binding mode between that seen in structures of CK2 alpha and Pim1 kinases. The HIPK2 kinase domain crystallized in the active conformation, which was stabilized by phosphorylation of the activation loop. We noted that the overall kinase domain fold of HIPK2 closely resembles that of evolutionarily related dual-specificity tyrosine-regulated kinases (DYRKs). Most significant structural differences between HIPK2 and DYRKs included an absence of the regulatory N-terminal domain and a unique conformation of the CMGC-insert region and of a newly defined insert segment in the alpha C-beta 4 loop. This first crystal structure of HIPK2 paves the way for characterizing the understudied members of the HIPK family and for developing HIPK2-directed therapies for managing cancer and fibrosis.	[Agnew, Christopher; Liu, Lijun; Jura, Natalia] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Jura, Natalia] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Liu, Shu; Xu, Wei; You, Liang; Jablons, David] Univ Calif San Francisco, Dept Surg, Thorac Oncol Lab, Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Yeung, Wayland; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Yeung, Wayland; Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Jablons, D (corresponding author), 1600 Divisadero St,A745, San Francisco, CA 94115 USA.; Jura, N (corresponding author), 555 Mission Bay Blvd S,Rm 452W, San Francisco, CA 94158 USA.	david.jablons@ucsf.edu; natalia.jura@ucsf.edu		Yeung, Wayland/0000-0002-2523-4984; Agnew, Christopher/0000-0003-0934-5534	National Institutes of Health [1U01CA239106]; Kazan McClain Partners' Foundation; H. N. and Frances C. Berger Foundation; NATIONAL CANCER INSTITUTE [U01CA239106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kazan McClain Partners' Foundation; H. N. and Frances C. Berger Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Institutes of Health Grant 1U01CA239106.; Supported by the Kazan McClain Partners' Foundation and the H. N. and Frances C. Berger Foundation.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Beiti MAM, 2008, AUST NZ J OBSTET GYN, V48, P329, DOI 10.1111/j.1479-828X.2008.00874.x; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Battistutta R, 2011, BIOCHEMISTRY-US, V50, P8478, DOI 10.1021/bi2008382; Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Berendsen H.J.C., 1998, CHEM PHYS, V81, P3684, DOI DOI 10.1063/1.448118; Blaquiere JA, 2017, CURR TOP DEV BIOL, V123, P73, DOI 10.1016/bs.ctdb.2016.10.002; Bogusz J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13557-z; Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chuang PY, 2013, J MOL MED, V91, P549, DOI 10.1007/s00109-012-0983-z; Comess KM, 2011, ACS CHEM BIOL, V6, P234, DOI 10.1021/cb1002619; Courcet JB, 2012, J MED GENET, V49, P731, DOI 10.1136/jmedgenet-2012-101251; Coutadeur S, 2015, J NEUROCHEM, V133, P440, DOI 10.1111/jnc.13018; Cozza G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089176; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; de la Vega L, 2012, MOL CELL, V46, P472, DOI 10.1016/j.molcel.2012.03.003; Deshmukh H, 2008, ONCOGENE, V27, P4745, DOI 10.1038/onc.2008.110; Duchon A, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00104; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan Y, 2014, KIDNEY INT SUPPL, V4, P97, DOI 10.1038/kisup.2014.18; Ferguson AD, 2011, FEBS LETT, V585, P104, DOI 10.1016/j.febslet.2010.11.019; Getlik M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039713; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; He P, 2017, BIOMED PHARMACOTHER, V85, P575, DOI 10.1016/j.biopha.2016.11.066; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hofmann TG, 2013, BIOESSAYS, V35, P55, DOI 10.1002/bies.201200060; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Huang YH, 2015, INT J MOL MED, V35, P311, DOI 10.3892/ijmm.2014.2008; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Jacob K, 2009, BRIT J CANCER, V101, P722, DOI 10.1038/sj.bjc.6605179; Jin YM, 2012, NAT MED, V18, P580, DOI 10.1038/nm.2685; Kallen J, 2018, CHEMMEDCHEM, V13, P1997, DOI 10.1002/cmdc.201800344; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kim EJ, 2002, J BIOL CHEM, V277, P32020, DOI 10.1074/jbc.M200153200; Kim K, 2018, J MOL BIOL, V430, P1521, DOI 10.1016/j.jmb.2018.04.001; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kinstrie R, 2006, BIOCHEM J, V398, P45, DOI 10.1042/BJ20060159; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kwon MJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1056427; Lanni C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010171; Larribere L, 2017, STEM CELL REP, V9, P1234, DOI 10.1016/j.stemcr.2017.08.023; Lee S, 2016, NEURON, V91, P41, DOI 10.1016/j.neuron.2016.05.021; Lee W, 2009, DEV BIOL, V325, P263, DOI 10.1016/j.ydbio.2008.10.029; Lee W, 2009, DEVELOPMENT, V136, P241, DOI 10.1242/dev.025460; Li K, 2002, J BIOL CHEM, V277, P47052, DOI 10.1074/jbc.M205374200; Liu RJ, 2017, J AM SOC NEPHROL, V28, P2133, DOI 10.1681/ASN.2016080841; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGrath DA, 2013, NAT STRUCT MOL BIOL, V20, P1407, DOI 10.1038/nsmb.2707; Meharena HS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001680; Mercer SE, 2005, J BIOL CHEM, V280, P25788, DOI 10.1074/jbc.M413594200; Miller CJ, 2018, TRENDS BIOCHEM SCI, V43, P380, DOI 10.1016/j.tibs.2018.02.009; Neuwald AF, 2003, GENOME RES, V13, P673, DOI 10.1101/gr.862303; Neuwald AF, 2014, J COMPUT BIOL, V21, P269, DOI 10.1089/cmb.2013.0099; Niefind K, 2009, CELL MOL LIFE SCI, V66, P1800, DOI 10.1007/s00018-009-9149-8; Nugent MM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00132; Oshima T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau9060; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padgett CS, 2010, EJC SUPPL, V8, P131, DOI 10.1016/S1359-6349(10)72121-2; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Pierre F, 2011, J MED CHEM, V54, P635, DOI 10.1021/jm101251q; Ricci A, 2013, J CELL PHYSIOL, V228, P235, DOI 10.1002/jcp.24129; Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Sarno S, 2011, CURR TOP MED CHEM, V11, P1340, DOI 10.2174/156802611795589638; Saul VV, 2013, J MOL MED, V91, P1051, DOI 10.1007/s00109-013-1042-0; Saul VV, 2013, J MOL CELL BIOL, V5, P27, DOI 10.1093/jmcb/mjs053; Scaglione A, 2018, PROTEIN SCI, V27, P725, DOI 10.1002/pro.3367; Schmitz ML, 2014, BIOL CHEM, V395, P375, DOI 10.1515/hsz-2013-0264; Shang YL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001527; Shojima N, 2012, DIABETOLOGIA, V55, P3318, DOI 10.1007/s00125-012-2711-1; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Siepi F, 2013, BBA-MOL CELL RES, V1833, P1443, DOI 10.1016/j.bbamcr.2013.02.018; Sombroek D, 2009, CELL DEATH DIFFER, V16, P187, DOI 10.1038/cdd.2008.154; Soundararajan M, 2013, STRUCTURE, V21, P986, DOI 10.1016/j.str.2013.03.012; Stotani S, 2016, FUTURE MED CHEM, V8, P681, DOI 10.4155/fmc-2016-0013; Sung KS, 2005, FEBS LETT, V579, P3001, DOI 10.1016/j.febslet.2005.04.053; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Torrente L, 2017, ONCOGENE, V36, P6204, DOI 10.1038/onc.2017.221; van der Laden J, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-014-0082-6; Whittaker SR, 2017, PHARMACOL THERAPEUT, V173, P83, DOI 10.1016/j.pharmthera.2017.02.008; Widowati Esti Wahyu, 2018, BMC Res Notes, V11, P297, DOI 10.1186/s13104-018-3416-4; Wiechmann S, 2003, BIOCHEM BIOPH RES CO, V302, P403, DOI 10.1016/S0006-291X(03)00148-7; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Xu M, 2019, EUR J MED CHEM, V164, P448, DOI 10.1016/j.ejmech.2018.12.073; Yu M, 2017, CELL RES, V27, P1441, DOI 10.1038/cr.2017.113; Zakharia K, 2019, TRANSL ONCOL, V12, P143, DOI 10.1016/j.tranon.2018.09.005; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhao YX, 2017, ANN PLAS SURG, V79, P546, DOI 10.1097/SAP.0000000000001243	104	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13545	13559		10.1074/jbc.RA119.009725	http://dx.doi.org/10.1074/jbc.RA119.009725			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31341017	hybrid, Green Published			2022-12-28	WOS:000486418600003
J	Arnal, G; Stogios, PJ; Asohan, J; Attia, MA; Skarina, T; Viborg, AH; Henrissat, B; Savchenko, A; Brumer, H				Arnal, Gregory; Stogios, Peter J.; Asohan, Jathavan; Attia, Mohamed A.; Skarina, Tatiana; Viborg, Alexander Holm; Henrissat, Bernard; Savchenko, Alexei; Brumer, Harry			Substrate specificity, regiospecificity, and processivity in glycoside hydrolase family 74	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; plant cell wall; polysaccharide; protein evolution; carbohydrate metabolism; glycobiology; glycosidase; phylogenetics; processivity; structure-function; carbohydrate-active enzymes (CAZymes); glycoside hydrolase family 74 (GH74); hemicellulose; xyloglucan; xyloglucanase; molecular phylogeny; enzyme evolution; enzyme structure-function relationships; cellulase	AMINO-ACID RESIDUE; ENDO-XYLOGLUCANASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CLOSTRIDIUM-THERMOCELLUM; ASPERGILLUS-NIGER; EXPRESSION; CLONING; REVEALS; PURIFICATION	Glycoside hydrolase family 74 (GH74) is a historically important family of endo-beta-glucanases. On the basis of early reports of detectable activity on cellulose and soluble cellulose derivatives, GH74 was originally considered to be a "cellulase" family, although more recent studies have generally indicated a high specificity toward the ubiquitous plant cell wall matrix glycan xyloglucan. Previous studies have indicated that GH74 xyloglucanases differ in backbone cleavage regiospecificities and can adopt three distinct hydrolytic modes of action: exo, endo-dissociative, and endo-processive. To improve functional predictions within GH74, here we coupled in-depth biochemical characterization of 17 recombinant proteins with structural biology-based investigations in the context of a comprehensive molecular phylogeny, including all previously characterized family members. Elucidation of four new GH74 tertiary structures, as well as one distantly related dual seven-bladed beta-propeller protein from a marine bacterium, highlighted key structure-function relationships along protein evolutionary trajectories. We could define five phylogenetic groups, which delineated the mode of action and the regiospecificity of GH74 members. At the extremes, a major group of enzymes diverged to hydrolyze the backbone of xyloglucan nonspecifically with a dissociative mode of action and relaxed backbone regiospecificity. In contrast, a sister group of GH74 enzymes has evolved a large hydrophobic platform comprising 10 subsites, which facilitates processivity. Overall, the findings of our study refine our understanding of catalysis in GH74, providing a framework for future experimentation as well as for bioinformatics predictions of sequences emerging from (meta)genomic studies.	[Arnal, Gregory; Asohan, Jathavan; Attia, Mohamed A.; Viborg, Alexander Holm; Brumer, Harry] Univ British Columbia, Michael Smith Labs, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada; [Stogios, Peter J.; Skarina, Tatiana; Savchenko, Alexei] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [Attia, Mohamed A.; Brumer, Harry] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Henrissat, Bernard] Aix Marseille Univ, CNRS, AFMB, F-13007 Marseille, France; [Henrissat, Bernard] INRA, USC1408 Architecture & Fonct Macromol Biol AFMB, F-13007 Marseille, France; [Savchenko, Alexei] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Brumer, Harry] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Brumer, Harry] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of Toronto; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; University of Calgary; University of British Columbia; University of British Columbia	Brumer, H (corresponding author), Univ British Columbia, Michael Smith Labs, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada.; Savchenko, A (corresponding author), Univ Calgary, Hlth Sci Ctr 3330, Calgary, AB T2N 1N4, Canada.	alexei.savchenko@ucalgary.ca; brumer@msl.ubc.ca	Viborg, Alexander/AAI-4943-2021; Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Brumer, Harry/0000-0002-0101-862X; Stogios, Peter/0000-0001-8663-1425	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	We thank Nobuhiko Watanabe and Bogulaw Nocek for synchrotron diffraction data collection and/or structure solution for NkGH74, SrGH74, and AFV00434. NkGH74 and SrGH74 data were collected at the Canadian Macromolecular Crystallography Facility (89). For AFV00434, structural work presented in this paper was performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by U. Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. Waters Corp. is gratefully acknowledged for the provision of the intact protein LC-MS system used in the present study. We thank Dr. Julie Grondin for critically reading and editing the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alahuhta M, 2013, ACTA CRYSTALLOGR F, V69, P1335, DOI 10.1107/S1744309113030005; ARAI M, 1989, AGR BIOL CHEM TOKYO, V53, P1411, DOI 10.1080/00021369.1989.10869470; Arnal G, 2018, BIOCHEM J, V475, P3963, DOI 10.1042/BCJ20180763; Arnal G, 2017, METHODS MOL BIOL, V1588, P3, DOI 10.1007/978-1-4939-6899-2_1; Arnal G, 2015, APPL ENVIRON MICROB, V81, P31, DOI 10.1128/AEM.02257-14; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Attia M, 2016, FEBS J, V283, P1701, DOI 10.1111/febs.13696; Attia MA, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1039-6; Attia MA, 2016, CURR OPIN STRUC BIOL, V40, P43, DOI 10.1016/j.sbi.2016.07.005; Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115; Bauer S, 2005, CARBOHYD RES, V340, P2590, DOI 10.1016/j.carres.2005.09.014; Berezina OV, 2017, APPL MICROBIOL BIOT, V101, P5653, DOI 10.1007/s00253-017-8297-2; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Chhabra SR, 2002, FEBS LETT, V531, P375, DOI 10.1016/S0014-5793(02)03493-2; Christensen SJ, 2018, FEBS J, V285, P4482, DOI 10.1111/febs.14668; Davies G. J., 2008, BIOCHEMIST, V30, P26, DOI DOI 10.1042/BJ20080382; Damasio ARD, 2017, APPL MICROBIOL BIOT, V101, P2893, DOI 10.1007/s00253-016-8014-6; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Desmet T, 2007, FEBS J, V274, P356, DOI 10.1111/j.1742-4658.2006.05582.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eklof JM, 2012, METHOD ENZYMOL, V510, P97, DOI 10.1016/B978-0-12-415931-0.00006-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enkhbaatar B, 2012, APPL ENVIRON MICROB, V78, P607, DOI 10.1128/AEM.06482-11; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Feng T, 2014, APPL MICROBIOL BIOT, V98, P9667, DOI 10.1007/s00253-014-5825-1; Galloway AF, 2018, NEW PHYTOL, V217, P1128, DOI 10.1111/nph.14897; Grishutin SG, 2004, BBA-GEN SUBJECTS, V1674, P268, DOI 10.1016/j.bbagen.2004.07.001; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Hamre AG, 2014, FEBS LETT, V588, P4620, DOI 10.1016/j.febslet.2014.10.034; Hasper AA, 2002, APPL ENVIRON MICROB, V68, P1556, DOI 10.1128/AEM.68.4.1556-1560.2002; HENRISSAT B, 1989, GENE, V81, P83, DOI 10.1016/0378-1119(89)90339-9; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ichinose H, 2012, APPL ENVIRON MICROB, V78, P7939, DOI 10.1128/AEM.01762-12; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Irwin D, 1998, J BACTERIOL, V180, P1709, DOI 10.1128/JB.180.7.1709-1714.1998; Irwin DC, 2003, EUR J BIOCHEM, V270, P3083, DOI 10.1046/j.1432-1033.2003.03695.x; Ishida T, 2007, FEBS J, V274, P5727, DOI 10.1111/j.1742-4658.2007.06092.x; Ishida T, 2009, J BIOL CHEM, V284, P10100, DOI 10.1074/jbc.M808122200; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lacerda GV, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw248; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lopez-Mondejar R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25279; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Martinez-Fleites C, 2006, J BIOL CHEM, V281, P24922, DOI 10.1074/jbc.M603583200; Matsuzawa T, 2016, TRENDS GLYCOSCI GLYC, V28, pE63, DOI 10.4052/tigg.1510.1E; Matsuzawa T, 2014, FEBS LETT, V588, P1731, DOI 10.1016/j.febslet.2014.03.023; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mishra A, 2009, J MATER CHEM, V19, P8528, DOI 10.1039/b911150f; Moroz OV, 2018, ACS CATAL, V8, P6021, DOI 10.1021/acscatal.8b00666; Nelson CE, 2017, ENVIRON MICROBIOL, V19, P5025, DOI 10.1111/1462-2920.13959; Pages S, 2001, J BIOL CHEM, V276, P33652, DOI 10.1074/jbc.M105770200; Park YB, 2015, PLANT CELL PHYSIOL, V56, P180, DOI 10.1093/pcp/pcu204; Pauly M, 1999, PLANT J, V20, P629, DOI 10.1046/j.1365-313X.1999.00630.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rozeboom HJ, 2013, FEBS J, V280, P6061, DOI 10.1111/febs.12524; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schultink Alex, 2014, Plants (Basel), V3, P526, DOI 10.3390/plants3040526; Sianidis G, 2006, J BIOTECHNOL, V121, P498, DOI 10.1016/j.jbiotec.2005.08.002; St John FJ, 2010, FEBS LETT, V584, P4435, DOI 10.1016/j.febslet.2010.09.051; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sundqvist G, 2007, J CHROMATOGR B, V852, P188, DOI 10.1016/j.jchromb.2007.01.011; Tsukagoshi H, 2014, BIOCHEM BIOPH RES CO, V452, P520, DOI 10.1016/j.bbrc.2014.08.103; Tuomivaara ST, 2015, CARBOHYD RES, V402, P56, DOI 10.1016/j.carres.2014.06.031; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wegmann U, 2014, ENVIRON MICROBIOL, V16, P2879, DOI 10.1111/1462-2920.12217; Yaoi K, 2005, APPL ENVIRON MICROB, V71, P7670, DOI 10.1128/AEM.71.12.7670-7678.2005; Yaoi K, 2004, STRUCTURE, V12, P1209, DOI 10.1016/j.str.2004.04.020; Yaoi K, 2004, FEBS LETT, V560, P45, DOI 10.1016/S0014-5793(04)00068-7; Yaoi K, 2002, J BIOL CHEM, V277, P48276, DOI 10.1074/jbc.M208443200; Yaoi K, 2007, J MOL BIOL, V370, P53, DOI 10.1016/j.jmb.2007.04.035; Yaoi K, 2009, FEBS J, V276, P5094, DOI 10.1111/j.1742-4658.2009.07205.x; Zhao YX, 1997, J BIOTECHNOL, V57, P181, DOI 10.1016/S0168-1656(97)00098-9; Zheng YZ, 2018, PLANT J, V93, P211, DOI 10.1111/tpj.13778; Zhou Q, 2007, CELLULOSE, V14, P625, DOI 10.1007/s10570-007-9109-0; Zverlov VV, 2005, MICROBIOL-SGM, V151, P3395, DOI 10.1099/mic.0.28206-0	89	20	21	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13233	13247		10.1074/jbc.RA119.009861	http://dx.doi.org/10.1074/jbc.RA119.009861			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31324716	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000486417200004
J	Driller, R; Ballaschk, M; Schmieder, P; Uchanska-Ziegler, B; Ziegler, A; Loll, B				Driller, Ronja; Ballaschk, Martin; Schmieder, Peter; Uchanska-Ziegler, Barbara; Ziegler, Andreas; Loll, Bernhard			Metal-triggered conformational reorientation of a self-peptide bound to a disease-associated HLA-B*27 subtype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmunity; nuclear magnetic resonance (NMR); X-ray crystallography; crystal structure; major histocompatibility complex (MHC); autoimmune disease; ankylosing spondylitis; conformational change; HLA-B*27; peptide dynamics; ensemble refinement; hypersensitivity; NMR spectroscopy	MAJOR HISTOCOMPATIBILITY COMPLEX; HLA-B27 SUBTYPES; ANKYLOSING-SPONDYLITIS; LIGAND INTERACTIONS; STRUCTURAL BASIS; SOFT ACIDS; T-CELLS; ANTIGEN; HYPERSENSITIVITY; SPONDYLOARTHRITIS	Conformational changes of major histocompatibility complex (MHC) antigens have the potential to be recognized by T cells and may arise from polymorphic variation of the MHC molecule, the binding of modifying ligands, or both. Here, we investigated whether metal ions could affect allele-dependent structural variation of the two minimally distinct human leukocyte antigen (HLA)-B*27:05 and HLA-B*27:09 subtypes, which exhibit differential association with the rheumatic disease ankylosing spondylitis (AS). We employed NMR spectroscopy and X-ray crystallography coupled with ensemble refinement to study the AS-associated HLA-B*27:05 subtype and the AS-nonassociated HLA-B*27:09 in complex with the self-peptide pVIPR (RRKWRRWHL). Both techniques revealed that pVIPR exhibits a higher degree of flexibility when complexed with HLA-B*27:05 than with HLA-B*27:09. Furthermore, we found that the binding of the metal ion Cu2+ or Ni2+, but not Mn2+, Zn2+, or Hg2+, affects the structure of a pVIPR-bound HLA-B*27 molecule in a subtype-dependent manner. In HLA-B*27:05, the metals triggered conformational reorientations of pVIPR, but no such structural changes were observed in the HLA-B*27:09 subtype, with or without bound metal ion. These observations provide the first demonstration that not only major histocompatibility complex class II, but also class I, molecules can undergo metal ion-induced conformational alterations. Our findings suggest that metals may have a role in triggering rheumatic diseases such as AS and also have implications for the molecular basis of metal-induced hypersensitivities and allergies.	[Driller, Ronja; Loll, Bernhard] Free Univ Berlin, AG Strukturbiochem, Inst Chemie Biochem, Takustr 6, D-14195 Berlin, Germany; [Ballaschk, Martin; Schmieder, Peter] Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany; [Uchanska-Ziegler, Barbara] Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, Thielallee 73, D-14195 Berlin, Germany; [Uchanska-Ziegler, Barbara; Ziegler, Andreas] Ziegler Biosolut, Fahrgasse 5, D-79761 Waldshut Tiengen, Germany; [Loll, Bernhard] MoloX GmbH, Takustr 6, D-14195 Berlin, Germany	Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Loll, B (corresponding author), Free Univ Berlin, AG Strukturbiochem, Inst Chemie Biochem, Takustr 6, D-14195 Berlin, Germany.; Ziegler, A (corresponding author), Ziegler Biosolut, Fahrgasse 5, D-79761 Waldshut Tiengen, Germany.	ziegler-biosolutions@gmx.de; loll@chemie.fu-berlin.de	Loll, Bernhard/J-4815-2019; Ballaschk, Martin/AAV-2426-2021	Loll, Bernhard/0000-0001-7928-4488; Schmieder, Peter/0000-0001-9968-9327; Driller, Ronja/0000-0001-8834-9087	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	We are grateful to Christina Schnick and Claudia Alings for excellent technical assistance. We acknowledge access to beamline BL14.2 of the BESSY II storage ring (Berlin, Germany) via the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien und Energie, the Freie Universitat Berlin, the Humboldt-Universitat zu Berlin, the Max-Delbruck Centrum, and the Leibniz-Institut fur Molekulare Pharmakologie. We also acknowledge beamtime and support at beamline P14 of PETRA III (Deutsches Elektronen Synchrotron, Hamburg, Germany).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ayres CM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00966; Beerbaum M, 2013, J BIOMOL NMR, V57, P167, DOI 10.1007/s10858-013-9777-z; Beltrami A, 2008, J BIOL CHEM, V283, P27189, DOI 10.1074/jbc.M802818200; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; Bowness P, 2015, ANNU REV IMMUNOL, V33, P29, DOI 10.1146/annurev-immunol-032414-112110; BREWERTON DA, 1973, LANCET, V1, P904; Budinger L, 2000, ALLERGY, V55, P108, DOI 10.1034/j.1398-9995.2000.00107.x; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; Clayton GM, 2014, CELL, V158, P132, DOI 10.1016/j.cell.2014.04.048; Colbert RA, 2017, BEST PRACT RES CL RH, V31, P797, DOI 10.1016/j.berh.2018.07.012; DeLano W.L, PYMOL MOL GRAPHICS S; Dulger S, 2019, JCR-J CLIN RHEUMATOL, V25, P288, DOI 10.1097/RHU.0000000000000851; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian H, 2011, FEBS J, V278, P1713, DOI 10.1111/j.1742-4658.2011.08097.x; Fabian H, 2010, ARTHRITIS RHEUM-US, V62, P978, DOI 10.1002/art.27316; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Fiorillo MT, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01475; Fiorillo MT, 2000, J CLIN INVEST, V106, P47, DOI 10.1172/JCI9295; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; Fodor J, 2018, J IMMUNOL, V200, P4134, DOI 10.4049/jimmunol.1800315; Fontenot AP, 2016, J IMMUNOL, V196, P22, DOI 10.4049/jimmunol.1502011; Gamerdinger K, 2003, J EXP MED, V197, P1345, DOI 10.1084/jem.20030121; GROS P, 1990, SCIENCE, V249, P1149, DOI 10.1126/science.2396108; Hafstrand I, 2019, P NATL ACAD SCI USA, V116, P5055, DOI 10.1073/pnas.1807656116; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Haustein K.-O., 2008, TABAKABHANGIGKEIT, P44; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Illing PT, 2013, CURR OPIN IMMUNOL, V25, P81, DOI 10.1016/j.coi.2012.10.002; Inman RD, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2610; Jiang JS, 2017, SCIENCE, V358, P1064, DOI 10.1126/science.aao5154; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Loll B, 2016, ARTHRITIS RHEUMATOL, V68, P1172, DOI 10.1002/art.39567; Loll B, 2011, PROTEIN SCI, V20, P278, DOI 10.1002/pro.559; de Castro JAL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02463; Lu L, 2003, J EXP MED, V197, P567, DOI 10.1084/jem.20021762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGonagle D, 2015, NAT REV RHEUMATOL, V11, P731, DOI 10.1038/nrrheum.2015.147; McShan AC, 2018, NAT CHEM BIOL, V14, P811, DOI 10.1038/s41589-018-0096-2; Narzi D, 2008, J BIOL CHEM, V283, P23093, DOI 10.1074/jbc.M710234200; Narzi D, 2012, J MOL BIOL, V415, P429, DOI 10.1016/j.jmb.2011.11.021; Natarajan K, 2019, CRIT REV BIOCHEM MOL, V54, P164, DOI 10.1080/10409238.2019.1610352; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; PEARSON RG, 1990, COORDIN CHEM REV, V100, P403, DOI 10.1016/0010-8545(90)85016-L; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; ROMAGNOLI P, 1991, EMBO J, V10, P1303, DOI 10.1002/j.1460-2075.1991.tb07648.x; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; Rowley B, 2005, MOL IMMUNOL, V42, P833, DOI 10.1016/j.molimm.2004.07.050; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schiraldi M, 2009, TRENDS IMMUNOL, V30, P502, DOI 10.1016/j.it.2009.07.005; Schittenhelm RB, 2016, MOL CELL PROTEOMICS, V15, P1867, DOI 10.1074/mcp.M115.056358; Schittenhelm RB, 2015, ARTHRITIS RHEUMATOL, V67, P702, DOI 10.1002/art.38963; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Taurog JD, 2009, ADV EXP MED BIOL, V649, P245; Thomas C, 2017, SCIENCE, V358, P1060, DOI 10.1126/science.aao6001; Uchanska-Ziegler B, 2012, EUR J CELL BIOL, V91, P274, DOI 10.1016/j.ejcb.2011.03.003; Wang Y, 2013, IMMUNOL RES, V55, P83, DOI 10.1007/s12026-012-8351-1; Wax PM, 2013, J MED TOXICOL, V9, P303, DOI 10.1007/s13181-013-0347-2; Wendling D, 2013, EXPERT REV CLIN IMMU, V9, P511, DOI [10.1586/ECI.13.35, 10.1586/eci.13.35]; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yin L, 2013, PROTEIN CELL, V4, P8, DOI 10.1007/s13238-012-2077-7; Zernich D, 2004, J EXP MED, V200, P13, DOI 10.1084/jem.20031680; Zheng H, 2017, ACTA CRYSTALLOGR D, V73, P223, DOI 10.1107/S2059798317001061	66	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13269	13279		10.1074/jbc.RA119.008937	http://dx.doi.org/10.1074/jbc.RA119.008937			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31296658	hybrid, Green Published			2022-12-28	WOS:000486417200006
J	Boczek, EE; Luo, Q; Dehling, M; Ropke, M; Mader, SL; Seidl, A; Kaila, VRI; Buchner, J				Boczek, Edgar E.; Luo, Qi; Dehling, Marco; Roepke, Michael; Mader, Sophie L.; Seidl, Andreas; Kaila, Ville R. I.; Buchner, Johannes			Autophosphorylation activates c-Src kinase through global structural rearrangements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; ATP; biophysics; conformational change; hydrogen; deuterium exchange; molecular dynamics; enzyme mechanism; oncogene; protein kinase; Src; activation	PROTEIN-TYROSINE KINASE; CRYSTAL-STRUCTURES; PHOSPHORYLATION; PP60C-SRC; COMPLEX; MECHANISM; DYNAMICS; DOMAIN; CONFORMATION; SITES	The prototypical kinase c-Src plays an important role in numerous signal transduction pathways, where its activity is tightly regulated by two phosphorylation events. Phosphorylation at a specific tyrosine by C-terminal Src kinase inactivates c-Src, whereas autophosphorylation is essential for the c-Src activation process. However, the structural consequences of the autophosphorylation process still remain elusive. Here we investigate how the structural landscape of c-Src is shaped by nucleotide binding and phosphorylation of Tyr(416) using biochemical experiments, hydrogen/deuterium exchange MS, and atomistic molecular simulations. We show that the initial steps of kinase activation involve large rearrangements in domain orientation. The kinase domain is highly dynamic and has strong cross-talk with the regulatory domains, which are displaced by autophosphorylation. Although the regulatory domains become more flexible and detach from the kinase domain because of autophosphorylation, the kinase domain gains rigidity, leading to stabilization of the ATP binding site and a 4-fold increase in enzymatic activity. Our combined results provide a molecular framework of the central steps in c-Src kinase regulation process with possible implications for understanding general kinase activation mechanisms.	[Boczek, Edgar E.; Luo, Qi; Dehling, Marco; Roepke, Michael; Mader, Sophie L.; Kaila, Ville R. I.; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, D-85748 Garching, Germany; [Boczek, Edgar E.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Luo, Qi] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou Shi 310027, Zhejiang Sheng, Peoples R China; [Luo, Qi] Zhejiang Univ, Dept Chem, Hangzhou Shi 310027, Zhejiang Sheng, Peoples R China; [Dehling, Marco; Seidl, Andreas] Hexal AG, Sandoz Biopharmaceut, Novartis Biol Tech Dev & Mfg, D-82041 Oberhaching, Germany; [Dehling, Marco] MorphoSys AG, Prot Sci, Physicochem Analyt, Semmelweisstr 7, D-82152 Planegg, Germany; [Seidl, Andreas] Leukocare AG, Klopferspitz 19, D-82152 Martinsried, Germany	Technical University of Munich; Max Planck Society; Zhejiang University; Zhejiang University; Hexal AG; Novartis; Sandoz; MorphoSys	Kaila, VRI; Buchner, J (corresponding author), Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany.	ville.kaila@ch.tum.de; johannes.buchner@tum.de	Buchner, Johannes/A-2651-2010; Kaila, Ville R. I./E-1449-2014	Mader, Sophie/0000-0002-3011-3319; Buchner, Johannes/0000-0003-1282-7737; Kaila, Ville/0000-0003-4464-6324	Deutsche Forschungsgemeinschaft [SFB1035]; Gauss Centre for Supercomputing/Leibniz Supercomputing Centre [pr84pa]; Studienstiftung des Deutschen Volkes; China Scholarship Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gauss Centre for Supercomputing/Leibniz Supercomputing Centre; Studienstiftung des Deutschen Volkes; China Scholarship Council(China Scholarship Council)	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB1035 (to V. R. I. K. and J. B.). Computer resources for this project were provided by Gauss Centre for Supercomputing/Leibniz Supercomputing Centre Grant pr84pa. M. D. and A. S. were employees of the Novartis group of companies, which develops, manufactures, and markets biopharmaceutical products, when this study was conducted. M. D. is currently employee of MorphoSys AG, which develops biopharmaceutical products. A. S. currently an employee of Leukocare AG, which supports partners in biopharmaceutical development.; Supported by a scholarship from the Studienstiftung des Deutschen Volkes.; Supported by the China Scholarship Council.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Boczek EE, 2015, P NATL ACAD SCI USA, V112, pE3189, DOI 10.1073/pnas.1424342112; Breitenlechner CB, 2005, J MOL BIOL, V353, P222, DOI 10.1016/j.jmb.2005.08.023; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Di Luca A, 2017, P NATL ACAD SCI USA, V114, pE6314, DOI 10.1073/pnas.1706278114; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Eswaran J, 2010, BBA-PROTEINS PROTEOM, V1804, P429, DOI 10.1016/j.bbapap.2009.10.013; Fajer M, 2017, J PHYS CHEM B, V121, P3352, DOI 10.1021/acs.jpcb.6b08409; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; FINCHAM VJ, 1995, ONCOGENE, V10, P2247; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson D, 2000, CELL DEATH DIFFER, V7, P685, DOI 10.1038/sj.cdd.4400700; Kaila VRI, 2014, P NATL ACAD SCI USA, V111, P6988, DOI 10.1073/pnas.1319156111; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P724; Luo Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep43996; LYDON NB, 1992, BIOCHEM J, V287, P985, DOI 10.1042/bj2870985; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Meng YL, 2014, J MOL BIOL, V426, P423, DOI 10.1016/j.jmb.2013.10.001; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; OKADA M, 1988, BIOCHEM BIOPH RES CO, V154, P796, DOI 10.1016/0006-291X(88)90210-0; Peng L. X., 2016, APPL NEW INFORM TOOL, DOI [10.1101/038323, DOI 10.1101/038323]; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Pucheta-Martinez E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24235; PURCHIO AF, 1982, J VIROL, V41, P1; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; REUTER C, 1990, EUR J BIOCHEM, V190, P343, DOI 10.1111/j.1432-1033.1990.tb15581.x; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Roskoski R, 2015, PHARMACOL RES, V94, P9, DOI 10.1016/j.phrs.2015.01.003; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sharma V, 2015, P NATL ACAD SCI USA, V112, P11571, DOI 10.1073/pnas.1503761112; Shukla D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4397; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; Wei H, 2012, J AM SOC MASS SPECTR, V23, P498, DOI 10.1007/s13361-011-0310-x; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	51	8	8	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13186	13197		10.1074/jbc.RA119.008199	http://dx.doi.org/10.1074/jbc.RA119.008199			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31331936	hybrid, Green Published			2022-12-28	WOS:000486416000026
J	Arriagada, C; Silva, P; Millet, M; Solano, L; Moraga, C; Torres, VA				Arriagada, Cecilia; Silva, Patricio; Millet, Martial; Solano, Luis; Moraga, Carolina; Torres, Vicente A.			Focal adhesion kinase-dependent activation of the early endocytic protein Rab5 is associated with cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						focal adhesion; cell migration; PTK2 protein tyrosine kinase 2 (PTK2); focal adhesion kinase (FAK); metastasis; tumor; small GTPase; early endosome; endocytic trafficking; integrin complex; Rab5	PHOSPHATIDYLINOSITOL 3-KINASE; P85 SUBUNIT; INTEGRIN; CASPASE-8; FAK	Focal adhesion kinase (FAK) is a central regulator of integrin-dependent cell adhesion and migration and has recently been shown to co-localize with endosomal proteins. The early endocytic protein Rab5 controls integrin trafficking, focal adhesion disassembly, and cell migration and has been shown to be activated upon integrin engagement by mechanisms that remain unclear. Because FAK is a critical regulator of integrin-dependent signaling and Rab5 recapitulates FAK-mediated effects, we evaluated the possibility that FAK activates Rab5 and contributes to cell migration. Pulldown assays revealed that Rab5-GTP levels are decreased upon treatment with a pharmacological inhibitor of FAK, PF562,271, in resting A549 cells. These events were associated with decreased peripheral Rab5 puncta and a reduced number of early endosome antigen 1 (EEA1)-positive early endosomes. Accordingly, as indicated by FAK inhibition experiments and in FAK-null fibroblasts, adhesion-induced FAK activity increased Rab5-GTP levels. In fact, expression of WT FAK and FAK/Y180A/M183A (open conformation), but not FAK/Arg(454) (kinase-dead), augmented Rab5-GTP levels in FAK-null fibroblasts and A549 cells. Moreover, expression of a GDP-bound Rab5 mutant (Rab5/S34N) or shRNA-mediated knockdown of endogenous Rab5 prevented FAK-induced A549 cell migration, whereas expression of WT or GTP-bound Rab5 (Rab5/Q79L), but not Rab5/S34N, promoted cell migration in FAK-null fibroblasts. Mechanistically, FAK co-immunoprecipitated with the GTPase-activating protein p85 alpha in a phosphorylation (Tyr(397))-dependent manner, preventing Rab5-GTP loading, as shown by knockdown and transfection recovery experiments. Taken together, these results reveal that FAK activates Rab5, leading to cell migration.	[Arriagada, Cecilia; Silva, Patricio; Millet, Martial; Solano, Luis; Moraga, Carolina; Torres, Vicente A.] Univ Chile, Fac Dent, Inst Res Dent Sci, Olivos 943, Santiago 8380000, Chile; [Silva, Patricio] Univ Cent Chile, Fac Hlth Sci, Santiago 8380000, Chile; [Torres, Vicente A.] Univ Chile, Adv Ctr Chron Dis, Santiago 8380000, Chile	Universidad de Chile; Universidad Central de Chile; Universidad de Chile	Torres, VA (corresponding author), Univ Chile, Fac Dent, Inst Res Dent Sci, Olivos 943, Santiago 8380000, Chile.	vatorres@med.uchile.cl		Arriagada, Cecilia/0000-0002-5351-2240; Torres, Vicente A/0000-0002-5973-7248	Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant [1180495]; Comision Nacional de Investigacion Cientifica y Tecnologica FONDAP [15130011]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [3170660]	Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant; Comision Nacional de Investigacion Cientifica y Tecnologica FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant 1180495 (to V. A. T.), Comision Nacional de Investigacion Cientifica y Tecnologica FONDAP Grant 15130011 (to V. A. T.), and Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant 3170660 (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alanko J, 2015, NAT CELL BIOL, V17, P1412, DOI 10.1038/ncb3250; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Chamberlain MD, 2008, J BIOL CHEM, V283, P15861, DOI 10.1074/jbc.M800941200; Chamberlain MD, 2010, CELL SIGNAL, V22, P1562, DOI 10.1016/j.cellsig.2010.05.025; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Diaz J, 2014, J CELL SCI, V127, P2401, DOI 10.1242/jcs.141689; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Guo LL, 2009, PATHOL RES PRACT, V205, P847, DOI 10.1016/j.prp.2009.07.005; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Kleinschmidt EG, 2017, CURR OPIN CELL BIOL, V45, P24, DOI 10.1016/j.ceb.2017.01.003; Lanzetti L, 2017, CANCER RES, V77, P1813, DOI 10.1158/0008-5472.CAN-16-3403; Lazo OM, 2013, J NEUROSCI, V33, P6112, DOI 10.1523/JNEUROSCI.4630-12.2013; Liu SS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-58; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Mendoza P, 2014, CURR MOL MED, V14, P235, DOI 10.2174/1566524014666140128111347; Mendoza Pablo, 2014, Small GTPases, V5, pe28195, DOI 10.4161/sgtp.28195; Mendoza P, 2013, J CELL SCI, V126, P3835, DOI 10.1242/jcs.119727; Mendoza PA, 2018, CELL ADHES MIGR, V12, P185, DOI 10.1080/19336918.2017.1377388; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nader GPF, 2016, NAT CELL BIOL, V18, P491, DOI 10.1038/ncb3333; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Palamidessi A, 2013, CURR BIOL, V23, P2355, DOI 10.1016/j.cub.2013.09.060; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Silva P, 2016, ONCOTARGET, V7, P29548, DOI 10.18632/oncotarget.8794; Torres VA, 2014, CELL ADHES MIGR, V8, P84, DOI 10.4161/cam.28510; Torres VA, 2010, MOL BIOL CELL, V21, P369, DOI 10.1091/mbc.E09-09-0769; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133	33	8	9	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12836	12845		10.1074/jbc.RA119.008667	http://dx.doi.org/10.1074/jbc.RA119.008667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31292193	Green Published, hybrid			2022-12-28	WOS:000484414600024
J	Sanchez, CP; Cubel, SM; Nyboer, B; Jankowska-Dollken, M; Schaeffer-Reiss, C; Ayoub, D; Planelles, G; Lanzer, M				Sanchez, Cecilia P.; Cubel, Sonia Moliner; Nyboer, Britta; Jankowska-Doellken, Monika; Schaeffer-Reiss, Christine; Ayoub, Daniel; Planelles, Gabrielle; Lanzer, Michael			Phosphomimetic substitution at Ser-33 of the chloroquine resistance transporter PfCRT reconstitutes drug responses in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Plasmodium; drug transport; drug resistance; phosphorylation; kinetics; genome editing; kinase inhibitors; PfCRT; transport velocity; virulence factor	MALARIA PARASITES; PROTEIN-KINASE; OKADAIC ACID; PHOSPHORYLATION; SUBSTRATE; SUSCEPTIBILITY; MUTATIONS; MECHANISM; AFFINITY; REVEALS	The chloroquine resistance transporter PfCRT of the human malaria parasite Plasmodium falciparum confers resistance to the former first-line antimalarial drug chloroquine, and it modulates the responsiveness to a wide range of quinoline and quinoline-like compounds. PfCRT is post-translationally modified by phosphorylation, palmitoylation, and, possibly, ubiquitination. However, the impact of these post-translational modifications on P. falciparum biology and, in particular, the drug resistance-conferring activity of PfCRT has remained elusive. Here, we confirm phosphorylation at Ser-33 and Ser-411 of PfCRT of the chloroquine-resistant P. falciparum strain Dd2 and show that kinase inhibitors can sensitize drug responsiveness. Using CRISPR/Cas9 genome editing to generate genetically engineered PfCRT variants in the parasite, we further show that substituting Ser-33 with alanine reduced chloroquine and quinine resistance by similar to 50% compared with the parental P. falciparum strain Dd2, whereas the phosphomimetic amino acid aspartic acid could fully and glutamic acid could partially reconstitute the level of chloroquine/quinine resistance. Transport studies conducted in the parasite and in PfCRT-expressing Xenopus laevis oocytes linked phosphomimetic substitution at Ser-33 to increased transport velocity. Our data are consistent with phosphorylation of Ser-33 relieving an autoinhibitory intramolecular interaction within PfCRT, leading to a stimulated drug transport activity. Our findings shed additional light on the function of PfCRT and suggest that chloroquine could be reevaluated as an antimalarial drug by targeting the kinase in P. falciparum that phosphorylates Ser-33 of PfCRT.	[Sanchez, Cecilia P.; Cubel, Sonia Moliner; Nyboer, Britta; Jankowska-Doellken, Monika; Lanzer, Michael] Heidelberg Univ Hosp, Ctr Infect Dis Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany; [Schaeffer-Reiss, Christine; Ayoub, Daniel] Univ Strasbourg, Lab Spectrometrie Masse Bioorgan, CNRS, IPHC,UMR 7178, F-67037 Strasbourg, France; [Planelles, Gabrielle] Univ Paris 06, INSERM, Ctr Rech Cordeliers, Unite 1138,CNRS,ERL8228, F-75006 Paris, France; [Cubel, Sonia Moliner] Heidelberg Univ, Heidelberg Biosci Int Grad Sch, Heidelberg, Germany; [Ayoub, Daniel] Glenmark Pharmaceut SA, Chemin Combeta 5, CH-2300 La Chaux De Fonds, Switzerland; [Lanzer, Michael] Res Cluster Excellence CellNetworks, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Ruprecht Karls University Heidelberg	Lanzer, M (corresponding author), Heidelberg Univ Hosp, Ctr Infect Dis Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.; Lanzer, M (corresponding author), Res Cluster Excellence CellNetworks, Heidelberg, Germany.	michael.lanzer@med.uni-heidelberg.de	Lanzer, Michael/E-9752-2013; Planelles, Gabrielle/F-9603-2013	Lanzer, Michael/0000-0002-0220-6526; Planelles, Gabrielle/0000-0002-7314-8837; Ayoub, Daniel/0000-0001-6433-9917	joint French-German Research Initiative - Agence Nationale de la Recherche (ANR); Deutsche Forschungsgemeinschaft (DFG) (EVOTRANSPORT) [ANR-14-CE35-0012-01, LA 941/11-1]; Partenariat Hubert Curien (PHC) PROCOPE [30995WE, 57051467]	joint French-German Research Initiative - Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft (DFG) (EVOTRANSPORT)(German Research Foundation (DFG)); Partenariat Hubert Curien (PHC) PROCOPE	This work was supported by the joint French-German Research Initiative sponsored by the Agence Nationale de la Recherche (ANR) and the Deutsche Forschungsgemeinschaft (DFG) (EVOTRANSPORT/Grant ANR-14-CE35-0012-01 and Grant LA 941/11-1) and the Partenariat Hubert Curien (PHC) PROCOPE (Grants 30995WE and ID 57051467). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal S, 2017, J INFECT DIS, V216, P468, DOI 10.1093/infdis/jix334; Antony HA, 2019, ACTA TROP, V189, P84, DOI 10.1016/j.actatropica.2018.10.001; Aryal B, 2015, BIOCHEM SOC T, V43, P966, DOI 10.1042/BST20150128; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bakouh N, 2017, J BIOL CHEM, V292, P16109, DOI 10.1074/jbc.M117.805200; Bellanca S, 2014, J BIOL CHEM, V289, P36336, DOI 10.1074/jbc.M114.614206; Ciarimboli G, 2005, J AM SOC NEPHROL, V16, P1562, DOI 10.1681/ASN.2004040256; Coronado LM, 2014, BBA-GEN SUBJECTS, V1840, P2032, DOI 10.1016/j.bbagen.2014.02.009; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dhingra SK, 2017, MBIO, V8, DOI [10.1128/mBio.00303-17, 10.1128/mbio.00303-17]; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; Egan TJ, 2006, J INORG BIOCHEM, V100, P916, DOI 10.1016/j.jinorgbio.2005.11.005; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Gabryszewski SJ, 2016, MOL BIOL EVOL, V33, P1554, DOI 10.1093/molbev/msw037; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Heinberg A, 2015, ANN NY ACAD SCI, V1342, P10, DOI 10.1111/nyas.12662; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holland Z, 2009, EUKARYOT CELL, V8, P388, DOI 10.1128/EC.00334-08; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Juge N, 2015, P NATL ACAD SCI USA, V112, P3356, DOI 10.1073/pnas.1417102112; Kuhn Y, 2010, TRAFFIC, V11, P236, DOI 10.1111/j.1600-0854.2009.01018.x; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Lin-Moshier Yaping, 2013, Cold Spring Harb Protoc, V2013, DOI 10.1101/pdb.prot072793; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Mehrens T, 2000, J AM SOC NEPHROL, V11, P1216, DOI 10.1681/ASN.V1171216; Moritz AE, 2015, J BIOL CHEM, V290, P29095, DOI 10.1074/jbc.M115.667055; Patzewitz EM, 2013, ANTIOXID REDOX SIGN, V19, P683, DOI 10.1089/ars.2012.4625; Petersen I, 2015, MOL MICROBIOL, V97, P381, DOI 10.1111/mmi.13035; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; SAITOH M, 1987, J BIOL CHEM, V262, P7796; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Sanchez CP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004382; Sanchez CP, 2011, MOL MICROBIOL, V82, P865, DOI 10.1111/j.1365-2958.2011.07855.x; Sanchez CP, 2004, BIOCHEMISTRY-US, V43, P16365, DOI 10.1021/bi048241x; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; SARDET C, 1991, J BIOL CHEM, V266, P19166; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Summers RL, 2014, P NATL ACAD SCI USA, V111, pE1759, DOI 10.1073/pnas.1322965111; Summers RL, 2012, CELL MOL LIFE SCI, V69, P1967, DOI 10.1007/s00018-011-0906-0; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tran CV, 2004, MICROBIOL-SGM, V150, P1, DOI 10.1099/mic.0.26818-0; Umeda D, 2008, EUR J PHARMACOL, V590, P61, DOI 10.1016/j.ejphar.2008.05.029; van Schalkwyk DA, 2016, J INFECT DIS, V213, P800, DOI 10.1093/infdis/jiv509; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Yamaki T, 1979, Rinsho Byori, VSuppl 40, P67; Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216; ZIMMER M, 1984, EUR J BIOCHEM, V139, P295, DOI 10.1111/j.1432-1033.1984.tb08007.x	54	7	7	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12766	12778		10.1074/jbc.RA119.009464	http://dx.doi.org/10.1074/jbc.RA119.009464			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31285265	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000484414600018
J	Duval, R; Bui, LC; Mathieu, C; Nian, Q; Berthelet, J; Xu, XM; Haddad, I; Vinh, J; Duprey, JM; Busi, F; Guidez, F; Chomienne, C; Rodrigues-Lima, F				Duval, Romain; Bui, Linh-Chi; Mathieu, Cecile; Nian, Qing; Berthelet, Jeremy; Xu, Ximing; Haddad, Iman; Vinh, Joelle; Duprey, Jean-Marie; Busi, Florent; Guidez, Fabien; Chomienne, Christine; Rodrigues-Lima, Fernando			Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carcinogenesis; tyrosine-protein phosphatase (tyrosine phosphatase); enzyme inactivation; leukemia; cell signaling; covalent adduct; metabolic activation; benzene; carcinogen; bioactivation; enzyme inhibition; leukemogenesis; cancer; protein tyrosine phosphatase non-receptor type 2 (PTPN2)	TOPOISOMERASE-II INHIBITION; TC-PTP; IN-VITRO; DNA CLEAVAGE; CELL; LEUKEMIA; TRANSCRIPTION; INACTIVATION; ALPHA; 1B	Protein tyrosine phosphatase, nonreceptor type 2 (PTPN2) is mainly expressed in hematopoietic cells, where it negatively regulates growth factor and cytokine signaling. PTPN2 is an important regulator of hematopoiesis and immune/inflammatory responses, as evidenced by loss-of-function mutations of PTPN2 in leukemia and lymphoma and knockout mice studies. Benzene is an environmental chemical that causes hematological malignancies, and its hematotoxicity arises from its bioactivation in the bone marrow to electrophilic metabolites, notably 1,4-benzoquinone, a major hematotoxic benzene metabolite. Although the molecular bases for benzene-induced leukemia are not well-understood, it has been suggested that benzene metabolites alter topoisomerases II function and thereby significantly contribute to leukemogenesis. However, several studies indicate that benzene and its hematotoxic metabolites may also promote the leukemogenic process by reacting with other targets and pathways. Interestingly, alterations of cell-signaling pathways, such as Janus kinase (JAK)/signal transducer and activator of transcription (STAT), have been proposed to contribute to benzene-induced malignant blood diseases. We show here that 1,4-benzoquinone directly impairs PTPN2 activity. Mechanistic and kinetic experiments with purified human PTPN2 indicated that this impairment results from the irreversible formation (k(inact) = 645 m(-1)s(-1)) of a covalent 1,4-benzoquinone adduct at the catalytic cysteine residue of the enzyme. Accordingly, cell experiments revealed that 1,4-benzoquinone exposure irreversibly inhibits cellular PTPN2 and concomitantly increases tyrosine phosphorylation of STAT1 and expression of STAT1-regulated genes. Our results provide molecular and cellular evidence that 1,4-benzoquinone covalently modifies key signaling enzymes, implicating it in benzene-induced malignant blood diseases.	[Duval, Romain; Bui, Linh-Chi; Mathieu, Cecile; Nian, Qing; Berthelet, Jeremy; Duprey, Jean-Marie; Busi, Florent; Rodrigues-Lima, Fernando] Univ Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France; [Xu, Ximing] Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Chinese Minist Educ, Qingdao 266003, Shandong, Peoples R China; [Haddad, Iman; Vinh, Joelle] PSL Univ, CNRS, ESPCI Paris, USR 3149, F-75005 Paris, France; [Guidez, Fabien; Chomienne, Christine] Univ Paris, Inst Rech St Louis, UMRS 1131, INSERM, F-75010 Paris, France; [Chomienne, Christine] Hop St Louis, AP HP, Serv Biol Cellulaire, F-75010 Paris, France; [Duval, Romain] Univ Paris, INSERM, BIGR, UMRS 1134, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Ocean University of China; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rodrigues-Lima, F (corresponding author), Univ Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.		Guidez, Fabien/B-3750-2009; Vinh, Joelle/K-1347-2015	Vinh, Joelle/0000-0001-7184-2668; Duval, Romain/0000-0002-5785-0685; Guidez, Fabien/0000-0003-1380-4473	University Paris Diderot, CNRS, INSERM; Plan Cancer AAP Environnement et Cancer 2013; Region Ile de France (Hors DIM 2012); University Paris Diderot (Ecole Doctorale BioSPC); China Scholarship Council (CSC); Region Ile de France (Canceropole 2015)	University Paris Diderot, CNRS, INSERM; Plan Cancer AAP Environnement et Cancer 2013; Region Ile de France (Hors DIM 2012); University Paris Diderot (Ecole Doctorale BioSPC); China Scholarship Council (CSC)(China Scholarship Council); Region Ile de France (Canceropole 2015)	This work was supported by University Paris Diderot, CNRS, INSERM, and Plan Cancer AAP Environnement et Cancer 2013 (to C.C. and F.R.-L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Ph.D. fellowships from Region Ile de France (Hors DIM 2012 and Canceropole 2015).; Supported by a Ph.D. fellowship from University Paris Diderot (Ecole Doctorale BioSPC). Present address: Dept. of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105.; Supported by a Ph.D. fellowship from the China Scholarship Council (CSC).	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Bender RP, 2007, BIOCHEMISTRY-US, V46, P2856, DOI 10.1021/bi062017l; Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Bohmer F, 2013, FEBS J, V280, P413, DOI 10.1111/j.1742-4658.2012.08655.x; Bohmer Frank-D, 2014, JAKSTAT, V3, pe28087, DOI 10.4161/jkst.28087; Bolton JL, 2017, CHEM RES TOXICOL, V30, P13, DOI 10.1021/acs.chemrestox.6b00256; Bourdeau A, 2007, BLOOD, V109, P4220, DOI 10.1182/blood-2006-08-044370; Copeland R. A., 2005, EVALUATION ENZYME IN, P214; Dorritie Kathleen A., 2014, Advances in Biological Regulation, V56, P30, DOI 10.1016/j.jbior.2014.05.004; Duval R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10750; Eastmond DA, 2005, CHEM-BIOL INTERACT, V153, P207, DOI 10.1016/j.cbi.2005.03.024; Eastmond DA, 2014, MUTAT RES-REV MUTAT, V761, P40, DOI 10.1016/j.mrrev.2014.04.001; Frantz CE, 1996, ENVIRON HEALTH PERSP, V104, P1319, DOI 10.2307/3433183; Goldstein BD, 2011, HUM EXP TOXICOL, V30, P725, DOI 10.1177/0960327110381682; Greim H, 2014, ANN NY ACAD SCI, V1310, P7, DOI 10.1111/nyas.12362; Gross SA, 2018, CRIT REV TOXICOL, V48, P217, DOI 10.1080/10408444.2017.1401581; Gurzov EN, 2014, CELL METAB, V20, P85, DOI 10.1016/j.cmet.2014.05.011; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; Kleppe M, 2011, HAEMATOL-HEMATOL J, V96, P1723, DOI 10.3324/haematol.2011.041921; Kleppe M, 2011, BLOOD, V117, P7090, DOI 10.1182/blood-2010-10-314286; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Klotz LO, 2014, MOLECULES, V19, P14902, DOI 10.3390/molecules190914902; KOLACHANA P, 1993, CANCER RES, V53, P1023; Li YT, 2016, FREE RADICAL BIO MED, V97, P148, DOI 10.1016/j.freeradbiomed.2016.05.019; Li ZG, 2017, J IMMUNOL, V198, P1865, DOI 10.4049/jimmunol.1601336; Lindsey RH, 2005, CHEM RES TOXICOL, V18, P761, DOI 10.1021/tx049659z; Lindsey RH, 2004, BIOCHEMISTRY-US, V43, P7563, DOI 10.1021/bi049756r; Loomis D, 2017, LANCET ONCOL, V18, P1574, DOI 10.1016/S1470-2045(17)30832-X; Mazzei L, 2016, DALTON T, V45, P5455, DOI 10.1039/c6dt00652c; Mbiya W, 2013, CHEM RES TOXICOL, V26, P112, DOI 10.1021/tx300417z; McHale CM, 2011, ENVIRON HEALTH PERSP, V119, P628, DOI 10.1289/ehp.1002546; Meek B, 2010, BLOOD, V115, P261, DOI 10.1182/blood-2009-05-223990; Minciullo PL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/937987; Mondrala S, 2010, CHEM-BIOL INTERACT, V184, P259, DOI 10.1016/j.cbi.2009.12.023; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Nishiyama-Fujita Y, 2013, LEUKEMIA RES, V37, P1150, DOI 10.1016/j.leukres.2013.05.008; O'Shea KM, 2015, ANN CLIN LAB SCI, V45, P487; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; PAZ MA, 1991, J BIOL CHEM, V266, P689; Pike KA, 2016, CYTOKINE, V82, P52, DOI 10.1016/j.cyto.2015.12.025; Poullet P, 2007, PROTEOMICS, V7, P2553, DOI 10.1002/pmic.200600784; Rappaport SM, 2005, CHEM-BIOL INTERACT, V153, P103, DOI 10.1016/j.cbi.2005.03.014; Reardon C, 2007, J IMMUNOL, V178, P4284, DOI 10.4049/jimmunol.178.7.4284; Rodriguez F, 2005, P NATL ACAD SCI USA, V102, P4718, DOI 10.1073/pnas.0501074102; Ruiz-Ramos R, 2005, TOXICOLOGY, V209, P279, DOI 10.1016/j.tox.2004.12.035; Sakamoto S, 2010, HYBRIDOMA, V29, P481, DOI 10.1089/hyb.2010.0052; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P41, DOI 10.4137/GRSB.S11433; Sauer E, 2018, ENVIRON RES, V166, P91, DOI 10.1016/j.envres.2018.05.029; Seiner DR, 2007, CHEM RES TOXICOL, V20, P1315, DOI 10.1021/tx700213s; Smith MT, 2011, CHEM-BIOL INTERACT, V192, P155, DOI 10.1016/j.cbi.2011.02.010; Snyder R, 2012, INT J ENV RES PUB HE, V9, P2875, DOI 10.3390/ijerph9082875; Tapper MA, 2000, TOXICOL SCI, V55, P327, DOI 10.1093/toxsci/55.2.327; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Verrax F, 2005, FREE RADICAL RES, V39, P649, DOI 10.1080/10715760500097906; Wang LP, 2012, CHEM RES TOXICOL, V25, P1303, DOI 10.1021/tx3001169; Wang QP, 2004, BIOCHEMISTRY-US, V43, P4294, DOI 10.1021/bi035986e; Whysner J, 2004, MUTAT RES-REV MUTAT, V566, P99, DOI 10.1016/S1383-5742(03)00053-X; Wiede F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036703; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zhang LP, 2010, CHEM-BIOL INTERACT, V184, P86, DOI 10.1016/j.cbi.2009.12.011; Zhou Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140013	66	12	12	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12483	12494		10.1074/jbc.RA119.008666	http://dx.doi.org/10.1074/jbc.RA119.008666			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248982	Green Published, hybrid			2022-12-28	WOS:000484402700019
J	Peffer, S; Goncalves, D; Morano, KA				Peffer, Sara; Goncalves, Davi; Morano, Kevin A.			Regulation of the Hsf1-dependent transcriptome via conserved bipartite contacts with Hsp70 promotes survival in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat shock factor protein 1 (HSF1); heat shock protein (HSP); proteostasis; Saccharomyces cerevisiae; stress response; cell stress; gene regulation; heat shock response; Hsp70; protein chaperone; transcription factor	HEAT-SHOCK FACTOR; SACCHAROMYCES-CEREVISIAE; TRANSACTIVATION DOMAIN; GENE-EXPRESSION; FACTOR CONTAINS; STRESS; BINDING; ACTIVATION; PHOSPHORYLATION; FACTOR-1	Protein homeostasis and cellular fitness in the presence of proteotoxic stress is promoted by heat shock factor 1 (Hsf1), which controls basal and stress-induced expression of molecular chaperones and other targets. The major heat shock proteins and molecular chaperones Hsp70 and Hsp90, in turn, participate in a negative feedback loop that ensures appropriate coordination of the heat shock response with environmental conditions. Features of this regulatory circuit in the budding yeast Saccharomyces cerevisiae have been recently defined, most notably regarding direct interaction between Hsf1 and the constitutively expressed Hsp70 protein Ssa1. Here, we sought to further examine the Ssa1/Hsf1 regulation. We found that Ssa1 interacts independently with both the previously defined CE2 site in the Hsf1 C-terminal transcriptional activation domain and with an additional site that we identified within the N-terminal activation domain. Consistent with both sites bearing a recognition signature for Hsp70, we demonstrate that Ssa1 contacts Hsf1 via its substrate-binding domain and that abolishing either regulatory site results in loss of Ssa1 interaction. Removing Hsp70 regulation of Hsf1 globally dysregulated Hsf1 transcriptional activity, with synergistic effects on both gene expression and cellular fitness when both sites are disrupted together. Finally, we report that Hsp70 interacts with both transcriptional activation domains of Hsf1 in the related yeast Lachancea kluyveri. Our findings indicate that Hsf1 transcriptional activity is tightly regulated to ensure cellular fitness and that a general and conserved Hsp70-HSF1 feedback loop regulates cellular proteostasis in yeast.	[Peffer, Sara; Goncalves, Davi; Morano, Kevin A.] Univ Texas Houston, Dept Microbiol & Mol Genet, McGovern Med Sch Houston, Houston, TX 77030 USA; [Peffer, Sara] MD Anderson UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Morano, KA (corresponding author), Univ Texas Houston, Dept Microbiol & Mol Genet, McGovern Med Sch Houston, Houston, TX 77030 USA.	kevin.a.morano@uth.tmc.edu		Peffer, Sara/0000-0003-3788-5044	National Institutes of Health [R01GM127287]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM127287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM127287. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Ausubel F. M., 2003, CURRENT PROTOCOLS IN; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Budzynski MA, 2015, MOL CELL BIOL, V35, P2530, DOI 10.1128/MCB.00816-14; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chowdhary S, 2019, CELL REP, V26, P18, DOI 10.1016/j.celrep.2018.12.034; Chowdhary S, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00292-17; Cotto JJ, 1996, J BIOL CHEM, V271, P3355; CRAIG EA, 1984, CELL, V38, P841, DOI 10.1016/0092-8674(84)90279-4; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Harris N, 2001, MOL GENET GENOMICS, V265, P258, DOI 10.1007/s004380000409; Hashikawa N, 2004, MOL CELL BIOL, V24, P3648, DOI 10.1128/MCB.24.9.3648-3659.2004; Hashikawa N, 2007, J BIOL CHEM, V282, P10333, DOI 10.1074/jbc.M609708200; JAKOBSEN BK, 1988, MOL CELL BIOL, V8, P5040, DOI 10.1128/MCB.8.11.5040; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Krakowiak J, 2018, ELIFE, V7, DOI 10.7554/eLife.31668; Leach MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11704; Leach MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032467; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Marshall AN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003376; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Morano KA, 1999, MOL CELL BIOL, V19, P402; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Neef DW, 2014, CELL REP, V9, P955, DOI 10.1016/j.celrep.2014.09.056; NIETOSOTELO J, 1990, CELL, V62, P807, DOI 10.1016/0092-8674(90)90124-W; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pincus D, 2018, MOL BIOL CELL, V29, P3168, DOI 10.1091/mbc.E18-06-0353; Rienzo A, 2012, YEAST, V29, P219, DOI 10.1002/yea.2905; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakurai H, 2007, J BIOL CHEM, V282, P13334, DOI 10.1074/jbc.M611801200; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; Solis EJ, 2016, MOL CELL, V63, P60, DOI 10.1016/j.molcel.2016.05.014; SORGER PK, 1990, CELL, V62, P793, DOI 10.1016/0092-8674(90)90123-V; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; Van Durme J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000475; Verghese J, 2012, EUKARYOT CELL, V11, P1003, DOI 10.1128/EC.00146-12; Wang YY, 2012, MOL BIOL CELL, V23, P3290, DOI 10.1091/mbc.E12-06-0447; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	53	26	28	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12191	12202		10.1074/jbc.RA119.008822	http://dx.doi.org/10.1074/jbc.RA119.008822			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31239354	hybrid, Green Published			2022-12-28	WOS:000484284500022
J	Warmack, RA; Shawa, H; Liu, K; Lopez, K; Loo, JA; Horwitz, J; Clarke, SG				Warmack, Rebeccah A.; Shawa, Harrison; Liu, Kate; Lopez, Katia; Loo, Joseph A.; Horwitz, Joseph; Clarke, Steven G.			The l-isoaspartate modification within protein fragments in the aging lens can promote protein aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lens; post-translational modification (PTM); aging; protein degradation; protein aggregation; L-isoaspartate	MOLECULAR-WEIGHT PROTEIN; AGE-RELATED-CHANGES; ALPHA-A CRYSTALLIN; GAMMA-S-CRYSTALLIN; EYE LENS; POSTTRANSLATIONAL MODIFICATIONS; ASPARTYL RESIDUES; DEAMIDATION; IDENTIFICATION; CATARACT	Transparency in the lens is accomplished by the dense packing and short-range order interactions of the crystallin proteins in fiber cells lacking organelles. These features are accompanied by a lack of protein turnover, leaving lens proteins susceptible to a number of damaging modifications and aggregation. The loss of lens transparency is attributed in part to such aggregation during aging. Among the damaging post-translational modifications that accumulate in long-lived proteins, isomerization at aspartate residues has been shown to be extensive throughout the crystallins. In this study of the human lens, we localize the accumulation of l-isoaspartate within water-soluble protein extracts primarily to crystallin peptides in high-molecular weight aggregates and show with MS that these peptides are from a variety of crystallins. To investigate the consequences of aspartate isomerization, we investigated two alpha A crystallin peptides (52)LFRTVLDSGISEVR(65) and (89)VQDDFVEIH(98), identified within this study, with the l-isoaspartate modification introduced at Asp(58) and Asp(91), respectively. Importantly, whereas both peptides modestly increase protein precipitation, the native (52)LFRTVLDSGISEVR(65) peptide shows higher aggregation propensity. In contrast, the introduction of l-isoaspartate within a previously identified anti-chaperone peptide from water-insoluble aggregates, alpha A crystallin (SDRDKFVIFL)-S-66(isoAsp)VKHF80, results in enhanced amyloid formation in vitro. The modification of this peptide also increases aggregation of the lens chaperone alpha B crystallin. These findings may represent multiple pathways within the lens wherein the isomerization of aspartate residues in crystallin peptides differentially results in peptides associating with water-soluble or water-insoluble aggregates. Here the eye lens serves as a model for the cleavage and modification of long-lived proteins within other aging tissues.	[Warmack, Rebeccah A.; Shawa, Harrison; Liu, Kate; Lopez, Katia; Loo, Joseph A.; Horwitz, Joseph; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr, Los Angeles, CA 90095 USA; [Warmack, Rebeccah A.; Shawa, Harrison; Liu, Kate; Lopez, Katia; Loo, Joseph A.; Clarke, Steven G.] Univ Calif Los Angeles, Mol Biol Inst, 607 Charles E Young Dr, Los Angeles, CA 90095 USA; [Horwitz, Joseph] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr, Los Angeles, CA 90095 USA.; Clarke, SG (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, 607 Charles E Young Dr, Los Angeles, CA 90095 USA.	Clarke@mbi.ucla.edu		Clarke, Steven/0000-0002-7303-6632	National Science Foundation [MCB-1714569]; UCLA Academic Senate Faculty Research Program; Life Extension Foundation, Inc.; Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center; NATIONAL EYE INSTITUTE [R01EY008313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); UCLA Academic Senate Faculty Research Program; Life Extension Foundation, Inc.; Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Science Foundation (MCB-1714569), the UCLA Academic Senate Faculty Research Program, the Life Extension Foundation, Inc., and the Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center (to S.G.C.). The authors declare that they have no conflicts of interest with the contents of this article. The dataset containing amino acid sequences of all identified crystallin protein fragments from this publication is available in the MassIVE database under accession code MSV000084028. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ajaz MS, 1997, J BIOL CHEM, V272, P11250; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Chondrogianni N, 2014, MOL ASPECTS MED, V35, P1, DOI 10.1016/j.mam.2012.09.001; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Forrester J. V., 2016, EYE BASIC SCI PRACTI, P102; Fujii N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.399972; Fujii N, 2016, BBA-GEN SUBJECTS, V1860, P183, DOI 10.1016/j.bbagen.2015.08.001; Grey AC, 2009, INVEST OPHTH VIS SCI, V50, P4319, DOI 10.1167/iovs.09-3522; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Harding JJ, 1984, EYE B, V1b, P207; Harrington V, 2007, MOL VIS, V13, P1680; Harrington V, 2004, MOL VIS, V10, P476; Hooi MYS, 2013, EXP EYE RES, V106, P34, DOI 10.1016/j.exer.2012.10.013; Hooi MYS, 2012, INVEST OPHTH VIS SCI, V53, P3554, DOI 10.1167/iovs.11-9085; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lampi KJ, 2014, PROG BIOPHYS MOL BIO, V115, P21, DOI 10.1016/j.pbiomolbio.2014.02.004; Lampi KJ, 2002, MOL VIS, V8, P359; LI LK, 1986, CURR EYE RES, V5, P127, DOI 10.3109/02713688609015101; Liu M, 2012, ANAL CHEM, V84, P1056, DOI 10.1021/ac202652z; LOWENSON JD, 1992, J BIOL CHEM, V267, P5985; Lyon YA, 2019, J BIOL CHEM, V294, P7546, DOI 10.1074/jbc.RA118.007052; Lyon YA, 2018, EXP EYE RES, V171, P131, DOI 10.1016/j.exer.2018.03.018; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; MCFADDEN PN, 1986, MECH AGEING DEV, V34, P91, DOI 10.1016/0047-6374(86)90107-7; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; Ni WQ, 2010, ANAL CHEM, V82, P7485, DOI 10.1021/ac101806e; Patananan AN, 2014, J BIOL CHEM, V289, P16936, DOI 10.1074/jbc.M114.564385; Raju M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044077; Ray Nicholas J, 2015, Biophys Rev, V7, P353, DOI 10.1007/s12551-015-0176-4; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; ROY D, 1976, EXP EYE RES, V22, P273, DOI 10.1016/0014-4835(76)90055-5; Santhoshkumar P, 2008, J BIOL CHEM, V283, P8477, DOI 10.1074/jbc.M705876200; Santhoshkumar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019291; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senthilkumar R, 2002, J BIOL CHEM, V277, P39136, DOI 10.1074/jbc.M204684200; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Srivastava OP, 2003, MOL VIS, V9, P110; SRIVASTAVA OP, 1988, EXP EYE RES, V47, P525, DOI 10.1016/0014-4835(88)90092-9; Srivastava OP, 1996, CURR EYE RES, V15, P511, DOI 10.3109/02713689609000762; Takata T, 2006, BIOCHEM BIOPH RES CO, V344, P263, DOI 10.1016/j.bbrc.2006.03.126; Takata T, 2016, FEBS J, V283, P850, DOI 10.1111/febs.13635; TAKEMOTO LJ, 1995, CURR EYE RES, V14, P837, DOI 10.3109/02713689508995806; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Thorne C. J. R., 1978, TECHNIQUES PROTEIN E, P2; Truscott RJW, 2007, PROTEIN MISFOLDING A; Truscott RJW, 2016, BBA-GEN SUBJECTS, V1860, P192, DOI 10.1016/j.bbagen.2015.08.016; Truscott RJW, 2012, EXP EYE RES, V99, P48, DOI 10.1016/j.exer.2012.04.002; VANKLEEF FSM, 1976, EUR J BIOCHEM, V66, P477; VOORTER CEM, 1988, J BIOL CHEM, V263, P19020; Wenk M, 2000, BIOPHYS CHEM, V86, P95, DOI 10.1016/S0301-4622(00)00161-7; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; YVON M, 1989, INT J PEPT PROT RES, V34, P166; Zhu XJ, 2018, J CELL MOL MED, V22, P1118, DOI 10.1111/jcmm.13363	59	11	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12203	12219		10.1074/jbc.RA119.009052	http://dx.doi.org/10.1074/jbc.RA119.009052			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31239355	Green Published, hybrid			2022-12-28	WOS:000484284500023
J	Garcia-Torres, D; Fierke, CA				Garcia-Torres, Desiree; Fierke, Carol A.			The chaperone SmgGDS-607 has a dual role, both activating and inhibiting farnesylation of small GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small GTPase; protein farnesylation; Ras protein; GTPase Kras (KRAS); enzyme kinetics; cell signaling; cancer; post-translational modification (PTM); protein prenylation; small GTP-binding protein GDP-dissociation stimulator (SmgGDS)	EXCHANGE FACTOR SMGGDS; PROTEIN FARNESYLTRANSFERASE; PRENYLATION; RAS; BINDING; CANCER; PRENYLTRANSFERASES; TRANSFERASE; SPECIFICITY; KINETICS	Ras family small GTPases undergo prenylation (such as farnesylation) for proper localization to the plasma membrane, where they can initiate oncogenic signaling pathways. Small GTP-binding protein GDP-dissociation stimulator (SmgGDS) proteins are chaperones that bind and traffic small GTPases, although their exact cellular function is unknown. Initially, SmgGDS proteins were classified as guanine nucleotide exchange factors, but recent findings suggest that SmgGDS proteins also regulate prenylation of small GTPases in vivo in a substrate-selective manner. SmgGDS-607 recognizes the polybasic region and the CAAX box of several small GTPases and inhibits prenylation by impeding their entry into the geranylgeranylation pathway. Here, using recombinant and purified enzymes for prenylation and protein-binding assays, we demonstrate that SmgGDS-607 differentially regulates farnesylation of several small GTPases. SmgGDS-607 inhibited farnesylation of some proteins, such as DiRas1, by sequestering the protein and limiting modification catalyzed by protein farnesyltransferase (FTase). We found that the competitive binding affinities of the small GTPase for SmgGDS-607 and FTase dictate the extent of this inhibition. Additionally, we discovered that SmgGDS-607 increases the rate of farnesylation of HRas by enhancing product release from FTase. Our work indicates that SmgGDS-607 binds to a broad range of small GTPases and does not require a PBR for recognition. Together, these results provide mechanistic insight into SmgGDS-607-mediated regulation of farnesylation of small GTPases and suggest that SmgGDS-607 has multiple modes of substrate recognition.	[Garcia-Torres, Desiree] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Fierke, Carol A.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fierke, CA (corresponding author), Texas A&M Univ, Dept Chem, JK Williams Suite 100, College Stn, TX 77843 USA.; Fierke, CA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, JK Williams Suite 100, College Stn, TX 77843 USA.	fierke@umich.edu			National Institutes of Health [5-R01-GM-040602]; University of Michigan Chemistry-Biology Interface training program through National Institutes of Health [5T32GM008597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008597, R01GM040602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Chemistry-Biology Interface training program through National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant 5-R01-GM-040602 (to C.A.F.) and University of Michigan Chemistry-Biology Interface training program through National Institutes of Health Grant 5T32GM008597 (to D.G.-T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; Bergom C, 2016, J BIOL CHEM, V291, P6534, DOI 10.1074/jbc.M115.696831; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Chenette EJ, 2011, ENZYMES, V29, P59, DOI 10.1016/B978-0-12-381339-8.00005-6; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox Adrienne D, 2010, Small GTPases, V1, P2; DeSolms SJ, 2003, J MED CHEM, V46, P2973, DOI 10.1021/jm020587n; Ellis CA, 2002, P NATL ACAD SCI USA, V99, P9876, DOI 10.1073/pnas.142193799; EPSTEIN WW, 1991, P NATL ACAD SCI USA, V88, P9668, DOI 10.1073/pnas.88.21.9668; Fiordalisi JJ, 2003, J BIOL CHEM, V278, P41718, DOI 10.1074/jbc.M305733200; FURFINE ES, 1995, BIOCHEMISTRY-US, V34, P6857, DOI 10.1021/bi00020a032; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Hamel B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191122; Hartman HL, 2005, BIOCHEMISTRY-US, V44, P15314, DOI 10.1021/bi0509503; Hicks KA, 2005, BIOCHEMISTRY-US, V44, P15325, DOI 10.1021/bi050951v; Hougland JL, 2010, J MOL BIOL, V395, P176, DOI 10.1016/j.jmb.2009.10.038; Jennings BC, 2018, BIOCHEMISTRY-US, V57, P4289, DOI 10.1021/acs.biochem.8b00567; KIRCHNER J, 2001, DATA ANAL TOOLKIT 5; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Li YF, 2012, BIOTECHNOL LETT, V34, P1629, DOI 10.1007/s10529-012-0942-3; Liu M, 2010, P NATL ACAD SCI USA, V107, P6471, DOI 10.1073/pnas.0908396107; Lobell RB, 2001, CANCER RES, V61, P8758; London N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002170; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Nussinov R, 2013, TRENDS MOL MED, V19, P695, DOI 10.1016/j.molmed.2013.07.009; Ochocki JD, 2013, MEDCHEMCOMM, V4, P476, DOI 10.1039/c2md20299a; Ogita Y, 2015, J BIOL CHEM, V290, P20245, DOI 10.1074/jbc.M115.637769; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Schuld NJ, 2014, J BIOL CHEM, V289, P6862, DOI 10.1074/jbc.M113.527192; Shimizu H, 2017, J BIOL CHEM, V292, P13441, DOI 10.1074/jbc.M117.792556; Strassheim D, 2000, J BIOL CHEM, V275, P6699, DOI 10.1074/jbc.275.10.6699; Tschantz WR, 1997, J BIOL CHEM, V272, P9989; Vikis HG, 2002, ONCOGENE, V21, P2425, DOI 10.1038/sj.onc.1205306; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Williams CL, 2013, CELL CYCLE, V12, P2933, DOI 10.4161/cc.26230; Wilson JM, 2016, J MOL BIOL, V428, P4929, DOI 10.1016/j.jmb.2016.10.016; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Wu Z, 1999, PROTEIN ENG, V12, P341, DOI 10.1093/protein/12.4.341; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	43	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11793	11804		10.1074/jbc.RA119.007438	http://dx.doi.org/10.1074/jbc.RA119.007438			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31197034	Green Published, hybrid			2022-12-28	WOS:000486127800016
J	Anandapadamanaban, M; Kyriakidis, NC; Csizmok, V; Wallenhammar, A; Espinosa, AC; Ahlner, A; Round, AR; Trewhella, J; Moche, M; Wahren-Herlenius, M; Sunnerhagen, M				Anandapadamanaban, Madhanagopal; Kyriakidis, Nikolaos C.; Csizmok, Veronika; Wallenhammar, Amelie; Espinosa, Alexander C.; Ahlner, Alexandra; Round, Adam R.; Trewhella, Jill; Moche, Martin; Wahren-Herlenius, Marie; Sunnerhagen, Maria			E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin-conjugating enzyme (E2 enzyme); substrate specificity; E3 ubiquitin ligase; ubiquitin; allosteric regulation	AUTOANTIGEN RO52; CATALYTIC ACTIVATION; STRUCTURAL BASIS; TRIM FAMILY; ENZYMES; MECHANISM; COMPLEX; INTERFERON; INSIGHTS; AUTOIMMUNITY	The E3 ubiquitin-protein ligase TRIM21, of the RING-containing tripartite motif (TRIM) protein family, is a major autoantigen in autoimmune diseases and a modulator of innate immune signaling. Together with ubiquitin-conjugating enzyme E2 E1 (UBE2E1), TRIM21 acts both as an E3 ligase and as a substrate in autoubiquitination. We here report a 2.82-angstrom crystal structure of the human TRIM21 RING domain in complex with the human E2-conjugating UBE2E1 enzyme, in which a ubiquitin-targeted TRIM21 substrate lysine was captured in the UBE2E1 active site. The structure revealed that the direction of lysine entry is similar to that described for human proliferating cell nuclear antigen (PCNA), a small ubiquitin-like modifier (SUMO)-targeted substrate, and thus differs from the canonical SUMO-targeted substrate entry. In agreement, we found that critical UBE2E1 residues involved in the capture of the TRIM21 substrate lysine are conserved in ubiquitin-conjugating E2s, whereas residues critical for SUMOylation are not conserved. We noted that coordination of the acceptor lysine leads to remodeling of amino acid side-chain interactions between the UBE2E1 active site and the E2-E3 direct interface, including the so-called linchpin residue conserved in RING E3s and required for ubiquitination. The findings of our work support the notion that substrate lysine activation of an E2-E3-connecting allosteric path may trigger catalytic activity and contribute to the understanding of specific lysine targeting by ubiquitin-conjugating E2s.	[Anandapadamanaban, Madhanagopal; Csizmok, Veronika; Wallenhammar, Amelie; Ahlner, Alexandra; Trewhella, Jill; Sunnerhagen, Maria] Linkoping Univ, Div Chem, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden; [Kyriakidis, Nikolaos C.; Espinosa, Alexander C.; Wahren-Herlenius, Marie] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Unit Expt Rheumatol, S-17176 Stockholm, Sweden; [Round, Adam R.] Grenoble Outstn, European Mol Biol Lab, 6 Rue Jules Horowitz, F-38042 Grenoble, France; [Trewhella, Jill] Univ Sydney, Sch Life & Environm Sci SoLES, Sydney, NSW 2006, Australia; [Moche, Martin] Karolinska Inst, Prot Sci Facil, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Kyriakidis, Nikolaos C.] UDLA, Grp Invest Biotecnol Aplicada Biomed BIOMED, Escuela Med, Fac Ciencias Salud, EC-170504 Ouito, Ecuador; [Round, Adam R.] European XFEL GmbH, Holzkoppel 4, D-22869 Schenefeld, Germany	Linkoping University; Karolinska Institutet; Karolinska University Hospital; European Molecular Biology Laboratory (EMBL); University of Sydney; Karolinska Institutet; European XFEL	Sunnerhagen, M (corresponding author), Linkoping Univ, Div Chem, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden.	maria.sunnerhagen@liu.se	Wahren-Herlenius, Marie/AAN-6942-2021	Wahren-Herlenius, Marie/0000-0002-0915-7245; Kyriakidis, Nikolaos C/0000-0003-1382-5661; Anandapadamanaban, Madhanagopal/0000-0002-4237-0048; Wallenhammar, Amelie/0000-0002-2867-8249; Moche, Martin/0000-0002-4834-7076	Swedish Research Council; Swedish Rheumatism Association; Swedish Heart-Lung Foundation; Stockholm County Council; King Gustaf the Vth 80-year foundation; Karolinska Institutet; Swedish Foundation for International Cooperation in Research and Higher Education; Swedish Child Cancer Foundation; Swedish Cancer Foundation; Carl Trygger Foundation; Linkoping University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); King Gustaf the Vth 80-year foundation; Karolinska Institutet(Karolinska Institutet); Swedish Foundation for International Cooperation in Research and Higher Education; Swedish Child Cancer Foundation; Swedish Cancer Foundation; Carl Trygger Foundation; Linkoping University	This work was supported by funding from the Swedish Research Council (to M. S., J. T., and M. W.-H.); The Swedish Rheumatism Association, The Swedish Heart-Lung Foundation, The Stockholm County Council, the King Gustaf the Vth 80-year foundation, and Karolinska Institutet (to M. W.-H.); and the Swedish Foundation for International Cooperation in Research and Higher Education, the Swedish Child Cancer Foundation, the Swedish Cancer Foundation, the Carl Trygger Foundation, and Linkoping University (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Banka PA, 2015, J MOL BIOL, V427, P2290, DOI 10.1016/j.jmb.2015.04.011; Benirschke RC, 2010, STRUCTURE, V18, P955, DOI 10.1016/j.str.2010.04.017; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Berndsen CE, 2011, ANAL BIOCHEM, V418, P102, DOI 10.1016/j.ab.2011.06.034; Brennich ME, 2016, J APPL CRYSTALLOGR, V49, P203, DOI 10.1107/S1600576715024462; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Buetow L, 2015, MOL CELL, V58, P297, DOI 10.1016/j.molcel.2015.02.017; Campbell EM, 2016, J VIROL, V90, P1849, DOI 10.1128/JVI.01948-15; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chakrabarti KS, 2017, STRUCTURE, V25, P794, DOI 10.1016/j.str.2017.03.016; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinosa A, 2006, J IMMUNOL, V176, P6277, DOI 10.4049/jimmunol.176.10.6277; Espinosa A, 2011, J BIOL CHEM, V286, P36478, DOI 10.1074/jbc.M111.241786; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Espinosa A, 2008, EXP CELL RES, V314, P3605, DOI 10.1016/j.yexcr.2008.09.011; Fletcher AJ, 2015, P NATL ACAD SCI USA, V112, P10014, DOI 10.1073/pnas.1507534112; Fletcher AJ, 2015, EMBO J, V34, P2078, DOI 10.15252/embj.201490361; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hillje AL, 2011, STEM CELLS, V29, P1437, DOI 10.1002/stem.687; Kar G, 2012, J PROTEOME RES, V11, P1196, DOI 10.1021/pr2009143; Koliopoulos MG, 2016, EMBO J, V35, P1204, DOI 10.15252/embj.201593741; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Li Y, 2014, CELL RES, V24, P762, DOI 10.1038/cr.2014.46; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Napolitano LM, 2011, BIOCHEM J, V434, P309, DOI 10.1042/BJ20101487; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Niklasson M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004022; Oke V, 2012, J AUTOIMMUN, V39, P77, DOI 10.1016/j.jaut.2012.01.014; Orthaber D, 2000, CHEM PHYS LIPIDS, V107, P179, DOI 10.1016/S0009-3084(00)00171-7; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Qin YF, 2016, CELL RES, V26, P613, DOI 10.1038/cr.2016.27; Rajsbaum R, 2014, J MOL BIOL, V426, P1265, DOI 10.1016/j.jmb.2013.12.005; Reddy BA, 2014, MOL CELL, V53, P458, DOI 10.1016/j.molcel.2013.12.017; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Round A, 2015, ACTA CRYSTALLOGR D, V71, P67, DOI 10.1107/S1399004714026959; Sanchez JG, 2016, CELL REP, V16, P1315, DOI 10.1016/j.celrep.2016.06.070; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Strandberg L, 2008, J CLIN IMMUNOL, V28, P220, DOI 10.1007/s10875-007-9157-0; Streich FC, 2016, NATURE, V536, P304, DOI 10.1038/nature19071; Taherbhoy AM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8621; Tickle I.J., 2018, STARANISO; Valimberti I, 2015, SCI REP-UK, V5, DOI 10.1038/srep14849; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; van Wijk SJL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002754; Wada K, 2006, BIOCHEM BIOPH RES CO, V339, P415, DOI 10.1016/j.bbrc.2005.11.029; Wada K, 2009, J BIOCHEM, V146, P821, DOI 10.1093/jb/mvp127; Wagner JM, 2016, ELIFE, V5, DOI [10.7554/elife.16309, 10.7554/eLife.16309]; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wheaton K, 2017, J BIOL CHEM, V292, P2893, DOI 10.1074/jbc.M116.749564; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamaguchi M, 2016, MOL CELL, V63, P593, DOI 10.1016/j.molcel.2016.07.003; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yudina Z, 2015, CELL REP, V12, P788, DOI 10.1016/j.celrep.2015.06.072; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492	80	10	10	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11404	11419		10.1074/jbc.RA119.008485	http://dx.doi.org/10.1074/jbc.RA119.008485			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31160341	Green Published, hybrid			2022-12-28	WOS:000478717600006
J	Pichlo, C; Juetten, L; Wojtalla, F; Schacherl, M; Diaz, D; Baumann, U				Pichlo, Christian; Juetten, Linda; Wojtalla, Fabian; Schacherl, Magdalena; Diaz, Dolores; Baumann, Ulrich			Molecular determinants of the mechanism and substrate specificity of Clostridium difficile proline-proline endopeptidase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metalloprotease; infectious disease; enzyme kinetics; protease; crystal structure; nuclear magnetic resonance (NMR); substrate specificity; Clostridium difficile	STRUCTURAL BASIS; COORDINATION SPHERE; ZINC; CLEAVAGE; BINDING; WATER; ZMP1; SITE	Pro-Pro endopeptidase-1 (PPEP-1) is a secreted metalloprotease from the bacterial pathogen Clostridium difficile that cleaves two endogenous adhesion proteins. PPEP-1 is therefore important for bacterial motility and hence for efficient gut colonization during infection. PPEP-1 exhibits a unique specificity for Pro-Pro peptide bonds within the consensus sequence VNP down arrow PVP. In this study, we combined information from crystal and NMR structures with mutagenesis and enzyme kinetics to investigate the mechanism and substrate specificity of PPEP-1. Our analyses revealed that the substrate-binding cleft of PPEP-1 is shaped complementarily to the major conformation of the substrate in solution. We found that it possesses features that accept a tertiary amide and help discriminate P1 ' residues by their amide hydrogen bond-donating potential. We also noted that residues Lys-101, Trp-103, and Glu-184 are crucial for proteolytic activity. Upon substrate binding, these residues position a flexible loop over the substrate-binding cleft and modulate the second coordination sphere of the catalytic zinc ion. On the basis of these findings, we propose an induced-fit model in which prestructured substrates are recognized followed by substrate positioning within the active-site cleft and a concomitant increase in the Lewis acidity of the catalytic Zn2+ ion. In conclusion, our findings provide detailed structural and mechanistic insights into the substrate recognition and specificity of PPEP-1 from the common gut pathogen C. difficile.	[Pichlo, Christian; Wojtalla, Fabian; Schacherl, Magdalena; Baumann, Ulrich] Univ Cologne, Inst Biochem, Dept Chem, D-50674 Cologne, Germany; [Juetten, Linda; Diaz, Dolores] Univ Cologne, Inst Organ Chem, Dept Chem, D-50939 Cologne, Germany; [Schacherl, Magdalena] Charite Univ Med Berlin, Inst Med Phys & Biophys, Charitepl 1, D-10117 Berlin, Germany	University of Cologne; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Baumann, U (corresponding author), Univ Cologne, Inst Biochem, Dept Chem, D-50674 Cologne, Germany.	ubaumann@uni-koeln.de	Schacherl, Magdalena/M-1590-2014; Baumann, Ulrich/B-1220-2013; Diaz, Dolores/AAS-1158-2020; Schacherl, Magdalena/AAT-6362-2021	Schacherl, Magdalena/0000-0002-5478-2509; Diaz, Dolores/0000-0002-2406-4952; Schacherl, Magdalena/0000-0002-5478-2509; Wojtalla, Fabian/0000-0001-7002-8955	German Research Foundation [INST 216/682-1 FUGG]; iNEXT initiative (European Union program Horizon 2020) [1859]; European Community's Seventh Framework Program (FP7/2007-2013) [283570]; University of Cologne	German Research Foundation(German Research Foundation (DFG)); iNEXT initiative (European Union program Horizon 2020); European Community's Seventh Framework Program (FP7/2007-2013); University of Cologne	We thank the staff of beamlines X06SA and X06DA at the Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland, and ID23-1, ID29, ID30A-1 and ID30A3 at the European Synchrotron Radiation Facility (ESRF), Grenoble, France as well as P13 at the Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany for support during data collection. Crystals were grown in the Cologne Crystallization facility (C<INF>2</INF>f). This work was supported by German Research Foundation Grant INST 216/682-1 FUGG for the Crystallization Facility, and the iNEXT initiative (European Union program Horizon 2020, pid 1859), and the European Community's Seventh Framework Program (FP7/2007-2013) under Grant Agreement 283570 (BioStruct-X) for the synchorotron access. The authors declare that they have no conflicts of interest with the contents of this article. D. D. is very grateful to the University of Cologne for supporting the JobSharing project.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bordeleau E, 2015, CURR GENET, V61, P497, DOI 10.1007/s00294-015-0484-z; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Carmona AK, 2006, NAT PROTOC, V1, P1971, DOI 10.1038/nprot.2006.306; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Corver J, 2017, MOL MICROBIOL, V105, P663, DOI 10.1111/mmi.13736; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; GAUTHIER TD, 1986, ENVIRON SCI TECHNOL, V20, P1162, DOI 10.1021/es00153a012; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Guo F, 2016, DALTON T, V45, P13648, DOI 10.1039/c6dt01860b; Hakkim V, 2010, J PHYS CHEM A, V114, P7952, DOI 10.1021/jp101515h; Hensbergen PJ, 2015, FEBS LETT, V589, P3952, DOI 10.1016/j.febslet.2015.10.027; Hensbergen PJ, 2014, MOL CELL PROTEOMICS, V13, P1231, DOI 10.1074/mcp.M113.034728; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller R., 2004, COMPUTER AIDED RESON, V1; Klychnikov OI, 2018, J BIOL CHEM, V293, P11154, DOI 10.1074/jbc.RA118.003244; Krimmer SG, 2014, CHEMMEDCHEM, V9, P833, DOI 10.1002/cmdc.201400013; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nguyen BD, 2007, J MAGN RESON, V184, P263, DOI 10.1016/j.jmr.2006.10.014; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Parkin G, 2004, SCIENCE, V305, P1117, DOI 10.1126/science.1102500; Peltier J, 2015, J BIOL CHEM, V290, P24453, DOI 10.1074/jbc.M115.665091; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pichlo C, 2016, JOVE-J VIS EXP, DOI 10.3791/55022; Ramsland PA, 2007, P NATL ACAD SCI USA, V104, P15051, DOI 10.1073/pnas.0706028104; Rubino JT, 2016, J BIOL INORG CHEM, V21, P185, DOI 10.1007/s00775-015-1319-6; Schacherl M, 2015, STRUCTURE, V23, P1632, DOI 10.1016/j.str.2015.06.018; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shook RL, 2010, INORG CHEM, V49, P3646, DOI 10.1021/ic901550k; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Turk BE, 2004, NAT STRUCT MOL BIOL, V11, P60, DOI 10.1038/nsmb708; Vidmar R, 2017, EMBO J, V36, P2455, DOI 10.15252/embj.201796750; Walden M, 2015, ELIFE, V4, DOI 10.7554/eLife.06638; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y	39	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11525	11535		10.1074/jbc.RA119.009029	http://dx.doi.org/10.1074/jbc.RA119.009029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31182482	Green Published, hybrid			2022-12-28	WOS:000478717600015
J	Zhang, ZH; Li, MD				Zhang, Zhihui; Li, Min-Dian			Setting fire to fat (vol 294, pg 9720, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													zhang, zh/GWV-4677-2022					Zhang ZH, 2019, J BIOL CHEM, V294, P9720, DOI 10.1074/jbc.H119.009488	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11653	11653		10.1074/jbc.AAC119.009988	http://dx.doi.org/10.1074/jbc.AAC119.009988			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31350285	hybrid, Green Published			2022-12-28	WOS:000478717600025
J	Lee, AW; Deruaz, M; Lynch, C; Davies, G; Singh, K; Alenazi, Y; Eaton, JRO; Kawamura, A; Shaw, J; Proudfoot, AEI; Dias, JM; Bhattacharya, S				Lee, Angela W.; Deruaz, Maud; Lynch, Christopher; Davies, Graham; Singh, Kamayani; Alenazi, Yara; Eaton, James R. O.; Kawamura, Akane; Shaw, Jeffrey; Proudfoot, Amanda E., I; Dias, Joao M.; Bhattacharya, Shoumo			A knottin scaffold directs the CXC-chemokine-binding specificity of tick evasins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; chemotaxis; crystal structure; inflammation; protein-protein interaction; host-pathogen interaction; evasin; immune response; knottin; tick	PROTEIN; REFINEMENT; NEUTRALIZATION; IMPROVEMENTS; PREDICTION; RECEPTORS; PEPTIDES; OPINION; DISPLAY; FAMILY	Tick evasins (EVAs) bind either CC- or CXC-chemokines by a poorly understood promiscuous or one-to-many mechanism to neutralize inflammation. Because EVAs potently inhibit inflammation in many preclinical models, highlighting their potential as biological therapeutics for inflammatory diseases, we sought to further unravel the CXC-chemokine-EVA interactions. Using yeast surface display, we identified and characterized 27 novel CXC-chemokine-binding evasins homologous to EVA3 and defined two functional classes. The first, which included EVA3, exclusively bound ELR+ CXC-chemokines, whereas the second class bound both ELR+ and ELR- CXC-chemokines, in several cases including CXC-motif chemokine ligand 10 (CXCL10) but, surprisingly, not CXCL8. The X-ray crystal structure of EVA3 at a resolution of 1.79 angstrom revealed a single antiparallel beta-sheet with six conserved cysteine residues forming a disulfide-bonded knottin scaffold that creates a contiguous solvent-accessible surface. Swapping analyses identified distinct knottin scaffold segments necessary for different CXC-chemokine-binding activities, implying that differential ligand positioning, at least in part, plays a role in promiscuous binding. Swapping segments also transferred chemokine-binding activity, resulting in a hybrid EVA with dual CXCL10- and CXCL8-binding activities. The solvent-accessible surfaces of the knottin scaffold segments have distinctive shape and charge, which we suggest drives chemokine-binding specificity. These studies provide structural and mechanistic insight into how CXC-chemokine-binding tick EVAs achieve class specificity but also engage in promiscuous binding.	[Lee, Angela W.; Lynch, Christopher; Davies, Graham; Singh, Kamayani; Alenazi, Yara; Eaton, James R. O.; Kawamura, Akane; Bhattacharya, Shoumo] Univ Oxford, Radcliffe Dept Med Div Cardiovasc Med, Oxford OX3 78N, England; [Deruaz, Maud; Shaw, Jeffrey; Proudfoot, Amanda E., I; Dias, Joao M.] Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland; [Eaton, James R. O.; Kawamura, Akane] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	University of Oxford; University of Oxford	Dias, JM (corresponding author), Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland.; Bhattacharya, S (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Oxford OX3 7BN, England.	jmdias@pfizer.com; sbhattac@well.ox.ac.uk	Bhattacharya, Shoumo/F-4127-2010	Bhattacharya, Shoumo/0000-0002-5571-0478; Lynch, Christopher/0000-0002-4534-4865; Lee, Angela/0000-0002-7591-825X	Saudi Arabian Cultural Bureau; Oxford BHF Centre of Research Excellence; Royal Society Dorothy Hodgkin fellowship; MRC [MC_PC_16056] Funding Source: UKRI	Saudi Arabian Cultural Bureau; Oxford BHF Centre of Research Excellence; Royal Society Dorothy Hodgkin fellowship(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a studentship from the Saudi Arabian Cultural Bureau.; Supported by a studentship from the Oxford BHF Centre of Research Excellence.; Supported by a Royal Society Dorothy Hodgkin fellowship.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Alenazi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24568-9; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bonvin P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00208; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Denisov SS, 2019, CHEM COMMUN, V55, P1374, DOI 10.1039/c8cc08777f; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Deruaz M, 2013, FEBS J, V280, P4876, DOI 10.1111/febs.12463; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Eaton JRO, 2018, J BIOL CHEM, V293, P6134, DOI 10.1074/jbc.RA117.000487; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Gonzalez-Motos V, 2016, CYTOKINE GROWTH F R, V30, P71, DOI 10.1016/j.cytogfr.2016.02.007; Hajnicka V, 2001, PARASITE IMMUNOL, V23, P483, DOI 10.1046/j.1365-3024.2001.00403.x; Hayward J, 2017, J BIOL CHEM, V292, P15670, DOI 10.1074/jbc.M117.807255; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Kintzing JR, 2016, CURR OPIN CHEM BIOL, V34, P143, DOI 10.1016/j.cbpa.2016.08.022; Kufareva I, 2017, ANNU REV BIOPHYS, V46, P175, DOI 10.1146/annurev-biophys-051013-022942; Kufareva I, 2016, CURR OPIN PHARMACOL, V30, P27, DOI 10.1016/j.coph.2016.07.006; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lavergne V, 2015, RSC DRUG DISCOV, V42, P37; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lua RC, 2014, PROG BIOPHYS MOL BIO, V116, P194, DOI 10.1016/j.pbiomolbio.2014.05.004; Nava S, 2009, FRONT BIOSCI-LANDMRK, V14, P2857, DOI 10.2741/3418; Nomiyama H, 2013, GENES CELLS, V18, P1, DOI 10.1111/gtc.12013; Postic G, 2018, NUCLEIC ACIDS RES, V46, pD454, DOI 10.1093/nar/gkx1084; Proudfoot AEI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00183; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Scholle MD, 2004, PROTEIN EXPRES PURIF, V37, P243, DOI 10.1016/j.pep.2004.05.012; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Singh K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05204-4; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Sommerstein R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005276; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Szekanecz Z, 2016, NAT REV RHEUMATOL, V12, P5, DOI 10.1038/nrrheum.2015.157; Van Raemdonck K, 2015, CYTOKINE GROWTH F R, V26, P311, DOI 10.1016/j.cytogfr.2014.11.009; Vancova I, 2010, VET PARASITOL, V167, P274, DOI 10.1016/j.vetpar.2009.09.029; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wikel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00337; Zohar Y, 2014, J CLIN INVEST, V124, P2009, DOI 10.1172/JCI71951	62	14	41	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11199	11212		10.1074/jbc.RA119.008817	http://dx.doi.org/10.1074/jbc.RA119.008817			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167786	Green Published, hybrid			2022-12-28	WOS:000478717400012
J	Wu, V; Yeerna, H; Nohata, N; Chiou, J; Harismendy, O; Raimondi, F; Inoue, A; Russell, RB; Tamayo, P; Gutkind, JS				Wu, Victoria; Yeerna, Huwate; Nohata, Nijiro; Chiou, Joshua; Harismendy, Olivier; Raimondi, Francesco; Inoue, Asuka; Russell, Robert B.; Tamayo, Pablo; Gutkind, J. Silvio			Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						G protein-coupled receptor (GPCR); G protein; signal transduction; cancer; immunotherapy; drug repurposing; oncocrine signaling; precision therapies	SARCOMA-ASSOCIATED HERPESVIRUS; REGULATORY T-CELLS; HETEROTRIMERIC G-PROTEINS; EPIDERMAL-GROWTH-FACTOR; BREAST-CANCER; COLON-CANCER; ACTIVATING MUTATIONS; CHEMOKINE RECEPTORS; SOMATIC MUTATIONS; SIGNALING PATHWAY	G protein-coupled receptors (GPCRs) are the largest gene family of cell membrane-associated molecules mediating signal transmission, and their involvement in key physiological functions is well-established. The ability of GPCRs to regulate a vast array of fundamental biological processes, such as cardiovascular functions, immune responses, hormone and enzyme release from endocrine and exocrine glands, neurotransmission, and sensory perception (e.g. vision, odor, and taste), is largely due to the diversity of these receptors and the layers of their downstream signaling circuits. Dysregulated expression and aberrant functions of GPCRs have been linked to some of the most prevalent human diseases, which renders GPCRs one of the top targets for pharmaceutical drug development. However, the study of the role of GPCRs in tumor biology has only just begun to make headway. Recent studies have shown that GPCRs can contribute to the many facets of tumorigenesis, including proliferation, survival, angiogenesis, invasion, metastasis, therapy resistance, and immune evasion. Indeed, GPCRs are widely dysregulated in cancer and yet are underexploited in oncology. We present here a comprehensive analysis of GPCR gene expression, copy number variation, and mutational signatures in 33 cancer types. We also highlight the emerging role of GPCRs as part of oncocrine networks promoting tumor growth, dissemination, and immune evasion, and we stress the potential benefits of targeting GPCRs and their signaling circuits in the new era of precision medicine and cancer immunotherapies.	[Wu, Victoria; Nohata, Nijiro; Gutkind, J. Silvio] UCSD Moores Canc Ctr, Dept Pharmacol, La Jolla, CA 92093 USA; [Yeerna, Huwate; Harismendy, Olivier; Tamayo, Pablo] UCSD Moores Canc Ctr, Dept Med, La Jolla, CA 92093 USA; [Chiou, Joshua] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Harismendy, Olivier] Univ Calif San Diego, Sch Med, Div Biomed Informat, La Jolla, CA 92093 USA; [Raimondi, Francesco; Russell, Robert B.] Heidelberg Univ, Bioquant, CellNetworks, Neuenheimer Feld 267, D-69120 Heidelberg, Germany; [Raimondi, Francesco; Russell, Robert B.] Heidelberg Univ, BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Nohata, Nijiro] MSD KK, Oncol Sci Unit, Tokyo 1028667, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Tohoku University; Merck & Company	Gutkind, JS (corresponding author), UCSD Moores Canc Ctr, Dept Pharmacol, La Jolla, CA 92093 USA.	sgutkind@ucsd.edu	Russell, Robert/GWU-6389-2022; Gutkind, J. Silvio/J-1201-2016; Russell, Rob/AAH-9145-2019; Harismendy, Olivier/AAM-2072-2021; Raimondi, Francesco/AAB-8586-2019; Nohata, Nijiro/H-5190-2011	Russell, Robert/0000-0002-7213-1398; Gutkind, J. Silvio/0000-0002-5150-4482; Russell, Rob/0000-0002-1905-4717; Harismendy, Olivier/0000-0002-8098-9888; Nohata, Nijiro/0000-0002-6816-2984; RAIMONDI, Francesco/0000-0002-6891-3178; Chiou, Joshua/0000-0002-4618-0647	National Institutes of Health [R33CA225291, U54CA209891, U01-CA217885, P30-CA023100, R01-HG009285, R01-GM074024, R01-CA172513, U24-CA194107, U24-CA220341]; NCI [U01CA196406]; NIDCR [U01DE028227]; NATIONAL CANCER INSTITUTE [U01CA196406, U54CA209891, U01CA217885, T32CA067754, P30CA023100, R33CA225291, U24CA220341, R01CA172513, U24CA194107] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE028227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R33CA225291 and U54CA209891 (to S. G. and V. W.) and U01CA196406 (to O. H.) from NCI, U01DE028227 from NIDCR (to S. G. and V. W.), and National Institutes of Health Grants U01-CA217885 and P30-CA023100 (to P. T. and H. Y.), and R01-HG009285, R01-GM074024, R01-CA172513, U24-CA194107, and U24-CA220341 (to P. T.). J. S. G. is a member of the Scientific Advisory Board of Oncoceutics Inc. and Domain Therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alakus H, 2014, GENOME MED, V6, DOI 10.1186/gm559; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; Amano H, 2009, CANCER SCI, V100, P2318, DOI 10.1111/j.1349-7006.2009.01322.x; Amersi FF, 2008, CLIN CANCER RES, V14, P638, DOI 10.1158/1078-0432.CCR-07-2025; Anderson GR, 2017, CELL REP, V20, P999, DOI 10.1016/j.celrep.2017.07.006; Annala S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau5948; Antonioli L, 2016, TRENDS CANCER, V2, P95, DOI 10.1016/j.trecan.2016.01.003; Arrillaga-Romany I, 2017, ONCOTARGET, V8, P79298, DOI 10.18632/oncotarget.17837; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Aust G, 1997, CANCER RES, V57, P1798; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Ayturk UM, 2016, AM J HUM GENET, V98, P789, DOI 10.1016/j.ajhg.2016.03.009; Bais C, 2003, CANCER CELL, V3, P131, DOI 10.1016/S1535-6108(03)00024-2; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Bayin NS, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.63; BLACKMORE M, 1992, BRIT J CANCER, V66, P32, DOI 10.1038/bjc.1992.212; Borea PA, 2018, PHYSIOL REV, V98, P1591, DOI 10.1152/physrev.00049.2017; Carvajal RD, 2018, J CLIN ONCOL, V36, P1232, DOI 10.1200/JCO.2017.74.1090; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chatzistamou I, 2000, BRIT J CANCER, V83, P906, DOI 10.1054/bjoc.2000.1374; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen EP, 2011, PROSTAG OTH LIPID M, V96, P14, DOI 10.1016/j.prostaglandins.2011.08.005; Chen X, 2017, CANCER CELL, V31, P685, DOI 10.1016/j.ccell.2017.04.002; Cheng KR, 2008, AM J PHYSIOL-GASTR L, V295, pG591, DOI 10.1152/ajpgi.00055.2008; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Choi KY, 2011, P NATL ACAD SCI USA, V108, P15219, DOI 10.1073/pnas.1107304108; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Dascal N, 2015, INT REV NEUROBIOL, V123, P27, DOI 10.1016/bs.irn.2015.06.001; Davies JQ, 2011, ONCOL REP, V25, P619, DOI 10.3892/or.2010.1117; De Giorgi V, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2017.2908; Devaud C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25961; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Drew DA, 2016, NAT REV CANCER, V16, P173, DOI 10.1038/nrc.2016.4; Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722; DuhamelClerin E, 1997, ARTERIOSCL THROM VAS, V17, P1931, DOI 10.1161/01.ATV.17.10.1931; Dutra-Oliveira A, 2012, BIOCHEM BIOPH RES CO, V421, P221, DOI 10.1016/j.bbrc.2012.03.140; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; Esapa C, 1997, J CLIN ENDOCR METAB, V82, P493, DOI 10.1210/jc.82.2.493; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fang XJ, 2000, ANN NY ACAD SCI, V905, P188; Feng XD, 2019, CANCER CELL, V35, P457, DOI 10.1016/j.ccell.2019.01.009; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Fischer SM, 2011, CANCER PREV RES, V4, P1728, DOI 10.1158/1940-6207.CAPR-11-0166; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gutierrez AN, 2017, CELL SIGNAL, V41, P65, DOI 10.1016/j.cellsig.2017.09.005; Gutkind JS, 2018, NAT REV MOL CELL BIO, V19, P615, DOI 10.1038/s41580-018-0041-y; GUTKIND JS, 1991, P NATL ACAD SCI USA, V88, P4703, DOI 10.1073/pnas.88.11.4703; Halmos G, 1997, P NATL ACAD SCI USA, V94, P956, DOI 10.1073/pnas.94.3.956; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hayakawa Y, 2017, CANCER CELL, V31, P21, DOI 10.1016/j.ccell.2016.11.005; HERBERT JM, 1994, BIOCHEM J, V303, P227, DOI 10.1042/bj3030227; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Hu Q, 2018, CELL, V173, P1254, DOI 10.1016/j.cell.2018.03.018; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Ideno N, 2018, GASTROENTEROLOGY, V155, P1593, DOI 10.1053/j.gastro.2018.08.006; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Iniguez MA, 1999, J IMMUNOL, V163, P111; Inoue A, 2019, CELL, V177, P1933, DOI 10.1016/j.cell.2019.04.044; Insel PA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00431; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Itadani H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-615; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Johnson-Holiday C, 2011, INT J ONCOL, V38, P1279, DOI 10.3892/ijo.2011.953; JULIUS D, 1989, SCIENCE, V244, P1057, DOI 10.1126/science.2727693; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kerksiek KM, 2005, BLOOD, V105, P742, DOI 10.1182/blood-2004-05-1891; Kiberstis PA, 2017, SCIENCE, V355, P1143, DOI [10.1126/science.355.6321.144-d, 10.1126/science.355.6330.1142]; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Kline CLB, 2018, NEOPLASIA, V20, P80, DOI 10.1016/j.neo.2017.10.002; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lapadula D, 2019, MOL CANCER RES, V17, P963, DOI 10.1158/1541-7786.MCR-18-0574; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee RTH, 2016, DEVELOPMENT, V143, P367, DOI 10.1242/dev.120154; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leone RD, 2015, COMPUT STRUCT BIOTEC, V13, P265, DOI 10.1016/j.csbj.2015.03.008; Li MH, 2018, CHEMSUSCHEM, V11, P171, DOI 10.1002/cssc.201701911; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lin P, 2003, J BIOL CHEM, V278, P14379, DOI 10.1074/jbc.M209101200; Liu SC, 2009, CANCER RES, V69, P6122, DOI 10.1158/0008-5472.CAN-08-3435; Liu YL, 2006, CANCER BIOL THER, V5, P1320, DOI 10.4161/cbt.5.10.3162; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Lopez-Giral S, 2004, J LEUKOCYTE BIOL, V76, P462, DOI 10.1189/jlb.1203652; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Maiga A, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.36; Mancini M, 2016, SEMIN CELL DEV BIOL, V50, P164, DOI 10.1016/j.semcdb.2015.09.018; Marin-Acevedo JA, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0582-8; Markwalder R, 1999, CANCER RES, V59, P1152; Martin D, 2011, CANCER CELL, V19, P805, DOI 10.1016/j.ccr.2011.05.005; Mathur P, 2015, BBA-MOL BASIS DIS, V1852, P406, DOI 10.1016/j.bbadis.2014.11.020; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Monje M, 2017, CANCER CELL, V31, P1, DOI 10.1016/j.ccell.2016.12.008; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Montaner S, 2013, ANNU REV PHARMACOL, V53, P331, DOI 10.1146/annurev-pharmtox-010510-100608; MOODY TW, 1981, SCIENCE, V214, P1246, DOI 10.1126/science.6272398; Moore AR, 2016, NAT GENET, V48, P675, DOI 10.1038/ng.3549; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Nazarko O, 2018, ISCIENCE, V3, P264, DOI 10.1016/j.isci.2018.04.019; Nilsson MB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4307; Nomura R, 2014, HUM PATHOL, V45, P2488, DOI 10.1016/j.humpath.2014.08.016; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; Nugent A, 2017, CELL SIGNAL, V39, P95, DOI 10.1016/j.cellsig.2017.08.002; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; O'Hayre M, 2016, ONCOGENE, V35, P3771, DOI 10.1038/onc.2015.442; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Obermajer N, 2012, ONCOIMMUNOLOGY, V1, P762, DOI 10.4161/onci.19681; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Offermanns S, 2014, ANNU REV PHARMACOL, V54, P407, DOI 10.1146/annurev-pharmtox-011613-135945; Ohta A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00109; Onken MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6852; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Parish AJ, 2018, CANCER-AM CANCER SOC, V124, P4080, DOI 10.1002/cncr.31724; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Patra KC, 2018, NAT CELL BIOL, V20, P811, DOI 10.1038/s41556-018-0122-3; Paulsen SJ, 2005, J VIROL, V79, P536, DOI 10.1128/JVI.79.1.536-546.2005; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pold M, 2004, CANCER RES, V64, P1853, DOI 10.1158/0008-5472.CAN-03-3262; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Pukrop T, 2010, GLIA, V58, P1477, DOI 10.1002/glia.21022; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Raimondi F., 2019, ONCOGENE; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Rasheed SAK, 2018, ONCOGENE, V37, P1340, DOI 10.1038/s41388-017-0038-6; Rasmussen JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046087; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Renz BW, 2018, CANCER CELL, V33, P75, DOI 10.1016/j.ccell.2017.11.007; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rybaczyk L, 2009, INFLAMM BOWEL DIS, V15, P971, DOI 10.1002/ibd.20893; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Sadeque A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-59; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018; Schulte G, 2018, TRENDS PHARMACOL SCI, V39, P828, DOI 10.1016/j.tips.2018.07.001; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shi XL, 2004, MOL CANCER RES, V2, P395; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Simonetti O, 2006, EUR J CANCER, V42, P1181, DOI 10.1016/j.ejca.2006.01.043; Sin WC, 2004, ONCOGENE, V23, P6299, DOI 10.1038/sj.onc.1207838; Singh R, 2011, INT J ONCOL, V39, P373, DOI 10.3892/ijo.2011.1059; Sivaraj KK, 2013, DEV CELL, V25, P427, DOI 10.1016/j.devcel.2013.04.008; SMITH JP, 1994, AM J PHYSIOL, V266, pR277, DOI 10.1152/ajpregu.1994.266.1.R277; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Song PF, 2003, CANCER RES, V63, P214; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Sreeramkumar V, 2012, IMMUNOL CELL BIOL, V90, P579, DOI 10.1038/icb.2011.75; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Sun BD, 2000, PROSTATE, V42, P295; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Thal DM, 2018, NATURE, V559, P45, DOI 10.1038/s41586-018-0259-z; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Thompson MD, 2014, METHODS MOL BIOL, V1175, P153, DOI 10.1007/978-1-4939-0956-8_8; Trusolino L, 2012, CANCER DISCOV, V2, P876, DOI 10.1158/2159-8290.CD-12-0400; Umansky V, 2017, CANCER IMMUNOL IMMUN, V66, P1015, DOI 10.1007/s00262-017-1988-9; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; van der Westhuizen ET, 2015, J PHARMACOL EXP THER, V353, P246, DOI 10.1124/jpet.114.221606; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Vazquez-Prado J, 2004, METHOD ENZYMOL, V390, P259; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Visser SS, 2000, BIOCHEM PHARMACOL, V60, P993, DOI 10.1016/S0006-2952(00)00414-7; von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Walter K, 2010, CLIN CANCER RES, V16, P1781, DOI 10.1158/1078-0432.CCR-09-1913; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang JH, 2018, ONCOL LETT, V15, P552, DOI 10.3892/ol.2017.7279; Wang NT, 2016, STEM CELL REP, V6, P668, DOI 10.1016/j.stemcr.2016.04.007; Wang NT, 2015, CLIN CANCER RES, V21, P4676, DOI 10.1158/1078-0432.CCR-14-3163; WARD PA, 1965, J EXP MED, V122, P327, DOI 10.1084/jem.122.2.327; WARD PA, 1968, AM J PATHOL, V52, P725; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Whitehead IP, 2001, ONCOGENE, V20, P1547, DOI 10.1038/sj.onc.1204188; Wootten D, 2018, NAT REV MOL CELL BIO, V19, P638, DOI 10.1038/s41580-018-0049-3; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Yang LQ, 2011, CANCER RES, V71, P5558, DOI 10.1158/0008-5472.CAN-10-4543; Yang L, 2018, IMMUNOPHARM IMMUNOT, V40, P91, DOI 10.1080/08923973.2017.1417997; Yoda A, 2015, NAT MED, V21, P71, DOI 10.1038/nm.3751; Young A, 2018, CANCER RES, V78, P1003, DOI 10.1158/0008-5472.CAN-17-2826; Young A, 2014, CANCER DISCOV, V4, P879, DOI 10.1158/2159-8290.CD-14-0341; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang JX, 2016, ONCOTARGET, V7, P4414, DOI 10.18632/oncotarget.6780; Zhang JJ, 2016, BIOCHEM PHARMACOL, V114, P69, DOI 10.1016/j.bcp.2016.03.021; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	241	82	86	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11062	11086		10.1074/jbc.REV119.005601	http://dx.doi.org/10.1074/jbc.REV119.005601			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31171722	Green Published, hybrid			2022-12-28	WOS:000478717400003
J	Le Mauff, F; Bamford, NC; Alnabelseya, N; Zhang, YZ; Baker, P; Robinson, H; Codee, JDC; Howell, PL; Sheppard, DC				Le Mauff, Francois; Bamford, Natalie C.; Alnabelseya, Noor; Zhang, Yongzhen; Baker, Perrin; Robinson, Howard; Codee, Jeroen D. C.; Howell, P. Lynne; Sheppard, Donald C.			Molecular mechanism of Aspergillus fumigatus biofilm disruption by fungal and bacterial glycoside hydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspergillus; biofilm; glycoside hydrolase; extracellular matrix; protein structure; virulence factor; substrate specificity; galactosaminogalactan; lung infection	GALACTOSAMINOGALACTAN; IDENTIFICATION; RESIDUES; SEQUENCE; SYSTEM; PEL	During infection, the fungal pathogen Aspergillus fumigatus forms biofilms that enhance its resistance to antimicrobials and host defenses. An integral component of the biofilm matrix is galactosaminogalactan (GAG), a cationic polymer of alpha-1,4-linked galactose and partially deacetylated N-acetylgalactosamine (GalNAc). Recent studies have shown that recombinant hydrolase domains from Sph3, an A. fumigatus glycoside hydrolase involved in GAG synthesis, and PelA, a multifunctional protein from Pseudomonas aeruginosa involved in Pel polysaccharide biosynthesis, can degrade GAG, disrupt A. fumigatus biofilms, and attenuate fungal virulence in a mouse model of invasive aspergillosis. The molecular mechanisms by which these enzymes disrupt biofilms have not been defined. We hypothesized that the hydrolase domains of Sph3 and PelA (Sph3(h) and PelA(h), respectively) share structural and functional similarities given their ability to degrade GAG and disrupt A. fumigatus biofilms. MALDI-TOF enzymatic fingerprinting and NMR experiments revealed that both proteins are retaining endo-alpha-1,4-N-acetylgalactosaminidases with a minimal substrate size of seven residues. The crystal structure of PelA(h) was solved to 1.54 angstrom and structure alignment to Sph3(h) revealed that the enzymes share similar catalytic site residues. However, differences in the substrate-binding clefts result in distinct enzyme-substrate interactions. PelA(h) hydrolyzed partially deacetylated substrates better than Sph3(h), a finding that agrees well with PelA(h)'s highly electronegative binding cleft versus the neutral surface present in Sph3(h). Our insight into PelA(h)'s structure and function necessitate the creation of a new glycoside hydrolase family, GH166, whose structural and mechanistic features, along with those of GH135 (Sph3), are reported here.	[Le Mauff, Francois; Sheppard, Donald C.] McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ H3A 284, Canada; [Le Mauff, Francois; Sheppard, Donald C.] McGill Univ, Hlth Ctr, Res Inst, Infect Dis & Immun Global Hlth, Montreal, PQ H4A 3J1, Canada; [Le Mauff, Francois; Sheppard, Donald C.] McGill Interdisciplinary Initiat Infect & Immun, Montreal, PQ H3A 1Y2, Canada; [Bamford, Natalie C.; Alnabelseya, Noor; Baker, Perrin; Howell, P. Lynne] Hosp Sick Children, Vogram Mol Med, Toronto, ON MSG 1X8, Canada; [Bamford, Natalie C.; Alnabelseya, Noor; Howell, P. Lynne] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON MSS 1A8, Canada; [Zhang, Yongzhen; Codee, Jeroen D. C.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA; [Alnabelseya, Noor] Diassess Inc, 1412 62nd St, Emeryville, CA 94608 USA; [Robinson, Howard] Covalon Technol Ltd, 660 Tech Ave 5, Mississauga, ON L4W 5S7, Canada	McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Leiden University; Leiden University - Excl LUMC; United States Department of Energy (DOE); Brookhaven National Laboratory	Sheppard, DC (corresponding author), McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ H3A 284, Canada.; Sheppard, DC (corresponding author), McGill Univ, Hlth Ctr, Res Inst, Infect Dis & Immun Global Hlth, Montreal, PQ H4A 3J1, Canada.; Sheppard, DC (corresponding author), McGill Interdisciplinary Initiat Infect & Immun, Montreal, PQ H3A 1Y2, Canada.	howell@sickkids.ca; donald.sheppard@mcgill.ca	Sheppard, Donald/B-4637-2008; Le Mauff, Francois/L-3453-2019	Sheppard, Donald/0000-0001-8877-880X; Le Mauff, Francois/0000-0003-0712-5837; Bamford, Natalie/0000-0003-1959-856X	United States Department of Energy Office; National Center for Research Resources Grant [P41RR012408]; NIGMS from the National Institutes of Health [P41GM103473]; BBSRC [BB/R012415/1] Funding Source: UKRI	United States Department of Energy Office(United States Department of Energy (DOE)); National Center for Research Resources Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS from the National Institutes of Health; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Dr. Todd Lowary, Department of Chemistry, University of Alberta, for assistance in the design and interpretation of the NMR spectra. We thank the Drug Discovery platform of the Research Institute of the McGill Health Center for use of the MALDI-TOF mass spectrometer and NMR equipment. Beam Line X29 at the National Synchrotron Light Source is supported by the United States Department of Energy Office and National Center for Research Resources Grant P41RR012408 and NIGMS Grant P41GM103473 from the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; [Anonymous], 2012, INT J MICROBIOL, DOI DOI 10.1155/2012/528521; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker P, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501632; Bamford NC, 2015, J BIOL CHEM, V290, P27438, DOI 10.1074/jbc.M115.679050; Briard B, 2016, MYCOLOGIA, V108, P572, DOI 10.3852/15-312; Cecchini DA, 2015, FEBS LETT, V589, P3098, DOI 10.1016/j.febslet.2015.08.012; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colvin KM, 2013, J BACTERIOL, V195, P2329, DOI 10.1128/JB.02150-12; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DeLano W.L, PYMOL MOL GRAPHICS S; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Gravelat FN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003575; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112; Kernien JF, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01968; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Le Mauff F, 2017, PLANT BIOTECHNOL J, V15, P285, DOI 10.1111/pbi.12607; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Lee MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00252-16; Lee MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005187; Lee MJ, 2014, J BIOL CHEM, V289, P1243, DOI 10.1074/jbc.M113.522516; Little DJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006998; Loussert C, 2010, CELL MICROBIOL, V12, P405, DOI 10.1111/j.1462-5822.2009.01409.x; Mehrad B, 1999, J IMMUNOL, V162, P1633; Moracci M, 1996, PROTEIN ENG, V9, P1191, DOI 10.1093/protein/9.12.1191; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Muller FMC, 2011, MED MYCOL, V49, pS96, DOI 10.3109/13693786.2010.502190; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce CG, 2013, CURR OPIN PHARMACOL, V13, P726, DOI 10.1016/j.coph.2013.08.008; Reichhardt C, 2015, EUKARYOT CELL, V14, P1064, DOI 10.1128/EC.00050-15; Seidler MJ, 2008, ANTIMICROB AGENTS CH, V52, P4130, DOI 10.1128/AAC.00234-08; Sheppard DC, 2016, J BIOL CHEM, V291, P12529, DOI 10.1074/jbc.R116.720995; Sheppard DC, 2011, CURR OPIN MICROBIOL, V14, P375, DOI 10.1016/j.mib.2011.07.006; Snarr BD, 2017, P NATL ACAD SCI USA, V114, P7124, DOI 10.1073/pnas.1702798114; Taccone FS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0722-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van de Veerdonk FL, 2017, NAT REV MICROBIOL, V15, P661, DOI 10.1038/nrmicro.2017.90; Yang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17585; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zhang H, 2018, NUCLEIC ACIDS RES, V46, pW95, DOI 10.1093/nar/gky418	51	26	26	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10760	10772		10.1074/jbc.RA119.008511	http://dx.doi.org/10.1074/jbc.RA119.008511			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31167793	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000478717200004
J	Heidemann, JL; Neumann, P; Dickmanns, A; Ficner, R				Heidemann, Jana L.; Neumann, Piotr; Dickmanns, Achim; Ficner, Ralf			Crystal structures of the c-di-AMP-synthesizing enzyme CdaA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						second messenger; cyclic di-AMP (c-di-AMP); X-ray crystallography; prokaryotic signal transduction; metal ion-protein interaction	SIGNAL-TRANSDUCTION; METAL SITES; GMP; IDENTIFICATION; NUCLEOTIDE; BACTERIA; BINDING; CAMP; CGMP	Cyclic di-AMP (c-di-AMP) is the only second messenger known to be essential for bacterial growth. It has been found mainly in Gram-positive bacteria, including pathogenic bacteria like Listeria monocytogenes. CdaA is the sole diadenylate cyclase in L. monocytogenes, making this enzyme an attractive target for the development of novel antibiotic compounds. Here we report crystal structures of CdaA from L. monocytogenes in the apo state, in the post-catalytic state with bound c-di-AMP and catalytic Co2+ ions, as well as in a complex with AMP. These structures reveal the flexibility of a tyrosine side chain involved in locking the adenine ring after ATP binding. The essential role of this tyrosine was confirmed by mutation to Ala, leading to drastic loss of enzymatic activity.	[Heidemann, Jana L.; Neumann, Piotr; Dickmanns, Achim; Ficner, Ralf] Georg August Univ Gottingen, Gottingen Ctr Mol Biosci, Inst Microbiol & Genet, Dept Mol Struct Biol, D-37077 Gottingen, Germany	University of Gottingen	Ficner, R (corresponding author), Georg August Univ Gottingen, Gottingen Ctr Mol Biosci, Inst Microbiol & Genet, Dept Mol Struct Biol, D-37077 Gottingen, Germany.	rficner@uni-goettingen.de			Deutsche Forschungsgemeinschaft Priority Programs SPP1879; Deutsche Forschungsgemeinschaft [INST186/1117]	Deutsche Forschungsgemeinschaft Priority Programs SPP1879; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Priority Programs SPP1879 and INST186/1117. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; Cho KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069425; Commichau FM, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00462-18; Commichau FM, 2015, MOL MICROBIOL, V97, P189, DOI 10.1111/mmi.13026; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Gundlach J, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3011; Gundlach J, 2015, J BIOL CHEM, V290, P3069, DOI 10.1074/jbc.M114.619619; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Hengge R, 2016, J BACTERIOL, V198, P15, DOI 10.1128/JB.00331-15; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Manikandan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086096; Mao LS, 2004, J MOL BIOL, V336, P787, DOI 10.1016/j.jmb.2003.12.056; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller M, 2015, BIOCHEM J, V469, P367, DOI 10.1042/BJ20150373; Nielsen MM, 2011, J BIOL CHEM, V286, P15155, DOI 10.1074/jbc.M110.199844; Putignano V, 2018, NUCLEIC ACIDS RES, V46, pD459, DOI 10.1093/nar/gkx989; Rosenberg J, 2015, J BIOL CHEM, V290, P6596, DOI 10.1074/jbc.M114.630418; Samol I, 2012, PLANT CELL, V24, P2596, DOI 10.1105/tpc.112.095703; Shi L, 2004, FRONT BIOSCI-LANDMRK, V9, P1382, DOI 10.2741/1318; Tosi T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007537; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zhou J, 2014, ANAL CHEM, V86, P2412, DOI 10.1021/ac403203x	32	7	8	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10463	10470		10.1074/jbc.RA119.009246	http://dx.doi.org/10.1074/jbc.RA119.009246			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31118276	Green Published, hybrid			2022-12-28	WOS:000478717100008
J	George, A; Aubol, BE; Fattet, L; Adams, JA				George, Athira; Aubol, Brandon E.; Fattet, Laurent; Adams, Joseph A.			Disordered protein interactions for an ordered cellular transition: Cdc2-like kinase 1 is transported to the nucleus via its Ser-Arg protein substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; RNA splicing; nuclear translocation; serine; threonine protein kinase; RNA processing; intrinsically disordered protein; post-transcriptional regulation; Arg-Ser repeat; cdc2-like kinase (CLK); splicing factor; SR protein	SHUTTLING SR PROTEINS; SPLICING FACTORS; PHOSPHORYLATION; IMPORT; CLK1; SPECIFICITY; LOCALIZATION; MECHANISM; ASF/SF2; SRPK1	Serine-arginine (SR) proteins are essential splicing factors that promote numerous steps associated with mRNA processing and whose biological function is tightly regulated through multi-site phosphorylation. In the nucleus, the cdc2-like kinases (CLKs) phosphorylate SR proteins on their intrinsically disordered Arg-Ser (RS) domains, mobilizing them from storage speckles to the splicing machinery. The CLKs have disordered N termini that bind tightly to RS domains, enhancing SR protein phosphorylation. The N termini also promote nuclear localization of CLKs, but their transport mechanism is presently unknown. To explore cytoplasmic-nuclear transitions, several classical nuclear localization sequences in the N terminus of the CLK1 isoform were identified, but their mutation had no effect on subcellular localization. Rather, we found that CLK1 amplifies its presence in the nucleus by forming a stable complex with the SR protein substrate and appropriating its NLS for transport. These findings indicate that, along with their well-established roles in mRNA splicing, SR proteins use disordered protein-protein interactions to carry their kinase regulator from the cytoplasm to the nucleus.	[George, Athira; Aubol, Brandon E.; Fattet, Laurent; Adams, Joseph A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Adams, JA (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	j2adams@ucsd.edu	Fattet, Laurent/ABH-5434-2020	Fattet, Laurent/0000-0001-5152-4937	National Institutes of Health [GM67969, GM98528]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098528, R01GM067969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM67969 and GM98528. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Aubol BE, 2018, J BIOL CHEM, V293, P16751, DOI 10.1074/jbc.RA118.004587; Aubol BE, 2018, BIOCHEM J, V475, P677, DOI 10.1042/BCJ20170672; Aubol BE, 2016, MOL CELL, V63, P218, DOI 10.1016/j.molcel.2016.05.034; Aubol BE, 2014, BIOCHEM J, V462, P143, DOI 10.1042/BJ20140494; Aubol BE, 2013, J MOL BIOL, V425, P2894, DOI 10.1016/j.jmb.2013.05.013; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Delestienne N, 2010, FEBS J, V277, P2496, DOI 10.1111/j.1742-4658.2010.07664.x; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; DUNCAN PI, 1995, J BIOL CHEM, V270, P21524, DOI 10.1074/jbc.270.37.21524; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Jain P, 2014, CURR DRUG TARGETS, V15, P539, DOI 10.2174/1389450115666140226112321; Jeong S, 2017, MOL CELLS, V40, P1, DOI 10.14348/molcells.2017.2319; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Keshwani MM, 2015, BIOCHEM J, V472, P329, DOI 10.1042/BJ20150903; Keshwani MM, 2015, BIOCHEM J, V466, P311, DOI 10.1042/BJ20141373; Kim YH, 2017, ANAT CELL BIOL, V50, P77, DOI 10.5115/acb.2017.50.2.77; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; Lai MC, 2004, J BIOL CHEM, V279, P31745, DOI 10.1074/jbc.C400173200; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Muller S, 1998, J MOL BIOL, V283, P383, DOI 10.1006/jmbi.1998.2078; Nayler O, 1997, BIOCHEM J, V326, P693, DOI 10.1042/bj3260693; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Prasad J, 2003, MOL CELL BIOL, V23, P4139, DOI 10.1128/MCB.23.12.4139-4149.2003; Sacco-Bubulya P, 2002, J CELL BIOL, V156, P425, DOI 10.1083/jcb.200107017; Saitoh N, 2012, MOL BIOL CELL, V23, P1115, DOI 10.1091/mbc.E11-09-0783; Sako Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep46126; Sanford JR, 2005, P NATL ACAD SCI USA, V102, P15042, DOI 10.1073/pnas.0507827102; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Soniat M, 2015, BIOCHEM J, V468, P353, DOI 10.1042/BJ20150368; Stojdl DF, 1999, BIOCHEM CELL BIOL, V77, P293, DOI 10.1139/bcb-77-4-293; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014; Zu M, 2015, MOLECULES, V20, P19735, DOI 10.3390/molecules201119653	40	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9631	9641		10.1074/jbc.RA119.008463	http://dx.doi.org/10.1074/jbc.RA119.008463			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31064840	Green Published, hybrid			2022-12-28	WOS:000472713000027
J	Guseman, AJ; Gronenborn, AM				Guseman, Alex J.; Gronenborn, Angela M.			Isomerization as the secret Achilles' heel of long-lived proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ASPARAGINYL; ASPARTYL; RESIDUES	Crystallin proteins, the dominant constituents of the eye lens, are prototypes of long-lived proteins. Such proteins can accumulate harmful modifications over their life span that render them prone to aggregation, which, in the case of lens crystallin, contributes to cataract formation. Lyon et al. now explore the structural and functional consequences of amino acid isomerization in -crystallins using mass spectrometry, molecular dynamics simulations, and other strategies. Their results highlight the potential deleterious effects of these under-detected modifications on protein structural integrity and function.	[Guseman, Alex J.; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15213 USA.	amg100@pitt.edu		Guseman, Alex/0000-0002-9796-5719; Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [GM082251, DK114855]; National Science Foundation [CHE-1708773]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the authors' laboratory is supported by National Institutes of Health Grants GM082251 and DK114855 and National Science Foundation Grant CHE-1708773. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; GEIGER T, 1987, J BIOL CHEM, V262, P785; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Lyon YA, 2019, J BIOL CHEM, V294, P7546, DOI 10.1074/jbc.RA118.007052; Lyon YA, 2018, EXP EYE RES, V171, P131, DOI 10.1016/j.exer.2018.03.018; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Toyama BH, 2013, NAT REV MOL CELL BIO, V14, P55, DOI 10.1038/nrm3496	8	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7556	7557		10.1074/jbc.H119.008716	http://dx.doi.org/10.1074/jbc.H119.008716			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	31076522	Green Published, hybrid			2022-12-28	WOS:000470153300003
J	Bera, AK; Lu, J; Wales, TE; Gondi, S; Gurbani, D; Nelson, A; Engen, JR; Westover, KD				Bera, Asim K.; Lu, Jia; Wales, Thomas E.; Gondi, Sudershan; Gurbani, Deepak; Nelson, Andrew; Engen, John R.; Westover, Kenneth D.			Structural basis of the atypical activation mechanism of KRAS(V14I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ras protein; GTPase; GTPase Kras (KRAS); guanine nucleotide-exchange factor (GEF); X-ray crystallography; GTPase; Noonan syndrome; nucleotide exchange; RAS; RASopathy	SWITCH-II POCKET; ONCOGENIC K-RAS; NOONAN SYNDROME; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; COMPLEX; FEATURES; MUTANT; SITES; GTP	RAS regulation and signaling are largely accomplished by direct protein-protein interactions, making RAS protein dynamics a critical determinant of RAS function. Here, we report a crystal structure of GDP-bound KRAS(V14I), a mutated KRAS variant associated with the developmental RASopathy disorder Noonan syndrome (NS), at 1.5-1.6 angstrom resolution. The structure is notable for revealing a marked extension of switch 1 away from the G-domain and nucleotide-binding site of the KRAS protein. We found that this extension is associated with a loss of the magnesium ion and a tilt in the position of the guanine base because of the additional carbon introduced by the isoleucine substitution. Hydrogen-deuterium exchange MS analysis confirmed that this conformation occurs in solution, but also disclosed a difference in kinetics when compared with KRAS(A146T), another RAS mutant that displays a nearly identical conformation in previously reported crystal structures. This conformational change contributed to a high rate of guanine nucleotide-exchange factor (GEF)-dependent and -independent nucleotide exchange and to an increase in affinity for SOS Ras/Rac GEF 1 (SOS1), which appears to be the major mode of activation for this RAS variant. These results highlight a mechanistic connection between KRAS(A146T) and KRAS(V14I) that may have implications for the regulation of these variants and for the development of therapeutic strategies to manage KRAS variant-associated disorders.	[Bera, Asim K.; Lu, Jia; Gondi, Sudershan; Gurbani, Deepak; Nelson, Andrew; Westover, Kenneth D.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Bera, Asim K.; Lu, Jia; Gondi, Sudershan; Gurbani, Deepak; Nelson, Andrew; Westover, Kenneth D.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Wales, Thomas E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Northeastern University	Westover, KD (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Westover, KD (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	Kenneth.Westover@UTSouthwestern.edu	Westover, Ken/AAZ-1795-2020	Westover, Ken/0000-0003-3653-5923; Wales, Thomas E./0000-0001-6133-5689; GURBANI, DEEPAK/0000-0002-0982-7173; Nelson, Andrew/0000-0002-1413-3766; Engen, John R./0000-0002-6918-9476	National Institutes of Health [U54 CA196519]; V Foundation for Cancer Research V Scholar Grant; DOD [W81XWH-16-1-0106]; Waters Corporation; NATIONAL CANCER INSTITUTE [U54CA196519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research V Scholar Grant; DOD(United States Department of Defense); Waters Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant U54 CA196519, a V Foundation for Cancer Research V Scholar Grant, DOD Grant W81XWH-16-1-0106 (to K. D. W.), and a research collaboration grant with the Waters Corporation (to J. R. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Buhrman G, 2007, STRUCTURE, V15, P1618, DOI 10.1016/j.str.2007.10.011; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FASANO O, 1984, P NATL ACAD SCI-BIOL, V81, P4008, DOI 10.1073/pnas.81.13.4008; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gentile DR, 2017, CELL CHEM BIOL, V24, P1455, DOI 10.1016/j.chembiol.2017.08.025; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Haigis KM, 2017, TRENDS CANCER, V3, P686, DOI 10.1016/j.trecan.2017.08.006; Hall BE, 2002, P NATL ACAD SCI USA, V99, P12138, DOI 10.1073/pnas.192453199; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Hammond DE, 2015, J PROTEOME RES, V14, P1535, DOI 10.1021/pr501191a; Harrison RA, 2016, J MOL BIOL, V428, P4723, DOI 10.1016/j.jmb.2016.10.017; Hernandez-Porras I, 2015, RARE DIS, V3, DOI 10.1080/21675511.2015.1045169; Hernandez-Porras I, 2016, J PATHOL, V239, P206, DOI 10.1002/path.4719; Hernandez-Porras I, 2014, P NATL ACAD SCI USA, V111, P16395, DOI 10.1073/pnas.1418126111; Hobbs GA, 2013, FREE RADICAL BIO MED, V57, P221, DOI 10.1016/j.freeradbiomed.2012.10.531; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Hunter JC, 2014, P NATL ACAD SCI USA, V111, P8895, DOI 10.1073/pnas.1404639111; Janes MR, 2018, CELL, V172, P578, DOI 10.1016/j.cell.2018.01.006; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Jongmans MCJ, 2011, EUR J HUM GENET, V19, P870, DOI 10.1038/ejhg.2011.37; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim E, 2016, CANCER DISCOV, V6, P714, DOI 10.1158/2159-8290.CD-16-0160; Kratz CP, 2015, BRIT J CANCER, V112, P1392, DOI 10.1038/bjc.2015.75; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lim SM, 2014, ANGEW CHEM INT EDIT, V53, P199, DOI 10.1002/anie.201307387; Lu J, 2018, BIOCHEMISTRY-US, V57, P324, DOI 10.1021/acs.biochem.7b00974; Lu J, 2017, STRUCTURE, V25, P1442, DOI 10.1016/j.str.2017.07.003; Lu J, 2015, DATA BRIEF, V5, P572, DOI 10.1016/j.dib.2015.10.001; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poulin EJ, 2019, CANCER DISCOV, V9, P738, DOI 10.1158/2159-8290.CD-18-1220; Saha M, 2012, BIOCHEM J, V447, P159, DOI 10.1042/BJ20120938; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013; SCHLICHTING I, 1988, BIOCHEM BIOPH RES CO, V150, P444, DOI 10.1016/0006-291X(88)90540-2; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter JJG, 2015, J MED CHEM, V58, P2265, DOI 10.1021/jm501660t	51	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13964	13972		10.1074/jbc.RA119.009131	http://dx.doi.org/10.1074/jbc.RA119.009131			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31341022	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000490729800011
J	Fan, TWM; Bruntz, RC; Yang, Y; Song, H; Chernyavskaya, Y; Deng, P; Zhang, Y; Shah, PP; Beverly, LJ; Qi, Z; Mahan, AL; Higashi, RM; Dang, CV; Lane, AN				Fan, Teresa W. M.; Bruntz, Ronald C.; Yang, Ye; Song, Huan; Chernyavskaya, Yelena; Deng, Pan; Zhang, Yan; Shah, Parag P.; Beverly, Levi J.; Qi, Zhen; Mahan, Angela L.; Higashi, Richard M.; Dang, Chi V.; Lane, Andrew N.			De novo synthesis of serine and glycine fuels purine nucleotide biosynthesis in human lung cancer tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolic tracer; metabolism; nucleoside; nucleotide biosynthesis; lung cancer; one-carbon metabolism; dynamic compartmentation; ex vivo human lung tissue slice cultures; multiplexed Stable Isotope-resolved Metabolomics (mSIRM)	ISOTOPE-RESOLVED METABOLOMICS; METABOLISM; PROLIFERATION; OPTIMIZATION; CONSTRAINTS; ALGORITHM; SUPPORTS; CELLS; MODEL; CYCLE	Nucleotide synthesis is essential to proliferating cells, but the preferred precursors for de novo biosynthesis are not defined in human cancer tissues. We have employed multiplexed stable isotope-resolved metabolomics to track the metabolism of [C-13(6)]glucose, D-2-glycine, [C-13(2)]glycine, and D-3-serine into purine nucleotides in freshly resected cancerous and matched noncancerous lung tissues from nonsmall cell lung cancer (NSCLC) patients, and we compared the metabolism with established NSCLC PC9 and A549 cell lines in vitro. Surprisingly, [C-13(6)] glucose was the best carbon source for purine synthesis in human NSCLC tissues, in contrast to the noncancerous lung tissues from the same patient, which showed lower mitotic indices and MYC expression. We also observed that D-3-Ser was preferentially incorporated into purine rings over D-2-glycine in both tissues and cell lines. MYC suppression attenuated [C-13(6)] glucose, D-3-serine, and [C-13(2)] glycine incorporation into purines and reduced proliferation in PC9 but not in A549 cells. Using detailed kinetic modeling, we showed that the preferred use of glucose as a carbon source for purine ring synthesis in NSCLC tissues involves cytoplasmic activation/compartmentation of the glucose-to-serine pathway and enhanced reversed one-carbon fluxes that attenuate exogenous serine incorporation into purines. Our findings also indicate that the substrate for de novo nucleotide synthesis differs profoundly between cancer cell lines and fresh human lung cancer tissues; the latter preferred glucose to exogenous serine or glycine but not the former. This distinction in substrate utilization in purine synthesis in human cancer tissues should be considered when targeting one-carbon metabolism for cancer therapy.	[Fan, Teresa W. M.; Bruntz, Ronald C.; Yang, Ye; Song, Huan; Chernyavskaya, Yelena; Deng, Pan; Zhang, Yan; Beverly, Levi J.; Higashi, Richard M.; Lane, Andrew N.] Univ Kentucky, Markey Canc Ctr, CESB, Lexington, KY 40536 USA; [Mahan, Angela L.] Univ Kentucky, Markey Canc Ctr, Dept Surg, Lexington, KY 40536 USA; [Fan, Teresa W. M.; Yang, Ye; Qi, Zhen; Higashi, Richard M.; Lane, Andrew N.] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Shah, Parag P.; Beverly, Levi J.] Univ Louisville, JG Brown Canc Ctr, Louisville, KY 40202 USA; [Dang, Chi V.] Ludwig Inst Canc Res, New York, NY 10017 USA; [Dang, Chi V.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Yang, Ye] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Qi, Zhen] 470 Stedford Ln, Johns Creek, GA 30097 USA; [Mahan, Angela L.] 4003 Kresge Way,Ste 224, Louisville, KY 40207 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Louisville; Ludwig Institute for Cancer Research; The Wistar Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fan, TWM; Lane, AN (corresponding author), Lee T Todd Bldg,789 S Limestone St, Lexington, KY 40536 USA.	twmfan@gmail.com; andrew.lane@uky.edu	Deng, Pan/AAS-2346-2020	Deng, Pan/0000-0003-2974-7389; Fan, Teresa/0000-0002-7292-8938; Song, Huan/0000-0002-2196-3610	National Institutes of Health [T32 CA165990, 5R01CA051497, 5R01CA057341, 1R01CA-118434-01, 3R01CA118434-02, 1R01ES022191-01, 1P01CA163223-01A1, 1U24DK097215-01A1]; Redox Metabolism Shared Resource of the University of Kentucky Markey Cancer Center National Institutes of Health [P30CA177558]; Lustgarten Fund [90049125]; Leukemia Lymphoma Society [LLS-6363-11]; Stand-Up-to-Cancer/American Association for Cancer Research translational grant; NATIONAL CANCER INSTITUTE [R01CA057341, P30CA010815, T32CA165990, P30CA177558, R01CA051497, P01CA163223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Redox Metabolism Shared Resource of the University of Kentucky Markey Cancer Center National Institutes of Health; Lustgarten Fund; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Stand-Up-to-Cancer/American Association for Cancer Research translational grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported National Institutes of Health Grants 1R01CA-118434-01, 3R01CA118434-02, and 1R01ES022191-01 (to T. W. M. F.); 1P01CA163223-01A1 (to A. N. L. and T. W. M. F.); 1U24DK097215-01A1 (to R. M. H., T. W. M. F., and A. N. L.); Redox Metabolism Shared Resource of the University of Kentucky Markey Cancer Center National Institutes of Health Grant P30CA177558; the Lustgarten Fund 90049125; National Institutes of Health Grant T32 CA165990 (to R. C. B.); National Institutes of Health Grants 5R01CA051497 and 5R01CA057341; Leukemia Lymphoma Society Grant LLS-6363-11; and Stand-Up-to-Cancer/American Association for Cancer Research translational grant (to C. V. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akbani R, 2014, MOL CELL PROTEOMICS, V13, P1625, DOI 10.1074/mcp.O113.034918; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Boellner Stefanie, 2015, Microarrays (Basel), V4, P98, DOI 10.3390/microarrays4020098; CONN AR, 1991, SIAM J NUMER ANAL, V28, P545, DOI 10.1137/0728030; Conn AR, 1997, MATH COMPUT, V66, P261, DOI 10.1090/S0025-5718-97-00777-1; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Dolfi SC, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-20; Fan T. W., 2012, HDB METABOLOMICS, P7, DOI [10.1007/978-1-61779-618-0_2, DOI 10.1007/978-1-61779-618-0_2]; Fan T. W., 2011, METHODOLOGIES METABO, P525; Fan T. W.-M., 2016, BIO-PROTOCOL, V6, pe1730, DOI [DOI 10.21769/BI0PR0T0C.1730, 10.21769/BioProtoc.1730, DOI 10.21769/BIOPROTOC.1730]; Fan TWM, 2008, PROG NUCL MAG RES SP, V52, P69, DOI 10.1016/j.pnmrs.2007.03.002; Fan TWM, 2005, METABOLOMICS, V1, P325, DOI 10.1007/s11306-005-0012-0; Fan TWM, 2012, PHARMACOL THERAPEUT, V133, P366, DOI 10.1016/j.pharmthera.2011.12.007; Fan TWM, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-79; Fan TWM, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a000893; Fan TWM, 2012, METABOLOMICS, V8, P517, DOI 10.1007/s11306-011-0337-9; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hori H, 1996, CANCER RES, V56, P5653; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Johnson M, 2008, 2008 10TH INTERNATIONAL CONFERENCE ON CONTROL AUTOMATION ROBOTICS & VISION: ICARV 2008, VOLS 1-4, P781, DOI 10.1109/ICARCV.2008.4795616; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Lane AN, 2009, ANAL CHIM ACTA, V651, P201, DOI 10.1016/j.aca.2009.08.032; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lorkiewicz P, 2012, METABOLOMICS, V8, P930, DOI 10.1007/s11306-011-0388-y; Maddocks ODK, 2017, NATURE, V544, P372, DOI 10.1038/nature22056; Marler RT, 2004, STRUCT MULTIDISCIP O, V26, P369, DOI 10.1007/s00158-003-0368-6; Momb J, 2013, P NATL ACAD SCI USA, V110, P549, DOI 10.1073/pnas.1211199110; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Moseley HNB, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-139; Murphy TA, 2013, METAB ENG, V15, P206, DOI 10.1016/j.ymben.2012.07.008; Paone A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.482; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Powell M. J. D., 1977, NUMERICAL ANAL, P144; Qi Z, 2008, PHARMACOPSYCHIATRY, V41, pS89, DOI 10.1055/s-2008-1080936; Rosner B., 2006, FUNDAMENTALS BIOSTAT, P573; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; Tedeschi PM, 2015, MOL CANCER RES, V13, P1361, DOI 10.1158/1541-7786.MCR-15-0117; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Voit EO, 2008, PHARMACOPSYCHIATRY, V41, pS78, DOI 10.1055/s-2008-1080911; Wikoff WR, 2015, CANCER PREV RES, V8, P410, DOI 10.1158/1940-6207.CAPR-14-0329; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Yang Y, 2017, ANAL CHIM ACTA, V976, P63, DOI 10.1016/j.aca.2017.04.014; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	54	38	39	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13464	13477		10.1074/jbc.RA119.008743	http://dx.doi.org/10.1074/jbc.RA119.008743			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31337706	hybrid, Green Published			2022-12-28	WOS:000486417200021
J	Mu, YW; Tian, Y; Zhang, ZC; Han, JH				Mu, Yawen; Tian, Yao; Zhang, Zi Chao; Han, Junhai			Metallophosphoesterase regulates light-induced rhodopsin endocytosis by promoting an association between arrestin and the adaptor protein AP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); rhodopsin; endocytosis; arrestin; retinal degeneration; clathrin adaptor protein AP2; photoreceptor function; clathrin; metallophosphoesterase (MPPE)	RETINAL DEGENERATION; VISUAL ARRESTIN; PLASMA-MEMBRANE; BETA-ARRESTINS; RECEPTOR; PHOTOTRANSDUCTION; PHOSPHORYLATION; MECHANISMS; CHANNEL; AP-2	Light-induced endocytosis of rhodopsin in the retina is critical for preventing photoreceptor hyperactivity and for the survival of photoreceptor cells. In Drosophila, this process is mediated by arrestin1 (Arr1). Because Arr1 lacks a clathrin-binding domain required for receptor internalization and the C-terminal sequence that interacts with the beta-subunit of the clathrin adaptor protein AP2, the mechanism of how Arr1 mediates endocytosis of the major rhodopsin Rh1 is unclear. Here, using several approaches, including Arr binding and pulldown assays, immunofluorescence techniques, and EM imaging, we found that Drosophila metallophosphoesterase (dMPPE) is involved in light-induced rhodopsin endocytosis. We observed that the photoreceptor cells of a dmppe mutant exhibit impaired light-induced rhodopsin endocytosis and that this impairment is independent of dMPPE phosphoesterase activity. Furthermore, dMPPE directly interacted with Arr1 and promoted the association of Arr1 with AP2. Of note, genetic dmppe deletion largely prevented retinal degeneration in norpA (encoding phospholipase C) mutants, which were reported previously to contribute to retinal degeneration, by suppressing Rh1 endocytosis. Our findings demonstrate that Arr1 interacts with AP2 and that dMPPE functions as a critical regulator in Rh1 endocytosis and retinal degeneration.	[Mu, Yawen; Tian, Yao; Zhang, Zi Chao; Han, Junhai] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Han, Junhai] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, JS, Peoples R China	Southeast University - China; Nantong University	Zhang, ZC; Han, JH (corresponding author), 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.	zhangzc@seu.edu.cn; junhaihan@seu.edu.cn		Tian, Yao/0000-0002-0367-6239	National Natural Science Foundation of China [31471031, 31771171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31471031 and 31771171 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; Barry DM, 2018, NEUROSCI BULL, V34, P156, DOI 10.1007/s12264-017-0125-2; Cao JG, 2011, EMBO J, V30, P3701, DOI 10.1038/emboj.2011.254; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Han J, 2007, EMBO J, V26, P4966, DOI 10.1038/sj.emboj.7601929; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hu W, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002115; Hu W, 2012, J BIOL CHEM, V287, P13911, DOI 10.1074/jbc.M112.339895; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu AH, 2019, NEUROSCI BULL, V35, P471, DOI 10.1007/s12264-018-0324-5; Liu L, 2017, DEV CELL, V41, P94, DOI 10.1016/j.devcel.2017.03.004; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; Orem NR, 2006, J CELL SCI, V119, P3141, DOI 10.1242/jcs.03052; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; PAGE LJ, 1995, J CELL BIOL, V131, P619, DOI 10.1083/jcb.131.3.619; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Schink KO, 2016, ANNU REV CELL DEV BI, V32, P143, DOI 10.1146/annurev-cellbio-111315-125349; Sengupta S, 2013, J CELL SCI, V126, P1247, DOI 10.1242/jcs.120592; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Stowers RS, 1999, GENETICS, V152, P1631; Tian Y, 2012, SCI CHINA LIFE SCI, V55, P27, DOI 10.1007/s11427-012-4272-4; Wan DD, 2015, HUM MOL GENET, V24, P4599, DOI 10.1093/hmg/ddv191; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang X, 2017, J MOL CELL BIOL, V9, P104, DOI 10.1093/jmcb/mjw041; Xiong B, 2013, TRENDS NEUROSCI, V36, P652, DOI 10.1016/j.tins.2013.08.003; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112; Xu Y, 2016, J CELL SCI, V129, P394, DOI 10.1242/jcs.178764	46	2	2	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12892	12900		10.1074/jbc.RA119.009602	http://dx.doi.org/10.1074/jbc.RA119.009602			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31324721	hybrid, Green Published			2022-12-28	WOS:000486416000003
J	Gottesman, ME; Mustaev, A				Gottesman, Max E.; Mustaev, Arkady			Ribonucleoside-5 '-diphosphates (NDPs) support RNA polymerase transcription, suggesting NDPs may have been substrates for primordial nucleic acid biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleoside; nucleotide analogue; transcription; RNA polymerase; substrate specificity; catalysis; NDP; nucleoside-5 '-diphosphates; substrate	DNA-POLYMERASE; DEOXYRIBONUCLEIC-ACID; INORGANIC-PHOSPHATE; RIBONUCLEIC-ACID; STRUCTURAL BASIS; ACTIVE-CENTER; MECHANISM; SELECTION; RESIDUES; SITE	A better understanding of the structural basis for the preferences of RNA and DNA polymerases for nucleoside-5 '-triphosphates (NTPs) could help define the catalytic mechanisms for nucleotidyl transfer during RNA and DNA synthesis and the origin of primordial nucleic acid biosynthesis. We show here that ribonucleoside-5 '-diphosphates (NDPs) can be utilized as substrates by RNA polymerase (RNAP). We found that NDP incorporation is template-specific and that noncognate NDPs are not incorporated. Compared with the natural RNAP substrates, NTPs, the K-m of RNAP for NDPs was increased similar to 4-fold, whereas the V-max was decreased similar to 200-fold. These properties could be accounted for by molecular modeling of NTP/RNAP co-crystal structures. This finding suggested that the terminal phosphate residue in NTP (not present in NDP) is important for positioning the nucleotide for nucleolytic attack in the nucleotidyl transfer reaction. Strikingly, a mutational substitution of the active-center beta R1106 side chain involved in NTP positioning also strongly inhibited NDP-directed synthesis, even though this residue does not contact NDP. Substitutions in the structurally analogous side chain in RB69 DNA polymerase (Arg-482) and HIV reverse transcriptase (Lys-65) were previously observed to inhibit dNDP incorporation. The unexpected involvement of these residues suggests that they affect a step in catalysis common for nucleic acid polymerases. The substrate activity of NDPs with RNAP along with those reported for DNA polymerases reinforces the hypothesis that NDPs may have been used for nucleic acid biosynthesis by primordial enzymes, whose evolution then led to the use of the more complex triphosphate derivatives.	[Gottesman, Max E.] Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY 10032 USA; [Mustaev, Arkady] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Mustaev, Arkady] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA	Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mustaev, A (corresponding author), Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA.; Mustaev, A (corresponding author), Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA.	mustaear@njms.rutgers.edu			internal Public Health Research Institute support grant; National Institutes of Health [R01 GM037219]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037219] Funding Source: NIH RePORTER	internal Public Health Research Institute support grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by internal Public Health Research Institute support grant (to A.M.) and by National Institutes of Health Grant R01 GM037219 (to M.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERTY RA, 1992, BIOCHEMISTRY-US, V31, P10610, DOI 10.1021/bi00158a025; Burke CR, 2018, P NATL ACAD SCI USA, V115, P980, DOI 10.1073/pnas.1712193115; CHAMBERLIN M, 1962, P NATL ACAD SCI USA, V48, P81, DOI 10.1073/pnas.48.1.81; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; Dikson M., 1979, ENZYMES; FURTH JJ, 1962, J BIOL CHEM, V237, P2611; Garforth SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002074; Gottesman ME, 2018, P NATL ACAD SCI USA, V115, P2746, DOI 10.1073/pnas.1720370115; GRUNBERGMANAGO M, 1956, BIOCHIM BIOPHYS ACTA, V20, P269, DOI 10.1016/0006-3002(56)90286-4; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; KORNBERG A, 1957, ADV ENZYMOL REL S BI, V18, P191; Kozlov M, 2005, ANAL BIOCHEM, V342, P206, DOI 10.1016/j.ab.2005.04.022; LIBANATI CM, 1969, J CELL BIOL, V42, P754, DOI 10.1083/jcb.42.3.754; MASON PW, 1981, J BIOL CHEM, V256, P1861; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Pritchard AE, 1999, J MOL BIOL, V285, P1067, DOI 10.1006/jmbi.1998.2352; ROZOVSKAYA TA, 1984, BIOCHEM J, V224, P645, DOI 10.1042/bj2240645; SAGITOV V, 1993, J BIOL CHEM, V268, P2195; Saturno J, 1998, J MOL BIOL, V283, P633, DOI 10.1006/jmbi.1998.2121; Sosunov V, 2005, NUCLEIC ACIDS RES, V33, P4202, DOI 10.1093/nar/gki688; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; SZAFRANSKI P, 1985, ACTA BIOCHIM POL, V32, P329; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Yang GW, 2002, BIOCHEMISTRY-US, V41, P2526, DOI 10.1021/bi0119924	27	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11785	11792		10.1074/jbc.RA119.009074	http://dx.doi.org/10.1074/jbc.RA119.009074			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31189650	hybrid, Green Published			2022-12-28	WOS:000486127800015
J	Radler, MI; Miller, DV; Laremore, TN; Booker, SJ				Radler, Matthew, I; Miller, Danielle, V; Laremore, Tatiana N.; Booker, Squire J.			Methanogenesis marker protein 10 (Mmp10) from Methanosarcina acetivorans is a radical S-adenosylmethionine methylase that unexpectedly requires cobalamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						S-adenosylmethionine (SAM); archaea; iron-sulfur protein; protein methylation; post-translational modification (PTM); radical; cobalamin; methanogenesis; methyl coenzyme M reductase; methylarginine; radical SAM	ADENOSYL-L-METHIONINE; COENZYME-M REDUCTASE; C-METHYLATION; IRON-SULFUR; SAM ENZYME; BIOSYNTHESIS; METHANE; SYSTEM; FOM3; TSRM	Methyl coenzyme M reductase (MCR) catalyzes the last step in the biological production of methane by methanogenic archaea, as well as the first step in the anaerobic oxidation of methane to methanol by methanotrophic archaea. MCR contains a number of unique post-translational modifications in its alpha subunit, including thioglycine, 1-N-methylhistidine, S-methylcysteine, 5-C-(S)-methylarginine, and 2-C-(S)-methylglutamine. Recently, genes responsible for the thioglycine and methylarginine modifications have been identified in bioinformatics studies and in vivo complementation of select mutants; however, none of these reactions has been verified in vitro. Herein, we purified and biochemically characterized the radical S-adenosylmethionine (SAM) protein MaMmp10, the product of the methanogenesis marker protein 10 gene in the methane-producing archaea Methanosarcina acetivorans. Using an array of approaches, including kinetic assays, LC-MS-based quantification, and MALDI TOF-TOF MS analyses, we found that MaMmp10 catalyzes the methylation of the equivalent of Arg(285) in a peptide substrate surrogate, but only in the presence of cobalamin. We noted that the methyl group derives from SAM, with cobalamin acting as an intermediate carrier, and that MaMmp10 contains a C-terminal cobalamin-binding domain. Given that Mmp10 has not been annotated as a cobalamin-binding protein, these findings suggest that cobalamin-dependent radical SAM proteins are more prevalent than previously thought.	[Radler, Matthew, I; Booker, Squire J.] Penn State Univ, Dept Chem, 302 Chem Bldg, University Pk, PA 16802 USA; [Miller, Danielle, V; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Laremore, Tatiana N.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Booker, Squire J.] Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), Penn State Univ, Dept Chem, 302 Chem Bldg, University Pk, PA 16802 USA.	squire@psu.edu			NIH [GM-122595]; Eberly Family Distinguished Chair in Science; Pennsylvania State University Huck Institute for Life Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122595] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eberly Family Distinguished Chair in Science; Pennsylvania State University Huck Institute for Life Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH GM-122595 (to S. J. B.), the Eberly Family Distinguished Chair in Science (S. J. B.), and The Pennsylvania State University Huck Institute for Life Sciences (T. N. L.). S. J. B is an investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen KD, 2014, BBA-PROTEINS PROTEOM, V1844, P2135, DOI 10.1016/j.bbapap.2014.09.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bauerle MR, 2015, J BIOL CHEM, V290, P3995, DOI 10.1074/jbc.R114.607044; Benjdia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9377; Blaszczyk AJ, 2017, J BIOL CHEM, V292, P15456, DOI 10.1074/jbc.M117.778548; Blaszczyk AJ, 2017, METHOD ENZYMOL, V595, P303, DOI 10.1016/bs.mie.2017.07.007; Blaszczyk AJ, 2016, J AM CHEM SOC, V138, P3416, DOI 10.1021/jacs.5b12592; Bridwell-Rabb J, 2017, NATURE, V544, P322, DOI 10.1038/nature21689; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Deobald D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25716-x; DIEKERT G, 1980, FEBS LETT, V119, P118, DOI 10.1016/0014-5793(80)81011-8; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; ELLEFSON WL, 1981, J BIOL CHEM, V256, P4259; ELLEFSON WL, 1982, P NATL ACAD SCI-BIOL, V79, P3707, DOI 10.1073/pnas.79.12.3707; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Frey PA, 1999, ADV FR RAD, V2, P1; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Grove TL, 2010, BIOCHEMISTRY-US, V49, P3783, DOI 10.1021/bi9022126; GUNSALUS RP, 1978, FEMS MICROBIOL LETT, V3, P191; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13496, DOI 10.1021/bi048693+; Kim HJ, 2013, J AM CHEM SOC, V135, P8093, DOI 10.1021/ja312641f; LaMattina JW, 2017, J AM CHEM SOC, V139, P17438, DOI 10.1021/jacs.7b08492; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Landgraf BJ, 2013, J AM CHEM SOC, V135, P15404, DOI 10.1021/ja4048448; Lanz ND, 2018, BIOCHEMISTRY-US, V57, P1475, DOI 10.1021/acs.biochem.7b01205; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Lyu Z., 2017, MMP10 IS REQUIRED PO, DOI [10.1101/211441, DOI 10.1101/211441]; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Miller SM, 2013, P NATL ACAD SCI USA, V110, P20018, DOI 10.1073/pnas.1314392110; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nayak DD, 2017, ELIFE, V6, DOI 10.7554/eLife.29218; NEUE HU, 1993, BIOSCIENCE, V43, P466, DOI 10.2307/1311906; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; RUDIGER H, 1971, EUR J BIOCHEM, V21, P264, DOI 10.1111/j.1432-1033.1971.tb01465.x; Sato S, 2018, BIOCHEMISTRY-US, V57, P4963, DOI 10.1021/acs.biochem.8b00614; Sato S, 2017, BIOCHEMISTRY-US, V56, P3519, DOI 10.1021/acs.biochem.7b00472; SCHERER P, 1984, ARCH MICROBIOL, V138, P354, DOI 10.1007/BF00410903; Selmer T, 2000, J BIOL CHEM, V275, P3755, DOI 10.1074/jbc.275.6.3755; Shima S, 2005, CURR OPIN MICROBIOL, V8, P643, DOI 10.1016/j.mib.2005.10.002; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; STUPPERICH E, 1988, ARCH MICROBIOL, V149, P268, DOI 10.1007/BF00422016; Wagner T, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00197-17; Wagner T, 2016, ANGEW CHEM INT EDIT, V55, P10630, DOI 10.1002/anie.201603882; Wang B, 2018, BIOCHEMISTRY-US, V57, P4972, DOI 10.1021/acs.biochem.8b00693; Wang YY, 2017, J AM CHEM SOC, V139, P1742, DOI 10.1021/jacs.6b10901; Wongnate T, 2016, SCIENCE, V352, P953, DOI 10.1126/science.aaf0616; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c; Zhang ZG, 2017, J AM CHEM SOC, V139, P18623, DOI 10.1021/jacs.7b10203; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	56	22	22	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11712	11725		10.1074/jbc.RA119.007609	http://dx.doi.org/10.1074/jbc.RA119.007609			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31113866	Green Published, hybrid			2022-12-28	WOS:000486127800008
J	Verstraete, MM; Morales, LD; Kobylarz, M; Loutet, SA; Laakso, HA; Pinter, TB; Stillman, MJ; Heinrichs, DE; Murphy, MEP				Verstraete, Meghan M.; Morales, L. Daniela; Kobylarz, Marekl; Loutet, Slade A.; Laakso, Holly A.; Pinter, Tyler B.; Stillman, Martin J.; Heinrichs, David E.; Murphy, Michael E. P.			The heme-sensitive regulator SbnI has a bifunctional role in staphyloferrin B production by Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; siderophore; crystal structure; iron metabolism; kinetics	MACROMOLECULAR CRYSTALLOGRAPHY EXPERIMENTS; OXIDATIVE STRESS RESISTANCE; IRON-SPARING RESPONSE; FREE SERINE KINASE; PSEUDOMONAS-AERUGINOSA; DEGRADING ENZYMES; LIGAND COMPLEXES; PROTEIN PHUS; BINDING; VIRULENCE	Staphylococcus aureus infection relies on iron acquisition from its host. S. aureus takes up iron through heme uptake by the iron-responsive surface determinant (Isd) system and by the production of iron-scavenging siderophores. Staphyloferrin B (SB) is a siderophore produced by the 9-gene sbn gene cluster for SB biosynthesis and efflux. Recently, the ninth gene product, SbnI, was determined to be a free l-serine kinase that produces O-phospho-l-serine (OPS), a substrate for SB biosynthesis. Previous studies have also characterized SbnI as a DNA-binding regulatory protein that senses heme to control sbn gene expression for SB synthesis. Here, we present crystal structures at 1.9-2.1 angstrom resolution of a SbnI homolog from Staphylococcus pseudintermedius (SpSbnI) in both apo form and in complex with ADP, a product of the kinase reaction; the latter confirmed the active-site location. The structures revealed that SpSbnI forms a dimer through C-terminal domain swapping and a dimer of dimers through intermolecular disulfide formation. Heme binding had only a modest effect on SbnI enzymatic activity, suggesting that its two functions are independent and structurally distinct. We identified a heme-binding site and observed catalytic heme transfer between a heme-degrading protein of the Isd system, IsdI, and SbnI. These findings support the notion that SbnI has a bifunctional role contributing precursor OPS to SB synthesis and directly sensing heme to control expression of the sbn locus. We propose that heme transfer from IsdI to SbnI enables S. aureus to control iron source preference according to the sources available in the environment.	[Verstraete, Meghan M.; Morales, L. Daniela; Kobylarz, Marekl; Loutet, Slade A.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Laakso, Holly A.; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Pinter, Tyler B.; Stillman, Martin J.] Univ Western Ontario, Dept Chem, London, ON N6A 5C1, Canada	University of British Columbia; Western University (University of Western Ontario); Western University (University of Western Ontario)	Murphy, MEP (corresponding author), Univ British Columbia, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	michael.murphy@ubc.ca	Heinrichs, David/ABD-5702-2021; Stillman, Martin/O-3191-2016	Stillman, Martin/0000-0001-6799-7560; Morales Duran, Laura Daniela/0000-0002-0625-4306; Verstraete, Meghan/0000-0003-0422-2826; Heinrichs, David/0000-0002-7217-2456	NSERC; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Anson Chan for assistance with data collection and Angele Arrieta for technical assistance. We also thank Dr. Lindsay Eltis for use of the stopped-flow instrument. We thank the staff at the CLS for assistance with crystallographic data collection. Research described in this paper was performed using beamlines 08B1-1 at the Canadian Light Source, which is supported by the NSERC, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and National Institutes of Health, NIGMS Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beasley FC, 2011, INFECT IMMUN, V79, P2345, DOI 10.1128/IAI.00117-11; Beasley FC, 2010, J INORG BIOCHEM, V104, P282, DOI 10.1016/j.jinorgbio.2009.09.011; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Bowden CFM, 2018, J BIOL CHEM, V293, P177, DOI 10.1074/jbc.M117.806562; Bowden CFM, 2014, BIOCHEMISTRY-US, V53, P2286, DOI 10.1021/bi500230f; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Celis AI, 2017, J AM CHEM SOC, V139, P1900, DOI 10.1021/jacs.6b11324; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Conger MA, 2017, METALLOMICS, V9, P556, DOI 10.1039/c7mt00035a; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Dale SE, 2004, J BACTERIOL, V186, P8356, DOI 10.1128/JB.186.24.8356-8362.2004; DAWSON JH, 1983, J BIOL CHEM, V258, P3637; DAWSON JH, 1987, CHEM REV, V87, P1255, DOI 10.1021/cr00081a015; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodje M, 2014, J SYNCHROTRON RADIAT, V21, P633, DOI 10.1107/S1600577514005578; Friedman DB, 2006, PLOS PATHOG, V2, P777, DOI 10.1371/journal.ppat.0020087; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gao JL, 2012, J BIOL CHEM, V287, P42243, DOI 10.1074/jbc.M112.392787; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Hames C, 2005, APPL ENVIRON MICROB, V71, P4097, DOI 10.1128/AEM.71.7.4097-4100.2005; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; HANTKE K, 1981, MOL GEN GENET, V182, P288, DOI 10.1007/BF00269672; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; HOEPELMAN IM, 1990, INFECT IMMUN, V58, P26, DOI 10.1128/IAI.58.1.26-31.1990; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Kobylarz MJ, 2016, BIOCHEMISTRY-US, V55, P927, DOI 10.1021/acs.biochem.5b01045; Kobylarz MJ, 2014, CHEM BIOL, V21, P379, DOI 10.1016/j.chembiol.2013.12.011; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laakso HA, 2016, J BIOL CHEM, V291, P29, DOI 10.1074/jbc.M115.696625; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Loutet SA, 2013, J BIOL CHEM, V288, P25749, DOI 10.1074/jbc.M113.470518; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Makino Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13446; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Nagata R, 2017, ACS CHEM BIOL, V12, P1514, DOI 10.1021/acschembio.7b00064; O'Neill MJ, 2012, P NATL ACAD SCI USA, V109, P5639, DOI 10.1073/pnas.1121549109; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Pond AE, 2000, INORG CHEM, V39, P6061, DOI 10.1021/ic0007198; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Richardson JS, 2017, J MOL BIOL, V429, P1321, DOI 10.1016/j.jmb.2017.03.017; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Rudolph F B, 1979, Methods Enzymol, V63, P22; Schuster D, 2017, INT J MED MICROBIOL, V307, P57, DOI 10.1016/j.ijmm.2016.11.003; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sheldon JR, 2014, MOL MICROBIOL, V92, P824, DOI 10.1111/mmi.12593; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Smaldone GT, 2012, J BACTERIOL, V194, P2594, DOI 10.1128/JB.05990-11; Smith AT, 2015, CHEM REV, V115, P2532, DOI 10.1021/cr500056m; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Song YQ, 2015, ACS CHEM BIOL, V10, P1610, DOI 10.1021/cb5009734; STERN JO, 1974, J BIOL CHEM, V249, P7495; Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P289, DOI 10.1016/0006-3002(59)90376-2; Tong SYC, 2015, INT J SYST EVOL MICR, V65, P15, DOI 10.1099/ijs.0.062752-0; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Verstraete MM, 2018, J BIOL CHEM, V293, P6147, DOI 10.1074/jbc.RA118.001875; Vetter SW, 2009, J BIOL INORG CHEM, V14, P179, DOI 10.1007/s00775-008-0436-x; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; Zhong FF, 2014, P NATL ACAD SCI USA, V111, pE306, DOI 10.1073/pnas.1317173111; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	79	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11622	11636		10.1074/jbc.RA119.007757	http://dx.doi.org/10.1074/jbc.RA119.007757			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31197035	Green Published, hybrid			2022-12-28	WOS:000478717600023
J	Wilson, MS; Jessen, HJ; Saiardi, A				Wilson, Miranda S.; Jessen, Henning J.; Saiardi, Adolfo			The inositol hexakisphosphate kinases IP6K1 and-2 regulate human cellular phosphate homeostasis, including XPR1-mediated phosphate export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inositol phosphate; cell signaling; ATP; metabolic regulation; mammal; inositol hexakisphosphate kinase (IP6K); inositol pyrophosphate; IP7; phosphate homeostasis; SPX domain	DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; GENE DELETION; PYROPHOSPHATES; POLYPHOSPHATES; IDENTIFICATION; RECEPTOR; BINDING; PURIFICATION; PROTEINS; REVEALS	Phosphate's central role in most biochemical reactions in a living organism requires carefully maintained homeostasis. Although phosphate homeostasis in mammals has long been studied at the organismal level, the intracellular mechanisms controlling phosphate metabolism are not well-understood. Inositol pyrophosphates have emerged as important regulatory elements controlling yeast phosphate homeostasis. To verify whether inositol pyrophosphates also regulate mammalian cellular phosphate homeostasis, here we knocked out inositol hexakisphosphate kinase (IP6K) 1 and IP6K2 to generate human HCT116 cells devoid of any inositol pyrophosphates. Using PAGE and HPLC analysis, we observed that the IP6K1/2-knockout cells have nondetectable levels of the IP6-derived IP7 and IP8 and also exhibit reduced synthesis of the IP5-derived PP-IP4. Nucleotide analysis showed that the knockout cells contain increased amounts of ATP, whereas the Malachite green assay found elevated levels of free intracellular phosphate. Furthermore, [P-32(i)] pulse labeling experiments uncovered alterations in phosphate flux, with both import and export of phosphate being decreased in the knockout cells. Functional analysis of the phosphate exporter xenotropic and polytropic retrovirus receptor 1 (XPR1) revealed that it is regulated by inositol pyrophosphates, which can bind to its SPX domain. We conclude that IP6K1 and -2 together control inositol pyrophosphate metabolism and thereby physiologically regulate phosphate export and other aspects of mammalian cellular phosphate homeostasis.	[Wilson, Miranda S.; Saiardi, Adolfo] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Jessen, Henning J.] Albert Ludwigs Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany	MRC Laboratory Molecular Biology; University of London; University College London; University of Freiburg	Saiardi, A (corresponding author), UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England.	a.saiardi@ucl.ac.uk	Wilson, Miranda/W-1453-2019; Jessen, Henning/O-1157-2019	Wilson, Miranda/0000-0001-7521-4036; Jessen, Henning/0000-0002-1025-9484; Saiardi, Adolfo/0000-0002-4351-0081	Medical Research Council (MRC) [MC_UU_12018/4]; Deutsche Forschungsgemeinschaft [JE 572/4-1]; MRC [MC_UU_12018/4, MC_UU_00012/4] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council (MRC) core support Grant MC_UU_12018/4 to the MRC/UCL Laboratory for Molecular Cell Biology University Unit (to A. S. and M. W.) and Deutsche Forschungsgemeinschaft Grant JE 572/4-1 (to H. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Ansermet C, 2017, J AM SOC NEPHROL, V28, P1073, DOI 10.1681/ASN.2016070726; Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Azevedo C, 2017, TRENDS BIOCHEM SCI, V42, P219, DOI 10.1016/j.tibs.2016.10.008; Azevedo C, 2010, METHODS MOL BIOL, V645, P73, DOI 10.1007/978-1-60327-175-2_5; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Capolicchio S, 2013, ANGEW CHEM INT EDIT, V52, P6912, DOI 10.1002/anie.201301092; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dick RA, 2018, NATURE, V560, P509, DOI 10.1038/s41586-018-0396-4; DIPIERRO D, 1995, ANAL BIOCHEM, V231, P407, DOI 10.1006/abio.1995.0071; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gerasimaite R, 2017, ACS CHEM BIOL, V12, P648, DOI 10.1021/acschembio.7b00026; Giovannini D, 2013, CELL REP, V3, P1866, DOI 10.1016/j.celrep.2013.05.035; GLENNON MC, 1993, BIOCHEM J, V293, P583, DOI 10.1042/bj2930583; Gonzalez B, 2010, P NATL ACAD SCI USA, V107, P9608, DOI 10.1073/pnas.0912979107; Gu CF, 2017, P NATL ACAD SCI USA, V114, P11968, DOI 10.1073/pnas.1702370114; Gu CF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165286; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Kestenbaum B, 2010, J AM SOC NEPHROL, V21, P1223, DOI 10.1681/ASN.2009111104; Knutsen T, 2010, GENE CHROMOSOME CANC, V49, P204, DOI 10.1002/gcc.20730; Laha D, 2015, PLANT CELL, V27, P1082, DOI 10.1105/tpc.114.135160; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Livermore TM, 2016, P NATL ACAD SCI USA, V113, P996, DOI 10.1073/pnas.1519440113; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mallery DL, 2018, ELIFE, V7, DOI 10.7554/eLife.35335; Michigami T, 2018, PHYSIOL REV, V98, P2317, DOI 10.1152/physrev.00022.2017; Moritoh Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32072; Morrison BH, 2009, ONCOGENE, V28, P2383, DOI 10.1038/onc.2009.113; Norbis F, 1997, J MEMBRANE BIOL, V156, P19, DOI 10.1007/s002329900183; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Pavlovic I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10622; Potapenko E, 2018, J BIOL CHEM, V293, P19101, DOI 10.1074/jbc.RA118.005884; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; Shin JJH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-85; Steidle EA, 2016, J BIOL CHEM, V291, P6772, DOI 10.1074/jbc.M116.714907; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; THEIBERT AB, 1991, P NATL ACAD SCI USA, V88, P3165, DOI 10.1073/pnas.88.8.3165; Veiga N, 2006, J INORG BIOCHEM, V100, P1800, DOI 10.1016/j.jinorgbio.2006.06.016; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305; Watson PJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11262; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; Wilson MSC, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2959; Wilson MSC, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150014; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Windhorst S, 2013, BIOCHEM J, V450, P115, DOI 10.1042/BJ20121524; Wundenberg T, 2014, BIOCHEM J, V462, P173, DOI 10.1042/BJ20130992; Wundenberg T, 2012, BIOL CHEM, V393, P979, DOI 10.1515/hsz-2012-0133; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; Yoshida T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39618	61	37	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11597	11608		10.1074/jbc.RA119.007848	http://dx.doi.org/10.1074/jbc.RA119.007848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31186349	Green Published, hybrid			2022-12-28	WOS:000478717600021
J	Yang, Y; Davis, I; Matsui, T; Rubalcava, I; Liu, AM				Yang, Yu; Davis, Ian; Matsui, Tsutomu; Rubalcava, Ivan; Liu, Aimin			Quaternary structure of alpha-amino-beta-carboxymuconate-E-semialdehyde decarboxylase (ACMSD) controls its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NAD biosynthesis; small-angle X-ray scattering (SAXS); protein structure; protein folding; protein dynamics; decarboxylase; X-ray crystallography; metabolism; enzyme catalysis; alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD); amidohydrolase; protein self-association; SEC-SAXS; solution structure; quaternary structure; amino acid degradation	SMALL-ANGLE SCATTERING; X-RAY SOLUTION; DIHYDROOROTATE DEHYDROGENASE-A; HALF-SITES REACTIVITY; BIOLOGICAL MACROMOLECULES; NITROAROMATIC COMPOUNDS; KYNURENINE PATHWAY; CRYSTAL-STRUCTURE; DEGRADATION; OLIGOMERIZATION	alpha-Amino-beta-carboxymuconate-E-semialdehyde decarboxylase (ACMSD) plays an important role in l-tryptophan degradation via the kynurenine pathway. ACMSD forms a homodimer and is functionally inactive as a monomer because its catalytic assembly requires an arginine residue from a neighboring subunit. However, how the oligomeric state and self-association of ACMSD are controlled in solution remains unexplored. Here, we demonstrate that ACMSD from Pseudomonas fluorescens can self-assemble into homodimer, tetramer, and higher-order structures. Using size-exclusion chromatography coupled with small-angle X-ray scattering (SEC-SAXS) analysis, we investigated the ACMSD tetramer structure, and fitting the SAXS data with X-ray crystal structures of the monomeric component, we could generate a pseudo-atomic structure of the tetramer. This analysis revealed a tetramer model of ACMSD as a head-on dimer of dimers. We observed that the tetramer is catalytically more active than the dimer and is in equilibrium with the monomer and dimer. Substituting a critical residue of the dimer-dimer interface, His-110, altered the tetramer dissociation profile by increasing the higher-order oligomer portion in solution without changing the X-ray crystal structure. ACMSD self-association was affected by pH, ionic strength, and other electrostatic interactions. Alignment of ACMSD sequences revealed that His-110 is highly conserved in a few bacteria that utilize nitrobenzoic acid as a sole source of carbon and energy, suggesting a dedicated functional role of ACMSD's self-assembly into the tetrameric and higher-order structures. These results indicate that the dynamic oligomerization status potentially regulates ACMSD activity and that SEC-SAXS coupled with X-ray crystallography is a powerful tool for studying protein self-association.	[Yang, Yu; Davis, Ian; Rubalcava, Ivan; Liu, Aimin] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Matsui, Tsutomu] Stanford Univ, SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Light Source, Menlo Pk, CA 94025 USA	University of Texas System; University of Texas at San Antonio (UTSA); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Liu, AM (corresponding author), Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA.	Feradical@utsa.edu	Liu, Aimin/C-1572-2017	Liu, Aimin/0000-0002-4182-8176; Yang, Yu/0000-0001-5305-2435; Davis, Ian/0000-0002-1566-4972	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108988, P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	X-ray synchrotron data were collected at the beamlines BL4-2 and BL9-2 of the Stanford Synchrotron Radiation Lightsource (SSRL) under user program 5B14, SLAC National Accelerator Laboratory. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by NIGMS, National Institutes of Health, Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Basu S, 2016, APPL ENVIRON MICROB, V82, P4253, DOI 10.1128/AEM.00739-16; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Bergdoll LA, 2018, P NATL ACAD SCI USA, V115, pE172, DOI 10.1073/pnas.1715464115; Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794; CHANDLER JL, 1972, ANAL BIOCHEM, V48, P529, DOI 10.1016/0003-2697(72)90108-X; Clouser AF, 2017, CELL STRESS CHAPERON, V22, P569, DOI 10.1007/s12192-017-0783-z; Colabroy KL, 2005, J AM CHEM SOC, V127, P840, DOI 10.1021/ja0446395; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai SD, 2000, SCIENCE, V287, P655, DOI 10.1126/science.287.5453.655; David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288; Davis I, 2018, J BIOL CHEM, V293, P9594, DOI 10.1074/jbc.RA118.003320; Davis I, 2015, EXPERT REV NEUROTHER, V15, P719, DOI 10.1586/14737175.2015.1049999; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hasegawa Y, 2000, FEMS MICROBIOL LETT, V190, P185, DOI 10.1016/S0378-1097(00)00329-3; Hershberger KA, 2017, NAT REV NEPHROL, V13, P213, DOI 10.1038/nrneph.2017.5; Ho MC, 2009, NATURE, V459, P393, DOI 10.1038/nature07938; Huo L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6935; Huo L, 2015, PROTEINS, V83, P178, DOI 10.1002/prot.24722; Huo L, 2013, J BIOL CHEM, V288, P30862, DOI 10.1074/jbc.M113.496869; Huo L, 2012, BIOCHEMISTRY-US, V51, P5811, DOI 10.1021/bi300635b; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6; Korasick DA, 2019, J MOL BIOL, V431, P576, DOI 10.1016/j.jmb.2018.12.010; Korasick DA, 2018, PROTEIN SCI, V27, P814, DOI 10.1002/pro.3376; Lee AL, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00047; Li TF, 2005, J AM CHEM SOC, V127, P12282, DOI 10.1021/ja0532234; Li TF, 2007, J AM CHEM SOC, V129, P9278, DOI 10.1021/ja073648l; Li TF, 2006, BIOCHEMISTRY-US, V45, P6628, DOI 10.1021/bi060108c; Liu Q, 2015, PLANT PHYSIOL, V169, P432, DOI 10.1104/pp.15.00622; Lolli G, 2017, BIOCHEM J, V474, P2405, DOI 10.1042/BCJ20170189; Martynowski D, 2006, BIOCHEMISTRY-US, V45, P10412, DOI 10.1021/bi060903q; Mathew E, 2004, J SYNCHROTRON RADIAT, V11, P314, DOI 10.1107/S0909049504014086; Mochalkin I, 2008, PROTEIN SCI, V17, P1706, DOI 10.1110/ps.035584.108; Morais MAB, 2015, J BIOL CHEM, V290, P8582, DOI 10.1074/jbc.M114.619205; Muraki T, 2003, APPL ENVIRON MICROB, V69, P1564, DOI 10.1128/AEM.69.3.1564-1572.2003; Orlando BJ, 2016, J BIOL CHEM, V291, P15069, DOI 10.1074/jbc.M116.725713; Ottosen MB, 2002, PROTEIN SCI, V11, P2575, DOI 10.1110/ps.0220302; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellicciari R, 2018, J MED CHEM, V61, P745, DOI 10.1021/acs.jmedchem.7b01254; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; RUIZHERRERA J, 1968, J BIOL CHEM, V243, P4083; Samanta SK, 2000, BIOCHEM BIOPH RES CO, V269, P117, DOI 10.1006/bbrc.2000.2204; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Shi J, 2006, P NATL ACAD SCI USA, V103, P5775, DOI 10.1073/pnas.0510482103; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; SJOBERG BM, 1987, J BIOL CHEM, V262, P9736; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Symons ZC, 2006, NAT PROD REP, V23, P845, DOI 10.1039/b502796a; Tabarani G, 2009, J BIOL CHEM, V284, P21229, DOI 10.1074/jbc.M109.021204; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Ulrih NP, 2004, BIOCHEMISTRY-US, V43, P9536, DOI 10.1021/bi049616h; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Vecsei L, 2013, NAT REV DRUG DISCOV, V12, P64, DOI 10.1038/nrd3793; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Watanabe S, 2017, P NATL ACAD SCI USA, V114, pE3224, DOI 10.1073/pnas.1621426114; Wielgus-Kutrowska B, 2018, ARCH BIOCHEM BIOPHYS, V642, P31, DOI 10.1016/j.abb.2018.01.011; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Yang Y, 2018, J BIOL CHEM, V293, P10415, DOI 10.1074/jbc.RA118.002698; Yang Y, 2016, J BIOL CHEM, V291, P26252, DOI 10.1074/jbc.M116.759712; Yoshino J, 2019, TRENDS ENDOCRIN MET, V30, P229, DOI 10.1016/j.tem.2019.02.002; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693	74	4	4	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11609	11621		10.1074/jbc.RA119.009035	http://dx.doi.org/10.1074/jbc.RA119.009035			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31189654	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000478717600022
J	Wang, SB; Dale, GL; Song, P; Viollet, B; Zou, MH				Wang, Shaobin; Dale, George L.; Song, Ping; Viollet, Benoit; Zou, Ming-Hui			AMPK alpha 1 deletion shortens erythrocyte life span in mice: Role of oxidative stress (vol 285, pg 19976, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10738	10738		10.1074/jbc.AAC119.009647	http://dx.doi.org/10.1074/jbc.AAC119.009647			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31278157	Green Published, hybrid			2022-12-28	WOS:000478717100031
J	Huang, HJ; Holub, C; Rolzin, P; Bilakovics, J; Fanjul, A; Satomi, Y; Plonowski, A; Larson, CJ; Farrell, PJ				Huang, Huey-Jing; Holub, Corine; Rolzin, Paul; Bilakovics, James; Fanjul, Andrea; Satomi, Yoshinori; Plonowski, Artur; Larson, Christopher J.; Farrell, Pamela J.			MetAP2 inhibition increases energy expenditure through direct action on brown adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						obesity; drug discovery; metabolomics; lipid metabolism; uncoupling protein; brown adipocyte; brown adipose tissue; energy expenditure	CATECHOLAMINE-INDUCED LIPOLYSIS; ADIPOSE-TISSUE; METHIONINE RESTRICTION; LIPID-METABOLISM; CONTROLLED TRIAL; SKELETAL-MUSCLE; WEIGHT-LOSS; BELORANIB; OBESITY; BODY	Inhibitors of methionine aminopeptidase 2 (MetAP2) have been shown to reduce body weight in obese mice and humans. The target tissue and cellular mechanism of MetAP2 inhibitors, however, have not been extensively examined. Using compounds with diverse chemical scaffolds, we showed that MetAP2 inhibition decreases body weight and fat mass and increases lean mass in the obese mice but not in the lean mice. Obesity is associated with catecholamine resistance and blunted -adrenergic receptor signaling activities, which could dampen lipolysis and energy expenditure resulting in weight gain. In the current study, we examined effect of MetAP2 inhibition on brown adipose tissue and brown adipocytes. Norepinephrine increases energy expenditure in brown adipose tissue by providing fatty acid substrate through lipolysis and by increasing expression of uncoupled protein-1 (UCP1). Metabolomic analysis shows that in response to MetAP2 inhibitor treatment, fatty acid metabolites in brown adipose tissue increase transiently and subsequently decrease to basal or below basal levels, suggesting an effect on fatty acid metabolism in this tissue. Treatment of brown adipocytes with MetAP2 inhibitors enhances norepinephrine-induced lipolysis and energy expenditure, and prolongs the activity of norepinephrine to increase ucp1 gene expression and energy expenditure in norepinephrine-desensitized brown adipocytes. In summary, we showed that the anti-obesity activity of MetAP2 inhibitors can be mediated, at least in part, through direct action on brown adipocytes by enhancing -adrenergic-signaling-stimulated activities.	[Huang, Huey-Jing; Holub, Corine; Rolzin, Paul; Bilakovics, James; Fanjul, Andrea; Plonowski, Artur; Larson, Christopher J.; Farrell, Pamela J.] Takeda Calif, San Diego, CA 92121 USA; [Satomi, Yoshinori] Takeda Pharmaceut Co Ltd, Fujisawa, Kanagawa 2510012, Japan; [Larson, Christopher J.] Sanford Burham Prebys Med Discovery Inst, San Diego, CA 92037 USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Takeda Pharmaceutical Company Ltd	Huang, HJ (corresponding author), Takeda Calif, San Diego, CA 92121 USA.	huey-jing.huang@takeda.com		Satomi, Yoshinori/0000-0002-8991-1040				Arner P, 1999, INT J OBESITY, V23, P10, DOI 10.1038/sj.ijo.0800789; Betz MJ, 2015, DIABETES, V64, P2352, DOI 10.2337/db15-0146; Bougneres P, 1997, J CLIN INVEST, V99, P2568, DOI 10.1172/JCI119444; Brakenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70; Chaurasia B, 2016, CELL METAB, V24, P820, DOI 10.1016/j.cmet.2016.10.002; Hasek BE, 2013, DIABETES, V62, P3362, DOI 10.2337/db13-0501; Horowitz JF, 2000, AM J PHYSIOL-ENDOC M, V278, pE1144, DOI 10.1152/ajpendo.2000.278.6.E1144; Hughes TE, 2013, OBESITY, V21, P1782, DOI 10.1002/oby.20356; Jocken JWE, 2008, PHYSIOL BEHAV, V94, P219, DOI 10.1016/j.physbeh.2008.01.002; Kim DD, 2015, DIABETES OBES METAB, V17, P566, DOI 10.1111/dom.12457; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lijnen HR, 2010, OBESITY, V18, P2241, DOI 10.1038/oby.2009.503; Bargut TCL, 2016, TISSUE CELL, V48, P452, DOI 10.1016/j.tice.2016.08.001; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; McCandless SE, 2017, DIABETES OBES METAB, V19, P1751, DOI 10.1111/dom.13021; REYNISDOTTIR S, 1994, DIABETOLOGIA, V37, P428, DOI 10.1007/s001250050128; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Shoemaker A, 2017, DIABETES OBES METAB, V19, P1165, DOI 10.1111/dom.12928; Towbin H, 2003, J BIOL CHEM, V278, P52964, DOI 10.1074/jbc.M309039200; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wanders D, 2015, FASEB J, V29, P2603, DOI 10.1096/fj.14-270348; Wang JY, 2003, CANCER RES, V63, P7861; White HM, 2012, OBESITY, V20, P2003, DOI 10.1038/oby.2012.87; Yehuda-Shnaidman E, 2010, DIABETES, V59, P2474, DOI 10.2337/db10-0245; Zhou XH, 2016, AMINO ACIDS, V48, P1533, DOI 10.1007/s00726-016-2247-7; Zlobine I, 2016, BBA-MOL CELL BIOL L, V1861, P1555, DOI 10.1016/j.bbalip.2016.02.011	26	4	4	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9567	9575		10.1074/jbc.RA118.007302	http://dx.doi.org/10.1074/jbc.RA118.007302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31048375	hybrid, Green Published			2022-12-28	WOS:000472713000022
J	Kim, SSY; Sze, L; Liu, CC; Lam, KP				Kim, Susana Soo-Yeon; Sze, Lynette; Liu, ChengCheng; Lam, Kong-Peng			The stress granule protein G3BP1 binds viral dsRNA and RIG-I to enhance interferon- response (vol 294, pg 6430, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Kim SSY, 2019, J BIOL CHEM, V294, P6430, DOI 10.1074/jbc.RA118.005868	1	2	2	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9655	9655		10.1074/jbc.AAC119.009397	http://dx.doi.org/10.1074/jbc.AAC119.009397			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31201243	hybrid, Green Published			2022-12-28	WOS:000472713000029
J	Youn, DY; Xiaoli, AM; Kwon, H; Yang, FJ; Pessin, JE				Youn, Dou Yeon; Xiaoli, Alus M.; Kwon, Hyokjoon; Yang, Fajun; Pessin, Jeffrey E.			The subunit assembly state of the Mediator complex is nutrient-regulated and is dysregulated in a genetic model of insulin resistance and obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mammalian target of rapamycin (mTOR); lipogenesis; liver; transcription regulation; Type 2 diabetes; kinase module; Mediator complex; mTORC1; lipogenic genes	POLYMERASE-II TRANSCRIPTION; MODULE ASSOCIATION; BINDING PROTEIN; CDK8; RICTOR; YEAST; AKT; PHOSPHORYLATION; ACTIVATION; ABLATION	The Mediator complex plays a critical role in the regulation of transcription by linking transcription factors to RNA polymerase II. By examining mouse livers, we have found that in the fasted state, the Mediator complex exists primarily as an approximately 1.2-MDa complex, consistent with the size of the large Mediator complex, whereas following feeding, it converts to an approximately 600-kDa complex, consistent with the size of the core Mediator complex. This dynamic change is due to the dissociation and degradation of the kinase module that includes the MED13, MED12, cyclin-dependent kinase 8 (CDK8), and cyclin C (CCNC) subunits. The dissociation and degradation of the kinase module are dependent upon nutrient activation of mTORC1 that is necessary for the induction of lipogenic gene expression because pharmacological or genetic inhibition of mTORC1 in the fed state restores the kinase module. The degradation but not dissociation of the kinase module depends upon the E3 ligase, SCFFBW7. In addition, genetically insulin-resistant and obese db/db mice in the fasted state displayed elevated lipogenic gene expression and loss of the kinase module that was reversed following mTORC1 inhibition. These data demonstrate that the assembly state of the Mediator complex undergoes physiologic regulation during normal cycles of fasting and feeding in the mouse liver. Furthermore, the assembly state of the Mediator complex is dysregulated in states of obesity and insulin resistance.	[Youn, Dou Yeon; Xiaoli, Alus M.; Yang, Fajun; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Xiaoli, Alus M.; Yang, Fajun] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Youn, Dou Yeon; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Yang, Fajun; Pessin, Jeffrey E.] Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, Bronx, NY 10461 USA; [Kwon, Hyokjoon] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Pessin, JE (corresponding author), Albert Einstein Coll Med, Dept Med, Price Ctr 375, Bronx, NY 10461 USA.	Jeffrey.pessin@einstein.yu.edu		Kwon, Hyok Joon/0000-0002-3436-0608; youn, dou yeon/0000-0002-3545-2993	National Institutes of Health [DK110063, DK098439, DK020541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants DK110063, DK098439, and DK020541. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Feng DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126240; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Jeronimo C, 2017, TRENDS CELL BIOL, V27, P765, DOI 10.1016/j.tcb.2017.07.001; Jin CY, 2014, MOL BIOL CELL, V25, P1396, DOI 10.1091/mbc.E13-09-0550; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kuuluvainen E, 2014, J BIOL CHEM, V289, P16252, DOI 10.1074/jbc.M113.541904; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Malik S, 2005, MOL CELL BIOL, V25, P2117, DOI 10.1128/MCB.25.6.2117-2129.2005; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Nagata T, 2010, ANAL BIOCHEM, V398, P178, DOI 10.1016/j.ab.2009.11.017; Nemet J, 2014, BIOCHIMIE, V97, P22, DOI 10.1016/j.biochi.2013.10.004; Nogales E, 2017, ANNU REV BIOPHYS, V46, P59, DOI 10.1146/annurev-biophys-070816-033751; Onoyama I, 2011, J CLIN INVEST, V121, P342, DOI 10.1172/JCI40725; Puertollano Rosa, 2014, F1000Prime Rep, V6, P52, DOI 10.12703/P6-52; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sauer F, 1997, CURR OPIN GENET DEV, V7, P176, DOI 10.1016/S0959-437X(97)80126-8; Song ZY, 2017, J BIOL CHEM, V292, P8918, DOI 10.1074/jbc.M117.776229; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Wang G, 2001, MOL CELL BIOL, V21, P4604, DOI 10.1128/MCB.21.14.4604-4613.2001; Willis SD, 2018, MICROB CELL, V5, P357, DOI 10.15698/mic2018.08.641; Zhao XP, 2014, DIABETES, V63, P2464, DOI 10.2337/db13-0835	38	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9076	9083		10.1074/jbc.RA119.007850	http://dx.doi.org/10.1074/jbc.RA119.007850			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31028171	hybrid, Green Published			2022-12-28	WOS:000471751600006
J	Gomez-Soler, M; Gehring, MP; Lechtenberg, BC; Zapata-Mercado, E; Hristova, K; Pasquale, EB				Gomez-Soler, Maricel; Gehring, Marina Petersen; Lechtenberg, Bernhard C.; Zapata-Mercado, Elmer; Hristova, Kalina; Pasquale, Elena B.			Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptide; dimerization; cancer; inflammation; crystal structure; receptor tyrosine kinase; agonist; antagonist; Eph receptor; ephrin	TARGETED DELIVERY; SYSTEM; DESIGN; RECOGNITION; ANTAGONIST; REVEALS; EPHRINS; CELLS	The EPH receptor A2 (EphA2) tyrosine kinase plays an important role in a plethora of biological and disease processes, ranging from angiogenesis and cancer to inflammation and parasitic infections. EphA2 is therefore considered an important drug target. Two short peptides previously identified by phage display, named YSA and SWL, are widely used as EphA2-targeting agents owing to their high specificity for this receptor. However, these peptides have only modest (micromolar) potency. Lack of structural information on the binding interactions of YSA and SWL with the extracellular EphA2 ligand-binding domain (LBD) has for many years precluded structure-guided improvements. We now report the high-resolution (1.53-2.20 angstrom) crystal structures of the YSA peptide and several of its improved derivatives in complex with the EphA2 LBD, disclosing that YSA targets the ephrin-binding pocket of EphA2 and mimics binding features of the ephrin-A ligands. The structural information obtained enabled iterative peptide modifications conferring low nanomolar potency. Furthermore, contacts observed in the crystal structures shed light on how C-terminal features can convert YSA derivatives from antagonists to agonists that likely bivalently interact with two EphA2 molecules to promote receptor oligomerization, autophosphorylation, and downstream signaling. Consistent with this model, quantitative FRET measurements in live cells revealed that the peptide agonists promote the formation of EphA2 oligomeric assemblies. Our findings now enable rational strategies to differentially modify EphA2 signaling toward desired outcomes by using appropriately engineered peptides. Such peptides could be used as research tools to interrogate EphA2 function and to develop pharmacological leads.	[Gomez-Soler, Maricel; Gehring, Marina Petersen; Lechtenberg, Bernhard C.; Pasquale, Elena B.] Sanford Burnham Prebys Med Discovery Inst, Ctr Canc, La Jolla, CA 92037 USA; [Zapata-Mercado, Elmer; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Sanford Burnham Prebys Medical Discovery Institute; Johns Hopkins University	Pasquale, EB (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Ctr Canc, La Jolla, CA 92037 USA.; Lechtenberg, BC (corresponding author), Walter & Eliza Hall Inst Med Res, Ubiquitin Signalling Div, Parkville, Vic 3052, Australia.; Lechtenberg, BC (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.	lechtenberg.b@wehi.edu.au; elenap@sbpdiscovery.org		Zapata-Mercado, Elmer/0000-0002-9766-8124; Lechtenberg, Bernhard Clemens/0000-0002-5674-6894; Gomez Soler, Martha Maricel/0000-0002-4412-8108	NCI, National Institutes of Health, Cancer Center Support Grant [P30CA030199]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM131374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087070] Funding Source: NIH RePORTER	NCI, National Institutes of Health, Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dave Boucher for generating the EphA2 LBD construct, Andrey Bobkov for performing the ITC experiments, Malgorzata Dobaczewska for technical assistance, and Denis Wirtz for providing HEK293T cells. Sanford Burnham Prebys Core Facilities were supported by NCI, National Institutes of Health, Cancer Center Support Grant P30CA030199.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barile E, 2014, CHEMMEDCHEM, V9, P1403, DOI 10.1002/cmdc.201400067; Barquilla A, 2016, MOL BIOL CELL, V27, P2757, DOI 10.1091/mbc.E16-01-0048; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Biener G, 2014, INT J MOL SCI, V15, P261, DOI 10.3390/ijms15010261; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; Duggineni S, 2013, ACS MED CHEM LETT, V4, P344, DOI 10.1021/ml3004523; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gambini L, 2018, ACS CHEM BIOL, V13, P2633, DOI 10.1021/acschembio.8b00556; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; King C, 2017, J BIOL CHEM, V292, P5291, DOI 10.1074/jbc.M116.764282; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamberto I, 2014, ACS CHEM BIOL, V9, P2787, DOI 10.1021/cb500677x; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miao H, 2009, INT J BIOCHEM CELL B, V41, P762, DOI 10.1016/j.biocel.2008.07.019; Mitra S, 2010, BIOCHEMISTRY-US, V49, P6687, DOI 10.1021/bi1006223; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nikolov DB, 2014, CELL ADHES MIGR, V8, P360, DOI 10.4161/19336918.2014.971684; Noberini R, 2012, SEMIN CELL DEV BIOL, V23, P51, DOI 10.1016/j.semcdb.2011.10.023; Pan YB, 2014, ANAL BIOANAL CHEM, V406, P6247, DOI 10.1007/s00216-014-8071-6; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Riedl SJ, 2015, CURR DRUG TARGETS, V16, P1031, DOI 10.2174/1389450116666150727115934; Salem AF, 2018, J MED CHEM, V61, P2052, DOI 10.1021/acs.jmedchem.7b01837; Seiradake E, 2013, NAT STRUCT MOL BIOL, V20, P958, DOI 10.1038/nsmb.2617; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Singh DR, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0017-7; Singh DR, 2016, BBA-GEN SUBJECTS, V1860, P1922, DOI 10.1016/j.bbagen.2016.06.004; Singh DR, 2015, J BIOL CHEM, V290, P27271, DOI 10.1074/jbc.M115.676866; Singh DR, 2015, BIOCHEM J, V471, P101, DOI 10.1042/BJ20150433; Wang S, 2013, CLIN CANCER RES, V19, P128, DOI 10.1158/1078-0432.CCR-12-2654; Wang S, 2012, J MED CHEM, V55, P2427, DOI 10.1021/jm201743s; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Zhang H, 2018, NAT MICROBIOL, V3, P164, DOI 10.1038/s41564-017-0080-8	47	20	20	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8791	8805		10.1074/jbc.RA119.008213	http://dx.doi.org/10.1074/jbc.RA119.008213			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31015204	hybrid, Green Published			2022-12-28	WOS:000470971100015
J	Hirayama, H; Matsuda, T; Tsuchiya, Y; Oka, R; Seino, J; Huang, CC; Nakajima, K; Noda, Y; Shichino, Y; Iwasaki, S; Suzuki, T				Hirayama, Hiroto; Matsuda, Tsugiyo; Tsuchiya, Yae; Oka, Ritsuko; Seino, Junichi; Huang, Chengcheng; Nakajima, Kazuki; Noda, Yoichi; Shichino, Yuichi; Iwasaki, Shintaro; Suzuki, Tadashi			Free glycans derived from O-mannosylated glycoproteins suggest the presence of an O-glycoprotein degradation pathway in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; glycoprotein; glycosylation; yeast metabolism; glucose metabolism; catabolite regulation; cell wall; free glycan; O-glycosylation; yeast	RETICULUM-ASSOCIATED DEGRADATION; PEPTIDE-N-GLYCANASE; FREE OLIGOSACCHARIDES; SACCHAROMYCES-CEREVISIAE; ALPHA-MANNOSIDASE; LINKED OLIGOSACCHARIDES; BIOLOGICAL ROLES; QUALITY-CONTROL; PROTEIN; GLYCOSYLATION	In eukaryotic cells, unconjugated oligosaccharides that are structurally related to N-glycans (i.e. free N-glycans) are generated either from misfolded N-glycoproteins destined for the endoplasmic reticulum?associated degradation or from lipid-linked oligosaccharides, donor substrates for N-glycosylation of proteins. The mechanism responsible for the generation of free N-glycans is now well-understood, but the issue of whether other types of free glycans are present remains unclear. Here, we report on the accumulation of free, O-mannosylated glycans in budding yeast that were cultured in medium containing mannose as the carbon source. A structural analysis of these glycans revealed that their structures are identical to those of O-mannosyl glycans that are attached to glycoproteins. Deletion of the cyc8 gene, which encodes for a general transcription repressor, resulted in the accumulation of excessive amounts of free O-glycans, concomitant with a severe growth defect, a reduction in the level of an O-mannosylated protein, and compromised cell wall integrity. Our findings provide evidence in support of a regulated pathway for the degradation of O-glycoproteins in yeast and offer critical insights into the catabolic mechanisms that control the fate of O-glycosylated proteins.	[Hirayama, Hiroto; Matsuda, Tsugiyo; Tsuchiya, Yae; Oka, Ritsuko; Seino, Junichi; Huang, Chengcheng; Suzuki, Tadashi] RIKEN, Cluster Pioneering Res, Glycometab Biochem Lab, Wako, Saitama 3510198, Japan; [Shichino, Yuichi; Iwasaki, Shintaro] RIKEN, Cluster Pioneering Res, RNA Syst Biochem Lab, Wako, Saitama 3510198, Japan; [Nakajima, Kazuki] Fujita Hlth Univ, Dept Acad Res Support Promot Facil, Ctr Res Promot & Support, Toyoake, Aichi 4701192, Japan; [Noda, Yoichi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Collaborat Res Inst Innovat Microbiol, Tokyo 1138657, Japan; [Iwasaki, Shintaro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba 2778561, Japan	RIKEN; RIKEN; Fujita Health University; University of Tokyo; University of Tokyo	Suzuki, T (corresponding author), RIKEN, Cluster Pioneering Res, Glycometab Biochem Lab, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	Suzuki, Tadashi/AAX-5707-2021; Suzuki, Tadashi/I-4536-2014; Iwasaki, Shintaro/D-1472-2017; huang, chengcheng/GRX-5340-2022	Suzuki, Tadashi/0000-0003-1030-7631; Iwasaki, Shintaro/0000-0001-7724-3754; Shichino, Yuichi/0000-0002-0093-1185; Hirayama, Hiroto/0000-0003-1909-9488	Japan Science Society Sasakawa Scientific Research Grant [24-411]; Society of Yeast Scientists (Japan) Dr. Yoshifumi Jigami Memorial Fund; Japan Society for the Promotion of Science (JSPS) [16K18521]; Noda Institute for Scientific Research (NISR); JSPS [25291030]; Mizutani Foundation for Glycoscience; RIKEN pioneering project (glycolipidologue initiative)	Japan Science Society Sasakawa Scientific Research Grant; Society of Yeast Scientists (Japan) Dr. Yoshifumi Jigami Memorial Fund; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Noda Institute for Scientific Research (NISR)(Noda Institute for Scientific Research); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mizutani Foundation for Glycoscience; RIKEN pioneering project (glycolipidologue initiative)	This work was supported by Japan Science Society Sasakawa Scientific Research Grant 24-411 (to H. H.), the Society of Yeast Scientists (Japan) Dr. Yoshifumi Jigami Memorial Fund (to H. H.), Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (B) 16K18521 (to H. H.), a research grant from Noda Institute for Scientific Research (NISR) (to H. H.), JSPS Grant-in-Aid for Scientific Research (B) 25291030 (to T. S.), the Mizutani Foundation for Glycoscience (to T. S.), and a RIKEN pioneering project (glycolipidologue initiative) (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.1042/BJ20030384; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Dwivedi R, 2013, BIOPOLYMERS, V99, P772, DOI 10.1002/bip.22296; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gietz RD, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3_1; Goder V, 2011, J CELL SCI, V124, P144, DOI 10.1242/jcs.072181; Hanlon SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019060; Harada Y, 2015, GLYCOBIOLOGY, V25, P1196, DOI 10.1093/glycob/cwv055; Harada Y, 2015, CELL MOL LIFE SCI, V72, P2509, DOI 10.1007/s00018-015-1881-7; Harada Y, 2013, J BIOL CHEM, V288, P32673, DOI 10.1074/jbc.M113.486985; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HILL K, 1992, GENETICS, V130, P273; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Hirayama H, 2015, SEMIN CELL DEV BIOL, V41, P110, DOI 10.1016/j.semcdb.2014.11.009; Hirayama H, 2011, GLYCOBIOLOGY, V21, P1341, DOI 10.1093/glycob/cwr073; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hossain MA, 2010, J BIOCHEM, V148, P603, DOI 10.1093/jb/mvq094; Hossain TJ, 2016, BIOSCI BIOTECH BIOCH, V80, P152, DOI 10.1080/09168451.2015.1072464; Iwatsuka K, 2013, J CHROMATOGR B, V928, P16, DOI 10.1016/j.jchromb.2013.03.010; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Lodder AL, 1999, GENETICS, V152, P1487; Lommel M, 2004, MOL CELL BIOL, V24, P46, DOI 10.1128/MCB.24.1.46-57.2004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; NAKANISHISHINDO Y, 1993, J BIOL CHEM, V268, P26338; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; Ohashi T, 2010, APPL MICROBIOL BIOT, V86, P263, DOI 10.1007/s00253-009-2297-9; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Suzuki T, 1997, P NATL ACAD SCI USA, V94, P6244, DOI 10.1073/pnas.94.12.6244; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Umekawa M, 2016, BBA-GEN SUBJECTS, V1860, P1192, DOI 10.1016/j.bbagen.2016.02.018; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Xu CC, 2013, SCIENCE, V340, P978, DOI 10.1126/science.1234055	45	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					15900	15911		10.1074/jbc.RA119.009491	http://dx.doi.org/10.1074/jbc.RA119.009491			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31311856	Green Published, hybrid			2022-12-28	WOS:000499478600004
J	Hoffman, KS; Vargas-Rodriguez, O; Bak, DW; Mukai, T; Woodward, LK; Weerapana, E; Soll, D; Reynolds, NM				Hoffman, Kyle S.; Vargas-Rodriguez, Oscar; Bak, Daniel W.; Mukai, Takahito; Woodward, Laura K.; Weerapana, Eranthie; Soll, Dieter; Reynolds, Noah M.			A cysteinyl-tRNA synthetase variant confers resistance against selenite toxicity and decreases selenocysteine misincorporation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						selenocysteine; aminoacyl tRNA synthetase; transfer RNA (tRNA); translation; selenium; Escherichia coli (E; coli); protein engineering; Astragalus bisulcatus; cysteinyl-tRNA synthetase; selenite toxicity	ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PLANTS; VOLATILIZATION; SULFUR; AMINOACYLATION; PURIFICATION; ASSIMILATION; MECHANISM; SEQUENCE	Selenocysteine (Sec) is the 21st genetically encoded amino acid in organisms across all domains of life. Although structurally similar to cysteine (Cys), the Sec selenol group has unique properties that are attractive for protein engineering and biotechnology applications. Production of designer proteins with Sec (selenoproteins) at desired positions is now possible with engineered translation systems in Escherichia coli. However, obtaining pure selenoproteins at high yields is limited by the accumulation of free Sec in cells, causing undesired incorporation of Sec at Cys codons due to the inability of cysteinyl-tRNA synthetase (CysRS) to discriminate against Sec. Sec misincorporation is toxic to cells and causes protein aggregation in yeast. To overcome this limitation, here we investigated a CysRS from the selenium accumulator plant Astragalus bisulcatus that is reported to reject Sec in vitro. Sequence analysis revealed a rare His -> Asn variation adjacent to the CysRS catalytic pocket. Introducing this variation into E. coli and Saccharomyces cerevisiae CysRS increased resistance to the toxic effects of selenite and selenomethionine (SeMet), respectively. Although the CysRS variant could still use Sec as a substrate in vitro, we observed a reduction in the frequency of Sec misincorporation at Cys codons in vivo. We surmise that the His -> Asn variation can be introduced into any CysRS to provide a fitness advantage for strains burdened by Sec misincorporation and selenium toxicity. Our results also support the notion that the CysRS variant provides higher specificity for Cys as a mechanism for plants to grow in selenium-rich soils.	[Hoffman, Kyle S.; Vargas-Rodriguez, Oscar; Mukai, Takahito; Woodward, Laura K.; Soll, Dieter; Reynolds, Noah M.] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA; [Soll, Dieter] Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06511 USA; [Bak, Daniel W.; Weerapana, Eranthie] Boston Coll, Dept Chem, Chestnut Hill, MA 02167 USA	Yale University; Yale University; Boston College	Reynolds, NM (corresponding author), Univ Illinois, Dept Biol, One Univ Dr, Springfield, IL 62703 USA.	nmreynol@uis.edu		Reynolds, Noah/0000-0002-7591-6174; Bak, Daniel/0000-0002-2252-1718; Vargas-Rodriguez, Oscar/0000-0002-2301-2800; Soll, Dieter/0000-0002-3077-8986	National Institutes of Health [R35GM122560, R01GM117004, R01GM118431-01A1]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy [DE-FG02-98ER20311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118431, R35GM122560, R01GM117004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35GM122560 (to D. S.) and R01GM117004 and R01GM118431-01A1 (to E. W.); the genetic experiments were supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy Grant DE-FG02-98ER20311 (to D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abo M, 2018, MOL PHARMACEUT, V15, P743, DOI 10.1021/acs.molpharmaceut.7b00832; Bak DW, 2018, CELL CHEM BIOL, V25, P1157, DOI 10.1016/j.chembiol.2018.05.017; Bockhorn J, 2008, P NATL ACAD SCI USA, V105, P17682, DOI 10.1073/pnas.0805642105; BOHMAN K, 1979, MOL GEN GENET, V176, P53, DOI 10.1007/BF00334295; BROWN TA, 1981, PLANT PHYSIOL, V67, P1051, DOI 10.1104/pp.67.5.1051; BURNELL JN, 1981, PLANT PHYSIOL, V68, P788; BURNELL JN, 1980, J INORG BIOCHEM, V12, P343, DOI 10.1016/S0162-0134(00)80275-5; BURNELL JN, 1979, PLANT PHYSIOL, V63, P1095, DOI 10.1104/pp.63.6.1095; BURNELL JN, 1977, PLANT PHYSIOL, V60, P670, DOI 10.1104/pp.60.5.670; Cakir O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135677; de Souza MP, 1998, PLANT PHYSIOL, V117, P1487, DOI 10.1104/pp.117.4.1487; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fernandes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050727; FIMMEL AL, 1977, J GEN MICROBIOL, V103, P37, DOI 10.1099/00221287-103-1-37; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6318; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Freeman JL, 2006, PLANT PHYSIOL, V142, P124, DOI 10.1104/pp.106.081158; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GIRLING CA, 1984, AGR ECOSYST ENVIRON, V11, P37, DOI 10.1016/0167-8809(84)90047-1; Gupta M, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02074; Hondal RJ, 2001, J AM CHEM SOC, V123, P5140, DOI 10.1021/ja005885t; HUBER RE, 1967, ARCH BIOCHEM BIOPHYS, V122, P164, DOI 10.1016/0003-9861(67)90136-1; Lazard Myriam, 2017, BioMolecular Concepts, V8, P93, DOI 10.1515/bmc-2017-0007; Lazard M, 2015, J BIOL CHEM, V290, P10741, DOI 10.1074/jbc.M115.640375; Lazard M, 2010, J BIOL CHEM, V285, P32029, DOI 10.1074/jbc.M110.139865; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; LeDuc DL, 2004, PLANT PHYSIOL, V135, P377, DOI 10.1104/pp.103.026989; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; LITOV RE, 1991, PEDIATRICS, V87, P339; Lyons GH, 2005, PLANT SOIL, V270, P179, DOI 10.1007/s11104-004-1390-1; Malkowski MG, 2007, P NATL ACAD SCI USA, V104, P6678, DOI 10.1073/pnas.0610337104; McDermott JR, 2010, MOL BIOL CELL, V21, P3934, DOI 10.1091/mbc.E10-06-0513; Mousa R, 2017, ANGEW CHEM INT EDIT, V56, P15818, DOI 10.1002/anie.201706876; Mukai T, 2018, ANGEW CHEM INT EDIT, V57, P7215, DOI 10.1002/anie.201713215; Muller S, 1997, ARCH MICROBIOL, V168, P421, DOI 10.1007/s002030050517; Nauser T, 2006, BIOCHEMISTRY-US, V45, P6038, DOI 10.1021/bi0602260; Newberry KJ, 2002, EMBO J, V21, P2778, DOI 10.1093/emboj/21.11.2778; Pilon-Smits EAH, 2009, CURR OPIN BIOTECH, V20, P207, DOI 10.1016/j.copbio.2009.02.001; Plateau P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44761; Qian Y, 2013, CHEMBIOCHEM, V14, P1410, DOI 10.1002/cbic.201300396; Reich HJ, 2016, ACS CHEM BIOL, V11, P821, DOI 10.1021/acschembio.6b00031; SHRIFT A, 1976, PLANT PHYSIOL, V58, P248, DOI 10.1104/pp.58.3.248; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SINGH R, 1991, J ORG CHEM, V56, P6931, DOI 10.1021/jo00024a041; So BR, 2011, J BIOL CHEM, V286, P31810, DOI 10.1074/jbc.M111.232611; Sors TG, 2005, PLANT J, V42, P785, DOI 10.1111/j.1365-313X.2005.02413.x; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Turner RJ, 1998, BIOMETALS, V11, P223, DOI 10.1023/A:1009290213301; Vargas-Rodriguez O, 2018, RNA BIOL, V15, P471, DOI 10.1080/15476286.2018.1474074; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; WEISS KF, 1965, J BACTERIOL, V90, P857, DOI 10.1128/JB.90.4.857-862.1965; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010; YOUNG PA, 1975, ARCH BIOCHEM BIOPHYS, V171, P483, DOI 10.1016/0003-9861(75)90057-0; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; Zayed A, 1998, PLANTA, V206, P284, DOI 10.1007/s004250050402; Zhang CM, 2003, J MOL BIOL, V327, P911, DOI 10.1016/S0022-2836(03)00241-9; ZIEVE R, 1984, SCI TOTAL ENVIRON, V32, P197, DOI 10.1016/0048-9697(84)90131-1	62	10	10	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12855	12865		10.1074/jbc.RA119.008219	http://dx.doi.org/10.1074/jbc.RA119.008219			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31296657	Green Published, hybrid			2022-12-28	WOS:000484414600026
J	Johnson, DT; Di Stefano, LH; Jones, LM				Johnson, Dante T.; Di Stefano, Luciano H.; Jones, Lisa M.			Fast photochemical oxidation of proteins (FPOP): A powerful mass spectrometry-based structural proteomics tool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						protein structure; mass spectrometry (MS); protein folding; molecular modeling; proteomics; biologics; hydroxyl radical footprinting	HYDROGEN/DEUTERIUM EXCHANGE; TOP-DOWN; CONFORMATIONAL DYNAMICS; MEMBRANE-PROTEINS; HYDROGEN-EXCHANGE; HIGH-RESOLUTION; EPITOPE; PEPTIDES; BINDING; DIETHYLPYROCARBONATE	Fast photochemical oxidation of proteins (FPOP) is a MS-based method that has proved useful in studies of protein structures, interactions, conformations, and protein folding. The success of this method relies on the irreversible labeling of solvent-exposed amino acid side chains by hydroxyl radicals. FPOP generates these radicals through laser-induced photolysis of hydrogen peroxide. The data obtained provide residue-level resolution of protein structures and interactions on the microsecond timescale, enabling investigations of fast processes such as protein folding and weak protein-protein interactions. An extensive comparison between FPOP and other footprinting techniques gives insight on their complementarity as well as the robustness of FPOP to provide unique structural information once unattainable. The versatility of this method is evidenced by both the heterogeneity of samples that can be analyzed by FPOP and the myriad of applications for which the method has been successfully used: from proteins of varying size to intact cells. This review discusses the wide applications of this technique and highlights its high potential. Applications including, but not limited to, protein folding, membrane proteins, structure elucidation, and epitope mapping are showcased. Furthermore, the use of FPOP has been extended to probing proteins in cells and in vivo. These promising developments are also presented herein.	[Johnson, Dante T.; Di Stefano, Luciano H.; Jones, Lisa M.] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jones, LM (corresponding author), Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.	ljones@rx.umaryland.edu		Bond, Nicholas/0000-0002-0312-7360; Johnson, Dante/0000-0002-9988-180X	National Institutes of Health [R01 GM128985]; University of Maryland; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036, R01GM128985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM128985 and startup funds from the University of Maryland. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abzalimov RR, 2009, J AM SOC MASS SPECTR, V20, P1514, DOI 10.1016/j.jasms.2009.04.006; Aprahamian ML, 2018, ANAL CHEM, V90, P7721, DOI 10.1021/acs.analchem.8b01624; Aye TT, 2005, ANAL CHEM, V77, P5814, DOI 10.1021/ac050353m; Back JW, 2002, ANAL CHEM, V74, P4417, DOI 10.1021/ac0257492; Baerga-Ortiz A, 2002, PROTEIN SCI, V11, P1300, DOI 10.1110/ps.4670102; Bern M, 2010, RAPID COMMUN MASS SP, V24, P768, DOI 10.1002/rcm.4447; Borotto NB, 2015, ANAL CHEM, V87, P10627, DOI 10.1021/acs.analchem.5b03180; Brenowitz M, 2002, CURR OPIN STRUC BIOL, V12, P648, DOI 10.1016/S0959-440X(02)00366-4; Calabrese AN, 2018, METHODS, V147, P187, DOI 10.1016/j.ymeth.2018.02.020; Chance MR, 1997, STRUCTURE, V5, P865, DOI 10.1016/S0969-2126(97)00241-4; Chavez JD, 2018, CELL SYST, V6, P136, DOI 10.1016/j.cels.2017.10.017; Chea EE, 2018, PROTEIN SCI, V27, P1047, DOI 10.1002/pro.3408; Chen BF, 2018, ANAL CHEM, V90, P110, DOI 10.1021/acs.analchem.7b04747; Chen D H, 1992, J Enzyme Inhib, V5, P259; Chen JW, 2012, J AM CHEM SOC, V134, P18724, DOI 10.1021/ja307606f; Chen JW, 2012, J AM SOC MASS SPECTR, V23, P1306, DOI 10.1007/s13361-012-0403-1; Chen JW, 2010, J AM CHEM SOC, V132, P15502, DOI 10.1021/ja106518d; Cheng M, 2017, ANGEW CHEM INT EDIT, V56, P14007, DOI 10.1002/anie.201706697; Chitta RK, 2009, J AM SOC MASS SPECTR, V20, P1813, DOI 10.1016/j.jasms.2009.05.017; Coales SJ, 2009, RAPID COMMUN MASS SP, V23, P639, DOI 10.1002/rcm.3921; Cummins DJ, 2016, ANAL CHEM, V88, P6607, DOI 10.1021/acs.analchem.6b01650; Deredge D, 2016, J BIOL CHEM, V291, P10078, DOI 10.1074/jbc.M115.708370; Erba EB, 2015, PROTEIN SCI, V24, P1176, DOI 10.1002/pro.2661; Espino JA, 2019, ANAL CHEM, V91, P6577, DOI 10.1021/acs.analchem.9b00244; Espino JA, 2015, ANAL CHEM, V87, P7971, DOI 10.1021/acs.analchem.5b01888; Farrokhi V, 2015, ANAL CHEM, V87, P8603, DOI 10.1021/acs.analchem.5b01962; FERREIRA JPM, 1994, EUR J BIOCHEM, V223, P611, DOI 10.1111/j.1432-1033.1994.tb19032.x; Gau B, 2011, BIOCHEMISTRY-US, V50, P8117, DOI 10.1021/bi200911c; Gau BC, 2013, BBA-PROTEINS PROTEOM, V1834, P1230, DOI 10.1016/j.bbapap.2013.02.023; Gau BC, 2010, ANAL CHEM, V82, P7821, DOI 10.1021/ac101760y; Gau BC, 2009, ANAL CHEM, V81, P6563, DOI 10.1021/ac901054w; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Gonen T, 2014, CURR OPIN STRUC BIOL, V27, pIV, DOI 10.1016/j.sbi.2014.09.002; Guan JQ, 2005, TRENDS BIOCHEM SCI, V30, P583, DOI 10.1016/j.tibs.2005.08.007; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; Hambly D, 2007, INT J MASS SPECTROM, V259, P124, DOI 10.1016/j.ijms.2006.08.018; Hambly DM, 2005, J AM SOC MASS SPECTR, V16, P2057, DOI 10.1016/j.jasms.2005.09.008; Heinkel F, 2016, J MOL BIOL, V428, P365, DOI 10.1016/j.jmb.2015.10.022; Hodkinson JP, 2009, J AM SOC MASS SPECTR, V20, P278, DOI 10.1016/j.jasms.2008.10.005; Houde D, 2009, ANAL CHEM, V81, P2644, DOI 10.1021/ac802575y; Huang W, 2015, BIOPHYS J, V108, P107, DOI 10.1016/j.bpj.2014.11.013; Johnson TE, 2003, EXP GERONTOL, V38, P1329, DOI 10.1016/j.exger.2003.10.020; Jones LM, 2011, ANAL CHEM, V83, P7657, DOI 10.1021/ac2007366; Kanu AB, 2008, J MASS SPECTROM, V43, P1, DOI 10.1002/jms.1383; Kaur P, 2009, ANAL CHEM, V81, P8141, DOI 10.1021/ac9013644; Kaur U, 2019, ANAL CHEM, V91, P142, DOI 10.1021/acs.analchem.8b05014; Kaur U, 2018, J PROTEOME RES, V17, P3614, DOI 10.1021/acs.jproteome.8b00341; Kiselar JG, 2010, J MASS SPECTROM, V45, P1373, DOI 10.1002/jms.1808; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Leser M, 2019, PROTEIN PEPTIDE LETT, V26, P61, DOI 10.2174/0929866526666181212164812; Li J, 2017, ANAL CHEM, V89, P2250, DOI 10.1021/acs.analchem.6b03058; Li KS, 2018, ACCOUNTS CHEM RES, V51, P736, DOI 10.1021/acs.accounts.7b00593; Li KS, 2017, ANAL CHEM, V89, P7742, DOI 10.1021/acs.analchem.7b01748; Li XY, 2017, BIOCHEMISTRY-US, V56, P957, DOI 10.1021/acs.biochem.6b00888; Li XY, 2015, J AM SOC MASS SPECTR, V26, P1424, DOI 10.1007/s13361-015-1129-7; Lu Y, 2016, ANAL CHEM, V88, P8827, DOI 10.1021/acs.analchem.6b01945; McClintock C, 2008, ANAL CHEM, V80, P3304, DOI 10.1021/ac702493a; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Mendoza VL, 2008, ANAL CHEM, V80, P2895, DOI 10.1021/ac701999b; Misra S. K., 2017, BIORXIV, DOI [10.1101/207910, DOI 10.1101/207910]; Monroe EB, 2013, ANAL CHEM, V85, P6185, DOI 10.1021/ac400107c; Niu B, 2017, J AM SOC MASS SPECTR, V28, P389, DOI 10.1007/s13361-016-1552-4; Niu B, 2015, J AM SOC MASS SPECTR, V26, P843, DOI 10.1007/s13361-015-1087-0; Nolting B, 1997, P NATL ACAD SCI USA, V94, P826, DOI 10.1073/pnas.94.3.826; NOLTING B, 1995, P NATL ACAD SCI USA, V92, P10668, DOI 10.1073/pnas.92.23.10668; Oganesyan I, 2018, METHODS, V144, P27, DOI 10.1016/j.ymeth.2018.04.023; Pan JX, 2009, J AM CHEM SOC, V131, P12801, DOI 10.1021/ja904379w; Pan Y, 2009, ANAL CHEM, V81, P28, DOI 10.1021/ac8020449; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Poor TA, 2014, P NATL ACAD SCI USA, V111, pE2596, DOI 10.1073/pnas.1408983111; Reading E, 2018, CHEM-EUR J, V24, P13391, DOI 10.1002/chem.201801556; Rinas A, 2016, ANAL CHEM, V88, P10052, DOI 10.1021/acs.analchem.6b02357; Rinas A, 2016, ANAL BIOANAL CHEM, V408, P3021, DOI 10.1007/s00216-016-9369-3; Schilling B, 2004, INT J MASS SPECTROM, V236, P117, DOI 10.1016/j.ijms.2004.06.004; Sinz A, 2018, ANGEW CHEM INT EDIT, V57, P6390, DOI 10.1002/anie.201709559; Stocks BB, 2012, J MOL BIOL, V423, P789, DOI 10.1016/j.jmb.2012.08.019; Su DA, 2011, BIOCHEMISTRY-US, V50, P82, DOI 10.1021/bi101248s; Tian JN, 2004, BIOMACROMOLECULES, V5, P1956, DOI 10.1021/bm049668m; Torossian K, 1996, BIOCHEM J, V319, P21, DOI 10.1042/bj3190021; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; Vahidi S, 2013, ANAL CHEM, V85, P8618, DOI 10.1021/ac401148z; Wang LW, 2011, ANAL CHEM, V83, P7234, DOI 10.1021/ac200567u; Watkinson TG, 2017, J AM SOC MASS SPECTR, V28, P50, DOI 10.1007/s13361-016-1421-1; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1498, DOI 10.1016/j.jasms.2006.05.014; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Woodson SA, 2010, ANNU REV BIOPHYS, V39, P61, DOI 10.1146/annurev.biophys.093008.131334; Wu L, 2013, ANAL CHEM, V85, P4920, DOI 10.1021/ac3033646; Xie B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04689-3; Xie B, 2015, ANAL CHEM, V87, P10719, DOI 10.1021/acs.analchem.5b02865; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Xu GZ, 2003, ANAL CHEM, V75, P6995, DOI 10.1021/ac035104h; Yan YT, 2014, J AM SOC MASS SPECTR, V25, P2084, DOI 10.1007/s13361-014-0993-x; Zhang BJ, 2016, J AM SOC MASS SPECTR, V27, P552, DOI 10.1007/s13361-015-1313-9; Zhang H, 2012, INT J MASS SPECTROM, V312, P78, DOI 10.1016/j.ijms.2011.07.015; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhou YP, 2012, J AM SOC MASS SPECTR, V23, P899, DOI 10.1007/s13361-012-0349-3; Zhu Y, 2017, J PROTEOME RES, V16, P2282, DOI 10.1021/acs.jproteome.7b00154	100	42	42	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					11969	11979		10.1074/jbc.REV119.006218	http://dx.doi.org/10.1074/jbc.REV119.006218			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31262727	Green Published, hybrid			2022-12-28	WOS:000484284500003
J	Ozeir, NM; Huyet, J; Burgevin, MC; Pinson, B; Chesney, F; Remy, JM; Siddiqi, AR; Lupoli, R; Pinon, G; Saint-Marc, C; Gibert, JF; Morales, R; Ceballos-Picot, I; Barouki, R; Daignan-Fornier, B; Olivier-Bandini, A; Auge, F; Nioche, P				Ozeir, N. Mohammad; Huyet, Jessica; Burgevin, Marie-Claude; Pinson, Benoit; Chesney, Francoise; Remy, Jean-Marc; Siddiqi, Abdul Rauf; Lupoli, Roland; Pinon, Grgory; Saint-Marc, Christelle; Gibert, Jean-Francois; Morales, Renaud; Ceballos-Picot, Irene; Barouki, Robert; Daignan-Fornier, Bertrand; Olivier-Bandini, Anne; Auge, Franck; Nioche, Pierre			Structural basis for substrate selectivity and nucleophilic substitution mechanisms in human adenine phosphoribosyltransferase catalyzed reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; purine; protein structure; nucleoside; nucleotide biosynthesis; quantum chemistry; adenine; hypoxanthine; QM; MM calculation; forward and reverse reactions; nucleoside monophosphate	PURINE NUCLEOSIDE PHOSPHORYLASE; CRYSTAL-STRUCTURE; ATOMIC MOTION; NUCLEOTIDES; COMPLEXES; KINETICS; FEATURES; REVEAL; LOOP	The reversible adenine phosphoribosyltransferase enzyme (APRT) is essential for purine homeostasis in prokaryotes and eukaryotes. In humans, APRT (hAPRT) is the only enzyme known to produce AMP in cells from dietary adenine. APRT can also process adenine analogs, which are involved in plant development or neuronal homeostasis. However, the molecular mechanism underlying substrate specificity of APRT and catalysis in both directions of the reaction remains poorly understood. Here we present the crystal structures of hAPRT complexed to three cellular nucleotide analogs (hypoxanthine, IMP, and GMP) that we compare with the phosphate-bound enzyme. We established that binding to hAPRT is substrate shape-specific in the forward reaction, whereas it is base-specific in the reverse reaction. Furthermore, a quantum mechanics/molecular mechanics (QM/MM) analysis suggests that the forward reaction is mainly a nucleophilic substitution of type 2 (S(N)2) with a mix of S(N)1-type molecular mechanism. Based on our structural analysis, a magnesium-assisted S(N)2-type mechanism would be involved in the reverse reaction. These results provide a framework for understanding the molecular mechanism and substrate discrimination in both directions by APRTs. This knowledge can play an instrumental role in the design of inhibitors, such as antiparasitic agents, or adenine-based substrates.	[Ozeir, N. Mohammad; Huyet, Jessica; Lupoli, Roland; Pinon, Grgory; Barouki, Robert; Nioche, Pierre] Univ Paris 05, Ctr Interdisciplinaire Chim Biol Paris, UFR Sci Fondamentales & Biomed, UMR 1124,Sorbonne Paris Cite, F-75006 Paris, France; [Ozeir, N. Mohammad; Huyet, Jessica; Lupoli, Roland; Pinon, Grgory; Barouki, Robert; Nioche, Pierre] INSERM, UMR 1124, F-75006 Paris, France; [Pinon, Grgory; Nioche, Pierre] Univ Paris 05, Struct & Mol Anal Platform, F-75006 Paris, France; [Burgevin, Marie-Claude; Chesney, Francoise; Remy, Jean-Marc; Gibert, Jean-Francois; Morales, Renaud; Olivier-Bandini, Anne; Auge, Franck] Sanofi R&D, Translat Sci Unit, F-91385 Chilly Mazarin, France; [Pinson, Benoit; Saint-Marc, Christelle; Daignan-Fornier, Bertrand] Univ Bordeaux, Inst Biochim & Genet Cellulaires, CNRS UMR 5095, F-33077 Bordeaux, France; [Siddiqi, Abdul Rauf] COMSATS Inst Informat Technol, Dept Biosci, Islamabad 45550, Pakistan; [Ceballos-Picot, Irene; Barouki, Robert] Hop Necker Enfants Malad, AP HP, Lab Biochim Metabol & Proteom, Fac Med Paris Descartes, F-75006 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Sanofi-Aventis; Sanofi France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; COMSATS University Islamabad (CUI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Nioche, P (corresponding author), Univ Paris 05, Ctr Interdisciplinaire Chim Biol Paris, UFR Sci Fondamentales & Biomed, UMR 1124,Sorbonne Paris Cite, F-75006 Paris, France.; Nioche, P (corresponding author), INSERM, UMR 1124, F-75006 Paris, France.; Nioche, P (corresponding author), Univ Paris 05, Struct & Mol Anal Platform, F-75006 Paris, France.; Auge, F (corresponding author), Sanofi R&D, Translat Sci Unit, F-91385 Chilly Mazarin, France.	franck.auge@sanofi.com; pierre.nioche@gmail.com	Gregory, Pinon/AAL-6974-2020	Gregory, Pinon/0000-0002-3895-3320	French National Research Agency [2010-CESA-015]; ARC Foundation; INSERM-University Chair; Sanofi research [116048, EU-TL-2013-003]; Ile de France Region; Paris City Hall	French National Research Agency(French National Research Agency (ANR)); ARC Foundation(Australian Research Council); INSERM-University Chair; Sanofi research; Ile de France Region(Region Ile-de-France); Paris City Hall	This work was supported by French National Research Agency Grant 2010-CESA-015 (to J.H. and P.N.), the ARC Foundation (to M.O.), an INSERM-University Chair (to P.N.), Paris City Hall and Ile de France Region grants (to P.N.), and Sanofi research contracts 116048 (to I.C.-P., B.P., and B.D.-F.) and EU-TL-2013-003 (to P.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; [Anonymous], 2014, QSITE; [Anonymous], 2014, MAESTR; Bashor C, 2002, BIOCHEMISTRY-US, V41, P4020, DOI 10.1021/bi0158730; Beresford RM, 1995, P NZ PLAN P, V48, P89, DOI 10.30843/nzpp.1995.48.11498; Bollee G, 2012, CLIN J AM SOC NEPHRO, V7, P1521, DOI 10.2215/CJN.02320312; Burgess J. P, 2008, TEMPLATE SYNTHESIS M; Chen XY, 1998, BIOCHEMISTRY-US, V37, P11605, DOI 10.1021/bi980990p; Costas ME, 1997, J PHYS CHEM A, V101, P8309, DOI 10.1021/jp970621n; Curto R, 1997, BIOCHEM J, V324, P761, DOI 10.1042/bj3240761; EADS JC, 1994, CELL, V78, P325, DOI 10.1016/0092-8674(94)90301-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; Ghanem M, 2009, CHEM BIOL, V16, P971, DOI 10.1016/j.chembiol.2009.07.012; GOITEIN RK, 1978, J BIOL CHEM, V253, P2963; GUTHRIE RD, 1989, ACCOUNTS CHEM RES, V22, P343, DOI 10.1021/ar00166a001; Gutierrez JA, 2009, NAT CHEM BIOL, V5, P251, DOI 10.1038/nchembio.153; Heinonen J.K, 2001, BIOL ROLE INORGANIC, DOI [10.1007/978-1-4615-1433-6, DOI 10.1007/978-1-4615-1433-6]; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Huyet J, 2018, CELL CHEM BIOL, V25, P666, DOI 10.1016/j.chembiol.2018.02.011; Johnson ER, 2010, J AM CHEM SOC, V132, P6498, DOI 10.1021/ja100936w; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; MURRAY AW, 1967, BIOCHEM J, V103, P271, DOI 10.1042/bj1030271; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Otilia C., 2004, METAL MEDIATED TEMPL; Phillips CL, 1999, EMBO J, V18, P3533, DOI 10.1093/emboj/18.13.3533; Schramm VL, 2001, CURR OPIN STRUC BIOL, V11, P657, DOI 10.1016/S0959-440X(01)00269-X; Shi WX, 1999, NAT STRUCT BIOL, V6, P588; Shi WX, 2002, J BIOL CHEM, V277, P39981, DOI 10.1074/jbc.M205596200; Silva CHTP, 2008, J BIOMOL STRUCT DYN, V25, P589, DOI 10.1080/07391102.2008.10507205; Silva M, 2004, BBA-PROTEINS PROTEOM, V1696, P31, DOI 10.1016/j.bbapap.2003.09.003; STEIN RL, 1981, J BIOL CHEM, V256, P767; Suarez J, 2013, CHEM BIOL, V20, P212, DOI 10.1016/j.chembiol.2013.01.009; TUTTLE JV, 1980, J BIOL CHEM, V255, P909; Wang GP, 1999, BIOCHEMISTRY-US, V38, P284, DOI 10.1021/bi982057s; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YUAN L, 1992, BIOCHEMISTRY-US, V31, P806, DOI 10.1021/bi00118a024; Zhang XY, 2013, MOL PLANT, V6, P1661, DOI 10.1093/mp/sst071	41	3	3	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					11980	11991		10.1074/jbc.RA119.009087	http://dx.doi.org/10.1074/jbc.RA119.009087			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31160323	Green Published, hybrid			2022-12-28	WOS:000484284500004
J	Shum, M; Houde, VP; Bellemare, V; Moreira, RJ; Bellmann, K; St-Pierre, P; Viollet, B; Foretz, M; Marette, A				Shum, Michael; Houde, Vanessa P.; Bellemare, Vicky; Moreira, Rafael Junges; Bellmann, Kerstin; St-Pierre, Philippe; Viollet, Benoit; Foretz, Marc; Marette, Andre			Inhibition of mitochondrial complex 1 by the S6K1 inhibitor PF-4708671 partly contributes to its glucose metabolic effects in muscle and liver cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; obesity; mechanistic target of rapamycin (mTOR); glucose metabolism; gluconeogenesis; AMPK-activated protein kinase (AMPK); glucose homeostasis; mitochondrial complex I; p70 S6 kinase (S6K1); PF-4708671	SKELETAL-MUSCLE; INSULIN-RESISTANCE; HEPATIC GLUCONEOGENESIS; AS160 PHOSPHORYLATION; AMINO-ACID; AMPK; ACTIVATION; RAPAMYCIN; KINASE; PATHWAY	mTOR complex 1 (mTORC1) and p70 S6 kinase (S6K1) are both involved in the development of obesity-linked insulin resistance. Recently, we showed that the S6K1 inhibitor PF-4708671 (PF) increases insulin sensitivity. However, we also reported that PF can increase glucose metabolism even in the absence of insulin in muscle and hepatic cells. Here we further explored the potential mechanisms by which PF increases glucose metabolism in muscle and liver cells independent of insulin. Time course experiments revealed that PF induces AMP-activated protein kinase (AMPK) activation before inhibiting S6K1. However, PF-induced glucose uptake was not prevented in primary muscle cells from AMPK alpha 1/2 double KO (dKO) mice. Moreover, PF-mediated suppression of hepatic glucose production was maintained in hepatocytes derived from AMPK alpha 1/2-dKO mice. Remarkably, PF could still reduce glucose production and activate AMPK in hepatocytes from S6K1/2 dKO mice. Mechanistically, bioenergetics experiments revealed that PF reduces mitochondrial complex I activity in both muscle and hepatic cells. The stimulatory effect of PF on glucose uptake was partially reduced by expression of the Saccharomyces cerevisiae NADH:ubiquinone oxidoreductase in L6 cells. These results indicate that PF-mediated S6K1 inhibition is not required for its effect on insulin-independent glucose metabolism and AMPK activation. We conclude that, although PF rapidly activates AMPK, its ability to acutely increase glucose uptake and suppress glucose production does not require AMPK activation. Unexpectedly, PF rapidly inhibits mitochondrial complex I activity, a mechanism that partially underlies PF's effect on glucose metabolism.	[Shum, Michael; Houde, Vanessa P.; Bellemare, Vicky; Moreira, Rafael Junges; Bellmann, Kerstin; St-Pierre, Philippe; Marette, Andre] Univ Laval, Quebec Heart & Lung Inst, Dept Med, Quebec City, PQ G1V 4G5, Canada; [Viollet, Benoit; Foretz, Marc] INSERM, Inst Cochin, U1016, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] CNRS, UMR8104, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France	Laval University; Quebec Heart & Lung Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Marette, A (corresponding author), Hop Laval, Quebec Heart & Lung Inst, Dept Med, Pavillon Marguerite dYouville,Room Y4308, Ste Foy, PQ G1V 4G5, Canada.	andre.marette@criucpq.ulaval.ca	FORETZ, Marc/O-7334-2017; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Moreira, Rafael/0000-0002-7796-4233; Marette, Andre/0000-0003-3950-5973; Houde, Vanessa P./0000-0003-1932-805X; Shum, Michael/0000-0001-8784-9928	Canadian Institutes of Health Research Foundation [143247]; Region Ile-de-France (CORDDIM); Societe Francophone du Diabete; Fondation pour le Recherche Medicale [DEQ20150934718]; Cardiometabolic Health, Diabetes, and Obesity Research Network	Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Region Ile-de-France (CORDDIM)(Region Ile-de-France); Societe Francophone du Diabete; Fondation pour le Recherche Medicale(Fondation pour la Recherche Medicale); Cardiometabolic Health, Diabetes, and Obesity Research Network	This work was funded by Canadian Institutes of Health Research Foundation Grant 143247, a grant from the Cardiometabolic Health, Diabetes, and Obesity Research Network (to A.M.), and grants from Region Ile-de-France (CORDDIM), Societe Francophone du Diabete, and Fondation pour le Recherche Medicale (DEQ20150934718) (to M.F. and B.V.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12; Bedard S, 1997, BIOCHEM J, V325, P487, DOI 10.1042/bj3250487; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; Deshmukh A, 2009, CELL MOL LIFE SCI, V66, P1457, DOI 10.1007/s00018-009-8818-y; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Hasenour CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170382; Hou WL, 2018, J CELL MOL MED, V22, P1316, DOI 10.1111/jcmm.13432; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kjobsted R, 2018, FASEB J, V32, P1741, DOI 10.1096/fj.201700442R; Lantier L, 2010, FASEB J, V24, P3555, DOI 10.1096/fj.10-155994; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shum M, 2016, DIABETOLOGIA, V59, P592, DOI 10.1007/s00125-015-3839-6; Treebak JT, 2007, AM J PHYSIOL-ENDOC M, V292, pE715, DOI 10.1152/ajpendo.00380.2006; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vainer GW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107364; Villani LA, 2016, MOL METAB, V5, P1048, DOI 10.1016/j.molmet.2016.08.014; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242	36	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12250	12260		10.1074/jbc.RA119.008488	http://dx.doi.org/10.1074/jbc.RA119.008488			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31243102	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000484284500026
J	Ryan, JJ; Sprunger, ML; Holthaus, K; Shorter, J; Jackrel, ME				Ryan, Jeremy J.; Sprunger, Macy L.; Holthaus, Kayla; Shorter, James; Jackrel, Meredith E.			Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heat shock protein (HSP); protein aggregation; translocation; cancer; chaperone; chromosomal translocation; EWS-FLI; FUS-CHOP; Hsp104; sarcoma	RNA-BINDING PROTEINS; AMYOTROPHIC-LATERAL-SCLEROSIS; ALPHA-SYNUCLEIN TOXICITY; TERMINAL DOMAIN; FET PROTEINS; TLS-CHOP; HSP104; AGGREGATION; ALS; GRANULES	FUS and EWSR1 are RNA-binding proteins with prion-like domains (PrLDs) that aggregate in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The FUS and EWSR1 genes are also prone to chromosomal translocation events, which result in aberrant fusions between portions of the PrLDs of FUS and EWSR1 and the transcription factors CHOP and FLI. The resulting fusion proteins, FUS-CHOP and EWS-FLI, drive aberrant transcriptional programs that underpin liposarcoma and Ewing's sarcoma, respectively. The translocated PrLDs alter the expression profiles of these proteins and promote their phase separation and aggregation. Here, we report the development of yeast models of FUS-CHOP and EWS-FLI toxicity and aggregation. These models recapitulated several salient features of sarcoma patient cells harboring the FUS-CHOP and EWS-FLI translocations. To reverse FUS and EWSR1 aggregation, we have explored Hsp104, a hexameric AAA+ protein disaggregase from yeast. Previously, we engineered potentiated Hsp104 variants to suppress the proteotoxicity, aggregation, and mislocalization of FUS and other proteins that aggregate in ALS/FTD and Parkinson's disease. Potentiated Hsp104 variants that robustly suppressed FUS toxicity and aggregation also suppressed the toxicity and aggregation of FUS-CHOP and EWS-FLI. We suggest that these new yeast models are powerful platforms for screening for modulators of FUS-CHOP and EWS-FLI phase separation. Moreover, Hsp104 variants might be employed to combat the toxicity and phase separation of aberrant fusion proteins involved in sarcoma.	[Ryan, Jeremy J.; Sprunger, Macy L.; Holthaus, Kayla; Jackrel, Meredith E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Shorter, James] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine	Jackrel, ME (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.; Shorter, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	jshorter@pennmedicine.upenn.edu; mjackrel@wustl.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Jackrel, Meredith/0000-0003-4406-9504; Ryan, Jeremy/0000-0002-0410-2456	Office of Research Infrastructure Programs (ORIP), a part of the National Institutes of Health Office of the Director [OD021629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM128772, R01GM099836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021629] Funding Source: NIH RePORTER	Office of Research Infrastructure Programs (ORIP), a part of the National Institutes of Health Office of the Director; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Peter Bayguinov and James Fitzpatrick of the Washington University Center for Cellular Imaging for assistance with microscopy. We thank Zach March, Korrie Mack, and Bede Portz for review of the manuscript and Jeffrey Toretsky for providing plasmids. Confocal data were generated on a Zeiss LSM 880 Airyscan confocal microscope, which was purchased with support from the Office of Research Infrastructure Programs (ORIP), a part of the National Institutes of Health Office of the Director, under Grant OD021629.	Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Bogaert E, 2018, CELL REP, V24, P529, DOI 10.1016/j.celrep.2018.06.070; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chuang E, 2018, J CELL SCI, V131, DOI 10.1242/jcs.189928; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; DeSantis ME, 2012, CHEM BIOL, V19, P1400, DOI 10.1016/j.chembiol.2012.09.013; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Flores BN, 2019, CELL REP, V27, P1133, DOI 10.1016/j.celrep.2019.03.093; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gitler AD, 2017, DIS MODEL MECH, V10, P499, DOI 10.1242/dmm.030205; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goransson M, 2002, EXP CELL RES, V278, P125, DOI 10.1006/excr.2002.5566; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Guo L, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024554; Guo L, 2015, MOL CELL, V60, P189, DOI 10.1016/j.molcel.2015.10.006; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Harvey ZH, 2018, MOL CELL, V69, P195, DOI 10.1016/j.molcel.2017.10.030; Jackrel ME, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00099; Jackrel ME, 2015, ACS CHEM BIOL, V10, P2672, DOI 10.1021/acschembio.5b00765; Jackrel ME, 2015, PRION, V9, P90, DOI 10.1080/19336896.2015.1020277; Jackrel ME, 2014, JOVE-J VIS EXP, DOI 10.3791/52089; Jackrel ME, 2014, DIS MODEL MECH, V7, P1175, DOI 10.1242/dmm.016113; Jackrel ME, 2014, CELL CYCLE, V13, P1379, DOI 10.4161/cc.28709; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Jakobson Christopher M, 2018, Curr Opin Syst Biol, V8, P16, DOI 10.1016/j.coisb.2017.11.012; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Klaips CL, 2014, ELIFE, V3, DOI 10.7554/eLife.04288; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kroschwald S, 2018, CELL REP, V23, P3327, DOI 10.1016/j.celrep.2018.05.041; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lindberg I, 2015, J NEUROSCI, V35, P13853, DOI 10.1523/JNEUROSCI.2600-15.2015; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Mack KL, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00008; March ZM, 2016, BRAIN RES, V1647, P9, DOI 10.1016/j.brainres.2016.02.037; Neumann M, 2012, ACTA NEUROPATHOL, V124, P705, DOI 10.1007/s00401-012-1020-6; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Newby GA, 2013, TRENDS CELL BIOL, V23, P251, DOI 10.1016/j.tcb.2013.01.007; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Park YN, 2014, EUKARYOT CELL, V13, P635, DOI 10.1128/EC.00300-13; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Pei F, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007085; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Shorter J, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a034033; Shorter J, 2017, CELL, V171, P30, DOI 10.1016/j.cell.2017.09.010; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Sweeny EA, 2016, J MOL BIOL, V428, P1870, DOI 10.1016/j.jmb.2015.11.016; Sweeny EA, 2015, MOL CELL, V57, P836, DOI 10.1016/j.molcel.2014.12.021; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Tariq A, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy042; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Thelin-Jarnum S, 2002, INT J CANCER, V97, P446, DOI 10.1002/ijc.1632; Tkach JM, 2008, TRAFFIC, V9, P39, DOI 10.1111/j.1600-0854.2007.00666.x; Torrente MP, 2016, J BIOL CHEM, V291, P5101, DOI 10.1074/jbc.M115.707976; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Yasuda K, 2017, J CELL BIOL, V216, P1015, DOI 10.1083/jcb.201608022; Yokom AL, 2016, NAT STRUCT MOL BIOL, V23, P830, DOI 10.1038/nsmb.3277; Zhao XH, 2017, J BIOL CHEM, V292, P8630, DOI 10.1074/jbc.M116.770719	82	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11286	11296		10.1074/jbc.RA119.009494	http://dx.doi.org/10.1074/jbc.RA119.009494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31171724	hybrid, Green Published			2022-12-28	WOS:000478717400019
J	Hui, GK; Gardener, AD; Begum, H; Eldrid, C; Thalassinos, K; Gor, J; Perkins, SJ				Hui, Gar Kay; Gardener, Antoni D.; Begum, Halima; Eldrid, Charles; Thalassinos, Konstantinos; Gor, Jayesh; Perkins, Stephen J.			The solution structure of the human IgG2 subclass is distinct from those for human IgG1 and IgG4 providing an explanation for their discrete functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; analytical ultracentrifugation; molecular modeling; neutron-scattering; small-angle X-ray scattering (SAXS); immunoglobulin G (IgG)	X-RAY-SCATTERING; NEUTRON-SCATTERING; DISULFIDE CONNECTIVITY; MONOCLONAL-ANTIBODIES; ANGLE; SEDIMENTATION; PROTEINS; ISOFORMS; AFFINITY; PROGRAM	Human IgG2 antibody displays distinct therapeutically-useful properties compared with the IgG1, IgG3, and IgG4 antibody subclasses. IgG2 is the second most abundant IgG subclass, being able to bind human Fc gamma RII/Fc gamma RIII but not to Fc gamma RI or complement C1q. Structural information on IgG2 is limited by the absence of a full-length crystal structure for this. To this end, we determined the solution structure of human myeloma IgG2 by atomistic X-ray and neutron-scattering modeling. Analytical ultracentrifugation disclosed that IgG2 is monomeric with a sedimentation coefficient (s20, w0) of 7.2 S. IgG2 dimer formation was <= 5% and independent of the buffer conditions. Small-angle X-ray scattering in a range of NaCl concentrations and in light and heavy water revealed that the X-ray radius of gyration (R-g) is 5.2-5.4 nm, after allowing for radiation damage at higher concentrations, and that the neutron R-g value of 5.0 nm remained unchanged in all conditions. The X-ray and neutron distance distribution curves (P(r)) revealed two peaks, M1 and M2, that were unchanged in different buffers. The creation of >123,000 physically-realistic atomistic models by Monte Carlo simulations for joint X-ray and neutron-scattering curve fits, constrained by the requirement of correct disulfide bridges in the hinge, resulted in the determination of symmetric Y-shaped IgG2 structures. These molecular structures were distinct from those for asymmetric IgG1 and asymmetric and symmetric IgG4 and were attributable to the four hinge disulfides. Our IgG2 structures rationalize the existence of the human IgG1, IgG2, and IgG4 subclasses and explain the receptor-binding functions of IgG2.	[Hui, Gar Kay; Gardener, Antoni D.; Begum, Halima; Eldrid, Charles; Thalassinos, Konstantinos; Gor, Jayesh; Perkins, Stephen J.] UCL, Inst Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Thalassinos, Konstantinos] Univ London, Birkbeck Coll, Inst Struct & Mol Biol, London, England	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London	Perkins, SJ (corresponding author), UCL, Inst Struct & Mol Biol, Div Biosci, London WC1E 6BT, England.	s.perkins@ucl.ac.uk		Perkins, Stephen/0000-0001-9218-9805; Gardener, Antoni/0000-0001-9000-8433; Eldrid, Charles/0000-0001-5306-3644	UCL Impact Studentship; Fight For Sight Charity; EPSRC [EP/K039121/1]; National Science Foundation [CHE-1265821]	UCL Impact Studentship; Fight For Sight Charity; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF))	Supported by a UCL Impact Studentship and the Fight For Sight Charity (Ref: 2011).; Supported by a Joint EPSRC Grant EP/K039121/1 and National Science Foundation Grant CHE-1265821 for CCP-SAS.	Antolinos AD, 2015, ACTA CRYSTALLOGR D, V71, P76, DOI 10.1107/S1399004714019609; BARRETT DJ, 1986, CLIN EXP IMMUNOL, V63, P127; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brennich M, 2017, ADV EXP MED BIOL, V1009, P47, DOI 10.1007/978-981-10-6038-0_4; Brezski RJ, 2011, MABS-AUSTIN, V3, P558, DOI 10.4161/mabs.3.6.18119; Brezski RJ, 2010, MABS-AUSTIN, V2, P212, DOI 10.4161/mabs.2.3.11780; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Clark NJ, 2013, J PHYS CHEM B, V117, P14029, DOI 10.1021/jp408710r; Cordeiro TN, 2017, ADV EXP MED BIOL, V1009, P107, DOI 10.1007/978-981-10-6038-0_7; Curtis JE, 2012, COMPUT PHYS COMMUN, V183, P382, DOI 10.1016/j.cpc.2011.09.010; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Falconer DJ, 2018, ACS CHEM BIOL, V13, P2179, DOI 10.1021/acschembio.8b00342; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Franey H, 2010, PROTEIN SCI, V19, P1601, DOI 10.1002/pro.434; Fukuda M, 2017, EUR J PHARM BIOPHARM, V112, P132, DOI 10.1016/j.ejpb.2016.11.027; Glatter O., 1982, SMALL ANGLE XRAY SCA; GREGORY L, 1987, MOL IMMUNOL, V24, P821, DOI 10.1016/0161-5890(87)90184-2; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hamilton R. G., 2001, HUMAN IGG SUBCLASSES, P7; Incardona MF, 2009, J SYNCHROTRON RADIAT, V16, P872, DOI 10.1107/S0909049509036681; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2011, J COMPUT CHEM, V32, P3135, DOI 10.1002/jcc.21886; Kabat EA, 1992, SEQUENCES PROTEINS I; KILAR F, 1985, EUR J BIOCHEM, V147, P17, DOI 10.1111/j.1432-1033.1985.tb08712.x; Kiyoshi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22199-8; Konig N, 2017, BIOPHYS CHEM, V231, P45, DOI 10.1016/j.bpc.2017.05.016; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lightle S, 2010, PROTEIN SCI, V19, P753, DOI 10.1002/pro.352; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; Liu YD, 2008, J BIOL CHEM, V283, P29266, DOI 10.1074/jbc.M804787200; Lu JH, 2015, P NATL ACAD SCI USA, V112, P833, DOI 10.1073/pnas.1418812112; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinez T, 2008, BIOCHEMISTRY-US, V47, P7496, DOI 10.1021/bi800576c; Mosbaek CR, 2012, PHARM RES-DORDR, V29, P2225, DOI 10.1007/s11095-012-0751-3; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pepinsky RB, 2010, PROTEIN SCI, V19, P954, DOI 10.1002/pro.372; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; PERKINS SJ, 1983, J MOL BIOL, V168, P847, DOI 10.1016/S0022-2836(83)80078-3; Perkins SJ, 2016, J APPL CRYSTALLOGR, V49, P1861, DOI 10.1107/S160057671601517X; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; PHILLIPS ML, 1994, MOL IMMUNOL, V31, P1201, DOI 10.1016/0161-5890(94)90034-5; PILZ I, 1973, BIOCHEMISTRY-US, V12, P4998, DOI 10.1021/bi00748a028; Raman EP, 2010, J PHYS CHEM B, V114, P12981, DOI 10.1021/jp105758h; Rayner LE, 2015, J BIOL CHEM, V290, P8420, DOI 10.1074/jbc.M114.631002; Rayner LE, 2014, J BIOL CHEM, V289, P20740, DOI 10.1074/jbc.M114.572404; Round A, 2015, ACTA CRYSTALLOGR D, V71, P67, DOI 10.1107/S1399004714026959; Ryazantsev S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064076; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scapin G, 2015, NAT STRUCT MOL BIOL, V22, P953, DOI 10.1038/nsmb.3129; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEINO J, 1993, CLIN EXP IMMUNOL, V94, P291; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; SIBER GR, 1980, NEW ENGL J MED, V303, P178, DOI 10.1056/NEJM198007243030402; Sivalingam GN, 2013, INT J MASS SPECTROM, V345, P54, DOI 10.1016/j.ijms.2012.09.005; Strohl WR, 2012, WOODH PUB SER BIOMED, P1, DOI 10.1533/9781908818096; Swinscow T. D. V., 2001, STAT SQUARE ONE; Teplyakov A, 2013, MOL IMMUNOL, V56, P131, DOI 10.1016/j.molimm.2013.03.018; Tian XS, 2015, IUCRJ, V2, P9, DOI 10.1107/S205225251402209X; Tian XS, 2014, J PHARM SCI-US, V103, P1701, DOI 10.1002/jps.23964; Ugurlar D, 2018, SCIENCE, V359, P794, DOI 10.1126/science.aao4988; Vafa O, 2014, METHODS, V65, P114, DOI 10.1016/j.ymeth.2013.06.035; Vidarsson G, 2001, J IMMUNOL, V166, P6250, DOI 10.4049/jimmunol.166.10.6250; Wright DW, 2015, J APPL CRYSTALLOGR, V48, P953, DOI 10.1107/S1600576715007062; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200; Yoo EM, 2003, J IMMUNOL, V170, P3134, DOI 10.4049/jimmunol.170.6.3134; Zhang AM, 2015, BIOCHEMISTRY-US, V54, P1956, DOI 10.1021/bi5015216; Zhang B, 2010, ANAL CHEM, V82, P1090, DOI 10.1021/ac902466z; Zhao HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126420	76	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10789	10806		10.1074/jbc.RA118.007134	http://dx.doi.org/10.1074/jbc.RA118.007134			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31088911	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000478717200006
J	Kolar, MJ; Konduri, S; Chang, T; Wang, HJ; McNerlin, C; Ohlsson, L; Harrod, M; Siegel, D; Saghatelian, A				Kolar, Matthew J.; Konduri, Srihari; Chang, Tina; Wang, Huijing; McNerlin, Clare; Ohlsson, Lena; Harrod, Magnus; Siegel, Dionicio; Saghatelian, Alan			Linoleic acid esters of hydroxy linoleic acids are anti-inflammatory lipids found in plants and mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid; lipid structure; lipid synthesis; lipid signaling; inflammation; FAHFAs; LAHLAs	FATTY-ACIDS; NITRIC-OXIDE; STEREOSELECTIVE-SYNTHESIS; PHENOLIC-ACIDS; AVENANTHRAMIDES; FAHFAS; ACTIVATION; COX-2; OATS; LPS	Fatty acid esters of hydroxy fatty acids (FAHFAs) are a recently discovered class of biologically active lipids. Here we identify the linoleic acid ester of 13-hydroxy linoleic acid (13-LAHLA) as an anti-inflammatory lipid. An oat oil fraction and FAHFA-enriched extract from this fraction showed anti-inflammatory activity in a lipopolysaccharide-induced cytokine secretion assay. Structural studies identified three LAHLA isomers (15-, 13-, and 9-LAHLA) as being the most abundant FAHFAs in the oat oil fraction. Of these LAHLAs, 13-LAHLA is the most abundant LAHLA isomer in human serum after ingestion of liposomes made of fractionated oat oil, and it is also the most abundant endogenous LAHLA in mouse and human adipose tissue. As a result, we chemically synthesized 13-LAHLA for biological assays. 13-LAHLA suppresses lipopolysaccharide-stimulated secretion of cytokines and expression of pro-inflammatory genes. These studies identify LAHLAs as an evolutionarily conserved lipid with anti-inflammatory activity in mammalian cells.	[Kolar, Matthew J.; Chang, Tina; Saghatelian, Alan] Clayton Fdn Labs Peptide Biol, Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Konduri, Srihari; Wang, Huijing; McNerlin, Clare; Siegel, Dionicio] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Ohlsson, Lena] Lund Univ, Dept Clin Sci, Div Expt Vasc Res, Box 117, S-22100 Lund, Sweden; [Harrod, Magnus] Harrod Res, Frans Persons Vag 6, S-40229 Gothenburg, Sweden; [Kolar, Matthew J.] Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; Lund University; University of California System; University of California San Diego	Saghatelian, A (corresponding author), Clayton Fdn Labs Peptide Biol, Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Siegel, D (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	drsiegel@ucsd.edu; asaghatelian@salk.edu	Ohlsson, Lena/AAI-1587-2021; Konduri, Srihari/Q-1030-2019	Konduri, Srihari/0000-0003-1618-3932; Saghatelian, Alan/0000-0002-0427-563X; Kolar, Matthew/0000-0001-8054-9121; Chang, Tina/0000-0002-7079-0226	NIDDK, National Institutes of Health [R01 DK106210, R56 DK110150-01A1, F31 DK112604]; NCI, National Institutes of Health [CA014195]; Ferring Pharmaceuticals Paulsen Chair; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC2DK114785, R56DK110150, R01DK106210] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021815] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ferring Pharmaceuticals Paulsen Chair(Ferring Pharmaceuticals); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIDDK, National Institutes of Health grants R01 DK106210 (to A.S.), R56 DK110150-01A1 (to D.S.), and F31 DK112604 (to A.S.); NCI, National Institutes of Health Grant CA014195 (to M.J.K., T.C., and A.S.), and a Ferring Pharmaceuticals Paulsen Chair (to A.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balas L, 2016, ORG BIOMOL CHEM, V14, P9012, DOI 10.1039/c6ob01597b; CHAN C, 1988, J CHEM SOC CHEM COMM, P971, DOI 10.1039/c39880000971; Chen CY, 2004, J NUTR, V134, P1459, DOI 10.1093/jn/134.6.1459; COLLINS FW, 1989, J AGR FOOD CHEM, V37, P60, DOI 10.1021/jf00085a015; Criquet M, 2012, CLIN COSMET INVESTI, V5, P183, DOI 10.2147/CCID.S31375; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Evans R., 1991, U. S. Patent, Patent No. [5,026,548, 5026548]; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hamberg M, 1998, LIPIDS, V33, P355, DOI 10.1007/s11745-998-0215-9; Harrod M., 2014, U. S. Patent, Patent No. [8,865,923, 8865923]; Hu T, 2018, ANAL BIOANAL CHEM, V410, P7415, DOI 10.1007/s00216-018-1350-x; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kim JB, 2007, BIOL PHARM BULL, V30, P2345, DOI 10.1248/bpb.30.2345; Kolar MJ, 2018, ANAL CHEM, V90, P5358, DOI 10.1021/acs.analchem.8b00503; Kolar MJ, 2016, BIOCHEMISTRY-US, V55, P4636, DOI 10.1021/acs.biochem.6b00565; Kuda O, 2016, DIABETES, V65, P2580, DOI 10.2337/db16-0385; Kurtz Ellen S, 2007, J Drugs Dermatol, V6, P167; Lee J, 2016, J BIOL CHEM, V291, P22207, DOI 10.1074/jbc.M115.703835; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Li Z, 2009, CHEM PHYS LIPIDS, V158, P39, DOI 10.1016/j.chemphyslip.2008.12.004; Ma Y, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0104-4; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; Mattila P, 2005, J AGR FOOD CHEM, V53, P8290, DOI 10.1021/jf051437z; Moreau RA, 2008, LIPIDS, V43, P533, DOI 10.1007/s11745-008-3181-6; Nelson AT, 2017, J AM CHEM SOC, V139, P4943, DOI 10.1021/jacs.7b01269; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohlsson L, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.24465; Parsons WH, 2016, NAT CHEM BIOL, V12, P367, DOI [10.1038/NCHEMBIO.2051, 10.1038/nchembio.2051]; Peterson DM, 2002, FOOD CHEM, V79, P473, DOI 10.1016/S0308-8146(02)00219-4; RAO AVR, 1985, TETRAHEDRON LETT, V26, P465, DOI 10.1016/S0040-4039(00)61912-3; RAO AVR, 1986, J ORG CHEM, V51, P4158, DOI 10.1021/jo00372a011; Reynertson KA, 2015, J DRUGS DERMATOL, V14, P43; STILLE JK, 1989, TETRAHEDRON LETT, V30, P3645, DOI 10.1016/S0040-4039(01)80470-6; Syed I, 2018, CELL METAB, V27, P419, DOI 10.1016/j.cmet.2018.01.001; YADAV JS, 1992, TETRAHEDRON, V48, P4465, DOI 10.1016/S0040-4020(01)80454-3; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Zhang TJ, 2016, NAT PROTOC, V11, P747, DOI 10.1038/nprot.2016.040; Zhu QF, 2018, ANAL CHEM, V90, P10056, DOI 10.1021/acs.analchem.8b02839	40	41	41	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10698	10707		10.1074/jbc.RA118.006956	http://dx.doi.org/10.1074/jbc.RA118.006956			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31152059	Green Published, hybrid			2022-12-28	WOS:000478717100027
J	Zyla, DS; Prota, AE; Capitani, G; Glockshuber, R				Zyla, Dawid S.; Prota, Andrea E.; Capitani, Guido; Glockshuber, Rudi			Alternative folding to a monomer or homopolymer is a common feature of the type 1 pilus subunit FimA from enteroinvasive bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; X-ray crystallography; Escherichia coli (E; coli); protein structure; protein stability; alternative folding; chaperone-usher pili; FimA; type 1 pilus; urinary tract infections	URINARY-TRACT; DISSOCIATION; STABILITY	Adhesive type 1 pili from enteroinvasive, Gram-negative bacteria mediate attachment to host cells. Up to 3000 copies of the main pilus subunit, FimA, assemble into the filamentous, helical quaternary structure of the pilus rod via a mechanism termed donor-strand complementation, in which the N-terminal extension of each subunit, the donor strand, is inserted into the incomplete immunoglobulin-like fold of the preceding FimA subunit. For FimA from Escherichia coli, it has been previously shown that the protein can also adopt a monomeric, self-complemented conformation in which the donor strand is inserted intramolecularly in the opposite orientation relative to that observed for FimA polymers. Notably, soluble FimA monomers can act as apoptosis inhibitors in epithelial cells after uptake of type 1-piliated pathogens. Here, we show that the FimA orthologues from Escherichia coli, Shigella flexneri, and Salmonella enterica can all fold to form self-complemented monomers. We solved X-ray structures of all three FimA monomers at 0.89-1.69 angstrom resolutions, revealing identical, intramolecular donor-strand complementation mechanisms. Our results also showed that the pseudo-palindromic sequences of the donor strands in all FimA proteins permit their alternative folding possibilities. All FimA monomers proved to be 50-60 kJ/mol less stable against unfolding than their pilus rod-like counterparts (which exhibited very high energy barriers of unfolding and refolding). We conclude that the ability of FimA to adopt an alternative, monomeric state with anti-apoptotic activity is a general feature of FimA proteins of type 1-piliated bacteria.	[Zyla, Dawid S.; Glockshuber, Rudi] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland; [Prota, Andrea E.; Capitani, Guido] Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, Forschungsstr 111, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Glockshuber, R (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	rudi@mol.biol.ethz.ch	Prota, Andrea Enrico/R-9526-2019; Żyła, Dawid/AAD-2381-2020	Prota, Andrea Enrico/0000-0003-0875-5339; Żyła, Dawid/0000-0001-8471-469X	Swiss National Science Foundation [310030B_176403/1, 31003A_156304]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 310030B_176403/1 and 31003A_156304 (to R.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen WJ, 2012, CURR OPIN STRUC BIOL, V22, P500, DOI 10.1016/j.sbi.2012.02.001; Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Busch A, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2013.0153; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Crespo MD, 2012, NAT CHEM BIOL, V8, P707, DOI [10.1038/NCHEMBIO.1019, 10.1038/nchembio.1019]; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erilov D, 2007, J AM CHEM SOC, V129, P8938, DOI 10.1021/ja0718927; ESHDAT Y, 1981, J BACTERIOL, V148, P308, DOI 10.1128/JB.148.1.308-314.1981; Fersht A., 1999, STRUCTURE MECH PROTE; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Hospenthal MK, 2017, STRUCTURE, V25, P1829, DOI 10.1016/j.str.2017.10.004; Hospenthal MK, 2017, NAT REV MICROBIOL, V15, P365, DOI 10.1038/nrmicro.2017.40; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Nozaki Y, 1972, Methods Enzymol, V26, P43; OHANLEY P, 1985, J CLIN INVEST, V75, P347, DOI 10.1172/JCI111707; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Puorger C, 2008, STRUCTURE, V16, P631, DOI 10.1016/j.str.2008.01.013; Puorger C, 2011, J MOL BIOL, V412, P520, DOI 10.1016/j.jmb.2011.07.044; Sauer MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10738; Schilling JD, 2001, J INFECT DIS, V183, pS36, DOI 10.1086/318855; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Spaulding C, 2018, ELIFE, V7, DOI 10.7554/eLife.31662; Sukumaran SK, 2010, MOL CELL, V37, P768, DOI 10.1016/j.molcel.2010.02.015; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Vetsch M, 2002, J MOL BIOL, V322, P827, DOI 10.1016/S0022-2836(02)00845-8; Vetsch M, 2006, EMBO REP, V7, P734, DOI 10.1038/sj.embor.7400722; Walczak MJ, 2014, J MOL BIOL, V426, P542, DOI 10.1016/j.jmb.2013.10.029	34	2	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10553	10563		10.1074/jbc.RA119.008610	http://dx.doi.org/10.1074/jbc.RA119.008610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31126987	Green Published, hybrid			2022-12-28	WOS:000478717100015
J	de Hoog, E; Lukewich, MK; Spencer, GE				de Hoog, Eric; Lukewich, Mark K.; Spencer, Gaynor E.			Retinoid receptor-based signaling plays a role in voltage-dependent inhibition of invertebrate voltage-gated Ca2+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retinoic acid; calcium channel; G protein; electrophysiology; invertebrate; Lymnaea stagnalis; retinoid receptor; synaptic plasticity; voltage clamp; voltage-gated calcium channel (VGCC)	PROTEIN BETA-GAMMA; G-ALPHA-I; CALCIUM-CHANNELS; GROWTH CONE; X-RECEPTOR; SYNAPTIC PLASTICITY; KINASE-C; ACID; BINDING; MODULATION	The retinoic acid receptor (RAR) and retinoid X receptor (RXR) mediate the cellular effects of retinoids (derivatives of vitamin A). Both RAR and RXR signaling events are implicated in hippocampal synaptic plasticity. Furthermore, retinoids can interact with calcium signaling during homeostatic plasticity. We recently provided evidence that retinoids attenuate calcium current (I-Ca) through neuronal voltage-gated calcium channels (VGCCs). We now examined the possibility that constitutive activity of neuronal RXR and/or RAR alters calcium influx via the VGCCs. We found that in neurons of the mollusk Lymnaea stagnalis, two different RXR antagonists (PA452 and HX531) had independent and opposing effects on I-Ca that were also time-dependent; whereas the RXR pan-antagonist PA452 enhanced I-Ca, HX531 reduced I-Ca. Interestingly, this effect of HX531 occurred through voltage-dependent inhibition of VGCCs, a phenomenon known to influence neurotransmitter release from neurons. This inhibition appeared to be independent of G proteins and was largely restricted to Ca(v)2 Ca2+ channels. Of note, an RAR pan-antagonist, LE540, also inhibited I-Ca but produced G protein-dependent, voltage-dependent inhibition of VGCCs. These findings provide evidence that retinoid receptors interact with G proteins in neurons and suggest mechanisms by which retinoids might affect synaptic calcium signaling.	[de Hoog, Eric; Lukewich, Mark K.; Spencer, Gaynor E.] Brock Univ, Dept Biol Sci, 1812 Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada	Brock University	Spencer, GE (corresponding author), Brock Univ, Dept Biol Sci, 1812 Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada.	gspencer@brocku.ca		Lukewich, Mark/0000-0001-7738-4688	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Discovery Grant (to G. E. S.) from the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Agosti F, 2017, NEUROSCIENCE, V346, P102, DOI 10.1016/j.neuroscience.2017.01.007; ALLENBY G, 1994, J BIOL CHEM, V269, P16689; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Arendt KL, 2015, P NATL ACAD SCI USA, V112, pE5744, DOI 10.1073/pnas.1510239112; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BOLAND LM, 1993, J NEUROSCI, V13, P516; Brody DL, 2000, J NEUROSCI, V20, P889, DOI 10.1523/JNEUROSCI.20-03-00889.2000; Carter CJ, 2015, J EXP ZOOL PART B, V324, P51, DOI 10.1002/jez.b.22604; Carter CJ, 2010, DEV BIOL, V343, P124, DOI 10.1016/j.ydbio.2010.03.023; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; de Hoog E, 2018, CELL CALCIUM, V72, P51, DOI 10.1016/j.ceca.2018.02.001; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Dong N, 2018, CHANNELS, V12, P153, DOI 10.1080/19336950.2018.1457897; Dunn TW, 2013, J NEUROPHYSIOL, V110, P2071, DOI 10.1152/jn.00217.2013; Ebisawa M, 1999, CHEM PHARM BULL, V47, P1778; ELMSLIE KS, 1994, J PHYSIOL-LONDON, V481, P35, DOI 10.1113/jphysiol.1994.sp020417; Farboud B, 2004, MOL ENDOCRINOL, V18, P2839, DOI 10.1210/me.2004-0236; Farrar NR, 2009, J NEUROSCI, V29, P14136, DOI 10.1523/JNEUROSCI.2921-09.2009; Han J, 2006, NEURON, V51, P575, DOI 10.1016/j.neuron.2006.07.012; Herlitze S, 2001, P NATL ACAD SCI USA, V98, P4699, DOI 10.1073/pnas.051628998; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Huang X, 2010, J EXP BIOL, V213, P2094, DOI 10.1242/jeb.042242; Hui K, 2008, EUR J NEUROSCI, V27, P631, DOI 10.1111/j.1460-9568.2008.06023.x; Jiang W, 2012, J NEUROCHEM, V121, P932, DOI 10.1111/j.1471-4159.2012.07697.x; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Kumar P, 2007, MOL ENDOCRINOL, V21, P1370, DOI 10.1210/me.2006-0360; Lee HK, 2000, J NEUROSCI, V20, P3115, DOI 10.1523/JNEUROSCI.20-09-03115.2000; Lopez-Andreo MJ, 2005, BIOCHEMISTRY-US, V44, P11353, DOI 10.1021/bi0504862; McCamphill PK, 2008, EUR J NEUROSCI, V27, P2033, DOI 10.1111/j.1460-9568.2008.06180.x; Moraes LA, 2007, BLOOD, V109, P3741, DOI 10.1182/blood-2006-05-022566; Nomoto M, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-8; Piskunov A, 2012, ONCOGENE, V31, P3333, DOI 10.1038/onc.2011.499; Rothwell CM, 2017, J NEUROPHYSIOL, V117, P692, DOI 10.1152/jn.00737.2016; Rothwell CM, 2014, NEUROBIOL LEARN MEM, V114, P127, DOI 10.1016/j.nlm.2014.05.010; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Taiakina V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061765; Takahashi B, 2002, J MED CHEM, V45, P3327, DOI 10.1021/jm0255320; Thapliyal A, 2008, AM J PHYSIOL-CELL PH, V295, pC1417, DOI 10.1152/ajpcell.00341.2008; Tsai EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143852; Vesprini ND, 2015, J NEUROPHYSIOL, V113, P172, DOI 10.1152/jn.00458.2014; Vesprini ND, 2014, J NEUROPHYSIOL, V111, P1318, DOI 10.1152/jn.00434.2013; Wang HL, 2011, J NEUROSCI, V31, P17764, DOI 10.1523/JNEUROSCI.3964-11.2011; Yan TD, 2010, CANCER RES, V70, P2285, DOI 10.1158/0008-5472.CAN-09-2968; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zamponi GW, 2013, BBA-BIOMEMBRANES, V1828, P1629, DOI 10.1016/j.bbamem.2012.10.004	50	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10076	10093		10.1074/jbc.RA118.006444	http://dx.doi.org/10.1074/jbc.RA118.006444			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31048374	hybrid, Green Published			2022-12-28	WOS:000474445600004
J	Bai, YF; Zhang, ZZ; Cheng, LJ; Wang, RX; Chen, XL; Kong, YF; Feng, F; Ahmad, N; Li, L; Liu, XQ				Bai, Yunfeng; Zhang, Zhuangzhuang; Cheng, Lijun; Wang, Ruixin; Chen, Xiaoliang; Kong, Yifan; Feng, Feng; Ahmad, Nihal; Li, Lang; Liu, Xiaoqi			Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; prostate cancer; androgen receptor; chemoresistance; tumor metastasis; castration-resistant prostate cancer; enzalutamide; EZH2	GROUP PROTEIN EZH2; ANDROGEN RECEPTOR; POLYCOMB; METHYLATION; ACTIVATION; CELLS	Enzalutamide, approved by the United States Food and Drug Administration in 2018 for the management of metastatic castration-resistant prostate cancer (CRPC), is an androgen receptor (AR) inhibitor. It blocks androgen binding to the AR, AR nuclear translocation, and AR-mediated DNA binding. Unfortunately, a considerable proportion of tumors eventually develop resistance during the treatment. The molecular mechanisms underlying enzalutamide resistance are not completely understood. Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of polycomb repressor complex 2, has been proposed as a prognostic marker for prostate cancer (PCa). With the goal to test whether EZH2 also plays a critical role in acquisition of enzalutamide resistance in CRPC, here we examined whether EZH2 inhibition/depletion enhances the efficacy of enzalutamide in enzalutamide-resistant PCa cells. We show that combining the EZH2 inhibitor GSK126 with enzalutamide synergistically inhibits cell proliferation and colony formation and promotes apoptosis in enzalutamide-resistant PCa cells. EZH2 depletion also overcomes enzalutamide resistance in both cultured cells and xenograft tumors. Mechanistically, we found that EZH2 directly binds to the promoter of prostate-specific antigen and inhibits its expression in enzalutamide-resistant PCa cells. In agreement, bioinformatics analysis of clinical RNA sequencing data involving GSEA indicated a strong correlation between AR and EZH2 gene expression during PCa progression. Our study provides critical insights into the mechanisms underlying enzalutamide resistance, which may offer new approaches to enhance the efficacy of enzalutamide in CRPC.	[Bai, Yunfeng; Zhang, Zhuangzhuang; Wang, Ruixin; Chen, Xiaoliang; Kong, Yifan; Liu, Xiaoqi] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Liu, Xiaoqi] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Bai, Yunfeng; Chen, Xiaoliang; Feng, Feng] Shanxi Datong Univ, Sch Chem & Environm Engn, Datong 037009, Shanxi, Peoples R China; [Cheng, Lijun; Li, Lang] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Ahmad, Nihal] Univ Wisconsin, Dept Dermatol, Madison, WI 53715 USA	University of Kentucky; University of Kentucky; Shanxi Datong University; University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Madison	Liu, XQ (corresponding author), Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.	Xiaoqi.Liu@uky.edu	Ahmad, Nihal/AAR-4249-2021	Ahmad, Nihal/0000-0002-4239-9887; Zhang, Zhuangzhuang/0000-0003-2578-7375; Feng, Feng/0000-0002-0063-2724				Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Donkena KV, 2010, CURR CANCER DRUG TAR, V10, P402, DOI 10.2174/156800910791208544; Ferraldeschi R, 2015, ONCOGENE, V34, P1745, DOI 10.1038/onc.2014.115; Gonzalez ME, 2014, P NATL ACAD SCI USA, V111, P3098, DOI 10.1073/pnas.1308953111; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Jung HY, 2013, MOL CELL, V52, P193, DOI 10.1016/j.molcel.2013.08.028; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kim J, 2018, CELL REP, V25, P2808, DOI 10.1016/j.celrep.2018.11.035; Kong YF, 2018, J BIOL CHEM, V293, P14328, DOI 10.1074/jbc.RA118.004442; Lee JM, 2012, MOL CELL, V48, P572, DOI 10.1016/j.molcel.2012.09.004; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Liu CF, 2015, CANCER RES, V75, P1413, DOI 10.1158/0008-5472.CAN-14-3080; Liu Q., 2019, INT J CANC; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Rodriguez-Vida A, 2015, DRUG DES DEV THER, V9, P3325, DOI 10.2147/DDDT.S69433; Sanulli S, 2015, MOL CELL, V57, P769, DOI 10.1016/j.molcel.2014.12.020; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vasanthakumar A, 2017, EMBO REP, V18, P619, DOI 10.15252/embr.201643237; Wang HJ, 2019, ONCOGENE, V38, P17, DOI 10.1038/s41388-018-0414-x; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang Z, 2014, CANCER RES, V74, P6635, DOI 10.1158/0008-5472.CAN-14-1916; Zhang ZZ, 2018, CANCER RES, V78, P3147, DOI 10.1158/0008-5472.CAN-17-3006	27	37	39	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9911	9923		10.1074/jbc.RA119.008152	http://dx.doi.org/10.1074/jbc.RA119.008152			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31085587	hybrid, Green Published			2022-12-28	WOS:000473277900022
J	[Anonymous]				[Anonymous]			Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells (Expression of Concern of Vol 283, Pg 27452, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200	1	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					10027	10027		10.1074/jbc.EC119.009611	http://dx.doi.org/10.1074/jbc.EC119.009611			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31227632	Green Published, hybrid			2022-12-28	WOS:000473277900040
J	Yan, Y; Haas, JP; Kim, M; Sgagias, MK; Cowan, KH				Yan, Ying; Haas, John P.; Kim, Min; Sgagias, Magdalene K.; Cowan, Kenneth H.			RETRACTION: BRCA1-induced apoptosis involves inactivation of ERK1/2 activities (Retraction of Vol 277, Pg 33422, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Yan Y, 2002, J BIOL CHEM, V277, P33422, DOI 10.1074/jbc.M201147200	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8309	8309		10.1074/jbc.W119.009053	http://dx.doi.org/10.1074/jbc.W119.009053			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	31101659	Green Published, hybrid			2022-12-28	WOS:000470656500026
J	Heumuller, SE; Talantikite, M; Napoli, M; Armengaud, J; Morgelin, M; Hartmann, U; Sengle, G; Paulsson, M; Moali, C; Wagener, R				Heumueller, Stefanie Elisabeth; Talantikite, Maya; Napoli, Manon; Armengaud, Jean; Moergelin, Matthias; Hartmann, Ursula; Sengle, Gerhard; Paulsson, Mats; Moali, Catherine; Wagener, Raimund			C-terminal proteolysis of the collagen VI alpha 3 chain by BMP-1 and proprotein convertase(s) releases endotrophin in fragments of different sizes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; extracellular matrix protein; electron microscopy (EM); muscular dystrophy; protein processing; BMP-1; microfibrils; proprotein convertase; collagen VI; Kunitz domain; endotrophin; Pro-C6	MORPHOGENETIC PROTEIN-1 PROCESSES; EXTRACELLULAR-MATRIX TURNOVER; PROCOLLAGEN-VII; DOMAIN; CLEAVAGE; MICE; DEFICIENCY; BIOMARKERS; COL6A3; ACTIVATION	The assembly of collagen VI microfibrils is a multistep process in which proteolytic processing within the C-terminal globular region of the collagen VI alpha 3 chain plays a major role. However, the mechanisms involved remain elusive. Moreover, C5, the short and most C-terminal domain of the alpha 3 chain, recently has been proposed to be released as an adipokine that enhances tumor progression, fibrosis, inflammation, and insulin resistance and has been named "endotrophin." Serum endotrophin could be a useful biomarker to monitor the progression of such disorders as chronic obstructive pulmonary disease, systemic sclerosis, and kidney diseases. Here, using biochemical and isotopic MS-based analyses, we found that the extracellular metalloproteinase bone morphogenetic protein 1 (BMP-1) is involved in endotrophin release and determined the exact BMP-1 cleavage site. Moreover, we provide evidence that several endotrophin-containing fragments are present in various tissues and body fluids. Among these, a large C2-C5 fragment, which contained endotrophin, was released by furin-like proprotein convertase cleavage. By using immunofluorescence microscopy and EM, we also demonstrate that these proteolytic maturations occur after secretion of collagen VI tetramers and during microfibril assembly. Differential localization of N- and C-terminal regions of the collagen VI alpha 3 chain revealed that cleavage products are deposited in tissue and cell cultures. The detailed information on the processing of the collagen VI alpha 3 chain reported here provides a basis for unraveling the function of endotrophin (C5) and larger endotrophin-containing fragments and for refining their use as biomarkers of disease progression.	[Heumueller, Stefanie Elisabeth; Hartmann, Ursula; Sengle, Gerhard; Paulsson, Mats; Wagener, Raimund] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Sengle, Gerhard; Paulsson, Mats; Wagener, Raimund] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, D-50931 Cologne, Germany; [Talantikite, Maya; Napoli, Manon; Moali, Catherine] Univ Lyon, CNRS, UMR5305, Tissue Biol & Therapeut Engn Lab, F-69367 Lyon, France; [Armengaud, Jean] Commissariat Energie Atom CEA Marcoule, Innovat Technol Detect & Diagnost Lab, DRF, JOLIOT,DMTS,SPI,Li2D, F-30200 Bagnols Sur Ceze, France; [Moergelin, Matthias] Colzyx AB, SE-22381 Lund, Sweden; [Sengle, Gerhard; Paulsson, Mats; Wagener, Raimund] CCMB, D-50931 Cologne, Germany; [Sengle, Gerhard] Fac Med, Dept Pediat & Adolescent Med, Expt Neonatol, D-50931 Cologne, Germany; [Sengle, Gerhard] Univ Hosp Cologne, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CEA; University of Cologne; University of Cologne	Moali, C (corresponding author), Tissue Biol & Therapeut Engn Lab LBTI, 7 Passage Vercors, F-69367 Lyon 7, France.; Wagener, R (corresponding author), Univ Cologne, Fac Med, Inst Biochem 2, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	catherine.moali@ibcp.fr; raimund.wagener@uni-koeln.de		ARMENGAUD, Jean/0000-0003-1589-445X; MOALI, Catherine/0000-0003-2479-4290	German Research Council [SFB 829-B2, FOR 2722-B1, SFB829/B11, SFB829/B12, FOR 2722-M2]; Region Rhone-Alpes Auvergne; CNRS; University of Lyon	German Research Council(German Research Foundation (DFG)); Region Rhone-Alpes Auvergne(Region Auvergne-Rhone-Alpes); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lyon	This study was supported by German Research Council Grants SFB 829-B2 and FOR 2722-B1 (to R. W. and M. P.) and Grants SFB829/B11 and B12 and FOR 2722-M2 (to G. S.), by the Region Rhone-Alpes Auvergne (to M. T. and C. M.), and by CNRS and the University of Lyon (to C. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aigner T, 2002, BIOCHEM BIOPH RES CO, V290, P743, DOI 10.1006/bbrc.2001.6227; Alexopoulos LG, 2009, ARTHRITIS RHEUM-US, V60, P771, DOI 10.1002/art.24293; BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; Beecher N, 2011, J BIOL CHEM, V286, P40266, DOI 10.1074/jbc.M111.265595; Bekhouche M, 2016, FASEB J, V30, P1741, DOI 10.1096/fj.15-279869; Bihlet AR, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0509-x; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Breibeck J, 2018, BIOPOLYMERS, V109, DOI 10.1002/bip.23069; Builles N, 2006, BIO-MED MATER ENG, V16, pS95; Cescon M, 2018, ACTA NEUROPATHOL, V136, P483, DOI 10.1007/s00401-018-1860-9; Cescon M, 2015, J CELL SCI, V128, P3525, DOI 10.1242/jcs.169748; Chen PW, 2015, J INVEST DERMATOL, V135, P2358, DOI 10.1038/jid.2015.187; Chen PW, 2015, ACTA NEUROPATHOL, V129, P97, DOI 10.1007/s00401-014-1369-9; Chen PW, 2014, FASEB J, V28, P1145, DOI 10.1096/fj.13-239533; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Christensen SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033397; Colombo M, 2003, BIOCHEMISTRY-US, V42, P11434, DOI 10.1021/bi034925d; Dassah M, 2014, J CELL SCI, V127, P828, DOI 10.1242/jcs.137802; Delolme F, 2015, CELL MOL LIFE SCI, V72, P1009, DOI 10.1007/s00018-014-1733-x; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Fenton A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175200; Fitzgerald J, 2001, J BIOL CHEM, V276, P187, DOI 10.1074/jbc.M008173200; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hung CW, 2016, J PROTEOMICS, V138, P136, DOI 10.1016/j.jprot.2016.02.031; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Izu Y, 2012, TISSUE CELL, V44, P1, DOI 10.1016/j.tice.2011.08.002; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Juhl P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207324; Karsdal MA, 2017, DIABETOLOGIA, V60, P50, DOI 10.1007/s00125-016-4094-1; Kim B, 2011, J BIOL CHEM, V286, P29014, DOI 10.1074/jbc.M111.252585; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Lee C, 2019, J PATHOL, V247, P99, DOI 10.1002/path.5172; Lettmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105686; Luther DJ, 2012, CIRC RES, V110, P851, DOI 10.1161/CIRCRESAHA.111.252734; Maass T, 2016, J BIOL CHEM, V291, P5247, DOI 10.1074/jbc.M115.705160; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; MAYER U, 1994, EUR J BIOCHEM, V225, P573, DOI 10.1111/j.1432-1033.1994.00573.x; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Nielsen SH, 2018, EUR J PREV CARDIOL, V25, P719, DOI 10.1177/2047487318758750; Pan TC, 2014, J BIOL CHEM, V289, P10293, DOI 10.1074/jbc.M114.549311; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Park J, 2013, EMBO MOL MED, V5, P935, DOI 10.1002/emmm.201202006; Park J, 2012, J CLIN INVEST, V122, P4243, DOI 10.1172/JCI63930; Rasmussen DGK, 2018, DIABETES CARE, V41, P1493, DOI 10.2337/dc17-2392; Rasmussen DGK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17470-3; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; ROTH J, 1980, J HISTOCHEM CYTOCHEM, V28, P55, DOI 10.1177/28.1.6153194; Sand JMB, 2016, CLIN BIOCHEM, V49, P1144, DOI 10.1016/j.clinbiochem.2016.09.003; Sand JMB, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0225-3; Schacke H, 1998, J BIOL CHEM, V273, P25937, DOI 10.1074/jbc.273.40.25937; Schlapschy M, 2013, PROTEIN ENG DES SEL, V26, P489, DOI 10.1093/protein/gzt023; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Snellman A, 2000, EMBO J, V19, P5051, DOI 10.1093/emboj/19.19.5051; Stolz D, 2017, CHEST, V151, P47, DOI 10.1016/j.chest.2016.08.1440; Stribos EGD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175898; Sun K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4485; Sun S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144525; Szlama G, 2016, FEBS J, V283, P4515, DOI 10.1111/febs.13938; Talantikite M, 2018, FEBS OPEN BIO, V8, P2011, DOI 10.1002/2211-5463.12540; Vadon-Le Goff S, 2015, MATRIX BIOL, V44-46, P14, DOI 10.1016/j.matbio.2015.02.006; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; Wagener R, 2009, MATRIX BIOL, V28, P307, DOI 10.1016/j.matbio.2009.05.003	71	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13769	13780		10.1074/jbc.RA119.008641	http://dx.doi.org/10.1074/jbc.RA119.008641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31346034	Green Published, hybrid			2022-12-28	WOS:000486418600021
J	Matsuda-Lennikov, M; Biancalana, M; Zou, J; Ravell, JC; Zheng, LX; Kanellopoulou, C; Jiang, P; Notarangelo, G; Jing, HE; Masutani, E; Oler, AJ; Olano, LR; Schulz, BL; Lenardo, MJ				Matsuda-Lennikov, Mami; Biancalana, Matthew; Zou, Juan; Ravell, Juan C.; Zheng, Lixin; Kanellopoulou, Chrysi; Jiang, Ping; Notarangelo, Giulia; Jing, Huie; Masutani, Evan; Oler, Andrew J.; Olano, Lisa Renee; Schulz, Benjamin L.; Lenardo, Michael J.			Magnesium transporter 1 (MAGT1) deficiency causes selective defects in N-linked glycosylation and expression of immune-response genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transporter; glycoprotein; glycosylation; immunodeficiency; infection; magnesium; immunology; Epstein-Barr virus (EBV) infection; magnesium transporter 1 (MAGT1); N-linked glycosylation (NLG) complex; oligosaccharyltransferase (OST); X-linked magnesium deficiency with Epstein-Barr virus infection and neoplasia (XMEN)	CD8 T-CELLS; OXIDOREDUCTASE ACTIVITY; IN-SITU; IMMUNODEFICIENCY; IDENTIFICATION; PROTEINS; TUSC3; ENRICHMENT; COMPLEXES; INFECTION	Magnesium transporter 1 (MAGT1) critically mediates magnesium homeostasis in eukaryotes and is highly-conserved across different evolutionary branches. In humans, loss-of-function mutations in the MAGT1 gene cause X-linked magnesium deficiency with Epstein-Barr virus (EBV) infection and neoplasia (XMEN), a disease that has a broad range of clinical and immunological consequences. We have previously shown that EBV susceptibility in XMEN is associated with defective expression of the antiviral natural-killer group 2 member D (NKG2D) protein and abnormal Mg2+ transport. New evidence suggests that MAGT1 is the human homolog of the yeast OST3/OST6 proteins that form an integral part of the N-linked glycosylation complex, although the exact contributions of these perturbations in the glycosylation pathway to disease pathogenesis are still unknown. Using MS-based glycoproteomics, along with CRISPR/Cas9-KO cell lines, natural killer cell-killing assays, and RNA-Seq experiments, we now demonstrate that humans lacking functional MAGT1 have a selective deficiency in both immune and nonimmune glycoproteins, and we identified several critical glycosylation defects in important immune-response proteins and in the expression of genes involved in immunity, particularly CD28. We show that MAGT1 function is partly interchangeable with that of the paralog protein tumor-suppressor candidate 3 (TUSC3) but that each protein has a different tissue distribution in humans. We observed that MAGT1-dependent glycosylation is sensitive to Mg2+ levels and that reduced Mg2+ impairs immune-cell function via the loss of specific glycoproteins. Our findings reveal that defects in protein glycosylation and gene expression underlie immune defects in an inherited disease due to MAGT1 deficiency.	[Matsuda-Lennikov, Mami; Biancalana, Matthew; Zou, Juan; Ravell, Juan C.; Zheng, Lixin; Kanellopoulou, Chrysi; Jiang, Ping; Notarangelo, Giulia; Masutani, Evan; Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Matsuda-Lennikov, Mami; Biancalana, Matthew; Zou, Juan; Ravell, Juan C.; Zheng, Lixin; Kanellopoulou, Chrysi; Jiang, Ping; Notarangelo, Giulia; Jing, Huie; Masutani, Evan; Lenardo, Michael J.] NIAID, Clin Genom Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Jing, Huie] NIAID, Human Immunol Dis Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Oler, Andrew J.] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Olano, Lisa Renee] NIMH, Lab Neurotoxicol, Bethesda, MD 20892 USA; [Schulz, Benjamin L.] Univ Queensland, Sch Chem & Mol Biol, St Lucia, Qld 4072, Australia; [Matsuda-Lennikov, Mami] Weizmann Inst Sci, IL-7610001 Rehovot, Israel; [Biancalana, Matthew] NYU, Langone Med Ctr, New York, NY 10016 USA; [Notarangelo, Giulia] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Masutani, Evan] Univ Calif San Diego, Sch Med, Med Scientist Training Program, San Diego, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Queensland; Weizmann Institute of Science; New York University; NYU Langone Medical Center; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Lenardo, MJ (corresponding author), NIAID, Mol Dev Immune Syst Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Lenardo, MJ (corresponding author), NIAID, Clin Genom Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mlenardo@niaid.nih.gov	Jing, Hui/GXM-4109-2022	Jing, Hui/0000-0002-8389-8252; Ravell, Juan/0000-0001-6687-2555; Biancalana, Matthew/0000-0002-1078-1838; notarangelo, giulia/0000-0003-3805-1834	Uehara Memorial Foundation [201330032]; Japan Society for the Promotion of Science (JSPS); NIH [71403]; NIH Office of Disease Prevention; Division of Intramural Research, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001187, ZICAI001051] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Disease Prevention; Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the Uehara Research Fellowship (201330032) from Uehara Memorial Foundation, the Japan Society for the Promotion of Science (JSPS) and NIH grant (71403), and by co-funding through the NIH Office of Disease Prevention, and by the Division of Intramural Research, NIAID, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abolhassani H, 2017, J EXP MED, V214, P91, DOI 10.1084/jem.20160849; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Caragata M, 2016, ANAL BIOCHEM, V497, P76, DOI 10.1016/j.ab.2015.11.024; Chaigne-Delalande B, 2013, SCIENCE, V341, P186, DOI 10.1126/science.1240094; Chen J, 2010, MECH AGEING DEV, V131, P29, DOI 10.1016/j.mad.2009.11.003; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Choi YI, 2008, IMMUNITY, V29, P888, DOI 10.1016/j.immuni.2008.10.008; Fokkink WJR, 2014, J PROTEOME RES, V13, P1722, DOI 10.1021/pr401213z; Garrity D, 2005, P NATL ACAD SCI USA, V102, P7641, DOI 10.1073/pnas.0502439102; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Garshasbi M, 2011, AM J MED GENET A, V155A, P1976, DOI 10.1002/ajmg.a.34077; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; GRUBBS RD, 1987, MAGNESIUM, V6, P113; Holl EK, 2011, J IMMUNOL, V186, P5603, DOI 10.4049/jimmunol.1003464; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; Huntoon KM, 2008, J LEUKOCYTE BIOL, V84, P170, DOI 10.1189/jlb.0208100; Hwang H, 2010, MASS SPECTROM REV, V29, P79, DOI 10.1002/mas.20221; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Li FY, 2014, BLOOD, V123, P2148, DOI 10.1182/blood-2013-11-538686; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacGrogan D, 1996, GENOMICS, V35, P55, DOI 10.1006/geno.1996.0322; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Pietrzak A, 2016, INT J DERMATOL, V55, pE241, DOI 10.1111/ijd.13152; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Ravell J, 2014, CURR OPIN PEDIATR, V26, P713, DOI 10.1097/MOP.0000000000000156; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin K, 2000, J NUTR BIOCHEM, V11, P94, DOI 10.1016/S0955-2863(99)00082-0; Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; TAO JG, 1992, J BIOL CHEM, V267, P24972; TAYLOR AK, 1988, MOL CELL BIOL, V8, P4197, DOI 10.1128/MCB.8.10.4197; Trifilieff P, 2011, BIOTECHNIQUES, V51, P111, DOI 10.2144/000113719; Urbaniak A, 2018, AM J CANCER RES, V8, P2150; Wild R, 2018, SCIENCE, V359, P545, DOI 10.1126/science.aar5140; Yang S, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9166-9; Yang WM, 2014, THERANOSTICS, V4, P1153, DOI 10.7150/thno.9510; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	53	41	41	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13638	13656		10.1074/jbc.RA119.008903	http://dx.doi.org/10.1074/jbc.RA119.008903			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31337704	hybrid, Green Published			2022-12-28	WOS:000486418600011
J	Vo, TM; Jain, S; Burchett, R; Monckton, EA; Godbout, R				The Minh Vo; Jain, Saket; Burchett, Rebecca; Monckton, Elizabeth A.; Godbout, Roseline			A positive feedback loop involving nuclear factor IB and calpain 1 suppresses glioblastoma cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; transcription factor; calpain; cancer biology; protein phosphorylation; gene regulation; cysteine protease; cell migration; immunofluorescence; nuclear factor I	MALIGNANT-GLIOMA-CELL; ACID-BINDING PROTEIN; CALPASTATIN LOCALIZATION; BREAST-CANCER; B-FABP; INVASION; BRAIN; CALCINEURIN; EXPRESSION; SYSTEM	Glioblastoma (GBM) is a brain tumor that remains largely incurable because of its highly-infiltrative properties. Nuclear factor I (NFI)-type transcription factors regulate genes associated with GBM cell migration and infiltration. We have previously shown that NFI activity depends on the NFI phosphorylation state and that calcineurin phosphatase dephosphorylates and activates NFI. Calcineurin is cleaved and activated by calpain proteases whose activity is, in turn, regulated by an endogenous inhibitor, calpastatin (CAST). The CAST gene is a target of NFI in GBM cells, with differentially phosphorylated NFIs regulating the levels of CAST transcript variants. Here, we uncovered an NFIB-calpain 1-positive feedback loop mediated through CAST and calcineurin. In NFI-hyperphosphorylated GBM cells, NFIB expression decreased the CAST-to-calpain 1 ratio in the cytoplasm. This reduced ratio increased autolysis and activity of cytoplasmic calpain 1. Conversely, in NFI-hypophosphorylated cells, NFIB expression induced differential subcellular compartmentalization of CAST and calpain 1, with CAST localizing primarily to the cytoplasm and calpain 1 to the nucleus. Overall, this altered compartmentalization increased nuclear calpain 1 activity. We also show that nuclear calpain 1, by cleaving and activating calcineurin, induces NFIB dephosphorylation. Of note, knockdown of calpain 1, NFIB, or both increased GBM cell migration and up-regulated the pro-migratory factors fatty acid-binding protein 7 (FABP7) and Ras homolog family member A (RHOA). In summary, our findings reveal bidirectional cross-talk between NFIB and calpain 1 in GBM cells. A physiological consequence of this positive feedback loop appears to be decreased GBM cell migration.	[The Minh Vo; Jain, Saket; Burchett, Rebecca; Monckton, Elizabeth A.; Godbout, Roseline] Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada	University of Alberta	Godbout, R (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	rgodbout@ualberta.ca	Jain, Saket/ABD-4746-2020; Godbout, Roseline/I-4639-2016	Jain, Saket/0000-0002-8655-2951; Burchett, Rebecca/0000-0002-0328-2336; Godbout, Roseline/0000-0002-4779-9265	Canadian Institutes of Health Research [130314]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant 130314. The authors declare that they have no conflicts of interest with the contents of this article.	Averna M, 2003, CELL MOL LIFE SCI, V60, P2669, DOI 10.1007/s00018-003-3288-0; Averna M, 2001, BIOCHEM J, V354, P25, DOI 10.1042/0264-6021:3540025; Baudry M, 2016, TRENDS NEUROSCI, V39, P235, DOI 10.1016/j.tins.2016.01.007; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Breznik B, 2017, ONCOTARGET, V8, P25482, DOI 10.18632/oncotarget.16041; Brun M, 2018, NEOPLASIA, V20, P1023, DOI 10.1016/j.neo.2018.08.007; Brun M, 2013, J BIOL CHEM, V288, P24104, DOI 10.1074/jbc.M113.455832; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Croce K, 1999, J BIOL CHEM, V274, P36321, DOI 10.1074/jbc.274.51.36321; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Ding FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155504; Donkor IO, 2011, EXPERT OPIN THER PAT, V21, P601, DOI 10.1517/13543776.2011.568480; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Fane ME, 2017, EBIOMEDICINE, V16, P63, DOI 10.1016/j.ebiom.2017.01.013; FigueiredoPereira ME, 1996, J BIOL CHEM, V271, P16455, DOI 10.1074/jbc.271.28.16455; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ge LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042661; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Heng YHE, 2012, NEUROSIGNALS, V20, P159, DOI 10.1159/000330651; Kallenberg K, 2013, J NEURO-ONCOL, V112, P217, DOI 10.1007/s11060-013-1049-y; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Kulkarni S, 2002, J BIOL CHEM, V277, P24435, DOI 10.1074/jbc.M203457200; Lal S, 2012, J NEUROSCI RES, V90, P769, DOI 10.1002/jnr.22794; Leloup L, 2011, EXPERT OPIN THER TAR, V15, P309, DOI 10.1517/14728222.2011.553611; Li HQ, 2004, BBA-MOL CELL RES, V1691, P91, DOI 10.1016/j.bbamcr.2003.12.006; Liang Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-97; Liu R, 2009, NEURO-ONCOLOGY, V11, P330, DOI 10.1215/15228517-2008-093; Liu RZ, 2019, J PATHOL, V247, P186, DOI 10.1002/path.5182; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; Mason W P, 2007, Curr Oncol, V14, P110, DOI 10.3747/co.2007.119; Melloni E, 1996, BIOCHEM BIOPH RES CO, V229, P193, DOI 10.1006/bbrc.1996.1779; Mirabello L, 2015, CANCER DISCOV, V5, P920, DOI 10.1158/2159-8290.CD-15-0125; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; NISHIMURA T, 1991, J BIOL CHEM, V266, P11842; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Ogura K, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-97; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/nov189, 10.1093/neuonc/noaa200, 10.1093/neuonc/noab200]; Pu X, 2016, HISTOPATHOLOGY, V68, P1021, DOI 10.1111/his.12896; Riss T.L., 2004, ASSAY GUIDANCE MANUA, P289; ROTHIG HJ, 1985, DRUG EXP CLIN RES, V11, P123; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Shankar A, 2014, CHIN J CANCER, V33, P148, DOI 10.5732/cjc.013.10095; Sheetz Michael P., 1999, P233; Staib P, 1998, ANN ONCOL, V9, P221, DOI 10.1023/A:1008235801218; Stifanese R, 2010, J BIOL CHEM, V285, P631, DOI 10.1074/jbc.M109.031674; Storr SJ, 2016, ONCOTARGET, V7, P47927, DOI 10.18632/oncotarget.10066; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Stringer BW, 2016, ONCOTARGET, V7, P29306, DOI 10.18632/oncotarget.8720; Talamillo A, 2017, ONCOGENE, V36, P1733, DOI 10.1038/onc.2016.341; Vo TM, 2019, J BIOL CHEM, V294, P1173, DOI 10.1074/jbc.RA118.004787; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; YANG BS, 1993, MOL CELL BIOL, V13, P3093, DOI 10.1128/MCB.13.5.3093; Yoshioka K, 1999, CANCER RES, V59, P2004; Zhou MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100620	67	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12638	12654		10.1074/jbc.RA119.008291	http://dx.doi.org/10.1074/jbc.RA119.008291			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31262726	hybrid, Green Published			2022-12-28	WOS:000484414600008
J	Vu, V; Hangasky, JA; Detomasi, TC; Henry, SJW; Ngo, ST; Span, EA; Marletta, MA				Vu, Van V.; Hangasky, John A.; Detomasi, Tyler C.; Henry, Skylar J. W.; Son Tung Ngo; Span, Elise A.; Marletta, Michael A.			Substrate selectivity in starch polysaccharide monooxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; polysaccharide; metalloprotein; copper; copper monooxygenase; amylose; auxiliary activity (AA) enzyme; oxygenase; polysaccharide monooxygenase; starch	CARBOHYDRATE-BINDING MODULES; HELICAL MOLECULAR-STRUCTURE; OXIDATIVE CLEAVAGE; AUTOMATED DOCKING; PACKING ANALYSIS; CELLULOSE; CELLOBIOHYDROLASE; DEGRADATION; DISCOVERY; ENZYMES	Degradation of polysaccharides is central to numerous biological and industrial processes. Starch-active polysaccharide monooxygenases (AA13 PMOs) oxidatively degrade starch and can potentially be used with industrial amylases to convert starch into a fermentable carbohydrate. The oxidative activities of the starch-active PMOs from the fungi Neurospora crassa and Myceliophthora thermophila, NcAA13 and MtAA13, respectively, on three different starch substrates are reported here. Using high-performance anion-exchange chromatography coupled with pulsed amperometry detection, we observed that both enzymes have significantly higher oxidative activity on amylose than on amylopectin and cornstarch. Analysis of the product distribution revealed that NcAA13 and MtAA13 more frequently oxidize glycosidic linkages separated by multiples of a helical turn consisting of six glucose units on the same amylose helix. Docking studies identified important residues that are involved in amylose binding and suggest that the shallow groove that spans the active-site surface of AA13 PMOs favors the binding of helical amylose substrates over nonhelical substrates. Truncations of NcAA13 that removed its native carbohydrate-binding module resulted in diminished binding to amylose, but truncated NcAA13 still favored amylose oxidation over other starch substrates. These findings establish that AA13 PMOs preferentially bind and oxidize the helical starch substrate amylose. Moreover, the product distributions of these two enzymes suggest a unique interaction with starch substrates.	[Vu, Van V.] Nguyen Tat Thanh Univ, Nguyen Tat Thanh Hitech Inst, Ho Chi Minh City 70000, Vietnam; [Hangasky, John A.; Marletta, Michael A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Detomasi, Tyler C.; Marletta, Michael A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Henry, Skylar J. W.; Marletta, Michael A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Span, Elise A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Son Tung Ngo] Ton Duc Thang Univ, Lab Theoret & Computat Biophys, Ho Chi Minh City 758307, Vietnam; [Son Tung Ngo] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City 758307, Vietnam	Nguyen Tat Thanh University (NTTU); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Ton Duc Thang University; Ton Duc Thang University	Vu, V (corresponding author), Nguyen Tat Thanh Univ, Nguyen Tat Thanh Hitech Inst, Ho Chi Minh City 70000, Vietnam.; Marletta, MA (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Marletta, MA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Marletta, MA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	vanvu@ntt.edu.vn; marletta@berkeley.edu	Ngo, Son Tung/F-8964-2013; Vu, Van/B-2098-2010	Ngo, Son Tung/0000-0003-1034-1768; Vu, Van/0000-0003-0009-6703; Hangasky, John/0000-0002-8386-3922; Detomasi, Tyler/0000-0003-4390-108X	National Science Foundation [1565770]; Vietnam National Foundation for Science and Technology Development Grant [106-NN.02-2016.33]	National Science Foundation(National Science Foundation (NSF)); Vietnam National Foundation for Science and Technology Development Grant	This research was funded by National Science Foundation Grant 1565770 and Vietnam National Foundation for Science and Technology Development Grant 106-NN.02-2016.33. The authors declare that they have no conflicts of interest with the contents of this article.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Badarau A, 2011, J AM CHEM SOC, V133, P2983, DOI 10.1021/ja1091547; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; BERRY CS, 1986, J CEREAL SCI, V4, P301, DOI 10.1016/S0733-5210(86)80034-0; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Buleon A, 1997, MACROMOLECULES, V30, P3952, DOI 10.1021/ma970136q; Caffalette CA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08646-8; Courtade G, 2018, J BIOL CHEM, V293, P13006, DOI 10.1074/jbc.RA118.004269; Couturier M, 2018, NAT CHEM BIOL, V14, P306, DOI [10.1038/NCHEMBIO.2558, 10.1038/nchembio.2558]; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DeLano W. L., 2012, THE PYMOL MOLECULAR; Eibinger M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01028-y; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Filiatrault-Chastel C, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1394-y; Forsberg Z, 2016, J BIOL CHEM, V291, P7300, DOI 10.1074/jbc.M115.700161; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Frommhagen M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0284-1; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hamre AG, 2014, FEBS LETT, V588, P4620, DOI 10.1016/j.febslet.2014.10.034; Hangasky JA, 2019, TRENDS CHEM, V1, P198, DOI 10.1016/j.trechm.2019.01.007; Hangasky JA, 2018, P NATL ACAD SCI USA, V115, P4915, DOI 10.1073/pnas.1801153115; Hemsworth GR, 2015, TRENDS BIOTECHNOL, V33, P747, DOI 10.1016/j.tibtech.2015.09.006; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Hu JG, 2014, ENERG ENVIRON SCI, V7, P2308, DOI 10.1039/c4ee00891j; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kruer-Zerhusen N, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0925-7; Liu B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189479; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Loose JSM, 2018, BIOCHEMISTRY-US, V57, P4114, DOI 10.1021/acs.biochem.8b00484; Moller MS, 2016, CELL MOL LIFE SCI, V73, P2619, DOI 10.1007/s00018-016-2241-y; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mutahir Z, 2018, FEBS LETT, V592, P2562, DOI 10.1002/1873-3468.13189; Nekiunaite L, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0604-0; Nekiunaite L, 2016, FEBS LETT, V590, P2737, DOI 10.1002/1873-3468.12293; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Sarkar A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-302; SARKO A, 1978, STARKE, V30, P73, DOI 10.1002/star.19780300302; SHANNO DF, 1970, MATH COMPUT, V24, P647, DOI 10.2307/2004840; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Tandrup T, 2018, BIOCHEM SOC T, V46, P1431, DOI 10.1042/BST20170549; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vamadevan V, 2015, STARCH-STARKE, V67, P55, DOI 10.1002/star.201400188; Varrot A, 2003, STRUCTURE, V11, P855, DOI 10.1016/S0969-2126(03)00124-2; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Vu VV, 2016, CELL MOL LIFE SCI, V73, P2809, DOI 10.1007/s00018-016-2251-9; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Wang SJ, 2015, COMPR REV FOOD SCI F, V14, P568, DOI 10.1111/1541-4337.12143; WU HCH, 1978, CARBOHYD RES, V61, P7; WU HCH, 1978, CARBOHYD RES, V61, P27; Xu GB, 2018, BIORESOURCE TECHNOL, V265, P558, DOI 10.1016/j.biortech.2018.05.086	68	17	17	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12157	12166		10.1074/jbc.RA119.009509	http://dx.doi.org/10.1074/jbc.RA119.009509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31235519	Green Published, hybrid			2022-12-28	WOS:000484284500019
J	Islam, MS; McDonough, MA; Chowdhury, R; Gault, J; Khan, A; Pires, E; Schofield, CJ				Islam, Md Saiful; McDonough, Michael A.; Chowdhury, Rasheduzzaman; Gault, Joseph; Khan, Amjad; Pires, Elisabete; Schofield, Christopher J.			Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA splicing; dioxygenase; X-ray crystallography; hypoxia; hydroxylysine (Hyl); hydroxylase; enzyme structure; enzyme catalysis; metalloenzyme; substrate specificity; 2-oxoglutarate and iron dependent dioxygenase; C-5 hydroxylysine; JmjC domain-containing protein 6; JMJD6	CONTAINING PROTEIN 6; PHOSPHATIDYLSERINE RECEPTOR; CRYSTAL-STRUCTURE; DOMAIN; HYDROXYLATION; INSIGHTS; BINDING; LYSINE; DEMETHYLATION; METHYLATION	JmjC domain-containing protein 6 (JMJD6) is a 2-oxoglutarate (2OG)-dependent oxygenase linked to various cellular processes, including splicing regulation, histone modification, transcriptional pause release, hypoxia sensing, and cancer. JMJD6 is reported to catalyze hydroxylation of lysine residue(s) of histones, the tumor-suppressor protein p53, and splicing regulatory proteins, including u2 small nuclear ribonucleoprotein auxiliary factor 65-kDa subunit (U2AF65). JMJD6 is also reported to catalyze N-demethylation of N-methylated (both mono- and di-methylated) arginine residues of histones and other proteins, including HSP70 (heat-shock protein 70), estrogen receptor alpha, and RNA helicase A. Here, we report MS- and NMR-based kinetic assays employing purified JMJD6 and multiple substrate fragment sequences, the results of which support the assignment of purified JMJD6 as a lysyl hydroxylase. By contrast, we did not observe N-methyl arginyl N-demethylation with purified JMJD6. Biophysical analyses, including crystallographic analyses of JMJD6(Delta 344-403) in complex with iron and 2OG, supported its assignment as a lysyl hydroxylase rather than an N-methyl arginyl-demethylase. The screening results supported some, but not all, of the assigned JMJD6 substrates and identified other potential JMJD6 substrates. We envision these results will be useful in cellular and biological work on the substrates and functions of JMJD6 and in the development of selective inhibitors of human 2OG oxygenases.	[Islam, Md Saiful; McDonough, Michael A.; Chowdhury, Rasheduzzaman; Gault, Joseph; Khan, Amjad; Pires, Elisabete; Schofield, Christopher J.] Univ Oxford, Dept Chem, 12 Mansfield Rd, Oxford OX1 3TA, England	University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, 12 Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk	; McDonough, Michael/G-2744-2013	Islam, Md. Saiful/0000-0001-9842-0676; Pires, Elisabete/0000-0001-8646-062X; Schofield, Christopher/0000-0002-0290-6565; McDonough, Michael/0000-0003-4664-6942	Wellcome Trust; Cancer Research UK; Biotechnological and Biological Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Biotechnological and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Wellcome Trust, Cancer Research UK, and Biotechnological and Biological Research Council.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aguilar JA, 2012, CHEM COMMUN, V48, P811, DOI 10.1039/c1cc16699a; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Alahari S, 2018, J CLIN ENDOCR METAB, V103, P1545, DOI 10.1210/jc.2017-02197; Alahari S, 2015, ENDOCRINOLOGY, V156, P3012, DOI 10.1210/en.2015-1262; Bottger A, 2015, BIOCHEM J, V468, P191, DOI 10.1042/BJ20150278; Bollinger JM, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P95; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chowdhury R, 2014, NATURE, V510, P422, DOI 10.1038/nature13263; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; Del Rizzo PA, 2012, MOL CELL BIOL, V32, P4044, DOI 10.1128/MCB.00513-12; Dessau MA, 2011, JOVE-J VIS EXP, DOI 10.3791/2285; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gao WW, 2015, P NATL ACAD SCI USA, V112, pE3327, DOI 10.1073/pnas.1509658112; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hahn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013769; Hamed RB, 2013, NAT PROD REP, V30, P21, DOI 10.1039/c2np20065a; Han G, 2012, J CELL BIOCHEM, V113, P1663, DOI 10.1002/jcb.24035; Hausinger RP, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P1; Heim A, 2014, NUCLEIC ACIDS RES, V42, P7833, DOI 10.1093/nar/gku488; Hewitson KS, 2008, J BIOL CHEM, V283, P25971, DOI 10.1074/jbc.M804999200; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Hopkinson RJ, 2013, ANGEW CHEM INT EDIT, V52, P7709, DOI 10.1002/anie.201303282; Horita S, 2015, STRUCTURE, V23, P639, DOI 10.1016/j.str.2015.01.014; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Islam MS, 2018, ANNU REV BIOCHEM, V87, P585, DOI 10.1146/annurev-biochem-061516-044724; Lawrence P, 2014, VIROLOGY, V452, P1, DOI 10.1016/j.virol.2013.12.040; Leung IKH, 2013, J MED CHEM, V56, P547, DOI 10.1021/jm301583m; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Mantri M, 2012, FEBS J, V279, P1563, DOI 10.1111/j.1742-4658.2012.08496.x; Mantri M, 2011, CHEMBIOCHEM, V12, P531, DOI 10.1002/cbic.201000641; Mantri M, 2010, J MOL BIOL, V401, P211, DOI 10.1016/j.jmb.2010.05.054; Markolovic S, 2018, NAT CHEM BIOL, V14, P688, DOI 10.1038/s41589-018-0071-y; Markolovic S, 2016, CURR OPIN STRUC BIOL, V41, P62, DOI 10.1016/j.sbi.2016.05.013; Markolovic S, 2015, J BIOL CHEM, V290, P20712, DOI 10.1074/jbc.R115.662627; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Morton CJ, 1996, STRUCTURE, V4, P705, DOI 10.1016/S0969-2126(96)00076-7; Noma A, 2010, J BIOL CHEM, V285, P34503, DOI 10.1074/jbc.M110.156398; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Tarhonskaya H, 2017, J MOL BIOL, V429, P2895, DOI 10.1016/j.jmb.2017.08.007; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; Tibrewal N, 2007, MOL CELL BIOCHEM, V304, P119, DOI 10.1007/s11010-007-9492-8; Tsai WC, 2017, J BIOL CHEM, V292, P18886, DOI 10.1074/jbc.M117.800706; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Walport LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11974; Wang F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001819; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilkins SE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03410-w; Wilkins SE, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P169; WITKOP B, 1956, EXPERIENTIA, V12, P372, DOI 10.1007/BF02157272; Wolf A, 2013, BIOCHEM J, V453, P357, DOI 10.1042/BJ20130529; Yu L, 2010, CELL RES, V20, P166, DOI 10.1038/cr.2010.8	67	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11637	11652		10.1074/jbc.RA119.008693	http://dx.doi.org/10.1074/jbc.RA119.008693			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31147442	Green Published, hybrid			2022-12-28	WOS:000478717600024
J	Haymond, A; Dey, D; Carter, R; Dailing, A; Nara, V; Nara, P; Venkatayogi, S; Paige, M; Liotta, L; Luchini, A				Haymond, Amanda; Dey, Douglass; Carter, Rachel; Dailing, Angela; Nara, Vaishnavi; Nara, Pranavi; Venkatayogi, Sravani; Paige, Mikell; Liotta, Lance; Luchini, Alessandra			Protein painting, an optimized MS-based technique, reveals functionally relevant interfaces of the PD-1/PD-L1 complex and the YAP2/ZO-1 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); cell signaling; protein-protein interaction; Yes-associated protein (YAP); structural biology; immune checkpoint inhibitor; PD-L1; programmed cell death protein 1 (PD-1); protein painting; ZO-1	SECONDARY STRUCTURE ANALYSES; CONGO RED; NUCLEAR-LOCALIZATION; PDZ DOMAIN; YAP; TARGETS; ORGANIZATION; MECHANISMS; STABILITY; MOLECULES	Protein-protein interactions lie at the heart of many biological processes and therefore represent promising drug targets. Despite this opportunity, identification of protein-protein interfaces remains challenging. We have previously developed a method that relies on coating protein surfaces with small-molecule dyes to discriminate between solvent-accessible protein surfaces and hidden interface regions. Dye-bound, solvent-accessible protein regions resist trypsin digestion, whereas hidden interface regions are revealed by denaturation and sequenced by MS. The small-molecule dyes bind promiscuously and with high affinity, but their binding mechanism is unknown. Here, we report on the optimization of a novel dye probe used in protein painting, Fast Blue B + naphthionic acid, and show that its affinity for proteins strongly depends on hydrophobic moieties that we call here hydrophobic clamps. We demonstrate the utility of this probe by sequencing the protein-protein interaction regions between the Hippo pathway protein Yes-associated protein 2 (YAP2) and tight junction protein 1 (TJP1 or ZO-1), uncovering interactions via the known binding domain as well as ZO-1's MAGUK domain and YAP's N-terminal proline-rich domain. Additionally, we demonstrate how residues predicted by protein painting are present exclusively in the complex interface and how these residues may guide the development of peptide inhibitors using a case study of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand 1 (PD-L1). Inhibitors designed around the PD-1/PD-L1 interface regions identified via protein painting effectively disrupted complex formation, with the most potent inhibitor having an IC50 of 5 mu m.	[Haymond, Amanda; Dey, Douglass; Carter, Rachel; Dailing, Angela; Venkatayogi, Sravani; Liotta, Lance; Luchini, Alessandra] George Mason Univ, Ctr Appl Proteom & Mol Med, Manassas, VA 20110 USA; [Paige, Mikell] George Mason Univ, Dept Chem & Biochem, Manassas, VA 20110 USA; [Nara, Vaishnavi] Thomas Jefferson High Sch Sci & Technol, Alexandria, VA 22312 USA; [Nara, Pranavi] Univ Pittsburgh, Pittsburgh, PA 15260 USA	George Mason University; George Mason University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Haymond, A (corresponding author), George Mason Univ, Ctr Appl Proteom & Mol Med, Manassas, VA 20110 USA.	ahaymond@gmu.edu	Luchini, Alessandra/M-5340-2014	Luchini, Alessandra/0000-0003-1599-0214; Paige, Mikell/0000-0001-9292-1277; Venkatayogi, Sravani/0000-0001-8976-6827	National Institutes of Health [P41-GM103311]; NATIONAL CANCER INSTITUTE [R33CA206937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We most gratefully acknowledge Dr. Paul Russo and Dr. Weidong Zhou for MS expertise. We also thank Dr. Barney Bishop for assistance with the CD experiments. Protein structure images were generated with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California (San Francisco, CA) with support from National Institutes of Health Grant P41-GM103311.	Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Bruzzoni-Giovanelli H, 2018, DRUG DISCOV TODAY, V23, P272, DOI 10.1016/j.drudis.2017.10.016; Celej MS, 2003, PROTEIN SCI, V12, P1496, DOI 10.1110/ps.0240003; Dailing A, 2015, EXPERT REV PROTEOMIC, V12, P457, DOI 10.1586/14789450.2015.1079487; EDELHOCH H, 1960, J BIOL CHEM, V235, P1326; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Francis DM, 2017, ADV DRUG DELIVER REV, V114, P33, DOI 10.1016/j.addr.2017.04.011; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Gunther S, 2017, IMMUNITY, V47, P510, DOI 10.1016/j.immuni.2017.08.004; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Holden JK, 2018, CANCERS, V10, DOI 10.3390/cancers10030081; Horita S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35297; Iglesias-Bexiga M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113828; Kamath Amrita V, 2016, Drug Discov Today Technol, V21-22, P75, DOI 10.1016/j.ddtec.2016.09.004; Khurana R, 2001, J BIOL CHEM, V276, P22715, DOI 10.1074/jbc.M011499200; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; Kobe B, 2008, BIOCHEM SOC T, V36, P1438, DOI 10.1042/BST0361438; Kurochkina Natalya, 2013, Biophys Rev, V5, P29, DOI 10.1007/s12551-012-0081-z; Lee MJ, 2014, J INVEST DERMATOL, V134, P518, DOI 10.1038/jid.2013.339; Li K, 2019, J DRUG TARGET, V27, P244, DOI 10.1080/1061186X.2018.1440400; Luchini A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5413; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Mehta SM, 1998, ANAL BIOCHEM, V263, P248, DOI 10.1006/abio.1998.2805; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Pan LF, 2011, J BIOL CHEM, V286, P40069, DOI 10.1074/jbc.C111.293084; Paris L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2807; Parmar AS, 2009, BIOPHYS J, V97, P590, DOI 10.1016/j.bpj.2009.04.045; PIGORSCH E, 1994, SPECTROCHIM ACTA A, V50, P2145, DOI 10.1016/0584-8539(94)00151-0; Samaranayake H, 2009, ANN MED, V41, P322, DOI 10.1080/07853890802698842; Schumacher B, 2010, ACTA CRYSTALLOGR F, V66, P978, DOI 10.1107/S1744309110025479; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Skalniak L, 2017, ONCOTARGET, V8, P72167, DOI 10.18632/oncotarget.20050; Smilgies DM, 2015, J APPL CRYSTALLOGR, V48, P1604, DOI 10.1107/S1600576715015551; Stefanini S, 1996, ARCH BIOCHEM BIOPHYS, V325, P58, DOI 10.1006/abbi.1996.0007; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; Sudol M, 2012, SEMIN CELL DEV BIOL, V23, P827, DOI 10.1016/j.semcdb.2012.05.002; TAL M, 1985, J BIOL CHEM, V260, P9976; Tan SG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14369; Thermo Scientific, 2010, PROT A280 THERM SCI; Verma Apoorva, 2018, Oncotarget, V9, P8068, DOI 10.18632/oncotarget.23909; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; White AM, 2016, EXPERT OPIN DRUG DIS, V11, P1151, DOI 10.1080/17460441.2016.1245720; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yan ZZ, 2018, MOL VIS, V24, P83; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zak KM, 2015, STRUCTURE, V23, P2341, DOI 10.1016/j.str.2015.09.010; Zhao Zhenjun, 2007, J Biomol Tech, V18, P331	56	7	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11180	11198		10.1074/jbc.RA118.007310	http://dx.doi.org/10.1074/jbc.RA118.007310			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167787	hybrid, Green Published			2022-12-28	WOS:000478717400011
J	Cragle, CE; MacNicol, MC; Byrum, SD; Hardy, LL; Mackintosh, SG; Richardson, WA; Gray, NK; Childs, GV; Tackett, AJ; MacNicol, AM				Cragle, Chad E.; MacNicol, Melanie C.; Byrum, Stephanie D.; Hardy, Linda L.; Mackintosh, Samuel G.; Richardson, William A.; Gray, Nicola K.; Childs, Gwen, V; Tackett, Alan J.; MacNicol, Angus M.			Musashi interaction with poly(A)-binding protein is required for activation of target mRNA translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; oocyte; translation control; polyadenylation; stem cells; cell plasticity; interactome analysis; Musashi; PABP; self-renewal	BINDING-PROTEIN; STEM-CELLS; CYTOPLASMIC POLYADENYLATION; STIMULATE TRANSLATION; MYELOID-LEUKEMIA; EXPRESSION; REPRESSION; FATE; MOS; INTEGRATION	The Musashi family of mRNA translational regulators controls both physiological and pathological stem cell self-renewal primarily by repressing target mRNAs that promote differentiation. In response to differentiation cues, Musashi can switch from a repressor to an activator of target mRNA translation. However, the molecular events that distinguish Musashi-mediated translational activation from repression are not understood. We have previously reported that Musashi function is required for the maturation of Xenopus oocytes and specifically for translational activation of specific dormant maternal mRNAs. Here, we employed MS to identify cellular factors necessary for Musashi-dependent mRNA translational activation. We report that Musashi1 needs to associate with the embryonic poly(A)-binding protein (ePABP) or the canonical somatic cell poly(A)-binding protein PABPC1 for activation of Musashi target mRNA translation. Co-immunoprecipitation studies demonstrated an increased Musashi1 interaction with ePABP during oocyte maturation. Attenuation of endogenous ePABP activity severely compromised Musashi function, preventing downstream signaling and blocking oocyte maturation. Ectopic expression of either ePABP or PABPC1 restored Musashi-dependent mRNA translational activation and maturation of ePABP-attenuated oocytes. Consistent with these Xenopus findings, PABPC1 remained associated with Musashi under conditions of Musashi target mRNA de-repression and translation during mammalian stem cell differentiation. Because association of Musashi1 with poly(A)-binding proteins has previously been implicated only in repression of Musashi target mRNAs, our findings reveal novel context-dependent roles for the interaction of Musashi with poly(A)-binding protein family members in response to extracellular cues that control cell fate.	[Cragle, Chad E.; MacNicol, Melanie C.; Hardy, Linda L.; Childs, Gwen, V; MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, 4301 Markham,Slot 814, Little Rock, AR 72205 USA; [Byrum, Stephanie D.; Childs, Gwen, V] Univ Arkansas Med Sci, Ctr Translat Neurosci, Little Rock, AR 72205 USA; [Byrum, Stephanie D.; Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Mackintosh, Samuel G.; Tackett, Alan J.] Univ Arkansas Med Sci, Arkansas Childrens Res Inst, Little Rock, AR 72205 USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Richardson, William A.; Gray, Nicola K.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Edinburgh	MacNicol, AM (corresponding author), Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, 4301 Markham,Slot 814, Little Rock, AR 72205 USA.	Angus@UAMS.edu	Childs, Gwen V/H-2648-2013	Childs, Gwen V/0000-0003-3764-1373	National Institutes of Health NCRR; National Center for Advancing Translational Sciences [UL1TR000039, KL2TR000063]; National Institutes of Health NIGMS Grant [P30 GM110702]; BBSRC [BB/J01687X/1] Funding Source: UKRI; MRC [MR/N022556/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD087057, R01HD093461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429, P20GM121293, P30GM110702] Funding Source: NIH RePORTER	National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health NIGMS Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The University of Arkansas for Medical Sciences (UAMS)Translational Research Institute was supported by National Institutes of Health NCRR and National Center for Advancing Translational Sciences Grants UL1TR000039 and KL2TR000063. The University of Arkansas for Medical Sciences Center for Translational Neuroscience was supported by National Institutes of Health NIGMS Grant P30 GM110702. We acknowledge the UAMS Proteomics Facility for mass spectrometric support. A. M. M. acknowledges training received through the advanced course in Proteomics/Bioinformatics held at the Welcome Genome Campus/European Bioinformatics Institute, Cambridge, United Kingdom.	Arumugam K, 2012, MOL REPROD DEV, V79, P553, DOI 10.1002/mrd.22060; Arumugam K, 2012, J BIOL CHEM, V287, P10639, DOI 10.1074/jbc.M111.300681; Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Brook M, 2012, BIOCHEM J, V441, P803, DOI 10.1042/BJ20111474; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243; Cragle C, 2014, J BIOL CHEM, V289, P14239, DOI 10.1074/jbc.M114.548271; Cragle CE, 2014, XENOPUS DEVELOPMENT, P38; de Andres-Aguayo L, 2012, CURR OPIN HEMATOL, V19, P268, DOI 10.1097/MOH.0b013e328353c778; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Fox RG, 2015, ANNU REV CELL DEV BI, V31, P249, DOI 10.1146/annurev-cellbio-100814-125446; Friend K, 2012, BIOCHEM J, V445, P93, DOI 10.1042/BJ20120304; Gorgoni B, 2011, P NATL ACAD SCI USA, V108, P7844, DOI 10.1073/pnas.1017664108; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Horisawa Kenichi, 2010, Biomol Concepts, V1, P59, DOI 10.1515/bmc.2010.005; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kanemura Y, 2001, DIFFERENTIATION, V68, P141, DOI 10.1046/j.1432-0436.2001.680208.x; Karaiskou A, 2001, J BIOL CHEM, V276, P36028, DOI 10.1074/jbc.M104722200; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kawahara H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199166; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kim JH, 2007, GENE DEV, V21, P2571, DOI 10.1101/gad.1593007; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Kwon HY, 2015, CELL STEM CELL, V17, P152, DOI 10.1016/j.stem.2015.06.006; Lasko P, 2009, PROG MOL BIOL TRANSL, V90, P211, DOI 10.1016/S1877-1173(09)90006-0; Lenormand JL, 1999, EMBO J, V18, P1869, DOI 10.1093/emboj/18.7.1869; Li N, 2015, CELL REP, V13, P2440, DOI 10.1016/j.celrep.2015.11.022; Machaca K, 2002, J CELL BIOL, V156, P75, DOI 10.1083/jcb.200110059; MacNicol AM, 2008, BIOCHEM SOC T, V36, P528, DOI 10.1042/BST0360528; MacNicol AM, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0064-y; MacNicol MC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11917-3; MacNicol MC, 2015, BIOMOLECULES, V5, P1580, DOI 10.3390/biom5031580; MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Nagata T, 1999, J MOL BIOL, V287, P315, DOI 10.1006/jmbi.1999.2596; Nakamura Y, 2010, DEV BIOL, V344, P272, DOI 10.1016/j.ydbio.2010.05.006; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Odle AK, 2018, ENDOCRINOLOGY, V159, P883, DOI 10.1210/en.2017-00586; Odle AK, 2018, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00367; Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Reverte CG, 2001, DEV BIOL, V231, P447, DOI 10.1006/dbio.2001.0153; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Smith AR, 2015, ONCOTARGET, V6, P12558, DOI 10.18632/oncotarget.3726; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; Sutherland JM, 2015, ASIAN J ANDROL, V17, P529, DOI 10.4103/1008-682X.151397; Szabat M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.119; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034; Voeltz GK, 2001, GENE DEV, V15, P774, DOI 10.1101/gad.872201; Vu LP, 2017, NAT GENET, V49, P866, DOI 10.1038/ng.3854; Wang XY, 2013, ONCOTARGET, V4, P739, DOI 10.18632/oncotarget.1034; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Wilkie GS, 2005, MOL CELL BIOL, V25, P2060, DOI 10.1128/MCB.25.5.2060-2071.2005; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	71	14	15	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10969	10986		10.1074/jbc.RA119.007220	http://dx.doi.org/10.1074/jbc.RA119.007220			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31152063	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000478717200019
J	Hirose, S; Hioki, Y; Miyashita, H; Hirade, N; Yoshitake, J; Shibata, T; Kikuchi, R; Matsushita, T; Chikazawa, M; Itakura, M; Zhang, M; Nagata, K; Uchida, K				Hirose, Sayumi; Hioki, Yusuke; Miyashita, Hiroaki; Hirade, Naoya; Yoshitake, Jun; Shibata, Takahiro; Kikuchi, Ryosuke; Matsushita, Tadashi; Chikazawa, Miho; Itakura, Masanori; Zhang, Mimin; Nagata, Koji; Uchida, Koji			Apolipoprotein E binds to and reduces serum levels of DNA-mimicking, pyrrolated proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification (PTM); apolipoprotein E (apoE); protein-protein interaction; serum; innate immunity; inflammation; damage-associated molecular pattern (DAMP); hyperlipidemia; Lysine N-pyrrolation; N-E-pyrrole-l-lysine	SELF-ASSOCIATION; PRODUCTS; ISOFORMS; HEPARIN; PLASMA; MODEL	Lysine N-pyrrolation, converting lysine residues to N-E-pyrrole-l-lysine, is a recently discovered post-translational modification. This naturally occurring reaction confers electrochemical properties onto proteins that potentially produce an electrical mimic to DNA and result in specificity toward DNA-binding molecules such as anti-DNA autoantibodies. The discovery of this unique covalent protein modification provides a rationale for establishing the molecular mechanism and broad functional significance of the formation and regulation of N-E-pyrrole-l-lysine-containing proteins. In this study, we used microbeads coupled to pyrrolated or nonpyrrolated protein to screen for binding activities of human serum-resident nonimmunoglobin proteins to the pyrrolated proteins. This screen identified apolipoprotein E (apoE) as a protein that innately binds the DNA-mimicking proteins in serum. Using an array of biochemical assays, we observed that the pyrrolated proteins bind to the N-terminal domain of apoE and that oligomeric apoE binds these proteins better than does monomeric apoE. Employing surface plasmon resonance and confocal microscopy, we further observed that apoE deficiency leads to significant accumulation of pyrrolated serum albumin and is associated with an enhanced immune response. These results, along with the observation that apoE facilitates the binding of pyrrolated proteins to cells, suggest that apoE may contribute to the clearance of pyrrolated serum proteins. Our findings uncover apoE as a binding target of pyrrolated proteins, providing a key link connecting covalent protein modification, lipoprotein metabolism, and innate immunity.	[Hirose, Sayumi; Hioki, Yusuke; Miyashita, Hiroaki; Hirade, Naoya; Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Yoshitake, Jun] Nagoya Univ, Inst Innovat Future Soc, Nagoya, Aichi 4648601, Japan; [Kikuchi, Ryosuke] Nagoya Univ, Dept Med Tech, Nagoya, Aichi 4668560, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi 4668560, Japan; [Chikazawa, Miho; Itakura, Masanori; Zhang, Mimin; Nagata, Koji; Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Uchida, Koji] Japan Agcy Med Res & Dev, CREST, Tokyo 1020076, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; University of Tokyo; Japan Science & Technology Agency (JST)	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.	a-uchida@mail.ecc.u-tokyo.ac.jp	Kikuchi, Ryosuke/AAX-4971-2021; Shibata, Takahiro/I-6872-2014	Shibata, Takahiro/0000-0003-3194-607X; Nagata, Koji/0000-0002-4704-0603; Uchida, Koji/0000-0003-3894-5299	Japan Society for the Promotion of Science KAKENHI [20117007, 21248016, 24658122]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 20117007, 21248016, and 24658122. The authors declare that they have no conflicts of interest with the contents of this article.	CARDIN AD, 1986, BIOCHEM BIOPH RES CO, V134, P783, DOI 10.1016/S0006-291X(86)80489-2; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; Cohn JS, 1996, ARTERIOSCL THROM VAS, V16, P149, DOI 10.1161/01.ATV.16.1.149; Frieden C, 2017, P NATL ACAD SCI USA, V114, P6292, DOI 10.1073/pnas.1705080114; Garai K, 2011, BIOCHEMISTRY-US, V50, P6356, DOI 10.1021/bi2006702; Garai K, 2011, BIOCHEMISTRY-US, V50, P2550, DOI 10.1021/bi1020106; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; HIDALGO FJ, 1995, CHEM PHYS LIPIDS, V77, P1; HIDALGO FJ, 1993, J BIOL CHEM, V268, P16190; Itakura K, 1998, J ORG CHEM, V63, P185, DOI 10.1021/jo971239+; Ma ZJ, 2008, CLIN IMMUNOL, V127, P168, DOI 10.1016/j.clim.2008.01.002; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miyashita H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05343; Moellering RE, 2013, SCIENCE, V341, P549, DOI 10.1126/science.1238327; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; PITAS RE, 1980, J BIOL CHEM, V255, P5454; Salomon RG, 1997, CHEM RES TOXICOL, V10, P536, DOI 10.1021/tx960157y; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; Theendakara V, 2016, J NEUROSCI, V36, P685, DOI 10.1523/JNEUROSCI.3562-15.2016; Walsh CT, 2006, NAT PROD REP, V23, P517, DOI 10.1039/b605245m; Wang YH, 2012, BIOCHEM BIOPH RES CO, V423, P805, DOI 10.1016/j.bbrc.2012.06.044; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Yamauchi Y, 2008, BIOCHEMISTRY-US, V47, P6702, DOI 10.1021/bi8003999; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a; Zhou Y, 1999, BRAIN RES BULL, V49, P173, DOI 10.1016/S0361-9230(99)00052-0	30	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					11035	11045		10.1074/jbc.RA118.006629	http://dx.doi.org/10.1074/jbc.RA118.006629			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31167785	Green Published, hybrid			2022-12-28	WOS:000478717200024
J	Toscanini, MA; Favarolo, MB; Flecha, FLG; Ebert, B; Rautengarten, C; Bredeston, LM				Agustina Toscanini, M.; Belen Favarolo, M.; Gonzalez Flecha, F. Luis; Ebert, Berit; Rautengarten, Carsten; Bredeston, Luis M.			Conserved Glu-47 and Lys-50 residues are critical for UDP-N-acetylglucosamine/UMP antiport activity of the mouse Golgi-associated transporter Slc35a3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Golgi; membrane transport; structural model; glycoprotein biosynthesis; membrane protein; antiporter; congenital glycosylation disorder; secretory pathway; solute carrier family 35 member A3 (SLC35A3); UDP-GlcNAc metabolism	CMP-SIALIC ACID; NUCLEOTIDE SUGAR TRANSPORTERS; MOLECULAR-CLONING; CONGENITAL DISORDER; SUBSTRATE RECOGNITION; ENDOPLASMIC-RETICULUM; FUCOSE TRANSPORTER; MEMBRANE-PROTEINS; STRUCTURAL BASIS; GALACTOSE	Nucleotide sugar transporters (NSTs) regulate the flux of activated sugars from the cytosol into the lumen of the Golgi apparatus where glycosyltransferases use them for the modification of proteins, lipids, and proteoglycans. It has been well-established that NSTs are antiporters that exchange nucleotide sugars with the respective nucleoside monophosphate. Nevertheless, information about the molecular basis of ligand recognition and transport is scarce. Here, using topology predictors, cysteine-scanning mutagenesis, expression of GFP-tagged protein variants, and phenotypic complementation of the yeast strain Kl3, we identified residues involved in the activity of a mouse UDP-GlcNAc transporter, murine solute carrier family 35 member A3 (mSlc35a3). We specifically focused on the putative transmembrane helix 2 (TMH2) and observed that cells expressing E47C or K50C mSlc35a3 variants had lower levels of GlcNAc-containing glycoconjugates than WT cells, indicating impaired UDP-GlcNAc transport activity of these two variants. A conservative substitution analysis revealed that single or double substitutions of Glu-47 and Lys-50 do not restore GlcNAc glycoconjugates. Analysis of mSlc35a3 and its genetic variants reconstituted into proteoliposomes disclosed the following: (i) all variants act as UDP-GlcNAc/UMP antiporters; (ii) conservative substitutions (E47D, E47Q, K50R, or K50H) impair UDP-GlcNAc uptake; and (iii) substitutions of Glu-47 and Lys-50 dramatically alter kinetic parameters, consistent with a critical role of these two residues in mSlc35a3 function. A bioinformatics analysis revealed that an EXXK motif in TMH2 is highly conserved across SLC35 A subfamily members, and a 3D-homology model predicted that Glu-47 and Lys-50 are facing the central cavity of the protein.	[Agustina Toscanini, M.; Belen Favarolo, M.; Gonzalez Flecha, F. Luis; Bredeston, Luis M.] Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, Dept Quim Biol,CONICET, Junin 956, RA-1113 Buenos Aires, DF, Argentina; [Ebert, Berit; Rautengarten, Carsten] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Agustina Toscanini, M.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Biotecnol, RA-1113 Caba, Argentina; [Belen Favarolo, M.] Univ Buenos Aires, CONICET, Fac Med, Inst Biol Celular & Neurociencias Prof E De Rober, RA-1113 Caba, Argentina; [Gonzalez Flecha, F. Luis; Bredeston, Luis M.] CNR, CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Melbourne; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bredeston, LM (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, Dept Quim Biol,CONICET, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	bredes@qb.ffyb.uba.ar	González Flecha, F Luis/J-7060-2014; Ebert, Berit/C-1748-2019	González Flecha, F Luis/0000-0003-2828-7907; Ebert, Berit/0000-0002-6914-5473; Bredeston, Luis/0000-0002-1272-8344; Favarolo, Maria Belen/0000-0002-4349-4085; Rautengarten, Carsten/0000-0001-5850-746X; Toscanini, Maria Agustina/0000-0001-9431-7794	National Research Council (CONICET, Argentina) [PIP-11220090100811]; University of Buenos Aires Travel Award; Australian Research Council [FT160100276, DP180102630]; Mizutani Foundation for Glycoscience [18-0237]	National Research Council (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires Travel Award; Australian Research Council(Australian Research Council); Mizutani Foundation for Glycoscience	This work was supported by the National Research Council (CONICET, Argentina) Grant PIP-11220090100811, and University of Buenos Aires Travel Award (to L. M. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Australian Research Council Future Fellowship FT160100276, Discovery Grant DP180102630 and Mizutani Foundation for Glycoscience Grant 18-0237.	Abeijon C, 1996, P NATL ACAD SCI USA, V93, P5963, DOI 10.1073/pnas.93.12.5963; Andersen PK, 2007, MOL MEMBR BIOL, V24, P519, DOI 10.1080/09687680701459877; Aoki K, 2003, J BIOL CHEM, V278, P22887, DOI 10.1074/jbc.M302620200; Aoki K, 2001, J BIOL CHEM, V276, P21555, DOI 10.1074/jbc.M101462200; BERNINSONE P, 1994, J BIOL CHEM, V269, P207; Bredeston LM, 2005, J BIOL CHEM, V280, P32168, DOI 10.1074/jbc.M507035200; Bredeston LM, 2017, GLYCOBIOLOGY, V27, P64, DOI 10.1093/glycob/cww092; Bruneel A, 2018, ELECTROPHORESIS, V39, P3123, DOI 10.1002/elps.201800021; Caffaro CE, 2007, J BIOL CHEM, V282, P27970, DOI 10.1074/jbc.M704485200; Caffaro CE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003331; CAPASSO JM, 1984, P NATL ACAD SCI-BIOL, V81, P7051, DOI 10.1073/pnas.81.22.7051; CAREY DJ, 1980, CELL, V19, P597, DOI 10.1016/S0092-8674(80)80036-5; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dauber A, 2014, HUM MOL GENET, V23, P2880, DOI 10.1093/hmg/ddu001; Ebert B, 2018, NAT PLANTS, V4, P792, DOI 10.1038/s41477-018-0235-5; Ebert B, 2015, PLANT CELL, V27, P1218, DOI 10.1105/tpc.114.133827; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; Eckhardt M, 1996, P NATL ACAD SCI USA, V93, P7572, DOI 10.1073/pnas.93.15.7572; Edmondson AC, 2017, AM J MED GENET A, V173, P2758, DOI 10.1002/ajmg.a.38374; Edvardson S, 2013, J MED GENET, V50, P733, DOI 10.1136/jmedgenet-2013-101753; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Furuichi T, 2009, J MED GENET, V46, P562, DOI 10.1136/jmg.2008.065201; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; Hirschberg CB, 2018, J BIOL CHEM, V293, P12653, DOI 10.1074/jbc.X118.004819; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Illergard K, 2011, PROTEINS, V79, P79, DOI 10.1002/prot.22859; Ishida N, 1999, J BIOCHEM, V126, P68, DOI 10.1093/oxfordjournals.jbchem.a022437; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klein MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06003-9; Kodera H, 2013, HUM MUTAT, V34, P1708, DOI 10.1002/humu.22446; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee Y, 2017, NAT PLANTS, V3, P825, DOI 10.1038/s41477-017-0022-8; Li LX, 2018, MBIO, V9, DOI 10.1128/mBio.02319-17; LI LX, 2018, PLOS PATHOG, V14, DOI DOI 10.1371/journal.ppat.1006765; Liu L, 2013, GLYCOCONJUGATE J, V30, P5, DOI 10.1007/s10719-012-9375-4; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Maggioni A, 2013, CHEMBIOCHEM, V14, P1936, DOI 10.1002/cbic.201300298; Marini C, 2017, AM J MED GENET A, V173, P1119, DOI 10.1002/ajmg.a.38112; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Martinez-Duncker I, 2005, BLOOD, V105, P2671, DOI 10.1182/blood-2004-09-3509; Maszczak-Seneczko D, 2015, J BIOL CHEM, V290, P15475, DOI 10.1074/jbc.M115.636670; Maszczak-Seneczko D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.460543; Miera N, 1996, J BIOCHEM-TOKYO, V120, P236; Mohamed M, 2013, NEUROLOGY, V81, P681, DOI 10.1212/WNL.0b013e3182a08f53; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Ng BG, 2013, AM J HUM GENET, V92, P632, DOI 10.1016/j.ajhg.2013.03.012; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Parker JL, 2017, NATURE, V551, P521, DOI 10.1038/nature24464; Rautengarten C, 2017, P NATL ACAD SCI USA, V114, P4261, DOI 10.1073/pnas.1701894114; Rautengarten C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12119; Rautengarten C, 2014, P NATL ACAD SCI USA, V111, P11563, DOI 10.1073/pnas.1406073111; Saez-Aguayo S, 2017, PLANT CELL, V29, P129, DOI 10.1105/tpc.16.00465; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Tabuchi M, 1997, BIOCHEM BIOPH RES CO, V232, P121, DOI 10.1006/bbrc.1997.6239; Takemoto M, 2018, STRUCTURE, V26, P1284, DOI 10.1016/j.str.2018.05.012; Takeshima-Futagami T, 2012, GLYCOBIOLOGY, V22, P1731, DOI 10.1093/glycob/cws116; Temple H, 2016, GLYCOBIOLOGY, V26, P913, DOI 10.1093/glycob/cww054; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tsuchiya H, 2016, NATURE, V534, P417, DOI 10.1038/nature17991; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x	70	6	6	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10042	10054		10.1074/jbc.RA119.008827	http://dx.doi.org/10.1074/jbc.RA119.008827			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31118275	Green Published, hybrid			2022-12-28	WOS:000474445600002
J	Chaudhary, AR; Lu, HL; Krementsova, EB; Bookwalter, CS; Trybus, KM; Hendricks, AG				Chaudhary, Abdullah R.; Lu, Hailong; Krementsova, Elena B.; Bookwalter, Carol S.; Trybus, Kathleen M.; Hendricks, Adam G.			MAP7 regulates organelle transport by recruiting kinesin-1 to microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microtubule; microtubule-associated protein (MAP); intracellular trafficking; optical tweezers; kinesin; dynein; cytoskeleton; kinesin-1; kinesin-2; MAP7; ensconsin; intracellular transport	TUG-OF-WAR; CARGO TRANSPORT; DYNEIN; MECHANISM; MOTILITY; PROTEIN; ENSCONSIN; MOTORS; FORCES; TAU	Microtubule-associated proteins (MAPs) regulate microtubule polymerization, dynamics, and organization. In addition, MAPs alter the motility of kinesin and dynein to control trafficking along microtubules. MAP7 (ensconsin, E-MAP-115) is a ubiquitous MAP that organizes the microtubule cytoskeleton in mitosis and neuronal branching. MAP7 also recruits kinesin-1 to microtubules. To understand how the activation of kinesin-1 by MAP7 regulates the motility of organelles transported by ensembles of kinesin and dynein, we isolated organelles and reconstituted their motility in vitro. In the absence of MAP7, isolated phagosomes exhibit approximately equal fractions of plus- and minus-end-directed motility along microtubules. MAP7 causes a pronounced shift in motility; phagosomes move toward the plus-end similar to 80% of the time, and kinesin teams generate more force. To dissect MAP7-mediated regulation of kinesin-driven transport, we examined its effects on the motility and force generation of single and teams of full-length kinesin-1 motors. We find that MAP7 does not alter the force exerted by a single kinesin-1 motor, but instead increases its binding rate to the microtubule. For ensembles of kinesin, a greater number of kinesin motors are simultaneously engaged and generating force to preferentially target organelles toward the microtubule plus-end.	[Chaudhary, Abdullah R.; Hendricks, Adam G.] McGill Univ, Dept Bioengn, Montreal, PQ H3A 0C3, Canada; [Lu, Hailong; Krementsova, Elena B.; Bookwalter, Carol S.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	McGill University; University of Vermont	Hendricks, AG (corresponding author), McGill Univ, Dept Bioengn, Montreal, PQ H3A 0C3, Canada.	adam.hendricks@mcgill.ca	Hendricks, Adam/B-3692-2009	Hendricks, Adam/0000-0003-3635-1577	CIHR [PJT-159490] Funding Source: Medline; NIGMS NIH HHS [R01 GM078097] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atherton J, 2013, BIOL CELL, V105, P465, DOI 10.1111/boc.201300012; Balabanian L, 2018, BIOCHEMISTRY-US, V40, P14, DOI DOI 10.1042/bio04002014; Balabanian L, 2017, BIOPHYS J, V113, P1551, DOI 10.1016/j.bpj.2017.08.009; Barlan K, 2013, CURR BIOL, V23, P317, DOI 10.1016/j.cub.2013.01.008; Bathe F, 2005, MOL BIOL CELL, V16, P3529, DOI 10.1091/mbc.E04-11-0957; Berger F, 2019, NANO LETT, V19, P2598, DOI 10.1021/acs.nanolett.9b00417; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Chaudhary AR, 2018, TRAFFIC, V19, P111, DOI 10.1111/tra.12537; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Furuta K, 2013, P NATL ACAD SCI USA, V110, P501, DOI 10.1073/pnas.1201390110; Gallaud E, 2014, J CELL BIOL, V204, P1111, DOI 10.1083/jcb.201311094; Gumy LF, 2017, NEURON, V94, P347, DOI 10.1016/j.neuron.2017.03.046; HEINS S, 1991, J CELL SCI, P121; Hendricks AG, 2014, METHOD ENZYMOL, V540, P249, DOI 10.1016/B978-0-12-397924-7.00014-5; Hendricks AG, 2012, P NATL ACAD SCI USA, V109, P18447, DOI 10.1073/pnas.1215462109; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hooikaas PJ, 2019, J CELL BIOL, V218, P1298, DOI 10.1083/jcb.201808065; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Kaan HYK, 2013, J BIOL CHEM, V288, P18588, DOI 10.1074/jbc.M113.462648; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Lipka J, 2016, EMBO J, V35, P302, DOI 10.15252/embj.201592929; Liu JS, 2012, MOL CELL, V47, P707, DOI 10.1016/j.molcel.2012.06.025; LOPEZ LA, 1993, CELL MOTIL CYTOSKEL, V24, P1, DOI 10.1002/cm.970240102; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; McKenney RJ, 2016, EMBO J, V35, P1175, DOI 10.15252/embj.201593071; Metivier M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.171579; Metzger T, 2012, NATURE, V484, P120, DOI 10.1038/nature10914; Monroy BY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03909-2; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Nelson SR, 2009, BIOPHYS J, V97, P509, DOI 10.1016/j.bpj.2009.04.052; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421, DOI 10.1146/annurev.cb.02.110186.002225; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Ramkumar A, 2018, DEV DYNAM, V247, P138, DOI 10.1002/dvdy.24599; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Semenova I, 2014, MOL BIOL CELL, V25, P3119, DOI 10.1091/mbc.E14-01-0022; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Sung HH, 2008, DEV CELL, V15, P866, DOI 10.1016/j.devcel.2008.10.006; Tas RP, 2017, NEURON, V96, P1264, DOI 10.1016/j.neuron.2017.11.018; Tint I, 2009, J NEUROSCI, V29, P10995, DOI 10.1523/JNEUROSCI.3399-09.2009; Tokuraku K, 2007, J BIOCHEM, V141, P585, DOI 10.1093/jb/mvm063; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; Tortosa E., 2016, DENDRITES DEV DIS, P31, DOI DOI 10.1007/978-4-431-56050-0_3; Tymanskyj SR, 2018, ELIFE, V7, DOI 10.7554/eLife.36374; Tymanskyj SR, 2017, J NEUROSCI, V37, P1648, DOI 10.1523/JNEUROSCI.3260-16.2017; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Wang Q, 2017, P NATL ACAD SCI USA, V114, pE8611, DOI 10.1073/pnas.1710328114; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Yadav S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099539; Yogev S, 2016, NEURON, V92, P449, DOI 10.1016/j.neuron.2016.09.036	52	21	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10160	10171		10.1074/jbc.RA119.008052	http://dx.doi.org/10.1074/jbc.RA119.008052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31085585	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000474445600010
J	Lin, S; Sahai, A; Chugh, SS; Pan, XM; Wallner, EI; Danesh, FR; Lomasney, JW; Kanwar, YS				Lin, Sun; Sahai, Atul; Chugh, Sumant S.; Pan, Xiaomin; Wallner, Elisabeth I.; Danesh, Farhad R.; Lomasney, Jon W.; Kanwar, Yashpal S.			RETRACTION: High glucose stimulates synthesis of fibronectin via a novel protein kinase C, Rap1b, and B-Raf signaling pathway (Retraction of Vol 277, Pg 41725, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction														Danesh, Farhad/0000-0001-6849-5239				Lin S, 2002, J BIOL CHEM, V277, P41725, DOI 10.1074/jbc.M203957200	1	0	0	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10381	10381		10.1074/jbc.W119.009587	http://dx.doi.org/10.1074/jbc.W119.009587			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31253689	Green Published, hybrid			2022-12-28	WOS:000474445600028
J	Killoran, RC; Smith, MJ				Killoran, Ryan C.; Smith, Matthew J.			Conformational resolution of nucleotide cycling and effector interactions for multiple small GTPases determined in parallel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small GTPase; nuclear magnetic resonance (NMR); Ras protein; guanine nucleotide exchange factor (GEF); GTPase activating protein (GAP); Rho (Rho GTPase); Rac (Rac GTPase); cancer; effector; multiplexed analysis	K-RAS; N-RAS; SIGNALING SPECIFICITY; STRUCTURAL-ANALYSIS; KRAS; GTP; ACTIVATION; MUTATIONS; EXCHANGE; RAC1	Small GTPases alternatively bind GDP/GTP guanine nucleotides to gate signaling pathways that direct most cellular processes. Numerous GTPases are implicated in oncogenesis, particularly the three RAS isoforms HRAS, KRAS, and NRAS and the RHO family GTPase RAC1. Signaling networks comprising small GTPases are highly connected, and there is some evidence of direct biochemical cross-talk between their functional G-domains. The activation potential of a given GTPase is contingent on a codependent interaction with the nucleotide and a Mg2+ ion, which bind to individual variants with distinct affinities coordinated by residues in the GTPase nucleotide-binding pocket. Here, we utilized a selective-labeling strategy coupled with real-time NMR spectroscopy to monitor nucleotide exchange, GTP hydrolysis, and effector interactions of multiple small GTPases in a single complex system. We provide insight into nucleotide preference and the role of Mg2+ in activating both WT and oncogenic mutant enzymes. Multiplexing revealed guanine nucleotide exchange factor (GEF), GTPase-activating protein (GAP), and effector-binding specificities in mixtures of GTPases and resolved that the three related RAS isoforms are biochemically equivalent. This work establishes that direct quantitation of the nucleotide-bound conformation is required to accurately determine an activation potential for any given GTPase, as small GTPases such as RAS-like proto-oncogene A (RALA) or the G12C mutant of KRAS display fast exchange kinetics but have a high affinity for GDP. Furthermore, we propose that the G-domains of small GTPases behave autonomously in solution and that nucleotide cycling proceeds independently of protein concentration but is highly impacted by Mg2+ abundance.	[Killoran, Ryan C.; Smith, Matthew J.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada; [Smith, Matthew J.] Univ Montreal, Dept Pathol & Cell Biol, Fac Med, Montreal, PQ H3T 1J4, Canada	Universite de Montreal; Universite de Montreal	Smith, MJ (corresponding author), Univ Montreal, IRIC, Dept Pathol & Cell Biol, 2950 Chemin Polytech,Pavillon Marcelle Coutu, Montreal, PQ H3T 1J4, Canada.	matthew.james.smith@umontreal.ca	Smith, Matthew J/AAI-8060-2020	Smith, Matthew J/0000-0003-2896-9350	Canadian Cancer Society Research Institute (CCSRI); Canadian Institutes for Health Research (CIHR); National Science and Engineering Council of Canada (NSERC)	Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Cancer Society Research Institute (CCSRI), Canadian Institutes for Health Research (CIHR), and National Science and Engineering Council of Canada (NSERC) (to M. J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ambrogio C, 2018, CELL, V172, P857, DOI 10.1016/j.cell.2017.12.020; Burgess MR, 2017, CELL, V168, P817, DOI 10.1016/j.cell.2017.01.020; Cheng CM, 2011, MOL CELL BIOL, V31, P983, DOI 10.1128/MCB.00137-10; Chung JK, 2018, BIOPHYS J, V114, P137, DOI 10.1016/j.bpj.2017.10.042; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fenwick RB, 2010, STRUCTURE, V18, P985, DOI 10.1016/j.str.2010.05.013; Ferrandez Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13619-2; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Fotiadou PP, 2007, MOL CELL BIOL, V27, P6742, DOI 10.1128/MCB.00234-07; Gebregiworgis T, 2018, J AM CHEM SOC, V140, P4473, DOI 10.1021/jacs.7b13703; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Goody RS, 2014, FEBS J, V281, P593, DOI 10.1111/febs.12551; GOODY RS, 1991, TRENDS BIOCHEM SCI, V16, P327, DOI 10.1016/0968-0004(91)90134-H; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Hobbs GA, 2016, J CELL SCI, V129, P1287, DOI 10.1242/jcs.182873; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Iwig JS, 2013, ELIFE, V2, DOI 10.7554/eLife.00813; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Jin SX, 2014, J BIOL CHEM, V289, P16551, DOI 10.1074/jbc.M114.557959; JOHN J, 1993, J BIOL CHEM, V268, P923; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson CW, 2017, J BIOL CHEM, V292, P12981, DOI 10.1074/jbc.M117.778886; Jones MK, 1998, J BIOL CHEM, V273, P1782, DOI 10.1074/jbc.273.3.1782; Khanday FA, 2006, J CELL BIOL, V172, P817, DOI 10.1083/jcb.200506001; Kong G, 2016, LEUKEMIA, V30, P1542, DOI 10.1038/leu.2016.40; Kovrigina EA, 2015, BIOPHYS J, V109, P1000, DOI 10.1016/j.bpj.2015.07.020; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Machesky LM, 2012, PIGM CELL MELANOMA R, V25, P762, DOI 10.1111/pcmr.12004; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Marshall C, 1999, CURR OPIN CELL BIOL, V11, P732, DOI 10.1016/S0955-0674(99)00044-7; Marshall CB, 2012, METHODS, V57, P473, DOI 10.1016/j.ymeth.2012.06.014; Mazhab-Jafari MT, 2013, J AM CHEM SOC, V135, P3367, DOI 10.1021/ja312508w; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Nicely NI, 2004, STRUCTURE, V12, P2025, DOI 10.1016/j.str.2004.08.011; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Prakash P, 2017, SCI REP-UK, V7, DOI 10.1038/srep40109; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rojas Jose M, 2011, Genes Cancer, V2, P298, DOI 10.1177/1947601911408078; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Schweins T, 1997, J MOL BIOL, V266, P847, DOI 10.1006/jmbi.1996.0814; Smith MJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01326-5; Smith MJ, 2014, NAT CHEM BIOL, V10, P223, DOI [10.1038/NCHEMBIO.1435, 10.1038/nchembio.1435]; Smith MJ, 2013, P NATL ACAD SCI USA, V110, P4574, DOI 10.1073/pnas.1218173110; Spencer-Smith R, 2017, NAT CHEM BIOL, V13, P62, DOI [10.1038/nchembio.2231, 10.1038/NCHEMBIO.2231]; Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P11, DOI 10.1016/S0098-2997(02)00088-2; Wuichet K, 2015, GENOME BIOL EVOL, V7, P57, DOI 10.1093/gbe/evu264; Xu SY, 2017, ACTA CRYSTALLOGR D, V73, P970, DOI 10.1107/S2059798317015418; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	61	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9937	9948		10.1074/jbc.RA119.008653	http://dx.doi.org/10.1074/jbc.RA119.008653			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31088913	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000473277900024
J	Li, ZY; Hassan, MQ; Jafferji, M; Aqeilan, RI; Garzon, R; Croce, CM; van Wijnen, AJ; Stein, JL; Stein, GS; Lian, JB				Li, Zhaoyong; Hassan, Mohammad Q.; Jafferji, Mohammed; Aqeilan, Rami I.; Garzon, Ramiro; Croce, Carlo M.; van Wijnen, Andrew J.; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.			Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation (vol 284, pg 15676, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Hassan, Mohammad/GZA-7507-2022; Aqeilan, Rami/AAT-7785-2020	Hassan, Mohammad/0000-0002-1712-0004; 				Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200	1	7	8	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					10018	10018		10.1074/jbc.AAC119.009552	http://dx.doi.org/10.1074/jbc.AAC119.009552			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31227623	Green Published, hybrid			2022-12-28	WOS:000473277900031
J	Getter, T; Suh, S; Hoang, T; Handa, JT; Dong, ZQ; Ma, XL; Chen, YY; Blackshaw, S; Palczewski, K				Getter, Tamar; Suh, Susie; Thanh Hoang; Handa, James T.; Dong, Zhiqian; Ma, Xiuli; Chen, Yuanyuan; Blackshaw, Seth; Palczewski, Krzysztof			The selective estrogen receptor modulator raloxifene mitigates the effect of all-trans-retinal toxicity in photoreceptor degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retina; vitamin A; vision; retinal degeneration; rhodopsin; all-trans-retinal (atRAL); high-throughput screen (HTS); estrogen receptor (ER); selective estrogen receptor modulator (SERM); photoreceptor degeneration; blindness; cytotoxicity; cell death	STARGARDT DISEASE; CALCIUM-UPTAKE; VISUAL CYCLE; ISOMERIZATION; PHARMACOLOGY; RAT; EYE; ATP; BIOLUMINESCENCE; IDENTIFICATION	The retinoid cycle is a metabolic process in the vertebrate retina that continuously regenerates 11-cis-retinal (11-cisRAL) from the all-trans-retinal (atRAL) isomer. atRAL accumulation can cause photoreceptor degeneration and irreversible visual dysfunction associated with incurable blinding retinal diseases, such as Stargardt disease, retinitis pigmentosa (RP), and atrophic age-related macular degeneration (AMD). The underlying cellular mechanisms leading to retinal degeneration remain uncertain, although previous studies have shown that atRAL promotes calcium influx associated with cell apoptosis. To identify compounds that mitigate the effects of atRAL toxicity, here we developed an unbiased and robust image-based assay that can detect changes in intracellular calcium levels in U2OS cells. Using our assay in a high-throughput screen of 2,400 compounds, we noted that selective estrogen receptor modulators (SERMs) potently stabilize intracellular calcium and thereby counteract atRAL-induced toxicity. In a light-induced retinal degeneration mouse model (Abca4(-/-)Rdh8(-/-)), raloxifene (a benzothiophene-type scaffold SERM) prevented the onset of photoreceptor apoptosis and thus protected the retina from degeneration. The minor structural differences between raloxifene and one of its derivatives (Y 134) had a major impact on calcium homeostasis after atRAL exposure in vitro, and we verified this differential impact in vivo. In summary, the SERM raloxifene has structural and functional neuroprotective effects in the retina. We propose that the highly sensitive image-based assay developed here could be applied for the discovery of additional drug candidates preventing photoreceptor degeneration.	[Getter, Tamar; Suh, Susie; Palczewski, Krzysztof] Univ Calif Irvine, Dept Ophthalmol, Gavin Herbert Eye Inst, Irvine, CA 92697 USA; [Getter, Tamar; Suh, Susie; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Thanh Hoang; Blackshaw, Seth] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21205 USA; [Handa, James T.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Dong, Zhiqian; Ma, Xiuli] Polgenix Inc, Irvine, CA 92617 USA; [Chen, Yuanyuan] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Chen, Yuanyuan] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA	University of California System; University of California Irvine; Case Western Reserve University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Getter, T; Palczewski, K (corresponding author), Univ Calif Irvine, Dept Ophthalmol, Gavin Herbert Eye Inst, Irvine, CA 92657 USA.	tgetter@uci.edu; kpalczew@uci.edu		Chen, Yuanyuan/0000-0001-9625-1610; DONG, ZHIQIAN/0000-0002-8748-4532	NEI, National Institutes of Health [R24EY024864, R24EY027283, EY024992, T32GM007250, F30EY029136-01A1, R01EY027691]; Research to Prevent Blindness; Canadian Institute for Advanced Research (CIFAR); Alcon Research Institute (ARI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F30EY029136, R24EY027283, R01EY027691, R24EY024864, K99EY024992, R00EY024992, R01EY020560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Alcon Research Institute (ARI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by NEI, National Institutes of Health, Grants R24EY024864 and R24EY027283 (to K. P.), EY024992 (to Y. C.), T32GM007250 and F30EY029136-01A1 (to S. S.), and R01EY027691 (to J. T. H.); an unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology at the University of California (Irvine, CA); the Canadian Institute for Advanced Research (CIFAR); and the Alcon Research Institute (ARI). K. P. is Chief Scientific Officer at Polgenix, Inc. Z. D. and X. M. are employees of Polgenix, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aboul-Enein HY, 2002, J PHARMACEUT BIOMED, V27, P441, DOI 10.1016/S0731-7085(01)00575-1; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Bray MA, 2004, ASSAY GUIDANCE MANUA; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen Y, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aag0245; Chen Y, 2013, J CLIN INVEST, V123, P5119, DOI 10.1172/JCI69076; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; CLARK JH, 1981, PHARMACOL THERAPEUT, V15, P467, DOI 10.1016/0163-7258(81)90055-3; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dickey RP, 1996, HUM REPROD UPDATE, V2, P483, DOI 10.1093/humupd/2.6.483; Dodds ML, 2001, BRIT J PHARMACOL, V132, P1374, DOI 10.1038/sj.bjp.0703924; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fan HL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41226; Gao H, 1999, CHEM REV, V99, P723, DOI 10.1021/cr980018g; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GREENBLATT R, 1961, FERTIL STERIL, V12, P402; Grese TA, 1998, CURR PHARM DESIGN, V4, P71; Grese TA, 1998, J MED CHEM, V41, P1272, DOI 10.1021/jm970688z; He JS, 2018, ASSAY DRUG DEV TECHN, V16, P320, DOI 10.1089/adt.2018.861; He MF, 2013, J CHROMATOGR A, V1271, P67, DOI 10.1016/j.chroma.2012.11.022; Holli K, 2000, J CLIN ONCOL, V18, P3487, DOI 10.1200/JCO.2000.18.20.3487; Holownia A, 1999, BRAIN RES, V833, P202, DOI 10.1016/S0006-8993(99)01529-2; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; KANGAS L, 1984, MED BIOL, V62, P338; Kiser PD, 2019, FASEB J, V33, P5782, DOI 10.1096/fj.201802493R; Kiser PD, 2015, NAT CHEM BIOL, V11, P409, DOI [10.1038/NCHEMBIO.1799, 10.1038/nchembio.1799]; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Kittelson J. M., 2011, J BIOPHARMACEUTICAL, V21, P1046, DOI [10.1080/10543406.2011.592364, DOI 10.1080/10543406.2011.592364]; Klinge CM, 2004, J MOL ENDOCRINOL, V33, P387, DOI 10.1677/jme.1.01541; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Levin ER, 2008, AM J PHYSIOL-REG I, V295, pR1425, DOI 10.1152/ajpregu.90605.2008; Lock JT, 2015, CELL CALCIUM, V58, P638, DOI 10.1016/j.ceca.2015.10.003; LoPachin RM, 2014, CHEM RES TOXICOL, V27, P1081, DOI 10.1021/tx5001046; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Molday RS, 2006, ADV EXP MED BIOL, V572, P465; Murdter TE, 2011, CLIN PHARMACOL THER, V89, P708, DOI 10.1038/clpt.2011.27; Ning M, 2007, BRIT J PHARMACOL, V150, P19, DOI 10.1038/sj.bjp.0706960; Ogueta SB, 1999, INVEST OPHTH VIS SCI, V40, P1906; Onishi A, 2010, P NATL ACAD SCI USA, V107, P11579, DOI 10.1073/pnas.1000102107; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Quazi F, 2014, P NATL ACAD SCI USA, V111, P5024, DOI 10.1073/pnas.1400780111; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Reznicek L, 2014, INT J OPHTHALMOL-CHI, V7, P697, DOI 10.3980/j.issn.2222-3959.2014.04.21; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Sato M, 2003, BIOCHEM BIOPH RES CO, V306, P826, DOI 10.1016/S0006-291X(03)01092-1; Sawaki M, 2012, ONCOL LETT, V3, P61, DOI 10.3892/ol.2011.449; Schmid CR, 1999, BIOORG MED CHEM LETT, V9, P523, DOI 10.1016/S0960-894X(99)00050-5; Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551; Sliney DH, 2002, INT J TOXICOL, V21, P501, DOI 10.1080/10915810290169927; Sliney DH, 2001, J PHOTOCH PHOTOBIO B, V64, P166, DOI 10.1016/S1011-1344(01)00229-9; Soltysik K, 2013, J PHYSIOL PHARMACOL, V64, P129; Takano Y, 2004, BIOCHEM BIOPH RES CO, V313, P1015, DOI 10.1016/j.bbrc.2003.12.034; Takeuchi K, 2008, EXP EYE RES, V86, P60, DOI 10.1016/j.exer.2007.09.008; Tsybovsky Y, 2011, BIOCHEMISTRY-US, V50, P6855, DOI 10.1021/bi200774w; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wang X, 2017, J NEUROSCI, V37, P3294, DOI 10.1523/JNEUROSCI.2717-16.2017; Wu TW, 2011, BRAIN RES, V1379, P34, DOI 10.1016/j.brainres.2011.01.034; Yamazaki H, 2002, INVEST OPHTH VIS SCI, V43, P919; Yang CH, 2005, BIOORG MED CHEM LETT, V15, P1505, DOI 10.1016/j.bmcl.2004.12.074; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JY, 2015, J CLIN INVEST, V125, P2781, DOI 10.1172/JCI80950; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	70	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9461	9475		10.1074/jbc.RA119.008697	http://dx.doi.org/10.1074/jbc.RA119.008697			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31073029	Green Published, hybrid			2022-12-28	WOS:000472713000015
J	Heppner, DE; Beyett, TS; Eck, MJ				Heppner, David E.; Beyett, Tyler S.; Eck, Michael J.			A driving test for oncogenic mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CELL LUNG-CANCER; ACTIVATION; MECHANISM; DOMAIN	Activating mutations in protein kinases are a frequent cause of cancer, and selecting drugs that act on these oncogenic kinases can lead to effective therapies. Targeted or whole-genome sequencing of tumor samples can readily reveal the presence of mutations, but discerning previously uncharacterized activating driver mutations that will respond to drug treatment from much more abundant but inconsequential passenger mutations is problematic. Chakroborty et al. apply a screening approach that leverages error-prone PCR and a proliferating cell model to identify such gain-of-function mutants in the epidermal growth factor receptor (EGFR) kinase. The screen is validated by the identification of known cancer-promoting mutations and reveals a previously unappreciated oncogenic EGFR mutation, A702V, demonstrating its power for discovery of driver mutations.	[Eck, Michael J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Eck, MJ (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	eck@crystal.harvard.edu	Heppner, David E./A-7029-2018	Heppner, David E./0000-0002-0722-5160	National Cancer Institute, National Institutes of Health [R01CA116020, R01CA201049]; Novartis Institutes for Biomedical Research and Takeda Oncology; NATIONAL CANCER INSTITUTE [R01CA116020, R01CA201049] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis Institutes for Biomedical Research and Takeda Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute, National Institutes of Health, Grants R01CA116020 and R01CA201049. Michael J. Eck receives sponsored research support from Novartis Institutes for Biomedical Research and Takeda Oncology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brenan L, 2016, CELL REP, V17, P1171, DOI 10.1016/j.celrep.2016.09.061; Chakroborty D, 2019, J BIOL CHEM, V294, P9377, DOI 10.1074/jbc.RA118.006336; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jiang JR, 2005, CANCER RES, V65, P8968, DOI 10.1158/0008-5472.CAN-05-1829; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pon JR, 2015, ANNU REV PATHOL-MECH, V10, P25, DOI 10.1146/annurev-pathol-012414-040312; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	10	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9390	9391		10.1074/jbc.H119.009452	http://dx.doi.org/10.1074/jbc.H119.009452			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31201242	Green Published, hybrid			2022-12-28	WOS:000472713000009
J	Du, WL; Dong, Q; Zhang, ZQ; Liu, BD; Zhou, T; Xu, RM; Wang, HL; Zhu, B; Li, YF				Du, Wenlong; Dong, Qiang; Zhang, Zhuqiang; Liu, Baodong; Zhou, Ting; Xu, Rui-ming; Wang, Hailin; Zhu, Bing; Li, Yingfeng			Stella protein facilitates DNA demethylation by disrupting the chromatin association of the RING finger-type E3 ubiquitin ligase UHRF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA demethylation; DNA methylation; gene regulation; epigenetics; protein-protein interaction; chromatin association; developmental pluripotency associated 3 (DPPA3); FRAP assay; Stella; ubiquitin-like with PHD and RING finger domains 1 (UHRF1)	HEMI-METHYLATED DNA; SRA DOMAIN; EPIGENETIC INHERITANCE; ANTILEUKEMIC AGENT; TANDEM TUDOR; CPG-BINDING; PHD DOMAIN; PHASE-I; RECOGNITION; GENE	Stella is a maternal gene required for oogenesis and early embryogenesis. Stella overexpression in somatic cells causes global demethylation. As we have recently shown, Stella sequesters nuclear ubiquitin-like with PHD and RING finger domains 1 (UHRF1), a RING finger-type E3 ubiquitin ligase essential for DNA methylation mediated by DNA methyltransferase 1 and triggers global demethylation. Here, we report an overexpressed mutant Stella protein without nuclear export activity surprisingly retained its ability to cause global demethylation. By combining biochemical interaction assays, isothermal titration calorimetry, immunostaining, and live-cell imaging with fluorescence recovery after photobleaching, we found that Stella disrupts UHRF1's association with chromatin by directly binding to the plant homeodomain of UHRF1 and competing for the interaction between UHRF1 and the histone H3 tail. Consistently, overexpression of Stella mutants that do not directly interact with UHRF1 fails to cause genome-wide demethylation. In the presence of nuclear Stella, UHRF1 could not bind to chromatin and exhibited increased dynamics in the nucleus. Our results indicate that Stella employs a multilayered mechanism to achieve robust UHRF1 inhibition, which involves the dissociation from chromatin and cytoplasmic sequestration of UHRF1.	[Du, Wenlong] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Du, Wenlong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Du, Wenlong; Dong, Qiang; Zhang, Zhuqiang; Zhou, Ting; Xu, Rui-ming; Zhu, Bing; Li, Yingfeng] Chinese Acad Sci, Natl Lab Biomacromol, CAS Ctr Excellence Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Liu, Baodong; Wang, Hailin] Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Res Ctr Ecoenvironm Sci, Beijing 100085, Peoples R China; [Xu, Rui-ming; Zhu, Bing] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Beijing Normal University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, YF (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, CAS Ctr Excellence Biomacromol, Inst Biophys, Beijing 100101, Peoples R China.	liyingfeng@nibs.ac.cn	xu, rui/GRX-5734-2022	Li, Yingfeng/0000-0002-9492-9931	Youth Innovation Promotion Association of the Chinese Academy of Sciences [2017133]	Youth Innovation Promotion Association of the Chinese Academy of Sciences	Supported by the Youth Innovation Promotion Association Grant 2017133 of the Chinese Academy of Sciences.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bortvin Alex, 2004, BMC Developmental Biology, V4; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cheng JD, 2013, J BIOL CHEM, V288, P1329, DOI 10.1074/jbc.M112.415398; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dong Q, 2018, P NATL ACAD SCI USA, V115, pE4013, DOI 10.1073/pnas.1800505115; Fang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11197; Funaki S, 2014, BIOCHEM BIOPH RES CO, V453, P455, DOI 10.1016/j.bbrc.2014.09.101; Han LS, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0081-2; Harrison JS, 2016, ELIFE, V5, DOI 10.7554/eLife.17101; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hu LL, 2011, CELL RES, V21, P1374, DOI 10.1038/cr.2011.124; Ishiyama S, 2017, MOL CELL, V68, P350, DOI 10.1016/j.molcel.2017.09.037; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Li T, 2018, NUCLEIC ACIDS RES, V46, P3218, DOI 10.1093/nar/gky104; Li X, 2018, J BIOL CHEM, V293, P7423, DOI 10.1074/jbc.RA117.000757; Li YF, 2018, NATURE, V564, P136, DOI 10.1038/s41586-018-0751-5; Mirza AN, 2019, CELL, V176, P198, DOI 10.1016/j.cell.2018.10.054; MOMPARLER RL, 1989, TOXICOLOGY, V57, P329, DOI 10.1016/0300-483X(89)90120-0; Momparler RL, 1997, ANTI-CANCER DRUG, V8, P358, DOI 10.1097/00001813-199704000-00008; MOMPARLER RL, 1981, DRUG CHEM TOXICOL, V4, P373, DOI 10.3109/01480548109017828; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Qian CM, 2008, J BIOL CHEM, V283, P34490, DOI 10.1074/jbc.C800169200; Qin WH, 2015, CELL RES, V25, P911, DOI 10.1038/cr.2015.72; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; RIVARD GE, 1981, LEUKEMIA RES, V5, P453, DOI 10.1016/0145-2126(81)90116-8; Rothbart SB, 2013, GENE DEV, V27, P1288, DOI 10.1101/gad.220467.113; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sakurai-Yageta M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116637; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shi HD, 2002, CANCER RES, V62, P3214; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Vaughan RM, 2018, P NATL ACAD SCI USA, V115, P8775, DOI 10.1073/pnas.1806373115; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Zhao BL, 2014, NUCLEIC ACIDS RES, V42, P1593, DOI 10.1093/nar/gkt1090	48	14	14	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8907	8917		10.1074/jbc.RA119.008008	http://dx.doi.org/10.1074/jbc.RA119.008008			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31018966	Green Published, hybrid			2022-12-28	WOS:000470971100024
J	O'Connor, CM; Lai, CK; Collins, K				O'Connor, Catherine M.; Lai, Cary K.; Collins, Kathleen			Two purified domains of telomerase reverse transcriptase reconstitute sequence-specific interactions with RNA (vol 280, pg 17533, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8713	8713		10.1074/jbc.AAC119.009170	http://dx.doi.org/10.1074/jbc.AAC119.009170			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31152094	Green Published, hybrid			2022-12-28	WOS:000470971100005
J	Petitjean, M; Teste, MA; Francois, JM; Parrou, JL				Petitjean, Marjorie; Teste, Marie-Ange; Francois, Jean M.; Parrou, Jean-Luc			RETRACTION: Withdrawal: Yeast tolerance to various stresses relies on the trehalose-6P synthase (Tps1) protein, not on trehalose. (Retraction of Vol 290, Pg 16177, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Petitjean M, 2015, J BIOL CHEM, V290, P16177, DOI 10.1074/jbc.M115.653899	1	0	0	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5812	5812		10.1074/jbc.W119.008564	http://dx.doi.org/10.1074/jbc.W119.008564			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30979854	Green Published, hybrid			2022-12-28	WOS:000465077500013
J	Hill, SE; Kwon, MS; Martin, MD; Suntharalingam, A; Hazel, A; Dickey, CA; Gumbart, JC; Lieberman, RL				Hill, Shannon E.; Kwon, Michelle S.; Martin, Mackenzie D.; Suntharalingam, Amirthaa; Hazel, Anthony; Dickey, Chad A.; Gumbart, James C.; Lieberman, Raquel L.			Stable calcium-free myocilin olfactomedin domain variants reveal challenges in differentiating between benign and glaucoma-causing mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; protein misfolding; protein secretion; extracellular matrix protein; X-ray crystallography; molecular dynamics; protein aggregation; glaucoma	TRABECULAR MESHWORK; EXTRACELLULAR-MATRIX; MOLECULAR-DYNAMICS; PROTEIN STABILITY; MUTANT MYOCILIN; ER STRESS; GENE; TIGR/MYOCILIN; PREVALENCE; REFINEMENT	Nonsynonymous gene mutations can be beneficial, neutral, or detrimental to the stability, structure, and biological function of the encoded protein, but the effects of these mutations are often not readily predictable. For example, the beta-propeller olfactomedin domain of myocilin (mOLF) exhibits a complex interrelationship among structure(s), stability, and aggregation. Numerous mutations within mOLF are linked to glaucoma; the resulting variants are less stable, aggregation-prone, and sequestered intracellularly, causing cytotoxicity. Here, we report the first stable mOLF variants carrying substitutions in the calcium-binding site that exhibit solution characteristics indistinguishable from those of glaucoma variants. Crystal structures of these stable variants at 1.8-2.0-angstrom resolution revealed features that we could not predict by molecular dynamics simulations, including loss of loop structure, helix unwinding, and a blade shift. Double mutants that combined a stabilizing substitution and a selected glaucoma-causing single-point mutant rescued in vitro folding and stability defects. In the context of full-length myocilin, secretion of stable single variants was indistinguishable from that of the WT protein, and the double mutants were secreted to varying extents. In summary, our finding that mOLF can tolerate particular substitutions that render the protein stable despite a conformational switch emphasizes the complexities in differentiating between benign and glaucoma-causing variants and provides new insight into the possible biological function of myocilin.	[Hill, Shannon E.; Kwon, Michelle S.; Martin, Mackenzie D.; Dickey, Chad A.; Gumbart, James C.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, 901 Atlantic Dr NW, Atlanta, GA 30332 USA; [Hazel, Anthony; Gumbart, James C.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Suntharalingam, Amirthaa; Dickey, Chad A.] Univ S Florida, Dept Mol Med, Tampa, FL 33613 USA; [Suntharalingam, Amirthaa; Dickey, Chad A.] Univ S Florida, Byrd Alzheimers Res Inst, Tampa, FL 33613 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Lieberman, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, 901 Atlantic Dr NW, Atlanta, GA 30332 USA.	Raquel.lieberman@chemistry.gatech.edu		Hazel, Anthony/0000-0002-8195-7909; Kwon, Michelle/0000-0003-4772-1553	National Institutes of Health Equipment [S10_RR25528, S10_RR028976]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL EYE INSTITUTE [R01EY021205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123169] Funding Source: NIH RePORTER	National Institutes of Health Equipment(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Petit Institute Core Facility for access to instrumentation. Southeast Regional Collaborative Access Team (SER-CAT) is supported by its member institutions and National Institutes of Health Equipment Grants S10_RR25528 and S10_RR028976. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Acott TS, 2014, J OCUL PHARMACOL TH, V30, P94, DOI 10.1089/jop.2013.0185; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anholt RRH, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00006; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Burns JN, 2011, BIOCHEMISTRY-US, V50, P5824, DOI 10.1021/bi200231x; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; Case D. A., 2019, AMBER 19; Challa P, 2002, J GLAUCOMA, V11, P416, DOI 10.1097/00061198-200210000-00008; Cheng H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003926; Clark AF, 2012, INVEST OPHTH VIS SCI, V53, P2473, DOI 10.1167/iovs.12-9483g; Colon W, 2017, BIOCHEMISTRY-US, V56, P6179, DOI 10.1021/acs.biochem.7b00942; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Donegan RK, 2015, HUM MOL GENET, V24, P2111, DOI 10.1093/hmg/ddu730; Donegan RK, 2012, J BIOL CHEM, V287, P43370, DOI 10.1074/jbc.M112.408906; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gershenson A, 2014, NAT CHEM BIOL, V10, P884, DOI 10.1038/nchembio.1670; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Han HJ, 2015, J BIOL CHEM, V290, P3612, DOI 10.1074/jbc.M114.627547; Hartmann MD, 2017, SUBCELL BIOCHEM, V82, P63, DOI 10.1007/978-3-319-49674-0_3; Hill SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130888; Hill SE, 2014, J MOL BIOL, V426, P921, DOI 10.1016/j.jmb.2013.12.002; Huard DJE, 2018, ACS CHEM BIOL, V13, P933, DOI 10.1021/acschembio.7b01083; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain A, 2017, P NATL ACAD SCI USA, V114, P11199, DOI 10.1073/pnas.1706193114; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keller KE, 2007, INVEST OPHTH VIS SCI, V48, P1164, DOI 10.1167/iovs.06-0875; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; Li Q, 2019, MOL GENET GENOMICS, V294, P875, DOI 10.1007/s00438-019-01549-9; Liton PB, 2008, J GLAUCOMA, V17, P378, DOI 10.1097/IJG.0b013e31815f52a8; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Mancl JM, 2019, STRUCTURE, V27, P785, DOI 10.1016/j.str.2019.02.006; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDowell CM, 2012, EXP EYE RES, V100, P65, DOI 10.1016/j.exer.2012.04.016; Orwig SD, 2012, J MOL BIOL, V421, P242, DOI 10.1016/j.jmb.2011.12.016; Orwig SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016347; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasband MN, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020495; Reich L, 2009, BIOPHYS CHEM, V141, P186, DOI 10.1016/j.bpc.2009.01.015; Sacca SC, 2009, MUTAT RES-FUND MOL M, V667, P98, DOI 10.1016/j.mrfmmm.2008.11.002; SCHREIBER C, 1994, STRUCTURE, V2, P945, DOI 10.1016/S0969-2126(94)00096-4; Schultz JE, 2013, TRENDS BIOCHEM SCI, V38, P538, DOI 10.1016/j.tibs.2013.08.005; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Stothert AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18344-4; Stothert AR, 2016, EXP EYE RES, V144, P38, DOI 10.1016/j.exer.2015.08.017; Stothert AR, 2014, HUM MOL GENET, V23, P6470, DOI 10.1093/hmg/ddu367; Stumpff F, 2000, OPHTHALMOLOGICA, V214, P33, DOI 10.1159/000027471; Suntharalingam A, 2012, J BIOL CHEM, V287, P40661, DOI 10.1074/jbc.M112.384800; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Whitford PC, 2007, J MOL BIOL, V366, P1661, DOI 10.1016/j.jmb.2006.11.085; Wiggs JL, 2017, HUM MOL GENET, V26, pR21, DOI 10.1093/hmg/ddx184; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098; Zenga LC, 2005, FEBS LETT, V579, P5443, DOI 10.1016/j.febslet.2005.08.064; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	72	8	8	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12717	12728		10.1074/jbc.RA119.009419	http://dx.doi.org/10.1074/jbc.RA119.009419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31270212	Green Published, hybrid			2022-12-28	WOS:000484414600014
J	Olotu, C; Lehmensiek, F; Koch, B; Kiefmann, M; Riegel, AK; Hammerschmidt, S; Kiefmann, R				Olotu, Cynthia; Lehmensiek, Felix; Koch, Bastian; Kiefmann, Martina; Riegel, Ann-Kathrin; Hammerschmidt, Sven; Kiefmann, Rainer			Streptococcus pneumoniae inhibits purinergic signaling and promotes purinergic receptor P2Y(2) internalization in alveolar epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pneumonia; purinergic receptor; lung; calcium; receptor internalization; Streptococcus; ATP; alveolar epithelial cells; receptor phosphorylation; Streptococcus pneumoniae; virulence	NUCLEOTIDE RECEPTOR; EXPRESSION; ADHERENCE; CA2+; DESENSITIZATION; TRANSDUCTION; RELEASE; UTP; PHOSPHORYLATION; TRANSLOCATION	Bacterial pneumonia is a global health challenge that causes up to 2 million deaths each year. Purinergic signaling plays a pivotal role in healthy alveolar epithelium. Here, we used fluorophore-based analysis and live-cell calcium imaging to address the question of whether the bacterial pathogen Streptococcus pneumoniae directly interferes with purinergic signaling in alveolar epithelial cells. Disturbed purinergic signaling might result in pathophysiologic changes like edema formation and atelectasis, which are commonly seen in bacterial pneumonia. Purine receptors are mainly activated by ATP, mediating a cytosolic calcium response. We found that this purinergic receptor P2Y(2)-mediated response is suppressed in the presence of S. pneumoniae in A549 and isolated primary alveolar cells in a temperature-dependent manner. Downstream inositol 3-phosphate (IP3) signaling appeared to be unaffected, as calcium signaling via protease-activated receptor 2 remained unaltered. S. pneumoniae-induced suppression of the P2Y(2)-mediated calcium response depended on the P2Y(2) phosphorylation sites Ser-243, Thr-344, and Ser-356, which are involved in receptor desensitization and internalization. Spinning-disk live-cell imaging revealed that S. pneumoniae induces P2Y(2) translocation into the cytosol. In conclusion, our results show that S. pneumoniae directly inhibits purinergic signaling by inducing P2Y(2) phosphorylation and internalization, resulting in the suppression of the calcium response of alveolar epithelial cells to ATP, thereby affecting cellular integrity and function.	[Olotu, Cynthia; Lehmensiek, Felix; Koch, Bastian; Kiefmann, Martina; Riegel, Ann-Kathrin; Kiefmann, Rainer] Univ Med Ctr Hamburg Eppendorf, Ctr Anesthesiol & Intens Care Med, Martinistr 52, D-22051 Hamburg, Germany; [Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funct Genom, Dept Mol Genet & Infect Biol, Felix Hausdorff Str 8, D-17489 Greifswald, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Ernst Moritz Arndt Universitat Greifswald	Olotu, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Anesthesiol & Intens Care Med, Martinistr 52, D-22051 Hamburg, Germany.	c.olotu@uke.de	Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681				Adamou JE, 1998, INFECT IMMUN, V66, P820, DOI 10.1128/IAI.66.2.820-822.1998; Andersson K, 1999, INFECT IMMUN, V67, P2567, DOI 10.1128/IAI.67.5.2567-2574.1999; Asmat TM, 2011, J BIOL CHEM, V286, P17861, DOI 10.1074/jbc.M110.212225; Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bonnet M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00016; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Cohen A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40779-0; Communi D, 1999, BRIT J PHARMACOL, V127, P562, DOI 10.1038/sj.bjp.0702560; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Nguyen CT, 2014, INFECT IMMUN, V82, P3802, DOI 10.1128/IAI.02012-14; Davis IC, 2004, AM J PHYSIOL-LUNG C, V286, pL112, DOI 10.1152/ajplung.00218.2003; Delclaux C, 2003, EUR RESPIR J, V22, p10S, DOI 10.1183/09031936.03.00420203; Devor DC, 1999, AM J PHYSIOL-CELL PH, V276, pC827, DOI 10.1152/ajpcell.1999.276.4.C827; DOBBS LG, 2002, CULTURE EPITHELIAL C, P277; DOUGLAS WHJ, 1974, IN VITRO CELL DEV B, V10, P230; Facco M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093612; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Flores RV, 2005, MOL CELL BIOCHEM, V280, P35, DOI 10.1007/s11010-005-8050-5; Garrad RC, 1998, J BIOL CHEM, V273, P29437, DOI 10.1074/jbc.273.45.29437; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Goldman N, 2013, CELL CALCIUM, V53, P297, DOI 10.1016/j.ceca.2013.01.004; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hoffmann G, 1995, BIOCHEM BIOPH RES CO, V217, P575, DOI 10.1006/bbrc.1995.2814; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Hu L, 2005, MICROBIOL-SGM, V151, P3097, DOI 10.1099/mic.0.27866-0; Isakson BE, 2001, AM J PHYSIOL-CELL PH, V281, pC1291, DOI 10.1152/ajpcell.2001.281.4.C1291; Jacob T, 2002, INFECT IMMUN, V70, P6399, DOI 10.1128/IAI.70.11.6399-6408.2002; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Johansson E. W., 2006, PNEUMONIA FORGOTTEN; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kern B, 2015, CELL MICROBIOL, V17, P1811, DOI 10.1111/cmi.12474; Kolli BK, 2008, MOL BIOCHEM PARASIT, V158, P163, DOI 10.1016/j.molbiopara.2007.12.010; Koslowski R, 2004, HISTOCHEM CELL BIOL, V121, P509, DOI 10.1007/s00418-004-0662-4; Krachler AM, 2011, J CELL BIOL, V195, P1083, DOI 10.1083/jcb.201107132; Lazarowski ER, 2001, NEWS PHYSIOL SCI, V16, P1; Le Duc D, 2017, ADV IMMUNOL, V136, P85, DOI 10.1016/bs.ai.2017.05.006; Lee IT, 2013, INT J BIOCHEM CELL B, V45, P1657, DOI 10.1016/j.biocel.2013.05.006; LETOURNEAU J, 2011, JOVE-J VIS EXP   MAY, DOI DOI 10.3791/2783; Ligeti E, 2012, ACTA PHYSIOL, V204, P469, DOI 10.1111/j.1748-1716.2012.02414.x; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; MAJEED M, 1994, INFECT IMMUN, V62, P126, DOI 10.1128/IAI.62.1.126-134.1994; Malloy JL, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-8; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Mccoy KL, 2010, MOL PHARMACOL, V77, P1005, DOI 10.1124/mol.109.062018; Merriam LA, 2013, J NEUROSCI, V33, P4614, DOI 10.1523/JNEUROSCI.4999-12.2013; Nhieu GT, 2004, BIOL CELL, V96, P93, DOI 10.1016/j.biocel.2003.10.006; Ostrowska E, 2007, AM J PHYSIOL-LUNG C, V293, pL1208, DOI 10.1152/ajplung.00137.2007; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; Park JY, 2016, ARCH PHARM RES, V39, P293, DOI 10.1007/s12272-016-0712-1; Parker D, 2011, MBIO, V2, DOI 10.1128/mBio.00016-11; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Qiao R, 2008, AM J RESP CELL MOL, V38, P239, DOI 10.1165/rcmb.2007-0172OC; Repp H, 2002, CELL MICROBIOL, V4, P483, DOI 10.1046/j.1462-5822.2002.00207.x; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; RICE WR, 1987, BRIT J PHARMACOL, V91, P833, DOI 10.1111/j.1476-5381.1987.tb11282.x; Rolan HG, 2013, CELL HOST MICROBE, V14, P306, DOI 10.1016/j.chom.2013.08.013; Saleh M, 2013, EMBO MOL MED, V5, P1852, DOI 10.1002/emmm.201202435; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Schafer R, 2003, AM J PHYSIOL-LUNG C, V285, pL376, DOI 10.1152/ajplung.00447.2002; Schmeck B, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-98; Sharif O, 2013, J IMMUNOL, V190, P5640, DOI 10.4049/jimmunol.1202270; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Sromek SM, 1998, MOL PHARMACOL, V54, P485, DOI 10.1124/mol.54.3.485; Talbot UM, 1996, INFECT IMMUN, V64, P3772, DOI 10.1128/IAI.64.9.3772-3777.1996; Teng HB, 2003, J PHYSIOL-LONDON, V551, P103, DOI 10.1113/jphysiol.2003.041152; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tulapurkar ME, 2006, J NEUROCHEM, V96, P624, DOI 10.1111/j.1471-4159.2005.03594.x; Ubl JJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1339, DOI 10.1152/ajplung.00392.2001; WALDRON RT, 1994, J BIOL CHEM, V269, P11927; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x; Zemskov Evgeny, 2011, J Cardiovasc Dis Res, V2, P14, DOI 10.4103/0975-3583.78582	75	8	8	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12795	12806		10.1074/jbc.RA118.007236	http://dx.doi.org/10.1074/jbc.RA118.007236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31289122	hybrid, Green Published			2022-12-28	WOS:000484414600020
J	Talbot, BE; Vandorpe, DH; Stotter, BR; Alper, SL; Schlondorff, JS				Talbot, Brianna E.; Vandorpe, David H.; Stotter, Brian R.; Alper, Seth L.; Schlondorff, Johannes S.			Transmembrane insertases and N-glycosylation critically determine synthesis, trafficking, and activity of the nonselective cation channel TRPC6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						channel activation; CRISPR; Cas; endoplasmic reticulum (ER); N-linked glycosylation; protein translocation; transient receptor potential channels (TRP channels); post-translational modification (PTM); nonselective cation channel	RECEPTOR POTENTIAL CHANNELS; OF-FUNCTION MUTATION; SMOOTH-MUSCLE; SURFACE EXPRESSION; CALCIUM-ENTRY; CANONICAL 6; CA2+ ENTRY; ACTIVATION; MEMBRANE; PODOCYTES	Transient receptor potential cation channel subfamily C member 6 (TRPC6) is a widely expressed ion channel. Gain-of-function mutations in the human TRPC6 channel cause autosomal-dominant focal segmental glomerulosclerosis, but the molecular components involved in disease development remain unclear. Here, we found that overexpression of gain-of-function TRPC6 channel variants is cytotoxic in cultured cells. Exploiting this phenotype in a genome-wide CRISPR/Cas screen for genes whose inactivation rescues cells from TRPC6-associated cytotoxicity, we identified several proteins essential for TRPC6 protein expression, including the endoplasmic reticulum (ER) membrane protein complex transmembrane insertase. We also identified transmembrane protein 208 (TMEM208), a putative component of a signal recognition particle-independent (SND) ER protein-targeting pathway, as being necessary for expression of TRPC6 and several other ion channels and transporters. TRPC6 expression was also diminished by loss of the previously uncharacterized WD repeat domain 83 opposite strand (WDR83OS), which interacted with both TRPC6 and TMEM208. Additionally enriched among the screen hits were genes involved in N-linked protein glycosylation. Deletion of the mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (MGAT1), necessary for the generation of complex N-linked glycans, abrogated TRPC6 gain-of-function variant-mediated Ca2+ influx and extracellular signal-regulated kinase activation in HEK cells, but failed to diminish cytotoxicity in cultured podocytes. However, mutating the two TRPC6 N-glycosylation sites abrogated the cytotoxicity of mutant TRPC6 and reduced its surface expression. These results expand the targets of TMEM208-mediated ER translocation to include multipass transmembrane proteins and suggest that TRPC6 N-glycosylation plays multiple roles in modulating channel trafficking and activity.	[Talbot, Brianna E.; Vandorpe, David H.; Stotter, Brian R.; Alper, Seth L.; Schlondorff, Johannes S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Stotter, Brian R.] Harvard Med Sch, Boston Childrens Hosp, Div Nephrol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Schlondorff, JS (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA.	jschlond@bidmc.harvard.edu	Stotter, Brian/AAX-9688-2020	Stotter, Brian/0000-0003-1505-7424; Schlondorff, Johannes/0000-0002-9973-9731; Talbot, Brianna/0000-0002-7959-9479	National Institutes of Health [R01DK115438, T32 DK007726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007726, R01DK115438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK115438 (to J. S.) and T32 DK007726 (B. R. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; Ambudkar I. S., 2007, V179, P541; Anderson M, 2013, AM J PHYSIOL-CELL PH, V305, pC276, DOI 10.1152/ajpcell.00095.2013; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Azumaya CM, 2018, J BIOL CHEM, V293, P10381, DOI 10.1074/jbc.RA118.003183; Barger CJ, 2019, CANCERS, V11, DOI 10.3390/cancers11020251; Basora N, 2003, J BIOL CHEM, V278, P31709, DOI 10.1074/jbc.M304437200; Beech DJ, 2004, J PHYSIOL-LONDON, V559, P685, DOI 10.1113/jphysiol.2004.068734; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Bouron A, 2016, ADV EXP MED BIOL, V898, P201, DOI 10.1007/978-3-319-26974-0_10; Casson J, 2017, J CELL SCI, V130, P3851, DOI 10.1242/jcs.207829; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Chaudhuri P, 2016, P NATL ACAD SCI USA, V113, P2110, DOI 10.1073/pnas.1600371113; Chiluiza D, 2013, J BIOL CHEM, V288, P18407, DOI 10.1074/jbc.M113.463059; Chitwood PJ, 2018, CELL, V175, P1507, DOI 10.1016/j.cell.2018.10.009; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Damann N, 2009, ACTA PHYSIOL, V195, P3, DOI 10.1111/j.1748-1716.2008.01918.x; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; de Souza LB, 2014, CELL CALCIUM, V56, P43, DOI 10.1016/j.ceca.2014.05.001; Dettmer U, 2010, J BIOL CHEM, V285, P26174, DOI 10.1074/jbc.M110.132548; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dietrich A, 2014, HANDB EXP PHARMACOL, V222, P157, DOI 10.1007/978-3-642-54215-2_7; Ding YF, 2011, J BIOL CHEM, V286, P31799, DOI 10.1074/jbc.M111.248344; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doleschal B, 2015, CARDIOVASC RES, V106, P163, DOI 10.1093/cvr/cvv022; Du WL, 2010, J CLIN INVEST, V120, P3480, DOI 10.1172/JCI43165; Dyachenko V, 2009, CELL CALCIUM, V45, P38, DOI 10.1016/j.ceca.2008.06.003; Estacion M, 2006, J PHYSIOL-LONDON, V572, P359, DOI 10.1113/jphysiol.2005.103143; Gigante M, 2011, CLIN J AM SOC NEPHRO, V6, P1626, DOI 10.2215/CJN.07830910; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gonzales AL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004732; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Gudermann Thomas, 2004, Sci STKE, V2004, ppe35; Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099; Hassdenteufel S, 2017, FEBS LETT, V591, P3211, DOI 10.1002/1873-3468.12831; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann K, 2017, BBA-MOL BASIS DIS, V1863, P560, DOI 10.1016/j.bbadis.2016.12.002; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hofstra JM, 2013, NEPHROL DIAL TRANSPL, V28, P1830, DOI 10.1093/ndt/gfs572; Ilatovskaya DV, 2018, J AM SOC NEPHROL, V29, P1917, DOI 10.1681/ASN.2018030280; Inoue R, 2019, SEMIN CELL DEV BIOL, V94, P40, DOI 10.1016/j.semcdb.2018.11.002; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Jiang LN, 2011, EXP BIOL MED, V236, P184, DOI 10.1258/ebm.2010.010237; Kanda S, 2011, MOL BIOL CELL, V22, P1824, DOI 10.1091/mbc.E10-12-0929; Kim EY, 2019, BIOCHEM BIOPHYS REP, V17, P139, DOI 10.1016/j.bbrep.2018.12.006; Kim EY, 2012, MOL PHARMACOL, V82, P728, DOI 10.1124/mol.112.079376; Kim EY, 2012, AM J PHYSIOL-RENAL, V302, pF298, DOI 10.1152/ajprenal.00423.2011; Kistler AD, 2013, J BIOL CHEM, V288, P36598, DOI 10.1074/jbc.M113.488122; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lemos VS, 2007, BIOCHEM BIOPH RES CO, V352, P130, DOI 10.1016/j.bbrc.2006.10.160; Liu BC, 2013, BBA-MOL CELL RES, V1833, P1434, DOI 10.1016/j.bbamcr.2013.02.031; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; Maddirevula S, 2019, GENET MED, V21, P1164, DOI 10.1038/s41436-018-0288-x; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Nikolova-Krstevski Vesna, 2017, JACC Basic Transl Sci, V2, P575, DOI 10.1016/j.jacbts.2017.05.006; Nilius B, 2005, PFLUG ARCH EUR J PHY, V451, P1, DOI 10.1007/s00424-005-1462-y; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Przybylla S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159778; Quick K, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120068; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Riehle M, 2016, J AM SOC NEPHROL, V27, P2771, DOI 10.1681/ASN.2015030318; Roshanravan H, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00351; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306; Schilling William P, 2004, Novartis Found Symp, V258, P18; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Spires D, 2018, AM J PHYSIOL-RENAL, V315, pF1091, DOI 10.1152/ajprenal.00155.2018; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Tang QL, 2018, CELL RES, V28, P746, DOI 10.1038/s41422-018-0038-2; Thakur DP, 2016, P NATL ACAD SCI USA, V113, P1092, DOI 10.1073/pnas.1522294113; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206; Verheijden KAT, 2018, J AM SOC NEPHROL, V29, P2099, DOI 10.1681/ASN.2016111248; Wang LM, 2019, KIDNEY INT, V95, P321, DOI 10.1016/j.kint.2018.09.026; Weber EW, 2015, J EXP MED, V212, P1883, DOI 10.1084/jem.20150353; Weissmann N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1660; Welsh DG, 2002, CIRC RES, V90, P248, DOI 10.1161/hh0302.105662; Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.1; Wilson C, 2014, AM J PHYSIOL-RENAL, V306, pF1018, DOI 10.1152/ajprenal.00662.2013; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Wu YL, 2017, KIDNEY INT, V91, P830, DOI 10.1016/j.kint.2016.09.039; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Xu XP, 2013, BIOPHYS J, V104, p454A, DOI 10.1016/j.bpj.2012.11.2513; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yao H, 2009, CELL DEATH DIFFER, V16, P1681, DOI 10.1038/cdd.2009.108; Yu H, 2016, J AM SOC NEPHROL, V27, P3308, DOI 10.1681/ASN.2015080896; Zhao YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064228; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127	111	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12655	12669		10.1074/jbc.RA119.008299	http://dx.doi.org/10.1074/jbc.RA119.008299			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31266804	hybrid, Green Published			2022-12-28	WOS:000484414600009
J	Dagnell, M; Cheng, Q; Rizvi, SHM; Pace, PE; Boivin, B; Winterbourn, CC; Arner, ESJ				Dagnell, Markus; Cheng, Qing; Rizvi, Syed Husain Mustafa; Pace, Paul E.; Boivin, Benoit; Winterbourn, Christine C.; Arner, Elias S. J.			Bicarbonate is essential for protein-tyrosine phosphatase 1B (PTP1B) oxidation and cellular signaling through EGF-triggered phosphorylation cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; bicarbonate; epidermal growth factor receptor (EGFR); thioredoxin reductase; peroxiredoxin; oxidative inactivation; peroxymonocarbonate; protein-tyrosine phosphatase (PTP); redox regulation; redox signaling; phosphorylation cascade	GROWTH-FACTOR RECEPTOR; CARBONIC-ANHYDRASE-IX; ACTIVE-SITE CYSTEINE; HUMAN BREAST-CANCER; HYDROGEN-PEROXIDE; REDOX REGULATION; REVERSIBLE INACTIVATION; OXIDIZED PTP1B; PH CONTROL; PEROXYMONOCARBONATE	Protein-tyrosine phosphatases (PTPs) counteract protein tyrosine phosphorylation and cooperate with receptor-tyrosine kinases in the regulation of cell signaling. PTPs need to undergo oxidative inhibition for activation of cellular cascades of protein-tyrosine kinase phosphorylation following growth factor stimulation. It has remained enigmatic how such oxidation can occur in the presence of potent cellular reducing systems. Here, using in vitro biochemical assays with purified, recombinant protein, along with experiments in the adenocarcinoma cell line A431, we discovered that bicarbonate, which reacts with H2O2 to form the more reactive peroxymonocarbonate, potently facilitates H2O2-mediated PTP1B inactivation in the presence of thioredoxin reductase 1 (TrxR1), thioredoxin 1 (Trx1), and peroxiredoxin 2 (Prx2) together with NADPH. The cellular experiments revealed that intracellular bicarbonate proportionally dictates total protein phosphotyrosine levels obtained after stimulation with epidermal growth factor (EGF) and that bicarbonate levels directly correlate with the extent of PTP1B oxidation. In fact, EGF-induced cellular oxidation of PTP1B was completely dependent on the presence of bicarbonate. These results provide a plausible mechanism for PTP inactivation during cell signaling and explain long-standing observations that growth factor responses and protein phosphorylation cascades are intimately linked to the cellular acid-base balance.	[Dagnell, Markus; Cheng, Qing; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden; [Pace, Paul E.; Winterbourn, Christine C.] Univ Otago, Dept Pathol & Biomed Sci, Ctr Free Rad Res, Christchurch 8011, New Zealand; [Rizvi, Syed Husain Mustafa; Boivin, Benoit] SUNY Polytech Inst, Dept Nanobiosci, Albany, NY 12203 USA	Karolinska Institutet; University of Otago; SUNY Polytechnic Institute	Dagnell, M; Arner, ESJ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden.; Winterbourn, CC (corresponding author), Univ Otago, Dept Pathol & Biomed Sci, Ctr Free Rad Res, Christchurch 8011, New Zealand.	Markus.Dagnell@ki.se; Christine.Winterbourn@otago.ac.nz; Elias.Arner@ki.se	RIZVI, SYED HUSAIN MUSTAFA/H-7282-2019; Arnér, Elias/K-6737-2019	RIZVI, SYED HUSAIN MUSTAFA/0000-0003-0136-9646; Arnér, Elias/0000-0002-4807-6114; Winterbourn, Christine/0000-0003-4160-572X; Boivin, Benoit/0000-0003-3306-5970; Dagnell, Markus/0000-0002-5925-6794	Karolinska Institutet; Knut and Alice Wallenberg Foundations; Swedish Cancer Society; Karolinska Institutet Research Foundations; Swedish Research Council [537-2014-360]; Swedish Society of Medicine [SLS-786841]; Ake Wiberg Stiftelse [M17-0101, M18-0141]; National Institutes of Health [HL138605]; American Heart Association [17GRNT33700265]; New Zealand Marsden Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL138605] Funding Source: NIH RePORTER	Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundations(Knut & Alice Wallenberg Foundation); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet Research Foundations(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Ake Wiberg Stiftelse; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Karolinska Institutet, the Knut and Alice Wallenberg Foundations, the Swedish Cancer Society, the Karolinska Institutet Research Foundations (to E.S.J.A.), Swedish Research Council Grant (to E.S.J.A. and M.D.) 537-2014-360, Swedish Society of Medicine Grant SLS-786841, Ake Wiberg Stiftelse Grants M17-0101 and M18-0141 (to M.D.), National Institutes of Health Grant HL138605, American Heart Association Grant 17GRNT33700265 (to B.B.), and the New Zealand Marsden Fund (to C.C.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aalkjaer C, 2014, COMPR PHYSIOL, V4, P1605, DOI 10.1002/cphy.c130005; Adam A, 1998, ANGEW CHEM INT EDIT, V37, P1387, DOI 10.1002/(SICI)1521-3773(19980605)37:10<1387::AID-ANIE1387>3.0.CO;2-3; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Antunes F, 2017, REDOX BIOL, V13, P1, DOI 10.1016/j.redox.2017.04.039; Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Bakhmutova-Albert EV, 2010, INORG CHEM, V49, P11287, DOI 10.1021/ic1007389; Balagam B, 2008, INORG CHEM, V47, P1173, DOI 10.1021/ic701402h; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Bertolotti M, 2016, J LEUKOCYTE BIOL, V100, P1071, DOI 10.1189/jlb.2AB0116-045R; Boedtkjer E, 2013, INT J CANCER, V132, P1288, DOI 10.1002/ijc.27782; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Boivin B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137pl2; Ch'en FT, 2008, BRIT J PHARMACOL, V153, P972, DOI 10.1038/sj.bjp.0707667; Dagnell M, 2017, J BIOL CHEM, V292, P14371, DOI 10.1074/jbc.M117.793745; Dagnell M, 2013, P NATL ACAD SCI USA, V110, P13398, DOI 10.1073/pnas.1302891110; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Dorai T, 2005, EUR J CANCER, V41, P2935, DOI 10.1016/j.ejca.2005.09.011; Frijhoff J, 2014, ANTIOXID REDOX SIGN, V20, P1994, DOI 10.1089/ars.2013.5643; Frijhoff J, 2014, FREE RADICAL BIO MED, V68, P268, DOI 10.1016/j.freeradbiomed.2013.12.022; Gorbatenko A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00130; Gorbatenko A, 2014, FASEB J, V28, P350, DOI 10.1096/fj.13-233288; Grandis JR, 2004, PHARMACOL THERAPEUT, V102, P37, DOI 10.1016/j.pharmthera.2004.01.002; Hulikova A, 2011, J BIOL CHEM, V286, P13815, DOI 10.1074/jbc.M111.219899; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Krishnan N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02252-2; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee S, 2016, ONCOGENE, V35, P2112, DOI 10.1038/onc.2015.273; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; McIntyre A, 2016, CANCER RES, V76, P3744, DOI 10.1158/0008-5472.CAN-15-1862; Medrano-Fernandez I, 2016, ANTIOXID REDOX SIGN, V24, P1031, DOI 10.1089/ars.2016.6636; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Parks SK, 2011, J CELL PHYSIOL, V226, P299, DOI 10.1002/jcp.22400; Parsons ZD, 2013, BIOCHEMISTRY-US, V52, P6412, DOI 10.1021/bi400451m; Richardson DE, 2003, FREE RADICAL BIO MED, V35, P1538, DOI 10.1016/j.freeradbiomed.2003.08.019; Rinna A, 2006, FREE RADICAL BIO MED, V41, P86, DOI 10.1016/j.freeradbiomed.2006.03.010; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schwertassek U, 2014, FEBS J, V281, P3545, DOI 10.1111/febs.12898; Sivaramakrishnan S, 2010, BIOORG MED CHEM LETT, V20, P444, DOI 10.1016/j.bmcl.2009.12.001; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Stocker S, 2018, NAT CHEM BIOL, V14, P148, DOI 10.1038/nchembio.2536; Svastova E, 2013, CELL ADHES MIGR, V7, P226, DOI 10.4161/cam.23257; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Trindade DF, 2006, CHEM RES TOXICOL, V19, P1475, DOI 10.1021/tx060146x; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wang XC, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00002; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Xu J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.574; Zhou HY, 2011, J AM CHEM SOC, V133, P15803, DOI 10.1021/ja2077137	57	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12330	12338		10.1074/jbc.RA119.009001	http://dx.doi.org/10.1074/jbc.RA119.009001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31197039	hybrid, Green Published			2022-12-28	WOS:000484402700006
J	Wang, Y; Wang, S; Nie, XY; Yang, KL; Xu, P; Wang, XN; Liu, MX; Yang, YS; Chen, Z; Wang, SH				Wang, Yu; Wang, Sen; Nie, Xinyi; Yang, Kunlong; Xu, Peng; Wang, Xiuna; Liu, Mengxin; Yang, Yongshuai; Chen, Zhuo; Wang, Shihua			Molecular and structural basis of nucleoside diphosphate kinase-mediated regulation of spore and sclerotia development in the fungus Aspergillus flavus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspergillus; inhibitor; crystal structure; developmental factor; sporulation; recombinant protein expression; pathology; protein kinase; microbiology; fungi; Aspergillus flavus; azidothymidine (AZT); nucleoside diphosphate kinase (NDK); sclerotium; spore	X-RAY STRUCTURE; CRYSTAL-STRUCTURE; AFLATOXIN BIOSYNTHESIS; GENE; DIPHOSPHOKINASE; CONTRIBUTES; INHIBITION; NDK; PURIFICATION; EXPRESSION	The fundamental biological function of nucleoside diphosphate kinase (NDK) is to catalyze the reversible exchange of the gamma-phosphate between nucleoside triphosphate (NTP) and nucleoside diphosphate (NDP). This kinase also has functions that extend beyond its canonically defined enzymatic role as a phosphotransferase. However, the role of NDK in filamentous fungi, especially in Aspergillus flavus (A. flavus), is not yet known. Here we report that A. flavus has two NDK-encoding gene copies as assessed by qPCR. Using gene-knockout and complementation experiments, we found that AfNDK regulates spore and sclerotia development and is involved in plant virulence as assessed in corn and peanut seed-based assays. An antifungal test with the inhibitor azidothymidine suppressed AfNDK activity in vitro and prevented spore production and sclerotia formation in A. flavus, confirming AfNDK's regulatory functions. Crystallographic analysis of AfNDK, coupled with site-directed mutagenesis experiments, revealed three residues (Arg-104, His-117, and Asp-120) as key sites that contribute to spore and sclerotia development. These results not only enrich our knowledge of the regulatory role of this important protein in A. flavus, but also provide insights into the prevention of A. flavus infection in plants and seeds, as well as into the structural features relevant for future antifungal drug development.	[Wang, Yu; Wang, Sen; Nie, Xinyi; Yang, Kunlong; Wang, Xiuna; Liu, Mengxin; Yang, Yongshuai; Chen, Zhuo; Wang, Shihua] Fujian Agr & Forestry Univ, Key Lab Pathogen Fungi & Mycotoxins Fujian Prov, Key Lab Biopesticide & Chem Biol, Educ Minist, Fuzhou 350002, Fujian, Peoples R China; [Wang, Yu; Wang, Sen; Nie, Xinyi; Yang, Kunlong; Wang, Xiuna; Liu, Mengxin; Yang, Yongshuai; Chen, Zhuo; Wang, Shihua] Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou 350002, Fujian, Peoples R China; [Xu, Peng; Yang, Yongshuai; Chen, Zhuo] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Xu, Peng; Yang, Yongshuai; Chen, Zhuo] Chinese Acad Sci, Fujian Inst Res Struct Matter, CAS Key Lab, Fuzhou 350002, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Wang, SH (corresponding author), Fujian Agr & Forestry Univ, Key Lab Pathogen Fungi & Mycotoxins Fujian Prov, Key Lab Biopesticide & Chem Biol, Educ Minist, Fuzhou 350002, Fujian, Peoples R China.; Wang, SH (corresponding author), Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou 350002, Fujian, Peoples R China.	wshyyl@sina.com	Kunlong, Yang/AHB-2840-2022; Chen, Zhuo/A-6144-2011	Yang, Kunlong/0000-0002-9246-101X; Wang, Yu/0000-0002-0542-3390; Chen, Zhuo/0000-0002-6351-8689	National Natural Science Foundation of China [31772105]; Natural Science Foundation of Fujian Province, China [2017J05043, 2018J07002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province)	This work was supported by National Natural Science Foundation of China Grant 31772105 and Natural Science Foundation of Fujian Province, China, Grants 2017J05043 and 2018J07002. The authors declare that they have no conflicts of interest with the contents of this article.	Adhikari A, 2004, ENVIRON INT, V29, P1071, DOI 10.1016/S0160-4120(03)00103-X; AGARWAL RP, 1971, J BIOL CHEM, V246, P2258; Amare MG, 2014, FUNGAL GENET BIOL, V66, P11, DOI 10.1016/j.fgb.2014.02.008; Anciaux K, 1997, FEBS LETT, V400, P75, DOI 10.1016/S0014-5793(96)01358-0; [Anonymous], 2012, PYMOL MOL GRAPHICS S; Arai S, 2012, PROTEIN SCI, V21, P498, DOI 10.1002/pro.2032; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; BERBERICH SJ, 1995, ONCOGENE, V10, P2343; BIGGS J, 1988, GENE DEV, V2, P1333, DOI 10.1101/gad.2.10.1333; Boissan M, 2014, SCIENCE, V344, P1510, DOI 10.1126/science.1253768; BROOK I, 1987, JAMA-J AM MED ASSOC, V258, P1517, DOI 10.1001/jama.258.11.1517; BURNIE JP, 1991, J CLIN MICROBIOL, V29, P2099, DOI 10.1128/JCM.29.10.2099-2106.1991; Carreto L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-524; Chang PK, 2010, J MICROBIOL METH, V81, P240, DOI 10.1016/j.mimet.2010.03.010; Chen CJ, 2003, J STRUCT BIOL, V142, P247, DOI 10.1016/S1047-8477(03)00014-5; Chen YX, 2002, PROTEINS, V47, P556, DOI 10.1002/prot.10113; CHENG YC, 1971, BIOCHEMISTRY-US, V10, P2139; CHIADMI M, 1993, STRUCTURE, V1, P283, DOI 10.1016/0969-2126(93)90016-A; Chopra P, 2003, EUR J BIOCHEM, V270, P625, DOI 10.1046/j.1432-1033.2003.03402.x; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; CREGG JM, 1989, MOL CELL BIOL, V9, P1316, DOI 10.1128/MCB.9.3.1316; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; ELWELL LP, 1987, ANTIMICROB AGENTS CH, V31, P274, DOI 10.1128/AAC.31.2.274; Fasoyin OE, 2018, FUNGAL GENET BIOL, V115, P41, DOI 10.1016/j.fgb.2018.04.008; FUKUCHI T, 1993, GENE, V129, P141; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Gomez DE, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00113; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Heinemann S, 2004, J HOSP INFECT, V57, P149, DOI 10.1016/j.jhin.2004.02.007; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Hu YL, 2018, TOXINS, V10, DOI 10.3390/toxins10070301; Im YJ, 2004, J MOL BIOL, V343, P659, DOI 10.1016/j.jmb.2004.08.054; IZUMIYA H, 1995, J BIOL CHEM, V270, P27859, DOI 10.1074/jbc.270.46.27859; Kim YJ, 2014, INFECT IMMUN, V82, P3252, DOI 10.1128/IAI.02007-14; Klich MA, 2007, MOL PLANT PATHOL, V8, P713, DOI 10.1111/J.1364-3703.2007.00436.X; Kolli BK, 2008, MOL BIOCHEM PARASIT, V158, P163, DOI 10.1016/j.molbiopara.2007.12.010; Krishnamurthy YL, 2006, LETT APPL MICROBIOL, V43, P469, DOI 10.1111/j.1472-765X.2006.02011.x; Krishnan S, 2009, MYCOSES, V52, P206, DOI 10.1111/j.1439-0507.2008.01642.x; Ladner JE, 1999, ACTA CRYSTALLOGR D, V55, P1127, DOI 10.1107/S0907444999002528; Lee B, 2006, MOL GENET GENOMICS, V275, P9, DOI 10.1007/s00438-005-0044-1; Lee MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28874; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; Lin XR, 2003, EUKARYOT CELL, V2, P1169, DOI 10.1128/EC.2.6.1169-1177.2003; Ma Lijiang, 2014, Curr Protoc Hum Genet, V80, DOI 10.1002/0471142905.hg0721s80; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mishra AK, 2017, J COMPUT AID MOL DES, V31, P547, DOI 10.1007/s10822-017-0022-9; Morera S, 1995, STRUCTURE, V3, P1307, DOI 10.1016/S0969-2126(01)00268-4; MOURAD N, 1966, J BIOL CHEM, V241, P271; Moynie L, 2007, PROTEINS, V67, P755, DOI 10.1002/prot.21316; Neeld D, 2014, MICROBIOL-SGM, V160, P1417, DOI 10.1099/mic.0.078139-0; Nie XY, 2016, J AGR FOOD CHEM, V64, P6772, DOI 10.1021/acs.jafc.6b02199; Ogura Y, 1999, EUR J BIOCHEM, V266, P709, DOI 10.1046/j.1432-1327.1999.00783.x; Ogura Y, 2001, J BIOL CHEM, V276, P21228, DOI 10.1074/jbc.M011381200; Okumura Y, 2004, J MED MICROBIOL, V53, P351, DOI 10.1099/jmm.0.05248-0; Okumura Yoshiyuki, 2008, Nihon Ishinkin Gakkai Zasshi, V49, P87, DOI 10.3314/jjmm.49.87; Pedelacq JD, 2005, PROTEIN SCI, V14, P2562, DOI 10.1110/ps.051664205; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Qian L, 2014, PROTEIN EXPRES PURIF, V103, P48, DOI 10.1016/j.pep.2014.08.014; Ren SL, 2018, MOL CELL PROTEOMICS, V17, P457, DOI [10.1074/mcp.RA117.000393, 10.1074/mcp.ra117.000393]; Runa F, 2015, FUNGAL GENET BIOL, V84, P62, DOI 10.1016/j.fgb.2015.09.003; SAEKI T, 1975, J ANTIBIOT, V28, P974, DOI 10.7164/antibiotics.28.974; SAMPOL E, 1995, BRIT J CLIN PHARMACO, V40, P83, DOI 10.1111/j.1365-2125.1995.tb04540.x; Schirrmeister BE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-177; Souza TACB, 2011, MOL BIOSYST, V7, P2189, DOI 10.1039/c0mb00307g; STRELKOV SV, 1995, J MOL BIOL, V249, P665, DOI 10.1006/jmbi.1995.0327; Sun Q, 2016, APPL MICROBIOL BIOT, V100, P1355, DOI 10.1007/s00253-015-7159-z; Tiwari S, 2004, J BIOL CHEM, V279, P43595, DOI 10.1074/jbc.M401704200; Valenti D, 1999, FEBS LETT, V444, P291, DOI 10.1016/S0014-5793(99)00071-X; Vieira PS, 2017, BIOCHEM BIOPH RES CO, V488, P461, DOI 10.1016/j.bbrc.2017.05.048; Vieira PS, 2015, J STRUCT BIOL, V192, P336, DOI 10.1016/j.jsb.2015.09.009; Vlatkovic N, 2015, N-S ARCH PHARMACOL, V388, P175, DOI 10.1007/s00210-014-1062-5; Wang S, 2016, CHINESE J STRUC CHEM, V35, P1708, DOI 10.14102/j.cnki.0254-5861.2011-1278; WILLIAMS RL, 1993, J MOL BIOL, V234, P1230, DOI 10.1006/jmbi.1993.1673; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wu HC, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7238; Yang KL, 2017, FUNGAL GENET BIOL, V101, P7, DOI 10.1016/j.fgb.2017.02.004; Yang KL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23259; Zhang DP, 2018, BMC BIOTECHNOL, V18, DOI 10.1186/s12896-018-0436-z; Zhang F, 2018, CURR GENET, V64, P1335, DOI 10.1007/s00294-018-0851-7; Zhang F, 2016, TOXINS, V8, DOI 10.3390/toxins8070202	80	18	19	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12415	12431		10.1074/jbc.RA119.007505	http://dx.doi.org/10.1074/jbc.RA119.007505			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31243100	hybrid, Green Published			2022-12-28	WOS:000484402700014
J	Esser, L; Zhou, F; Yu, CA; Xia, D				Esser, Lothar; Zhou, Fei; Yu, Chang-An; Xia, Di			Crystal structure of bacterial cytochrome bc(1) in complex with azoxystrobin reveals a conformational switch of the Rieske iron-sulfur protein subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome; conformational change; respiratory chain; electron transfer; X-ray crystallography; conformation switch; cytochrome bc1; electron transfer; electron transfer mechanism; respiratory inhibitors	QUINOL OXIDATION SITE; ELECTRON-TRANSFER; PROTON TRANSLOCATION; DOMAIN MOVEMENT; BC1 COMPLEX; MITOCHONDRIAL; INHIBITORS; BINDING; OXIDOREDUCTASE; SPHAEROIDES	Cytochrome bc(1) complexes (cyt bc(1)), also known as complex III in mitochondria, are components of the cellular respiratory chain and of the photosynthetic apparatus of non-oxygenic photosynthetic bacteria. They catalyze electron transfer (ET) from ubiquinol to cytochrome c and concomitantly translocate protons across the membrane, contributing to the cross-membrane potential essential for a myriad of cellular activities. This ET-coupled proton translocation reaction requires a gating mechanism that ensures bifurcated electron flow. Here, we report the observation of the Rieske iron-sulfur protein (ISP) in a mobile state, as revealed by the crystal structure of cyt bc(1) from the photosynthetic bacterium Rhodobacter sphaeroides in complex with the fungicide azoxystrobin. Unlike cyt bc(1) inhibitors stigmatellin and famoxadone that immobilize the ISP, azoxystrobin causes the ISP-ED to separate from the cyt b subunit and to remain in a mobile state. Analysis of anomalous scattering signals from the iron-sulfur cluster of the ISP suggests the existence of a trajectory for electron delivery. This work supports and solidifies the hypothesis that the bimodal conformation switch of the ISP provides a gating mechanism for bifurcated ET, which is essential to the Q-cycle mechanism of cyt bc(1) function.	[Esser, Lothar; Zhou, Fei; Xia, Di] NCI, Lab Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oklahoma State University System; Oklahoma State University - Stillwater	Xia, D (corresponding author), NCI, Lab Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	xiad@mail.nih.gov		Xia, Di/0000-0002-2748-0679	Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010319] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; BRANDT U, 1988, EUR J BIOCHEM, V173, P499, DOI 10.1111/j.1432-1033.1988.tb14026.x; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Darrouzet E, 2000, BIOCHEMISTRY-US, V39, P15475, DOI 10.1021/bi000750l; DUTTON PL, 1972, EUR J BIOCHEM, V30, P495, DOI 10.1111/j.1432-1033.1972.tb02121.x; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Esser L, 2016, J BIOL CHEM, V291, P25019, DOI 10.1074/jbc.M116.744391; Esser Lothar, 2007, Biophysical Reviews and Letters, V2, P229, DOI 10.1142/S1793048007000532; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Hansen KC, 2000, BBA-BIOENERGETICS, V1456, P121, DOI 10.1016/S0005-2728(99)00107-3; Iwata M, 1999, J BIOENERG BIOMEMBR, V31, P169, DOI 10.1023/A:1005407410005; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Izrailev S, 1999, BIOPHYS J, V77, P1753, DOI 10.1016/S0006-3495(99)77022-0; Keilin D, 1925, P R SOC LOND B-CONTA, V98, P312, DOI 10.1098/rspb.1925.0039; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; LAWFORD HG, 1973, BIOCHEM J, V136, P711, DOI 10.1042/bj1360711; MOSER CC, 1995, J BIOENERG BIOMEMBR, V27, P263, DOI 10.1007/BF02110096; PRINCE RC, 1977, BIOCHIM BIOPHYS ACTA, V462, P731, DOI 10.1016/0005-2728(77)90114-1; PRINCE RC, 1975, FEBS LETT, V51, P108, DOI 10.1016/0014-5793(75)80864-7; ROBERTSON DE, 1984, J BIOL CHEM, V259, P1758; Sadoski RC, 2000, BIOCHEMISTRY-US, V39, P4231, DOI 10.1021/bi000003o; Schnaufer A, 2000, CURR GENET, V37, P234, DOI 10.1007/s002940050525; Tian H, 1999, J BIOL CHEM, V274, P7146, DOI 10.1074/jbc.274.11.7146; Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; WIKSTROM MK, 1972, BIOCHIM BIOPHYS ACTA, V283, P403, DOI 10.1016/0005-2728(72)90258-7; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008; Xiao KH, 2004, BIOCHEMISTRY-US, V43, P1488, DOI 10.1021/bi035378z; Xiao KH, 2000, J BIOL CHEM, V275, P38597, DOI 10.1074/jbc.M007444200; Xiao YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093765; Yu LD, 2009, METHOD ENZYMOL, V456, P459, DOI 10.1016/S0076-6879(08)04425-X; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104	38	13	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12007	12019		10.1074/jbc.RA119.008381	http://dx.doi.org/10.1074/jbc.RA119.008381			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31182483	Green Published, hybrid			2022-12-28	WOS:000484284500007
J	Khan, N; Shah, PP; Ban, D; Trigo-Mourino, P; Carneiro, MG; DeLeeuw, L; Dean, WL; Trent, JO; Beverly, LJ; Konrad, M; Lee, D; Sabo, TM				Khan, Nazimuddin; Shah, Parag P.; Ban, David; Trigo-Mourino, Pablo; Carneiro, Marta G.; DeLeeuw, Lynn; Dean, William L.; Trent, John O.; Beverly, Levi J.; Konrad, Manfred; Lee, Donghan; Sabo, T. Michael			Solution structure and functional investigation of human guanylate kinase reveals allosteric networking and a crucial role for the enzyme in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); protein structure; enzyme kinetics; enzyme mutation; lung cancer; guanylate kinase; hGMPK; non-synonymous single nucleotide variants (nsSNV); solution structure	DIPOLAR COUPLINGS; THYMIDINE KINASE; MONOPHOSPHATE; GMP; PHOSPHORYLATION; MECHANISM; EXPRESSION; PROTEINS; CLONING; BINDING	Human guanylate kinase (hGMPK) is the only known enzyme responsible for cellular GDP production, making it essential for cellular viability and proliferation. Moreover, hGMPK has been assigned a critical role in metabolic activation of antiviral and antineoplastic nucleoside-analog prodrugs. Given that hGMPK is indispensable for producing the nucleotide building blocks of DNA, RNA, and cGMP and that cancer cells possess elevated GTP levels, it is surprising that a detailed structural and functional characterization of hGMPK is lacking. Here, we present the first high-resolution structure of hGMPK in the apo form, determined with NMR spectroscopy. The structure revealed that hGMPK consists of three distinct regions designated as the LID, GMP-binding (GMP-BD), and CORE domains and is in an open configuration that is nucleotide binding-competent. We also demonstrate that nonsynonymous single-nucleotide variants (nsSNVs) of the hGMPK CORE domain distant from the nucleotide-binding site of this domain modulate enzymatic activity without significantly affecting hGMPK's structure. Finally, we show that knocking down the hGMPK gene in lung adenocarcinoma cell lines decreases cellular viability, proliferation, and clonogenic potential while not altering the proliferation of immortalized, noncancerous human peripheral airway cells. Taken together, our results provide an important step toward establishing hGMPK as a potential biomolecular target, from both an orthosteric (ligand-binding sites) and allosteric (location of CORE domain-located nsSNVs) standpoint.	[Khan, Nazimuddin; Shah, Parag P.; Ban, David; DeLeeuw, Lynn; Dean, William L.; Trent, John O.; Beverly, Levi J.; Lee, Donghan; Sabo, T. Michael] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, 505 S Hancock St, Louisville, KY 40202 USA; [Trigo-Mourino, Pablo; Carneiro, Marta G.] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany; [Konrad, Manfred] Max Planck Inst Biophys Chem, Enzyme Biochem Grp, Fassberg 11, D-37077 Gottingen, Germany; [Ban, David] Merck Res Labs, Biochem & Biophys, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA; [Trigo-Mourino, Pablo] Merck Res Labs, Struct Elucidat Grp, Analyt Enabling Technol, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA; [Carneiro, Marta G.] ZoBio BV, Biopartner Bldg 2,JH Oortweg 19, NL-2333 CH Leiden, Netherlands	University of Louisville; Max Planck Society; Max Planck Society; Merck & Company; Merck & Company	Lee, D; Sabo, TM (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Dept Med, 505 S Hancock St, Louisville, KY 40202 USA.; Konrad, M (corresponding author), Max Planck Inst Biophys Chem, Enzyme Biochem Grp, Fassberg 11, D-37077 Gottingen, Germany.	mkonrad@mpibpc.mpg.de; donghan.lee@louisville.edu; mike.sabo@louisville.edu	Sabo, T./H-9681-2019	Sabo, T./0000-0002-9573-145X; trent, John/0000-0002-7346-4231	Deutscher Akademischer Austauschdienst (DAAD) scholarship; Max Planck Society; James Graham Brown Cancer Center	Deutscher Akademischer Austauschdienst (DAAD) scholarship(Deutscher Akademischer Austausch Dienst (DAAD)); Max Planck Society(Max Planck SocietyFoundation CELLEX); James Graham Brown Cancer Center	This research was supported by a Deutscher Akademischer Austauschdienst (DAAD) scholarship (to N. K.), by the Max Planck Society, and by funds provided by the James Graham Brown Cancer Center.	Aden J, 2012, J AM CHEM SOC, V134, P16562, DOI 10.1021/ja3032482; Agarwal K C, 1978, Methods Enzymol, V51, P483; Ardiani A, 2009, PROTEIN ENG DES SEL, V22, P225, DOI 10.1093/protein/gzn078; ASHTON WT, 1982, BIOCHEM BIOPH RES CO, V108, P1716, DOI 10.1016/S0006-291X(82)80109-5; Auvynet C, 2009, BIOCHEM BIOPH RES CO, V388, P6, DOI 10.1016/j.bbrc.2009.07.089; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bianchi-Smiraglia A, 2015, CELL DEATH DIFFER, V22, P1858, DOI 10.1038/cdd.2015.47; Blaszczyk J, 2001, J MOL BIOL, V307, P247, DOI 10.1006/jmbi.2000.4427; BOEHME RE, 1984, J BIOL CHEM, V259, P2346; Brady WA, 1996, J BIOL CHEM, V271, P16734, DOI 10.1074/jbc.271.28.16734; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Case D. A., 2018, AMBER 2019; Choi B, 2007, BIOPHYS J, V92, P1651, DOI 10.1529/biophysj.106.092866; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deville-Bonne D, 2010, ANTIVIR RES, V86, P101, DOI 10.1016/j.antiviral.2010.02.001; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; El Omari K, 2006, ACTA CRYSTALLOGR F, V62, P949, DOI 10.1107/S174430910603613X; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; FIELD AK, 1983, P NATL ACAD SCI-BIOL, V80, P4139, DOI 10.1073/pnas.80.13.4139; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; GAIDAROV IO, 1993, FEBS LETT, V335, P81, DOI 10.1016/0014-5793(93)80444-Y; Gallion J, 2017, HUM MUTAT, V38, P569, DOI 10.1002/humu.23193; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gentry BG, 2011, BIOCHEM PHARMACOL, V81, P43, DOI 10.1016/j.bcp.2010.09.005; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HALL SW, 1986, EUR J BIOCHEM, V161, P551, DOI 10.1111/j.1432-1033.1986.tb10477.x; Hazra S, 2011, BIOCHEMISTRY-US, V50, P2870, DOI 10.1021/bi2001032; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Hible G, 2006, BIOCHIMIE, V88, P1157, DOI 10.1016/j.biochi.2006.04.002; Hible G, 2006, PROTEINS, V62, P489, DOI 10.1002/prot.20662; Hible G, 2005, J MOL BIOL, V352, P1044, DOI 10.1016/j.jmb.2005.07.042; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Jain R, 2016, EUR BIOPHYS J BIOPHY, V45, P81, DOI 10.1007/s00249-015-1079-9; Johansson M, 2005, BIOCHEM PHARMACOL, V70, P987, DOI 10.1016/j.bcp.2005.06.023; Johnston CA, 2011, P NATL ACAD SCI USA, V108, pE973, DOI 10.1073/pnas.1104365108; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Keller R., 2004, THESIS; Khan N, 2018, BIOMOL NMR ASSIGN, V12, P11, DOI 10.1007/s12104-017-9771-6; KONRAD M, 1992, J BIOL CHEM, V267, P25652; Kovermann M, 2016, Q REV BIOPHYS, V49, DOI 10.1017/S0033583516000019; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li GD, 1998, ENDOCRINOLOGY, V139, P3752, DOI 10.1210/en.139.9.3752; Li Y, 1996, J BIOL CHEM, V271, P28038, DOI 10.1074/jbc.271.45.28038; Liu J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004966; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Meinhardt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083502; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Michielssens S, 2014, ANGEW CHEM INT EDIT, V53, P10367, DOI 10.1002/anie.201403102; Miller M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41329; MILLER RL, 1977, BIOCHEM PHARMACOL, V26, P1573, DOI 10.1016/0006-2952(77)90071-5; MILLER WH, 1992, J BIOL CHEM, V267, P21220; MILLER WH, 1980, J BIOL CHEM, V255, P7204; Miosge LA, 2015, P NATL ACAD SCI USA, V112, pE5189, DOI 10.1073/pnas.1511585112; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; NAVE JF, 1992, ARCH BIOCHEM BIOPHYS, V295, P253, DOI 10.1016/0003-9861(92)90515-X; Niroula A, 2016, HUM MUTAT, V37, P579, DOI 10.1002/humu.22987; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Prinz H, 1999, J BIOL CHEM, V274, P35337, DOI 10.1074/jbc.274.50.35337; Qiu Y, 2000, TRANSPLANTATION, V69, P890; Saavedra HG, 2018, NATURE, V558, P324, DOI 10.1038/s41586-018-0183-2; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Segura-Pena D, 2004, J BIOL CHEM, V279, P33882, DOI 10.1074/jbc.M401989200; Segura-Pena D, 2007, STRUCTURE, V15, P1555, DOI 10.1016/j.str.2007.09.025; Sekulic N, 2002, J BIOL CHEM, V277, P30236, DOI 10.1074/jbc.M204668200; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shuvalov O, 2017, ONCOTARGET, V8, P23955, DOI 10.18632/oncotarget.15053; STEHLE T, 1992, J MOL BIOL, V224, P1127, DOI 10.1016/0022-2836(92)90474-X; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Whitney DS, 2016, J AM CHEM SOC, V138, P15150, DOI 10.1021/jacs.6b05954; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wojcik EJ, 2013, GENE, V531, P133, DOI 10.1016/j.gene.2013.08.004; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zweckstetter M, 2001, J BIOMOL NMR, V20, P365, DOI 10.1023/A:1011263920003	84	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11920	11933		10.1074/jbc.RA119.009251	http://dx.doi.org/10.1074/jbc.RA119.009251			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31201273	hybrid, Green Published			2022-12-28	WOS:000486127800026
J	Kindermann, B; Valkova, C; Kramer, A; Perner, B; Engelmann, C; Behrendt, L; Kritsch, D; Jungnickel, B; Kehlenbach, RH; Oswald, F; Englert, C; Kaether, C				Kindermann, Bastian; Valkova, Christina; Kraemer, Andreas; Perner, Birgit; Engelmann, Christian; Behrendt, Laura; Kritsch, Daniel; Jungnickel, Berit; Kehlenbach, Ralph H.; Oswald, Franz; Englert, Christoph; Kaether, Christoph			The nuclear pore proteins Nup88/214 and T-cell acute lymphatic leukemia-associated NUP214 fusion proteins regulate Notch signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Notch pathway; nuclear pore; nuclear transport; leukemia; cell compartmentalization; cancer; cell signaling; gene regulation; nucleoporin 214 (Nup214); nucleoporin 88 (Nup88); recombination signal-binding protein for immunoglobulin kappa J region (RBP-J); T-cell acute lymphatic leukemia (T-ALL)	INTRACELLULAR DOMAIN; COMPLEX COMPOSITION; ACTIVATION; GENE; EXPRESSION; TRANSPORT; RECEPTOR; EXPORT; TRANSCRIPTION; SET-NUP214	The Notch receptor is a key mediator of developmental programs and cell-fate decisions. Imbalanced Notch signaling leads to developmental disorders and cancer. To fully characterize the Notch signaling pathway and exploit it in novel therapeutic interventions, a comprehensive view on the regulation and requirements of Notch signaling is needed. Notch is regulated at different levels, ranging from ligand binding, stability to endocytosis. Using an array of different techniques, including reporter gene assays, immunocytochemistry, and ChIP-qPCR we show here, to the best of our knowledge for the first time, regulation of Notch signaling at the level of the nuclear pore. We found that the nuclear pore protein Nup214 (nucleoporin 214) and its interaction partner Nup88 negatively regulate Notch signaling in vitro and in vivo in zebrafish. In mammalian cells, loss of Nup88/214 inhibited nuclear export of recombination signal-binding protein for immunoglobulin kappa J region (RBP-J), the DNA-binding component of the Notch pathway. This inhibition increased binding of RBP-J to its cognate promoter regions, resulting in increased downstream Notch signaling. Interestingly, we also found that NUP214 fusion proteins, causative for certain cases of T-cell acute lymphatic leukemia, potentially contribute to tumorigenesis via a Notch-dependent mechanism. In summary, the nuclear pore components Nup88/214 suppress Notch signaling in vitro, and in zebrafish, nuclear RBP-J levels are rate-limiting factors for Notch signaling in mammalian cells, and regulation of nucleocytoplasmic transport of RBP-J may contribute to fine-tuning Notch activity in cells.	[Kindermann, Bastian; Valkova, Christina; Kraemer, Andreas; Perner, Birgit; Engelmann, Christian; Behrendt, Laura; Englert, Christoph; Kaether, Christoph] Fritz Lipmann Inst, Leibniz Inst Alternsforsch, Beutenbergstr 11, D-07745 Jena, Germany; [Kritsch, Daniel; Jungnickel, Berit; Englert, Christoph] Friedrich Schiller Univ Jena, Inst Biochem & Biophys, D-07745 Jena, Germany; [Kehlenbach, Ralph H.] Univ Med Gottingen, Dept Mol Biol, D-37073 Gottingen, Germany; [Oswald, Franz] Univ Klinikum Ulm, Zentrum Innere Med, Abt Innere Med 1, D-89081 Ulm, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena; University of Gottingen; Ulm University	Kaether, C (corresponding author), Fritz Lipmann Inst, Leibniz Inst Alternsforsch, Beutenbergstr 11, D-07745 Jena, Germany.	ckaether@fli-leibniz.de	Jungnickel, Berit/AAU-5297-2021; Oswald, Franz/AAO-9584-2020	Kehlenbach, Ralph/0000-0003-4920-9916	FLI imaging facility	FLI imaging facility	We are grateful to Christina Ebert and Eric Rivera-Milla for technical assistance, to John Postlethwait for hybridization probes, and to Carl Sanden (Lund University) for DEK-NUP. We acknowledge the support from the FLI imaging facility and Torsten Kroll from the functional genomics facility.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bally-Cuif L, 1998, MECH DEVELOP, V77, P31, DOI 10.1016/S0925-4773(98)00109-9; Belver L, 2016, NAT REV CANCER, V16, P494, DOI 10.1038/nrc.2016.63; Ben Abdelali R, 2014, BLOOD, V123, P1860, DOI 10.1182/blood-2013-08-521518; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Braud C, 2012, PLANT PHYSIOL, V160, P823, DOI 10.1104/pp.112.202192; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Cautain B, 2015, FEBS J, V282, P445, DOI 10.1111/febs.13163; D'Angelo MA, 2012, DEV CELL, V22, P446, DOI 10.1016/j.devcel.2011.11.021; De Keersmaecker K, 2008, MOL CELL, V31, P134, DOI 10.1016/j.molcel.2008.05.005; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Fassa A, 2007, NEURODEGENER DIS, V4, P148, DOI 10.1159/000101839; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; FORNEROD M, 1995, ONCOGENE, V10, P1739; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Gomez-Cavazos JS, 2012, CURR OPIN CELL BIOL, V24, P775, DOI 10.1016/j.ceb.2012.08.008; Gorello P, 2010, HAEMATOL-HEMATOL J, V95, P2161, DOI 10.3324/haematol.2010.029769; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Gravina GL, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-46; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hein K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005892; Huenniger K, 2010, CELL MOL LIFE SCI, V67, P3187, DOI 10.1007/s00018-010-0378-7; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Ishitani T, 2010, NAT CELL BIOL, V12, P278, DOI 10.1038/ncb2028; Kim MY, 2007, MOL CELL BIOL, V27, P6506, DOI 10.1128/MCB.01515-06; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koch U, 2011, TRENDS IMMUNOL, V32, P434, DOI 10.1016/j.it.2011.06.005; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Lahmann I, 2019, GENE DEV, V33, P524, DOI 10.1101/gad.322818.118; Latimer AJ, 2006, DEV BIOL, V298, P392, DOI 10.1016/j.ydbio.2006.05.039; Le Bras S, 2011, TRAFFIC, V12, P149, DOI 10.1111/j.1600-0854.2010.01126.x; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Port SA, 2016, J BIOL CHEM, V291, P23068, DOI 10.1074/jbc.M116.735340; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461; Ranganathan P, 2011, J BIOL CHEM, V286, P28844, DOI 10.1074/jbc.M111.243600; Saito S, 2016, MOL CELL BIOL, V36, P1820, DOI 10.1128/MCB.00158-16; Sanden C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-440; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; Sun QX, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2016.10; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Takke C, 1999, DEVELOPMENT, V126, P1811; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Trotman LC, 2001, NAT CELL BIOL, V3, P1092, DOI 10.1038/ncb1201-1092; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308	71	3	3	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11741	11750		10.1074/jbc.RA118.006357	http://dx.doi.org/10.1074/jbc.RA118.006357			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31186352	hybrid, Green Published			2022-12-28	WOS:000486127800011
J	Malecki, J; Willemen, HLDM; Pinto, R; Ho, AYY; Moen, A; Eijkelkamp, N; Falnes, PO				Malecki, Jedrzej; Willemen, Hanneke L. D. M.; Pinto, Rita; Ho, Angela Y. Y.; Moen, Anders; Eijkelkamp, Niels; Falnes, Pal O.			Human FAM173A is a mitochondrial lysine-specific methyltransferase that targets adenine nucleotide translocase and affects mitochondrial respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						posttranslational modification (PTM); mitochondrial transport; membrane enzyme; mitochondria; nucleoside; nucleotide transport; bioenergetics; cardiolipin; proteomics; protein methylation; transmembrane domain; adenine nucleotide translocase; ADP; ATP carrier; ADP; ATP translocase; ANT-KMT; FAM173A; lysine methylation; methyltransferase; KMT; transmembrane protein; solute carrier protein	ELONGATION-FACTOR 1A; ADP/ATP CARRIER; PROTEIN COMPLEX; HUMAN METTL12; ATP CARRIER; METHYLATION; ADP; IDENTIFICATION; RESIDUES; SEQUENCE	Lysine methylation is a common posttranslational modification of nuclear and cytoplasmic proteins but is also present in mitochondria. The human protein denoted family with sequence similarity 173 member B (FAM173B) was recently uncovered as a mitochondrial lysine (K)-specific methyltransferase (KMT) targeting the c-subunit of mitochondrial ATP synthase (ATPSc), and was therefore renamed ATPSc-KMT. We here set out to investigate the biochemical function of its yet uncharacterized paralogue FAM173A. We demonstrate that FAM173A localizes to mitochondria, mediated by a noncanonical targeting sequence that is partially retained in the mature protein. Immunoblotting analysis using methyllysine-specific antibodies revealed that FAM173A knock-out (KO) abrogates lysine methylation of a single mitochondrial protein in human cells. Mass spectrometry analysis identified this protein as adenine nucleotide translocase (ANT), represented by two highly similar isoforms ANT2 and ANT3. We found that methylation occurs at Lys-52 of ANT, which was previously reported to be trimethylated. Complementation of KO cells with WT or enzyme-dead FAM173A indicated that the enzymatic activity of FAM173A is required for ANT methylation at Lys-52 to occur. Both in human cells and in rat organs, Lys-52 was exclusively trimethylated, indicating that this modification is constitutive, rather than regulatory and dynamic. Moreover, FAM173A-deficient cells displayed increased mitochondrial respiration compared with FAM173A-proficient cells. In summary, we demonstrate that FAM173A is the long-sought KMT responsible for ANT methylation at Lys-52, and point out the functional significance of Lys-52 methylation in ANT. Based on the established naming nomenclature for KMTs, we propose to rename FAM173A to ANT-KMT (gene name ANTKMT).	[Malecki, Jedrzej; Pinto, Rita; Ho, Angela Y. Y.; Moen, Anders; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway; [Willemen, Hanneke L. D. M.; Eijkelkamp, Niels] Univ Utrecht, Univ Med Ctr Utrecht, LTI, NL-3584 EA Utrecht, Netherlands	University of Oslo; Utrecht University; Utrecht University Medical Center	Malecki, J; Falnes, PO (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway.	j.m.malecki@ibv.uio.no; pal.falnes@imbv.uio.no	Falnes, Pål Ø./AAA-4581-2020	Malecki, Jedrzej/0000-0003-0825-7962; Falnes, Pal/0000-0001-8114-6025	Netherlands Organization for Scientific Research (NWO) [016.VENI.192.053]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was also supported by the Netherlands Organization for Scientific Research (NWO) Grant 016.VENI.192.053 (to H. L. D. M. W.).	AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P345; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Brenner C, 2011, ONCOGENE, V30, P883, DOI 10.1038/onc.2010.501; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; Duncan AL, 2016, P NATL ACAD SCI USA, V113, P8687, DOI 10.1073/pnas.1608396113; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Hamey JJ, 2017, MOL CELL PROTEOMICS, V16, P2229, DOI 10.1074/mcp.M116.066308; Hamey JJ, 2016, MOL CELL PROTEOMICS, V15, P164, DOI 10.1074/mcp.M115.052449; Hedger G, 2016, BIOCHEMISTRY-US, V55, P6238, DOI 10.1021/acs.biochem.6b00751; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Iuso A, 2017, METHODS MOL BIOL, V1567, P217, DOI 10.1007/978-1-4939-6824-4_13; Jakobsson ME, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05646-y; Jakobsson ME, 2017, NUCLEIC ACIDS RES, V45, P8239, DOI 10.1093/nar/gkx432; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; KLINGENBERG M, 1978, BIOCHIM BIOPHYS ACTA, V503, P193, DOI 10.1016/0005-2728(78)90182-2; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Liu S, 2019, CELL, V176, P491, DOI 10.1016/j.cell.2018.11.038; Lu YW, 2017, MOL BIOL CELL, V28, P1489, DOI 10.1091/mbc.E17-03-0195; Malecki J, 2017, J BIOL CHEM, V292, P17950, DOI 10.1074/jbc.M117.808451; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; Malecki J, 2015, J BIOL CHEM, V290, P423, DOI 10.1074/jbc.M114.614115; Malecki JM, 2019, J BIOL CHEM, V294, P1128, DOI 10.1074/jbc.RA118.005473; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Rhein VF, 2017, FEBS LETT, V591, P1641, DOI 10.1002/1873-3468.12649; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schultheiss HP, 2006, E SCHERING RES FDN W, V55, P3; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Walpole TB, 2015, MOL CELL PROTEOMICS, V14, P828, DOI 10.1074/mcp.M114.047456; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787	45	14	14	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11654	11664		10.1074/jbc.RA119.009045	http://dx.doi.org/10.1074/jbc.RA119.009045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31213526	hybrid, Green Published			2022-12-28	WOS:000486127800001
J	Regue, L; Minichiello, L; Avruch, J; Dai, N				Regue, Laura; Minichiello, Liliana; Avruch, Joseph; Dai, Ning			Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver metabolism; lipid metabolism; fatty acid oxidation; RNA binding protein; hepatocyte; obesity; carnitine palmitoyltransferase 1A (CPT-1A); IGF2 mRNA binding protein 2; IGF2BP2; IMP2; peroxisome proliferator-activated receptor alpha (PPAR alpha)	GENOME-WIDE ASSOCIATION; TRANSLATION; PROTEINS; FAMILY; LOCI; IMP2	Insulin-like growth factor 2 mRNA-binding proteins 1-3 (IGF2BP1-3, also known as IMP1-3) contribute to the regulation of RNAs in a transcriptome-specific context. Global deletion of the mRNA-binding protein insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2 or IMP2) in mice causes resistance to obesity and fatty liver induced by a high-fat diet (HFD), whereas liver-specific IMP2 overexpression results in steatosis. To better understand the role of IMP2 in hepatic triglyceride metabolism, here we crossed mice expressing albumin-Cre with mice bearing a floxed Imp2 gene to generate hepatocyte-specific IMP2 knockout (LIMP2 KO) mice. Unexpectedly, the livers of LIMP2 KO mice fed an HFD accumulated more triglyceride. Although hepatocyte-specific IMP2 deletion did not alter lipogenic gene expression, it substantially decreased the levels of the IMP2 client mRNAs encoding carnitine palmitoyltransferase 1A (CPT1A) and peroxisome proliferator-activated receptor alpha (PPAR alpha). This decrease was associated with their more rapid turnover and accompanied by significantly diminished rates of palmitate oxidation by isolated hepatocytes and liver mitochondria. HFD-fed control and LIMP2 KO mice maintained a similar glucose tolerance and insulin sensitivity up to 6 months; however, by 6 months, blood glucose and serum triglycerides in LIMP2 KO mice were modestly elevated but without evidence of liver damage. In conclusion, hepatocyte-specific IMP2 deficiency promotes modest diet-induced fatty liver by impairing fatty acid oxidation through increased degradation of the IMP2 client mRNAs PPAR alpha and CPT1A. This finding indicates that the previously observed marked protection against fatty liver conferred by global IMP2 deficiency in mice is entirely due to their reduced adiposity.	[Regue, Laura; Avruch, Joseph; Dai, Ning] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Regue, Laura; Avruch, Joseph; Dai, Ning] Massachusetts Gen Hosp, Diabet Unit Med Serv, Boston, MA 02114 USA; [Regue, Laura; Avruch, Joseph; Dai, Ning] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Minichiello, Liliana] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Dai, Ning] Rutgers State Univ, Dept Med, Rutgers Robert Wood Johnson Med Sch, 125 Paterson St,Clin Acad Bldg, New Brunswick, NJ 08901 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Oxford; Rutgers State University New Brunswick; Rutgers State University Medical Center	Avruch, J; Dai, N (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Avruch, J; Dai, N (corresponding author), Massachusetts Gen Hosp, Diabet Unit Med Serv, Boston, MA 02114 USA.; Avruch, J; Dai, N (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Dai, N (corresponding author), Rutgers State Univ, Dept Med, Rutgers Robert Wood Johnson Med Sch, 125 Paterson St,Clin Acad Bldg, New Brunswick, NJ 08901 USA.	avruch@molbio.mgh.harvard.edu; ning@molbio.mgh.harvard.edu	Barrufet, Laura Regue/AAB-9465-2020; Minichiello, Liliana/AAA-7190-2022	Barrufet, Laura Regue/0000-0003-1341-3413; 	National Institutes of Health [DK17776]; Massachusetts General Hospital; Lundbeck Foundation [177/05]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK017776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital(General Electric); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK17776 (to J. A.) and Massachusetts General Hospital institutional resources. L. M. was supported in part by Lundbeck Foundation Grant 177/05. The authors declare that they have no conflicts of interest with the contents of this article.	Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Dai N, 2017, ELIFE, V6, DOI [10.7554/eLife.27155.001, 10.7554/eLife.27155]; Dai N, 2015, CELL METAB, V21, P609, DOI 10.1016/j.cmet.2015.03.006; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Degrauwe N, 2016, GENE DEV, V30, P2459, DOI 10.1101/gad.287540.116; Degrauwe N, 2016, CELL REP, V15, P1634, DOI 10.1016/j.celrep.2016.04.086; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Greenwald WW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09975-4; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Kessler SM, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.241; Kessler SM, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00147; Laggai S, 2014, J LIPID RES, V55, P1087, DOI 10.1194/jlr.M045500; Nagarajan SR, 2019, AM J PHYSIOL-ENDOC M, V316, pE578, DOI 10.1152/ajpendo.00365.2018; Napal L, 2005, J MOL BIOL, V354, P751, DOI 10.1016/j.jmb.2005.09.097; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Oliveira AF, 2015, BIOTECHNIQUES, V58, P228, DOI 10.2144/000114285; Regue L, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00528-18; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Tybl E, 2011, J HEPATOL, V54, P994, DOI 10.1016/j.jhep.2010.08.034; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang JY, 1999, J EXP MED, V189, P1101, DOI 10.1084/jem.189.7.1101	26	23	23	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11944	11951		10.1074/jbc.RA119.008778	http://dx.doi.org/10.1074/jbc.RA119.008778			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31209109	hybrid, Green Published			2022-12-28	WOS:000486127800028
J	Lessard, CB; Rodriguez, E; Ladd, TB; Minter, LM; Osborne, BA; Miele, L; Golde, TE; Ran, Y				Lessard, Christian B.; Rodriguez, Edgardo; Ladd, Thomas B.; Minter, Lisa M.; Osborne, Barbara A.; Miele, Lucio; Golde, Todd E.; Ran, Yong			Individual and combined presenilin 1 and 2 knockouts reveal that both have highly overlapping functions in HEK293T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						presenilin; inhibitor; gamma-secretase; amyloid-beta (AB); Notch protein; amyloid protein precursor; aspartyl protease; cancer; neurodegeneration; NOTCH	GAMMA-SECRETASE INHIBITORS; ALZHEIMERS-DISEASE; BETA PEPTIDES; IDENTIFICATION; NICASTRIN; APH-1; DISTINCT; SEMAGACESTAT; DEFICIENCY; GENERATION	Presenilins 1 and 2 (PS1 and 2) are the catalytic subunits of gamma-secretase, a multiprotein protease that cleaves amyloid protein precursor and other type I transmembrane proteins. Previous studies with mouse models or cells have indicated differences in PS1 and PS2 functions. We have recently reported that clinical gamma-secretase inhibitors (GSIs), initially developed to manage Alzheimer's disease and now being considered for other therapeutic interventions, are both pharmacologically and functionally distinct. Here, using CRISPR/Cas9-based gene editing, we established human HEK 293T cell lines in which endogenous PS1, PS2, or both have been knocked out. Using these knockout lines to examine differences in PS1- and PS2-mediated cleavage events, we confirmed that PS2 generates more intracellular beta-amyloid than does PS1. Moreover, we observed subtle differences in PS1- and PS2-mediated cleavages of select substrates. In exploring the question of whether differences in activity among clinical GSIs could be attributed to differential inhibition of PS1 or PS2, we noted that select GSIs inhibit PS1 and PS2 activities on specific substrates with slightly different potencies. We also found that endoproteolysis of select PS1 FAD-linked variants in human cells is more efficient than what has been previously reported for mouse cell lines. Overall, these results obtained with HEK293T cells suggest that selective PS1 or PS2 inhibition by a given GSI does not explain the previously observed differences in functional and pharmacological properties among various GSIs.	[Lessard, Christian B.; Ladd, Thomas B.; Golde, Todd E.; Ran, Yong] Univ Florida, Dept Neurosci & Neurol, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Lessard, Christian B.; Ladd, Thomas B.; Golde, Todd E.; Ran, Yong] Univ Florida, Dept Neurosci & Neurol, McKnight Brain Inst, Coll Med, Gainesville, FL 32610 USA; [Rodriguez, Edgardo] Univ Florida, Dept Pharmacol & Therapeut, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Rodriguez, Edgardo] Univ Florida, Dept Pharmacol & Therapeut, McKnight Brain Inst, Gainesville, FL 32610 USA; [Minter, Lisa M.; Osborne, Barbara A.] Univ Massachusetts, Dept Vet & Anim Sci, Ctr Bioact Delivery, Inst Appl Life Sci, Amherst, MA 01003 USA; [Minter, Lisa M.; Osborne, Barbara A.] Univ Massachusetts, Dept Vet & Anim Sci, Ctr Bioact Delivery, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Miele, Lucio] Louisiana State Univ, Dept Genet & Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Golde, TE; Ran, Y (corresponding author), 1275 Ctr Dr,POB 100159, Gainesville, FL 32610 USA.	tgolde@ufl.edu; yran@ufl.edu			NCI, National Institutes of Health [1P01CA166009 01A1]; NATIONAL CANCER INSTITUTE [P01CA166009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI, National Institutes of Health Grant 1P01CA166009 01A1 (to B. A. O., L. M., and T. E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Borgegard T, 2012, J NEUROSCI, V32, P17297, DOI 10.1523/JNEUROSCI.1451-12.2012; Cummings J, 2010, BIOL PSYCHIAT, V68, P876, DOI 10.1016/j.biopsych.2010.09.020; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dermaut B, 2000, J NEUROL, V247, P364, DOI 10.1007/s004150050603; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Espinoza I, 2013, ONCOTARGETS THER, V6, P1249, DOI 10.2147/OTT.S36162; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kretner B, 2016, EMBO MOL MED, V8, P458, DOI 10.15252/emmm.201505952; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lee J, 2011, BIOCHEMISTRY-US, V50, P4973, DOI 10.1021/bi200026m; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lessard CB, 2010, P NATL ACAD SCI USA, V107, P21236, DOI 10.1073/pnas.1016284108; Meckler X, 2016, J BIOL CHEM, V291, P12821, DOI 10.1074/jbc.M115.708297; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran Y, 2017, EMBO MOL MED, V9, P950, DOI 10.15252/emmm.201607265; Ran Y, 2014, J BIOL CHEM, V289, P3276, DOI 10.1074/jbc.M113.512921; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Samson K, 2010, ANN NEUROL, V68, pA11, DOI 10.1002/ana.22249; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Schor NF, 2011, ANN NEUROL, V69, P237, DOI 10.1002/ana.22365; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Stanga S, 2018, J CELL MOL MED, V22, P823, DOI 10.1111/jcmm.13364; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; van de Craen M, 1999, FEBS LETT, V445, P149, DOI 10.1016/S0014-5793(99)00108-8; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200	38	8	8	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11276	11285		10.1074/jbc.RA119.008041	http://dx.doi.org/10.1074/jbc.RA119.008041			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167792	Green Published, hybrid			2022-12-28	WOS:000478717400018
J	Bego, MG; Miguet, N; Laliberte, A; Aschman, N; Gerard, F; Merakos, AA; Weissenhorn, W; Cohen, EA				Bego, Mariana G.; Miguet, Nolwenn; Laliberte, Alexandre; Aschman, Nicolas; Gerard, Francine; Merakos, Angelique A.; Weissenhorn, Winfried; Cohen, Eric A.			Activation of the ILT7 receptor and plasmacytoid dendritic cell responses are governed by structurally-distinct BST2 determinants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor regulation; interferon; innate immunity; dendritic cell; protein conformation; bone marrow stromal cell antigen 2 (BST2); coiled-coil; immunoglobulin-like transcript 7 (ILT7); leukocyte immunoglobulin-like receptor A4 (LILRA4); Tetherin	I INTERFERON; MOLECULAR-CLONING; HIV-1 RELEASE; PROTEIN; GENE; SURFACE; ALPHA; BST2/TETHERIN; RESTRICTION; MECHANISMS	Type I interferons (IFN-I) are key innate immune effectors predominantly produced by activated plasmacytoid dendritic cells (pDCs). By modulating immune responses at their foundation, IFNs can widely reshape immunity to control infectious diseases and malignancies. Nevertheless, their biological activities can also be detrimental to surrounding healthy cells, as prolonged IFN-I signaling is associated with excessive inflammation and immune dysfunction. The interaction of the human pDC receptor immunoglobulin-like transcript 7 (ILT7) with its IFN-I-regulated ligand, bone marrow stromal cell antigen 2 (BST2) plays a key role in controlling the IFN-I amounts produced by pDCs in response to Toll-like receptor (TLR) activation. However, the structural determinants and molecular features of BST2 that govern ILT7 engagement and activation are largely undefined. Using two functional assays to measure BST2-stimulated ILT7 activation as well as biophysical studies, here we identified two structurally-distinct regions of the BST2 ectodomain that play divergent roles during ILT7 activation. We found that although the coiled-coil region contains a newly defined ILT7-binding surface, the N-terminal region appears to suppress ILT7 activation. We further show that a stable BST2 homodimer binds to ILT7, but post-binding events associated with the unique BST2 coiled-coil plasticity are required to trigger receptor signaling. Hence, BST2 with an unstable or a rigid coiled-coil fails to activate ILT7, whereas substitutions in its N-terminal region enhance activation. Importantly, the biological relevance of these newly defined domains of BST2 is underscored by the identification of substitutions having opposing potentials to activate ILT7 in pathological malignant conditions.	[Bego, Mariana G.; Laliberte, Alexandre; Merakos, Angelique A.; Cohen, Eric A.] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Miguet, Nolwenn; Aschman, Nicolas; Gerard, Francine; Weissenhorn, Winfried] Univ Grenoble Alpes, CNRS, IBS, CEA Grenoble, F-38044 Grenoble, France; [Cohen, Eric A.] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3T 1J4, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Montreal	Cohen, EA (corresponding author), Inst Rech Clin Montreal, Lab Human Retrovirol, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	eric.cohen@ircm.qc.ca		Bego, Mariana/0000-0002-1963-5503; Weissenhorn, Winfried/0000-0001-5532-4959	Canadian Institutes of Health Research (CIHR) [PJT148686, FDN 154324]; IRCM-UdeM Chair of Excellence in HIV research; ANRS [073744]; Institute Universitaire de France (IUF); Grenoble Partnership for Structural Biology platforms (ISBG) - FRISBI [UMS 3518 CNRS-CEA-UJF-EMBL, ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]; Fond National de la Recherche Luxembourg	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); IRCM-UdeM Chair of Excellence in HIV research; ANRS(ANRSFrench National Research Agency (ANR)); Institute Universitaire de France (IUF); Grenoble Partnership for Structural Biology platforms (ISBG) - FRISBI; GRAL; Fond National de la Recherche Luxembourg(Luxembourg National Research Fund)	This work was supported by Canadian Institutes of Health Research (CIHR) Grants PJT148686 and FDN 154324 and an IRCM-UdeM Chair of Excellence in HIV research (to E. A. C.), ANRS Grant 073744 (to W. W.), the Institute Universitaire de France (IUF) and Grenoble Partnership for Structural Biology platforms (ISBG) UMS 3518 CNRS-CEA-UJF-EMBL funded by FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01). This work was also supported by a Ph.D. fellowship from the Fond National de la Recherche Luxembourg (to N. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrew AJ, 2012, J BIOL CHEM, V287, P44278, DOI 10.1074/jbc.M112.418822; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Bego MG, 2016, J VIROL, V90, P10236, DOI 10.1128/JVI.01131-16; Bego MG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005024; Bego MG, 2012, J VIROL, V86, P3513, DOI 10.1128/JVI.06971-11; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2010, IMMUNOL REV, V234, P163, DOI 10.1111/j.0105-2896.2009.00867.x; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Chen K, 2017, J AUTOIMMUN, V83, P1, DOI 10.1016/j.jaut.2017.03.008; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Di Franco S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00878; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Epeldegui M, 2015, EUR J IMMUNOL, V45, P728, DOI 10.1002/eji.201444787; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Gong SY, 2015, INT J CLIN EXP PATHO, V8, P1613; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hammonds J, 2012, J VIROL, V86, P2259, DOI 10.1128/JVI.05906-11; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; KUSTER H, 1992, J BIOL CHEM, V267, P12782; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Mahauad-Fernandez WD, 2016, IMMUN INFLAMM DIS, V4, P4, DOI 10.1002/iid3.92; Mahauad-Fernandez WD, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0493-8; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Mukai S, 2017, ANN SURG ONCOL, V24, P594, DOI 10.1245/s10434-016-5100-z; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Picard C, 2017, AUTOIMMUN REV, V16, P897, DOI 10.1016/j.autrev.2017.07.001; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Schubert HL, 2010, P NATL ACAD SCI USA, V107, P17951, DOI 10.1073/pnas.1008206107; Snell LM, 2017, TRENDS IMMUNOL, V38, P542, DOI 10.1016/j.it.2017.05.005; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Weissenhorn W, 2012, CURR HIV RES, V10, P298, DOI 10.2174/157016212800792487; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	46	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10503	10518		10.1074/jbc.RA119.008481	http://dx.doi.org/10.1074/jbc.RA119.008481			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31118237	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000478717100011
J	Wang, H; Pilch, PF; Liu, LB				Wang, Hong; Pilch, Paul F.; Liu, Libin			Cavin-1/PTRF mediates insulin-dependent focal adhesion remodeling and ameliorates high-fat diet-induced inflammatory responses in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolae; focal adhesion; insulin; adipocyte; lipid raft; inflammation; adipose tissue; osmotic swelling; obesity; cavin-1; focal complex; phosphorylation; PTRF	TRANSCRIPT RELEASE FACTOR; LIPID TRAFFICKING; CELL-ADHESION; POLYMERASE-I; CAVEOLAE; CAVIN; DYNAMICS; PROTEIN; PTRF; PHOSPHORYLATION	Cavin-1/polymerase I and transcript release factor (PTRF) is a requisite component of caveolae, small plasma membrane invaginations that are highly abundant in adipocytes. Cavin-1 is a dynamic molecule whose dissociation from caveolae plays an important role in mechanoprotection and rRNA synthesis. In the former situation, the acute dissociation of cavin-1 from caveolae allows cell membrane expansion that occurs upon insulin-aided lipid uptake into the fat cells. Cavin-1 dissociation from caveolae and membrane flattening alters the cytoskeleton and the interaction of plasma membrane proteins with the extracellular matrix through interactions with focal adhesion structures. Here, using cavin-1 knockout mice, subcellular fractionation, and immunoblotting methods, we addressed the relationship of cavin-1 with focal adhesion complexes following nutritional stimulation. We found that cavin-1 is acutely translocated to focal complex compartments upon insulin stimulation, where it regulates focal complex formation through an interaction with paxillin. We found that loss of cavin-1 impairs focal complex remodeling and focal adhesion formation and causes a mechanical stress response, concomitant with activation of proinflammatory and senescence/apoptosis pathways. We conclude that cavin-1 plays key roles in dynamic remodeling of focal complexes upon metabolic stimulation. This mechanism also underlies the crucial role of caveolae in the long-term healthy expansion of the adipocyte.	[Wang, Hong; Pilch, Paul F.; Liu, Libin] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Pilch, Paul F.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Liu, Libin] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Wang, Hong] Broad Inst, Cambridge, MA 02142 USA	Boston University; Boston University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Liu, LB (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	libin@bu.edu	Liu, Libin/ABH-6019-2020	Liu, Libin/0000-0001-5056-1517	National Institutes of Health [DK-112945]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK-112945 (to P. F. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aboulaich N, 2006, BIOCHEM BIOPH RES CO, V350, P657, DOI 10.1016/j.bbrc.2006.09.094; Bailey KM, 2008, J BIOL CHEM, V283, P13714, DOI 10.1074/jbc.M709329200; Balamatsias D, 2011, J BIOL CHEM, V286, P43229, DOI 10.1074/jbc.M111.306621; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Briand N, 2014, DIABETES, V63, P4032, DOI 10.2337/db13-1961; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Cheng JPX, 2015, J CELL BIOL, V211, P53, DOI 10.1083/jcb.201504042; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Ding SY, 2014, J BIOL CHEM, V289, P8473, DOI 10.1074/jbc.M113.546242; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; Gambin Y, 2014, ELIFE, V3, DOI 10.7554/eLife.01434; Garcia J, 2017, CURR BIOL, V27, P1982, DOI 10.1016/j.cub.2017.05.035; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Golani G, 2019, DEV CELL, V48, P523, DOI 10.1016/j.devcel.2018.12.005; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hill MM, 2007, TRAFFIC, V8, P1695, DOI 10.1111/j.1600-0854.2007.00653.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Jansa P, 1999, MOL GEN GENET, V262, P508, DOI 10.1007/s004380051112; Jansa P, 2001, NUCLEIC ACIDS RES, V29, P423, DOI 10.1093/nar/29.2.423; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Joshi B, 2012, J CELL BIOL, V199, P425, DOI 10.1083/jcb.201207089; Kleinschmidt EG, 2017, CURR OPIN CELL BIOL, V45, P24, DOI 10.1016/j.ceb.2017.01.003; Lim YW, 2017, CURR BIOL, V27, P1968, DOI 10.1016/j.cub.2017.05.067; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Liu LB, 2006, MOL BIOL CELL, V17, P4249, DOI 10.1091/mbc.E06-04-0278; Liu LB, 2016, ELIFE, V5, DOI 10.7554/eLife.17508; Lo HP, 2015, J CELL BIOL, V210, P833, DOI 10.1083/jcb.201501046; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; Martin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046242; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Meshulam T, 2011, J LIPID RES, V52, P1526, DOI 10.1194/jlr.M015628; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; PALADE GE, 1953, J APPL PHYS, V24, P1424; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Parton RG, 2018, ANNU REV CELL DEV BI, V34, P111, DOI 10.1146/annurev-cellbio-100617-062737; Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Pilch PF, 2011, CLIN LIPIDOL, V6, P49, DOI 10.2217/CLP.10.80; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Souto RP, 2003, J BIOL CHEM, V278, P18321, DOI 10.1074/jbc.M211541200; Wei Z, 2015, BIOCHEM BIOPH RES CO, V456, P750, DOI 10.1016/j.bbrc.2014.12.035; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yang L, 2017, J BIOL CHEM, V292, P3779, DOI 10.1074/jbc.M116.768499; Yeow I, 2017, CURR BIOL, V27, P2951, DOI 10.1016/j.cub.2017.07.047	52	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10544	10552		10.1074/jbc.RA119.008824	http://dx.doi.org/10.1074/jbc.RA119.008824			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31126986	hybrid, Green Published			2022-12-28	WOS:000478717100014
J	Burroughs, AM; Glasner, ME; Barry, KP; Taylor, EA; Aravind, L				Burroughs, A. Maxwell; Glasner, Margaret E.; Barry, Kevin P.; Taylor, Erika A.; Aravind, L.			Oxidative opening of the aromatic ring: Tracing the natural history of a large superfamily of dioxygenase domains and their relatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dioxygenase; isoprenoid; RNA modification; phosphorylase; hydrolase; AMMECR1; LigB; Memo; protocatechuate dioxygenase; YgiD	POLY-GAMMA-GLUTAMATE; GERANYLGERANYLGLYCERYL PHOSPHATE SYNTHASE; SPHINGOMONAS-PAUCIMOBILIS SYK-6; EXTRADIOL CATECHOL DIOXYGENASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; 2-AMINOPHENOL 1,6-DIOXYGENASE; DOPA 4,5-DIOXYGENASE; GALLATE DIOXYGENASE; CATABOLIC PATHWAYS	A diverse collection of enzymes comprising the protocatechuate dioxygenases (PCADs) has been characterized in several extradiol aromatic compound degradation pathways. Structural studies have shown a relationship between PCADs and the more broadly-distributed, functionally enigmatic Memo domain linked to several human diseases. To better understand the evolution of this PCAD-Memo protein superfamily, we explored their structural and functional determinants to establish a unified evolutionary framework, identifying 15 clearly-delineable families, including a previously-underappreciated diversity in five Memo clade families. We place the superfamily's origin within the greater radiation of the nucleoside phosphorylase/hydrolase-peptide/amidohydrolase fold prior to the last universal common ancestor of all extant organisms. In addition to identifying active-site residues across the superfamily, we describe three distinct, structurally-variable regions emanating from the core scaffold often housing conserved residues specific to individual families. These were predicted to contribute to the active-site pocket, potentially in substrate specificity and allosteric regulation. We also identified several previously-undescribed conserved genome contexts, providing insight into potentially novel substrates in PCAD clade families. We extend known conserved contextual associations for the Memo clade beyond previously-described associations with the AMMECR1 domain and a radical S-adenosylmethionine family domain. These observations point to two distinct yet potentially overlapping contexts wherein the elusive molecular function of the Memo domain could be finally resolved, thereby linking it to nucleotide base and aliphatic isoprenoid modification. In total, this report throws light on the functions of large swaths of the experimentally-uncharacterized PCAD-Memo families.	[Burroughs, A. Maxwell; Aravind, L.] NIH, Natl Lib Med, NCBI, Computat Biol Branch, Bethesda, MD 20894 USA; [Glasner, Margaret E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Barry, Kevin P.; Taylor, Erika A.] Wesleyan Univ, Dept Chem, Middletown, CT 06459 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Texas A&M University System; Texas A&M University College Station; Wesleyan University	Aravind, L (corresponding author), NIH, Natl Lib Med, NCBI, Computat Biol Branch, Bethesda, MD 20894 USA.; Aravind, L (corresponding author), 52 Lawn Ave,Hall Atwater,Rm 142, Middletown, CT 06459 USA.; Taylor, EA (corresponding author), Bldg 38A,Rm 5N503,8600 Rockville Pike, Bethesda, MD 20894 USA.	eataylor@wesleyan.edu; aravind@ncbi.nlm.nih.gov	Taylor, Erika A./F-5635-2015	Taylor, Erika A./0000-0001-5598-640X; Burroughs, A. Max/0000-0002-2229-8771; Glasner, Margaret/0000-0003-1818-1965	Intramural Research Program, National Library of Medicine, National Institutes of Health	Intramural Research Program, National Library of Medicine, National Institutes of Health	Supported by Intramural Research Program, National Library of Medicine, National Institutes of Health.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2003, CURR OPIN CHEM BIOL, V7, P12, DOI 10.1016/S1367-5931(02)00018-2; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; Aravind L, 2000, GENOME RES, V10, P1074, DOI 10.1101/gr.10.8.1074; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Arcos M, 2010, ENVIRON MICROBIOL, V12, P1684, DOI 10.1111/j.1462-2920.2010.02233.x; Ashiuchi M, 2002, APPL MICROBIOL BIOT, V59, P9, DOI 10.1007/s00253-002-0984-x; Ashiuchi M, 2001, EUR J BIOCHEM, V268, P5321, DOI 10.1046/j.0014-2956.2001.02475.x; Balaji S, 2007, NUCLEIC ACIDS RES, V35, P5658, DOI 10.1093/nar/gkm558; Barber AE, 2012, BIOINFORMATICS, V28, P2845, DOI 10.1093/bioinformatics/bts532; Barnes MR, 1997, J BACTERIOL, V179, P6145, DOI 10.1128/jb.179.19.6145-6153.1997; Barry KP, 2013, BIOCHEMISTRY-US, V52, P6724, DOI 10.1021/bi400665t; Barry KP, 2015, ARCH BIOCHEM BIOPHYS, V567, P35, DOI 10.1016/j.abb.2014.12.019; Bartos P, 2014, BIOORG CHEM, V56, P49, DOI 10.1016/j.bioorg.2014.05.012; Basu A, 2017, P NATL ACAD SCI USA, V114, pE8165, DOI 10.1073/pnas.1709588114; Benseddik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055211; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Booker Squire J, 2010, F1000 Biol Rep, V2, P52, DOI 10.3410/B2-52; Budd A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r38; Buis JM, 2005, ARCH BIOCHEM BIOPHYS, V433, P288, DOI 10.1016/j.abb.2004.09.028; Burkhart BJ, 2015, NAT CHEM BIOL, V11, P564, DOI 10.1038/nchembio.1856; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Burroughs AM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1267; Burroughs AM, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0053-x; Burroughs AM, 2014, RNA BIOL, V11, P360, DOI 10.4161/rna.28302; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Dellas N, 2013, ELIFE, V2, DOI 10.7554/eLife.00672; Demaneche S, 2004, APPL ENVIRON MICROB, V70, P6714, DOI 10.1128/AEM.70.11.6714-6725.2004; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dumelin CE, 2012, NAT CHEM BIOL, V8, P913, DOI [10.1038/nchembio.1070, 10.1038/NCHEMBIO.1070]; Eaton RW, 2001, J BACTERIOL, V183, P3689, DOI 10.1128/JB.183.12.3689-3703.2001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewald CY, 2017, ELIFE, V6, DOI 10.7554/eLife.19493; Fetzner S, 2012, APPL ENVIRON MICROB, V78, P2505, DOI 10.1128/AEM.07651-11; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fischer F, 1999, J BACTERIOL, V181, P5725, DOI 10.1128/JB.181.18.5725-5733.1999; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gandia-Herrero F, 2014, APPL MICROBIOL BIOT, V98, P1165, DOI 10.1007/s00253-013-4961-3; Gandia-Herrero F, 2013, TRENDS PLANT SCI, V18, P334, DOI 10.1016/j.tplants.2013.01.003; Gandia-Herrero F, 2012, PLANTA, V236, P91, DOI 10.1007/s00425-012-1593-2; Gasc C, 2015, RES MICROBIOL, V166, P814, DOI 10.1016/j.resmic.2015.06.001; GIROD PA, 1991, PHYTOCHEMISTRY, V30, P169, DOI 10.1016/0031-9422(91)84119-D; Grochowski LL, 2006, J BACTERIOL, V188, P3192, DOI 10.1128/JB.188.9.3192-3198.2006; He PQ, 2011, J INORG BIOCHEM, V105, P1259, DOI 10.1016/j.jinorgbio.2011.06.006; Heger A, 2000, PROG BIOPHYS MOL BIO, V73, P321, DOI 10.1016/S0079-6107(00)00013-4; Hinz UG, 1997, MOL GEN GENET, V256, P1, DOI 10.1007/s004380050539; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hori H, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010023; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Iyer LM, 2010, NUCLEIC ACIDS RES, V38, P5261, DOI 10.1093/nar/gkq265; Iyer LM, 2009, MOL BIOSYST, V5, P1636, DOI 10.1039/b917682a; Kamimura N., 2014, BIODEGRADATIVE BACTE, P207, DOI DOI 10.1007/978-4-431-54520-0_10; Kasai D, 2005, J BACTERIOL, V187, P5067, DOI 10.1128/JB.187.15.5067-5074.2005; Kasai D, 2004, J BACTERIOL, V186, P4951, DOI 10.1128/JB.186.15.4951-4959.2004; Kasai D, 2007, FEMS MICROBIOL LETT, V274, P323, DOI 10.1111/j.1574-6968.2007.00855.x; Kasai D, 2009, J BACTERIOL, V191, P6758, DOI 10.1128/JB.00840-09; Khan MI, 2015, PHYTOCHEMISTRY, V117, P267, DOI 10.1016/j.phytochem.2015.06.008; Kim J, 2013, NATURE, V498, P123, DOI 10.1038/nature12180; Kondo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094114; Kostova KK, 2017, SCIENCE, V357, P414, DOI 10.1126/science.aam7787; Kuatsjah E, 2017, FEBS LETT, V591, P1001, DOI 10.1002/1873-3468.12611; Kulakov LA, 1998, MICROBIOL-UK, V144, P955, DOI 10.1099/00221287-144-4-955; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Latham JA, 2015, J BIOL CHEM, V290, P12908, DOI 10.1074/jbc.M115.646521; Laurie AD, 1999, J BACTERIOL, V181, P531, DOI 10.1128/JB.181.2.531-540.1999; Lendenmann U, 1996, J BACTERIOL, V178, P6227, DOI 10.1128/jb.178.21.6227-6232.1996; Li DF, 2013, ACTA CRYSTALLOGR D, V69, P32, DOI 10.1107/S0907444912042072; Lipscomb JD, 2008, CURR OPIN STRUC BIOL, V18, P644, DOI 10.1016/j.sbi.2008.11.001; Liu ZJ, 2005, ACTA CRYSTALLOGR D, V61, P679, DOI 10.1107/S0907444905013132; MacDonald G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004870; Machonkin TE, 2011, BIOCHEMISTRY-US, V50, P8899, DOI 10.1021/bi200855m; Marin M, 2012, J BACTERIOL, V194, P3851, DOI 10.1128/JB.00430-12; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Martone PT, 2009, CURR BIOL, V19, P169, DOI 10.1016/j.cub.2008.12.031; Maruyama K, 2004, BIOSCI BIOTECH BIOCH, V68, P1434, DOI 10.1271/bbb.68.1434; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Matsumi R, 2011, RES MICROBIOL, V162, P39, DOI 10.1016/j.resmic.2010.10.003; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Mendel S, 2004, BIOCHEMISTRY-US, V43, P13390, DOI 10.1021/bi048518t; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nemoto N, 2003, J BIOCHEM, V133, P651, DOI 10.1093/jb/mvg083; Nishitani Y, 2016, ACTA CRYSTALLOGR F, V72, P427, DOI 10.1107/S2053230X16006920; Nogales J, 2005, J BIOL CHEM, V280, P35382, DOI 10.1074/jbc.M502585200; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Ogris C, 2018, NUCLEIC ACIDS RES, V46, pD601, DOI 10.1093/nar/gkx1138; Peng X, 1998, APPL ENVIRON MICROB, V64, P2520; Pornsuwan S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171135; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Providenti MA, 2001, MICROBIOL-SGM, V147, P2157, DOI 10.1099/00221287-147-8-2157; Puehringer Sandra, 2008, BMC Biochemistry, V9, P8, DOI 10.1186/1471-2091-9-8; Purschke WG, 1997, J BACTERIOL, V179, P1344, DOI 10.1128/jb.179.4.1344-1353.1997; Qiu C, 2008, J BIOL CHEM, V283, P2734, DOI 10.1074/jbc.M703523200; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; ROPER DI, 1990, FEBS LETT, V275, P53, DOI 10.1016/0014-5793(90)81437-S; Samanovic MI, 2015, MOL CELL, V57, P984, DOI 10.1016/j.molcel.2015.01.024; Sasaki N, 2009, PLANT CELL PHYSIOL, V50, P1012, DOI 10.1093/pcp/pcp053; Sato S, 1997, J BACTERIOL, V179, P4841, DOI 10.1128/jb.179.15.4841-4849.1997; Schlosrich J, 2006, CHEMBIOCHEM, V7, P1899, DOI 10.1002/cbic.200600296; Schweizer U, 2017, RNA BIOL, V14, P1197, DOI 10.1080/15476286.2017.1294309; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Shen YQ, 2012, BIOCHEMISTRY-US, V51, P2265, DOI 10.1021/bi201763d; Sierant M, 2018, FEBS LETT, V592, P2248, DOI 10.1002/1873-3468.13124; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Soderberg T, 2001, BIOCHEMISTRY-US, V40, P14847, DOI 10.1021/bi0111799; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; SPARNINS VL, 1974, J BACTERIOL, V120, P159, DOI 10.1128/JB.120.1.159-167.1974; SPARNINS VL, 1976, J BACTERIOL, V127, P362, DOI 10.1128/JB.127.1.362-366.1976; Spence EL, 1996, J BACTERIOL, V178, P5249, DOI 10.1128/jb.178.17.5249-5256.1996; Sugimoto K, 1999, STRUCTURE, V7, P953, DOI 10.1016/S0969-2126(99)80122-1; Sugimoto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092249; TACK BF, 1972, J BIOL CHEM, V247, P6438; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tsai TY, 2009, PROTEINS, V76, P1042, DOI 10.1002/prot.22461; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; VanNice JC, 2014, J BACTERIOL, V196, P1055, DOI 10.1128/JB.01230-13; Vetting MW, 2000, STRUCTURE, V8, P429, DOI 10.1016/S0969-2126(00)00122-2; Vinokur JM, 2015, PROTEIN SCI, V24, P212, DOI 10.1002/pro.2607; Vitelli F, 1999, GENOMICS, V55, P335, DOI 10.1006/geno.1998.5666; Wang R, 2015, CHEM COMMUN, V51, P16369, DOI 10.1039/c5cc07479g; Wattiau P, 2001, RES MICROBIOL, V152, P861, DOI 10.1016/S0923-2508(01)01269-4; Winkelblech J, 2015, APPL MICROBIOL BIOT, V99, P7379, DOI 10.1007/s00253-015-6811-y; WOLGEL SA, 1993, J BACTERIOL, V175, P4414, DOI 10.1128/JB.175.14.4414-4426.1993; Wu JF, 2006, APPL ENVIRON MICROB, V72, P1759, DOI 10.1128/AEM.72.3.1759-1765.2006; Wu JF, 2005, ARCH MICROBIOL, V183, P1, DOI 10.1007/s00203-004-0738-5; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107; Zhang DP, 2014, CURR OPIN STRUC BIOL, V26, P92, DOI 10.1016/j.sbi.2014.05.008; Zhen D, 2006, APPL MICROBIOL BIOT, V72, P797, DOI 10.1007/s00253-006-0345-2	136	16	16	3	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10211	10235		10.1074/jbc.RA119.007595	http://dx.doi.org/10.1074/jbc.RA119.007595			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31092555	Green Published, hybrid			2022-12-28	WOS:000474445600014
J	Palcekova, Z; Angala, SK; Belardinelli, JM; Eskandarian, HA; Joe, M; Brunton, R; Rithner, C; Jones, V; Nigou, J; Lowary, TL; Gilleron, M; McNeil, M; Jackson, M				Palcekova, Zuzana; Angala, Shiva K.; Belardinelli, Juan Manuel; Eskandarian, Haig A.; Joe, Maju; Brunton, Richard; Rithner, Christopher; Jones, Victoria; Nigou, Jerome; Lowary, Todd L.; Gilleron, Martine; McNeil, Michael; Jackson, Mary			Disruption of the SucT acyltransferase in Mycobacterium smegmatis abrogates succinylation of cell envelope polysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mycobacteria; Mycobacterium smegmatis; polysaccharide; tuberculosis; cell surface; arabinogalactan; lipoarabinomannan; succinylation	GALACTOSAMINE SUBSTITUENT; BIOSYNTHESIS; LIPOARABINOMANNAN; IMPACT; ARABINOGALACTAN; IDENTIFICATION; ACETYLATION; LIPOMANNAN; APOPTOSIS; TRANSPORT	Similar to other prokaryotes, mycobacteria decorate their major cell envelope glycans with minor covalent substituents whose biological significance remains largely unknown. We report on the discovery of a mycobacterial enzyme, named here SucT, that adds succinyl groups to the arabinan domains of both arabinogalactan (AG) and lipoarabinomannan (LAM). Disruption of the SucT-encoding gene in Mycobacterium smegmatis abolished AG and LAM succinylation and altered the hydrophobicity and rigidity of the cell envelope of the bacilli without significantly altering AG and LAM biosynthesis. The changes in the cell surface properties of the mutant were consistent with earlier reports of transposon mutants of the closely related species Mycobacterium marinum and Mycobacterium avium harboring insertions in the orthologous gene whose ability to microaggregate and form biofilms were altered. Our findings point to an important role of SucT-mediated AG and LAM succinylation in modulating the cell surface properties of mycobacteria.	[Palcekova, Zuzana; Angala, Shiva K.; Belardinelli, Juan Manuel; Jones, Victoria; McNeil, Michael; Jackson, Mary] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Eskandarian, Haig A.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, VD, Switzerland; [Joe, Maju; Brunton, Richard; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Rithner, Christopher] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Nigou, Jerome; Gilleron, Martine] Colorado State Univ, Dept Chem, Cent Instrumentat Facil, Ft Collins, CO 80523 USA; [Nigou, Jerome; Gilleron, Martine] Univ Toulouse, Inst Pharmacol & Biol Struct, CNRS, UPS, 205 Route Narbonne, F-31077 Toulouse, France	Colorado State University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Alberta; University of Alberta; Colorado State University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Jackson, M (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu	Belardinelli, Juan Manuel/N-7335-2019; Lowary, Todd L/F-9608-2019; Jackson, Mary/D-5345-2017	Belardinelli, Juan Manuel/0000-0003-1336-9141; Lowary, Todd L/0000-0002-8331-8211; Jackson, Mary/0000-0002-9212-0258; Eskandarian, Haig Alexander/0000-0002-0610-0550	NIAID, National Institutes of Health [AI064798]; Alberta Glycomics Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798, R21AI144344] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Alberta Glycomics Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant AI064798 (to M.J.) and the Alberta Glycomics Centre (to T.L.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angala SK, 2018, NAT CHEM BIOL, V14, P193, DOI 10.1038/nchembio.2571; Angala SK, 2014, CRIT REV BIOCHEM MOL, V49, P361, DOI 10.3109/10409238.2014.925420; Belardinelli JM, 2016, ACS INFECT DIS, V2, P702, DOI 10.1021/acsinfecdis.6b00095; Berg S, 2005, J BIOL CHEM, V280, P5651, DOI 10.1074/jbc.M411418200; Bhamidi S, 2008, J BIOL CHEM, V283, P12992, DOI 10.1074/jbc.M800222200; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Daffe M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0021-2013; De P, 2018, J BIOL CHEM, V293, P9706, DOI 10.1074/jbc.RA118.002582; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; Driessen NN, 2010, MICROBIOL-SGM, V156, P3492, DOI 10.1099/mic.0.037507-0; Eskandarian HA, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.94; Etienne G, 2002, MICROBIOL-SGM, V148, P3089, DOI 10.1099/00221287-148-10-3089; Gerlach D, 2018, NATURE, V563, P705, DOI 10.1038/s41586-018-0730-x; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Guerardel Y, 2003, J BIOL CHEM, V278, P36637, DOI 10.1074/jbc.M305427200; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Maldonado RF, 2016, FEMS MICROBIOL REV, V40, P480, DOI 10.1093/femsre/fuw007; Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; OrtaloMagne A, 1996, MICROBIOL-UK, V142, P927, DOI 10.1099/00221287-142-4-927; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rajagopal M, 2017, CURR TOP MICROBIOL, V404, P1, DOI 10.1007/82_2015_5021; Rose SJ, 2014, INFECT IMMUN, V82, P405, DOI 10.1128/IAI.00820-13; Schneewind O, 2014, J BACTERIOL, V196, P1133, DOI 10.1128/JB.01155-13; Skovierova H, 2010, J BIOL CHEM, V285, P41348, DOI 10.1074/jbc.M110.188110; Slauch JM, 1996, J BACTERIOL, V178, P5904, DOI 10.1128/jb.178.20.5904-5909.1996; Stadthagen G, 2007, J BIOL CHEM, V282, P27270, DOI 10.1074/jbc.M702676200; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Thanweer F, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-13; Thanweer F, 2008, BIOCHEM BIOPH RES CO, V375, P581, DOI 10.1016/j.bbrc.2008.08.069; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Torrelles JB, 2012, GLYCOBIOLOGY, V22, P1118, DOI 10.1093/glycob/cws078; Torrelles JB, 2011, J BIOL CHEM, V286, P35438, DOI 10.1074/jbc.M111.232587; WEBER PL, 1979, CARBOHYD RES, V74, P259, DOI 10.1016/S0008-6215(00)84781-3; Wheat WH, 2015, TUBERCULOSIS, V95, P476, DOI 10.1016/j.tube.2015.04.002; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Yamaryo-Botte Y, 2015, ACS CHEM BIOL, V10, P734, DOI 10.1021/cb5007689; Yamazaki Y, 2006, APPL ENVIRON MICROB, V72, P819, DOI 10.1128/AEM.72.1.819-825.2006; Yamazaki Y, 2006, CELL MICROBIOL, V8, P806, DOI 10.1111/j.1462-5822.2005.00667.x	42	10	10	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10325	10335		10.1074/jbc.RA119.008585	http://dx.doi.org/10.1074/jbc.RA119.008585			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31110045	hybrid, Green Published			2022-12-28	WOS:000474445600022
J	Bu, PL; Nagar, S; Bhagwat, M; Kaur, P; Shah, A; Zeng, J; Vancurova, I; Vancura, A				Bu, Pengli; Nagar, Shreya; Bhagwat, Madhura; Kaur, Pritpal; Shah, Ankita; Zeng, Joey; Vancurova, Ivana; Vancura, Ales			DNA damage response activates respiration and thereby enlarges dNTP pools to promote cell survival in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage response; respiration; ATP; histone; chromatin; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); energy metabolism; cell stress; dNTP; oxidative phosphorylation (OXPHOS)	RIBONUCLEOTIDE REDUCTASE INHIBITOR; HISTONE GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR-LOCALIZATION; SIGNAL-TRANSDUCTION; CLN2 TRANSCRIPTION; DOWN-REGULATION; NUCLEAR IMPORT; RAD53 KINASE; LIFE-SPAN	The DNA damage response (DDR) is an evolutionarily conserved process essential for cell survival. Previously, we found that decreased histone expression induces mitochondrial respiration, raising the question whether the DDR also stimulates respiration. Here, using oxygen consumption and ATP assays, RT-qPCR and ChIP-qPCR methods, and dNTP analyses, we show that DDR activation in the budding yeast Saccharomyces cerevisiae, either by genetic manipulation or by growth in the presence of genotoxic chemicals, induces respiration. We observed that this induction is conferred by reduced transcription of histone genes and globally decreased DNA nucleosome occupancy. This globally altered chromatin structure increased the expression of genes encoding enzymes of tricarboxylic acid cycle, electron transport chain, oxidative phosphorylation, elevated oxygen consumption, and ATP synthesis. The elevated ATP levels resulting from DDR-stimulated respiration drove enlargement of dNTP pools; cells with a defect in respiration failed to increase dNTP synthesis and exhibited reduced fitness in the presence of DNA damage. Together, our results reveal an unexpected connection between respiration and the DDR and indicate that the benefit of increased dNTP synthesis in the face of DNA damage outweighs possible cellular damage due to increased oxygen metabolism.	[Bu, Pengli; Nagar, Shreya; Bhagwat, Madhura; Kaur, Pritpal; Zeng, Joey; Vancurova, Ivana; Vancura, Ales] St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA; [Shah, Ankita] St Johns Univ, Dept Pharmaceut Sci, Queens, NY 11439 USA; [Shah, Ankita] Freund Vector Corp, 675 44th St, Marion, IA 52302 USA; [Zeng, Joey] Harvard Sch Dent Med, 188 Longwood Ave, Boston, MA 02115 USA	Saint John's University; Saint John's University; Harvard University; Harvard School of Dental Medicine	Vancura, A (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA.	vancuraa@stjohns.edu	NAGAR, SHREYA/GZH-1987-2022; Bu, Pengli/J-3575-2019	NAGAR, SHREYA/0000-0002-5985-2027; Bu, Pengli/0000-0003-2576-0607; Vancura, Ales/0000-0002-5895-1218; Kaur, Pritpal/0000-0002-8172-2624	National Institutes of Health [GM120710]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM120710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM120710 (to A. V). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreson BL, 2010, NUCLEIC ACIDS RES, V38, P6490, DOI 10.1093/nar/gkq552; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Bashkirov VI, 2003, MOL CELL BIOL, V23, P1441, DOI 10.1128/MCB.23.4.1441-1452.2003; Bolzan AD, 2018, MUTAT RES-REV MUTAT, V775, P51, DOI 10.1016/j.mrrev.2018.02.003; Brace LE, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.22; Branzei D, 2006, EXP CELL RES, V312, P2654, DOI 10.1016/j.yexcr.2006.06.012; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; de Oliveira FMB, 2012, EMBO J, V31, P1798, DOI 10.1038/emboj.2012.27; Eriksson PR, 2012, GENETICS, V191, P7, DOI 10.1534/genetics.112.140145; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; FRIEDBERG EC, 1995, TRENDS BIOCHEM SCI, V20, P381, DOI 10.1016/S0968-0004(00)89082-9; Galdieri L, 2016, MOL CELL BIOL, V36, P1064, DOI 10.1128/MCB.00770-15; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hess D, 2005, GENETICS, V170, P87, DOI 10.1534/genetics.104.039214; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Jaehnig EJ, 2013, CELL REP, V4, P174, DOI 10.1016/j.celrep.2013.05.041; Kitanovic A, 2009, FEMS YEAST RES, V9, P535, DOI 10.1111/j.1567-1364.2009.00505.x; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kurat CF, 2014, CELL MOL LIFE SCI, V71, P599, DOI 10.1007/s00018-013-1443-9; Lee YD, 2008, MOL CELL, V32, P70, DOI 10.1016/j.molcel.2008.08.018; Lee YD, 2006, GENE DEV, V20, P334, DOI 10.1101/gad.1380506; Libuda DE, 2010, GENETICS, V184, P985, DOI 10.1534/genetics.109.113662; Longhese MP, 1998, EMBO J, V17, P5525, DOI 10.1093/emboj/17.19.5525; Mathews CK, 2015, NAT REV CANCER, V15, P528, DOI 10.1038/nrc3981; Misko TA, 2016, FEBS LETT, V590, P1704, DOI 10.1002/1873-3468.12207; Mortensen UH, 2009, CURR BIOL, V19, pR676, DOI 10.1016/j.cub.2009.06.001; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013; OSLEY MA, 1987, MOL CELL BIOL, V7, P4204, DOI 10.1128/MCB.7.12.4204; Pellicioli A, 2005, CURR BIOL, V15, pR769, DOI 10.1016/j.cub.2005.08.057; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Putnam CD, 2017, GENETICS, V206, P1187, DOI 10.1534/genetics.112.145805; Putnam CD, 2009, DNA REPAIR, V8, P974, DOI 10.1016/j.dnarep.2009.04.021; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanvisens N, 2016, J BIOL CHEM, V291, P9807, DOI 10.1074/jbc.M116.720862; Sanvisens Nerea, 2013, Biomed J, V36, P51, DOI 10.4103/2319-4170.110398; Schmidt TT, 2017, P NATL ACAD SCI USA, V114, pE4442, DOI 10.1073/pnas.1618714114; SHERMAN F, 1991, P3; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Sidorova JM, 2003, MOL CELL BIOL, V23, P3405, DOI 10.1128/MCB.23.10.3405-3416.2003; Simpson-Lavy KJ, 2015, CELL REP, V12, P1865, DOI 10.1016/j.celrep.2015.08.025; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120; Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053; Travesa A, 2012, EMBO J, V31, P1811, DOI 10.1038/emboj.2012.28; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Tsaponina O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002061; Watt DL, 2016, NUCLEIC ACIDS RES, V44, P1669, DOI 10.1093/nar/gkv1298; Wilson PM, 2011, NUCLEIC ACIDS RES, V39, pE112, DOI 10.1093/nar/gkr350; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Wu XR, 2008, MOL CELL BIOL, V28, P7156, DOI 10.1128/MCB.01388-08; XU HX, 1992, MOL CELL BIOL, V12, P5249, DOI 10.1128/MCB.12.11.5249; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Yao RJ, 2003, P NATL ACAD SCI USA, V100, P6628, DOI 10.1073/pnas.1131932100; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000; Zhang TT, 2017, J BIOL CHEM, V292, P16942, DOI 10.1074/jbc.M117.790923; Zhang Z, 2006, P NATL ACAD SCI USA, V103, P1422, DOI 10.1073/pnas.0510516103; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; Zhou CS, 2016, P NATL ACAD SCI USA, V113, pE3667, DOI 10.1073/pnas.1602827113; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	74	12	13	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9771	9786		10.1074/jbc.RA118.007266	http://dx.doi.org/10.1074/jbc.RA118.007266			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31073026	hybrid, Green Published			2022-12-28	WOS:000473277900012
J	[Anonymous]				[Anonymous]			Activation of 5-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells: Role of peroxynitrite (Expression of Concern of Vol 278, Pg 34003, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200	1	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					10023	10023		10.1074/jbc.EC119.009569	http://dx.doi.org/10.1074/jbc.EC119.009569			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31227628	hybrid, Green Published			2022-12-28	WOS:000473277900036
J	Robb, EL; Hall, AR; Prime, TA; Eaton, S; Szibor, M; Viscomi, C; James, AM; Murphy, MP				Robb, Ellen L.; Hall, Andrew R.; Prime, Tracy A.; Eaton, Simon; Szibor, Marten; Viscomi, Carlo; James, Andrew M.; Murphy, Michael P.			Control of mitochondrial superoxide production by reverse electron transport at complex I. (vol 293, pg 9869, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													James, Andrew M/A-2639-2015; viscomi, Carlo/R-1940-2016	James, Andrew M/0000-0002-0515-9649; Eaton, Simon/0000-0003-0892-9204				Robb EL, 2018, J BIOL CHEM, V293, P9869, DOI 10.1074/jbc.RA118.003647	1	0	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7966	7966		10.1074/jbc.AAC119.008929	http://dx.doi.org/10.1074/jbc.AAC119.008929			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	31076523	Green Published, hybrid			2022-12-28	WOS:000470153300034
J	Tiwari, A; Shivananda, S; Gopinath, KS; Kumar, A				Tiwari, Ankana; Shivananda, Swamy; Gopinath, Kodaganur S.; Kumar, Arun			RETRACTION: Withdrawal: MicroRNA-125a reduces proliferation and invasion of oral squamous cell carcinoma cells by targeting estrogen-related receptor : Implications for cancer therapeutics. (Retraction of Vol 289, Pg 32276, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Tiwari A, 2014, J BIOL CHEM, V289, P32276, DOI 10.1074/jbc.M114.584136	1	1	1	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5811	5811		10.1074/jbc.W119.008507	http://dx.doi.org/10.1074/jbc.W119.008507			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30979853	hybrid, Green Published			2022-12-28	WOS:000465077500012
J	Picking, JW; Behrman, EJ; Zhang, LW; Krzycki, JA				Picking, Jonathan W.; Behrman, Edward J.; Zhang, Liwen; Krzycki, Joseph A.			MtpB, a member of the MttB superfamily from the human intestinal acetogen Eubacterium limosum, catalyzes proline betaine demethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial metabolism; microbiology; energy metabolism; folate; microbiome; enzyme catalysis; acetogenesis; cobalamin; one-carbon metabolism; trimethylamine methyltransferase; cobalamin	GLYCINE BETAINE; TRIMETHYLAMINE METHYLTRANSFERASE; ENERGY-CONSERVATION; METABOLISM; CATABOLISM; MELILOTI; STACHYDRINE; PYRROLYSINE; RESPONSES; BACTERIA	The trimethylamine methyltransferase MttB is the founding member of a widely distributed superfamily of microbial proteins. Genes encoding most members of the MttB superfamily lack the codon for pyrrolysine that distinguishes previously characterized trimethylamine methyltransferases, leaving the function(s) of most of the enzymes in this superfamily unknown. Here, investigating the MttB family member MtpB from the human intestinal isolate Eubacterium limosum ATCC 8486, an acetogen that excretes N-methyl proline during growth on proline betaine, we demonstrate that MtpB catalyzes anoxic demethylation of proline betaine. MtpB along with MtqC (a corrinoid protein) and MtqA (a methylcorrinoid:tetrahydrofolate methyltransferase) was much more abundant in E. limosum cells grown on proline betaine than on lactate. We observed that recombinant MtpB methylates Co(I)-MtqC in the presence of proline betaine and that other quaternary amines are much less preferred substrates. MtpB, MtqC, and MtqA catalyze tetrahydrofolate methylation with proline betaine, thereby forming a key intermediate in the Wood-Ljungdahl acetogenesis pathway. To our knowledge, MtpB methylation of Co(I)-MtqC for the subsequent methylation of tetrahydrofolate represents the first described anoxic mechanism of proline betaine demethylation. The activities of MtpB and associated proteins in acetogens or other anaerobes provide a possible mechanism for the production of N-methyl proline by the gut microbiome. MtpB's activity characterized here strengthens the hypothesis that much of the MttB superfamily comprises quaternary amine-dependent methyltransferases.	[Picking, Jonathan W.; Krzycki, Joseph A.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Behrman, Edward J.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Zhang, Liwen] Ohio State Univ, Campus Chem Instrument Ctr, Mass Spectrometry & Prote Facil, Columbus, OH 43210 USA; [Krzycki, Joseph A.] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	Krzycki.1@osu.edu	Zhang, Li/GWM-7501-2022		National Institute of Health [1R01DK109345]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109345] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institute of Health Grant 1R01DK109345. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almanza-Aguilera E, 2017, J NUTR BIOCHEM, V48, P36, DOI 10.1016/j.jnutbio.2017.06.001; Atkinson W, 2007, EUR J NUTR, V46, P446, DOI 10.1007/s00394-007-0684-5; Aurelio L, 2003, J ORG CHEM, V68, P2652, DOI 10.1021/jo026722l; Bashir A, 2014, MICROBIOL-SGM, V160, P2283, DOI 10.1099/mic.0.079665-0; Boscari A, 2002, J BACTERIOL, V184, P2654, DOI 10.1128/JB.184.10.2654-2663.2002; Burnet MW, 2000, GENE, V244, P151, DOI 10.1016/S0378-1119(99)00554-5; CHAMBERS ST, 1987, J CLIN INVEST, V79, P731, DOI 10.1172/JCI112878; CORNFORTH JW, 1952, J CHEM SOC, P601, DOI 10.1039/jr9520000601; Daughtry KD, 2012, J AM CHEM SOC, V134, P2823, DOI 10.1021/ja2111898; Drake HL, 2008, ANN NY ACAD SCI, V1125, P100, DOI 10.1196/annals.1419.016; Evans JC, 2004, P NATL ACAD SCI USA, V101, P3729, DOI 10.1073/pnas.0308082100; Feng Y, 2018, INT J SYST EVOL MICR, V68, P3546, DOI 10.1099/ijsem.0.003028; Ferguson DJ, 1997, J BACTERIOL, V179, P846, DOI 10.1128/jb.179.3.846-852.1997; Ferguson T, 2009, J BIOL CHEM, V284, P2285, DOI 10.1074/jbc.M807392200; GLOUX K, 1989, ARCH MICROBIOL, V151, P143, DOI 10.1007/BF00414429; GOLDMANN A, 1991, MOL PLANT MICROBE IN, V4, P571, DOI 10.1094/MPMI-4-571; Hennig SE, 2012, P NATL ACAD SCI USA, V109, P5235, DOI 10.1073/pnas.1117126109; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jeong J, 2015, APPL ENVIRON MICROB, V81, P4782, DOI 10.1128/AEM.00675-15; Karrer P, 1925, HELV CHIM ACTA, V8, P364, DOI 10.1002/hlca.19250080157; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kremp F, 2018, ENVIRON MICROBIOL, V20, P4369, DOI 10.1111/1462-2920.14356; Krzycki JA, 2004, CURR OPIN CHEM BIOL, V8, P484, DOI 10.1016/j.cbpa.2004.08.012; Kumar R, 2014, MBIO, V5, DOI 10.1128/mBio.00933-13; Lang R, 2017, J AGR FOOD CHEM, V65, P1613, DOI 10.1021/acs.jafc.6b05824; Lechtenfeld M, 2018, ENVIRON MICROBIOL, V20, P4512, DOI 10.1111/1462-2920.14389; LEVER M, 1994, BBA-GEN SUBJECTS, V1200, P259, DOI 10.1016/0304-4165(94)90165-1; Lin N.-H., 1996, United States Patent, Patent No. [US5516912A, 5516912]; Loo RL, 2018, AM J CLIN NUTR, V107, P323, DOI 10.1093/ajcn/nqx072; Lustgarten MS, 2014, AGING CELL, V13, P918, DOI 10.1111/acel.12251; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Matthews Rowena G., 2009, V6, P53, DOI [10.1039/9781847559159-00053, 10.1039/BK9781847559159-00053]; MULLER E, 1981, APPL ENVIRON MICROB, V42, P439; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; PFENNIG N, 1966, ARCH MIKROBIOL, V55, P245, DOI 10.1007/BF00410246; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Rebholz CM, 2018, AM J CLIN NUTR, V108, P243, DOI 10.1093/ajcn/nqy099; Roh H, 2011, J BACTERIOL, V193, P307, DOI 10.1128/JB.01217-10; Schilhabel A, 2009, J BACTERIOL, V191, P588, DOI 10.1128/JB.01104-08; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Schoelmerich MC, 2018, ENVIRON MICROBIOL, V20, P4587, DOI 10.1111/1462-2920.14412; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; Servillo L, 2011, J AGR FOOD CHEM, V59, P9410, DOI 10.1021/jf2014815; Soares JA, 2005, J BIOL CHEM, V280, P36962, DOI 10.1074/jbc.M506402200; Song Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14123-3; Song Y, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01564-14; Tang WHW, 2019, J AM COLL CARDIOL, V73, P2089, DOI 10.1016/j.jacc.2019.03.024; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Ticak T, 2014, P NATL ACAD SCI USA, V111, pE4668, DOI 10.1073/pnas.1409642111; Trinchant JC, 2004, PLANT PHYSIOL, V135, P1583, DOI 10.1104/pp.103.037556; Webb BA, 2017, MOL MICROBIOL, V103, P333, DOI 10.1111/mmi.13561; Weghoff MC, 2015, ENVIRON MICROBIOL, V17, P670, DOI 10.1111/1462-2920.12493; Zhang RH, 2018, PHYTOCHEMISTRY, V147, P167, DOI 10.1016/j.phytochem.2017.12.016; Zhao SW, 2013, NATURE, V502, P698, DOI 10.1038/nature12576; Zheng L, 2015, AM J PHYSIOL-CELL PH, V309, pC350, DOI 10.1152/ajpcell.00191.2015; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x	56	13	13	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13697	13707		10.1074/jbc.RA119.009886	http://dx.doi.org/10.1074/jbc.RA119.009886			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31341018	hybrid, Green Published			2022-12-28	WOS:000486418600015
J	Dall, M; Trammell, SAJ; Asping, M; Hassing, AS; Agerholm, M; Vienberg, SG; Gillum, MP; Larsen, S; Treebak, JT				Dall, Morten; Trammell, Samuel A. J.; Asping, Magnus; Hassing, Anna S.; Agerholm, Marianne; Vienberg, Sara G.; Gillum, Matthew P.; Larsen, Steen; Treebak, Jonas T.			Mitochondrial function in liver cells is resistant to perturbations in NAD(+) salvage capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NAMPT; nicotinamide adenine dinucleotide (NAD); mitochondrial metabolism; hepatocyte; NAD biosynthesis; fatty-acid metabolism; respiration; tryptophan metabolism	NICOTINAMIDE MONONUCLEOTIDE; DIPHOSPHOPYRIDINE NUCLEOTIDE; OXIDATIVE-PHOSPHORYLATION; ENERGY HOMEOSTASIS; RESPIRATORY-CHAIN; SKELETAL-MUSCLE; MICE; DIET; METABOLISM; RIBOSIDE	Supplementation with NAD precursors such as nicotinamide riboside (NR) has been shown to enhance mitochondrial function in the liver and to prevent hepatic lipid accumulation in high-fat diet (HFD)-fed rodents. Hepatocyte-specific knockout of the NAD(+)-synthesizing enzyme nicotinamide phosphoribosyltransferase (NAMPT) reduces liver NAD(+) levels, but the metabolic phenotype of Nampt-deficient hepatocytes in mice is unknown. Here, we assessed Nampt's role in maintaining mitochondrial and metabolic functions in the mouse liver. Using the Cre-LoxP system, we generated hepatocyte-specific Nampt knockout (HNKO) mice, having a 50% reduction of liver NAD(+) levels. We screened the HNKO mice for signs of metabolic dysfunction following 60% HFD feeding for 20 weeks +/- NR supplementation and found that NR increases hepatic NAD(+) levels without affecting fat mass or glucose tolerance in HNKO or WT animals. High-resolution respirometry revealed that NR supplementation of the HNKO mice did not increase state III respiration, which was observed in WT mice following NR supplementation. Mitochondrial oxygen consumption and fatty-acid oxidation were unaltered in primary HNKO hepatocytes. Mitochondria isolated from whole-HNKO livers had only a 20% reduction in NAD(+), suggesting that the mitochondrial NAD(+) pool is less affected by HNKO than the whole-tissue pool. When stimulated with tryptophan in the presence of [N-15]glutamine, HNKO hepatocytes had a higher [N-15]NAD(+) enrichment than WT hepatocytes, indicating that HNKO mice compensate through de novo NAD(+) synthesis. We conclude that NAMPT-deficient hepatocytes can maintain substantial NAD(+) levels and that the Nampt knockout has only minor consequences for mitochondrial function in the mouse liver.	[Dall, Morten; Trammell, Samuel A. J.; Hassing, Anna S.; Agerholm, Marianne; Vienberg, Sara G.; Gillum, Matthew P.; Treebak, Jonas T.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Asping, Magnus; Larsen, Steen] Univ Copenhagen, Dept Biomed Sci, Ctr Healthy Aging, Xlab, DK-2200 Copenhagen, Denmark; [Larsen, Steen] Med Univ Bialystok, Clin Res Ctr, PL-15089 Bialystok, Poland; [Agerholm, Marianne] Laval Univ, Dept Med, Quebec City, PQ H7A 0A1, Canada; [Vienberg, Sara G.] Novo Nordisk, Dept Diabet Biol, DK-2760 Malov, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Medical University of Bialystok; Laval University; Novo Nordisk	Treebak, JT (corresponding author), Univ Copenhagen, Novo Nordisk Fdn, Integrat Metab & Environm Influences, Ctr Basic Metab Res,Fac Hlth & Med Sci, Blegdamsvej 3B,7-7-46, DK-2200 Copenhagen, Denmark.	jttreebak@sund.ku.dk	Treebak, Jonas Thue/B-4521-2017; Larsen, Steen/L-2069-2013	Treebak, Jonas Thue/0000-0003-1488-7012; Dall, Morten/0000-0002-8577-3162; Gillum, Matthew/0000-0003-4893-012X; Hassing, Anna Skab/0000-0003-1650-8784; Larsen, Steen/0000-0002-5170-4337; Trammell, Samuel/0000-0002-5941-4094; Agerholm Jensen, Marianne/0000-0001-8687-1031	Novo Nordisk Foundation [NNF14OC0009315]; Danish Council for Independent Research [DFF 4004-00235]; Novo Nordisk Foundation Center for Basic Metabolic Research; Danish Diabetes Academy	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); Danish Diabetes Academy	This work was supported in part by Novo Nordisk Foundation Excellence Project Award NNF14OC0009315, Danish Council for Independent Research Grant DFF 4004- 00235) ( to J. T. T.), and by the Novo Nordisk Foundation Center for Basic Metabolic Research. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a one- third Ph.D. stipend from the Danish Diabetes Academy.	Agerholm M, 2018, AM J PHYSIOL-ENDOC M, V314, pE377, DOI 10.1152/ajpendo.00213.2017; Agledal L, 2010, REDOX REP, V15, P2, DOI 10.1179/174329210X12650506623122; Airhart SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186459; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Bahjat FR, 2000, J IMMUNOL, V165, P6559, DOI 10.4049/jimmunol.165.11.6559; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; BENDER DA, 1983, MOL ASPECTS MED, V6, P101, DOI 10.1016/0098-2997(83)90005-5; Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Brandauer J, 2013, J PHYSIOL-LONDON, V591, P5207, DOI 10.1113/jphysiol.2013.259515; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135; Dall M, 2018, MOL CELL ENDOCRINOL, V473, P245, DOI 10.1016/j.mce.2018.01.025; Davila A, 2018, ELIFE, V7, DOI 10.7554/eLife.33246; Dellinger RW, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0016-9; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dollerup OL, 2018, AM J CLIN NUTR, V108, P343, DOI 10.1093/ajcn/nqy132; Drew JE, 2016, J NUTR BIOCHEM, V37, P20, DOI 10.1016/j.jnutbio.2016.07.013; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; ELLIOTT GC, 1980, ANAL BIOCHEM, V107, P199, DOI 10.1016/0003-2697(80)90512-6; Gandin V., 2008, PROTOC EXCH, DOI [10.1038/nprot. 2008.209, DOI 10.1038/NPROT.2008.209]; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; Giles DA, 2017, NAT MED, V23, P829, DOI 10.1038/nm.4346; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Gutierrez-Aguilar M, 2013, BIOCHEM J, V454, P371, DOI 10.1042/BJ20121753; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Kalliokoski O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111065; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018; Lund MT, 2016, J PHYSIOL-LONDON, V594, P4351, DOI 10.1113/JP272105; Martens CR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03421-7; Midani FS, 2017, ANAL BIOCHEM, V520, P27, DOI 10.1016/j.ab.2016.12.011; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Mori V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113939; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Mukherjee S, 2017, HEPATOLOGY, V65, P616, DOI 10.1002/hep.28912; NARROD SA, 1961, J BIOL CHEM, V236, P931; Nielsen KN, 2018, MOL METAB, V11, P178, DOI 10.1016/j.molmet.2018.02.014; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Penke M, 2015, MOL CELL ENDOCRINOL, V412, P65, DOI 10.1016/j.mce.2015.05.028; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103; Ryu D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5504; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schuster S, 2015, BIOCHEM BIOPH RES CO, V458, P334, DOI 10.1016/j.bbrc.2015.01.111; Schuster S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091045; Shi W, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600878; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Tonkonogi M, 1997, ACTA PHYSIOL SCAND, V161, P345, DOI 10.1046/j.1365-201X.1997.00222.x; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933; Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012; Uddin GM, 2016, FRONT PHARMACOL, V7, DOI [10.3389/fphar.2016.00258, 10.13389/fphar.2016.00258]; Wang LF, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0464-z; Wang X, 2017, MOLECULES, V22, DOI 10.3390/molecules22081315; Xu RH, 2017, ONCOL REP, V38, P1767, DOI 10.3892/or.2017.5793; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhang ZF, 2014, BIOCHEM PHARMACOL, V91, P74, DOI 10.1016/j.bcp.2014.07.002; Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513	70	21	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13304	13326		10.1074/jbc.RA118.006756	http://dx.doi.org/10.1074/jbc.RA118.006756			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31320478	Green Published, hybrid			2022-12-28	WOS:000486417200009
J	Gupta, S; Merriman, C; Petzold, CJ; Ralston, CY; Fu, D				Gupta, Sayan; Merriman, Chengfeng; Petzold, Christopher J.; Ralston, Corie Y.; Fu, Dax			Water molecules mediate zinc mobility in the bacterial zinc diffusion channel ZIPB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zinc; transport; membrane protein; transport metal; protein conformation; metal ion-protein interaction; mechanism; water; X-ray footprinting	PROTEIN; COORDINATION; DYNAMICS; COPPER	Regulated ion diffusion across biological membranes is vital for cell function. In a nanoscale ion channel, the active role of discrete water molecules in modulating hydrodynamic behaviors of individual ions is poorly understood because of the technical challenge of tracking water molecules through the channel. Here we report the results of a hydroxyl radical footprinting analysis of the zinc-selective channel ZIPB from the Gram-negative bacterium, Bordetella bronchiseptica. Irradiating ZIPB by microsecond X-ray pulses activated water molecules to form covalent hydroxyl radical adducts at nearby residues, which were identified by bottom-up proteomics to detect residues that interact either with zinc or water in response to zinc binding. We found a series of residues exhibiting reciprocal changes in water accessibility attributed to alternating zinc and water binding. Mapping these residues to the previously reported crystal structure of ZIPB, we identified a water-reactive pathway that superimposed on a zinc translocation pathway consisting of two binuclear metal centers and an interim zinc-binding site. The cotranslocation of zinc and water suggested that pore-lining residues undergo a mode switch between zinc coordination and water binding to confer zinc mobility. The unprecedented details of water-mediated zinc transport identified here highlight an essential role of solvated waters in driving zinc coordination dynamics and transmembrane crossing.	[Gupta, Sayan; Ralston, Corie Y.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; [Petzold, Christopher J.] Lawrence Berkeley Natl Lab, Biol Syst Div, Berkeley, CA 94720 USA; [Petzold, Christopher J.] Lawrence Berkeley Natl Lab, Engn Div, Berkeley, CA 94720 USA; [Merriman, Chengfeng; Fu, Dax] Johns Hopkins Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Johns Hopkins University; Johns Hopkins Medicine	Fu, D (corresponding author), Johns Hopkins Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	dfu3@jhmi.edu		Petzold, Christopher/0000-0002-8270-5228; Fu, Dax/0000-0002-2663-1316	Office of Science, Office of Biological and Environmental Research of the Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126218] Funding Source: NIH RePORTER	Office of Science, Office of Biological and Environmental Research of the Department of Energy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lean-Jade G. Chan for MS data collection at the Joint BioEnergy Institute. We thank Jun Feng for beamline support at beamline 5.3.1 of the Advanced Light Source. XFMS was conducted at the Advanced Light Source and Joint BioEnergy Institute, supported by the Office of Science, Office of Biological and Environmental Research of the Department of Energy under contract DE-AC02-05CH11231.	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Antala S, 2015, J BIOL CHEM, V290, P17796, DOI 10.1074/jbc.M114.617613; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Fernandez-Nino SMG, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00044; Franz MC, 2018, BIOCHEMISTRY-US, V57, P3976, DOI 10.1021/acs.biochem.8b00511; Gupta S, 2016, J SYNCHROTRON RADIAT, V23, P1056, DOI 10.1107/S1600577516009024; Gupta S, 2014, NATURE, V512, P101, DOI 10.1038/nature13382; Gupta S, 2014, J SYNCHROTRON RADIAT, V21, P690, DOI 10.1107/S1600577514007000; Gupta S, 2012, P NATL ACAD SCI USA, V109, P14882, DOI 10.1073/pnas.1209060109; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; Gyimesi G, 2019, J BIOL CHEM, V294, P8046, DOI 10.1074/jbc.RA118.006113; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Ostmeyer J, 2013, NATURE, V501, DOI 10.1038/nature12395; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Renthal R, 2008, PROTEIN SCI, V17, P293, DOI 10.1110/ps.073237508; Roux B, 2011, J GEN PHYSIOL, V137, P415, DOI 10.1085/jgp.201010577; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Xu GZ, 2005, ANAL CHEM, V77, P3029, DOI 10.1021/ac048282z; Zhang T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700344; Zheng XJ, 2008, STRUCTURE, V16, P38, DOI 10.1016/j.str.2007.10.019	28	8	8	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13327	13335		10.1074/jbc.RA119.009239	http://dx.doi.org/10.1074/jbc.RA119.009239			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31320477	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000486417200010
J	Francisco, J; Byun, J; Zhang, Y; Kalloo, OB; Mizushima, W; Oka, S; Zhai, PY; Sadoshima, J; Del Re, DP				Francisco, Jamie; Byun, Jaemin; Zhang, Yu; Kalloo, Olivia Berman; Mizushima, Wataru; Oka, Shinichi; Zhai, Peiyong; Sadoshima, Junichi; Del Re, Dominic P.			The tumor suppressor RASSF1A modulates inflammation and injury in the reperfused murine myocardium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myocardial infarction; inflammation; cardiomyocyte; macrophage; Hippo pathway; heart disease; ischemia; reperfusion (I/R); Ras association domain family member 1 isoform A (RASSF1A)	RESIDENT CARDIAC MACROPHAGES; NF-KAPPA-B; STEADY-STATE; PROTEIN; HEART; INFARCTION; ISOFORM; TRANSCRIPTION; INACTIVATION; HYPERTROPHY	Inflammation is a central feature of cardiovascular disease, including myocardial infarction and heart failure. Reperfusion of the ischemic myocardium triggers a complex inflammatory response that can exacerbate injury and worsen heart function, as well as prevent myocardial rupture and mediate wound healing. Therefore, a more complete understanding of this process could contribute to interventions that properly balance inflammatory responses for improved outcomes. In this study, we leveraged several approaches, including global and regional ischemia/reperfusion (I/R), genetically modified mice, and primary cell culture, to investigate the cell type-specific function of the tumor suppressor Ras association domain family member 1 isoform A (RASSF1A) in cardiac inflammation. Our results revealed that genetic inhibition of RASSF1A in cardiomyocytes affords cardioprotection, whereas myeloid-specific deletion of RASSF1A exacerbates inflammation and injury caused by I/R in mice. Cell-based studies revealed that RASSF1A negatively regulates NF-kappa B and thereby attenuates inflammatory cytokine expression. These findings indicate that myeloid RASSF1A antagonizes I/R-induced myocardial inflammation and suggest that RASSF1A may be a promising target in immunomodulatory therapy for the management of acute heart injury.	[Francisco, Jamie; Byun, Jaemin; Zhang, Yu; Kalloo, Olivia Berman; Mizushima, Wataru; Oka, Shinichi; Zhai, Peiyong; Sadoshima, Junichi; Del Re, Dominic P.] Rutgers State Univ, New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Del Re, DP (corresponding author), Rutgers State Univ, New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA.	delredo@njms.rutgers.edu		Del Re, Dominic/0000-0002-5504-9114	National Institutes of Health [HL127339, HL122669, HL135726, HL112330]; Leducq Fondation [15CBD04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112330, R15HL135726, R01HL127339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Fondation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL127339, HL122669, and HL135726 (to D. P. D.) and HL112330 (to J. S.) and the Leducq Fondation 15CBD04 (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Bajpai G, 2019, CIRC RES, V124, P263, DOI 10.1161/CIRCRESAHA.118.314028; Byun J, 2019, J BIOL CHEM, V294, P3603, DOI 10.1074/jbc.RA118.006123; Chen BJ, 2019, CIRC RES, V125, P55, DOI 10.1161/CIRCRESAHA.119.315069; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Courties G, 2014, J AM COLL CARDIOL, V63, P1556, DOI 10.1016/j.jacc.2013.11.023; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Del Re DP, 2014, MOL CELL, V54, P639, DOI 10.1016/j.molcel.2014.04.007; Del Re DP, 2013, J BIOL CHEM, V288, P3977, DOI 10.1074/jbc.M112.436311; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-019-0363-8, 10.1038/s41590-018-0272-2]; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Gordon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075483; Grawenda AM, 2015, BRIT J CANCER, V113, P372, DOI 10.1038/bjc.2015.221; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Honold L, 2018, CIRC RES, V122, P113, DOI 10.1161/CIRCRESAHA.117.311071; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Ikeda S, 2019, CIRC RES, V124, P292, DOI 10.1161/CIRCRESAHA.118.314048; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; Matsuda T, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003658; Matsuda T, 2016, CIRC RES, V119, P596, DOI 10.1161/CIRCRESAHA.116.308586; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; O'Donoghue ML, 2016, JAMA-J AM MED ASSOC, V315, P1591, DOI 10.1001/jama.2016.3609; Oceandy D, 2009, CIRCULATION, V120, P607, DOI 10.1161/CIRCULATIONAHA.109.868554; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Schmidt ML, 2018, CANCER RES, V78, P2614, DOI 10.1158/0008-5472.CAN-17-2466; Swirski FK, 2018, NAT REV IMMUNOL, V18, P733, DOI 10.1038/s41577-018-0065-8; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; White HD, 2014, NEW ENGL J MED, V370, P1702, DOI 10.1056/NEJMoa1315878; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yang YF, 2015, CIRC RES, V117, P891, DOI 10.1161/CIRCRESAHA.115.306624; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	44	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13131	13144		10.1074/jbc.RA119.008970	http://dx.doi.org/10.1074/jbc.RA119.008970			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31311858	Green Published, hybrid			2022-12-28	WOS:000486416000022
J	Adamopoulos, A; Heidebrecht, T; Roosendaal, J; Touw, WG; Phan, IQ; Beijnen, J; Perrakis, A				Adamopoulos, Athanassios; Heidebrecht, Tatjana; Roosendaal, Jeroen; Touw, Wouter G.; Phan, Isabelle Q.; Beijnen, Jos; Perrakis, Anastassis			The domain architecture of the protozoan protein J-DNA-binding protein 1 suggests synergy between base J DNA binding and thymidine hydroxylase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA binding protein; small-angle X-ray scattering (SAXS); mass spectrometry (MS); hydroxylase; 5-hydroxymethylcytosine (5-hmC); beta-D-glucosyl-hydroxymethyluracil (base J); epigenetics; kinetoplastid parasites; thymidine hydroxylase	SMALL-ANGLE SCATTERING; BIOLOGICAL MACROMOLECULES; X-RAY; STRUCTURAL BASIS; GENOMIC DNA; SAXS DATA; HYDROXYMETHYLURACIL; RECOGNITION; RESOLUTION; GLUCOSYLTRANSFERASE	J-DNA-binding protein 1 (JBP1) contributes to the biosynthesis and maintenance of base J (beta-d-glucosyl-hydroxymethyluracil), an epigenetic modification of thymidine (T) confined to pathogenic protozoa such as Trypanosoma and Leishmania. JBP1 has two known functional domains: an N-terminal T hydroxylase (TH) homologous to the 5-methylcytosine hydroxylase domain in TET proteins and a J-DNA-binding domain (JDBD) that resides in the middle of JBP1. Here, we show that removing JDBD from JBP1 results in a soluble protein (Delta-JDBD) with the N- and C-terminal regions tightly associated together in a well-ordered structure. We found that this Delta-JDBD domain retains TH activity in vitro but displays a 15-fold lower apparent rate of hydroxylation compared with JBP1. Small-angle X-ray scattering (SAXS) experiments on JBP1 and JDBD in the presence or absence of J-DNA and on Delta-JDBD enabled us to generate low-resolution three-dimensional models. We conclude that Delta-JDBD, and not the N-terminal region of JBP1 alone, is a distinct folding unit. Our SAXS-based model supports the notion that binding of JDBD specifically to J-DNA can facilitate T hydroxylation 12-14 bp downstream on the complementary strand of the J-recognition site. We postulate that insertion of the JDBD module into the Delta-JDBD scaffold during evolution provided a mechanism that synergized J recognition and T hydroxylation, ensuring inheritance of base J in specific sequence patterns following DNA replication in kinetoplastid parasites.	[Adamopoulos, Athanassios; Heidebrecht, Tatjana; Touw, Wouter G.; Perrakis, Anastassis] Netherlands Canc Inst, Dept Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Roosendaal, Jeroen; Beijnen, Jos] Netherlands Canc Inst, Dept Clin Pharmacol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Phan, Isabelle Q.] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle Struct Genom Ctr Infect Dis, Seattle, WA 98109 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Seattle Children's Hospital	Perrakis, A (corresponding author), Netherlands Canc Inst, Dept Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.perrakis@nki.nl	Perrakis, Anastassis/E-8704-2013	Perrakis, Anastassis/0000-0002-1151-6227	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [714.014.002]; NIAID, National Institutes of Health, Department of Health and Human Services [HHSN272201700059C]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); NIAID, National Institutes of Health, Department of Health and Human Services	This work was supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek Grant 714.014.002. Work from the Seattle Structural Genomics Center for Infectious Disease was supported by NIAID, National Institutes of Health, Department of Health and Human Services, under Contract HHSN272201700059C. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bizien T, 2016, PROTEIN PEPTIDE LETT, V23, P217, DOI 10.2174/0929866523666160106153655; Bullard W, 2014, J BIOL CHEM, V289, P20273, DOI 10.1074/jbc.M114.579821; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Cliffe LJ, 2012, J BIOL CHEM, V287, P19886, DOI 10.1074/jbc.M112.341974; Cliffe LJ, 2010, NUCLEIC ACIDS RES, V38, P3923, DOI 10.1093/nar/gkq146; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; Cross M, 1999, EMBO J, V18, P6573, DOI 10.1093/emboj/18.22.6573; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Genest PA, 2007, NUCLEIC ACIDS RES, V35, P2116, DOI 10.1093/nar/gkm050; Genest PA, 2015, NUCLEIC ACIDS RES, V43, P2102, DOI 10.1093/nar/gkv095; GOMMERSAMPT JH, 1993, CELL, V75, P1129, DOI 10.1016/0092-8674(93)90322-H; Grover RK, 2007, ANGEW CHEM INT EDIT, V46, P2839, DOI 10.1002/anie.200604635; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; Heidebrecht T, 2012, J AM CHEM SOC, V134, P13357, DOI 10.1021/ja303423t; Heidebrecht T, 2011, NUCLEIC ACIDS RES, V39, P5715, DOI 10.1093/nar/gkr125; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu LL, 2015, NATURE, V527, P118, DOI 10.1038/nature15713; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Iyer LM, 2013, NUCLEIC ACIDS RES, V41, P7635, DOI 10.1093/nar/gkt573; Konarev PV, 2015, IUCRJ, V2, P352, DOI 10.1107/S2052252515005163; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Mohanty B, 2016, J MOL BIOL, V428, P4298, DOI 10.1016/j.jmb.2016.08.028; Mooij WTM, 2009, NUCLEIC ACIDS RES, V37, pW402, DOI 10.1093/nar/gkp256; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Petoukhov MV, 2015, ACTA CRYSTALLOGR D, V71, P1051, DOI 10.1107/S1399004715002576; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Piiadov V, 2019, PROTEIN SCI, V28, P454, DOI 10.1002/pro.3528; Rambo RP, 2015, METHOD ENZYMOL, V558, P363, DOI 10.1016/bs.mie.2015.02.004; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rambo RP, 2010, CURR OPIN STRUC BIOL, V20, P128, DOI 10.1016/j.sbi.2009.12.015; Roosendaal J, 2019, J PHARMACEUT BIOMED, V164, P16, DOI 10.1016/j.jpba.2018.10.001; Schindler CEM, 2016, STRUCTURE, V24, P1387, DOI 10.1016/j.str.2016.06.007; Sekar A, 2014, MOL BIOCHEM PARASIT, V196, P9, DOI 10.1016/j.molbiopara.2014.07.005; Shen A, 2009, STRUCTURE, V17, P769, DOI 10.1016/j.str.2009.02.018; Shkumatov AV, 2015, ACTA CRYSTALLOGR D, V71, P1347, DOI 10.1107/S1399004715007154; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; van Luenen HGAM, 2012, CELL, V150, P909, DOI 10.1016/j.cell.2012.07.030; vanLeeuwen F, 1996, NUCLEIC ACIDS RES, V24, P2476, DOI 10.1093/nar/24.13.2476; vanLeeuwen F, 1997, GENE DEV, V11, P3232, DOI 10.1101/gad.11.23.3232; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Yu Z, 2007, NUCLEIC ACIDS RES, V35, P2107, DOI 10.1093/nar/gkm049	48	0	0	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12815	12825		10.1074/jbc.RA119.007393	http://dx.doi.org/10.1074/jbc.RA119.007393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31292194	hybrid, Green Published			2022-12-28	WOS:000484414600022
J	Lomash, RM; Petralia, RS; Holtzclaw, LA; Tsuda, MC; Wang, YX; Badger, JD; Cameron, HA; Youle, RJ; Roche, KW				Lomash, Richa Madan; Petralia, Ronald S.; Holtzclaw, Lynne A.; Tsuda, Mumeko C.; Wang, Ya-Xian; Badger, John D., II; Cameron, Heather A.; Youle, Richard J.; Roche, Katherine W.			Neurolastin, a dynamin family GTPase, translocates to mitochondria upon neuronal stress and alters mitochondrial morphology in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dynamin; GTPase; E3 ubiquitin ligase; membrane fusion; mitochondria; brain; mechanoenzyme; membrane remodeling; neurotransmission; organellar morphology; synaptic transmission	DEPENDENT PROTEIN-KINASE; RING FINGER PROTEIN; 179 PATHWAY; FISSION; DRP1; OPA1; PHOSPHORYLATION; LOCALIZATION; EXPRESSION; MATURATION	Neurolastin is a dynamin family GTPase that also contains a RING domain and exhibits both GTPase and E3 ligase activities. It is specifically expressed in the brain and is important for synaptic transmission, as neurolastin knockout animals have fewer dendritic spines and exhibit a reduction in functional synapses. Our initial study of neurolastin revealed that it is membrane-associated and partially co-localizes with endosomes. Using various biochemical and cell-culture approaches, we now show that neurolastin also localizes to mitochondria in HeLa cells, cultured neurons, and brain tissue. We found that the mitochondrial localization of neurolastin depends upon an N-terminal mitochondrial targeting sequence and that neurolastin is imported into the mitochondrial intermembrane space. Although neurolastin was only partially mitochondrially localized at steady state, it displayed increased translocation to mitochondria in response to neuronal stress and mitochondrial fragmentation. Interestingly, inactivation or deletion of neurolastin's RING domain also increased its mitochondrial localization. Using EM, we observed that neurolastin knockout animals have smaller but more numerous mitochondria in cerebellar Purkinje neurons, indicating that neurolastin regulates mitochondrial morphology. We conclude that the brain-specific dynamin GTPase neurolastin exhibits stress-responsive localization to mitochondria and is required for proper mitochondrial morphology.	[Lomash, Richa Madan; Badger, John D., II; Roche, Katherine W.] NINDS, Receptor Biol Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Youle, Richard J.] NINDS, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Petralia, Ronald S.; Wang, Ya-Xian] NIDCD, Adv Imaging Core, NIH, Bethesda, MD 20892 USA; [Holtzclaw, Lynne A.] NICHHD, Microscopy & Imaging Core, NIH, Bethesda, MD 20892 USA; [Tsuda, Mumeko C.; Cameron, Heather A.] NIMH, Sect Neuroplastic, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Lomash, RM; Roche, KW (corresponding author), NINDS, Receptor Biol Sect, Porter Neurosci Res Ctr, Bldg 35,Rm 2C-903, Bethesda, MD 20892 USA.	richa.madanlomash@nih.gov; rochek@ninds.nih.gov	Lomash, Richa Madan/I-1307-2019; Roche, Katherine/W-9893-2019; Cameron, Heather/E-6221-2011	Cameron, Heather/0000-0002-3245-5777; Holtzclaw, Lynne/0000-0001-5102-8992	NINDS, National Institutes of Health (NIH); NIDCD (NIH)-Advanced Imaging Core; NICHD (NIH)-Microscopy and Imaging Core; NIMH (NIH); NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZICDC000081] Funding Source: NIH RePORTER	NINDS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDCD (NIH)-Advanced Imaging Core; NICHD (NIH)-Microscopy and Imaging Core; NIMH (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is supported by intramural funding of the NINDS, National Institutes of Health (NIH); NIDCD (NIH)-Advanced Imaging Core; NICHD (NIH)-Microscopy and Imaging Core; and NIMH (NIH). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aceti M, 2015, BIOL PSYCHIAT, V77, P805, DOI 10.1016/j.biopsych.2014.08.001; Amutha B, 2004, BIOCHEM J, V381, P19, DOI 10.1042/BJ20040566; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Chuang JY, 2017, REDOX BIOL, V11, P135, DOI 10.1016/j.redox.2016.11.012; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cohen MM, 2011, J CELL SCI, V124, P1403, DOI 10.1242/jcs.079293; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Daumke O, 2016, BIOPOLYMERS, V105, P580, DOI 10.1002/bip.22855; Del Dotto V, 2018, BBA-BIOENERGETICS, V1859, P263, DOI 10.1016/j.bbabio.2018.01.005; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091954; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Filadi R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0023-6; Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Gao Y, 2013, NEUROSCI RES, V77, P137, DOI 10.1016/j.neures.2013.08.007; George AJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00029; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Heymann JAW, 2009, J CELL SCI, V122, P3427, DOI 10.1242/jcs.051714; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; Jaskolski F, 2009, J BIOL CHEM, V284, P12491, DOI 10.1074/jbc.M808401200; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Khacho M, 2018, DEV DYNAM, V247, P47, DOI 10.1002/dvdy.24538; Kim KH, 2012, J ALZHEIMERS DIS, V29, P793, DOI 10.3233/JAD-2012-111793; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Lee YC, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0479-4; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lin AW, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/432057; Lomash RM, 2015, CELL REP, V12, P743, DOI 10.1016/j.celrep.2015.06.064; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Orimo A, 1998, GENOMICS, V54, P59, DOI 10.1006/geno.1998.5541; Pao PC, 2011, CELL DEATH DIFFER, V18, P1791, DOI 10.1038/cdd.2011.52; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Pinti M, 2016, BBA-BIOENERGETICS, V1857, P1300, DOI 10.1016/j.bbabio.2016.03.025; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Rendon OZ, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00412-17; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Snyder JS, 2009, HIPPOCAMPUS, V19, P898, DOI 10.1002/hipo.20552; Su TC, 2016, NEUROPHARMACOLOGY, V105, P1, DOI 10.1016/j.neuropharm.2016.01.015; Tsou JH, 2017, MOL NEUROBIOL, V54, P2286, DOI 10.1007/s12035-016-9812-7; Wu CC, 2018, REDOX BIOL, V19, P74, DOI 10.1016/j.redox.2018.08.001; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054	57	1	1	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11498	11512		10.1074/jbc.RA118.007245	http://dx.doi.org/10.1074/jbc.RA118.007245			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31177092	Green Published, hybrid			2022-12-28	WOS:000478717600013
J	Hemmis, CW; Heard, SC; Hill, CP				Hemmis, Casey W.; Heard, Stephanie C.; Hill, Christopher P.			Phosphorylation of Tyr-950 in the proteasome scaffolding protein RPN2 modulates its interaction with the ubiquitin receptor RPN13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; ubiquitin; phosphotyrosine; phosphorylation; protein structure; protein-protein interaction; adhesion regulating molecule 1 (ADRM1); fluorescence polarization; RPN13; RPN2	NF-KAPPA-B; CELL-MIGRATION; MULTIPLE-MYELOMA; CANCER; ADRM1; AMPLIFICATION; ACTIVATION; UCH37; INFLAMMATION; KNOCKDOWN	Protein substrates are targeted to the 26S proteasome through several ubiquitin receptors. One of these receptors, RPN13, is recruited to the proteasome by binding of its N-terminal pleckstrin-like receptor of ubiquitin (PRU) domain to C-terminal residues of the scaffolding protein RPN2. The RPN13 PRU domain is followed by a flexible linker and a C-terminal deubiquitylase adaptor (DEUBAD) domain, which recruits and activates the deubiquitylase UCH37. Both RPN13 and UCH37 have been implicated in human cancers, and inhibitors of the RPN2-RPN13 interaction are being developed as potential therapeutic anticancer agents. Our current study builds on the recognition that a residue central to the RPN2-RPN13 interaction, RPN2 Tyr-950, is phosphorylated in Jurkat cells. We found that the Tyr-950 phosphorylation enhances binding to RPN13. The crystal structure of the RPN2-RPN13 pTyr-950-ubiquitin complex was determined at 1.76-angstrom resolution and reveals specific interactions with positively charged side chains in RPN13 that explain how phosphorylation increases binding affinity without inducing conformational change. Mutagenesis and quantitative binding assays were then used to validate the crystallographic interface. Our findings support a model in which RPN13 recruitment to the proteasome is enhanced by phosphorylation of RPN2 Tyr-950, have important implications for efforts to develop specific inhibitors of the RPN2-RPN13 interaction, and suggest the existence of a previously unknown stress-response pathway.	[Hemmis, Casey W.; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Heard, Stephanie C.] Univ Utah, Sch Med, Dept Med Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Hill, CP (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	chris@biochem.utah.edu		Hemmis, Casey/0000-0002-3538-8434	American Cancer Society [PF-16-100-01]; NIGMS, National Institutes of Health [R21 CA191929]; NATIONAL CANCER INSTITUTE [R21CA191929, P30CA042014] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by American Cancer Society Grant PF-16-100-01 (to C.W.H.) and NIGMS, National Institutes of Health Grant R21 CA191929 (to C.P.H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Shami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013654; Anchoori RK, 2018, ACS OMEGA, V3, P11917, DOI 10.1021/acsomega.8b01479; Anchoori RK, 2013, CANCER CELL, V24, P791, DOI 10.1016/j.ccr.2013.11.001; Arpalahti L, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317716078; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W, 2009, ONCOL REP, V21, P531, DOI 10.3892/or_00000254; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Chen YJ, 2012, DIGEST DIS SCI, V57, P2310, DOI 10.1007/s10620-012-2181-9; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang Y, 2013, BBA-MOL CELL RES, V1833, P559, DOI 10.1016/j.bbamcr.2012.11.020; Fatimababy AS, 2010, FEBS J, V277, P796, DOI 10.1111/j.1742-4658.2009.07531.x; Fejzo MS, 2008, GENE CHROMOSOME CANC, V47, P873, DOI 10.1002/gcc.20592; Fejzo MS, 2015, GENE CHROMOSOME CANC, V54, P506, DOI 10.1002/gcc.22262; Fejzo MS, 2013, INT J MOL SCI, V14, P3094, DOI 10.3390/ijms14023094; Fejzo MS, 2011, GENE CHROMOSOME CANC, V50, P434, DOI 10.1002/gcc.20868; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hamazaki J, 2007, MOL CELL BIOL, V27, P6629, DOI 10.1128/MCB.00509-07; Hamazaki J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005401; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jang SH, 2014, CLIN EXP METASTAS, V31, P727, DOI 10.1007/s10585-014-9663-4; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Lu XX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15540; Lu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140518; Mazumdar T, 2010, P NATL ACAD SCI USA, V107, P13854, DOI 10.1073/pnas.0913495107; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Sahtoe DD, 2015, MOL CELL, V57, P887, DOI 10.1016/j.molcel.2014.12.039; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Soong RS, 2016, ONCOTARGET, V7, P68489, DOI 10.18632/oncotarget.12095; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Tian Z, 2014, BLOOD, V123, P706, DOI 10.1182/blood-2013-05-500033; Trader DJ, 2015, J AM CHEM SOC, V137, P6312, DOI 10.1021/jacs.5b02069; VanderLinden RT, 2017, J BIOL CHEM, V292, P9493, DOI 10.1074/jbc.M117.785287; VanderLinden RT, 2015, MOL CELL, V57, P901, DOI 10.1016/j.molcel.2015.01.016; Wang L, 2014, TUMOR BIOL, V35, P11427, DOI 10.1007/s13277-014-2446-3; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang X, 2012, ONCOL REP, V28, P283, DOI 10.3892/or.2012.1767; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zheng XH, 2015, ACTA HAEMATOL-BASEL, V134, P88, DOI 10.1159/000369916	55	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9659	9665		10.1074/jbc.AC119.008881	http://dx.doi.org/10.1074/jbc.AC119.008881			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31064842	Green Published, hybrid			2022-12-28	WOS:000473277900001
J	Howell, M; Dumitrescu, DG; Blankenship, LR; Herkert, D; Hatzios, SK				Howell, Matthew; Dumitrescu, Daniel G.; Blankenship, Lauren R.; Herkert, Darby; Hatzios, Stavroula K.			Functional characterization of a subtilisin-like serine protease from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serine protease; bacteria; host-pathogen interaction; lectin; pathogenesis; cholera; intelectin; subtilisin	INTRAMOLECULAR CHAPERONE; MEDIATED ACTIVATION; PROPEPTIDE; IDENTIFICATION; INTELECTIN-1; EXPRESSION; MATURATION; SUBTILASES; PATHOGEN; COMPLEX	Vibrio cholerae, the causative agent of the human diarrheal disease cholera, exports numerous enzymes that facilitate its adaptation to both intestinal and aquatic niches. These secreted enzymes can mediate nutrient acquisition, biofilm assembly, and V. cholerae interactions with its host. We recently identified a V. cholerae-secreted serine protease, IvaP, that is active in V. cholerae-infected rabbits and human choleric stool. IvaP alters the activity of several host and pathogen enzymes in the gut and, along with other secreted V. cholerae proteases, decreases binding of intelectin, an intestinal carbohydrate-binding protein, to V. cholerae in vivo. IvaP bears homology to subtilisin-like enzymes, a large family of serine proteases primarily comprised of secreted endopeptidases. Following secretion, IvaP is cleaved at least three times to yield a truncated enzyme with serine hydrolase activity, yet little is known about the mechanism of extracellular maturation. Here, we show that IvaP maturation requires a series of sequential N- and C-terminal cleavage events congruent with the enzyme's mosaic protein domain structure. Using a catalytically inactive reporter protein, we determined that IvaP can be partially processed in trans, but intramolecular proteolysis is most likely required to generate the mature enzyme. Unlike many other subtilisin-like enzymes, the IvaP cleavage pattern is consistent with stepwise processing of the N-terminal propeptide, which could temporarily inhibit, and be cleaved by, the purified enzyme. Furthermore, IvaP was able to cleave purified intelectin, which inhibited intelectin binding to V. cholerae. These results suggest that IvaP plays a role in modulating intelectin-V. cholerae interactions.	[Howell, Matthew; Dumitrescu, Daniel G.; Blankenship, Lauren R.; Herkert, Darby; Hatzios, Stavroula K.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Dumitrescu, Daniel G.; Hatzios, Stavroula K.] Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06511 USA; [Howell, Matthew; Dumitrescu, Daniel G.; Blankenship, Lauren R.; Herkert, Darby; Hatzios, Stavroula K.] Yale Univ, Microbial Sci Inst, West Haven, CT 06516 USA	Yale University; Yale University; Yale University	Hatzios, SK (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.; Hatzios, SK (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06511 USA.; Hatzios, SK (corresponding author), Yale Univ, Microbial Sci Inst, West Haven, CT 06516 USA.	stavroula.hatzios@yale.edu		Howell, Matthew/0000-0001-7246-8006; Blankenship, Lauren/0000-0002-1714-4399; Hatzios, Stavroula/0000-0001-8658-8949; Herkert, Darby/0000-0002-9092-691X	Yale University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067543] Funding Source: NIH RePORTER	Yale University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by new faculty start-up funds from Yale University (to S. K. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Dorr T, 2016, P NATL ACAD SCI USA, V113, P404, DOI 10.1073/pnas.1520333113; Ellis CN, 2015, INFECT IMMUN, V83, P1089, DOI 10.1128/IAI.02765-14; Foophow T, 2010, PROTEIN ENG DES SEL, V23, P347, DOI 10.1093/protein/gzp092; Gao XA, 2010, P NATL ACAD SCI USA, V107, P17569, DOI 10.1073/pnas.1005681107; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hasan NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI 10.1073/pnas.1207359109; Hatzios SK, 2016, NAT CHEM BIOL, V12, P268, DOI [10.1038/NCHEMBIO.2025, 10.1038/nchembio.2025]; Hatzios SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043175; Hayes CA, 2017, ENVIRON MICROBIOL, V19, P4154, DOI 10.1111/1462-2920.13866; Hohl M, 2017, J BIOL CHEM, V292, P6389, DOI 10.1074/jbc.M117.775445; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Li YY, 1996, J MOL BIOL, V262, P591, DOI 10.1006/jmbi.1996.0537; Lu ZH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-110; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; MILLER VL, 1989, J BACTERIOL, V171, P1288, DOI 10.1128/jb.171.3.1288-1293.1989; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Nielsen AT, 2006, PLOS PATHOG, V2, P933, DOI 10.1371/journal.ppat.0020109; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; POWER SD, 1986, P NATL ACAD SCI USA, V83, P3096, DOI 10.1073/pnas.83.10.3096; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P2491, DOI 10.1016/B978-0-12-382219-2.00559-7; Ritchie JM, 2009, CURR TOP MICROBIOL, V337, P37, DOI 10.1007/978-3-642-01846-6_2; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Tsuji S, 2007, GLYCOBIOLOGY, V17, P1045, DOI 10.1093/glycob/cwm075; Voehringer D, 2007, EXP PARASITOL, V116, P458, DOI 10.1016/j.exppara.2007.02.015; Weaver AI, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01326-18; Weill FX, 2019, NATURE, V565, P230, DOI 10.1038/s41586-018-0818-3; Wesener DA, 2015, NAT STRUCT MOL BIOL, V22, P603, DOI 10.1038/nsmb.3053; Yabuta Y, 2001, J BIOL CHEM, V276, P44427, DOI 10.1074/jbc.M107573200; Yan J, 2017, ISME J, V11, P1569, DOI 10.1038/ismej.2017.33; Zhu H, 2013, J BIOL CHEM, V288, P34826, DOI 10.1074/jbc.M113.498774	41	5	5	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9888	9900		10.1074/jbc.RA119.007745	http://dx.doi.org/10.1074/jbc.RA119.007745			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31076508	Green Published, hybrid			2022-12-28	WOS:000473277900020
J	Gundlach, J; Kruger, L; Herzberg, C; Turdiev, A; Poehlein, A; Tascon, I; Weiss, M; Hertel, D; Daniel, R; Hanelt, I; Lee, VT; Stulke, J				Gundlach, Jan; Krueger, Larissa; Herzberg, Christina; Turdiev, Asan; Poehlein, Anja; Tascon, Igor; Weiss, Martin; Hertel, Dietrich; Daniel, Rolf; Haenelt, Inga; Lee, Vincent T.; Stuelke, Joerg			Sustained sensing in potassium homeostasis: Cyclic di-AMP controls potassium uptake by KimA at the levels of expression and activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic diadenosine monophosphate (c-di-AMP); potassium transport; prokaryotic signal-transduction; Bacillus; bacterial genetics; second messenger; Bacillus subtilis; cation homeostasis; cyclic di-AMP; dinucleotide signaling; osmoregulation	BACILLUS-SUBTILIS; STAPHYLOCOCCUS-AUREUS; PROTEIN; BINDING; IDENTIFICATION; DOMAIN; KTRAB; TRANSPORTERS; DEGRADATION; REGULATOR	The signaling nucleotide cyclic di-AMP (c-di-AMP) is the only known essential second messenger in bacteria. Recently, c-di-AMP has been identified as being essential for controlling potassium uptake in the model organism Bacillus subtilis and several other bacteria. A B. subtilis strain lacking c-di-AMP is not viable at high potassium concentrations, unless the bacteria acquire suppressor mutations. In this study, we isolated such suppressor mutants and found mutations that reduced the activities of the potassium transporters KtrCD and KimA. Although c-di-AMP-mediated control of KtrCD has previously been demonstrated, it is unknown how c-di-AMP affects KimA activity. Using the DRaCALA screening assay, we tested for any interactions of KimA and other potential target proteins in B. subtilis with c-di-AMP. This assay identified KimA, as well as the K+/H+ antiporter KhtT, the potassium exporter CpaA (YjbQ), the osmoprotectant transporter subunit OpuCA, the primary Mg2+ importer MgtE, and DarB (YkuL), a protein of unknown function, as bona fide c-di-AMP-binding proteins. Further, binding of c-di-AMP to KimA inhibited potassium uptake. Our results indicate that c-di-AMP controls KimA-mediated potassium transport at both kimA gene expression and KimA activity levels. Moreover, the discovery that potassium exporters are c-di-AMP targets indicates that this second messenger controls potassium homeostasis in B. subtilis at a global level by binding to riboswitches and to different classes of transport proteins involved in potassium uptake and export.	[Gundlach, Jan; Krueger, Larissa; Herzberg, Christina; Weiss, Martin; Stuelke, Joerg] Georg August Univ Gottingen, Gottingen Ctr Mol Biosci, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Poehlein, Anja; Daniel, Rolf] Georg August Univ Gottingen, Gottingen Ctr Mol Biosci, Dept Genom & Appl Microbiol, D-37077 Gottingen, Germany; [Hertel, Dietrich] Georg August Univ Gottingen, Dept Plant Ecol & Ecosyst Res, D-37077 Gottingen, Germany; [Turdiev, Asan; Lee, Vincent T.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Tascon, Igor; Haenelt, Inga] Goethe Univ Frankfurt, Inst Biochem, D-60323 Frankfurt, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University System of Maryland; University of Maryland College Park; Goethe University Frankfurt	Stulke, J (corresponding author), Georg August Univ Gottingen, Dept Gen Microbiol, Gottingen, Germany.	jstuelk@gwdg.de	Tascón, Igor/AAA-9466-2019; Stülke, Jörg/AAD-1600-2021; Daniel, Rolf/AAQ-5933-2021; Hänelt, Inga/N-2982-2016	Tascón, Igor/0000-0003-2526-6238; Daniel, Rolf/0000-0002-8646-7925; Hänelt, Inga/0000-0003-1495-3163; Weiss, Martin/0000-0002-2596-1938; Lee, Vincent T./0000-0002-3593-0318; Stulke, Jorg/0000-0001-5881-5390; Kruger, Larissa/0000-0003-2053-4010	Deutsche Forschungsgemeinschaft [SPP1879]; National Institutes of Health [AI133670]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI133670] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Deutsche Forschungsgemeinschaft via Priority Program Grant SPP1879 (to J. S.) and by National Institutes of Health Grant AI133670 (to V. T. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Blotz C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01328; Chin KH, 2015, BIOCHEMISTRY-US, V54, P4936, DOI 10.1021/acs.biochem.5b00633; Choi PH, 2017, P NATL ACAD SCI USA, V114, pE7226, DOI 10.1073/pnas.1704756114; Commichau FM, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00462-18; Commichau FM, 2018, TRENDS MICROBIOL, V26, P175, DOI 10.1016/j.tim.2017.09.003; Commichau FM, 2015, MOL MICROBIOL, V97, P189, DOI 10.1111/mmi.13026; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; Detsch C, 2003, MICROBIOL-SGM, V149, P3289, DOI 10.1099/mic.0.26512-0; Devaux L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007342; Fujisawa M, 2007, P NATL ACAD SCI USA, V104, P13289, DOI 10.1073/pnas.0703709104; Gundlach J, 2017, MBIO, V8, DOI 10.1128/mBio.00861-17; Gundlach J, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3011; Gundlach J, 2015, J BACTERIOL, V197, P3265, DOI 10.1128/JB.00564-15; Gundlach J, 2015, J BIOL CHEM, V290, P3069, DOI 10.1074/jbc.M114.619619; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Pham HT, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007574; Kappes RM, 1999, MOL MICROBIOL, V32, P203, DOI 10.1046/j.1365-2958.1999.01354.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lehnik-Habrink M, 2011, J BACTERIOL, V193, P5431, DOI 10.1128/JB.05500-11; Lehnik-Habrink M, 2011, MOL MICROBIOL, V81, P1459, DOI 10.1111/j.1365-2958.2011.07777.x; Mehne FMP, 2014, J BIOL CHEM, V289, P21098, DOI 10.1074/jbc.M114.562066; Meinken C, 2003, MICROBIOL-SGM, V149, P751, DOI 10.1099/mic.0.26078-0; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Moscoso JA, 2016, J BACTERIOL, V198, P98, DOI 10.1128/JB.00480-15; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Orr MW, 2017, METHODS MOL BIOL, V1535, P25, DOI 10.1007/978-1-4939-6673-8_3; Orr MW, 2016, CURR OPIN MICROBIOL, V34, P119, DOI 10.1016/j.mib.2016.08.010; Prindle A, 2015, NATURE, V527, P59, DOI 10.1038/nature15709; Quintana IM, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00028-19; Radchenko MV, 2006, J BIOL CHEM, V281, P19822, DOI 10.1074/jbc.M600333200; Reuss DR, 2017, GENOME RES, V27, P289, DOI 10.1101/gr.215293.116; Rocha R, 2019, J STRUCT BIOL, V205, P34, DOI 10.1016/j.jsb.2019.02.002; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Rosenberg J, 2015, J BIOL CHEM, V290, P6596, DOI 10.1074/jbc.M114.630418; Sambrook J., 2001, MOL CLONING LAB MANU; Schirmer F, 1997, J BACTERIOL, V179, P1329, DOI 10.1128/jb.179.4.1329-1336.1997; Schuster CF, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7279; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Huynh TN, 2016, MOL MICROBIOL, V102, P233, DOI 10.1111/mmi.13456; Vieira-Pires RS, 2013, NATURE, V496, P323, DOI 10.1038/nature12055; Wakeman CA, 2014, J BACTERIOL, V196, P1206, DOI 10.1128/JB.01238-13; Whiteley AT, 2015, CELL HOST MICROBE, V17, P788, DOI 10.1016/j.chom.2015.05.006; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Zeden MS, 2018, J BIOL CHEM, V293, P3180, DOI 10.1074/jbc.M117.818716; Zhu BY, 2018, NUCLEIC ACIDS RES, V46, pD743, DOI 10.1093/nar/gkx908; Zweers JC, 2009, APPL ENVIRON MICROB, V75, P7356, DOI 10.1128/AEM.01560-09	53	34	36	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9605	9614		10.1074/jbc.RA119.008774	http://dx.doi.org/10.1074/jbc.RA119.008774			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31061098	Green Published, hybrid			2022-12-28	WOS:000472713000025
J	Byun, S; Jung, H; Chen, JJ; Kim, YC; Kim, DH; Kong, B; Guo, G; Kemper, B; Kemper, JK				Byun, Sangwon; Jung, Hyunkyung; Chen, Jinjing; Kim, Young-Chae; Kim, Dong-Hyun; Kong, Bo; Guo, Grace; Kemper, Byron; Kemper, Jongsook Kim			Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; cholesterol regulation; bile acid; post-translational modification (PTM); nuclear receptor; ATP-binding cassette subfamily G member 5 (Abcg5); Abcg8; hypercholesterolemia; reverse cholesterol transport; scavenger receptor class B member 1 (Scarb1); biliary excretion; metabolic homeostasis; FGF15	FACTOR 15 DEFICIENCY; BILE-ACID; LIVER; BINDING; FIBROBLAST-GROWTH-FACTOR-19; TRANSPORTERS; INFLAMMATION; REPRESSION; OBESITY; EFFLUX	The bile acid (BA) nuclear receptor, farnesoid X receptor (FXR/NR1H4), maintains metabolic homeostasis by transcriptional control of numerous genes, including an intestinal hormone, fibroblast growth factor-19 (FGF19; FGF15 in mice). Besides activation by BAs, the gene-regulatory function of FXR is also modulated by hormone or nutrient signaling-induced post-translational modifications. Recently, phosphorylation at Tyr-67 by the FGF15/19 signaling-activated nonreceptor tyrosine kinase Src was shown to be important for FXR function in BA homeostasis. Here, we examined the role of this FXR phosphorylation in cholesterol regulation. In both hepatic FXR-knockout and FXR-knockdown mice, reconstitution of FXR expression up-regulated cholesterol transport genes for its biliary excretion, including scavenger receptor class B member 1 (Scarb1) and ABC subfamily G member 8 (Abcg5/8), decreased hepatic and plasma cholesterol levels, and increased biliary and fecal cholesterol levels. Of note, these sterol-lowering effects were blunted by substitution of Phe for Tyr-67 in FXR. Moreover, consistent with Src's role in phosphorylating FXR, Src knockdown impaired cholesterol regulation in mice. In hypercholesterolemic apolipoprotein E-deficient mice, expression of FXR, but not Y67F-FXR, ameliorated atherosclerosis, whereas Src down-regulation exacerbated it. Feeding or treatment with an FXR agonist induced Abcg5/8 and Scarb1 expression in WT, but not FGF15-knockout, mice. Furthermore, FGF19 treatment increased occupancy of FXR at Abcg5/8 and Scarb1, expression of these genes, and cholesterol efflux from hepatocytes. These FGF19-mediated effects were blunted by the Y67F-FXR substitution or Src down-regulation or inhibition. We conclude that phosphorylation of hepatic FXR by FGF15/19-induced Src maintains cholesterol homeostasis and protects against atherosclerosis.	[Byun, Sangwon; Jung, Hyunkyung; Chen, Jinjing; Kim, Young-Chae; Kim, Dong-Hyun; Kemper, Byron; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Kong, Bo; Guo, Grace] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; [Byun, Sangwon] KBRI, Dept Neural Dev & Dis, 61 Cheomdan Ro, Daegu 41068, South Korea; [Kim, Dong-Hyun] Chonnam Natl Univ, Dept Internal Med, Med Sch, Gwangju 61469, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; Rutgers State University New Brunswick; Korea Brain Research Institute (KBRI); Chonnam National University	Kemper, JK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 407 S Goodwin Ave, Urbana, IL 61801 USA.	jongsook@illinois.edu		Kim, Young-Chae/0000-0002-5130-4413; Byun, Sangwon/0000-0001-5101-8372; Kim, Dong-Hyun/0000-0001-8995-9426	American Heart Association (AHA) Postdoctoral Fellowship [17POST33410223]; American Diabetes Association (ADA) Postdoctoral Fellowship [1-19-PDF-117]; AHA Scientist Development Award [16SDG27570006]; AHA Post-doctoral Fellowship [14POST20420006]; National Institutes of Health [DK062777, DK095842]; ADA Innovative Basic Science Grant [1-16-IBS-156]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095842, R01DK062777] Funding Source: NIH RePORTER	American Heart Association (AHA) Postdoctoral Fellowship(American Heart Association); American Diabetes Association (ADA) Postdoctoral Fellowship; AHA Scientist Development Award(American Heart Association); AHA Post-doctoral Fellowship(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA Innovative Basic Science Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by American Heart Association (AHA) Postdoctoral Fellowship 17POST33410223 (to S. B.), American Diabetes Association (ADA) Postdoctoral Fellowship 1-19-PDF-117 (to J. C.), AHA Scientist Development Award 16SDG27570006 (to Y. K.), AHA Post-doctoral Fellowship 14POST20420006 (to D. K.), and National Institutes of Health Grants DK062777 and DK095842 and ADA Innovative Basic Science Grant 1-16-IBS-156 (to J. K. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berrabah W, 2014, HEPATOLOGY, V59, P2022, DOI 10.1002/hep.26710; Byun S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04697-5; Byun S, 2017, EMBO J, V36, P1755, DOI 10.15252/embj.201695500; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; de Aguiar VT, 2013, CIRC RES, V112, P300648, DOI DOI 10.1161/CIRCRESAHA.112.300648; de Boer JF, 2017, GASTROENTEROLOGY, V152, P1126, DOI 10.1053/j.gastro.2016.12.037; De Magalhaes Filho C Daniel, 2016, Cell, V166, P789, DOI 10.1016/j.cell.2016.08.001; Degirolamo C, 2016, NAT REV DRUG DISCOV, V15, P51, DOI 10.1038/nrd.2015.9; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; Hanniman EA, 2005, J LIPID RES, V46, P2595, DOI 10.1194/jlr.M500390-JLR200; Katafuchi T, 2015, CELL METAB, V21, P898, DOI 10.1016/j.cmet.2015.05.004; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kim DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12179; Kim DH, 2015, EMBO J, V34, P184, DOI 10.15252/embj.201489527; Kim YC, 2019, GASTROENTEROLOGY, V156, P1052, DOI 10.1053/j.gastro.2018.11.061; Kim YC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03060-y; Kim YC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0835-6; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Kliewer SA, 2015, DIGEST DIS, V33, P327, DOI 10.1159/000371670; Kong B, 2014, AM J PHYSIOL-GASTR L, V306, pG893, DOI 10.1152/ajpgi.00337.2013; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lee J, 2012, HEPATOLOGY, V56, P108, DOI 10.1002/hep.25609; Lenihan DJ, 2013, ONCOLOGIST, V18, P900, DOI 10.1634/theoncologist.2012-0466; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Luo J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009098; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Schumacher JD, 2017, TOXICOL APPL PHARM, V330, P1, DOI 10.1016/j.taap.2017.06.023; Seok S, 2018, J CLIN INVEST, V128, P3144, DOI 10.1172/JCI97736; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Xu Y, 2016, HEPATOLOGY, V64, P1072, DOI 10.1002/hep.28712; Yu LQ, 2005, J BIOL CHEM, V280, P8742, DOI 10.1074/jbc.M411080200; Zhang YQ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.083899	42	19	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8732	8744		10.1074/jbc.RA119.008360	http://dx.doi.org/10.1074/jbc.RA119.008360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30996006	Green Published, hybrid			2022-12-28	WOS:000470971100010
J	Lou, B; Liu, Q; Hou, JH; Kabir, I; Liu, PP; Ding, TB; Dong, JB; Mo, MG; Ye, DY; Chen, Y; Bui, HH; Roth, K; Cao, Y; Jiang, XC				Lou, Bin; Liu, Qi; Hou, Jiahui; Kabir, Inamul; Liu, Peipei; Ding, Tingbo; Dong, Jibin; Mo, Mingguang; Ye, Deyong; Chen, Yang; Bui, Hai H.; Roth, Kenneth; Cao, Yu; Jiang, Xian-Cheng			2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity (vol 293, pg 18328, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Ye, Deyong/AAE-2173-2022	Ye, Deyong/0000-0003-0498-3019	National Institutes of Health [NIH R56 HL121409]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	There was an error in the grant footnote. The National Institutes of Health grant number was incorrect. The correct grant number is NIH R56 HL121409.	Lou B, 2018, J BIOL CHEM, V293, P18328, DOI 10.1074/jbc.RA118.005904	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8716	8716		10.1074/jbc.AAC119.009289	http://dx.doi.org/10.1074/jbc.AAC119.009289			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31152097	Green Published, hybrid			2022-12-28	WOS:000470971100008
J	Matlock, AO; Smith, BA; Jackman, JE				Matlock, Ashanti O.; Smith, Brian A.; Jackman, Jane E.			Chemical footprinting and kinetic assays reveal dual functions for highly conserved eukaryotic tRNA(His) guanylyltransferase residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transfer RNA (tRNA); RNA modification; RNA-protein interaction; enzyme mechanism; RNA polymerase; translation; 3-5 polymerase; guanylyltransferase; GUG anticodon; noncanonical polymerase; site-directed mutagenesis; RNA maturation; nucleic acid specificity	HISTIDINE TRANSFER-RNA; 3'-5' NUCLEOTIDE ADDITION; SACCHAROMYCES-CEREVISIAE; 5-TERMINAL GUANYLATE; IDENTITY; G(-1); RECOGNITION; POLYMERIZATION; IDENTIFICATION; MITOCHONDRIA	tRNA(His) guanylyltransferase (Thg1) adds a single guanine to the -1 position of tRNA(His) as part of its maturation. This seemingly modest addition of one nucleotide to tRNA(His) ensures translational fidelity by providing a critical identity element for the histidyl aminoacyl tRNA synthetase (HisRS). Like HisRS, Thg1 utilizes the GUG anticodon for selective tRNA(His) recognition, and Thg1-tRNA complex structures have revealed conserved residues that interact with anticodon nucleotides. Separately, kinetic analysis of alanine variants has demonstrated that many of these same residues are required for catalytic activity. A model in which loss of activity with the variants was attributed directly to loss of the critical anticodon interaction has been proposed to explain the combined biochemical and structural results. Here we used RNA chemical footprinting and binding assays to test this model and further probe the molecular basis for the requirement for two critical tRNA-interacting residues, His-152 and Lys-187, in the context of human Thg1 (hThg1). Surprisingly, we found that His-152 and Lys-187 alanine-substituted variants maintain a similar overall interaction with the anticodon region, arguing against the sufficiency of this interaction for driving catalysis. Instead, conservative mutagenesis revealed a new direct function for these residues in recognition of a non-Watson-Crick G(-1):A(73) bp, which had not been described previously. These results have important implications for the evolution of eukaryotic Thg1 from a family of ancestral promiscuous RNA repair enzymes to the highly selective enzymes needed for their essential function in tRNA(His) maturation.	[Matlock, Ashanti O.; Smith, Brian A.; Jackman, Jane E.] Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol, Columbus, OH 43210 USA; [Matlock, Ashanti O.; Smith, Brian A.; Jackman, Jane E.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Smith, Brian A.] Lawrence Tech Univ, Dept Nat Sci, Southfield, MI USA	Ohio State University; Ohio State University	Jackman, JE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol, Columbus, OH 43210 USA.	bsmith2@ltu.edu; jackman.14@osu.edu	jackman, jane/AAE-1854-2022	jackman, jane/0000-0001-9291-8852	National Institutes of Health [R01 GM087543]; Cellular and Molecular Biosciences training grant; Center for RNA Biology fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM086252, R01GM087543] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Biosciences training grant; Center for RNA Biology fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01 GM087543 (to J.E.J.), a Cellular and Molecular Biosciences training grant (to A.O.M.), and a Center for RNA Biology fellowship (to B.A.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abad MG, 2011, RNA, V17, P613, DOI 10.1261/rna.2517111; Abad MG, 2010, P NATL ACAD SCI USA, V107, P674, DOI 10.1073/pnas.0910961107; Ardell DH, 2006, NUCLEIC ACIDS RES, V34, P893, DOI 10.1093/nar/gkj449; BURKARD U, 1988, J BIOL CHEM, V263, P9578; BURKARD U, 1988, J BIOL CHEM, V263, P2447; COOLEY L, 1982, P NATL ACAD SCI-BIOL, V79, P6475, DOI 10.1073/pnas.79.21.6475; Desai R, 2018, RNA BIOL, V15, P614, DOI 10.1080/15476286.2017.1372076; Gu WF, 2003, GENE DEV, V17, P2889, DOI 10.1101/gad.1148603; HIMENO H, 1989, NUCLEIC ACIDS RES, V17, P7855, DOI 10.1093/nar/17.19.7855; Hyde SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067465; Hyde SJ, 2010, P NATL ACAD SCI USA, V107, P20305, DOI 10.1073/pnas.1010436107; Jackman JE, 2008, BIOCHEMISTRY-US, V47, P4817, DOI 10.1021/bi702517q; Jackman JE, 2006, P NATL ACAD SCI USA, V103, P8640, DOI 10.1073/pnas.0603068103; Jackman JE, 2006, RNA, V12, P1007, DOI 10.1261/rna.54706; Jackman JE, 2012, RNA, V18, P886, DOI 10.1261/rna.032300.112; JAHN D, 1991, J BIOL CHEM, V266, P22832; Kimura S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501397; LABBE D, 1990, J BIOL CHEM, V265, P2988; Lee K, 2017, BIOCHEM BIOPH RES CO, V490, P400, DOI 10.1016/j.bbrc.2017.06.054; Long YC, 2016, NUCLEIC ACIDS RES, V44, P8395, DOI 10.1093/nar/gkw681; Nakamura A, 2013, P NATL ACAD SCI USA, V110, P20970, DOI 10.1073/pnas.1321312111; NAMEKI N, 1995, NUCLEIC ACIDS RES, V23, P389, DOI 10.1093/nar/23.3.389; ORELLANA O, 1986, MOL CELL BIOL, V6, P525, DOI 10.1128/MCB.6.2.525; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Placido A, 2010, NUCLEIC ACIDS RES, V38, P7711, DOI 10.1093/nar/gkq646; Rao BS, 2015, RNA, V21, P243, DOI 10.1261/rna.048389.114; Rao BS, 2013, NUCLEIC ACIDS RES, V41, P1885, DOI 10.1093/nar/gks1242; Rao BS, 2011, NUCLEIC ACIDS RES, V39, P1833, DOI 10.1093/nar/gkq976; Rio D. C, 2011, RNA LAB MANUAL, P276; RUDINGER J, 1994, NUCLEIC ACIDS RES, V22, P5031, DOI 10.1093/nar/22.23.5031; Rudinger J, 1997, BIOORGAN MED CHEM, V5, P1001, DOI 10.1016/S0968-0896(97)00061-8; Smith BA, 2012, BIOCHEMISTRY-US, V51, P453, DOI 10.1021/bi201397f; Wang CX, 2007, J BACTERIOL, V189, P1954, DOI 10.1128/JB.01203-06	33	2	2	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8885	8893		10.1074/jbc.RA119.007939	http://dx.doi.org/10.1074/jbc.RA119.007939			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31000629	Green Published, hybrid			2022-12-28	WOS:000470971100022
J	Dickerhof, N; Isles, V; Pattemore, P; Hampton, MB; Kettle, AJ				Dickerhof, Nina; Isles, Vivienne; Pattemore, Philip; Hampton, Mark B.; Kettle, Anthony J.			Exposure of Pseudomonas aeruginosa to bactericidal hypochlorous acid during neutrophil phagocytosis is compromised in cystic fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myeloperoxidase; neutrophil; cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); Pseudomonas aeruginosa (P; aeruginosa); coenzyme A (CoA); glutathione; glutathione sulfonamide (GSA); hypochlorous acid; immune response	GAMMA-GLUTAMYL-TRANSPEPTIDASE; ABSOLUTE RATE CONSTANTS; ESCHERICHIA-COLI; OXIDATIVE STRESS; MICE DEFICIENT; CATHEPSIN-C; MYELOPEROXIDASE; CHLORINATION; CFTR; GLUTATHIONE	Myeloperoxidase is a major neutrophil antimicrobial protein, but its role in immunity is often overlooked because individuals deficient in this enzyme are usually in good health. Within neutrophil phagosomes, myeloperoxidase uses superoxide generated by the NADPH oxidase to oxidize chloride to the potent bactericidal oxidant hypochlorous acid (HOCl). In this study, using phagocytosis assays and LC-MS analyses, we monitored GSH oxidation in Pseudomonas aeruginosa to gauge their exposure to HOCl inside phagosomes. Doses of reagent HOCl that killed most of the bacteria oxidized half the cells' GSH, producing mainly glutathione disulfide (GSSG) and other low-molecular-weight disulfides. Glutathione sulfonamide (GSA), a HOCl-specific product, was also formed. When neutrophils phagocytosed P. aeruginosa, half of the bacterial GSH was lost. Bacterial GSA production indicated that HOCl had reacted with the bacterial cells, oxidized their GSH, and was sufficient to be solely responsible for bacterial killing. Inhibition of NADPH oxidase and myeloperoxidase lowered GSA formation in the bacterial cells, but the bacteria were still killed, presumably by compensatory nonoxidative mechanisms. Of note, bacterial GSA formation in neutrophils from patients with cystic fibrosis (CF) was normal during early phagocytosis, but it was diminished at later time points, which was mirrored by a small decrease in bacterial killing. In conclusion, myeloperoxidase generates sufficient HOCl within neutrophil phagosomes to kill ingested bacteria. The unusual kinetics of phagosomal HOCl production in CF neutrophils confirm a role for the cystic fibrosis transmembrane conductance regulator in maintaining HOCl production in neutrophil phagosomes.	[Dickerhof, Nina; Hampton, Mark B.; Kettle, Anthony J.] Univ Otago Christchurch, Dept Pathol & Biomed Sci, Ctr Free Rad Res, Christchurch 8011, New Zealand; [Pattemore, Philip] Univ Otago Christchurch, Dept Paediat, Christchurch 8011, New Zealand; [Isles, Vivienne] Christchurch Hosp, Childrens Outreach Nursing Serv, Christchurch 8011, New Zealand	University of Otago; University of Otago; Christchurch Hospital New Zealand	Dickerhof, N (corresponding author), Univ Otago, Ctr Free Rad Res, POB 4345, Christchurch 8140, New Zealand.	nina.dickerhof@otago.ac.nz	Hampton, Mark/A-8490-2008	Hampton, Mark/0000-0002-7349-3729; Kettle, Tony/0000-0002-8218-7766; Dickerhof, Nina/0000-0003-2269-4595	Health Research Council of New Zealand [15/333, 15/479]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by Health Research Council of New Zealand Grants 15/333 and 15/479. The authors declare that they have no conflicts of interest with the contents of this article.	Albrett AM, 2018, J BIOL CHEM, V293, P15715, DOI 10.1074/jbc.RA118.004789; Aratani Y, 2000, J INFECT DIS, V182, P1276, DOI 10.1086/315843; Beaumont PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099029; Berkebile AR, 2014, INT J BIOCHEM CELL B, V52, P124, DOI 10.1016/j.biocel.2014.02.009; Bhavsar T, 2010, EXP LUNG RES, V36, P94, DOI 10.3109/01902140903154608; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Chesney JA, 1996, J BACTERIOL, V178, P2131, DOI 10.1128/jb.178.7.2131-2135.1996; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Coker MS, 2018, ARCH BIOCHEM BIOPHYS, V646, P80, DOI 10.1016/j.abb.2018.03.039; Cole AM, 2005, J LEUKOCYTE BIOL, V78, P1081, DOI 10.1189/jlb.0205073; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Degrossoli A, 2018, ELIFE, V7, DOI 10.7554/eLife.32288; Dickerhof N, 2017, FREE RADICAL BIO MED, V113, P236, DOI 10.1016/j.freeradbiomed.2017.09.028; Foote JR, 2017, JOVE-J VIS EXP, DOI 10.3791/55107; Fruhwirth M, 1998, INT ARCH ALLERGY IMM, V117, P270, DOI 10.1159/000024022; GABIG TG, 1979, BLOOD, V53, P1133; GORTER J, 1970, BIOCHIM BIOPHYS ACTA, V198, P546, DOI 10.1016/0005-2744(70)90132-4; Green JN, 2014, FREE RADICAL BIO MED, V77, P49, DOI 10.1016/j.freeradbiomed.2014.08.013; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Harwood DT, 2006, BIOCHEM J, V399, P161, DOI 10.1042/BJ20060978; Harwood DT, 2009, J CHROMATOGR B, V877, P3393, DOI 10.1016/j.jchromb.2009.04.018; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hawkins CL, 2002, CHEM RES TOXICOL, V15, P83, DOI 10.1021/tx015548d; Hirche TO, 2008, J IMMUNOL, V181, P4945, DOI 10.4049/jimmunol.181.7.4945; Horvath AK, 2006, J PHYS CHEM A, V110, P4753, DOI 10.1021/jp060246b; Houston N, 2013, J CYST FIBROS, V12, P352, DOI 10.1016/j.jcf.2012.11.004; ISHIYE M, 1993, BIOTECHNOL PROGR, V9, P323, DOI 10.1021/bp00021a012; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; KETTLE AJ, 1989, BIOCHEM J, V263, P823, DOI 10.1042/bj2630823; Korkmaz B, 2013, SEMIN IMMUNOPATHOL, V35, P411, DOI 10.1007/s00281-013-0362-z; Lanza F, 1998, J MOL MED-JMM, V76, P676, DOI 10.1007/s001090050267; Levine AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125906; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; McKeon DJ, 2010, EUR RESPIR J, V35, P1264, DOI 10.1183/09031936.00089709; Miao XY, 2015, CHINESE MED J-PEKING, V128, P2792, DOI 10.4103/0366-6999.167360; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Ng HP, 2016, J LEUKOCYTE BIOL, V100, P1413, DOI 10.1189/jlb.4A0316-130RR; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Painter RG, 2010, J LEUKOCYTE BIOL, V87, P933, DOI 10.1189/jlb.1009655; Palazzolo AM, 2005, BIOCHEMISTRY-US, V44, P6910, DOI 10.1021/bi047342s; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Pattison DI, 2003, CHEM RES TOXICOL, V16, P439, DOI 10.1021/tx025670s; Rada B, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6010010; Robledo-Avila FH, 2018, J IMMUNOL, V201, P2016, DOI 10.4049/jimmunol.1800076; Rosen H, 1997, INFECT IMMUN, V65, P4173, DOI 10.1128/IAI.65.10.4173-4178.1997; Rosen H, 2002, J BIOL CHEM, V277, P30463, DOI 10.1074/jbc.M202331200; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; SCHILLER J, 1994, BIOL CHEM H-S, V375, P167, DOI 10.1515/bchm3.1994.375.3.167; Schwartz J, 2009, J IMMUNOL, V183, P2632, DOI 10.4049/jimmunol.0804110; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SEGAL AW, 1980, J CELL BIOL, V85, P42, DOI 10.1083/jcb.85.1.42; Storkey C, 2014, FREE RADICAL BIO MED, V73, P60, DOI 10.1016/j.freeradbiomed.2014.04.024; SUZUKI H, 1986, J BACTERIOL, V168, P1332, DOI 10.1128/jb.168.3.1332-1335.1986; Tai KP, 2015, INNATE IMMUN-LONDON, V21, P17, DOI 10.1177/1753425913514784; Tiden AK, 2011, J BIOL CHEM, V286, P37578, DOI 10.1074/jbc.M111.266981; Wang GS, 2016, IMMUNOL REV, V273, P219, DOI 10.1111/imr.12438; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; WitkoSarsat V, 1996, J IMMUNOL, V157, P2728; Xie KB, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.101087	67	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13502	13514		10.1074/jbc.RA119.009934	http://dx.doi.org/10.1074/jbc.RA119.009934			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31341024	hybrid, Green Published			2022-12-28	WOS:000486417200024
J	Mandati, V; Del Maestro, L; Dingli, F; Lombard, B; Loew, D; Molinie, N; Romero, S; Bouvard, D; Louvard, D; Gautreau, AM; Pasmant, E; Lallemand, D				Mandati, Vinay; Del Maestro, Laurence; Dingli, Florent; Lombard, Berangere; Loew, Damarys; Molinie, Nicolas; Romero, Stephane; Bouvard, Daniel; Louvard, Daniel; Gautreau, Alexis M.; Pasmant, Eric; Lallemand, Dominique			Phosphorylation of Merlin by Aurora A kinase appears necessary for mitotic progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; mitosis; phosphorylation; tumor suppressor gene; tubulin; cell proliferation; Aurora A; isoforms; Merlin; neurofibromatosis type 2; NF2; Merlin; NF2; ezrin	TUMOR-SUPPRESSOR GENE; NEUROFIBROMATOSIS TYPE-2; MISSENSE MUTATION; ERM PROTEINS; CELL CORTEX; NF2; ACTIVATION; TUMORIGENESIS; PRODUCT; PATHWAY	Although Merlin's function as a tumor suppressor and regulator of mitogenic signaling networks such as the Ras/rac, Akt, and Hippo pathways is well-documented, in mammals as well as in insects, its role during cell cycle progression remains unclear. In this study, using a combination of approaches, including FACS analysis, time-lapse imaging, immunofluorescence microscopy, and co-immunoprecipitation, we show that Ser-518 of Merlin is a substrate of the Aurora protein kinase A during mitosis and that its phosphorylation facilitates the phosphorylation of a newly discovered site, Thr-581. We found that the expression in HeLa cells of a Merlin variant that is phosphorylation-defective on both sites leads to a defect in centrosomes and mitotic spindles positioning during metaphase and delays the transition from metaphase to anaphase. We also show that the dual mitotic phosphorylation not only reduces Merlin binding to microtubules but also timely modulates ezrin interaction with the cytoskeleton. Finally, we identify several point mutants of Merlin associated with neurofibromatosis type 2 that display an aberrant phosphorylation profile along with defective alpha-tubulin-binding properties. Altogether, our findings of an Aurora A-mediated interaction of Merlin with alpha-tubulin and ezrin suggest a potential role for Merlin in cell cycle progression.	[Mandati, Vinay; Del Maestro, Laurence; Louvard, Daniel; Lallemand, Dominique] PSL Res Univ, CNRS, UMR144, Inst Curie, F-75005 Paris, France; [Dingli, Florent; Lombard, Berangere; Loew, Damarys] PSL Res Univ, Inst Curie, Lab Spectrometrie Masse Prote, F-75005 Paris, France; [Molinie, Nicolas; Romero, Stephane; Gautreau, Alexis M.] Inst Polytech Paris, CNRS, UMR7654, BIOC, F-91128 Palaiseau, France; [Bouvard, Daniel] INSERM, U823, Inst Albert Bonniot, F-38042 Grenoble, France; [Pasmant, Eric] Univ Paris 05, Sorbonne Paris Cite, INSERM, Inst Cochin,U1016, F-75014 Paris, France; [Mandati, Vinay] Cold Spring Harbor Lab, New York, NY 11724 USA; [Del Maestro, Laurence] Univ Paris, CNRS, UMR 7216, Epigenet & Cell Fate, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Lallemand, D (corresponding author), Univ Paris 05, Sorbonne Paris Cite, INSERM, Inst Cochin,U1016, F-75014 Paris, France.	dominique.lallemand@inserm.fr	Pasmant, Eric/O-7249-2017; Romero, Stephane/K-5998-2017; Mandati, Vinay/AAZ-1898-2020; Romero, Stephane/GLR-3472-2022; lallemand, dominique/O-7445-2017; Gautreau, Alexis/AAT-2751-2020	Pasmant, Eric/0000-0002-1881-8762; Romero, Stephane/0000-0002-7358-3871; Romero, Stephane/0000-0002-7358-3871; lallemand, dominique/0000-0002-0212-7342; Gautreau, Alexis/0000-0002-2369-4362	Pierre Gilles de Gennes Foundation; Association pour la Recherche sur le Cancer (ARC); Association Neurofibromatose et Recklinghausen (ANR); Institut National du Cancer (INCA); Centre Nationale de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut Curie	Pierre Gilles de Gennes Foundation; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Neurofibromatose et Recklinghausen (ANR)(French National Research Agency (ANR)); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Centre Nationale de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie	This work was supported by the Pierre Gilles de Gennes Foundation (to V. M.). The project was also supported by Association pour la Recherche sur le Cancer (ARC), Association Neurofibromatose et Recklinghausen (ANR), and Institut National du Cancer (INCA), Centre Nationale de la Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), and Institut Curie. The authors declare that they have no conflicts of interest with the contents of this article.	Baser ME, 2002, AM J HUM GENET, V71, P715, DOI 10.1086/342716; Boin A, 2014, NEURO-ONCOLOGY, V16, P1196, DOI 10.1093/neuonc/nou020; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Chinthalapudi K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03648-4; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Giovannini M, 2000, GENE DEV, V14, P1617; Giovannini M, 1999, GENE DEV, V13, P978, DOI 10.1101/gad.13.8.978; Gronholm M, 2006, ONCOGENE, V25, P4389, DOI 10.1038/sj.onc.1209475; Guerrant W, 2016, CANCER RES, V76, P3507, DOI 10.1158/0008-5472.CAN-15-1144; Hebert AM, 2012, GENE DEV, V26, P2709, DOI 10.1101/gad.194027.112; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kluwe L, 1996, HUM GENET, V97, P224, DOI 10.1007/BF02265270; Kschonsak YT, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214544; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Laulajainen M, 2012, J CELL MOL MED, V16, P2161, DOI 10.1111/j.1582-4934.2012.01525.x; Laulajainen M, 2011, NEOPLASIA, V13, P643, DOI 10.1593/neo.11356; Li W, 2014, CANCER CELL, V26, P48, DOI 10.1016/j.ccr.2014.05.001; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Machicoane M, 2014, J CELL BIOL, V205, P791, DOI 10.1083/jcb.201401049; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; McClatchey AI, 1997, GENE DEV, V11, P1253, DOI 10.1101/gad.11.10.1253; Meng JJ, 2000, J NEUROSCI RES, V62, P491, DOI 10.1002/1097-4547(20001115)62:4<491::AID-JNR3>3.0.CO;2-D; Moleirinho S, 2017, ELIFE, V6, DOI 10.7554/eLife.23966; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Muranen T, 2005, ONCOGENE, V24, P1150, DOI 10.1038/sj.onc.1208283; Muranen T, 2007, HUM MOL GENET, V16, P1742, DOI 10.1093/hmg/ddm122; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Reboutier D, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00290; Ruttledge MH, 1996, AM J HUM GENET, V59, P331; Schulz A, 2013, NAT NEUROSCI, V16, P426, DOI 10.1038/nn.3348; Scoles DR, 1996, NEUROLOGY, V47, P544, DOI 10.1212/WNL.47.2.544; Sher I, 2012, DEV CELL, V22, P703, DOI 10.1016/j.devcel.2012.03.008; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Smole Z, 2014, CANCER RES, V74, P353, DOI 10.1158/0008-5472.CAN-13-1334; Solinet S, 2013, J CELL BIOL, V202, P251, DOI 10.1083/jcb.201304052; Su T, 2017, DEV CELL, V40, P478, DOI 10.1016/j.devcel.2017.02.004; TIKOO A, 1994, J BIOL CHEM, V269, P23387; Xing WC, 2017, BIOCHEM BIOPH RES CO, V493, P46, DOI 10.1016/j.bbrc.2017.09.077; Yabuta N, 2011, CELL CYCLE, V10, P2724, DOI 10.4161/cc.10.16.16873; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015	52	6	7	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12992	13005		10.1074/jbc.RA118.006937	http://dx.doi.org/10.1074/jbc.RA118.006937			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296571	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000486416000011
J	Chen, JC; Kuroki, S; Someda, M; Yonehara, S				Chen, Jiancheng; Kuroki, Shunsuke; Someda, Masataka; Yonehara, Shin			Interferon-gamma induces the cell surface exposure of phosphatidylserine by activating the protein MLKL in the absence of caspase-8 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caspase; cell death; interferon; necrosis (necrotic death); phosphatidylserine; receptor-interacting protein (RIP); interferon-gamma; MLKL; necroptosis; RIPK3	MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; APOPTOTIC CELLS; DEATH; NECROSIS; PHOSPHORYLATION; NECROPTOSIS; EXPRESSION; IDENTIFICATION; DOWNSTREAM	Phosphatidylserine (PS), an anionic phospholipid enriched in the inner leaflet of the plasma membrane, is exposed to the outer leaflet during apoptosis. PS exposure was recently shown to be induced during tumor necrosis factor-induced necroptosis. We herein demonstrated that interferon (IFN)-gamma induced necroptosis in Caspase-8-knockout mouse-derived embryonic fibroblasts (C8KO MEFs), as well as in WT MEFs co-treated with the pan-caspase inhibitor, z-VAD-fmk. PS exposure and necroptosis were significant after 6- and 24-h treatments with IFN-gamma, respectively. To elucidate the molecular mechanisms underlying IFN-gamma-induced PS exposure, we generated C8KO MEF-derived cell lines without the expression of RIPK3 (receptor-interacting protein kinase 3), an essential molecule in tumor necrosis factor-induced necroptosis, and IFN-gamma-induced PS exposure and necrotic cell death were shown to be specifically inhibited by the loss of RIPK3 expression. Furthermore, the down-regulated expression of MLKL (mixed lineage kinase domain-like protein), a key molecule for inducing membrane rupture downstream of RIPK3 in necroptosis, abolished IFN-gamma-induced PS exposure in C8KO MEFs. In human colorectal adenocarcinoma-derived HT29 cells, PS exposure and necroptosis were similarly induced by treatment with IFN-gamma in the presence of Smac mimetics and z-VAD-fmk. The removal of IFN-gamma from PS-exposing MEFs after a 6-h treatment completely inhibited necroptotic cell death but not the subsequent increase in the number of PS-exposing cells. Therefore, PS exposure mediated by RIPK3-activated MLKL oligomers was induced by a treatment with IFN-gamma for a significant interval of time before the induction of necroptosis by membrane rupture.	[Chen, Jiancheng; Kuroki, Shunsuke; Someda, Masataka; Yonehara, Shin] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Chen, Jiancheng; Someda, Masataka; Yonehara, Shin] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Kuroki, Shunsuke] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Kyoto University; Kyoto University; Osaka University	Yonehara, S (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Yoshida Shimoadachi Cho 46-29, Kyoto 6068501, Japan.	yonehara.shin.8s@kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15H01376]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (homeostatic regulation by various types of cell death) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15H01376 to S.Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Balachandran S, 2013, J INTERF CYTOK RES, V33, P171, DOI 10.1089/jir.2012.0087; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cekay MJ, 2017, CANCER LETT, V410, P228, DOI 10.1016/j.canlet.2017.09.002; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dondelinger Y, 2016, TRENDS CELL BIOL, V26, P721, DOI 10.1016/j.tcb.2016.06.004; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lee KK, 2002, J BIOL CHEM, V277, P12351, DOI 10.1074/jbc.M108138200; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Liu SZ, 2017, P NATL ACAD SCI USA, V114, pE7450, DOI 10.1073/pnas.1707531114; Miyasaka K, 2004, EUR J IMMUNOL, V34, P1414, DOI 10.1002/eji.200424930; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; Ousingsawat J, 2017, CELL MOL LIFE SCI, V74, P173, DOI 10.1007/s00018-016-2338-3; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Suzuki J, 2014, J BIOL CHEM, V289, P30257, DOI 10.1074/jbc.M114.583419; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takahashi S, 2013, INT IMMUNOL, V25, P287, DOI 10.1093/intimm/dxs109; Tanzer MC, 2017, CELL DEATH DIFFER, V24, P481, DOI 10.1038/cdd.2016.147; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Toda S, 2012, MOL CELL BIOL, V32, P118, DOI 10.1128/MCB.05993-11; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang HB, 2017, P NATL ACAD SCI USA, V114, P11944, DOI 10.1073/pnas.1715742114; Yoon S, 2017, IMMUNITY, V47, P51, DOI 10.1016/j.immuni.2017.06.001; Zargarian S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002711	42	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					11994	12006		10.1074/jbc.RA118.007161	http://dx.doi.org/10.1074/jbc.RA118.007161			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31217278	hybrid, Green Published			2022-12-28	WOS:000484284500006
J	Aggett, R; Mallette, E; Gilbert, SE; Vachon, MA; Schroeter, KL; Kimber, MS; Seah, SYK				Aggett, Rebecca; Mallette, Evan; Gilbert, Stephanie E.; Vachon, Melody A.; Schroeter, Kurt L.; Kimber, Matthew S.; Seah, Stephen Y. K.			The steroid side-chain-cleaving aldolase Ltp2-ChsH2(DUF35) is a thiolase superfamily member with a radically repurposed active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						steroid; cholesterol; bile acid; beta-oxidation; actinobacteria; protein evolution; biodegradation; aldolase; bile acid; C-C bond cleavage; cholesterol; thiolase	MYCOBACTERIUM-TUBERCULOSIS; CHOLESTEROL CATABOLISM; ARCHITECTURE; SYNTHASE; REVEALS	An aldolase from the bile acid-degrading actinobacterium Thermomonospora curvata catalyzes the C-C bond cleavage of an isopropyl-CoA side chain from the D-ring of the steroid metabolite 17-hydroxy-3-oxo-4-pregnene-20-carboxyl-CoA (17-HOPC-CoA). Like its homolog from Mycobacterium tuberculosis, the T. curvata aldolase is a protein complex of Ltp2 with a DUF35 domain derived from the C-terminal domain of a hydratase (ChsH2(DUF35)) that catalyzes the preceding step in the pathway. We determined the structure of the Ltp2-ChsH2(DUF35) complex at 1.7 angstrom resolution using zinc-single anomalous diffraction. The enzyme adopts an alpha beta beta alpha organization, with the two Ltp2 protomers forming a central dimer, and the two ChsH2(DUF35) protomers being at the periphery. Docking experiments suggested that Ltp2 forms a tight complex with the hydratase but that each enzyme retains an independent CoA-binding site. Ltp2 adopted a fold similar to those in thiolases; however, instead of forming a deep tunnel, the Ltp2 active site formed an elongated cleft large enough to accommodate 17-HOPC-CoA. The active site lacked the two cysteines that served as the nucleophile and general base in thiolases and replaced a pair of oxyanion-hole histidine residues with Tyr-246 and Tyr-344. Phenylalanine replacement of either of these residues decreased aldolase catalytic activity at least 400-fold. On the basis of a 17-HOPC-CoA -docked model, we propose a catalytic mechanism where Tyr-294 acts as the general base abstracting a proton from the D-ring hydroxyl of 17-HOPC-CoA and Tyr-344 as the general acid that protonates the propionyl-CoA anion following C-C bond cleavage.	[Aggett, Rebecca; Mallette, Evan; Gilbert, Stephanie E.; Vachon, Melody A.; Schroeter, Kurt L.; Kimber, Matthew S.; Seah, Stephen Y. K.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON NG 5E9, Canada; [Gilbert, Stephanie E.] Hosp Sick Children, 686 Bay St, Toronto, ON M5G 0A4, Canada; [Vachon, Melody A.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Guelph; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Waterloo	Kimber, MS; Seah, SYK (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON NG 5E9, Canada.	mkimber@uoguelph.ca; sseah@uoguelph.ca		Aggett, Rebecca/0000-0003-0112-1966; Kimber, Matthew/0000-0001-9454-5586	Natural Science and Engineering Research Council of Canada [2015-05366, 2015-04045]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Grants 2015-05366 and 2015-04045 from the Natural Science and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahnert SE, 2015, SCIENCE, V350, DOI 10.1126/science.aaa2245; Anbazhagan P, 2014, TUBERCULOSIS, V94, P405, DOI 10.1016/j.tube.2014.03.003; Baker P, 2012, BIOCHEMISTRY-US, V51, P1942, DOI 10.1021/bi201832a; Bergstrand LH, 2016, MBIO, V7, DOI 10.1128/mBio.00166-16; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Clapes P, 2010, CURR OPIN CHEM BIOL, V14, P154, DOI 10.1016/j.cbpa.2009.11.029; DeLano W.L, PYMOL MOL GRAPHICS S; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/s2213-2600(17)30079-6, 10.1016/S2213-2600(17)30079-6]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewing TA, 2017, J BIOL CHEM, V292, P14668, DOI 10.1074/jbc.M117.778449; Garcia JL, 2012, MICROB BIOTECHNOL, V5, P679, DOI 10.1111/j.1751-7915.2012.00331.x; Gilbert S, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00512-17; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Harijan RK, 2016, PROTEINS, V84, P1075, DOI 10.1002/prot.25054; Harijan RK, 2013, BIOCHEM J, V455, P119, DOI 10.1042/BJ20130669; Janardan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041894; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobylarz MJ, 2014, J BIOL CHEM, V289, P33797, DOI 10.1074/jbc.M114.603175; Krishna SS, 2010, ACTA CRYSTALLOGR F, V66, P1160, DOI 10.1107/S1744309110002514; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lorentzen E, 2005, BIOCHEMISTRY-US, V44, P4222, DOI 10.1021/bi048192o; McGurn LD, 2016, BIOCHEM J, V473, P4559, DOI 10.1042/BCJ20160773; Mohn WW, 2012, J BACTERIOL, V194, P6712, DOI 10.1128/JB.01169-12; Nakashima N, 2004, APPL ENVIRON MICROB, V70, P5557, DOI 10.1128/AEM.70.9.5557-5568.2004; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pavkov-Keller T, 2019, CHEMBIOCHEM, V20, P88, DOI 10.1002/cbic.201800462; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruprecht A, 2015, J BACTERIOL, V197, P1360, DOI 10.1128/JB.02420-14; Schaefer CM, 2015, STRUCTURE, V23, P21, DOI 10.1016/j.str.2014.10.010; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Thomas ST, 2011, J BIOL CHEM, V286, P43668, DOI 10.1074/jbc.M111.313643; Tittmann K, 2014, BIOORG CHEM, V57, P263, DOI 10.1016/j.bioorg.2014.09.001; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Vogeli B, 2018, P NATL ACAD SCI USA, V115, P3380, DOI 10.1073/pnas.1718649115; Wipperman MF, 2014, CRIT REV BIOCHEM MOL, V49, P269, DOI 10.3109/10409238.2014.895700; Yang M, 2014, ACS CHEM BIOL, V9, P2632, DOI 10.1021/cb500232h; Zarzycki J, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-28	42	12	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11934	11943		10.1074/jbc.RA119.008889	http://dx.doi.org/10.1074/jbc.RA119.008889			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31209106	hybrid, Green Published			2022-12-28	WOS:000486127800027
J	Li, YX; Shen, JC; Niu, HY				Li, Yuxi; Shen, Jiangchuan; Niu, Hengyao			DNA duplex recognition activates Exo1 nuclease activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						homologous recombination; DNA repair; DNA binding protein; DNA structure; DNA endonuclease; DNA end resection; DNA hairpin; Exo1; replication protein A (RPA)	MOLECULE IMAGING REVEALS; SINGLE-STRANDED-DNA; EXONUCLEASE 1; KU HETERODIMER; END RESECTION; MECHANISM; COMPLEX; INTERPLAY; REPAIR; DAMAGE	Exonuclease 1 (Exo1) is an evolutionarily conserved eukaryotic nuclease that plays a multifaceted role in maintaining genome stability. The biochemical attributes of Exo1 have been extensively characterized via conventional assays. However, the key step governing its activation remains elusive. Extending the previous finding that Exo1 can digest a randomly selected single-stranded DNA (ssDNA) but not a poly(dT) oligonucleotide and using purified recombinant Exo1 and nuclease and electrophoretic mobility shift assays, here we determined that DNA hairpins with a stem size of 4 bp or longer are able to activate Exo1-mediated digestion of ssDNA. We further provide evidence suggesting that Exo1 uses an evolutionarily conserved residue, Lys(185). This residue interacted with the phosphate group bridging the third and fourth nucleotide on the digestion strand of the substrate DNA for duplex recognition, critical for Exo1 activation on not only ssDNA but also dsDNA. Additionally, the defect of an exo1-K185A mutant in duplex digestion was partially rescued by longer overhanging DNA. However, we noted that the enhanced Exo1 nuclease activity by longer overhanging DNA is largely eliminated by replication protein A (RPA), likely because of the previously reported RPA activity that strips Exo1 off the ssDNA. We conclude that duplex DNA contact by Exo1 is a general mechanism that controls its activation and that this mechanism is particularly important for digestion of duplex DNA whose nascent ssDNA is bound by RPA.	[Li, Yuxi; Shen, Jiangchuan; Niu, Hengyao] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Li, Yuxi] Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Niu, HY (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	hniu@indiana.edu	Li, Yuxi/AAP-4808-2021; Niu, Hengyao/AAE-9269-2020		National Institutes of Health [R35 GM124765]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R35 GM124765. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; Bowen N, 2017, P NATL ACAD SCI USA, V114, P3607, DOI 10.1073/pnas.1701753114; Bowen N, 2013, P NATL ACAD SCI USA, V110, P18472, DOI 10.1073/pnas.1318971110; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Doerfler Lillian, 2011, Genome Integr, V2, P8, DOI 10.1186/2041-9414-2-8; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; Gao Y, 2006, NUCLEIC ACIDS RES, V34, P3370, DOI 10.1093/nar/gkl422; Garcia-Rodriguez N, 2018, EMBO J, V37, DOI 10.15252/embj.201798369; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Goellner EM, 2015, DNA REPAIR, V32, P24, DOI 10.1016/j.dnarep.2015.04.010; Krasner DS, 2015, J BIOL CHEM, V290, P18806, DOI 10.1074/jbc.M115.660191; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lemacon D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01180-5; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Morin I, 2008, EMBO J, V27, P2400, DOI 10.1038/emboj.2008.171; Myler LR, 2017, MOL CELL, V67, P891, DOI 10.1016/j.molcel.2017.08.002; Myler LR, 2016, P NATL ACAD SCI USA, V113, pE1170, DOI 10.1073/pnas.1516674113; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Potenski CJ, 2014, NATURE, V511, P251, DOI 10.1038/nature13292; Shi YQ, 2017, P NATL ACAD SCI USA, V114, P6010, DOI 10.1073/pnas.1704845114; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; SZANKASI P, 1992, J BIOL CHEM, V267, P3014; Teixeira-Silva A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02144-5; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; Tran PT, 2001, P NATL ACAD SCI USA, V98, P9760, DOI 10.1073/pnas.161175998; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000	36	1	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11559	11567		10.1074/jbc.RA119.008549	http://dx.doi.org/10.1074/jbc.RA119.008549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31182486	hybrid, Green Published			2022-12-28	WOS:000478717600018
J	Ahern, BM; Levitan, BM; Veeranki, S; Shah, M; Ali, N; Sebastian, A; Su, W; Gong, MC; Li, JY; Stelzer, JE; Andres, DA; Satin, J				Ahern, Brooke M.; Levitan, Bryana M.; Veeranki, Sudhakar; Shah, Mihir; Ali, Nemat; Sebastian, Andrea; Su, Wen; Gong, Ming C.; Li, Jiayang; Stelzer, Julian E.; Andres, Douglas A.; Satin, Jonathan			Myocardial-restricted ablation of the GTPase RAD results in a pro-adaptive heart response in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; cardiomyocyte; GTPase; heart failure; transgenic mice; gene knockout; positive inotrope; RGK GTPase	DEPENDENT CALCIUM-CHANNELS; VASCULAR LESION FORMATION; CA2+ CHANNEL; SARCOPLASMIC-RETICULUM; PHENOTYPE RESISTANT; CARDIAC FIBROSIS; UP-REGULATION; GENE-THERAPY; REM; MUSCLE	Existing therapies to improve heart function target beta-adrenergic receptor (beta-AR) signaling and Ca2+ handling and often lead to adverse outcomes. This underscores an unmet need for positive inotropes that improve heart function without any adverse effects. The GTPase Ras associated with diabetes (RAD) regulates L-type Ca2+ channel (LTCC) current (I-Ca,I-L). Global RAD-knockout mice (gRAD(-/-)) have elevated Ca2+ handling and increased cardiac hypertrophy, but RAD is expressed also in noncardiac tissues, suggesting the possibility that pathological remodeling is due also to noncardiac effects. Here, we engineered a myocardial-restricted inducible RAD-knockout mouse (RAD(Delta/Delta)). Using an array of methods and techniques, including single-cell electrophysiological and calcium transient recordings, echocardiography, and radiotelemetry monitoring, we found that RAD deficiency results in a sustained increase of inotropy without structural or functional remodeling of the heart. I-Ca,I-L was significantly increased, with RAD loss conferring a beta-AR-modulated phenotype on basal I-Ca,I-L. Cardiomyocytes from RAD(Delta/Delta) hearts exhibited enhanced cytosolic Ca2+ handling, increased contractile function, elevated sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2a) expression, and faster lusitropy. These results argue that myocardial RAD ablation promotes a beneficial elevation in Ca2+ dynamics, which would obviate a need for increased beta-AR signaling to improve cardiac function.	[Ahern, Brooke M.; Levitan, Bryana M.; Shah, Mihir; Sebastian, Andrea; Su, Wen; Gong, Ming C.; Satin, Jonathan] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Levitan, Bryana M.] Univ Kentucky, Gill Heart & Vasc Inst, Lexington, KY 40536 USA; [Veeranki, Sudhakar; Ali, Nemat; Andres, Douglas A.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Li, Jiayang; Stelzer, Julian E.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	University of Kentucky; University of Kentucky; University of Kentucky; Case Western Reserve University	Satin, J (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA.; Andres, DA (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	dandres@uky.edu; Jsatin1@uky.edu	ALI, NEMAT/AAK-3922-2020	ALI, NEMAT/0000-0001-6525-4202	Institutional Development Award (IDeA) from NIGMS National Institutes of Health [P20 GM103527]; Saha Cardiovascular Research Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL131782, R01HL114770, R01HL131782, T32HL007567, R01HL146676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527, T32GM118292, T32GM007250] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from NIGMS National Institutes of Health; Saha Cardiovascular Research Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Wendy Katz for histology support provided by an Institutional Development Award (IDeA) from NIGMS National Institutes of Health Grant P20 GM103527. We thank Tanya Seward for surgical support for radiotelemetry in the Physiology Department core facility. The Vevo3100 was supported by The Saha Cardiovascular Research Center.	Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Bertero E, 2018, NAT REV CARDIOL, V15, P780, DOI 10.1038/s41569-018-0116-7; Bristow MR, 2011, CIRC RES, V109, P1176, DOI 10.1161/CIRCRESAHA.111.245092; Bupha-Intr T, 2009, J APPL PHYSIOL, V107, P1105, DOI 10.1152/japplphysiol.00407.2009; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chen XW, 2011, J MOL CELL CARDIOL, V50, P460, DOI 10.1016/j.yjmcc.2010.11.012; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Correll RN, 2007, J BIOL CHEM, V282, P28431, DOI 10.1074/jbc.M706176200; Correll RN, 2017, CARDIOVASC RES, V113, P749, DOI 10.1093/cvr/cvx046; Davis J, 2016, CELL, V165, P1147, DOI 10.1016/j.cell.2016.04.002; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Freeman K, 2001, J CLIN INVEST, V107, P967, DOI 10.1172/JCI12083; Fu MG, 2005, CIRCULATION, V111, P1071, DOI 10.1161/01.CIR.0000156439.55349.AD; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Goldhaber JI, 2010, CIRCULATION, V121, P1655, DOI 10.1161/CIRCULATIONAHA.109.899294; Gresham KS, 2017, J APPL PHYSIOL, V122, P520, DOI 10.1152/japplphysiol.00306.2016; Gresham KS, 2016, J PHYSIOL-LONDON, V594, P669, DOI 10.1113/JP270959; Gunton JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039462; Jaski BE, 2009, J CARD FAIL, V15, P171, DOI 10.1016/j.cardfail.2009.01.013; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Kobirumaki-Shimozawa F, 2016, J GEN PHYSIOL, V147, P53, DOI 10.1085/jgp.201511484; Levitan BM, 2016, J CARDIOVASC TRANSL, V9, P432, DOI 10.1007/s12265-016-9716-y; Lexow J, 2013, DIS MODEL MECH, V6, P1470, DOI 10.1242/dmm.010470; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Maack C, 2019, EUR HEART J, V40, P3626, DOI 10.1093/eurheartj/ehy600; Magyar J, 2012, CHANNELS, V6, P166, DOI 10.4161/chan.20192; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; Makarewich CA, 2012, CIRC RES, V110, P669, DOI 10.1161/CIRCRESAHA.111.264028; Manning JR, 2018, JACC-BASIC TRANSL SC, V3, P83, DOI 10.1016/j.jacbts.2017.09.004; Manning JR, 2015, AM J PHYSIOL-HEART C, V309, pH336, DOI 10.1152/ajpheart.00389.2015; Manning JR, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000459; Mebazaa A, 2011, INTENS CARE MED, V37, P290, DOI 10.1007/s00134-010-2073-4; Muth JN, 1999, J BIOL CHEM, V274, P21503, DOI 10.1074/jbc.274.31.21503; Muth JN, 2001, CIRCULATION, V103, P140; Puckerin AA, 2018, P NATL ACAD SCI USA, V115, P12051, DOI 10.1073/pnas.1811024115; Puhl HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100694; Raake PW, 2012, CIRCULATION, V125, P2108, DOI 10.1161/CIRCULATIONAHA.111.044255; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; Satin J., 2017, CARDIAC ELECTROPHYSI, P1424; Schmid E, 2015, NAT MED, V21, P1298, DOI 10.1038/nm.3972; SIPIDO KR, 1995, CIRC RES, V76, P102, DOI 10.1161/01.RES.76.1.102; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Tacon CL, 2012, INTENS CARE MED, V38, P359, DOI 10.1007/s00134-011-2435-6; Wang G, 2010, CIRC RES, V106, P317, DOI 10.1161/CIRCRESAHA.109.208272; Wang JN, 2011, ARTERIOSCL THROM VAS, V31, pE19, DOI 10.1161/ATVBAHA.111.230706; Wang Y, 2014, J BIOL CHEM, V289, P14225, DOI 10.1074/jbc.M113.527671; Withers CN, 2017, BONE, V103, P270, DOI 10.1016/j.bone.2017.07.018; Yang TT, 2013, BBA-BIOMEMBRANES, V1828, P1644, DOI 10.1016/j.bbamem.2012.10.005; Zhang J, 2011, CARDIOVASC RES, V91, P90, DOI 10.1093/cvr/cvr068	50	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10913	10927		10.1074/jbc.RA119.008782	http://dx.doi.org/10.1074/jbc.RA119.008782			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31147441	Green Published, hybrid			2022-12-28	WOS:000478717200015
J	Choi, HC; Son, P; Xie, ZL; Wu, Y; Xu, J; Zhang, M; Dong, YZ; Wang, SX; Lau, K; Zou, MH				Choi, Hyoung Chul; Son, Ping; Xie, Zhonglin; Wu, Yong; Xu, Jian; Zhang, Miao; Dong, Yunzhou; Wang, Shuangxi; Lau, Kai; Zou, Ming-Hui			RETRACTION: Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo (Retraction of Vol 283, Pg 20186, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200	1	1	1	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10742	10742		10.1074/jbc.W119.009748	http://dx.doi.org/10.1074/jbc.W119.009748			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31278161	Green Published, hybrid			2022-12-28	WOS:000478717100035
J	Khadka, N; Farquhar, ER; Hill, HE; Shi, W; von Lintig, J; Kiser, PD				Khadka, Nimesh; Farquhar, Erik R.; Hill, Hannah E.; Shi, Wuxian; von Lintig, Johannes; Kiser, Philip D.			Evidence for distinct rate-limiting steps in the cleavage of alkenes by carotenoid cleavage dioxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; iron; crystallography; carotenoid; dioxygenase; non-heme iron; O-2 activation; solvent isotope effect; stilbenoid; X-ray absorption spectroscopy	SOLVENT ISOTOPE; MECHANISM; ENZYME; OXYGENASES; INSIGHTS	Carotenoid cleavage dioxygenases (CCDs) use a nonheme Fe(II) cofactor to split alkene bonds of carotenoid and stilbenoid substrates. The iron centers of CCDs are typically five-coordinate in their resting states, with solvent occupying an exchangeable site. The involvement of this iron-bound solvent in CCD catalysis has not been experimentally addressed, but computational studies suggest two possible roles. 1) Solvent dissociation provides a coordination site for O-2, or 2) solvent remains bound to iron but changes its equilibrium position to allow O-2 binding and potentially acts as a proton source. To test these predictions, we investigated isotope effects (H2O versus D2O) on two stilbenoid-cleaving CCDs, Novosphingobium aromaticivorans oxygenase 2 (NOV2) and Neurospora crassa carotenoid oxygenase 1 (CAO1), using piceatannol as a substrate. NOV2 exhibited an inverse isotope effect (k(H)/k(D) similar to 0.6) in an air-saturated buffer, suggesting that solvent dissociates from iron during the catalytic cycle. By contrast, CAO1 displayed a normal isotope effect (k(H)/k(D) similar to 1.7), suggesting proton transfer in the rate-limiting step. X-ray absorption spectroscopy on NOV2 and CAO1 indicated that the protonation states of the iron ligands are unchanged within pH 6.5-8.5 and that the Fe(II)-aquo bond is minimally altered by substrate binding. We pinpointed the origin of the differential kinetic behaviors of NOV2 and CAO1 to a single amino acid difference near the solvent-binding site of iron, and X-ray crystallography revealed that the substitution alters binding of diffusible ligands to the iron center. We conclude that solvent-iron dissociation and proton transfer are both associated with the CCD catalytic mechanism.	[Khadka, Nimesh; Hill, Hannah E.; von Lintig, Johannes; Kiser, Philip D.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Farquhar, Erik R.; Shi, Wuxian] Brookhaven Natl Lab, Natl Synchrotron Light Source 2, Upton, NY 11973 USA; [Farquhar, Erik R.; Shi, Wuxian] Case Western Reserve Univ, Ctr Proteom & Bioinformat, Ctr Synchrotron Biosci, Sch Med, Cleveland, OH 44106 USA; [Kiser, Philip D.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA	Case Western Reserve University; United States Department of Energy (DOE); Brookhaven National Laboratory; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Kiser, PD (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, 837 Hlth Sci Rd, Irvine, CA 92617 USA.	pkiser@uci.edu		Farquhar, Erik/0000-0002-6419-038X	National Institutes of Health (NIH) [GM103403, RR029205]; United States Department of Energy (DOE) [DE-AC02-06CH11357]; United States DOE Office of Science [DE-AC02-76SF00515]; NIH [P41-GM-103393, GM111244, EB009998]; DOE Office of Biological and Environmental Research Grant [KP1605010]; DOE Office of Science, Office of Basic Energy Sciences Program [DE-SC0012704 (Grant KC0401040)]; NATIONAL EYE INSTITUTE [R01EY009339, R01EY020551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002683] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy (DOE)(United States Department of Energy (DOE)); United States DOE Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Biological and Environmental Research Grant(United States Department of Energy (DOE)); DOE Office of Science, Office of Basic Energy Sciences Program(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work is based in part upon research conducted at the Advanced Photon Source Northeastern Collaborative Access Team beamline 24ID-E supported by National Institutes of Health (NIH) Grants GM103403 and RR029205 and United States Department of Energy (DOE) Contract DE-AC02-06CH11357. Use of SSRL beamlines 7-3 and 9-3 was made possible by the United States DOE Office of Science under Contract DE-AC02-76SF00515 to SLAC National Accelerator Laboratory and NIH Grant P41-GM-103393 (SSRL Structural Molecular Biology Program). Data for this study were measured at beamline 17-ID-2 (FMX) of the National Synchrotron Light Source-II, which is supported by NIH Grant GM111244 and DOE Office of Biological and Environmental Research Grant KP1605010. The NSLS-II is supported in part by the DOE Office of Science, Office of Basic Energy Sciences Program under Contract DE-SC0012704 (Grant KC0401040). The Case Center for Synchrotron Biosciences is supported by NIH Grant EB009998.	Al-Babili S, 2015, ANNU REV PLANT BIOL, V66, P161, DOI 10.1146/annurev-arplant-043014-114759; Borowski T, 2008, CHEM-EUR J, V14, P2264, DOI 10.1002/chem.200701344; Choi EH, 2018, HUM MOL GENET, V27, P2225, DOI 10.1093/hmg/ddy128; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flagg SC, 2012, BIOCHEMISTRY-US, V51, P6654, DOI 10.1021/bi300229y; Gadda G, 2013, FEBS LETT, V587, P2785, DOI 10.1016/j.febslet.2013.04.021; Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P926, DOI 10.1271/bbb.57.926; KARSTEN WE, 1995, J AM CHEM SOC, V117, P5914, DOI 10.1021/ja00127a002; KASSEBAUM JW, 1989, J AM CHEM SOC, V111, P2691, DOI 10.1021/ja00189a052; Khadka N, 2017, J AM CHEM SOC, V139, P13518, DOI 10.1021/jacs.7b07311; Kloer DP, 2006, CELL MOL LIFE SCI, V63, P2291, DOI 10.1007/s00018-006-6176-6; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kohen Amnon and Limbach Hans Heinrich, 2006, ISOTOPE EFFECTS CHEM, P995; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Loewen PC, 2018, BMC BIOCHEM, V19, DOI 10.1186/s12858-018-0098-4; McAndrew RP, 2016, P NATL ACAD SCI USA, V113, P14324, DOI 10.1073/pnas.1608917113; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Moise AR, 2005, TRENDS PLANT SCI, V10, P178, DOI 10.1016/j.tplants.2005.02.006; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neidig ML, 2005, CHEM COMMUN, P5843, DOI 10.1039/b510233m; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Scherzinger D, 2006, BIOCHEM J, V398, P361, DOI 10.1042/BJ20060592; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Sui XW, 2018, J BIOL INORG CHEM, V23, P887, DOI 10.1007/s00775-018-1586-0; Sui XW, 2017, BIOCHEMISTRY-US, V56, P2836, DOI 10.1021/acs.biochem.7b00251; Sui XW, 2015, J BIOL CHEM, V290, P30212, DOI 10.1074/jbc.M115.696799; Sui XW, 2014, J BIOL CHEM, V289, P12286, DOI 10.1074/jbc.M114.552836; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012; Sutherlin KD, 2018, J AM CHEM SOC, V140, P16495, DOI 10.1021/jacs.8b06517; VENKATASUBBAN KS, 1984, CRC CR REV BIOCH MOL, V17, P1, DOI 10.3109/10409238409110268; WEISS PM, 1987, BIOCHEMISTRY-US, V26, P7378, DOI 10.1021/bi00397a027; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wyss A, 2004, J NUTR, V134, p246S, DOI 10.1093/jn/134.1.246S	40	5	5	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10596	10606		10.1074/jbc.RA119.007535	http://dx.doi.org/10.1074/jbc.RA119.007535			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138651	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000478717100018
J	Liu, GY; Moon, SH; Jenkins, CM; Sims, HF; Guan, SP; Gross, RW				Liu, Gao-Yuan; Moon, Sung Ho; Jenkins, Christopher M.; Sims, Harold F.; Guan, Shaoping; Gross, Richard W.			Synthesis of oxidized phospholipids by sn-1 acyltransferase using 2-15-HETE lysophospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid synthesis; lipid peroxidation; acyltransferase; phospholipase A; phospholipid; lysophospholipid; stereoselectivity; mass spectrometry (MS); lipid metabolism; lipidomics; oxidized lysophospholipid; oxidized phospholipid; sn-1 acyltransferase	ESTERIFIED EICOSANOIDS; HUMAN PLATELETS; MITOCHONDRIAL; METABOLISM; OXIDATION; IDENTIFICATION; GLYCEROLIPIDS; IPLA(2)GAMMA; GENERATION; A(2)GAMMA	Recently, oxidized phospholipid species have emerged as important signaling lipids in activated immune cells and platelets. The canonical pathway for the synthesis of oxidized phospholipids is through the release of arachidonic acid by cytosolic phospholipase A(2)alpha (cPLA(2)alpha) followed by its enzymatic oxidation, activation of the carboxylate anion by acyl-CoA synthetase(s), and re-esterification to the sn-2 position by sn-2 acyltransferase activity (i.e. the Lands cycle). However, recent studies have demonstrated the unanticipated significance of sn-1 hydrolysis of arachidonoyl-containing choline and ethanolamine glycerophospholipids by other phospholipases to generate the corresponding 2-arachidonoyl-lysolipids. Herein, we identified a pathway for oxidized phospholipid synthesis comprising sequential sn-1 hydrolysis by a phospholipase A(1) (e.g. by patatin-like phospholipase domain-containing 8 (PNPLA8)), direct enzymatic oxidation of the resultant 2-arachidonoyl-lysophospholipids, and the esterification of oxidized 2-arachidonoyl-lysophospholipids by acyl-CoA-dependent sn-1 acyltransferase(s). To circumvent ambiguities associated with acyl migration or hydrolysis, we developed a synthesis for optically active (d- and l-enantiomers) nonhydrolyzable analogs of 2-arachidonoyl-lysophosphatidylcholine (2-AA-LPC). sn-1 acyltransferase activity in murine liver microsomes stereospecifically and preferentially utilized the naturally occurring l-enantiomer of the ether analog of lysophosphatidylcholine. Next, we demonstrated the high selectivity of the sn-1 acyltransferase activity for saturated acyl-CoA species. Importantly, we established that 2-15-hydroxyeicosatetraenoic acid (HETE) ether-LPC sn-1 esterification is markedly activated by thrombin treatment of murine platelets to generate oxidized PC. Collectively, these findings demonstrate the enantiomeric specificity and saturated acyl-CoA selectivity of microsomal sn-1 acyltransferase(s) and reveal its participation in a previously uncharacterized pathway for the synthesis of oxidized phospholipids with cell-signaling properties.	[Liu, Gao-Yuan; Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63110 USA; [Liu, Gao-Yuan; Moon, Sung Ho; Jenkins, Christopher M.; Sims, Harold F.; Guan, Shaoping; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dev Biol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Renter Cardiovasc Res, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [R01HL118639, R01HL133178]; Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133178, R01HL118639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01HL118639 and R01HL133178. R. W. G. has a financial relationship with Platomics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe A, 2006, J LIPID RES, V47, P2268, DOI 10.1194/jlr.M600183-JLR200; Aldrovandi M, 2013, J LIPID RES, V54, P3085, DOI 10.1194/jlr.M041533; AYANOGLU E, 1984, J AM CHEM SOC, V106, P5246, DOI 10.1021/ja00330a035; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Chu LH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03409-3; Clark SR, 2011, BLOOD, V117, P2033, DOI 10.1182/blood-2010-04-278887; Cotte AK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02732-5; Cowling BS, 2012, PLOS GENET, V8, P31, DOI 10.1371/journal.pgen.1002595; Eto M, 2012, INT J MOL SCI, V13, P16267, DOI 10.3390/ijms131216267; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Gaspard GJ, 2015, CHEM PHYS LIPIDS, V193, P1, DOI 10.1016/j.chemphyslip.2015.09.005; Huang X, 2017, J BIOL CHEM, V292, P14625, DOI 10.1074/jbc.M117.793901; Huang ZH, 2006, J AM CHEM SOC, V128, P60, DOI 10.1021/ja057024w; Hutchins PM, 2012, J LIPID RES, V53, P1588, DOI 10.1194/jlr.M026799; Jenkins CM, 2018, J BIOL CHEM, V293, P8693, DOI 10.1074/jbc.RA117.001629; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/NCHEMBIO.2238, 10.1038/nchembio.2238]; Kuosmanen SM, 2018, NUCLEIC ACIDS RES, V46, P1124, DOI 10.1093/nar/gkx1155; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1963, J BIOL CHEM, V238, P898; Lin S, 2015, J BIOL CHEM, V290, P18559, DOI 10.1074/jbc.M115.666701; Liu XP, 2016, CELL CHEM BIOL, V23, P1217, DOI 10.1016/j.chembiol.2016.08.009; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Morgan AH, 2009, J BIOL CHEM, V284, P21185, DOI 10.1074/jbc.M109.021634; O'Donnell VB, 2012, BLOOD, V120, P1985, DOI 10.1182/blood-2012-04-402826; Oehler B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05348-3; Pete MJ, 1996, J BIOL CHEM, V271, P18114, DOI 10.1074/jbc.271.30.18114; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Shayman JA, 2011, PROG LIPID RES, V50, P1, DOI 10.1016/j.plipres.2010.10.006; Slatter DA, 2016, CELL METAB, V23, P930, DOI 10.1016/j.cmet.2016.04.001; SNYDER JM, 1982, J AM OIL CHEM SOC, V59, P469, DOI 10.1007/BF02636144; Tabe S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16902-4; Thomas CP, 2010, J BIOL CHEM, V285, P6891, DOI 10.1074/jbc.M109.078428; TOMBO GMR, 1986, TETRAHEDRON LETT, V27, P5707, DOI 10.1016/S0040-4039(00)85306-X; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	39	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10146	10159		10.1074/jbc.RA119.008766	http://dx.doi.org/10.1074/jbc.RA119.008766			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31080170	hybrid, Green Published			2022-12-28	WOS:000474445600009
J	Sabalette, KB; Romaniuk, MA; Noe, G; Cassola, A; Campo, VA; De Gaudenzi, JG				Sabalette, Karina B.; Romaniuk, Maria Albertina; Noe, Griselda; Cassola, Alejandro; Campo, Vanina A.; De Gaudenzi, Javier G.			The RNA-binding protein TcUBP1 up-regulates an RNA regulon for a cell surface-associated Trypanosoma cruzi glycoprotein and promotes parasite infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA binding protein; RNA-protein interaction; RNA metabolism; gene regulation; trypanosome; post-transcriptional regulation; Chagas disease; RNA regulon; virulence	3' UNTRANSLATED REGION; MESSENGER-RNA; GENE-EXPRESSION; POSTTRANSCRIPTIONAL CONTROL; RICH ELEMENT; LIFE-CYCLE; BRUCEI; TRANSCRIPTS; STABILITY; SEQUENCE	The regulation of transcription in trypanosomes is unusual. To modulate protein synthesis during their complex developmental stages, these unicellular microorganisms rely largely on post-transcriptional gene expression pathways. These pathways include a plethora of RNA-binding proteins (RBPs) that modulate all steps of the mRNA life cycle in trypanosomes and help organize transcriptomes into clusters of post-transcriptional regulons. The aim of this work was to characterize an RNA regulon comprising numerous transcripts of trypomastigote-associated cell-surface glycoproteins that are preferentially expressed in the infective stages of the human parasite Trypanosoma cruzi. In vitro and in vivo RNA-binding assays disclosed that these glycoprotein mRNAs are targeted by the small trypanosomatid-exclusive RBP in T. cruzi, U-rich RBP 1 (TcUBP1). Overexpression of a GFP-tagged TcUBP1 in replicative parasites resulted in >10 times up-regulated expression of transcripts encoding surface proteins and in changes in their subcellular localization from the posterior region to the perinuclear region of the cytoplasm, as is typically observed in the infective parasite stages. Moreover, RT-quantitative PCR analysis of actively translated mRNAs by sucrose cushion fractionation revealed an increased abundance of these target transcripts in the polysome fraction of TcUBP1-induced samples. Because these surface proteins are involved in cell adherence or invasion during host infection, we also carried out in vitro infections with TcUBP1-transgenic trypomastigotes and observed that TcUBP1 overexpression significantly increases parasite infectivity. Our findings provide evidence for a role of TcUBP1 in trypomastigote stage-specific gene regulation important for T. cruzi virulence.	[Sabalette, Karina B.; Romaniuk, Maria Albertina; Noe, Griselda; Cassola, Alejandro; Campo, Vanina A.; De Gaudenzi, Javier G.] UNSAM CONICET, Inst Invest Biotecnol, RA-1650 San Martin, Buenos Aires, Argentina; [Romaniuk, Maria Albertina] UBA CONICET, Inst Invest Biomed Retrovirus & SIDA, Paraguay 2155, RA-1121 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Campo, VA; De Gaudenzi, JG (corresponding author), UNSAM CONICET, Inst Invest Biotecnol, RA-1650 San Martin, Buenos Aires, Argentina.	vcampo@iibintech.com.ar; jdegaudenzi@iib.unsam.edu.ar		Sabalette, Karina Belen/0000-0002-3869-949X	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2016-0235, PICT 2016-0465, PICT 2014-1798]; Research Career of CONICET; CONICET research fellowship	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Research Career of CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET research fellowship	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica Grants PICT 2016-0235 and PICT 2016-0465 (to J. G. D. G.) and PICT 2014-1798 (to V. A. C.); funds from the Research Career of CONICET (to M. A. R., A. C., V. A. C., and J. G. D. G.); and a CONICET research fellowship (to K. B. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Romaniuk MA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007059; Alcantara MV, 2018, MOL BIOCHEM PARASIT, V221, P1, DOI 10.1016/j.molbiopara.2018.01.006; Alvarez VE, 2012, BBA-PROTEINS PROTEOM, V1824, P195, DOI 10.1016/j.bbapap.2011.05.011; Alves LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081375; Alves LR, 2014, RNA BIOL, V11, P921, DOI 10.4161/rna.29622; Araujo PR, 2011, MEM I OSWALDO CRUZ, V106, P257, DOI 10.1590/S0074-02762011000300002; Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barderi P, 1998, BIOCHEM J, V330, P951, DOI 10.1042/bj3300951; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Bayer-Santos E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-127; Bayer-Santos E, 2012, ACTA TROP, V123, P230, DOI 10.1016/j.actatropica.2012.03.014; Belew AT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006767; Berna L, 2017, PEERJ, V5, DOI 10.7717/peerj.3017; Blackinton JG, 2014, SEMIN CELL DEV BIOL, V34, P44, DOI 10.1016/j.semcdb.2014.05.014; Callejas-Hernandez F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32877-2; Campos PC, 2008, INT J PARASITOL, V38, P1383, DOI 10.1016/j.ijpara.2008.07.001; Correa PRC, 2013, SCI WORLD J, DOI 10.1155/2013/156734; Chavez S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188441; D'Orso I, 2002, J BIOL CHEM, V277, P50520, DOI 10.1074/jbc.M209092200; D'Orso I, 2001, J BIOL CHEM, V276, P34801, DOI 10.1074/jbc.M102120200; Das A, 2015, MOL BIOCHEM PARASIT, V199, P1, DOI 10.1016/j.molbiopara.2015.02.003; Das A, 2012, RNA, V18, P1968, DOI 10.1261/rna.033829.112; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; De Gaudenzi JG, 2016, J EUKARYOT MICROBIOL, V63, P440, DOI 10.1111/jeu.12288; De Gaudenzi JG, 2013, PEERJ, V1, DOI 10.7717/peerj.118; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; De Gaudenzi JG, 2003, J BIOL CHEM, V278, P18884, DOI 10.1074/jbc.M301756200; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Fernandez-Moya SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048870; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; de Godoy LMF, 2012, PROTEOMICS, V12, P2694, DOI 10.1002/pmic.201200078; Freire ER, 2014, RNA, V20, P1272, DOI 10.1261/rna.045534.114; Freitas LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025914; Gil DPI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148131; Guerra-Slompo EP, 2012, BIOCHEM BIOPH RES CO, V420, P302, DOI 10.1016/j.bbrc.2012.02.154; Guerreiro A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0493-0; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Holzer TR, 2008, MOL BIOCHEM PARASIT, V157, P54, DOI 10.1016/j.molbiopara.2007.10.001; Jackson AP, 2015, PARASITOLOGY, V142, pS40, DOI 10.1017/S0031182014000894; Jager AV, 2007, P NATL ACAD SCI USA, V104, P2035, DOI 10.1073/pnas.0611125104; Jensen BC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-911; Jha BA, 2015, FEBS LETT, V589, P1966, DOI 10.1016/j.febslet.2015.05.036; Ji XJ, 2003, MOL CELL BIOL, V23, P899, DOI 10.1128/MCB.23.3.899-907.2003; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2014, NATL SCI REV, V1, P184, DOI 10.1093/nsr/nwu004; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Kolev NG, 2014, CELL MICROBIOL, V16, P482, DOI 10.1111/cmi.12268; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Li Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005511; Li ZH, 2012, J BIOL CHEM, V287, P19058, DOI 10.1074/jbc.M111.338699; Mansfield KD, 2009, BIOL CELL, V101, P169, DOI 10.1042/BC20080055; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; Michaeli S, 2014, CURR OPIN MICROBIOL, V20, P146, DOI 10.1016/j.mib.2014.06.006; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Mittal N, 2011, J MOL BIOL, V409, P466, DOI 10.1016/j.jmb.2011.03.064; Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Morris AR, 2010, WIRES SYST BIOL MED, V2, P162, DOI 10.1002/wsbm.54; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Noe G, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-107; Oliveira C, 2017, GENET MOL BIOL, V40, P22, DOI [10.1590/1678-4685-GMB-2016-0258, 10.1590/1678-4685-gmb-2016-0258]; Pascuale CA, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00430; Pastro L, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00008; Pastro L, 2013, EXP PARASITOL, V134, P511, DOI 10.1016/j.exppara.2013.04.004; Perez-Diaz L, 2017, MOL BIOCHEM PARASIT, V211, P1, DOI 10.1016/j.molbiopara.2016.12.005; Perez-Diaz L, 2013, BIOCHEM BIOPH RES CO, V436, P295, DOI 10.1016/j.bbrc.2013.05.096; Perez-Diaz L, 2012, MEM I OSWALDO CRUZ, V107, P1076, DOI 10.1590/S0074-02762012000800021; Rao SJ, 2017, J BIOSCIENCES, V42, P189, DOI 10.1007/s12038-016-9660-7; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Santos CMB, 2018, MEM I O CRUZ, V113; Singh A, 2014, NUCLEIC ACIDS RES, V42, P4652, DOI 10.1093/nar/gkt1416; Smircich P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1563-8; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; Tonelli RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027904	76	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10349	10364		10.1074/jbc.RA118.007123	http://dx.doi.org/10.1074/jbc.RA118.007123			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31113862	Green Published, hybrid			2022-12-28	WOS:000474445600024
J	[Anonymous]				[Anonymous]			Activation of AMP-activated protein kinase 1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and Survivin. (Expression of Concern of Vol 285, Pg 15346, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Liu C, 2010, J BIOL CHEM, V285, P15346, DOI 10.1074/jbc.M110.102491	1	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					10021	10021		10.1074/jbc.EC119.009567	http://dx.doi.org/10.1074/jbc.EC119.009567			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31227626	Green Published, hybrid			2022-12-28	WOS:000473277900034
J	Bhat, SP; Gangalum, RK; Kim, D; Mangul, S; Kashyap, RK; Zhou, XK; Elashoff, D				Bhat, Suraj P.; Gangalum, Rajendra K.; Kim, Dongjae; Mangul, Serghei; Kashyap, Raj K.; Zhou, Xinkai; Elashoff, David			Transcriptional profiling of single fiber cells in a transgenic paradigm of an inherited childhood cataract reveals absence of molecular heterogeneity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallin; lens; cataract; vision; transcription; gene expression; crystallin gene expression; genetic cataract; lens; single cells; spatial transcriptomics	LAMELLAR CATARACT; LENS DEVELOPMENT; HSF4; ALPHA; EXPRESSION; CRYSTALLINS; EYE; DIVERSITY; MUTATION; GROWTH	Our recent single-cell transcriptomic analysis has demonstrated that heterogeneous transcriptional activity attends molecular transition from the nascent to terminally differentiated fiber cells in the developing mouse lens. To understand the role of transcriptional heterogeneity in terminal differentiation and the functional phenotype (transparency) of this tissue, here we present a single-cell analysis of the developing lens, in a transgenic paradigm of an inherited pathology, known as the lamellar cataract. Cataracts hinder transmission of light into the eye. Lamellar cataract is the most prevalent bilateral childhood cataract. In this disease of early infancy, initially, the opacities remain confined to a few fiber cells, thus presenting an opportunity to investigate early molecular events that lead to cataractogenesis. We used a previously established paradigm that faithfully recapitulates this disease in transgenic mice. About 500 single fiber cells, manually isolated from a 2-day-old transgenic lens were interrogated individually for the expression of all known 17 crystallins and 78 other relevant genes using a Biomark HD (Fluidigm). We find that fiber cells from spatially and developmentally discrete regions of the transgenic (cataract) lens show remarkable absence of the heterogeneity of gene expression. Importantly, the molecular variability of cortical fiber cells, the hallmark of the WT lens, is absent in the transgenic cataract, suggesting absence of specific cell-type(s). Interestingly, we find a repetitive pattern of gene activity in progressive states of differentiation in the transgenic lens. This molecular dysfunction portends pathology much before the physical manifestations of the disease.	[Bhat, Suraj P.; Gangalum, Rajendra K.; Kim, Dongjae; Kashyap, Raj K.] Univ Calif Los Angeles, Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA; [Bhat, Suraj P.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Bhat, Suraj P.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Mangul, Serghei] Univ Calif Los Angeles, Dept Comp Sci & Human Genet, Los Angeles, CA 90095 USA; [Zhou, Xinkai; Elashoff, David] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bhat, SP (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA.; Bhat, SP (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA.; Bhat, SP (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	bhat@jsei.ucla.edu	huang, dezhi/ABC-6566-2021; Gangalum, Rajendra K/H-1369-2013	Bhat, Suraj P/0000-0003-4707-5870; Gangalum, Rajendra K/0000-0002-8746-0266; Kim, Dongjae/0000-0002-4911-5656	National Institutes of Health [1R01EY024929]; Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY024929, P30EY000331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant 1R01EY024929 (to S.P.B.) and by the Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund and by a Research to Prevent Blindness, Inc. unrestricted grant to the Department of Ophthalmology at UCLA. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bassnett S, 2017, PROG RETIN EYE RES, V60, P181, DOI 10.1016/j.preteyeres.2017.04.001; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat SP, 2003, PROG DRUG RES, V60, P205; Bhat SP, 2001, BIOSCIENCE REP, V21, P537, DOI 10.1023/A:1017952128502; Birkenfeld J, 2013, VISION RES, V86, P27, DOI 10.1016/j.visres.2013.04.004; Brennan LA, 2018, EXP EYE RES, V174, P173, DOI 10.1016/j.exer.2018.06.003; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Buenrostro JD, 2018, CELL, V173, P1535, DOI 10.1016/j.cell.2018.03.074; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Enoki Y, 2010, BBA-MOL BASIS DIS, V1802, P749, DOI 10.1016/j.bbadis.2010.06.001; Falls HF, 1943, ARCH OPHTHALMOL-CHIC, V29, P210, DOI 10.1001/archopht.1943.00880140056002; Forster JE, 2006, OPHTHAL PHYSL OPT, V26, P372, DOI 10.1111/j.1475-1313.2006.00370.x; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Gangalum RK, 2018, ISCIENCE, V10, P66, DOI 10.1016/j.isci.2018.11.024; Gangalum RK, 2014, INVEST OPHTH VIS SCI, V55, P7227, DOI 10.1167/iovs.14-14594; Gao M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.478; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Iribarren R, 2015, PROG RETIN EYE RES, V47, P86, DOI 10.1016/j.preteyeres.2015.02.002; Javadiyan Shari, 2016, BMC Res Notes, V9, P83, DOI 10.1186/s13104-016-1890-0; Jing Z, 2014, HUM MUTAT, V35, P1068, DOI 10.1002/humu.22610; Jing Z, 2013, CELL STRESS CHAPERON, V18, P377, DOI 10.1007/s12192-012-0386-7; Lein E, 2017, SCIENCE, V358, P64, DOI 10.1126/science.aan6827; Mahendiran K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05195; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; Mou LS, 2010, INVEST OPHTH VIS SCI, V51, P396, DOI 10.1167/iovs.09-3772; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; PIERSCIONEK B, 1987, VISION RES, V27, P1539, DOI 10.1016/0042-6989(87)90162-3; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shi XH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-10; Skelly DA, 2018, CELL REP, V22, P600, DOI 10.1016/j.celrep.2017.12.072; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Somasundaram T, 2000, J BIOL CHEM, V275, P17154, DOI 10.1074/jbc.M000304200; Somasundaram T, 2004, J BIOL CHEM, V279, P44497, DOI 10.1074/jbc.M405813200; Srivastava SK, 1997, INVEST OPHTH VIS SCI, V38, P2300; Symmons O, 2016, MOL CELL, V62, P788, DOI 10.1016/j.molcel.2016.05.023; Tan DWM, 2013, DEVELOPMENT, V140, P1433, DOI 10.1242/dev.087551; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Zhao HY, 2011, J MOL BIOL, V411, P680, DOI 10.1016/j.jmb.2011.06.007; Zhao WJ, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0066-3	45	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13530	13544		10.1074/jbc.RA119.008853	http://dx.doi.org/10.1074/jbc.RA119.008853			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31243103	Green Published, hybrid			2022-12-28	WOS:000486418600002
J	Ishizuka, S; Tsuchiya, S; Ohashi, Y; Terabe, K; Askew, EB; Ishizuka, N; Knudson, CB; Knudson, W				Ishizuka, Shinya; Tsuchiya, Saho; Ohashi, Yoshifumi; Terabe, Kenya; Askew, Emily B.; Ishizuka, Naoko; Knudson, Cheryl B.; Knudson, Warren			Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hyaluronan; chondrocyte; matrix metalloproteinase (MMP); metabolomics; osteoarthritis; inflammation; cartilage catabolism; hyaluronan synthase 2 (HAS2); aggrecan	MOLECULAR-WEIGHT HYALURONAN; ARTICULAR-CARTILAGE; PROTEOGLYCAN AGGREGATE; OSTEOARTHRITIS; EXPRESSION; METABOLISM; AGGRECAN; RECEPTOR; GROWTH; CD44	Osteoarthritis (OA) is a progressive degenerative disease of the joints caused in part by a change in the phenotype of resident chondrocytes within affected joints. This altered phenotype, often termed proinflammatory or procatabolic, features enhanced production of endoproteinases and matrix metallo-proteinases (MMPs) as well as secretion of endogenous inflammatory mediators. Degradation and reduced retention of the proteoglycan aggrecan is an early event in OA. Enhanced turnover of hyaluronan (HA) is closely associated with changes in aggrecan. Here, to determine whether experimentally increased HA production promotes aggrecan retention and generates a positive feedback response, we overexpressed HA synthase-2 (HAS2) in chondrocytes via an inducible adenovirus construct (HA synthase-2 viral overexpression; HAS2-OE). HAS2-OE incrementally increased high-molecular-mass HA >100-fold within the cell-associated and growth medium pools. More importantly, our results indicated that the HAS2-OE expression system inhibits MMP3, MMP13, and other markers of the procatabolic phenotype (such as TNF-stimulated gene 6 protein (TSG6)) and also enhances aggrecan retention. These markers were inhibited in OA-associated chondrocytes and in chondrocytes activated by interleukin-1 beta (IL1 beta), but also chondrocytes activated by lipopolysaccharide (LPS), tumor necrosis factor alpha (TNF alpha), or HA oligosaccharides. However, the enhanced extracellular HA resulting from HAS2-OE did not reduce the procatabolic phenotype of neighboring nontransduced chondrocytes as we had expected. Rather, HA-mediated inhibition of the phenotype occurred only in transduced cells. In addition, high HA biosynthesis rates, especially in transduced procatabolic chondrocytes, resulted in marked changes in chondrocyte dependence on glycolysis versus oxidative phosphorylation for their metabolic energy needs.	[Ishizuka, Shinya; Tsuchiya, Saho; Ohashi, Yoshifumi; Terabe, Kenya; Askew, Emily B.; Ishizuka, Naoko; Knudson, Cheryl B.; Knudson, Warren] East Carolina Univ, Dept Anat & Cell Biol, Brody Sch Med, 600 Moye Blvd,Mailstop 620, Greenville, NC 27834 USA; [Ishizuka, Shinya; Terabe, Kenya; Ishizuka, Naoko] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan	University of North Carolina; East Carolina University; Nagoya University	Knudson, W (corresponding author), East Carolina Univ, Dept Anat & Cell Biol, Brody Sch Med, 600 Moye Blvd,Mailstop 620, Greenville, NC 27834 USA.	knudsonw@ecu.edu		Ishizuka, Shinya/0000-0003-1877-9502	National Institutes of Health [R01-AR039507, R21-AR066581, R21-AR072682]; Mizutani Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR072682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported in part by National Institutes of Health Grants R01-AR039507 (to C. B. K.), R21-AR066581 (to W. K.), and R21-AR072682 (to W. K.) as well as a grant from the Mizutani Foundation (to W. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ariyoshi W, 2012, ARTHRITIS RHEUM-US, V64, P187, DOI 10.1002/art.33329; Ariyoshi W, 2010, J BIOL CHEM, V285, P36216, DOI 10.1074/jbc.M110.129270; Campo GM, 2011, BBA-MOL BASIS DIS, V1812, P1170, DOI 10.1016/j.bbadis.2011.06.006; Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Chanmee T, 2016, J BIOL CHEM, V291, P24105, DOI 10.1074/jbc.M116.751263; Chanmee T, 2014, J BIOL CHEM, V289, P26038, DOI 10.1074/jbc.M114.564120; Chou CH, 2018, OSTEOARTHR CARTILAGE, V26, P245, DOI 10.1016/j.joca.2017.10.019; Danielson BT, 2015, J BIOL CHEM, V290, P9555, DOI 10.1074/jbc.M115.643171; Durigova M, 2008, OSTEOARTHR CARTILAGE, V16, P98, DOI 10.1016/j.joca.2007.05.002; Durigova M, 2011, EUR CELLS MATER, V21, P31, DOI 10.22203/eCM.v021a03; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Flory JJE, 2006, ARTHRITIS RHEUM-US, V54, P443, DOI 10.1002/art.21623; FOSANG AJ, 1991, MATRIX, V11, P17, DOI 10.1016/S0934-8832(11)80223-4; Furuta J, 2017, J ORTHOP RES, V35, P331, DOI 10.1002/jor.23266; Goldberg VM, 2005, OSTEOARTHR CARTILAGE, V13, P216, DOI 10.1016/j.joca.2004.11.010; Goldring MB, 2015, CURR OPIN PHARMACOL, V22, P51, DOI 10.1016/j.coph.2015.03.004; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Hascall VC, 2014, MATRIX BIOL, V35, P14, DOI 10.1016/j.matbio.2014.01.014; Hirabara S, 2013, BIOCHEM BIOPH RES CO, V430, P519, DOI 10.1016/j.bbrc.2012.12.003; HOLMES MWA, 1988, BIOCHEM J, V250, P435, DOI 10.1042/bj2500435; Huang Y, 2016, MATRIX BIOL, V56, P74, DOI 10.1016/j.matbio.2016.04.002; Iacob S, 2006, INT J BIOCHEM CELL B, V38, P123, DOI 10.1016/j.biocel.2005.08.011; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Ishizuka S, 2016, J BIOL CHEM, V291, P12087, DOI 10.1074/jbc.M115.709683; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Knudson W, 2000, ARTHRITIS RHEUM-US, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H; Knudson W, 2019, MATRIX BIOL, V78-79, P32, DOI 10.1016/j.matbio.2018.02.005; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Liu-Bryan R, 2010, ARTHRITIS RHEUM-US, V62, P2004, DOI 10.1002/art.27475; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Mehlhorn AT, 2006, TISSUE ENG, V12, P2853, DOI 10.1089/ten.2006.12.2853; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Mobasheri A, 2017, NAT REV RHEUMATOL, V13, P302, DOI 10.1038/nrrheum.2017.50; MORALES TI, 1988, J BIOL CHEM, V263, P3632; Muto J, 2009, MOL IMMUNOL, V47, P449, DOI 10.1016/j.molimm.2009.08.026; NG CK, 1992, ARCH BIOCHEM BIOPHYS, V298, P70, DOI 10.1016/0003-9861(92)90095-E; Nishida Y, 1999, J BIOL CHEM, V274, P21893, DOI 10.1074/jbc.274.31.21893; Nishida Y, 2000, ARTHRITIS RHEUM, V43, P1315, DOI 10.1002/1529-0131(200006)43:6<1315::AID-ANR14>3.0.CO;2-#; Ohno S, 2006, J BIOL CHEM, V281, P17952, DOI 10.1074/jbc.M602750200; Orlowsky EW, 2015, J RHEUMATOL, V42, P363, DOI 10.3899/jrheum.140382; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasmussen TB, 2003, ARCH VIROL, V148, P2005, DOI 10.1007/s00705-003-0145-2; RIZKALLA G, 1992, J CLIN INVEST, V90, P2268, DOI 10.1172/JCI116113; Roughley Peter J, 2014, J Exp Orthop, V1, P8, DOI 10.1186/s40634-014-0008-7; Ruppert SM, 2014, IMMUNOL RES, V58, P186, DOI 10.1007/s12026-014-8495-2; Sandy JD, 2015, OSTEOARTHR CARTILAGE, V23, P1939, DOI 10.1016/j.joca.2015.03.027; Schmitz I, 2010, OSTEOARTHR CARTILAGE, V18, P447, DOI 10.1016/j.joca.2009.10.007; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Strand V, 2015, J PAIN RES, V8, P217, DOI 10.2147/JPR.S83076; Sztrolovics R, 2002, BIOCHEM J, V362, P473, DOI 10.1042/0264-6021:3620473; Terabe K, 2019, ARCH BIOCHEM BIOPHYS, V665, P1, DOI 10.1016/j.abb.2019.01.038; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	62	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13562	13579		10.1074/jbc.RA119.008567	http://dx.doi.org/10.1074/jbc.RA119.008567			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31270213	Green Published, hybrid			2022-12-28	WOS:000486418600005
J	Kelleher, ZT; Wang, CB; Forrester, MT; Foster, MW; Marshall, HE				Kelleher, Zachary T.; Wang, Chunbo; Forrester, Michael T.; Foster, Matthew W.; Marshall, Harvey E.			ERK-dependent proteasome degradation of Txnip regulates thioredoxin oxidoreductase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thioredoxin; extracellular-signal-regulated kinase (ERK); proteasome; ubiquitylation (ubiquitination); nitrosative stress; oxidative stress; epithelial cell	KAPPA-B ACTIVATION; INTERACTING PROTEIN; EPITHELIAL-CELLS; GENE-EXPRESSION; APOPTOSIS; ASSOCIATION; STRESS	Dynamic control of thioredoxin (Trx) oxidoreductase activity is essential for balancing the need of cells to rapidly respond to oxidative/nitrosative stress and to temporally regulate thiol-based redox signaling. We have previously shown that cytokine stimulation of the respiratory epithelium induces a precipitous decline in cell S-nitrosothiol, which depends upon enhanced Trx activity and proteasome-mediated degradation of Txnip (thioredoxin-interacting protein). We now show that tumor necrosis factor-alpha-induced Txnip degradation in A549 respiratory epithelial cells is regulated by the extracellular signal-regulated protein kinase (ERK) mitogen-activated protein kinase pathway and that ERK inhibition augments both intracellular reactive oxygen species and S-nitrosothiol. ERK-dependent Txnip ubiquitination and proteasome degradation depended upon phosphorylation of a PXTP motif threonine (Thr(349)) located within the C-terminal alpha-arrestin domain and proximal to a previously characterized E3 ubiquitin ligase-binding site. Collectively, these findings demonstrate the ERK mitogen-activated protein kinase pathway to be integrally involved in regulating Trx oxidoreductase activity and that the regulation of Txnip lifetime via ERK-dependent phosphorylation is an important mediator of this effect.	[Kelleher, Zachary T.; Wang, Chunbo; Foster, Matthew W.; Marshall, Harvey E.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA; [Foster, Matthew W.] Duke Univ, Med Ctr, Prote & Metabol Shared Resource, Durham, NC 27710 USA; [Forrester, Michael T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Duke University; Duke University; Harvard University; Massachusetts General Hospital	Marshall, HE (corresponding author), Duke Univ, Med Ctr, Box 2613, Durham, NC 27710 USA.	harvey.marshall@dm.duke.edu			National Institutes of Health [HL092994]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL092994 (to H. E. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Brindicci C, 2010, AM J RESP CRIT CARE, V181, P21, DOI 10.1164/rccm.200904-0493OC; Buckley S, 1999, AM J PHYSIOL-LUNG C, V277, pL159, DOI 10.1152/ajplung.1999.277.1.L159; Chen B, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.81; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Forrester MT, 2009, J BIOL CHEM, V284, P36160, DOI 10.1074/jbc.M109.057729; Foster MW, 2017, J PROTEOME RES, V16, P538, DOI 10.1021/acs.jproteome.6b00672; Foster MW, 2014, J PROTEOME RES, V13, P3722, DOI 10.1021/pr500307f; Frullanti E, 2012, INT J CANCER, V131, pE643, DOI 10.1002/ijc.27426; He XQ, 2012, MOL PHARMACOL, V82, P887, DOI 10.1124/mol.112.081133; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29196; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Ji SR, 2015, CELL RES, V25, P561, DOI 10.1038/cr.2015.30; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Kelleher ZT, 2014, J BIOL CHEM, V289, P3066, DOI 10.1074/jbc.M113.503938; Kim H, 2008, EXP MOL MED, V40, P167, DOI 10.3858/emm.2008.40.2.167; Kim SJ, 2002, J BIOL CHEM, V277, P1332, DOI 10.1074/jbc.M107231200; Kwon HJ, 2010, J IMMUNOL, V185, P3980, DOI 10.4049/jimmunol.1000990; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Liu YL, 2016, BIOCHEM J, V473, P179, DOI 10.1042/BJ20150830; Nishizawa K, 2011, CARCINOGENESIS, V32, P1459, DOI 10.1093/carcin/bgr137; Otaki Y, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002485; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Qiao SX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8014; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Yeh PY, 2004, J BIOL CHEM, V279, P26143, DOI 10.1074/jbc.M402362200; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	32	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13336	13343		10.1074/jbc.RA119.007733	http://dx.doi.org/10.1074/jbc.RA119.007733			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31320475	hybrid, Green Published			2022-12-28	WOS:000486417200011
J	Bashiri, G; Grove, TL; Hegde, SS; Lagautriere, T; Gerfen, GJ; Almo, SC; Squire, CJ; Blanchard, JS; Baker, EN				Bashiri, Ghader; Grove, Tyler L.; Hegde, Subray S.; Lagautriere, Thomas; Gerfen, Gary J.; Almo, Steven C.; Squire, Christopher J.; Blanchard, John S.; Baker, Edward N.			The active site of the Mycobacterium tuberculosis branched-chain amino acid biosynthesis enzyme dihydroxyacid dehydratase contains a 2Fe-2S cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; iron-sulfur protein; crystal structure; protein structure; Mycobacterium tuberculosis; protein stability; dihydroxyacid dehydratase	IRON-SULFUR PROTEIN; CRYSTAL; VALIDATION; REFINEMENT; ACONITASE; GROWTH	Iron-sulfur clusters are protein cofactors with an ancient evolutionary origin. These clusters are best known for their roles in redox proteins such as ferredoxins, but some iron-sulfur clusters have nonredox roles in the active sites of enzymes. Such clusters are often prone to oxidative degradation, making the enzymes difficult to characterize. Here we report a structural and functional characterization of dihydroxyacid dehydratase (DHAD) from Mycobacterium tuberculosis (Mtb), an essential enzyme in the biosynthesis of branched-chain amino acids. Conducting this analysis under fully anaerobic conditions, we solved the DHAD crystal structure, at 1.88 angstrom resolution, revealing a 2Fe-2S cluster in which one iron ligand is a potentially exchangeable water molecule or hydroxide. UV and EPR spectroscopy both suggested that the substrate binds directly to the cluster or very close to it. Kinetic analysis implicated two ionizable groups in the catalytic mechanism, which we postulate to be Ser-491 and the iron-bound water/hydroxide. Site-directed mutagenesis showed that Ser-491 is essential for activity, and substrate docking indicated that this residue is perfectly placed for proton abstraction. We found that a bound Mg2+ ion 6.5 angstrom from the 2Fe-2S cluster plays a key role in substrate binding. We also identified a putative entry channel that enables access to the cluster and show that Mtb-DHAD is inhibited by a recently discovered herbicide, aspterric acid, that, given the essentiality of DHAD for Mtb survival, is a potential lead compound for the design of novel anti-TB drugs.	[Bashiri, Ghader; Lagautriere, Thomas; Squire, Christopher J.; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand; [Bashiri, Ghader; Lagautriere, Thomas; Squire, Christopher J.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Grove, Tyler L.; Hegde, Subray S.; Gerfen, Gary J.; Almo, Steven C.; Blanchard, John S.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10805 USA	University of Auckland; University of Auckland; Yeshiva University; Albert Einstein College of Medicine	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz	Bashiri, Ghader/R-4957-2017	Bashiri, Ghader/0000-0002-5092-3749; Baker, Edward/0000-0003-2456-7661	Tertiary Education Commission of New Zealand (Centre of Research Excellence fund); Health Research Council of New Zealand program grant; Hercus Health Research Fellowship; National Institutes of Health [RO1-060899, R21-AI133329, P01-GM118303-01, U54-GM093342, U54-GM094662]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI133329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM118303] Funding Source: NIH RePORTER	Tertiary Education Commission of New Zealand (Centre of Research Excellence fund); Health Research Council of New Zealand program grant; Hercus Health Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Tertiary Education Commission of New Zealand (Centre of Research Excellence funding to the Maurice Wilkins Centre); a Health Research Council of New Zealand program grant (to E. N. B.); a Hercus Health Research Fellowship (to G. B.); and National Institutes of Health Grants RO1-060899 (to J. S. B.), R21-AI133329 (to T. L. G. and S. C. A.), P01-GM118303-01 (to J. A. Gerlt and S. C. A.), U54-GM093342 (to J. A. Gerlt and S. C. A.), and U54-GM094662 (to S. C. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ARMSTRONG FB, 1977, BIOCHIM BIOPHYS ACTA, V498, P282, DOI 10.1016/0304-4165(77)90266-5; Bak DW, 2014, CURR OPIN CHEM BIOL, V19, P50, DOI 10.1016/j.cbpa.2013.12.015; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Booth MPS, 2010, PROTEIN EXPRES PURIF, V74, P204, DOI 10.1016/j.pep.2010.07.010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Duan XW, 2009, BIOCHEM J, V417, P783, DOI 10.1042/BJ20081423; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flint DH, 1996, CHEM REV, V96, P2315, DOI 10.1021/cr950041r; FLINT DH, 1993, J BIOL CHEM, V268, P14732; FLINT DH, 1988, J BIOL CHEM, V263, P3558; Franco TMA, 2017, BIOCHEMISTRY-US, V56, P5849, DOI 10.1021/acs.biochem.7b00849; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LAUBLE H, 1992, BIOCHEMISTRY-US, V31, P2735, DOI 10.1021/bi00125a014; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; MYERS JW, 1961, J BIOL CHEM, V236, P1414; Orme-Johnson NR, 1982, METAL IONS BIOL SERI, V4, P67; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rahman MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19192-6; Rahman MM, 2017, ACS CHEM BIOL, V12, P1919, DOI 10.1021/acschembio.7b00304; RIESKE JS, 1964, BIOCHEM BIOPH RES CO, V15, P338, DOI 10.1016/0006-291X(64)90171-8; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schneider D, 2005, BBA-BIOENERGETICS, V1710, P1, DOI 10.1016/j.bbabio.2005.09.003; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Singh V, 2011, MICROBIOL-SGM, V157, P38, DOI 10.1099/mic.0.042358-0; TSUDA Y, 1978, J CHEM SOC CHEM COMM, P160, DOI 10.1039/c39780000160; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yan Y, 2018, NATURE, V559, P416, DOI 10.1038/s41586-018-0319-4	31	10	10	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13158	13170		10.1074/jbc.RA119.009498	http://dx.doi.org/10.1074/jbc.RA119.009498			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31315931	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000486416000024
J	Jo, S; Lockridge, A; Alejandro, EU				Jo, Seokwon; Lockridge, Amber; Alejandro, Emilyn U.			eIF4G1 and carboxypeptidase E axis dysregulation in O-GlcNAc transferase- deficient pancreatic beta-cells contributes to hyperproinsulinemia in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); insulin synthesis; post-translational modification (PTM); diabetes; Chop; eIF4G1; ER-stress; hyperproinsulinemia; islet	LINKED N-ACETYLGLUCOSAMINE; ACUTE INSULIN-RESPONSE; ENDOPLASMIC-RETICULUM; INTACT PROINSULIN; GLUCOSE; GLCNACYLATION; GLYCOSYLATION; RESISTANCE; SECRETION; PROTEINS	An early hallmark of type 2 diabetes is a failure of proinsulin-to-insulin processing in pancreatic beta-cells, resulting in hyperproinsulinemia. Proinsulin processing is quite sensitive to nutrient flux, and beta-cell-specific deletion of the nutrient-sensing protein modifier OGlcNAc transferase (beta OGTKO) causes beta-cell failure and diabetes, including early development of hyperproinsulinemia. The mechanisms underlying this latter defect are unknown. Here, using several approaches, including site-directed mutagenesis, Click O-GlcNAc labeling, immunoblotting, and immunofluorescence and EM imaging, we provide the first evidence for a relationship between the O-GlcNAcylation of eukaryotic translation initiation factor 4 gamma 1 (eIF4G1) and carboxypeptidase E (CPE)-dependent proinsulin processing in beta OGTKO mice. We first established that beta OGTKO hyperproinsulinemia is independent of age, sex, glucose levels, and endoplasmic reticulum-CCAAT enhancer-binding protein homologous protein (CHOP)-mediated stress status. Of note, OGT loss was associated with a reduction in beta-cell-resident CPE, and genetic reconstitution of CPE in beta OGTKO islets rescued the dysfunctional proinsulin-to-insulin ratio. We show that although CPE is not directly OGlcNAc modified in islets, overexpression of the suspected OGT target eIF4G1, previously shown to regulate CPE translation in beta-cells, increases islet CPE levels, and fully reverses beta OGTKO islet-induced hyperproinsulinemia. Furthermore, our results reveal that OGT O-GlcNAc-modifies eIF4G1 at Ser-61 and that this modification is critical for eIF4G1 protein stability. Together, these results indicate a direct link between nutrient-sensitive OGT and insulin processing, underscoring the importance of post-translational O-GlcNAc modification in general cell physiology.	[Jo, Seokwon; Lockridge, Amber; Alejandro, Emilyn U.] Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Alejandro, EU (corresponding author), Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	ealejand@umn.edu		Lockridge, Amber/0000-0003-1122-6286; Jo, Seokwon/0000-0002-8989-4893	National Institutes of Health, NIDDK [K01 DK103823, R21 DK112144, R03 DK114465, R01 DK115720, F31 DK113694, 5T32DK083250]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK112144, K01DK103823, T32DK083250, R03DK114465, R01DK115720, F31DK113694] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health, NIDDK Grants K01 DK103823, R21 DK112144, R03 DK114465, and R01 DK115720 (to E.U. A.), and F31 DK113694, 5T32DK083250 (to A. L). E.U. A. is the guarantor of this work. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alejandro EU, 2015, CELL REP, V13, P2527, DOI 10.1016/j.celrep.2015.11.020; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Blandino-Rosano M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16014; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Bravo R, 2013, INT REV CEL MOL BIO, V301, P215, DOI 10.1016/B978-0-12-407704-1.00005-1; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Chu KY, 2011, ISLETS, V3, P155, DOI 10.4161/isl.3.4.15767; de Queiroz RM, 2016, J BIOL CHEM, V291, P18897, DOI 10.1074/jbc.M116.734533; Dhanvantari S, 2002, BIOCHEMISTRY-US, V41, P52, DOI 10.1021/bi015698n; FRICKER LD, 1990, J BIOL CHEM, V265, P2476; Furuta M, 1998, J BIOL CHEM, V273, P3431, DOI 10.1074/jbc.273.6.3431; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; GELDING SV, 1995, CLIN ENDOCRINOL, V42, P255, DOI 10.1111/j.1365-2265.1995.tb01873.x; Gomez E, 2004, J BIOL CHEM, V279, P53937, DOI 10.1074/jbc.M408682200; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Liew CW, 2014, P NATL ACAD SCI USA, V111, pE2319, DOI 10.1073/pnas.1323066111; Liu M, 2014, VITAM HORM, V95, P35, DOI 10.1016/B978-0-12-800174-5.00002-8; Lockridge AD, 2016, ISLETS, V8, P195, DOI 10.1080/19382014.2016.1260797; Ma JF, 2013, EXPERT REV PROTEOMIC, V10, P365, DOI 10.1586/14789450.2013.820536; Mykkanen L, 1999, DIABETOLOGIA, V42, P1060, DOI 10.1007/s001250051271; NAGAMATSU S, 1987, ENDOCRINOLOGY, V120, P1225, DOI 10.1210/endo-120-4-1225; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Pfutzner A, 2004, DIABETES CARE, V27, P682, DOI 10.2337/diacare.27.3.682; Roder ME, 1999, DIABETES CARE, V22, P609, DOI 10.2337/diacare.22.4.609; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Varlamov O, 1997, ENDOCRINOLOGY, V138, P4883, DOI 10.1210/en.138.11.4883; Xu SL, 2017, P NATL ACAD SCI USA, V114, pE1536, DOI 10.1073/pnas.1610452114; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Zethelius B, 2003, DIABETOLOGIA, V46, P20, DOI 10.1007/s00125-002-0995-2; Zhang XQ, 2018, NAT CHEM BIOL, V14, P909, DOI 10.1038/s41589-018-0120-6	39	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13040	13050		10.1074/jbc.RA119.008670	http://dx.doi.org/10.1074/jbc.RA119.008670			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31300553	hybrid, Green Published			2022-12-28	WOS:000486416000015
J	LaRock, DL; Sands, JS; Ettouati, E; Richard, M; Bushway, PJ; Adler, ED; Nizet, V; LaRock, CN				LaRock, Doris L.; Sands, Jenna S.; Ettouati, Ethan; Richard, Marine; Bushway, Paul J.; Adler, Eric D.; Nizet, Victor; LaRock, Christopher N.			Inflammasome inhibition blocks cardiac glycoside cell toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; cardiomyocyte; macrophage; IL-1; cell death; caspase 1 (CASP1); cardiac glycoside	NLRP3 INFLAMMASOME; NERIUM-OLEANDER; HEART-FAILURE; DIGOXIN; ACTIVATION; MORTALITY; ASSOCIATION; RECRUITMENT; PYROPTOSIS; IL-1-BETA	Chronic heart failure and cardiac arrhythmias have high morbidity and mortality, and drugs for the prevention and management of these diseases are a large part of the pharmaceutical market. Among these drugs are plant-derived cardiac glycosides, which have been used by various cultures over millennia as both medicines and poisons. We report that digoxin and related compounds activate the NLRP3 inflammasome in macrophages and cardiomyocytes at concentrations achievable during clinical use. Inflammasome activation initiates the maturation and release of the inflammatory cytokine IL-1 beta and the programmed cell death pathway pyroptosis in a caspase-1-dependent manner. Notably, the same fluxes of potassium and calcium cations that affect heart contraction also induce inflammasome activation in human but not murine cells. Pharmaceuticals that antagonize these fluxes, including glyburide and verapamil, also inhibit inflammasome activation by cardiac glycosides. Cardiac glycoside-induced cellular cytotoxicity and IL-1 beta signaling are likewise antagonized by inhibitors of the NLRP3 inflammasome or the IL-1 receptor-targeting biological agent anakinra. Our results inform on the molecular mechanism by which the inflammasome integrates the diverse signals that activate it through secondary signals like cation flux. Furthermore, this mechanism suggests a contribution of the inflammasome to the toxicity and adverse events associated with cardiac glycosides use in humans and that targeted anti-inflammatories could provide an additional adjunct therapeutic countermeasure.	[LaRock, Doris L.; Ettouati, Ethan; Richard, Marine; Nizet, Victor; LaRock, Christopher N.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [LaRock, Doris L.; Ettouati, Ethan; Richard, Marine; Nizet, Victor; LaRock, Christopher N.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Richard, Marine] Inst Superieur Sante & Bioproduits, F-49000 Angers, France; [Bushway, Paul J.; Adler, Eric D.] Univ Calif San Diego, Dept Cardiovasc Med, La Jolla, CA 92093 USA; [LaRock, Doris L.; Sands, Jenna S.; LaRock, Christopher N.] Emory Sch Med, Dept Microbiol & Immunol, Atlanta, GA USA; [LaRock, Doris L.; Sands, Jenna S.; LaRock, Christopher N.] Emory Sch Med, Dept Med, Atlanta, GA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Emory University; Emory University	Nizet, V (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr,Mail Code 0760, La Jolla, CA 92093 USA.; LaRock, CN (corresponding author), Emory Univ, Sch Med, 1510 Clifton Rd NE,Ste 3019, Atlanta, GA 30322 USA.	vnizet@ucsd.edu; christopher.larock@emory.edu	LaRock, Christopher/E-1554-2013; Nizet, Victor/AAF-3190-2019	LaRock, Christopher/0000-0003-3035-5331; Nizet, Victor/0000-0003-3847-0422; LaRock, Doris/0000-0002-2661-6853; Sands, Jenna/0000-0001-9107-7780	NICHD, National Institutes of Health [HD090259]; NIAID, National Institutes of Health [AI130223]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI130223] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NICHD, National Institutes of Health Grant HD090259 (to V.N.) and NIAID, National Institutes of Health Grant AI130223 (to C. N. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed A, 2006, EUR HEART J, V27, P178, DOI 10.1093/eurheartj/ehi687; Ainscough JS, 2015, J BIOL CHEM, V290, P31151, DOI 10.1074/jbc.M115.680694; Aslani MR, 2007, IRAN J VETERINARY RE, V8, P58; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Chao MW, 2017, SCI REP-UK, V7, DOI 10.1038/srep46134; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; COLTART J, 1972, BMJ-BRIT MED J, V2, P318, DOI 10.1136/bmj.2.5809.318; Dawson A. H., 2016, MEDICINE, V44, P158, DOI [10.1016/j.mpmed.2015.12.006, DOI 10.1016/J.MPMED.2015.12.006]; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; ESPOSITO AL, 1988, J INFECT DIS, V157, P1084, DOI 10.1093/infdis/157.5.1084; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; GUPTA RS, 1986, J CELL PHYSIOL, V127, P197, DOI 10.1002/jcp.1041270202; Hensler ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002446; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Ip WKE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7931; KARJALAINEN J, 1974, ACTA PHARMACOL TOX, V34, P385; Karthikeyan G, 2019, HEART, V105, P363, DOI 10.1136/heartjnl-2018-313614; KELLY RA, 1992, AM J CARDIOL, V69, pG108, DOI 10.1016/0002-9149(92)91259-7; KINLAY S, 1995, J TOXICOL-CLIN TOXIC, V33, P55, DOI 10.3109/15563659509020216; Kobayashi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176676; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; LaRock CN, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3539; LaRock CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003793; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; LEOR J, 1995, CARDIOVASC DRUG THER, V9, P723, DOI 10.1007/BF00878556; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Perry G, 1997, NEW ENGL J MED, V336, P525; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Roberts DM, 2016, BRIT J CLIN PHARMACO, V81, P488, DOI 10.1111/bcp.12814; SCHWARTZ WL, 1974, VET PATHOL, V11, P259, DOI 10.1177/030098587401100307; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Van Tassell BW, 2013, CIRCULATION, V128, P1910, DOI 10.1161/CIRCULATIONAHA.113.003199; Withering W, 1785, ACCOUNT FOXGLOVE SOM; WOOLF AD, 1992, NEW ENGL J MED, V326, P1739, DOI 10.1056/NEJM199206253262604; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; YAMATO K, 1989, J CELL PHYSIOL, V139, P610, DOI 10.1002/jcp.1041390322; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Yang QF, 2005, P NATL ACAD SCI USA, V102, P9631, DOI 10.1073/pnas.0504097102; Yaron JR, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.277	53	7	7	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12846	12854		10.1074/jbc.RA119.008330	http://dx.doi.org/10.1074/jbc.RA119.008330			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31300552	hybrid, Green Published			2022-12-28	WOS:000484414600025
J	Ardestani, G; West, MC; Maresca, TJ; Fissore, RA; Stratton, MM				Ardestani, Goli; West, Megan C.; Maresca, Thomas J.; Fissore, Rafael A.; Stratton, Margaret M.			FRET-based sensor for CaMKII activity (FRESCA): A useful tool for assessing CaMKII activity in response to Ca2+ oscillations in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ca2+; calmodulin-dependent protein kinase II (CaMKII); calcium imaging; biosensor; fertilization; phosphorylation; Camui; fertility; FRESCA (FRET-based sensor for CaMKII activity); reporter	DEPENDENT PROTEIN-KINASE; MOUSE OOCYTES; PLC-ZETA; CALCIUM; EGG; FERTILIZATION; PHOSPHORYLATION; ACTIVATION; DOMAIN; AUTOPHOSPHORYLATION	Ca2+ oscillations and consequent Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation are required for embryogenesis, as well as neuronal, immunological, and cardiac signaling. Fertilization directly results in Ca2+ oscillations, but the resultant pattern of CaMKII activity remains largely unclear. To address this gap, we first employed the one existing biosensor for CaMKII activation. This sensor, Camui, comprises CaMKII alpha and therefore solely reports on the activation of this CaMKII variant. Additionally, to detect the activity of all endogenous CaMKII variants simultaneously, we constructed a substrate-based sensor for CaMKII activity, FRESCA (FRET-based sensor for CaMKII activity). To examine the differential responses of the Camui and FRESCA sensors, we used several approaches to stimulate Ca2+ release in mouse eggs, including addition of phospholipase C zeta cRNA, which mimics natural fertilization. We found that the Camui response is delayed or terminates earlier than the FRESCA response. FRESCA enables assessment of endogenous CaMKII activity in real-time by both fertilization and artificial reagents, such as Sr2+, which also leads to CaMKII activation. FRESCA's broad utility will be important for optimizing artificial CaMKII activation for clinical use to manage infertility. Moreover, FRESCA provides a new view on CaMKII activity, and its application in additional biological systems may reveal new signaling paradigms in eggs, as well as in neurons, cardiomyocytes, immune cells, and other CaMKII-expressing cells.	[Ardestani, Goli; Fissore, Rafael A.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Ardestani, Goli] Univ Massachusetts, Vet & Anim Sci Grad Program, Amherst, MA 01003 USA; [West, Megan C.; Stratton, Margaret M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Maresca, Thomas J.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Stratton, MM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	mstratton@biochem.umass.edu		Stratton, Margaret/0000-0003-2686-9022; Ardestani, Goli/0000-0002-2599-5361	University of Massachusetts, Amherst; National Institutes of Health, NIGMS [5R01GM123157]; National Institutes of Health, NICHD [HD051872, HD092499]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD092499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123157, R01GM107026] Funding Source: NIH RePORTER	University of Massachusetts, Amherst; National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Massachusetts, Amherst, and National Institutes of Health, NIGMS Grant 5R01GM123157 (to M. M. S.) and NICHD Grants HD051872 and HD092499 (to R. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Bhattacharyya M, 2016, ELIFE, V5, DOI [10.7554/eLife.13405, 10.7554/eLife.13045]; BOSMIKICH A, 1995, MOL REPROD DEV, V42, P254, DOI 10.1002/mrd.1080420215; Brooks IM, 2011, J BIOL CHEM, V286, P6697, DOI 10.1074/jbc.M110.183558; Carvacho I, 2013, CELL REP, V5, P1375, DOI 10.1016/j.celrep.2013.11.007; Chang HY, 2009, DEVELOPMENT, V136, P4077, DOI 10.1242/dev.042143; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; CUTHBERTSON KSR, 1981, NATURE, V294, P754, DOI 10.1038/294754a0; CUTHBERTSON KSR, 1985, NATURE, V316, P541, DOI 10.1038/316541a0; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Deguchi R, 2000, DEV BIOL, V218, P299, DOI 10.1006/dbio.1999.9573; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; Ducibella T, 2006, SEMIN CELL DEV BIOL, V17, P324, DOI 10.1016/j.semcdb.2006.02.010; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Eisner DA, 2017, CIRC RES, V121, P181, DOI 10.1161/CIRCRESAHA.117.310230; Escoffier J, 2016, HUM MOL GENET, V25, P878, DOI 10.1093/hmg/ddv617; FISSORE RA, 1992, BIOL REPROD, V47, P960, DOI 10.1095/biolreprod47.6.960; Gangeswaran R, 1997, FEBS LETT, V412, P309, DOI 10.1016/S0014-5793(97)00782-5; Gonzalez-Garcia JR, 2013, J CELL PHYSIOL, V228, P110, DOI 10.1002/jcp.24110; Gou XB, 2018, J MOL CELL CARDIOL, V116, P165, DOI 10.1016/j.yjmcc.2018.02.010; Halet G, 2004, BBA-MOL CELL RES, V1742, P185, DOI 10.1016/j.bbamcr.2004.09.012; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; Hatch KR, 2001, MOL REPROD DEV, V58, P69, DOI 10.1002/1098-2795(200101)58:1&lt;69::AID-MRD10&gt;3.0.CO;2-O; Herring BE, 2016, ANNU REV PHYSIOL, V78, P351, DOI 10.1146/annurev-physiol-021014-071753; KIKKAWA U, 1982, J BIOL CHEM, V257, P13341; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Kurokawa M, 2007, DEV BIOL, V312, P407, DOI 10.1016/j.ydbio.2007.09.040; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; Markoulaki S, 2004, DEV BIOL, V272, P15, DOI 10.1016/j.ydbio.2004.04.008; Matsu-ura T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40931-w; Medvedev S, 2014, CELL CYCLE, V13, P1482, DOI 10.4161/cc.28432; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Miao YL, 2012, P NATL ACAD SCI USA, V109, P4169, DOI 10.1073/pnas.1112333109; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; Neef S, 2018, J MOL CELL CARDIOL, V115, P73, DOI 10.1016/j.yjmcc.2017.12.015; Ozil JP, 2005, DEV BIOL, V282, P39, DOI 10.1016/j.ydbio.2005.02.035; Presler M, 2017, P NATL ACAD SCI USA, V114, pE10838, DOI 10.1073/pnas.1709207114; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; RUTECKI PA, 1992, J CLIN NEUROPHYSIOL, V9, P195, DOI 10.1097/00004691-199204010-00003; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Stratton M, 2014, ELIFE, V3, DOI 10.7554/eLife.01610; Suzuki M, 2011, DEVELOPMENT, V138, P385, DOI 10.1242/dev.062976; Suzuki T, 2010, DEVELOPMENT, V137, P3281, DOI 10.1242/dev.052480; Swann K, 2013, CELL CALCIUM, V53, P55, DOI 10.1016/j.ceca.2012.11.001; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang SF, 2010, P NATL ACAD SCI USA, V107, P17639, DOI 10.1073/pnas.1013185107; Wong MH, 2019, J MOL BIOL, V431, P1440, DOI 10.1016/j.jmb.2019.02.001; Wu JQ, 2008, J CELL SCI, V121, P3509, DOI 10.1242/jcs.036855; Yoon SY, 2008, J CLIN INVEST, V118, P3671, DOI 10.1172/JCI36942	55	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11876	11891		10.1074/jbc.RA119.009235	http://dx.doi.org/10.1074/jbc.RA119.009235			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31201271	Green Published, hybrid			2022-12-28	WOS:000486127800023
J	Eguchi, S; Takefuji, M; Sakaguchi, T; Ishihama, S; Mori, Y; Tsuda, T; Takikawa, T; Yoshida, T; Ohashi, K; Shimizu, Y; Hayashida, R; Kondo, K; Bando, YK; Ouchi, N; Murohara, T				Eguchi, Shunsuke; Takefuji, Mikito; Sakaguchi, Teruhiro; Ishihama, Sohta; Mori, Yu; Tsuda, Takuma; Takikawa, Tomonobu; Yoshida, Tatsuya; Ohashi, Koji; Shimizu, Yuuki; Hayashida, Ryo; Kondo, Kazuhisa; Bando, Yasuko K.; Ouchi, Noriyuki; Murohara, Toyoaki			Cardiomyocytes capture stem cell-derived, anti-apoptotic microRNA-214 via clathrin-mediated endocytosis in acute myocardial infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); endocytosis; cardiomyocyte; clathrin; extracellular vesicles; myocardial infarction; ischemia; heart health; microRNA-214; paracrine signaling	CARDIAC MYOCYTES; HEART-FAILURE; EXOSOMES; PHOSPHORYLATION; INFLAMMATION; PROTEIN-2; OVERLOAD; PROTECTS; THERAPY; RUPTURE	Extracellular vesicles (EVs) have emerged as key mediators of intercellular communication that have the potential to improve cardiac function when used in cell-based therapy. However, the means by which cardiomyocytes respond to EVs remains unclear. Here, we sought to clarify the role of exosomes in improving cardiac function by investigating the effect of cardiomyocyte endocytosis of exosomes from mesenchymal stem cells on acute myocardial infarction (MI). Exposing cardiomyocytes to the culture supernatant of adipose-derived regenerative cells (ADRCs) prevented cardiomyocyte cell damage under hypoxia in vitro. In vivo, the injection of ADRCs into the heart simultaneous with coronary artery ligation decreased overall cardiac infarct area and prevented cardiac rupture after acute MI. Quantitative RT-PCR-based analysis of the expression of 35 known anti-apoptotic and secreted microRNAs (miRNAs) in ADRCs revealed that ADRCs express several of these miRNAs, among which miR-214 was the most abundant. Of note, miR-214 silencing in ADRCs significantly impaired the anti-apoptotic effects of the ADRC treatment on cardiomyocytes in vitro and in vivo. To examine cardiomyocyte endocytosis of exosomes, we cultured the cardiomyocytes with ADRC-derived exosomes labeled with the fluorescent dye PKH67 and found that hypoxic culture conditions increased the levels of the labeled exosomes in cardiomyocytes. Chlorpromazine, an inhibitor of clathrin-mediated endocytosis, significantly suppressed the ADRC-induced decrease of hypoxia-damaged cardiomyocytes and also decreased hypoxia-induced cardiomyocyte capture of both labeled EVs and extracellular miR-214 secreted from ADRCs. Our results indicate that clathrin-mediated endocytosis in cardiomyocytes plays a critical role in their uptake of circulating, exosome-associated miRNAs that inhibit apoptosis.	[Eguchi, Shunsuke; Takefuji, Mikito; Sakaguchi, Teruhiro; Ishihama, Sohta; Mori, Yu; Tsuda, Takuma; Takikawa, Tomonobu; Yoshida, Tatsuya; Ohashi, Koji; Shimizu, Yuuki; Hayashida, Ryo; Kondo, Kazuhisa; Bando, Yasuko K.; Ouchi, Noriyuki; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan	Nagoya University	Takefuji, M; Murohara, T (corresponding author), Nagoya Univ, Dept Cardiol, Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	takefuji@med.nagoya-u.ac.jp; murohara@med.nagoya-u.ac.jp	Bando, Yasuko K./M-4831-2014	Bando, Yasuko K./0000-0003-4166-6784; Shimizu, Yuuki/0000-0003-3103-1160	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. T.).	Akat KM, 2014, P NATL ACAD SCI USA, V111, P11151, DOI 10.1073/pnas.1401724111; Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Anzai T, 2013, CIRC J, V77, P580, DOI 10.1253/circj.CJ-13-0013; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929; Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; Barile L, 2017, EUR HEART J, V38, P1372, DOI 10.1093/eurheartj/ehw304; Boon RA, 2015, NAT REV CARDIOL, V12, P135, DOI 10.1038/nrcardio.2014.207; Chen ZP, 2006, AM J RESP CELL MOL, V35, P127, DOI 10.1165/rcmb.2006-0044OC; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Gao XM, 2010, INT J CARDIOL, V143, P20, DOI 10.1016/j.ijcard.2009.01.019; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gray WD, 2015, CIRC RES, V116, P255, DOI 10.1161/CIRCRESAHA.116.304360; Gyongyosi M, 2018, CIRC RES, V123, P301, DOI 10.1161/CIRCRESAHA.117.311302; Gyongyosi M, 2016, CIRC RES, V118, P1254, DOI 10.1161/CIRCRESAHA.115.307347; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Korf-Klingebiel M, 2011, CIRCULATION, V123, P504, DOI 10.1161/CIRCULATIONAHA.110.989665; Li YQ, 2014, P NATL ACAD SCI USA, V111, P13511, DOI 10.1073/pnas.1411295111; Lu F, 2007, J MOL CELL CARDIOL, V43, P535, DOI 10.1016/j.yjmcc.2007.06.011; Lv GW, 2014, J CELL BIOCHEM, V115, P93, DOI 10.1002/jcb.24636; Matsusaka H, 2006, CARDIOVASC RES, V70, P457, DOI 10.1016/j.cardiores.2006.02.001; Mettlen M, 2018, ANNU REV BIOCHEM, V87, P871, DOI 10.1146/annurev-biochem-062917-012644; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Sahoo S, 2014, CIRC RES, V114, P333, DOI 10.1161/CIRCRESAHA.114.300639; Shukla S, 2017, EUR J CELL BIOL, V96, P728, DOI 10.1016/j.ejcb.2017.09.002; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Suzuki E, 2016, WORLD J STEM CELLS, V8, P297, DOI 10.4252/wjsc.v8.i9.297; Takefuji M, 2012, CIRCULATION, V126, P1972, DOI 10.1161/CIRCULATIONAHA.112.109256; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang Y, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4971261; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zampetaki A, 2012, CIRC RES, V110, P508, DOI 10.1161/CIRCRESAHA.111.247445; Zipes DP, 2019, BRAUNWALDS HEART DIS, V11th	43	35	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11665	11674		10.1074/jbc.RA119.007537	http://dx.doi.org/10.1074/jbc.RA119.007537			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31217281	Green Published, hybrid			2022-12-28	WOS:000486127800002
J	Mao, FF; Liu, T; Hou, XF; Zhao, HQ; He, WH; Li, C; Jing, ZY; Sui, JH; Wang, FC; Liu, XH; Han, J; Borchers, CH; Wang, JS; Li, WH				Mao, Fengfeng; Liu, Teng; Hou, Xinfeng; Zhao, Hanqing; He, Wenhui; Li, Cong; Jing, Zhiyi; Sui, Jianhua; Wang, Fengchao; Liu, Xiaohui; Han, Jun; Borchers, Christoph H.; Wang, Jian-She; Li, Wenhui			Increased sulfation of bile acids in mice and human subjects with sodium taurocholate cotransporting polypeptide deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bile acid; sulfotransferase; liver metabolism; mass spectrometry (MS); lipid metabolism; SLC10A1; sulfation; hypercholanemia; TLCA-3-sulfate; Sult2a1	HEPATITIS-B; ELIMINATION; DETOXIFICATION; METABOLISM; LIVER; SLC10A1; PATHWAY; SALTS	Sodium taurocholate cotransporting polypeptide (NTCP, encoded by Slc10a1/SLC10A1) deficiency can result in hypercholanemia but no obvious symptoms in both mice and humans. However, the consequence of and response to long-term hypercholanemia caused by NTCP deficiency remain largely unexplored. Here, we analyzed lifelong dynamics of serum total bile acid (TBA) levels in Slc10a1(-/-) mice, and we also assessed changes of TBA levels in 33 young individuals with SLC10A1 loss-of-function variant p.Ser267Phe. We found that overall serum TBA levels tended to decrease gradually with age in both Slc10a1(-/-) mice and p.Ser267Phe individuals. Liver mRNA profiling revealed notable transcription alterations in hypercholanemic Slc10a1(-/-) mice, including inhibition of bile acid (BA) synthesis, enhancement of BA detoxification, and altered BA transport. Members of the sulfotransferase (SULT) family showed the most dramatic increases in livers of hypercholanemic Slc10a1(-/-) mice, and one of their BA sulfates, taurolithocholic acid 3-sulfate, significantly increased. Importantly, consistent with the mouse studies, comprehensive profiling of 58 BA species in sera of p.Ser267Phe individuals revealed a markedly increased level of BA sulfates. Together, our findings indicate that the enhanced BA sulfation is a major mechanism for BA detoxification and elimination in both mice and humans with Slc10a1/SLC10A1 deficiency.	[Mao, Fengfeng; Sui, Jianhua] Beijing Normal Univ, Sch Life Sci, Beijing 100875, Peoples R China; [Mao, Fengfeng; Hou, Xinfeng; Zhao, Hanqing; He, Wenhui; Li, Cong; Jing, Zhiyi; Sui, Jianhua; Wang, Fengchao; Li, Wenhui] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Liu, Teng; Wang, Jian-She] Fudan Univ, Ctr Pediat Liver Dis, Childrens Hosp, Shanghai 201102, Peoples R China; [Liu, Teng; Wang, Jian-She] Fudan Univ, Dept Pediat, Shanghai Med Coll, Shanghai 200333, Peoples R China; [Liu, Teng] Fudan Univ, Dept Pediat, Jinshan Hosp, Shanghai 201512, Peoples R China; [Hou, Xinfeng; Li, Cong] Peking Univ, Sch Life Sci, Beijing 100091, Peoples R China; [Sui, Jianhua; Wang, Fengchao; Li, Wenhui] Tsinghua Univ, Tsinghua Inst Multidisciplinary Biomed Res, Beijing 100091, Peoples R China; [Liu, Xiaohui] Tsinghua Univ, Sch Life Sci, Beijing 100091, Peoples R China; [Han, Jun; Borchers, Christoph H.] Univ Victoria, UVic Genome BC Prote Ctr, Victoria, BC V8Z 5N3, Canada; [Han, Jun; Borchers, Christoph H.] Univ Victoria, Div Med Sci, Columbia, BC V8P 5C2, Canada; [Borchers, Christoph H.] Univ Victoria, Dept Biochem & Microbiol, Columbia, BC V8P 5C2, Canada; [Borchers, Christoph H.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Gerald Bronfman Dept Oncol,Segal Canc Ctr, Montreal, PQ H4A 3T2, Canada; [Borchers, Christoph H.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Prote Ctr,Segal Canc Ctr, Montreal, PQ H4A 3T2, Canada	Beijing Normal University; National Institute of Biological Sciences, Beijing; Fudan University; Fudan University; Fudan University; Peking University; Tsinghua University; Tsinghua University; University of Victoria; University of Victoria; University of Victoria; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University	Wang, JS (corresponding author), 399 Wanyuan Rd, Shanghai 201102, Peoples R China.; Li, WH (corresponding author), 7 Sci Pk Rd,ZGC Life Sci Pk, Beijing 102206, Peoples R China.	jshwang@shmu.edu.cn; liwenhui@nibs.ac.cn	, 毛峰峰/AAQ-8349-2020; hou, xinfeng/GWM-7623-2022	teng, liu/0000-0002-0858-2151; wang, jianshe/0000-0003-0823-586X; SUI, JIANHUA/0000-0002-1272-9662; Li, Wenhui/0000-0003-1305-7404	National Natural Science Foundation of China [81525018, 81570468, 81741056]; Science and Technology Major Project of Beijing Grant [D171100003117003]; China Scholarship Council [201606100226]; Science and Technology Bureau of Beijing Municipal Government; Leading Edge Endowment Fund (University of Victoria); Segal McGill Chair in Molecular Oncology at McGill University (Montreal, Canada); Warren Y. Soper Charitable Trust; Alvin Segal Family Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Major Project of Beijing Grant; China Scholarship Council(China Scholarship Council); Science and Technology Bureau of Beijing Municipal Government; Leading Edge Endowment Fund (University of Victoria); Segal McGill Chair in Molecular Oncology at McGill University (Montreal, Canada); Warren Y. Soper Charitable Trust; Alvin Segal Family Foundation	This work was supported by National Natural Science Foundation of China Grants 81525018 (to W. L.) and 81570468 and 81741056 (to J.-S.W.); Science and Technology Major Project of Beijing Grant D171100003117003 (to W. L.); China Scholarship Council Grant 201606100226 (to T. L.); the Science and Technology Bureau of Beijing Municipal Government (to W. L. and J. S.); the Metabolomics Innovation Centre (TMIC) through the Genome Innovations Network (GIN) from Genome Canada, Genome BC, and Genome Alberta for operations (205MET and 7203) and technology development (215MET and MC3T) (to J. H. and C. H. B.); the Leading Edge Endowment Fund (University of Victoria) and the Segal McGill Chair in Molecular Oncology at McGill University (Montreal, Canada) (to C. H. B.); and the Warren Y. Soper Charitable Trust and the Alvin Segal Family Foundation to the Jewish General Hospital (Montreal, Canada) (to C. H. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbing RLR, 2017, HEPATOLOGY, V66, p938A; Alnouti Y, 2008, J CHROMATOGR B, V873, P209, DOI 10.1016/j.jchromb.2008.08.018; Alnouti Y, 2009, TOXICOL SCI, V108, P225, DOI 10.1093/toxsci/kfn268; Dawson PA, 2015, J LIPID RES, V56, P1085, DOI 10.1194/jlr.R054114; Deng M, 2016, EXP THER MED, V12, P3294, DOI 10.3892/etm.2016.3752; Feng L, 2017, J LIPID RES, V58, P1114, DOI 10.1194/jlr.M074302; Fickert P, 2006, GASTROENTEROLOGY, V130, P465, DOI 10.1053/j.gastro.2005.10.018; Fuchs CD, 2017, J HEPATOL, V66, P95, DOI 10.1016/j.jhep.2016.08.017; Han J, 2015, ANAL CHEM, V87, P1127, DOI 10.1021/ac503816u; He WH, 2016, J VIROL, V90, P8866, DOI 10.1128/JVI.00901-16; He WH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004840; Humbert L, 2012, J CHROMATOGR B, V899, P135, DOI 10.1016/j.jchromb.2012.05.015; Kulkarni SR, 2016, HEPATOLOGY, V64, P2151, DOI 10.1002/hep.28826; Liu RH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07012-2; Marschall HU, 2006, J LIPID RES, V47, P582, DOI 10.1194/jlr.M500427-JLR200; Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300; PALMER RH, 1967, P NATL ACAD SCI USA, V58, P1047, DOI 10.1073/pnas.58.3.1047; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Qiu YL, 2017, HEPATOLOGY, V65, P1655, DOI 10.1002/hep.29020; RADOMINSKA A, 1990, BIOCHEM J, V272, P597, DOI 10.1042/bj2720597; Runge-Morris M, 2013, DRUG METAB REV, V45, P15, DOI 10.3109/03602532.2012.748794; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Slijepcevic D, 2015, HEPATOLOGY, V62, P207, DOI 10.1002/hep.27694; Van Herpe F, 2017, J INHERIT METAB DIS, V40, P313, DOI 10.1007/s10545-017-0031-9; Vaz FM, 2017, DIGEST DIS, V35, P259, DOI 10.1159/000450984; Vaz FM, 2015, HEPATOLOGY, V61, P260, DOI 10.1002/hep.27240; Wagner M, 2005, HEPATOLOGY, V42, P420, DOI 10.1002/hep.20784; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zollner G, 2006, AM J PHYSIOL-GASTR L, V290, pG923, DOI 10.1152/ajpgi.00490.2005	30	18	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11853	11862		10.1074/jbc.RA118.007179	http://dx.doi.org/10.1074/jbc.RA118.007179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31201272	hybrid, Green Published			2022-12-28	WOS:000486127800021
J	Petrillo, MG; Oakley, RH; Cidlowski, JA				Petrillo, Maria G.; Oakley, Robert H.; Cidlowski, John A.			beta-Arrestin-1 inhibits glucocorticoid receptor turnover and alters glucocorticoid signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucocorticoid receptor; arrestin; E3 ubiquitin ligase; post-translational modification (PTM); protein stability; glucocorticoid signaling	E3 UBIQUITIN LIGASES; BETA-ARRESTINS; NUCLEAR RECEPTORS; GENE-EXPRESSION; DOWN-REGULATION; CROSS-TALK; PROTEIN; ROLES; DEGRADATION; ACTIVATION	Glucocorticoids are among the most widely used drugs to treat many autoimmune and inflammatory diseases. Although much research has been focused on investigating glucocorticoid activity, it remains unclear how glucocorticoids regulate distinct processes in different cells. Glucocorticoids exert their effects through the glucocorticoid receptor (GR), which, upon glucocorticoid binding, interacts with regulatory proteins, affecting its activity and function. These protein-protein interactions are necessary for the resolution of glucocorticoid-dependent physiological and pharmacological processes. In this study, we discovered a novel protein interaction between the glucocorticoid receptor and beta-arrestin-1, a scaffold protein with a well-established role in G protein-coupled receptor signaling. Using co-immunoprecipitation and in situ proximity ligation assays in A549 cells, we observed that beta-arrestin-1 and unliganded GR interact in the cytoplasm and that, following glucocorticoid binding, the protein complex is found in the nucleus. We show that siRNA-mediated beta-arrestin-1 knockdown alters GR protein turnover by up-regulating the E3 ubiquitin ligase Pellino-1, which catalyzes GR ubiquitination and thereby marks the receptor for proteasomal degradation. The enhanced GR turnover observed in beta-arrestin-1-deficient cells limits the duration of the glucocorticoid response on GR target genes. These results demonstrate that beta-arrestin-1 is a crucial player for the stability of the glucocorticoid receptor. The GR/beta-arrestin-1 interaction uncovered here may help unravel mechanisms that contribute to the cell type-specific activities of glucocorticoids.	[Petrillo, Maria G.; Oakley, Robert H.; Cidlowski, John A.] NIEHS, Signal Transduct Lab, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, NIH, POB 12233,MD F3-07, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	; Cidlowski, John/G-2548-2019	Petrillo, Maria Grazia/0000-0001-5999-9355; Cidlowski, John/0000-0003-1420-0516	Intramural Research Program of the NIEHS, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090057] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the NIEHS, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmadzai MM, 2017, ADV IMMUNOL, V136, P279, DOI 10.1016/bs.ai.2017.05.004; ALMLOF T, 1995, J BIOL CHEM, V270, P17535, DOI 10.1074/jbc.270.29.17535; Ayroldi E, 2015, CELL DEATH DIFFER, V22, P118, DOI 10.1038/cdd.2014.129; Bouazza B, 2014, AM J RESP CELL MOL, V50, P301, DOI 10.1165/rcmb.2012-0522OC; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Choo Yeun Su, 2009, J Vis Exp, DOI 10.3791/1293; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Davies L, 2008, MOL ENDOCRINOL, V22, P1331, DOI 10.1210/me.2007-0360; Deroo BJ, 2002, MOL CELL BIOL, V22, P4113, DOI 10.1128/MCB.22.12.4113-4123.2002; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Helzer KT, 2015, J MOL ENDOCRINOL, V54, pR151, DOI 10.1530/JME-14-0308; Hsiao JJ, 2016, J BIOL CHEM, V291, P18818, DOI 10.1074/jbc.M116.732313; Humphries F, 2015, IMMUNOL REV, V266, P93, DOI 10.1111/imr.12306; Ismail A, 2005, IUBMB LIFE, V57, P483, DOI 10.1080/15216540500147163; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Jeon YK, 2017, CELL DEATH DIFFER, V24, P469, DOI 10.1038/cdd.2016.143; Jin W, 2012, CELL MOL IMMUNOL, V9, P113, DOI 10.1038/cmi.2011.60; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; Kim YS, 2005, ENDOCRINOLOGY, V146, P3133, DOI 10.1210/en.2004-1455; Kinyamu HK, 2003, MOL CELL BIOL, V23, P5867, DOI 10.1128/MCB.23.16.5867-5881.2003; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kommaddi RP, 2013, PROG MOL BIOL TRANSL, V118, P175, DOI 10.1016/B978-0-12-394440-5.00007-3; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Lambert WM, 2013, MOL CELL BIOL, V33, P3700, DOI 10.1128/MCB.00150-13; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; Li DW, 2018, CANCER RES, V78, P2897, DOI 10.1158/0008-5472.CAN-17-3531; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Moynagh PN, 2014, NAT REV IMMUNOL, V14, P122, DOI 10.1038/nri3599; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Oakley RH, 2017, J BIOL CHEM, V292, P5825, DOI 10.1074/jbc.M116.758888; Oakley RH, 2012, P NATL ACAD SCI USA, V109, P17591, DOI 10.1073/pnas.1209411109; Ohtake F, 2016, MOL CELL, V64, P251, DOI 10.1016/j.molcel.2016.09.014; OKRET S, 1991, BIOCHIMIE, V73, P51, DOI 10.1016/0300-9084(91)90074-B; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; PALCZEWSKI K, 1994, PROTEIN SCI, V3, P1355, DOI 10.1002/pro.5560030901; Park CW, 2014, BMB REP, V47, P475, DOI 10.5483/BMBRep.2014.47.9.128; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; Petta Ioanna, 2016, Microbiol Mol Biol Rev, V80, P495, DOI 10.1128/MMBR.00064-15; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Quinn MA, 2018, CELL REP, V22, P2690, DOI 10.1016/j.celrep.2018.02.041; Ramamoorthy S, 2013, ENDOCR DEV, V24, P41, DOI 10.1159/000342502; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Robinson-Rechavi M, 2001, TRENDS GENET, V17, P554, DOI 10.1016/S0168-9525(01)02417-9; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Saklatvala J, 2002, ARTHRITIS RES, V4, P146, DOI 10.1186/ar398; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SILVA CM, 1994, STEROIDS, V59, P436, DOI 10.1016/0039-128X(94)90013-2; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Simon Jeremy M, 2013, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2126s102; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song Q, 2018, INT J MOL MED, V41, P631, DOI 10.3892/ijmm.2017.3288; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1254, DOI 10.1210/me.2014-1023; Takabe S, 2008, ARCH BIOCHEM BIOPHYS, V475, P1, DOI 10.1016/j.abb.2008.03.036; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Usui I, 2004, MOL CELL BIOL, V24, P8929, DOI 10.1128/MCB.24.20.8929-8937.2004; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Wallace AD, 2010, STEROIDS, V75, P1016, DOI 10.1016/j.steroids.2010.06.015; Wang HB, 2017, P NATL ACAD SCI USA, V114, P11944, DOI 10.1073/pnas.1715742114; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang XJ, 2005, MOL ENDOCRINOL, V19, P1474, DOI 10.1210/me.2004-0383; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; WIRA C, 1970, J BIOL CHEM, V245, P3436; Witchel SF, 2006, NAT CLIN PRACT ENDOC, V2, P621, DOI 10.1038/ncpendmet0323; Wong AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120530; Xiao YC, 2013, NAT MED, V19, P595, DOI 10.1038/nm.3111; Yudt MR, 2002, MOL ENDOCRINOL, V16, P1719, DOI 10.1210/me.2002-0106; Zhang MF, 2011, MECH DEVELOP, V128, P368, DOI 10.1016/j.mod.2011.07.003	84	8	9	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11225	11239		10.1074/jbc.RA118.007150	http://dx.doi.org/10.1074/jbc.RA118.007150			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167788	Green Published, hybrid			2022-12-28	WOS:000478717400014
J	Lypova, N; Telang, S; Chesney, J; Imbert-Fernandez, Y				Lypova, Nadiia; Telang, Sucheta; Chesney, Jason; Imbert-Fernandez, Yoannis			Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lung cancer; glycolysis; metabolism; epidermal growth factor (EGF); epidermal growth factor receptor (EGFR); 6-phosphofructo-2-kinase; fructose-2; 6-bisphosphatase; erlotinib; PFKFB3; tumorigenesis; tyrosine kinase inhibitor; small molecule antagonist	EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; EARLY PREDICTION; NEVER SMOKERS; PFKFB3; GENE; INHIBITION; PHOSPHORYLATION; EXPRESSION; MUTATIONS	Constitutive activation of the epidermal growth factor receptor (EGFR) because of somatic mutations of the EGFR gene is commonly observed in tumors of non-small cell lung cancer (NSCLC) patients. Consequently, tyrosine kinase inhibitors (TKI) targeting the EGFR are among the most effective therapies for patients with sensitizing EGFR mutations. Clinical responses to the EGFR-targeting TKIs are evaluated through 2-[F-18]fluoro-2-deoxy-glucose ((18)FDG)-PET uptake, which is decreased in patients responding favorably to therapy and is positively correlated with survival. Recent studies have reported that EGFR signaling drives glucose metabolism in NSCLC cells; however, the precise downstream effectors required for this EGFR-driven metabolic effect are largely unknown. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is an essential glycolytic regulator that is consistently overexpressed in lung cancer. Here, we found that PFKFB3 is an essential target of EGFR signaling and that PFKFB3 activation is required for glycolysis stimulation upon EGFR activation. We demonstrate that exposing NSCLC cells harboring either WT or mutated EGFR to EGF rapidly increases PFKFB3 phosphorylation, expression, and activity and that PFKFB3 inhibition markedly reduces the EGF-mediated increase in glycolysis. Furthermore, we found that prolonged NSCLC cell exposure to the TKI erlotinib drives PFKFB3 expression and that chemical PFKFB3 inhibition synergizes with erlotinib in increasing erlotinib's anti-proliferative activity in NSCLC cells. We conclude that PFKFB3 has a key role in mediating glucose metabolism and survival of NSCLC cells in response to EGFR signaling. These results support the potential clinical utility of using PFKFB3 inhibitors in combination with EGFR-TKIs to manage NSCLC.	[Lypova, Nadiia; Telang, Sucheta; Chesney, Jason; Imbert-Fernandez, Yoannis] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Div Med Oncol & Hematol, Louisville, KY 40202 USA	University of Louisville	Chesney, J (corresponding author), 529 S Jackson St, Louisville, KY 40202 USA.; Imbert-Fernandez, Y (corresponding author), 505 S Hancock St, Louisville, KY 40202 USA.	jason.chesney@louisville.edu; yoannis.imbertfernandez@louisville.edu	Lypova, Nadiia/AAH-3405-2021; Lypova, Nadiia/GWR-2435-2022	Lypova, Nadiia/0000-0003-1506-8545; 	Kentucky Lung Cancer Research Program Grant; James Graham Brown Foundation	Kentucky Lung Cancer Research Program Grant; James Graham Brown Foundation	This work was supported by Kentucky Lung Cancer Research Program Grant (to Y. I.-F.) and James Graham Brown Foundation Grant (to J. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Apicella M, 2018, CELL METAB, V28, P848, DOI 10.1016/j.cmet.2018.08.006; Atsumi T, 2002, CANCER RES, V62, P5881; Bando H, 2005, CLIN CANCER RES, V11, P5784, DOI 10.1158/1078-0432.CCR-05-0149; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Cordero-Espinoza L, 2013, J BIOL CHEM, V288, P36020, DOI 10.1074/jbc.M113.510289; Cossu-Rocca P, 2016, AM J CANCER RES, V6, P71; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; De Rosa V, 2015, CLIN CANCER RES, V21, P5110, DOI 10.1158/1078-0432.CCR-15-0375; Dempke WCM, 2015, ANTICANCER RES, V35, P2503; DIAMOND I, 1978, J BIOL CHEM, V253, P866; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Hachemi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087629; Hafner M, 2017, NAT BIOTECHNOL, V35, P500, DOI 10.1038/nbt.3882; Imbert-Fernandez Y, 2014, J BIOL CHEM, V289, P9440, DOI 10.1074/jbc.M113.529990; Kim JH, 2018, CANCER RES, V78, P4482, DOI 10.1158/0008-5472.CAN-18-0117; Klarer AC, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-2; Li XL, 2018, MOL CELL BIOCHEM, V445, P123, DOI 10.1007/s11010-017-3258-8; Lu CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414391; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma PF, 2016, THERANOSTICS, V6, P1232, DOI 10.7150/thno.14409; Macdonald-Obermann JL, 2018, J BIOL CHEM, V293, P13401, DOI 10.1074/jbc.RA118.004139; Makinoshima H, 2014, J BIOL CHEM, V289, P20813, DOI 10.1074/jbc.M114.575464; Manes NP, 2005, ARCH BIOCHEM BIOPHYS, V438, P125, DOI 10.1016/j.abb.2005.04.011; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Minchenko H., 2005, Ukrainskii Biokhimicheskii Zhurnal, V77, P46; Momcilovic M, 2017, CELL REP, V18, P601, DOI 10.1016/j.celrep.2016.12.061; Nan XL, 2017, ONCOTARGET, V8, P75712, DOI 10.18632/oncotarget.20095; Novellasdemunt L, 2012, BIOCHEM J, V442, P345, DOI 10.1042/BJ20111418; Oxnard GR, 2018, JAMA ONCOL, V4, P1527, DOI 10.1001/jamaoncol.2018.2969; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park JH, 2012, BIOCHEM J, V448, P417, DOI 10.1042/BJ20121513; Perez-Soler R., 2004, J CLIN ONCOL, V22, P7026, DOI 10.1200/jco.2004.22.90140.7026; Ranayhossaini DJ, 2014, INT J MOL SCI, V15, P17686, DOI 10.3390/ijms151017686; Ray P, 2016, ONCOTARGET, V7, P68597, DOI 10.18632/oncotarget.11860; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Redman R, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-CT206; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Scagliotti GV, 2015, CANCER TREAT REV, V41, P465, DOI 10.1016/j.ctrv.2015.04.001; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Sunaga N, 2008, LUNG CANCER, V59, P203, DOI 10.1016/j.lungcan.2007.08.012; Tan XJ, 2016, TRENDS CELL BIOL, V26, P352, DOI 10.1016/j.tcb.2015.12.006; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Telang S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-S1-P14; Tiseo M, 2014, CANCER CHEMOTH PHARM, V73, P299, DOI 10.1007/s00280-013-2356-x; Valley CC, 2015, MOL BIOL CELL, V26, P4087, DOI 10.1091/mbc.E15-05-0269; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P887, DOI 10.1042/bj1920887; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P897, DOI 10.1042/bj1920897; Vivanco I, 2014, BRIT J CANCER, V111, P2033, DOI 10.1038/bjc.2014.461; Wu SG, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0777-1; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zander T, 2011, J CLIN ONCOL, V29, P1701, DOI 10.1200/JCO.2010.32.4939; Zhang L, 2017, ONCOTARGET, V8, P13126, DOI 10.18632/oncotarget.14480	60	16	17	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10530	10543		10.1074/jbc.RA119.007784	http://dx.doi.org/10.1074/jbc.RA119.007784			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31126985	Green Published, hybrid			2022-12-28	WOS:000478717100013
J	Shang, ZS; Zhao, J; Zhang, Q; Cao, C; Tian, SS; Zhang, K; Liu, L; Shi, L; Yu, N; Yang, SD				Shang, Zesen; Zhao, Jiao; Zhang, Qi; Cao, Cheng; Tian, Shanshan; Zhang, Kai; Liu, Ling; Shi, Lei; Yu, Na; Yang, Shangda			USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); breast cancer; cell signaling; carcinogenesis; Wnt pathway; B-cell CLL; lymphoma 9 (BCL9); Lys-63-linked polyubiquitins; ubiquitin-specific peptidase 9; X-linked (USP9X)	BETA-CATENIN; MULTIPLE-MYELOMA; FAT-FACETS; USP9X; PYGOPUS; GENE; EXPRESSION; LEGLESS; COMPLEX; BINDING	Hyperactivation of the canonical Wnt-signaling pathway is a prominent feature of a number of human malignancies. Transcriptional activation of this signaling cascade depends on the formation of the -catenin-B-cell CLL/lymphoma 9 (BCL9)-pygopus (PYGO) family plant homeodomain finger 1 complex, yet how the assembly of this complex is regulated remains to be investigated. Here, using MCF-7, HeLa, HEK293T, MDA-MB-231, and Sf9 cells, along with immunoblotting and immunofluorescence, nano-HPLC-MS/MS, deubiquitination, immunoprecipitation, and chromatin immunoprecipitation (ChIP) assays, we report that BCL9 physically associates with a protein deubiquitinase, ubiquitin-specific peptidase 9, X-linked (USP9X), and that USP9X removes Lys-63-linked polyubiquitin on Lys-212 of BCL9. Importantly, the USP9X-mediated BCL9 deubiquitination facilitated the formation of the -catenin-BCL9-PYGO complex, thereby potentiating the transcriptional activation of Wnt/-catenin target genes. We also show that USP9X-mediated BCL9 deubiquitination promotes the proliferation and invasion of breast cancer cells. Together, these results uncover USP9X as a deubiquitinase of BCL9, implicating USP9X in Wnt/-catenin signaling and breast carcinogenesis.	[Shang, Zesen; Zhao, Jiao; Zhang, Qi; Cao, Cheng; Tian, Shanshan; Zhang, Kai; Liu, Ling; Shi, Lei; Yu, Na; Yang, Shangda] Tianjin Med Univ, 2011 Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin Key Lab Med Epigenet,Key Lab Breast Canc, Key Lab Immune Microenvironm & Dis,Dept Biochem &, Tianjin 300070, Peoples R China; [Yang, Shangda] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Peking Union Med Coll, Tianjin 300020, Peoples R China; [Yang, Shangda] Chinese Acad Med Sci, Blood Dis Hosp, Peking Union Med Coll, Tianjin 300020, Peoples R China	Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College	Yu, N; Yang, SD (corresponding author), Tianjin Med Univ, Dept Biochem & Mol Biol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	na_yuna2001@tmu.edu.cn; yangshangda@tmu.edu.cn		Zhang, Kai/0000-0003-2800-0531	National Natural Science Foundation of China [81602511]; Excellent Talent Project of Tianjin Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Talent Project of Tianjin Medical University	This work was supported by Grant 81602511 from the National Natural Science Foundation of China (to N. Y.) and a grant from Excellent Talent Project of Tianjin Medical University(to L. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi S, 2004, CANCER RES, V64, P8496, DOI 10.1158/0008-5472.CAN-04-2254; Agrawal P, 2012, J BIOL CHEM, V287, P21164, DOI 10.1074/jbc.M111.328021; Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Bridges CR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00149-0; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chim CS, 2007, LEUKEMIA, V21, P2527, DOI 10.1038/sj.leu.2404939; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Das A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006791; de la Roche M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1680; de la Roche M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-199; Debeb BG, 2012, STEM CELLS, V30, P2366, DOI 10.1002/stem.1219; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Edwards CM, 2008, BLOOD, V112, P216, DOI 10.1182/blood-2008-04-149278; Elsarraj HS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0630-z; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Gang EJ, 2014, ONCOGENE, V33, P2169, DOI 10.1038/onc.2013.169; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gough NR, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002806; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hoffmans R, 2005, CURR BIOL, V15, P1207, DOI 10.1016/j.cub.2005.05.054; Izrailit J, 2017, ONCOGENE, V36, P1048, DOI 10.1038/onc.2016.276; Jang GB, 2015, CANCER RES, V75, P1691, DOI 10.1158/0008-5472.CAN-14-2041; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Li J, 2013, CELL REP, V5, P1650, DOI 10.1016/j.celrep.2013.11.037; Li X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14866; Li X, 2014, P NATL ACAD SCI USA, V111, P7096, DOI 10.1073/pnas.1324036111; Li YH, 2016, CANCER RES, V76, P3364, DOI 10.1158/0008-5472.CAN-15-2302; Lien WH, 2014, GENE DEV, V28, P1517, DOI 10.1101/gad.244772.114; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Mieszczanek J, 2008, P NATL ACAD SCI USA, V105, P19324, DOI 10.1073/pnas.0806098105; Miller TCR, 2010, J MOL BIOL, V401, P969, DOI 10.1016/j.jmb.2010.07.007; Moor AE, 2015, EBIOMEDICINE, V2, P1932, DOI 10.1016/j.ebiom.2015.10.030; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Murtaza M, 2015, CELL MOL LIFE SCI, V72, P2075, DOI 10.1007/s00018-015-1851-0; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Ouyang W, 2016, ONCOL REP, V35, P717, DOI 10.3892/or.2015.4463; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pohl SG, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.14; Premarathne S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05451-5; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Savio MG, 2016, CURR BIOL, V26, P173, DOI 10.1016/j.cub.2015.11.050; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Su DX, 2018, J CLIN INVEST, V128, P4280, DOI 10.1172/JCI120518; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Takada K, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003808; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Thompson BJ, 2004, CURR BIOL, V14, P458, DOI 10.1016/j.cub.2004.02.026; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van Andel H, 2017, P NATL ACAD SCI USA, V114, P376, DOI 10.1073/pnas.1618650114; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Willis TG, 1998, BLOOD, V91, P1873, DOI 10.1182/blood.V91.6.1873.1873_1873_1881; Wu Y, 2017, CANCER RES, V77, P1383, DOI [10.1158/0008-5472.CAN-16-2012, 10.1158/0008-5472.can-16-2012]; Xu J, 2005, EUR J NEUROSCI, V21, P3017, DOI 10.1111/j.1460-9568.2005.04134.x; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409; Yang S, 2018, INT J ADV MANUF TECH, V9, P1, DOI DOI 10.1038/s41467-018-03588-z; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704	71	16	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9844	9857		10.1074/jbc.RA119.007655	http://dx.doi.org/10.1074/jbc.RA119.007655			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31073027	Green Published, hybrid			2022-12-28	WOS:000473277900017
J	Zhang, JL; Chen, JF; Shi, D; Shi, HY; Zhang, X; Liu, JB; Cao, LY; Zhu, XD; Liu, Y; Wang, XB; Ji, ZY; Feng, L				Zhang, Jialin; Chen, Jianfei; Shi, Da; Shi, Hongyan; Zhang, Xin; Liu, Jianbo; Cao, Liyan; Zhu, Xiangdong; Liu, Ye; Wang, Xiaobo; Ji, Zhaoyang; Feng, Li			Porcine deltacoronavirus enters cells via two pathways: A protease-mediated one at the cell surface and another facilitated by cathepsins in the endosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virology; virus; virus entry; protease; proteolytic enzyme; porcine deltacoronavirus; cell entry; cathepsins; trypsin; membrane fusion; endosome; viral pathogenesis; spike glycoprotein; porcine diarrhea	RESPIRATORY SYNDROME CORONAVIRUS; EPIDEMIC DIARRHEA CORONAVIRUS; RECEPTOR-BINDING DOMAIN; SPIKE PROTEIN; SARS-CORONAVIRUS; PROTEOLYTIC ACTIVATION; FUSION PROTEIN; MERS-COV; VIRUS; ENTRY	Porcine deltacoronavirus (PDCoV) is a pathogen belonging to the genus Deltacoronavirus that in 2014 caused outbreaks of piglet diarrhea in the United States. To identify suitable therapeutic targets, a more comprehensive understanding of the viral entry pathway is required, particularly of the role of proteases. Here, we identified the proteases that activate the viral spike (S) glycoprotein to initiate cell entry and also pinpointed the host-cellular pathways that PDCoV uses for entry. Our results revealed that cathepsin L (CTSL) and cathepsin B (CTSB) in lysosomes and extracellular trypsin in cell cultures independently activate the S protein for membrane fusion. Pretreating the cells with the lysosomal acidification inhibitor bafilomycin-A1 (Baf-A1) completely inhibited PDCoV entry, and siRNA-mediated ablation of CTSL or CTSB expression significantly reduced viral infection, indicating that PDCoV uses an endosomal pathway for entry. Of note, trypsin treatment of cell cultures also activated PDCoV entry, even when the endosomal pathway was inhibited. This observation indicated that trypsin-induced S protein cleavage and activation in cell cultures enables viral entry directly from the cell surface. Our results provide critical insights into the PDCoV infection mechanism, uncovering two distinct viral entry pathways: one through cathepsin L and cathepsin B in the endosome and another via a protease at the cell surface. Because PDCoV infection sites represent a proteases-rich environment, these findings suggest that endosome inhibitor treatment alone is insufficient to block PDCoV entry into intestinal epithelial cells in vivo. Therefore, approaches that inhibit viral entry from the cell membrane should also be considered.	[Zhang, Jialin; Chen, Jianfei; Shi, Da; Shi, Hongyan; Zhang, Xin; Liu, Jianbo; Cao, Liyan; Zhu, Xiangdong; Liu, Ye; Wang, Xiaobo; Ji, Zhaoyang; Feng, Li] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150069, Heilongjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Feng, L (corresponding author), 678 Haping Rd, Harbin 150069, Heilongjiang, Peoples R China.	fengli@caas.cn			National Key Technology R&D Program of China [2016YFD0500103]; National Natural Science Foundation of China [31602072, 31572541]; Natural Science Foundation of Heilongjiang Province of China [C2017079]; State Key Laboratory of Veterinary Biotechnology Foundation Grant [SKLVBP2018002]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); State Key Laboratory of Veterinary Biotechnology Foundation Grant	This work was supported by the National Key Technology R&D Program of China Grant 2016YFD0500103, National Natural Science Foundation of China Grants 31602072 and 31572541, Natural Science Foundation of Heilongjiang Province of China Grant C2017079, and the State Key Laboratory of Veterinary Biotechnology Foundation Grant SKLVBP2018002. The authors declare that they have no conflicts of interest with the contents of this article.	Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Bergeron E, 2005, BIOCHEM BIOPH RES CO, V326, P554, DOI 10.1016/j.bbrc.2004.11.063; Bonavia A, 2003, J VIROL, V77, P2530, DOI 10.1128/JVI.77.4.2530-2538.2003; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Chen Q, 2015, VIROLOGY, V482, P51, DOI 10.1016/j.virol.2015.03.024; de Haan CAM, 2004, J VIROL, V78, P6048, DOI 10.1128/JVI.78.11.6048-6054.2004; Dong N, 2015, EMERG INFECT DIS, V21, P2254, DOI 10.3201/eid2112.150283; Fan MZ, 2001, J ANIM SCI, V79, P371; Fang PX, 2017, J GEN VIROL, V98, P173, DOI 10.1099/jgv.0.000690; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; GARWES DJ, 1975, J GEN VIROL, V29, P25, DOI 10.1099/0022-1317-29-1-25; Gierer S, 2015, J INFECT DIS, V211, P889, DOI 10.1093/infdis/jiu407; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Guo CH, 2017, J VIROL, V91, DOI [10.1128/JVI.00625-17, 10.1128/jvi.00625-17]; HAMPSON DJ, 1986, RES VET SCI, V40, P24, DOI 10.1016/S0034-5288(18)30481-8; Hofmann H, 2006, J VIROL, V80, P8639, DOI 10.1128/JVI.00560-06; HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235, DOI 10.1128/JCM.26.11.2235-2239.1988; Hu H, 2015, J CLIN MICROBIOL, V53, P1537, DOI 10.1128/JCM.00031-15; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Janetanakit T, 2016, EMERG INFECT DIS, V22, P757, DOI 10.3201/eid2204.151852; Jung K, 2015, EMERG INFECT DIS, V21, P650, DOI 10.3201/eid2104.141859; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Lee S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01191-14; Li GW, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00278-14; Li WT, 2018, P NATL ACAD SCI USA, V115, pE5135, DOI 10.1073/pnas.1802879115; Li Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06056-w; Liu C, 2016, J BIOL CHEM, V291, P24779, DOI 10.1074/jbc.M116.740746; Ma YM, 2015, MBIO, V6, DOI 10.1128/mBio.00064-15; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; Marthaler D, 2014, EMERG INFECT DIS, V20, P1347, DOI [10.3201/eid2008.14-0526, 10.3201/eid2008.140526]; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; Matsuyama S, 2009, J VIROL, V83, P11133, DOI 10.1128/JVI.00959-09; Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111; Ojkic D, 2015, CAN VET J, V56, P149; Okuma K, 1999, VIROLOGY, V254, P235, DOI 10.1006/viro.1998.9530; Phillips JM, 2017, J VIROL, V91, DOI 10.1128/JVI.01564-16; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Saeng-Chuto K, 2017, TRANSBOUND EMERG DIS, V64, P3, DOI 10.1111/tbed.12585; Sainz B, 2005, J VIROL, V79, P7195, DOI 10.1128/JVI.79.11.7195-7206.2005; Shang J, 2018, J VIROL, V92, DOI 10.1128/JVI.01556-17; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2006, ADV EXP MED BIOL, V581, P235; Simmons G, 2013, ANTIVIR RES, V100, P605, DOI 10.1016/j.antiviral.2013.09.028; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Ujike M, 2008, J VIROL, V82, P588, DOI 10.1128/JVI.01697-07; Wang B, 2018, J VIROL, V92, DOI [10.1128/jvi.00318-18, 10.1128/JVI.00318-18]; Wang LY, 2014, EMERG INFECT DIS, V20, P1227, DOI 10.3201/eid2007.140296; Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92; Watanabe R, 2008, J VIROL, V82, P11985, DOI 10.1128/JVI.01412-08; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wicht O, 2014, J VIROL, V88, P7952, DOI 10.1128/JVI.00297-14; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Yamada Y, 2009, J VIROL, V83, P8744, DOI 10.1128/JVI.00613-09; Zhao PW, 2018, ANTIVIR RES, V150, P1, DOI 10.1016/j.antiviral.2017.11.021; Zhou N, 2016, J BIOL CHEM, V291, P9218, DOI 10.1074/jbc.M116.716100	62	30	36	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9830	9843		10.1074/jbc.RA119.007779	http://dx.doi.org/10.1074/jbc.RA119.007779			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31068417	hybrid, Green Published			2022-12-28	WOS:000473277900016
J	Walker, MP; Lindner, SE				Walker, Michael P.; Lindner, Scott E.			Ribozyme-mediated, multiplex CRISPR gene editing and CRISPR interference (CRISPRi) in rodent-infectious Plasmodium yoelii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Plasmodium; CRISPR; Cas; gene regulation; ribozyme (catalytic RNA) (RNA enzyme); parasitology; ALBA; HDR; sgRNA; UIS4	HIGH-EFFICIENCY TRANSFECTION; SEQUENCE-SPECIFIC CONTROL; MALARIA PARASITES; IN-VIVO; FALCIPARUM; ACTIVATION; REVEAL; MECHANISMS; EXPRESSION; SELECTION	Malaria remains a major global health issue, affecting millions and killing hundreds of thousands of people annually. Efforts to break the transmission cycle of the causal Plasmodium parasite, and to cure those that are afflicted, rely upon functional characterization of genes essential to the parasite's growth and development. These studies are often based upon manipulations of the parasite genome to disrupt or modify a gene of interest to understand its importance and function. However, these approaches can be limited by the availability of selectable markers and the time required to generate transgenic parasites. Moreover, there also is a risk of disrupting native gene regulatory elements with the introduction of exogenous sequences. To address these limitations, we have developed CRISPR-RGR, a Streptococcus pyogenes (Sp)Cas9-based gene editing system for Plasmodium that utilizes a ribozyme-guide-ribozyme (RGR) single guide RNA (sgRNA) expression strategy with RNA polymerase II promoters. Using rodent-infectious Plasmodium yoelii, we demonstrate that both gene disruptions and coding sequence insertions are efficiently generated, producing marker-free parasites with homology arms as short as 80-100 bp. Additionally, we find that the common practice of using one sgRNA can produce both unintended plasmid integration and desired locus replacement editing events, whereas the use of two sgRNAs results in only locus replacement editing. Lastly, we show that CRISPR-RGR can be used for CRISPR interference (CRISPRi) by binding catalytically dead SpCas9 (dSpCas9) to the region upstream of a gene of interest, resulting in a position-dependent, but strand-independent reduction in gene expression. This robust and flexible system facilitates efficient genetic characterizations of rodent-infectious Plasmodium species.	[Walker, Michael P.; Lindner, Scott E.] Penn State Univ, Dept Biochem & Mol Biol, Huck Ctr Malaria Res, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lindner, SE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	Scott.Lindner@psu.edu		Lindner, Scott/0000-0003-1799-3726	National Institutes of Health [R01AI123341, R21AI130692]; Pennsylvania State University; Huck Institutes of the Life Sciences Graduate Research Innovation award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI130692, R01AI123341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State University; Huck Institutes of the Life Sciences Graduate Research Innovation award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01AI123341 and R21AI130692 and Pennsylvania State University start-up funds (to S. E. L.) and by a Huck Institutes of the Life Sciences Graduate Research Innovation award (to M. P. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Baum J, 2009, NUCLEIC ACIDS RES, V37, P3788, DOI 10.1093/nar/gkp239; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Crawford ED, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178163; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; Farasat I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004724; Fonager J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-155; Ganesan SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10727; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Henrici RC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02693-1; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jongco AM, 2006, MOL BIOCHEM PARASIT, V146, P242, DOI 10.1016/j.molbiopara.2006.01.001; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; Lacroix C, 2011, NAT PROTOC, V6, P1412, DOI 10.1038/nprot.2011.363; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lee AH, 2014, MICROBIOL MOL BIOL R, V78, P469, DOI 10.1128/MMBR.00059-13; Lee RTH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166020; Lin JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029289; Lindner SE, 2013, CELL MICROBIOL, V15, P1266, DOI 10.1111/cmi.12116; Liu C, 2018, MOL BIOCHEM PARASIT, V224, P37, DOI 10.1016/j.molbiopara.2018.07.010; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Miller JL, 2012, INFECT IMMUN, V80, P1399, DOI 10.1128/IAI.05861-11; Mu W, 2019, PROTEIN CELL, V10, P223, DOI 10.1007/s13238-018-0552-5; Munoz EE, 2017, MOL MICROBIOL, V106, P266, DOI 10.1111/mmi.13762; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qian PG, 2018, MOL BIOCHEM PARASIT, V222, P21, DOI 10.1016/j.molbiopara.2018.04.003; Reece SE, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-183; Ribeiro JM, 2018, INT J PARASITOL, V48, P825, DOI 10.1016/j.ijpara.2018.03.009; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Schwach F, 2015, NUCLEIC ACIDS RES, V43, pD1176, DOI 10.1093/nar/gku1143; Shrinivas K., 2018, ENHANCER FEATURES DR, DOI [10.1101/495606, DOI 10.1101/495606]; Singer M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0811-1; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; World Health Organization, 2018, WORLD MAL REP 2018; Xiao B, 2019, P NATL ACAD SCI USA, V116, P255, DOI 10.1073/pnas.1813542116; Xie C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06216-w; Yin H, 2017, NAT BIOTECHNOL, V35, P1179, DOI 10.1038/nbt.4005; Zhang C, 2017, CELL DEATH DIS, V8, pe2695, DOI DOI 10.1128/mBio.01986-17; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096908; Zhang C, 2017, MOL BIOCHEM PARASIT, V212, P1, DOI 10.1016/j.molbiopara.2016.12.010; Zhang WW, 2015, MBIO, V6, DOI 10.1128/mBio.00861-15	53	19	20	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9555	9566		10.1074/jbc.RA118.007121	http://dx.doi.org/10.1074/jbc.RA118.007121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31043479	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000472713000021
J	Bagenholm, V; Wiemann, M; Reddy, SK; Bhattacharya, A; Rosengren, A; Logan, DT; Stalbrand, H				Bagenholm, Viktoria; Wiemann, Mathias; Reddy, Sumitha K.; Bhattacharya, Abhishek; Rosengren, Anna; Logan, Derek T.; Stalbrand, Henrik			A surface-exposed GH26 beta-mannanase from Bacteroides ovatus: Structure, role, and phylogenetic analysis of BoMan26B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; structure-function; Gram-negative bacteria; phylogenetics; enzyme kinetics; glycoside hydrolase; Bacteroides ovatus; galactomannan; human gut bacteria; polysaccharide utilization loci	CARBOHYDRATE-ACTIVE ENZYMES; HUMAN GUT SYMBIONT; BIOCHEMICAL ANALYSES; THERMAL-STABILITY; DIETARY FIBER; BINDING; METABOLISM; MICROBIOTA; HYDROLASE; PROTEIN	The galactomannan utilization locus (BoManPUL) of the human gut bacterium Bacteroides ovatus encodes BoMan26B, a cell-surface-exposed endomannanase whose functional and structural features have been unclear. Our study now places BoMan26B in context with related enzymes and reveals the structural basis for its specificity. BoMan26B prefers longer substrates and is less restricted by galactose side-groups than the mannanase BoMan26A of the same locus. Using galactomannan, BoMan26B generated a mixture of (galactosyl) manno-oligosaccharides shorter than mannohexaose. Three defined manno-oligosaccharides had affinity for the SusD-like surface-exposed glycan-binding protein, predicted to be implicated in saccharide transport. Co-incubation of BoMan26B and the periplasmic -galactosidase BoGal36A increased the rate of galactose release by about 10-fold compared with the rate without BoMan26B. The results suggested that BoMan26B performs the initial attack on galactomannan, generating oligosaccharides that after transport to the periplasm are processed by BoGal36A. A crystal structure of BoMan26B with galactosyl-mannotetraose bound in subsites -5 to -2 revealed an open and long active-site cleft with Trp-112 in subsite -5 concluded to be involved in mannosyl interaction. Moreover, Lys-149 in the -4 subsite interacted with the galactosyl side-group of the ligand. A phylogenetic tree consisting of GH26 enzymes revealed four strictly conserved GH26 residues and disclosed that BoMan26A and BoMan26B reside on two distinct phylogenetic branches (A and B). The three other branches contain lichenases, xylanases, or enzymes with unknown activities. Lys-149 is conserved in a narrow part of branch B, and Trp-112 is conserved in a wider group within branch B.	[Bagenholm, Viktoria; Wiemann, Mathias; Bhattacharya, Abhishek; Rosengren, Anna; Logan, Derek T.; Stalbrand, Henrik] Lund Univ, Dept Biochem & Struct Biol, POB 124, S-22100 Lund, Sweden; [Reddy, Sumitha K.] Swedish Univ Agr Sci, Dept Mol Sci, Box 7015, S-75007 Uppsala, Sweden	Lund University; Swedish University of Agricultural Sciences	Stalbrand, H (corresponding author), Lund Univ, Dept Biochem & Struct Biol, POB 124, S-22100 Lund, Sweden.	henrik.stalbrand@biochemistry.lu.se	Logan, Derek T/A-1114-2011; Logan, Derek/O-2497-2019	Logan, Derek T/0000-0002-0098-8560; Logan, Derek/0000-0002-0098-8560; Bhattacharya, Abhishek/0000-0002-4861-1674; Stalbrand, Henrik/0000-0001-9517-6428; Wiemann, Mathias/0000-0003-0803-0370	FORMAS [213-2014-1254, 942-2016-117]; Carl Trygger Foundation [16:452]; Swedish Foundation for Strategic Research [RBP 14-0046]; Swedish Research Council [2016-04855]	FORMAS(Swedish Research Council Formas); Carl Trygger Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Grants 213-2014-1254 and 942-2016-117 (to H. S.) from FORMAS, Grant 16:452 from the Carl Trygger Foundation, and Grant RBP 14-0046 from the Swedish Foundation for Strategic Research and by a grant (to D. L. T.) from the Swedish Research Council (2016-04855). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht S, 2011, J AGR FOOD CHEM, V59, P12658, DOI 10.1021/jf203091h; Armstrong Z, 2018, ISME J, V12, P2757, DOI 10.1038/s41396-018-0215-9; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bagenholm V, 2017, J BIOL CHEM, V292, P229, DOI 10.1074/jbc.M116.746438; Barak S, 2014, INT J BIOL MACROMOL, V66, P74, DOI 10.1016/j.ijbiomac.2014.02.017; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Bolam DN, 1996, BIOCHEMISTRY-US, V35, P16195, DOI 10.1021/bi961866d; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Couturier M, 2011, APPL ENVIRON MICROB, V77, P237, DOI 10.1128/AEM.01761-10; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dea I. C. M., 1975, Advances in Carbohydrate Chemistry and Biochemistry, V31, P241; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Glenwright AJ, 2017, NATURE, V541, P407, DOI 10.1038/nature20828; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Hekmat O, 2010, BIOCHEMISTRY-US, V49, P4884, DOI 10.1021/bi100097f; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hsu YH, 2018, APPL MICROBIOL BIOT, V102, P1737, DOI 10.1007/s00253-017-8726-2; Hudson KL, 2015, J AM CHEM SOC, V137, P15152, DOI 10.1021/jacs.5b08424; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawaguchi K, 2014, ARCH MICROBIOL, V196, P17, DOI 10.1007/s00203-013-0938-y; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kim S, 2018, CLIN SCI, V132, P701, DOI [10.1042/CS20180087, 10.1042/cs20180087]; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kulcinskaja E, 2013, APPL ENVIRON MICROB, V79, P133, DOI 10.1128/AEM.02118-12; Kumagai Y, 2012, BIOCHIMIE, V94, P2783, DOI 10.1016/j.biochi.2012.09.012; Kumagai Y, 2011, BBA-PROTEINS PROTEOM, V1814, P1127, DOI 10.1016/j.bbapap.2011.04.017; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lundqvist J, 2002, CARBOHYD POLYM, V48, P29, DOI 10.1016/S0144-8617(01)00210-7; Malgas S, 2015, ENZYME MICROB TECH, V70, P1, DOI 10.1016/j.enzmictec.2014.12.007; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; MCCLEARY BV, 1974, PHYTOCHEMISTRY, V13, P1747, DOI 10.1016/0031-9422(74)85084-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNulty NP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001637; MEIER H, 1958, BIOCHIM BIOPHYS ACTA, V28, P229, DOI 10.1016/0006-3002(58)90468-2; Morrill J, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0055-4; Movahedin M, 2017, GLYCOBIOLOGY, V27, P677, DOI 10.1093/glycob/cww131; Mudgil D, 2014, J FOOD SCI TECH MYS, V51, P409, DOI 10.1007/s13197-011-0522-x; Ndeh D, 2018, FEMS MICROBIOL REV, V42, P146, DOI 10.1093/femsre/fuy002; NYMAN M, 1986, BRIT J NUTR, V55, P487, DOI 10.1079/BJN19860056; O'Keefe SJD, 2009, J NUTR, V139, P2044, DOI 10.3945/jn.109.104380; Phansopa C, 2014, BIOCHEM J, V458, P499, DOI 10.1042/BJ20131415; Porter NT, 2017, ANNU REV MICROBIOL, V71, P349, DOI 10.1146/annurev-micro-102215-095316; Reddy SK, 2016, FEBS LETT, V590, P2106, DOI 10.1002/1873-3468.12250; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Srivastava PK, 2016, ENZYME MICROB TECH, V84, P41, DOI 10.1016/j.enzmictec.2015.12.010; STALBRAND H, 1993, J BIOTECHNOL, V29, P229, DOI 10.1016/0168-1656(93)90055-R; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Taylor EJ, 2005, J BIOL CHEM, V280, P32761, DOI 10.1074/jbc.M506580200; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tsukagoshi H, 2014, J BIOL CHEM, V289, P10843, DOI 10.1074/jbc.M114.555383; Vandeputte D, 2017, GUT, V66, P1968, DOI 10.1136/gutjnl-2016-313271; von Freiesleben P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38602-x; von Freiesleben P, 2016, ENZYME MICROB TECH, V83, P68, DOI 10.1016/j.enzmictec.2015.10.011; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34360; Wernersson S, 2019, BIOMOL NMR ASSIGN, V13, P213, DOI 10.1007/s12104-019-09879-w; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu HY, 2017, METHODS MOL BIOL, V1588, P129, DOI 10.1007/978-1-4939-6899-2_10; Yan XX, 2008, J MOL BIOL, V379, P535, DOI 10.1016/j.jmb.2008.03.068; Zhang ML, 2014, P NATL ACAD SCI USA, V111, pE3708, DOI 10.1073/pnas.1406156111	77	14	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9100	9117		10.1074/jbc.RA118.007171	http://dx.doi.org/10.1074/jbc.RA118.007171			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31000630	hybrid, Green Published			2022-12-28	WOS:000471751600008
J	Scheiber, IF; Wu, YZ; Morgan, SE; Zhao, NN				Scheiber, Ivo Florin; Wu, Yuze; Morgan, Shannon Elizabeth; Zhao, Ningning			The intestinal metal transporter ZIP14 maintains systemic manganese homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						manganese; intestine; metal; transporter; homeostasis; absorption; CaCo-2; SLC39A14; ZIP14	CACO-2 CELLS; IRON UPTAKE; IN-VITRO; ABSORPTION; SLC39A14; ZINC; MUTATIONS; HYPERMANGANESEMIA; SLC30A10; COPPER	ZIP14 (encoded by the solute carrier 39 family member 14 (SLC39A14) gene) is a manganese transporter that is abundantly expressed in the liver and small intestine. Loss-of-function mutations in SLC39A14 cause severe hypermanganesemia. Because the liver is regarded as the main regulatory organ involved in manganese homeostasis, impaired hepatic manganese uptake for subsequent biliary excretion has been proposed as the underlying disease mechanism. However, liver-specific Zip14 KO mice exhibit decreased manganese only in the liver and do not develop manganese accumulation in other tissues under normal conditions. This suggests that impaired hepatobiliary excretion is not the primary cause for manganese overload observed in individuals lacking functional ZIP14. We therefore hypothesized that increased intestinal manganese absorption could induce manganese hyperaccumulation when ZIP14 is inactivated. To elucidate the role of ZIP14 in manganese absorption, here we used CaCo-2 Transwell cultures as a model system for intestinal epithelia. The generation of a ZIP14-deficient CaCo-2 cell line enabled the identification of ZIP14 as the major transporter mediating basolateral manganese uptake in enterocytes. Lack of ZIP14 severely impaired basolateral-to-apical (secretory) manganese transport and strongly enhanced manganese transport in the apical-to-basolateral (absorptive) direction. Mechanistic studies provided evidence that ZIP14 restricts manganese transport in the absorptive direction via direct basolateral reuptake of freshly absorbed manganese. In support of such function of intestinal ZIP14 in vivo, manganese levels in the livers and brains of intestine-specific Zip14 KO mice were significantly elevated. Our findings highlight the importance of intestinal ZIP14 in regulating systemic manganese homeostasis.	[Scheiber, Ivo Florin; Wu, Yuze; Morgan, Shannon Elizabeth; Zhao, Ningning] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA	University of Arizona	Zhao, NN (corresponding author), Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA.	zhaonn@email.arizona.edu			National Institutes of Health [R00DK104066]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK104066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R00DK104066 (to N. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avila Daiana Silva, 2013, Met Ions Life Sci, V13, P199, DOI 10.1007/978-94-007-7500-8_7; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Bannon DI, 2003, AM J PHYSIOL-CELL PH, V284, pC44, DOI 10.1152/ajpcell.00184.2002; Bentz J, 2013, DRUG METAB DISPOS, V41, P1347, DOI 10.1124/dmd.112.050500; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; BRITTON AA, 1966, AM J PHYSIOL, V211, P203, DOI 10.1152/ajplegacy.1966.211.1.203; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Chua ACG, 1997, J COMP PHYSIOL B, V167, P361, DOI 10.1007/s003600050085; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DAVIS CD, 1992, J NUTR, V122, P1300, DOI 10.1093/jn/122.6.1300; Dorman DC, 2001, TOXICOL SCI, V60, P242, DOI 10.1093/toxsci/60.2.242; FINLEY JW, 1994, AM J CLIN NUTR, V60, P949, DOI 10.1093/ajcn/60.6.949; Finley JW, 1997, J NUTR BIOCHEM, V8, P92, DOI 10.1016/S0955-2863(96)00180-5; Geszvain K, 2012, BIOCHEM SOC T, V40, P1244, DOI 10.1042/BST20120229; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Guthrie GJ, 2015, AM J PHYSIOL-GASTR L, V308, pG171, DOI 10.1152/ajpgi.00021.2014; Hennigar SR, 2016, J NUTR, V146, P2167, DOI 10.3945/jn.116.237081; Hoch E., 2018, BIORXIV, DOI [10.1101/474528, DOI 10.1101/474528]; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Jayasena T, 2007, NEUROSCI RES, V57, P454, DOI 10.1016/j.neures.2006.12.004; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Juneja M, 2018, J GENE MED, V20, DOI 10.1002/jgm.3012; Klein LD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183367; Knopfel M, 2005, BIOCHEMISTRY-US, V44, P3454, DOI 10.1021/bi048768; Leblondel G, 1999, BIOL TRACE ELEM RES, V67, P13, DOI 10.1007/BF02784271; Li XL, 2013, BIOMETALS, V26, P941, DOI 10.1007/s10534-013-9670-y; Liu CY, 2017, J BIOL CHEM, V292, P16605, DOI 10.1074/jbc.M117.804989; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; LONNERDAL B, 1983, AM J DIS CHILD, V137, P433; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marti-Sanchez L, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0758-x; Missy P, 2000, HUM EXP TOXICOL, V19, P448, DOI 10.1191/096032700682694260; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Rahelic D, 2006, COLLEGIUM ANTROPOL, V30, P523; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodan LH, 2018, MOL GENET METAB, V124, P161, DOI 10.1016/j.ymgme.2018.04.002; Sandberg AS, 2010, INT J VITAM NUTR RES, V80, P307, DOI 10.1024/0300-9831/a000038; Shawki A, 2015, AM J PHYSIOL-GASTR L, V309, pG635, DOI 10.1152/ajpgi.00160.2015; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Taylor CA, 2019, J BIOL CHEM, V294, P1860, DOI 10.1074/jbc.RA118.005628; Teeguarden JG, 2007, J TOXICOL ENV HEAL A, V70, P1493, DOI 10.1080/15287390701384601; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wedler FC., 1994, MANGANESE HLTH DIS, P1; WEIGAND E, 1986, BIOL TRACE ELEM RES, V10, P265, DOI 10.1007/BF02802395; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248	52	30	31	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9147	9160		10.1074/jbc.RA119.008762	http://dx.doi.org/10.1074/jbc.RA119.008762			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31028174	hybrid, Green Published			2022-12-28	WOS:000471751600011
J	Cho, H; Shen, GQ; Wang, XF; Wang, F; Archacki, S; Li, YB; Yu, G; Chakrabarti, S; Chen, QY; Wang, QK				Cho, Hyosuk; Shen, Gong-Qing; Wang, Xiaofeng; Wang, Fan; Archacki, Stephen; Li, Yabo; Yu, Gang; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth			Long noncoding RNA ANRIL regulates endothelial cell activities associated with coronary artery disease by up-regulating CLIP1, EZR, and LYVE1 genes (vol 294, pg 3881, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Chakrabarti, Susmita/CAH-2331-2022	Chakrabarti, Susmita/0000-0003-1197-2780				Cho H, 2019, J BIOL CHEM, V294, P3881, DOI 10.1074/jbc.RA118.005050	1	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8715	8715		10.1074/jbc.AAC119.009250	http://dx.doi.org/10.1074/jbc.AAC119.009250			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31152096	Green Published, hybrid			2022-12-28	WOS:000470971100007
J	Molinaro, R; Mukherjee, T; Flick, R; Philpott, DJ; Girardin, SE				Molinaro, Raphael; Mukherjee, Tapas; Flick, Robert; Philpott, Dana J.; Girardin, Stephen E.			Trace levels of peptidoglycan in serum underlie the NOD-dependent cytokine response to endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Nod-like receptor (NLR); innate immunity; cell signaling; cell biology; calcium intracellular release; endoplasmic reticulum stress (ER stress); NOD1; NOD2	SLOW-WAVE SLEEP; MURAMYL DIPEPTIDE; BACTERIAL PEPTIDOGLYCAN; SUBTILASE CYTOTOXIN; SYNTHETIC ADJUVANT; CRITICAL RESIDUES; CANDIDA-ALBICANS; HOST RECOGNITION; ACTIVATION; INTERNALIZATION	NOD1 and NOD2 are intracellular sensors of bacterial peptidoglycan that belong to the Nod-like receptor family of innate immune proteins. In addition to their role as direct bacterial sensors, it was proposed that the nucleotide-binding oligomerization domain (NOD) proteins could detect endoplasmic reticulum (ER) stress induced by thapsigargin, an inhibitor of the sarcoplasmic or endoplasmic reticulum calcium ATPase family that pumps Ca2+ into the ER, resulting in pro-inflammatory signaling. Here, we confirm that thapsigargin induces NOD-dependent pro-inflammatory signaling in epithelial cells. However, the effect was specific to thapsigargin, as tunicamycin and the subtilase cytotoxin SubAB from Shiga toxigenic Escherichia coli, which induce ER stress by other mechanisms, did not induce cytokine expression. The calcium ionophore A23187 also induced NOD-dependent signaling, and calcium chelators demonstrated a role for both intracellular and extracellular calcium in mediating thapsigargin-induced and NOD-dependent pro-inflammatory signaling, in part through the activation of plasma membrane-associated calcium release-activated channels. Moreover, our results demonstrate that both endocytosis and the addition of serum to the cell culture medium were required for thapsigargin-mediated NOD activation. Finally, we analyzed cell culture grade fetal calf serum as well as serum from laboratory mice using HPLC and MS identified the presence of various peptidoglycan fragments. We propose that cellular perturbations that affect intracellular Ca2+ can trigger internalization of peptidoglycan trace contaminants found in culture serum, thereby stimulating pro-inflammatory signaling. The presence of peptidoglycan in animal serum suggests that a homeostatic function of NOD signaling may have been previously overlooked.	[Molinaro, Raphael; Mukherjee, Tapas; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, 100 Coll St, Toronto, ON M5S 1A8, Canada; [Philpott, Dana J.; Girardin, Stephen E.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Flick, Robert] Univ Toronto, Fac Appl Sci & Engn, BioZone, Toronto, ON M5S 3E5, Canada	University of Toronto; University of Toronto; University of Toronto	Girardin, SE (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, 100 Coll St, Toronto, ON M5S 1A8, Canada.; Girardin, SE (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	stephen.girardin@utoronto.ca		MUKHERJEE, TAPAS/0000-0002-9433-3716	Canadian Institutes for Health Research; Crohn's and Colitis Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Canada	This work was supported by grants from the Canadian Institutes for Health Research (to the D.J.P. and S.E.G. laboratories) and by the Crohn's and Colitis Canada (to S.E.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Cavallari JF, 2017, CELL METAB, V25, P1063, DOI 10.1016/j.cmet.2017.03.021; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chan KL, 2017, CELL REP, V18, P2415, DOI 10.1016/j.celrep.2017.02.027; Chong DC, 2008, CELL MICROBIOL, V10, P795, DOI 10.1111/j.1462-5822.2007.01085.x; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Di Paola S, 2018, CELL CALCIUM, V69, P112, DOI 10.1016/j.ceca.2017.06.006; FRASERSMITH EB, 1981, INFECT IMMUN, V34, P676, DOI 10.1128/IAI.34.3.676-683.1981; Ganley IG, 2011, AUTOPHAGY, V7, P1397, DOI 10.4161/auto.7.11.17651; Gaudet RG, 2017, CELL REP, V19, P1418, DOI 10.1016/j.celrep.2017.04.063; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Grimes CL, 2012, J AM CHEM SOC, V134, P13535, DOI 10.1021/ja303883c; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; KRUEGER JM, 1984, J BIOL CHEM, V259, P2659; KRUEGER JM, 1982, P NATL ACAD SCI-BIOL, V79, P6102, DOI 10.1073/pnas.79.19.6102; Laroui H, 2011, J BIOL CHEM, V286, P31003, DOI 10.1074/jbc.M111.257501; LECLERC C, 1979, CELL IMMUNOL, V45, P199, DOI 10.1016/0008-8749(79)90377-0; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; LOWY I, 1980, J IMMUNOL, V124, P320; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; MARTIN SA, 1984, J BIOL CHEM, V259, P2652; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Moon SH, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-018-1381-7; Mukherjee T, 2019, ARCH BIOCHEM BIOPHYS, V670, P69, DOI 10.1016/j.abb.2018.12.022; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Rubino SJ, 2013, INNATE IMMUN-LONDON, V19, P493, DOI 10.1177/1753425912471691; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Tattoli I, 2016, CELL REP, V14, P2576, DOI 10.1016/j.celrep.2016.02.065; Tsalikis J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2999-1; Voronina S, 2015, BIOCHEM J, V465, P405, DOI 10.1042/BJ20140398; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014; Yeung PSW, 2017, CELL CALCIUM, V63, P14, DOI 10.1016/j.ceca.2016.12.006; Zeng B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02094-y	41	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					9007	9015		10.1074/jbc.RA119.007997	http://dx.doi.org/10.1074/jbc.RA119.007997			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30996003	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000470971100031
J	Wang, SJ; Mao, Y; Narimatsu, Y; Ye, ZL; Tian, WH; Goth, CK; Lira-Navarrete, E; Pedersen, NB; Benito-Vicente, A; Martin, C; Uribe, KB; Hurtado-Guerrero, R; Christoffersen, C; Seidah, NG; Nielsen, R; Christensen, EI; Hansen, L; Bennett, EP; Vakhrushev, SY; Schjoldager, KT; Clausen, H				Wang, Shengjun; Mao, Yang; Narimatsu, Yoshiki; Ye, Zilu; Tian, Weihua; Goth, Christoffer K.; Lira-Navarrete, Erandi; Pedersen, Nis B.; Benito-Vicente, Asier; Martin, Cesar; Uribe, Kepa B.; Hurtado-Guerrero, Ramon; Christoffersen, Christina; Seidah, Nabil G.; Nielsen, Rikke; Christensen, Erik I.; Hansen, Lars; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.; Clausen, Henrik			Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions (vol 293, pg 7408, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Tian, Weihua/AAC-8919-2022; Uribe, Kepa B./AAC-2163-2019; Lira-Navarrete, Erandi/L-5359-2015; clausen, henrik/AAD-8016-2021; Uribe, Kepa B./AGZ-5717-2022; Vakhrushev, Sergey Y/A-7638-2014; marttin, cesar/GWC-4638-2022; martin, cesar/L-1303-2014; Narimatsu, Yoshiki/G-8388-2019; Seidah, Nabil/I-3596-2013	Uribe, Kepa B./0000-0002-4502-4853; Uribe, Kepa B./0000-0002-4502-4853; Vakhrushev, Sergey Y/0000-0002-0418-5765; martin, cesar/0000-0002-4087-8729; Narimatsu, Yoshiki/0000-0003-1428-5695; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; Seidah, Nabil/0000-0001-6503-9342; Christoffersen, Christina/0000-0003-3751-5203				Wang SJ, 2018, J BIOL CHEM, V293, P7408, DOI 10.1074/jbc.M117.817981	1	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8349	8349		10.1074/jbc.AAC119.009121	http://dx.doi.org/10.1074/jbc.AAC119.009121			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	31127061	Green Published, hybrid			2022-12-28	WOS:000471108200004
J	Wang, XH; Chen, QQ; Yi, S; Liu, QY; Zhang, RR; Wang, P; Qian, TM; Li, SY				Wang, Xinghui; Chen, Qianqian; Yi, Sheng; Liu, Qianyan; Zhang, Ruirui; Wang, Pan; Qian, Tianmei; Li, Shiying			The microRNAs let-7 and miR-9 down-regulate the axon-guidance genes Ntn1 and Dcc during peripheral nerve regeneration (vol 294, pg 3489, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Wang, Xinghui; Chen, Qianqian; Yi, Sheng; Liu, Qianyan; Zhang, Ruirui; Wang, Pan; Qian, Tianmei; Li, Shiying] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong 226001, Jiangsu, Peoples R China; [Wang, Xinghui; Chen, Qianqian; Yi, Sheng; Liu, Qianyan; Zhang, Ruirui; Wang, Pan; Qian, Tianmei; Li, Shiying] Nantong Univ, Minist Educ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China	Nantong University; Nantong University	Wang, XH (corresponding author), Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong 226001, Jiangsu, Peoples R China.; Wang, XH (corresponding author), Nantong Univ, Minist Educ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.							Wang XH, 2019, J BIOL CHEM, V294, P3489, DOI 10.1074/jbc.RA119.007389	1	2	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6695	6695		10.1074/jbc.AAC119.008724	http://dx.doi.org/10.1074/jbc.AAC119.008724			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	31028164	hybrid, Green Published			2022-12-28	WOS:000467394700008
J	Jagessar, KL; Mchaourab, HS; Claxton, DP				Jagessar, Kevin L.; Mchaourab, Hassane S.; Claxton, Derek P.			The N-terminal domain of an archaeal multidrug and toxin extrusion (MATE) transporter mediates proton coupling required for prokaryotic drug resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; transporter; cell growth; protein expression; fluorescence; allostery; ion-coupled substrate transport; multidrug and toxin extrusion (MATE)	EFFLUX PUMP; EVOLUTIONARY CONSERVATION; STAPHYLOCOCCUS-AUREUS; MOLECULAR-MECHANISMS; ESCHERICHIA-COLI; STRUCTURAL BASIS; FAMILY; CLONING; NORM	As a contributor to multidrug resistance, the family of multidrug and toxin extrusion (MATE) transporters couples the efflux of chemically dissimilar compounds to electrochemical ion gradients. Although divergent transport mechanisms have been proposed for these transporters, previous structural and functional analyses of members of the MATE subfamily DinF suggest that the N-terminal domain (NTD) supports substrate and ion binding. In this report, we investigated the relationship of ligand binding within the NTD to the drug resistance mechanism of the H+-dependent MATE from the hyperthermophilic archaeon Pyrococcus furiosus (PfMATE). To facilitate this study, we developed a cell growth assay in Escherichia coli to characterize the resistance conferred by PfMATE to toxic concentrations of the antimicrobial compound rhodamine 6G. Expression of WT PfMATE promoted cell growth in the presence of drug, but amino acid substitutions of conserved NTD residues compromised drug resistance. Steady-state binding analysis with purified PfMATE indicated that substrate affinity was unperturbed in these NTD variants. However, exploiting Trp fluorescence as an intrinsic reporter of conformational changes, we found that these variants impaired formation of a unique H+-stabilized structural intermediate. These results imply that disruption of H+ coupling is the origin of compromised toxin resistance in PfMATE variants. These findings support a model mechanism wherein the NTD mediates allosteric coupling to ion gradients through conformational changes to drive substrate transport in PfMATE. Furthermore, the results provide evidence for diverging transport mechanisms within a prokaryotic MATE subfamily.	[Jagessar, Kevin L.; Mchaourab, Hassane S.; Claxton, Derek P.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Claxton, DP (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	derek.p.claxton@vanderbilt.edu		JAGESSAR, KEVIN/0000-0003-1475-2513; Claxton, Derek P/0000-0002-1374-7176	NIGMS, National Institutes of Health [R01 GM077659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077659] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01 GM077659 (to H.S.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alibert S, 2017, EXPERT OPIN DRUG MET, V13, P301, DOI 10.1080/17425255.2017.1251581; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; Chen ZL, 2016, CANCER LETT, V370, P153, DOI 10.1016/j.canlet.2015.10.010; Claxton DP, 2018, P NATL ACAD SCI USA, V115, pE6182, DOI 10.1073/pnas.1802417115; Du DJ, 2015, CURR OPIN STRUC BIOL, V33, P76, DOI 10.1016/j.sbi.2015.07.015; Ficici E, 2018, P NATL ACAD SCI USA, V115, pE6172, DOI 10.1073/pnas.1802080115; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Huda MN, 2003, MICROBIOL IMMUNOL, V47, P419, DOI 10.1111/j.1348-0421.2003.tb03379.x; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; Kozachkov L, 2011, P NATL ACAD SCI USA, V108, P15769, DOI 10.1073/pnas.1109256108; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Kusakizako T, 2019, STRUCTURE, V27, P293, DOI 10.1016/j.str.2018.10.004; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Long F, 2008, ANTIMICROB AGENTS CH, V52, P3052, DOI 10.1128/AAC.00475-08; Lu M, 2016, CHANNELS, V10, P88, DOI 10.1080/19336950.2015.1106654; Lu M, 2013, NAT STRUCT MOL BIOL, V20, P1310, DOI 10.1038/nsmb.2687; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; MITCHELL P, 1967, ADV ENZYMOL RAMB, V29, P33; Miyauchi H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01541-0; Mousa JJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.9, 10.1038/nmicrobiol.2015.9]; Nishima W, 2016, BIOPHYS J, V110, P1346, DOI 10.1016/j.bpj.2016.01.027; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Radchenko M, 2016, J BIOL CHEM, V291, P9818, DOI 10.1074/jbc.M116.715227; Radchenko M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8995; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Smirnova I, 2009, P NATL ACAD SCI USA, V106, P21561, DOI 10.1073/pnas.0911434106; Smriti, 2009, J BIOL CHEM, V284, P13904, DOI 10.1074/jbc.M900837200; Steed PR, 2013, BIOCHEMISTRY-US, V52, P5790, DOI 10.1021/bi4008935; Su XZ, 2005, ANTIMICROB AGENTS CH, V49, P4362, DOI 10.1128/AAC.49.10.4362-4364.2005; Tal N, 2009, P NATL ACAD SCI USA, V106, P9051, DOI 10.1073/pnas.0902400106; Tanaka Y, 2017, STRUCTURE, V25, P1455, DOI 10.1016/j.str.2017.07.009; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yilmaz C, 2017, BIOCHEM PHARMACOL, V133, P43, DOI 10.1016/j.bcp.2016.10.005; Yonezawa A, 2011, BRIT J PHARMACOL, V164, P1817, DOI 10.1111/j.1476-5381.2011.01394.x; Yu EW, 2003, J BACTERIOL, V185, P5657, DOI 10.1128/JB.185.19.5657-5664.2003	42	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12807	12814		10.1074/jbc.RA119.009195	http://dx.doi.org/10.1074/jbc.RA119.009195			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31289123	hybrid, Green Published			2022-12-28	WOS:000484414600021
J	Blahut, M; Wise, CE; Bruno, MR; Dong, G; Makris, TM; Frantom, PA; Dunkle, JA; Outten, FW				Blahut, Matthew; Wise, Courtney E.; Bruno, Michael R.; Dong, Guangchao; Makris, Thomas M.; Frantom, Patrick A.; Dunkle, Jack A.; Outten, F. Wayne			Direct observation of intermediates in the SufS cysteine desulfurase reaction reveals functional roles of conserved active-site residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; iron-sulfur protein; pre-steady-state kinetics; enzyme catalysis; enzyme mechanism; cysteine desulfurase; cysteine sulfur bond cleavage; PLP; PLP-dependent sulfur abstraction; SufS	FE-S CLUSTER; ESCHERICHIA-COLI COUNTERPART; LYASE C-DES; SELENOCYSTEINE LYASE; QUINONOID INTERMEDIATE; GENE CLONING; SULFUR; MECHANISM; PROTEIN; BIOGENESIS	Iron-sulfur (Fe-S) clusters are necessary for the proper functioning of numerous metalloproteins. Fe-S cluster (Isc) and sulfur utilization factor (Suf) pathways are the key biosynthetic routes responsible for generating these Fe-S cluster prosthetic groups in Escherichia coli. Although Isc dominates under normal conditions, Suf takes over during periods of iron depletion and oxidative stress. Sulfur acquisition via these systems relies on the ability to remove sulfur from free cysteine using a cysteine desulfurase mechanism. In the Suf pathway, the dimeric SufS protein uses the cofactor pyridoxal 5 '-phosphate (PLP) to abstract sulfur from free cysteine, resulting in the production of alanine and persulfide. Despite much progress, the stepwise mechanism by which this PLP-dependent enzyme operates remains unclear. Here, using rapid-mixing kinetics in conjunction with X-ray crystallography, we analyzed the pre-steady-state kinetics of this process while assigning early intermediates of the mechanism. We employed H123A and C364A SufS variants to trap Cys-aldimine and Cys-ketimine intermediates of the cysteine desulfurase reaction, enabling direct observations of these intermediates and associated conformational changes of the SufS active site. Of note, we propose that Cys-364 is essential for positioning the Cys-aldimine for C alpha deprotonation, His-123 acts to protonate the Ala-enamine intermediate, and Arg-56 facilitates catalysis by hydrogen bonding with the sulfhydryl of Cys-aldimine. Our results, along with previous SufS structural findings, suggest a detailed model of the SufS-catalyzed reaction from Cys binding to C-S bond cleavage and indicate that Arg-56, His-123, and Cys-364 are critical SufS residues in this C-S bond cleavage pathway.	[Blahut, Matthew; Wise, Courtney E.; Dong, Guangchao; Makris, Thomas M.; Outten, F. Wayne] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Bruno, Michael R.; Frantom, Patrick A.; Dunkle, Jack A.] Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA	University of South Carolina System; University of South Carolina Columbia; University of Alabama System; University of Alabama Tuscaloosa	Outten, FW (corresponding author), Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.; Dunkle, JA (corresponding author), Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA.	jadunkle@ua.edu; woutten@sc.edu	Dunkle, Jack/ABB-9713-2020; Frantom, Patrick/GQB-1040-2022	Dunkle, Jack/0000-0001-6252-0587; Outten, Franklin/0000-0002-9095-0194; Wise, Courtney/0000-0002-8712-9039; Makris, Thomas/0000-0001-7927-620X	National Institutes of Health NIGMS Grant [GM112919]; University of South Carolina Office of Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112919] Funding Source: NIH RePORTER	National Institutes of Health NIGMS Grant; University of South Carolina Office of Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grant GM112919 (to F. W. O. and P. A. F.) and in part by a grant from the University of South Carolina Office of Research (to T. M. M. and F. W. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht AG, 2011, FEBS LETT, V585, P465, DOI 10.1016/j.febslet.2011.01.005; Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Black KA, 2015, BBA-MOL CELL RES, V1853, P1470, DOI 10.1016/j.bbamcr.2014.10.018; Blauenburg B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158749; Campanini B, 2006, J BIOL CHEM, V281, P38769, DOI 10.1074/jbc.M607098200; Dai YY, 2015, BIOCHEMISTRY-US, V54, P4824, DOI 10.1021/acs.biochem.5b00663; Dai YY, 2012, FEBS LETT, V586, P4016, DOI 10.1016/j.febslet.2012.10.001; Dunkle JA, 2019, BIOCHEMISTRY-US, V58, P687, DOI 10.1021/acs.biochem.8b01122; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Hirayama A, 2015, CHEMBIOCHEM, V16, P2484, DOI 10.1002/cbic.201500426; Kaiser JT, 2003, J BIOL CHEM, V278, P357, DOI 10.1074/jbc.M209862200; Karsten WE, 2009, BBA-GEN SUBJECTS, V1790, P575, DOI 10.1016/j.bbagen.2009.02.012; Kim D, 2018, BIOCHEMISTRY-US, V57, P5210, DOI 10.1021/acs.biochem.7b01275; Kim S, 2013, J BIOL CHEM, V288, P27172, DOI 10.1074/jbc.M113.480277; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Liang J, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00004; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Omi R, 2010, J BIOL CHEM, V285, P12133, DOI 10.1074/jbc.M109.084475; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Phillips RS, 2011, BBA-PROTEINS PROTEOM, V1814, P1481, DOI 10.1016/j.bbapap.2010.12.003; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Selbach BP, 2013, BIOCHEMISTRY-US, V52, P4089, DOI 10.1021/bi4001479; Singh H, 2013, J BIOL CHEM, V288, P36189, DOI 10.1074/jbc.M113.525709; Soniya K, 2018, J COMPUT CHEM, V39, P1629, DOI 10.1002/jcc.25338; Sun SX, 1999, BIOCHEMISTRY-US, V38, P4058, DOI 10.1021/bi982924t; Tirupati B, 2004, BIOCHEMISTRY-US, V43, P12210, DOI 10.1021/bi0491447; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Toney MD, 2011, BBA-PROTEINS PROTEOM, V1814, P1407, DOI 10.1016/j.bbapap.2011.05.019; Trotter V, 2009, MOL MICROBIOL, V74, P1527, DOI 10.1111/j.1365-2958.2009.06954.x; Van Hoewyk D, 2007, P NATL ACAD SCI USA, V104, P5686, DOI 10.1073/pnas.0700774104; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zhou XZ, 1999, BIOCHEMISTRY-US, V38, P311, DOI 10.1021/bi981455s	44	17	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12444	12458		10.1074/jbc.RA119.009471	http://dx.doi.org/10.1074/jbc.RA119.009471			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248989	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000484402700016
J	Libiad, M; Vitvitsky, V; Bostelaar, T; Bak, DW; Lee, HJ; Sakamoto, N; Fearon, E; Lyssiotis, CA; Weerapana, E; Banerjee, R				Libiad, Marouane; Vitvitsky, Victor; Bostelaar, Trever; Bak, Daniel W.; Lee, Ho-Joon; Sakamoto, Naoya; Fearon, Eric; Lyssiotis, Costas A.; Weerapana, Eranthie; Banerjee, Ruma			Hydrogen sulfide perturbs mitochondrial bioenergetics and triggers metabolic reprogramming in colon cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell metabolism; hydrogen sulfide; bioenergetics; colorectal cancer; cell signaling; redox signaling; colonocytes; gut epithelium; metabolic reprogramming; microbiome	OXIDATION; PROTEIN; THIOSULFATE; GROWTH	Unlike most other tissues, the colon epithelium is exposed to high levels of H2S derived from gut microbial metabolism. H2S is a signaling molecule that modulates various physiological effects. It is also a respiratory toxin that inhibits complex IV in the electron transfer chain (ETC). Colon epithelial cells are adapted to high environmental H2S exposure as they harbor an efficient mitochondrial H2S oxidation pathway, which is dedicated to its disposal. Herein, we report that the sulfide oxidation pathway enzymes are apically localized in human colonic crypts at the host-microbiome interface, but that the normal apical-to-crypt gradient is lost in colorectal cancer epithelium. We found that sulfide quinone oxidoreductase (SQR), which catalyzes the committing step in the mitochondrial sulfide oxidation pathway and couples to complex III, is a critical respiratory shield against H2S poisoning. H2S at concentrations <= 20 mu m stimulated the oxygen consumption rate in colon epithelial cells, but, when SQR expression was ablated, H2S concentrations as low as 5 mu m poisoned cells. Mitochondrial H2S oxidation altered cellular bioenergetics, inducing a reductive shift in the NAD(+)/NADH redox couple. The consequent electron acceptor insufficiency caused uridine and aspartate deficiency and enhanced glutamine-dependent reductive carboxylation. The metabolomic signature of this H2S-induced stress response mapped, in part, to redox-sensitive nodes in central carbon metabolism. Colorectal cancer tissues and cell lines appeared to counter the growth-restricting effects of H2S by overexpressing sulfide oxidation pathway enzymes. Our findings reveal an alternative mechanism for H2S signaling, arising from alterations in mitochondrial bioenergetics that drive metabolic reprogramming	[Libiad, Marouane; Vitvitsky, Victor; Bostelaar, Trever; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Lee, Ho-Joon; Lyssiotis, Costas A.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Fearon, Eric; Lyssiotis, Costas A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Bak, Daniel W.; Weerapana, Eranthie] Boston Coll, Chem Dept, Chestnut Hill, MA 02467 USA; [Sakamoto, Naoya] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima 7348553, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Boston College; Hiroshima University	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Lyssiotis, Costas A/AAI-1923-2019; Vitvitsky, Victor/ABA-2967-2021; Lee, Ho-Joon/AAA-3160-2020	Lyssiotis, Costas A/0000-0001-9309-6141; Vitvitsky, Victor/0000-0001-6251-6115; Lee, Ho-Joon/0000-0003-3616-5387; Libiad, Marouane/0000-0003-1717-9206; Bak, Daniel/0000-0002-2252-1718	National Institutes of Health [DK097153, GM130183]; Charles Woodson Research Fund; University of Michigan Pediatric Brain Tumor Initiative; University of Michigan Comprehensive Cancer Center Core Grant [P30 CA046592]; 2017 AACR NextGen Grant for Transformative Cancer Research [17-20-01-LYSS]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM130183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles Woodson Research Fund; University of Michigan Pediatric Brain Tumor Initiative; University of Michigan Comprehensive Cancer Center Core Grant; 2017 AACR NextGen Grant for Transformative Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health Grant GM130183 (to R. B). Metabolomics studies performed at the University of Michigan were supported by National Institutes of Health Grant DK097153, the Charles Woodson Research Fund, and the University of Michigan Pediatric Brain Tumor Initiative. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by University of Michigan Comprehensive Cancer Center Core Grant P30 CA046592.; Supported by a 2017 AACR NextGen Grant for Transformative Cancer Research (17-20-01-LYSS).	Bak DW, 2017, ACS CHEM BIOL, V12, P947, DOI 10.1021/acschembio.6b01074; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; DePlancke B, 2003, EXP BIOL MED, V228, P424, DOI 10.1177/153537020322800413; Doka E, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500968; Edge SB., 2010, AJCC CANC STAGING MA, P143; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; HARRIS M, 1980, SOMAT CELL GENET, V6, P699, DOI 10.1007/BF01538969; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Landry AP, 2017, J BIOL CHEM, V292, P11641, DOI 10.1074/jbc.M117.788547; Lee H.-J., 2019, METAANALYSIS TARGETE, DOI [10.1101/509372, DOI 10.1101/509372]; Libiad M, 2018, J BIOL CHEM, V293, P2675, DOI 10.1074/jbc.RA117.000826; Libiad M, 2015, J BIOL CHEM, V290, P23579, DOI 10.1074/jbc.M115.675694; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Linden DR, 2014, ANTIOXID REDOX SIGN, V20, P818, DOI 10.1089/ars.2013.5312; LOFFLER M, 1982, MOL CELL BIOCHEM, V48, P77; MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x; Magee EA, 2000, AM J CLIN NUTR, V72, P1488; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Qian Y, 2013, CHEMBIOCHEM, V14, P1410, DOI 10.1002/cbic.201300396; Ramsden JD, 2001, J CLIN ENDOCR METAB, V86, P2709, DOI 10.1210/jc.86.6.2709; Speers AE, 2005, J AM CHEM SOC, V127, P10018, DOI 10.1021/ja0532842; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Vitvitsky V, 2018, ACS CHEM BIOL, V13, P2300, DOI 10.1021/acschembio.8b00463; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Warburg O, 1924, BIOCHEM Z, V152, P309; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang DH, 2014, ANGEW CHEM INT EDIT, V53, P575, DOI 10.1002/anie.201305876	44	54	55	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12077	12090		10.1074/jbc.RA119.009442	http://dx.doi.org/10.1074/jbc.RA119.009442			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31213529	hybrid, Green Published			2022-12-28	WOS:000484284500012
J	Wang, JL; Zielewicz, L; Grewer, C				Wang, Jiali; Zielewicz, Laura; Grewer, Christof			A K+/Na+ co-binding state: Simultaneous versus competitive binding of K+ and Na+ to glutamate transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; neurotransmitter transport; electrophysiology; kinetics; potassium transport	AMINO-ACID TRANSPORTER; GLIAL-CELLS; NA+/CA2+ EXCHANGER; ION-EXCHANGE; ASPARTATE; MECHANISM; SODIUM; POTASSIUM; SUBSTRATE; RESIDUE	Plasma membrane-associated glutamate transporters play a key role in signaling by the major excitatory neurotransmitter glutamate. Uphill glutamate uptake into cells is energetically driven by coupling to co-transport of three Na+ ions. In exchange, one K+ ion is counter-transported. Currently accepted transport mechanisms assume that Na+ and K+ effects are exclusive, resulting from competition of these cations at the binding level. Here, we used electrophysiological analysis to test the effects of K+ and Na+ on neuronal glutamate transporter excitatory amino acid carrier 1 (EAAC1; the rat homologue of human excitatory amino acid transporter 3 (EAAT3)). Unexpectedly, extracellular K+ application to EAAC1 induced anion current, but only in the presence of Na+. This result could be explained with a K+/Na+ co-binding state in which the two cations simultaneously bind to the transporter. We obtained further evidence for this co-binding state, and its anion conductance, by analyzing transient currents when Na+ was exchanged for K+ and effects of the [K+]/[Na+] ratio on glutamate affinity. Interestingly, we observed the K+/Na+ co-binding state not only in EAAC1 but also in the subtypes EAAT1 and -2, which, unlike EAAC1, conducted anions in response to K+ only. We incorporated these experimental findings in a revised transport mechanism, including the K+/Na+ co-binding state and the ability of K+ to activate anion current. Overall, these results suggest that differentiation between Na+ and K+ does not occur at the binding level but is conferred by coupling of cation binding to conformational changes. These findings have implications also for other exchangers.	[Wang, Jiali; Zielewicz, Laura; Grewer, Christof] Binghamton Univ, Dept Chem, 4400 Vestal Pkwy East, Binghamton, NY 13902 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Grewer, C (corresponding author), Binghamton Univ, Dept Chem, 4400 Vestal Pkwy East, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu		wang, jiali/0000-0002-9520-8140	National Science Foundation [1515028]; United States-Israel Binational Science Foundation [2007051]	National Science Foundation(National Science Foundation (NSF)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by National Science Foundation Grant 1515028 (to C.G.) and United States-Israel Binational Science Foundation Grant 2007051 (to C.G. and Baruch Kanner). The authors declare that they have no conflicts of interest with the contents of this article.	AMATO A, 1994, J PHYSIOL-LONDON, V479, P371, DOI 10.1113/jphysiol.1994.sp020302; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BARBOUR B, 1988, NATURE, V335, P433, DOI 10.1038/335433a0; Bergles DE, 2002, J NEUROSCI, V22, P10153; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Cater RJ, 2014, BIOPHYS J, V107, P621, DOI 10.1016/j.bpj.2014.05.046; Cheng MH, 2017, ELIFE, V6, DOI 10.7554/eLife.25850; Divito CB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00150; Fahlke C, 2016, PFLUG ARCH EUR J PHY, V468, P491, DOI 10.1007/s00424-015-1768-3; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2012, J BIOL CHEM, V287, P26921, DOI 10.1074/jbc.M112.364059; Heinzelmann G, 2014, BIOPHYS J, V106, P2675, DOI 10.1016/j.bpj.2014.05.010; Heinzelmann G, 2011, BIOPHYS J, V101, P2380, DOI 10.1016/j.bpj.2011.10.010; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Liao J, 2016, NAT STRUCT MOL BIOL, V23, P590, DOI 10.1038/nsmb.3230; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; Marinelli F, 2014, P NATL ACAD SCI USA, V111, pE5354, DOI 10.1073/pnas.1415751111; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; REEVES JP, 1983, J BIOL CHEM, V258, P3178; Setiadi J, 2015, BIOMOLECULES, V5, P3067, DOI 10.3390/biom5043067; Shlosman I, 2018, J GEN PHYSIOL, V150, P51, DOI 10.1085/jgp.201711897; Sibille J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004137; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; Verdon G, 2014, ELIFE, V3, DOI 10.7554/eLife.02283; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wang JL, 2018, J PHYS CHEM B, V122, P28, DOI 10.1021/acs.jpcb.7b09059; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104; Zielewicz L, 2019, ACS CHEM BIOL, V14, P1002, DOI 10.1021/acschembio.9b00194	48	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12180	12190		10.1074/jbc.RA119.009421	http://dx.doi.org/10.1074/jbc.RA119.009421			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31235523	hybrid, Green Published			2022-12-28	WOS:000484284500021
J	De Wit, F; Pillalamarri, SR; Sebastian-Martin, A; Venkatesham, A; Van Aerschot, A; Debyser, Z				De Wit, Fiore; Pillalamarri, Sambasiva Rao; Sebastian-Martin, Alba; Venkatesham, Akkaladevi; Van Aerschot, Arthur; Debyser, Zeger			Design of reverse transcriptase-specific nucleosides to visualize early steps of HIV-1 replication by click labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); reverse transcription; click chemistry; fluorescence; nucleoside; nucleotide analog; viral replication; chemical probe; propargylated deoxynucleosides; single viral particle detection	IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEAR ENTRY; IN-VIVO; DNA; INHIBITORS; INFECTION; PROGRESSION; CELLS; ASSAY; EDU	Only a small portion of human immunodeficiency virus type 1 (HIV-1) particles entering the host cell results in productive infection, emphasizing the importance of identifying the functional virus population. Because integration of viral DNA (vDNA) is required for productive infection, efficient vDNA detection is crucial. Here, we use click chemistry to label viruses with integrase coupled to eGFP (HIVIN-eGFP) and visualize vDNA. Because click labeling with 5-ethynyl-2 '-deoxyuridine is hampered by intense background staining of the host nucleus, we opted for developing HIV-1 reverse transcriptase (RT)-specific 2 '-deoxynucleoside analogs that contain a clickable triple bond. We synthesized seven propargylated 2 '-deoxynucleosides and tested them for lack of cytotoxicity and viral replication inhibition, RT-specific primer extension and incorporation kinetics in vitro, and the capacity to stain HIV-1 DNA. The triphosphate of analog A5 was specifically incorporated by HIV-1 RT, but no vDNA staining was detected during infection. Analog A3 was incorporated in vitro by HIV-1 RT and human DNA polymerase gamma and did enable specific HIV-1 DNA labeling. Additionally, A3 supported mitochondria-specific DNA labeling, in line with the in vitro findings. After obtaining proof-of-principle of RT-specific DNA labeling reported here, further chemical refinement is necessary to develop even more efficient HIV-1 DNA labels without background staining of the nucleus or mitochondria.	[De Wit, Fiore; Sebastian-Martin, Alba; Debyser, Zeger] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium; [Pillalamarri, Sambasiva Rao; Venkatesham, Akkaladevi; Van Aerschot, Arthur] Katholieke Univ Leuven, Med Chem, Rega Inst Med Res, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium; [Sebastian-Martin, Alba] CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28006, Spain	KU Leuven; KU Leuven; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Debyser, Z (corresponding author), Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium.; Van Aerschot, A (corresponding author), Katholieke Univ Leuven, Med Chem, Rega Inst Med Res, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium.	arthur.vanaerschot@kuleuven.be; zeger.debyser@kuleuven.be	debyser, zeger/H-1310-2013	debyser, zeger/0000-0002-3982-1565; Van Aerschot, Arthur/0000-0003-3528-8588; Sebastian-Martin, Alba/0000-0001-7354-8964	KU Leuven [C14/17/095]; Fonds Wetenschappelijk Onderzoek [G0A5316N, G077814N, 1110218N]; Spanish Ministry of Education, Culture and Sport [FPU2013/00693]	KU Leuven(KU Leuven); Fonds Wetenschappelijk Onderzoek(FWO); Spanish Ministry of Education, Culture and Sport(Spanish Government)	This work was supported by KU Leuven Grant C14/17/095, Fonds Wetenschappelijk Onderzoek Grants G0A5316N (to Z. D.), G077814N (to A. V. A.), and 1110218N (to F. D. W.), and Spanish Ministry of Education, Culture and Sport Grant FPU2013/00693 (to A. S.-M.). The authors declare that they have no conflicts of interest with the contents of this article.	Albanese A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002413; Ambrose Z, 2014, VIROLOGY, V454, P371, DOI 10.1016/j.virol.2014.02.004; Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; Back DJ, 2005, JAIDS-J ACQ IMM DEF, V39, pS1, DOI 10.1097/01.qai.0000168882.67942.3f; Borrenberghs D, 2016, SCI REP-UK, V6, DOI 10.1038/srep36485; Brinkman K, 2000, CURR OPIN INFECT DIS, V13, P5, DOI 10.1097/00001432-200002000-00002; Burdick RC, 2013, P NATL ACAD SCI USA, V110, pE4780, DOI 10.1073/pnas.1315996110; Campbell EM, 2007, VIROLOGY, V360, P286, DOI 10.1016/j.virol.2006.10.025; Campbell EM, 2015, NAT REV MICROBIOL, V13, P471, DOI 10.1038/nrmicro3503; Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036; Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Di Primio C, 2013, P NATL ACAD SCI USA, V110, P5636, DOI 10.1073/pnas.1216254110; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Francis AC, 2018, CELL HOST MICROBE, V23, P536, DOI 10.1016/j.chom.2018.03.009; Francis AC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005709; Gierlich J, 2007, CHEM-EUR J, V13, P9486, DOI 10.1002/chem.200700502; Gierlich J, 2006, ORG LETT, V8, P3639, DOI 10.1021/ol0610946; Hanes JW, 2008, ANTIMICROB AGENTS CH, V52, P253, DOI 10.1128/AAC.00778-07; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; LUDWIG J, 1981, ACTA BIOCHIM BIOPHYS, V16, P131; Mamede JI, 2017, P NATL ACAD SCI USA, V114, pE7169, DOI 10.1073/pnas.1706245114; Marini B, 2015, NATURE, V521, P227, DOI 10.1038/nature14226; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Menendez-Arias L, 2017, VIRUS RES, V234, P153, DOI 10.1016/j.virusres.2016.12.019; Neef AB, 2011, P NATL ACAD SCI USA, V108, P20404, DOI 10.1073/pnas.1101126108; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; Peng K, 2014, ELIFE, V3, DOI 10.7554/eLife.04114; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Puray-Chavez M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01693-z; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Ross HH, 2011, J NEURO-ONCOL, V105, P485, DOI 10.1007/s11060-011-0621-6; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Stultz RD, 2017, J VIROL, V91, DOI 10.1128/JVI.00034-17; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; SZUCS G, 1988, B WORLD HEALTH ORGAN, V66, P729; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Venkatesham A, 2019, MOLECULES, V24, DOI 10.3390/molecules24030468; Wang IH, 2013, CELL HOST MICROBE, V14, P468, DOI 10.1016/j.chom.2013.09.004; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249	42	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11863	11875		10.1074/jbc.RA118.007185	http://dx.doi.org/10.1074/jbc.RA118.007185			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31201270	Green Published, hybrid			2022-12-28	WOS:000486127800022
J	Klip, A; McGraw, TE; James, DE				Klip, Amira; McGraw, Timothy E.; James, David E.			Thirty sweet years of GLUT4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						glucose transport; glucose metabolism; insulin; exercise; diabetes; signal transduction; GLUT4 storage vesicle (GSV); metabolic syndrome; solute carrier family 2 member 4 (SLC2A4); vesicle traffic	REGULATABLE GLUCOSE-TRANSPORTER; HUMAN SKELETAL-MUSCLE; RAT ADIPOSE-CELLS; INSULIN-RESPONSIVE TRAFFICKING; PLASMA-MEMBRANE; AKT SUBSTRATE; INTRACELLULAR SEQUESTRATION; SUBCELLULAR TRAFFICKING; APPARENT TRANSLOCATION; INTERNALIZATION MOTIF	A pivotal metabolic function of insulin is the stimulation of glucose uptake into muscle and adipose tissues. The discovery of the insulin-responsive glucose transporter type 4 (GLUT4) protein in 1988 inspired its molecular cloning in the following year. It also spurred numerous cellular mechanistic studies laying the foundations for how insulin regulates glucose uptake by muscle and fat cells. Here, we reflect on the importance of the GLUT4 discovery and chronicle additional key findings made in the past 30 years. That exocytosis of a multispanning membrane protein regulates cellular glucose transport illuminated a novel adaptation of the secretory pathway, which is to transiently modulate the protein composition of the cellular plasma membrane. GLUT4 controls glucose transport into fat and muscle tissues in response to insulin and also into muscle during exercise. Thus, investigation of regulated GLUT4 trafficking provides a major means by which to map the essential signaling components that transmit the effects of insulin and exercise. Manipulation of the expression of GLUT4 or GLUT4-regulating molecules in mice has revealed the impact of glucose uptake on whole-body metabolism. Remaining gaps in our understanding of GLUT4 function and regulation are highlighted here, along with opportunities for future discoveries and for the development of therapeutic approaches to manage metabolic disease.	[Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [McGraw, Timothy E.] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10065 USA; [James, David E.] Univ Sydney, Sydney Med Sch, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2050, Australia	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Cornell University; University of Sydney	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada.; McGraw, TE (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10065 USA.; James, DE (corresponding author), Univ Sydney, Sydney Med Sch, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2050, Australia.	amira@sickkids.ca; temcgraw@med.cornell.edu; david.james@sydney.edu.au		James, David/0000-0001-5946-5257	NIDDK NIH HHS [P30 DK020541] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashrafi G, 2017, NEURON, V93, P606, DOI 10.1016/j.neuron.2016.12.020; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bakirtzi K, 2009, J NEUROSCI, V29, P5193, DOI 10.1523/JNEUROSCI.0858-09.2009; Beg M, 2017, ELIFE, V6, DOI 10.7554/eLife.26896; Blot V, 2008, MOL BIOL CELL, V19, P3477, DOI 10.1091/mbc.E08-03-0236; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Boguslavsky S, 2012, MOL BIOL CELL, V23, P4065, DOI 10.1091/mbc.E12-04-0263; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; Bruno J, 2016, J CELL BIOL, V214, P61, DOI 10.1083/jcb.201509052; Capilla E, 2007, MOL ENDOCRINOL, V21, P3087, DOI 10.1210/me.2006-0476; Chadt A, 2015, DIABETES, V64, P746, DOI 10.2337/db14-0368; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Chiu TT, 2010, MOL BIOL CELL, V21, P3529, DOI 10.1091/mbc.E10-04-0316; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; Daugaard JR, 2000, DIABETES, V49, P1092, DOI 10.2337/diabetes.49.7.1092; DEHERREROS AG, 1989, J BIOL CHEM, V264, P19994; Di Chiara M, 2015, AM J PHYSIOL-RENAL, V309, pF779, DOI 10.1152/ajprenal.00139.2015; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Etgen GJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE864, DOI 10.1152/ajpendo.1997.272.5.E864; Etgen GJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE294, DOI 10.1152/ajpendo.1996.271.2.E294; Fazakerley DJ, 2019, J LIPID RES, V60, P1720, DOI 10.1194/jlr.R087510; Fazakerley DJ, 2015, J BIOL CHEM, V290, P23528, DOI 10.1074/jbc.M115.657361; Fazakerley DJ, 2009, J CELL SCI, V122, P727, DOI 10.1242/jcs.041178; Foley KP, 2014, BIOL OPEN, V3, P314, DOI 10.1242/bio.20147898; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; GARIPPA RJ, 1994, J CELL BIOL, V124, P705, DOI 10.1083/jcb.124.5.705; Garippa RJ, 1996, J BIOL CHEM, V271, P20660, DOI 10.1074/jbc.271.34.20660; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; GARVEY WT, 1993, DIABETES, V42, P1773, DOI 10.2337/diabetes.42.12.1773; GIBBS EM, 1995, J CLIN INVEST, V95, P1512, DOI 10.1172/JCI117823; Gillingham AK, 1999, J CELL SCI, V112, P4793; Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108; Goodyear LJ, 1996, DIABETES, V45, P1051, DOI 10.2337/diabetes.45.8.1051; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Habtemichael EN, 2018, J BIOL CHEM, V293, P10466, DOI 10.1074/jbc.RA118.003021; Habtemichael EN, 2011, J BIOL CHEM, V286, P10115, DOI 10.1074/jbc.M111.217935; Hammarstedt A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34113-3; HANEY PM, 1991, J CELL BIOL, V114, P689, DOI 10.1083/jcb.114.4.689; HANEY PM, 1995, J CELL BIOL, V129, P641, DOI 10.1083/jcb.129.3.641; Hansen PA, 1998, J BIOL CHEM, V273, P18173, DOI 10.1074/jbc.273.29.18173; Hargett SR, 2016, AM J PHYSIOL-ENDOC M, V310, pE276, DOI 10.1152/ajpendo.00342.2015; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; HOLLOSZY JO, 1965, J BIOL CHEM, V240, P3493; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; Howlett KF, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.65; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jaldin-Fincati JR, 2017, TRENDS ENDOCRIN MET, V28, P597, DOI 10.1016/j.tem.2017.05.002; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KAHN B B, 1985, Diabetes Metabolism Reviews, V1, P203; KAHN BB, 1994, J NUTR, V124, pS1289, DOI 10.1093/jn/124.suppl_8.1289S; KANAI F, 1993, J BIOL CHEM, V268, P14523; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Kennedy JW, 1999, DIABETES, V48, P1192, DOI 10.2337/diabetes.48.5.1192; KLIP A, 1990, BIOCHEM BIOPH RES CO, V172, P728, DOI 10.1016/0006-291X(90)90735-6; KLIP A, 1987, FEBS LETT, V224, P224, DOI 10.1016/0014-5793(87)80452-0; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Koumanov F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044141; Kristiansen S, 1996, BBA-BIOMEMBRANES, V1282, P71, DOI 10.1016/0005-2736(96)00041-7; Kristiansen S, 1996, AM J PHYSIOL-ENDOC M, V270, pE197, DOI 10.1152/ajpendo.1996.270.1.E197; Lampson MA, 2001, MOL BIOL CELL, V12, P3489, DOI 10.1091/mbc.12.11.3489; Lampson MA, 2000, J CELL SCI, V113, P4065; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Li CH, 2004, CELL RES, V14, P480, DOI 10.1038/sj.cr.7290251; Li DL, 2001, J BIOL CHEM, V276, P22883, DOI 10.1074/jbc.M010143200; Li LV, 2005, MOL ENDOCRINOL, V19, P2145, DOI 10.1210/me.2005-0032; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Lund S, 1997, DIABETES, V46, P1965, DOI 10.2337/diabetes.46.12.1965; Mafakheri S, 2018, J BIOL CHEM, V293, P17853, DOI 10.1074/jbc.RA118.005040; Mafakheri S, 2018, BIOCHEM SOC T, V46, P683, DOI 10.1042/BST20170479; Malide D, 1997, J HISTOCHEM CYTOCHEM, V45, P1083, DOI 10.1177/002215549704500806; Manousaki D, 2016, DIABETES CARE, V39, P1889, DOI 10.2337/dc16-0769; MARETTE A, 1992, AM J PHYSIOL, V263, pC443, DOI 10.1152/ajpcell.1992.263.2.C443; McGee SL, 2004, DIABETES, V53, P1208, DOI 10.2337/diabetes.53.5.1208; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Moraes-Vieira PM, 2016, DIABETES, V65, P1808, DOI 10.2337/db16-0221; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Ng Y, 2010, J BIOL CHEM, V285, P2255, DOI 10.1074/jbc.M109.060236; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Okada S, 2008, J BIOL CHEM, V283, P35455, DOI 10.1074/jbc.M806531200; Pan X, 2017, MOL BIOL CELL, V28, P1667, DOI 10.1091/mbc.E16-11-0777; Pillon NJ, 2018, J LIPID RES, V59, P1148, DOI 10.1194/jlr.M080788; PIPER RC, 1992, J CELL BIOL, V117, P729, DOI 10.1083/jcb.117.4.729; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; PLOUG T, 1993, AM J PHYSIOL, V264, pE270, DOI 10.1152/ajpendo.1993.264.2.E270; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; RAMLAL T, 1989, ENDOCRINOLOGY, V125, P890, DOI 10.1210/endo-125-2-890; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Ren HX, 2015, DIABETES, V64, P405, DOI 10.2337/db14-0752; Reno CM, 2017, DIABETES, V66, P587, DOI 10.2337/db16-0917; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; ROTHMAN DL, 1992, J CLIN INVEST, V89, P1069, DOI 10.1172/JCI115686; Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x; Ryder JW, 2000, DIABETES, V49, P647, DOI 10.2337/diabetes.49.4.647; Sadacca LA, 2013, MOL BIOL CELL, V24, P2544, DOI 10.1091/mbc.E13-02-0103; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; SATOH S, 1993, J BIOL CHEM, V268, P17820; Shamni O, 2017, BBA-BIOMEMBRANES, V1859, P1900, DOI 10.1016/j.bbamem.2017.06.013; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Shewan AM, 2000, BIOCHEM J, V350, P99, DOI 10.1042/0264-6021:3500099; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Sun Y, 2016, MOL BIOL CELL, V27, P75, DOI 10.1091/mbc.E15-05-0319; Sun Y, 2014, MOL BIOL CELL, V25, P1159, DOI 10.1091/mbc.E13-08-0493; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; Sylow L, 2017, DIABETES, V66, P1548, DOI 10.2337/db16-1138; Sylow L, 2017, NAT REV ENDOCRINOL, V13, P133, DOI 10.1038/nrendo.2016.162; Sylow L, 2014, CELL SIGNAL, V26, P323, DOI 10.1016/j.cellsig.2013.11.007; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Tan SX, 2012, MOL CELL BIOL, V32, P4946, DOI 10.1128/MCB.00761-12; Tokarz VL, 2018, J CELL BIOL, V217, P2273, DOI 10.1083/jcb.201802095; Tonks KT, 2013, DIABETOLOGIA, V56, P875, DOI 10.1007/s00125-012-2811-y; Tucker DF, 2018, P NATL ACAD SCI USA, V115, pE4990, DOI 10.1073/pnas.1716788115; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Vazirani RP, 2016, DIABETES, V65, P1577, DOI 10.2337/db15-1128; VERHEY KJ, 1995, J CELL BIOL, V130, P1071, DOI 10.1083/jcb.130.5.1071; WALLBERGHENRIKSSON H, 1984, J APPL PHYSIOL, V57, P1045, DOI 10.1152/jappl.1984.57.4.1045; WALLBERGHENRIKSSON H, 1985, AM J PHYSIOL, V249, pC233, DOI 10.1152/ajpcell.1985.249.3.C233; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Wang WC, 1996, J CELL BIOL, V135, P415, DOI 10.1083/jcb.135.2.415; WARDZALA LJ, 1978, J BIOL CHEM, V253, P8002; WARDZALA LJ, 1981, J BIOL CHEM, V256, P7090; Wasik AA, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00155; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Whitfield J, 2017, J BIOL CHEM, V292, P16653, DOI 10.1074/jbc.M117.806786; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang Z, 2016, FASEB J, V30, P1037, DOI 10.1096/fj.15-274704; Zaid H, 2009, BIOCHEM J, V419, P475, DOI 10.1042/BJ20081319; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071; Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	152	131	137	13	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11369	11381		10.1074/jbc.REV119.008351	http://dx.doi.org/10.1074/jbc.REV119.008351			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31175156	Green Published, hybrid			2022-12-28	WOS:000478717600002
J	Lin, DW; Chung, BP; Huang, JW; Wang, XR; Huang, L; Kaiser, P				Lin, Da-Wei; Chung, Benjamin P.; Huang, Jia-Wei; Wang, Xiaorong; Huang, Lan; Kaiser, Peter			Microhomology-based CRISPR tagging tools for protein tracking, purification, and depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; auxin; protein engineering; gene expression; protein purification; protein degradation; AID; epitope tagging; microhomology	DEGRON SYSTEM; CELLS; IDENTIFICATION; COMPLEXES; MECHANISM; CLEAVAGE; MODEL; PP2A; TAG	Work in yeast models has benefitted tremendously from the insertion of epitope or fluorescence tags at the native gene locus to study protein function and behavior under physiological conditions. In contrast, work in mammalian cells largely relies on overexpression of tagged proteins because high-quality antibodies are only available for a fraction of the mammalian proteome. CRISPR/Cas9-mediated genome editing has recently emerged as a powerful genome-modifying tool that can also be exploited to insert various tags and fluorophores at gene loci to study the physiological behavior of proteins in most organisms, including mammals. Here we describe a versatile toolset for rapid tagging of endogenous proteins. The strategy utilizes CRISPR/Cas9 and microhomology-mediated end joining repair for efficient tagging. We provide tools to insert 3xHA, His(6)FLAG, His(6)-Biotin-TEV-RGSHis(6), mCherry, GFP, and the auxin-inducible degron tag for compound-induced protein depletion. This approach and the developed tools should greatly facilitate functional analysis of proteins in their native environment.	[Lin, Da-Wei; Chung, Benjamin P.; Huang, Jia-Wei; Kaiser, Peter] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92617 USA; [Wang, Xiaorong; Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92617 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Kaiser, P (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92617 USA.	pkaiser@uci.edu			National Institutes of Health [R01GM066164, R01GM128432, R01GM074830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066164, R01GM074830, R01GM128432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R01GM066164 and R01GM128432 to P. K. and R01GM074830 to L.	Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bonger KM, 2011, NAT CHEM BIOL, V7, P531, DOI [10.1038/nchembio.598, 10.1038/NCHEMBIO.598]; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Chung HK, 2015, NAT CHEM BIOL, V11, P713, DOI [10.1038/nchembio.1869, 10.1038/NCHEMBIO.1869]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dalvai M, 2015, CELL REP, V13, P621, DOI 10.1016/j.celrep.2015.09.009; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Murakami K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056012; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/nchembio.597, 10.1038/NCHEMBIO.597]; Nishimura Kohei, 2014, Curr Protoc Cell Biol, V64, DOI 10.1002/0471143030.cb2009s64; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Paix A, 2014, GENETICS, V198, P1347, DOI 10.1534/genetics.114.170423; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Ryan MD, 1999, BIOORG CHEM, V27, P55, DOI 10.1006/bioo.1998.1119; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Savic D, 2015, GENOME RES, V25, P1581, DOI 10.1101/gr.193540.115; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Tagwerker C, 2006, YEAST, V23, P623, DOI 10.1002/yea.1380; Taleei R, 2013, MUTAT RES-GEN TOX EN, V756, P206, DOI 10.1016/j.mrgentox.2013.06.004; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wlodarchak N, 2016, CRIT REV BIOCHEM MOL, V51, P162, DOI 10.3109/10409238.2016.1143913; Zhou ZX, 2000, J HISTOCHEM CYTOCHEM, V48, P585, DOI 10.1177/002215540004800502	38	7	7	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10877	10885		10.1074/jbc.RA119.008422	http://dx.doi.org/10.1074/jbc.RA119.008422			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31138654	Green Published, hybrid			2022-12-28	WOS:000478717200012
J	Gerlits, O; Kong, XT; Cheng, XL; Wymore, T; Blumenthal, DK; Taylor, P; Radic, Z; Kovalevsky, A				Gerlits, Oksana; Kong, Xiaotian; Cheng, Xiaolin; Wymore, Troy; Blumenthal, Donald K.; Taylor, Palmer; Radic, Zoran; Kovalevsky, Andrey			Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylcholinesterase (AChE); X-ray crystallography; molecular modeling; protein chemical modification; structure-function; oxime reactivator; reactivation mechanism; RS-170B; VX-inhibition	ORGANOPHOSPHOROUS NERVE AGENTS; CRYSTAL-STRUCTURES; NEUTRON CRYSTALLOGRAPHY; MOLECULAR-DYNAMICS; BASIS-SETS; COMPLEX; SITE; DESIGN; INTEGRATION; METABOLITES	Exposure to organophosphorus compounds (OPs) may be fatal if untreated, and a clear and present danger posed by nerve agent OPs has become palpable in recent years. OPs inactivate acetylcholinesterase (AChE) by covalently modifying its catalytic serine. Inhibited AChE cannot hydrolyze the neurotransmitter acetylcholine leading to its build-up at the cholinergic synapses and creating an acute cholinergic crisis. Current antidotes, including oxime reactivators that attack the OP-AChE conjugate to free the active enzyme, are inefficient. Better reactivators are sought, but their design is hampered by a conformationally rigid portrait of AChE extracted exclusively from 100K X-ray crystallography and scarcity of structural knowledge on human AChE (hAChE). Here, we present room temperature X-ray structures of native and VX-phosphonylated hAChE with an imidazole-based oxime reactivator, RS-170B. We discovered that inhibition with VX triggers substantial conformational changes in bound RS-170B from a nonproductive pose (the reactive aldoxime group points away from the VX-bound serine) in the reactivator-only complex to a semi-productive orientation in the VX-modified complex. This observation, supported by concurrent molecular simulations, suggested that the narrow active-site gorge of hAChE may be significantly more dynamic than previously thought, allowing RS-170B to reorient inside the gorge. Furthermore, we found that small molecules can bind in the choline-binding site hindering approach to the phosphorous of VX-bound serine. Our results provide structural and mechanistic perspectives on the reactivation of OP-inhibited hAChE and demonstrate that structural studies at physiologically relevant temperatures can deliver previously overlooked insights applicable for designing next-generation antidotes.	[Gerlits, Oksana] Univ Tennessee, Bredesen Ctr, Knoxville, TN 37996 USA; [Kong, Xiaotian; Cheng, Xiaolin] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Wymore, Troy] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; [Taylor, Palmer; Radic, Zoran] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Kovalevsky, Andrey] Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN 37831 USA	University of Tennessee System; University of Tennessee Knoxville; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; United States Department of Energy (DOE); Oak Ridge National Laboratory	Kovalevsky, A (corresponding author), Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN 37831 USA.	kovalevskyay@ornl.gov		Kovalevsky, Andrey/0000-0003-4459-9142; Blumenthal, Donald/0000-0002-8614-1167; Cheng, Xiaolin/0000-0002-7396-3225	United States DOE [DE-AC02-06CH11357]; Office of Biological and Environmental Research; Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS098998, U01NS083451] Funding Source: NIH RePORTER	United States DOE(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	X-ray crystallographic data presented here were collected at Argonne National Laboratory using Structural Biology Center (SBC) beamline ID19 at the Advanced Photon Source. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract number DE-AC02-06CH11357. The Office of Biological and Environmental Research supported research at the Center for Structural Molecular Biology (CSMB) at ORNL using facilities supported by the Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allgardsson A, 2016, P NATL ACAD SCI USA, V113, P5514, DOI 10.1073/pnas.1523362113; Amitai G, 2007, TOXICOLOGY, V233, P187, DOI 10.1016/j.tox.2006.09.020; Artursson E, 2013, BIOCHEM PHARMACOL, V85, P1389, DOI 10.1016/j.bcp.2013.01.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr JR, 2004, J ANAL TOXICOL, V28, P372, DOI 10.1093/jat/28.5.372; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bester SM, 2018, CHEM RES TOXICOL, V31, P1405, DOI 10.1021/acs.chemrestox.8b00294; Bourne Y, 1999, J BIOL CHEM, V274, P2963, DOI 10.1074/jbc.274.5.2963; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carletti E, 2010, J MED CHEM, V53, P4002, DOI 10.1021/jm901853b; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheung J, 2013, ACS MED CHEM LETT, V4, P1091, DOI 10.1021/ml400304w; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; Clifford E. F., 2002, ACTA CRYSTALLOGR D, V58, P1765, DOI [10.1107/S0907444902011642, DOI 10.1107/S0907444902011642]; Cochran R, 2011, J BIOL CHEM, V286, P29718, DOI 10.1074/jbc.M111.264739; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; Dym O, 2016, PROTEIN SCI, V25, P1096, DOI 10.1002/pro.2923; Ekstrom F, 2006, BIOCHEMISTRY-US, V45, P74, DOI 10.1021/bi051286t; Ekstrom FJ, 2007, CLIN PHARMACOL THER, V82, P282, DOI 10.1038/sj.clpt.6100151; Ekstrom F, 2006, BIOCHEM PHARMACOL, V72, P597, DOI 10.1016/j.bcp.2006.05.027; Ekstrom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005957; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franklin MC, 2016, PROTEINS, V84, P1246, DOI 10.1002/prot.25073; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gerlits O, 2017, J MED CHEM, V60, P2018, DOI 10.1021/acs.jmedchem.6b01767; Gorecki L, 2016, ARCH TOXICOL, V90, P2831, DOI 10.1007/s00204-016-1827-3; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Hornberg A, 2007, BIOCHEMISTRY-US, V46, P4815, DOI 10.1021/bi0621361; Huang GY, 2014, BIOCHEMISTRY-US, V53, P6725, DOI 10.1021/bi501012v; Jorgensen WL, 2005, P NATL ACAD SCI USA, V102, P6665, DOI 10.1073/pnas.0408037102; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kastner J, 2011, WIRES COMPUT MOL SCI, V1, P932, DOI 10.1002/wcms.66; Katalinic M, 2018, TOXICOLOGY, V406, P104, DOI 10.1016/j.tox.2018.05.008; Katalinic M, 2012, CROAT CHEM ACTA, V85, P209, DOI 10.5562/cca1815; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kovalevsky A, 2018, STRUCTURE, V26, P383, DOI 10.1016/j.str.2018.01.006; Kovalevsky A, 2016, ANN NY ACAD SCI, V1378, P41, DOI 10.1111/nyas.13128; Kovarik Z, 2015, CHEM RES TOXICOL, V28, P1036, DOI 10.1021/acs.chemrestox.5b00060; KREIMER DI, 1994, BIOCHEMISTRY-US, V33, P14407, DOI 10.1021/bi00252a006; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Legler PM, 2015, ACTA CRYSTALLOGR D, V71, P1788, DOI 10.1107/S1399004715011281; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Millard CB, 1999, BIOCHEMISTRY-US, V38, P7032, DOI 10.1021/bi982678l; Millard CB, 1999, J AM CHEM SOC, V121, P9883, DOI 10.1021/ja992704i; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Radic Z, 2010, CHEM-BIOL INTERACT, V187, P163, DOI 10.1016/j.cbi.2010.04.014; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanson B, 2009, J MED CHEM, V52, P7593, DOI 10.1021/jm900433t; Santoni G, 2018, J MED CHEM, V61, P7630, DOI 10.1021/acs.jmedchem.8b00592; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Sit RK, 2014, J MED CHEM, V57, P1378, DOI 10.1021/jm401650z; Solberg Y, 1997, TRENDS PHARMACOL SCI, V18, P183, DOI 10.1016/S0165-6147(97)89540-5; Souaille M, 2001, COMPUT PHYS COMMUN, V135, P40, DOI 10.1016/S0010-4655(00)00215-0; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Tsuchihashi H, 1998, J ANAL TOXICOL, V22, P383, DOI 10.1093/jat/22.5.383; Vandavasi VG, 2018, STRUCTURE, V26, P1645, DOI 10.1016/j.str.2018.08.001; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; VELAN B, 1993, BIOCHEM J, V296, P649, DOI 10.1042/bj2960649; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Wandhammer M, 2013, CHEM-BIOL INTERACT, V203, P19, DOI 10.1016/j.cbi.2012.08.005; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weber IT, 2013, J MED CHEM, V56, P5631, DOI 10.1021/jm400684f; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Worek F, 2002, ARCH TOXICOL, V76, P523, DOI 10.1007/s00204-002-0375-1; Yang YC, 1996, J ORG CHEM, V61, P8407, DOI 10.1021/jo9614506; Zorbaz T, 2018, CHEM-EUR J, V24, P9675, DOI 10.1002/chem.201801394	79	10	10	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10607	10618		10.1074/jbc.RA119.008725	http://dx.doi.org/10.1074/jbc.RA119.008725			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138650	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000478717100019
J	dos Santos, NM; de Oliveira, GAP; Rocha, MR; Pedrote, MM; Ferretti, GDD; Rangel, LP; Morgado-Diaz, JA; Silva, JL; Gimba, ERP				dos Santos, Nataly Melo; de Oliveira, Guilherme A. P.; Rocha, Murilo Ramos; Pedrote, Murilo M.; da Silva Ferretti, Giulia Diniz; Rangel, Luciana Pereira; Morgado-Diaz, Jose A.; Silva, Jerson L.; Pereira Gimba, Etel Rodrigues			Loss of the p53 transactivation domain results in high amyloid aggregation of the 40p53 isoform in endometrial carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; p53; cancer biology; amyloid; protein misfolding; endometrium carcinoma; p53 isoforms; p53 transactivation domain (TAD)	PRION-LIKE AGGREGATION; MUTANT P53; PHOSPHORYLATION; DELTA-40P53; LACKING	Dysfunctional p53 formation and activity can result from aberrant expression and subcellular localization of distinct p53 isoforms or aggregates. Endometrial carcinoma (EC) is a cancer type in which p53 status is correlated with prognosis, and TP53 mutations are a frequent genetic modification. Here we aimed to evaluate the expression patterns of different p53 isoforms and their contributions to the formation and subcellular localization of p53 amyloid aggregates in both EC and endometrial nontumor cell lines. We found that full-length (fl) p53 and a truncated p53 isoform, 40p53, resulting from alternative splicing of exon 2 or alternative initiation of translation at ATG-40, are the predominantly expressed p53 variants in EC cells. However, 40p53 was the major p53 isoform in endometrial nontumor cells. Immunofluorescence assays revealed that 40p53 is mainly localized to cytoplasmic punctate structures of EC cells, resembling solid-phase structures similar to those found in neurodegenerative pathologies. Using light-scattering kinetics, CD, and transmission EM, we noted that the p53 N-terminal transactivation domain significantly reduces aggregation of the WT p53 DNA-binding domain, confirming the higher aggregation tendency of 40p53, which lacks this domain. This is the first report of cytoplasmic 40p53 in EC cells being a major component of amyloid aggregates. The differential aggregation properties of p53 isoforms in EC cells may open up new avenues in the development of therapeutic strategies that preferentially target specific p53 isoforms to prevent p53 amyloid aggregate formation.	[dos Santos, Nataly Melo; Rocha, Murilo Ramos; Morgado-Diaz, Jose A.; Pereira Gimba, Etel Rodrigues] Inst Nacl Canc, Coordenacao Pesquisa, Programa Oncobiol Celular & Mol, Rio De Janeiro, Brazil; [de Oliveira, Guilherme A. P.; Pedrote, Murilo M.; da Silva Ferretti, Giulia Diniz; Rangel, Luciana Pereira; Silva, Jerson L.; Pereira Gimba, Etel Rodrigues] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Inst Bioquim Med Leopoldo Meis, BR-21941902 Rio De Janeiro, Brazil; [de Oliveira, Guilherme A. P.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Rangel, Luciana Pereira] Univ Fed Rio de Janeiro, Fac Farm, BR-21941170 Rio De Janeiro, Brazil; [Pereira Gimba, Etel Rodrigues] Univ Fed Fluminense, Inst Humanidades & Saude, Dept Ciencias Nat, BR-28895532 Rio De Janeiro, Brazil; Univ Fed Fluminense, Programa Pos Grad Ciencias Biomed Fisiol & Farmac, BR-24210130 Niteroi, RJ, Brazil	National Cancer Institute (Inca); Universidade Federal do Rio de Janeiro; University of Virginia; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal Fluminense	Gimba, ERP (corresponding author), Inst Nacl Canc, Coordenacao Pesquisa, Programa Oncobiol Celular & Mol, Rio De Janeiro, Brazil.; Silva, JL; Gimba, ERP (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Inst Bioquim Med Leopoldo Meis, BR-21941902 Rio De Janeiro, Brazil.; Gimba, ERP (corresponding author), Univ Fed Fluminense, Inst Humanidades & Saude, Dept Ciencias Nat, BR-28895532 Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br; etelgimba@id.uff.brand	Morgado-Diaz, Jose A./A-9649-2010; de Oliveira, Guilherme A. P./O-1192-2013; SILVA, JERSON Lima/GRF-1442-2022; Rocha, Murilo/M-9489-2017; Silva, Jerson/J-8984-2014; Rangel, Luciana/E-7861-2018	de Oliveira, Guilherme A. P./0000-0002-0063-5888; SILVA, JERSON Lima/0000-0001-9523-9441; Rocha, Murilo/0000-0001-5499-6374; Silva, Jerson/0000-0001-9523-9441; /0000-0002-6154-0815	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB) - Institutos Nacionais de Ciencia e Tecnologia (INCT) Program) [310591/2014-7, 476871/2013-1, 465395/2014-7, 402321/2016-2]; Coordenacao de Aperfeicoamento de Ensino Superior Grant [99999.008550/2014-00]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants [E-26/210.394/2014, E-26/010.002007/2014, E-26/203.204/2015, 100.102/2018, 210.394/2014, 210.008/2018, 202.840/2018, 010.002007/2014]; Pro-reitoria de Pesquisa e Inovacao/Universidade Federal Fluminense; Ministerio da Saude	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB) - Institutos Nacionais de Ciencia e Tecnologia (INCT) Program); Coordenacao de Aperfeicoamento de Ensino Superior Grant; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants; Pro-reitoria de Pesquisa e Inovacao/Universidade Federal Fluminense; Ministerio da Saude	This research was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grants 310591/2014-7, 476871/2013-1, 465395/2014-7 (Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB) - Institutos Nacionais de Ciencia e Tecnologia (INCT) Program), 402321/2016-2; Coordenacao de Aperfeicoamento de Ensino Superior Grant 99999.008550/2014-00; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants E-26/210.394/2014, E-26/010.002007/2014, E-26/203.204/2015; 100.102/2018, 210.394/2014, 210.008/2018, 202.840/2018, and 010.002007/2014; Pro-reitoria de Pesquisa e Inovacao/Universidade Federal Fluminense; and Ministerio da Saude. The authors declare that they have no conflicts of interest with the contents of this article.	BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Bykov VJN, 2018, NAT REV CANCER, V18, P89, DOI 10.1038/nrc.2017.109; Carra G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121997; Cino EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32535; Comel A, 2014, FEBS LETT, V588, P2600, DOI 10.1016/j.febslet.2014.04.015; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Ghosh S, 2017, CELL DEATH DIFFER, V24, P1784, DOI 10.1038/cdd.2017.105; Ghosh S, 2014, BIOCHEMISTRY-US, V53, P5995, DOI 10.1021/bi500825d; Hafsi H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-134; Hussein YR, 2018, PATHOLOGY, V50, P151, DOI 10.1016/j.pathol.2017.09.010; Joruiz SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026039; Kim S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003993; Kovachev PS, 2017, J BIOL CHEM, V292, P9345, DOI 10.1074/jbc.M116.762096; Krois AS, 2018, P NATL ACAD SCI USA, V115, pE11302, DOI 10.1073/pnas.1814051115; Lei JT, 2019, FASEB J, V33, P4225, DOI 10.1096/fj.201801973R; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366; Marcel Virginie, 2013, Methods Mol Biol, V962, P15, DOI 10.1007/978-1-62703-236-0_2; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; Ota A, 2017, J CELL SCI, V130, P614, DOI 10.1242/jcs.190736; Pedrote MM, 2018, J BIOL CHEM, V293, P11374, DOI 10.1074/jbc.RA118.003285; Pijnenborg JMA, 2006, GYNECOL ONCOL, V100, P397, DOI 10.1016/j.ygyno.2005.09.056; Powell DJ, 2008, CELL CYCLE, V7, P950, DOI 10.4161/cc.7.7.5626; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Silva JL, 2018, ACCOUNTS CHEM RES, V51, P181, DOI 10.1021/acs.accounts.7b00473; Silva JL, 2014, TRENDS BIOCHEM SCI, V39, P260, DOI 10.1016/j.tibs.2014.04.001; Stiewe T, 2002, J BIOL CHEM, V277, P14177, DOI 10.1074/jbc.M200480200; Takahashi R, 2014, J INVEST DERMATOL, V134, P791, DOI 10.1038/jid.2013.391; Nguyen TT, 2015, VIRCHOWS ARCH, V466, P695, DOI 10.1007/s00428-015-1752-5; Wang DB, 2014, BBA-MOL BASIS DIS, V1842, P1186, DOI 10.1016/j.bbadis.2013.12.015; Wei JX, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/687359; Yang-Hartwich Y, 2015, ONCOGENE, V34, P3605, DOI 10.1038/onc.2014.296; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179	36	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9430	9439		10.1074/jbc.RA119.007566	http://dx.doi.org/10.1074/jbc.RA119.007566			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31028175	Green Published, hybrid			2022-12-28	WOS:000472713000013
J	Lippens, G; Gigant, B				Lippens, Guy; Gigant, Benoit			Elucidating Tau function and dysfunction in the era of cryo-EM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cryo-electron microscopy; tauopathy; Tau protein (Tau); amyloid; microtubule; tubulin; neurodegeneration; frontotemporal dementia; Alzheimer's disease	PAIRED HELICAL FILAMENTS; PROTEIN-TAU; ALZHEIMERS-DISEASE; MICROTUBULE-BINDING; NEUROFIBRILLARY TANGLES; AGGREGATION; PHOSPHORYLATION; POLYMERIZATION; ACETYLATION; COMPONENT	Tau is a microtubule-associated protein involved in the regulation of axonal microtubules in neurons. In pathological conditions, it forms fibrils that are molecular hallmarks of neurological disorders known as tauopathies. In the last 2 years, cryo-EM has given unprecedented high-resolution views of Tau in both physiological and pathological conditions. We review here these new findings and put them into the context of the knowledge about Tau before this structural breakthrough. The first structures of Tau fibrils, a molecular hallmark of Alzheimer's disease (AD), were based on fibrils from the brain of an individual with AD and, along with similar patient-derived structures, have set the gold standard for the field. Cryo-EM structures of Tau fibers in three distinct diseases, AD, Pick's disease, and chronic traumatic encephalopathy, represent the end points of Tau's molecular trajectory. We propose that the recent Tau structures may call for a re-examination of databases that link different Tau variants to various forms of dementia. We also address the question of how this structural information may link Tau's functional and pathological aspects. Because this structural information on Tau was obtained in a very short period, the new structures should be viewed in light of earlier structural observations and past and present functional data to shed additional light on Tau function and dysfunction.	[Lippens, Guy] Univ Toulouse, CNRS, INRA, Lab Ingn Syst Biol LISBP,INSA, 135 Ave Rangueil, F-31077 Toulouse 04, France; [Gigant, Benoit] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); INRAE; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lippens, G (corresponding author), Univ Toulouse, CNRS, INRA, Lab Ingn Syst Biol LISBP,INSA, 135 Ave Rangueil, F-31077 Toulouse 04, France.	glippens@insa-toulouse.fr		Lippens, Guy/0000-0002-8236-0901; Gigant, Benoit/0000-0002-5946-6759				Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; Al-Hilaly YK, 2017, J MOL BIOL, V429, P3650, DOI 10.1016/j.jmb.2017.09.007; Baas PW, 2019, TRENDS CELL BIOL, V29, P452, DOI 10.1016/j.tcb.2019.02.007; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brandt R, 2017, J NEUROCHEM, V143, P409, DOI 10.1111/jnc.14011; BRION JP, 1986, LANCET, V2, P1098, DOI 10.1016/S0140-6736(86)90495-2; Buee L, 1999, BRAIN PATHOL, V9, P681; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chemerovski-Glikman M, 2017, CHEM-EUR J, V23, P9618, DOI 10.1002/chem.201701218; Cheng YF, 2018, SCIENCE, V361, P876, DOI 10.1126/science.aat4346; Cisek K, 2014, CURR ALZHEIMER RES, V11, P918, DOI 10.2174/1567205011666141107150331; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; CROWTHER RA, 1985, EMBO J, V4, P3661, DOI 10.1002/j.1460-2075.1985.tb04132.x; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; Despres C, 2017, P NATL ACAD SCI USA, V114, P9080, DOI 10.1073/pnas.1708448114; Duan AR, 2012, MOL BIOL CELL, V23, P4796, DOI 10.1091/mbc.E12-05-0374; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Elbaum-Garfinkle S, 2014, P NATL ACAD SCI USA, V111, P6311, DOI 10.1073/pnas.1315983111; ENNULAT DJ, 1989, J BIOL CHEM, V264, P5327; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, ACTA NEUROPATHOL, V136, P699, DOI 10.1007/s00401-018-1914-z; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Fauquant C, 2011, J BIOL CHEM, V286, P33358, DOI 10.1074/jbc.M111.223545; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gandhi NS, 2015, ANGEW CHEM INT EDIT, V54, P6819, DOI 10.1002/anie.201501898; Gigant B, 2014, J AM CHEM SOC, V136, P12615, DOI 10.1021/ja504864m; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guerrero-Ferreira R, 2018, ELIFE, V7, DOI 10.7554/eLife.36402; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Huvent I, 2014, BIOCHEM BIOPH RES CO, V445, P299, DOI 10.1016/j.bbrc.2014.01.161; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1999, J NEUROSCI RES, V55, P713, DOI 10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G; JOACHIM CL, 1987, ANN NEUROL, V22, P514, DOI 10.1002/ana.410220411; Kamah A, 2014, BIOCHEMISTRY-US, V53, P3020, DOI 10.1021/bi500006v; Kellogg EH, 2018, SCIENCE, V360, P1242, DOI 10.1126/science.aat1780; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Leboeuf AC, 2008, J BIOL CHEM, V283, P36406, DOI 10.1074/jbc.M803519200; Li B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03169-0; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; Makrides V, 2003, J BIOL CHEM, V278, P33298, DOI 10.1074/jbc.M305207200; Malia TJ, 2016, PROTEINS, V84, P427, DOI 10.1002/prot.24988; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Meyer V, 2016, METHODS MOL BIOL, V1345, P185, DOI 10.1007/978-1-4939-2978-8_12; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; MURAYAMA S, 1990, ANN NEUROL, V27, P394, DOI 10.1002/ana.410270407; Niewidok B, 2016, MOL BIOL CELL, V27, P3537, DOI 10.1091/mbc.E16-06-0402; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Perez M, 1996, J NEUROCHEM, V67, P1183; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Qiang L, 2018, CURR BIOL, V28, P2181, DOI 10.1016/j.cub.2018.05.045; Renaud JP, 2018, NAT REV DRUG DISCOV, V17, P471, DOI 10.1038/nrd.2018.77; Sato C, 2018, NEURON, V97, P1284, DOI 10.1016/j.neuron.2018.02.015; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Spillantini MG, 1997, P NATL ACAD SCI USA, V94, P4113, DOI 10.1073/pnas.94.8.4113; Stohr J, 2017, NAT CHEM, V9, P874, DOI [10.1038/NCHEM.2754, 10.1038/nchem.2754]; Tacik P, 2015, ACTA NEUROPATHOL, V130, P199, DOI 10.1007/s00401-015-1425-0; TELLEZNAGEL I, 1973, ARCH NEUROL-CHICAGO, V29, P324, DOI 10.1001/archneur.1973.00490290064007; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang CK, 2016, EUR J MED CHEM, V109, P342, DOI 10.1016/j.ejmech.2016.01.006; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Yang GH, 2019, NATURE, V565, P192, DOI 10.1038/s41586-018-0813-8; Zhang WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.43584; Zhou R, 2019, SCIENCE, V363, P708, DOI 10.1126/science.aaw0930; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	91	33	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9316	9325		10.1074/jbc.REV119.008031	http://dx.doi.org/10.1074/jbc.REV119.008031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31088912	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000472713000001
J	King, C; Hristova, K				King, Christopher; Hristova, Kalina			Direct measurements of VEGF-VEGFR2 binding affinities reveal the coupling between ligand binding and receptor dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor tyrosine kinase; fluorescence; thermodynamics; signaling; ligand-binding protein	SIGNAL-TRANSDUCTION; TYROSINE KINASE; VEGF; ANGIOGENESIS; ACTIVATION; BIOLOGY; KDR	Vascular endothelial growth factor receptor 2 (VEGFR2) controls angiogenesis and is critically important for normal human development and cancer progression. A recent finding that VEGFR2 can dimerize in the absence of ligand raises the question whether VEGF binds to either VEGFR2 monomers or dimers or to both. Although VEGF-VEGFR2 effective binding constants have been measured, these prior measurements have not discriminated between the association state of the receptor. Because ligand binding is coupled to receptor dimerization, this coupling lends complexity to a seemingly straightforward problem. Here, we unravel this complexity by applying a rigorous thermodynamics approach and performing binding measurements over a broad range of receptor and ligand concentrations. By applying a global fitting procedure to a large data set, we reveal a 45-fold difference between VEGF binding affinities for monomeric and dimeric forms of VEGFR2.	[King, Christopher; Hristova, Kalina] Johns Hopkins Univ, Inst NanoBioTechnol, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [King, Christopher] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Hristova, K (corresponding author), Johns Hopkins Univ, Inst NanoBioTechnol, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	kh@jhu.edu		King, Christopher/0000-0002-2400-5717	National Institutes of Health [GM068619]; National Science Foundation [MCB 1712740, DGE-1232825]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Institutes of Health Grant GM068619, National Science Foundation Grant MCB 1712740, and National Science Foundation Graduate Research Fellowship DGE-1232825. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Anderson CR, 2010, INVEST RADIOL, V45, P579, DOI 10.1097/RLI.0b013e3181efd581; Backer MV, 2001, BIOCONJUGATE CHEM, V12, P1066, DOI 10.1021/bc015534j; Biener G, 2014, INT J MOL SCI, V15, P261, DOI 10.3390/ijms15010261; Blankenberg FG, 2011, J NUCL MED, V52, P1630, DOI 10.2967/jnumed.111.091629; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Imoukhuede PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044791; Jeltsch M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009183; Kilpatrick LE, 2017, BIOCHEM PHARMACOL, V136, P62, DOI 10.1016/j.bcp.2017.04.006; King C, 2018, BBA-BIOMEMBRANES, V1860, P2118, DOI 10.1016/j.bbamem.2018.03.023; King C, 2017, BBA-GEN SUBJECTS, V1861, P2559, DOI 10.1016/j.bbagen.2017.08.021; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; King C, 2014, BIOPHYS J, V106, P1309, DOI 10.1016/j.bpj.2014.01.039; Klagsbrun M, 2002, ADV EXP MED BIOL, V515, P33; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kut C, 2007, BRIT J CANCER, V97, P978, DOI 10.1038/sj.bjc.6603923; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Mac Gabhann F, 2010, WIRES SYST BIOL MED, V2, P694, DOI 10.1002/wsbm.92; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Nessa A, 2009, Mymensingh Med J, V18, P264; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Peach CJ, 2018, CELL CHEM BIOL, V25, P1208, DOI 10.1016/j.chembiol.2018.06.012; Quitub AA, 2009, IEEE ENG MED BIOL, V28, P14, DOI 10.1109/MEMB.2009.931791; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Rauch C, 2000, BIOPHYS J, V78, P3036, DOI 10.1016/S0006-3495(00)76842-1; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Sarabipour S, 2016, ELIFE, V5, DOI 10.7554/eLife.13876; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Singh DR, 2017, J MOL BIOL, V429, P2231, DOI 10.1016/j.jmb.2017.05.020; Singh DR, 2015, J BIOL CHEM, V290, P27271, DOI 10.1074/jbc.M115.676866; Singh DR, 2015, BIOCHEM J, V471, P101, DOI 10.1042/BJ20150433; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Vempati P, 2014, CYTOKINE GROWTH F R, V25, P1, DOI 10.1016/j.cytogfr.2013.11.002; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang H, 2012, THERANOSTICS, V2, P607, DOI 10.7150/thno.4611; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Zachary IC, 2011, BIOCHEM SOC T, V39, P1583, DOI 10.1042/BST20110697	46	23	23	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9064	9075		10.1074/jbc.RA119.007737	http://dx.doi.org/10.1074/jbc.RA119.007737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31023826	hybrid, Green Published			2022-12-28	WOS:000471751600005
J	Chawsheen, HA; Jiang, H; Ying, Q; Ding, N; Thapa, P; Wei, Q				Chawsheen, Hedy A.; Jiang, Hong; Ying, Qi; Ding, Na; Thapa, Pratik; Wei, Qiou			The redox regulator sulfiredoxin forms a complex with thioredoxin domain-containing 5 protein in response to ER stress in lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antioxidant; protein-protein interaction; proteomics; enzyme mechanism; oxidative stress; protein-disulfide isomerase; pulmonary carcinoma; sulfiredoxin; thioredoxin-domain containing 5 (TXNDC5); tumorigenesis	CYSTEINE-SULFINIC ACID; ANCHORAGE-INDEPENDENT GROWTH; TRANSCRIPTION FACTORS; NUDE-MICE; PEROXIREDOXIN; EXPRESSION; REDUCTION; TUMORIGENICITY; SURVIVAL; NRF2	Sulfiredoxin (Srx) reduces hyperoxidized 2-cysteine-containing peroxiredoxins (Prxs) and protects cells against oxidative stress. Previous studies have shown that Srx is highly expressed in primary specimens of lung cancer patients and plays a pivotal role in lung tumorigenesis and cancer progression. However, the oncogenic mechanisms of Srx in cancer are incompletely understood. In this study, we found that Srx knockdown sensitizes lung cancer cells to endoplasmic reticulum (ER) stress-induced cell death. Through MS analysis, we determined that Srx forms a complex with the ER-resident protein thioredoxin domain-containing protein 5 (TXNDC5). Using reciprocal co-immunoprecipitation, immunofluorescence imaging, subcellular fractionation, and domain-mapping assays with site-specific mutagenesis and purified recombinant proteins, we further characterized the Srx-TXNDC5 interaction. In response to ER stress but not to oxidative stress, Srx exhibits an increased association with TXNDC5, facilitating the retention of Srx in the ER. Of note, TXNDC5 knockdown in lung cancer cells inhibited cell proliferation and repressed anchorage-independent colony formation and migration, but increased cell invasion and activation of mitogen-activated protein kinases. Using immunohistochemical staining, we demonstrate that TXNDC5 is highly expressed in patient-derived lung cancer specimens. Bioinformatics analysis of publicly available data sets revealed that those with high Srx levels have significantly shorter survival and that those with high TXNDC5 levels have longer survival. We conclude that the cellular levels of Srx and TXNDC5 may be useful as biomarkers to predict the survival of individuals with lung cancer.	[Chawsheen, Hedy A.; Jiang, Hong; Ying, Qi; Ding, Na; Thapa, Pratik; Wei, Qiou] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Wei, Qiou] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Chawsheen, Hedy A.] Salahaddin Univ Erbil, Dept Biol, Coll Sci, Erbil 44001, Iraq	University of Kentucky; University of Kentucky; Salahaddin University	Wei, Q (corresponding author), Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.	qiou.wei@uky.edu		Ding, Na/0000-0003-2343-9625; Wei, Qiou/0000-0001-6752-8692; Thapa, Pratik/0000-0002-4266-0125	NCI, National Institutes of Health [R01CA222596]; Department of Defense [W81XWH-16-1-0203]; American Cancer Society [RSG-16-213-01-TBE]; Kentucky Lung Cancer Research Program [KLCRP2016]; NATIONAL CANCER INSTITUTE [R01CA222596, P30CA177558] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI, National Institutes of Health, Grant R01CA222596; Department of Defense Grant W81XWH-16-1-0203; American Cancer Society Grant RSG-16-213-01-TBE; and Kentucky Lung Cancer Research Program Grant KLCRP2016.	Akter S, 2018, NAT CHEM BIOL, V14, P995, DOI 10.1038/s41589-018-0116-2; Baek JY, 2012, J BIOL CHEM, V287, P81, DOI 10.1074/jbc.M111.316711; Bailey D, 2007, ANTIOXID REDOX SIGN, V9, P2305, DOI 10.1089/ars.2007.1796; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chawsheen HA, 2018, GENES DIS, V5, P312, DOI 10.1016/j.gendis.2018.09.003; COLBURN NH, 1978, CANCER RES, V38, P624; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Hampton MB, 2018, ANTIOXID REDOX SIGN, V28, P591, DOI 10.1089/ars.2017.7422; Han J, 2017, GENE DEV, V31, P1417, DOI 10.1101/gad.297374.117; Hassler J, 2012, DEV CELL, V23, P921, DOI 10.1016/j.devcel.2012.10.025; Hwang JA, 2015, INT J CLIN EXP PATHO, V8, P6627; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jiang H, 2014, AM J CANCER RES, V4, P445; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Kennedy D, 2015, METHODS MOL BIOL, V1292, P3, DOI 10.1007/978-1-4939-2522-3_1; Kil IS, 2015, MOL CELL, V59, P651, DOI 10.1016/j.molcel.2015.06.031; Kim J, 2016, FREE RADICAL BIO MED, V101, P384, DOI 10.1016/j.freeradbiomed.2016.11.001; Kim JH, 2008, CLIN CANCER RES, V14, P2326, DOI 10.1158/1078-0432.CCR-07-4457; Kim Young Sun, 2011, Korean Journal of Internal Medicine, V26, P304, DOI 10.3904/kjim.2011.26.3.304; Kinnula VL, 2004, FEBS LETT, V569, P1, DOI 10.1016/j.febslet.2004.05.045; Lu J, 2014, ANTIOXID REDOX SIGN, V21, P457, DOI 10.1089/ars.2014.5849; Merikallio H, 2012, HUM PATHOL, V43, P577, DOI 10.1016/j.humpath.2011.05.024; Noda I, 1999, INT J CANCER, V80, P279, DOI 10.1002/(SICI)1097-0215(19990118)80:2<279::AID-IJC18>3.3.CO;2-E; Noh YH, 2009, J BIOL CHEM, V284, P8470, DOI 10.1074/jbc.M808981200; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Ramming Thomas, 2013, Int J Cell Biol, V2013, P180906, DOI 10.1155/2013/180906; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shih YC, 2018, CIRC RES, V122, P1052, DOI 10.1161/CIRCRESAHA.117.312130; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Soini Y, 2014, PATHOL RES PRACT, V210, P35, DOI 10.1016/j.prp.2013.10.001; Soriano FX, 2008, J NEUROCHEM, V107, P533, DOI 10.1111/j.1471-4159.2008.05648.x; Wang L, 2015, ONCOGENE, V34, P4735, DOI 10.1038/onc.2014.401; Wang YH, 2007, EXP BIOL MED, V232, P1152, DOI 10.3181/0701-RM-8; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108; Wei Q, 2008, P NATL ACAD SCI USA, V105, P19738, DOI 10.1073/pnas.0810676105; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yang JK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15001; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang L, 2010, J CANCER RES CLIN, V136, P1497, DOI 10.1007/s00432-010-0807-x	43	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8991	9006		10.1074/jbc.RA118.005804	http://dx.doi.org/10.1074/jbc.RA118.005804			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31000628	Green Published, hybrid			2022-12-28	WOS:000470971100030
J	Hayward, D; Kouznetsova, VL; Pierson, HE; Hasan, NM; Guzman, ER; Tsigelny, IF; Lutsenko, S				Hayward, Dawn; Kouznetsova, Valentina L.; Pierson, Hannah E.; Hasan, Nesrin M.; Guzman, Estefany R.; Tsigelny, Igor F.; Lutsenko, Svetlana			ANKRD9 is a metabolically-controlled regulator of IMPDH2 abundance and macro-assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ankyrin; nucleotide; cell metabolism; complex; protein-protein interaction; ANKRD9; GTP; IMPDH2; nucleotide; ankyrin repeat domain; rod; cytoophidia	ANKYRIN REPEAT DOMAIN; CTP SYNTHASE; DEHYDROGENASE	Members of a large family of Ankyrin Repeat Domain (ANKRD) proteins regulate numerous cellular processes by binding to specific protein targets and modulating their activity, stability, and other properties. The same ANKRD protein may interact with different targets and regulate distinct cellular pathways. The mechanisms responsible for switches in the ANKRDs' behavior are often unknown. We show that cells' metabolic state can markedly alter interactions of an ANKRD protein with its target and the functional outcomes of this interaction. ANKRD9 facilitates degradation of inosine monophosphate dehydrogenase 2 (IMPDH2), the rate-limiting enzyme in GTP biosynthesis. Under basal conditions ANKRD9 is largely segregated from the cytosolic IMPDH2 in vesicle-like structures. Upon nutrient limitation, ANKRD9 loses its vesicular pattern and assembles with IMPDH2 into rodlike filaments, in which IMPDH2 is stable. Inhibition of IMPDH2 activity with ribavirin favors ANKRD9 binding to IMPDH2 rods. The formation of ANKRD9/IMPDH2 rods is reversed by guanosine, which restores ANKRD9 associations with the vesicle-like structures. The conserved Cys(109)Cys(110) motif in ANKRD9 is required for the vesicle-to-rods transition as well as binding and regulation of IMPDH2. Oppositely to overexpression, ANKRD9 knockdown increases IMPDH2 levels and prevents formation of IMPDH2 rods upon nutrient limitation. Taken together, the results suggest that a guanosine-dependent metabolic switch determines the mode of ANKRD9 action toward IMPDH2.	[Hayward, Dawn; Pierson, Hannah E.; Hasan, Nesrin M.; Guzman, Estefany R.; Tsigelny, Igor F.; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; [Kouznetsova, Valentina L.; Tsigelny, Igor F.] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Tsigelny, Igor F.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Johns Hopkins University; University of California System; University of California San Diego; University of California System; University of California San Diego	Lutsenko, S (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA.	Lutsenko@jhmi.edu		Lutsenko, Svetlana/0000-0001-5275-2587	National Institutes of Health [R01DK071865, 2R56DK071865, T32 GM007445]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01DK071865 and 2R56DK071865 (to S. L.). This work was also supported by Training Grant T32 GM007445 (to D. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anthony SA, 2017, MOL BIOL CELL, V28, P2600, DOI 10.1091/mbc.E17-04-0263; Arking DE, 2014, NAT GENET, V46, P826, DOI 10.1038/ng.3014; Aughey GN, 2016, CRIT REV BIOCHEM MOL, V51, P282, DOI 10.3109/10409238.2016.1172555; Buey RM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02805-x; Buey RM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9923; Calise SJ, 2016, J CELL SCI, V129, P3042, DOI 10.1242/jcs.183400; Calise SJ, 2014, CELL MOL LIFE SCI, V71, P2963, DOI 10.1007/s00018-014-1567-6; Carcamo WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029690; Chang CC, 2015, J CELL SCI, V128, P3550, DOI 10.1242/jcs.175265; Chiang KM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19520-w; Duong-Ly KC, 2018, J CELL SCI, V131, DOI 10.1242/jcs.223289; Gou KM, 2014, EXP CELL RES, V323, P242, DOI 10.1016/j.yexcr.2014.01.029; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Inada H, 2012, BIOCHEMISTRY-US, V51, P6195, DOI 10.1021/bi300279b; Islam Z, 2018, INT J BIOL MACROMOL, V109, P1164, DOI 10.1016/j.ijbiomac.2017.11.101; Ji YS, 2006, J BIOL CHEM, V281, P206, DOI 10.1074/jbc.M507056200; Keppeke GD, 2018, CELL DIV, V13, DOI 10.1186/s13008-018-0038-0; Keppeke GD, 2015, J GENET GENOMICS, V42, P287, DOI 10.1016/j.jgg.2015.04.002; Keppeke GD, 2015, CELL BIOSCI, V5, DOI 10.1186/2045-3701-5-1; Labesse G, 2015, ACTA CRYSTALLOGR D, V71, P1890, DOI 10.1107/S1399004715013115; Labesse G, 2013, STRUCTURE, V21, P975, DOI 10.1016/j.str.2013.03.011; Lee Y, 2018, BBA-MOL BASIS DIS, V1864, P3145, DOI 10.1016/j.bbadis.2018.07.001; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Lynch EM, 2017, NAT STRUCT MOL BIOL, V24, P507, DOI 10.1038/nsmb.3407; Malinouski M, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms4301, 10.1038/ncomms6167]; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Noree C, 2014, MOL BIOL CELL, V25, P2282, DOI 10.1091/mbc.E14-04-0912; O'Connell JD, 2012, ANNU REV CELL DEV BI, V28, P89, DOI 10.1146/annurev-cellbio-101011-155841; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Su ZD, 2018, J BIOL CHEM, V293, P8578, DOI 10.1074/jbc.RA117.001058; Takahashi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5994; Thomas EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051096; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; Wang HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128551; Wang XF, 2009, BMB REP, V42, P568, DOI 10.5483/BMBRep.2009.42.9.568; Yang HJ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006519; Yang JM, 2006, NUCLEIC ACIDS RES, V34, P3646, DOI 10.1093/nar/gkl395	40	10	11	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14454	14466		10.1074/jbc.RA119.008231	http://dx.doi.org/10.1074/jbc.RA119.008231			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31337707	hybrid, Green Published			2022-12-28	WOS:000499248200024
J	Frobel, J; Blummel, AS; Drepper, F; Warscheid, B; Muller, M				Froebel, Julia; Bluemmel, Anne-Sophie; Drepper, Friedel; Warscheid, Bettina; Mueller, Matthias			Surface-exposed domains of TatB involved in the structural and functional assembly of the Tat translocase in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein export; membrane protein; membrane trafficking; protein cross-linking; protein complex; protein translocation; translocation; mass spectrometry (MS); structure-function; TatBC complex; twin-arginine translocation; zero space cross-linker; Tat translocase assembly; TatB; LC-MS; MS; membrane transport	TWIN-ARGININE TRANSLOCASE; PROTEIN-TRANSPORT; SIGNAL PEPTIDE; PRECURSOR PROTEINS; MEMBRANE-PROTEIN; BINDING-SITE; COMPONENT; SUBUNIT; CORE; THA4	Twin-arginine-dependent translocases transport folded proteins across bacterial, archaeal, and chloroplast membranes. Upon substrate binding, they assemble from hexahelical TatC and single-spanning TatA and TatB membrane proteins. Although structural and functional details of individual Tat subunits have been reported previously, the sequence and dynamics of Tat translocase assembly remain to be determined. Employing the zero-space cross-linker N,N'-dicyclohexylcarbodiimide (DCCD) in combination with LC-MS/MS, we identified as yet unknown intra- and intermolecular contact sites of TatB and TatC. In addition to their established intramembrane binding sites, both proteins were thus found to contact each other through the soluble N terminus of TatC and the interhelical linker region around the conserved glutamyl residue Glu(49) of TatB from Escherichia coli. Functional analyses suggested that by interacting with the TatC N terminus, TatB improves the formation of a proficient substrate recognition site of TatC. The Glu(49) region of TatB was found also to contact distinct downstream sites of a neighboring TatB molecule and to thereby mediate oligomerization of TatB within the TatBC receptor complex. Finally, we show that global DCCD-mediated cross-linking of TatB and TatC in membrane vesicles or, alternatively, creating covalently linked TatC oligomers prevents TatA from occupying a position close to the TatBC-bound substrate. Collectively, our results are consistent with a circular arrangement of the TatB and TatC units within the TatBC receptor complex and with TatA entering the interior TatBC-binding cavity through lateral gates between TatBC protomers.	[Froebel, Julia; Bluemmel, Anne-Sophie; Mueller, Matthias] Univ Freiburg, Fac Med, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Univ Freiburg, Inst Biol 2 Biochem Funct Prote, Fac Biol, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Warscheid, Bettina] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de		Warscheid, Bettina/0000-0001-5096-1975	Deutsche Forschungsgemeinschaft [SFB 747, FOR 1905]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	We thank Bettina Knapp for excellent technical assistance.This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 747 (to M. M.) and FOR 1905 (to B. W.) and by the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS to B. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alcock F, 2016, ELIFE, V5, DOI 10.7554/eLife.20718; Alcock F, 2013, P NATL ACAD SCI USA, V110, pE3650, DOI 10.1073/pnas.1306738110; Aldridge C, 2014, J CELL BIOL, V205, P51, DOI 10.1083/jcb.201311057; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Baglieri J, 2012, J BIOL CHEM, V287, P7335, DOI 10.1074/jbc.M111.326355; Blummel AS, 2017, J BIOL CHEM, V292, P21320, DOI 10.1074/jbc.M117.812560; Blummel AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8234; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Celedon JM, 2012, J CELL BIOL, V197, P523, DOI 10.1083/jcb.201201096; Cleon F, 2015, MOL MICROBIOL, V98, P111, DOI 10.1111/mmi.13106; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Combe CW, 2015, MOL CELL PROTEOMICS, V14, P1137, DOI 10.1074/mcp.O114.042259; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Eimer E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19640-3; Eimer E, 2015, J BIOL CHEM, V290, P29281, DOI 10.1074/jbc.M115.696005; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Habersetzer J, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170091; Hamsanathan S, 2017, BIOPHYS J, V113, P2650, DOI 10.1016/j.bpj.2017.09.036; Hauer RS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08818-w; Hauer RS, 2013, BBA-MOL CELL RES, V1833, P957, DOI 10.1016/j.bbamcr.2013.01.030; Hou B, 2018, J BIOL CHEM, V293, P7592, DOI 10.1074/jbc.RA118.002205; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Huang Q, 2017, MBIO, V8, DOI 10.1128/mBio.00909-17; Huang Q, 2017, P NATL ACAD SCI USA, V114, pE1958, DOI 10.1073/pnas.1615056114; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Kneuper H, 2012, MOL MICROBIOL, V85, P945, DOI 10.1111/j.1365-2958.2012.08151.x; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; LESLEY SA, 1991, J BIOL CHEM, V266, P2632; Ma XY, 2013, PLANT CELL, V25, P999, DOI 10.1105/tpc.112.107409; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Moser Michael, 2007, V390, P63; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Pettersson P, 2018, FEBS J, V285, P1886, DOI 10.1111/febs.14452; Ramasamy S, 2013, STRUCTURE, V21, P777, DOI 10.1016/j.str.2013.03.004; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Rose P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069488; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; Sutherland GA, 2018, J BIOL CHEM, V293, P6672, DOI 10.1074/jbc.RA117.000880; Taubert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119761; Taubert J, 2014, BIOL CHEM, V395, P827, DOI 10.1515/hsz-2014-0170; Ulfig A, 2018, J BIOL CHEM, V293, P7281, DOI 10.1074/jbc.RA118.002576; Ulfig A, 2017, J BIOL CHEM, V292, P10865, DOI 10.1074/jbc.M117.788950; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103157; Zhang Y, 2014, BBA-BIOMEMBRANES, V1838, P1881, DOI 10.1016/j.bbamem.2014.03.015; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	59	2	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13902	13914		10.1074/jbc.RA119.009298	http://dx.doi.org/10.1074/jbc.RA119.009298			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31341014	Green Published, hybrid			2022-12-28	WOS:000490729800006
J	Cohen, NR; Zitzewitz, JA; Bilsel, O; Matthews, CR				Cohen, Noah R.; Zitzewitz, Jill A.; Bilsel, Osman; Matthews, C. Robert			Nonnative structure in a peptide model of the unfolded state of superoxide dismutase 1 (SOD1): Implications for ALS-linked aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						superoxide dismutase (SOD); amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); peptides; fluorescence resonance energy transfer (FRET); protein folding; protein misfolding; maximum entropy modeling	AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN AGGREGATION; FAMILIAL FORM; FLUORESCENCE; MUTATIONS; DECAY; ZINC; PATHWAY; CU	Dozens of mutations throughout the sequence of the gene encoding superoxide dismutase 1 (SOD1) have been linked to toxic protein aggregation in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). A parsimonious explanation for numerous genotypes resulting in a common phenotype would be mutation-induced perturbation of the folding free-energy surface that increases the populations of high-energy states prone to aggregation. The absence of intermediates in the folding of monomeric SOD1 suggests that the unfolded ensemble is a potential source of aggregation. To test this hypothesis, here we dissected SOD1 into a set of peptides end-labeled with FRET probes to model the local behavior of the corresponding sequences in the unfolded ensemble. Using time-resolved FRET, we observed that the peptide corresponding to the Loop VII-beta 8 sequence at the SOD1 C terminus was uniquely sensitive to denaturant. Utilizing a two-dimensional form of maximum entropy modeling, we demonstrate that the sensitivity to denaturant is the surprising result of a two-state-like transition from a compact to an expanded state. Variations of the peptide sequence revealed that the compact state involves a nonnative interaction between the disordered N terminus and the hydrophobic C terminus of the peptide. This nonnative intramolecular structure could serve as a precursor for intermolecular association and result in aggregation associated with ALS. We propose that this precursor would provide a common molecular target for therapeutic intervention in the dozens of ALS-linked SOD1 mutations.	[Cohen, Noah R.; Zitzewitz, Jill A.; Bilsel, Osman; Matthews, C. Robert] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, 364 Plantat St LRB 928, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Matthews, CR (corresponding author), Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, 364 Plantat St LRB 928, Worcester, MA 01605 USA.	c.robert.matthews@umassmed.edu		Bilsel, Osman/0000-0003-0414-3060	National Institutes of Health [GM54836]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant GM54836. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; BAJZER Z, 1993, BIOPHYS J, V65, P2313, DOI 10.1016/S0006-3495(93)81325-0; Borel F, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau6414; Chan CK, 1997, P NATL ACAD SCI USA, V94, P1779, DOI 10.1073/pnas.94.5.1779; Chattopadhyay M, 2015, J BIOL CHEM, V290, P30624, DOI 10.1074/jbc.M115.666503; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Culik RM, 2018, P NATL ACAD SCI USA, V115, pE2546, DOI 10.1073/pnas.1721022115; Danielsson J, 2011, J BIOL CHEM, V286, P33070, DOI 10.1074/jbc.M111.251223; Das RK, 2015, CURR OPIN STRUC BIOL, V32, P102, DOI 10.1016/j.sbi.2015.03.008; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Engelborghs Y, 2001, SPECTROCHIM ACTA A, V57, P2255, DOI 10.1016/S1386-1425(01)00485-1; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Forsberg K, 2019, J NEUROL NEUROSUR PS, V90, P861, DOI 10.1136/jnnp-2018-319386; Forsberg K, 2011, ACTA NEUROPATHOL, V121, P623, DOI 10.1007/s00401-011-0805-3; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Goldenberg DP, 2003, J MOL BIOL, V326, P1615, DOI 10.1016/S0022-2836(03)00033-0; Guinn EJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7861; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Jagannathan B, 2012, P NATL ACAD SCI USA, V109, P17820, DOI 10.1073/pnas.1201800109; Kathuria SV, 2014, J MOL BIOL, V426, P1980, DOI 10.1016/j.jmb.2014.02.020; Kayatekin C, 2012, J MOL BIOL, V424, P192, DOI 10.1016/j.jmb.2012.09.009; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Kohn JE, 2009, J MOL BIOL, V394, P343, DOI 10.1016/j.jmb.2009.09.005; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Kumar ATN, 2001, J PHYS CHEM B, V105, P7847, DOI 10.1021/jp0101209; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lang L, 2015, P NATL ACAD SCI USA, V112, P9878, DOI 10.1073/pnas.1503328112; Lang LS, 2012, P NATL ACAD SCI USA, V109, P17868, DOI 10.1073/pnas.1201795109; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Oskarsson B, 2018, MAYO CLIN PROC, V93, P1617, DOI 10.1016/j.mayocp.2018.04.007; Redler RL, 2012, PROG MOL BIOL TRANSL, V107, P215, DOI 10.1016/B978-0-12-385883-2.00002-3; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sekhar A, 2016, P NATL ACAD SCI USA, V113, pE6939, DOI 10.1073/pnas.1611418113; Sekhar A, 2015, ELIFE, V4, DOI 10.7554/eLife.07296; Sen Mojumdar S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01996-1; SKILLING J, 1984, MON NOT R ASTRON SOC, V211, P111, DOI 10.1093/mnras/211.1.111; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; Svensson AKE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010064; SZABO AG, 1980, J AM CHEM SOC, V102, P554, DOI 10.1021/ja00522a020; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wu Y, 2008, P NATL ACAD SCI USA, V105, P13367, DOI 10.1073/pnas.0802788105	51	4	4	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13708	13717		10.1074/jbc.RA119.008765	http://dx.doi.org/10.1074/jbc.RA119.008765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31341015	hybrid, Green Published			2022-12-28	WOS:000486418600016
J	Ying, G; Wang, J; Mallevaey, T; Van Calenbergh, S; Zajonc, DM				Ying, Ge; Wang, Jing; Mallevaey, Thierry; Van Calenbergh, Serge; Zajonc, Dirk M.			Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolipid; antigen presentation; major histocompatibility complex (MHC); T-cell receptor (TCR); antibody; cellular immune response; 1B1 Fab; immune signaling; natural killer T-cell activation	RECOMBINANT ANTIBODIES; ALPHA-GALACTOSYLCERAMIDE; ANTIGEN PRESENTATION; HUMAN CD1D; RECOGNITION; COMPLEX; GLYCOLIPIDS; SPECIFICITY; TOOLS; POPULATION	Natural killer T (NKT) cells are a subset of T lymphocytes that recognize glycolipid antigens presented by the CD1d molecule (CD1d). They rapidly respond to antigen challenge and can activate both innate and adaptive immune cells. To study the role of antigen presentation in NKT cell activation, previous studies have developed several anti-CD1d antibodies that block CD1d binding to T-cell receptors (TCRs). Antibodies that are specific to both CD1d and the presented antigen can only be used to study the function of only a limited number of antigens. In contrast, antibodies that bind CD1d and block TCR binding regardless of the presented antigen can be widely used to assess the role of TCR-mediated NKT cell activation in various disease models. Here, we report the crystal structure of the widely used anti-mouse CD1d antibody 1B1 bound to CD1d at a resolution of 2.45 angstrom and characterized its binding to CD1d-presented glycolipids. We observed that 1B1 uses a long hydrophobic H3 loop that is inserted deep into the binding groove of CD1d where it makes intimate nonpolar contacts with the lipid backbone of an incorporated spacer lipid. Using an NKT cell agonist that has a modified sphingosine moiety, we further demonstrate that 1B1 in its monovalent form cannot block TCR-mediated NKT cell activation, because 1B1 fails to bind with high affinity to mCD1d. Our results suggest potential limitations of using 1B1 to assess antigen recognition by NKT cells, especially when investigating antigens that do not follow the canonical two alkyl-chain rule.	[Ying, Ge; Wang, Jing; Zajonc, Dirk M.] La Jolla Inst Immunol, Div Immune Regulat, La Jolla, CA 92037 USA; [Mallevaey, Thierry] Univ Toronto, Dept Immunol, Toronto, ON M5S 3G9, Canada; [Mallevaey, Thierry] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Van Calenbergh, Serge] Univ Ghent, Fac Pharmaceut Sci, Lab Med Chem FFW, B-9000 Ghent, Belgium; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; University of Toronto; University of Toronto; Ghent University; Ghent University	Zajonc, DM (corresponding author), Pfizer, Canc Immunol Discovery, San Diego, CA 92121 USA.	Dirk.Zajonc@pfizer.com	Mallevaey, Thierry/AAH-4499-2020	Zajonc, Dirk/0000-0001-7215-1981	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI137230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and National Institutes of Health, NIGMS Grant P41GM103393.	Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brady JL, 2006, J IMMUNOL METHODS, V315, P61, DOI 10.1016/j.jim.2006.07.002; Brossay L, 1997, J IMMUNOL, V159, P1216; Cohen CJ, 2003, J MOL RECOGNIT, V16, P324, DOI 10.1002/jmr.640; Dahan R, 2011, EUR J IMMUNOL, V41, P1465, DOI 10.1002/eji.201041241; Denkberg G, 2008, EUR J IMMUNOL, V38, P829, DOI 10.1002/eji.200737518; Denkberg G, 2006, AUTOIMMUN REV, V5, P252, DOI 10.1016/j.autrev.2005.07.004; Dieude M, 2011, J IMMUNOL, V186, P4771, DOI 10.4049/jimmunol.1000921; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florence WC, 2009, EMBO J, V28, P3781, DOI 10.1038/emboj.2009.348; Gilliland LK, 1996, TISSUE ANTIGENS, V47, P1, DOI 10.1111/j.1399-0039.1996.tb02509.x; Girardi E, 2016, J BIOL CHEM, V291, P10677, DOI 10.1074/jbc.M115.702118; Girardi E, 2012, IMMUNOL REV, V250, P167, DOI 10.1111/j.1600-065X.2012.01166.x; Girardi E, 2012, NAT IMMUNOL, V13, P851, DOI 10.1038/ni.2371; Girardi E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001189; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Guillaume J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04461-7; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Hava DL, 2005, CURR OPIN IMMUNOL, V17, P88, DOI 10.1016/j.coi.2004.12.003; Ito Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078191; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Le Nours J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10570; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mareeva T, 2008, J BIOL CHEM, V283, P29053, DOI 10.1074/jbc.M804996200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel O, 2012, NAT IMMUNOL, V13, P857, DOI 10.1038/ni.2372; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Tatituri RVV, 2013, P NATL ACAD SCI USA, V110, P1827, DOI 10.1073/pnas.1220601110; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047989; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Ying G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182296; Yu ED, 2012, J BIOL CHEM, V287, P1269, DOI 10.1074/jbc.M111.308783; Yu KOA, 2007, J IMMUNOL METHODS, V323, P11, DOI 10.1016/j.jim.2007.03.006; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2016, IMMUNOGENETICS, V68, P561, DOI 10.1007/s00251-016-0931-0; Zajonc DM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00400; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	58	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12947	12956		10.1074/jbc.RA119.009403	http://dx.doi.org/10.1074/jbc.RA119.009403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296659	hybrid, Green Published			2022-12-28	WOS:000486416000008
J	Wang, Y; Mack, JA; Maytin, EV				Wang, Yan; Mack, Judith A.; Maytin, Edward, V			CD44 inhibits alpha-SMA gene expression via a novel G-actin/MRTF-mediated pathway that intersects with TGF beta R/p38MAPK signaling in murine skin fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myofibroblast; CD44; actin; myocardin; p38MAPK; transforming growth factor beta (TGF-B); cytoskeleton; TGF beta R; smooth muscle actin; MRTF	HYALURONAN-CD44 INTERACTION; MYOFIBROBLAST DIFFERENTIATION; CELL-ADHESION; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTOR; UP-REGULATION; MRTF-A; ACTIVATION; GROWTH; RECEPTOR	Well-regulated differentiation of fibroblasts into myofibroblasts (MF) is critical for skin wound healing. Neoexpression of alpha-smooth muscle actin (alpha-SMA), an established marker for MF differentiation, is driven by TGF beta receptor (TGF beta R)-mediated signaling. Hyaluronan (HA) and its receptor CD44 may also participate in this process. To further understand this process, primary mouse skin fibroblasts were isolated and treated in vitro with recombinant TGF-beta 1 (rTGF-beta 1) to induce alpha-SMA expression. CD44 expression was also increased. Paradoxically, CD44 knockdown by RNA interference (RNAi) led to increased alpha-SMA expression and alpha-SMA-containing stress fibers. Removal of extracellular HA or inhibition of HA synthesis had no effect on alpha-SMA levels, suggesting a dispensable role for HA. Exploration of mechanisms linking CD44 knockdown to alpha-SMA induction, using RNAi and chemical inhibitors, revealed a requirement for noncanonical TGF beta R signaling through p38MAPK. Decreased monomeric G-actin but increased filamentous F-actin following CD44 RNAi suggested a possible role for myocardin-related transcription factor (MRTF), a known regulator of alpha-SMA transcription and itself regulated by G-actin binding. CD44 RNAi promoted nuclear accumulation of MRTF and the binding to its transcriptional cofactor SRF. MRTF knockdown abrogated the increased alpha-SMA expression caused by CD44 RNAi, suggesting that MRTF is required for CD44-mediated regulation of alpha-SMA. Finally, chemical inhibition of p38MAPK reversed nuclear MRTF accumulation after rTGF-beta 1 addition or CD44 RNAi, revealing a central involvement of p38MAPK in both cases. We concluded that CD44 regulates alpha-SMA gene expression through cooperation between two intersecting signaling pathways, one mediated by G-actin/MRTF and the other via TGF beta R/p38MAPK.	[Wang, Yan; Mack, Judith A.; Maytin, Edward, V] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Mack, Judith A.; Maytin, Edward, V] Cleveland Clin, Dermatol & Plast Surg Inst, Dept Dermatol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Maytin, EV (corresponding author), Mailstop ND-20,9500 Euclid Ave, Cleveland, OH 44195 USA.	maytine@ccf.org			National Institutes of Health [P01 HL107147, NIH1K12HL141952, S10OD019972]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL141952, P01HL107147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants P01 HL107147, NIH1K12HL141952, and S10OD019972. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afify A, 2009, EXP MOL PATHOL, V86, P95, DOI 10.1016/j.yexmp.2008.12.003; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Andrews JP, 2016, MATRIX BIOL, V51, P37, DOI 10.1016/j.matbio.2016.01.013; Ansorge HL, 2009, J ORTHOP RES, V27, P1386, DOI 10.1002/jor.20891; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Bourguignon LYW, 2014, AM J PATHOL, V184, P1912, DOI 10.1016/j.ajpath.2014.03.010; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P29654, DOI 10.1074/jbc.M403608200; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Crider BJ, 2011, J INVEST DERMATOL, V131, P2378, DOI 10.1038/jid.2011.219; Ebrahimi Hedyeh, 2016, Middle East J Dig Dis, V8, P166; Evanko SP, 2015, MATRIX BIOL, V42, P74, DOI 10.1016/j.matbio.2014.12.001; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gasparics A, 2018, DEV DYNAM, V247, P396, DOI 10.1002/dvdy.24544; Ghatak S, 2017, J BIOL CHEM, V292, P10465, DOI 10.1074/jbc.M116.752451; Govindaraju P, 2019, MATRIX BIOL, V75-76, P314, DOI 10.1016/j.matbio.2018.06.004; Hinz B, 2016, CURR RES TRANSL MED, V64, P171, DOI 10.1016/j.retram.2016.09.003; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2016, EXP EYE RES, V142, P56, DOI 10.1016/j.exer.2015.07.009; Jordan AR, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00182; Kim SI, 2012, KIDNEY RES CLIN PRAC, V31, P94, DOI 10.1016/j.krcp.2012.04.322; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; Konopka A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155053; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Luchsinger LL, 2011, J BIOL CHEM, V286, P44116, DOI 10.1074/jbc.M111.276931; Mack CP, 2005, J THROMB HAEMOST, V3, P1976, DOI 10.1111/j.1538-7836.2005.01316.x; Maytin EV, 2016, GLYCOBIOLOGY, V26, P553, DOI 10.1093/glycob/cww033; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; MERZAK A, 1994, CANCER RES, V54, P3988; Meyer-ter-Vehn T, 2011, INVEST OPHTH VIS SCI, V52, P9149, DOI 10.1167/iovs.10-6679; Midgley AC, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aao1822; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Molkentin JD, 2017, CIRCULATION, V136, P549, DOI 10.1161/CIRCULATIONAHA.116.026238; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Orian-Rousseau V, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00154; Passi A, 2004, EXP CELL RES, V296, P123, DOI 10.1016/j.yexer.2004.01.031; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Porsch H, 2014, J BIOL CHEM, V289, P19747, DOI 10.1074/jbc.M114.547273; Ronkina N, 2016, SCI REP-UK, V6, DOI 10.1038/srep31219; Roszkowska M, 2016, MOL BIOL CELL, V27, P4055, DOI 10.1091/mbc.E16-06-0423; Schmitt M, 2015, CELL DEATH DIFFER, V22, P677, DOI 10.1038/cdd.2014.156; Sebe A, 2008, FEBS LETT, V582, P291, DOI 10.1016/j.febslet.2007.12.021; Shatirishvili M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.342; SHIMIZU Y, 1989, J IMMUNOL, V143, P2457; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Small EM, 2012, J CARDIOVASC TRANSL, V5, P794, DOI 10.1007/s12265-012-9397-0; Stambe C, 2004, J AM SOC NEPHROL, V15, P326, DOI 10.1097/01.ASN.0000108520.63445.E0; Strauch Arthur Roger, 2013, Biology (Basel), V2, P555, DOI 10.3390/biology2020555; Stunova A, 2018, CYTOKINE GROWTH F R, V39, P137, DOI 10.1016/j.cytogfr.2018.01.003; Tammi RH, 2009, J INVEST DERMATOL, V129, P1858, DOI 10.1038/jid.2009.91; van Caam A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02452; Velasco J, 2011, J BIOL CHEM, V286, P26016, DOI 10.1074/jbc.M110.208694; Velasquez LS, 2013, P NATL ACAD SCI USA, V110, P16850, DOI 10.1073/pnas.1316764110; Wang Y, 2014, J BIOL CHEM, V289, P32253, DOI 10.1074/jbc.M114.578377; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Xu SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126015; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zhang P, 2014, FASEB J, V28, P4591, DOI 10.1096/fj.11-202747; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	75	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12779	12794		10.1074/jbc.RA119.007834	http://dx.doi.org/10.1074/jbc.RA119.007834			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31285260	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000484414600019
J	Trotta, E				Trotta, Edoardo			RNA polymerase II (RNAP II)-associated factors are recruited to tRNA loci, revealing that RNAP II- and RNAP III-mediated transcriptions overlap in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase II; RNA polymerase III; transfer RNA (tRNA); precursor tRNA (pre-tRNA); gene silencing; chromatin immunoprecipitation (ChiP); RNA-binding protein; transcriptomics; gene regulation; genome-wide transcription	NUCLEOLAR LOCALIZATION; BINDING PROTEIN; MULTIPLE ROLES; NAB2 FUNCTIONS; MOD5 PROTEIN; GENE; NUCLEAR; WIDE; SPT6; IDENTIFICATION	In yeast (Saccharomyces cerevisiae), the synthesis of tRNAs by RNA polymerase III (RNAP III) down-regulates the transcription of the nearby RNAP II-transcribed genes by a mechanism that is poorly understood. To clarify the basis of this tRNA gene-mediated (TGM) silencing, here, conducting a bioinformatics analysis of available ChIP-chip and ChIP-sequencing genomic data from yeast, we investigated whether the RNAP III transcriptional machinery can recruit protein factors required for RNAP II transcription. An analysis of 46 genome-wide protein-density profiles revealed that 12 factors normally implicated in RNAP II-mediated gene transcription are more enriched at tRNA than at mRNA loci. These 12 factors typically have RNA-binding properties, participate in the termination stage of the RNAP II transcription, and preferentially localize to the tRNA loci by a mechanism that apparently is based on the RNAP III transcription level. The factors included two kinases of RNAP II (Bur1 and Ctk1), a histone demethylase (Jhd2), and a mutated form of a nucleosome-remodeling factor (Spt6) that have never been reported to be recruited to tRNA loci. Moreover, we show that the expression levels of RNAP II-transcribed genes downstream of tRNA loci correlate with the distance from the tRNA gene by a mechanism that depends on their orientation. These results are consistent with the notion that pre-tRNAs recruit RNAP II-associated factors, thereby reducing the availability of these factors for RNAP II transcription and contributing, at least in part, to the TGM-silencing mechanism.	[Trotta, Edoardo] CNR, Inst Translat Pharmacol, Via Fosso Cavaliere 100, I-00133 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Trotta, E (corresponding author), CNR, Inst Translat Pharmacol, Via Fosso Cavaliere 100, I-00133 Rome, Italy.	edoardo.trotta@ift.cnr.it	Trotta, Edoardo/AAW-4697-2020	Trotta, Edoardo/0000-0002-1417-9238				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baejen C, 2014, MOL CELL, V55, P745, DOI 10.1016/j.molcel.2014.08.005; Baranello L, 2016, CHROMOSOME RES, V24, P175, DOI 10.1007/s10577-015-9509-1; Battaglia S, 2017, ELIFE, V6, DOI 10.7554/eLife.25637; Bertrand E, 1998, GENE DEV, V12, P2463, DOI 10.1101/gad.12.16.2463; Blair LP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501662; Bolton EC, 2003, GENOME RES, V13, P254, DOI 10.1101/gr.612203; Burugula BB, 2014, MOL CELL BIOL, V34, P4115, DOI 10.1128/MCB.00695-14; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; DeGennaro CM, 2013, MOL CELL BIOL, V33, P4779, DOI 10.1128/MCB.01068-13; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Gard S, 2009, J CELL BIOL, V187, P455, DOI 10.1083/jcb.200906075; Gonzalez-Aguilera C, 2011, MOL BIOL CELL, V22, P2729, DOI 10.1091/mbc.E11-01-0055; Good PD, 2013, GENE, V526, P7, DOI 10.1016/j.gene.2013.05.016; Haeusler RA, 2008, GENE DEV, V22, P2204, DOI 10.1101/gad.1675908; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; HULL MW, 1994, MOL CELL BIOL, V14, P1266, DOI 10.1128/MCB.14.2.1266; Jamonnak N, 2011, RNA, V17, P2011, DOI 10.1261/rna.2840711; Johnson SA, 2011, NAT STRUCT MOL BIOL, V18, P1164, DOI 10.1038/nsmb.2126; Kendall A, 2000, P NATL ACAD SCI USA, V97, P13108, DOI 10.1073/pnas.240454997; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; KINSEY PT, 1991, NUCLEIC ACIDS RES, V19, P1317, DOI 10.1093/nar/19.6.1317; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003914; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Murawski Marcin, 1994, Acta Biochimica Polonica, V41, P441; Pai DA, 2014, RNA, V20, P644, DOI 10.1261/rna.040444.113; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Perales R, 2013, EMBO J, V32, P2645, DOI 10.1038/emboj.2013.194; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Pratt-Hyatt M, 2013, P NATL ACAD SCI USA, V110, pE3081, DOI 10.1073/pnas.1219946110; Read DF, 2017, FEBS LETT, V591, P1601, DOI 10.1002/1873-3468.12627; Reuter LM, 2015, GENE DEV, V29, P1565, DOI 10.1101/gad.266205.115; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sdano MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28723; Smaldino PJ, 2015, GENE, V556, P13, DOI 10.1016/j.gene.2014.09.049; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Taddei A, 2009, GENOME RES, V19, P611, DOI 10.1101/gr.083881.108; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Tokuda N, 2017, BIOPHYS J, V112, P491, DOI 10.1016/j.bpj.2016.11.3201; Tolerico LH, 1999, GENETICS, V151, P57; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Waldminghaus T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-414; Wang L, 2005, J BIOL CHEM, V280, P8637, DOI 10.1074/jbc.C500017200; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Yuen KC, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007118	58	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12349	12358		10.1074/jbc.RA119.008529	http://dx.doi.org/10.1074/jbc.RA119.008529			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31235518	Green Published, hybrid			2022-12-28	WOS:000484402700008
J	Farrugia, BL; Mizumoto, S; Lord, MS; O'Grady, RL; Kuchel, RP; Yamada, S; Whitelock, JM				Farrugia, Brooke L.; Mizumoto, Shuji; Lord, Megan S.; O'Grady, Robert L.; Kuchel, Rhiannon P.; Yamada, Shuhei; Whitelock, John M.			Hyaluronidase-4 is produced by mast cells and can cleave serglycin chondroitin sulfate chains into lower molecular weight forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondroitin sulfate; hyaluronidase; mast cell; glycosaminoglycan; proteoglycan; alpha-granule; glycosaminoglycan depolymerizing enzyme; oligosaccharide	MONOCLONAL-ANTIBODIES; SECRETORY GRANULES; SYNOVIAL-FLUID; MICE DEFICIENT; IDENTIFICATION; HEPARIN; PROTEOGLYCANS; HYALURONAN; HYDROLASE; LOCALIZATION	Mast cells represent a heterogeneous cell population that is well-known for the production of heparin and the release of histamine upon activation. Serglycin is a proteoglycan that within mast cell alpha-granules is predominantly decorated with the glycosaminoglycans heparin or chondroitin sulfate (CS) and has a known role in granule homeostasis. Heparanase is a heparin-degrading enzyme, is present within the alpha-granules, and contributes to granule homeostasis, but an equivalent CS-degrading enzyme has not been reported previously. In this study, using several approaches, including epitope-specific antibodies, immunohistochemistry, and EM analyses, we demonstrate that human HMC-1 mast cells produce the CS-degrading enzymes hyaluronidase-1 (HYAL1) and HYAL4. We observed that treating the two model CS proteoglycans aggrecan and serglycin with HYAL1 and HYAL4 in vitro cleaves the CS chains into lower molecular weight forms with nonreducing end oligosaccharide structures similar to CS stub neoepitopes generated after digestion with the bacterial lyase chondroitinase ABC. We found that these structures are associated with both the CS linkage region and with structures more distal toward the nonreducing end of the CS chain. Furthermore, we noted that HYAL4 cleaves CS chains into lower molecular weight forms that range in length from tetra- to dodecasaccharides. These results provide first evidence that mast cells produce HYAL4 and that this enzyme may play a specific role in maintaining alpha-granule homeostasis in these cells by cleaving CS glycosaminoglycan chains attached to serglycin.	[Farrugia, Brooke L.] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic 3010, Australia; [Farrugia, Brooke L.; Lord, Megan S.; O'Grady, Robert L.; Whitelock, John M.] UNSW, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia; [Mizumoto, Shuji; Yamada, Shuhei] Meijo Univ, Fac Pharm, Dept Pathobiochem, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan; [Kuchel, Rhiannon P.] UNSW, Electron Microscope Unit, Sydney, NSW 2052, Australia	University of Melbourne; University of New South Wales Sydney; Meijo University; University of New South Wales Sydney	Farrugia, BL (corresponding author), Univ Melbourne, Dept Biomed Engn, Melbourne, Vic 3010, Australia.; Farrugia, BL (corresponding author), UNSW, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.	brooke.farrugia@unimelb.edu.au	Mizumoto, Shuji/F-8313-2018; Farrugia, Brooke/J-1292-2012; Lord, Megan/D-4673-2013	Mizumoto, Shuji/0000-0002-4641-1505; Farrugia, Brooke/0000-0003-1303-4165; Lord, Megan/0000-0002-0506-9811; Whitelock, John/0000-0003-1835-802X				Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Asari A, 1996, OSTEOARTHR CARTILAGE, V4, P149, DOI 10.1016/S1063-4584(05)80324-3; AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; BASHKIN P, 1990, BLOOD, V75, P2204; Bourguignon V, 2016, FASEB J, V30, P2108, DOI 10.1096/fj.201500178R; CATERSON B, 1985, FED PROC, V44, P386; CATERSON B, 1990, J CELL SCI, V97, P411; COUCHMAN JR, 1984, NATURE, V307, P650, DOI 10.1038/307650a0; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; DEAN G, 1993, BRIT J RHEUMATOL, V32, P671; Farrugia BL, 2016, J HISTOCHEM CYTOCHEM, V64, P85, DOI 10.1369/0022155415620649; Farrugia BL, 2014, BIOMATERIALS, V35, P1462, DOI 10.1016/j.biomaterials.2013.10.068; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; GotisGraham I, 1997, ARTHRITIS RHEUM, V40, P479, DOI 10.1002/art.1780400314; Gushulak L, 2012, J BIOL CHEM, V287, P16689, DOI 10.1074/jbc.M112.350447; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Hayes AJ, 2008, J HISTOCHEM CYTOCHEM, V56, P125, DOI 10.1369/jhc.7A7320.2007; Higashi N, 2014, BIOCHEM J, V458, P291, DOI 10.1042/BJ20131463; Honda T, 2012, BIOMOLECULES, V2, P549, DOI 10.3390/biom2040549; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Kaneiwa T, 2008, J BIOL CHEM, V283, P14971, DOI 10.1074/jbc.M709236200; Kaneiwa T, 2012, J BIOL CHEM, V287, P42119, DOI 10.1074/jbc.M112.360693; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; KJELLEN L, 1989, BIOCHEM J, V263, P105, DOI 10.1042/bj2630105; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; Lord MS, 2016, METAB ENG, V38, P105, DOI 10.1016/j.ymben.2016.07.006; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; Melrose J, 2012, HISTOCHEM CELL BIOL, V138, P461, DOI 10.1007/s00418-012-0968-6; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mizumoto S, 2012, METHODS MOL BIOL, V836, P99, DOI 10.1007/978-1-61779-498-8_7; Mulloy B, 2017, GLYCOCONJUGATE J, V34, P351, DOI 10.1007/s10719-016-9749-0; Muto J, 2014, J CLIN INVEST, V124, P1309, DOI 10.1172/JCI67947; Nagaya H, 1999, ANN RHEUM DIS, V58, P186, DOI 10.1136/ard.58.3.186; Ohtake-Niimi S, 2010, J BIOL CHEM, V285, P20793, DOI 10.1074/jbc.M109.084749; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Prabhakar V, 2006, ADV PHARMACOL, V53, P69, DOI 10.1016/S1054-3589(06)53005-9; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Ronnberg E, 2012, J HISTOCHEM CYTOCHEM, V60, P950, DOI 10.1369/0022155412458927; SLATER RR, 1995, ARTHRITIS RHEUM-US, V38, P655, DOI 10.1002/art.1780380513; SORRELL JM, 1990, J HISTOCHEM CYTOCHEM, V38, P393, DOI 10.1177/38.3.1689338; STEVENS RL, 1988, P NATL ACAD SCI USA, V85, P2284, DOI 10.1073/pnas.85.7.2284; STEVENS RL, 1986, J IMMUNOL, V137, P291; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; THOMPSON HL, 1988, J IMMUNOL, V140, P2708; Wang B, 2011, J ALLERGY CLIN IMMUN, V128, P1310, DOI 10.1016/j.jaci.2011.04.011; Watanabe I, 2015, GLYCOBIOLOGY, V25, P953, DOI 10.1093/glycob/cwv039; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; YAMAGATA M, 1987, J BIOL CHEM, V262, P4146	49	10	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11458	11472		10.1074/jbc.RA119.008647	http://dx.doi.org/10.1074/jbc.RA119.008647			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31175155	hybrid, Green Published			2022-12-28	WOS:000478717600010
J	Espiritu, EB; Jiang, HJ; Moreau-Marquis, S; Sullivan, M; Yan, K; Stolz, DB; Sampson, MG; Hukriede, NA; Swiatecka-Urban, A				Espiritu, Eugenel B.; Jiang, Huajun; Moreau-Marquis, Sophie; Sullivan, Mara; Yan, Kunimasa; Stolz, Donna Beer; Sampson, Matthew G.; Hukriede, Neil A.; Swiatecka-Urban, Agnieszka			The human nephrin (YRSL)-R-1139 motif is essential for podocyte foot process organization and slit diaphragm formation during glomerular development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell culture; cell adhesion; cell surface protein; cell-cell interaction; zebrafish; podocyte; nephrology; endocytosis; clathrin; clathrin-dependent endocytosis; foot processes; nephrin; nephrotic syndrome; slit diaphragm; kidney; glomerulus	TRANSMEMBRANE CONDUCTANCE REGULATOR; CONGENITAL NEPHROTIC SYNDROME; DIABETIC-NEPHROPATHY; ZEBRAFISH PRONEPHROS; PROTEIN; ENDOCYTOSIS; EXPRESSION; L1; MUTATIONS; ADHESION	Nephrin is an immunoglobulin-type cell-adhesion molecule with a key role in the glomerular interpodocyte slit diaphragm. Mutations in the nephrin gene are associated with defects in the slit diaphragm, leading to early-onset nephrotic syndrome, typically resistant to treatment. Although the endocytic trafficking of nephrin is essential for the assembly of the slit diaphragm, nephrin's specific endocytic motifs remain unknown. To search for endocytic motifs, here we performed a multisequence alignment of nephrin and identified a canonical YXXO-type motif, (YRSL)-R-1139, in the nephrin cytoplasmic tail, expressed only in primates. Using site-directed mutagenesis, various biochemical methods, single-plane illumination microscopy, a human podocyte line, and a human nephrin-expressing zebrafish model, we found that (YRSL)-R-1139 is a novel endocytic motif and a structural element for clathrin-mediated nephrin endocytosis that functions as a phosphorylation-sensitive signal. We observed that (YRSL)-R-1139 motif-mediated endocytosis helps to localize nephrin to specialized plasma membrane domains in podocytes and is essential for normal foot process organization into a functional slit diaphragm between neighboring foot processes in zebrafish. The importance of nephrin (YRSL)-R-1139 for healthy podocyte development was supported by population-level analyses of genetic variations at this motif, revealing that such variations are very rare, suggesting that mutations in this motif have autosomal-recessive negative effects on kidney health. These findings expand our understanding of the mechanism underlying nephrin endocytosis and may lead to improved diagnostic tools or therapeutic strategies for managing early-onset, treatment-resistant nephrotic syndrome.	[Espiritu, Eugenel B.; Hukriede, Neil A.] Univ Pittsburgh, Dept Dev Biol, Sch Med, Pittsburgh, PA 15201 USA; [Jiang, Huajun; Swiatecka-Urban, Agnieszka] Univ Pittsburgh, Dept Pediat, Sch Med, Pittsburgh, PA 15224 USA; [Moreau-Marquis, Sophie] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Sullivan, Mara; Stolz, Donna Beer] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Dept Nephrol, Sch Med, Pittsburgh, PA 15201 USA; [Yan, Kunimasa] Kyorin Univ, Dept Pediat, Sch Med, Mitaka, Tokyo 1818611, Japan; [Sampson, Matthew G.] Univ Michigan, Sch Med, Dept Pediat Nephrol, Ann Arbor, MI 48109 USA; [Jiang, Huajun] Huazhong Univ Sci & Technol, Union Hosp, Dept Nephrol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kyorin University; University of Michigan System; University of Michigan; Huazhong University of Science & Technology	Swiatecka-Urban, A (corresponding author), UPMC Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15201 USA.	asurban@pitt.edu	Swiatecka-Urban, Agnieszka/AAP-6041-2020; Sampson, Matthew/U-4501-2017	Sampson, Matthew/0000-0001-9560-076X; Hukriede, Neil/0000-0002-9655-9030; Swiatecka-Urban, Agnieszka/0000-0002-6575-0334	National Institutes of Health [T32DK061296, P30DK06010, 1S10RR019003-01]; American Heart Association [15GRNT25700019]; NephCure Kidney International Grant [2012-RFE-003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL144539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, T32DK061296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NephCure Kidney International Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants T32DK061296 (to E.B.E.) and P30DK06010 and 1S10RR019003-01 (to N. A. H.), American Heart Association Grant 15GRNT25700019 (to A. S. U.), and NephCure Kidney International Grant 2012-RFE-003 (to A. S. U.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asanuma Katsuhiko, 2003, Clin Exp Nephrol, V7, P255, DOI 10.1007/s10157-003-0259-6; Babayeva S, 2013, J BIOL CHEM, V288, P24035, DOI 10.1074/jbc.M113.452904; Benigni A, 2004, KIDNEY INT, V65, P2193, DOI 10.1111/j.1523-1755.2004.00636.x; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brummendorf T, 2001, CURR OPIN CELL BIOL, V13, P611, DOI 10.1016/S0955-0674(00)00259-3; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cihil KM, 2012, J BIOL CHEM, V287, P15087, DOI 10.1074/jbc.M112.341875; Conti S, 2017, CURR OPIN NEPHROL HY, V26, P148, DOI 10.1097/MNH.0000000000000322; Datta N, 2016, EXP CELL RES, V340, P32, DOI 10.1016/j.yexcr.2015.10.035; DELARUE F, 1991, KIDNEY INT, V40, P906, DOI 10.1038/ki.1991.292; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Doublier S, 2001, AM J PATHOL, V158, P1723, DOI 10.1016/S0002-9440(10)64128-4; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fornoni A, 2010, DIABETES, V59, P190, DOI 10.2337/db09-0655; Fukuyo Y, 2014, MOL MED REP, V9, P457, DOI 10.3892/mmr.2013.1844; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Grahammer F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86177; Haraldsson B, 2009, CURR OPIN NEPHROL HY, V18, P331, DOI 10.1097/MNH.0b013e32832c9dba; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ichimura K, 2013, J HISTOCHEM CYTOCHEM, V61, P313, DOI 10.1369/0022155413477115; Ichimura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045286; Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135; Jeon J, 2012, J BIOL CHEM, V287, P28932, DOI 10.1074/jbc.M112.389452; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 1998, MOL CELL NEUROSCI, V12, P48, DOI 10.1006/mcne.1998.0702; Kapodistria K, 2015, MOL CELL ENDOCRINOL, V400, P112, DOI 10.1016/j.mce.2014.11.003; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JJ, 2007, J AM SOC NEPHROL, V18, P2303, DOI 10.1681/ASN.2006101145; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Langham RG, 2002, DIABETOLOGIA, V45, P1572, DOI 10.1007/s00125-002-0946-y; Lenkkeri U, 1999, AM J HUM GENET, V64, P51, DOI 10.1086/302182; Lewko B, 2009, J CELL PHYSIOL, V221, P288, DOI 10.1002/jcp.21856; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Long KE, 2001, J BIOL CHEM, V276, P1285, DOI 10.1074/jbc.M006658200; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; Martin CE, 2018, J AM SOC NEPHROL, V29, P92, DOI 10.1681/ASN.2017030285; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nielsen MS, 2008, TRAFFIC, V9, P980, DOI 10.1111/j.1600-0854.2008.00731.x; Nishimura N, 2009, FRONT BIOSCI-LANDMRK, V14, P2115, DOI 10.2741/3366; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Palmen T, 2001, DIABETOLOGIA, V44, P1274, DOI 10.1007/s001250100641; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Patrakka J, 2000, KIDNEY INT, V58, P972, DOI 10.1046/j.1523-1755.2000.00254.x; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; REID RA, 1992, J MOL NEUROSCI, V3, P127, DOI 10.1007/BF02919404; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schenk H, 2017, CELL TISSUE RES, V369, P127, DOI 10.1007/s00441-017-2593-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schoeb DS, 2010, NEPHROL DIAL TRANSPL, V25, P2970, DOI 10.1093/ndt/gfq088; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shono A, 2009, HUM MOL GENET, V18, P2943, DOI 10.1093/hmg/ddp232; Sugie A, 2010, DEVELOPMENT, V137, P3303, DOI 10.1242/dev.047332; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093999; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00032; Swiatecka-Urban A, 2013, PEDIATR NEPHROL, V28, P1723, DOI 10.1007/s00467-012-2281-y; Takeda Y, 1996, J NEUROCHEM, V66, P2338; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Welsh GI, 2010, J PATHOL, V220, P328, DOI 10.1002/path.2661; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881	75	4	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10773	10788		10.1074/jbc.RA119.008235	http://dx.doi.org/10.1074/jbc.RA119.008235			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31152064	Green Published, hybrid			2022-12-28	WOS:000478717200005
J	Agarwal, E; Altman, BJ; Seo, JH; Ghosh, JC; Kossenkov, AV; Tang, HY; Krishn, SR; Languino, LR; Gabrilovich, DI; Speicher, DW; Dang, CV; Altieri, DC				Agarwal, Ekta; Altman, Brian J.; Seo, Jae Ho; Ghosh, Jagadish C.; Kossenkov, Andrew, V; Tang, Hsin-Yao; Krishn, Shiv Ram; Languino, Lucia R.; Gabrilovich, Dmitry, I; Speicher, David W.; Dang, Chi, V; Altieri, Dario C.			Myc-mediated transcriptional regulation of the mitochondrial chaperone TRAP1 controls primary and metastatic tumor growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; mitochondria; Myc (c-Myc); metastasis; invasion; oxidative phosphorylation; TRAP1	N-MYC; CANCER; GENES; CELLS; NEUROBLASTOMA; METABOLISM; EXPRESSION	The role of mitochondria in cancer continues to be debated, and whether exploitation of mitochondrial functions is a general hallmark of malignancy or a tumor- or context-specific response is still unknown. Using a variety of cancer cell lines and several technical approaches, including siRNA-mediated gene silencing, ChIP assays, global metabolomics and focused metabolite analyses, bioenergetics, and cell viability assays, we show that two oncogenic Myc proteins, c-Myc and N-Myc, transcriptionally control the expression of the mitochondrial chaperone TNFR-associated protein-1 (TRAP1) in cancer. In turn, this Myc-mediated regulation preserved the folding and function of mitochondrial oxidative phosphorylation (OXPHOS) complex II and IV subunits, dampened reactive oxygen species production, and enabled oxidative bioenergetics in tumor cells. Of note, we found that genetic or pharmacological targeting of this pathway shuts off tumor cell motility and invasion, kills Myc-expressing cells in a TRAP1-dependent manner, and suppresses primary and metastatic tumor growth in vivo. We conclude that exploitation of mitochondrial functions is a general trait of tumorigenesis and that this reliance of cancer cells on mitochondrial OXPHOS pathways could offer an actionable therapeutic target in the clinic.	[Agarwal, Ekta; Seo, Jae Ho; Ghosh, Jagadish C.; Krishn, Shiv Ram; Languino, Lucia R.; Gabrilovich, Dmitry, I; Speicher, David W.; Altieri, Dario C.] Wistar Inst Anat & Biol, Prostate Canc Discovery & Dev Program, Philadelphia, PA 19104 USA; [Agarwal, Ekta; Seo, Jae Ho; Ghosh, Jagadish C.; Gabrilovich, Dmitry, I; Altieri, Dario C.] Wistar Inst Anat & Biol, Immunol Microenvironm & Metastasis Program, Philadelphia, PA 19104 USA; [Kossenkov, Andrew, V; Tang, Hsin-Yao; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Speicher, David W.; Dang, Chi, V] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Altman, Brian J.] Univ Rochester, Dept Biomed Genet, Med Ctr, Rochester, NY 14642 USA; [Altman, Brian J.] Univ Rochester, Wilmot Canc Inst, Med Ctr, Rochester, NY 14642 USA; [Languino, Lucia R.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Dang, Chi, V] Ludwig Inst Canc Res, New York, NY 10017 USA	The Wistar Institute; The Wistar Institute; The Wistar Institute; The Wistar Institute; University of Rochester; University of Rochester; Jefferson University; Ludwig Institute for Cancer Research	Altieri, DC (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	daltieri@wistar.org	Gabrilovich, Dmitry/ABE-7122-2020; Altman, Brian J./X-2783-2019	Altman, Brian J./0000-0002-3954-4916; Tang, Hsin-Yao/0000-0003-1838-018X; Agarwal, Ekta/0000-0002-5992-3358; KRISHN, SHIV RAM/0000-0002-4770-6671	National Institutes of Health [P01 CA140043, R35 CA220446, R50 CA221838, R00 CA204593, R50 CA211199]; NATIONAL CANCER INSTITUTE [R50CA221838, P01CA140043, R50CA211199, R35CA220446, R00CA204593, P30CA010815] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants P01 CA140043 (to D.C.A., D.W.S., L.R.L., and D.I.G.), R35 CA220446 (to D.C.A.), R50 CA221838 (to H.-Y.T.), R00 CA204593 (to B.J.A), and R50 CA211199 (to A.V.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altieri DC, 2013, CELL MOL LIFE SCI, V70, P2463, DOI 10.1007/s00018-012-1177-0; Altman BJ, 2015, CELL METAB, V22, P1009, DOI 10.1016/j.cmet.2015.09.003; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bryant KG, 2017, ONCOTARGET, V8, P112184, DOI 10.18632/oncotarget.23097; Caino MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13730; Caino MC, 2015, P NATL ACAD SCI USA, V112, P8638, DOI 10.1073/pnas.1500722112; Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841; Chae YC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3139; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lee KM, 2017, CELL METAB, V26, P633, DOI 10.1016/j.cmet.2017.09.009; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lisanti S, 2016, J BIOL CHEM, V291, P25247, DOI 10.1074/jbc.M116.745950; Lisanti S, 2014, CELL REP, V8, P671, DOI 10.1016/j.celrep.2014.06.061; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094; Rodriguez-Bravo V, 2018, CELL, V174, P1200, DOI 10.1016/j.cell.2018.07.015; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Seibel Philipp N, 2006, BMC BIOINFORMATICS, V7, DOI [10.1186/1471-2105-7-498, DOI 10.1186/1471-2105-7-498, DOI 10.1186/1471-2105-7-109]; Seo JH, 2018, CANCER RES, V78, P4215, DOI 10.1158/0008-5472.CAN-18-0595; Seo JH, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002507; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Ushmorov A, 2008, ONCOGENE, V27, P3424, DOI 10.1038/sj.onc.1211017; Valentijn LJ, 2005, CANCER RES, V65, P3136, DOI 10.1158/0008-5472.CAN-04-2469; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Zeid R, 2018, NAT GENET, V50, P515, DOI 10.1038/s41588-018-0044-9	37	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10407	10414		10.1074/jbc.AC119.008656	http://dx.doi.org/10.1074/jbc.AC119.008656			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31097545	Green Published, hybrid			2022-12-28	WOS:000478717100003
J	Arturo, EC; Gupta, K; Hansen, MR; Borne, E; Jaffe, EK				Arturo, Emilia C.; Gupta, Kushol; Hansen, Michael R.; Borne, Elias; Jaffe, Eileen K.			Biophysical characterization of full-length human phenylalanine hydroxylase provides a deeper understanding of its quaternary structure equilibrium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; small-angle X-ray scattering (SAXS); X-ray crystallography; protein conformation; inborn error of metabolism; structural biology; ACT domain; phenylalanine hydroxylase; phenylketonuria; resting-state structure; structural modeling	REGULATORY DOMAIN; ACT DOMAIN; BIOLOGICAL MACROMOLECULES; ALLOSTERIC REGULATION; CATALYTIC DOMAIN; PROTEIN; ACTIVATION; RESOLUTION; EXPRESSION; SCATTERING	Dysfunction of human phenylalanine hydroxylase (hPAH, EC 1.14.16.1) is the primary cause of phenylketonuria, the most common inborn error of amino acid metabolism. The dynamic domain rearrangements of this multimeric protein have thwarted structural study of the full-length form for decades, until now. In this study, a tractable C29S variant of hPAH (C29S) yielded a 3.06 angstrom resolution crystal structure of the tetrameric resting-state conformation. We used size-exclusion chromatography in line with small-angle X-ray scattering (SEC-SAXS) to analyze the full-length hPAH solution structure both in the presence and absence of Phe, which serves as both substrate and allosteric activators. Allosteric Phe binding favors accumulation of an activated PAH tetramer conformation, which is biophysically distinct in solution. Protein characterization with enzyme kinetics and intrinsic fluorescence revealed that the C29S variant and hPAH are otherwise equivalent in their response to Phe, further supported by their behavior on various chromatography resins and by analytical ultracentrifugation. Modeling of resting-state and activated forms of C29S against SAXS data with available structural data created and evaluated several new models for the transition between the architecturally distinct conformations of PAH and highlighted unique intra- and inter-subunit interactions. Three best-fitting alternative models all placed the allosteric Phe-binding module 8-10 angstrom farther from the tetramer center than do all previous models. The structural insights into allosteric activation of hPAH reported here may help inform ongoing efforts to treat phenylketonuria with novel therapeutic approaches.	[Arturo, Emilia C.; Hansen, Michael R.; Borne, Elias; Jaffe, Eileen K.] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA; [Arturo, Emilia C.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Gupta, Kushol] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Arturo, Emilia C.] Scripps Res Inst, La Jolla, CA 92037 USA; [Hansen, Michael R.] Janssen Res & Dev, Spring House, PA 19477 USA; [Borne, Elias] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Drexel University; University of Pennsylvania; Pennsylvania Medicine; Scripps Research Institute; Johnson & Johnson; Janssen Pharmaceuticals; Jefferson University	Jaffe, EK (corresponding author), Temple Univ Hlth Syst, Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA.	eileen.jaffe@fccc.edu	Arturo, Emilia/ABA-8516-2020; Gupta, Kushol/GOE-5620-2022	Arturo, Emilia/0000-0002-6911-129X; Gupta, Kushol/0000-0002-7006-2667; Jaffe, Eileen/0000-0003-4294-0386	National Institutes of Health [5R01-NS100081]; National PKU Alliance; National Institutes of Health NCI Cancer Center Support Grant [P30 CA006927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National PKU Alliance; National Institutes of Health NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant 5R01-NS100081 (to E. K. J. and K. G.) and a grant from the National PKU Alliance (to E. K. J.) and in part by the National Institutes of Health NCI Cancer Center Support Grant P30 CA006927. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen OA, 2001, J MOL BIOL, V314, P279, DOI 10.1006/jmbi.2001.5061; Arturo EC, 2016, P NATL ACAD SCI USA, V113, P2394, DOI 10.1073/pnas.1516967113; BEAVEN GH, 1952, ADV PROTEIN CHEM, V7, P319, DOI 10.1016/S0065-3233(08)60022-4; Blau N, 2016, HUM MUTAT, V37, P508, DOI 10.1002/humu.22980; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; Carluccio C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079482; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Daubner SC, 1997, ARCH BIOCHEM BIOPHYS, V348, P295, DOI 10.1006/abbi.1997.0435; DELANO WL, 2004, ABSTR PAP AM CHEM 1, V228; DiFabio J, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952872; Djordjevic M, 2013, JIMD REP, V9, P49, DOI 10.1007/8904_2012_178; EDELHOCH H, 1962, J BIOL CHEM, V237, P2788; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erlandsen H, 1999, MOL GENET METAB, V68, P103, DOI 10.1006/mgme.1999.2922; Fitzpatrick PF, 2015, CURR OPIN STRUC BIOL, V35, P1, DOI 10.1016/j.sbi.2015.07.004; Fitzpatrick PF, 2012, ARCH BIOCHEM BIOPHYS, V519, P194, DOI 10.1016/j.abb.2011.09.012; Ge YH, 2018, J BIOL CHEM, V293, P19532, DOI 10.1074/jbc.RA118.004909; GIBBS BS, 1991, BIOCHEMISTRY-US, V30, P6795, DOI 10.1021/bi00241a024; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaffe EK, 2017, MOL GENET METAB, V121, P289, DOI 10.1016/j.ymgme.2017.06.005; Jaffe EK, 2013, ARCH BIOCHEM BIOPHYS, V530, P73, DOI 10.1016/j.abb.2012.12.017; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; Joosten RP, 2009, J APPL CRYSTALLOGR, V42, P376, DOI 10.1107/S0021889809008784; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; Khan CA, 2019, J BIOL CHEM, V294, P4359, DOI 10.1074/jbc.RA118.006477; Khan CA, 2018, BIOCHEMISTRY-US, V57, P6274, DOI 10.1021/acs.biochem.8b00919; KNAPPSKOG PM, 1995, BIOCHEMISTRY-US, V34, P11790, DOI 10.1021/bi00037a017; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Korasick DA, 2017, J BIOL CHEM, V292, P9652, DOI 10.1074/jbc.M117.786855; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEDLEY FD, 1987, J BIOL CHEM, V262, P2228; Li J, 2013, ARCH BIOCHEM BIOPHYS, V535, P115, DOI 10.1016/j.abb.2013.03.006; Li J, 2011, ARCH BIOCHEM BIOPHYS, V505, P250, DOI 10.1016/j.abb.2010.10.009; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MAEDER M, 1987, ANAL CHEM, V59, P527, DOI 10.1021/ac00130a035; Malaby AW, 2015, J APPL CRYSTALLOGR, V48, P1102, DOI 10.1107/S1600576715010420; MARTINEZ A, 1995, BIOCHEM J, V306, P589, DOI 10.1042/bj3060589; Meisburger SP, 2016, J AM CHEM SOC, V138, P6506, DOI 10.1021/jacs.6b01563; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PARNIAK MA, 1981, J BIOL CHEM, V256, P6876; PARNIAK MA, 1988, J BIOL CHEM, V263, P1223; Patel D, 2016, SCI REP-UK, V6, DOI 10.1038/srep23748; Paxman JJ, 2017, METHODS MOL BIOL, V1549, P209, DOI 10.1007/978-1-4939-6740-7_16; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PHILLIPS RS, 1984, BIOCHEMISTRY-US, V23, P3836, DOI 10.1021/bi00312a007; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Selwood T, 2008, BIOCHEMISTRY-US, V47, P3245, DOI 10.1021/bi702113z; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shen N, 2016, MOL GENET METAB, V117, P328, DOI 10.1016/j.ymgme.2016.01.004; SHIMAN R, 1979, J BIOL CHEM, V254, P1300; Staudigl M, 2011, HUM MOL GENET, V20, P2628, DOI 10.1093/hmg/ddr165; STONE KJ, 1976, BIOCHEM J, V157, P105, DOI 10.1042/bj1570105; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wang GA, 2001, P NATL ACAD SCI USA, V98, P1537, DOI 10.1073/pnas.031561698; Wasserman H, 2016, ANNU REV VIROL, V3, P373, DOI 10.1146/annurev-virology-100114-054923; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Zhang SN, 2016, J BIOL CHEM, V291, P7418, DOI 10.1074/jbc.M115.709998; Zhang SN, 2015, BIOCHEMISTRY-US, V54, P5167, DOI 10.1021/acs.biochem.5b00616; Zhang SN, 2014, J MOL BIOL, V426, P1483, DOI 10.1016/j.jmb.2013.12.015	71	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10131	10145		10.1074/jbc.RA119.008294	http://dx.doi.org/10.1074/jbc.RA119.008294			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31076506	Green Published, hybrid			2022-12-28	WOS:000474445600008
J	Tischbein, M; Baron, DM; Lin, YC; Gall, KV; Landers, JE; Fallini, C; Bosco, DA				Tischbein, Maeve; Baron, Desiree M.; Lin, Yen-Chen; Gall, Katherine, V; Landers, John E.; Fallini, Claudia; Bosco, Daryl A.			The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for GRIA2 mRNA processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); excitotoxicity; RNA transport; neurodegeneration; glutamate; excitatory neurotransmission; fused in sarcoma; translocated in liposarcoma (FUS; TLS); glutamate ionotropic receptor AMPA type subunit 2 (Gria2); glutamate receptor 2 (GluA2); nucleocytoplasmic transport	AMYOTROPHIC-LATERAL-SCLEROSIS; EXCITATORY AMINO-ACIDS; MOTOR-NEURONS; ELONGATION FACTOR-2; CEREBROSPINAL-FLUID; AMPA RECEPTORS; FUS; GLUTAMATE; ALS; MUTATIONS	Excitotoxic levels of glutamate represent a physiological stress that is strongly linked to amyotrophic lateral sclerosis (ALS) and other neurological disorders. Emerging evidence indicates a role for neurodegenerative disease-linked RNA-binding proteins (RBPs) in the cellular stress response. However, the relationships between excitotoxicity, RBP function, and disease have not been explored. Here, using primary cortical and motor neurons, we found that excitotoxicity induced the translocation of select ALS-linked RBPs from the nucleus to the cytoplasm within neurons. RBPs affected by excitotoxicity included TAR DNA-binding protein 43 (TDP-43) and, most robustly, fused in sarcoma/translocated in liposarcoma (FUS/TLS or FUS). We noted that FUS is translocated through a calcium-dependent mechanism and that its translocation coincides with striking alterations in nucleocytoplasmic transport. Furthermore, glutamate-induced up-regulation of glutamate ionotropic receptor alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type subunit 2 (GRIA2) in neurons depended on FUS expression, consistent with a functional role for FUS in excitotoxic stress. These findings reveal molecular links among prominent factors in neurodegenerative diseases, namely excitotoxicity, disease-associated RBPs, and nucleocytoplasmic transport.	[Tischbein, Maeve; Baron, Desiree M.; Lin, Yen-Chen; Gall, Katherine, V; Landers, John E.; Fallini, Claudia; Bosco, Daryl A.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Tischbein, Maeve] Wave Life Sci, 733 Concord Ave, Cambridge, MA 02138 USA; [Gall, Katherine, V] Homol Med Inc, 1 Patriots Pk, Bedford, MA 01730 USA	University of Massachusetts System; University of Massachusetts Worcester	Bosco, DA (corresponding author), Univ Massachusetts, Med Ctr, Dept Neurol, Worcester, MA 01605 USA.	Daryl.Bosco@umassmed.edu	Lin, Yen-Chen/ABD-6437-2021; Fallini, Claudia/AAZ-1244-2020	Fallini, Claudia/0000-0001-8329-3467; Landers, John/0000-0001-8084-5043; Bosco, Daryl/0000-0002-3735-3729	National Institutes of Health Grants from NINDS [R21 NS091860, R01 NS078145]; ALS Association Grant [18-IIA-418]; Zelda Haidek Memorial Scholarship from University of Massachusetts Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078145, R21NS091860] Funding Source: NIH RePORTER	National Institutes of Health Grants from NINDS; ALS Association Grant; Zelda Haidek Memorial Scholarship from University of Massachusetts Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R21 NS091860 (to D.A.B.) and R01 NS078145 (to D.A.B.) from NINDS; ALS Association Grant 18-IIA-418 (to C.F.), and a Zelda Haidek Memorial Scholarship from University of Massachusetts Medical School (to M.T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Archbold HC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22858-w; Bano D, 2010, CELL DEATH DIFFER, V17, P119, DOI 10.1038/cdd.2009.112; Baron DM, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-30; Barrera I, 2008, NEUROCHEM INT, V52, P1167, DOI 10.1016/j.neuint.2007.12.006; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Boyd JD, 2014, J BIOMOL SCREEN, V19, P44, DOI 10.1177/1087057113501553; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1038/nrdp.2017.71, 10.1016/S0140-6736(10)61156-7, 10.1056/NEJMc1710379, 10.1038/nrdp.2017.85, 10.1016/S0140-6736(17)31287-4]; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Capauto D, 2018, MOL NEUROBIOL, V55, P7635, DOI 10.1007/s12035-018-0884-4; Cheah BC, 2010, CURR MED CHEM, V17, P1942, DOI 10.2174/092986710791163939; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; DEWEY CM, 2011, J BACTERIOL, V193, P1098, DOI DOI 10.1128/MCB.01279-10; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Ederle H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25007-5; Fiszman ML, 2010, ACTA NEUROL SCAND, V121, P120, DOI 10.1111/j.1600-0404.2009.01200.x; Fogarty MJ, 2018, BRAIN RES BULL, V140, P318, DOI 10.1016/j.brainresbull.2018.05.023; Fryer HJL, 1999, J NEUROCHEM, V72, P500, DOI 10.1046/j.1471-4159.1999.0720500.x; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Gascon E, 2014, NAT MED, V20, P1444, DOI 10.1038/nm.3717; Grima JC, 2017, NEURON, V94, P93, DOI 10.1016/j.neuron.2017.03.023; Haines JD, 2015, NAT NEUROSCI, V18, P511, DOI 10.1038/nn.3953; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hideyama T, 2012, NEUROBIOL DIS, V45, P1121, DOI 10.1016/j.nbd.2011.12.033; Hock EM, 2018, CELL REP, V24, P987, DOI 10.1016/j.celrep.2018.06.094; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Ito D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5436; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kahl A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21063-z; Kamelgarn M, 2018, P NATL ACAD SCI USA, V115, pE11904, DOI 10.1073/pnas.1810413115; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Keller BA, 2012, ACTA NEUROPATHOL, V124, P733, DOI 10.1007/s00401-012-1035-z; Kelley JB, 2007, MOL BIOL CELL, V18, P4365, DOI 10.1091/mbc.E07-01-0089; Kia A, 2018, GLIA, V66, P1016, DOI 10.1002/glia.23298; Kim HJ, 2017, NEURON, V96, P285, DOI 10.1016/j.neuron.2017.07.029; Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Li N, 2018, NAT NEUROSCI, V21, P156, DOI 10.1038/s41593-017-0066-0; Lopez-Erauskin J, 2018, NEURON, V100, P816, DOI 10.1016/j.neuron.2018.09.044; Marin P, 1997, J NEUROSCI, V17, P3445; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Mitchell J, 2010, P NATL ACAD SCI USA, V107, P7556, DOI 10.1073/pnas.0914128107; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; ORREGO F, 1967, J BIOL CHEM, V242, P665; PLAITAKIS A, 1993, BRAIN RES BULL, V30, P381, DOI 10.1016/0361-9230(93)90269-H; Rhoads SN, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030886; Rose CR, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00451; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; Sama RRK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00091-1; Sama RRK, 2013, J CELL PHYSIOL, V228, P2222, DOI 10.1002/jcp.24395; Sama RRK, 2014, ASN NEURO, V6, DOI 10.1177/1759091414544472; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schubert D, 2001, J NEUROSCI, V21, P7455, DOI 10.1523/JNEUROSCI.21-19-07455.2001; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Spreux-Varoquaux O, 2002, J NEUROL SCI, V193, P73, DOI 10.1016/S0022-510X(01)00661-X; Starr A, 2018, BRAIN RES, V1693, P98, DOI 10.1016/j.brainres.2018.02.011; Sugiyama K, 2017, J NEUROSCI, V37, P8830, DOI 10.1523/JNEUROSCI.0730-17.2017; Taha E, 2013, NEUROBIOL LEARN MEM, V105, P100, DOI 10.1016/j.nlm.2013.04.015; Takuma H, 1999, ANN NEUROL, V46, P806, DOI 10.1002/1531-8249(199912)46:6<806::AID-ANA2>3.0.CO;2-S; Van Damme P, 2007, P NATL ACAD SCI USA, V104, P14825, DOI 10.1073/pnas.0705046104; Van den Bosch L, 2006, BBA-MOL BASIS DIS, V1762, P1068, DOI 10.1016/j.bbadis.2006.05.002; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Ward CL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.508; Xu GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049021; Yasuda K, 2013, J CELL BIOL, V203, P737, DOI 10.1083/jcb.201306058; Yasuda Y, 2006, EXP CELL RES, V312, P512, DOI 10.1016/j.yexcr.2005.11.017; Zhang K, 2018, CELL, V173, P958, DOI 10.1016/j.cell.2018.03.025	76	14	14	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10194	10210		10.1074/jbc.RA118.005933	http://dx.doi.org/10.1074/jbc.RA118.005933			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31092554	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000474445600013
J	Huang, K; Xhani, S; Albrecht, AV; Ha, VT; Esaki, S; Poon, GMK				Huang, Kenneth; Xhani, Suela; Albrecht, Amanda V.; Ha, Van L. T.; Esaki, Shingo; Poon, Gregory M. K.			Mechanism of cognate sequence discrimination by the ETS-family transcription factor ETS-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ETS transcription factor family; transcription factor; developmental factor; transcription enhancer; molecular dynamics; DNA binding protein; allosteric regulation; DNA sequence motif; DNA-binding domain; ETS proto-oncogene 1 transcription factor (ETS1); low-affinity DNA binding; suboptimization	FACTOR-BINDING SITES; DNA-BINDING; STROMELYSIN-1 PROMOTER; CORRELATED MOTIONS; MOLECULAR-DYNAMICS; HEMATOPOIETIC STEM; STRUCTURAL BASIS; NONSPECIFIC DNA; MURINE ETS-1; SPECIFICITY	Functional evidence increasingly implicates low-affinity DNA recognition by transcription factors as a general mechanism for the spatiotemporal control of developmental genes. Although the DNA sequence requirements for affinity are well-defined, the dynamic mechanisms that execute cognate recognition are much less resolved. To address this gap, here we examined ETS1, a paradigm developmental transcription factor, as a model for which cognate discrimination remains enigmatic. Using molecular dynamics simulations, we interrogated the DNA-binding domain of murine ETS1 alone and when bound to high-and low-affinity cognate sites or to nonspecific DNA. The results of our analyses revealed collective backbone and side-chain motions that distinguished cognate versus nonspecific as well as high- versus low-affinity cognate DNA binding. Combined with binding experiments with site-directed ETS1 mutants, the molecular dynamics data disclosed a triad of residues that respond specifically to low-affinity cognate DNA. We found that a DNA-contacting residue (Gln-336) specifically recognizes low-affinity DNA and triggers the loss of a distal salt bridge (Glu-343/Arg-378) via a large side-chain motion that compromises the hydrophobic packing of two core helices. As an intact Glu-343/Arg-378 bridge is the default state in unbound ETS1 and maintained in high-affinity and nonspecific complexes, the low-affinity complex represents a unique conformational adaptation to the suboptimization of developmental enhancers.	[Huang, Kenneth; Xhani, Suela; Albrecht, Amanda V.; Ha, Van L. T.; Esaki, Shingo; Poon, Gregory M. K.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Poon, Gregory M. K.] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Poon, GMK (corresponding author), POB 3965, Atlanta, GA 30302 USA.	gpoon@gsu.edu			National Science Foundation [MCB 1545160, ACI-1548562]	National Science Foundation(National Science Foundation (NSF))	This investigation was supported by National Science Foundation Grant MCB 1545160 (to G. M. K. P.). This work used the Comet cluster at the San Diego Super Computing Center through allocation TG-MCB160186 provided by the Extreme Science and Engineering Discovery Environment, which is supported by National Science Foundation Grant ACI-1548562. The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht AV, 2018, NUCLEIC ACIDS RES, V46, P10577, DOI 10.1093/nar/gky894; Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Cary GA, 2017, P NATL ACAD SCI USA, V114, P5854, DOI 10.1073/pnas.1610611114; Ciau-Uitz A, 2013, BLOOD CELL MOL DIS, V51, P248, DOI 10.1016/j.bcmd.2013.07.010; Crocker J, 2016, CURR TOP DEV BIOL, V117, P455, DOI 10.1016/bs.ctdb.2015.11.018; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Curina A, 2017, GENE DEV, V31, P399, DOI 10.1101/gad.293134.116; DEGNAN BM, 1993, NUCLEIC ACIDS RES, V21, P3479, DOI 10.1093/nar/21.15.3479; Del S, 2014, J MOL BIOL, V426, P1390, DOI 10.1016/j.jmb.2013.11.031; Desjardins G, 2016, BIOCHEMISTRY-US, V55, P4105, DOI 10.1021/acs.biochem.6b00460; Desjardins G, 2014, P NATL ACAD SCI USA, V111, P11019, DOI 10.1073/pnas.1401891111; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; Farley EK, 2016, P NATL ACAD SCI USA, V113, P6508, DOI 10.1073/pnas.1605085113; Farley EK, 2015, SCIENCE, V350, P325, DOI 10.1126/science.aac6948; Fitzsimmons D, 2009, J MOL BIOL, V392, P452, DOI 10.1016/j.jmb.2009.07.028; Galindo-Murillo R, 2016, J CHEM THEORY COMPUT, V12, P4114, DOI 10.1021/acs.jctc.6b00186; Gao ZG, 2010, DEVELOPMENT, V137, P1543, DOI 10.1242/dev.047696; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Graves BJ, 1996, NATURE, V384, P322, DOI 10.1038/384322a0; Handberg-Thorsager M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1261; He GF, 2015, NUCLEIC ACIDS RES, V43, P4322, DOI 10.1093/nar/gkv267; Hogart A, 2012, GENOME RES, V22, P1407, DOI 10.1101/gr.132878.111; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kamberaj H, 2009, BIOPHYS J, V97, P1747, DOI 10.1016/j.bpj.2009.07.019; Kamberaj H, 2009, BIOPHYS J, V96, P1307, DOI 10.1016/j.bpj.2008.11.019; Karolak A, 2012, BIOPHYS CHEM, V165, P74, DOI 10.1016/j.bpc.2012.03.007; LAUDET V, 1993, BIOCHEM BIOPH RES CO, V190, P8, DOI 10.1006/bbrc.1993.1002; Laudet V, 1999, ONCOGENE, V18, P1351, DOI 10.1038/sj.onc.1202444; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Obika S, 2003, J MOL BIOL, V331, P345, DOI 10.1016/S0022-2836(03)00726-5; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Poon GMK, 2017, TRANSCR-AUSTIN, V8, P193, DOI 10.1080/21541264.2017.1302901; Poon GMK, 2012, J BIOL CHEM, V287, P18297, DOI 10.1074/jbc.M112.342345; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Ramos AI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0018; Reddy SY, 2003, P NATL ACAD SCI USA, V100, P15475, DOI 10.1073/pnas.1936251100; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Shrivastava T, 2014, LEUKEMIA, V28, P2040, DOI 10.1038/leu.2014.111; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stephens DC, 2016, NUCLEIC ACIDS RES, V44, P8671, DOI 10.1093/nar/gkw528; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Wang CD, 2015, J BIOL CHEM, V290, P21925, DOI 10.1074/jbc.M115.644864; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; Wang S, 2014, J BIOL CHEM, V289, P21605, DOI 10.1074/jbc.M114.575340; Wang ZP, 2009, EVOL BIOINFORM, V5, P119; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Weingarten-Gabbay S, 2014, HUM GENET, V133, P701, DOI 10.1007/s00439-013-1413-1; Xhani S, 2017, J PHYS CHEM B, V121, P2748, DOI 10.1021/acs.jpcb.7b00325; Zentner GE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9733	61	1	1	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9666	9678		10.1074/jbc.RA119.007866	http://dx.doi.org/10.1074/jbc.RA119.007866			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31048376	hybrid, Green Published			2022-12-28	WOS:000473277900002
J	Scott, IM; Rubinstein, GM; Poole, FL; Lipscomb, GL; Schut, GJ; Williams-Rhaesa, AM; Stevenson, DM; Amador-Noguez, D; Kelly, RM; Adams, MWW				Scott, Israel M.; Rubinstein, Gabriel M.; Poole, Farris L., II; Lipscomb, Gina L.; Schut, Gerrit J.; Williams-Rhaesa, Amanda M.; Stevenson, David M.; Amador-Noguez, Daniel; Kelly, Robert M.; Adams, Michael W. W.			The thermophilic biomass-degrading bacterium Caldicellulosiruptor bescii utilizes two enzymes to oxidize glyceraldehyde 3-phosphate during glycolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolysis; cellulose; metabolism; metabolomics; metalloenzyme; oxidation-reduction (redox); anaerobic glycolysis; iron-sulfur protein; pterin; tungsten	FORMALDEHYDE FERREDOXIN OXIDOREDUCTASE; ARCHAEON PYROCOCCUS-FURIOSUS; TUNGSTEN-CONTAINING ENZYME; HYPERTHERMOPHILIC ARCHAEON; EMBDEN-MEYERHOF; PLANT BIOMASS; ALDEHYDE OXIDOREDUCTASE; CARBOHYDRATE-METABOLISM; THERMOPROTEUS-TENAX; STRUCTURAL BASIS	Caldicellulosiruptor bescii is an extremely thermophilic, cellulolytic bacterium with a growth optimum at 78 degrees C and is the most thermophilic cellulose degrader known. It is an attractive target for biotechnological applications, but metabolic engineering will require an in-depth understanding of its primary pathways. A previous analysis of its genome uncovered evidence that C. bescii may have a completely uncharacterized aspect to its redox metabolism, involving a tungsten-containing oxidoreductase of unknown function. Herein, we purified and characterized this new member of the aldehyde ferredoxin oxidoreductase family of tungstoenzymes. We show that it is a heterodimeric glyceraldehyde-3-phosphate (GAP) ferredoxin oxidoreductase (GOR) present not only in all known Caldicellulosiruptor species, but also in 44 mostly anaerobic bacterial genera. GOR is phylogenetically distinct from the monomeric GAP-oxidizing enzyme found previously in several Archaea. We found that its large subunit (GOR-L) contains a single tungstopterin site and one iron-sulfur [4Fe-4S] cluster, that the small subunit (GOR-S) contains four [4Fe-4S] clusters, and that GOR uses ferredoxin as an electron acceptor. Deletion of either subunit resulted in a distinct growth phenotype on both C-5 and C-6 sugars, with an increased lag phase, but higher cell densities. Using metabolomics and kinetic analyses, we show that GOR functions in parallel with the conventional GAP dehydrogenase, providing an alternative ferredoxin-dependent glycolytic pathway. These two pathways likely facilitate the recycling of reduced redox carriers (NADH and ferredoxin) in response to environmental H-2 concentrations. This metabolic flexibility has important implications for the future engineering of this and related species.	[Scott, Israel M.; Rubinstein, Gabriel M.; Poole, Farris L., II; Lipscomb, Gina L.; Schut, Gerrit J.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Williams-Rhaesa, Amanda M.] Univ Georgia, New Mat Inst, Athens, GA 30602 USA; [Stevenson, David M.; Amador-Noguez, Daniel] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Kelly, Robert M.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; North Carolina State University	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adamsm@uga.edu		Kelly, Robert/0000-0002-0639-3592	United States Department of Energy, Office of Science, Office of Biological and Environmental Research Grant [DE-SC0019391]; Bioenergy Science Center at Oak Ridge National Laboratory [DE-PS02-06ER64304]; United States National Science Foundation [CBET1264053]	United States Department of Energy, Office of Science, Office of Biological and Environmental Research Grant(United States Department of Energy (DOE)); Bioenergy Science Center at Oak Ridge National Laboratory; United States National Science Foundation(National Science Foundation (NSF))	This work was supported by United States Department of Energy, Office of Science, Office of Biological and Environmental Research Grant DE-SC0019391, Bioenergy Science Center at Oak Ridge National Laboratory Grant DE-PS02-06ER64304, and United States National Science Foundation Grant CBET1264053. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed H, 2004, BIOCHEM SOC T, V32, P303, DOI 10.1042/BST0320303; Arndt F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00071; Baker LMS, 2001, J BACTERIOL, V183, P1961, DOI 10.1128/JB.183.6.1961-1973.2001; Basen M, 2014, BIORESOURCE TECHNOL, V152, P384, DOI 10.1016/j.biortech.2013.11.024; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bell RAV, 2014, PEERJ, V2, DOI 10.7717/peerj.634; Bevers LE, 2005, J BACTERIOL, V187, P7056, DOI 10.1128/JB.187.20.7056-7061.2005; Bevers LE, 2009, COORDIN CHEM REV, V253, P269, DOI 10.1016/j.ccr.2008.01.017; Bielen Abraham A. M., 2013, Life-Basel, V3, P52, DOI 10.3390/life3010052; Bielen AAM, 2013, INT J HYDROGEN ENERG, V38, P1837, DOI 10.1016/j.ijhydene.2012.11.082; Blumer-Schuette SE, 2014, FEMS MICROBIOL REV, V38, P393, DOI 10.1111/1574-6976.12044; Blumer-Schuette SE, 2012, J BACTERIOL, V194, P4015, DOI 10.1128/JB.00266-12; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cha M, 2016, APPL MICROBIOL BIOT, V100, P1823, DOI 10.1007/s00253-015-7025-z; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; Chung D, 2014, P NATL ACAD SCI USA, V111, P8931, DOI 10.1073/pnas.1402210111; Chung D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062881; ENGELAND K, 1993, P NATL ACAD SCI USA, V90, P2491, DOI 10.1073/pnas.90.6.2491; Groom J, 2018, J IND MICROBIOL BIOT, V45, P753, DOI 10.1007/s10295-018-2049-x; Hagedoorn PL, 2005, J BIOL INORG CHEM, V10, P259, DOI 10.1007/s00775-005-0637-5; Havarushka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086030; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Iobbi-Nivol C, 2013, BBA-BIOENERGETICS, V1827, P1086, DOI 10.1016/j.bbabio.2012.11.007; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Kataeva I, 2013, ENERG ENVIRON SCI, V6, P2186, DOI 10.1039/c3ee40932e; Kletzin A, 1996, FEMS MICROBIOL REV, V18, P5, DOI 10.1016/0168-6445(95)00025-9; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lee LL, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02694-17; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lipscomb GL, 2016, APPL ENVIRON MICROB, V82, P4421, DOI 10.1128/AEM.00570-16; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; McLaughlin KJ, 2010, MOL CELL, V38, P563, DOI 10.1016/j.molcel.2010.05.006; MUKUND S, 1995, J BIOL CHEM, V270, P8389, DOI 10.1074/jbc.270.15.8389; MUKUND S, 1991, J BIOL CHEM, V266, P14208; MUKUND S, 1993, J BIOL CHEM, V268, P13592; Oberto J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-4; Olson DG, 2012, CURR OPIN BIOTECH, V23, P396, DOI 10.1016/j.copbio.2011.11.026; Park MO, 2007, J BACTERIOL, V189, P7281, DOI 10.1128/JB.00828-07; Reher M, 2007, FEMS MICROBIOL LETT, V273, P196, DOI 10.1111/j.1574-6968.2007.00787.x; Reschke S, 2019, BIOCHEMISTRY-US, V58, P2228, DOI 10.1021/acs.biochem.9b00078; Roy R, 2002, MET IONS BIOL SYST, V39, P673; Roy R, 2002, J BACTERIOL, V184, P6952, DOI 10.1128/JB.184.24.6952-6956.2002; Roy R, 1999, J BACTERIOL, V181, P1171, DOI 10.1128/JB.181.4.1171-1180.1999; Rozovsky S, 2007, P NATL ACAD SCI USA, V104, P2080, DOI 10.1073/PNAS.0608876104; Rydzak T, 2017, METAB ENG, V41, P182, DOI 10.1016/j.ymben.2017.04.002; Sander K, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.639; SCHAFER T, 1993, ARCH MICROBIOL, V159, P354, DOI 10.1007/BF00290918; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Scott IM, 2015, APPL ENVIRON MICROB, V81, P7339, DOI 10.1128/AEM.01634-15; Seidler NW, 2012, GAPDH BIOL PROPERTIE; Selig M, 1997, ARCH MICROBIOL, V167, P217, DOI 10.1007/BF03356097; SIEBERS B, 1993, FEMS MICROBIOL LETT, V111, P1; Siebers B, 2004, J BACTERIOL, V186, P2179, DOI 10.1128/JB.186.7.2179-2194.2004; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Straub CT, 2017, CURR OPIN BIOTECH, V45, P104, DOI 10.1016/j.copbio.2017.02.016; Vaccaro BJ, 2012, CURRENT PROTOCOLS CH, V4, P249, DOI DOI 10.1002/9780470559277.CH120031; van der Oost J, 1998, J BIOL CHEM, V273, P28149, DOI 10.1074/jbc.273.43.28149; Weinert T, 2015, NAT CHEM BIOL, V11, P586, DOI 10.1038/nchembio.1849; Williams-Rhaesa Amanda M, 2018, Metab Eng Commun, V7, pe00073, DOI 10.1016/j.mec.2018.e00073; Williams-Rhaesa AM, 2018, EXTREMOPHILES, V22, P629, DOI 10.1007/s00792-018-1023-x; WRBA A, 1990, BIOCHEMISTRY-US, V29, P7584, DOI 10.1021/bi00485a007; Yang SJ, 2010, INT J SYST EVOL MICR, V60, P2011, DOI 10.1099/ijs.0.017731-0; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09	65	14	15	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9995	10005		10.1074/jbc.RA118.007120	http://dx.doi.org/10.1074/jbc.RA118.007120			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31097544	Green Published, hybrid			2022-12-28	WOS:000473277900029
J	Schmidtke, C; Tiede, S; Thelen, M; Kakela, R; Jabs, S; Makrypidi, G; Sylvester, M; Schweizer, M; Braren, I; Brocke-Ahmadinejad, N; Cotman, SL; Schulz, A; Gieselmann, V; Braulke, T				Schmidtke, Carolin; Tiede, Stephan; Thelen, Melanie; Kaekelae, Reijo; Jabs, Sabrina; Makrypidi, Georgia; Sylvester, Marc; Schweizer, Michaela; Braren, Ingke; Brocke-Ahmadinejad, Nahal; Cotman, Susan L.; Schulz, Angela; Gieselmann, Volkmar; Braulke, Thomas			Lysosomal proteome analysis reveals that CLN3-defective cells have multiple enzyme deficiencies associated with changes in intracellular trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein sorting; trafficking; lysosome; neurodegenerative disease; lipid droplet; lipid metabolism; endocytosis; electron microscopy (EM); mannose 6-phosphate receptors; pH regulation; proteomics; membrane protein	NEURONAL-CEROID-LIPOFUSCINOSIS; BATTEN-DISEASE GENE; CLN3; RECEPTOR; BIOGENESIS; PROTEINS; BTN1; DEPOSITION; TRANSPORT; PATHOLOGY	Numerous lysosomal enzymes and membrane proteins are essential for the degradation of proteins, lipids, oligosaccharides, and nucleic acids. The CLN3 gene encodes a lysosomal membrane protein of unknown function, and CLN3 mutations cause the fatal neurodegenerative lysosomal storage disorder CLN3 (Batten disease) by mechanisms that are poorly understood. To define components critical for lysosomal homeostasis that are affected by this disease, here we quantified the lysosomal proteome in cerebellar cell lines derived from a CLN3 knock-in mouse model of human Batten disease and control cells. We purified lysosomes from SILAC-labeled, and magnetite-loaded cerebellar cells by magnetic separation and analyzed them by MS. This analysis identified 70 proteins assigned to the lysosomal compartment and 3 lysosomal cargo receptors, of which most exhibited a significant differential abundance between control and CLN3-defective cells. Among these, 28 soluble lysosomal proteins catalyzing the degradation of various macromolecules had reduced levels in CLN3-defective cells. We confirmed these results by immunoblotting and selected protease and glycosidase activities. The reduction of 11 lipid-degrading lysosomal enzymes correlated with reduced capacity for lipid droplet degradation and several alterations in the distribution and composition of membrane lipids. In particular, levels of lactosylceramides and glycosphingolipids were decreased in CLN3-defective cells, which were also impaired in the recycling pathway of the exocytic transferrin receptor. Our findings suggest that CLN3 has a crucial role in regulating lysosome composition and their function, particularly in degrading of sphingolipids, and, as a consequence, in membrane transport along the recycling endosome pathway.	[Schmidtke, Carolin; Tiede, Stephan; Makrypidi, Georgia; Schulz, Angela; Braulke, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, D-20246 Hamburg, Germany; [Thelen, Melanie; Sylvester, Marc; Brocke-Ahmadinejad, Nahal; Gieselmann, Volkmar] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Kaekelae, Reijo] Univ Helsinki, Mol & Integrat Biosci Res Programme, FIN-00014 Helsinki, Finland; [Jabs, Sabrina] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Jabs, Sabrina] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Schweizer, Michaela] Univ Med Ctr Hamburg Eppendorf, Dept Electron Microscopy, Ctr Mol Neurobiol, D-20251 Hamburg, Germany; [Braren, Ingke] Univ Med Ctr Hamburg Eppendorf, Vector Core Unit, D-20251 Hamburg, Germany; [Cotman, Susan L.] Harvard Med Sch, Ctr Genom Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jabs, Sabrina] Inst Pasteur, Unite Interact Bacteries Cellules, 25 Rue Dr Roux, F-75015 Paris, France	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; University of Helsinki; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard Medical School; Massachusetts General Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Braulke, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, D-20246 Hamburg, Germany.	braulke@uke.de	Jabs, Sabrina/F-9026-2019; Braulke, Thomas/AAV-9121-2020	Jabs, Sabrina/0000-0001-8065-8002; Braulke, Thomas/0000-0002-2336-8532; Sylvester, Marc/0000-0002-4275-0200; Thelen, Melanie/0000-0003-0707-5921; Brocke-Ahmadinejad, Nahal/0000-0002-7335-6564; Tiede, Stephan/0000-0002-6045-3736	University Medical Center Hamburg-Eppendorf	University Medical Center Hamburg-Eppendorf	We thank the Microscopy Imaging Facility of the University Medical Center Hamburg-Eppendorf for support.	Barbato DL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.404; Bonifacino JS, 2017, CURR OPIN CELL BIOL, V47, P1, DOI 10.1016/j.ceb.2017.01.008; Bosch ME, 2016, J NEUROSCI, V36, P9669, DOI 10.1523/JNEUROSCI.1635-16.2016; BRAULKE T, 1987, J CELL BIOL, V104, P1735, DOI 10.1083/jcb.104.6.1735; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Chandrachud U, 2015, J BIOL CHEM, V290, P14361, DOI 10.1074/jbc.M114.621706; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Codlin S, 2008, J CELL SCI, V121, P2860, DOI 10.1242/jcs.030122; Cotman SL, 2012, CLIN LIPIDOL, V7, P79, DOI 10.2217/CLP.11.70; Di Lorenzo G, 2018, MOL CELL PROTEOMICS, V17, P1612, DOI 10.1074/mcp.RA118.000720; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Gachet Y, 2005, J CELL SCI, V118, P5525, DOI 10.1242/jcs.02656; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Henne WM, 2016, J STRUCT BIOL, V196, P15, DOI 10.1016/j.jsb.2016.05.003; Hiesberger T, 1998, EMBO J, V17, P4617, DOI 10.1093/emboj/17.16.4617; Jabs S, 2008, J NEUROCHEM, V106, P1415, DOI 10.1111/j.1471-4159.2008.05497.x; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kakela R, 2005, MAR ECOL PROG SER, V293, P191, DOI 10.3354/meps293191; Kakela R, 2003, J NEUROCHEM, V84, P1051, DOI 10.1046/j.1471-4159.2003.01602.x; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, SEMIN CELL DEV BIOL, V9, P517, DOI 10.1006/scdb.1998.0257; Kollmann K, 2012, BRAIN, V135, P2661, DOI 10.1093/brain/aws209; Kollmann K, 2013, BBA-MOL BASIS DIS, V1832, P1866, DOI 10.1016/j.bbadis.2013.01.019; KORNER C, 1995, J BIOL CHEM, V270, P287, DOI 10.1074/jbc.270.1.287; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Langmann T, 1999, J LIPID RES, V40, P870; Lim CY, 2016, J CELL BIOL, V214, P653, DOI 10.1083/jcb.201607005; Luiro K, 2004, HUM MOL GENET, V13, P3017, DOI 10.1093/hmg/ddh321; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Markmann S, 2015, TRAFFIC, V16, P743, DOI 10.1111/tra.12284; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Metcalf DJ, 2008, TRAFFIC, V9, P1905, DOI 10.1111/j.1600-0854.2008.00807.x; Nielsen R, 2007, P NATL ACAD SCI USA, V104, P5407, DOI 10.1073/pnas.0700330104; Padilla-Lopez S, 2006, J BIOL CHEM, V281, P10273, DOI 10.1074/jbc.M510625200; Palmer DN, 2013, BBA-MOL BASIS DIS, V1832, P1882, DOI 10.1016/j.bbadis.2013.05.014; Parenti G, 2015, ANNU REV MED, V66, P471, DOI 10.1146/annurev-med-122313-085916; Park JH, 2005, BBA-GENE STRUCT EXPR, V1732, P82, DOI 10.1016/j.bbaexp.2006.01.002; Pearce DA, 1999, NAT GENET, V22, P55, DOI 10.1038/8861; Ramirez-Montealegre D, 2005, HUM MOL GENET, V14, P3759, DOI 10.1093/hmg/ddi406; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rusyn E, 2008, PEDIATR RES, V63, P625, DOI 10.1203/PDR.0b013e31816fdc17; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Schwammle V, 2013, J PROTEOME RES, V12, P3874, DOI 10.1021/pr400045u; Somogyi A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020625; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sztalryd C, 2017, BBA-MOL CELL BIOL L, V1862, P1221, DOI 10.1016/j.bbalip.2017.07.009; Takahashi M, 2009, GLYCOCONJUGATE J, V26, P705, DOI 10.1007/s10719-008-9191-z; Tecedor L, 2013, J NEUROSCI, V33, P18065, DOI 10.1523/JNEUROSCI.0498-13.2013; Thelen M, 2017, METHODS MOL BIOL, V1594, P1, DOI 10.1007/978-1-4939-6934-0_1; Tommasino C, 2015, APOPTOSIS, V20, P645, DOI 10.1007/s10495-015-1102-8; Tuxworth RI, 2009, HUM MOL GENET, V18, P667, DOI 10.1093/hmg/ddn396; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Van Diggelen O P, 2001, Eur J Paediatr Neurol, V5 Suppl A, P189, DOI 10.1053/ejpn.2000.0460; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Wyant GA, 2018, SCIENCE, V360, P751, DOI 10.1126/science.aar2663; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8	59	25	25	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9592	9604		10.1074/jbc.RA119.008852	http://dx.doi.org/10.1074/jbc.RA119.008852			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31040178	hybrid, Green Published			2022-12-28	WOS:000472713000024
J	Chen, TC; Lee, RA; Tsai, SL; Kanamaluru, D; Gray, NE; Yiv, N; Cheang, RT; Tan, JH; Lee, JY; Fitch, MD; Hellerstein, MK; Wang, JC				Chen, Tzu-Chieh; Lee, Rebecca A.; Tsai, Sam L.; Kanamaluru, Deepthi; Gray, Nora E.; Yiv, Nicholas; Cheang, Rachel T.; Tan, Jenna H.; Lee, Justin Y.; Fitch, Mark D.; Hellerstein, Marc K.; Wang, Jen-Chywan			An ANGPTL4-ceramide-protein kinase C axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver; glucocorticoid; ceramide; triglyceride; metabolic syndrome; steroid hormone; dyslipidemia; lipogenesis; fatty liver disease; hepatosteatosis; hypertriglyceridemia	FATTY LIVER-DISEASE; INSULIN-RESISTANCE; CERAMIDE; GLUCOSE; DYSLIPIDEMIA; LIPOGENESIS; LIPOLYSIS; PROTEIN; ACCUMULATION; PATHOGENESIS	Chronic or excess glucocorticoid exposure causes lipid disorders such as hypertriglyceridemia and hepatic steatosis. Angptl4 (angiopoietin-like 4), a primary target gene of the glucocorticoid receptor in hepatocytes and adipocytes, is required for hypertriglyceridemia and hepatic steatosis induced by the synthetic glucocorticoid dexamethasone. Angptl4 has also been shown to be required for dexamethasone-induced hepatic ceramide production. Here, we further examined the role of ceramide-mediated signaling in hepatic dyslipidemia caused by chronic glucocorticoid exposure. Using a stable isotope-labeling technique, we found that dexamethasone treatment induced the rate of hepatic de novo lipogenesis and triglyceride synthesis. These dexamethasone responses were compromised in Angptl4-null mice (Angptl4(-/-)). Treating mice with myriocin, an inhibitor of the rate-controlling enzyme of de novo ceramide synthesis, serine palmitoyltransferase long-chain base subunit 1 (SPTLC1)/SPTLC2, decreased dexamethasone-induced plasma and liver triglyceride levels in WT but not Angptl4(-/-) mice. We noted similar results in mice infected with adeno-associated virus-expressing small hairpin RNAs targeting Sptlc2. Protein phosphatase 2 phosphatase activator (PP2A) and protein kinase C (PKC) are two known downstream effectors of ceramides. We found here that mice treated with an inhibitor of PKC, 2-acetyl-1,3-cyclopentanedione (ACPD), had lower levels of dexamethasone-induced triglyceride accumulation in plasma and liver. However, small hairpin RNA-mediated targeting of the catalytic PP2A subunit (Ppp2ca) had no effect on dexamethasone responses on plasma and liver triglyceride levels. Overall, our results indicate that chronic dexamethasone treatment induces an ANGPTL4-ceramide-PKC axis that activates hepatic de novo lipogenesis and triglyceride synthesis, resulting in lipid disorders.	[Chen, Tzu-Chieh; Lee, Rebecca A.; Tsai, Sam L.; Kanamaluru, Deepthi; Gray, Nora E.; Yiv, Nicholas; Cheang, Rachel T.; Tan, Jenna H.; Lee, Justin Y.; Fitch, Mark D.; Hellerstein, Marc K.; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Chen, Tzu-Chieh; Gray, Nora E.; Wang, Jen-Chywan] Univ Calif Berkeley, Metab Biol Grad Program, Berkeley, CA 94720 USA; [Lee, Rebecca A.; Wang, Jen-Chywan] Univ Calif Berkeley, Endocrinol Grad Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wang, JC (corresponding author), Univ Calif Berkeley, 315 Morgan Hall, Berkeley, CA 94720 USA.	walwang@berkeley.edu	Wang, Jen-Chywan/AAX-4445-2020; Tan, Jenna/Q-7760-2016	Wang, Jen-Chywan/0000-0001-6030-6886; Tan, Jenna/0000-0003-3854-9536; Cheang, Rachel TengChi/0000-0001-8091-2197	National Institutes of Health [R01DK083591, R01DK113019]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health Grants R01DK083591 and R01DK113019 (to J. C. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMATRUDA JM, 1983, BIOCHEM J, V212, P135, DOI 10.1042/bj2120135; Anil TM, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-43; Arnaldi G, 2010, NEUROENDOCRINOLOGY, V92, P86, DOI 10.1159/000314213; Aye ILMH, 2014, MOL ENDOCRINOL, V28, P512, DOI 10.1210/me.2013-1401; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Baraille F, 2015, PHYSIOLOGY, V30, P428, DOI 10.1152/physiol.00016.2015; Baranowski M, 2007, J PHYSIOL PHARMACOL, V58, P57; BERDANIER CD, 1989, FASEB J, V3, P2179, DOI 10.1096/fasebj.3.10.2666232; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Chen TC, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7905; de Guia RM, 2015, ADV EXP MED BIOL, V872, P127, DOI 10.1007/978-1-4939-2895-8_6; Dolinsky VW, 2004, BIOCHEM J, V378, P967, DOI 10.1042/BJ20031320; Garg A, 1996, DIABETES CARE, V19, P387, DOI 10.2337/diacare.19.4.387; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Gray NE, 2012, J BIOL CHEM, V287, P8444, DOI 10.1074/jbc.M111.294124; HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988; HELLERSTEIN MK, 1991, J CLIN INVEST, V87, P1841, DOI 10.1172/JCI115206; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Jornayvaz FR, 2010, ANNU REV NUTR, V30, P273, DOI 10.1146/annurev.nutr.012809.104726; Kasumov T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126910; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Kong LB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-246; Kuo TY, 2014, J LIPID RES, V55, P919, DOI 10.1194/jlr.M047860; Kurek K, 2014, LIVER INT, V34, P1074, DOI 10.1111/liv.12331; Li GP, 2011, J LIPID RES, V52, P971, DOI 10.1194/jlr.M013748; Luz JG, 2015, J MED CHEM, V58, P6607, DOI 10.1021/acs.jmedchem.5b00736; McQueen AE, 2017, J BIOL CHEM, V292, P16122, DOI 10.1074/jbc.M117.803973; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Nasiri M, 2015, ENDOCRINOLOGY, V156, P2863, DOI 10.1210/en.2015-1149; Nuotio-Antar AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1517, DOI 10.1152/ajpendo.00522.2007; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Priyadarshini E, 2017, CAN J DIABETES, V41, P41, DOI 10.1016/j.jcjd.2016.06.003; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Rivier M, 2000, J INVEST DERMATOL, V114, P681, DOI 10.1046/j.1523-1747.2000.00939.x; Robins SJ, 2011, ARTERIOSCL THROM VAS, V31, P1208, DOI 10.1161/ATVBAHA.110.219055; Sajan MP, 2015, J LIPID RES, V56, P70, DOI 10.1194/jlr.M052977; Seckl JR, 2004, RECENT PROG HORM RES, V59, P359, DOI 10.1210/rp.59.1.359; Stefan N, 2014, LANCET DIABETES ENDO, V2, P406, DOI 10.1016/S2213-8587(13)70170-0; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Wang JC, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-19; Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074; Wang YH, 2013, MOL CELL, V49, P283, DOI 10.1016/j.molcel.2012.10.028; Woods CP, 2015, J STEROID BIOCHEM, V154, P94, DOI 10.1016/j.jsbmb.2015.07.020; Xavier GD, 2006, J LIPID RES, V47, P2482, DOI 10.1194/jlr.M600289-JLR200; Xia JY, 2015, CELL METAB, V22, P266, DOI 10.1016/j.cmet.2015.06.007; Xie L, 2013, CELL REP, V3, P678, DOI 10.1016/j.celrep.2013.01.029; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200	49	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9213	9224		10.1074/jbc.RA118.006259	http://dx.doi.org/10.1074/jbc.RA118.006259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31053639	Green Published, hybrid			2022-12-28	WOS:000471751600016
J	Johnson, E; McTigue, M; Gallego, RA; Johnson, TW; Timofeevski, S; Maestre, M; Fisher, TS; Kania, R; Sawasdikosol, S; Burakoff, S; Cronin, CN				Johnson, Eric; McTigue, Michele; Gallego, Rebecca A.; Johnson, Ted W.; Timofeevski, Sergei; Maestre, Michael; Fisher, Timothy S.; Kania, Robert; Sawasdikosol, Sansana; Burakoff, Steven; Cronin, Ciaran N.			Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; serine; threonine protein kinase; inhibitor; drug discovery; dimerization; conformational change; cancer; conformational plasticity; domain swapping; hematopoietic progenitor kinase 1 (HPK1); trans-regulation	HEMATOPOIETIC PROGENITOR KINASE-1; CASPASE-MEDIATED CLEAVAGE; CRYSTAL-STRUCTURE; ACTIVATION; INHIBITOR; AUTOPHOSPHORYLATION; REFINEMENT; MECHANISM; LOOP	Hematopoietic progenitor kinase 1 (HPK1 or MAP4K1) is a Ser/Thr kinase that operates via the c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) signaling pathways to dampen the T-cell response and antitumor immunity. Accordingly, selective HPK1 inhibition is considered a means to enhance antitumor immunity. Sunitinib, a multi-receptor tyrosine kinase (RTK) inhibitor approved for the management of gastrointestinal stromal tumors (GISTs), renal cell carcinoma (RCC), and pancreatic cancer, has been reported to inhibit HPK1 in vitro. In this report, we describe the crystal structures of the native HPK1 kinase domain in both nonphosphorylated and doubly phosphorylated states, in addition to a double phosphomimetic mutant (T165E,S171E), each complexed with sunitinib at 2.17-3.00- resolutions. The native nonphosphorylated cocrystal structure revealed an inactive dimer in which the activation loop of each monomer partially occupies the ATP- and substrate-binding sites of the partner monomer. In contrast, the structure of the protein with a doubly phosphorylated activation loop exhibited an active kinase conformation with a greatly reduced monomer-monomer interface. Conversely, the phosphomimetic mutant cocrystal structure disclosed an alternative arrangement in which the activation loops are in an extended domain-swapped configuration. These structural results indicate that HPK1 is a highly dynamic kinase that undergoes trans-regulation via dimer formation and extensive intramolecular and intermolecular remodeling of the activation segment.	[Johnson, Eric; McTigue, Michele; Gallego, Rebecca A.; Johnson, Ted W.; Timofeevski, Sergei; Maestre, Michael; Fisher, Timothy S.; Kania, Robert; Cronin, Ciaran N.] Pfizer Worldwide Res & Dev, La Jolla Labs, 10770 Sci Ctr Dr,CB2, San Diego, CA 92121 USA; [Sawasdikosol, Sansana; Burakoff, Steven] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA	Pfizer; Icahn School of Medicine at Mount Sinai	Cronin, CN (corresponding author), Pfizer Worldwide Res & Dev, La Jolla Labs, 10770 Sci Ctr Dr,CB2, San Diego, CA 92121 USA.	ciaran.cronin@pfizer.com						Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alzabin S, 2010, CANCER IMMUNOL IMMUN, V59, P419, DOI 10.1007/s00262-009-0761-0; Alzabin S, 2009, J IMMUNOL, V182, P6187, DOI 10.4049/jimmunol.0802631; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Arnold R, 2005, MOL CELL BIOL, V25, P2364, DOI 10.1128/MCB.25.6.2364-2383.2005; Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Bennett MJ, 2004, STRUCTURE, V12, P1339, DOI 10.1016/j.str.2004.07.004; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Blanc E., 2011, BUSTER VERSION 2 11; Brenner D, 2007, BLOOD, V110, P3968, DOI 10.1182/blood-2007-01-071167; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gajiwala KS, 2009, P NATL ACAD SCI USA, V106, P1542, DOI 10.1073/pnas.0812413106; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Li Y, 2009, PROTEIN SCI, V18, P678, DOI 10.1002/pro.98; Liu JQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212670; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Marcotte D, 2017, PROTEIN SCI, V26, P152, DOI 10.1002/pro.3062; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McTigue M, 2012, P NATL ACAD SCI USA, V109, P18281, DOI 10.1073/pnas.1207759109; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Rousseau F, 2012, ADV EXP MED BIOL, V747, P137, DOI 10.1007/978-1-4614-3229-6_9; Sawasdikosol S, 2019, STRUCTURE, V27, P1, DOI 10.1016/j.str.2018.12.009; Sawasdikosol S, 2012, IMMUNOL RES, V54, P262, DOI 10.1007/s12026-012-8319-1; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang XH, 2012, J BIOL CHEM, V287, P11037, DOI 10.1074/jbc.M111.310946; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wu P, 2019, STRUCTURE, V27, P125, DOI 10.1016/j.str.2018.10.025	39	12	12	5	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9029	9036		10.1074/jbc.AC119.007466	http://dx.doi.org/10.1074/jbc.AC119.007466			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31018963	Green Published, hybrid			2022-12-28	WOS:000471751600002
J	Wang, C; Arrington, J; Ratliff, AC; Chen, JJ; Horton, HE; Nie, YH; Yue, F; Hrycyna, CA; Tao, WA; Kuang, SH				Wang, Chao; Arrington, Justine; Ratliff, Anna C.; Chen, Jingjuan; Horton, Hannah E.; Nie, Yaohui; Yue, Feng; Hrycyna, Christine A.; Tao, W. Andy; Kuang, Shihuan			Methyltransferase-like 21c methylates and stabilizes the heat shock protein Hspa8 in type I myofibers in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular chaperone; myogenesis; development; autophagy; skeletal muscle; chaperone-mediated autophagy (CMA); methyltransferase-like 21c (Mettl21c); myocyte enhancer factor 2 (Mef2); protein methylation; skeletal muscle; posttranslational modification; heat shock protein family A (Hsp70) member 8 (HSPA8); Hsc70	MEF2 TRANSCRIPTION FACTOR; LYSINE METHYLATION; QUALITY-CONTROL; AUTOPHAGY; DEGRADATION; ACTIVATION; ROLES; DIFFERENTIATION; METTL21C; PATHWAY	Protein methyltransferases mediate posttranslational modifications of both histone and nonhistone proteins. Whereas histone methylation is well-known to regulate gene expression, the biological significance of nonhistone methylation is poorly understood. Methyltransferase-like 21c (Mettl21c) is a newly classified nonhistone lysine methyltransferase whose in vivo function has remained elusive. Using a Mettl21c(LacZ) knockin mouse model, we show here that Mettl21c expression is absent during myogenesis and restricted to mature type I (slow) myofibers in the muscle. Using co-immunoprecipitation, MS, and methylation assays, we demonstrate that Mettl21c trimethylates heat shock protein 8 (Hspa8) at Lys-561 to enhance its stability. As such, Mettl21c knockout reduced Hspa8 trimethylation and protein levels in slow muscles, and Mettl21c overexpression in myoblasts increased Hspa8 trimethylation and protein levels. We further show that Mettl21c-mediated stabilization of Hspa8 enhances its function in chaperone-mediated autophagy, leading to degradation of client proteins such as the transcription factors myocyte enhancer factor 2A (Mef2A) and Mef2D. In contrast, Mettl21c knockout increased Mef2 protein levels in slow muscles. These results identify Hspa8 as a Mettl21c substrate and reveal that nonhistone methylation has a physiological function in protein stabilization.	[Wang, Chao; Chen, Jingjuan; Nie, Yaohui; Yue, Feng; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Arrington, Justine; Ratliff, Anna C.; Hrycyna, Christine A.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Horton, Hannah E.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Hrycyna, Christine A.; Tao, W. Andy; Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wang, C; Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.; Kuang, SH (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.	wangc129@gmail.com; skuang@purdue.edu	Wang, Chao/V-8994-2019	Wang, Chao/0000-0002-4051-364X; Arrington, Justine/0000-0003-1511-8805; Kuang, Shihuan/0000-0001-9180-3180	National Institutes of Health [R01AR071649]; National Institute of Food and Agriculture [NC-1184]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health Grant R01AR071649 and the National Institute of Food and Agriculture Grant NC-1184. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Huang J, 2014, J BONE MINER RES, V29, P1531, DOI 10.1002/jbmr.2200; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Ornatsky OI, 1999, NUCLEIC ACIDS RES, V27, P2646, DOI 10.1093/nar/27.13.2646; Page N, 2011, ANN RHEUM DIS, V70, P837, DOI 10.1136/ard.2010.139832; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Stricher F, 2013, AUTOPHAGY, V9, P1937, DOI 10.4161/auto.26448; Tahrir FG, 2017, J CELL PHYSIOL, V232, P797, DOI 10.1002/jcp.25476; Wang C, 2019, FASEB J, V33, P9672, DOI 10.1096/fj.201900582R; Wang C, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2279; Wang C, 2017, DEVELOPMENT, V144, P235, DOI 10.1242/dev.138099; Wang C, 2015, J BIOL CHEM, V290, P29707, DOI 10.1074/jbc.M115.688671; Wiederstein JL, 2018, CELL REP, V23, P1342, DOI 10.1016/j.celrep.2018.03.136; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu H, 2002, J CLIN INVEST, V109, P1327, DOI 10.1172/JCI200215417; Wust S, 2018, CELL METAB, V27, P1026, DOI 10.1016/j.cmet.2018.02.022; Yang CC, 1998, NUCLEIC ACIDS RES, V26, P4771, DOI 10.1093/nar/26.20.4771; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zhang HQ, 2015, STRUCTURE, V23, P472, DOI 10.1016/j.str.2015.01.003; Zhang L, 2014, AUTOPHAGY, V10, P1015, DOI 10.4161/auto.28477	40	11	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13718	13728		10.1074/jbc.RA119.008430	http://dx.doi.org/10.1074/jbc.RA119.008430			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31346037	Green Published, hybrid			2022-12-28	WOS:000486418600017
J	Poli, M; Anower-E-Khuda, F; Asperti, M; Ruzzenenti, P; Gryzik, M; Denardo, A; Gordts, PLSM; Arosio, P; Esko, JD				Poli, Maura; Anower-E-Khuda, Ferdous; Asperti, Michela; Ruzzenenti, Paola; Gryzik, Magdalena; Denardo, Andrea; Gordts, Philip L. S. M.; Arosio, Paolo; Esko, Jeffrey D.			Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heparan sulfate; iron metabolism; bone morphogenetic protein (BMP); hepatocyte; inflammation; glycoprotein; cytokine; heparan sulfate proteoglycan (HSPG); hepcidin 2	IN-VITRO; BMP6; MATRIPTASE-2; PROTEOGLYCANS; INHIBITORS; CLEARANCE; LIVER	Hepcidin is a liver-derived peptide hormone that controls systemic iron homeostasis. Its expression is regulated by the bone morphogenetic protein 6 (BMP6)/SMAD1/5/8 pathway and by the proinflammatory cytokine interleukin 6 (IL6). Proteoglycans that function as receptors of these signaling proteins in the liver are commonly decorated by heparan sulfate, but the potential role of hepatic heparan sulfate in hepcidin expression and iron homeostasis is unclear. Here, we show that modulation of hepatic heparan sulfate significantly alters hepcidin expression and iron metabolism both in vitro and in vivo. Specifically, enzymatic removal of heparan sulfate from primary human hepatocytes, CRISPR/Cas9 manipulation of heparan sulfate biosynthesis in human hepatoma cells, or pharmacological manipulation of heparan sulfate-protein interactions using sodium chlorate or surfen dramatically reduced baseline and BMP6/SMAD1/5/8-dependent hepcidin expression. Moreover inactivation of the heparan sulfate biosynthetic gene N-deacetylase and N-sulfotransferase 1 (Ndst1) in murine hepatocytes (Ndst1(f/f)AlbCre(+)) reduced hepatic hepcidin expression and caused a redistribution of systemic iron, leading to iron accumulation in the liver and serum of mice. Manipulation of heparan sulfate had a similar effect on IL6-dependent hepcidin expression in vitro and suppressed IL6-mediated iron redistribution induced by lipopolysaccharide in vivo. These results provide compelling evidence that hepatocyte heparan sulfate plays a key role in regulating hepcidin expression and iron homeostasis in mice and in human hepatocytes.	[Poli, Maura; Asperti, Michela; Ruzzenenti, Paola; Gryzik, Magdalena; Denardo, Andrea; Arosio, Paolo] Univ Brescia, Dept Mol & Translat Med, Viale Europa 11, I-25123 Brescia, Italy; [Anower-E-Khuda, Ferdous; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Gordts, Philip L. S. M.; Esko, Jeffrey D.] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Gordts, Philip L. S. M.] Univ Calif San Diego, Div Endocrinol & Metab, Dept Med, La Jolla, CA 92093 USA	University of Brescia; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Poli, M (corresponding author), Univ Brescia, Dept Mol & Translat Med, Viale Europa 11, I-25123 Brescia, Italy.	maura.poli@unibs.it		Poli, Maura/0000-0001-9206-8122; Gordts, Philip/0000-0001-7224-4328; arosio, paolo/0000-0002-5343-8992	Telethon Grant [GGP15064]; Regione Lombardia project "New Opportunities and Ways toward ERC" [2014-2256]; National Institutes of Health [GM33063]; EMBO [ASTF121-2016]; Fondation Leducq [01CVD16]; Fondazione Cariplo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063] Funding Source: NIH RePORTER	Telethon Grant(Fondazione Telethon); Regione Lombardia project "New Opportunities and Ways toward ERC"; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); Fondation Leducq(Leducq Foundation); Fondazione Cariplo(Fondazione Cariplo); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by Telethon Grant GGP15064 (to M. P.), by Fondazione Cariplo and Regione Lombardia project "New Opportunities and Ways toward ERC" 2014-2256 (to M. P.), and National Institutes of Health Grant GM33063(to J. D. E.). This work was also supported by short-term EMBO Fellowship ASTF121-2016 (to M. P.) and Fondation Leducq 01CVD16 (to P. L. S. M. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no conflicts of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Asperti M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164183; Asperti M, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00316; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Billings PC, 2018, J BIOL CHEM, V293, P14371, DOI 10.1074/jbc.RA118.003191; Crawford BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010691; Deng YP, 2012, HEPATOLOGY, V55, P277, DOI 10.1002/hep.24626; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Foley EM, 2013, ARTERIOSCL THROM VAS, V33, P2065, DOI 10.1161/ATVBAHA.113.301637; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Gordts PLSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038330; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kautz L, 2011, HAEMATOL-HEMATOL J, V96, P199, DOI 10.3324/haematol.2010.031963; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Poli M, 2017, MOLECULES, V22, DOI 10.3390/molecules22040598; Poli M, 2014, BIOCHEM PHARMACOL, V92, P467, DOI 10.1016/j.bcp.2014.09.007; Poli M, 2014, BLOOD, V123, P1564, DOI 10.1182/blood-2013-07-515221; Poli M, 2011, BLOOD, V117, P997, DOI 10.1182/blood-2010-06-289082; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rausa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122696; Rider CC, 2017, MOLECULES, V22, DOI 10.3390/molecules22050713; Roetto A, 2010, BLOOD, V115, P3382, DOI 10.1182/blood-2009-09-240960; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Valore EV, 2008, BLOOD CELL MOL DIS, V40, P132, DOI 10.1016/j.bcmd.2007.07.009; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wahedi M, 2017, J BIOL CHEM, V292, P18354, DOI 10.1074/jbc.M117.801795; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weiss RJ, 2015, CHEM SCI, V6, P5984, DOI 10.1039/c5sc01208b; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314	43	12	13	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13292	13303		10.1074/jbc.RA118.007213	http://dx.doi.org/10.1074/jbc.RA118.007213			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31315930	Green Published, hybrid			2022-12-28	WOS:000486417200008
J	Yang, XH; Bennett, B; Holz, RC				Yang, Xinhang; Bennett, Brian; Holz, Richard C.			Insights into the catalytic mechanism of a bacterial hydrolytic dehalogenase that degrades the fungicide chlorothalonil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme kinetics; enzyme mechanism; zinc; hydrolase; bioremediation; Chd; chlorothalonil; dehalogenase; stopped-flow	DEGRADATION; AMINOPEPTIDASE; ARGININE	Chlorothalonil (2,4,5,6-tetrachloroisophtalonitrile; TPN) is one of the most commonly used fungicides in the United States. Given TPN's widespread use, general toxicity, and potential carcinogenicity, its biodegradation has garnered significant attention. Here, we developed a direct spectrophotometric assay for the Zn(II)-dependent, chlorothalonil-hydrolyzing dehalogenase from Pseudomonas sp. CTN-3 (Chd), enabling determination of its metal-binding properties; pH dependence of the kinetic parameters k(cat), K-m, and k(cat)/K-m; and solvent isotope effects. We found that a single Zn(II) ion binds a Chd monomer with a K-d of 0.17 mu m, consistent with inductively coupled plasma MS data for the as-isolated Chd dimer. We observed that Chd was maximally active toward chlorothalonil in the pH range 7.0-9.0, and fits of these data yielded a pK(ES1) of 5.4 +/- 0.2, a pK(ES2) of 9.9 +/- 0.1 (k(cat)' = 24 +/- 2 s(-1)), a pK(E1) of 5.4 +/- 0.3, and a pK(E2) of 9.5 +/- 0.1 (k(cat)'/k(m)' = 220 +/- 10 s(-1) mm(-1)). Proton inventory studies indicated that one proton is transferred in the rate-limiting step of the reaction at pD 7.0. Fits of UV-visible stopped-flow data suggested a three-step model and provided apparent rate constants for intermediate formation (i.e. a k(2)' of 35.2 +/- 0.1 s(-1)) and product release (i.e. a k(3)' of 1.1 +/- 0.2 s(-1)), indicating that product release is the slow step in catalysis. On the basis of these results, along with those previously reported, we propose a mechanism for Chd catalysis.	[Yang, Xinhang; Holz, Richard C.] Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA; [Bennett, Brian] Marquette Univ, Dept Phys, Milwaukee, WI 53233 USA; [Holz, Richard C.] Colorado Sch Mines, Dept Chem, Golden, CO 80401 USA	Marquette University; Marquette University; Colorado School of Mines	Holz, RC (corresponding author), Colorado Sch Mines, Dept Chem, Golden, CO 80401 USA.	rholz@mines.edu		Holz, Richard/0000-0001-6093-2799	National Science Foundation [CHE-1808711]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant CHE-1808711 (to R. C. H. and B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson V. E., 1992, CURR OPIN STRUC BIOL, V2, P757; Ang TF, 2018, MOLECULES, V23, DOI 10.3390/molecules23051100; Beil S, 1998, J BACTERIOL, V180, P5520, DOI 10.1128/JB.180.21.5520-5528.1998; Biro F Noah, 2010, J Vis Exp, DOI 10.3791/1874; Bunge M, 2003, NATURE, V421, P357, DOI 10.1038/nature01237; Carlo-Rojas Z, 2004, WATER AIR SOIL POLL, V151, P397, DOI 10.1023/B:WATE.0000009918.70113.c5; Caux PY, 1996, CRIT REV ENV SCI TEC, V26, P45, DOI 10.1080/10643389609388486; Chen H., 2016, APPL ENV BIOTECHNOL, V1, P30, DOI [10.18063/AEB.2016.01.003, DOI 10.18063/AEB.2016.01.00]; Chow C, 2013, BIOCHEMISTRY-US, V52, P4097, DOI 10.1021/bi400177y; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; CLELAND WW, 1982, CRC CR REV BIOCH MOL, V13, P385; D'souza VM, 2000, BIOCHEMISTRY-US, V39, P3817, DOI 10.1021/bi9925827; Dey A, 2006, J AM CHEM SOC, V128, P533, DOI 10.1021/ja0549695; Dreyton CJ, 2014, BIOCHEMISTRY-US, V53, P4426, DOI 10.1021/bi500554b; ELROD JP, 1980, J AM CHEM SOC, V102, P3917, DOI 10.1021/ja00531a039; Evers TH, 2008, PROTEIN ENG DES SEL, V21, P529, DOI 10.1093/protein/gzn029; Jenson DL, 2009, J AM CHEM SOC, V131, P10567, DOI 10.1021/ja902896e; Kwon JW, 2006, J AGR FOOD CHEM, V54, P3651, DOI 10.1021/jf052847q; Leisinger Thomas, 1994, Biodegradation, V5, P237, DOI 10.1007/BF00696462; Liang B, 2011, APPL ENVIRON MICROB, V77, P4268, DOI 10.1128/AEM.02457-10; Light KM, 2015, CHEM SCI, V6, P6280, DOI 10.1039/c5sc02012c; Martinez S, 2014, J AM CHEM SOC, V136, P1186, DOI 10.1021/ja410462j; Mitra S, 2007, J BIOL CHEM, V282, P7397, DOI 10.1074/jbc.M604117200; Mozzachio AM, 2008, ENVIRON RES, V108, P400, DOI 10.1016/j.envres.2008.07.018; ORSER CS, 1993, J BACTERIOL, V175, P2640, DOI 10.1128/JB.175.9.2640-2644.1993; Reddy GVB, 2000, MICROBIOL-UK, V146, P405, DOI 10.1099/00221287-146-2-405; Ren XJ, 2011, CURR MICROBIOL, V62, P1068, DOI 10.1007/s00284-010-9824-x; Sakkas VA, 2002, CHEMOSPHERE, V48, P939, DOI 10.1016/S0045-6535(02)00121-2; SALOMAA P, 1964, J AM CHEM SOC, V86, P1, DOI 10.1021/ja01055a001; VANDERPLOEG J, 1991, J BACTERIOL, V173, P7925, DOI 10.1128/jb.173.24.7925-7933.1991; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0; Viciu MS, 2001, ORGANOMETALLICS, V20, P3607, DOI 10.1021/om010332s; VICKERS AEM, 1985, ENVIRON HEALTH PERSP, V59, P121, DOI 10.2307/3429884; Vickery HB, 1928, J BIOL CHEM, V78, P627; Wang GL, 2010, J BACTERIOL, V192, P2737, DOI 10.1128/JB.01547-09; Watterson SJ, 2008, BIOCHEMISTRY-US, V47, P11885, DOI 10.1021/bi801499g; WINZOR DJ, 1995, QUANTITATIVE CHARACT; XUN LY, 1992, J BACTERIOL, V174, P8003, DOI 10.1128/JB.174.24.8003-8007.1992; YOKOTA T, 1986, AGR BIOL CHEM TOKYO, V50, P453, DOI 10.1080/00021369.1986.10867402; Yue WL, 2015, J BIOSCI BIOENG, V120, P544, DOI 10.1016/j.jbiosc.2015.03.013	40	2	3	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13411	13420		10.1074/jbc.RA119.009094	http://dx.doi.org/10.1074/jbc.RA119.009094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31331935	Green Published, hybrid			2022-12-28	WOS:000486417200017
J	Reddish, MJ; Guengerich, FP				Reddish, Michael J.; Guengerich, F. Peter			Human cytochrome P450 11B2 produces aldosterone by a processive mechanism due to the lactol form of the intermediate 18-hydroxycorticosterone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; steroid; steroidogenesis; enzyme kinetics; kinetics; pre-steady-state kinetics; conformational change; aldosterone synthesis; corticosterone; CYP11B2; deoxycorticosterone; P450 11B2	CHAIN CLEAVAGE ENZYME; CYP11B2 INHIBITORS; MUTATIONS; POTENT; CORTISOL; EXPRESSION; DISCOVERY; OXIDATION; EXPLORER; PYRIDYL	Human cytochrome P450 (P450) 11B2 catalyzes the formation of aldosterone, the major endogenous human mineralocorticoid. Aldosterone is important for the regulation of electrolyte homeostasis. Mutations and overexpression of P450 11B2 (also known as aldosterone synthase) can lead to hypertension, congestive heart failure, and diabetic nephropathy. The enzyme is therefore a target for drug development to manage these various disorders. P450 11B2 catalyzes aldosterone formation from 11-deoxycorticosterone through three distinct oxidation steps. It is currently unknown to which degree these reactions happen in sequence without the intermediate products dissociating from the enzyme (i.e. processively) or whether these reactions happen solely distributively, in which the intermediate products must first dissociate and then rebind to the enzyme before subsequent oxidation. We present here a comprehensive investigation of processivity in P450 11B2-catalyzed reactions using steady-state, pre-steady-state, pulse-chase, equilibrium-binding titrations, and stopped-flow binding studies. We utilized the data obtained to develop a kinetic model for P450 11B2 and tested this model by enzyme kinetics simulations. We found that although aldosterone is produced processively, the enzyme preferentially utilizes a distributive mechanism that ends with the production of 18-OH corticosterone. This seemingly contradictory observation could be resolved by considering the ability of the intermediate product 18-OH corticosterone to exist as a lactol form, with the equilibrium favoring the ring-closed lactol configuration. In summary, our refined model for P450 11B2 catalysis indicates isomerization of the intermediate to a lactol can explain why P450 11B2 must produce aldosterone through a processive mechanism despite favoring a distributive mechanism.	[Reddish, Michael J.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Reddish, Michael/D-9150-2013	Reddish, Michael/0000-0002-0237-786X	National Institutes of Health [R01 GM118122, T32 ES007028]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM118122 (to F. P. G.) and T32 ES007028 (to F. P. G. for support of M. J. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auchus RJ, 2017, J STEROID BIOCHEM, V165, P71, DOI 10.1016/j.jsbmb.2016.02.002; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Bottner B, 1996, J BIOL CHEM, V271, P8028; Boudi A, 1999, TETRAHEDRON, V55, P5171, DOI 10.1016/S0040-4020(99)00187-8; Chowdhury G, 2012, BIOCHEMISTRY-US, V51, P9995, DOI 10.1021/bi301092c; Chowdhury G, 2010, J BIOL CHEM, V285, P8031, DOI 10.1074/jbc.M109.088039; Curnow KM, 1997, NAT STRUCT BIOL, V4, P32, DOI 10.1038/nsb0197-32; Ferrari P, 2010, BBA-MOL BASIS DIS, V1802, P1178, DOI 10.1016/j.bbadis.2009.10.017; Gobbi S, 2016, J MED CHEM, V59, P2468, DOI 10.1021/acs.jmedchem.5b01609; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; GOUX WJ, 1985, J AM CHEM SOC, V107, P4320, DOI 10.1021/ja00300a041; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2017, CHEM RES TOXICOL, V30, P2, DOI 10.1021/acs.chemrestox.6b00226; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Hobler A, 2012, J STEROID BIOCHEM, V132, P57, DOI 10.1016/j.jsbmb.2012.03.002; Hoyt SB, 2015, ACS MED CHEM LETT, V6, P861, DOI 10.1021/acsmedchemlett.5b00048; Hu QZ, 2015, J MED CHEM, V58, P2530, DOI 10.1021/acs.jmedchem.5b00079; Hu QZ, 2010, J MED CHEM, V53, P5749, DOI 10.1021/jm100317b; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Imai T, 1998, BIOCHEMISTRY-US, V37, P8097, DOI 10.1021/bi9802768; Johnson KA, 2019, BEILSTEIN J ORG CHEM, V15, P16, DOI 10.3762/bjoc.15.2; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Katsumata N, 2002, J CLIN ENDOCR METAB, V87, P3808, DOI 10.1210/jc.87.8.3808; KEM DC, 1985, J CLIN ENDOCR METAB, V60, P67, DOI 10.1210/jcem-60-1-67; Kim CJ, 2008, J CLIN ENDOCR METAB, V93, P696, DOI 10.1210/jc.2007-2330; Martin RE, 2015, J MED CHEM, V58, P8054, DOI 10.1021/acs.jmedchem.5b00851; Mendieta MAEPB, 2013, J MED CHEM, V56, P6101, DOI 10.1021/jm400484p; Mulatero P, 1998, J CLIN ENDOCR METAB, V83, P3996, DOI 10.1210/jc.83.11.3996; Mulatero P, 2012, J CLIN ENDOCR METAB, V97, P881, DOI 10.1210/jc.2011-2384; OELKERS W, 1988, J CLIN ENDOCR METAB, V66, P181, DOI 10.1210/jcem-66-1-181; OMURA T, 1964, J BIOL CHEM, V239, P2370; Parajes S, 2010, J CLIN ENDOCR METAB, V95, P779, DOI 10.1210/jc.2009-0651; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P4996, DOI 10.1073/pnas.89.11.4996; Peng HM, 2018, J STEROID BIOCHEM, V181, P63, DOI 10.1016/j.jsbmb.2018.03.003; Perrin CL, 2017, J CHEM EDUC, V94, P669, DOI 10.1021/acs.jchemed.6b00629; Portrat-Doyen S, 1998, J CLIN ENDOCR METAB, V83, P4156, DOI 10.1210/jc.83.11.4156; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Schumacher CD, 2013, J HYPERTENS, V31, P2085, DOI 10.1097/HJH.0b013e328363570c; Simpson ER, 2000, J SOC GYNECOL INVEST, V7, pS18, DOI 10.1177/1071557600007001S07; SIMPSON SA, 1954, HELV CHIM ACTA, V37, P1163, DOI 10.1002/hlca.19540370423; SIMPSON SA, 1954, EXPERIENTIA, V10, P132, DOI 10.1007/BF02158515; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Strushkevich N, 2013, MOL ENDOCRINOL, V27, P315, DOI 10.1210/me.2012-1287; Ulmschneider S, 2005, J MED CHEM, V48, P1563, DOI 10.1021/jm0492397; Wilczynski C, 2015, ENDOCR PRACT, V21, P957, DOI 10.4158/EP14551.RA; Yoshimoto FK, 2016, J AM CHEM SOC, V138, P12124, DOI 10.1021/jacs.6b04437; Young MJ, 2001, J CLIN ENDOCR METAB, V86, P5121, DOI 10.1210/jc.86.11.5121	49	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12975	12991		10.1074/jbc.RA119.009830	http://dx.doi.org/10.1074/jbc.RA119.009830			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296661	hybrid, Green Published			2022-12-28	WOS:000486416000010
J	Hendricson, A; Umlauf, S; Choi, JY; Thekkiniath, J; Surovtseva, YV; Fuller, KK; Reynolds, TB; Voelker, DR; Ben Mamoun, C				Hendricson, Adam; Umlauf, Sheila; Choi, Jae-Yeon; Thekkiniath, Jose; Surovtseva, Yulia, V; Fuller, Kevin K.; Reynolds, Todd B.; Voelker, Dennis R.; Ben Mamoun, Choukri			High-throughput screening for phosphatidylserine decarboxylase inhibitors using a distyrylbenzene-bis-aldehyde (DSB-3)-based fluorescence assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylethanolamine; phosphatidylserine; phosphatidylserine decarboxylase; plasmodium; high-throughput screening (HTS); Candida albicans; Plasmodium knowlesi; Plasmodium falciparum; enzyme; parasitic disease; antimicrobial agent; phospholipids	MODULATES LIPID-METABOLISM; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; TUMOR-SUPPRESSOR; MEMBRANE-LIPIDS; PHOSPHATIDYLETHANOLAMINE; YEAST; GENE; COMPLEMENTATION; IDENTIFICATION	Phosphatidylserine decarboxylases (PSDs) catalyze the decarboxylation of phosphatidylserine to generate phosphatidylethanolamine, a critical step in phospholipid metabolism in both prokaryotes and eukaryotes. Most PSDs are membrane-bound, and classical radioisotope-based assays for determining their activity in vitro are not suitable for high-throughput drug screening. The finding that the PkPSD from Plasmodium knowlesi can be purified in a soluble and active form and the recent development of a fluorescence-based distyrylbenzene-bis-aldehyde (DSB-3) assay to measure PSD activity in vitro have laid the groundwork for screening chemical libraries for PSD inhibitors. Using this assay, here we conducted a high-throughput screen of a structurally diverse 130,858-compound library against PkPSD. Further characterization of the hits identified in this screening yielded five PkPSD inhibitors with IC50 values ranging from 3.1 to 42.3 mu m. Lead compounds were evaluated against the pathogenic yeast Candida albicans in the absence or presence of exogenous ethanolamine, and YU253467 and YU254403 were identified as inhibiting both native C. albicans PSD mitochondrial activity and C. albicans growth, with an MIC50 of 22.5 and 15 mu g/ml without ethanolamine and an MIC50 of 75 and 60 mu g/ml with ethanolamine, respectively. Together, these results provide the first proof of principle for the application of DSB-3-based fluorescent readouts in high-throughput screening for PSD inhibitors. The data set the stage for future analyses to identify more selective and potent PSD inhibitors with antimicrobial or antitumor activities.	[Hendricson, Adam; Umlauf, Sheila; Surovtseva, Yulia, V] Yale Ctr Mol Discovery, West Haven, CT 06516 USA; [Choi, Jae-Yeon; Voelker, Dennis R.] Natl Jewish Hlth, Basic Sci Sect, Dept Med, Denver, CO 80206 USA; [Thekkiniath, Jose; Ben Mamoun, Choukri] Yale Sch Med, Dept Internal Med, Sect Infect Dis, TAC-S469C,300 Cedar St, New Haven, CT 06520 USA; [Fuller, Kevin K.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Fuller, Kevin K.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Reynolds, Todd B.] Univ Tennessee, Coll Arts & Sci, Dept Microbiol, Knoxville, TN 37996 USA	National Jewish Health; Yale University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Tennessee System; University of Tennessee Knoxville	Ben Mamoun, C (corresponding author), Yale Sch Med, Dept Internal Med, Sect Infect Dis, TAC-S469C,300 Cedar St, New Haven, CT 06520 USA.	choukri.benmamoun@yale.edu		Reynolds, Todd/0000-0002-2867-7182	PITCH program of the Connecticut Bioscience Innovation Fund; National Institutes of Health [AI097218, GM110506, AI123321, R43AI136118, GM104485]; Bill and Melinda Gates Foundation [OPP1021571]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123321, R01AI097218] Funding Source: NIH RePORTER	PITCH program of the Connecticut Bioscience Innovation Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the PITCH program of the Connecticut Bioscience Innovation Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants AI097218 and GM104485.; Supported by National Institutes of Health Grants AI097218, GM110506, AI123321, and R43AI136118 and Bill and Melinda Gates Foundation Grant OPP1021571.	Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Baunaure F, 2004, MOL MICROBIOL, V51, P33, DOI 10.1046/j.1365-2958.2003.03822.x; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Chen YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18610-5; Choi JY, 2018, J BIOL CHEM, V293, P1493, DOI 10.1074/jbc.RA117.000525; Choi JY, 2016, MOL MICROBIOL, V99, P999, DOI 10.1111/mmi.13280; Choi JY, 2015, J BIOL CHEM, V290, P10972, DOI 10.1074/jbc.M115.642413; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Davis SE, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00815-17, 10.1128/iai.00815-17]; Eriksson O, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00396; Forbes CD, 2007, J BIOMOL SCREEN, V12, P628, DOI 10.1177/1087057107301320; Friedman JR, 2018, DEV CELL, V44, P261, DOI 10.1016/j.devcel.2017.11.023; Gupta N, 2012, J BIOL CHEM, V287, P22938, DOI 10.1074/jbc.M112.373639; Hartmann A, 2014, J BIOL CHEM, V289, P6809, DOI 10.1074/jbc.M113.509406; HAWROT E, 1975, P NATL ACAD SCI USA, V72, P1112, DOI 10.1073/pnas.72.3.1112; KANFER J, 1964, J BIOL CHEM, V239, P1720; Keckesova Z, 2017, NATURE, V543, P681, DOI 10.1038/nature21408; KUGE O, 1991, J BIOL CHEM, V266, P6370; MILLER MA, 1986, J BIOL CHEM, V261, P9753; Nerlich A, 2007, PLANT PHYSIOL, V144, P904, DOI 10.1104/pp.107.095414; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Rontein D, 2003, PLANT PHYSIOL, V132, P1678, DOI 10.1104/pp.103.023242; Short DPG, 2013, FUNGAL GENET BIOL, V53, P59, DOI 10.1016/j.fgb.2013.01.004; TOBIAS LD, 1979, LIPIDS, V14, P181, DOI 10.1007/BF02533870; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669	32	1	1	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12146	12156		10.1074/jbc.RA119.007766	http://dx.doi.org/10.1074/jbc.RA119.007766			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31227523	Green Published, hybrid			2022-12-28	WOS:000484284500018
J	Nahle, S; Pasquin, S; Laplante, V; Rousseau, F; Sharma, M; Gauchat, JF				Nahle, Sarah; Pasquin, Sarah; Laplante, Veronique; Rousseau, Francois; Sharma, Mukut; Gauchat, Jean-Francois			Cardiotrophin-like cytokine (CLCF1) modulates mesenchymal stem cell osteoblastic differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; cytokine; mesenchymal stem cells (MSCs); osteoblast; osteoporosis; cardiotrophin-like cytokine (CLCF1)	CILIARY NEUROTROPHIC FACTOR; STUVE-WIEDEMANN-SYNDROME; MARROW STROMAL CELLS; TERM-FOLLOW-UP; FACTOR-RECEPTOR; STIMULATING FACTOR-3; SIGNALING PATHWAYS; MICE LACKING; IN-VITRO; BONE	Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into adipocytes, chondrocytes, or osteocytes. MSCs secrete an array of cytokines and express the LIFR beta (leukemia inhibitory factor receptor) chain on their surface. Mutations in the gene coding for LIFR beta lead to a syndrome with altered bone metabolism. LIFR beta is one of the signaling receptor chains for cardiotrophin-like cytokine (CLCF1), a neurotrophic factor known to modulate B and myeloid cell functions. We investigated its effect on MSCs induced to differentiate into osteocytes in vitro. Our results indicate that CLCF1 binds mouse MSCs, triggers STAT1 and -3 phosphorylation, inhibits the up-regulation of master genes involved in the control of osteogenesis, and markedly prevents osteoblast generation and mineralization. This suggests that CLCF1 could be a target for therapeutic intervention with agents such as cytokine traps or blocking mAbs in bone diseases such as osteoporosis.	[Nahle, Sarah; Pasquin, Sarah; Laplante, Veronique; Gauchat, Jean-Francois] Univ Montreal, Dept Pharmacol & Physiol, Montreal, PQ H3T 1J4, Canada; [Rousseau, Francois] Novimmune SA, CH-1228 Plan Les Ouates, Switzerland; [Sharma, Mukut] Kansas City Vet Affairs Med Ctr, Renal Div, Kansas City, MO 64128 USA	Universite de Montreal; NovImmune SA	Gauchat, JF (corresponding author), Univ Montreal, Dept Pharmacol & Physiol, Montreal, PQ H3T 1J4, Canada.	jf.gauchat@umontreal.ca			Canadian Institutes of Health Research (CIHR) [MOP-57832, PTJ 159654]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP-57832 and PTJ 159654 (to J.-F.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander WS, 1999, CURR BIOL, V9, P605, DOI 10.1016/S0960-9822(99)80266-8; Askmyr M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15529; Chen C, 2012, J CELL BIOCHEM, V113, P3672, DOI 10.1002/jcb.24240; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Dagoneau N, 2004, AM J HUM GENET, V74, P298, DOI 10.1086/381715; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; Djouad F, 2005, ARTHRITIS RES THER, V7, pR1304, DOI 10.1186/ar1827; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Gaspar IM, 2008, AM J MED GENET A, V146A, P1748, DOI 10.1002/ajmg.a.32325; Ge JR, 2018, CHIN J INTEGR MED, V24, P415, DOI 10.1007/s11655-016-2744-2; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hahn AF, 2010, J NEUROL SCI, V293, P68, DOI 10.1016/j.jns.2010.02.028; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Heo JS, 2017, INT J MOL MED, V40, P1486, DOI 10.3892/ijmm.2017.3142; Honda Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03420; Huang S, 2015, J ORTHOP TRANSL, V3, P26, DOI 10.1016/j.jot.2014.07.005; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Jung C, 2010, CLIN GENET, V77, P266, DOI 10.1111/j.1399-0004.2009.01314.x; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Larsen JV, 2016, MOL CELL BIOL, V36, P1272, DOI 10.1128/MCB.00917-15; Larsen JV, 2010, MOL CELL BIOL, V30, P4175, DOI 10.1128/MCB.00274-10; Lelievre E, 2001, J BIOL CHEM, V276, P22476, DOI 10.1074/jbc.M101681200; Maeda S, 2002, J CELL PHYSIOL, V193, P73, DOI 10.1002/jcp.10151; McGregor NE, 2010, CALCIFIED TISSUE INT, V86, P261, DOI 10.1007/s00223-010-9337-4; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pasquin S, 2018, J IMMUNOL, V201, P2462, DOI 10.4049/jimmunol.1800733; Pasquin S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22400-y; Pasquin S, 2016, CYTOKINE, V82, P122, DOI 10.1016/j.cyto.2015.12.019; Perret D, 2004, J BIOL CHEM, V279, P43961, DOI 10.1074/jbc.M407686200; Rousseau F, 2006, P NATL ACAD SCI USA, V103, P10068, DOI 10.1073/pnas.0509598103; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Senaldi G, 2002, J IMMUNOL, V168, P5690, DOI 10.4049/jimmunol.168.11.5690; Shi Y, 1999, BIOCHEM BIOPH RES CO, V262, P132, DOI 10.1006/bbrc.1999.1181; SIFFERT RS, 1951, J EXP MED, V93, P415, DOI 10.1084/jem.93.5.415; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; Tormo AJ, 2012, CYTOKINE, V60, P653, DOI 10.1016/j.cyto.2012.08.014; Udagawa N, 2000, ENDOCRINOLOGY, V141, P3478, DOI 10.1210/en.141.9.3478; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zou X, 2009, VET PATHOL, V46, P514, DOI 10.1354/vp.08-VP-0239-B-BC	42	11	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					11952	11959		10.1074/jbc.AC119.008361	http://dx.doi.org/10.1074/jbc.AC119.008361			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31248987	Green Published, hybrid			2022-12-28	WOS:000484284500001
J	Inniss, NL; Prehna, G; Morrison, DA				Inniss, Nicole L.; Prehna, Gerd; Morrison, Donald A.			The pneumococcal sigma(X) activator, ComW, is a DNA-binding protein critical for natural transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Streptococcus; microbiology; RNA polymerase; DNA transformation; protein structure; bacterial transcription; competence; ComW; pneumococcus; sigma factor	STREPTOCOCCUS-PNEUMONIAE MUTATIONS; COLI RNA-POLYMERASE; GENETIC-TRANSFORMATION; SECONDARY STRUCTURE; BACILLUS-SUBTILIS; CONTROLS COMPETENCE; STRUCTURAL BASIS; IDENTIFICATION; PROMOTER; TRANSCRIPTION	Natural genetic transformation via horizontal gene transfer enables rapid adaptation to dynamic environments and contributes to both antibiotic resistance and vaccine evasion among bacterial populations. In Streptococcus pneumoniae (pneumococcus), transformation occurs when cells enter competence, a transient state in which cells express the competence master regulator, SigX (sigma(Chi)), an alternative sigma factor (sigma), and a competence co-regulator, ComW. Together, ComW and sigma(X) facilitate expression of the genes required for DNA uptake and genetic recombination. SigX activity depends on ComW, as Delta comW cells transcribe late genes and transform at levels 10- and 10,000-fold below that of WT cells, respectively. Previous findings suggest that ComW functions during assembly of the RNA polymerase-sigma(X) holoenzyme to help promote transcription from sigma(X)-targeted promoters. However, it remains unknown how ComW facilitates holoenzyme assembly. As ComW seems to be unique to Gram-positive cocci and has no sequence similarity with known transcriptional activators, here we used Rosetta to generate an ab initio model of pneumococcal ComW's 3D-structure. Using this model as a basis for further biochemical, biophysical, and genetic investigations into the molecular features important for its function, we report that ComW is a predicted globular protein and that it interacts with DNA, independently of DNA sequence. We also identified conserved motifs in ComW and show that key residues in these motifs contribute to DNA binding. Lastly, we provide evidence that ComW's DNA-binding activity is important for transformation in pneumococcus. Our findings begin to fill the gaps in understanding how ComW regulates sigma(Chi) activity during bacterial natural transformation.	[Inniss, Nicole L.; Morrison, Donald A.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Prehna, Gerd] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Manitoba	Morrison, DA (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA.; Prehna, G (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	gerd.prehna@umanitoba.ca; damorris@uic.edu		Inniss, Nicole/0000-0002-1510-7412; Prehna, Gerd/0000-0001-5539-7533	University of Illinois at Chicago through the Abraham Lincoln Fellowship; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [1R03AI128228]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI128228] Funding Source: NIH RePORTER	University of Illinois at Chicago through the Abraham Lincoln Fellowship; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the University of Illinois at Chicago through the Abraham Lincoln Fellowship awarded to NLI, as well as an R03 grant to GP and DAM from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (1R03AI128228). The authors declare that they have no conflicts of interest with the contents of this article.	Andam CP, 2015, INFECT GENET EVOL, V33, P334, DOI 10.1016/j.meegid.2014.11.007; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Banta AB, 2014, J BACTERIOL, V196, P3279, DOI 10.1128/JB.01910-14; Bartilson M, 2001, MOL MICROBIOL, V39, P126, DOI 10.1046/j.1365-2958.2001.02218.x; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Campagne S, 2014, NAT STRUCT MOL BIOL, V21, P269, DOI 10.1038/nsmb.2777; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 1998, MOL MICROBIOL, V27, P929, DOI 10.1046/j.1365-2958.1998.00737.x; Cavaliere Paola, 2016, BioMolecular Concepts, V7, P197, DOI 10.1515/bmc-2016-0006; CHAMBERLIN M, 1962, P NATL ACAD SCI USA, V48, P81, DOI 10.1073/pnas.48.1.81; CHANDLER MS, 1988, J BACTERIOL, V170, P3136, DOI 10.1128/jb.170.7.3136-3141.1988; Cheng Q, 1997, MOL MICROBIOL, V23, P683, DOI 10.1046/j.1365-2958.1997.2481617.x; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; DEHASETH PL, 1995, MOL MICROBIOL, V16, P817, DOI 10.1111/j.1365-2958.1995.tb02309.x; Devkota SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174284; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dou Y, 2016, MOL ORAL MICROBIOL, V31, P270, DOI 10.1111/omi.12122; England P, 2008, J BIOL CHEM, V283, P33455, DOI 10.1074/jbc.M807380200; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; Fontaine L, 2013, MOL MICROBIOL, V87, P1113, DOI 10.1111/mmi.12157; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; FOX TD, 1976, J MOL BIOL, V101, P427, DOI 10.1016/0022-2836(76)90157-1; Gao XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101229; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goutam K, 2017, NUCLEIC ACIDS RES, V45, P9760, DOI 10.1093/nar/gkx609; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gu D, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005645; Havarstein LS, 2010, MOL MICROBIOL, V78, P541, DOI 10.1111/j.1365-2958.2010.07380.x; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Heinrich J, 2009, RES MICROBIOL, V160, P696, DOI 10.1016/j.resmic.2009.08.019; Hill KE, 2002, J MED MICROBIOL, V51, P949, DOI 10.1099/0022-1317-51-11-949; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUI FM, 1991, J BACTERIOL, V173, P372, DOI 10.1128/jb.173.1.372-381.1991; HUI FM, 1995, GENE, V153, P25, DOI 10.1016/0378-1119(94)00841-F; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; JONES CH, 1992, J BACTERIOL, V174, P6815, DOI 10.1128/JB.174.21.6815-6821.1992; JONES CH, 1992, P NATL ACAD SCI USA, V89, P1958, DOI 10.1073/pnas.89.5.1958; JUANG YL, 1995, BIOCHEMISTRY-US, V34, P8465, DOI 10.1021/bi00026a030; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; Khan R, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00038-15; Khan R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04768-5; Konovalova A, 2014, FEMS MICROBIOL REV, V38, P493, DOI 10.1111/1574-6976.12050; Lee MS, 1999, J BACTERIOL, V181, P5004, DOI 10.1128/JB.181.16.5004-5016.1999; Li W, 2002, J MOL BIOL, V323, P225, DOI 10.1016/S0022-2836(02)00948-8; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Liu H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0078-1; Luo P, 2004, MOL MICROBIOL, V54, P172, DOI 10.1111/j.1365-2958.2004.04254.x; Luo P, 2003, MOL MICROBIOL, V50, P623, DOI 10.1046/j.1365-2958.2003.03714.x; Luo P, 2003, J BACTERIOL, V185, P349, DOI 10.1128/JB.185.1.349-358.2003; MacLellan SR, 2008, MOL MICROBIOL, V69, P954, DOI 10.1111/j.1365-2958.2008.06331.x; MacLellan SR, 2009, P NATL ACAD SCI USA, V106, P21323, DOI 10.1073/pnas.0910006106; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; Martin B, 2013, MOL MICROBIOL, V87, P394, DOI 10.1111/mmi.12104; Martin B, 2010, MOL MICROBIOL, V75, P1513, DOI 10.1111/j.1365-2958.2010.07071.x; Mashburn-Warren L, 2012, J BACTERIOL, V194, P4589, DOI 10.1128/JB.00830-12; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Morrison DA, 2000, RES MICROBIOL, V151, P445, DOI 10.1016/S0923-2508(00)00171-6; Murakami KS, 2015, BIOMOLECULES, V5, P848, DOI 10.3390/biom5020848; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nechaev S, 2004, P NATL ACAD SCI USA, V101, P17365, DOI 10.1073/pnas.0408028101; Neiditch MB, 2017, ANNU REV GENET, V51, P311, DOI 10.1146/annurev-genet-120116-023507; Paget MS, 2015, BIOMOLECULES, V5, P1245, DOI 10.3390/biom5031245; Parashar V, 2015, P NATL ACAD SCI USA, V112, P5177, DOI 10.1073/pnas.1500357112; PERO J, 1975, P NATL ACAD SCI USA, V72, P1589, DOI 10.1073/pnas.72.4.1589; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Piotrowski A., 2010, STREPTOCOCCUS PNEUMO; Piotrowski A, 2009, J BACTERIOL, V191, P3359, DOI 10.1128/JB.01750-08; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Qiu J, 2001, J BACTERIOL, V183, P1921, DOI 10.1128/JB.183.6.1921-1927.2001; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Shanker E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005979; Sung CK, 2005, J BACTERIOL, V187, P3052, DOI 10.1128/JB.187.9.3052-3061.2005; Talagas A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005980; TALKINGTON C, 1978, P NATL ACAD SCI USA, V75, P1185, DOI 10.1073/pnas.75.3.1185; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Tovpeko Y, 2016, J BACTERIOL, V198, P2370, DOI 10.1128/JB.00354-16; Tovpeko Y, 2014, J BACTERIOL, V196, P3724, DOI 10.1128/JB.01933-14; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Ween O, 1999, MOL MICROBIOL, V33, P817, DOI 10.1046/j.1365-2958.1999.01528.x; Weng LM, 2009, J MICROBIOL METH, V79, P353, DOI 10.1016/j.mimet.2009.10.007; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WILLIAMS KP, 1989, J BACTERIOL, V171, P3579, DOI 10.1128/jb.171.6.3579-3582.1989; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	95	8	8	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11101	11118		10.1074/jbc.RA119.007571	http://dx.doi.org/10.1074/jbc.RA119.007571			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31160340	Green Published, hybrid			2022-12-28	WOS:000478717400005
J	Ma, QY; Liang, MM; Wu, YT; Ding, N; Duan, LL; Yu, T; Bai, Y; Kang, F; Dong, SW; Xu, JZ; Dou, C				Ma, Qinyu; Liang, Mengmeng; Wu, Yutong; Ding, Ning; Duan, Lianli; Yu, Tao; Bai, Yun; Kang, Fei; Dong, Shiwu; Xu, Jianzhong; Dou, Ce			Mature osteoclast-derived apoptotic bodies promote osteogenic differentiation via RANKL-mediated reverse signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoclast; osteoblast; apoptosis; bone; cell differentiation; bone remodeling; cell coupling	ILIAC TRABECULAR BONE; KINETIC-MODEL; VESICLES; CELLS; RECONSTRUCTION; MECHANISMS; RESORPTION; LIGAND; DEATH; SITE	In bone remodeling, after a lifespan of similar to 2 weeks, osteoclasts undergo apoptosis in each bone turnover cycle, resulting in generation of a large number of apoptotic bodies (ABs). However, the biological roles of osteoclast-derived ABs (OC-ABs) in bone remodeling have not been investigated and remain unknown. In this study, we stimulated bone marrow macrophages with receptor activator of NF-kappa B ligand (RANKL) to obtain both preosteoclasts and mature osteoclasts (mOCs). We then used alendronate to induce apoptosis in preosteoclasts and mOCs and generate the respective ABs and used flow cytometry and immunoblotting to characterize the sizes and immunogenic characteristics of the extracted ABs. We show that mOC-ABs are engulfed by preosteoblastic MC3T3-E1 cells and promote the viability of these cells. Among all osteoclast-derived extracellular vesicles, mOC-ABs had the highest osteogenic potency. We further observed that mOC-ABs had the highest vesicular receptor activator of NF-kappa B (RANK) levels among all types of osteoclast-derived extracellular vesicles. Of note, masking of vesicular RANK by soluble RANKL strongly abolished the osteogenic potency of osteoclast-derived ABs. Mechanistically, we found that mOC-ABs induce osteoblast differentiation by activatingPI3K/AKT/mechanistic target of rapamycin (mTOR)/ribosomal protein S6 kinase signaling. In conclusion, OC-ABs promote osteogenic differentiation by stimulating osteoblast differentiation via activation of RANKL reverse signaling. These findings provide important insights into the reversal phase between the bone resorption and formation stages during bone remodeling and identify an AB-dependent cellular signaling mechanism in osteoclast-osteoblast coupling.	[Ma, Qinyu; Wu, Yutong; Duan, Lianli; Yu, Tao; Bai, Yun; Xu, Jianzhong; Dou, Ce] Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Gaotanyan St 30, Chongqing 400038, Peoples R China; [Liang, Mengmeng; Kang, Fei; Dong, Shiwu] Third Mil Med Univ, Southwest Hosp, Dept Biomed Mat Sci, Chongqing 400038, Peoples R China; [Ding, Ning] Gen Hosp Shenyang Mil Area Command, Dept Blood Purificat, Shenyang 110000, Liaoning, Peoples R China; [Dou, Ce] Johns Hopkins Univ, Sch Med, Dept Orthoped Surg, Baltimore, MD 21205 USA	Army Medical University; Army Medical University; Johns Hopkins University	Xu, JZ; Dou, C (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Gaotanyan St 30, Chongqing 400038, Peoples R China.	xujianzhong1962@163.com; lance.douce@gmail.com	Duan, Lianli/GQP-3771-2022	Liang, Mengmneg/0000-0002-2200-7487; Ma, Qinyu/0000-0002-3817-6023	Nature Science Foundation of China [81802166]; China Postdoctoral Science Foundation [2017M613315]; TMMU [2017MPRC-04]; China Scholarship Council (CSC)	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); TMMU; China Scholarship Council (CSC)(China Scholarship Council)	This work was funded by the grant from the Nature Science Foundation of China (81802166), first class General Financial Grant from the China Postdoctoral Science Foundation (2017M613315), and TMMU funding for young investigators (2017MPRC-04), as well as postdoc training award (to CD) from the China Scholarship Council (CSC). The authors declare that they have no conflicts of interest with the contents of this article.	Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Atkin-Smith GK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8439; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; BOYCE BF, 1995, ENDOCRINOLOGY, V136, P5751, DOI 10.1210/en.136.12.5751; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Caruso S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01486; Cerri PS, 2005, ANAT REC PART A, V286A, P833, DOI 10.1002/ar.a.20220; Ding N, 2018, J CELL PHYSIOL, V233, P7415, DOI 10.1002/jcp.26587; Dou C, 2016, J CELL PHYSIOL, V231, P558, DOI 10.1002/jcp.24916; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; ERIKSEN EF, 1984, METAB BONE DIS RELAT, V5, P243, DOI 10.1016/0221-8747(84)90066-3; ERIKSEN EF, 1984, METAB BONE DIS RELAT, V5, P235, DOI 10.1016/0221-8747(84)90065-1; Favaloro B, 2012, AGING-US, V4, P330, DOI 10.18632/aging.100459; Garcia AJ, 2013, J BONE MINER RES, V28, P283, DOI 10.1002/jbmr.1747; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204; Hristov M, 2004, BLOOD, V104, P2761, DOI 10.1182/blood-2003-10-3614; Hughes DE, 1997, J CLIN PATHOL-MOL PA, V50, P132, DOI 10.1136/mp.50.3.132; Ikebuchi Y, 2018, NATURE, V561, P195, DOI 10.1038/s41586-018-0482-7; Ito M, 1999, BONE, V25, P447, DOI 10.1016/S8756-3282(99)00197-0; Jilka RL, 2003, MED PEDIATR ONCOL, V41, P182, DOI 10.1002/mpo.10334; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MARKS SC, 1985, BONE, V6, P451, DOI 10.1016/8756-3282(85)90223-6; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Sims NA, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00041; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; VAN PT, 1982, CELL TISSUE RES, V225, P283; Wang L, 2015, CELL DEATH DIFFER, V22, P1654, DOI 10.1038/cdd.2015.14; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zirngibl M, 2015, CLIN EXP IMMUNOL, V179, P39, DOI 10.1111/cei.12342	36	27	29	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11240	11247		10.1074/jbc.RA119.007625	http://dx.doi.org/10.1074/jbc.RA119.007625			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167789	Green Published, hybrid			2022-12-28	WOS:000478717400015
J	Camacho, E; Vij, R; Chrissian, C; Prados-Rosales, R; Gil, D; O'Meally, RN; Cordero, RJB; Cole, RN; McCaffery, JM; Stark, RE; Casadevall, A				Camacho, Emma; Vij, Raghav; Chrissian, Christine; Prados-Rosales, Rafael; Gil, David; O'Meally, Robert N.; Cordero, Radames J. B.; Cole, Robert N.; McCaffery, J. Michael; Stark, Ruth E.; Casadevall, Arturo			The structural unit of melanin in the cell wall of the fungal pathogen Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fungi; cell wall; melanogenesis; cryo-electron microscopy; solid-state NMR; basic unit; biopolymer; melanin; melanosomes; supramolecular structure	SOLID-STATE NMR; EXTRACELLULAR VESICLES; PIGMENT PRODUCTION; MEMBRANE-PROTEINS; CHITIN SYNTHASE; VIRULENCE; EUMELANINS; ULTRASTRUCTURE; MELANIZATION; GROWTH	Melanins are synthesized macromolecules that are found in all biological kingdoms. These pigments have a myriad of roles that range from microbial virulence to key components of the innate immune response in invertebrates. Melanins also exhibit unique properties with potential applications in physics and material sciences, ranging from electrical batteries to novel therapeutics. In the fungi, melanins, such as eumelanins, are components of the cell wall that provide protection against biotic and abiotic elements. Elucidation of the smallest fungal cell wall-associated melanin unit that serves as a building block is critical to understand the architecture of these polymers, its interaction with surrounding components, and their functional versatility. In this study, we used isopycnic gradient sedimentation, NMR, EPR, high-resolution microscopy, and proteomics to analyze the melanin in the cell wall of the human pathogenic fungus Cryptococcus neoformans. We observed that melanin is assembled into the cryptococcal cell wall in spherical structures similar to 200 nm in diameter, termed melanin granules, which are in turn composed of nanospheres similar to 30 nm in diameter, termed fungal melanosomes. We noted that melanin granules are closely associated with proteins that may play critical roles in the fungal melanogenesis and the supramolecular structure of this polymer. Using this structural information, we propose a model for C. neoformans' melanization that is similar to the process used in animal melanization and is consistent with the phylogenetic relatedness of the fungal and animal kingdoms.	[Camacho, Emma; Vij, Raghav; Cordero, Radames J. B.; Casadevall, Arturo] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Chrissian, Christine; Stark, Ruth E.] CUNY, Dept Chem & Biochem, New York, NY 10031 USA; [Chrissian, Christine; Stark, Ruth E.] CUNY, Inst Macromol Assemblies, New York, NY 10031 USA; [Chrissian, Christine; Stark, Ruth E.] CUNY, PhD Programs Biochem, New York, NY 10016 USA; [Stark, Ruth E.] CUNY, PhD Programs Chem, New York, NY 10016 USA; [Prados-Rosales, Rafael] Yeshiva Univ, Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Prados-Rosales, Rafael; Gil, David] CIC BioGUNE, Derio 48160, Vizcaya, Spain; [Prados-Rosales, Rafael] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth & Microbiol, Madrid 28049, Spain; [O'Meally, Robert N.; Cole, Robert N.] Johns Hopkins Univ, Johns Hopkins Mass Spectrometry & Prote Facil, Baltimore, MD 21205 USA; [McCaffery, J. Michael] Johns Hopkins Univ, Engn Oncol Ctr, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA; [McCaffery, J. Michael] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine; CIC bioGUNE; Autonomous University of Madrid; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Casadevall, A (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Microbiol & Mol Immunol, 615 N Wolfe St,Rm E5132, Baltimore, MD 21205 USA.	acasade1@jhu.edu	Prados-Rosales, Rafael/D-5840-2019; Vij, Raghav/GQY-8282-2022; Camacho, Emma/AAE-5285-2019; Carton, David Gil/M-9332-2019; Cordero, Radames JB/F-6912-2011	Prados-Rosales, Rafael/0000-0001-5964-0166; Vij, Raghav/0000-0001-5812-0484; Camacho, Emma/0000-0001-8591-8176; Carton, David Gil/0000-0003-4241-1302; Chrissian, Christine/0000-0003-2858-4864; Cordero, Radames JB/0000-0002-3026-7094; McCaffery, J. Michael/0000-0001-7153-9933; Stark, Ruth E/0000-0002-3132-4580	National Institutes of Health [PA200A120211, PA200A150068]; National Institute on Minority Health and Health Disparities of the National Institutes of Health [8G12 MD007603]; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities of the National Institutes of Health; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank Alexander Idnurm for kindly providing us with C. neoformans strain ST211A, Subhasish Chatterjee for useful discussions during the preliminary stages of this work, Carolina Coelho for critical reading of the manuscript, and Andre Nicola and Alexander Alanio for valuable discussion of experimental designs. We also gratefully acknowledge expertise and technical support from Barbara Smith (Microscopy Facility, School of Medicine, Johns Hopkins University) with transmission EM, SEM, and negative staining. We thank Joel Tang for technical support for data acquisition in connection with EPR analyses. City College of New York is supported by National Institutes of Health Grants PA200A120211 and PA200A150068. The NMR facilities used in this work are operated by City College and the CUNY Institute for Macromolecular Assemblies, with additional infrastructural support provided by Grant 8G12 MD007603 from the National Institute on Minority Health and Health Disparities of the National Institutes of Health.	Albuquerque P, 2014, MBIO, V5, DOI 10.1128/mBio.00986-13; ALDOORY Y, 1971, SABOURAUD, V9, P113; ALVIANO CS, 1991, J GEN MICROBIOL, V137, P837, DOI 10.1099/00221287-137-4-837; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Baker LG, 2009, EUKARYOT CELL, V8, P1692, DOI 10.1128/EC.00227-09; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; Bissig C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091438; Brach T, 2011, J CELL SCI, V124, P328, DOI 10.1242/jcs.078519; Bungeler A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091901; Bungeler A, 2017, LANGMUIR, V33, P6895, DOI 10.1021/acs.langmuir.7b01634; BULL A T, 1970, Journal of General Microbiology, V63, P75; Cadieux B, 2013, J INFECT DIS, V207, P1339, DOI 10.1093/infdis/jit029; Camacho E, 2017, MICROBIOL-SGM, V163, P1540, DOI 10.1099/mic.0.000552; Casadevall A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030299; CHASKES S, 1975, J CLIN MICROBIOL, V1, P509, DOI 10.1128/JCM.1.6.509-514.1975; CHASKES S, 1978, J CLIN MICROBIOL, V7, P146; Chatterjee S, 2018, J BIOL CHEM, V293, P20157, DOI 10.1074/jbc.RA118.005791; Chatterjee S, 2015, J BIOL CHEM, V290, P13779, DOI 10.1074/jbc.M114.618389; Chatterjee S, 2014, ORG BIOMOL CHEM, V12, P6730, DOI 10.1039/c4ob01066c; Chatterjee S, 2012, BIOCHEMISTRY-US, V51, P6080, DOI 10.1021/bi300325m; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Chun CD, 2011, CELL HOST MICROBE, V9, P243, DOI 10.1016/j.chom.2011.02.003; Clancy CMR, 2001, BIOCHEMISTRY-US, V40, P13353, DOI 10.1021/bi010786t; Clarke SC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006051; Cordero RJB, 2018, CURR BIOL, V28, P2657, DOI 10.1016/j.cub.2018.06.034; Cordero RJB, 2017, FUNGAL BIOL REV, V31, P99, DOI 10.1016/j.fbr.2016.12.003; d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121; d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Dange T, 2011, J BIOL CHEM, V286, P42830, DOI 10.1074/jbc.M111.300178; Delevoye C, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P247; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Eisenman HC, 2009, MICROBIOL-SGM, V155, P3860, DOI 10.1099/mic.0.032854-0; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Foderaro JE, 2017, J FUNGI, V3, DOI 10.3390/jof3040061; Franzen AJ, 1999, FEMS MICROBIOL LETT, V173, P395, DOI 10.1111/j.1574-6968.1999.tb13531.x; Franzen AJ, 2008, J STRUCT BIOL, V162, P75, DOI 10.1016/j.jsb.2007.11.004; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Geddes JMH, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0532-3; Gomez BL, 2003, CURR OPIN INFECT DIS, V16, P91, DOI 10.1097/00001432-200304000-00005; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Groux-Degroote S, 2008, TRAFFIC, V9, P951, DOI 10.1111/j.1600-0854.2008.00740.x; HEGNAUER H, 1985, EXP MYCOL, V9, P221; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; Homer CM, 2016, CELL HOST MICROBE, V19, P849, DOI 10.1016/j.chom.2016.05.001; Hommel B, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006982; Hong S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7457; Hu GG, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030042; HUFFNAGLE GB, 1995, J IMMUNOL, V155, P3507; Ito S, 2003, PIGM CELL RES, V16, P230, DOI 10.1034/j.1600-0749.2003.00037.x; Ito S, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P167; Jung WH, 2009, EUKARYOT CELL, V8, P1511, DOI 10.1128/EC.00166-09; KWONCHUNG KJ, 1983, J CLIN MICROBIOL, V18, P1419, DOI 10.1128/JCM.18.6.1419-1421.1983; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Liu Y, 2003, PIGM CELL RES, V16, P606, DOI 10.1046/j.1600-0749.2003.00098.x; LUDVIGSEN S, 1992, BIOCHEMISTRY-US, V31, P8783, DOI 10.1021/bi00152a014; Martinez LR, 2006, ANTIMICROB AGENTS CH, V50, P1021, DOI 10.1128/AAC.50.3.1021-1033.2006; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Momen-Heravi F, 2013, BIOL CHEM, V394, P1253, DOI 10.1515/hsz-2013-0141; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; Nosanchuk JD, 2003, MICROBIOL-SGM, V149, P1945, DOI 10.1099/mic.0.26333-0; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 1997, INFECT IMMUN, V65, P1836, DOI 10.1128/IAI.65.5.1836-1841.1997; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Oliveira DL, 2009, FUNGAL GENET BIOL, V46, P956, DOI 10.1016/j.fgb.2009.09.001; Panzella L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061753; PROTA G, 1988, MED RES REV, V8, P525, DOI 10.1002/med.2610080405; Riesz J, 2006, BIOPHYS J, V90, P4137, DOI 10.1529/biophysj.105.075713; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Rodrigues ML, 2013, CURR OPIN MICROBIOL, V16, P414, DOI 10.1016/j.mib.2013.04.002; SanBlas G, 1996, CURR MICROBIOL, V32, P11, DOI 10.1007/s002849900003; SARNA T, 1978, FOL HISTOCH CYTOCHEM, V16, P275; SEALY RC, 1982, SCIENCE, V217, P545, DOI 10.1126/science.6283638; SEIJI M, 1963, NATURE, V197, P1082, DOI 10.1038/1971082a0; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; STOETZNER H, 1971, MYCOPATH MYCOL APPL, V45, P327, DOI 10.1007/BF02051980; Tajima K, 2019, FEBS OPEN BIO, V9, P791, DOI 10.1002/2211-5463.12615; Tsirilakis K, 2012, MYCOPATHOLOGIA, V173, P83, DOI 10.1007/s11046-011-9483-x; Upadhyay S, 2016, CELL REP, V14, P2511, DOI 10.1016/j.celrep.2016.02.059; Walker CA, 2010, EUKARYOT CELL, V9, P1329, DOI 10.1128/EC.00051-10; Walker L, 2018, MBIO, V9, DOI 10.1128/mBio.02383-17; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; WANG YL, 1995, INFECT IMMUN, V63, P3131, DOI 10.1128/IAI.63.8.3131-3136.1995; WANG YL, 1994, ANTIMICROB AGENTS CH, V38, P2648, DOI 10.1128/AAC.38.11.2648; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; Wang Z, 1999, INFECT IMMUN, V67, P6619; Waterman SR, 2007, INFECT IMMUN, V75, P714, DOI 10.1128/IAI.01351-06; WHITE LP, 1958, NATURE, V182, P1427, DOI 10.1038/1821427a0; Wolf JM, 2014, EUKARYOT CELL, V13, P1484, DOI 10.1128/EC.00111-14; Xiao M, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0045; ZAJAC GW, 1994, BBA-GEN SUBJECTS, V1199, P271, DOI 10.1016/0304-4165(94)90006-X; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r; Zhu XD, 2001, INFECT IMMUN, V69, P5589, DOI 10.1128/IAI.69.9.5589-5596.2001	98	50	50	0	31	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10471	10489		10.1074/jbc.RA119.008684	http://dx.doi.org/10.1074/jbc.RA119.008684			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31118223	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000478717100009
J	Wang, F; Yang, XY; Lu, YT; Li, ZH; Xu, YH; Hu, J; Liu, JK; Xiong, WY				Wang, Fang; Yang, Xiaoyan; Lu, Yanting; Li, Zhenghui; Xu, Yuhui; Hu, Jing; Liu, Jikai; Xiong, Wenyong			The natural product antroalbol H promotes phosphorylation of liver kinase B1 (LKB1) at threonine 189 and thereby enhances cellular glucose uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose metabolism; liver kinase B1 (LKB1); AMP-activated kinase (AMPK); glucose transporter type 4 (GLUT4); fungi; Basidiomycete; diabetes; energy sensing; glucose homeostasis; sesquiterpene	ACTIVATED PROTEIN-KINASE; SOMATIC MUTATIONS; SKELETAL-MUSCLE; C-ZETA; AMPK; TRANSPORT; GENE; TRANSLOCATION; HYPERGLYCEMIA; CYTOTOXICITY	Hypoglycemic drugs such as metformin increase glucose uptake and utilization by peripheral tissues to maintain glucose homeostasis, and the AMP-activated protein kinase (AMPK) signaling pathway is an important component of this pharmacological activity. Liver kinase B1 (LKB1) acts as a kinase upstream of AMPK and plays an important regulatory role in glucose metabolism. In recent years, as a tumor suppressor, LKB1's antitumor activity has been widely studied, yet its hypoglycemic activity is not clear. Here, using biochemical and cell viability assays, site-directed mutagenesis, immunoblotting, and immunofluorescence staining, we found that a natural product, antroalbol H isolated from the basidiomycete mushroom Antrodiella albocinnamomea, increases cellular glucose uptake in murine L6 myotubes and 3T3-L1 adipocytes. Of note, our results indicated that this effect is related to LKB1-mediated Thr-172 phosphorylation of AMPK alpha. Furthermore, we observed that antroalbol H induces the phosphorylation of LKB1 specifically at Thr-189 and changes subcellular localization of LKB1. Finally, antroalbol H treatment strikingly promoted glucose transporter type 4 (GLUT4) translocation to the plasma membrane. We conclude that antroalbol H promotes Thr-189 phosphorylation of LKB1, leading to AMPK activation, revealing this residue as a potential target for increasing glucose uptake, and that antroalbol H therefore has potential for managing hyperglycemia.	[Wang, Fang; Yang, Xiaoyan; Lu, Yanting; Xu, Yuhui; Hu, Jing; Xiong, Wenyong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China; [Li, Zhenghui; Liu, Jikai] South Cent Univ Nationalities, Sch Pharmaceut Sci, Wuhan 430074, Hubei, Peoples R China; [Xiong, Wenyong] Ningxia Med Univ, Gen Hosp, Yinchuan 750004, Peoples R China; [Wang, Fang; Lu, Yanting] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yang, Xiaoyan] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650201, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; South Central Minzu University; Ningxia Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming University of Science & Technology	Xiong, WY (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China.; Liu, JK (corresponding author), South Cent Univ Nationalities, Sch Pharmaceut Sci, Wuhan 430074, Hubei, Peoples R China.	liujikai@mail.scuec.edu.cn; xiong.wenyong@mail.kib.ac.cn	xiong, wenyong/C-3835-2013	xiong, wenyong/0000-0001-9174-3667	National Key R&D Program of China [2017YFC1700906]; National Natural Science Foundation of China [81561148013]; Yunnan Provincial Science and Technology Department of China [2017FA044, 2013HA023]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Science and Technology Department of China	This work was supported by National Key R&D Program of China Grant 2017YFC1700906 (to Fei Li), National Natural Science Foundation of China Grant 81561148013 (to J.L.), and Yunnan Provincial Science and Technology Department of China Grants 2017FA044 and 2013HA023 (to W.X.). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi Y, 2014, J NAT PROD, V77, P1262, DOI 10.1021/np400867m; Al-Fatimi M, 2013, PHARMAZIE, V68, P221, DOI 10.1691/ph.2013.2729; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arha D, 2018, MOL CELL ENDOCRINOL, V460, P134, DOI 10.1016/j.mce.2017.07.015; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Cilerdzic JL, 2018, CHEM BIODIVERS, V15, DOI 10.1002/cbdv.201800036; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Dong SM, 1998, CANCER RES, V58, P3787; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Ha J, 2015, MOL ASPECTS MED, V46, P46, DOI 10.1016/j.mam.2015.08.002; Han J, 2015, J ETHNOPHARMACOL, V172, P368, DOI 10.1016/j.jep.2015.05.016; Han J, 2015, MOL CELL ENDOCRINOL, V405, P63, DOI 10.1016/j.mce.2015.02.008; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Holloszy JO, 2003, AM J PHYSIOL-ENDOC M, V284, pE453, DOI 10.1152/ajpendo.00463.2002; ISMAILBEIGI F, 1993, J MEMBRANE BIOL, V135, P1; Kalamidas SA, 1999, HISTOL HISTOPATHOL, V14, P23, DOI 10.14670/HH-14.23; Kim JH, 2013, INT J MOL MED, V32, P179, DOI 10.3892/ijmm.2013.1364; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; Kristensen JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1099, DOI 10.1152/ajpendo.00417.2013; Kuo YH, 2015, J AGR FOOD CHEM, V63, P10140, DOI 10.1021/acs.jafc.5b04400; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Li Q, 2014, AM J PHYSIOL-ENDOC M, V307, pE209, DOI 10.1152/ajpendo.00045.2014; Liu YG, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9374026; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Murase T, 2010, AM J PHYSIOL-ENDOC M, V299, pE266, DOI 10.1152/ajpendo.00774.2009; Park WS, 1998, INT J ONCOL, V13, P601; REN JM, 1993, J BIOL CHEM, V268, P16113; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Tao QQ, 2016, PLANTA MED, V82, P639, DOI 10.1055/s-0041-111629; Thyagarajan-Sahu A, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-74; Umeo SH, 2015, GENET MOL RES, V14, P9907, DOI 10.4238/2015.August.19.25; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao C, 2017, J ETHNOPHARMACOL, V196, P47, DOI 10.1016/j.jep.2016.11.044; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	42	15	15	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10415	10427		10.1074/jbc.RA118.007231	http://dx.doi.org/10.1074/jbc.RA118.007231			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31113861	Green Published, hybrid			2022-12-28	WOS:000478717100004
J	Njuma, OJ; Su, Y; Guengerich, FP				Njuma, Olive J.; Su, Yan; Guengerich, F. Peter			The abundant DNA adduct N-7-methyl deoxyguanosine contributes to miscoding during replication by human DNA polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA polymerase; DNA enzyme; DNA replication; DNA damage; DNA adduct; fidelity of DNA synthesis; miscoding; replication bypass; translesion synthesis	ESCHERICHIA-COLI; ABASIC SITES; TRANSLESION SYNTHESIS; MUTAGENIC PROPERTIES; ERROR-PRONE; LIVER DNA; IN-VITRO; REPAIR; FORMAMIDOPYRIMIDINE; 7-METHYLGUANINE	Aside from abasic sites and ribonucleotides, the DNA adduct N-7-methyl deoxyguanosine (N-7-CH3 dG) is one of the most abundant lesions in mammalian DNA. Because N-7-CH3 dG is unstable, leading to deglycosylation and ring-opening, its miscoding potential is not well-understood. Here, we employed a 2 '-fluoro isostere approach to synthesize an oligonucleotide containing an analog of this lesion (N-7-CH3 2 '-F dG) and examined its miscoding potential with four Y-family translesion synthesis DNA polymerases (pols): human pol (hpol) eta, hpol kappa, and hpol iota and Dpo4 from the archaeal thermophile Sulfolobus solfataricus. We found that hpol eta and Dpo4 can bypass the N-7-CH3 2 '-F dG adduct, albeit with some stalling, but hpol kappa is strongly blocked at this lesion site, whereas hpol iota showed no distinction with the lesion and the control templates. hpol eta yielded the highest level of misincorporation opposite the adduct by inserting dATP or dTTP. Moreover, hpol eta did not extend well past an N-7-CH3 2 '-F dG:dT mispair. MS-based sequence analysis confirmed that hpol eta catalyzes mainly error-free incorporation of dC, with misincorporation of dA and dG in 5-10% of products. We conclude that N-7-CH3 2 '-F dG and, by inference, N-7-CH3 dG have miscoding and mutagenic potential. The level of misincorporation arising from this abundant adduct can be considered as potentially mutagenic as a highly miscoding but rare lesion.	[Njuma, Olive J.; Su, Yan; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R01 ES010546, T32 ES007028]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, R01ES010546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010546 (to F.P.G.) and T32 ES007028 (to F.P.G. and O.J.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asagoshi K, 2000, J BIOL CHEM, V275, P24781, DOI 10.1074/jbc.M000576200; Asagoshi K, 2000, J BIOL CHEM, V275, P4956, DOI 10.1074/jbc.275.7.4956; Bailey EA, 1996, P NATL ACAD SCI USA, V93, P1535, DOI 10.1073/pnas.93.4.1535; Barbado C, 2018, P NATL ACAD SCI USA, V115, pE916, DOI 10.1073/pnas.1719497115; BARBIN A, 1985, CANCER RES, V45, P2440; BARROWS LR, 1982, CARCINOGENESIS, V3, P349, DOI 10.1093/carcin/3.3.349; BERANEK DT, 1983, BIOCHEM BIOPH RES CO, V110, P625, DOI 10.1016/0006-291X(83)91195-6; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Boysen G, 2009, MUTAT RES-GEN TOX EN, V678, P76, DOI 10.1016/j.mrgentox.2009.05.006; BROOKES P, 1960, BIOCHEM J, V77, P478, DOI 10.1042/bj0770478; Caldecott KW, 2014, SCIENCE, V343, P260, DOI 10.1126/science.1248234; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Christov PP, 2012, CHEM RES TOXICOL, V25, P1652, DOI 10.1021/tx300113e; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; DENENGELSE L, 1986, CARCINOGENESIS, V7, P393; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; Dizdaroglu M, 2008, FREE RADICAL BIO MED, V45, P1610, DOI 10.1016/j.freeradbiomed.2008.07.004; Dolan ME, 1999, CLIN CANCER RES, V5, P2059; Elmquist CE, 2004, J AM CHEM SOC, V126, P11189, DOI 10.1021/ja0487022; Erickson RP, 2003, MUTAT RES-REV MUTAT, V543, P125, DOI 10.1016/S1383-5742(03)00010-3; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Gates KS, 2004, CHEM RES TOXICOL, V17, P839, DOI 10.1021/tx049965c; GIBBS PEM, 1995, J MOL BIOL, V251, P229, DOI 10.1006/jmbi.1995.0430; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; HENDLER S, 1970, BIOCHEMISTRY-US, V9, P4141, DOI 10.1021/bi00823a017; Hollis T, 2000, MUTAT RES-DNA REPAIR, V460, P201, DOI 10.1016/S0921-8777(00)00027-6; HUMPHREYS WG, 1991, CHEM RES TOXICOL, V4, P632, DOI 10.1021/tx00024a005; Ikeda H, 1998, NUCLEIC ACIDS RES, V26, P2237, DOI 10.1093/nar/26.9.2237; INSKEEP PB, 1986, CANCER RES, V46, P2839; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; KADLUBAR FF, 1984, CARCINOGENESIS, V5, P587, DOI 10.1093/carcin/5.5.587; Kalam MA, 2006, NUCLEIC ACIDS RES, V34, P2305, DOI 10.1093/nar/gkl099; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Koag MC, 2014, NUCLEIC ACIDS RES, V42, P8755, DOI 10.1093/nar/gku554; Kou Y, 2018, BIOCHEMISTRY-US, V57, P5105, DOI 10.1021/acs.biochem.8b00331; Kunkel T A, 1999, Trends Genet, V15, P93, DOI 10.1016/S0168-9525(98)01664-3; LAWLEY P D, 1970, Chemico-Biological Interactions, V2, P154, DOI 10.1016/0009-2797(70)90047-5; LAWLEY P. D., 1962, JOUR MOLECULAR BIOL, V4, P216, DOI 10.1016/S0022-2836(62)80053-9; Lawley P. D., 1984, CHEM CARCINOGENS, P324; LAWLEY PD, 1961, NATURE, V192, P1081, DOI 10.1038/1921081b0; Lee S, 2008, J AM CHEM SOC, V130, P11570, DOI 10.1021/ja8025328; LIDOR YJ, 1991, INT J CANCER, V49, P704, DOI 10.1002/ijc.2910490513; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Mao H, 1998, BIOCHEMISTRY-US, V37, P4374, DOI 10.1021/bi9718292; MARQUEZ VE, 1990, J MED CHEM, V33, P978, DOI 10.1021/jm00165a015; McGuire WP, 2003, BRIT J CANCER, V89, pS3, DOI 10.1038/sj.bjc.6601494; MITRA G, 1989, P NATL ACAD SCI USA, V86, P8650, DOI 10.1073/pnas.86.22.8650; Mullins EA, 2017, P NATL ACAD SCI USA, V114, P4400, DOI 10.1073/pnas.1703066114; MUSTONEN R, 1992, CARCINOGENESIS, V13, P1951, DOI 10.1093/carcin/13.11.1951; NEWBOLD RF, 1980, NATURE, V283, P596, DOI 10.1038/283596a0; NEWELL D, 1987, CANCER CHEMOTH PHARM, V19, P91; OIDA T, 1991, BIOCHEMISTRY-US, V30, P10513, DOI 10.1021/bi00107a021; PARK JW, 1988, P NATL ACAD SCI USA, V85, P7467, DOI 10.1073/pnas.85.20.7467; Parsons ZD, 2016, J AM CHEM SOC, V138, P11485, DOI 10.1021/jacs.6b07399; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Patro JN, 2007, BIOCHEMISTRY-US, V46, P10202, DOI 10.1021/bi700628c; Pence MG, 2010, J BIOL CHEM, V285, P40666, DOI 10.1074/jbc.M110.183665; PULLMAN A, 1981, Q REV BIOPHYS, V14, P289, DOI 10.1017/S0033583500002341; SCHARER OD, 1995, J AM CHEM SOC, V117, P10781, DOI 10.1021/ja00148a036; Sedgeman CA, 2017, CHEM RES TOXICOL, V30, P1188, DOI 10.1021/acs.chemrestox.7b00022; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sharma V, 2014, CHEM RES TOXICOL, V27, P480, DOI 10.1021/tx5000602; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SOWERS LC, 1987, MUTAT RES, V177, P201, DOI 10.1016/0027-5107(87)90003-0; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; WEI X, 1993, P NATL ACAD SCI USA, V90, P2117, DOI 10.1073/pnas.90.6.2117; Weismann CG, 2007, CURR OPIN CARDIOL, V22, P200, DOI 10.1097/HCO.0b013e3280f629c7; Williams JS, 2014, DNA REPAIR, V19, P27, DOI 10.1016/j.dnarep.2014.03.029; Wilson TJ, 2010, P NATL ACAD SCI USA, V107, P11751, DOI 10.1073/pnas.1004255107; Wolfle WT, 2003, GENE DEV, V17, P2191, DOI 10.1101/gad.1108603; Yoon JH, 2017, J BIOL CHEM, V292, P18682, DOI 10.1074/jbc.M117.808659; Yu SL, 2003, MOL CELL BIOL, V23, P382, DOI 10.1128/MCB.23.1.382-388.2003; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhao LL, 2012, ANGEW CHEM INT EDIT, V51, P5466, DOI 10.1002/anie.201109004	78	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10253	10265		10.1074/jbc.RA119.008986	http://dx.doi.org/10.1074/jbc.RA119.008986			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31101656	hybrid, Green Published			2022-12-28	WOS:000474445600016
J	Faria, AVD; Akyala, AI; Parikh, K; Bruggemann, LW; Spek, CA; Cao, WL; Bruno, MJ; Bijlsma, MF; Fuhler, GM; Peppelenbosch, MP				Faria, Alessandra V. de S.; Akyala, Adamu Ishaku; Parikh, Kaushal; Brueggemann, Lois W.; Spek, C. Arnold; Cao, Wanlu; Bruno, Marco J.; Bijlsma, Maarten F.; Fuhler, Gwenny M.; Peppelenbosch, Maikel P.			Smoothened-dependent and -independent pathways in mammalian noncanonical Hedgehog signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Sonic Hedgehog (Shh); signal transduction; endocytosis; Hedgehog signaling pathway; signaling; noncanonical morphogen signaling; cell fate; kinome profiling; cell signaling; cancer; cell receptor; cytoskeletal remodeling	BASAL-CELL CARCINOMA; COLON-CANCER; MORPHOGEN; INHIBITION; MECHANISM; GROWTH	Hedgehog proteins are pivotal morphogens acting through a canonical pathway involving first activation of ligand binding to Patched followed by alleviation of Smoothened receptor inhibition, leading to activation of Gli transcription factors. Noncanonical Hedgehog signaling remains poorly characterized but is thought to be mainly dependent on Smoothened. However, Smoothened inhibitors have yielded only partial success in combating Hedgehog signal transduction-dependent cancer, suggesting that noncanonical Smoothened-independent pathways also are clinically relevant. Moreover, several Smoothened-dependent effects (e.g. neurite projection) do not require transcriptional activation, further suggesting biological importance of noncanonical Smoothened-dependent pathways. We comprehensively characterized the cellular kinome in Hedgehog-challenged murine WT and Smoothened(-/-) fibroblasts as well as Smoothened agonist-stimulated cells. A peptide assay-based kinome analysis (in which cell lysates are used to phosphorylate specific kinase substrates), along with endocytosis, Lucifer Yellow-based, and immunoblotting assays, identified an elaborate signaling network of both Smoothened-dependent and -independent pathways that mediates actin reorganization through Src-like kinases, activates various proinflammatory signaling cascades, and concomitantly stimulates Wnt and Notch signaling while suppressing bone morphogenetic protein (BMP) signaling. The contribution of noncanonical Smoothened-independent signaling to the overall effects of Hedgehog on cellular physiology appears to be much larger than previously envisioned and may explain the transcriptionally independent effects of Hedgehog signaling on cytoskeleton. The observation that Patched-dependent, Smoothened-independent, noncanonical Hedgehog signaling increases Wnt/Notch signaling provides a possible explanation for the failure of Smoothened antagonists in combating Hedgehog-dependent but Smoothened inhibitor-resistant cancer. Our findings suggest that inhibiting Hedgehog-Patched interaction could result in more effective therapies as compared with conventional Smoothened-directed therapies.	[Faria, Alessandra V. de S.; Akyala, Adamu Ishaku; Cao, Wanlu; Bruno, Marco J.; Fuhler, Gwenny M.; Peppelenbosch, Maikel P.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Faria, Alessandra V. de S.] Univ Estadual Campinas, Dept Biochem & Tissue Biol, Biol Inst, BR-13083862 Campinas, SP, Brazil; [Akyala, Adamu Ishaku] Nasarawa State Univ, Dept Microbiol, Fac Nat & Appl Sci, Keffi, Nasarawa State, Nigeria; [Parikh, Kaushal; Peppelenbosch, Maikel P.] Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 GZ Groningen, Netherlands; [Brueggemann, Lois W.; Spek, C. Arnold; Bijlsma, Maarten F.] Acad Med Ctr, Ctr Expt & Mol Med, Room H2-257,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Universidade Estadual de Campinas; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	Peppelenbosch, MP (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.peppelenbosch@erasmusmc.nl	de Sousa Faria, Alessandra Valeria/AAA-1899-2020; Fuhler, Gwenny/AAC-7122-2019; Spek, Arnold/AAC-5866-2019	de Sousa Faria, Alessandra Valeria/0000-0003-1161-5724; Fuhler, Gwenny/0000-0001-9221-4855; Spek, Arnold/0000-0002-2149-4068; Peppelenbosch, Maikel/0000-0001-9112-6028; Parikh, Kaushal/0000-0002-3247-3676	Sao Paulo Research Foundation (FAPESP) Fellowship [2018/00736-0]; Federal Government of Nigeria (TETFUND); Nasarawa State University, Keffi (NSUK), Nasarawa State	Sao Paulo Research Foundation (FAPESP) Fellowship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Federal Government of Nigeria (TETFUND); Nasarawa State University, Keffi (NSUK), Nasarawa State	Supported by Sao Paulo Research Foundation (FAPESP) Fellowship 2018/00736-0.; Supported by a research scholarship provided by the Federal Government of Nigeria (TETFUND) in conjunction with the Nasarawa State University, Keffi (NSUK), Nasarawa State.	Alanko J, 2016, TRENDS CELL BIOL, V26, P391, DOI 10.1016/j.tcb.2016.02.001; Baharani A, 2017, BIOCHEM SOC T, V45, P65, DOI 10.1042/BST20160163; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bijlsma MF, 2008, STEM CELLS, V26, P1138, DOI 10.1634/stemcells.2007-0841; Bijlsma MF, 2007, CELL SIGNAL, V19, P2596, DOI 10.1016/j.cellsig.2007.08.011; Bijlsma MF, 2004, BIOESSAYS, V26, P387, DOI 10.1002/bies.20007; Brennan D, 2012, VITAM HORM, V88, P55, DOI 10.1016/B978-0-12-394622-5.00003-1; Briscoe J, 2015, DEVELOPMENT, V142, P3996, DOI 10.1242/dev.129452; Buller NVJA, 2012, PHYSIOLOGY, V27, P148, DOI 10.1152/physiol.00003.2012; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Didiasova M, 2018, MOLECULES, V23, DOI 10.3390/molecules23051003; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Gerling M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12321; Gilmour D, 2017, NATURE, V541, P311, DOI 10.1038/nature21348; Gorlin RJ, 2004, GENET MED, V6, P530, DOI 10.1097/01.GIM.0000144188.15902.C4; Haga Raquel B, 2016, Small GTPases, V7, P207; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; Kasper M, 2012, J CLIN INVEST, V122, P455, DOI 10.1172/JCI58779; Kasper M, 2009, CARCINOGENESIS, V30, P903, DOI 10.1093/carcin/bgp048; Khatra H, 2017, CURR MED CHEM, V24, P2033, DOI 10.2174/0929867324666170316115500; Li S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005414; Li SX, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002481; Li Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002429; Maier D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004399; Maughan BL, 2016, CANCER CHEMOTH PHARM, V78, P1297, DOI 10.1007/s00280-016-3191-7; Moore BS, 2016, P NATL ACAD SCI USA, V113, P13069, DOI 10.1073/pnas.1602393113; Pak E, 2016, DEV CELL, V38, P333, DOI 10.1016/j.devcel.2016.07.026; Pani AM, 2018, ELIFE, V7, DOI 10.7554/eLife.38325; Parikh K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006763; Peppelenbosch MP, 2016, EXPERT REV PROTEOMIC, V13, P571, DOI 10.1080/14789450.2016.1187564; PEPPELENBOSCH MP, 1993, CELL, V74, P565, DOI 10.1016/0092-8674(93)80057-L; Petrov K, 2017, ANNU REV CELL DEV BI, V33, P145, DOI 10.1146/annurev-cellbio-100616-060847; Regan JL, 2017, CELL REP, V21, P2813, DOI 10.1016/j.celrep.2017.11.025; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Tabler JM, 2017, ELIFE, V6, DOI 10.7554/eLife.19153; Tukachinsky H, 2016, P NATL ACAD SCI USA, V113, pE5866, DOI 10.1073/pnas.1606719113; van Baal JWPM, 2006, CANCER RES, V66, P11605, DOI 10.1158/0008-5472.CAN-06-1370; van den Brink GR, 2007, CANCER CELL, V11, P109, DOI 10.1016/j.ccr.2007.01.003; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang WS, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4248; Wu CC, 2017, DEV CELL, V43, P673, DOI 10.1016/j.devcel.2017.10.011; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang M, 2016, BBA-BIOMEMBRANES, V1858, P1400, DOI 10.1016/j.bbamem.2016.03.020	46	13	14	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9787	9798		10.1074/jbc.RA119.007956	http://dx.doi.org/10.1074/jbc.RA119.007956			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	30992365	hybrid, Green Published			2022-12-28	WOS:000473277900013
J	Hewitt, SC; Lierz, SL; Garcia, M; Hamilton, KJ; Gruzdev, A; Grimm, SA; Lydon, JP; Demayo, FJ; Korach, KS				Hewitt, Sylvia C.; Lierz, Sydney L.; Garcia, Marleny; Hamilton, Katherine J.; Gruzdev, Artiom; Grimm, Sara A.; Lydon, John P.; Demayo, Francesco J.; Korach, Kenneth S.			A distal super enhancer mediates estrogen-dependent mouse uterine-specific gene transcription of Igf1 (insulin-like growth factor 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen receptor; transcription enhancer; insulin-like growth factor (IGF); chromatin immunoprecipitation (ChiP); reproduction; mouse; hormone receptor; nuclear receptor; chromatin structure; uterus	GROWTH-FACTOR-I; EPITHELIAL PROLIFERATION; RECEPTOR-ALPHA; INSULIN; EXPRESSION; BINDING; ESTRADIOL; UTERUS; SYSTEM; IMPLANTATION	Insulin-like growth factor 1 (IGF1) is primarily synthesized in and secreted from the liver; however, estrogen (E2), through E2 receptor (ER), increases uterine Igf1 mRNA levels. Previous ChIP-seq analyses of the murine uterus have revealed a potential enhancer region distal from the Igf1 transcription start site (TSS) with multiple E2-dependent ER-binding regions. Here, we show E2-dependent super enhancer-associated characteristics and suggest contact between the distal enhancer and the Igf1 TSS. We hypothesized that this distal super-enhancer region controls E2-responsive induction of uterine Igf1 transcripts. We deleted 430 bp, encompassing one of the ER-binding sites, thereby disrupting interactions of the enhancer with gene-regulatory factors. As a result, E2-mediated induction of mouse uterine Igf1 mRNA is completely eliminated, whereas hepatic Igf1 expression remains unaffected. This highlights the central role of a distal enhancer in the assembly of the factors necessary for E2-dependent interaction with the Igf1 TSS and induction of uterus-specific Igf1 transcription. Of note, loss of the enhancer did not affect fertility or uterine growth responses. Deletion of uterine Igf1 in a PgrCre;Igf1f/f model decreased female fertility but did not impact the E2-induced uterine growth response. Moreover, E2-dependent activation of uterine IGF1 signaling was not impaired by disrupting the distal enhancer or by deleting the coding transcript. This indicated a role for systemic IGF1, suggested that other growth mediators drive uterine response to E2, and suggested that uterine-derived IGF1 is essential for reproductive success. Our findings elucidate the role of a super enhancer in Igf1 regulation and uterine growth.	[Hewitt, Sylvia C.; Lierz, Sydney L.; Garcia, Marleny; Hamilton, Katherine J.; Korach, Kenneth S.] NIEHS, Receptor Biol Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Gruzdev, Artiom] NIEHS, Knockout Mouse Core Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Demayo, Francesco J.] NIEHS, Pregnancy & Female Reprod Grp, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Grimm, Sara A.] NIEHS, Integrat Bioinformat Support Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Baylor College of Medicine	Hewitt, SC (corresponding author), NIEHS, Receptor Biol Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	Sylvia.hewitt@nih.gov		Hewitt, Sylvia/0000-0001-7713-0805; Lierz, Sydney/0000-0002-9185-8576	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [1ZIAES070065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, ZICES102425] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences 1ZIAES070065 (to K. S. K.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adesanya OO, 1999, P NATL ACAD SCI USA, V96, P3287, DOI 10.1073/pnas.96.6.3287; Blumbach K, 2012, J BIOL CHEM, V287, P6431, DOI 10.1074/jbc.M111.283119; Bojcsuk D, 2017, NUCLEIC ACIDS RES, V45, P3693, DOI 10.1093/nar/gkw1283; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chung D, 2015, MOL CELL ENDOCRINOL, V400, P48, DOI 10.1016/j.mce.2014.11.002; Clemmons DR, 2016, TRENDS ENDOCRIN MET, V27, P375, DOI 10.1016/j.tem.2016.03.019; Davey HW, 2001, ENDOCRINOLOGY, V142, P3836, DOI 10.1210/en.142.9.3836; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du HL, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a023002; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Falkenberg U, 2008, J DAIRY SCI, V91, P3862, DOI 10.3168/jds.2007-0887; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Hastings JM, 2003, ENDOCRINOLOGY, V144, P326, DOI 10.1210/en.2002-220641; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Holt RIG, 2002, TRENDS ENDOCRIN MET, V13, P392, DOI 10.1016/S1043-2760(02)00697-5; Jefferson WN, 2018, NUCLEIC ACIDS RES, V46, P5487, DOI 10.1093/nar/gky260; Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117; Kelleher AM, 2017, P NATL ACAD SCI USA, V114, pE1018, DOI 10.1073/pnas.1618433114; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Klover P, 2007, ENDOCRINOLOGY, V148, P1489, DOI 10.1210/en.2006-1431; Ko JY, 2017, MOL CELLS, V40, P169, DOI 10.14348/molcells.2017.0033; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee DS, 2005, J REPROD DEVELOP, V51, P787, DOI 10.1262/jrd.17039; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MURPHY LJ, 1987, MOL ENDOCRINOL, V1, P445, DOI 10.1210/mend-1-7-445; Palierne G, 2016, MOL ENDOCRINOL, V30, P709, DOI 10.1210/me.2015-1311; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramer I, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.04.026; Richards RG, 1996, P NATL ACAD SCI USA, V93, P12002, DOI 10.1073/pnas.93.21.12002; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Sato T, 2002, ENDOCRINOLOGY, V143, P2673, DOI 10.1210/en.143.7.2673; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Simmen RCM, 2015, J MOL ENDOCRINOL, V54, pR89, DOI 10.1530/JME-14-0310; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Sugathan A, 2013, MOL CELL BIOL, V33, P3594, DOI 10.1128/MCB.00280-13; WALMER DK, 1992, ENDOCRINOLOGY, V131, P1458, DOI 10.1210/en.131.3.1458; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang JJ, 2016, BRIEF FUNCT GENOMICS, V15, P385, DOI 10.1093/bfgp/elv062; Winuthayanon W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07728-1; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhu L, 2007, P NATL ACAD SCI USA, V104, P15847, DOI 10.1073/pnas.0705749104	53	17	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9746	9759		10.1074/jbc.RA119.008759	http://dx.doi.org/10.1074/jbc.RA119.008759			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31073032	hybrid, Green Published			2022-12-28	WOS:000473277900010
J	Lebeau, PF; Byun, JH; Platko, K; MacDonald, ME; Poon, SV; Faiyaz, M; Seidah, NG; Austin, RC				Lebeau, Paul F.; Byun, Jae Hyun; Platko, Khrystyna; MacDonald, Melissa E.; Poon, Samantha V.; Faiyaz, Mahi; Seidah, Nabil G.; Austin, Richard C.			Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing de novo PCSK9 expression in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular disease; liver metabolism; lipid; cell-surface protein; cell biology	ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; GENE-EXPRESSION; NONALCOHOLIC STEATOHEPATITIS; NATURAL-HISTORY; MOUSE; ACCUMULATION; CHOLESTEROL; RECEPTOR; ATHEROSCLEROSIS	The worldwide prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing rapidly. Although this condition is generally benign, accumulating evidence now suggests that patients with NAFLD are also at increased risk of cardiovascular disease (CVD); the leading cause of death in developed nations. Despite the well-established role of the liver as a central regulator of circulating low-density lipoprotein (LDL) cholesterol levels, a known driver of CVD, the mechanism(s) by which hepatic steatosis contributes to CVD remains elusive. Interestingly, a recent study has shown that circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) levels correlate positively with liver steatosis grade. Given that PCSK9 degrades the LDL receptor (LDLR) and prevents the removal of LDL from the blood into the liver, in the present study we examined the effect of hepatic steatosis on LDLR expression and circulating LDL cholesterol levels. We now report that in a manner consistent with findings in patients, diet-induced steatosis increases circulating PCSK9 levels as a result of de novo expression in mice. We also report the finding that steatosis abrogates hepatic LDLR expression and increases circulating LDL levels in a PCSK9-dependent manner. These findings provide important mechanistic insights as to how hepatic steatosis modulates lipid regulatory genes, including PCSK9 and the LDLR, and also highlights a novel mechanism by which liver disease may contribute to CVD.	[Lebeau, Paul F.; Byun, Jae Hyun; Platko, Khrystyna; MacDonald, Melissa E.; Poon, Samantha V.; Faiyaz, Mahi; Austin, Richard C.] McMaster Univ, Res Inst St Joes Hamilton, Dept Med, Hamilton, ON L8N 4A6, Canada; [Seidah, Nabil G.] Univ Montreal, Montreal Clin Res Inst, Lab Biochem Neuroendocrinol, Montreal, PQ H2W 1R7, Canada	McMaster University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Austin, RC (corresponding author), 50 Charlton Ave East,Rm T-3313, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; Byun, Jae Hyun/0000-0002-1231-511X	Heart and Stroke Foundation of Canada [G-13-0003064, G-15-0009389]; Canadian Institutes of Health Research [74477]; Leducq Foundation [13 CVD 03]; CIHR Foundation [148363]; Canada Research Chair Grant [216684]; Research Institute of St. Joe's Hamilton	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Leducq Foundation(Leducq Foundation); CIHR Foundation(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Grant(Canada Research Chairs); Research Institute of St. Joe's Hamilton	This work was supported by the Heart and Stroke Foundation of Canada Research Grants G-13-0003064 and G-15-0009389 and Canadian Institutes of Health Research Grant 74477 (to R. C. A.), Leducq Foundation Grant 13 CVD 03, CIHR Foundation Grant 148363, and Canada Research Chair Grant 216684 (to N. G. S.), and the Research Institute of St. Joe's Hamilton. The authors declare that they have no conflicts of interest with the contents of this article.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Mosbah I, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.29; Benedict M, 2017, WORLD J HEPATOL, V9, P715, DOI 10.4254/wjh.v9.i16.715; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Bertot LC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050774; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Carta G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00902; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Colgan SM, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001742; Cui W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059921; Dara L, 2011, HEPATOLOGY, V53, P1752, DOI 10.1002/hep.24279; Denis M, 2012, CIRCULATION, V125, P894, DOI 10.1161/CIRCULATIONAHA.111.057406; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Emmer BT, 2018, ELIFE, V7, DOI 10.7554/eLife.38839; Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125; Francque SM, 2016, J HEPATOL, V65, P425, DOI 10.1016/j.jhep.2016.04.005; Gauthier MS, 2018, J CLIN LIPIDOL, V12, P1027, DOI 10.1016/j.jacl.2018.03.092; Giunzioni L, 2015, VASC HEALTH RISK MAN, V11, P493, DOI 10.2147/VHRM.S74692; Gu LL, 2017, ONCOTARGET, V8, P80826, DOI 10.18632/oncotarget.20590; Jensen KK, 2016, J LIPID RES, V57, P2150, DOI 10.1194/jlr.M071498; Jo HK, 2014, BIOL PHARM BULL, V37, P1341, DOI 10.1248/bpb.b14-00281; Khera AV, 2015, AM J CARDIOL, V115, P178, DOI 10.1016/j.amjcard.2014.10.018; Kumar S, 2017, LAB INVEST, V97, P935, DOI 10.1038/labinvest.2017.47; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lebeau P, 2018, J BIOL CHEM, V293, P7329, DOI 10.1074/jbc.RA117.001049; Lebeau P, 2017, J BIOL CHEM, V292, P1510, DOI 10.1074/jbc.M116.744235; Lee HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep27799; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Li J, 2012, J HEPATOL, V56, P900, DOI 10.1016/j.jhep.2011.10.018; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayne J, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-22; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; Nissar AU, 2017, J LIPID RES, V58, P1855, DOI 10.1194/jlr.M077537; Patil Rashmee, 2017, World J Gastrointest Pathophysiol, V8, P51, DOI 10.4291/wjgp.v8.i2.51; Pickhardt PJ, 2014, AM J ROENTGENOL, V202, P752, DOI 10.2214/AJR.13.11367; Retterstol K, 2018, ATHEROSCLEROSIS, V279, P52, DOI 10.1016/j.atherosclerosis.2018.10.013; Ricci C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20425-x; Ruiz R, 2014, J BIOL CHEM, V289, P5510, DOI 10.1074/jbc.M113.541110; Ruscica M, 2016, ANN MED, V48, P384, DOI 10.1080/07853890.2016.1188328; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sayiner M, 2016, CLIN LIVER DIS, V20, P205, DOI 10.1016/j.cld.2015.10.001; Seidah Nabil G, 2017, Glob Cardiol Sci Pract, V2017, pe201702, DOI 10.21542/gcsp.2017.2; Seidah NG, 2017, PHARMACOL REV, V69, P33, DOI 10.1124/pr.116.012989; Shao W, 2014, J BIOL CHEM, V289, P7547, DOI 10.1074/jbc.M113.545699; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Sui GG, 2018, J AGR FOOD CHEM, V66, P8983, DOI 10.1021/acs.jafc.8b02696; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wadhera RK, 2016, J CLIN LIPIDOL, V10, P472, DOI 10.1016/j.jacl.2015.11.010; Wang Y, 2012, J LIPID RES, V53, P1932, DOI 10.1194/jlr.M028563; Wargny M, 2018, ATHEROSCLEROSIS, V278, P82, DOI 10.1016/j.atherosclerosis.2018.09.008; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144; WHO, 2016, HEARTS TECHN PACK CA; Woo SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091111; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Zabielski P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25397-6; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang Y, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0916-0; Zhang Y, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-1	63	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9037	9047		10.1074/jbc.RA119.008094	http://dx.doi.org/10.1074/jbc.RA119.008094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31004037	hybrid, Green Published			2022-12-28	WOS:000471751600003
J	Ugalde, CL; Lawson, VA; Finkelstein, DI; Hill, AF				Ugalde, Cathryn L.; Lawson, Victoria A.; Finkelstein, David I.; Hill, Andrew F.			The role of lipids in alpha-synuclein misfolding and neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						alpha-synuclein; protein misfolding; neurodegenerative disease; Parkinson disease; lipid; neurotoxicity; neurodegeneration; amyloid; synucleinopathy; Lewy body; mitochondrial function	POLYUNSATURATED FATTY-ACIDS; GLIAL CYTOPLASMIC INCLUSIONS; NATIVELY UNFOLDED PROTEINS; DISEASE-LINKED MUTATIONS; MULTIPLE SYSTEM ATROPHY; A-BETA COMPONENT; KINASE-C-DELTA; PARKINSONS-DISEASE; LEWY BODIES; COMPLEX-I	The misfolding and aggregation of -synuclein (syn) in the central nervous system is associated with a group of neurodegenerative disorders referred to as the synucleinopathies. In addition to being a pathological hallmark of disease, it is now well-established that upon misfolding, syn acquires pathogenic properties, such as neurotoxicity, that can contribute to disease development. The mechanisms that produce syn misfolding and the molecular events underlying the neuronal damage caused by these misfolded species are not well-defined. A consistent observation that may be relevant to syn's pathogenicity is its ability to associate with lipids. This appears important not only to how syn aggregates, but also to the mechanism by which the misfolded protein causes intracellular damage. This review discusses the current literature reporting a role of lipids in syn misfolding and neurotoxicity in various synucleinopathy disorders and provides an overview of current methods to assess protein misfolding and pathogenicity both in vitro and in vivo.	[Ugalde, Cathryn L.; Hill, Andrew F.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia; [Ugalde, Cathryn L.; Lawson, Victoria A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Ugalde, Cathryn L.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Ugalde, Cathryn L.; Finkelstein, David I.] Howard Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia	La Trobe University; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health	Ugalde, CL; Hill, AF (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia.	c.ugalde@latrobe.edu.au; andrew.hill@latrobe.edu.au	Hill, Andrew F./AAH-2854-2020; Lawson, Victoria/AAJ-7392-2021; Finkelstein, David/B-9617-2009; Hill, Andrew F./GZL-4124-2022	Finkelstein, David/0000-0002-8167-4917; Hill, Andrew F./0000-0001-5581-2354; Lawson, Victoria/0000-0002-7362-7176; Ugalde, Cathryn/0000-0001-8663-6437				Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; Aoki R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002425; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Baba M, 1998, AM J PATHOL, V152, P879; Bartels T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103727; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bender A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062277; Bereczki E, 2016, ALZHEIMERS DEMENT, V12, P1149, DOI 10.1016/j.jalz.2016.04.005; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Broersen K, 2006, BIOCHEMISTRY-US, V45, P15610, DOI 10.1021/bi061743l; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen RHC, 2013, J BIOL CHEM, V288, P7438, DOI 10.1074/jbc.M112.439497; Cheng CY, 2013, P NATL ACAD SCI USA, V110, P16838, DOI 10.1073/pnas.1307678110; Chesselet MF, 2011, LANCET NEUROL, V10, P1108, DOI 10.1016/S1474-4422(11)70227-7; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Choi BK, 2013, P NATL ACAD SCI USA, V110, P4087, DOI 10.1073/pnas.1218424110; Citron BA, 2002, NEUROCHEM INT, V40, P69, DOI 10.1016/S0197-0186(01)00062-6; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; Dalfo E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Franceschi G, 2017, J BIOL CHEM, V292, P6927, DOI 10.1074/jbc.M116.765149; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Di Pasquale E, 2010, J MOL BIOL, V397, P202, DOI 10.1016/j.jmb.2010.01.046; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Fantini J, 2011, BBA-BIOMEMBRANES, V1808, P2343, DOI 10.1016/j.bbamem.2011.06.017; Fantini J, 2011, J MOL BIOL, V408, P654, DOI 10.1016/j.jmb.2011.03.009; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Furukawa K, 2006, J NEUROCHEM, V97, P1071, DOI 10.1111/j.1471-4159.2006.03803.x; Fusco G, 2017, SCIENCE, V358, P1440, DOI 10.1126/science.aan6160; Fusco G, 2016, SCI REP-UK, V6, DOI 10.1038/srep27125; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Garcia-Esparcia P, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0257-4; Geng XH, 2011, AM J PHYSIOL-ENDOC M, V300, pE276, DOI 10.1152/ajpendo.00262.2010; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; Gross RW, 2017, BBA-MOL CELL BIOL L, V1862, P731, DOI 10.1016/j.bbalip.2017.04.006; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hashimoto M, 2002, J BIOL CHEM, V277, P11465, DOI 10.1074/jbc.M111428200; Herva ME, 2014, J BIOL CHEM, V289, P11897, DOI 10.1074/jbc.M113.542340; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; Itokawa K, 2013, MOVEMENT DISORD, V28, P384, DOI 10.1002/mds.25243; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jensen MB, 2011, J BIOL CHEM, V286, P42603, DOI 10.1074/jbc.M111.271130; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jin HJ, 2011, J NEUROSCI, V31, P2035, DOI 10.1523/JNEUROSCI.5634-10.2011; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Karampetsou M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15813-8; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Latchoumycandane C, 2005, J PHARMACOL EXP THER, V313, P46, DOI 10.1124/jpet.104.078469; Lautenschlager J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03111-4; Lee HJ, 2011, EXP MOL MED, V43, P216, DOI 10.3858/emm.2011.43.4.026; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085815; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Lohman DC, 2019, MOL CELL, V73, P763, DOI 10.1016/j.molcel.2018.11.033; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Lou XC, 2017, BIOCHEM J, V474, P2039, DOI 10.1042/BCJ20170200; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Ma MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37130; Maiti NC, 2004, J AM CHEM SOC, V126, P2399, DOI 10.1021/ja0356176; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Masliah E, 1996, AM J PATHOL, V148, P201; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McCann H, 2014, PARKINSONISM RELAT D, V20, P62, DOI DOI 10.1016/S1353-8020(13)70017-8; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nakamura T, 2001, BIOCHEM BIOPH RES CO, V280, P1085, DOI 10.1006/bbrc.2000.4253; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Reeve AK, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.166; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rizzo G, 2016, NEUROLOGY, V86, P566, DOI 10.1212/WNL.0000000000002350; Rodriguez-Araujo G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12081; Rodriguez-Araujo G, 2013, CELL MOL LIFE SCI, V70, P1123, DOI 10.1007/s00018-012-1198-8; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Samuel F, 2016, J BIOL CHEM, V291, P4374, DOI 10.1074/jbc.M115.705095; Sarafian TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063557; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Sharma SK, 2015, SCI REP-UK, V5, DOI 10.1038/srep12531; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Shi Z, 2015, PHYS CHEM CHEM PHYS, V17, P15561, DOI 10.1039/c4cp05883f; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Tenreiro S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004302; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; Tsang AHK, 2009, BBA-MOL BASIS DIS, V1792, P643, DOI 10.1016/j.bbadis.2008.12.006; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Ugalde CL, 2016, J NEUROCHEM, V139, P162, DOI 10.1111/jnc.13772; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Vallortigara J, 2016, J ALZHEIMERS DIS, V50, P101, DOI 10.3233/JAD-150707; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; van Maarschalkerweerd A, 2015, FEBS LETT, V589, P2661, DOI 10.1016/j.febslet.2015.08.013; van Maarschalkerweerd A, 2014, BIOMACROMOLECULES, V15, P3643, DOI 10.1021/bm500937p; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Wang GF, 2010, PROTEIN SCI, V19, P1686, DOI 10.1002/pro.449; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Yang W, 2013, NEUROCHEM INT, V63, P180, DOI 10.1016/j.neuint.2013.06.010; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2006, BIOCHEMISTRY-US, V45, P8135, DOI 10.1021/bi052584t; Zhu YG, 2011, INT J BIOCHEM CELL B, V43, P732, DOI 10.1016/j.biocel.2011.01.014; Zigoneanu IG, 2012, BBA-BIOMEMBRANES, V1818, P512, DOI 10.1016/j.bbamem.2011.11.024	181	32	32	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9016	9028		10.1074/jbc.REV119.007500	http://dx.doi.org/10.1074/jbc.REV119.007500			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31064841	Green Published, hybrid			2022-12-28	WOS:000471751600001
J	Gao, S; Ghoshal, S; Zhang, LY; Stevens, JR; McCommis, KS; Finck, BN; Lopaschuk, GD; Butler, AA				Gao, Su; Ghoshal, Sarbani; Zhang, Liyan; Stevens, Joseph R.; McCommis, Kyle S.; Finck, Brian N.; Lopaschuk, Gary D.; Butler, Andrew A.			The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						type 2 diabetes; insulin resistance; c-Jun N-terminal kinase (JNK); endoplasmic reticulum stress (ER stress); lipogenesis; insulin receptor substrate 1 (IRS1); energy metabolism; gluconeogenesis; protein kinase A (PKA); adropin	ENDOPLASMIC-RETICULUM STRESS; ER STRESS; INSULIN ACTION; LIVER; GLUCONEOGENESIS; STEATOSIS; RECEPTOR; TRANSCRIPTION; HOMEOSTASIS; DEFICIENCY	The peptide hormone adropin regulates energy metabolism in skeletal muscle and plays important roles in the regulation of metabolic homeostasis. Besides muscle, the liver has an essential role in regulating glucose homeostasis. Previous studies have reported that treatment of diet-induced obese (DIO) male mice with adropin(34-76) (the putative secreted domain) reduces fasting blood glucose independently of body weight changes, suggesting that adropin suppresses glucose production in the liver. Here, we explored the molecular mechanisms underlying adropin's effects on hepatic glucose metabolism in DIO mice. Male DIO B6 mice maintained on a high-fat diet received five intraperitoneal injections of adropin(34-76) (450 nmol/kg/injection) over a 48-h period. We found that adropin(34-76) enhances major intracellular signaling activities in the liver that are involved in insulin-mediated regulation of glucose homeostasis. Moreover, treatment with adropin(34-76) alleviated endoplasmic reticulum stress responses and reduced activity of c-Jun N-terminal kinase in the liver, explaining the enhanced activities of hepatic insulin signaling pathways observed with adropin(34-76) treatment. Furthermore, adropin(34-76) suppressed cAMP activated protein kinase A (PKA) activities, resulting in reduced phosphorylation of inositol trisphosphate receptor, which mediates endoplasmic reticulum calcium efflux, and of cAMP-responsive element-binding protein, a key transcription factor in hepatic regulation of glucose metabolism. Adropin(34-76) directly affected liver metabolism, decreasing glucose production and reducing PKA-mediated phosphorylation in primary mouse hepatocytes in vitro. Our findings indicate that major hepatic signaling pathways contribute to the improved glycemic control achieved with adropin(34-76) treatment in situations of obesity.	[Gao, Su; Zhang, Liyan; Lopaschuk, Gary D.] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2R7, Canada; [Gao, Su; Butler, Andrew A.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Ghoshal, Sarbani; Stevens, Joseph R.; Butler, Andrew A.] St Louis Univ, Sch Med, Ctr Cardiovasc Res, Dept Pharmacol & Physiol, 1402 South Grand Blvd, St Louis, MO 63104 USA; [Ghoshal, Sarbani; Stevens, Joseph R.; Butler, Andrew A.] St Louis Univ, Sch Med, Henry & Amelia Nasrallah Ctr Neurosci, 1402 South Grand Blvd, St Louis, MO 63104 USA; [McCommis, Kyle S.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA; [Gao, Su] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Ghoshal, Sarbani] CUNY Queensborough Community Coll, Dept Biol Sci & Geol, Bayside, NY USA; [McCommis, Kyle S.] St Louis Univ, Sch Med, Cardiovasc Res Ctr, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [McCommis, Kyle S.] St Louis Univ, Sch Med, Liver Ctr, St Louis, MO 63104 USA	University of Alberta; Scripps Research Institute; Saint Louis University; Saint Louis University; Washington University (WUSTL); Columbia University; City University of New York (CUNY) System; Saint Louis University; Saint Louis University	Butler, AA (corresponding author), St Louis Univ, Sch Med, Ctr Cardiovasc Res, Dept Pharmacol & Physiol, 1402 South Grand Blvd, St Louis, MO 63104 USA.; Butler, AA (corresponding author), St Louis Univ, Sch Med, Henry & Amelia Nasrallah Ctr Neurosci, 1402 South Grand Blvd, St Louis, MO 63104 USA.	andrew.butler@health.slu.edu	Zhang, Li/GWM-7501-2022	Finck, Brian/0000-0001-5411-3674; McCommis, Kyle/0000-0003-2381-1589; Butler, Andrew/0000-0001-7196-0170; Ghoshal, Sarbani/0000-0002-1089-084X	Proof of Principle Award from Novo Nordisk's Diabetes Innovations Award Program; American Diabetes Association [7-08-RA16]; Canadian Institutes of Health Research; NHLBI, National Institutes of Health (NIH) [K99 HL136658]; NIDDK, NIH [R01 DK104735, P30 DK052574]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL136658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104735, P30DK056341, P30DK052574] Funding Source: NIH RePORTER	Proof of Principle Award from Novo Nordisk's Diabetes Innovations Award Program; American Diabetes Association(American Diabetes Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NHLBI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Proof of Principle Award from Novo Nordisk's Diabetes Innovations Award Program (to A. A. B.), by American Diabetes Association Grant 7-08-RA16 (to A. A. B.), and in part by a grant from the Canadian Institutes of Health Research (to G. D. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NHLBI, National Institutes of Health (NIH), Grant K99 HL136658 and NIDDK, NIH, Grant P30 DK052574.; Work in this author's laboratory is supported by NIDDK, NIH, Grants R01 DK104735 and P30 DK052574.	Agius L, 2009, DIABETES, V58, P18, DOI 10.2337/db08-1470; Altamimi TR, 2019, METABOLISM, V98, P37, DOI 10.1016/j.metabol.2019.06.005; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010; Baiceanu A, 2016, NAT REV ENDOCRINOL, V12, P710, DOI 10.1038/nrendo.2016.124; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Butler AA, 2019, J BIOL CHEM, V294, P9706, DOI 10.1074/jbc.RA119.007528; Butler AA, 2012, J CLIN ENDOCR METAB, V97, P3783, DOI 10.1210/jc.2012-2194; Chen S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.362; Chen X, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.101068; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Dara L, 2011, HEPATOLOGY, V53, P1752, DOI 10.1002/hep.24279; Das M, 2009, CELL, V136, P249, DOI 10.1016/j.cell.2008.11.017; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gao S, 2015, MOL METAB, V4, P310, DOI 10.1016/j.molmet.2015.01.005; Gao S, 2014, DIABETES, V63, P3242, DOI 10.2337/db14-0388; Haedersdal S, 2018, MAYO CLIN PROC, V93, P217, DOI 10.1016/j.mayocp.2017.12.003; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kang JK, 2017, P NATL ACAD SCI USA, V114, P11926, DOI 10.1073/pnas.1706489114; Kumar KG, 2012, OBESITY, V20, P1394, DOI 10.1038/oby.2012.31; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Kumashiro N, 2013, DIABETES, V62, P2183, DOI 10.2337/db12-1311; Lovren F, 2010, CIRCULATION, V122, pS185, DOI 10.1161/CIRCULATIONAHA.109.931782; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; Oh SY, 2003, J BIOL CHEM, V278, P28410, DOI 10.1074/jbc.M300553200; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sanders FWB, 2016, BIOL REV, V91, P452, DOI 10.1111/brv.12178; Sassone-Corsi P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011148; Solinas G, 2017, MOL METAB, V6, DOI 10.1016/j.molmet.2016.12.001; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; Stein LM, 2016, AM J PHYSIOL-REG I, V310, pR476, DOI 10.1152/ajpregu.00511.2015; Thapa D, 2018, REDOX BIOL, V18, P25, DOI 10.1016/j.redox.2018.06.003; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Win S, 2018, HEPATOLOGY, V67, P2013, DOI 10.1002/hep.29689; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	48	39	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13366	13377		10.1074/jbc.RA119.008967	http://dx.doi.org/10.1074/jbc.RA119.008967			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31324719	Green Published, hybrid			2022-12-28	WOS:000486417200014
J	Liu, HY; Li, ZW; Yang, QQ; Liu, W; Wan, J; Li, JC; Zhang, MJ				Liu, Haiyang; Li, Zhiwei; Yang, Qingqing; Liu, Wei; Wan, Jun; Li, Jianchao; Zhang, Mingjie			Substrate docking-mediated specific and efficient lysine methylation by the SET domain-containing histone methyltransferase SETD7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone methylation; protein methylation; epigenetics; docking; enzyme catalysis; SET domain-containing 7 histone methyltransferase (SETD7); MORN repeats; lysine methylation; docking interaction; substrate specificity; gene regulation; protein-protein interaction; posttranslational modification; charge-charge interaction	PROTEIN METHYLATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNA RECOGNITION; P53 ACTIVITY; H3; TRANSCRIPTION; CALMODULIN; REPRESSION; ALPHA	Lysine methylation of cellular proteins is catalyzed by dozens of lysine methyltransferases (KMTs), occurs in thousands of different histone and nonhistone proteins, and regulates diverse biological processes. Dysregulation of KMT-mediated lysine methylations underlies many human diseases. A key unanswered question is how proteins, nonhistone proteins in particular, are specifically methylated by each KMT. Here, using several biochemical approaches, including analytical gel filtration chromatography, isothermal titration calorimetry, and in vitro methylation assays, we discovered that SET domain-containing 7 histone lysine methyltransferase (SETD7), a KMT capable of methylating both histone and nonhistone proteins, uses its N-terminal membrane occupation and recognition nexus (MORN) repeats to dock its substrates and subsequently juxtapose their Lys methylation motif for efficient and specific methylation by the catalytic SET domain. Such docking site-mediated methylation mechanism rationalizes binding and methylation of previously known substrates and predicts new SETD7 substrates. Our findings further suggest that other KMTs may also use docking-mediated substrate recognition mechanisms to achieve their catalytic specificity and efficiency.	[Liu, Haiyang; Wan, Jun; Li, Jianchao; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China; [Liu, Haiyang; Li, Zhiwei; Yang, Qingqing; Liu, Wei; Wan, Jun; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Biomed Res Inst, Med Ctr,Shenzhen Key Lab Neuronal Struct Biol, Shenzhen 518036, Peoples R China; [Li, Jianchao] South China Univ Technol, Sch Med, Div Cell Dev & Integrat Biol, Guangzhou 510006, Guangdong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Sci, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Inst Adv Study, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; South China University of Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Li, JC; Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China.; Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Biomed Res Inst, Med Ctr,Shenzhen Key Lab Neuronal Struct Biol, Shenzhen 518036, Peoples R China.; Li, JC (corresponding author), South China Univ Technol, Sch Med, Div Cell Dev & Integrat Biol, Guangzhou 510006, Guangdong, Peoples R China.; Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Sci, Hong Kong, Peoples R China.; Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Inst Adv Study, Hong Kong, Peoples R China.	lijch@scut.edu.cn; mzhang@ust.hk	LI, Jianchao/J-2053-2017	LI, Jianchao/0000-0002-8921-1626	National Key R&D Program of China from the Ministry of Science and Technology of China [2016YFA0501903]; RGC of Hong Kong [AoE-M09-12, C6004-17G]; National Natural Science Foundation of China [31670765, 31700673, 81571043]; Natural Science Foundation of Guangdong Province [2016A030312016]; Shenzhen Basic Research Grants [JCYJ20160229153100269, JCYJ20170411090807530]	National Key R&D Program of China from the Ministry of Science and Technology of China; RGC of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen Basic Research Grants	This research was supported by National Key R&D Program of China Grant 2016YFA0501903 from the Ministry of Science and Technology of China and RGC of Hong Kong Grants AoE-M09-12 and C6004-17G (to M. Z.); National Natural Science Foundation of China Grants 31670765 (to W. L.), 31700673 (to H. L.), and 81571043 (to J. W.); Natural Science Foundation of Guangdong Province Grant 2016A030312016 (to M. Z.); and Shenzhen Basic Research Grants JCYJ20160229153100269 (to M. Z.) and JCYJ20170411090807530 (to W. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Batista IDA, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0017-6; AMBLER RP, 1959, NATURE, V184, P56, DOI 10.1038/184056b0; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Cornett EM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aav2623; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Del Rizzo PA, 2011, EPIGENETICS-US, V6, P1059, DOI 10.4161/epi.6.9.16069; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Ibanez G, 2010, ANAL BIOCHEM, V401, P203, DOI 10.1016/j.ab.2010.03.010; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Li J, 2019, JOULE, V3, P4, DOI 10.1016/j.joule.2018.12.007; Li QX, 2018, BIOCHEMISTRY-US, V57, P2132, DOI 10.1021/acs.biochem.8b00057; Liu N, 2015, GENE DEV, V29, P379, DOI 10.1101/gad.254425.114; Liu S, 2019, CELL, V176, P491, DOI 10.1016/j.cell.2018.11.038; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Liu X, 2015, NUCLEIC ACIDS RES, V43, P5081, DOI 10.1093/nar/gkv379; Longo A, 2007, BIOCHEMISTRY-US, V46, P2948, DOI 10.1021/bi060969l; Luo M, 2018, CHEM REV, V118, P6656, DOI 10.1021/acs.chemrev.8b00008; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; Murn J, 2017, NAT REV MOL CELL BIO, V18, P517, DOI 10.1038/nrm.2017.35; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Oudhoff MJ, 2013, DEV CELL, V26, P188, DOI 10.1016/j.devcel.2013.05.025; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; ROBERTS DM, 1986, J BIOL CHEM, V261, P1491; Sankaran SM, 2016, J BIOL CHEM, V291, P8465, DOI 10.1074/jbc.M116.720748; Shen CC, 2015, FASEB J, V29, P4313, DOI 10.1096/fj.15-273540; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tao YZ, 2011, J CELL BIOL, V194, P551, DOI 10.1083/jcb.201010090; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; WATTERSON DM, 1980, J BIOL CHEM, V255, P962; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Wingender E, 2018, NUCLEIC ACIDS RES, V46, pD343, DOI 10.1093/nar/gkx987; ZHANG MJ, 1994, J BIOL CHEM, V269, P5099	48	4	5	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13355	13365		10.1074/jbc.RA119.009630	http://dx.doi.org/10.1074/jbc.RA119.009630			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31324717	hybrid, Green Published			2022-12-28	WOS:000486417200013
J	Mizuguchi, C; Nakagawa, M; Namba, N; Sakai, M; Kurimitsu, N; Suzuki, A; Fujita, K; Horiuchi, S; Baba, T; Ohgita, T; Nishitsuji, K; Saito, H				Mizuguchi, Chiharu; Nakagawa, Miho; Namba, Norihiro; Sakai, Misae; Kurimitsu, Naoko; Suzuki, Ayane; Fujita, Kaho; Horiuchi, Sayaka; Baba, Teruhiko; Ohgita, Takashi; Nishitsuji, Kazuchika; Saito, Hiroyuki			Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; fibril; apolipoprotein; protein structure; protein aggregation; activation energy; apolipoprotein A-I; G26R variant; hereditary systemic amyloidosis; pyrene labeling	WATZKY 2-STEP MODEL; KINETIC-DATA; SECONDARY NUCLEATION; STRUCTURAL INSIGHTS; HYDROGEN-EXCHANGE; CRYSTAL-STRUCTURE; ENERGY BARRIERS; DOMAIN; PROPENSITY; MUTATIONS	The N-terminal (1-83) fragment of the major constituent of plasma high-density lipoprotein, apolipoprotein A-I (apoA-I), strongly tends to form amyloid fibrils, leading to systemic amyloidosis. Here, using a series of deletion variants, we examined the roles of two major amyloidogenic segments (residues 14-22 and 50-58) in the aggregation and fibril formation of an amyloidogenic G26R variant of the apoA-I 1-83 fragment (apoA-I 1-83/G26R). Thioflavin T fluorescence assays and atomic force microscopy revealed that elimination of residues 14-22 completely inhibits fibril formation of apoA-I 1-83/G26R, whereas Delta 32-40 and Delta 50-58 variants formed fibrils with markedly reduced nucleation and fibril growth rates. CD measurements revealed structural transitions from random coil to beta-sheet structures in all deletion variants except for the Delta 14-22 variant, indicating that residues 14-22 are critical for the beta-transition and fibril formation. Thermodynamic analysis of the kinetics of fibril formation by apoA-I 1-83/G26R indicated that both nucleation and fibril growth are enthalpically unfavorable, whereas entropically, nucleation is favorable, but fibril growth is unfavorable. Interestingly, the nucleation of the Delta 50-58 variant was entropically unfavorable, indicating that residues 50-58 entropically promote the nucleation step in fibril formation of apoA-I 1-83/G26R. Moreover, a residue-level structural investigation of apoA-I 1-83/G26R fibrils with site-specific pyrene labeling indicated that the two amyloidogenic segments are in close proximity to form an amyloid core structure, whereas the N- and C-terminal tail regions are excluded from the amyloid core. These results provide critical insights into the aggregation mechanism and fibril structure of the amyloidogenic N-terminal fragment of apoA-I.	[Mizuguchi, Chiharu; Nakagawa, Miho; Namba, Norihiro; Sakai, Misae; Kurimitsu, Naoko; Suzuki, Ayane; Fujita, Kaho; Horiuchi, Sayaka; Ohgita, Takashi; Saito, Hiroyuki] Kyoto Pharmaceut Univ, Dept Biophys Chem, Yamashina Ku, 5 Misasagi Nakauchi Cho, Kyoto 6078414, Japan; [Baba, Teruhiko] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba Cent 5, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan; [Nishitsuji, Kazuchika] Wakayama Med Univ, Dept Biochem, 811-1 Kimiidera, Wakayama 6418509, Japan; [Mizuguchi, Chiharu] Osaka Inst Publ Hlth, Div Hyg Chem, Osaka 5430026, Japan	Kyoto Pharmaceutical University; National Institute of Advanced Industrial Science & Technology (AIST); Wakayama Medical University; Osaka Prefectural Institute of Public Health	Saito, H (corresponding author), Kyoto Pharmaceut Univ, Dept Biophys Chem, Yamashina Ku, 5 Misasagi Nakauchi Cho, Kyoto 6078414, Japan.	hsaito@mb.kyoto-phu.ac.jp	Baba, Teruhiko/J-3351-2018	Baba, Teruhiko/0000-0002-9075-2999	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP17H03979]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant JP17H03979 (to H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abedini A, 2006, J MOL BIOL, V355, P274, DOI 10.1016/j.jmb.2005.10.052; Adachi E, 2014, FEBS LETT, V588, P389, DOI 10.1016/j.febslet.2013.11.031; Adachi E, 2013, J BIOL CHEM, V288, P2848, DOI 10.1074/jbc.M112.428052; Andreola A, 2003, J BIOL CHEM, V278, P2444, DOI 10.1074/jbc.M204801200; Arciello A, 2016, FEBS LETT, V590, P4171, DOI 10.1002/1873-3468.12468; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Bains G, 2011, MOLECULES, V16, P7909, DOI 10.3390/molecules16097909; Buell AK, 2012, ANGEW CHEM INT EDIT, V51, P5247, DOI 10.1002/anie.201108040; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chetty PS, 2012, BIOCHEMISTRY-US, V51, P8993, DOI 10.1021/bi300926j; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Cohen SIA, 2018, NAT CHEM, V10, P523, DOI 10.1038/s41557-018-0023-x; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Das M, 2014, FEBS J, V281, P2525, DOI 10.1111/febs.12809; Girych M, 2014, J STRUCT BIOL, V185, P116, DOI 10.1016/j.jsb.2013.10.017; Gursky O, 2012, BIOCHEMISTRY-US, V51, P10, DOI 10.1021/bi2017014; Haney CM, 2018, CHEM COMMUN, V54, P833, DOI 10.1039/c7cc08601f; Hortschansky P, 2005, PROTEIN SCI, V14, P2915, DOI 10.1110/ps.051585905; Iashchishyn IA, 2017, ACS CHEM NEUROSCI, V8, P2152, DOI 10.1021/acschemneuro.7b00251; Gallea JI, 2014, J BIOL CHEM, V289, P26733, DOI 10.1074/jbc.M114.566695; Joy T, 2003, CLIN BIOCHEM, V36, P641, DOI 10.1016/S0009-9120(03)00110-3; Kono M, 2008, BIOCHEMISTRY-US, V47, P11340, DOI 10.1021/bi801503r; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493; Levitan K, 2011, J MOL BIOL, V411, P329, DOI 10.1016/j.jmb.2011.05.046; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Mendoza-Espinosa P, 2014, MOL CELL BIOCHEM, V393, P99, DOI 10.1007/s11010-014-2050-2; Mikawa S, 2016, FEBS LETT, V590, P3492, DOI 10.1002/1873-3468.12426; Mizuguchi C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23920-3; Mizuguchi C, 2015, J BIOL CHEM, V290, P20947, DOI 10.1074/jbc.M115.664227; Mizuguchi C, 2012, BIOCHEMISTRY-US, V51, P5580, DOI 10.1021/bi300672s; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Morris AM, 2009, BIOPHYS CHEM, V140, P9, DOI 10.1016/j.bpc.2008.11.003; Nakajima K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22015; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Sabate R, 2009, FEBS J, V276, P5053, DOI 10.1111/j.1742-4658.2009.07202.x; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; Tamamizu-Kato S, 2006, BIOCHEMISTRY-US, V45, P10947, DOI 10.1021/bi060939i; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Thirunavukkuarasu S, 2008, J MOL BIOL, V378, P1064, DOI 10.1016/j.jmb.2008.03.034; Tornquist M, 2018, CHEM COMMUN, V54, P8667, DOI 10.1039/c8cc02204f; Tougaard BG, 2016, EUR J MED GENET, V59, P474, DOI 10.1016/j.ejmg.2016.05.015; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Watzky MA, 2008, BIOCHEMISTRY-US, V47, P10790, DOI 10.1021/bi800726m; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Witkowski A, 2018, FASEB J, V32, P3149, DOI 10.1096/fj.201701127R; Wong YQ, 2012, FEBS LETT, V586, P1754, DOI 10.1016/j.febslet.2012.05.007	55	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13515	13524		10.1074/jbc.RA119.008000	http://dx.doi.org/10.1074/jbc.RA119.008000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31341020	Green Published, hybrid			2022-12-28	WOS:000486417200025
J	Macias, I; Lain, A; Bernardo-Seisdedos, G; Gil, D; Gonzalez, E; Falcon-Perez, JM; Millet, O				Macias, Iratxe; Lain, Ana; Bernardo-Seisdedos, Ganeko; Gil, David; Gonzalez, Esperanza; Falcon-Perez, Juan M.; Millet, Oscar			Hereditary tyrosinemia type I-associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; protein stability; enzyme mutation; nuclear magnetic resonance (NMR); biophysics; tyrosine; fumaryl acetoacetate hydrolase; rare disease; tyrosinemia type I	UROPORPHYRINOGEN III SYNTHASE; CRYSTAL-STRUCTURE; CATALYTIC MECHANISM; CLINICAL-ASPECTS; GENE; INTERMEDIATE; INHIBITION; SIMULATION	More than 100 mutations in the gene encoding fumarylacetoacetate hydrolase (FAH) cause hereditary tyrosinemia type I (HT1), a metabolic disorder characterized by elevated blood levels of tyrosine. Some of these mutations are known to decrease FAH catalytic activity, but the mechanisms of FAH mutation-induced pathogenicity remain poorly understood. Here, using diffusion ordered NMR spectroscopy, cryo-EM, and CD analyses, along with site-directed mutagenesis, enzymatic assays, and molecular dynamics simulations, we investigated the putative role of thermodynamic and kinetic stability in WT FAH and a representative set of 19 missense mutations identified in individuals with HT1. We found that at physiological temperatures and concentrations, WT FAH is in equilibrium between a catalytically active dimer and a monomeric species, with the latter being inactive and prone to oligomerization and aggregation. We also found that the majority of the deleterious mutations reduce the kinetic stability of the enzyme and always accelerate the FAH aggregation pathway. Depending mainly on the position of the amino acid in the structure, pathogenic mutations either reduced the dimer population or decreased the energy barrier that separates the monomer from the aggregate. The mechanistic insights reported here pave the way for the development of pharmacological chaperones that target FAH to tackle the severe disease HT1.	[Macias, Iratxe; Lain, Ana; Bernardo-Seisdedos, Ganeko; Millet, Oscar] CIC bioGUNE, Prot Stabil & Inherited Dis Lab, Bizkaia Technol Pk,Bldg 800, Derio 48160, Bizkaia, Spain; [Gil, David] CIC bioGUNE, Electron Microscopy Platform, Bizkaia Technol Pk, Derio 48160, Bizkaia, Spain; [Gonzalez, Esperanza; Falcon-Perez, Juan M.] CIC bioGUNE, Exosomes Lab, Bizkaia Technol Pk, Derio 48160, Bizkaia, Spain; [Falcon-Perez, Juan M.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	CIC bioGUNE; CIC bioGUNE; CIC bioGUNE; Basque Foundation for Science	Millet, O (corresponding author), CIC bioGUNE, Prot Stabil & Inherited Dis Lab, Bizkaia Technol Pk,Bldg 800, Derio 48160, Bizkaia, Spain.	omillet@cicbiogune.es	González, Esperanza/AAK-4097-2020; Falcon-Perez, Juan M/F-5920-2011; Macias, Iratxe/AAA-7631-2020; Carton, David Gil/M-9332-2019; Millet, Oscar/F-9696-2011; González, Esperanza/H-5450-2015; Bernardo-Seisdedos, Ganeko/C-6923-2016	González, Esperanza/0000-0002-3831-4596; Macias, Iratxe/0000-0003-4900-9949; Carton, David Gil/0000-0003-4241-1302; Millet, Oscar/0000-0001-8748-4105; González, Esperanza/0000-0002-3831-4596; Bernardo-Seisdedos, Ganeko/0000-0002-1372-3844; Lain, Ana/0000-0001-7069-9126; Falcon-Perez, Juan M/0000-0003-3133-0670	Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country Elkartek [BG2015, BG2017]; Agencia Estatal de Investigacion (Spain) [CTQ2015-68756-R]; Severo Ochoa Excellence Accreditation [SEV-2016-0644]	Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country Elkartek; Agencia Estatal de Investigacion (Spain); Severo Ochoa Excellence Accreditation	This work was supported by the Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country Elkartek Grants BG2015 and BG2017, by Agencia Estatal de Investigacion (Spain) for Grant CTQ2015-68756-R, and by Severo Ochoa Excellence Accreditation SEV-2016-0644. The authors declare that they have no conflicts of interest with the contents of this article.	Angileri F, 2015, JIMD REP, V19, P43, DOI 10.1007/8904_2014_363; Angileri F, 2014, CANCERS, V6, P998, DOI 10.3390/cancers6020998; BAIN MD, 1990, EUR J PEDIATR, V149, P637, DOI 10.1007/BF02034752; Bateman RL, 2007, BIOCHEM J, V402, P251, DOI 10.1042/BJ20060961; Bateman RL, 2001, J BIOL CHEM, V276, P15284, DOI 10.1074/jbc.M007621200; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; ben Bdira F, 2014, HUM MOL GENET, V23, P5805, DOI 10.1093/hmg/ddu298; Bergeron A, 2001, J BIOL CHEM, V276, P15225, DOI 10.1074/jbc.M009341200; Blouin JM, 2013, P NATL ACAD SCI USA, V110, P18238, DOI 10.1073/pnas.1314177110; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cao YY, 2012, CHINESE MED J-PEKING, V125, P2132, DOI 10.3760/cma.j.issn.0366-6999.2012.12.010; Chen AD, 1999, ANAL CHEM, V71, p669A, DOI 10.1021/ac9907179; Dursun A, 2011, JIMD REP, V1, P17, DOI 10.1007/8904_2011_10; FernandezCanon JM, 1997, ANAL BIOCHEM, V245, P218, DOI 10.1006/abio.1996.9957; Fortian A, 2011, J BIOL CHEM, V286, P13127, DOI 10.1074/jbc.M110.205849; Fortian A, 2009, BIOCHEMISTRY-US, V48, P454, DOI 10.1021/bi801731q; Geppert J, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0696-z; Harder ME, 2004, PROTEIN SCI, V13, P2207, DOI 10.1110/ps.03229504; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchesson ACJ, 1996, ARCH DIS CHILD-FETAL, V74, pF191, DOI 10.1136/fn.74.3.F191; Jerschow A, 1998, J MAGN RESON, V134, P17, DOI 10.1006/jmre.1998.1491; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Manjasetty BA, 2004, BIOL CHEM, V385, P935, DOI 10.1515/BC.2004.122; Medina-Carmona E, 2017, HUM MOL GENET, V26, P3531, DOI 10.1093/hmg/ddx238; Morrow G, 2017, ADV EXP MED BIOL, V959, P9, DOI 10.1007/978-3-319-55780-9_2; Morrow G, 2017, ADV EXP MED BIOL, V959, P25, DOI 10.1007/978-3-319-55780-9_3; Pinto GP, 2015, J CHEM THEORY COMPUT, V11, P2508, DOI 10.1021/acs.jctc.5b00222; Ran TT, 2013, BIOCHEM J, V449, P51, DOI 10.1042/BJ20120913; Rootwelt H, 1996, HUM MUTAT, V7, P239, DOI 10.1002/(SICI)1098-1004(1996)7:3<239::AID-HUMU8>3.3.CO;2-E; Russo PA, 2001, PEDIATR DEVEL PATHOL, V4, P212, DOI 10.1007/s100240010146; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Tanguay RM, 2017, ADV EXP MED BIOL, V959, P49, DOI 10.1007/978-3-319-55780-9_4; Taniguchi Y, 2008, BIOPHYS J, V95, P5296, DOI 10.1529/biophysj.108.141275; Timm DE, 1999, STRUCTURE, V7, P1023, DOI 10.1016/S0969-2126(99)80170-1; Urquiza P, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat7467	36	10	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13051	13060		10.1074/jbc.RA119.009367	http://dx.doi.org/10.1074/jbc.RA119.009367			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31300554	Green Published, hybrid			2022-12-28	WOS:000486416000016
J	McDermott, BT; Peffers, MJ; McDonagh, B; Tew, SR				McDermott, Benjamin T.; Peffers, Mandy J.; McDonagh, Brian; Tew, Simon R.			Translational regulation contributes to the secretory response of chondrocytic cells following exposure to interleukin-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondrocyte; inflammation; interleukin 1 (IL-1); osteoarthritis; post-transcriptional regulation; proteomics; superoxide dismutase (SOD)	RIBOSOME PROFILING REVEALS; GENE-EXPRESSION; ARTICULAR CHONDROCYTES; CARTILAGE; PROTEIN; INFLAMMATION; IL-1; DEGRADATION; ACTIVATION; COMPLEXITY	Osteoarthritis is a chronic disease characterized by the loss of articular cartilage in synovial joints through a process of extracellular matrix destruction that is strongly associated with inflammatory stimuli. Chondrocytes undergo changes to their protein translational capacity during osteoarthritis, but a study of how disease-relevant signals affect chondrocyte protein translation at the transcriptomic level has not previously been performed. In this study, we describe how the inflammatory cytokine interleukin 1-beta (IL-1 beta) rapidly affects protein translation in the chondrocytic cell line SW1353. Using ribosome profiling we demonstrate that IL-1 beta induced altered translation of inflammatory-associated transcripts such as NFKB1, TNFAIP2, MMP13, CCL2, and CCL7, as well as a number of ribosome-associated transcripts, through differential translation and the use of multiple open reading frames. Proteomic analysis of the cellular layer and the conditioned media of these cells identified changes in a number of the proteins that were differentially translated. Translationally regulated secreted proteins included a number of chemokines and cytokines, underlining the rapid, translationally mediated inflammatory cascade that is initiated by IL-1 beta. Although fewer cellular proteins were found to be regulated in both ribosome profiling and proteomic data sets, we did find increased levels of SOD2, indicative of redox changes within SW1353 cells being modulated at the translational level. In conclusion, we have produced combined ribosome profiling and proteomic data sets that provide a valuable resource in understanding the processes that occur during cytokine stimulation of chondrocytic cells.	[McDermott, Benjamin T.; Peffers, Mandy J.; Tew, Simon R.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, William Henry Duncan Bldg,6 West Derby St, Liverpool L7 8TX, Merseyside, England; [McDonagh, Brian] NUI, Sch Med, Dept Physiol, Galway H91 TK33, Ireland	University of Liverpool	McDermott, BT (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, William Henry Duncan Bldg,6 West Derby St, Liverpool L7 8TX, Merseyside, England.	benmcd@liverpool.ac.uk	Peffers, Mandy Jayne/AAV-9411-2020; Tew, Simon Robert/G-4087-2011; McDonagh, Brian/I-1903-2015	Peffers, Mandy Jayne/0000-0001-6979-0440; Tew, Simon Robert/0000-0002-1213-5418; McDonagh, Brian/0000-0003-2534-4427	Biotechnology and Biological Sciences Research Council [BB/K00381X/1]; Medical Research Council [MR/N011333/1]; University of Liverpool's Department of Musculoskeletal Biology; University of Liverpool Technology Directorate; BBSRC [BB/K00381X/1] Funding Source: UKRI; MRC [MR/P020941/1, MR/N011333/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Liverpool's Department of Musculoskeletal Biology; University of Liverpool Technology Directorate; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/K00381X/1, Medical Research Council Grant MR/N011333/1, the University of Liverpool's Department of Musculoskeletal Biology, and the University of Liverpool Technology Directorate. The authors declare that they have no conflicts of interest with the contents of this article.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Aigner T, 2004, METH MOLEC MED, V100, P109; Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Balaskas P, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/2713725; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; Brar GA, 2015, NAT REV MOL CELL BIO, V16, P651, DOI 10.1038/nrm4069; Chang ZK, 2018, J CELL BIOCHEM, V119, P4775, DOI 10.1002/jcb.26669; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; Diaz-Prado S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-144; Fields AP, 2015, MOL CELL, V60, P816, DOI 10.1016/j.molcel.2015.11.013; Friedlander RM, 1996, J EXP MED, V184, P717, DOI 10.1084/jem.184.2.717; Gebauer M, 2005, OSTEOARTHR CARTILAGE, V13, P697, DOI 10.1016/j.joca.2005.04.004; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Greene MA, 2015, OSTEOARTHR CARTILAGE, V23, P1966, DOI 10.1016/j.joca.2015.01.008; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ingolia NT, 2016, CELL, V165, P22, DOI 10.1016/j.cell.2016.02.066; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kasza A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-14; Katsara O, 2018, J ORTHOP RES, V36, P2728, DOI 10.1002/jor.24049; Katsara O, 2017, ARTHRITIS RHEUMATOL, V69, P586, DOI 10.1002/art.39947; Kharaz YA, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700018; Lane RS, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0566-9; Larsson O, 2010, P NATL ACAD SCI USA, V107, P21487, DOI 10.1073/pnas.1006821107; Lepetsos P, 2016, BBA-MOL BASIS DIS, V1862, P576, DOI 10.1016/j.bbadis.2016.01.003; Li M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0502; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mathy-Hartert M, 2008, OSTEOARTHR CARTILAGE, V16, P756, DOI 10.1016/j.joca.2007.10.009; McDermott BT, 2016, OSTEOARTHR CARTILAGE, V24, P1263, DOI 10.1016/j.joca.2016.01.988; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Michel AM, 2016, RNA BIOL, V13, P316, DOI 10.1080/15476286.2016.1141862; Michel AM, 2013, WIRES RNA, V4, P473, DOI 10.1002/wrna.1172; Miettinen TP, 2015, NUCLEIC ACIDS RES, V43, P1019, DOI 10.1093/nar/gku1310; Min ZX, 2015, INT J CLIN EXP MED, V8, P1009; Mueller AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33956; Peffers MJ, 2014, J BIOL CHEM, V289, P25867, DOI 10.1074/jbc.M114.566554; Peffers MJ, 2014, GENOM DATA, V2, P27, DOI 10.1016/j.gdata.2014.03.001; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Sandell LJ, 2008, OSTEOARTHR CARTILAGE, V16, P1560, DOI 10.1016/j.joca.2008.04.027; Santoro A, 2015, J ORTHOP RES, V33, P1784, DOI 10.1002/jor.22954; Sato T, 2006, ARTHRITIS RHEUM-US, V54, P808, DOI 10.1002/art.21638; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Shi J, 2004, INFLAMM RES, V53, P377, DOI 10.1007/s00011-004-1271-3; Silverwood V, 2015, OSTEOARTHR CARTILAGE, V23, P507, DOI 10.1016/j.joca.2014.11.019; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Spector Tim D, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS39; Steinbusch MMF, 2017, SCI REP-UK, V7, DOI 10.1038/srep43558; Stone AV, 2014, OSTEOARTHR CARTILAGE, V22, P264, DOI 10.1016/j.joca.2013.11.002; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tew SR, 2014, ARTHRITIS RHEUMATOL, V66, P3052, DOI 10.1002/art.38849; Tonner P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-412; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Verma P, 2011, J CELL BIOCHEM, V112, P3507, DOI 10.1002/jcb.23298; Vincenti MP, 2001, ARTHRITIS RES, V3, P381, DOI 10.1186/ar331; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459; Xiao ZT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11194; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zou K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3483-2; Zupanic A, 2014, RNA, V20, P1507, DOI 10.1261/rna.045286.114	66	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13027	13039		10.1074/jbc.RA118.006865	http://dx.doi.org/10.1074/jbc.RA118.006865			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31300557	hybrid, Green Published			2022-12-28	WOS:000486416000014
J	Fujiwara, M; Tian, L; Le, PT; DeMambro, VE; Becker, KA; Rosen, CJ; Guntur, AR				Fujiwara, Makoto; Tian, Li; Le, Phuong T.; DeMambro, Victoria E.; Becker, Kathleen A.; Rosen, Clifford J.; Guntur, Anyonya R.			The mitophagy receptor Bcl-2-like protein 13 stimulates adipogenesis by regulating mitochondrial oxidative phosphorylation and apoptosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						B-cell lymphoma 2 (Bcl-2) family; adipogenesis; mitochondria; apoptosis; mitophagy; adipocyte; bone marrow; mitochondrial metabolism; energy metabolism; Bcl-2-like protein 13 (Bcl2l13); lineage determination; metabolic reprogramming; oxidative phosphorylation	HORMONE-SENSITIVE LIPASE; CHROMOSOMAL INVERSION; BCL-RAMBO; DIFFERENTIATION; CELLS; IDENTIFICATION; AUTOPHAGY; HOMOLOG; DEATH; FAT	Metabolic programming of bone marrow stromal cells (BMSCs) could influence the function of progenitor osteoblasts or adipocytes and hence determine skeletal phenotypes. Adipocytes predominantly utilize oxidative phosphorylation, whereas osteoblasts use glycolysis to meet ATP demand. Here, we compared progenitor differentiation from the marrow of two inbred mouse strains, C3H/HeJ (C3H) and C57BL6J (B6). These strains differ in both skeletal mass and bone marrow adiposity. We hypothesized that genetic regulation of metabolic programs controls skeletal stem cell fate. Our experiments identified Bcl-2-like protein 13 (Bcl2l13), a mitochondrial mitophagy receptor, as being critical for adipogenic differentiation. We also found that Bcl2l13 is differentially expressed in the two mouse strains, with C3H adipocyte progenitor differentiation being accompanied by a >2-fold increase in Bcl2l13 levels relative to B6 marrow adipocytes. Bcl2l13 expression also increased during adipogenic differentiation in mouse ear mesenchymal stem cells (eMSCs) and the murine preadipocyte cell line 3T3-L1. The higher Bcl2l13 expression correlated with increased mitochondrial fusion and biogenesis. Importantly, Bcl2l13 knockdown significantly impaired adipocyte differentiation in both 3T3-L1 cells and eMSCs. Mechanistically, Bcl2l13 knockdown reprogrammed cells to rely more on glycolysis to meet ATP demand in the face of impaired oxidative phosphorylation. Bcl2l13 knockdown in eMSCs increased mitophagy. Moreover, Bcl2l13 prevented apoptosis during adipogenesis. Our findings indicate that the mitochondrial receptor Bcl2l13 promotes adipogenesis by increasing oxidative phosphorylation, suppressing apoptosis, and providing mitochondrial quality control through mitophagy. We conclude that genetic programming of metabolism may be important for lineage determination and cell function within the bone marrow.	[Fujiwara, Makoto; Le, Phuong T.; DeMambro, Victoria E.; Becker, Kathleen A.; Rosen, Clifford J.] Maine Med Ctr, Ctr Clin & Translat Res, Res Inst, Scarborough, ME 04074 USA; [Tian, Li; Rosen, Clifford J.; Guntur, Anyonya R.] Maine Med Ctr, Ctr Mol Med, Res Inst, 81 Res Dr, Scarborough, ME 04074 USA	Maine Medical Center; Maine Medical Center	Guntur, AR (corresponding author), Maine Med Ctr, Ctr Mol Med, Res Inst, 81 Res Dr, Scarborough, ME 04074 USA.	guntua@mmc.org		Guntur, Anyonya/0000-0001-6366-200X	NIGMS, National Institutes of Health (NIH) [U54GM115516-02, 1P20GM121301, P30GM106391]; NIDDK, NIH [R24 DK092759-06]; NIAMS, NIH [R03 AR068095]; Maine Medical Center Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR068095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121301, P30GM106391, U54GM115516] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Maine Medical Center Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health (NIH), Grants U54GM115516-02, 1P20GM121301, and P30GM106391; NIDDK, NIH, Grant R24 DK092759-06; NIAMS, NIH, Grant R03 AR068095; and start-up research funds from the Maine Medical Center Research Institute (to G. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackert-Bicknell CL, 2007, ANN NY ACAD SCI, V1116, P291, DOI 10.1196/annals.1402.010; Akeson EC, 2006, GENOMICS, V87, P311, DOI 10.1016/j.ygeno.2005.09.022; Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Altshuler-Keylin S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai9248; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Bonnet N, 2014, BONE, V68, P100, DOI 10.1016/j.bone.2014.07.024; Forni MF, 2016, STEM CELLS, V34, P743, DOI 10.1002/stem.2248; Gawronska-Kozak B, 2007, J CELL BIOCHEM, V102, P122, DOI 10.1002/jcb.21286; Giroud M, 2016, MOL METAB, V5, P615, DOI 10.1016/j.molmet.2016.06.005; Griffin EE, 2006, BBA-MOL CELL RES, V1763, P482, DOI 10.1016/j.bbamcr.2006.02.003; Guntur AR, 2018, J BONE MINER RES, V33, P1052, DOI 10.1002/jbmr.3390; Guntur AR, 2014, ENDOCRINOLOGY, V155, P1589, DOI 10.1210/en.2013-1974; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P5682, DOI 10.1073/pnas.1316700111; Ju LP, 2018, BIOCHEM BIOPH RES CO, V506, P485, DOI 10.1016/j.bbrc.2018.10.034; Kataoka T, 2001, J BIOL CHEM, V276, P19548, DOI 10.1074/jbc.M010520200; Kim JY, 2012, FEBS LETT, V586, P3142, DOI 10.1016/j.febslet.2012.08.015; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Li QQ, 2017, PROTEIN CELL, V8, P439, DOI 10.1007/s13238-017-0385-7; MAGNELLI L, 1994, BIOCHEM BIOPH RES CO, V204, P84, DOI 10.1006/bbrc.1994.2429; Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003; McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039; Mitterberger MC, 2012, STEM CELL RES, V9, P35, DOI 10.1016/j.scr.2012.04.001; Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527; Patel R, 2013, J BIOL CHEM, V288, P26834, DOI 10.1074/jbc.M113.482638; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Rojo M, 2002, J CELL SCI, V115, P1663; Rosen CJ, 2004, BONE, V35, P1046, DOI 10.1016/j.bone.2004.07.008; Scheller EL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8808; Shen LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059070, 10.1371/journal.pone.0077077, 10.1371/journal.pone.0077515]; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; Sheng MHC, 2006, CALCIFIED TISSUE INT, V78, P293, DOI 10.1007/s00223-005-0303-5; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smith AJ, 2008, J BIOL CHEM, V283, P33536, DOI 10.1074/jbc.M806732200; Sorisky A, 2000, INT J OBESITY, V24, pS3, DOI 10.1038/sj.ijo.0801491; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Veldhuis-Vlug AG, 2018, J INTERN MED, V283, P121, DOI 10.1111/joim.12718; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	41	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12683	12694		10.1074/jbc.RA119.008630	http://dx.doi.org/10.1074/jbc.RA119.008630			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31266807	hybrid, Green Published			2022-12-28	WOS:000484414600011
J	Hobbs, JK; Pluvinage, B; Robb, M; Smith, SP; Boraston, AB				Hobbs, Joanne K.; Pluvinage, Benjamin; Robb, Melissa; Smith, Steven P.; Boraston, Alisdair B.			Two complementary alpha-fucosidases from Streptococcus pneumoniae promote complete degradation of host-derived carbohydrate antigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Streptococcus; glycoside hydrolase; host-pathogen interaction; structure-function; X-ray crystallography	BETA-GALACTOSIDASE; BIFIDOBACTERIUM-BIFIDUM; MOLECULAR-CLONING; SURFACE-PROTEINS; ENZYMES; IDENTIFICATION; EXPRESSION; GENE; EXOGLYCOSIDASES; LOCALIZATION	An important aspect of the interaction between the opportunistic bacterial pathogen Streptococcus pneumoniae and its human host is its ability to harvest host glycans. The pneumococcus can degrade a variety of complex glycans, including N- and O-linked glycans, glycosaminoglycans, and carbohydrate antigens, an ability that is tightly linked to the virulence of S. pneumoniae. Although S. pneumoniae is known to use a sophisticated enzyme machinery to attack the human glycome, how it copes with fucosylated glycans, which are primarily histo-blood group antigens, is largely unknown. Here, we identified two pneumococcal enzymes, SpGH29(C) and SpGH95(C), that target alpha-(1 -> 3/4) and alpha-(1 -> 2) fucosidic linkages, respectively. X-ray crystallography studies combined with functional assays revealed that SpGH29(C) is specific for the Lewis(A) and Lewis(X) antigen motifs and that SpGH95(C) is specific for the H(O)-antigen motif. Together, these enzymes could defucosylate Lewis(Y) and Lewis(B) antigens in a complementary fashion. In vitro reconstruction of glycan degradation cascades disclosed that the individual or combined activities of these enzymes expose the underlying glycan structure, promoting the complete deconstruction of a glycan that would otherwise be resistant to pneumococcal enzymes. These experiments expand our understanding of the extensive capacity of S. pneumoniae to process host glycans and the likely roles of alpha-fucosidases in this. Overall, given the importance of enzymes that initiate glycan breakdown in pneumococcal virulence, such as the neuraminidase NanA and the mannosidase SpGH92, we anticipate that the alpha-fucosidases identified here will be important factors in developing more refined models of the S. pneumoniae-host interaction.	[Hobbs, Joanne K.; Pluvinage, Benjamin; Robb, Melissa; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 5C2, Canada; [Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	University of Victoria; Queens University - Canada	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 5C2, Canada.	boraston@uvic.ca		Hobbs, Joanne/0000-0001-5239-8039; Boraston, Alisdair/0000-0001-6417-0592	DOE Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank the beamline staff at the Stanford Synchrotron Research Laboratory (SSRL). SSRL is a Directorate of Stanford Linear Accelerator Center (SLAC) National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (Grant P41RR001209), and the National Institute of General Medical Sciences. Research described in this paper was performed using beamline 08B1-1 at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Afzal M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00158; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Barik S, 1996, Methods Mol Biol, V57, P203; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; BERRY AM, 1994, INFECT IMMUN, V62, P1101, DOI 10.1128/IAI.62.3.1101-1108.1994; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Bongaerts RJM, 2000, INFECT IMMUN, V68, P7141, DOI 10.1128/IAI.68.12.7141-7143.2000; Brockhausen I, 2015, ESSENTIALS GLYCOBIOL; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Buckwalter CM, 2012, TRENDS MICROBIOL, V20, P517, DOI 10.1016/j.tim.2012.08.008; Chen HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002950; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLARKE VA, 1995, J BIOL CHEM, V270, P8805, DOI 10.1074/jbc.270.15.8805; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flynn JM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005846; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Greene NG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004996; Gregg KJ, 2011, J BIOL CHEM, V286, P15586, DOI 10.1074/jbc.M111.223172; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Higgins MA, 2014, J MOL BIOL, V426, P1469, DOI 10.1016/j.jmb.2013.12.006; Higgins MA, 2009, J BIOL CHEM, V284, P26161, DOI 10.1074/jbc.M109.024067; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; Hobbs JK, 2018, FEBS LETT, V592, P3865, DOI 10.1002/1873-3468.13045; HUGHES RC, 1964, BIOCHEMISTRY-US, V3, P1535, DOI 10.1021/bi00898a025; Jeong JK, 2009, J BACTERIOL, V191, P3011, DOI 10.1128/JB.01601-08; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; LACKS S, 1968, GENETICS, V60, P685; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marion C, 2009, INFECT IMMUN, V77, P1389, DOI 10.1128/IAI.01215-08; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean R, 2015, J BIOL CHEM, V290, P21231, DOI 10.1074/jbc.M115.664847; Muramatsu H, 2001, J BIOCHEM, V129, P923, DOI 10.1093/oxfordjournals.jbchem.a002938; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Paixao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121042; Perez-Dorado I, 2012, MOL ORAL MICROBIOL, V27, P221, DOI 10.1111/j.2041-1014.2012.00655.x; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Robb M, 2017, METHODS MOL BIOL, V1588, P215, DOI 10.1007/978-1-4939-6899-2_17; Robb M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006090; Robb M, 2015, J BIOL CHEM, V290, P30888, DOI 10.1074/jbc.M115.688630; Rosenow C, 1999, GENOME RES, V9, P1189, DOI 10.1101/gr.9.12.1189; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; Schnaar RL, 2015, ESSENTIALS GLYCOBIOL; Seeberger P.H, 2015, ESSENTIALS GLYCOBIOL; Singh AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004364; Stanley P., 2015, ESSENTIALS GLYCOBIOL; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Terra VS, 2010, INFECT IMMUN, V78, P348, DOI 10.1128/IAI.00721-09; Unione L, 2017, CURR MED CHEM, V24, P4057, DOI 10.2174/0929867324666170217093702; Varki A., 1995, SEMIN DEV BIOL, V6, P127, DOI [DOI 10.1016/S1044-5781(06)80022-8, 10.1016/s1044-5781(06)80022-8]; VIJAYAKUMAR MN, 1986, J BACTERIOL, V165, P689, DOI 10.1128/jb.165.3.689-695.1986; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; Weiser JN, 2018, NAT REV MICROBIOL, V16, P354, DOI 10.1038/s41579-018-0001-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu GG, 2011, J AM CHEM SOC, V133, P1718, DOI 10.1021/ja110733q; Zahner D, 2000, J BACTERIOL, V182, P5919, DOI 10.1128/JB.182.20.5919-5921.2000	74	9	9	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12670	12682		10.1074/jbc.RA119.009368	http://dx.doi.org/10.1074/jbc.RA119.009368			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31266803	hybrid, Green Published			2022-12-28	WOS:000484414600010
J	Hu, QB; Zhang, JX; Chen, Y; Hu, LH; Li, WH; He, ZG				Hu, Qingbin; Zhang, Jiaxun; Chen, Yu; Hu, Lihua; Li, Weihui; He, Zheng-Guo			Cyclic di-GMP co-activates the two-component transcriptional regulator DevR in Mycobacterium smegmatis in response to oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic di-GMP (c-di-GMP); transcription regulation; histidine kinase; Mycobacterium smegmatis; oxidative stress; antioxidant	HISTIDINE PROTEIN-KINASE; BIOFILM FORMATION; GENE-EXPRESSION; TUBERCULOSIS; BINDING; SYSTEM; MATRIX; DOMAIN; IDENTIFICATION; ADAPTATION	Cyclic di-GMP (c-di-GMP) is an important second messenger in bacteria, and its regulatory network has been extensively studied. However, information regarding the activation mechanisms of its receptors remains limited. In this study, we characterized the two-component regulator DevR as a new c-di-GMP receptor and further uncovered a novel co-activation mechanism for effective regulation of DevR in mycobacteria. We show that high c-di-GMP levels induce the expression of the devR operon in Mycobacterium smegmatis and increase mycobacterial survival under oxidative stress. The deletion of either DevR or its two-component kinase DevS significantly weakened the stimulating effect of c-di-GMP on oxidative-stress tolerance of mycobacteria. We also found that DevR senses the c-di-GMP signal through its C-terminal structure and that c-di-GMP alone does not directly affect the DNA-binding activity of DevR. Strikingly, c-di-GMP stimulated DevR phosphorylation by the kinase DevS, thereby activating DevR's DNA-binding affinity. In summary, our results indicated that c-di-GMP triggers a phosphorylation-dependent mechanism that co-activates DevR's transcriptional activity. Our findings suggest a novel paradigm for the cross-talk between c-di-GMP signaling and two-component regulatory systems that activates transcription of stress-response genes in bacteria.	[Hu, Qingbin; Zhang, Jiaxun; Chen, Yu; Hu, Lihua; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China; [Li, Weihui] Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China	Huazhong Agricultural University; Guangxi University	Li, WH (corresponding author), Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China.; He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China.	lwhlbx@163.com; hezhengguo2019@163.com			National Natural Science Foundation of China [31730005]; National Key R&D Program of China [2017YFD0500300]; NSFC [31670075, 31870036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grant 31730005, National Key R&D Program of China Grant 2017YFD0500300, and NSFC Grants 31670075 and 31870036. The authors declare that they have no conflicts of interest with the contents of this article.	Altamirano-Silva P, 2018, INFECT IMMUN, V86, DOI [10.1128/iai.00713-17, 10.1128/IAI.00713-17]; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; Crepin S, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00168-17; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Kariisa AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148478; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; KINGER AK, 1993, GENE, V131, P113, DOI 10.1016/0378-1119(93)90678-V; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Li WH, 2018, NUCLEIC ACIDS RES, V46, P7270, DOI 10.1093/nar/gky611; Li WH, 2018, NUCLEIC ACIDS RES, V46, P3595, DOI 10.1093/nar/gky146; Li WH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9330; Li WH, 2012, NUCLEIC ACIDS RES, V40, P11292, DOI 10.1093/nar/gks923; Li XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134595; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lori C, 2015, NATURE, V523, P236, DOI 10.1038/nature14473; Miller J. H, 1972, EXPT MOL GENETICS; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Nde CW, 2011, APPL MICROBIOL BIOT, V90, P277, DOI 10.1007/s00253-010-2931-6; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Petters T, 2012, MOL MICROBIOL, V84, P147, DOI 10.1111/j.1365-2958.2012.08015.x; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Saini DK, 2002, PROTEIN EXPRES PURIF, V25, P203, DOI 10.1006/prep.2002.1628; Stokes RW, 2009, FUTURE MICROBIOL, V4, P1317, DOI [10.2217/fmb.09.94, 10.2217/FMB.09.94]; Strempel N, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02311; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Tao J, 2014, FEMS MICROBIOL LETT, V358, P81, DOI 10.1111/1574-6968.12529; Tschowri N, 2014, CELL, V158, P1136, DOI 10.1016/j.cell.2014.07.022; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Wisedchaisri G, 2008, J MOL BIOL, V378, P227, DOI 10.1016/j.jmb.2008.02.029; Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x	45	7	8	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12729	12742		10.1074/jbc.RA119.008252	http://dx.doi.org/10.1074/jbc.RA119.008252			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31270210	hybrid, Green Published			2022-12-28	WOS:000484414600015
J	Inamdar, VV; Reddy, H; Dangelmaier, C; Kostyak, JC; Kunapuli, SP				Inamdar, Vaishali V.; Reddy, Haritha; Dangelmaier, Carol; Kostyak, John C.; Kunapuli, Satya P.			The protein tyrosine phosphatase PTPN7 is a negative regulator of ERK activation and thromboxane generation in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular signal-regulated kinase (ERK); platelet; thrombosis; hemostasis; aggregation; PTPN7	CYTOSOLIC PHOSPHOLIPASE A(2); P38 MAP KINASE; ADP RECEPTOR; THROMBIN; PHOSPHORYLATION; COLLAGEN; TRANSLOCATION; AGGREGATION; SIGNAL	Protein tyrosine phosphatase nonreceptor type 7 (PTPN7), also called hematopoietic protein tyrosine phosphatase, controls extracellular signal-regulated protein kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase in T lymphocytes. Because ERK1/2 plays an important role in regulating thromboxane A(2) (TXA(2)) generation in platelets, we investigated the function of PTPN7 in these cells. Using immunoblot analysis, we detected PTPN7 in both human and mouse platelets but not in PTPN7-null mice. PTPN7 KO mouse platelets exhibited increased platelet functional responses, including aggregation, dense granule secretion, and TXA(2) generation, compared with platelets from WT littermates, upon stimulation with both G protein-coupled receptor (GPCR) and glycoprotein VI (GPVI) agonists. Using the GPCR agonist AYPGKF in the presence of the COX inhibitor indomethacin, we found that PTPN7 KO mouse platelets aggregated and secreted to the same extent as WT platelets, suggesting that elevated TXA(2) is responsible for the potentiation of platelet functional responses in PTPN7-KO platelets. Phosphorylation of ERK1/2 was also elevated in PTPN7 KO platelets. Stimulation of platelets with the GPVI agonist collagen-related peptide along with the COX inhibitor indomethacin did not result in phosphorylation of ERK1/2, indicating that GPVI-mediated ERK phosphorylation occurs through TXA(2). Although bleeding times did not significantly differ between PTPN7-null and WT mice, time to death was significantly faster in PTPN7-null mice than in WT mice in a pulmonary thromboembolism model. We conclude that PTPN7 regulates platelet functional responses downstream of GPCR agonists, but not GPVI agonists, through inhibition of ERK activation and thromboxane generation.	[Inamdar, Vaishali V.; Reddy, Haritha; Dangelmaier, Carol; Kostyak, John C.; Kunapuli, Satya P.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kunapuli, SP (corresponding author), Temple Univ, Rm 403 MRB,3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu	Inamdar, Vaishali/R-5093-2019	Inamdar, Vaishali/0000-0002-3049-1977	National Institutes of Health [HL137721, HL137207, HL132171, HL93231]; American Heart Association Grant [17SDG33370020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137207, R01HL132171, R01HL137721, R01HL093231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL137721, HL137207, HL132171, and HL93231 ( to S. P. K) and American Heart Association Grant 17SDG33370020 ( to J. C. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badolia R, 2015, BLOOD, V125, P175, DOI 10.1182/blood-2014-05-576306; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P4449, DOI 10.1074/jbc.273.8.4449; BorschHaubold AG, 1997, EUR J BIOCHEM, V245, P751, DOI 10.1111/j.1432-1033.1997.t01-1-00751.x; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; FITZGERALD DJ, 1986, NEW ENGL J MED, V315, P983, DOI 10.1056/NEJM198610163151602; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; Garcia A, 2007, BIOCHEM J, V404, P299, DOI 10.1042/BJ20061584; Garcia A, 2010, BIOCHEM J, V429, P369, DOI 10.1042/BJ20100166; Gasparyan AY, 2008, J AM COLL CARDIOL, V51, P1829, DOI 10.1016/j.jacc.2007.11.080; Gronda M, 2001, MOL CELL BIOL, V21, P6851, DOI 10.1128/MCB.21.20.6851-6858.2001; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; KOUDSTAAL PJ, 1993, STROKE, V24, P219, DOI 10.1161/01.STR.24.2.219; KRAMER RM, 1995, J BIOL CHEM, V270, P27395, DOI 10.1074/jbc.270.46.27395; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Kuliopulos A, 2004, THROMB HAEMOSTASIS, V92, P1387, DOI 10.1160/TH04-03-0187; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MatijevicAleksic N, 1996, BRIT J HAEMATOL, V92, P212, DOI 10.1046/j.1365-2141.1996.279813.x; McAlees JW, 2009, MOL CELL BIOL, V29, P675, DOI 10.1128/MCB.01466-08; Nadal-Wollbold F, 2002, FEBS LETT, V531, P475, DOI 10.1016/S0014-5793(02)03587-1; PAPKOFF J, 1994, MOL CELL BIOL, V14, P463, DOI 10.1128/MCB.14.1.463; Pettiford SM, 2003, LEUKEMIA, V17, P366, DOI 10.1038/sj.leu.2402767; Roger S, 2004, FEBS LETT, V556, P227, DOI 10.1016/S0014-5793(03)01430-3; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Saxena M, 1998, J BIOL CHEM, V273, P15340, DOI 10.1074/jbc.273.25.15340; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; Tulasne D, 2002, EUR J BIOCHEM, V269, P1511, DOI 10.1046/j.1432-1033.2002.02798.x; ZANKE B, 1994, LEUKEMIA, V8, P236; ZANKE B, 1992, EUR J IMMUNOL, V22, P235, DOI 10.1002/eji.1830220134	30	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12547	12554		10.1074/jbc.RA119.007735	http://dx.doi.org/10.1074/jbc.RA119.007735			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31266805	hybrid, Green Published			2022-12-28	WOS:000484402700024
J	Sugiura, K; Yokochi, Y; Fu, N; Fukaya, Y; Yoshida, K; Mihara, S; Hisabori, T				Sugiura, Kazunori; Yokochi, Yuichi; Fu, Nae; Fukaya, Yuki; Yoshida, Keisuke; Mihara, Shoko; Hisabori, Toru			The thioredoxin (Trx) redox state sensor protein can visualize Trx activities in the light/dark response in chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosensor; chloroplast; fluorescence; FRET); redox regulation; thioredoxin	DISULFIDE BOND FORMATION; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; THIOL MODULATION; IDENTIFICATION; RESIDUES; SYSTEM	Thiol-based redox regulation via ferredoxin-thioredoxin (Trx) reductase/Trx controls various functions in chloroplasts in response to light/dark changes. Trx is a key factor of this regulatory system, and five Trx subtypes, including 10 isoforms, have been identified as chloroplast-localized forms in Arabidopsis thaliana. These subtypes display distinct target selectivity, and, consequently, they form a complicated redox regulation network in chloroplasts. In this study, we developed a FRET-based sensor protein by combining CFP, YFP, and the N-terminal region of CP12, a redox-sensitive regulatory and Trx-targeted protein in chloroplasts. This sensor protein enabled us to monitor the redox change of chloroplast thioredoxin in vivo, and we therefore designated this protein change in redox state of Trx (CROST). Using CP12 isoforms, we successfully prepared two types of CROST sensors that displayed different affinities for two major chloroplast Trx isoforms (f-type and m-type). These sensor proteins helped unravel the real-time redox dynamics of Trx molecules in chloroplasts during the light/dark transition.	[Sugiura, Kazunori; Yokochi, Yuichi; Fu, Nae; Fukaya, Yuki; Yoshida, Keisuke; Mihara, Shoko; Hisabori, Toru] Tokyo Inst Technol, Lab Chem & Life Sci, Inst Innovat Res, Midori Ku, Nagatsuta Cho 4259, Yokohama, Kanagawa 2268503, Japan; [Yokochi, Yuichi; Fu, Nae; Yoshida, Keisuke; Mihara, Shoko; Hisabori, Toru] Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Nagatsuta Cho 4259, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Hisabori, T (corresponding author), Tokyo Inst Technol, Lab Chem & Life Sci, Inst Innovat Res, Midori Ku, Nagatsuta Cho 4259, Yokohama, Kanagawa 2268503, Japan.; Hisabori, T (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Nagatsuta Cho 4259, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Mihara, Shoko/AAG-7591-2020; Yoshida, Keisuke/E-5231-2014; Hisabori, Toru/E-5205-2014	Mihara, Shoko/0000-0001-8698-9355; Yoshida, Keisuke/0000-0001-6542-6254; Hisabori, Toru/0000-0003-2046-0277	MEXT-KAKENHI [16H06556]; Dynamic Alliance for Open Innovation Bridging Human, Environment, and Materials	MEXT-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Dynamic Alliance for Open Innovation Bridging Human, Environment, and Materials	This work was supported by MEXT-KAKENHI Grant 16H06556 (to T.H.) and the Dynamic Alliance for Open Innovation Bridging Human, Environment, and Materials. The authors declare that they have no conflicts of interest with the contents of this article.	BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; BUCHANAN BB, 1991, ARCH BIOCHEM BIOPHYS, V288, P1, DOI 10.1016/0003-9861(91)90157-E; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fan YC, 2017, NAT CHEM BIOL, V13, P1045, DOI [10.1038/NCHEMBIO.2417, 10.1038/nchembio.2417]; Fan YC, 2015, ANAL CHEM, V87, P2802, DOI 10.1021/ac5041988; Fu CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115318; Geck RK, 1996, J BIOL CHEM, V271, P24736, DOI 10.1074/jbc.271.40.24736; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Ikegami A, 2007, J BIOL CHEM, V282, P19282, DOI 10.1074/jbc.M703324200; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mihara S, 2018, BIOCHEM J, V475, P1091, DOI 10.1042/BCJ20170869; Mihara S, 2017, PLANT CELL PHYSIOL, V58, P86, DOI 10.1093/pcp/pcw182; MILLS JD, 1982, BIOCHIM BIOPHYS ACTA, V679, P75, DOI 10.1016/0005-2728(82)90257-2; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; SCHEIBE R, 1981, BIOCHIM BIOPHYS ACTA, V636, P58, DOI 10.1016/0005-2728(81)90075-X; Schwarz O, 1997, J BIOL CHEM, V272, P16924, DOI 10.1074/jbc.272.27.16924; Sugiura K, 2019, BBA-GEN SUBJECTS, V1863, P1098, DOI 10.1016/j.bbagen.2019.01.016; Sugiura K, 2015, BIOCHEM BIOPH RES CO, V457, P242, DOI 10.1016/j.bbrc.2014.12.095; Wedel N, 1997, P NATL ACAD SCI USA, V94, P10479, DOI 10.1073/pnas.94.19.10479; Wenderoth I, 1997, J BIOL CHEM, V272, P26985, DOI 10.1074/jbc.272.43.26985; Yoshida K, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7110153; Yoshida K, 2018, P NATL ACAD SCI USA, V115, pEB296, DOI 10.1073/pnas.1808284115; Yoshida K, 2016, P NATL ACAD SCI USA, V113, pE3967, DOI 10.1073/pnas.1604101113; Yoshida K, 2015, J BIOL CHEM, V290, P19540, DOI 10.1074/jbc.A115.647545; Yoshida K, 2014, PLANT CELL PHYSIOL, V55, P1415, DOI 10.1093/pcp/pcu066	29	16	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12091	12098		10.1074/jbc.RA119.007616	http://dx.doi.org/10.1074/jbc.RA119.007616			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31217277	Green Published, hybrid			2022-12-28	WOS:000484284500013
J	Vanoye, CG; Sakakura, M; Follis, RM; Trevisan, AJ; Narayan, M; Li, J; Sanders, CR; Carter, BD				Vanoye, Carlos G.; Sakakura, Masayoshi; Follis, Rose M.; Trevisan, Alexandra J.; Narayan, Malathi; Li, Jun; Sanders, Charles R.; Carter, Bruce D.			Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Schwann cells; Charcot-Marie-Tooth disease (CMT); stromal interaction molecule 1 (STIM1); calcium release-activated calcium channel protein 1 (ORAI1); endoplasmic reticulum stress (ER stress); transient receptor potential channels (TRP channels); gas3; myelin protein; myelination; neuropathy; PMP22_L16P	PATCH-CLAMP TECHNIQUES; SCHWANN-CELLS; CA2+ CHANNELS; HEREDITARY NEUROPATHY; MONOVALENT CATIONS; EPITHELIAL-CELLS; PLASMA-MEMBRANE; PMP22; TREMBLER; MUTATIONS	Charcot-Marie-Tooth (CMT) disease is a peripheral neuropathy associated with gene duplication and point mutations in the peripheral myelin protein 22 (PMP22) gene. However, the role of PMP22 in Schwann cell physiology and the mechanisms by which PMP22 mutations cause CMT are not well-understood. On the basis of homology between PMP22 and proteins associated with modulation of ion channels, we hypothesized that PMP22 alters ion channel activity. Using whole-cell electrophysiology, we show here that heterologous PMP22 expression increases the amplitude of currents similar to those ascribed to store-operated calcium (SOC) channels, particularly those involving transient receptor canonical channel 1 (TrpC1). These channels help replenish Ca2+ in the endoplasmic reticulum (ER) following stimulus-induced depletion. Currents with similar properties were recorded in WT but not pmp22(-/-) mouse Schwann cells. Heterologous expression of the CMT-associated PMP22_L16P variant, which fails to reach the plasma membrane and localizes to the ER, led to larger currents than WT PMP22. Similarly, Schwann cells isolated from Trembler J (TrJ; PMP22_L16P) mice had larger currents than WT littermates. Calcium imaging in live nerves and cultured Schwann cells revealed elevated intracellular Ca2+ in TrJ mice compared with WT. Moreover, we found that PMP22 co-immunoprecipitated with stromal interaction molecule 1 (STIM1), the Ca2+ sensor SOC channel subunit in the ER. These results suggest that in the ER, PMP22 interacts with STIM1 and increases Ca2+ influx through SOC channels. Excess or mutant PMP22 in the ER may elevate intracellular Ca2+ levels, which could contribute to CMT pathology.	[Vanoye, Carlos G.] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Searle 8-519,320 East Super St, Chicago, IL 60611 USA; [Vanoye, Carlos G.; Sanders, Charles R.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Sakakura, Masayoshi; Follis, Rose M.; Trevisan, Alexandra J.; Narayan, Malathi; Sanders, Charles R.; Carter, Bruce D.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Li, Jun] Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA; [Follis, Rose M.; Narayan, Malathi; Li, Jun; Sanders, Charles R.; Carter, Bruce D.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Vanoye, Carlos G.] Vanderbilt Univ, Div Human Genet, Nashville, TN 37232 USA; [Sakakura, Masayoshi] Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA; [Sakakura, Masayoshi] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 2360027, Japan; [Li, Jun] Wayne State Univ, Dept Neurol, Sch Med, Detroit, MI 48201 USA	Northwestern University; Feinberg School of Medicine; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Yokohama City University; Wayne State University	Vanoye, CG (corresponding author), Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Searle 8-519,320 East Super St, Chicago, IL 60611 USA.; Carter, BD (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 625 Light Hall, Nashville, TN 37232 USA.	carlos.vanoye@northwestern.edu; bruce.carter@vanderbilt.edu		, Bruce/0000-0002-3242-6634	National Institutes of Health [R01 NS058815, R01 NS095989, R01NS038220, R01NS102365, R01NS066927]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066927, R01NS095989, R01NS102365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 NS058815 and R01 NS095989 (to C.R.S. and B.C.), R01NS038220 and R01NS102365 (to B.C.), and R01NS066927 (to J.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; Ambudkar IS, 2017, CELL CALCIUM, V63, P33, DOI 10.1016/j.ceca.2016.12.009; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Bugaj V, 2005, J BIOL CHEM, V280, P16790, DOI 10.1074/jbc.M500192200; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Chittoor VG, 2013, ASN NEURO, V5, DOI 10.1042/AN20130024; Colby J, 2000, NEUROBIOL DIS, V7, P561, DOI 10.1006/nbdi.2000.0323; D'Urso D, 1999, J NEUROSCI, V19, P3396; D'Urso D, 1998, J NEUROSCI, V18, P731; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; FABBRETTI E, 1995, GENE DEV, V9, P1846, DOI 10.1101/gad.9.15.1846; Gabreels-Festen A, 1999, ANN NY ACAD SCI, V883, P336, DOI 10.1111/j.1749-6632.1999.tb08595.x; Grandis Marina, 2005, Curr Treat Options Neurol, V7, P23, DOI 10.1007/s11940-005-0003-5; Guo JS, 2014, ANN NEUROL, V75, P255, DOI 10.1002/ana.24086; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYASAKA K, 1992, BIOCHEM BIOPH RES CO, V186, P827, DOI 10.1016/0006-291X(92)90820-B; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jetten AM, 2000, PROG NUCLEIC ACID RE, V64, P97, DOI 10.1016/S0079-6603(00)64003-5; Lee S, 2014, J NEUROSCI, V34, P16140, DOI 10.1523/JNEUROSCI.1908-14.2014; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; LEVRAM V, 1995, J NEUROSCI, V15, P2628; Li J, 2004, MUSCLE NERVE, V29, P205, DOI 10.1002/mus.10521; Li J, 2013, MOL NEUROBIOL, V47, P673, DOI 10.1007/s12035-012-8370-x; Li J, 2012, SEMIN NEUROL, V32, P204, DOI 10.1055/s-0032-1329198; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu X, 2004, J MEMBRANE BIOL, V200, P93, DOI 10.1007/s00232-004-0698-3; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Liu XB, 2003, J BIOL CHEM, V278, P11337, DOI 10.1074/jbc.M213271200; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2001, J BIOL CHEM, V276, P21365, DOI 10.1074/jbc.M102311200; Milius D, 2007, TOXICOLOGY, V238, P60, DOI 10.1016/j.tox.2007.05.028; Mittendorf KF, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700220; Mittendorf KF, 2014, BIOCHEMISTRY-US, V53, P6139, DOI 10.1021/bi500809t; Myers JK, 2008, BIOCHEMISTRY-US, V47, P10620, DOI 10.1021/bi801157p; Naef R, 1999, NEUROBIOL DIS, V6, P1, DOI 10.1006/nbdi.1998.0227; Nobbio L, 2009, J BIOL CHEM, V284, P23146, DOI 10.1074/jbc.M109.027128; Notterpek L, 1999, NEUROBIOL DIS, V6, P450, DOI 10.1006/nbdi.1999.0274; Notterpek L, 2001, P NATL ACAD SCI USA, V98, P14404, DOI 10.1073/pnas.251548398; Okamoto Y, 2013, HUM MOL GENET, V22, P4698, DOI 10.1093/hmg/ddt318; Ong HL, 2017, ADV EXP MED BIOL, V993, P159, DOI 10.1007/978-3-319-57732-6_9; Pareek S, 1997, J NEUROSCI, V17, P7754; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; Roux KJ, 2005, MOL BIOL CELL, V16, P1142, DOI 10.1091/mbc.E04-07-0551; Saitoh N, 2011, J CELL BIOCHEM, V112, P147, DOI 10.1002/jcb.22910; Sakakura M, 2011, STRUCTURE, V19, P1160, DOI 10.1016/j.str.2011.05.009; Sanders CR, 2001, BIOCHEMISTRY-US, V40, P9453, DOI 10.1021/bi010894f; Schlebach JP, 2015, J AM CHEM SOC, V137, P8758, DOI 10.1021/jacs.5b03743; SMITH KJ, 1985, J NEUROL SCI, V71, P19, DOI 10.1016/0022-510X(85)90034-6; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Sociali G, 2016, NEUROBIOL DIS, V95, P145, DOI 10.1016/j.nbd.2016.07.017; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; TIMMERMAN V, 1990, AM J HUM GENET, V47, P680; Tobler AR, 2002, P NATL ACAD SCI USA, V99, P483, DOI 10.1073/pnas.012593399; Tobler AR, 1999, J NEUROSCI, V19, P2027; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Vanoye CG, 1999, AM J PHYSIOL-CELL PH, V276, pC279, DOI 10.1152/ajpcell.1999.276.1.C279; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Worthington RA, 1999, ELECTROPHORESIS, V20, P2065; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004; Zhang Y, 1998, J PHYSIOL-LONDON, V508, P763, DOI 10.1111/j.1469-7793.1998.763bp.x; ZOIDL G, 1995, EMBO J, V14, P1122, DOI 10.1002/j.1460-2075.1995.tb07095.x	69	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12054	12065		10.1074/jbc.RA118.006248	http://dx.doi.org/10.1074/jbc.RA118.006248			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31213528	Green Published, hybrid			2022-12-28	WOS:000484284500010
J	Mopidevi, B; Kaw, MK; Sivankutty, I; Jain, S; Perla, SK; Kumar, A				Mopidevi, Brahmaraju; Kaw, Meenakshi K.; Sivankutty, Indu; Jain, Sudhir; Perla, Sravan Kumar; Kumar, Ashok			A polymorphism in intron I of the human angiotensinogen gene (hAGT) affects binding by HNF3 and hAGT expression and increases blood pressure in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transgenic mice; hypertension; genetics; angiotensin; single-nucleotide polymorphism (SNP); gene expression; cardiovascular disease; renin angiotensin system; vasopressor agent	TRANSGENIC MICE; TRANSCRIPTIONAL REGULATION; HUMAN HYPERTENSION; ASSOCIATION; HAPLOTYPE; RECEPTOR; C/EBP; RENIN; PROMOTER; ISOFORMS	Angiotensinogen (AGT) is the precursor of one of the most potent vasoconstrictors, peptide angiotensin II. Genome-wide association studies have shown that two A/G polymorphisms (rs2493134 and rs2004776), located at +507 and +1164 in intron I of the human AGT (hAGT) gene, are associated with hypertension. Polymorphisms of the AGT gene result in two main haplotypes. Hap-I contains the variants -217A, -6A, +507G, and +1164A and is pro-hypertensive, whereas Hap-II contains the variants -217G, -6G, +507A, and +1164G and does not affect blood pressure. The nucleotide sequence of intron I of the hAGT gene containing the +1164A variant has a stronger homology with the hepatocyte nuclear factor 3 (HNF3)-binding site than +1164G. Here we found that an oligonucleotide containing +1164A binds HNF3 beta more strongly than +1164G and that Hap-I-containing reporter gene constructs have increased basal and HNF3- and glucocorticoid-induced promoter activity in transiently transfected liver and kidney cells. Using a knock-in approach at the hypoxanthine-guanine phosphoribosyltransferase locus, we generated a transgenic mouse model containing the human renin (hREN) gene and either Hap-I or Hap-II. We show that transgenic animals containing Hap-I have increased blood pressure compared with those containing Hap-II. Moreover, the transcription factors glucocorticoid receptor, CCAAT enhancer-binding protein beta, and HNF3 beta bound more strongly to chromatin obtained from the liver of transgenic animals containing Hap-I than to liver chromatin from Hap-II-containing animals. These findings suggest that, unlike Hap-II variants, Hap-I variants of the hAGT gene have increased transcription rates, resulting in elevated blood pressure.	[Mopidevi, Brahmaraju; Sivankutty, Indu; Jain, Sudhir; Perla, Sravan Kumar; Kumar, Ashok] New York Med Coll, Dept Pathol, Basic Sci Bldg, Valhalla, NY 10595 USA; [Kaw, Meenakshi K.] Univ Toledo, Dept Physiol & Pharmacol, Toledo, OH 43614 USA	New York Medical College; University of Toledo	Kumar, A (corresponding author), New York Med Coll, Dept Pathol, Basic Sci Bldg, Valhalla, NY 10595 USA.	akumar5@nymc.edu	Mopidevi, Brahmaraju/D-6003-2015	Mopidevi, Brahmaraju/0000-0003-1231-7796	Norris Cotton Cancer Center Shared Grant [P30CA023108]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122742, R01HL130344] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD025170] Funding Source: NIH RePORTER	Norris Cotton Cancer Center Shared Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Transgenic animals were made at Dartmouth Medical Center. We acknowledge help from the Dartmouth Mouse Modeling Shared Resource, which receives support from Norris Cotton Cancer Center Shared Grant P30CA023108.	ALAM T, 1993, J BIOL CHEM, V268, P15681; Bai X, 2017, J CLIN INVEST, V127, P670, DOI 10.1172/JCI88899; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Corvol P, 1997, PATHOL BIOL, V45, P229; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Evangelou E, 2018, NAT GENET, V50, P1412, DOI 10.1038/s41588-018-0205-x; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Galis ZS, 2013, HYPERTENSION, V61, P757, DOI 10.1161/HYPERTENSIONAHA.111.00770; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; HATAE T, 1994, MOL CELL BIOCHEM, V131, P43, DOI 10.1007/BF01075723; INOUE I, 1995, J BIOL CHEM, V270, P11430, DOI 10.1074/jbc.270.19.11430; Iwafuchi-Doi M, 2016, MOL CELL, V62, P79, DOI 10.1016/j.molcel.2016.03.001; IWAI N, 1995, HYPERTENSION, V25, P688, DOI 10.1161/01.HYP.25.4.688; Jain S, 2010, J BIOL CHEM, V285, P41172, DOI 10.1074/jbc.M110.167585; Jain S, 2008, AM J PHYSIOL-REG I, V295, pR1849, DOI 10.1152/ajpregu.90637.2008; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Johnson AD, 2011, HYPERTENSION, V57, P903, DOI 10.1161/HYPERTENSIONAHA.110.158667; Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013; Kayima J, 2017, CLIN GENET, V92, P487, DOI 10.1111/cge.12974; Kretowski A, 2007, DIABETES, V56, P863, DOI 10.2337/db06-1321; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; Mopidevi B, 2015, CIRC-CARDIOVASC GENE, V8, P30, DOI 10.1161/CIRCGENETICS.114.000694; Mopidevi B, 2013, PHYSIOL GENOMICS, V45, P901, DOI 10.1152/physiolgenomics.00056.2013; Nejatizadeh A, 2008, J HYPERTENS, V26, P1094, DOI 10.1097/HJH.0b013e3282fad951; Padmanabhan S, 2015, CIRC RES, V116, P937, DOI 10.1161/CIRCRESAHA.116.303647; Rana A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176373; Rasmussen-Torvik LJ, 2005, HYPERTENSION, V46, P1294, DOI 10.1161/01.HYP.0000192653.17209.84; Schmidt H, 2004, STROKE, V35, P2592, DOI 10.1161/01.STR.0000144646.96121.d2; Schmidt H, 2001, STROKE, V32, P405, DOI 10.1161/01.STR.32.2.405; Seidel E, 2017, PHYSIOL GENOMICS, V49, P630, DOI 10.1152/physiolgenomics.00032.2017; Simino J, 2014, AM J HUM GENET, V95, P24, DOI 10.1016/j.ajhg.2014.05.010; Watkins WS, 2010, J HYPERTENS, V28, P65, DOI 10.1097/HJH.0b013e328332031a; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	44	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11829	11839		10.1074/jbc.RA119.007715	http://dx.doi.org/10.1074/jbc.RA119.007715			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31201268	Green Published, hybrid			2022-12-28	WOS:000486127800019
J	Brady, S; Singh, G; Bolinger, C; Song, ZW; Boeras, I; Weng, KX; Trent, B; Brown, WC; Singh, K; Boris-Lawrie, K; Heng, X				Brady, Samantha; Singh, Gatikrushna; Bolinger, Cheryl; Song, Zhenwei; Boeras, Ioana; Weng, Kexin; Trent, Bria; Brown, William Clay; Singh, Kamalendra; Boris-Lawrie, Kathleen; Heng, Xiao			Virion-associated, host-derived DHX9/RNA helicase A enhances the processivity of HIV-1 reverse transcriptase on genomic RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); reverse transcription; processivity; viral replication; RNA helicase; host-pathogen interaction; DNA synthesis; DHX9; RHA; lymphocyte infection; Primer; primer extension; Template	TYPE-1 NUCLEOCAPSID PROTEIN; STRAND DNA-SYNTHESIS; A INTERACTS; VIRAL-RNA; VIRUS; INITIATION; BINDING; REPLICATION; TRANSLATION; ELONGATION	DHX9/RNA helicase A (RHA) is a host RNA helicase that participates in many critical steps of the HIV-1 life cycle. It co-assembles with the viral RNA genome into the capsid core. Virions deficient in RHA are less infectious as a result of reduced reverse transcription efficiency, demonstrating that the virion-associated RHA promotes reverse transcription before the virion gains access to the new host's RHA. Here, we quantified reverse-transcription intermediates in HIV-1-infected T cells to clarify the mechanism by which RHA enhances HIV-1 reverse transcription efficiency. Consistently, purified recombinant human RHA promoted reverse transcription efficiency under in vitro conditions that mimic the early reverse transcription steps prior to capsid core uncoating. We did not observe RHA-mediated structural remodeling of the tRNA(Lys3)-viral RNA-annealed complex. RHA did not enhance the DNA synthesis rate until incorporation of the first few nucleotides, suggesting that RHA participates primarily in the elongation phase of reverse transcription. Pre-steady-state and steady-state kinetic studies revealed that RHA has little impact on the kinetics of single-nucleotide incorporation. Primer extension assays performed in the presence of trap dsDNA disclosed that RHA enhances the processivity of HIV-1 reverse transcriptase (RT). The biochemical assays used here effectively reflected and explained the low RT activity in HIV-1 virions produced from RHA-depleted cells. Moreover, RT activity in our assays indicated that RHA in HIV-1 virions is required for the efficient catalysis of (-)cDNA synthesis during viral infection before capsid uncoating. Our study identifies RHA as a processivity factor of HIV-1 RT.	[Brady, Samantha; Song, Zhenwei; Weng, Kexin; Trent, Bria; Heng, Xiao] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Singh, Kamalendra] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Brady, Samantha; Song, Zhenwei; Weng, Kexin; Trent, Bria; Heng, Xiao] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Singh, Gatikrushna; Boeras, Ioana; Boris-Lawrie, Kathleen] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Bolinger, Cheryl; Boris-Lawrie, Kathleen] Ohio State Univ, pt Vet Biosci, Columbus, OH 43210 USA; [Brown, William Clay] Univ Michigan, Life Sci Inst, Ctr Struct Biol, Ann Arbor, MI 48109 USA; [Bolinger, Cheryl] Intrexon Corp, Gaithersburg, MD 20876 USA; [Boeras, Ioana] Lucian Blaga Univ, Coll Sci, Sibiu 550012, Romania	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Lucian Blaga University of Sibiu	Heng, X (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.; Heng, X (corresponding author), Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.; Boris-Lawrie, K (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.; Boris-Lawrie, K (corresponding author), Ohio State Univ, pt Vet Biosci, Columbus, OH 43210 USA.	kbl@umn.edu; hengx@missouri.edu	Boris-Lawrie, Kathleen/AAB-8953-2020; Song, Zhenwei/W-6191-2019; Boeras, Ioana/L-5822-2018; Boeras, Ioana/GRJ-8087-2022	Boris-Lawrie, Kathleen/0000-0001-6366-6270; Song, Zhenwei/0000-0002-9679-5113; Brady, Samantha/0000-0002-8319-8977; Boeras, Ioana/0000-0002-1952-5654	National Institutes of Health [R01AI150460, R01GM119932, R01CA108882]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI150460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01AI150460 (reassigned from R01GM119932; to X. H. and K.-B.-L.) and R01CA108882 (to K. B.-L). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arts EJ, 1996, P NATL ACAD SCI USA, V93, P10063, DOI 10.1073/pnas.93.19.10063; Boeras I, 2016, J MOL BIOL, V428, P2418, DOI 10.1016/j.jmb.2016.04.011; Bolinger C, 2007, NUCLEIC ACIDS RES, V35, P2629, DOI 10.1093/nar/gkm124; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; Butsch M, 2000, J VIROL, V74, P11531, DOI 10.1128/JVI.74.24.11531-11537.2000; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Coffin J, 1997, RETROVIRUSES; Cosnefroy O, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0292-7; Derebail SS, 2004, J BIOL CHEM, V279, P47446, DOI 10.1074/jbc.M408927200; Driscoll MD, 2000, J VIROL, V74, P8785, DOI 10.1128/JVI.74.19.8785-8792.2000; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Guo F, 2009, J VIROL, V83, P8099, DOI 10.1128/JVI.00488-09; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Heng X, 2012, J MOL BIOL, V417, P224, DOI 10.1016/j.jmb.2012.01.033; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; Kadare G, 1997, J VIROL, V71, P2583; KARPEL RL, 1987, J BIOL CHEM, V262, P4961; KATI WM, 1992, J BIOL CHEM, V267, P25988; Keane SC, 2015, SCIENCE, V348, P917, DOI 10.1126/science.aaa9266; Koh HR, 2014, NUCLEIC ACIDS RES, V42, P8556, DOI 10.1093/nar/gku523; Kovalev N, 2012, VIROLOGY, V432, P470, DOI 10.1016/j.virol.2012.06.030; Kovalev N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002537; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Lahaye X, 2015, CURR OPIN VIROL, V11, P55, DOI 10.1016/j.coviro.2015.01.013; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lanchy JM, 1998, J BIOL CHEM, V273, P24425, DOI 10.1074/jbc.273.38.24425; Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x; Lanchy JM, 1996, BIOCHIMIE, V78, P1087, DOI 10.1016/S0300-9084(97)86734-X; Lanciault C, 2006, J VIROL, V80, P2483, DOI 10.1128/JVI.80.5.2483-2494.2006; Langston LD, 2006, MOL CELL, V23, P155, DOI 10.1016/j.molcel.2006.05.034; LEE CG, 1992, J BIOL CHEM, V267, P4398; Lelek M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7483; Li XG, 1996, J VIROL, V70, P4996, DOI 10.1128/JVI.70.8.4996-5004.1996; Lin L, 2012, J VIROL, V86, P1942, DOI 10.1128/JVI.06362-11; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; Mamede JI, 2017, P NATL ACAD SCI USA, V114, pE7169, DOI 10.1073/pnas.1706245114; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001; Mbisa Jean L., 2009, V485, P55, DOI 10.1007/978-1-59745-170-3_5; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Ndongwe TP, 2012, NUCLEIC ACIDS RES, V40, P345, DOI 10.1093/nar/gkr694; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Piekna-Przybylska D, 2014, BIOCHEMISTRY-US, V53, P2581, DOI 10.1021/bi4016692; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; Ranji A, 2011, J BIOL CHEM, V286, P5328, DOI 10.1074/jbc.M110.176339; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Roy BB, 2006, J BIOL CHEM, V281, P12625, DOI 10.1074/jbc.M510596200; Santos S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-65; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schutz P, 2010, J MOL BIOL, V400, P768, DOI 10.1016/j.jmb.2010.05.046; Seif E, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0171-7; Sharma A, 2012, METHOD ENZYMOL, V511, P405, DOI 10.1016/B978-0-12-396546-2.00019-X; Singh G., 2018, RETROVIRUS CELL INTE, P253; Singh K, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.398180; Stephenson ST, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-107; Tanner JA, 2003, J BIOL CHEM, V278, P39578, DOI 10.1074/jbc.C300328200; VENCZEL EA, 1993, BIOCHEMISTRY-US, V32, P6220, DOI 10.1021/bi00075a015; Wang XX, 2012, J VIROL, V86, P3777, DOI 10.1128/JVI.06594-11; Warren K, 2009, VIRUSES-BASEL, V1, P873, DOI 10.3390/v1030873; Xia HJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005067; Xing L, 2011, J VIROL, V85, P1847, DOI 10.1128/JVI.02010-10; Zhang SS, 1997, J BIOL CHEM, V272, P11487	65	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11473	11485		10.1074/jbc.RA119.007679	http://dx.doi.org/10.1074/jbc.RA119.007679			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31175158	hybrid, Green Published			2022-12-28	WOS:000478717600011
J	Wu, SY; Ma, SM; Yin, XL; Yi, P; Liu, JF				Wu, Shiyong; Ma, Shumin; Yin, Xueliang; Yi, Ping; Liu, Jianfeng			An integrated PKD1-dependent signaling network amplifies IRE1 prosurvival signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); protein kinase D (PKD); c-Jun N-terminal kinase (JNK); cell death; signal transduction; IRE1; MKP1	PROTEIN-KINASE-D; N-TERMINAL KINASE; ER STRESS SENSOR; UNFOLDED PROTEIN; ENDOPLASMIC-RETICULUM; CELL FATE; MESSENGER-RNA; ACTIVATION; APOPTOSIS; JNK1	Following the accumulation of improperly folded proteins in the endoplasmic reticulum (ER), a condition known as ER stress in this compartment triggers an adaptive signaling pathway referred to as the unfolded protein response (UPR). The UPR aims at restoring ER homeostasis; if the ER stress cannot be resolved, apoptosis is triggered. However, the mechanisms responsible for regulating the balance between cell life and death decisions that occur after exposure to ER stress remain unclear. Protein kinase D1 (PKD1) has been reported to initiate protective signaling against oxidative stress or ischemia, two conditions that impinge on the induction of ER stress. In addition, the high levels of expression of PKD1, observed in highly proliferative cancers and tumors with poor prognosis, contribute to enhanced resistance to chemotherapy. In this study, we show that the ER stress inducers tunicamycin and thapsigargin lead to the activation of PKD1 in human prostate cancer PC-3 cells and in hepatoma HepG2 cells through a PKC delta-dependent mechanism. Moreover, our data indicate that PKD1 is required for the stabilization of inositol-requiring enzyme 1 (IRE1) and the subsequent regulation of its activity. PKD1 activation contributes to the phosphorylation of mitogen-activated protein kinase phosphatase 1, resulting in decreased IRE1-mediated c-Jun N-terminal kinase activation. This study unveils the existence of a novel PKD1-dependent prosurvival mechanism that is activated upon ER stress and selectively enhances IRE1 prosurvival signaling.	[Wu, Shiyong; Ma, Shumin; Yin, Xueliang; Yi, Ping; Liu, Jianfeng] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Yi, P; Liu, JF (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.	pingy@hust.edu.cn; jfliu@hust.edu.cn		Yi, Ping/0000-0002-6954-102X	National Natural Science Foundation of China [31371423, 81720108031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31371423 and 81720108031. The authors declare that they have no conflicts of interest with the contents of this article.	Arensdorf Angela M., 2013, Frontiers in Genetics, V4, P256, DOI 10.3389/fgene.2013.00256; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bagowski CP, 1999, EMBO J, V18, P5567, DOI 10.1093/emboj/18.20.5567; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Caruso ME, 2008, MOL CELL BIOL, V28, P4261, DOI 10.1128/MCB.02252-07; Charonis AS, 2017, J CELL MOL MED, V21, P3141, DOI 10.1111/jcmm.13413; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dieterich S, 1996, FEBS LETT, V381, P183, DOI 10.1016/0014-5793(96)00116-0; Eisenberg-Lerner A, 2007, CELL DEATH DIFFER, V14, P1908, DOI 10.1038/sj.cdd.4402212; Eisenberg-Lerner A, 2012, CELL DEATH DIFFER, V19, P788, DOI 10.1038/cdd.2011.149; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Hurd C, 2002, ONCOGENE, V21, P2154, DOI 10.1038/sj.onc.1205290; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Larroque-Cardoso P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.47; Li B, 2013, BIOCHEM J, V452, P139, DOI 10.1042/BJ20121671; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Marza E, 2015, EMBO REP, V16, P332, DOI 10.15252/embr.201439123; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Plastira I, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1024-1; Qi X, 2008, J CELL SCI, V121, P804, DOI 10.1242/jcs.024653; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Solier S, 2012, P NATL ACAD SCI USA, V109, P12866, DOI 10.1073/pnas.1203617109; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2012, CELL SIGNALING & MOLECULAR TARGETS IN CANCER, P245, DOI 10.1007/978-1-4614-0730-0_11; Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266; Tavernier SJ, 2017, NAT CELL BIOL, V19, P698, DOI 10.1038/ncb3518; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang HZ, 2015, J CELL SCI, V128, P100, DOI 10.1242/jcs.155101; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Xu XH, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/817604; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200	54	3	3	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11119	11130		10.1074/jbc.RA118.003311	http://dx.doi.org/10.1074/jbc.RA118.003311			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167779	Green Published, hybrid			2022-12-28	WOS:000478717400006
J	Yang, CP; Zeng, F; Gao, XY; Zhao, SJ; Li, X; Liu, S; Li, N; Deng, CL; Zhang, B; Gong, R				Yang, Chunpeng; Zeng, Fang; Gao, Xinyu; Zhao, Shaojuan; Li, Xuan; Liu, Sheng; Li, Na; Deng, Chenglin; Zhang, Bo; Gong, Rui			Characterization of two engineered dimeric Zika virus envelope proteins as immunogens for neutralizing antibody selection and vaccine design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; vaccine; flavivirus; dimerization; protein structure; dimer; envelope protein; Fc fragment; quaternary epitope; Zika virus; immunogen; neutralizing antibody; vaccine development; Flaviviridae; neurological disease	STRUCTURAL BIOLOGY; DENGUE; MATURATION; POTENT; BRAZIL	The envelope protein of Zika virus (ZIKV) exists as a dimer on the mature viral surface and is an attractive antiviral target because it mediates viral entry. However, recombinant soluble wild-type ZIKV envelope (wtZE) might preferentially exist as monomer (monZE). Recently, it has been shown that the A264C substitution could promote formation of dimeric ZIKV envelope protein (ZE(A264C)), requiring further characterization of purified ZE(A264C) for its potential applications in vaccine development. We also noted that ZE(A264C), connected by disulfide bond, might be different from the noncovalent native envelope dimer on the virion surface. Because the antibody Fc fragment exists as dimer and is widely used for fusion protein construction, here we fused wtZE to human immunoglobulin G1 (IgG1) Fc fragment (ZE-Fc) for noncovalent wtZE dimerization. Using a multistep purification procedure, we separated dimeric ZE(A264C) and ZE-Fc, revealing that they both exhibit typical beta-sheet-rich secondary structures and stabilities similar to those of monZE. The binding activities of monZE, ZE(A264C), and ZE-Fc to neutralizing antibodies targeting different epitopes indicated that ZE(A264C) and ZE-Fc could better mimic the native dimeric status, especially in terms of the formation of tertiary and quaternary epitopes. Both ZE(A264C) and ZE-Fc recognize a ZIKV-sensitive cell line as does monZE, indicating that the two constructs are still functional. Furthermore, a murine immunization assay disclose that ZE(A264C) and ZE-Fc elicit more neutralizing antibody responses than monZE does. These results suggest that the two immunogen candidates ZE(A264C) and ZE-Fc have potential utility for neutralizing antibody selection and vaccine design against ZIKV.	[Yang, Chunpeng; Zeng, Fang; Gao, Xinyu; Zhao, Shaojuan; Li, Xuan; Li, Na; Deng, Chenglin; Zhang, Bo; Gong, Rui] Chinese Acad Sci, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China; [Yang, Chunpeng; Zeng, Fang; Gao, Xinyu; Zhao, Shaojuan; Li, Na] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Liu, Sheng] Huazhong Univ Sci & Technol, Key Lab Biomed Photon MOE, Wuhan Natl Lab Optoelect Hubei Bioinformat, Coll Life Sci & Technol,Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China; [Liu, Sheng] Huazhong Univ Sci & Technol, Mol Imaging Key Lab Syst, Coll Life Sci & Technol, Syst Biol Theme,Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Gong, R (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China.	gongr@wh.iov.cn			Core Facility and Technical Support, Wuhan Institute of Virology, Chinese Academy of Sciences; Wuhan Institute of Biotechnology; Wuhan Key Laboratory on Emerging Infectious Diseases and Biosafety; Wuhan National Bio-Safety Level 4 Lab of the Chinese Academy of Sciences	Core Facility and Technical Support, Wuhan Institute of Virology, Chinese Academy of Sciences; Wuhan Institute of Biotechnology; Wuhan Key Laboratory on Emerging Infectious Diseases and Biosafety; Wuhan National Bio-Safety Level 4 Lab of the Chinese Academy of Sciences	We are thankful to the Core Facility and Technical Support, Wuhan Institute of Virology, Chinese Academy of Sciences; Wuhan Institute of Biotechnology; Wuhan Key Laboratory on Emerging Infectious Diseases and Biosafety; as well as Wuhan National Bio-Safety Level 4 Lab of the Chinese Academy of Sciences for the support.	Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005; Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3; Blazevic J, 2016, J VIROL, V90, P6365, DOI 10.1128/JVI.00447-16; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5; Chao LH, 2014, ELIFE, V3, DOI 10.7554/eLife.04389; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; de Oliveira WK, 2017, LANCET, V390, P861, DOI [10.1016/S0140-6736(17)31368-5, 10.1016/s0140-6736(17)31368-5]; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5; Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8; Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004; Liu LM, 2018, PROTEIN CELL, V9, P15, DOI 10.1007/s13238-017-0408-4; Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553; Medin CL, 2017, ARCH PATHOL LAB MED, V141, P33, DOI 10.5858/arpa.2016-0409-RA; Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166; Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6; Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469; Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001; Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006; Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79; Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406; Yang CP, 2019, VIROL SIN, V34, P168, DOI 10.1007/s12250-019-00093-5; Yang CP, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01860; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742; Zeng F, 2018, J BIOL CHEM, V293, P19127, DOI 10.1074/jbc.RA118.005367; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	43	5	5	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10638	10648		10.1074/jbc.RA119.007443	http://dx.doi.org/10.1074/jbc.RA119.007443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138647	Green Published, hybrid			2022-12-28	WOS:000478717100022
J	Chowdhury, M; Li, CF; He, Z; Lu, YZ; Liu, XS; Wang, YF; Ip, YT; Strand, MR; Yu, XQ				Chowdhury, Munmun; Li, Chun-Feng; He, Zhen; Lu, Yuzhen; Liu, Xu-Sheng; Wang, Yu-Feng; Ip, Y. Tony; Strand, Michael R.; Yu, Xiao-Qiang			Toll family members bind multiple Spatzle proteins and activate antimicrobial peptide gene expression in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); insect immunity; signal transduction; toll receptor; gene regulation; cytokine response; sex-specific difference; Spatzle	HOST-DEFENSE; ANTIVIRAL AUTOPHAGY; TOBACCO HORNWORM; RECEPTORS; RECOGNITION; PATHWAY; DORSAL; MELANOGASTER; ANTIFUNGAL; 18-WHEELER	The Toll signaling pathway in Drosophila melanogaster regulates several immune-related functions, including the expression of antimicrobial peptide (AMP) genes. The canonical Toll receptor (Toll-1) is activated by the cytokine Spatzle (Spz-1), but Drosophila encodes eight other Toll genes and five other Spz genes whose interactions with one another and associated functions are less well-understood. Here, we conducted in vitro assays in the Drosophila S2 cell line with the Toll/interleukin-1 receptor (TIR) homology domains of each Toll family member to determine whether they can activate a known target of Toll-1, the promoter of the antifungal peptide gene drosomycin. All TIR family members activated the drosomycin promoter, with Toll-1 and Toll-7 TIRs producing the highest activation. We found that the Toll-1 and Toll-7 ectodomains bind Spz-1, -2, and -5, and also vesicular stomatitis virus (VSV) virions, and that Spz-1, -2, -5, and VSV all activated the promoters of drosomycin and several other AMP genes in S2 cells expressing full-length Toll-1 or Toll-7. In vivo experiments indicated that Toll-1 and Toll-7 mutants could be systemically infected with two bacterial species (Enterococcus faecalis and Pseudomonas aeruginosa), the opportunistic fungal pathogen Candida albicans, and VSV with different survival times in adult females and males compared with WT fly survival. Our results suggest that all Toll family members can activate several AMP genes. Our results further indicate that Toll-1 and Toll-7 bind multiple Spz proteins and also VSV, but they differentially affect adult survival after systemic infection, potentially because of sex-specific differences in Toll-1 and Toll-7 expression.	[Chowdhury, Munmun; Li, Chun-Feng; He, Zhen; Yu, Xiao-Qiang] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA; [He, Zhen; Liu, Xu-Sheng; Wang, Yu-Feng; Yu, Xiao-Qiang] Cent China Normal Univ, Sch Life Sci, Wuhan 430079, Hubei, Peoples R China; [Lu, Yuzhen; Yu, Xiao-Qiang] South China Normal Univ, Guangzhou Key Lab Insect Dev Regulat & Applicat R, Inst Insect Sci & Technol, Guangzhou 510631, Guangdong, Peoples R China; [Lu, Yuzhen; Yu, Xiao-Qiang] South China Normal Univ, Sch Life Sci, Guangzhou 510631, Guangdong, Peoples R China; [Li, Chun-Feng] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Strand, Michael R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Ip, Y. Tony] Univ Massachusetts, Program Mol Med, Med Sch, Worcester, MA 01605 USA	University of Missouri System; University of Missouri Kansas City; Central China Normal University; South China Normal University; South China Normal University; Southwest University - China; University System of Georgia; University of Georgia; University of Massachusetts System; University of Massachusetts Worcester	Yu, XQ (corresponding author), Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA.; Strand, MR (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	mrstrand@uga.edu; Yux@umkc.edu	YU, XIAO-QIANG/AAL-1797-2021; Chowdhury, Munmun/W-2090-2019; YU, XiaoQiang/GRJ-1077-2022; Li, Chunfeng/ABD-8502-2020	YU, XIAO-QIANG/0000-0003-1419-9009; 	University of Missouri-Kansas City Funding for Excellence; National Natural Science Foundation of China [31472019]	University of Missouri-Kansas City Funding for Excellence; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the University of Missouri-Kansas City Funding for Excellence and National Natural Science Foundation of China Grant 31472019. The authors declare that they have no conflicts of interest with the contents of this article.	Akhouayri I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002319; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065; Bettencourt R, 2004, J ENDOTOXIN RES, V10, P261, DOI 10.1179/096805104225004897; Bilak H, 2003, BIOCHEM SOC T, V31, P648, DOI 10.1042/bst0310648; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; Heinrich BS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000958; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jin MS, 2008, CURR OPIN IMMUNOL, V20, P414, DOI 10.1016/j.coi.2008.06.002; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lamiable O, 2016, J VIROL, V90, P5415, DOI 10.1128/JVI.00238-16; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Ligoxygakis P, 2002, EMBO REP, V3, P666, DOI 10.1093/embo-reports/kvf130; Lionakis Michail S, 2012, Methods Mol Biol, V845, P455, DOI 10.1007/978-1-61779-539-8_32; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo C, 2001, INSECT MOL BIOL, V10, P457, DOI 10.1046/j.0962-1075.2001.00284.x; McIlroy G, 2013, NAT NEUROSCI, V16, P1248, DOI 10.1038/nn.3474; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; Narbonne-Reveau K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017470; Ooi JY, 2002, EMBO REP, V3, P82, DOI 10.1093/embo-reports/kvf004; Parthier C, 2014, P NATL ACAD SCI USA, V111, P6281, DOI 10.1073/pnas.1320678111; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; Yagi Y, 2010, DEV GROWTH DIFFER, V52, P771, DOI 10.1111/j.1440-169X.2010.01213.x; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Zhong X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02830-w; Zhong X, 2016, SCI REP-UK, V6, DOI 10.1038/srep20654; Zhong X, 2012, INSECT BIOCHEM MOLEC, V42, P514, DOI 10.1016/j.ibmb.2012.03.009	44	29	32	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10172	10181		10.1074/jbc.RA118.006804	http://dx.doi.org/10.1074/jbc.RA118.006804			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31088910	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000474445600011
J	Hailemariam, S; Kumar, S; Burgers, PM				Hailemariam, Sarem; Kumar, Sandeep; Burgers, Peter M.			Activation of Tel1(ATM) kinase requires Rad50 ATPase and long nucleosome-free DNA but no DNA ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						checkpoint control; phosphorylation; DNA damage response; ataxia telangiectasia; PI3K; ATM; MRN; MRX	STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; ATM ACTIVATION; PROTEIN-KINASE; CONFORMATIONAL-CHANGES; NUCLEASE ACTIVITIES; BUDDING YEAST; COMPLEX; MRE11; CHECKPOINT	In Saccharomyces cerevisiae, Tel1 protein kinase, the ortholog of human ataxia telangiectasia-mutated (ATM), is activated in response to DNA double-strand breaks. Biochemical studies with human ATM and genetic studies in yeast suggest that recruitment and activation of Tel1(ATM) depends on the heterotrimeric MRXMRN complex, composed of Mre11, Rad50, and Xrs2 (human Nbs1). However, the mechanism of activation of Tel1 by MRX remains unclear, as does the role of effector DNA. Here we demonstrate that dsDNA and MRX activate Tel1 synergistically. Although minimal activation was observed with 80-mer duplex DNA, the optimal effector for Tel1 activation is long, nucleosome-free DNA. However, there is no requirement for DNA double-stranded termini. The ATPase activity of Rad50 is critical for activation. In addition to DNA and Rad50, either Mre11 or Xrs2, but not both, is also required. Each of the three MRX subunits shows a physical association with Tel1. Our study provides a model of how the individual subunits of MRX and DNA regulate Tel1 kinase activity.	[Hailemariam, Sarem; Kumar, Sandeep; Burgers, Peter M.] Washington Univ, Dept Biochem & Mol Biophys, Sch Med, St Louis, MO 63110 USA; [Kumar, Sandeep] Intellia Therapeut, Cambridge, MA 02139 USA	Washington University (WUSTL)	Burgers, PM (corresponding author), Washington Univ, Dept Biochem & Mol Biophys, Sch Med, St Louis, MO 63110 USA.	burgers@wustl.edu	Burgers, Peter M/AAW-6621-2021		NIGMS, National Institutes of Health [GM118129]; National Science Foundation [2014157291]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118129] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIGMS, National Institutes of Health Grant GM118129 (to P. M. B.) and National Science Foundation Graduate Research Fellowship 2014157291 (to S. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Adelman CA, 2009, CELL CYCLE, V8, P1510, DOI 10.4161/cc.8.10.8380; Anderson DE, 2001, J BIOL CHEM, V276, P37027, DOI 10.1074/jbc.M106179200; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Bylund GO, 2006, METHOD ENZYMOL, V409, P1, DOI 10.1016/S0076-6879(05)09001-4; Cassani C, 2019, NUCLEIC ACIDS RES, V47, P3550, DOI 10.1093/nar/gkz038; Chen L, 2005, J BIOL CHEM, V280, P2620, DOI 10.1074/jbc.M410192200; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Deshpande RA, 2017, NUCLEIC ACIDS RES, V45, P5255, DOI 10.1093/nar/gkx173; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lau WCY, 2016, CELL CYCLE, V15, P1117, DOI 10.1080/15384101.2016.1158362; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee JH, 2013, J BIOL CHEM, V288, P12840, DOI 10.1074/jbc.M113.460378; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Mallory JC, 2000, P NATL ACAD SCI USA, V97, P13749, DOI 10.1073/pnas.250475697; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Myler LR, 2017, MOL CELL, V67, P891, DOI 10.1016/j.molcel.2017.08.002; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Ogi H, 2015, MOL BIOL CELL, V26, P3480, DOI 10.1091/mbc.E15-05-0259; Oh J, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120589; Oh J, 2016, MOL CELL, V64, P405, DOI 10.1016/j.molcel.2016.09.011; Osley MA, 2006, TRENDS GENET, V22, P671, DOI 10.1016/j.tig.2006.09.007; Paull TT, 2018, MOL CELL, V71, P419, DOI 10.1016/j.molcel.2018.06.033; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; POLTORATSKY VP, 1995, J IMMUNOL, V155, P4529; RAYMOND WE, 1993, NUCLEIC ACIDS RES, V21, P3851, DOI 10.1093/nar/21.16.3851; Reginato G, 2017, GENE DEV, V31, P2325, DOI 10.1101/gad.308254.117; Reid RJD, 2011, GENOME RES, V21, P477, DOI 10.1101/gr.109033.110; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Sawicka M, 2016, J BIOL CHEM, V291, P13436, DOI 10.1074/jbc.M115.708263; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Usui T, 2009, MOL CELL, V33, P147, DOI 10.1016/j.molcel.2008.12.022; van der Linden E, 2009, NUCLEIC ACIDS RES, V37, P1580, DOI 10.1093/nar/gkn1072; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11655; Wanrooij PH, 2016, J BIOL CHEM, V291, P393, DOI 10.1074/jbc.M115.687145; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	67	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10120	10130		10.1074/jbc.RA119.008410	http://dx.doi.org/10.1074/jbc.RA119.008410			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31073030	Green Published, hybrid			2022-12-28	WOS:000474445600007
J	Sambri, I; Capasso, R; Pucci, P; Perna, AF; Ingrosso, D				Sambri, Irene; Capasso, Rosanna; Pucci, Piero; Perna, Alessandra F.; Ingrosso, Diego			RETRACTION: The microRNA 15a/16-1 cluster down-regulates protein repair isoaspartyl methyltransferase in hepatoma cells: Implications for apoptosis regulation (Retraction of Vol 286, Pg 43690, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Ingrosso, Diego/AHE-4980-2022; Perna, Alessandra F/AAC-3952-2022					Sambri I, 2011, J BIOL CHEM, V286, P43690, DOI 10.1074/jbc.M111.290437	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8350	8350		10.1074/jbc.RX119.009146	http://dx.doi.org/10.1074/jbc.RX119.009146			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	31127062	hybrid, Green Published			2022-12-28	WOS:000471108200005
J	Jobin, PG; Solis, N; Machado, Y; Bell, PA; Kwon, NH; Kim, S; Overall, CM; Butler, GS				Jobin, Parker G.; Solis, Nestor; Machado, Yoan; Bell, Peter A.; Kwon, Nam Hoon; Kim, Sunghoon; Overall, Christopher M.; Butler, Georgina S.			Matrix metalloproteinases inactivate the proinflammatory functions of secreted moonlighting tryptophanyl-tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						multifunctional protein; aminoacyl tRNA synthetase; proteolysis; matrix metalloproteinase (MMP); interferon; inflammation; toll-like receptor (TLR); monocyte; macrophage; innate immunity	NF-KAPPA-B; INTERFERON-GAMMA; PROTEOMIC IDENTIFICATION; MACROPHAGE ACTIVATION; MASS-SPECTROMETRY; CLEAVAGE SITES; HUMAN TRPRS; INFLAMMATION; EXPRESSION; CYTOKINE	Tryptophanyl-tRNA synthetase (WRS) is a cytosolic aminoacyl-tRNA synthetase essential for protein synthesis. WRS is also one of a growing number of intracellular proteins that are attributed distinct noncanonical "moonlighting" functions in the extracellular milieu. Moonlighting aminoacyl-tRNA synthetases regulate processes such as inflammation, but how these multifunctional enzymes are themselves regulated remains unclear. Here, we demonstrate that WRS is secreted from human macrophages, fibroblasts, and endothelial cells in response to the proinflammatory cytokine interferon gamma (IFN gamma). WRS signaled primarily through Toll-like receptor 2 (TLR2) in macrophages, leading to phosphorylation of the p65 subunit of NF-kappa B with associated loss of NF-kappa B inhibitor alpha (I kappa B-alpha) protein. This signaling initiated secretion of tumor necrosis factor alpha (TNF alpha) and CXCL8 (IL8) from macrophages. We also demonstrated that WRS is a potent monocyte chemoattractant. Of note, WRS increased matrix metalloproteinase (MMP) activity in the conditioned medium of macrophages in a TNF alpha-dependent manner. Using purified recombinant proteins and LC-MS/MS to identify proteolytic cleavage sites, we demonstrated that multiple MMPs, but primarily macrophage MMP7 and neutrophil MMP8, cleave secreted WRS at several sites. Loss of the WHEP domain following cleavage at Met(48) generated a WRS proteoform that also results from alternative splicing, designated Delta 1-47 WRS. The MMP-cleaved WRS lacked TLR signaling and proinflammatory activities. Thus, our results suggest that moonlighting WRS promotes IFN gamma proinflammatory activities, and these responses can be dampened by MMPs.	[Jobin, Parker G.; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Jobin, Parker G.; Solis, Nestor; Machado, Yoan; Bell, Peter A.; Overall, Christopher M.; Butler, Georgina S.] Univ British Columbia, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Solis, Nestor; Machado, Yoan; Bell, Peter A.; Overall, Christopher M.; Butler, Georgina S.] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, 2199 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Kwon, Nam Hoon; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea; [Kwon, Nam Hoon; Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergance Res Ctr, Seoul 151742, South Korea	University of British Columbia; University of British Columbia; University of British Columbia; Seoul National University (SNU); Seoul National University (SNU)	Overall, CM (corresponding author), Univ British Columbia, 2350 Hlth Sci Mall,Rm 4-401, Vancouver, BC V6T 1Z3, Canada.	chris.overall@ubc.ca	Machado, Yoan/AAC-4976-2020; Kim, Sunghoon/AAE-8314-2020; Butler, Georgina/GQP-7553-2022; Machado, Yoan/D-9429-2016	Butler, Georgina/0000-0003-1172-1578; Jobin, Parker/0000-0001-5852-7890; kim, sunghoon/0000-0002-1570-3230; Machado, Yoan/0000-0002-8251-3744	Canadian Institutes of Health Research (CIHR) [MOP-111055]; CIHR Foundation [FDN-148408]; Michael Smith Foundation for Health Research (MSFHR) [IN-NPG-00105]; Canada Foundation for Innovation Grant [31059]; Vancouver Coastal Health Research Institute (VCHRI)-CIHR-University of British Columbia (UBC) M.D./Ph.D. studentship; CIHR Vanier Canada graduate scholarship; UBC4-year doctoral fellowship; Centre for Blood Research graduate award; Canadian MSFHR research trainee fellowship; Australian early career fellowship; Canada Research Chair in Protease Proteomics and Systems Biology [950-20-3877]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Foundation(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canada Foundation for Innovation Grant(Canada Foundation for Innovation); Vancouver Coastal Health Research Institute (VCHRI)-CIHR-University of British Columbia (UBC) M.D./Ph.D. studentship; CIHR Vanier Canada graduate scholarship(Canadian Institutes of Health Research (CIHR)); UBC4-year doctoral fellowship; Centre for Blood Research graduate award; Canadian MSFHR research trainee fellowship; Australian early career fellowship; Canada Research Chair in Protease Proteomics and Systems Biology	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-111055 (to C. M. O. and G. S. B.), CIHR Foundation Grant FDN-148408 (to C. M. O.), Michael Smith Foundation for Health Research (MSFHR) Grant IN-NPG-00105 to establish the British Columbia Proteomics Network (to C. M. O.), and Canada Foundation for Innovation Grant 31059 (to C. M. O.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Vancouver Coastal Health Research Institute (VCHRI)-CIHR-University of British Columbia (UBC) M.D./Ph.D. studentship, CIHR Vanier Canada graduate scholarship, UBC4-year doctoral fellowship, and a Centre for Blood Research graduate award.; Recipients of a Canadian MSFHR research trainee fellowship.; Recipient of an Australian early career fellowship.; Holds a Canada Research Chair in Protease Proteomics and Systems Biology (Grant 950-20-3877). To whom correspondence should be addressed: University of British Columbia, 2350 Health Sciences Mall, Rm. 4.401, Vancouver, British Columbia V6T 1Z3, Canada. Tel.: 604-822-3561; Fax: 604-822-7742; E-mail: chris.overall@ubc.ca.	Ahn YH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.191; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Bellac CL, 2014, CELL REP, V9, P618, DOI 10.1016/j.celrep.2014.09.006; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Butler GS, 2013, PERIODONTOL 2000, V63, P123, DOI 10.1111/prd.12035; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Casas-Tinto S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10022; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Cypryk W, 2014, J PROTEOME RES, V13, P2468, DOI 10.1021/pr4012552; Daigo K, 2016, IMMUNOL REV, V274, P202, DOI 10.1111/imr.12476; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Doucet A, 2011, METHOD ENZYMOL, V501, P275, DOI 10.1016/B978-0-12-385950-1.00013-4; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Dufour A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04717-4; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Eckhard U, 2016, MATRIX BIOL, V49, P37, DOI 10.1016/j.matbio.2015.09.003; FLECKNER J, 1995, CYTOKINE, V7, P70, DOI 10.1006/cyto.1995.1009; FLECKNER J, 1991, P NATL ACAD SCI USA, V88, P11520, DOI 10.1073/pnas.88.24.11520; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jin M, 2019, EXP MOL MED, V51, DOI [10.1038/s12276-018-0190-2, 10.1038/s12276-018-0196-9]; Jobin PG, 2017, BBA-MOL CELL RES, V1864, P2043, DOI 10.1016/j.bbamcr.2017.05.013; Kapoor M, 2008, J BIOL CHEM, V283, P2070, DOI 10.1074/jbc.M706028200; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Klein T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9777; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Lee HC, 2019, J VIROL, V93, DOI 10.1128/JVI.01291-18; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; Lorey MB, 2017, MOL CELL PROTEOMICS, V16, pS187, DOI 10.1074/mcp.M116.064840; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Melisi D, 2007, EXPERT OPIN THER TAR, V11, P133, DOI 10.1517/14728222.11.2.133; Mistry P, 2015, P NATL ACAD SCI USA, V112, P5455, DOI 10.1073/pnas.1422576112; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Planesse C, 2015, CYTOKINE, V73, P190, DOI 10.1016/j.cyto.2015.01.028; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; REANO A, 1993, J INVEST DERMATOL, V100, P775, DOI 10.1111/1523-1747.ep12476463; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; RUBIN BY, 1991, J BIOL CHEM, V266, P24245; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Starr AE, 2009, METHOD ENZYMOL, V461, P281, DOI 10.1016/S0076-6879(09)05413-5; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; TOLSTRUP AB, 1995, J BIOL CHEM, V270, P397, DOI 10.1074/jbc.270.1.397; Turpaev KT, 1996, EUR J BIOCHEM, V240, P732, DOI 10.1111/j.1432-1033.1996.0732h.x; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Xu XL, 2018, RNA BIOL, V15, P649, DOI 10.1080/15476286.2017.1377868; Yao ZL, 2019, J PROTEOME RES, V18, P855, DOI 10.1021/acs.jproteome.8b00514; Yazdan-Ashoori P, 2011, J CRIT CARE, V26, P556, DOI 10.1016/j.jcrc.2011.01.008; Zeng R, 2011, HEART VESSELS, V26, P69, DOI 10.1007/s00380-010-0032-1; Zhu YH, 2015, J PROTEOME RES, V14, P4319, DOI 10.1021/acs.jproteome.5b00770	79	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12866	12879		10.1074/jbc.RA119.009584	http://dx.doi.org/10.1074/jbc.RA119.009584			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31324718	Green Published, hybrid			2022-12-28	WOS:000486416000001
J	Saito, T; Mihira, N; Matsuba, Y; Sasaguri, H; Hashimoto, S; Narasimhan, S; Zhang, B; Murayama, S; Higuchi, M; Lee, VMY; Trojanowski, JQ; Saido, TC				Saito, Takashi; Mihira, Naomi; Matsuba, Yukio; Sasaguri, Hiroki; Hashimoto, Shoko; Narasimhan, Sneha; Zhang, Bin; Murayama, Shigeo; Higuchi, Makoto; Lee, Virginia M. Y.; Trojanowski, John Q.; Saido, Takaomi C.			Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); amyloid-beta (AB); tau protein (tau); tauopathy; dystrophic neurite; humanized mouse model; knock-in; neurodegeneration; tau propagation; dystrophic neurite; plaque deposit	MOUSE MODELS; ALZHEIMERS-DISEASE; PROTEIN-TAU; LOCALIZATION; ACTIVATION; ISOFORMS; CALPAIN; BRAIN; MICE; APP	In cortical regions of brains from individuals with preclinical or clinical Alzheimer's disease (AD), extracellular beta-amyloid (A beta) deposition precedes the aggregation of pathological intracellular tau (the product of the gene microtubule-associated protein tau (MAPT)). To our knowledge, current mouse models of tauopathy reconstitute tau pathology by overexpressing mutant human tau protein. Here, through a homologous recombination approach that replaced the entire murine Mapt gene with the human ortholog, we developed knock-in mice with humanized Mapt to create an in vivo platform for studying human tauopathy. Of note, the humanized Mapt expressed all six tau isoforms present in humans. We next cross-bred the MAPT knock-in mice with single amyloid precursor protein (App) knock-in mice to investigate the A beta-tau axis in AD etiology. The double-knock-in mice exhibited higher tau phosphorylation than did single MAPT knock-in mice but initially lacked apparent tauopathy and neurodegeneration, as observed in the single App knock-in mice. We further observed that tau humanization significantly accelerates cell-to-cell propagation of AD brain-derived pathological tau both in the absence and presence of A beta-amyloidosis. In the presence of A beta-amyloidosis, tau accumulation was intensified and closely associated with dystrophic neurites, consistently showing that A beta-amyloidosis affects tau pathology. Our results also indicated that the pathological human tau interacts better with human tau than with murine tau, suggesting species-specific differences between these orthologous pathogenic proteins. We propose that the MAPT knock-in mice will make it feasible to investigate the behaviors and characteristics of human tau in an animal model.	[Saito, Takashi; Mihira, Naomi; Matsuba, Yukio; Sasaguri, Hiroki; Hashimoto, Shoko; Saido, Takaomi C.] RIKEN, Ctr Brain Sci, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Saito, Takashi] Nagoya Univ, Res Inst Environm Med, Dept Neurosci & Pathobiol, Nagoya, Aichi 4648601, Japan; [Narasimhan, Sneha; Zhang, Bin; Lee, Virginia M. Y.; Trojanowski, John Q.] Univ Penn, Sch Med, Inst Aging, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Narasimhan, Sneha; Zhang, Bin; Lee, Virginia M. Y.; Trojanowski, John Q.] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan; [Higuchi, Makoto] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Funct Brain Imaging Res, Chiba 2638555, Japan	RIKEN; Nagoya University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Tokyo Metropolitan Institute of Gerontology; National Institutes for Quantum Science & Technology	Saito, T; Saido, TC (corresponding author), RIKEN, Ctr Brain Sci, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.; Saito, T (corresponding author), Nagoya Univ, Res Inst Environm Med, Dept Neurosci & Pathobiol, Nagoya, Aichi 4648601, Japan.	takashi.saito.aa@riken.jp; saido@brain.riken.jp	Saito, Takashi/G-2563-2015; Saido, Takaomi/N-5472-2015	Saito, Takashi/0000-0002-9659-9251; Saido, Takaomi/0000-0003-1970-6903	RIKEN Center for Brain Science; RIKEN Aging Project; MEXT; Precursory Research for Embryonic Science and Technology from JST; Cell Science Research Foundation; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development (AMED) [JP18dm027001]; Astellas Pharma, Inc. JSPS KAKENHI [JP16H06277]; National Institutes of Health [AG10124, AG17586]; NATIONAL INSTITUTE ON AGING [U19AG062418, P30AG010124, P01AG017586] Funding Source: NIH RePORTER	RIKEN Center for Brain Science; RIKEN Aging Project; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Precursory Research for Embryonic Science and Technology from JST; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Astellas Pharma, Inc. JSPS KAKENHI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by research grants from the RIKEN Center for Brain Science, research grants from the RIKEN Aging Project, a Grant-in-Aid-for Scientific Research (B) from MEXT (to T.S.), Precursory Research for Embryonic Science and Technology from JST (to T.S.), the Cell Science Research Foundation (to T.S.), the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development (AMED) (Grant JP18dm027001) (to T.C.S.), Astellas Pharma, Inc. JSPS KAKENHI Grant JP16H06277 (to S.M.), and National Institutes of Health Grants AG10124 and AG17586 (to V.M. Y.L. and J.Q.T.). T.S., Y.M., S.H., and T.C.S. serve as advisor, director, researcher, and CEO, respectively, for RIKEN BIO Co. Ltd., which sublicenses animal models, App KI mice, to for-profit organizations, the proceeds from which are used for the identification of disease biomarkers. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Ando K, 2010, BIOCHEM SOC T, V38, P1001, DOI 10.1042/BST0381001; Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Boyko S, 2019, J BIOL CHEM, V294, P11054, DOI 10.1074/jbc.AC119.009198; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chen YX, 2018, BIOCHEM BIOPH RES CO, V496, P1006, DOI 10.1016/j.bbrc.2017.04.153; Enya M, 1999, AM J PATHOL, V154, P271, DOI 10.1016/S0002-9440(10)65273-X; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Goodwin LO, 2019, GENOME RES, V29, P494, DOI 10.1101/gr.233866.117; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Hashimoto S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10278-x; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Iovino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013947; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Jankowsky JL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0231-7; Kubo A, 2019, J COMP NEUROL, V527, P985, DOI 10.1002/cne.24577; Kumar H, 2019, BBA-PROTEINS PROTEOM, V1867, P922, DOI 10.1016/j.bbapap.2019.04.004; Lee VMY, 1999, NEURON, V24, P507, DOI 10.1016/S0896-6273(00)81106-X; Luk KC, 2016, CELL REP, V16, P3373, DOI 10.1016/j.celrep.2016.08.053; Narasimhan S, 2017, METHOD CELL BIOL, V141, P287, DOI 10.1016/bs.mcb.2017.06.009; Puig B, 2014, PRION, V8, P11, DOI 10.4161/pri.27892; Robinson JL, 2018, BRAIN, V141, P2181, DOI 10.1093/brain/awy146; Saito T, 2016, J NEUROSCI, V36, P9933, DOI 10.1523/JNEUROSCI.1907-16.2016; Sasaguri H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05262-w; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Schoch KM, 2016, NEURON, V90, P941, DOI 10.1016/j.neuron.2016.04.042; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stefanoska K, 2018, J BIOL CHEM, V293, P3710, DOI 10.1074/jbc.RA118.001784; Vasili E, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00107; Wolfe MS, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/796024; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	44	60	61	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12754	12765		10.1074/jbc.RA119.009487	http://dx.doi.org/10.1074/jbc.RA119.009487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31273083	hybrid, Green Published			2022-12-28	WOS:000484414600017
J	Wu, XF; Zhang, Y; Chuang, KH; Cai, XD; Ajaz, H; Zheng, XY				Wu, Xuefeng; Zhang, Ya; Chuang, Kun-Han; Cai, Xudong; Ajaz, Humna; Zheng, Xiaoyan			The Drosophila Hedgehog receptor component Interference hedgehog (Ihog) mediates cell-cell interactions through trans-homophilic binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hedgehog signaling pathway; adhesion; receptor regulation; signaling; cell biology; dual roles; receptor; trans-homophilic interaction; type I transmembrane protein	ADHESION MOLECULE; SONIC HEDGEHOG; CDO; PROTEINS; PATHWAY; RANGE; CYTONEMES; GRADIENT; GUIDANCE; RELEASE	Hedgehog (Hh) signaling is crucial for establishing complex cellular patterns in embryonic tissues and maintaining homeostasis in adult organs. In Drosophila, Interference hedgehog (Ihog) or its close paralogue Brother of Ihog (Boi) forms a receptor complex with Patched to mediate intracellular Hh signaling. Ihog proteins (Ihog and Boi) also contribute to cell segregation in wing imaginal discs through an unknown mechanism independent of their role in transducing the Hh signal. Here, we report a molecular mechanism by which the Ihog proteins mediate cell-cell interactions. We found that Ihog proteins are enriched at the site of cell-cell contacts and engage in trans-homophilic interactions in a calcium-independent manner. The region that we identified as mediating the trans-Ihog-Ihog interaction overlaps with the Ihog-Hh interface on the first fibronectin repeat of the extracellular domain of Ihog. We further demonstrate that Hh interferes with Ihog-mediated homophilic interactions by competing for Ihog binding. These results, thus, not only reveal a mechanism for Ihog-mediated cell-cell interactions but also suggest a direct Hh-mediated regulation of both intracellular signaling and cell adhesion through Ihog.	[Wu, Xuefeng; Zhang, Ya; Chuang, Kun-Han; Cai, Xudong; Ajaz, Humna; Zheng, Xiaoyan] George Washington Univ, Dept Anat & Cell Biol, Sch Med & Hlth Sci, Washington, DC 20037 USA; [Wu, Xuefeng; Zhang, Ya; Chuang, Kun-Han; Cai, Xudong; Ajaz, Humna; Zheng, Xiaoyan] George Washington Canc Ctr, SEH Suite 8840,800 22nd St NW, Washington, DC 20052 USA	George Washington University; George Washington University	Zheng, XY (corresponding author), George Washington Canc Ctr, SEH Suite 8840,800 22nd St NW, Washington, DC 20052 USA.	xzheng@gwu.edu	Zheng, Xiaoyan/AAG-1251-2020; Chuang, Kun-Han/S-5439-2016	Zheng, Xiaoyan/0000-0003-4983-5503; Chuang, Kun-Han/0000-0003-3241-8586	NIGMS, National Institutes of Health [R01GM117440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117440] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM117440 (to X.Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ayers KL, 2010, DEV CELL, V18, P605, DOI 10.1016/j.devcel.2010.02.015; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bilioni A, 2013, DEV BIOL, V376, P198, DOI 10.1016/j.ydbio.2012.12.013; Bischoff M, 2013, NAT CELL BIOL, V15, P1269, DOI 10.1038/ncb2856; Callejo A, 2011, P NATL ACAD SCI USA, V108, P12591, DOI 10.1073/pnas.1106881108; Camp D, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-28; Chen WT, 2017, DEVELOPMENT, V144, P3134, DOI 10.1242/dev.149856; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; Chou YH, 2010, CELL, V142, P954, DOI 10.1016/j.cell.2010.08.015; FREI T, 1992, J CELL BIOL, V118, P177, DOI 10.1083/jcb.118.1.177; Gonzalez-Mendez L, 2017, ELIFE, V6, DOI 10.7554/eLife.24045; Hsia EYC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01364-z; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Kang JS, 1997, J CELL BIOL, V138, P203, DOI 10.1083/jcb.138.1.203; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kasevayuth K, 2004, BIOCHEM BIOPH RES CO, V324, P205, DOI 10.1016/j.bbrc.2004.09.036; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Martin-Bermudo MD, 1999, GENE DEV, V13, P729, DOI 10.1101/gad.13.6.729; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Orian-Rousseau V, 2008, ADV CANCER RES, V101, P63, DOI 10.1016/S0065-230X(08)00404-1; Sjostrand D, 2007, J BIOL CHEM, V282, P12734, DOI 10.1074/jbc.M701588200; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	38	6	6	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12339	12348		10.1074/jbc.RA119.008744	http://dx.doi.org/10.1074/jbc.RA119.008744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31209108	hybrid, Green Published			2022-12-28	WOS:000484402700007
J	Yang, YY; Liu, ZX; Selby, CP; Sancar, A				Yang, Yanyan; Liu, Zhenxing; Selby, Christopher P.; Sancar, Aziz			Long-term, genome-wide kinetic analysis of the effect of the circadian clock and transcription on the repair of cisplatin-DNA adducts in the mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; circadian clock; DNA damage; kinetics; nucleotide excision repair; chemotherapy; chronotherapy; cisplatin; excision repair sequencing (XR-seq); transcription-coupled repair; DNA adduct	RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; MOLECULAR-MECHANISMS; ULTRAVIOLET-LIGHT; COUPLED REPAIR; DAMAGE; CANCER; INITIATION; RECOVERY; CORE	Cisplatin is the most commonly used chemotherapeutic drug for managing solid tumors. However, toxicity and the innate or acquired resistance of cancer cells to the drug limit its usefulness. Cisplatin kills cells by forming cisplatin-DNA adducts, most commonly the Pt-d(GpG) diadduct. We recently showed that, in mice, repair of this adduct 2 h following injection is controlled by two circadian programs. 1) The circadian clock controls transcription of 2000 genes in liver and, via transcription-directed repair, controls repair of the transcribed strand (TS) of these genes in a rhythmic fashion unique to each gene's phase of transcription. 2) The excision repair activity itself is controlled by the circadian clock with a single phase at which the repair of the nontranscribed strand (NTS) and the rest of the genome takes place. Here, we followed the repair kinetic for long periods genome-wide both globally and at single nucleotide resolution by the Excision Repair-sequencing (XR-seq) method to better understand cisplatin DNA damage and repair. We find that transcription-driven repair is nearly complete after 2 days, whereas weeks are required for repair of the NTS and the rest of the genome. TS repair oscillates in rhythmically expressed genes up to 2 days post injection, and in all expressed genes, we see a trend in TS repair with time from the 5 ' to 3 ' end. These findings help to understand the circadian- and transcription-dependent and -independent control of repair in response to cisplatin, and should aid in designing cisplatin chemotherapy regimens with improved therapeutic indexes.	[Yang, Yanyan; Liu, Zhenxing; Selby, Christopher P.; Sancar, Aziz] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Liu, Zhenxing/U-2062-2019; Liu, Zhenxing/HCH-6877-2022; liu, zhenxing/GWC-9542-2022	liu, zhenxing/0000-0001-8236-1931	National Institutes of Health [GM118102, ES027255]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES027255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118102 and ES027255 (to A.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adar S, 2016, P NATL ACAD SCI USA, V113, pE2124, DOI 10.1073/pnas.1603388113; Adebali O, 2017, J BIOL CHEM, V292, P18386, DOI 10.1074/jbc.C117.818807; Andrade-Lima LC, 2015, BIOMOLECULES, V5, P1600, DOI 10.3390/biom5031600; Andrade-Lima LC, 2015, NUCLEIC ACIDS RES, V43, P2744, DOI 10.1093/nar/gkv148; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Bugai A, 2019, MOL CELL, V74, P254, DOI 10.1016/j.molcel.2019.01.033; Chaney SG, 1996, JNCI-J NATL CANCER I, V88, P1346, DOI 10.1093/jnci/88.19.1346; Chiou YY, 2018, J BIOL CHEM, V293, P2476, DOI 10.1074/jbc.RA117.000971; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gaddameedhi S, 2011, P NATL ACAD SCI USA, V108, P18790, DOI 10.1073/pnas.1115249108; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Jiang HY, 2019, GENE DEV, V33, P705, DOI 10.1101/gad.322453.118; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Laine JP, 2006, EMBO J, V25, P387, DOI 10.1038/sj.emboj.7600933; Lavigne MD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02145-4; Li WT, 2018, P NATL ACAD SCI USA, V115, pE3408, DOI 10.1073/pnas.1801687115; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Ljungman M, 1999, CARCINOGENESIS, V20, P395, DOI 10.1093/carcin/20.3.395; Ngoc LV, 2017, GENE DEV, V31, P1289, DOI 10.1101/gad.303149.117; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Nojima T, 2016, NAT PROTOC, V11, P413, DOI 10.1038/nprot.2016.012; Oztas O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03922-5; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Pines A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03484-6; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Sancar A, 2015, BIOCHEMISTRY-US, V54, P110, DOI 10.1021/bi5007354; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Tippens ND, 2018, GENE DEV, V32, P1, DOI 10.1101/gad.311605.118; Tremeau-Bravard A, 2004, J BIOL CHEM, V279, P7751, DOI 10.1074/jbc.M309853200; Veloso A, 2014, GENOME RES, V24, P896, DOI 10.1101/gr.171405.113; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Xu J, 2017, NATURE, V551, P653, DOI 10.1038/nature24658; Yang YY, 2018, P NATL ACAD SCI USA, V115, pE4777, DOI 10.1073/pnas.1804493115; Yimit A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08290-2	49	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					11960	11968		10.1074/jbc.RA119.009579	http://dx.doi.org/10.1074/jbc.RA119.009579			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31217280	Green Published, hybrid			2022-12-28	WOS:000484284500002
J	Guo, L; Guo, YY; Li, BY; Peng, WQ; Chang, XX; Gao, X; Tang, QQ				Guo, Liang; Guo, Ying-Ying; Li, Bai-Yu; Peng, Wan-Qiu; Chang, Xin-Xia; Gao, Xin; Tang, Qi-Qun			Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; lipogenesis; sirtuin; hepatocyte; protein stability; lipid metabolism; ATP-citrate lyase (ACLY); deacetylase; hepatic steatosis; metabolic disorder; nonalcoholic fatty liver disease (NAFLD)	ADIPOCYTE DIFFERENTIATION; METABOLISM; SIRTUINS; STEATOSIS; OBESITY; FOXO1	Hepatic steatosis is a hallmark of nonalcoholic fatty liver disease (NAFLD) and is promoted by dysregulated de novo lipogenesis. ATP-citrate lyase (ACLY) is a crucial lipogenic enzyme that is up-regulated in individuals with NAFLD. A previous study has shown that acetylation of ACLY at Lys-540, Lys-546, and Lys-554 (ACLY-3K) increases ACLY protein stability by antagonizing its ubiquitylation, thereby promoting lipid synthesis and cell proliferation in lung cancer cells. But the functional importance of this regulatory mechanism in other cellular or tissue contexts or under other pathophysiological conditions awaits further investigation. Here, we show that ACLY-3K acetylation also promotes ACLY protein stability in AML12 cells, a mouse hepatocyte cell line, and found that the deacetylase sirtuin 2 (SIRT2) deacetylates ACLY-3K and destabilizes ACLY in these cells. Of note, the livers of mice and humans with NAFLD had increased ACLY protein and ACLY-3K acetylation levels and decreased SIRT2 protein levels. Mimicking ACLY-3K acetylation by replacing the three lysines with three glutamines (ACLY-3KQ variant) promoted lipid accumulation both in high glucose-treated AML12 cells and in the livers of high-fat/high-sucrose (HF/HS) diet-fed mice. Moreover, overexpressing SIRT2 in AML12 cells inhibited lipid accumulation, which was more efficiently reversed by overexpressing the ACLY-3KQ variant than by overexpressing WT ACLY. Additionally, hepatic SIRT2 overexpression decreased ACLY-3K acetylation and its protein level and alleviated hepatic steatosis in HF/HS diet-fed mice. Our findings reveal a posttranscriptional mechanism underlying the up-regulation of hepatic ACLY in NAFLD and suggest that the SIRT2/ACLY axis is involved in NAFLD progression.	[Guo, Liang; Guo, Ying-Ying; Li, Bai-Yu; Peng, Wan-Qiu; Chang, Xin-Xia; Gao, Xin; Tang, Qi-Qun] Fudan Univ, Key Lab Metab & Mol Med, Minist Educ,Zhongshan Hosp, Dept Biochem & Mol Biol,Sch Basic Med Sci, Shanghai 200032, Peoples R China; [Guo, Liang; Guo, Ying-Ying; Li, Bai-Yu; Peng, Wan-Qiu; Chang, Xin-Xia; Gao, Xin; Tang, Qi-Qun] Fudan Univ, Dept Endocrinol & Metab, Zhongshan Hosp, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Guo, L (corresponding author), Fudan Univ, Key Lab Metab & Mol Med, Minist Educ,Zhongshan Hosp, Dept Biochem & Mol Biol,Sch Basic Med Sci, Shanghai 200032, Peoples R China.	liangguo@fudan.edu.cn; qqtang@shmu.edu.cn		Guo, Liang/0000-0001-7353-8336; Gao, Xin/0000-0003-1864-7796	National Ministry of Education Program (985 Project) [985 III-YFX0302]	National Ministry of Education Program (985 Project)	We thank Dr. Qun-Ying Lei (Fudan University, Shanghai, China) for the kind gift of the anti-ACLY-3K-Ac antibody. The Department of Endocrinology and Metabolism of Zhongshan Hospital is supported by National Ministry of Education Program (985 Project 985 III-YFX0302).	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dietrich P, 2014, BEST PRACT RES CL GA, V28, P637, DOI 10.1016/j.bpg.2014.07.008; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Guo L, 2019, J BIOL CHEM, V294, P9642, DOI [10.1074/jbc.RA119.008419, 10.1074/jbc.ra119.008419]; Guo L, 2017, J CLIN INVEST, V127, P4449, DOI 10.1172/JCI96324; Guo L, 2016, MOL CELL BIOL, V36, P2553, DOI 10.1128/MCB.00227-16; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Koo SH, 2013, CLIN MOL HEPATOL, V19, P210, DOI 10.3350/cmh.2013.19.3.210; Koppe SWP, 2014, TRANSL RES, V164, P312, DOI 10.1016/j.trsl.2014.06.008; Lin RT, 2013, MOL CELL, V51, P506, DOI 10.1016/j.molcel.2013.07.002; Liu Y, 2018, J BIOL CHEM, V293, P14012, DOI 10.1074/jbc.RA118.004401; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Marchesini G, 2006, Minerva Cardioangiol, V54, P229; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Nassir F, 2016, WORLD J GASTROENTERO, V22, P10084, DOI 10.3748/wjg.v22.i46.10084; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Neuschwander-Tetri BA, 2007, CURR OPIN GASTROEN, V23, P193, DOI 10.1097/MOG.0b013e32801421a9; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Saito T, 2007, INTERNAL MED, V46, P101, DOI 10.2169/internalmedicine.46.1784; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; Song J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00724; SRERE PA, 1959, J BIOL CHEM, V234, P2544; Thapa D, 2018, J BIOL CHEM, V293, P17676, DOI 10.1074/jbc.AC118.005462; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Zhao D, 2014, J CLIN INVEST, V124, P5453, DOI 10.1172/JCI76611; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	34	31	31	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11805	11816		10.1074/jbc.RA119.008708	http://dx.doi.org/10.1074/jbc.RA119.008708			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31197036	hybrid, Green Published			2022-12-28	WOS:000486127800017
J	Solan, JL; Marquez-Rosado, L; Lampe, PD				Solan, Joell L.; Marquez-Rosado, Lucrecia; Lampe, Paul D.			Cx43 phosphorylation-mediated effects on ERK and Akt protect against ischemia reperfusion injury and alter the stability of the stress-inducible protein NDRG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gap junction; connexin; cell signaling; phosphorylation; cell junction; hypoxia; casein kinase 1; myocardium; N-Myc downstream-regulated gene 1 (NDRG1)	GAP-JUNCTION PROTEIN; METASTASIS SUPPRESSOR; KINASE-C; MICE DEFICIENT; MOUSE HEARTS; CONNEXIN43; EXPRESSION; GENE; GROWTH; LOCALIZATION	Gap junctions contain intercellular channels that enable intercellular communication of small molecules while also serving as a signaling scaffold. Connexins, the proteins that form gap junctions in vertebrates, are highly regulated and typically have short (<2 h) half-lives. Connexin43 (Cx43), the predominate connexin in the myocardium and epithelial tissues, is phosphorylated on more than a dozen serine residues and interacts with a variety of protein kinases. These interactions regulate Cx43 and gap junction formation and stability. Casein kinase 1 (CK1)-mediated phosphorylation of Cx43 promotes gap junction assembly. Using murine knock-in technology and quantitative PCR, immunoblotting, and immunoprecipitation assays, we show here that mutation of the CK1 phosphorylation sites in Cx43 reduces the levels of total Cx43 in the myocardium and increases Cx43 phosphorylation on sites phosphorylated by extracellular signal-regulated kinase (ERK). In aged myocardium, we found that, compared with WT Cx43, mutant Cx43 expression increases ERK activation, phosphorylation of Akt substrates, and protection from ischemia-induced injury. Our findings also uncovered that Cx43 interacts with the hypoxia-inducible protein N-Myc downstream-regulated gene 1 protein (NDRG1) and that Cx43 phosphorylation status controls this interaction and dramatically affects NDRG1 stability. We propose that, in addition to altering gap junction stability, Cx43 phosphorylation directly and dynamically regulates cellular signaling through ERK and Akt in response to ischemic injury. We conclude that gap junction-dependent NDRG1 regulation might explain some cellular responses to hypoxia.	Fred Hutchinson Canc Res Ctr, Translat Res Program, Publ Hlth Sci Div, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Translat Res Program, Human Biol Div, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Lampe, PD (corresponding author), Fred Hutchinson Canc Res Ctr, Translat Res Program, M5-C800,POB 19024, Seattle, WA 98109 USA.	plampe@fredhutch.org		Lampe, Paul/0000-0002-1399-2761	NIGMS, National Institutes of Health [GM055632]; National Institutes of Health [P30 DK017047, P30 CA015704]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055632] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIGMS, National Institutes of Health Grant GM055632 (P. D. L.) and National Institutes of Health Grants P30 DK017047 and P30 CA015704. P. D. L. and J. L. S. receive royalties from sales of the Cx43IF1 and Cx43NT1 antibodies.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azhar G, 1999, EXP GERONTOL, V34, P699, DOI 10.1016/S0531-5565(99)00031-5; BERTHOUD VM, 1992, EUR J CELL BIOL, V57, P40; Boengler K, 2007, AM J PHYSIOL-HEART C, V292, pH1764, DOI 10.1152/ajpheart.01071.2006; BRISSETTE JL, 1991, MOL CELL BIOL, V11, P5364, DOI 10.1128/MCB.11.10.5364; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Chen B, 2006, J BIOL CHEM, V281, P2764, DOI 10.1074/jbc.M507330200; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Chiao YA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025148; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Doble BW, 2000, CIRC RES, V86, P293, DOI 10.1161/01.RES.86.3.293; Dunn CA, 2014, J CELL SCI, V127, P455, DOI 10.1242/jcs.142497; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Fan GC, 2005, CIRCULATION, V111, P1792, DOI 10.1161/01.CIR.0000160851.41872.C6; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Gupta A, 2019, BIOCHEM BIOPH RES CO, V509, P728, DOI 10.1016/j.bbrc.2018.12.173; Hausenloy DJ, 2004, CARDIOVASC RES, V63, P305, DOI 10.1016/j.cardiores.2004.04.011; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Huang Guo-Ying, 2011, J Cardiovasc Dis Res, V2, P206, DOI 10.4103/0975-3583.89804; Hund TJ, 2007, HEART RHYTHM, V4, P1183, DOI 10.1016/j.hrthm.2007.05.030; Jain SK, 2003, CIRC RES, V92, P1138, DOI 10.1161/01.RES.0000074883.66422.C5; Jin RS, 2014, J CELL SCI, V127, P3116, DOI 10.1242/jcs.147835; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; KADLE R, 1991, MOL CELL BIOL, V11, P363, DOI 10.1128/MCB.11.1.363; King TJ, 2004, CARCINOGENESIS, V25, P669, DOI 10.1093/carcin/bgh071; Kitowska A, 2010, ACTA BIOCHIM POL, V57, P15; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kurdistani SK, 1998, CANCER RES, V58, P4439; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Menezes SV, 2019, J BIOL CHEM, V294, P4045, DOI 10.1074/jbc.RA118.006279; Menezes SV, 2019, CARCINOGENESIS, V40, P805, DOI 10.1093/carcin/bgy178; Miura T, 2004, AM J PHYSIOL-HEART C, V286, pH214, DOI 10.1152/ajpheart.00441.2003; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Park KC, 2018, BBA-MOL BASIS DIS, V1864, P2644, DOI 10.1016/j.bbadis.2018.04.011; Przyklenk K, 2008, J AM COLL CARDIOL, V51, P1393, DOI 10.1016/j.jacc.2007.11.070; Quan NH, 2017, FASEB J, V31, P4153, DOI 10.1096/fj.201700063R; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sibold S, 2007, FEBS LETT, V581, P989, DOI 10.1016/j.febslet.2007.01.080; Singh D, 2005, J BIOL CHEM, V280, P30416, DOI 10.1074/jbc.M506799200; Slavi N, 2018, P NATL ACAD SCI USA, V115, pE5934, DOI 10.1073/pnas.1803907115; Solan JL, 2008, CELL COMMUN ADHES, V15, P75, DOI 10.1080/15419060802014016; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2018, BBA-BIOMEMBRANES, V1860, P83, DOI 10.1016/j.bbamem.2017.04.008; Solan JL, 2016, SEMIN CELL DEV BIOL, V50, P40, DOI 10.1016/j.semcdb.2015.12.010; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Solan Joell L., 2009, P263, DOI 10.1007/978-1-59745-489-6_11; Srisakuldee W, 2009, CARDIOVASC RES, V83, P672, DOI 10.1093/cvr/cvp142; Sun J, 2013, CARCINOGENESIS, V34, P1943, DOI 10.1093/carcin/bgt163; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Wu F, 2015, J ENVIRON PATHOL TOX, V34, P213, DOI 10.1615/JEnvironPatholToxicolOncol.2015013472; Zhang Z, 2018, MOL MED REP, V18, P3547, DOI 10.3892/mmr.2018.9375	64	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11762	11771		10.1074/jbc.RA119.009162	http://dx.doi.org/10.1074/jbc.RA119.009162			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31189653	Green Published, hybrid			2022-12-28	WOS:000486127800013
J	Wade, AK; Liu, YP; Bethea, MM; Toren, E; Tse, HM; Hunter, CS				Wade, Alexa K.; Liu, Yanping; Bethea, Maigen M.; Toren, Eliana; Tse, Hubert M.; Hunter, Chad S.			LIM-domain transcription complexes interact with ring-finger ubiquitin ligases and thereby impact islet beta-cell function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; transcription factor; transcription regulation; histone modification; chromatin immunoprecipitation (ChiP); insulin secretion; pancreas; islet; H2Bub1; H3K4me3	H2B UBIQUITYLATION; HISTONE H2B; PANCREAS DEVELOPMENT; STATISTICAL-MODEL; IN-VIVO; PROTEIN; INSULIN; ALPHA; PDX1; MAFA	Diabetes is characterized by a loss of beta-cell mass, and a greater understanding of the transcriptional mechanisms governing beta-cell function is required for future therapies. Previously, we reported that a complex of the Islet-1 (Isl1) transcription factor and the co-regulator single-stranded DNA-binding protein 3 (SSBP3) regulates the genes necessary for beta-cell function, but few proteins are known to interact with this complex in beta-cells. To identify additional components, here we performed SSBP3 reverse-cross-linked immunoprecipitation (ReCLIP)- and MS-based experiments with mouse beta-cell extracts and compared the results with those from our previous Isl1 ReCLIP study. Our analysis identified the E3 ubiquitin ligases ring finger protein 20 (RNF20) and RNF40, factors that in nonpancreatic cells regulate transcription through imparting monoubiquitin marks on histone H2B (H2Bub1), a precursor to histone H3 lysine 4 trimethylation (H3K4me3). We hypothesized that RNF20 and RNF40 regulate similar genes as those regulated by Isl1 and SSBP3 and are important for beta-cell function. We observed that Rnf20 and Rnf40 depletion reduces beta-cell H2Bub1 marks and uncovered several target genes, including glucose transporter 2 (Glut2), MAF BZIP transcription factor A (MafA), and uncoupling protein 2 (Ucp2). Strikingly, we also observed that Isl1 and SSBP3 depletion reduces H2Bub1 and H3K4me3 marks, suggesting that they have epigenetic roles. We noted that the RNF complex is required for glucose-stimulated insulin secretion and normal mitochondrial reactive oxygen species levels. These findings indicate that RNF20 and RNF40 regulate beta-cell gene expression and insulin secretion and establish a link between Isl1 complexes and global cellular epigenetics.	[Wade, Alexa K.; Liu, Yanping; Bethea, Maigen M.; Toren, Eliana; Hunter, Chad S.] Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Dept Med, 1825 Univ Blvd,SHEL 1211, Birmingham, AL 35294 USA; [Wade, Alexa K.; Liu, Yanping; Bethea, Maigen M.; Toren, Eliana; Tse, Hubert M.; Hunter, Chad S.] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Tse, Hubert M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Hunter, CS (corresponding author), Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Dept Med, 1825 Univ Blvd,SHEL 1211, Birmingham, AL 35294 USA.	huntercs@uab.edu	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022	Bethea, Maigen/0000-0001-9847-4885; Hunter, Chad/0000-0002-1644-447X; Tse, Hubert/0000-0001-5861-7597; Toren, Eliana/0000-0002-6827-4521	National Institutes of Health from the NCI [P30CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK111181, P30DK079626, R01DK111483, R01DK099550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jessica Kepple (University of Alabama at Birmingham) for manuscript critiques. The University of Alabama at Birmingham Comprehensive Cancer Center was recipient of National Institutes of Health Grant P30CA013148 from the NCI.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Beissbarth T, 2004, BIOINFORMATICS, V20, P31, DOI 10.1093/bioinformatics/bth924; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Cao J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00026; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Deering TG, 2009, DIABETES, V58, P185, DOI 10.2337/db08-1150; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Duan Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12648; Ediger BN, 2017, J CLIN INVEST, V127, P215, DOI 10.1172/JCI88016; Ediger BN, 2014, DIABETES, V63, P4206, DOI 10.2337/db14-0096; Eeckhoute J, 2006, J MOL BIOL, V364, P567, DOI 10.1016/j.jmb.2006.07.096; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Fuchs G, 2014, BBA-GENE REGUL MECH, V1839, P694, DOI 10.1016/j.bbagrm.2014.01.002; Galloway JR, 2015, MOL ENDOCRINOL, V29, P1774, DOI 10.1210/me.2015-1165; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Gerber PA, 2017, ANTIOXID REDOX SIGN, V26, P501, DOI 10.1089/ars.2016.6755; Golson ML, 2017, MOL METAB, V6, P1066, DOI 10.1016/j.molmet.2017.05.015; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gungor C, 2007, P NATL ACAD SCI USA, V104, P15000, DOI 10.1073/pnas.0703738104; Gupta R, 2018, J BIOL CHEM, V293, P18086, DOI 10.1074/jbc.RA118.005403; Hang Y, 2014, DIABETES, V63, P1994, DOI 10.2337/db13-1001; Herbert TP, 2016, DIABETES, V65, P1472, DOI 10.2337/db15-1633; Hunter CS, 2013, DIABETES, V62, P875, DOI 10.2337/db12-0952; Hunter CS, 2013, J BIOL CHEM, V288, P3795, DOI 10.1074/jbc.M112.434282; Hunter CS, 2011, MOL ENDOCRINOL, V25, P339, DOI 10.1210/me.2010-0362; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Liu AH, 2004, MOL CELL BIOL, V24, P4372, DOI 10.1128/MCB.24.10.4372-4383.2004; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu JX, 2012, ISLETS, V4, P199, DOI 10.4161/isl.19982; Lonard DM, 2012, NAT REV ENDOCRINOL, V8, P598, DOI 10.1038/nrendo.2012.100; Ma C, 2015, J BIOTECHNOL, V193, P108, DOI 10.1016/j.jbiotec.2014.10.036; McKenna B, 2015, CELL REP, V10, P2032, DOI 10.1016/j.celrep.2015.02.054; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Nicholls DG, 2016, PHYSIOL REV, V96, P1385, DOI 10.1152/physrev.00009.2016; Offield MF, 1996, DEVELOPMENT, V122, P983; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pagliuca FW, 2013, DEVELOPMENT, V140, P2472, DOI 10.1242/dev.093187; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Scoville DW, 2015, DIABETES, V64, P3772, DOI 10.2337/db15-0281; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shiloh Y, 2011, FEBS LETT, V585, P2795, DOI 10.1016/j.febslet.2011.07.034; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Thomas MK, 1999, MOL CELL BIOL, V19, P8492; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wong CK, 2018, DIABETES, V67, P412, DOI 10.2337/db17-0237; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Xie RY, 2015, WIRES SYST BIOL MED, V7, P1, DOI 10.1002/wsbm.1287; Xie WH, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1159-5; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yan CZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39308; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhang H, 2009, J MOL BIOL, V392, P566, DOI 10.1016/j.jmb.2009.07.036; Zhuang SW, 2013, GENE EXPR PATTERNS, V13, P407, DOI 10.1016/j.gep.2013.07.001	72	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11728	11740		10.1074/jbc.RA118.006985	http://dx.doi.org/10.1074/jbc.RA118.006985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31186351	hybrid, Green Published			2022-12-28	WOS:000486127800010
J	Pazdernik, M; Mares, J; Pilny, J; Sobotka, R				Pazdernik, Marek; Mares, Jan; Pilny, Jan; Sobotka, Roman			The antenna-like domain of the cyanobacterial ferrochelatase can bind chlorophyll and carotenoids in an energy-dissipative configuration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant biochemistry; photosynthetic pigment; photosynthesis; chloroplast; membrane protein; heme; carotenoid; chlorophyll; ferrochelatase; light harvesting complex (LHC)-like proteins; pigment binding; Synechocystis	LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-II COMPLEX; SYNECHOCYSTIS PCC 6803; TETRAPYRROLE BIOSYNTHESIS; INDUCIBLE PROTEINS; CHELATASE ACTIVITY; LIL3; PHOTOPROTECTION; SUPERFAMILY; EXPRESSION	Ferrochelatase (FeCh) is an essential enzyme catalyzing the synthesis of heme. Interestingly, in cyanobacteria, algae, and plants, FeCh possesses a conserved transmembrane chlorophyll a/b binding (CAB) domain that resembles the first and the third helix of light-harvesting complexes, including a chlorophyll-binding motif. Whether the FeCh CAB domain also binds chlorophyll is unknown. Here, using biochemical and radiolabeled precursor experiments, we found that partially inhibited activity of FeCh in the cyanobacterium Synechocystis PCC 6803 leads to overproduction of chlorophyll molecules that accumulate in the thylakoid membrane and, together with carotenoids, bind to FeCh. We observed that pigments bound to purified FeCh are organized in an energy-dissipative conformation and further show that FeCh can exist in vivo as a monomer or a dimer depending on its own activity. However, pigmented FeCh was purified exclusively as a dimer. Separately expressed and purified FeCH CAB domain contained a pigment composition similar to that of full-length FeCh and retained its quenching properties. Phylogenetic analysis suggested that the CAB domain was acquired by a fusion between FeCh and a single-helix, high light-inducible protein early in the evolution of cyanobacteria. Following this fusion, the FeCh CAB domain with a functional chlorophyll-binding motif was retained in all currently known cyanobacterial genomes except for a single lineage of endosymbiotic cyanobacteria. Our findings indicate that FeCh from Synechocystis exists mostly as a pigment-free monomer in cells but can dimerize, in which case its CAB domain creates a functional pigment-binding segment organized in an energy-dissipating configuration.	[Pazdernik, Marek; Mares, Jan; Pilny, Jan; Sobotka, Roman] Czech Acad Sci, Ctr Algatech, Inst Microbiol, Novohradska 237, Trebon 37981, Czech Republic; [Pazdernik, Marek; Mares, Jan; Sobotka, Roman] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Mares, Jan] Czech Acad Sci, Biol Ctr, Inst Hydrobiol, Ceske Budejovice 37005, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Sobotka, R (corresponding author), Czech Acad Sci, Ctr Algatech, Inst Microbiol, Novohradska 237, Trebon 37981, Czech Republic.	sobotka@alga.cz	Mareš, Jan/B-2395-2009; Sobotka, Roman/J-3077-2014	Mareš, Jan/0000-0002-5745-7023; Pazdernik, Marek/0000-0002-6717-7121; Sobotka, Roman/0000-0001-5909-3879	Czech Science Foundation [17-08755S]; Czech Ministry of Education [LO1416]; University of South Bohemia [04-026/2017]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); University of South Bohemia	This work was supported by Czech Science Foundation Grant 17-08755S and Czech Ministry of Education Project LO1416. This work was also supported by University of South Bohemia Grant 04-026/2017 (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamska I, 1999, EUR J BIOCHEM, V260, P453, DOI 10.1046/j.1432-1327.1999.00178.x; Brzezowski P, 2015, BBA-BIOENERGETICS, V1847, P968, DOI 10.1016/j.bbabio.2015.05.007; Bucinska L, 2018, PLANT PHYSIOL, V176, P2931, DOI 10.1104/pp.18.00061; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; Christodoulou D, 2018, CELL SYST, V6, P569, DOI 10.1016/j.cels.2018.04.009; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-5; Crawford TS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01060; Czarnecki O, 2012, J EXP BOT, V63, P1675, DOI 10.1093/jxb/err437; Dailey HA, 2007, BIOCHEMISTRY-US, V46, P7973, DOI 10.1021/bi700151f; de Armas-Ricard M, 2011, BIOCHEM BIOPH RES CO, V405, P134, DOI 10.1016/j.bbrc.2011.01.013; Engelken J, 2012, ADV PHOTOSYNTH RESP, V33, P265, DOI 10.1007/978-94-007-1533-2_11; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; Heddad M, 2012, ADV PHOTOSYNTH RESP, V34, P299, DOI 10.1007/978-94-007-1579-0_14; Hey D, 2018, PLANT PHYSIOL, V177, P1453, DOI 10.1104/pp.18.00540; Hey D, 2017, PLANT PHYSIOL, V174, P1037, DOI 10.1104/pp.17.00505; Hontani Y, 2018, J PHYS CHEM LETT, V9, P1788, DOI 10.1021/acs.jpclett.8b00663; HUANG LQ, 1990, PLANT PHYSIOL, V92, P172, DOI 10.1104/pp.92.1.172; Ikushiro H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32591-z; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kilian O, 2008, MOL PLANT, V1, P155, DOI 10.1093/mp/ssm019; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; Komenda J, 2016, BBA-BIOENERGETICS, V1857, P288, DOI 10.1016/j.bbabio.2015.08.011; Kopecna J, 2015, J BIOL CHEM, V290, P28477, DOI 10.1074/jbc.M115.664987; Koreny L, 2011, PLANT CELL, V23, P3454, DOI 10.1105/tpc.111.089102; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Llansola-Portoles MJ, 2017, J BIOL CHEM, V292, P1396, DOI 10.1074/jbc.M116.753723; Lohscheider JN, 2015, PLANT CELL ENVIRON, V38, P2115, DOI 10.1111/pce.12540; Mares J, 2018, HYDROBIOLOGIA, V811, P19, DOI 10.1007/s10750-017-3373-2; Masoumi A, 2008, MICROBIOL-SGM, V154, P3707, DOI 10.1099/mic.0.2008/018705-0; Medlock A, 2007, P NATL ACAD SCI USA, V104, P1789, DOI 10.1073/pnas.0606144104; Medlock AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135896; Miller MA, 2015, EVOL BIOINFORM, V11, P43, DOI 10.4137/EBO.S21501; Mork-Jansson A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133145; Myouga F, 2018, PLANT PHYSIOL, V176, P2277, DOI 10.1104/pp.17.01782; Neilson JAD, 2010, GENOME, V53, P68, DOI [10.1139/G09-081, 10.1139/g09-081]; Niedzwiedzki DM, 2016, BBA-BIOENERGETICS, V1857, P1430, DOI 10.1016/j.bbabio.2016.04.280; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Papenbrock J, 2001, PLANT J, V28, P41, DOI 10.1046/j.1365-313X.2001.01126.x; Papenbrock J, 2000, PLANT PHYSIOL, V122, P1161, DOI 10.1104/pp.122.4.1161; Papenbrock J, 2000, PLANT J, V22, P155, DOI 10.1046/j.1365-313x.2000.00724.x; Pilny J, 2015, BIOPROTOCOL, V5, pe1390, DOI DOI 10.21769/BI0PR0T0C.1390; Rast A, 2015, BBA-BIOENERGETICS, V1847, P821, DOI 10.1016/j.bbabio.2015.01.007; Reisinger V, 2008, FEBS LETT, V582, P1547, DOI 10.1016/j.febslet.2008.03.042; Rochaix JD, 2019, BIOCHEM J, V476, P581, DOI 10.1042/BCJ20180718; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanchez-Baracaldo P, 2017, P NATL ACAD SCI USA, V114, pE7737, DOI 10.1073/pnas.1620089114; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scharfenberg M, 2015, PLANT CELL ENVIRON, V38, P280, DOI 10.1111/pce.12248; Schottkowski M, 2009, MOL PLANT, V2, P1289, DOI 10.1093/mp/ssp075; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Shipovskov S, 2005, J MOL BIOL, V352, P1081, DOI 10.1016/j.jmb.2005.08.002; Shukla MK, 2018, PHOTOSYNTH RES, V137, P29, DOI 10.1007/s11120-017-0475-7; Sinha RK, 2012, PLANT CELL ENVIRON, V35, P806, DOI 10.1111/j.1365-3040.2011.02454.x; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; Sobotka R, 2014, PHOTOSYNTH RES, V119, P223, DOI 10.1007/s11120-013-9797-2; Sobotka R, 2011, PLANT PHYSIOL, V155, P1735, DOI 10.1104/pp.110.167528; Staleva H, 2015, NAT CHEM BIOL, V11, P287, DOI [10.1038/nchembio.1755, 10.1038/NCHEMBIO.1755]; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Storm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055569; Takahashi K, 2014, J BIOL CHEM, V289, P987, DOI 10.1074/jbc.M113.525428; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Terry MJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00014; Tichy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00648; Uniacke J, 2007, PLANT CELL, V19, P3640, DOI 10.1105/tpc.107.054882; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020; Xiong W, 2017, PHOTOSYNTH RES, V131, P267, DOI 10.1007/s11120-016-0316-0; Xu H, 2002, PLANT MOL BIOL, V49, P149, DOI 10.1023/A:1014900806905; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yuan XJ, 2016, P NATL ACAD SCI USA, V113, pE5144, DOI 10.1073/pnas.1609865113; Zhao L, 2017, PLANT PHYSIOL, V174, P2419, DOI 10.1104/pp.16.01465; Zhou F, 2017, P NATL ACAD SCI USA, V114, P6866, DOI 10.1073/pnas.1705689114	76	16	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11131	11143		10.1074/jbc.RA119.008434	http://dx.doi.org/10.1074/jbc.RA119.008434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167780	Green Published, hybrid			2022-12-28	WOS:000478717400007
J	Abetov, DA; Kiyan, VS; Zhylkibayev, AA; Sarbassova, DA; Alybayev, SD; Spooner, E; Song, MS; Bersimbaev, RI; Sarbassov, D				Abetov, Danysh A.; Kiyan, Vladimir S.; Zhylkibayev, Assylbek A.; Sarbassova, Dilara A.; Alybayev, Sanzhar D.; Spooner, Eric; Song, Min Sup; Bersimbaev, Rakhmetkazhy, I; Sarbassov, Dos D.			Formation of mammalian preribosomes proceeds from intermediate to composed state during ribosome maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mammalian target of rapamycin (mTOR); ribosomal RNA processing (rRNA processing); ribosomal ribonucleic acid (rRNA) (ribosomal RNA); precursor ribosomal RNA (pre-rRNA); rRNA processing; subcellular fractionation; gradient fractionation; pre-ribosomal complexes; ribosomal biogenesis factors; ribosomal proteins	RNA-POLYMERASE-I; CELL-GROWTH; PRE-RIBOSOMES; HUMAN NAT10; U3 SNORNP; BOX C/D; MTOR; BIOGENESIS; CANCER; SUBUNIT	In eukaryotes, ribosome assembly is a rate-limiting step in ribosomal biogenesis that takes place in a distinctive subnuclear organelle, the nucleolus. How ribosomes get assembled at the nucleolar site by forming initial preribosomal complexes remains poorly characterized. In this study, using several human and murine cell lines, we developed a method for isolation of native mammalian preribosomal complexes by lysing cell nuclei through mild sonication. A sucrose gradient fractionation of the nuclear lysate resolved several ribonucleoprotein (RNP) complexes containing rRNAs and ribosomal proteins. Characterization of the RNP complexes with MS-based protein identification and Northern blotting-based rRNA detection approaches identified two types of preribosomes we named here as intermediate preribosomes (IPRibs) and composed preribosome (CPRib). IPRib complexes comprised large preribosomes (105S to 125S in size) containing the rRNA modification factors and premature rRNAs. We further observed that a distinctive CPRib complex consists of an 85S preribosome assembled with mature rRNAs and a ribosomal biogenesis factor, Ly1 antibody-reactive (LYAR), that does not associate with premature rRNAs and rRNA modification factors. rRNA-labeling experiments uncovered that IPRib assembly precedes CPRib complex formation. We also found that formation of the preribosomal complexes is nutrient-dependent because the abundances of IPRib and CPRib decreased substantially when cells were either deprived of amino acids or exposed to an mTOR kinase inhibitor. These findings indicate that preribosomes form via dynamic and nutrient-dependent processing events and progress from an intermediate to a composed state during ribosome maturation.	[Abetov, Danysh A.; Kiyan, Vladimir S.; Zhylkibayev, Assylbek A.; Sarbassova, Dilara A.; Alybayev, Sanzhar D.; Song, Min Sup; Sarbassov, Dos D.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Spooner, Eric] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Song, Min Sup; Sarbassov, Dos D.] MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Bersimbaev, Rakhmetkazhy, I] LN Gumilyov Eurasian Natl Univ, Dept Nat Sci, Nur Sultan 010000, Kazakhstan; [Sarbassov, Dos D.] Nazarbayev Univ, Dept Biol, Nur Sultan 010000, Kazakhstan; [Abetov, Danysh A.] Cornell Univ, Grad Sch, Ithaca, NY 14853 USA; [Kiyan, Vladimir S.] S Seifullin Kazakh Agro Tech Univ, Dept Microbiol & Biotechnol, Res Platform Agr Biotechnol, Nur Sultan 010000, Kazakhstan; [Zhylkibayev, Assylbek A.] Natl Ctr Biotechnol, Lab Stem Cells, Nur Sultan 010000, Kazakhstan; [Alybayev, Sanzhar D.] Al Farabi Kazakh Natl Univ, Grad Sch, Alma Ata 050040, Kazakhstan	University of Texas System; UTMD Anderson Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Texas System; UTMD Anderson Cancer Center; L.N. Gumilyov Eurasian National University; Nazarbayev University; Cornell University; Saken Seifullin Kazakh Agrotechnical University; National Center for Biotechnology (NCB); Al-Farabi Kazakh National University	Sarbassov, D (corresponding author), Nazarbayev Univ, Dept Biol, Nur Sultan 010000, Kazakhstan.	dos.sarbassov@nu.edu.kz	Sarbassov, Dos/AAS-4950-2020; Kiyan, Vladimir/O-7403-2017; Zhylkibayev, Assylbek A/N-4113-2017; Bersimbaev, Rakhmetkazhy/D-6841-2015	Kiyan, Vladimir/0000-0001-9787-9151; Zhylkibayev, Assylbek A/0000-0001-9244-1505; Bersimbaev, Rakhmetkazhy/0000-0002-9671-1178; Alybayev, Sanzhar/0000-0002-7909-1835; Sarbassov, Dos/0000-0002-6848-1133	Cancer Prevention and Research Institute of Texas (CPRIT) [RP130276, RP140408]; Nazarbayev University; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); Nazarbayev University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cancer Prevention and Research Institute of Texas (CPRIT) Grants RP130276 and RP140408 and startup funding provided by Nazarbayev University (to D.D.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; BOCHNER BR, 1983, ANAL BIOCHEM, V131, P510, DOI 10.1016/0003-2697(83)90206-3; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chasse H, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw907; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Derenzini M, 1998, AM J PATHOL, V152, P1291; Deschoolmeester V, 2010, BRIT J CANCER, V103, P1627, DOI 10.1038/sj.bjc.6605959; Dez C, 2007, RNA, V13, P1516, DOI 10.1261/rna.609807; Dinman Jonathan D, 2005, Int J Biomed Sci, V1, P2; Gandin V, 2014, JOVE-J VIS EXP, DOI 10.3791/51455; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hayano T, 2003, J BIOL CHEM, V278, P34309, DOI 10.1074/jbc.M304304200; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ishii K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-37; Ito S, 2014, J BIOL CHEM, V289, P35724, DOI 10.1074/jbc.C114.602698; Jack K, 2011, MOL CELL, V44, P660, DOI 10.1016/j.molcel.2011.09.017; James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200; KAPOOR CL, 1983, CELL BIOL INT REP, V7, P49, DOI 10.1016/0309-1651(83)90104-2; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kiparisov S, 2005, MOL GENET GENOMICS, V274, P235, DOI 10.1007/s00438-005-0020-9; Klinge S, 2019, NAT REV MOL CELL BIO, V20, P116, DOI 10.1038/s41580-018-0078-y; Kornprobst M, 2016, CELL, V166, P380, DOI 10.1016/j.cell.2016.06.014; Lam YW, 2005, J CELL SCI, V118, P1335, DOI 10.1242/jcs.01736; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lechertier T, 2009, EXP CELL RES, V315, P928, DOI 10.1016/j.yexcr.2009.01.016; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li ZF, 2015, METHODS MOL BIOL, V1228, P35, DOI 10.1007/978-1-4939-1680-1_4; Marks MS, 2001, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb0503s00, DOI 10.1002/0471143030.CB0503S00]; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; MCSWIGGAN DA, 1975, J CLIN PATHOL, V28, P410, DOI 10.1136/jcp.28.5.410; Miyazawa N, 2014, GENES CELLS, V19, P273, DOI 10.1111/gtc.12129; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Nazar RN, 2004, IUBMB LIFE, V56, P457, DOI 10.1080/15216540400010867; Nerurkar P, 2015, INT REV CEL MOL BIO, V319, P107, DOI 10.1016/bs.ircmb.2015.07.002; Pan WA, 2015, RNA BIOL, V12, P255, DOI 10.1080/15476286.2015.1017221; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Pestov Dimitri G, 2008, Curr Protoc Cell Biol, VChapter 22, DOI 10.1002/0471143030.cb2211s39; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Sharma S, 2015, NUCLEIC ACIDS RES, V43, P2242, DOI 10.1093/nar/gkv075; Shimoji K, 2012, NUCLEIC ACIDS RES, V40, P4574, DOI 10.1093/nar/gks057; Sun Q, 2017, ELIFE, V6, DOI 10.7554/eLife.22086; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; TRAPMAN J, 1975, EXP CELL RES, V90, P95, DOI 10.1016/0014-4827(75)90361-4; Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Turner AJ, 2009, MOL CELL BIOL, V29, P3007, DOI 10.1128/MCB.00029-09; Wang MS, 2016, METHODS MOL BIOL, V1455, P147, DOI 10.1007/978-1-4939-3792-9_12; WARNER JR, 1967, P NATL ACAD SCI USA, V58, P1984, DOI 10.1073/pnas.58.5.1984; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; YAMAMOTO R, 1990, J IMMUNOL, V144, P1808; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445	62	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10746	10757		10.1074/jbc.AC119.008378	http://dx.doi.org/10.1074/jbc.AC119.008378			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31076509	Green Published, hybrid			2022-12-28	WOS:000478717200002
J	Guengerich, FP; Wilkey, CJ; Phan, TTN				Guengerich, F. Peter; Wilkey, Clayton J.; Phan, Thanh T. N.			Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; enzyme kinetics; pre-steady-state kinetics; steroid; enzyme mechanism; steroidogenesis; drug metabolism; conformational selection; CYP; induced fit; P450	INDUCED FIT; ESCHERICHIA-COLI; KINETIC-ANALYSIS; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; MOLECULAR-WEIGHT; CAMPHOR BINDING; P-450 REDUCTASE; LIGAND-BINDING; OXIDATION	Cytochrome P450 (P450) enzymes are major catalysts involved in the oxidations of most drugs, steroids, carcinogens, fat-soluble vitamins, and natural products. The binding of substrates to some of the 57 human P450s and other mammalian P450s is more complex than a two-state system and has been proposed to involve mechanisms such as multiple ligand occupancy, induced-fit, and conformational-selection. Here, we used kinetic analysis of binding with multiple concentrations of substrates and computational modeling of these data to discern possible binding modes of several human P450s. We observed that P450 2D6 binds its ligand rolapitant in a mechanism involving conformational-selection. P450 4A11 bound the substrate lauric acid via conformational-selection, as did P450 2C8 with palmitic acid. Binding of the steroid progesterone to P450 21A2 was also best described by a conformational-selection model. Hexyl isonicotinate binding to P450 2E1 could be described by either a conformational-selection or an induced-fit model. Simulation of the binding of the ligands midazolam, bromocriptine, testosterone, and ketoconazole to P450 3A4 was consistent with an induced-fit or a conformational-selection model, but the concentration dependence of binding rates for varying both P450 3A4 and midazolam concentrations revealed discordance in the parameters, indicative of conformational-selection. Binding of the P450s 2C8, 2D6, 3A4, 4A11, and 21A2 was best described by conformational-selection, and P450 2E1 appeared to fit either mode. These findings highlight the complexity of human P450-substrate interactions and that conformational-selection is a dominant feature of many of these interactions.	[Guengerich, F. Peter; Wilkey, Clayton J.; Phan, Thanh T. N.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Phan, Thanh T. N.] Univ N Carolina, Dept Biochem & Biophys, Genet Med Bldg,Bay 3100F,120 Mason Farm Rd, Chapel Hill, NC 27599 USA	Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill	Guengerich, FP (corresponding author), 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Wilkey, Clayton/0000-0001-6062-1093	National Institutes of Health [R01 GM118122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM118122 (to F. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asciutto EK, 2012, BIOCHEMISTRY-US, V51, P3383, DOI 10.1021/bi300007r; BACKES WL, 1985, BIOCHEMISTRY-US, V24, P5130, DOI 10.1021/bi00340a026; Bart AG, 2018, J BIOL CHEM, V293, P19201, DOI 10.1074/jbc.RA118.005588; Bell LC, 1997, J BIOL CHEM, V272, P29643, DOI 10.1074/jbc.272.47.29643; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Chakraborty P, 2017, BIOCHEMISTRY-US, V56, P2853, DOI 10.1021/acs.biochem.7b00340; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; Colthart AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22035; Dabrowski MJ, 2002, J AM CHEM SOC, V124, P11866, DOI 10.1021/ja027552x; Davydov DR, 2013, BIOCHEM J, V453, P219, DOI 10.1042/BJ20130398; Davydov DR, 2003, BIOCHEM BIOPH RES CO, V312, P121, DOI 10.1016/j.bbrc.2003.09.247; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; Fitch William L, 2009, Drug Metab Lett, V3, P191; Follmer AH, 2018, J AM CHEM SOC, V140, P16222, DOI 10.1021/jacs.8b09441; FRENCH JS, 1980, J BIOL CHEM, V255, P4112; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; GILLAM EMJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P59, DOI 10.1006/abbi.1994.1280; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; Glass SM, 2019, DRUG METAB DISPOS, V47, P567, DOI 10.1124/dmd.118.085928; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; Guengerich FP, 2019, J BIOL CHEM, V294, P10028, DOI 10.1074/jbc.RA119.008860; Guengerich FP, 2018, ACS CATAL, V8, P10964, DOI 10.1021/acscatal.8b03401; Guengerich FP, 2018, CHEM REV, V118, P6573, DOI 10.1021/acs.chemrev.8b00031; GUENGERICH FP, 1983, BIOCHEMISTRY-US, V22, P2811, DOI 10.1021/bi00281a007; Guengerich FP, 1996, CRIT REV TOXICOL, V26, P551, DOI 10.3109/10408449609037477; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; GUENGERICH FP, 1979, BIOCHEMISTRY-US, V18, P5442, DOI 10.1021/bi00591a029; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hanna IH, 2001, ARCH BIOCHEM BIOPHYS, V393, P255, DOI 10.1006/abbi.2001.2510; HILDEBRA.A, 1968, BIOCHEM BIOPH RES CO, V30, P607, DOI 10.1016/0006-291X(68)90555-X; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Imai Y., 1978, CYTOCHROME P450, P37; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Johnson K. A., 2017, 12 NEW ENZ KIN WORKS, P23; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Johnson KM, 2017, J BIOL CHEM, V292, P13672, DOI 10.1074/jbc.M116.773937; Johnston WA, 2011, J BIOL CHEM, V286, P40750, DOI 10.1074/jbc.M111.300871; KATAGIRI M, 1982, BIOCHEM BIOPH RES CO, V108, P379, DOI 10.1016/0006-291X(82)91877-0; Kaur P, 2016, J MED CHEM, V59, P4210, DOI 10.1021/acs.jmedchem.5b01146; Kim D, 2014, BIOCHEMISTRY-US, V53, P6161, DOI 10.1021/bi500710e; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lampe JN, 2008, J AM CHEM SOC, V130, P16168, DOI 10.1021/ja8071463; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; MARDEN MC, 1987, ARCH BIOCHEM BIOPHYS, V253, P100, DOI 10.1016/0003-9861(87)90642-4; Menard A, 2012, CHEMBIOCHEM, V13, P2527, DOI 10.1002/cbic.201200524; MITANI F, 1969, J BIOCHEM-TOKYO, V66, P139, DOI 10.1093/oxfordjournals.jbchem.a129129; MITANI F, 1969, J BIOCHEM-TOKYO, V65, P269; Mueller Ernest J., 1995, P83; OHAVER TC, 1976, ANAL CHEM, V48, P312, DOI 10.1021/ac60366a016; OPRIAN DD, 1979, J BIOL CHEM, V254, P8895; Ortiz de Montellano P. R., 2015, CYTOCHROME P450 STRU, P111, DOI DOI 10.1007/978-3-319-12108-6_4; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Parisi G, 2019, FASEB J, V33, P1787, DOI 10.1096/fj.201800450RR; Pearson JT, 2006, BIOCHEMISTRY-US, V45, P6341, DOI 10.1021/bi0600042; Peng CC, 2010, ARCH BIOCHEM BIOPHYS, V497, P68, DOI 10.1016/j.abb.2010.03.011; PETERSON JA, 1976, J BIOL CHEM, V251, P4010; Petrunak EM, 2017, DRUG METAB DISPOS, V45, P635, DOI 10.1124/dmd.117.075317; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Poulos T. L., 2015, CYTOCHROME P450 STRU, V4th, P3, DOI DOI 10.1007/978-3-319-12108-6_1; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; REMMER H, 1966, MOL PHARMACOL, V2, P187; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Rendic SP, 2018, DRUG METAB REV, V50, P256, DOI 10.1080/03602532.2018.1483401; SANDHU P, 1994, ARCH BIOCHEM BIOPHYS, V309, P168, DOI 10.1006/abbi.1994.1099; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Scott E., 2018, 2018 INT M 22 MICR D; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; Sohl CD, 2008, J BIOL CHEM, V283, P7293, DOI 10.1074/jbc.M709783200; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Tang ZM, 2009, ANAL CHEM, V81, P3071, DOI 10.1021/ac900021a; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Vogt AD, 2014, BIOPHYS CHEM, V186, P13, DOI 10.1016/j.bpc.2013.09.003; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Walsh AA, 2013, J BIOL CHEM, V288, P12932, DOI 10.1074/jbc.M113.452953; Yao H, 2007, PROTEINS, V69, P125, DOI 10.1002/prot.21508; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200; Zhou HX, 2010, BIOPHYS J, V98, pL15, DOI 10.1016/j.bpj.2009.11.029	93	26	26	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10928	10941		10.1074/jbc.RA119.009305	http://dx.doi.org/10.1074/jbc.RA119.009305			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31147443	Green Published, hybrid			2022-12-28	WOS:000478717200016
J	Loc'h, J; Gerodimos, CA; Rosario, S; Tekpinar, M; Lieber, MR; Delarue, M				Loc'h, Jerome; Gerodimos, Christina A.; Rosario, Sandrine; Tekpinar, Mustafa; Lieber, Michael R.; Delarue, Marc			Structural evidence for an in trans base selection mechanism involving Loop1 in polymerase mu at an NHEJ double-strand break junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA repair; X-ray crystallography; structural biology; DNA damage; non-homologous DNA end joining; double-strand break; DNA bridging; DNA synapsis; DNA polymerase Pol X family; V(D)J recombination; junctional diversity; ternary complex; Pol mu catalytic cycle	TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; XRCC4-DNA LIGASE-IV; HUMAN POL-MU; DNA-POLYMERASE; CRYSTAL-STRUCTURES; RECOMBINATION; VALIDATION; EXPRESSION; INSERTION; COMPLEX	Eukaryotic DNA polymerase (Pol) X family members such as Pol mu and terminal deoxynucleotidyl transferase (TdT) are important components for the nonhomologous DNA end-joining (NHEJ) pathway. TdT participates in a specialized version of NHEJ, V(D)J recombination. It has primarily nontemplated polymerase activity but can take instructions across strands from the downstream dsDNA, and both activities are highly dependent on a structural element called Loop1. However, it is unclear whether Pol mu follows the same mechanism, because the structure of its Loop1 is disordered in available structures. Here, we used a chimeric TdT harboring Loop1 of Pol mu that recapitulated the functional properties of Pol mu in ligation experiments. We solved three crystal structures of this TdT chimera bound to several DNA substrates at 1.96-2.55 angstrom resolutions, including a full DNA double-strand break (DSB) synapsis. We then modeled the full Pol mu sequence in the context of one these complexes. The atomic structure of an NHEJ junction with a Pol X construct that mimics Pol mu in a reconstituted system explained the distinctive properties of Pol mu compared with TdT. The structure suggested a mechanism of base selection relying on Loop1 and taking instructions via the in trans templating base independently of the primer strand. We conclude that our atomic-level structural observations represent a paradigm shift for the mechanism of base selection in the Pol X family of DNA polymerases.	[Loc'h, Jerome; Rosario, Sandrine; Tekpinar, Mustafa; Delarue, Marc] Inst Pasteur, UMR 3528 CNRS, Unite Dynam Structurale Macromol, 25 Rue Dr Roux, F-75015 Paris, France; [Gerodimos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA; [Gerodimos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Gerodimos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Gerodimos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biol Sci,Sect Mol & Computat Biol, Los Angeles, CA 90033 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Delarue, M (corresponding author), Inst Pasteur, UMR 3528 CNRS, Unite Dynam Structurale Macromol, 25 Rue Dr Roux, F-75015 Paris, France.	marc.delarue@pasteur.fr		Gerodimos, Christina/0000-0002-1787-616X; Lieber, Michael/0000-0003-3700-6345; Tekpinar, Mustafa/0000-0002-0207-0446; Lieber, Michael/0000-0001-8809-0909	Fondation ARC pour la recherche sur la cancer; NATIONAL CANCER INSTITUTE [R01CA100504, R01CA196671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118009] Funding Source: NIH RePORTER	Fondation ARC pour la recherche sur la cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the "Fondation ARC pour la recherche sur la cancer" through a postdoctoral fellowship (to J. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrade P, 2009, P NATL ACAD SCI USA, V106, P16203, DOI 10.1073/pnas.0908492106; Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; Azuara C, 2006, NUCLEIC ACIDS RES, V34, pW38, DOI 10.1093/nar/gkl072; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; Bienstock RJ, 2014, DNA REPAIR, V22, P77, DOI 10.1016/j.dnarep.2014.07.003; Blanc E., 2011, BUSTER VERSION 2 11; Bollum F J, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P347; Brissett NC, 2011, MOL CELL, V41, P221, DOI 10.1016/j.molcel.2010.12.026; Chang HHY, 2016, J BIOL CHEM, V291, P24377, DOI 10.1074/jbc.M116.752329; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esteban V, 2013, DNA REPAIR, V12, P824, DOI 10.1016/j.dnarep.2013.07.007; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Freudenthal BD, 2012, STRUCTURE, V20, P1829, DOI 10.1016/j.str.2012.08.008; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Gerodimos CA, 2017, J BIOL CHEM, V292, P13914, DOI 10.1074/jbc.M117.798850; Gouge J, 2015, EMBO J, V34, P1126, DOI 10.15252/embj.201489643; Gouge J, 2013, J MOL BIOL, V425, P4334, DOI 10.1016/j.jmb.2013.07.009; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Heyer Wolf-Dietrich, 2007, Top Curr Genet, V17, P95; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Martin MJ, 2014, NUCLEIC ACIDS RES, V42, P7923, DOI 10.1093/nar/gku475; Juarez R, 2006, NUCLEIC ACIDS RES, V34, P4572, DOI 10.1093/nar/gkl457; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATO KI, 1967, J BIOL CHEM, V242, P2780; LANDAU NR, 1987, MOL CELL BIOL, V7, P3237, DOI 10.1128/MCB.7.9.3237; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Loc'h J, 2018, CURR OPIN STRUC BIOL, V53, P22, DOI 10.1016/j.sbi.2018.03.019; Loc'h J, 2016, STRUCTURE, V24, P1452, DOI 10.1016/j.str.2016.06.014; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mahajan KN, 1999, P NATL ACAD SCI USA, V96, P13926, DOI 10.1073/pnas.96.24.13926; Malu S, 2012, J EXP MED, V209, P955, DOI 10.1084/jem.20111437; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Mickelsen S, 1999, J IMMUNOL, V163, P834; Moon AF, 2007, NAT STRUCT MOL BIOL, V14, P45, DOI 10.1038/nsmb1180; Moon AF, 2015, P NATL ACAD SCI USA, V112, pE4530, DOI 10.1073/pnas.1505798112; Moon AF, 2014, NAT STRUCT MOL BIOL, V21, P253, DOI 10.1038/nsmb.2766; Nakane S, 2012, J MOL BIOL, V417, P179, DOI 10.1016/j.jmb.2012.01.025; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pryor JM, 2015, P NATL ACAD SCI USA, V112, pE4537, DOI 10.1073/pnas.1505805112; Romain F, 2009, NUCLEIC ACIDS RES, V37, P4642, DOI 10.1093/nar/gkp460; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; THODE S, 1990, CELL, V60, P921, DOI 10.1016/0092-8674(90)90340-K; Waters CA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5286; Waters CA, 2014, DNA REPAIR, V17, P39, DOI 10.1016/j.dnarep.2014.02.008; Yang K, 2016, ACTA BIOCH BIOPH SIN, V48, P632, DOI 10.1093/abbs/gmw046	57	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10579	10595		10.1074/jbc.RA119.008739	http://dx.doi.org/10.1074/jbc.RA119.008739			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138645	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000478717100017
J	Xu, YM; Gao, Q; Xue, YQ; Li, XX; Xu, L; Li, CW; Qin, YQ; Fang, J				Xu, Yiming; Gao, Qiang; Xue, Yaqian; Li, Xiuxiu; Xu, Liang; Li, Chenwei; Qin, Yanqing; Fang, Jing			Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; protein stability; mouse double minute 2 homolog (MDM2); cancer stem cells; colon cancer; prolyl hydroxylase 3	BINDING-SITE; STEM-CELLS; IKK-BETA; HYPOXIA; PROTEIN; PHD3; NANOG; APOPTOSIS; MDM2; DIFFERENTIATION	Prolyl hydroxylase 3 (PHD3) has initially been reported to hydroxylase hypoxia-inducible factor (HIF) and mediate HIF degradation. More recent studies have shown that, in addition to HIF, PHD3 has also other substrates. Moreover, pHD3 is believed to act as a tumor suppressor, but the underlying mechanism remains to be elucidated. Here, we demonstrate that PHD3 stabilizes p53 in a hydroxylase-independent manner. We found that PHD3 overexpression increases and PHD3 knockdown decreases p53 levels. Mechanistically, PHD3 bound MDM2 proto-oncogene (MDM2) and prevented MDM2 from interacting with p53, thereby inhibiting MDM2-mediated p53 degradation. Interestingly, we found that PHD3 overexpression could enhance p53 in the presence of the prolyl hydroxylase inhibitor dimethyloxalylglycine, and the prolyl hydroxylase activity-deficient variant PHD3-H196A also inhibited the p53-MDM2 interaction and stabilized p53. Genetic ablation of PHD3 decreased p53 protein levels in mice intestinal epithelial cells, but a genetic knockin of PHD3-H196A did not affect p53 protein levels in vivo. These results suggest that the prolyl hydroxylase activity of PHD3 is dispensable for its ability to stabilize p53. We found that both PHD3 and PHD3-H196A suppress the expression of the stem cell-associated gene NANOG and inhibited the properties of colon cancer stem cells through p53. Our results reveal an additional critical mechanism underlying the regulation of p53 expression and highlight that PHD3 plays a role in the suppression of colon cancer cell stemness in a hydroxylase-independent manner.	[Xu, Yiming; Gao, Qiang; Xue, Yaqian; Li, Xiuxiu; Qin, Yanqing] Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Xu, Liang] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Li, Chenwei] Shanghai Sunstem Biotechnol, Shanghai 200437, Peoples R China; [Fang, Jing] Qingdao Univ, Canc Inst, Affiliated Hosp, Qingdao 266061, Shandong, Peoples R China; [Fang, Jing] Qingdao Univ, Canc Inst, Qingdao 266061, Shandong, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Qingdao University; Qingdao University	Fang, J (corresponding author), Qingdao Univ, Canc Inst, Affiliated Hosp, Qingdao 266061, Shandong, Peoples R China.; Fang, J (corresponding author), Qingdao Univ, Canc Inst, Qingdao 266061, Shandong, Peoples R China.	jfang@sibs.ac.cn			Ministry of Science and Technology of China [2017YFD0400206]; National Natural Science Foundation of China [31470769, 31670785]; Chinese Academy of Sciences [KFZD-SW-213]; Shanghai Ministry of Science and Technology [16JC1406100]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Ministry of Science and Technology	This work was supported by Ministry of Science and Technology of China Grant 2017YFD0400206, National Natural Science Foundation of China Grants 31470769 and 31670785, Chinese Academy of Sciences Grant KFZD-SW-213, and Shanghai Ministry of Science and Technology Grant 16JC1406100. The authors declare that they have no conflicts of interest with the contents of this article.	Aloni-Grinstein R, 2014, FEBS LETT, V588, P2580, DOI 10.1016/j.febslet.2014.02.011; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bonizzi G, 2012, TRENDS MOL MED, V18, P6, DOI 10.1016/j.molmed.2011.08.002; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chen Y, 2015, J BIOL CHEM, V290, P20580, DOI 10.1074/jbc.M115.653584; Cui L, 2014, MOL CARCINOGEN, V53, P736, DOI 10.1002/mc.22025; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13; Gong S, 2015, MOL CARCINOGEN, V54, P679, DOI 10.1002/mc.22340; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Grand RJA, 1999, ONCOGENE, V18, P449, DOI 10.1038/sj.onc.1202304; Hatzimichael E, 2010, EUR J HAEMATOL, V84, P47, DOI 10.1111/j.1600-0609.2009.01344.x; Henze AT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6582; Hock AK, 2014, BBA-MOL CELL RES, V1843, P137, DOI 10.1016/j.bbamcr.2013.05.022; Ibrahim EE, 2012, STEM CELLS, V30, P2076, DOI 10.1002/stem.1182; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karni-Schmidt O, 2016, ANNU REV PATHOL-MECH, V11, P617, DOI 10.1146/annurev-pathol-012414-040349; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu DP, 2010, NAT CELL BIOL, V12, P993, DOI 10.1038/ncb2100; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Moll UM, 2003, MOL CANCER RES, V1, P1001; Pan Y, 2004, ONCOGENE, V23, P4975, DOI 10.1038/sj.onc.1207657; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Peurala E, 2012, BREAST CANCER RES TR, V133, P179, DOI 10.1007/s10549-011-1750-5; Place TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014617; Rantanen K, 2008, MOL BIOL CELL, V19, P2231, DOI 10.1091/mbc.E07-11-1124; Rodriguez J, 2018, CELL REP, V24, P1316, DOI 10.1016/j.celrep.2018.06.108; Rodriguez J, 2016, CELL REP, V14, P2745, DOI 10.1016/j.celrep.2016.02.043; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Su CL, 2012, MED ONCOL, V29, P2710, DOI 10.1007/s12032-012-0171-6; Tanaka T, 2014, J CANCER RES CLIN, V140, P503, DOI 10.1007/s00432-014-1593-7; Tennant DA, 2010, J MOL MED, V88, P839, DOI 10.1007/s00109-010-0627-0; Wang YX, 2016, CANCER LETT, V383, P1, DOI 10.1016/j.canlet.2016.09.009; Xie L, 2012, J CLIN INVEST, V122, P2827, DOI 10.1172/JCI62374; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004	47	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9949	9958		10.1074/jbc.RA118.007181	http://dx.doi.org/10.1074/jbc.RA118.007181			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31092600	Green Published, hybrid			2022-12-28	WOS:000473277900025
J	[Anonymous]				[Anonymous]			Liver kinase B1 expression promotes phosphatase activity and abrogation of receptor tyrosine kinase phosphorylation in human cancer cells (Expression of Concern of Vol 289, Pg 1639, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Okon IS, 2014, J BIOL CHEM, V289, P1639, DOI 10.1074/jbc.M113.500934	1	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					10022	10022		10.1074/jbc.EC119.009568	http://dx.doi.org/10.1074/jbc.EC119.009568			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31227627	Green Published, hybrid			2022-12-28	WOS:000473277900035
J	Benseny-Cases, N; Karamanos, TK; Hoop, CL; Baum, J; Radford, SE				Benseny-Cases, Nuria; Karamanos, Theodoros K.; Hoop, Cody L.; Baum, Jean; Radford, Sheena E.			Extracellular matrix components modulate different stages in (2)-microglobulin amyloid formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; protein aggregation; protein misfolding; collagen; extracellular matrix; fibril; 2-microglobulin; dialysis-related amyloidosis (DRA); glycosaminoglycan; heparin; MHC I	DIALYSIS-RELATED AMYLOIDOSIS; BETA-2-MICROGLOBULIN; BETA(2)-MICROGLOBULIN; HEMODIALYSIS; GLYCOSAMINOGLYCANS; FIBRILS; INHIBIT; AGGREGATION; CHAPERONES; AFFINITY	Amyloid deposition of WT human (2)-microglobulin (WT-h(2)m) in the joints of long-term hemodialysis patients is the hallmark of dialysis-related amyloidosis. In vitro, WT-h(2)m does not form amyloid fibrils at physiological pH and temperature unless co-solvents or other reagents are added. Therefore, understanding how fibril formation is initiated and maintained in the joint space is important for elucidating WT-h(2)m aggregation and dialysis-related amyloidosis onset. Here, we investigated the roles of collagen I and the commonly administered anticoagulant, low-molecular-weight (LMW) heparin, in the initiation and subsequent aggregation phases of WT-h(2)m in physiologically relevant conditions. Using thioflavin T fluorescence to study the kinetics of amyloid formation, we analyzed how these two agents affect specific stages of WT-h(2)m assembly. Our results revealed that LMW-heparin strongly promotes WT-h(2)m fibrillogenesis during all stages of aggregation. However, collagen I affected WT-h(2)m amyloid formation in contrasting ways: decreasing the lag time of fibril formation in the presence of LMW-heparin and slowing the rate at higher concentrations. We found that in self-seeded reactions, interaction of collagen I with WT-h(2)m amyloid fibrils attenuates surface-mediated growth of WT-h(2)m fibrils, demonstrating a key role of secondary nucleation in WT-h(2)m amyloid formation. Interestingly, collagen I fibrils did not suppress surface-mediated assembly of WT-h(2)m monomers when cross-seeded with fibrils formed from the N-terminally truncated variant N6-h(2)m. Together, these results provide detailed insights into how collagen I and LMW-heparin impact different stages in the aggregation of WT-h(2)m into amyloid, which lead to dramatic effects on the time course of assembly.	[Benseny-Cases, Nuria; Karamanos, Theodoros K.; Radford, Sheena E.] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Benseny-Cases, Nuria; Karamanos, Theodoros K.; Radford, Sheena E.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Hoop, Cody L.; Baum, Jean] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Benseny-Cases, Nuria] ALBA Synchrotron Light Source, Carrer Llum 2-26, Cerdanyola Del Valles 08290, Catalonia, Spain; [Karamanos, Theodoros K.] NIDDK, NIH, Bethesda, MD 20892 USA	University of Leeds; University of Leeds; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Baum, J (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.; Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.; Radford, SE (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	jean.baum@rutgers.edu; s.e.radford@leeds.ac.uk	Karamanos, Theodoros/GNH-3307-2022	Benseny-Cases, Nuria/0000-0003-4603-6829; Karamanos, Theodoros/0000-0003-2297-540X; Radford, Sheena/0000-0002-3079-8039	Wellcome Trust [094232]; University of Leeds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045302] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); University of Leeds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our laboratories for helpful discussions and Nasir Khan for excellent technical support. The NMR instrumentation was funded by Wellcome Trust Grant 094232 and by the University of Leeds.	Arosio P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10948; BARDIN T, 1985, ARTHRITIS RHEUM, V28, P1052, DOI 10.1002/art.1780280913; Bella J, 2006, J MOL BIOL, V362, P298, DOI 10.1016/j.jmb.2006.07.014; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; BRODSKY B, 1992, BIOPOLYMERS, V32, P447, DOI 10.1002/bip.360320423; Calabrese MF, 2008, NAT STRUCT MOL BIOL, V15, P965, DOI 10.1038/nsmb.1483; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dember LM, 2006, SEMIN DIALYSIS, V19, P105, DOI 10.1111/j.1525-139X.2006.00134.x; Dobson J, 2017, P NATL ACAD SCI USA, V114, P4673, DOI 10.1073/pnas.1702724114; Dzido G, 2003, Minerva Urol Nefrol, V55, P121; Eakin CM, 2005, BBA-PROTEINS PROTEOM, V1753, P92, DOI 10.1016/j.bbapap.2005.09.002; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Esposito G, 2013, J BIOL CHEM, V288, P17844, DOI 10.1074/jbc.M112.448639; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; GEJYO F, 1986, KIDNEY INT, V30, P385, DOI 10.1038/ki.1986.196; Giorgetti S, 2005, PROTEIN SCI, V14, P696, DOI 10.1110/ps.041194005; Goodchild SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104492; Habchi J, 2017, P NATL ACAD SCI USA, V114, pE200, DOI 10.1073/pnas.1615613114; HADJIPAVLOU A, 1988, J BONE JOINT SURG AM, V70A, P119, DOI 10.2106/00004623-198870010-00019; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; HOMMA N, 1989, NEPHRON, V53, P37, DOI 10.1159/000185699; Iadanza MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06761-6; Iannuzzi C, 2016, BBA-MOL BASIS DIS, V1862, P93, DOI 10.1016/j.bbadis.2015.10.021; Inoue S, 1997, KIDNEY INT, V52, P1543, DOI 10.1038/ki.1997.484; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; LONG CG, 1993, BIOCHEMISTRY-US, V32, P11688, DOI 10.1021/bi00094a027; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Moe SM, 2001, SEMIN DIALYSIS, V14, P127, DOI 10.1046/j.1525-139x.2001.00032.x; Morgan CJ, 2001, J MOL BIOL, V309, P339, DOI 10.1006/jmbi.2001.4661; MUNOZGOMEZ J, 1985, ANN RHEUM DIS, V44, P729, DOI 10.1136/ard.44.11.729; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Platt GW, 2009, FEBS LETT, V583, P2623, DOI 10.1016/j.febslet.2009.05.005; Quittot N, 2017, BIOCHEM CELL BIOL, V95, P329, DOI 10.1139/bcb-2016-0236; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; SANANTONIO JD, 1994, J CELL BIOL, V125, P1179, DOI 10.1083/jcb.125.5.1179; Sarell CJ, 2013, J BIOL CHEM, V288, P7327, DOI 10.1074/jbc.M112.447524; Scarpioni R, 2016, INT J NEPHROL RENOV, V9, P319, DOI 10.2147/IJNRD.S84784; Stewart Katie L, 2017, Biophys Rev, V9, P405, DOI 10.1007/s12551-017-0271-9; Stewart KL, 2017, J MOL BIOL, V429, P2449, DOI 10.1016/j.jmb.2017.07.003; Stewart KL, 2016, J AM CHEM SOC, V138, P8328, DOI 10.1021/jacs.6b02816; Sultan A, 2013, J BIOL CHEM, V288, P32326, DOI 10.1074/jbc.M113.498337; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wieczorek M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00292; Wyatt AR, 2012, J MOL BIOL, V421, P499, DOI 10.1016/j.jmb.2012.01.004; Yamamoto K, 2008, J MOL BIOL, V376, P258, DOI 10.1016/j.jmb.2007.12.002; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7	54	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9392	9401		10.1074/jbc.RA119.008300	http://dx.doi.org/10.1074/jbc.RA119.008300			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	30996004	Green Published, hybrid			2022-12-28	WOS:000472713000010
J	Pandey, AK; Pain, J; Dancis, A; Pain, D				Pandey, Ashutosh K.; Pain, Jayashree; Dancis, Andrew; Pain, Debkumar			Mitochondria export iron-sulfur and sulfur intermediates to the cytoplasm for iron-sulfur cluster assembly and tRNA thiolation in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						yeast; mitochondria; iron; sulfur; ABC transporter; iron-sulfur protein; cytoplasm; export; metal cofactor; tRNA thiolation	ABC TRANSPORTER; CFD1-NBP35 COMPLEX; FE4S4 CLUSTER; PROTEIN; BIOGENESIS; FRATAXIN; REVEALS; MATURATION; COMPONENT; SCAFFOLD	Iron-sulfur clusters are essential cofactors of proteins. In eukaryotes, iron-sulfur cluster biogenesis requires a mitochondrial iron-sulfur cluster machinery (ISC) and a cytoplasmic iron-sulfur protein assembly machinery (CIA). Here we used mitochondria and cytoplasm isolated from yeast cells, and [S-35]cysteine to detect cytoplasmic Fe-S-35 cluster assembly on a purified apoprotein substrate. We showed that mitochondria generate an intermediate, called (Fe-S)(int), needed for cytoplasmic iron-sulfur cluster assembly. The mitochondrial biosynthesis of (Fe-S)(int) required ISC components such as Nfs1 cysteine desulfurase, Isu1/2 scaffold, and Ssq1 chaperone. Mitochondria then exported (Fe-S)(int) via the Atm1 transporter in the inner membrane, and we detected (Fe-S)(int) in active form. When (Fe-S)(int) was added to cytoplasm, CIA utilized it for iron-sulfur cluster assembly without any further help from the mitochondria. We found that both iron and sulfur for cytoplasmic iron-sulfur cluster assembly originate from the mitochondria, revealing a surprising and novel mitochondrial role. Mitochondrial (Fe-S)(int) export was most efficient in the presence of cytoplasm containing an apoprotein substrate, suggesting that mitochondria respond to the cytoplasmic demand for iron-sulfur cluster synthesis. Of note, the (Fe-S)(int) is distinct from the sulfur intermediate called S-int, which is also made and exported by mitochondria but is instead used for cytoplasmic tRNA thiolation. In summary, our findings establish a direct and vital role of mitochondria in cytoplasmic iron-sulfur cluster assembly in yeast cells.	[Pandey, Ashutosh K.; Pain, Jayashree; Pain, Debkumar] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, 185 South Orange Ave,Med Sci Bldg,Rm I-669, Newark, NJ 07103 USA; [Dancis, Andrew] Univ Penn, Dept Med, Perelman Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Pennsylvania Medicine	Pain, D (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, 185 South Orange Ave,Med Sci Bldg,Rm I-669, Newark, NJ 07103 USA.	painde@njms.rutgers.edu	Pandey, Ashutosh K/X-9389-2018		National Institutes of Health [R01 GM107542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM107542 (to D. P. and A. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; Amutha B, 2009, METHOD ENZYMOL, V456, P247, DOI 10.1016/S0076-6879(08)04414-5; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Bekri S, 2000, BLOOD, V96, P3256; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Boniecki MT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01497-1; Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970; Braymer JJ, 2018, CELL CHEM BIOL, V25, P645, DOI 10.1016/j.chembiol.2018.06.003; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Chen S, 2007, J BIOL CHEM, V282, P21561, DOI 10.1074/jbc.M702383200; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Cory SA, 2017, P NATL ACAD SCI USA, V114, pE5325, DOI 10.1073/pnas.1702849114; Dlouhy AC, 2013, METAL IONS LIFE SCI, V12, P241, DOI 10.1007/978-94-007-5561-1_8; Dutkiewicz R, 2004, J BIOL CHEM, V279, P29167, DOI 10.1074/jbc.M402947200; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li JW, 2015, CHEM COMMUN, V51, P2253, DOI 10.1039/c4cc09175b; Li LT, 2011, J BIOL CHEM, V286, P38488, DOI 10.1074/jbc.M111.286666; Lill R, 2015, EUR J CELL BIOL, V94, P280, DOI 10.1016/j.ejcb.2015.05.002; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu YC, 2016, P NATL ACAD SCI USA, V113, P12703, DOI 10.1073/pnas.1615732113; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Melber A, 2018, METHOD ENZYMOL, V599, P265, DOI 10.1016/bs.mie.2017.09.004; Nakai Y, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010017; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2012, J BIOL CHEM, V287, P12365, DOI 10.1074/jbc.M111.328914; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Pandey A, 2018, CELL CHEM BIOL, V25, P738, DOI 10.1016/j.chembiol.2018.04.002; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Pandey A, 2012, MITOCHONDRION, V12, P539, DOI 10.1016/j.mito.2012.07.103; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Ranatunga W, 2016, J BIOL CHEM, V291, P10378, DOI 10.1074/jbc.M115.712414; Rezgui VAN, 2013, P NATL ACAD SCI USA, V110, P12289, DOI 10.1073/pnas.1300781110; Rietzschel N, 2015, MOL CELL BIOL, V35, P370, DOI 10.1128/MCB.01033-14; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Schaedler TA, 2014, J BIOL CHEM, V289, P23264, DOI 10.1074/jbc.M114.553438; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Uzarska MA, 2013, MOL BIOL CELL, V24, P1830, DOI 10.1091/mbc.E12-09-0644; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Vergara SV, 2009, CELL, V137, P1179, DOI 10.1016/j.cell.2009.06.005; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Webert H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6013; Winkler M, 2010, EUR J CELL BIOL, V89, P998, DOI 10.1016/j.ejcb.2010.06.018; Yoon H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005135; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	61	37	37	8	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9489	9502		10.1074/jbc.RA119.008600	http://dx.doi.org/10.1074/jbc.RA119.008600			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31040179	Green Published, hybrid			2022-12-28	WOS:000472713000017
J	Dunne, OM; Davies, OR				Dunne, Orla M.; Davies, Owen R.			A molecular model for self-assembly of the synaptonemal complex protein SYCE3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						meiosis; protein self-assembly; small-angle X-ray scattering (SAXS); molecular modeling; biophysics; structural biology; chromatin structure; coiled-coil; domain swap; SYCE3; synaptonemal complex; chromosomes; protein structure	MEIOSIS-SPECIFIC PROTEIN; CENTRAL ELEMENT; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CENTRAL REGION; RESOLUTION; SCP1; ORGANIZATION; ANEUPLOIDY; SYNAPSIS	The synaptonemal complex (SC) is a supramolecular protein assembly that mediates homologous chromosome synapsis during meiosis. This zipper-like structure assembles in a continuous manner between homologous chromosome axes, enforcing a 100-nm separation along their entire length and providing the necessary three-dimensional framework for cross-over formation. The mammalian SC comprises eight componentssynaptonemal complex protein 1-3 (SYCP1-3), synaptonemal complex central element protein 1-3 (SYCE1-3), testis-expressed 12 (TEX12), and six6 opposite strand transcript 1 (SIX6OS1)arranged in transverse and longitudinal structures. These largely -helical, coiled-coil proteins undergo heterotypic interactions, coupled with recursive self-assembly of SYCP1, SYCE2-TEX12, and SYCP2-SYCP3, to achieve the vast supramolecular SC structure. Here, we report a novel self-assembly mechanism of the SC central element component SYCE3, identified through multi-angle light scattering and small-angle X-ray scattering (SAXS) experiments. These analyses revealed that SYCE3 adopts a dimeric four-helical bundle structure that acts as the building block for concentration-dependent self-assembly into a series of discrete higher-order oligomers. We observed that this is achieved through staggered lateral interactions between self-assembly surfaces of SYCE3 dimers and through end-on interactions that likely occur through intermolecular domain swapping between dimer folds. These mechanisms are combined to achieve potentially limitless SYCE3 assembly, particularly favoring formation of dodecamers of three laterally associated end-on tetramers. Our findings extend the family of self-assembling proteins within the SC and reveal additional means for structural stabilization of the SC central element.	[Dunne, Orla M.; Davies, Owen R.] Newcastle Univ, Inst Cell & Mol Biosci, Fac Med Sci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Davies, OR (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Fac Med Sci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	owen.davies@newcastle.ac.uk	Davies, Owen/J-4820-2019	Davies, Owen/0000-0002-3806-5403	Wellcome Trust [104158/Z/14/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai YS, 2016, CHEM SOC REV, V45, P2756, DOI 10.1039/c6cs00004e; Bolcun-Filas E, 2007, J CELL BIOL, V176, P741, DOI 10.1083/jcb.200610027; Bolcun-Filas E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000393; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davies OR, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120099; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Dunce JM, 2018, NAT STRUCT MOL BIOL, V25, P557, DOI 10.1038/s41594-018-0078-9; Dunne OM, 2019, CHROMOSOMA, V128, P223, DOI 10.1007/s00412-018-00688-z; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fraune J, 2012, EXP CELL RES, V318, P1340, DOI 10.1016/j.yexcr.2012.02.018; Garcia-Seisdedos H, 2017, NATURE, V548, P244, DOI 10.1038/nature23320; Geisinger A, 2016, CYTOGENET GENOME RES, V150, P77, DOI 10.1159/000453344; Gomez L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13298; Hamer G, 2008, J CELL SCI, V121, P2445, DOI 10.1242/jcs.033233; Hamer G, 2006, J CELL SCI, V119, P4025, DOI 10.1242/jcs.03182; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hernandez-Hernandez A, 2016, J CELL SCI, V129, P2239, DOI 10.1242/jcs.182477; Herrmann H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018242; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Jordan PW, 2012, J CELL SCI, V125, P5061, DOI 10.1242/jcs.105015; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kouznetsova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028255; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Liu JG, 1996, EXP CELL RES, V226, P11, DOI 10.1006/excr.1996.0197; Lu J, 2014, SCI REP-UK, V4, DOI 10.1038/srep07059; McManus JJ, 2016, CURR OPIN COLLOID IN, V22, P73, DOI 10.1016/j.cocis.2016.02.011; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; MOSES MJ, 1956, J BIOPHYS BIOCHEM CY, V2, P215, DOI 10.1083/jcb.2.2.215; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; Ollinger R, 2005, MOL BIOL CELL, V16, P212; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmekel K, 1996, EXP CELL RES, V226, P20, DOI 10.1006/excr.1996.0198; SCHMEKEL K, 1995, TRENDS CELL BIOL, V5, P239, DOI 10.1016/S0962-8924(00)89017-0; SCHMEKEL K, 1993, CHROMOSOMA, V102, P682, DOI 10.1007/BF00650894; Schramm S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002088; Schucker K, 2015, P NATL ACAD SCI USA, V112, P2029, DOI 10.1073/pnas.1414814112; SOLARI AJ, 1980, CHROMOSOMA, V81, P315, DOI 10.1007/BF00368145; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Syrjanen JL, 2014, ELIFE, V3, DOI 10.7554/eLife.02963; Syrjanen JL, 2017, ELIFE, V6, DOI 10.7554/eLife.22582; West AMV, 2019, ELIFE, V8, DOI 10.7554/eLife.40372; WESTERGAARD M, 1972, ANNU REV GENET, V6, P71, DOI 10.1146/annurev.ge.06.120172.000443; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 1998, J CELL BIOL, V142, P331, DOI 10.1083/jcb.142.2.331; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626	56	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9260	9275		10.1074/jbc.RA119.008404	http://dx.doi.org/10.1074/jbc.RA119.008404			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31023827	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000471751600019
J	Kornilov, A; Kennedy, PD; Aldrovandi, M; Watson, AJA; Hinz, C; Harless, B; Colombo, J; Maxey, KM; Tyrrell, VJ; Simon, M; Aggarwal, VK; Boeglin, WE; Brash, AR; Murphy, RC; O'Donnell, VB				Kornilov, Andrei; Kennedy, Paul D.; Aldrovandi, Maceler; Watson, Andrew J. A.; Hinz, Christine; Harless, Bryan; Colombo, Joseph; Maxey, Kirk M.; Tyrrell, Victoria J.; Simon, Matthew; Aggarwal, Varinder K.; Boeglin, William E.; Brash, Alan R.; Murphy, Robert C.; O'Donnell, Valerie B.			Revising the structure of a new eicosanoid from human platelets to 8,9-11,12-diepoxy-13-hydroxyeicosadienoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eicosanoid; cyclooxygenase (COX); platelet; lipid; lipid metabolism; 8; 9-11; 12-diepoxy-13-hydroxyeicosadienoic acid (8; 9-11; 12-DiEp-13-HEDE); 8-hydroxy-9; 11-dioxolane eicosatetraenoic acid (DXA3); DiEpHEDE; immunity; leukocyte-regulating lipid	IDENTIFICATION; ENDOPEROXIDES; NEUTROPHILS; THROMBOSIS	Eicosanoids are critical mediators of fever, pain, and inflammation generated by immune and tissue cells. We recently described a new bioactive eicosanoid generated by cyclooxygenase-1 (COX-1) turnover during platelet activation that can stimulate human neutrophil integrin expression. On the basis of mass spectrometry (MS/MS and MS3), stable isotope labeling, and GC-MS analysis, we previously proposed a structure of 8-hydroxy-9,11-dioxolane eicosatetraenoic acid (DXA(3)). Here, we achieved enzymatic synthesis and H-1 NMR characterization of this compound with results in conflict with the previously proposed structural assignment. Accordingly, by using LC-MS, we screened autoxidation reactions of 11-hydroperoxy-eicosatetraenoic acid (11-HpETE) and thereby identified a candidate sharing the precise reverse-phase chromatographic and MS characteristics of the platelet product. We optimized these methods to increase yield, allowing full structural analysis by H-1 NMR. The revised assignment is presented here as 8,9-11,12-diepoxy-13-hydroxyeicosadienoic acid, abbreviated to 8,9-11,12-DiEp-13-HEDE or DiEpHEDE, substituted for the previous name DXA(3). We found that in platelets, the lipid likely forms via dioxolane ring opening with rearrangement to the diepoxy moieties followed by oxygen insertion at C13. We present its enzymatic biosynthetic pathway and MS/MS fragmentation pattern and, using the synthetic compound, demonstrate that it has bioactivity. For the platelet lipid, we estimate 16 isomers based on our current knowledge (and four isomers for the synthetic lipid). Determining the exact isomeric structure of the platelet lipid remains to be undertaken.	[Kornilov, Andrei; Kennedy, Paul D.; Harless, Bryan; Colombo, Joseph; Maxey, Kirk M.; Simon, Matthew] Cayman Chem, 1180 E Ellsworth Rd, Ann Arbor, MI 48108 USA; [Aldrovandi, Maceler; Watson, Andrew J. A.; Hinz, Christine; Tyrrell, Victoria J.; O'Donnell, Valerie B.] Cardiff Univ, Syst Immun Res Inst, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Aggarwal, Varinder K.] Univ Bristol, Sch Chem, Bristol BS6 6RU, Avon, England; [Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Sch Med, Nashville, TN 37232 USA; [Murphy, Robert C.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA	Cardiff University; University of Bristol; Vanderbilt University; Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus	Kornilov, A (corresponding author), Cayman Chem, 1180 E Ellsworth Rd, Ann Arbor, MI 48108 USA.; O'Donnell, VB (corresponding author), Cardiff Univ, Syst Immun Res Inst, Sch Med, Cardiff CF14 4XN, S Glam, Wales.	akornilov@caymanchem.com; o-donnellvb@cardiff.ac.uk	Murphy, Robert/AAO-5349-2020; Aggarwal, Varinder/AAG-8504-2019	Murphy, Robert/0000-0002-9430-6515; Aggarwal, Varinder/0000-0003-0344-6430	Wellcome Trust [094143/Z/10/Z]; British Heart Foundation [RG/12/11/29815]; European Research Council (LipidArrays); National Institutes of Health [HL 117798]; EPSRC [EP/L011999/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L011999/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); European Research Council (LipidArrays); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Wellcome Trust Grant 094143/Z/10/Z, British Heart Foundation Grant RG/12/11/29815, and the European Research Council (LipidArrays) (to V. B. O.) and by National Institutes of Health Grant HL 117798 (to R. C. M.). R. C. M. is a consultant for Avanti Polar Lipids and Cayman Chemical. K. M. M. is President and CEO of Cayman Chemical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aldrovandi M, 2017, REDOX BIOL, V11, P663, DOI 10.1016/j.redox.2017.01.001; Gilbert NC, 2018, METHOD ENZYMOL, V605, P33, DOI 10.1016/bs.mie.2018.02.010; Hinz C, 2016, J BIOL CHEM, V291, P13448, DOI 10.1074/jbc.M115.700609; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Maugeri N, 2014, J THROMB HAEMOST, V12, P2074, DOI 10.1111/jth.12710; Murphy R. C., 2015, TANDEM MASS SPECTROM; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Smith JP, 2010, THROMB RES, V126, pE23, DOI 10.1016/j.thromres.2010.04.003; Teder T, 2014, J LIPID RES, V55, P2587, DOI 10.1194/jlr.M054072; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Yin HY, 2007, J BIOL CHEM, V282, P29890, DOI 10.1074/jbc.M703108200; Yin HY, 2004, J BIOL CHEM, V279, P3766, DOI 10.1074/jbc.M307137200	13	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9225	9238		10.1074/jbc.RA119.008915	http://dx.doi.org/10.1074/jbc.RA119.008915			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	31061099	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000471751600017
J	Landers, CT; Tung, HY; Knight, JM; Madison, MC; Wu, YF; Zeng, ZM; Porter, PC; Rodriguez, A; Flick, MJ; Kheradmand, F; Corry, DB				Landers, Cameron T.; Tung, Hui-Ying; Knight, J. Morgan; Madison, Matthew C.; Wu, Yifan; Zeng, Zhimin; Porter, Paul C.; Rodriguez, Antony; Flick, Matthew J.; Kheradmand, Farrah; Corry, David B.			Selective cleavage of fibrinogen by diverse proteinases initiates innate allergic and antifungal immunity through CD11b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergy; proteinase; fibrinogen; fungi; integrin; innate immunity; Toll-like receptor 4 (TLR4)	AIRWAY EPITHELIAL-CELLS; HOUSE-DUST MITE; MAC-1 CD11B/CD18; INFLAMMATION; MECHANISM; MOLD; ASTHMA; MICE; RECOGNITION; ACTIVATION	Proteinases are essential drivers of allergic airway disease and innate antifungal immunity in part through their ability cleave the clotting factor fibrinogen (FBG) into fibrinogen cleavage products (FCPs) that signal through Toll-like receptor 4 (TLR4). However, the mechanism by which FCPs engage TLR4 remains unknown. Here, we show that the proteinases from Aspergillus melleus (PAM) and other allergenic organisms rapidly hydrolyze FBG to yield relatively few FCPs that drive distinct antifungal mechanisms through TLR4. Functional FCPs, termed cryptokines, were characterized by rapid loss of the FBG chain with substantial preservation of the and chains, including a chain sequence (Fib390-396) that binds the integrin Mac-1 (CD11b/CD18). PAM-derived cryptokines could be generated from multiple FBG domains, and the ability of cryptokines to induce fungistasis in vitro and innate allergic airway disease in vivo strongly depended on both Mac-1 and the Mac-1-binding domain of FBG (Fib390-396). Our findings illustrate the essential concept of proteinase-activated immune responses and for the first time link Mac-1, cryptokines, and TLR4 to innate antifungal immunity and allergic airway disease.	[Landers, Cameron T.; Madison, Matthew C.; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Tung, Hui-Ying; Knight, J. Morgan; Wu, Yifan; Rodriguez, Antony; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Landers, Cameron T.; Tung, Hui-Ying; Knight, J. Morgan; Madison, Matthew C.; Wu, Yifan; Porter, Paul C.; Rodriguez, Antony; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Tung, Hui-Ying; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA; [Landers, Cameron T.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Kheradmand, Farrah; Corry, David B.] Michael E DeBakey Vet Affairs Ctr Translat Res In, Houston, TX 77030 USA; [Zeng, Zhimin] Sun Yat Sen Univ, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [Flick, Matthew J.] Cincinnati Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Sun Yat Sen University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Kheradmand, F (corresponding author), Baylor Coll Med, One Baylor Plaza,BCM 285, Houston, TX 77030 USA.; Corry, DB (corresponding author), Baylor Coll Med, One Baylor Plaza,BCM 245, Houston, TX 77030 USA.	farrahk@bcm.edu; dcorry@bcm.edu		Landers, Cameron/0000-0002-1507-282X; Madison, Matthew/0000-0001-8143-7471	National Institutes of Health [T32AI053831, R01HL117181, R01AI135803, R41AI124997]; Veterans Affairs Office of Research and Development [5I01BX002221]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI135803, T32AI053831] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Office of Research and Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants T32AI053831, R01HL117181, R01AI135803, and R41AI124997 and Veterans Affairs Office of Research and Development Grant 5I01BX002221. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Akinbami Lara J, 2012, NCHS Data Brief, P1; ALTIERI DC, 1995, J BIOL CHEM, V270, P696, DOI 10.1074/jbc.270.2.696; Arnot CJ, 2010, J BIOL CHEM, V285, P19502, DOI 10.1074/jbc.M109.098186; Aubier M, 2016, J ALLERGY CLIN IMMUN, V138, P729, DOI 10.1016/j.jaci.2015.12.1332; Balenga NA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7763; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; Boehm Tobias K., 2008, Human Antibodies, V17, P45; Burr ML, 2007, THORAX, V62, P767, DOI 10.1136/thx.2006.070847; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Chiu LL, 2007, J IMMUNOL, V178, P5237, DOI 10.4049/jimmunol.178.8.5237; Cho M, 2018, J ALLERGY CLIN IMMUN, V142, P530, DOI 10.1016/j.jaci.2017.09.019; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Das AM, 1997, J IMMUNOL, V159, P1466; Denis O, 2007, IMMUNOLOGY, V122, P268, DOI 10.1111/j.1365-2567.2007.02636.x; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Esnault S, 2016, J ALLERGY CLIN IMMUN, V137, P767, DOI 10.1016/j.jaci.2015.05.053; Flick MJ, 2004, EXP BIOL MED, V229, P1105, DOI 10.1177/153537020422901104; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Florsheim E, 2015, J IMMUNOL, V194, P4621, DOI 10.4049/jimmunol.1402493; Goswami S, 2009, NAT IMMUNOL, V10, P496, DOI 10.1038/ni.1719; Hadebe S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134219; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hodgkinson CR, 2008, THROMB HAEMOSTASIS, V100, P301, DOI 10.1160/TH08-03-0179; Homma T, 2016, AM J RESP CELL MOL, V54, P60, DOI 10.1165/rcmb.2015-0062OC; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Jia GQ, 1999, INT IMMUNOL, V11, P1, DOI 10.1093/intimm/11.1.1; Kanwar S, 2001, AM J RESP CELL MOL, V25, P170, DOI 10.1165/ajrcmb.25.2.4295; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kohler S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004346; KUMAR P, 1990, ANN ALLERGY, V64, P174; Larangeira AP, 2001, INFLAMM RES, V50, P309, DOI 10.1007/PL00000249; Lee SH, 2008, J IMMUNOL, V180, P4656, DOI 10.4049/jimmunol.180.7.4656; Lee SH, 2003, NAT MED, V9, P1281, DOI 10.1038/nm932; Ling GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4039; Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200; Loftus PA, 2015, INT FORUM ALLERGY RH, V5, pS7, DOI 10.1002/alr.21547; Mak G, 2013, CLIN IMMUNOL, V146, P77, DOI 10.1016/j.clim.2012.11.005; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Nadeem A, 2015, IMMUNOLOGY, V145, P391, DOI 10.1111/imm.12453; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Porter PC, 2014, J ALLERGY CLIN IMMUN, V134, P325, DOI 10.1016/j.jaci.2014.04.028; Porter PC, 2011, BBA-GEN SUBJECTS, V1810, P1059, DOI 10.1016/j.bbagen.2011.04.019; Porter PC, 2011, INFECT IMMUN, V79, P4459, DOI 10.1128/IAI.05209-11; Pulimood TB, 2007, J ALLERGY CLIN IMMUN, V120, P610, DOI 10.1016/j.jaci.2007.04.045; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Rubel C, 2003, EUR J IMMUNOL, V33, P1429, DOI 10.1002/eji.200323512; Schuliga M, 2016, AM J RESP CELL MOL, V54, P200, DOI 10.1165/rcmb.2014-0419OC; Sharpe RA, 2015, J ALLERGY CLIN IMMUN, V135, P110, DOI 10.1016/j.jaci.2014.07.002; Shinagawa K, 2007, AM J RESP CRIT CARE, V175, P136, DOI 10.1164/rccm.200608-1097OC; Sitrin RG, 1998, J IMMUNOL, V161, P1462; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Stroo I, 2017, AM J PHYSIOL-LUNG C, V312, pL163, DOI 10.1152/ajplung.00320.2016; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Tripathi P, 2009, J CLIN IMMUNOL, V29, P292, DOI 10.1007/s10875-008-9261-9; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tung HY, 2018, SEMIN RESP CRIT CARE, V39, P64, DOI 10.1055/s-0037-1607981; Tung HY, 2016, CURR OPIN ALLERGY CL, V16, P51, DOI 10.1097/ACI.0000000000000233; VOGEL SN, 1979, J IMMUNOL, V122, P619; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Weisel JW, 2017, SUBCELL BIOCHEM, V82, P405, DOI 10.1007/978-3-319-49674-0_13; Yamanaka Y, 2016, ANTIBODIES, V5, DOI 10.3390/antib5020013; Zhmurov A, 2011, STRUCTURE, V19, P1615, DOI 10.1016/j.str.2011.08.013	66	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8834	8847		10.1074/jbc.RA118.006724	http://dx.doi.org/10.1074/jbc.RA118.006724			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30992366	hybrid, Green Published			2022-12-28	WOS:000470971100018
J	Dupont, L; Du, L; Poulter, M; Choi, S; McIntosh, M; Reeves, MB				Dupont, Liane; Du, Lily; Poulter, Madeleine; Choi, Stephanie; McIntosh, Megan; Reeves, Matthew B.			Src family kinase activity drives cytomegalovirus reactivation by recruiting MOZ histone acetyltransferase activity to the viral promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; herpesvirus; gene expression; histone acetylation; chromatin modification; cytomegalovirus reactivation; epigenetic regulation; hematopoietic cell kinase; lysine acetyltransferase 6A (KAT6A); phosphoproteomics	ENDOGENOUS HUMAN CYTOMEGALOVIRUS; LATENT HUMAN CYTOMEGALOVIRUS; NF-KAPPA-B; GENE-EXPRESSION; DENDRITIC CELLS; PROTEIN; TRANSCRIPTION; DIFFERENTIATION; STIMULATION; INHIBITION	Human cytomegalovirus (HCMV) latency and reactivation rely on a complex interplay between cellular differentiation, cell signaling pathways, and viral gene functions. HCMV reactivation in dendritic cells (DCs) is triggered by IL-6 and extracellular signal-regulated kinase (ERK)-mitogen-activated protein kinase signaling. However, activation of the same pathway fails to reactivate HCMV in other myeloid cell types, despite this signaling axis being active in those cells. We hypothesized that IL-6-induced ERK activation initiates the changes in chromatin structure required for viral reactivation but that a concomitant signal is necessary to complete the changes in chromatin structure required for gene expression to occur. Using a differential phosphoproteomics approach in cells that do or do not support IL-6-induced viral reactivation, we identified the concomitant activation of an Src family kinase (SFK), hematopoietic cell kinase (HCK), specifically in DCs in response to IL-6. Pharmacological and genetic inhibition of HCK activity indicated that HCK is required for HCMV reactivation. Furthermore, the HCK/SFK activity was linked to recruitment of the monocytic leukemia zinc finger protein (MOZ) histone acetyltransferase to the viral promoter, which promoted histone acetylation after ERK-mediated histone phosphorylation. Importantly, pharmacological and genetic inhibition of MOZ activity prevented reactivation. These results provide an explanation for the selective activation of viral gene expression in DCs by IL-6, dependent on concomitant SFK and ERK signaling. They also reveal a previously unreported role for SFK activity in the regulation of chromatin structure at promoters in eukaryotic cells via MOZ histone acetyltransferase activity.	[Dupont, Liane; Du, Lily; Poulter, Madeleine; Choi, Stephanie; McIntosh, Megan; Reeves, Matthew B.] UCL, Royal Free Hosp, Div Infect & Immun, Inst Immun & Transplantat, London NW3 2PF, England; [Dupont, Liane] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0QQ, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Reeves, MB (corresponding author), UCL, Royal Free Hosp, Div Infect & Immun, Inst Immun & Transplantat, London NW3 2PF, England.	matthew.reeves@ucl.ac.uk		Reeves, Matthew/0000-0002-4909-1076; Choi, Stephanie/0000-0002-9155-7407; Dupont, Liane/0000-0002-2124-4069	Medical Research Council Career Development Award Fellowship [G:0900466]; Wellcome Trust [WT/204870/Z/16/Z]; Medical Research Council Research [MR/RO21384/1]; MRC [G0900466, MR/R021384/1] Funding Source: UKRI	Medical Research Council Career Development Award Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Career Development Award Fellowship G:0900466 and a Medical Research Council Research Grant MR/RO21384/1 (to M. B. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Wellcome Trust Grant WT/204870/Z/16/Z. To whom correspondence should be addressed. Tel.: 44-203-1086783; E-mail: matthew.reeves@ucl.ac.uk.	Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Buehler J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005655; Catley MC, 2004, J BIOL CHEM, V279, P18457, DOI 10.1074/jbc.M400765200; Chan EM, 2007, EXP HEMATOL, V35, P1782, DOI 10.1016/j.exphem.2007.07.015; Cheng F, 2015, J VIROL, V89, P9262, DOI 10.1128/JVI.01098-15; Cliffe AR, 2015, CELL HOST MICROBE, V18, P649, DOI 10.1016/j.chom.2015.11.007; Compton T., 2000, METHODS MOL MED CYTO, P53; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Dupont L, 2016, REV MED VIROL, V26, P75, DOI 10.1002/rmv.1862; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gerhart J, 1999, TERATOLOGY, V60, P226; Goodrum F, 2007, BLOOD, V110, P937, DOI 10.1182/blood-2007-01-070078; Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937; Hargett D, 2010, P NATL ACAD SCI USA, V107, P20039, DOI 10.1073/pnas.1014509107; Huang MM, 2012, J VIROL, V86, P8507, DOI 10.1128/JVI.00598-12; Ioudinkova E, 2006, GENE, V384, P120, DOI 10.1016/j.gene.2006.07.021; Keller MJ, 2007, J VIROL, V81, P6669, DOI 10.1128/JVI.01524-06; Kew VG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004195; Keyes LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052827; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Kitabayashi I, 2001, LEUKEMIA, V15, P89, DOI 10.1038/sj.leu.2401983; Krishna BA, 2019, P NATL ACAD SCI USA, V116, P1755, DOI 10.1073/pnas.1816933116; Krishna BA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080445; Krishna BA, 2017, MBIO, V8, DOI 10.1128/mBio.01754-17; Meier JL, 1996, INTERVIROLOGY, V39, P331, DOI 10.1159/000150504; Mendelson M, 1996, J GEN VIROL, V77, P3099, DOI 10.1099/0022-1317-77-12-3099; Murphy JC, 2002, EMBO J, V21, P1112, DOI 10.1093/emboj/21.5.1112; Perez-Campo FM, 2013, IMMUNOLOGY, V139, P161, DOI 10.1111/imm.12072; Poh AR, 2015, ONCOTARGET, V6, P15752, DOI 10.18632/oncotarget.4199; Prosch S, 1999, INTERVIROLOGY, V42, P308, DOI 10.1159/000053965; Reeves MB, 2011, J VIROL, V85, P12750, DOI 10.1128/JVI.05878-11; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102; Sindre H, 1996, BLOOD, V88, P4526, DOI 10.1182/blood.V88.12.4526.bloodjournal88124526; Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; TAYLORWIEDEMAN J, 1994, J VIROL, V68, P1597, DOI 10.1128/JVI.68.3.1597-1604.1994; Yuan JX, 2009, J VIROL, V83, P6391, DOI 10.1128/JVI.00061-09	40	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12901	12910		10.1074/jbc.RA119.009667	http://dx.doi.org/10.1074/jbc.RA119.009667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31273084	Green Published, hybrid			2022-12-28	WOS:000486416000004
J	Yang, XY; Wang, GQ; Cao, T; Zhang, L; Ma, YZ; Jiang, SH; Teng, XC; Sun, XH				Yang, Xiaoying; Wang, Guiqin; Cao, Ting; Zhang, Li; Ma, Yunzhi; Jiang, Shuhui; Teng, Xinchen; Sun, Xiaohui			Large-conductance calcium-activated potassium channels mediate lipopolysaccharide-induced activation of murine microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipopolysaccharide (LPS); microglia; neuroinflammation; NF-kappa B (NF-KB); Toll-like receptor 4 (TLR4); BK channel; cytokine; innate immunity	CA2+-ACTIVATED K+ CHANNELS; BK CHANNELS; SMOOTH-MUSCLE; ION CHANNELS; EXPRESSION; MAXIK; MITOCHONDRIAL; INVOLVEMENT; TRANSIENTS; ADHESION	Large-conductance calcium-activated potassium (BK) channels are ubiquitously expressed in most cell types where they regulate many cellular, organ, and organismal functions. Although BK currents have been recorded specifically in activated murine and human microglia, it is not yet clear whether and how the function of this channel is related to microglia activation. Here, using patch-clamping, Griess reaction, ELISA, immunocytochemistry, and immunoblotting approaches, we show that specific inhibition of the BK channel with paxilline (10 mu M) or siRNA-mediated knockdown of its expression significantly suppresses lipopolysaccharide (LPS)-induced (100 ng/ml) BV-2 and primary mouse microglial cell activation. We found that membrane BK current is activated by LPS at a very early stage through Toll-like receptor 4 (TLR4), leading to nuclear translocation of NF-kappa B and to production of inflammatory cytokines. Furthermore, we noted that BK channels are also expressed intracellularly, and their nuclear expression significantly increases in late stages of LPS-mediated microglia activation, possibly contributing to production of nitric oxide, tumor necrosis factor-alpha, and interleukin-6. Of note, a specific TLR4 inhibitor suppressed BK channel expression, whereas an NF-kappa B inhibitor did not. Taken together, our findings indicate that BK channels participate in both the early and the late stages of LPS-stimulated murine microglia activation involving both membrane-associated and nuclear BK channels.	[Yang, Xiaoying; Wang, Guiqin; Cao, Ting; Zhang, Li; Ma, Yunzhi; Jiang, Shuhui; Teng, Xinchen; Sun, Xiaohui] Soochow Univ, Coll Pharmaceut Sci, Collaborat Innovat Ctr Brain Sci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China	Sun, XH (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Collaborat Innovat Ctr Brain Sci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Jiangsu, Peoples R China.	sxh961@hotmail.com	sun, Xiaohui/G-5146-2013	sun, Xiaohui/0000-0003-0294-6855	National Natural Science Foundation of China [31400924, 31401197]; Priority Academic Program Development of the Jiangsu Higher Education Institutes (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of the Jiangsu Higher Education Institutes (PAPD)	This work was supported by National Natural Science Foundation of China Grants 31400924 (to X. S.) and 31401197 (to X. T.) and the Priority Academic Program Development of the Jiangsu Higher Education Institutes (PAPD). The authors declare that they have no conflicts of interest with the contents of this article.	BADER MF, 1994, GLIA, V11, P336, DOI 10.1002/glia.440110406; Balderas E, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00104; Bentzen BH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00389; Bordey A, 2003, EUR J NEUROSCI, V18, P2893, DOI 10.1111/j.1460-9568.2003.03021.x; Burgazli KM, 2014, EUR REV MED PHARMACO, V18, P646; Cao Q, 2015, DEV CELL, V33, P427, DOI 10.1016/j.devcel.2015.04.010; Chen YJ, 2016, J CEREBR BLOOD F MET, V36, P2146, DOI 10.1177/0271678X15611434; Chen YJ, 2011, J CEREBR BLOOD F MET, V31, P2363, DOI 10.1038/jcbfm.2011.101; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Contet C, 2016, INT REV NEUROBIOL, V128, P281, DOI 10.1016/bs.irn.2016.04.001; Duncan PJ, 2016, INT REV NEUROBIOL, V128, P343, DOI 10.1016/bs.irn.2016.03.004; Erdogan A, 2007, ATHEROSCLEROSIS, V190, P100, DOI 10.1016/j.atherosclerosis.2006.02.035; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hayashi Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11697; Hayashi Y, 2011, J NEUROSCI, V31, P17370, DOI 10.1523/JNEUROSCI.4152-11.2011; Hoang LM, 1997, NEUROSCI LETT, V231, P25, DOI 10.1016/S0304-3940(97)00519-3; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Jin LW, 2019, ANN CLIN TRANSL NEUR, V6, P723, DOI 10.1002/acn3.754; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Korvers L, 2016, CELL CALCIUM, V60, P396, DOI 10.1016/j.ceca.2016.09.004; Krabbendam IE, 2018, CELL CALCIUM, V69, P101, DOI 10.1016/j.ceca.2017.07.005; Krishnamoorthy-Natarajan G, 2016, INT REV NEUROBIOL, V128, P401, DOI 10.1016/bs.irn.2016.03.017; Li B, 2016, INT REV NEUROBIOL, V128, P163, DOI 10.1016/bs.irn.2016.03.018; Li BX, 2014, NAT NEUROSCI, V17, P1055, DOI 10.1038/nn.3744; Maezawa Izumi, 2012, Int J Alzheimers Dis, V2012, P868972, DOI 10.1155/2012/868972; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; MCLARNON JG, 1995, BRAIN RES, V693, P8, DOI 10.1016/0006-8993(95)00664-C; McLarnon JG, 1997, NEUROSCIENCE, V78, P1217, DOI 10.1016/S0306-4522(96)00680-X; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Muller M, 2003, J ENDOTOXIN RES, V9, P181, DOI 10.1179/096805103125001595; Papavlassopoulos M, 2006, J IMMUNOL, V177, P4086, DOI 10.4049/jimmunol.177.6.4086; Price DL, 2002, BRAIN RES, V956, P183, DOI 10.1016/S0006-8993(02)03266-3; Pyott SJ, 2016, INT REV NEUROBIOL, V128, P369, DOI 10.1016/bs.irn.2016.03.016; Ren JD, 2014, IMMUNOLOGY, V141, P345, DOI 10.1111/imm.12193; SAWADA M, 1990, BRAIN RES, V509, P119, DOI 10.1016/0006-8993(90)90317-5; Scheel O, 2006, INFECT IMMUN, V74, P4354, DOI 10.1128/IAI.01783-05; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schilling T, 2007, BRAIN RES, V1186, P21, DOI 10.1016/j.brainres.2007.10.027; Schilling T, 2015, GLIA, V63, P664, DOI 10.1002/glia.22776; Schilling T, 2011, J CELL PHYSIOL, V226, P3295, DOI 10.1002/jcp.22675; Schroeder ME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01836-8; Seydel U, 2001, J ENDOTOXIN RES, V7, P243, DOI 10.1177/09680519010070030901; Singh H, 2012, J PHYSIOL-LONDON, V590, P5937, DOI 10.1113/jphysiol.2011.215533; SUZUMURA A, 1984, BRAIN RES, V324, P379, DOI 10.1016/0006-8993(84)90054-4; Tao J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00248; Vanheel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035544; Wang WY, 2017, J CELL BIOL, V216, P1715, DOI 10.1083/jcb.201612123; Yakubovich N, 2001, BBA-BIOMEMBRANES, V1514, P239, DOI 10.1016/S0005-2736(01)00378-9; Yang XY, 2017, BIOPHYS J, V112, p548A, DOI 10.1016/j.bpj.2016.11.2960; Yeh J, 2019, AM J PHYSIOL-RENAL, V316, pF617, DOI 10.1152/ajprenal.00554.2018; Yu M, 2016, ACTA PHARMACOL SIN, V37, P56, DOI 10.1038/aps.2015.139; Zhou Y, 2014, J GEN PHYSIOL, V144, P415, DOI 10.1085/jgp.201411259	56	7	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12921	12932		10.1074/jbc.RA118.006425	http://dx.doi.org/10.1074/jbc.RA118.006425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296663	hybrid, Green Published			2022-12-28	WOS:000486416000006
J	Deredge, D; Wintrode, PL; Tulapurkar, ME; Nagarsekar, A; Zhang, YH; Webei, DJ; Shapiro, P; Hasday, JD				Deredge, Daniel; Wintrode, Patrick L.; Tulapurkar, Mohan E.; Nagarsekar, Ashish; Zhang, Yinghua; Webei, David J.; Shapiro, Paul; Hasday, Jeffrey D.			A temperature-dependent conformational shift in p38 alpha MAPK substrate-binding region associated with changes in substrate phosphorylation profile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p38 MAPK; protein structure; substrate specificity; signaling; hydrogen-deuterium exchange; hyperthermia; MAPKAPK-2; pyrogen; substrate-docking site; temperature-dependence; pulmonary damage	ACTIVATED PROTEIN-KINASE; MICROVASCULAR ENDOTHELIAL-CELLS; GENE-EXPRESSION; LUNG INJURY; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; MEDIATED ACTIVATION; MILD HYPERTHERMIA; P38; APOPTOSIS	Febrile-range hyperthermia worsens and hypothermia mitigates lung injury, and temperature dependence of lung injury is blunted by inhibitors of p38 mitogen-activated protein kinase (MAPK). Of the two predominant p38 isoforms, p38 alpha is proinflammatory and p38 beta is cytoprotective. Here, we analyzed the temperature dependence of p38 MAPK activation, substrate interaction, and tertiary structure. Incubating HeLa cells at 39.5 degrees C stimulated modest p38 activation, but did not alter tumor necrosis factor-alpha (TNF alpha)-induced p38 activation. In in vitro kinase assays containing activated p38 alpha and MAPK-activated kinase-2 (MK2), MK2 phosphorylation was 14.5-fold greater at 39.5 degrees C than at 33 degrees C. By comparison, we observed only 3.1- and 1.9-fold differences for activating transcription factor-2 (ATF2) and signal transducer and activator of transcription-1 alpha (STAT1 alpha) and a 7.7-fold difference for p38 beta phosphorylation of MK2. The temperature dependence of p38 alpha:substrate binding affinity, as measured by surface plasmon resonance, paralleled substrate phosphorylation. Hydrogen-deuterium exchange MS (HDX-MS) of p38 alpha performed at 33, 37, and 39.5 degrees C indicated temperature-dependent conformational changes in an alpha helix near the common docking and glutamate:aspartate substrate-binding domains at the known binding site for MK2. In contrast, HDX-MS analysis of p38 beta did not detect significant temperature-dependent conformational changes in this region. We observed no conformational changes in the catalytic domain of either isoform and no corresponding temperature dependence in the C-terminal p38 alpha-interacting region of MK2. Because MK2 participates in the pathogenesis of lung injury, the observed changes in the structure and function of proinflammatory p38 alpha may contribute to the temperature dependence of acute lung injury.	[Deredge, Daniel; Wintrode, Patrick L.; Shapiro, Paul] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Tulapurkar, Mohan E.; Nagarsekar, Ashish; Hasday, Jeffrey D.] Univ Maryland, Sch Pharm, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Zhang, Yinghua] Univ Maryland, Sch Pharm, Dept Physiol, Baltimore, MD 21201 USA; [Webei, David J.] Univ Maryland, Sch Pharm, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Hasday, Jeffrey D.] Baltimore Vet Affairs Med Ctr, Med & Res Serv, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Hasday, JD (corresponding author), Univ Maryland, Sch Med, Dept Med, 110 S Paca St,Rm 2N149, Baltimore, MD 21201 USA.	jhasday@medicine.umaryland.edu	Weber, David J/B-5349-2011	Weber, David J/0000-0002-8824-1110; Hasday, Jeffrey/0000-0001-5011-5621	University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069057] Funding Source: NIH RePORTER	University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Amy Defnet provided technical assistance. Additional support was provided by the University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014).	Arcus VL, 2016, BIOCHEMISTRY-US, V55, P1681, DOI 10.1021/acs.biochem.5b01094; Asaduzzaman M, 2008, CRIT CARE MED, V36, P482, DOI 10.1097/01.CCM.0B013E31816204FA; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Bedoya-Lopez A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151529; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; Burkhard KA, 2011, J BIOL CHEM, V286, P2477, DOI 10.1074/jbc.M110.177899; Cara DC, 2001, J IMMUNOL, V167, P6552, DOI 10.4049/jimmunol.167.11.6552; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; Damarla M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004600; Daniel RM, 2013, FEBS LETT, V587, P2738, DOI 10.1016/j.febslet.2013.06.027; Engen JR, 2013, INT REV PHYS CHEM, V32, P96, DOI 10.1080/0144235X.2012.751175; Feng YJ, 2011, J DIGEST DIS, V12, P327, DOI 10.1111/j.1751-2980.2011.00525.x; Ferrari G, 2012, MOL CANCER RES, V10, P605, DOI 10.1158/1541-7786.MCR-11-0507; Fisher DT, 2011, J CLIN INVEST, V121, P3846, DOI 10.1172/JCI44952; Fisk M, 2014, AM J CARDIOVASC DRUG, V14, P155, DOI 10.1007/s40256-014-0063-6; Frantz B, 1998, BIOCHEMISTRY-US, V37, P13846, DOI 10.1021/bi980832y; Garcia JGN, 2002, FASEB J, V16, P1064, DOI 10.1096/fj.01-0895com; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gupta A, 2013, J BIOL CHEM, V288, P2756, DOI 10.1074/jbc.M112.427336; Guttman M, 2013, J AM SOC MASS SPECTR, V24, P1906, DOI 10.1007/s13361-013-0727-5; Hamanaka K, 2007, AM J PHYSIOL-LUNG C, V293, pL923, DOI 10.1152/ajplung.00221.2007; Hasday JD, 2003, AM J PATHOL, V162, P2005, DOI 10.1016/S0002-9440(10)64333-7; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Kariya A, 2013, INT J MOL MED, V32, P195, DOI 10.3892/ijmm.2013.1366; Krementsov DN, 2013, MOL CELL BIOL, V33, P3728, DOI 10.1128/MCB.00688-13; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085272; Lukas SM, 2004, BIOCHEMISTRY-US, V43, P9950, DOI 10.1021/bi049508v; Mallory M, 2016, CRIT REV ONCOL HEMAT, V97, P56, DOI 10.1016/j.critrevonc.2015.08.003; Mittelstadt PR, 2009, J BIOL CHEM, V284, P15469, DOI 10.1074/jbc.M901004200; Nagarsekar A, 2008, J IMMUNOL, V181, P2636, DOI 10.4049/jimmunol.181.4.2636; Nagarsekar A, 2012, AM J RESP CELL MOL, V47, P824, DOI 10.1165/rcmb.2012-0105OC; Nash SP, 2005, INT IMMUNOPHARMACOL, V5, P1870, DOI 10.1016/j.intimp.2005.06.005; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; O'Reilly FM, 2003, J INVEST DERMATOL, V120, P489, DOI 10.1046/j.1523-1747.2003.12063.x; Oganesyan I, 2018, METHODS, V144, P27, DOI 10.1016/j.ymeth.2018.04.023; Oyeyemi OA, 2011, BIOCHEMISTRY-US, V50, P8251, DOI 10.1021/bi200640s; Oyeyemi OA, 2010, P NATL ACAD SCI USA, V107, P10074, DOI 10.1073/pnas.1003678107; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Potla R, 2015, RNA, V21, P1261, DOI 10.1261/rna.049122.114; Qian F, 2016, CURR PROTEIN PEPT SC, V17, P332, DOI 10.2174/1389203716666150629121324; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rice P, 2005, J IMMUNOL, V174, P3676, DOI 10.4049/jimmunol.174.6.3676; SHAH NG, 2009, AM J RESP CRIT CARE, V179, DOI DOI 10.1164/ajrccm-conference.2009.179.1_MeetingAbstracts.A4014; Shah NG, 2017, J IMMUNOL, V198, P3296, DOI 10.4049/jimmunol.1602059; Shah NG, 2012, INT J HYPERTHER, V28, P627, DOI 10.3109/02656736.2012.690547; Singh IS, 2013, INT J HYPERTHER, V29, P423, DOI 10.3109/02656736.2013.808766; Slack DF, 2017, CRIT CARE MED, V45, P1152, DOI 10.1097/CCM.0000000000002338; Sonna LA, 2004, J APPL PHYSIOL, V96, P1943, DOI 10.1152/japplphysiol.00886.2003; Sonna LA, 2006, PHYSIOL GENOMICS, V26, P91, DOI 10.1152/physiolgenomics.00296.2005; Sours KM, 2008, J MOL BIOL, V379, P1075, DOI 10.1016/j.jmb.2008.04.044; Sutcliffe IT, 2001, J CEREBR BLOOD F MET, V21, P1310, DOI 10.1097/00004647-200111000-00007; Szczur K, 2006, BLOOD, V108, P4205, DOI 10.1182/blood-2006-03-013789; Tabuchi Y, 2008, INT J HYPERTHER, V24, P613, DOI 10.1080/02656730802140777; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; ter Haar E, 2007, J BIOL CHEM, V282, P9733, DOI 10.1074/jbc.M611165200; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]; Tulapurkar ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118010; Tulapurkar ME, 2012, AM J RESP CELL MOL, V46, P807, DOI 10.1165/rcmb.2011-0378OC; Tzarum N, 2013, J BIOL CHEM, V288, P19537, DOI 10.1074/jbc.M113.464511; VILLAR J, 1993, RESUSCITATION, V26, P183, DOI 10.1016/0300-9572(93)90178-S; Wang Q, 2005, AM J PHYSIOL-LUNG C, V288, pL359, DOI 10.1152/ajplung.00292.2004; Wang Q, 2001, J IMMUNOL, V166, P6877, DOI 10.4049/jimmunol.166.11.6877; Wang YX, 2010, J SURG RES, V161, P119, DOI 10.1016/j.jss.2008.10.030; Yang D, 2010, CARDIOVASC RES, V85, P520, DOI 10.1093/cvr/cvp323; Yu T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/950472	74	6	6	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12624	12637		10.1074/jbc.RA119.007525	http://dx.doi.org/10.1074/jbc.RA119.007525			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31213525	hybrid, Green Published			2022-12-28	WOS:000484414600007
J	Hansen, LH; Madsen, TD; Goth, CK; Clausen, H; Chen, Y; Dzhoyashvili, N; Iyer, SR; Sangaralingham, SJ; Burnett, JC; Rehfeld, JF; Vakhrushev, SY; Schjoldager, KT; Goetze, JP				Hansen, Lasse H.; Madsen, Thomas Daugbjerg; Goth, Christoffer K.; Clausen, Henrik; Chen, Yang; Dzhoyashvili, Nina; Iyer, Seethalakshmi R.; Sangaralingham, S. Jeson; Burnett, John C., Jr.; Rehfeld, Jens F.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.; Goetze, Jens P.			Discovery of O-glycans on atrial natriuretic peptide (ANP) that affect both its proteolytic degradation and potency at its cognate receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						natriuretic peptide; glycobiology; glycoprotein; glycosylation; cardiovascular; heart; heart failure; cardiovascular disease; post-translational modification (PTM); peptide hormone; blood pressure; natriuresis	HEART-FAILURE; DOUBLE-BLIND; GLYCOSYLATION; PLASMA; NEPRILYSIN; GENE; METABOLISM; CLEARANCE; ENALAPRIL; IDENTIFICATION	Atrial natriuretic peptide (ANP) is a peptide hormone that in response to atrial stretch is secreted from atrial myocytes into the circulation, where it stimulates vasodilatation and natriuresis. ANP is an important biomarker of heart failure where low plasma concentrations exclude cardiac dysfunction. ANP is a member of the natriuretic peptide (NP) family, which also includes the B-type natriuretic peptide (BNP) and the C-type natriuretic peptide. The proforms of these hormones undergo processing to mature peptides, and for proBNP, this process has previously been demonstrated to be regulated by O-glycosylation. It has been suggested that proANP also may undergo post-translational modifications. Here, we conducted a targeted O-glycoproteomics approach to characterize O-glycans on NPs and demonstrate that all NP members can carry O-glycans. We identified four O-glycosites in proANP in the porcine heart, and surprisingly, two of these were located on the mature bioactive ANP itself. We found that one of these glycans is located within a conserved sequence motif of the receptor-binding region, suggesting that O-glycans may serve a function beyond intracellular processing and maturation. We also identified an O-glycoform of proANP naturally occurring in human circulation. We demonstrated that site-specific O-glycosylation shields bioactive ANP from proteolytic degradation and modifies potency at its cognate receptor in vitro. Furthermore, we showed that ANP O-glycosylation attenuates acute renal and cardiovascular ANP actions in vivo. The discovery of novel glycosylated ANP proteoforms reported here significantly improves our understanding of cardiac endocrinology and provides important insight into the etiology of heart failure.	[Hansen, Lasse H.; Rehfeld, Jens F.; Goetze, Jens P.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, 3 Blegdamsvej, DK-2200 Copenhagen, Denmark; [Hansen, Lasse H.; Rehfeld, Jens F.; Goetze, Jens P.] Univ Copenhagen, Sch Dent, 3 Blegdamsvej, DK-2200 Copenhagen, Denmark; [Hansen, Lasse H.; Madsen, Thomas Daugbjerg; Goth, Christoffer K.; Clausen, Henrik; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.] Univ Copenhagen, Copenhagen Ctr Glyc, Sch Dent, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Chen, Yang; Dzhoyashvili, Nina; Iyer, Seethalakshmi R.; Sangaralingham, S. Jeson; Burnett, John C., Jr.] Mayo Clin, Dept Cardiovasc Med, Cardiorenal Res Lab, Rochester, MN 55905 USA; [Goetze, Jens P.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, 3 Blegdamsvej, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Mayo Clinic; University of Copenhagen	Goetze, JP (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, 3 Blegdamsvej, DK-2200 Copenhagen, Denmark.; Goetze, JP (corresponding author), Univ Copenhagen, Sch Dent, 3 Blegdamsvej, DK-2200 Copenhagen, Denmark.; Schjoldager, KT (corresponding author), Univ Copenhagen, Copenhagen Ctr Glyc, Sch Dent, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark.	Schjoldager@sund.ku.dk; JPG@dadlnet.dk	clausen, henrik/AAD-8016-2021; Chen, Yang/HHS-2613-2022; Vakhrushev, Sergey Y/A-7638-2014	Chen, Yang/0000-0002-2443-4087; Vakhrushev, Sergey Y/0000-0002-0418-5765; Goth, Christoffer/0000-0002-5766-1411; Hansen, Lasse Holst/0000-0001-6517-0412; Madsen, Thomas Daugbjerg/0000-0002-7598-4636	Rigshospitalets Forskningsraad; Novo Nordisk Foundation; Lundbeck Foundation; Danish National Research Foundation [DNRF107]; Danish Biotechnology Center for Cellular Communication (CCC)	Rigshospitalets Forskningsraad; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Biotechnology Center for Cellular Communication (CCC)	This work was supported by Rigshospitalets Forskningsraad, the Novo Nordisk Foundation, the Lundbeck Foundation, Danish National Research Foundation Grant DNRF107, and the Danish Biotechnology Center for Cellular Communication (CCC). The University of Copenhagen and Rigshospitalet have filed a patent application on part of the subject matter presented. L. H. H., T. D. M., C. K. G., S. Y. V., H. C., K. T. S., and J. P. G. are named co-inventors on the application.	Bagdonaite I, 2016, J BIOL CHEM, V291, P12014, DOI 10.1074/jbc.M116.721746; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boerrigter G, 2011, J AM COLL CARDIOL, V58, P904, DOI 10.1016/j.jacc.2010.12.053; BOVY PR, 1989, J MED CHEM, V32, P869, DOI 10.1021/jm00124a023; Charles CJ, 1996, AM J PHYSIOL-REG I, V271, pR373, DOI 10.1152/ajpregu.1996.271.2.R373; Chen Y, 2019, J MOL CELL CARDIOL, V130, P140, DOI 10.1016/j.yjmcc.2019.03.024; Costello-Boerrigter LC, 2013, JACC-HEART FAIL, V1, P207, DOI 10.1016/j.jchf.2013.03.001; Dickey DM, 2008, J BIOL CHEM, V283, P35003, DOI 10.1074/jbc.M804538200; Goetze JP, 2012, CLIN CHEM, V58, P83, DOI 10.1373/clinchem.2011.165696; Goetze JP, 2003, EUR HEART J, V24, P1471, DOI 10.1016/S0195-668X(03)00283-5; Goth CK, 2018, TRENDS BIOCHEM SCI, V43, P269, DOI 10.1016/j.tibs.2018.02.005; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Halfinger B, 2017, CLIN CHEM, V63, P359, DOI 10.1373/clinchem.2016.265397; Hata N, 2008, CIRC J, V72, P1787, DOI 10.1253/circj.CJ-08-0130; Hintze J, 2018, J BIOL CHEM, V293, P19064, DOI 10.1074/jbc.RA118.004516; Hunter I, 2011, CLIN CHEM, V57, P1327, DOI 10.1373/clinchem.2011.166330; Hunter I, 2011, J IMMUNOL METHODS, V370, P104, DOI 10.1016/j.jim.2011.06.005; Ichiki T, 2014, EUR HEART J, V35, P3001, DOI 10.1093/eurheartj/ehu381; JOHNSON GR, 1989, J BIOL CHEM, V264, P11637; Joshi HJ, 2018, GLYCOBIOLOGY, V28, P131, DOI 10.1093/glycob/cwx104; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Khetarpal SA, 2016, CELL METAB, V24, P234, DOI 10.1016/j.cmet.2016.07.012; King SL, 2017, BLOOD ADV, V1, P429, DOI 10.1182/bloodadvances.2016002121; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Kostis OB, 2004, AM J HYPERTENS, V17, P103, DOI 10.1016/j.amjhyper.2003.09.014; Larsen ISB, 2017, J BIOL CHEM, V292, P11586, DOI 10.1074/jbc.M117.794487; Levery SB, 2015, BBA-GEN SUBJECTS, V1850, P33, DOI 10.1016/j.bbagen.2014.09.026; Li Y, 2014, HYPERTENSION, V63, P846, DOI 10.1161/HYPERTENSIONAHA.113.01772; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Ruilope LM, 2010, LANCET, V375, P1255, DOI 10.1016/S0140-6736(09)61966-8; Moyes AJ, 2020, EUR HEART J, V41, P1006, DOI 10.1093/eurheartj/ehz093; Moyes AJ, 2014, J CLIN INVEST, V124, P4039, DOI 10.1172/JCI74281; Nagai-Okatani C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150210; Nakagawa Y, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.003601; Nielsen SJ, 2009, APMIS, V117, P60, DOI 10.1111/j.1600-0463.2008.00016.x; Nielsen SJ, 2008, REGUL PEPTIDES, V146, P204, DOI 10.1016/j.regpep.2007.09.022; Nishikimi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053233; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50; Pedersen NB, 2014, J BIOL CHEM, V289, P17312, DOI 10.1074/jbc.M113.545053; Peng JH, 2011, BIOCHEM BIOPH RES CO, V411, P593, DOI 10.1016/j.bbrc.2011.06.192; Potter LR, 2011, FEBS J, V278, P1808, DOI 10.1111/j.1742-4658.2011.08082.x; Ren MX, 2018, HUM MOL GENET, V27, P199, DOI 10.1093/hmg/ddx375; SCARBOROUGH RM, 1988, J BIOL CHEM, V263, P16818; Schellenberger U, 2006, ARCH BIOCHEM BIOPHYS, V451, P160, DOI 10.1016/j.abb.2006.03.028; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Smith J, 2013, ENDOCRINOLOGY, V154, P1864, DOI 10.1210/en.2012-2186; Socki T, 2005, J AM COLL CARDIOL, V45, P608, DOI 10.1016/j.jacc.2004.10.067; Solomon SD, 2012, LANCET, V380, P1387, DOI 10.1016/S0140-6736(12)61227-6; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Tonne JM, 2011, CLIN CHEM, V57, P864, DOI 10.1373/clinchem.2010.157438; Topol EJ, 2005, NEW ENGL J MED, V353, P113, DOI 10.1056/NEJMp058139; Topol EJ, 2011, NEW ENGL J MED, V365, P81, DOI 10.1056/NEJMe1103116; van Deursen VM, 2014, CIRCULATION, V130, P958, DOI 10.1161/CIRCULATIONAHA.113.003046; VANNESTE Y, 1988, BIOCHEM J, V254, P531, DOI 10.1042/bj2540531; Vodovar N, 2014, EUR HEART J, V35, P3434, DOI 10.1093/eurheartj/ehu314; YANDLE TG, 1986, LIFE SCI, V38, P1827, DOI 10.1016/0024-3205(86)90137-2; Yang WM, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188486; Yip CYY, 2011, ARTERIOSCL THROM VAS, V31, P1881, DOI 10.1161/ATVBAHA.111.223974; Zois NE, 2014, NAT REV CARDIOL, V11, P403, DOI 10.1038/nrcardio.2014.64	66	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12567	12578		10.1074/jbc.RA119.008102	http://dx.doi.org/10.1074/jbc.RA119.008102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31186350	Green Published, hybrid			2022-12-28	WOS:000484414600001
J	Amemiya, S; Toyoda, H; Kimura, M; Saito, H; Kobayashi, H; Ihara, K; Kamagata, K; Kawabata, R; Kato, S; Nakashimada, Y; Furuta, T; Hamamoto, S; Uozumi, N				Amemiya, Shun; Toyoda, Hayato; Kimura, Mami; Saito, Hiromi; Kobayashi, Hiroshi; Ihara, Kunio; Kamagata, Kiyoto; Kawabata, Ryuji; Kato, Setsu; Nakashimada, Yutaka; Furuta, Tadaomi; Hamamoto, Shin; Uozumi, Nobuyuki			The mechanosensitive channel YbdG from Escherichia coli has a role in adaptation to osmotic up-shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; cell biology; stress; stress response; membrane protein; mechanosensitive channel; high osmolarity; YbdG; mechanosensor; gain-of-function mutation; Escherichia coli; osmotic shock; ion channel; YbdG-I167T; signal transduction	ION-CHANNEL; HIGH-THROUGHPUT; COMPLETE SET; MSCS; EXPRESSION; GENE; K-12; INACTIVATION; ORGANIZATION; ACTIVATION	Mechanosensitive channels play an important role in the adaptation of cells to hypo-osmotic shock. Among members of this channel family in Escherichia coli, the exact function and physiological role of the mechanosensitive channel homolog YbdG remain unclear. Characterization of YbdG's physiological role has been hampered by its lack of measurable transport activity. Using a nitrosoguanidine mutagenesis-aided screen in combination with next-generation sequencing, here we isolated a mutant with a point mutation in ybdG. This mutation (resulting in a I167T change) conferred sensitivity to high osmotic stress, and the mutant cells differed from WT cells in morphology during hyperosmotic stress at alkaline pH. Interestingly, unlike the cells containing the I167T variant, a null-ybdG mutant did not exhibit this sensitivity and phenotype. Although I167T was located near the putative ion-conducting pore in a transmembrane region of YbdG, no change in ion channel activities of YbdG-I167T was detected. Of note, introduction of the WT C-terminal cytosolic region of YbdG into the I167T variant complemented the osmo-sensitive phenotype. Co-precipitation of proteins interacting with the C-terminal YbdG region led to the isolation of HldD and FbaA, whose overexpression in cells containing the YbdG-I167T variant partially rescued the osmo-sensitive phenotype. This study indicates that YbdG functions as a component of a mechanosensing system that transmits signals triggered by external osmotic changes to intracellular factors. The cellular role of YbdG uncovered here goes beyond its predicted function as an ion or solute transport protein.	[Amemiya, Shun; Toyoda, Hayato; Kimura, Mami; Hamamoto, Shin; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aobayama 6-6-07, Sendai, Miyagi 9808579, Japan; [Saito, Hiromi; Kobayashi, Hiroshi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Chiba 2608675, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Kamagata, Kiyoto] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan; [Kawabata, Ryuji] Hiroshima Univ, Sch Engn, Higashihiroshima 7398527, Japan; [Kato, Setsu; Nakashimada, Yutaka] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398530, Japan; [Furuta, Tadaomi] Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, B-62 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan	Tohoku University; Chiba University; Nagoya University; Tohoku University; Hiroshima University; Hiroshima University; Tokyo Institute of Technology	Uozumi, N (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aobayama 6-6-07, Sendai, Miyagi 9808579, Japan.	uozumi@tohoku.ac.jp	Uozumi, Nobuyuki/AAG-3252-2019; Furuta, Tadaomi/D-5225-2015; Kato, Setsu/AAC-1418-2019; IHARA, Kunio/D-1952-2011; Nakashimada, Yutaka/B-5493-2010	Furuta, Tadaomi/0000-0003-4568-9043; Nakashimada, Yutaka/0000-0002-7452-7433; Uozumi, Nobuyuki/0000-0003-4268-1126	Japan Society for the Promotion of Science (JSPS) [16H06558, 19K22264, 19H02880, 15K186780]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research 16H06558, 19K22264, and 19H02880 (to N.U.) and 15K186780 (to S.H.) from Japan Society for the Promotion of Science (JSPS). The authors declare that they have no conflicts of interest with the contents of this article.	Amir A, 2014, P NATL ACAD SCI USA, V111, P5778, DOI 10.1073/pnas.1317497111; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bartlett TM, 2017, CELL, V168, P172, DOI 10.1016/j.cell.2016.12.019; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Chen CM, 2013, BIOINFORMATICS, V29, P2808, DOI 10.1093/bioinformatics/btt484; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Edwards MD, 2012, CHANNELS, V6, P272, DOI 10.4161/chan.20998; Grajkowski W, 2005, BIOPHYS J, V88, P3050, DOI 10.1529/biophysj.104.053546; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Jeanguenin L, 2011, PLANT J, V67, P570, DOI 10.1111/j.1365-313X.2011.04617.x; Joloba ML, 2004, J BACTERIOL, V186, P8542, DOI 10.1128/JB.186.24.8542-8546.2004; Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73; Kera K, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00664-17; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kobayashi H, 2000, J GEN APPL MICROBIOL, V46, P235, DOI 10.2323/jgam.46.235; Koprowski P, 2003, J BIOL CHEM, V278, P11237, DOI 10.1074/jbc.M212073200; Koprowski P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127029; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; Li YZ, 2002, EMBO J, V21, P5323, DOI 10.1093/emboj/cdf537; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Marin K, 1998, J BACTERIOL, V180, P4843, DOI 10.1128/JB.180.18.4843-4849.1998; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; MIZUNO T, 1987, J BIOCHEM-TOKYO, V101, P387, DOI 10.1093/oxfordjournals.jbchem.a121923; Murata A, 2015, J MOL BIOL, V427, P2663, DOI 10.1016/j.jmb.2015.06.016; Nanatani K, 2015, J BACTERIOL, V197, P676, DOI 10.1128/JB.02276-14; Nanatani K, 2013, CHANNELS, V7, P238, DOI 10.4161/chan.25350; Nomura T, 2008, BIOPHYS J, V94, P1638, DOI 10.1529/biophysj.107.114785; OHYAMA T, 1994, J BACTERIOL, V176, P4311, DOI 10.1128/jb.176.14.4311-4315.1994; Osanai T, 2005, J BIOL CHEM, V280, P34684, DOI 10.1074/jbc.M507489200; Paintdakhi A, 2016, MOL MICROBIOL, V99, P767, DOI 10.1111/mmi.13264; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P143, DOI 10.1016/S0968-0004(98)01196-7; REED RH, 1985, FEMS MICROBIOL LETT, V28, P225, DOI 10.1016/0378-1097(85)90086-2; Rowe I, 2014, J GEN PHYSIOL, V143, P543, DOI 10.1085/jgp.201311114; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Shi HD, 2018, CELL, V172, P1294, DOI 10.1016/j.cell.2018.02.050; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2527, DOI 10.1099/00221287-136-12-2527; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112; Wood JM, 2015, J GEN PHYSIOL, V145, P381, DOI 10.1085/jgp.201411296; Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus	55	5	5	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12281	12292		10.1074/jbc.RA118.007340	http://dx.doi.org/10.1074/jbc.RA118.007340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31256002	hybrid, Green Published			2022-12-28	WOS:000484402700002
J	Norleans, J; Wang, JY; Kuryatov, A; Leffler, A; Doebelin, C; Kamenecka, TM; Lindstrom, J				Norleans, Jack; Wang, Jingyi; Kuryatov, Alexander; Leffler, Abba; Doebelin, Christelle; Kamenecka, Theodore M.; Lindstrom, Jon			Discovery of an intrasubunit nicotinic acetylcholine receptor-binding site for the positive allosteric modulator Br-PBTC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); allosteric regulation; molecular docking; drug design; receptor desensitization; positive allosteric modulator	AGONIST; SUBUNIT; DOCKING; ALPHA-5; ACTIVATION; DESENSITIZATION; MECHANISM; SOFTWARE; DOMAIN	Nicotinic acetylcholine receptor (nAChR) ligands that lack agonist activity but enhance activation in the presence of an agonist are called positive allosteric modulators (PAMs). nAChR PAMs have therapeutic potential for the treatment of nicotine addiction and several neuropsychiatric disorders. PAMs need to be selectively targeted toward certain nAChR subtypes to tap this potential. We previously discovered a novel PAM, (R)-7-bromo-N-(piperidin-3-yl)benzo[b]thiophene-2-carboxamide (Br-PBTC), which selectively potentiates the opening of alpha 4 beta 2*, alpha 2 beta 2*, alpha 2 beta 4*, and (alpha 4 beta 4)(2)alpha 4 nAChRs and reactivates some of these subtypes when desensitized (* indicates the presence of other subunits). We located the Br-PBTC-binding site through mutagenesis and docking in alpha 4. The amino acids Glu-282 and Phe-286 near the extracellular domain on the third transmembrane helix were found to be crucial for Br-PBTC's PAM effect. E282Q abolishes Br-PBTC potentiation. Using (alpha 4(E282Q)beta 2)(2)alpha 5 nAChRs, we discovered that the trifluoromethylated derivatives of Br-PBTC can potentiate channel opening of alpha 5-containing nAChRs. Mutating Tyr-430 in the alpha 5 M4 domain changed alpha 5-selectivity among Br-PBTC derivatives. There are two kinds of alpha 4 subunits in alpha 4 beta 2 nAChRs. Primary alpha 4 forms an agonist-binding site with another beta 2 subunit. Accessory alpha 4 forms an agonist-binding site with another alpha 4 subunit. The pharmacological effect of Br-PBTC depends both on its own and agonists' occupancy of primary and accessory alpha 4 subunits. Br-PBTC reactivates desensitized (alpha 4 beta 2)(2)alpha 4 nAChRs. Its full efficacy requires intact Br-PBTC sites in at least one accessory and one primary alpha 4 subunit. PAM potency increases with higher occupancy of the agonist sites. Br-PBTC and its derivatives should prove useful as alpha subunit-selective nAChR PAMs.	[Norleans, Jack; Kuryatov, Alexander; Lindstrom, Jon] Univ Penn, Dept Neurosci, Perelman Sch Med, 130A John Morgan Bldg, Philadelphia, PA 19104 USA; [Wang, Jingyi] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Leffler, Abba] NYU, Sackler Inst Grad Biomed Sci, Neurosci Grad Program, Sch Med, New York, NY 10010 USA; [Doebelin, Christelle; Kamenecka, Theodore M.] Scripps Res Inst, Dept Mol Med, Scripps, FL USA; [Doebelin, Christelle; Kamenecka, Theodore M.] Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA	University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Austin; New York University; Scripps Research Institute	Lindstrom, J (corresponding author), Univ Penn, Dept Neurosci, Perelman Sch Med, 130A John Morgan Bldg, Philadelphia, PA 19104 USA.	jslkk@pennmedicine.upenn.edu	Wang, Jin/GYA-2019-2022; wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022; wang, jing/GVT-8700-2022		Neuroscience Department of the Perelman School of Medicine at the University of Pennsylvania; National Institutes of Health NIDA Grant [DA030929]	Neuroscience Department of the Perelman School of Medicine at the University of Pennsylvania; National Institutes of Health NIDA Grant	This work was supported by the Neuroscience Department of the Perelman School of Medicine at the University of Pennsylvania and National Institutes of Health NIDA Grant DA030929. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcaino C, 2017, J BIOL CHEM, V292, P551, DOI 10.1074/jbc.M116.751206; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arnold LE, 2012, J CHILD ADOL PSYCHOP, V22, P198, DOI 10.1089/cap.2011.0056; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Carignano C, 2016, BBA-BIOMEMBRANES, V1858, P1964, DOI 10.1016/j.bbamem.2016.05.019; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; Deba F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19790-4; Domville JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22150-x; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Glaab E, 2016, BRIEF BIOINFORM, V17, P352, DOI 10.1093/bib/bbv037; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Henault CM, 2015, NEUROPHARMACOLOGY, V96, P157, DOI 10.1016/j.neuropharm.2014.11.011; Houston DR, 2013, J CHEM INF MODEL, V53, P384, DOI 10.1021/ci300399w; Jain A, 2016, J BIOL CHEM, V291, P23452, DOI 10.1074/jbc.M116.749150; Jin XC, 2011, J NEUROSCI, V31, P5045, DOI 10.1523/JNEUROSCI.4802-10.2011; Jin Z, 2014, BIOORG MED CHEM LETT, V24, P674, DOI 10.1016/j.bmcl.2013.11.049; Kamenecka T. M., 2016, International Patent, Patent No. [PCT/US2016/033774, 2016033774]; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Mazzaferro S, 2017, J BIOL CHEM, V292, P2729, DOI 10.1074/jbc.M116.764183; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; McFedries A, 2013, CHEM BIOL, V20, P667, DOI 10.1016/j.chembiol.2013.04.008; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newcombe J, 2018, MOL PHARMACOL, V93, P128, DOI 10.1124/mol.117.110551; Pandya A, 2011, J MOL NEUROSCI, V45, P42, DOI 10.1007/s12031-011-9509-3; Paradiso KG, 2003, J PHYSIOL-LONDON, V553, P857, DOI 10.1113/jphysiol.2003.053447; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prickaerts J, 2012, NEUROPHARMACOLOGY, V62, P1099, DOI 10.1016/j.neuropharm.2011.10.024; Quadri M, 2019, MOL PHARMACOL, V95, P43, DOI 10.1124/mol.118.113340; Quik M, 2011, PHARMACOL REV, V63, P938, DOI 10.1124/pr.110.003269; Ray C, 2017, ACS CHEM BIOL, V12, P702, DOI 10.1021/acschembio.6b01117; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tuccinardi T, 2014, J CHEM INF MODEL, V54, P2980, DOI 10.1021/ci500424n; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Walsh RM, 2018, NATURE, V557, P261, DOI 10.1038/s41586-018-0081-7; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Wang JY, 2018, BRIT J PHARMACOL, V175, P1805, DOI 10.1111/bph.13745; Wang JY, 2015, J BIOL CHEM, V290, P28834, DOI 10.1074/jbc.M115.676551; Wang JY, 2015, J BIOL CHEM, V290, P13907, DOI 10.1074/jbc.M115.646786; Wang JY, 2012, J BIOL CHEM, V287, P21957, DOI 10.1074/jbc.M112.339796; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	61	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12132	12145		10.1074/jbc.RA118.006253	http://dx.doi.org/10.1074/jbc.RA118.006253			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31221718	Green Published, hybrid			2022-12-28	WOS:000484284500017
J	Li, H; Xu, J; Shen, ZS; Wang, GM; Tang, MX; Du, XR; Lv, YT; Wang, JJ; Zhang, FF; Qi, Z; Zhang, Z; Sokabe, MSRO; Tang, QY				Li, Hui; Xu, Jie; Shen, Zhong-Shan; Wang, Guang-Ming; Tang, Mingxi; Du, Xiang-Rong; Lv, Yan-Tian; Wang, Jing-Jing; Zhang, Fei-Fei; Qi, Zhi; Zhang, Zhe; Sokabe, Masahiro; Tang, Qiong-Yao			The neuropeptide GsMTx4 inhibits a mechanosensitive BK channel through the voltage-dependent modification specific to mechano-gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; peptides; inhibition mechanism; gating; kinetics; molecular dynamics; structural model; patch clamp; biophysics; heart; arrhythmias; BK channel; lipid-peptide interaction; mechanosensitive channel; single channel kinetics	CA2+-ACTIVATED K+ CHANNELS; PIEZO PROTEINS; SPIDER VENOM; PEPTIDE; ACTIVATION; TOXIN; BLOCK; SENSITIVITY; ISCHEMIA; RECEPTOR	The cardiac mechanosensitive BK (Slo1) channels are gated by Ca2+, voltage, and membrane stretch. The neuropeptide GsMTx4 is a selective inhibitor of mechanosensitive (MS) channels. It has been reported to suppress stretch-induced cardiac fibrillation in the heart, but the mechanism underlying the specificity and even the targeting channel(s) in the heart remain elusive. Here, we report that GsMTx4 inhibits a stretch-activated BK channel (SAKcaC) in the heart through a modulation specific to mechano-gating. We show that membrane stretching increases while GsMTx4 decreases the open probability (P-o) of SAKcaC. These effects were mostly abolished by the deletion of the STREX axis-regulated (STREX) exon located between RCK1 and RCK2 domains in BK channels. Single-channel kinetics analysis revealed that membrane stretch activates SAKcaC by prolonging the open-time duration (tau(O)) and shortening the closed-time constant (tau(C)). In contrast, GsMTx4 reversed the effects of membrane stretch, suggesting that GsMTx4 inhibits SAKcaC activity by interfering with mechano-gating of the channel. Moreover, GsMTx4 exerted stronger efficacy on SAKcaC under membrane-hyperpolarized/resting conditions. Molecular dynamics simulation study revealed that GsMTx4 appeared to have the ability to penetrate deeply within the bilayer, thus generating strong membrane deformation under the hyperpolarizing/resting conditions. Immunostaining results indicate that BK variants containing STREX are also expressed in mouse ventricular cardiomyocytes. Our results provide common mechanisms of peptide actions on MS channels and may give clues to therapeutic suppression of cardiac arrhythmias caused by excitatory currents through MS channels under hyper-mechanical stress in the heart.	[Li, Hui; Xu, Jie; Shen, Zhong-Shan; Wang, Guang-Ming; Du, Xiang-Rong; Lv, Yan-Tian; Wang, Jing-Jing; Zhang, Fei-Fei; Zhang, Zhe; Tang, Qiong-Yao] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Jiangsu, Peoples R China; [Tang, Mingxi] Southwest Med Univ, Dept Pathol, Affiliated Hosp, Luzhou 646000, Sichuan, Peoples R China; [Qi, Zhi] Xiamen Univ, Dept Basic Med Sci, Med Coll, Xiamen 361102, Fujian, Peoples R China; [Sokabe, Masahiro; Tang, Qiong-Yao] Japan Sci & Technol Agcy, ICORP Cell Mechanosensing, Nagoya, Aichi 4668550, Japan; [Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Dept Physiol, Nagoya, Aichi 4668550, Japan	Xuzhou Medical University; Southwest Medical University; Xiamen University; Japan Science & Technology Agency (JST); Nagoya University	Tang, QY (corresponding author), Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Jiangsu, Peoples R China.; Sokabe, MSRO (corresponding author), Nagoya Univ, Grad Sch Med, Mechanobiol Lab, Nagoya, Aichi 4668550, Japan.	msokabe@med.nagoya-u.ac.jp; qiongyaotang@xzhmu.edu.cn	wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022; Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022		NSFC [81471314, 81671090, 81450064, 31671212]; Xuzhou Science and Technology Program [KC16H0230]; JSPS KAKENHI [JP15H05936]; Key Project in Sichuan province department of education [16ZA0196]; Jiangsu Provincial Special Program of Medical Science [BL2014029]	NSFC(National Natural Science Foundation of China (NSFC)); Xuzhou Science and Technology Program; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Key Project in Sichuan province department of education; Jiangsu Provincial Special Program of Medical Science	This work was supported by NSFC grants 81450064 and 31671212 (to Q.-Y. T.), NSFC grants 81471314 and 81671090 (to Z. Z.), Xuzhou Science and Technology Program KC16H0230 (to Q.-Y. T.), JSPS KAKENHI JP15H05936 (to M. S.), Key Project in Sichuan province department of education 16ZA0196 (to M. X. T.), and Jiangsu Provincial Special Program of Medical Science BL2014029 (to W. R).	AUERBACH A, 1991, BIOPHYS J, V60, P660, DOI 10.1016/S0006-3495(91)82095-1; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Bagriantsev SN, 2014, J BIOL CHEM, V289, P31673, DOI 10.1074/jbc.R114.612697; Blumenthal NR, 2014, P NATL ACAD SCI USA, V111, P16124, DOI 10.1073/pnas.1412740111; Bode F, 2001, NATURE, V409, P35, DOI 10.1038/35051165; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; CUEVAS J, 1994, BRIT J PHARMACOL, V111, P663, DOI 10.1111/j.1476-5381.1994.tb14789.x; DOPICO AM, 1994, AM J HYPERTENS, V7, P82, DOI 10.1093/ajh/7.1.82; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Frankenreiter S, 2017, CIRCULATION, V136, P2337, DOI 10.1161/CIRCULATIONAHA.117.028723; Geng YY, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00532; Gnanasambandam R, 2017, BIOPHYS J, V112, P31, DOI 10.1016/j.bpj.2016.11.013; Gu YZ, 2014, MOL NEUROBIOL, V50, P339, DOI 10.1007/s12035-014-8654-4; Hara M, 2012, AM J PHYSIOL-CELL PH, V302, pC1741, DOI 10.1152/ajpcell.00068.2012; He BH, 2017, OSTEOARTHR CARTILAGE, V25, P2091, DOI 10.1016/j.joca.2017.08.012; Hite RK, 2017, NATURE, V541, P52, DOI 10.1038/nature20775; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Kawakubo T, 1999, AM J PHYSIOL-HEART C, V276, pH1827, DOI 10.1152/ajpheart.1999.276.6.H1827; Kocer A, 2015, CURR OPIN CHEM BIOL, V29, P120, DOI 10.1016/j.cbpa.2015.10.006; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111; Mallouk N, 2000, AM J PHYSIOL-CELL PH, V278, pC473, DOI 10.1152/ajpcell.2000.278.3.C473; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Naruse K, 2009, BIOCHEM BIOPH RES CO, V385, P634, DOI 10.1016/j.bbrc.2009.05.105; Nishizawa K, 2015, BBA-BIOMEMBRANES, V1848, P2767, DOI 10.1016/j.bbamem.2015.09.003; Nishizawa M, 2007, BIOPHYS J, V92, P4233, DOI 10.1529/biophysj.106.101071; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Pallante BA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P186, DOI 10.1161/CIRCEP.109.928820; Peng AW, 2016, J NEUROSCI, V36, P2945, DOI 10.1523/JNEUROSCI.3011-15.2016; Ruta V, 2004, BIOCHEMISTRY-US, V43, P10071, DOI 10.1021/bi049463y; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Shelley C, 2010, J GEN PHYSIOL, V135, P461, DOI 10.1085/jgp.200910331; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Singh H, 2013, P NATL ACAD SCI USA, V110, P10836, DOI 10.1073/pnas.1302028110; Su JY, 2011, ACS NANO, V5, P351, DOI 10.1021/nn1014616; Suchyna TM, 2017, PROG BIOPHYS MOL BIO, V130, P244, DOI 10.1016/j.pbiomolbio.2017.07.011; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Tang QY, 2016, CELL REP, V14, P129, DOI 10.1016/j.celrep.2015.12.019; Tang QY, 2014, J BIOL CHEM, V289, P18860, DOI 10.1074/jbc.M113.538033; Tang QY, 2010, J BIOL CHEM, V285, P19259, DOI 10.1074/jbc.M109.100156; Tang QY, 2010, CHANNELS, V4, P22, DOI 10.4161/chan.4.1.10481; Tang QY, 2009, J GEN PHYSIOL, V134, P409, DOI 10.1085/jgp.200910251; Tang QY, 2003, J MEMBRANE BIOL, V196, P185, DOI 10.1007/s00232-003-0637-8; Tao X, 2017, NATURE, V541, P46, DOI 10.1038/nature20608; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Walewska A, 2018, BBA-BIOENERGETICS, V1859, P797, DOI 10.1016/j.bbabio.2018.05.006; Wang JL, 2016, J MOL CELL CARDIOL, V98, P83, DOI 10.1016/j.yjmcc.2016.07.005; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Zhang Z, 2010, J NEUROSCI, V30, P7554, DOI 10.1523/JNEUROSCI.0525-10.2010; Zhao HC, 2008, CELL RES, V18, P871, DOI 10.1038/cr.2008.88	57	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11892	11909		10.1074/jbc.RA118.005511	http://dx.doi.org/10.1074/jbc.RA118.005511			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31201274	Green Published, hybrid			2022-12-28	WOS:000486127800024
J	Mori, Y; Akita, K; Ojima, K; Iwamoto, S; Yamashita, T; Morii, E; Nakada, H				Mori, Yugo; Akita, Kaoru; Ojima, Kazuki; Iwamoto, Shungo; Yamashita, Tomoko; Morii, Eiichi; Nakada, Hiroshi			Trophoblast cell surface antigen 2 (Trop-2) phosphorylation by protein kinase C alpha/delta (PKC alpha/delta) enhances cell motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase C (PKC); protein phosphorylation; cancer; cell motility; cell adhesion; tight junction; cell signaling; claudin-7; transmembrane glycoprotein; trophoblast cell surface antigen 2 (Trop-2)	TIGHT JUNCTION; DOWN-REGULATION; CANCER; EXPRESSION; CARCINOMA; IDENTIFICATION; INVASION; CARCINOGENESIS; INVASIVENESS; METASTASIS	Dysfunction of tight junctions is a critical step during the initial stage of tumor progression. Trophoblast cell surface antigen 2 (Trop-2) belongs to the family of tumor-associated calcium signal transducer (TACSTD) and is required for the stability of claudin-7 and claudin-1, which are often dysregulated or lost in carcinogenesis. Here, we investigated the effects of Trop-2 phosphorylation on cell motility. Analyses using HCT116 cells expressing WT Trop-2 (HCT116/WT) or Trop-2 alanine-substituted at Ser-303 (HCT116/S303A) or Ser-322 (HCT116/S322A) revealed that Trop-2 is phosphorylated at Ser-322. Furthermore, coimmunoprecipitation and Transwell assays indicated that Trop-2 S322A interacted with claudin-7 the strongest, and a phosphomimetic variant, Trop-2 S322E, the weakest and that HCT116/S322E cells have the highest motility and HCT116/S322A cells the lowest. All cell lines had similar levels of claudin-7 mRNA, but levels of claudin-7 protein were markedly decreased in the HCT116/S322E cells, suggesting posttranscriptional control of claudin-7. Moreover, claudin-7 was clearly localized to cell-cell borders in HCT116/S322A cells but was diffusely distributed on the membrane and partially localized in the cytoplasm of HCT116/S322E and HCT116/WT cells. These observations suggested that Trop-2 phosphorylation plays a role in the decrease or mislocalization of claudin-7. Using protein kinase C (PKC) inhibitors and PKC-specific siRNAs, we found that PKC alpha and PKC delta are responsible for Trop-2 phosphorylation. Of note, chemical PKC inhibition and PKC alpha- and PKC delta-specific siRNAs reduced motility. In summary, our findings provide evidence that Trop-2 is phosphorylated at Ser-322 by PKC alpha/delta and that this phosphorylation enhances cell motility and decreases claudin-7 localization to cellular borders.	[Mori, Yugo; Akita, Kaoru; Ojima, Kazuki; Iwamoto, Shungo; Yamashita, Tomoko; Nakada, Hiroshi] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 6038555, Japan; [Morii, Eiichi] Osaka Univ, Dept Pathol, Grad Sch Med, Osaka 5650871, Japan	Kyoto Sangyo University; Osaka University	Nakada, H (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan.	hnakada@cc.kyoto-su.ac.jp			Japan Society for the Promotion of Science KAKENHI [17K14998]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 17K14998 (to Y. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Akita K, 2013, EUR J CELL BIOL, V92, P257, DOI 10.1016/j.ejcb.2013.10.005; Al Moustafa AE, 2002, ONCOGENE, V21, P2634, DOI 10.1038/sj.onc.1205351; BASU A, 1995, INT J CANCER, V62, P472, DOI 10.1002/ijc.2910620419; Bignotti E, 2010, EUR J CANCER, V46, P944, DOI 10.1016/j.ejca.2009.12.019; Bornholdt J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-65; Cubas R, 2009, BBA-REV CANCER, V1796, P309, DOI 10.1016/j.bbcan.2009.08.001; Ding L, 2012, GASTROENTEROLOGY, V142, P305, DOI 10.1053/j.gastro.2011.10.025; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Gan HC, 2013, J BIOL CHEM, V288, P37343, DOI 10.1074/jbc.M113.511527; Gastl G, 2000, LANCET, V356, P1981, DOI 10.1016/S0140-6736(00)03312-2; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Kyuno D, 2013, CARCINOGENESIS, V34, P1232, DOI 10.1093/carcin/bgt057; Lei ZL, 2012, DEV BIOL, V371, P136, DOI 10.1016/j.ydbio.2012.07.005; LIPINSKI M, 1981, P NATL ACAD SCI-BIOL, V78, P5147, DOI 10.1073/pnas.78.8.5147; Lu Z, 2011, EXP CELL RES, V317, P1935, DOI 10.1016/j.yexcr.2011.05.019; Michl P, 2003, CANCER RES, V63, P6265; Mori Y, 2014, J BIOL CHEM, V289, P35193, DOI 10.1074/jbc.M114.586461; Nakatsukasa M, 2010, AM J PATHOL, V177, P1344, DOI 10.2353/ajpath.2010.100149; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rangel LBA, 2003, CLIN CANCER RES, V9, P2567; Ripani E, 1998, INT J CANCER, V76, P671; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Seligson DB, 2004, CLIN CANCER RES, V10, P2659, DOI 10.1158/1078-0432.CCR-1132-03; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Steinberg SF, 2012, PHYSIOLOGY, V27, P130, DOI 10.1152/physiol.00009.2012; Stoyanova T, 2012, GENE DEV, V26, P2271, DOI 10.1101/gad.196451.112; Takaoka M, 2007, INVEST OPHTH VIS SCI, V48, P1095, DOI 10.1167/iovs.06-0740; Tinsley JH, 2004, AM J PHYSIOL-CELL PH, V286, pC105, DOI 10.1152/ajpcell.00340.2003; Trerotola M, 2013, ONCOGENE, V32, P222, DOI 10.1038/onc.2012.36; Trerotola M, 2013, CANCER RES, V73, P3155, DOI 10.1158/0008-5472.CAN-12-3266; Tsujikawa M, 1999, NAT GENET, V21, P420, DOI 10.1038/7759; Usami Y, 2006, HUM PATHOL, V37, P569, DOI 10.1016/j.humpath.2005.12.018; Wang JB, 2008, MOL CANCER THER, V7, P280, DOI 10.1158/1535-7163.MCT-07-2003; Wang JB, 2011, MOL CANCER RES, V9, P1686, DOI 10.1158/1541-7786.MCR-11-0241; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Wu CJ, 2013, J BIOL CHEM, V288, P12253, DOI 10.1074/jbc.M113.457499; Xie JH, 2016, ONCOTARGET, V7, P44492, DOI 10.18632/oncotarget.9876; Zeng P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33658	42	14	15	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11513	11524		10.1074/jbc.RA119.008084	http://dx.doi.org/10.1074/jbc.RA119.008084			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31177095	hybrid, Green Published			2022-12-28	WOS:000478717600014
J	Jin, UH; Karki, K; Cheng, YT; Michelhaugh, SK; Mittal, S; Safe, S				Jin, Un-Ho; Karki, Keshav; Cheng, Yating; Michelhaugh, Sharon K.; Mittal, Sandeep; Safe, Stephen			The aryl hydrocarbon receptor is a tumor suppressor-like gene in glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aryl hydrocarbon receptor (AhR); tumor suppressor gene; glioblastoma; invasion; migration; gene regulation; gut microbiome; kynurenine; nuclear transcription factor; tryptophan catabolism	CANCER CELL INVASION; AHR ACTIVATION; LIGAND; KYNURENINE; MIGRATION; 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN; CARCINOGENESIS; PROLIFERATION; PROMISCUITY; INHIBITION	The aryl hydrocarbon receptor (AhR) plays an important role in maintaining cellular homeostasis and also in pathophysiology. For example, the interplay between the gut microbiome and microbially derived AhR ligands protects against inflammation along the gut-brain axis. The AhR and its ligands also inhibit colon carcinogenesis, but it has been reported that the AhR and its ligand kynurenine enhance glioblastoma (GBM). In this study, using both established and patient-derived GBM cells, we re-examined the role of kynurenine and the AhR in GBM, observing that kynurenine does not modulate AhR-mediated gene expression and does not affect invasion of GBM cells. Therefore, using an array of approaches, including ChIP, quantitative real-time PCR, and cell migration assays, we primarily focused on investigating the role of the AhR in GBM at the functional molecular and genomic levels. The results of transient and stable CRISPR/Cas9-mediated AhR knockdown in GBM cells indicated that loss of AhR enhances GBM tumor growth in a mouse xenograft model, increases GBM cell invasion, and up-regulates expression of pro-invasion/pro-migration genes, as determined by ingenuity pathway analysis of RNA-Seq data. We conclude that the AhR is a tumor suppressor-like gene in GBM; future studies are required to investigate whether the AhR could be a potential drug target for treating patients with GBM who express this receptor.	[Jin, Un-Ho; Karki, Keshav; Cheng, Yating; Safe, Stephen] Texas A&M Univ, Dept Vet Phys & Pharmacol, 4466 TAMU, College Stn, TX 77843 USA; [Michelhaugh, Sharon K.] Wayne State Univ, Dept Neurosurg, Detroit, MI 48201 USA; [Mittal, Sandeep] Virginia Tech Caril Sch Med, Roanoke, VA 24016 USA	Texas A&M University System; Texas A&M University College Station; Wayne State University	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Phys & Pharmacol, 4466 TAMU, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu	Karki, Keshav/AAR-2421-2021	Cheng, Yating/0000-0002-2352-8647; Jin, Unho/0000-0002-0553-4082	National Institutes of Health [P30-ES023512, R01-ES025713, R01-CA202697, T32-ES026568]; Texas A&M AgriLife Research; Sid Kyle Chair Endowment; Karmanos Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA202697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512, R01ES025713, T32ES026568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M AgriLife Research; Sid Kyle Chair Endowment; Karmanos Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants P30-ES023512 (to S. S.), R01-ES025713 (to S. S.), R01-CA202697 (to S. S.), and T32-ES026568 (to K. K.); Texas A&M AgriLife Research (to S. S.), the Sid Kyle Chair Endowment (to S. S.), and the Karmanos Cancer Institute (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; D'Amato NC, 2015, CANCER RES, V75, P4651, DOI 10.1158/0008-5472.CAN-15-2011; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Diaz-Diaz CJ, 2016, ANN SURG, V264, P429, DOI 10.1097/SLA.0000000000001874; DiNatale BC, 2012, MOL CANCER RES, V10, P1369, DOI 10.1158/1541-7786.MCR-12-0216; DiNatale BC, 2011, MOL CARCINOGEN, V50, P173, DOI 10.1002/mc.20702; DiNatale BC, 2010, TOXICOL SCI, V115, P89, DOI 10.1093/toxsci/kfq024; Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Goettel JA, 2016, CELL REP, V17, P1318, DOI 10.1016/j.celrep.2016.09.082; Gramatzki D, 2009, ONCOGENE, V28, P2593, DOI 10.1038/onc.2009.104; Guastellal AR, 2018, J NEURO-ONCOL, V139, P239, DOI 10.1007/s11060-018-2869-6; Huang TC, 2011, FEBS LETT, V585, P3582, DOI 10.1016/j.febslet.2011.10.025; Hubbard TD, 2015, DRUG METAB DISPOS, V43, P1522, DOI 10.1124/dmd.115.064246; Islam J, 2017, J NUTR BIOCHEM, V42, P43, DOI 10.1016/j.jnutbio.2016.12.019; Jin DQ, 2004, NEUROSCI LETT, V363, P69, DOI 10.1016/j.neulet.2004.03.047; Jin UH, 2008, J CELL BIOCHEM, V104, P15, DOI 10.1002/jcb.21599; Jin UH, 2018, TOXICOL SCI, V164, P205, DOI 10.1093/toxsci/kfy075; Jin UH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10824-x; Jin UH, 2015, CHEM RES TOXICOL, V28, P907, DOI 10.1021/tx5005198; Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165; Jordan VC, 2007, JNCI-J NATL CANCER I, V99, P350, DOI 10.1093/jnci/djk062; Katzenellenbogen JA, 1996, MOL ENDOCRINOL, V10, P119, DOI 10.1210/me.10.2.119; Kawajiri K, 2009, P NATL ACAD SCI USA, V106, P13481, DOI 10.1073/pnas.0902132106; Kolluri SK, 2017, ARCH TOXICOL, V91, P2497, DOI 10.1007/s00204-017-1981-2; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li QS, 2016, J IMMUNOL, V197, P962, DOI 10.4049/jimmunol.1502615; Liu YY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15207; Morales-Hernandez A, 2016, NEUROTOXICOLOGY, V56, P55, DOI 10.1016/j.neuro.2016.07.001; Moyer BJ, 2016, TOXICOL APPL PHARM, V300, P13, DOI 10.1016/j.taap.2016.03.011; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Murray IA, 2010, MOL PHARMACOL, V77, P247, DOI 10.1124/mol.109.061788; Novikov O, 2016, MOL PHARMACOL, V90, P674, DOI 10.1124/mol.116.105361; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; POLAND A, 1976, J BIOL CHEM, V251, P4936; Poormasjedi-Meibod MS, 2016, J CELL PHYSIOL, V231, P2749, DOI 10.1002/jcp.25383; Qiao NA, 2016, TUMOR BIOL, V37, P8169, DOI 10.1007/s13277-015-4686-2; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Sanchez-Martin FJ, 2010, NEUROTOXICOLOGY, V31, P267, DOI 10.1016/j.neuro.2010.03.005; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Seok SH, 2018, J BIOL CHEM, V293, P1994, DOI 10.1074/jbc.RA117.000631; Shiizaki K, 2014, MOL PHARMACOL, V85, P279, DOI 10.1124/mol.113.088856; Singh NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023522; Soshilov AA, 2014, MOL CELL BIOL, V34, P1707, DOI 10.1128/MCB.01183-13; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Vinci M, 2015, JOVE-J VIS EXP, DOI 10.3791/52686; Wheeler MA, 2017, J BIOL CHEM, V292, P12383, DOI 10.1074/jbc.R116.767723; Xie Q, 2014, NEURO-ONCOLOGY, V16, P1575, DOI 10.1093/neuonc/nou147; Xing YN, 2012, TOXICOL SCI, V129, P86, DOI 10.1093/toxsci/kfs194; Ye J, 2017, CELL REP, V21, P2277, DOI 10.1016/j.celrep.2017.10.114; Yu YC, 2014, DNA CELL BIOL, V33, P543, DOI 10.1089/dna.2013.2289; Zang XJ, 2018, FASEB J, V32, P1944, DOI 10.1096/fj.201700853R; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	58	21	21	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11342	11353		10.1074/jbc.RA119.008882	http://dx.doi.org/10.1074/jbc.RA119.008882			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31171720	hybrid, Green Published			2022-12-28	WOS:000478717400024
J	Bitra, A; Nemcovicova, I; Picarda, G; Doukov, T; Wang, J; Benedict, CA; Zajonc, DM				Bitra, Aruna; Nemcovicova, Ivana; Picarda, Gaelle; Doukov, Tzanko; Wang, Jing; Benedict, Chris A.; Zajonc, Dirk M.			Structure of human cytomegalovirus UL144, an HVEM orthologue, bound to the B and T cell lymphocyte attenuator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); viral protein; protein-protein interaction; recombinant protein expression; cell-surface receptor; X-ray crystallography	TNF SUPERFAMILY; ENTRY; ACTIVATION; MEMBER; BTLA; GENE; HERPESVIRUSES; LYMPHOTOXIN; PROGRAM; VACCINE	Human cytomegalovirus (HCMV) is a beta-herpesvirus that has co-evolved with the host immune system to establish lifelong persistence. HCMV encodes many immunomodulatory molecules, including the glycoprotein UL144. UL144 is a structural mimic of the tumor necrosis factor receptor superfamily member HVEM (herpesvirus entry mediator), which binds to the various ligands LIGHT, LT alpha, BTLA, CD160, and gD. However, in contrast to HVEM, UL144 only binds BTLA, inhibiting T-cell activation. Here, we report the crystal structure of the UL144-BTLA complex, revealing that UL144 utilizes residues from its N-terminal cysteine-rich domain 1 (CRD1) to interact uniquely with BTLA. The shorter CRD2 loop of UL144 also alters the relative orientation of BTLA binding with both N-terminal CRDs. By employing structure-guided mutagenesis, we have identified a mutant of BTLA (L123A) that interferes with HVEM binding but preserves UL144 interactions. Furthermore, our results illuminate structural differences between UL144 and HVEM that explain its binding selectivity and highlight it as a suitable scaffold for designing superior, immune inhibitory BTLA agonists.	[Bitra, Aruna; Picarda, Gaelle; Wang, Jing; Benedict, Chris A.; Zajonc, Dirk M.] La Jolla Inst Immunol, Div Immune Regulat, La Jolla, CA 92037 USA; [Nemcovicova, Ivana] Slovak Acad Sci, Biomed Res Ctr, SK-84505 Bratislava, Slovakia; [Doukov, Tzanko] SLAC, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; Slovak Academy of Sciences; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Ghent University	Zajonc, DM (corresponding author), Pfizer, Canc Immunol Discovery, 10777 Sci Ctr Dr, San Diego, CA 92129 USA.	Dirk.Zajonc@pfizer.com	Nemčovičová, Ivana/I-3477-2013; Nemčovičová, Ivana/ABA-6080-2021	Nemčovičová, Ivana/0000-0003-1733-9986; Nemčovičová, Ivana/0000-0003-1733-9986; Bitra, Aruna/0000-0003-1675-3544; Zajonc, Dirk/0000-0001-7215-1981; Doukov, Tzanko/0000-0001-8625-2572	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health under NIGMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI139749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health under NIGMS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Stanford Synchrotron Lightsource (SSRL) for access to remote data collection and the SSRL beamline scientists for support. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, and by the National Institutes of Health under NIGMS Grant P41GM103393. We thank Kyowa Kirin Pharmaceutical Research, La Jolla, CA, for production and purification of recombinant UL144-Fc proteins.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benedict CA, 1999, J IMMUNOL, V162, P6967; Benedict CA, 2013, EXPERT REV VACCINES, V12, P1235, DOI 10.1586/14760584.2013.844653; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Holzerlandt R, 2002, GENOME RES, V12, P1739, DOI 10.1101/gr.334302; Lurain NS, 1999, J VIROL, V73, P10040, DOI 10.1128/JVI.73.12.10040-10050.1999; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; McFadden G, 2000, CURR OPIN MICROBIOL, V3, P371, DOI 10.1016/S1369-5274(00)00107-7; Mocarski ES, 2004, CELL MICROBIOL, V6, P707, DOI 10.1111/j.1462-5822.2004.00425.x; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson CA, 2008, J IMMUNOL, V180, P940, DOI 10.4049/jimmunol.180.2.940; Nemcovicova I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003224; Picarda G, 2018, J IMMUNOL, V200, P3881, DOI 10.4049/jimmunol.1800171; Poole E, 2006, EMBO J, V25, P4390, DOI 10.1038/sj.emboj.7601287; Poole E, 2015, MED MICROBIOL IMMUN, V204, P421, DOI 10.1007/s00430-015-0401-6; Poole E, 2013, J VIROL, V87, P4261, DOI 10.1128/JVI.03497-12; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schlfiss MR, 2007, J PEDIATR-US, V151, P564, DOI 10.1016/j.jpeds.2007.07.015; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Sedy JR, 2017, J BIOL CHEM, V292, P21060, DOI 10.1074/jbc.M117.813295; Sedy JR, 2013, J IMMUNOL, V191, P828, DOI 10.4049/jimmunol.1300894; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang JW, 2004, ACTA CRYSTALLOGR D, V60, P1244, DOI 10.1107/S0907444904010674; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Ware CF, 2011, CURR OPIN IMMUNOL, V23, P627, DOI 10.1016/j.coi.2011.08.008; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10519	10529		10.1074/jbc.RA119.009199	http://dx.doi.org/10.1074/jbc.RA119.009199			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31126984	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000478717100012
J	Sun, L; Dutta, RK; Xie, P; Kanwar, YS				Sun, Lin; Dutta, Rajesh K.; Xie, Ping; Kanwar, Yashpal S.			RETRACTION: myo-Inositol oxygenase overexpression accentuates generation of reactive oxygen species and exacerbates cellular injury following high glucose ambience: A new mechanism relevant to the pathogenesis of diabetic nephropathy (Retraction of Vol 291, Pg 5688, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Sun L, 2016, J BIOL CHEM, V291, P5688, DOI 10.1074/jbc.M115.669952	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10380	10380		10.1074/jbc.W119.009586	http://dx.doi.org/10.1074/jbc.W119.009586			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31253688	hybrid, Green Published			2022-12-28	WOS:000474445600027
J	Rovere, M; Powers, AE; Jiang, HY; Pitino, JC; Fonseca-Ornelas, L; Patel, DS; Achille, A; Langen, R; Varkey, J; Bartels, T				Rovere, Matteo; Powers, Alex E.; Jiang, Haiyang; Pitino, Julia C.; Fonseca-Ornelas, Luis; Patel, Dushyant S.; Achille, Alessandro; Langen, Ralf; Varkey, Jobin; Bartels, Tim			E46K-like -synuclein mutants increase lipid interactions and disrupt membrane selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-synuclein; Parkinson disease; neurodegeneration; intrinsically disordered protein; protein-lipid interaction; CD; isothermal titration calorimetry (ITC); 11; 3 helix; large unilamellar vesicle; small unilamellar vesicle	STEAROYL-COA DESATURASE; BOUND ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; PHOSPHOLIPID-BINDING; HYDROPHOBIC MOMENT; ALZHEIMERS-DISEASE; E46K MUTATION; PROTEIN; HELIX; PERIODICITY	Parkinson's disease (PD) is one of the most common neurodegenerative disorders, and both genetic and histopathological evidence have implicated the ubiquitous presynaptic protein -synuclein (Syn) in its pathogenesis. Recent work has investigated how disrupting Syn's interaction with membranes triggers trafficking defects, cellular stress, and apoptosis. Special interest has been devoted to a series of mutants exacerbating the effects of the E46K mutation (associated with autosomal dominant PD) through homologous Glu-to-Lys substitutions in Syn's N-terminal region (i.e. E35K and E61K). Such E46K-like mutants have been shown to cause dopaminergic neuron loss and severe but L-DOPA-responsive motor defects in mouse overexpression models, presenting enormous translational potential for PD and other synucleinopathies. In this work, using a variety of biophysical techniques, we characterize the molecular pathology of E46K-like Syn mutants by studying their structure and membrane-binding and remodeling abilities. We find that, although a slight increase in the mutants' avidity for synaptic vesicle-like membranes can be detected, most of their deleterious effects are connected to their complete disruption of Syn's curvature selectivity. Indiscriminate binding can shift Syn's subcellular localization away from its physiological interactants at the synaptic bouton toward trafficking vesicles and organelles, as observed in E46K-like cellular and murine models, as well as in human pathology. In conclusion, our findings suggest that a loss of curvature selectivity, rather than increased membrane affinity, could be the critical dyshomeostasis in synucleinopathies.	[Rovere, Matteo; Powers, Alex E.; Jiang, Haiyang; Pitino, Julia C.; Fonseca-Ornelas, Luis; Patel, Dushyant S.; Bartels, Tim] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA; [Rovere, Matteo; Powers, Alex E.; Jiang, Haiyang; Pitino, Julia C.; Fonseca-Ornelas, Luis; Patel, Dushyant S.; Bartels, Tim] Harvard Med Sch, Boston, MA 02115 USA; [Achille, Alessandro] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; [Langen, Ralf; Varkey, Jobin] Univ Southern Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Bartels, Tim] UCL, Dementia Res Inst, Gower St,Cruciform Bldg,Wing 2-4, London WC1E 6BT, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of Southern California; University of London; University College London	Bartels, T (corresponding author), UCL, Dementia Res Inst, Gower St,Cruciform Bldg,Wing 2-4, London WC1E 6BT, England.	t.bartels@ucl.ac.uk	Rovere, Matteo/GQZ-6505-2022; Bartels, Tim/AAD-6128-2021; Rovere, Matteo/AHC-1539-2022; Fonseca-Ornelas, Luis/GPX-3085-2022	Rovere, Matteo/0000-0002-3260-4955; Fonseca-Ornelas, Luis/0000-0001-7810-5564; Bartels, Tim/0000-0002-4071-5612	NINDS, National Institutes of Health [R21NS107950]; American Parkinson Disease Association [PF-JFA-1884]; National Institutes of Health [NS084345, GM115736]; Office of Naval Research [N00014-13-1-0563]; Parkinson's Disease Foundation [PF-JFA-1884]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS104576, R01NS084345] Funding Source: NIH RePORTER; MRC [UKDRI-1012] Funding Source: UKRI	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Parkinson Disease Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); Parkinson's Disease Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NINDS, National Institutes of Health Grant R21NS107950 (to T. B.), American Parkinson Disease Association Grant PF-JFA-1884 (to T. B.), National Institutes of Health Grants NS084345 and GM115736 (to R. L.), and Office of Naval Research Grant N00014-13-1-0563 (to (A. A.) and Parkinson's Disease Foundation Grant PF-JFA-1884 (to T. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Croke RL, 2008, PROTEIN SCI, V17, P1434, DOI 10.1110/ps.033803.107; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dettmer U, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00623; Dettmer U, 2017, HUM MOL GENET, V26, P3466, DOI 10.1093/hmg/ddx227; Dettmer U, 2016, CURR OPIN NEUROBIOL, V36, P15, DOI 10.1016/j.conb.2015.07.007; Dettmer U, 2015, P NATL ACAD SCI USA, V112, P9596, DOI 10.1073/pnas.1505953112; Dettmer U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8314; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fanning S, 2019, MOL CELL, V73, P1001, DOI 10.1016/j.molcel.2018.11.028; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; GRACE AA, 1984, J NEUROSCI, V4, P2877; Indyk L, 1998, METHOD ENZYMOL, V295, P350; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jiang ZP, 2015, J PHYS CHEM B, V119, P4812, DOI 10.1021/jp512499r; JONES MK, 1992, J LIPID RES, V33, P287; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lautenschlager J, 2017, TRENDS CELL BIOL, V27, P468, DOI 10.1016/j.tcb.2017.02.002; LIM VI, 1978, FEBS LETT, V89, P10, DOI 10.1016/0014-5793(78)80511-0; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Nielsen JT, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00004; Nuber S, 2018, NEURON, V100, P75, DOI 10.1016/j.neuron.2018.09.014; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1111/ene.14108, 10.1038/nrdp.2017.13]; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; Shahmoradian S. H., 2017, BIORXIV, DOI [10.1101/137976, DOI 10.1101/137976]; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Varkey J, 2013, J BIOL CHEM, V288, P17620, DOI 10.1074/jbc.M113.476697; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Vincent BM, 2018, CELL REP, V25, P2742, DOI 10.1016/j.celrep.2018.11.028; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wise-Scira O, 2013, ACS CHEM NEUROSCI, V4, P498, DOI 10.1021/cn3002027; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	65	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9799	9812		10.1074/jbc.RA118.006551	http://dx.doi.org/10.1074/jbc.RA118.006551			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31048377	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000473277900014
J	[Anonymous]				[Anonymous]			Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: A role for oxidant stress (Expression of Concern of Vol 282, Pg 26793, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200	1	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					10025	10025		10.1074/jbc.EC119.009571	http://dx.doi.org/10.1074/jbc.EC119.009571			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31227630	Green Published, hybrid			2022-12-28	WOS:000473277900038
J	Yang, LN; Uboldi, AD; Seizova, S; Wilde, ML; Coffey, MJ; Katris, NJ; Yamaryo-Botte, Y; Kocan, M; Bathgate, RAD; Stewart, RJ; McConville, MJ; Thompson, PE; Botte, CY; Tonkin, CJ				Yang, Luning; Uboldi, Alessandro D.; Seizova, Simona; Wilde, Mary-Louise; Coffey, Michael J.; Katris, Nicholas J.; Yamaryo-Botte, Yoshiki; Kocan, Martina; Bathgate, Ross A. D.; Stewart, Rebecca J.; McConville, Malcolm J.; Thompson, Philip E.; Botte, Cyrille Y.; Tonkin, Christopher J.			An apically located hybrid guanylate cyclase-ATPase is critical for the initiation of Ca2+ signaling and motility in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; Toxoplasma gondii; cell motility; cyclic GMP (cGMP); cyclic nucleotide	PHOSPHATIDIC-ACID; MICRONEME SECRETION; PROTEIN SECRETION; CELL EGRESS; HOST-CELLS; ADENYLYL; KINASE; INVASION; IDENTIFICATION; EXOCYTOSIS	Protozoan parasites of the phylum Apicomplexa actively move through tissue to initiate and perpetuate infection. The regulation of parasite motility relies on cyclic nucleotide-dependent kinases, but how these kinases are activated remains unknown. Here, using an array of biochemical and cell biology approaches, we show that the apicomplexan parasite Toxoplasma gondii expresses a large guanylate cyclase (TgGC) protein, which contains several upstream ATPase transporter-like domains. We show that TgGC has a dynamic localization, being concentrated at the apical tip in extracellular parasites, which then relocates to a more cytosolic distribution during intracellular replication. Conditional TgGC knockdown revealed that this protein is essential for acute-stage tachyzoite growth, as TgGC-deficient parasites were defective in motility, host cell attachment, invasion, and subsequent host cell egress. We show that TgGC is critical for a rapid rise in cytosolic [Ca2+] and for secretion of microneme organelles upon stimulation with a cGMP agonist, but these deficiencies can be bypassed by direct activation of signaling by a Ca2+ ionophore. Furthermore, we found that TgGC is required for transducing changes in extracellular pH and [K+] to activate cytosolic [Ca2+] flux. Together, the results of our work implicate TgGC as a putative signal transducer that activates Ca2+ signaling and motility in Toxoplasma.	[Yang, Luning; Uboldi, Alessandro D.; Seizova, Simona; Wilde, Mary-Louise; Coffey, Michael J.; Stewart, Rebecca J.; Tonkin, Christopher J.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Yang, Luning; Uboldi, Alessandro D.; Seizova, Simona; Wilde, Mary-Louise; Coffey, Michael J.; Stewart, Rebecca J.; Tonkin, Christopher J.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia; [Yang, Luning] Tsinghua Univ, Sch Med, Beijing 100006, Peoples R China; [Katris, Nicholas J.; Yamaryo-Botte, Yoshiki; Botte, Cyrille Y.] Univ Grenoble Alpes, ApicoLipid Team, Inst Adv Biosci, CNRS,UMR5309,INSERM,U1209, Grenoble, France; [Kocan, Martina; Bathgate, Ross A. D.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Bathgate, Ross A. D.; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3052, Australia; [Thompson, Philip E.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne; Tsinghua University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Monash University	Tonkin, CJ (corresponding author), Walter & Eliza Hall Inst Med Res, Div Infect Dis & Immune Def, 1G Royal Pde, Parkville, Vic 3052, Australia.	tonkin@wehi.edu.au	Bathgate, Ross/ABE-6471-2020; Tonkin, Christopher/J-2580-2016	Bathgate, Ross/0000-0001-6301-861X; Thompson, Philip/0000-0002-5910-7625; Tonkin, Christopher/0000-0002-7036-6222; Coffey, Michael/0000-0002-8025-4558; Botte, Cyrille/0000-0002-2245-536X; Kocan, Martina/0000-0003-3468-6197; Katris, Nicholas/0000-0002-7419-3410	Australian Research Council (ARC) Future Fellowship [FT120100164]; China Council scholarship; Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council (NHMRC) Independent Medical Research Institutes Infrastructure Support Scheme (IRIISS); Agence Nationale de la Recherche, France [ANR-12-PDOC-0028]; Atip-Avenir program (CNRS-INSERM-FinoviAtip-Avenir Apicolipid projects); Finovi program (CNRS-INSERM-FinoviAtip-Avenir Apicolipid projects); Laboratoire d' Excellence Parafrap, France [ANR-11-LABX-0024]; Laboratoire International Associe (LIA) CNRS Program (Apicolipid project); NHMR Cprinciple research fellowship	Australian Research Council (ARC) Future Fellowship(Australian Research Council); China Council scholarship(China Scholarship Council); Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council (NHMRC) Independent Medical Research Institutes Infrastructure Support Scheme (IRIISS)(National Health and Medical Research Council (NHMRC) of Australia); Agence Nationale de la Recherche, France(French National Research Agency (ANR)); Atip-Avenir program (CNRS-INSERM-FinoviAtip-Avenir Apicolipid projects); Finovi program (CNRS-INSERM-FinoviAtip-Avenir Apicolipid projects); Laboratoire d' Excellence Parafrap, France; Laboratoire International Associe (LIA) CNRS Program (Apicolipid project); NHMR Cprinciple research fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council (ARC) Future Fellowship FT120100164 (to C.J.T.); a China Council scholarship (to L.Y.); Victorian State Government Operational Infrastructure Support and the Australian Government National Health and Medical Research Council (NHMRC) Independent Medical Research Institutes Infrastructure Support Scheme (IRIISS); Agence Nationale de la Recherche, France Grant ANR-12-PDOC-0028-Project Apicolipid, the Atip-Avenir and Finovi programs (CNRS-INSERM-FinoviAtip-Avenir Apicolipid projects), and Laboratoire d' Excellence Parafrap, France Grant ANR-11-LABX-0024 (to C.Y.B., Y.Y.-B., and N.J.K.); the Laboratoire International Associe (LIA) CNRS Program (Apicolipid project) (to C.Y.B. and C.J.T.); and an NHMR Cprinciple research fellowship (to M.J.M.).	Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Amiar S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005765; Baker DA, 2004, IUBMB LIFE, V56, P535, DOI 10.1080/15216540400013937; Baker DA, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170213; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Beuve A, 1999, METHODS, V19, P545, DOI 10.1006/meth.1999.0896; Bisio H, 2019, NAT MICROBIOL, V4, P420, DOI 10.1038/s41564-018-0339-8; Borges-Pereira L, 2015, J BIOL CHEM, V290, P26914, DOI 10.1074/jbc.M115.652511; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Brown KM, 2018, CELL HOST MICROBE, V24, P804, DOI 10.1016/j.chom.2018.10.015; Brown KM, 2017, MBIO, V8, DOI [10.1128/mBio.00375-17, 10.1128/mbio.00375-17]; Brown KM, 2016, J BIOL CHEM, V291, P9554, DOI 10.1074/jbc.M115.700518; Bullen HE, 2016, FEBS LETT, V590, P2469, DOI 10.1002/1873-3468.12296; Bullen HE, 2016, CELL HOST MICROBE, V19, P349, DOI 10.1016/j.chom.2016.02.006; BULOW R, 1991, J IMMUNOL, V147, P3496; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Dawn A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004520; Donald RGK, 2002, EUKARYOT CELL, V1, P317, DOI 10.1128/EC.1.3.317-328.2002; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Frenal K, 2017, NAT REV MICROBIOL, V15, P645, DOI 10.1038/nrmicro.2017.86; Gaji RY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005268; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Howard BL, 2015, ACS CHEM BIOL, V10, P1145, DOI 10.1021/cb501004q; Jia YG, 2017, EMBO J, V36, P3250, DOI 10.15252/embj.201796794; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kumar S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00053-1; Linder JU, 1999, EMBO J, V18, P4222, DOI 10.1093/emboj/18.15.4222; Lourido S, 2015, CELL CALCIUM, V57, P186, DOI 10.1016/j.ceca.2014.12.010; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; McCoy JM, 2017, J BIOL CHEM, V292, P7662, DOI 10.1074/jbc.M117.775114; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Paul AS, 2015, CELL HOST MICROBE, V18, P49, DOI 10.1016/j.chom.2015.06.003; Philip N, 2015, CELL HOST MICROBE, V18, P122, DOI 10.1016/j.chom.2015.05.018; Risco-Castillo V, 2015, CELL HOST MICROBE, V18, P593, DOI 10.1016/j.chom.2015.10.006; Roiko MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004488; Roiko MS, 2013, J BIOL CHEM, V288, P8712, DOI 10.1074/jbc.M113.450932; Sidik SM, 2016, J BIOL CHEM, V291, P9566, DOI 10.1074/jbc.M115.703546; Stewart RJ, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12685; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Tanaka T, 2012, J AGR FOOD CHEM, V60, P4156, DOI 10.1021/jf300147y; Tardieux I, 2016, J CELL BIOL, V214, P507, DOI 10.1083/jcb.201605100; Treeck M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004197; Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495	57	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8959	8972		10.1074/jbc.RA118.005491	http://dx.doi.org/10.1074/jbc.RA118.005491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30992368	Green Published, hybrid			2022-12-28	WOS:000470971100028
J	Das, K; Paul, S; Singh, A; Ghosh, A; Roy, A; Ansari, SA; Prasad, R; Mukherjee, A; Sen, P				Das, Kaushik; Paul, Subhojit; Singh, Arpana; Ghosh, Arnab; Roy, Abhishek; Ansari, Shabbir Ahmed; Prasad, Ramesh; Mukherjee, Ashis; Sen, Prosenjit			Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metastasis; microRNA (miRNA); proliferation; post-transcriptional regulation; breast cancer; anti-apoptosis; microRNA221; microvesicles; oncogenic miR (OncomiR); protease-activated receptor 2	ACTIVATED RECEPTOR 2; MIR-221 PROMOTES; TISSUE FACTOR; STEM-CELLS; KAPPA-B; EXPRESSION; TARGET; AXIS; PROLIFERATION; PROGRESSION	The triple-negative phenotype is the most prevalent form of human breast cancer worldwide and is characterized by poor survival, high aggressiveness, and recurrence. Microvesicles (MV) are shredded plasma membrane components and critically mediate cell-cell communication, but can also induce cancer proliferation and metastasis. Previous studies have revealed that protease-activated receptor 2 (PAR2) contributes significantly to human triple-negative breast cancer (TNBC) progression by releasing nano-size MV and promoting cell proliferation, migration, and invasion. MV isolated from highly aggressive human TNBC cells impart metastatic potential to nonmetastatic cells. Over-expression of microRNA221 (miR221) has also been reported to enhance the metastatic potential of human TNBC, but miR221's relationship to PAR2-induced MV is unclear. Here, using isolated MV, immunoblotting, quantitative RT-PCR, FACS analysis, and enzymatic assays, we show that miR221 is translocated via human TNBC-derived MV, which upon fusion with recipient cells, enhance their proliferation, survival, and metastasis both in vitro and in vivo by inducing the epithelial-to-mesenchymal transition (EMT). Administration of anti-miR221 significantly impaired MV-induced expression of the mesenchymal markers Snail, Slug, N-cadherin, and vimentin in the recipient cells, whereas restoring expression of the epithelial marker E-cadherin. We also demonstrate that MV-associated miR221 targets phosphatase and tensin homolog (PTEN) in the recipient cells, followed by AKT Ser/Thr kinase (AKT)/NF-kappa B activation, which promotes EMT. Moreover, elevated miR221 levels in MV derived from human TNBC patients' blood could induce cell proliferation and metastasis in recipient cells. In summary, miR221 transfer from TNBC cells via PAR2-derived MV induces EMT and enhances the malignant potential of recipient cells.	[Das, Kaushik; Paul, Subhojit; Singh, Arpana; Ghosh, Arnab; Roy, Abhishek; Prasad, Ramesh; Sen, Prosenjit] Indian Assoc Cultivat Sci, Sch Biol Sci, Kolkata 700032, India; [Mukherjee, Ashis] Netaji Subhash Chandra Bose Canc Res Inst, Kolkata 700016, India; [Ansari, Shabbir Ahmed] Univ Texas Hlth Sci Ctr Tyler, Tyler, TX 75708 USA	Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Sen, P (corresponding author), 2A & 2B Raja SC Mullick Rd, Kolkata 700032, India.	bcps@iacs.res.in	ansari, shabbir/HDO-7187-2022; Ansari, Shabbir/GNW-5542-2022; Roy, Abhishek/AAA-7591-2021	ansari, shabbir/0000-0002-1939-7066; 	Department of Science and Technology, Government of India DST [SR/SO/BB-0125/2012]; Council of Scientific and Industrial Research, India	Department of Science and Technology, Government of India DST(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Department of Science and Technology, Government of India DST SR/SO/BB-0125/2012 for project grants and a fellowship from the Council of Scientific and Industrial Research, India. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn SG, 2016, J BREAST CANCER, V19, P223, DOI 10.4048/jbc.2016.19.3.223; Al-Mahmood S, 2018, DRUG DELIV TRANSL RE, V8, P1483, DOI 10.1007/s13346-018-0551-3; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borowiec AS, 2007, J CELL PHYSIOL, V212, P690, DOI 10.1002/jcp.21065; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Carvalho E, 2018, BIOCHEM BIOPH RES CO, V504, P270, DOI 10.1016/j.bbrc.2018.08.169; Chiang KC, 2016, ANTICANCER RES, V36, P3997; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Cole M, 2013, ONCOLOGIST, V18, P14, DOI 10.1634/theoncologist.2012-0322; Das K, 2018, MOL CARCINOGEN, V57, P1707, DOI 10.1002/mc.22891; Das K, 2018, BIOMED PHARMACOTHER, V105, P395, DOI 10.1016/j.biopha.2018.05.155; Das K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25725-w; Deng L, 2017, ONCOTARGET, V8, P108712, DOI 10.18632/oncotarget.21561; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Dong R, 2007, BRAZ J MED BIOL RES, V40, P1071, DOI 10.1590/S0100-879X2007000800007; Falkenberg N, 2013, BRIT J CANCER, V109, P2714, DOI 10.1038/bjc.2013.625; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hyslop T, 2013, BIOMARK MED, V7, P11, DOI [10.2217/bmm.12.114, 10.2217/BMM.12.114]; Iablokov V, 2014, J BIOL CHEM, V289, P34366, DOI 10.1074/jbc.M114.610485; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim JE, 2012, J BREAST CANCER, V15, P197, DOI 10.4048/jbc.2012.15.2.197; Kong LX, 2016, INT J ONCOL, V48, P1085, DOI 10.3892/ijo.2016.3343; Krishnan RK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7658; Li BL, 2017, CHEM-BIOL INTERACT, V277, P33, DOI 10.1016/j.cbi.2017.08.014; Li BL, 2016, BIOMED PHARMACOTHER, V79, P93, DOI 10.1016/j.biopha.2016.01.045; Liao GY, 2014, CELL SIGNAL, V26, P2131, DOI 10.1016/j.cellsig.2014.06.004; Liu J, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0028-3; Maguire O, 2015, J IMMUNOL METHODS, V423, P3, DOI 10.1016/j.jim.2015.03.018; Matej R, 2007, PHYSIOL RES, V56, P475, DOI 10.33549/physiolres.930959; Miike S, 2001, J IMMUNOL, V167, P6615, DOI 10.4049/jimmunol.167.11.6615; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; Pan Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep25798; Rojas-Puentes L, 2016, CANCER MED-US, V5, P1989, DOI 10.1002/cam4.751; Roy A, 2017, J BIOL CHEM, V292, P13688, DOI 10.1074/jbc.M116.764670; Salido-Guadarrama I, 2014, ONCOTARGETS THER, V7, P1327, DOI 10.2147/OTT.S61562; Schmadeka R, 2014, AM J CLIN PATHOL, V141, P462, DOI 10.1309/AJCPQN8GZ8SILKGN; Sharma S, 2016, FRONT GENET, V7, DOI 10.5589/fgene.2016.00175; Sigurosson HH, 2015, MOL CANCER RES, V13, P63, DOI 10.1158/1541-7786.MCR-14-0011; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245; Soung YH, 2016, BMB REP, V49, P18, DOI 10.5483/BMBRep.2016.49.1.239; Storci G, 2010, J CELL PHYSIOL, V225, P682, DOI 10.1002/jcp.22264; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Sun L, 2018, WORLD J GASTROENTERO, V24, P1120, DOI 10.3748/wjg.v24.i10.1120; Vahed SZ, 2016, BIOIMPACTS, V6, P24, DOI 10.15171/bi.2016.04; Wang T, 2014, P NATL ACAD SCI USA, V111, pE3234, DOI 10.1073/pnas.1410041111; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Ye ZQ, 2016, TUMOR BIOL, V37, P4509, DOI 10.1007/s13277-015-4267-4; Zhang XS, 2017, ONCOTARGET, V8, P59086, DOI 10.18632/oncotarget.19175	55	13	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13681	13696		10.1074/jbc.RA119.008619	http://dx.doi.org/10.1074/jbc.RA119.008619			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31341019	Green Published, hybrid			2022-12-28	WOS:000486418600014
J	Schweig, JE; Yao, HL; Coppola, K; Jin, C; Crawford, F; Mullan, M; Paris, D				Schweig, Jonas Elias; Yao, Hailan; Coppola, Kyle; Jin, Chao; Crawford, Fiona; Mullan, Michael; Paris, Daniel			Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer's disease; spleen tyrosine kinase (Syk); Tau protein (Tau); tauopathy; mammalian target of rapamycin (mTOR); Akt PKB; autophagy; LC3; S6K; Tau degradation; Tg Tau P301S	MOUSE MODEL; MICROGLIAL ACTIVATION; MAMMALIAN TARGET; STRESS GRANULES; INSOLUBLE TAU; MTOR PATHWAY; PHOSPHORYLATION; INHIBITION; TAUOPATHY; PROTEIN	Spleen tyrosine kinase (SYK) plays a major role in inflammation and in adaptive immune responses and could therefore contribute to the neuroinflammation observed in various neurodegenerative diseases. Indeed, previously we have reported that SYK also regulates beta-amyloid (A beta) production and hyperphosphorylation of Tau protein involved in these diseases. Moreover, SYK hyperactivation occurs in a subset of activated microglia, in dystrophic neurites surrounding A beta deposits, and in neurons affected by Tau pathology both in individuals with Alzheimer's disease (AD) and in AD mouse models. SYK activation increases Tau phosphorylation and accumulation, suggesting that SYK could be an attractive target for treating AD. However, the mechanism by which SYK affects Tau pathology is not clear. In this study, using cell biology and biochemical approaches, along with immunoprecipitation and immunoblotting, quantitative RT-PCR, and ELISAs, we found that SYK inhibition increases autophagic Tau degradation without impacting Tau production. Using neuron-like SH-SY5Y cells, we demonstrate that SYK acts upstream of the mammalian target of rapamycin (mTOR) pathway and that pharmacological inhibition or knockdown of SYK decreases mTOR pathway activation and increases autophagic Tau degradation. Interestingly, chronic SYK inhibition in a tauopathy mouse model profoundly reduced Tau accumulation, neuroinflammation, neuronal and synaptic loss, and also reversed defective autophagy. Our results further suggest that the SYK up-regulation observed in the brains of individuals with AD contributes to defective autophagic clearance leading to the accumulation of pathogenic Tau species. These findings further highlight SYK as a therapeutic target for the treatment of tauopathies and other neurodegenerative proteinopathies associated with defective autophagic clearance.	[Schweig, Jonas Elias; Yao, Hailan; Coppola, Kyle; Jin, Chao; Crawford, Fiona; Mullan, Michael; Paris, Daniel] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Schweig, Jonas Elias; Crawford, Fiona; Mullan, Michael; Paris, Daniel] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Schweig, Jonas Elias; Yao, Hailan; Coppola, Kyle; Crawford, Fiona; Paris, Daniel] James A Haley Vet Hosp, Tampa, FL 33612 USA	Open University - UK; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Schweig, JE (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	jschweig@roskampinstitute.net		Paris, Daniel/0000-0002-9622-0846	Department of Veterans Affairs VA Merit Award [1I01BX002572]; Roskamp Foundation; Veterans Affairs [I01BX002572] Funding Source: NIH RePORTER	Department of Veterans Affairs VA Merit Award; Roskamp Foundation; Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Department of Veterans Affairs VA Merit Award 1I01BX002572 (to F. C.) and the Roskamp Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; Bain HDC, 2019, NEUROPATH APPL NEURO, V45, P244, DOI 10.1111/nan.12500; Bartaula-Brevik S, 2018, EXPERT OPIN INV DRUG, V27, P377, DOI 10.1080/13543784.2018.1459562; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bellucci A, 2004, AM J PATHOL, V165, P1643, DOI 10.1016/S0002-9440(10)63421-9; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Carnevale J, 2013, LEUKEMIA, V27, P2118, DOI 10.1038/leu.2013.89; Chen XB, 2011, J NEUROSCI, V31, P6329, DOI 10.1523/JNEUROSCI.5968-10.2011; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chesser AS, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00122; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Choi SH, 2015, AUTOPHAGY, V11, P785, DOI 10.1080/15548627.2015.1037061; Choi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043418; Chuang JY, 2014, INT J MOL SCI, V15, P545, DOI 10.3390/ijms15010545; Combs CK, 2001, J NEUROSCI, V21, P1179; Combs CK, 1999, J NEUROSCI, V19, P928; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Elias EE, 2018, HAEMATOLOGICA, V103, pE458, DOI 10.3324/haematol.2018.188680; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Faruki S, 2000, J CELL SCI, V113, P2557; Fatouros C, 2012, HUM MOL GENET, V21, P3587, DOI 10.1093/hmg/dds190; Fernandez-Nogales M, 2014, NAT MED, V20, P881, DOI 10.1038/nm.3617; Fruchon S, 2012, LEUKEMIA, V26, P795, DOI 10.1038/leu.2011.248; Funderburk SF, 2010, MT SINAI J MED, V77, P59, DOI 10.1002/msj.20161; Gao P, 2017, ONCOTARGET, V8, P83900, DOI 10.18632/oncotarget.19911; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Ghosh S, 2015, EBIOMEDICINE, V2, P1785, DOI 10.1016/j.ebiom.2015.09.053; Hayashi H, 2018, J PHARMACOL EXP THER, V366, P84, DOI 10.1124/jpet.118.248153; Jiang T, 2014, NEUROPHARMACOLOGY, V85, P121, DOI 10.1016/j.neuropharm.2014.05.032; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura T, 2010, J BIOL CHEM, V285, P38692, DOI 10.1074/jbc.M110.136630; Korzhevskii D.E., 2016, NEUROSCI BEHAV PHYSL, V46, P284, DOI [DOI 10.1007/S11055-016-0231-Z, 10.1007/s11055-016-0231-z]; Kragh CL, 2012, BRAIN PATHOL, V22, P99, DOI 10.1111/j.1750-3639.2011.00545.x; Krisenko MO, 2015, J BIOL CHEM, V290, P27803, DOI 10.1074/jbc.M115.642900; Lee CK, 2016, ONCOGENE, V35, P1988, DOI 10.1038/onc.2015.275; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Leseux L, 2006, BLOOD, V108, P4156, DOI 10.1182/blood-2006-05-026203; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Maximova OA, 2010, VACCINE, V28, P8315, DOI 10.1016/j.vaccine.2010.07.070; McDonald DR, 1997, J NEUROSCI, V17, P2284; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Neil J, 2016, INT J ONCOL, V48, P1045, DOI 10.3892/ijo.2015.3311; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Ozcelik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062459; Paris D, 2014, J BIOL CHEM, V289, P33927, DOI 10.1074/jbc.M114.608091; Park JE, 2018, CLIN IMMUNOL, V192, P50, DOI 10.1016/j.clim.2018.04.007; Puertollano Rosa, 2014, F1000Prime Rep, V6, P52, DOI 10.12703/P6-52; Pugsley HR, 2017, JOVE-J VIS EXP, DOI 10.3791/55637; Roders N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00787; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schweig JE, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0472-2; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Srivastava IN, 2016, NEUROBIOL DIS, V85, P144, DOI 10.1016/j.nbd.2015.10.001; Taft CE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0134; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tsujimura T, 2001, FEBS LETT, V489, P129, DOI 10.1016/S0014-5793(01)02097-X; von Bernhardi R, 2010, J NEUROCHEM, V112, P1099, DOI 10.1111/j.1471-4159.2009.06537.x; Wang HJ, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0042-16.2016; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Wang XM, 2011, J MOL CELL BIOL, V3, P206, DOI 10.1093/jmcb/mjq038; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xu N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00209; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Yanamandra K, 2015, ANN CLIN TRANSL NEUR, V2, P278, DOI 10.1002/acn3.176; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yu Y, 2015, CANCER CELL, V28, P82, DOI 10.1016/j.ccell.2015.05.009; Yura T., 2001, U. S. Patent, Patent No. [WO/2001/083485A1, 2001083485]; Zare-shahabadi A, 2015, REV NEUROSCIENCE, V26, P385, DOI 10.1515/revneuro-2014-0076; Zhang J, 2013, BBA-MOL BASIS DIS, V1832, P1980, DOI 10.1016/j.bbadis.2013.06.013; Zheng HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070472; Zhou XG, 2011, BIOCHEM BIOPH RES CO, V411, P271, DOI 10.1016/j.bbrc.2011.06.117	82	12	13	6	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13378	13395		10.1074/jbc.RA119.008033	http://dx.doi.org/10.1074/jbc.RA119.008033			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31324720	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000486417200015
J	Pinkwart, K; Schneider, F; Lukoseviciute, M; Sauka-Spengler, T; Lyman, E; Eggeling, C; Sezgin, E				Pinkwart, Kerstin; Schneider, Falk; Lukoseviciute, Martyna; Sauka-Spengler, Tatjana; Lyman, Edward; Eggeling, Christian; Sezgin, Erdinc			Nanoscale dynamics of cholesterol in the cell membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; fluorescence correlation spectroscopy (FCS); plasma membrane; membrane biophysics; membrane lipid; membrane structure; Bodipy-cholesterol; diffusion; hindered diffusion; membrane asymmetry; model membranes	FLUORESCENCE CORRELATION SPECTROSCOPY; PLASMA-MEMBRANE; BODIPY-CHOLESTEROL; LIPID ORGANIZATION; PHASE-SEPARATION; DIFFUSION; MODEL; PROTEINS; HEDGEHOG; ANALOGS	Cholesterol constitutes similar to 30-40% of the mammalian plasma membrane, a larger fraction than of any other single component. It is a major player in numerous signaling processes as well as in shaping molecular membrane architecture. However, our knowledge of the dynamics of cholesterol in the plasma membrane is limited, restricting our understanding of the mechanisms regulating its involvement in cell signaling. Here, we applied advanced fluorescence imaging and spectroscopy approaches on in vitro (model membranes) and in vivo (live cells and embryos) membranes as well as in silico analysis to systematically study the nanoscale dynamics of cholesterol in biological membranes. Our results indicate that cholesterol diffuses faster than phospholipids in live membranes, but not in model membranes. Interestingly, a detailed statistical diffusion analysis suggested two-component diffusion for cholesterol in the plasma membrane of live cells. One of these components was similar to a freely diffusing phospholipid analogue, whereas the other one was significantly faster. When a cholesterol analogue was localized to the outer leaflet only, the fast diffusion of cholesterol disappeared, and it diffused similarly to phospholipids. Overall, our results suggest that cholesterol diffusion in the cell membrane is heterogeneous and that this diffusional heterogeneity is due to cholesterol's nanoscale interactions and localization in the membrane.	[Pinkwart, Kerstin; Schneider, Falk; Eggeling, Christian; Sezgin, Erdinc] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Lukoseviciute, Martyna; Sauka-Spengler, Tatjana] Univ Oxford, Adcliffe Dept Med, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Lyman, Edward] Univ Delaware, Dept Phys, Newark, DE 19716 USA; [Lyman, Edward] Univ Delaware, Dept Astron, Newark, DE 19716 USA; [Lyman, Edward] Univ Delaware, Dept Chem, Newark, DE 19716 USA; [Lyman, Edward] Univ Delaware, Dept Biochem, Newark, DE 19716 USA; [Eggeling, Christian] Friedrich Schiller Univ Jena, Inst Appl Opt & Biophys, Max Wien Pl 4, D-07743 Jena, Germany; [Eggeling, Christian] Leibniz Inst Photon Technol eV, Albert Einstein Str 9, D-07745 Jena, Germany	University of Oxford; University of Oxford; University of Delaware; University of Delaware; University of Delaware; University of Delaware; Friedrich Schiller University of Jena; Leibniz Institut fur Photonische Technologien	Sezgin, E (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England.	erdinc.sezgin@rdm.ox.ac.uk	Sezgin, Erdinc/R-1980-2018	Sezgin, Erdinc/0000-0002-4915-388X; Eggeling, Christian/0000-0002-3698-5599; Sauka-Spengler, Tatjana/0000-0001-9289-0263; Lukoseviciute, Martyna/0000-0002-8915-5249; Schneider, Falk/0000-0003-0502-9139	Wellcome Trust [091911]; United States National Science Foundation [ACI-1548562]; National Institutes of Health [R01GM116961]; BBSRC [BB/P026354/1] Funding Source: UKRI; MRC [MC_UU_00008/9, G0902418, MR/K01577X/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120351, R01GM116961] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); United States National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Wolfson Imaging Centre Oxford and the Micron Advanced Bioimaging Unit supported by Wellcome Trust Strategic Award 091911 for providing microscope facility and financial support. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by United States National Science Foundation Grant ACI-1548562. Anton 2 computer time was provided by the Pittsburgh Supercomputing Center (PSC) through Grant R01GM116961 from the National Institutes of Health. The Anton2 machine at NRBSC/PSC was generously made available by Delaware Shaw Research.	Allender DW, 2019, BIOPHYS J, V116, P2356, DOI 10.1016/j.bpj.2019.03.028; Andrade DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11454; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Bukiya AN, 2017, J LIPID RES, V58, P1044, DOI 10.1194/jlr.R073452; Camley BA, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4932980; Chiantia S, 2011, BIOPHYS J, V100, pLO1, DOI 10.1016/j.bpj.2010.11.051; Clausen MP, 2013, NANO LETT, V13, P2332, DOI 10.1021/nl303151f; Courtney KC, 2018, CELL REP, V24, P1037, DOI 10.1016/j.celrep.2018.06.104; Eggeling C, 2015, ESSAYS BIOCHEM, V57, P69, DOI [10.1042/BSE0570069, 10.1042/bse0570069]; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Endapally S, 2019, CELL, V176, P1040, DOI 10.1016/j.cell.2018.12.042; Fantini J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21907; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Fujimoto T, 2017, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00155; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Garcia-Saez AJ, 2010, METHODS MOL BIOL, V606, P493, DOI 10.1007/978-1-60761-447-0_33; Gimpl G, 2007, BIOSCIENCE REP, V27, P335, DOI 10.1007/s10540-007-9060-1; Gimpl G, 2011, STEROIDS, V76, P216, DOI 10.1016/j.steroids.2010.11.001; Guixa-Gonzalez R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14505; Hiramoto-Yamaki N, 2014, TRAFFIC, V15, P583, DOI 10.1111/tra.12163; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Holtta-Vuori M, 2016, TRAFFIC, V17, P1054, DOI 10.1111/tra.12414; Honigmann A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6412; Honigmann A, 2013, FARADAY DISCUSS, V161, P77, DOI [10.1039/c2fd20107k, 10.1039/C2FD20107K]; Huang PX, 2016, CELL, V166, P1176, DOI 10.1016/j.cell.2016.08.003; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Javanainen M, 2019, PHYS CHEM CHEM PHYS, V21, P11660, DOI 10.1039/c9cp02022e; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kanerva K, 2013, DEV CELL, V27, P249, DOI 10.1016/j.devcel.2013.09.016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lagerholm BC, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa519e; Levi V, 2003, BIOCHEM SOC T, V31, P997; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Lin QQ, 2015, BIOPHYS J, V108, P2212, DOI 10.1016/j.bpj.2015.03.056; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Marks DL, 2008, HISTOCHEM CELL BIOL, V130, P819, DOI 10.1007/s00418-008-0509-5; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Maxfield FR, 2012, METHOD CELL BIOL, V108, P367, DOI 10.1016/B978-0-12-386487-1.00017-1; Mobarak E, 2018, BBA-BIOMEMBRANES, V1860, P2436, DOI 10.1016/j.bbamem.2018.07.003; Mondal M, 2009, MOL BIOL CELL, V20, P581, DOI 10.1091/mbc.E08-07-0785; Mueller V, 2011, BIOPHYS J, V101, P1651, DOI 10.1016/j.bpj.2011.09.006; Ostasov P, 2013, CHEM PHYS LIPIDS, V167, P62, DOI 10.1016/j.chemphyslip.2013.02.006; Plochberger B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15949-7; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Pourmousa M, 2014, J PHYS CHEM B, V118, P7345, DOI 10.1021/jp406883k; Ramirez DMC, 2010, BBA-BIOMEMBRANES, V1798, P558, DOI 10.1016/j.bbamem.2009.12.005; Ramstedt B, 1999, BIOPHYS J, V76, P908, DOI 10.1016/S0006-3495(99)77254-1; Regmi R, 2017, NANO LETT, V17, P6295, DOI 10.1021/acs.nanolett.7b02973; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; Schneider F, 2018, ACS NANO, V12, P8540, DOI 10.1021/acsnano.8b04080; Schneider F, 2017, MOL BIOL CELL, V28, P1507, DOI 10.1091/mbc.E16-07-0536; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sezgin E, 2019, NAT PROTOC, V14, P1054, DOI 10.1038/s41596-019-0127-9; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Sezgin E, 2016, J LIPID RES, V57, P299, DOI 10.1194/jlr.M065326; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sodt AJ, 2014, J AM CHEM SOC, V136, P725, DOI 10.1021/ja4105667; Solanko LM, 2013, BIOPHYS J, V105, P2082, DOI 10.1016/j.bpj.2013.09.031; Thallmair S, 2018, J PHYS CHEM LETT, V9, P5527, DOI 10.1021/acs.jpclett.8b01877; Waithe D, 2018, METHODS, V140, P62, DOI 10.1016/j.ymeth.2017.09.010; Waithe D, 2016, BIOINFORMATICS, V32, P958, DOI 10.1093/bioinformatics/btv687; Weiner MD, 2018, J PHYS CHEM B, V122, P8193, DOI 10.1021/acs.jpcb.8b03949; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Winkler PM, 2018, J PHYS CHEM LETT, V9, P110, DOI 10.1021/acs.jpclett.7b02818; Wustner D, 2016, CHEM PHYS LIPIDS, V194, P12, DOI 10.1016/j.chemphyslip.2015.08.007	75	26	26	6	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12599	12609		10.1074/jbc.RA119.009683	http://dx.doi.org/10.1074/jbc.RA119.009683			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31270209	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000484414600004
J	Wichmann, L; Dulai, JS; Marles-Wright, J; Maxeiner, S; Szczesniak, PP; Manzini, I; Althaus, M				Wichmann, Lukas; Dulai, Jasdip Singh; Marles-Wright, Jon; Maxeiner, Stephan; Szczesniak, Pawel Piotr; Manzini, Ivan; Althaus, Mike			An extracellular acidic cleft confers profound H+-sensitivity to epithelial sodium channels containing the delta-subunit in Xenopus laevis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); Xenopus; evolution; allosteric regulation; molecular evolution; delta-subunit; pH; sodium self-inhibition; tetrapod; water-to-land transition	SENSING ION CHANNELS; NA+ CHANNEL; ENAC; TOAD; ACTIVATION; RESIDUES; ASIC1; INHIBITION; EXCRETION; AFFINITY	The limited sodium availability of freshwater and terrestrial environments was a major physiological challenge during vertebrate evolution. The epithelial sodium channel (ENaC) is present in the apical membrane of sodium-absorbing vertebrate epithelia and evolved as part of a machinery for efficient sodium conservation. ENaC belongs to the degenerin/ENaC protein family and is the only member that opens without an external stimulus. We hypothesized that ENaC evolved from a proton-activated sodium channel present in ionocytes of freshwater vertebrates and therefore investigated whether such ancestral traits are present in ENaC isoforms of the aquatic pipid frog Xenopus laevis. Using whole-cell and single-channel electrophysiology of Xenopus oocytes expressing ENaC isoforms assembled from alpha beta gamma- or delta beta gamma-subunit combinations, we demonstrate that Xenopus delta beta gamma-ENaC is profoundly activated by extracellular acidification within biologically relevant ranges (pH 8.0-6.0). This effect was not observed in Xenopus alpha beta gamma-ENaC or human ENaC orthologs. We show that protons interfere with allosteric ENaC inhibition by extracellular sodium ions, thereby increasing the probability of channel opening. Using homology modeling of ENaC structure and site-directed mutagenesis, we identified a cleft region within the extracellular loop of the delta-subunit that contains several acidic amino acid residues that confer proton-sensitivity and enable allosteric inhibition by extracellular sodium ions. We propose that Xenopus delta beta gamma-ENaC can serve as a model for investigating ENaC transformation from a proton-activated toward a constitutively-active ion channel. Such transformation might have occurred during the evolution of tetrapod vertebrates to enable bulk sodium absorption during the water-to-land transition.	[Wichmann, Lukas; Dulai, Jasdip Singh; Marles-Wright, Jon; Althaus, Mike] Newcastle Univ, Sch Nat & Environm Sci, Ridley Bldg 2, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Maxeiner, Stephan] Saarland Univ, Inst Anat & Cell Biol, D-66421 Homburg, Germany; [Szczesniak, Pawel Piotr] Goethe Univ Frankfurt, Dept Med, Haematol Oncol, D-60323 Frankfurt, Germany; [Wichmann, Lukas; Manzini, Ivan] Justus Liebig Univ Giessen, Dept Anim Physiol & Mol Biomed, Inst Anim Physiol, D-35390 Giessen, Germany	Newcastle University - UK; Universitatsklinikum des Saarlandes; Goethe University Frankfurt; Justus Liebig University Giessen	Althaus, M (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Ridley Bldg 2, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	mike.althaus@newcastle.ac.uk	Maxeiner, Stephan/Y-7692-2019; Manzini, Ivan/V-4545-2019	Maxeiner, Stephan/0000-0002-4472-695X; Manzini, Ivan/0000-0002-3575-9637; Dulai, Jasdip Singh/0000-0002-6784-5214; Marles-Wright, Jon/0000-0002-9156-3284; Wichmann, Lukas/0000-0001-9808-8407				Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Assmann M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0084-2; Awayda MS, 2000, AM J PHYSIOL-CELL PH, V279, pC1896, DOI 10.1152/ajpcell.2000.279.6.C1896; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; BALINSKY JB, 1961, J EXP BIOL, V38, P695; Bayley M, 2019, PHYSIOLOGY, V34, P14, DOI 10.1152/physiol.00028.2018; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Boscardin E, 2016, BRIT J PHARMACOL, V173, P2671, DOI 10.1111/bph.13533; Chalfant ML, 1999, AM J PHYSIOL-CELL PH, V276, pC477, DOI 10.1152/ajpcell.1999.276.2.C477; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cottrell GA, 1997, J EXP BIOL, V200, P2377; Dymowska AK, 2015, J EXP BIOL, V218, P1244, DOI 10.1242/jeb.113118; Dymowska AK, 2014, AM J PHYSIOL-CELL PH, V307, pC255, DOI 10.1152/ajpcell.00398.2013; Evans BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142823; FRAZIER LW, 1971, BIOCHIM BIOPHYS ACTA, V241, P20, DOI 10.1016/0005-2736(71)90299-9; Giraldez T, 2012, AM J PHYSIOL-RENAL, V303, pF328, DOI 10.1152/ajprenal.00116.2012; Hanukoglu I, 2016, GENE, V579, P95, DOI 10.1016/j.gene.2015.12.061; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HUMPHREYS BD, 1994, AM J PHYSIOL-CELL PH, V267, pC1295, DOI 10.1152/ajpcell.1994.267.5.C1295; Ianevski A, 2017, BIOINFORMATICS, V33, P2413, DOI 10.1093/bioinformatics/btx162; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Kashlan OB, 2018, FASEB J, V32; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; LEAF A, 1964, AM J PHYSIOL, V207, P547, DOI 10.1152/ajplegacy.1964.207.3.547; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lynagh T, 2018, P NATL ACAD SCI USA, V115, P8430, DOI 10.1073/pnas.1806614115; MCBEAN RL, 1970, AM J PHYSIOL, V219, P1115, DOI 10.1152/ajplegacy.1970.219.4.1115; MCCLANAHAN L, 1967, COMP BIOCHEM PHYSIOL, V20, P73, DOI 10.1016/0010-406X(67)90726-8; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; PALMER LG, 1987, AM J PHYSIOL, V253, pF333, DOI 10.1152/ajprenal.1987.253.2.F333; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHOEMAKER VH, 1964, COMP BIOCHEM PHYSIOL, V13, P261, DOI 10.1016/0010-406X(64)90121-5; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STEINMETZ PR, 1974, PHYSIOL REV, V54, P890, DOI 10.1152/physrev.1974.54.4.890; Studer RA, 2011, PHYSIOL GENOMICS, V43, P844, DOI 10.1152/physiolgenomics.00002.2011; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; USSING HH, 1949, ACTA PHYSIOL SCAND, V17, P1, DOI 10.1111/j.1748-1716.1949.tb00550.x; Wichmann L, 2018, J BIOL CHEM, V293, P6647, DOI 10.1074/jbc.RA118.002543; Yadav B, 2015, COMPUT STRUCT BIOTEC, V13, P504, DOI 10.1016/j.csbj.2015.09.001; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang P, 1999, BIOPHYS J, V77, P3043, DOI 10.1016/S0006-3495(99)77135-3	51	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12507	12520		10.1074/jbc.RA119.008255	http://dx.doi.org/10.1074/jbc.RA119.008255			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31248986	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000484402700021
J	Mattson, AM; Begun, DL; Molstad, DHH; Meyer, MA; Oursler, MJ; Westendorf, JJ; Bradley, E				Mattson, Anna M.; Begun, Dana L.; Molstad, David H. H.; Meyer, Margaret A.; Oursler, Merry Jo; Westendorf, Jennifer J.; Bradley, Elizabeth			Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell polarity; phosphatase; Akt PKB; cytoskeleton; protein kinase C (PKC); bone resorption; collagen triple helix repeat containing 1 (CTHRC1); colony-stimulating factor 1 receptor (CSF1R); mineralization; macrophage colony-stimulating factor (M-CSF); protein kinase C zeta (PKC zeta)	PROTEIN-KINASE-C; M-CSF; CELL POLARITY; PH-DOMAIN; EXPRESSION; DELETION; AKT; PROMOTION; AMPLITUDE; PATHWAY	Enhanced osteoclast-mediated bone resorption and diminished formation may promote bone loss. Pleckstrin homology (PH) domain and leucine-rich repeat protein phosphatase 1 (Phlpp1) regulates protein kinase C (PKC) and other proteins in the control of bone mass. Germline Phlpp1 deficiency reduces bone volume, but the mechanisms remain unknown. Here, we found that conditional Phlpp1 deletion in murine osteoclasts increases their numbers, but also enhances bone mass. Despite elevating osteoclasts, Phlpp1 deficiency did not increase serum markers of bone resorption, but elevated serum markers of bone formation. These results suggest that Phlpp1 suppresses osteoclast formation and production of paracrine factors controlling osteoblast activity. Phlpp1 deficiency elevated osteoclast numbers and size in ex vivo osteoclastogenesis assays, accompanied by enhanced expression of proto-oncogene C-Fms (C-Fms) and hyper-responsiveness to macrophage colony-stimulating factor (M-CSF) in bone marrow macrophages. Although Phlpp1 deficiency increased TRAP(+) cell numbers, it suppressed actin-ring formation and bone resorption in these assays. We observed that Phlpp1 deficiency increases activity of PKC zeta, a PKC isoform controlling cell polarity, and that addition of a PKC zeta pseudosubstrate restores osteoclastogenesis and bone resorption of Phlpp1-deficient osteoclasts. Moreover, Phlpp1 deficiency increased expression of the bone-coupling factor collagen triple helix repeat-containing 1 (Cthrc1). Conditioned growth medium derived from Phlpp1-deficient osteoclasts enhanced mineralization of ex vivo osteoblast cultures, an effect that was abrogated by Cthrc1 knockdown. In summary, Phlpp1 critically regulates osteoclast numbers, and Phlpp1 deficiency enhances bone mass despite higher osteoclast numbers because it apparently disrupts PKC zeta activity, cell polarity, and bone resorption and increases secretion of bone-forming Cthrc1.	[Mattson, Anna M.; Begun, Dana L.; Molstad, David H. H.; Meyer, Margaret A.; Westendorf, Jennifer J.; Bradley, Elizabeth] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55901 USA; [Oursler, Merry Jo; Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55901 USA; [Oursler, Merry Jo] Mayo Clin, Endocrine Res Unit, Rochester, MN 55901 USA; [Oursler, Merry Jo] Mayo Clin, Kogod Ctr Aging, Rochester, MN 55901 USA; [Bradley, Elizabeth] Mayo Clin, Dept Biomed Engn & Physiol, Rochester, MN 55901 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Bradley, E (corresponding author), 200 First St SW, Rochester, MN 55901 USA.	Bradley.elizabeth1@mayo.edu		Bradley, Elizabeth/0000-0002-8814-5524; Westendorf, Jennifer J/0000-0002-4464-6108	National Institutes of Health Research [AR065397, AR072634, AR068103, AR065402, AR067129]; Mayo Clinic Center for Biomedical Discovery; Mayo Clinic Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067129, K01AR065397, R01AR072634, R01AR068103] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Biomedical Discovery; Mayo Clinic Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work supported by National Institutes of Health Research Grants AR065397, AR072634, AR068103, AR065402, and AR067129, the Mayo Clinic Center for Biomedical Discovery, and the Mayo Clinic Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen LAH, 2002, CURR BIOL, V12, P1762, DOI 10.1016/S0960-9822(02)01216-2; BARON R, 1989, CONNECT TISSUE RES, V20, P109, DOI 10.3109/03008208909023879; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Bradley EW, 2008, J CELL PHYSIOL, V217, P752, DOI 10.1002/jcp.21550; Bradley EW, 2008, J CELL BIOCHEM, V104, P1439, DOI 10.1002/jcb.21719; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; Bradley EW, 2015, J BIOL CHEM, V290, P16272, DOI 10.1074/jbc.M114.612937; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; Coxon FP, 2008, SEMIN CELL DEV BIOL, V19, P424, DOI 10.1016/j.semcdb.2008.08.004; Debnath S, 2018, NATURE, V562, P133, DOI 10.1038/s41586-018-0554-8; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Grzechnik AT, 2016, BIOCHEM SOC T, V44, P1675, DOI 10.1042/BST20160170; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kimura H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003174; Li X, 2014, EMBO REP, V15, P191, DOI 10.1002/embr.201338119; Linch M, 2014, CARCINOGENESIS, V35, P396, DOI 10.1093/carcin/bgt313; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; McGee-Lawrence ME, 2014, BONE, V66, P277, DOI 10.1016/j.bone.2014.06.022; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Reyes G, 2014, P NATL ACAD SCI USA, V111, pE3957, DOI 10.1073/pnas.1404221111; Ross FP, 2006, ANN NY ACAD SCI, V1068, P110, DOI 10.1196/annals.1346.014; Ruiz P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36201; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493; Warfel NA, 2012, J BIOL CHEM, V287, P3610, DOI 10.1074/jbc.R111.318675; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005; Xiong XP, 2016, J BIOL CHEM, V291, P25167, DOI 10.1074/jbc.M116.740639; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396	38	12	12	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11772	11784		10.1074/jbc.RA119.007660	http://dx.doi.org/10.1074/jbc.RA119.007660			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31189651	hybrid, Green Published			2022-12-28	WOS:000486127800014
J	Poulsen, ET; Nielsen, NS; Scavenius, C; Mogensen, EH; Risor, MW; Runager, K; Lukassen, MV; Rasmussen, CB; Christiansen, G; Richner, M; Vorum, H; Enghild, JJ				Poulsen, Ebbe Toftgaard; Nielsen, Nadia Sukusu; Scavenius, Carsten; Mogensen, Emilie Hage; Risor, Michael W.; Runager, Kasper; Lukassen, Marie, V; Rasmussen, Casper B.; Christiansen, Gunna; Richner, Mette; Vorum, Henrik; Enghild, Jan J.			The serine protease HtrA1 cleaves misfolded transforming growth factor beta-induced protein (TGFBIp) and induces amyloid formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cornea; protein folding; protein misfolding; protein turnover; protease; BIGH3; corneal dystrophy; HTRA1; granular corneal dystrophy (GCD); high-temperature requirement protein A1 (HtrA1); transforming growth factor beta-induced protein (TGFBIp); lattice corneal dystrophy (LCD); amyloid; eye disorder; proteolytic processing	MUTATIONS; LATTICE; MATRIX; SUSCEPTIBILITY; IDENTIFICATION; MECHANISMS; BETA-IG-H3; PROTEOMICS; REVEALS; CORNEA	The serine protease high-temperature requirement protein A1 (HtrA1) is associated with protein-misfolding disorders such as Alzheimer's disease and transforming growth factor beta-induced protein (TGFBIp)-linked corneal dystrophy. In this study, using several biochemical and biophysical approaches, including recombinant protein expression, LC-MS/MS and 2DE analyses, and thioflavin T (ThT) fluorescence assays for amyloid fibril detection, and FTIR assays, we investigated the role of HtrA1 both in normal TGFBIp turnover and in corneal amyloid formation. We show that HtrA1 can cleave WT TGFBIp but prefers amyloidogenic variants. Corneal TGFBIp is extensively processed in healthy people, resulting in C-terminal degradation products spanning the FAS1-4 domain of TGFBIp. We show here that HtrA1 cleaves the WT FAS1-4 domain only inefficiently, whereas the amyloidogenic FAS1-4 mutations transform this domain into a considerably better HTRA1 substrate. Moreover, HtrA1 cleavage of the mutant FAS1-4 domains generated peptides capable of forming in vitro amyloid aggregates. Significantly, these peptides have been previously identified in amyloid deposits in vivo, supporting the idea that HtrA1 is a causative agent for TGFBIp-associated amyloidosis in corneal dystrophy. In summary, our results indicate that TGFBIp is an HtrA1 substrate and that some mutations in the gene encoding TGFBIp cause aberrant HtrA1-mediated processing that results in amyloidogenesis in corneal dystrophies.	[Poulsen, Ebbe Toftgaard; Nielsen, Nadia Sukusu; Scavenius, Carsten; Mogensen, Emilie Hage; Risor, Michael W.; Runager, Kasper; Lukassen, Marie, V; Rasmussen, Casper B.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Nielsen, Nadia Sukusu; Risor, Michael W.; Runager, Kasper; Lukassen, Marie, V; Enghild, Jan J.] Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark; [Christiansen, Gunna; Richner, Mette] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Vorum, Henrik] Aalborg Univ Hosp, Dept Ophthalmol, DK-9000 Aalborg, Denmark	Aarhus University; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital	Enghild, JJ (corresponding author), Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	jje@mbg.au.dk	Scavenius, Carsten/Q-5941-2017	Scavenius, Carsten/0000-0002-4304-0681; Vestergaard Lukassen, Marie/0000-0003-3237-2696; Richner, Mette/0000-0003-0211-8574; Toftgaard Poulsen, Ebbe/0000-0002-4416-0431; Christiansen, Gunna/0000-0003-0540-1367	VELUX Foundation; Lundbeck Foundation [R164-2013-15912]; Danish Council for Independent Research-Medical Sciences Grant [DFF-4004-00471]; Dagmar Marshalls Fond; Fabrikant Einar Willumsens Mindelegat; Svend Helge Arvid Schroder og Hustru Ketty Lydia Larsen Schroders Fond; Maskinfabrikant Jochum Jensen og hustru Mette Marie Jensen F. Poulsens Mindelegat; Grosserer Chr. Andersen og hustru Ingeborg Andersen, f. Schmidts Legat; Fight for Sight, Denmark; National Institutes of Health [EY025090, CA217642]; NATIONAL CANCER INSTITUTE [R01CA217642] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY025090] Funding Source: NIH RePORTER	VELUX Foundation(Velux Fonden); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research-Medical Sciences Grant; Dagmar Marshalls Fond; Fabrikant Einar Willumsens Mindelegat; Svend Helge Arvid Schroder og Hustru Ketty Lydia Larsen Schroders Fond; Maskinfabrikant Jochum Jensen og hustru Mette Marie Jensen F. Poulsens Mindelegat; Grosserer Chr. Andersen og hustru Ingeborg Andersen, f. Schmidts Legat; Fight for Sight, Denmark; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the VELUX Foundation, Lundbeck Foundation Grant R164-2013-15912, Danish Council for Independent Research-Medical Sciences Grant DFF-4004-00471, Dagmar Marshalls Fond, Fabrikant Einar Willumsens Mindelegat, Svend Helge Arvid Schroder og Hustru Ketty Lydia Larsen Schroders Fond, Maskinfabrikant Jochum Jensen og hustru Mette Marie Jensen F. Poulsens Mindelegat, Grosserer Chr. Andersen og hustru Ingeborg Andersen, f. Schmidts Legat, Fight for Sight, Denmark, and National Institutes of Health Grants EY025090 and CA217642. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Cabrera AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14208-z; Courtney DG, 2015, INVEST OPHTH VIS SCI, V56, P4653, DOI 10.1167/iovs.15-16922; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Dyrlund TF, 2012, J PROTEOME RES, V11, P4231, DOI 10.1021/pr300358k; Garcia-Castellanos R, 2017, STRUCTURE, V25, P1740, DOI 10.1016/j.str.2017.09.001; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grothe HL, 2013, MOL VIS, V19, P593; Jurkunas UV, 2009, INVEST OPHTH VIS SCI, V50, P1129, DOI 10.1167/iovs.08-2525; Karring H, 2013, MOL VIS, V19, P861; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Karring H, 2010, EXP EYE RES, V90, P57, DOI 10.1016/j.exer.2009.09.011; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lakshminarayanan R, 2014, OCUL SURF, V12, P234, DOI 10.1016/j.jtos.2013.12.002; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Nielsen NS, 2017, BIOCHEMISTRY-US, V56, P6470, DOI 10.1021/acs.biochem.7b00668; Nielsen NS, 2014, J PROTEOM BIOINFORM, V8, P002; Poepsel S, 2015, NAT CHEM BIOL, V11, P862, DOI [10.1038/NCHEMBIO.1931, 10.1038/nchembio.1931]; Poulsen ET, 2018, FEBS J, V285, P101, DOI 10.1111/febs.14321; Poulsen ET, 2016, PROTEOMICS, V16, P539, DOI 10.1002/pmic.201500287; Poulsen ET, 2014, PROTEOM CLIN APPL, V8, P168, DOI 10.1002/prca.201300058; Pousen ET, 2014, J PROTEOME RES, V13, P4659, DOI 10.1021/pr500252r; Risor MW, 2014, BIOCHEMISTRY-US, V53, P3851, DOI 10.1021/bi401633w; Runager K, 2013, BIOCHEMISTRY-US, V52, P2821, DOI 10.1021/bi400212m; Runager K, 2011, J BIOL CHEM, V286, P4951, DOI 10.1074/jbc.M110.181099; Schmitt-Bernard CF, 2000, BIOCHEM BIOPH RES CO, V273, P649, DOI 10.1006/bbrc.2000.2955; Sorensen CS, 2015, BIOCHEMISTRY-US, V54, P2943, DOI 10.1021/acs.biochem.5b00292; Tennstaedt A, 2012, J BIOL CHEM, V287, P20931, DOI 10.1074/jbc.M111.316232; Underhaug J, 2013, BBA-PROTEINS PROTEOM, V1834, P2812, DOI 10.1016/j.bbapap.2013.10.008; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zurawa-Janicka D, 2017, ARCH BIOCHEM BIOPHYS, V621, P6, DOI 10.1016/j.abb.2017.04.004	36	7	7	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11817	11828		10.1074/jbc.RA119.009050	http://dx.doi.org/10.1074/jbc.RA119.009050			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31197037	hybrid, Green Published			2022-12-28	WOS:000486127800018
J	Chen, K; Li, XX; Song, GL; Zhou, T; Long, Y; Li, Q; Zhong, S; Cui, ZB				Chen, Kai; Li, Xixi; Song, Guili; Zhou, Tong; Long, Yong; Li, Qing; Zhong, Shan; Cui, Zongbin			Deficiency in the membrane protein Tmbim3a/Grinaa initiates cold-induced ER stress and cell death by activating an intrinsic apoptotic pathway in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); calcium intracellular release; apoptosis; zebrafish; stress response; apoptosis; calcium homeostasis; cold exposure; endoplasmic reticulum stress; calcium homeostasis; Grinaa; transmembrane BAX inhibitor motif (TMBIM); unfolded protein response (UPR); cell death	ENDOPLASMIC-RETICULUM; BAX INHIBITOR-1; SERCA PUMP; CALCIUM; IDENTIFICATION; MODULATION; RELEASE; GENE; CA2+	Most members of the family of proteins containing a transmembrane BAX inhibitor motif (TMBIM) have anti-apoptotic activity, but their in vivo functions and intracellular mechanisms remain obscure. Here, we report that zebrafish Tmbim3a/Grinaa functions in the prevention of cold-induced endoplasmic reticulum (ER) stress and apoptosis. Using a gene-trapping approach, we obtained a mutant zebrafish line in which the expression of the tmbim3a/grinaa gene is disrupted by a Tol2 transposon insertion. Homozygous tmbim3a/grinaa mutant larvae exhibited time-dependently increased mortality and apoptosis under cold exposure (at 16 degrees C). Mechanistically, using immunofluorescence, fluorescence-based assessments of intracellular/mitochondrial Ca2+ levels, mitochondrial membrane potential measurements, and Ca2+-ATPase assays, we found that cold exposure suppresses sarcoplasmic/ER Ca2+-ATPase (SERCA) activity and induces the unfolded protein response (UPR) and ER stress. We also found that the cold-induced ER stress is increased in homozygous tmbim3a/grinaa mutant embryos. The cold-stress hypersensitivity of the tmbim3a/grinaa mutants was tightly associated with disrupted intracellular Ca2+ homeostasis, followed by mitochondrial Ca2+ overload and cytochrome c release, leading to the activation of caspase 9- and caspase-3-mediated intrinsic apoptotic pathways. Treatment of zebrafish larvae with the intracellular Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N ',N '-tetraacetate-acetoxymethyl ester (BAPTA-AM) or with 2-aminoethoxydiphenyl borate (2-APB), an inhibitor of the calcium-releasing protein inositol 1,4,5-trisphosphate receptor (IP3R), alleviated cold-induced cell death. Together, these findings unveil a key role of Tmbim3a/Grinaa in relieving cold-induced ER stress and in protecting cells against caspase 9- and caspase 3-mediated apoptosis during zebrafish development.	[Chen, Kai; Li, Xixi; Song, Guili; Zhou, Tong; Long, Yong; Li, Qing; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Hubei, Peoples R China; [Chen, Kai; Li, Xixi; Zhou, Tong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhong, Shan] Wuhan Univ, Dept Genet, Wuhan 430071, Hubei, Peoples R China; [Cui, Zongbin] Chinese Acad Sci, Innovat Acad Seed Design, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University; Chinese Academy of Sciences	Cui, ZB (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China.	zbcui@ihb.ac.cn			Science Fund for the Creative Research Group of the National Natural Science Foundation of China [31721005]; National Natural Science Foundation of China [31872554, 31572610, 31772836]	Science Fund for the Creative Research Group of the National Natural Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Science Fund for the Creative Research Group of the National Natural Science Foundation of China Grant 31721005 and National Natural Science Foundation of China Grants 31872554, 31572610, and 31772836. The authors declare that they have no conflicts of interest with the contents of this article.	Bonneau B, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004480; Cai ZJ, 2013, ARTERIOSCL THROM VAS, V33, P2345, DOI 10.1161/ATVBAHA.112.300226; Chen B, 2014, CALCIFIED TISSUE INT, V94, P353, DOI 10.1007/s00223-013-9817-4; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; de Mattia F, 2009, MOL BIOL CELL, V20, P3638, DOI 10.1091/mbc.E09-05-0385; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gubser C, 2007, PLOS PATHOG, V3, P246, DOI 10.1371/journal.ppat.0030017; Han RQ, 2016, MOL REPROD DEV, V83, P442, DOI 10.1002/mrd.22643; Hattori K, 2017, EMBO REP, V18, P2067, DOI 10.15252/embr.201744228; Hawkins TA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-42; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Higgins ER, 2006, BIOPHYS J, V91, P151, DOI 10.1529/biophysj.105.075747; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Hu P, 2015, NUCLEIC ACIDS RES, V43, P9198, DOI 10.1093/nar/gkv780; Kang S, 2016, J BIOL CHEM, V291, P5185, DOI 10.1074/jbc.M115.705012; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Liu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139612; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Lockshin Richard A., 2005, Journal de la Societe de Biologie, V199, P169, DOI 10.1051/jbio:2005017; Long Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1560-y; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Long Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037209; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; Mininni AN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-765; Nielsen JA, 2011, MOL CELL BIOCHEM, V357, P73, DOI 10.1007/s11010-011-0877-3; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Pyati UJ, 2011, DEV CELL, V21, P492, DOI 10.1016/j.devcel.2011.07.012; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rojas-Rivera D, 2015, ONCOGENE, V34, P269, DOI 10.1038/onc.2014.6; Rojas-Rivera D, 2012, CELL DEATH DIFFER, V19, P1013, DOI 10.1038/cdd.2011.189; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Sheridan C, 2010, MITOCHONDRION, V10, P640, DOI 10.1016/j.mito.2010.08.005; Shukla S, 2011, APOPTOSIS, V16, P162, DOI 10.1007/s10495-010-0556-y; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Song GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044123; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Wang H, 2015, TOXICOLOGY, V333, P137, DOI 10.1016/j.tox.2015.04.015; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102492; Wang SH, 2008, CELL MOL LIFE SCI, V65, P3640, DOI 10.1007/s00018-008-8383-9; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Xu JM, 2010, CANCER RES, V70, P6566, DOI 10.1158/0008-5472.CAN-10-0942; Yuan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064330; Zhao P, 2012, VIRUS RES, V169, P1, DOI 10.1016/j.virusres.2012.04.006	52	11	12	10	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11445	11457		10.1074/jbc.RA119.007813	http://dx.doi.org/10.1074/jbc.RA119.007813			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31171717	hybrid, Green Published			2022-12-28	WOS:000478717600009
J	Li, YR; Lou, WJ; Raja, V; Denis, S; Yu, WX; Schmidtke, MW; Reynolds, CA; Schlame, M; Houtkooper, RH; Greenberg, ML				Li, Yiran; Lou, Wenjia; Raja, Vaishnavi; Denis, Simone; Yu, Wenxi; Schmidtke, Michael W.; Reynolds, Christian A.; Schlame, Michael; Houtkooper, Riekelt H.; Greenberg, Miriam L.			Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; pyruvate dehydrogenase complex (PDC); pyruvate carboxylase (PC); tricarboxylic acid cycle (TCA cycle) (Krebs cycle); mitochondria	BARTH-SYNDROME; CARDIOSKELETAL MYOPATHY; PHOSPHORYLATION; NEUTROPENIA; PHOSPHATASE; DEFICIENCY; METABOLISM; HEART; GENE; PERTURBATION	Cardiolipin (CL) is the signature phospholipid of mitochondrial membranes. Although it has long been known that CL plays an important role in mitochondrial bioenergetics, recent evidence in the yeast model indicates that CL is also essential for intermediary metabolism. To gain insight into the function of CL in energy metabolism in mammalian cells, here we analyzed the metabolic flux of [U-C-13]glucose in a mouse C2C12 myoblast cell line, TAZ-KO, which is CL-deficient because of CRISPR/Cas9-mediated knockout of the CL-remodeling enzyme tafazzin (TAZ). TAZ-KO cells exhibited decreased flux of [U-C-13]glucose to [C-13]acetyl-CoA and M2 and M4 isotopomers of tricarboxylic acid (TCA) cycle intermediates. The activity of pyruvate carboxylase, the predominant enzyme for anaplerotic replenishing of the TCA cycle, was elevated in TAZ-KO cells, which also exhibited increased sensitivity to the pyruvate carboxylase inhibitor phenylacetate. We attributed a decreased carbon flux from glucose to acetyl-CoA in the TAZ-KO cells to a similar to 50% decrease in pyruvate dehydrogenase (PDH) activity, which was observed in both TAZ-KO cells and cardiac tissue from TAZ-KO mice. Protein-lipid overlay experiments revealed that PDH binds to CL, and supplementing digitonin-solubilized TAZ-KO mitochondria with CL restored PDH activity to WT levels. Mitochondria from TAZ-KO cells exhibited an increase in phosphorylated PDH, levels of which were reduced in the presence of supplemented CL. These findings indicate that CL is required for optimal PDH activation, generation of acetyl-CoA, and TCA cycle function, findings that link the key mitochondrial lipid CL to TCA cycle function and energy metabolism.	[Li, Yiran; Lou, Wenjia; Raja, Vaishnavi; Yu, Wenxi; Schmidtke, Michael W.; Reynolds, Christian A.; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Schlame, Michael] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Schlame, Michael] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Denis, Simone; Houtkooper, Riekelt H.] Univ Amsterdam, Amsterdam UMC, Lab Genet Metab Dis, Amsterdam, Netherlands; [Denis, Simone; Houtkooper, Riekelt H.] Univ Amsterdam, Amsterdam UMC, Amsterdam Gastroenterol & Metab, Amsterdam, Netherlands; [Denis, Simone; Houtkooper, Riekelt H.] Univ Amsterdam, Amsterdam UMC, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands; [Li, Yiran] Harvard Med Sch, Dept Otolaryngol, Boston, MA 02114 USA; [Li, Yiran] Massachusetts Eye & Ear Infirm, Eaton Peabody Labs, Boston, MA 02114 USA; [Lou, Wenjia] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Raja, Vaishnavi] Henry Ford Hlth Syst, Dept Womens Hlth Serv, Div Gynecol Oncol, Detroit, MI 48202 USA; [Yu, Wenxi] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Reynolds, Christian A.] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI 48202 USA	Wayne State University; New York University; New York University; University of Amsterdam; University of Amsterdam; University of Amsterdam; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mgreenberg@wayne.edu	Houtkooper, Riekelt/P-5001-2019; Reynolds, Christian/AAR-4826-2020	Reynolds, Christian/0000-0002-7090-8335; Houtkooper, Riekelt/0000-0001-9961-0842	National Institutes of Health [U24 DK097153]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Avanti Polar Lipids, Inc. for the generous gift of MLCL. The University of Michigan Metabolomics Core Services is supported by grant U24 DK097153 from the National Institutes of Health Common Funds Project to the University of Michigan.	ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309; Barth PG, 1999, J PEDIATR-US, V135, P273, DOI 10.1016/S0022-3476(99)70118-6; Bashir A, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13130; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; BRENZA JM, 1985, BIOCHEM PHARMACOL, V34, P4291, DOI 10.1016/0006-2952(85)90287-4; Chen GL, 1996, J BIOL CHEM, V271, P28064, DOI 10.1074/jbc.271.45.28064; CHRISTODOULOU J, 1994, AM J MED GENET, V50, P255, DOI 10.1002/ajmg.1320500309; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; DALZIEL K, 1968, BIOCHEM J, V110, P223, DOI 10.1042/bj1100223; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Dudek J, 2016, EMBO MOL MED, V8, P139, DOI 10.15252/emmm.201505644; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; GIBSON KM, 1993, PEDIATR NEUROL, V9, P120, DOI 10.1016/0887-8994(93)90046-F; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; HATCH GM, 1994, BIOCHEM J, V297, P201, DOI 10.1042/bj2970201; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; He Q, 2014, CHEM PHYS LIPIDS, V179, P75, DOI 10.1016/j.chemphyslip.2013.10.007; Held NM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27875-3; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Johnston J, 1997, AM J HUM GENET, V61, P1053, DOI 10.1086/301604; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Korman SH, 2005, CLIN CHEM, V51, P610, DOI 10.1373/clinchem.2004.043265; Korotchkina LG, 2006, J BIOL CHEM, V281, P9688, DOI 10.1074/jbc.M511481200; KOROTCHKINA LG, 1995, J BIOL CHEM, V270, P14297, DOI 10.1074/jbc.270.24.14297; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Lee JH, 2014, MOL CELL ENDOCRINOL, V383, P48, DOI 10.1016/j.mce.2013.12.002; Lou WJ, 2018, BBA-MOL CELL BIOL L, V1863, P857, DOI 10.1016/j.bbalip.2018.04.015; Lussey-Lepoutre C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9784; MAMER OA, 1976, BIOCHEM J, V160, P417, DOI 10.1042/bj1600417a; Marziliano N, 2007, AM J MED GENET A, V143A, P907, DOI 10.1002/ajmg.a.31653; Monteiro-Cardoso VF, 2015, J ALZHEIMERS DIS, V43, P1375, DOI 10.3233/JAD-141002; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938; PAYNE J, 1969, J GEN MICROBIOL, V59, P97, DOI 10.1099/00221287-59-1-97; PHELPS A, 1986, BIOCHEM SOC T, V14, P893, DOI 10.1042/bst0140893; Planas-Iglesias J, 2015, BIOPHYS J, V109, P1282, DOI 10.1016/j.bpj.2015.07.034; Raja V, 2019, BBA-MOL CELL BIOL L, V1864, P654, DOI 10.1016/j.bbalip.2019.02.001; Raja V, 2017, J BIOL CHEM, V292, P1092, DOI 10.1074/jbc.M116.753624; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sandlers Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151802; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schmidt MR, 2004, ACTA PAEDIATR, V93, P419, DOI 10.1080/08035250410022837; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Shan CL, 2014, J BIOL CHEM, V289, P21413, DOI 10.1074/jbc.M114.581124; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Tyurina YY, 2013, MOL NUTR FOOD RES, V57, P1410, DOI 10.1002/mnfr.201200801; WYSOCKI SJ, 1976, CLIN CHIM ACTA, V73, P373, DOI 10.1016/0009-8981(76)90186-8; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200	63	19	19	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11568	11578		10.1074/jbc.RA119.009037	http://dx.doi.org/10.1074/jbc.RA119.009037			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31186346	Green Published, hybrid			2022-12-28	WOS:000478717600019
J	Ueda, M; Okada, M; Mizuguchi, M; Kluve-Beckerman, B; Kanenawa, K; Isoguchi, A; Misumi, Y; Tasaki, M; Ueda, A; Kanai, A; Sasaki, R; Masuda, T; Inoue, Y; Nomura, T; Shinriki, S; Shuto, T; Kai, H; Yamashita, T; Matsui, H; Benson, MD; Ando, Y				Ueda, Mitsuharu; Okada, Masamitsu; Mizuguchi, Mineyuki; Kluve-Beckerman, Barbara; Kanenawa, Kyosuke; Isoguchi, Aito; Misumi, Yohei; Tasaki, Masayoshi; Ueda, Akihiko; Kanai, Akinori; Sasaki, Ryoko; Masuda, Teruaki; Inoue, Yasuteru; Nomura, Toshiya; Shinriki, Satoru; Shuto, Tsuyoshi; Kai, Hirofumi; Yamashita, Taro; Matsui, Hirotaka; Benson, Merrill D.; Ando, Yukio			A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; drug screening; drug discovery; protein aggregation; protein conformation; amyloid disrupters; apomorphine hydrochloride; pyrvinium pamoate; transthyretin (TTR)	SENILE SYSTEMIC AMYLOIDOSIS; LIVER-TRANSPLANTATION; POLYNEUROPATHY; MECHANISM; CARDIOMYOPATHY; AGGREGATION; DIFLUNISAL; INHIBITORS; CLEAVAGE; DEPOSITS	Transthyretin (TTR) is a major amyloidogenic protein associated with hereditary (ATTRm) and nonhereditary (ATTRwt) intractable systemic transthyretin amyloidosis. The pathological mechanisms of ATTR-associated amyloid fibril formation are incompletely understood, and there is a need for identifying compounds that target ATTR. C-terminal TTR fragments are often present in amyloid-laden tissues of most patients with ATTR amyloidosis, and on the basis of in vitro studies, these fragments have been proposed to play important roles in amyloid formation. Here, we found that experimentally-formed aggregates of full-length TTR are cleaved into C-terminal fragments, which were also identified in patients' amyloid-laden tissues and in SH-SY5Y neuronal and U87MG glial cells. We observed that a 5-kDa C-terminal fragment of TTR, TTR81-127, is highly amyloidogenic in vitro, even at neutral pH. This fragment formed amyloid deposits and induced apoptosis and inflammatory gene expression also in cultured cells. Using the highly amyloidogenic TTR81-127 fragment, we developed a cell-based high-throughput screening method to discover compounds that disrupt TTR amyloid fibrils. Screening a library of 1280 off-patent drugs, we identified two candidate repositioning drugs, pyrvinium pamoate and apomorphine hydrochloride. Both drugs disrupted patient-derived TTR amyloid fibrils ex vivo, and pyrvinium pamoate also stabilized the tetrameric structure of TTR ex vivo in patient plasma. We conclude that our TTR81-127-based screening method is very useful for discovering therapeutic drugs that directly disrupt amyloid fibrils. We propose that repositioning pyrvinium pamoate and apomorphine hydrochloride as TTR amyloid-disrupting agents may enable evaluation of their clinical utility for managing ATTR amyloidosis.	[Ueda, Mitsuharu; Okada, Masamitsu; Kanenawa, Kyosuke; Isoguchi, Aito; Misumi, Yohei; Tasaki, Masayoshi; Ueda, Akihiko; Masuda, Teruaki; Inoue, Yasuteru; Nomura, Toshiya; Yamashita, Taro; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, 1-1-1 Honjo, Kumamoto 8600811, Japan; [Mizuguchi, Mineyuki] Univ Toyama, Fac Pharm & Pharmaceut Sci, Lab Struct Biol, Toyama 9300194, Japan; [Kluve-Beckerman, Barbara; Benson, Merrill D.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Tasaki, Masayoshi] Kumamoto Univ, Grad Sch Hlth Sci, Dept Morphol & Physiol Sci, Kumamoto 8620976, Japan; [Kanai, Akinori] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Oncol, Hiroshima 7348553, Japan; [Sasaki, Ryoko; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan; [Shinriki, Satoru; Matsui, Hirotaka] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Lab Med, Kumamoto 8600811, Japan	Kumamoto University; University of Toyama; Indiana University System; Indiana University Bloomington; Kumamoto University; Hiroshima University; Kumamoto University; Kumamoto University	Ueda, M (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, 1-1-1 Honjo, Kumamoto 8600811, Japan.	mitt@rb3.so-net.ne.jp	Matsui, Hirotaka/AED-6669-2022; Ueda, Mitsuharu/Q-8595-2019	Matsui, Hirotaka/0000-0002-6266-3227; 	Japan Society for the Promotion of Science KAKENHI [18K07502, 15K09318, 15H04841, 25870541]; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI Grants 18K07502, 15K09318, 15H04841, and 25870541 and by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adams D, 2018, NEW ENGL J MED, V379, P11, DOI 10.1056/NEJMoa1716153; Ando Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-31; Annamalai K, 2016, ANGEW CHEM INT EDIT, V55, P4822, DOI 10.1002/anie.201511524; Barbarino M, 2018, J CELL PHYSIOL, V233, P7391, DOI 10.1002/jcp.26579; Baures PW, 1998, BIOORGAN MED CHEM, V6, P1389, DOI 10.1016/S0968-0896(98)00130-8; BECK JW, 1959, AM J TROP MED HYG, V8, P349, DOI 10.4269/ajtmh.1959.8.349; Benson MD, 2018, NEW ENGL J MED, V379, P22, DOI 10.1056/NEJMoa1716793; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; Benson MD, 2018, AMYLOID, V25, P215, DOI 10.1080/13506129.2018.1549825; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Dionisio PA, 2015, NEUROBIOL AGING, V36, P228, DOI 10.1016/j.neurobiolaging.2014.08.034; Ferreira N, 2009, FEBS LETT, V583, P3569, DOI 10.1016/j.febslet.2009.10.062; Giorgetti S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092677; Goncalves NP, 2014, EXP NEUROL, V257, P76, DOI 10.1016/j.expneurol.2014.04.030; Gustafsson S, 2012, TRANSPLANTATION, V93, P1017, DOI 10.1097/TP.0b013e31824b3749; Higaki JN, 2016, AMYLOID, V23, P86, DOI 10.3109/13506129.2016.1148025; Iadanza MG, 2018, NAT REV MOL CELL BIO, V19, P755, DOI 10.1038/s41580-018-0060-8; Ihse E, 2008, J PATHOL, V216, P253, DOI 10.1002/path.2411; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Katzenschlager R, 2018, LANCET NEUROL, V17, P749, DOI 10.1016/S1474-4422(18)30239-4; Klimtchuk ES, 2018, P NATL ACAD SCI USA, V115, pE6428, DOI 10.1073/pnas.1802977115; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200; Li B, 2014, CANCER RES, V74, P4811, DOI 10.1158/0008-5472.CAN-14-0317; Macedo B, 2007, MOL MED, V13, P584, DOI 10.2119/2007-00068.Macedo; Mangione PP, 2014, P NATL ACAD SCI USA, V111, P1539, DOI 10.1073/pnas.1317488111; Marcoux J, 2015, EMBO MOL MED, V7, P1337, DOI 10.15252/emmm.201505357; Matsubara K, 2003, PROTEIN EXPRES PURIF, V30, P55, DOI 10.1016/S1046-5928(03)00069-X; Maurer MS, 2018, NEW ENGL J MED, V379, P1007, DOI 10.1056/NEJMoa1805689; Merlini G, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0034-3; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Misumi Y, 2009, J PATHOL, V219, P481, DOI 10.1002/path.2618; Mitsui T, 2005, BIOSCI BIOTECH BIOCH, V69, P1923, DOI 10.1271/bbb.69.1923; Miyata M, 2010, BIOCHEMISTRY-US, V49, P6104, DOI 10.1021/bi1004409; Mizuguchi M, 2008, PROTEINS, V72, P261, DOI 10.1002/prot.21919; Mizuguchi M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4822; Obici L, 2012, AMYLOID, V19, P34, DOI 10.3109/13506129.2012.678508; Oshima T, 2014, J NEUROL NEUROSUR PS, V85, P740, DOI 10.1136/jnnp-2013-305973; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Richards DB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan3128; Saelices L, 2018, PROTEIN SCI, V27, P1295, DOI 10.1002/pro.3420; Saelices L, 2015, J BIOL CHEM, V290, P28932, DOI 10.1074/jbc.M115.659912; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sant'Anna R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10787; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; SMITH RV, 1979, RES COMMUN CHEM PATH, V24, P483; SMITH TC, 1976, CLIN PHARMACOL THER, V19, P802; Sperry BW, 2018, J AM COLL CARDIOL, V72, P2040, DOI 10.1016/j.jacc.2018.07.092; Suenaga G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01775-4; Sueyoshi T, 2011, HUM PATHOL, V42, P1259, DOI 10.1016/j.humpath.2010.11.017; Suhr OB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211983; Tasaki M, 2019, J PATHOL, V247, P444, DOI 10.1002/path.5203; THYLEN C, 1993, EMBO J, V12, P743, DOI 10.1002/j.1460-2075.1993.tb05708.x; Tsuda Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36357-5; Ueda M, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-19; Ueda M, 2011, MODERN PATHOL, V24, P1533, DOI 10.1038/modpathol.2011.117; van den Berg MP, 2019, EUR HEART J, V40, P1287, DOI 10.1093/eurheartj/ehz057; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Yamashita T, 2012, NEUROLOGY, V78, P637, DOI 10.1212/WNL.0b013e318248df18; Yanagisawa A, 2015, MODERN PATHOL, V28, P201, DOI 10.1038/modpathol.2014.102	62	10	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11259	11275		10.1074/jbc.RA119.007851	http://dx.doi.org/10.1074/jbc.RA119.007851			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167790	hybrid, Green Published			2022-12-28	WOS:000478717400017
J	Jacinto, E				Jacinto, Estela			The young and the restless: Isolating the dynamic mammalian preribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PRE-RIBOSOMAL-RNA	Despite the advances in understanding the assembly of yeast preribosomes using affinity purification and structural analysis, studies on mammalian ribosome biogenesis have lagged behind. Using an unbiased method to purify native mammalian preribosomal complexes from the nucleus, Abetov et al. now uncover two types of premature ribonucleoprotein complexes that are nutrient- and mTOR-dependent. This purification scheme, combined with genome-editing techniques, could be exploited to untangle the complexities underlying human ribosome biogenesis and ribosomopathies.	[Jacinto, Estela] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Jacinto, E (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	jacintes@rwjms.rutgers.edu			National Institutes of Health [GM079176]; New Jersey Commission on Cancer Research Bridge Grant [DFHS18CRF008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research Bridge Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM079176 and New Jersey Commission on Cancer Research Bridge Grant DFHS18CRF008 (to E. J.). The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Abetov DA, 2019, J BIOL CHEM, V294, P10746, DOI 10.1074/jbc.AC119.008378; Bassler J, 2019, ANNU REV BIOCHEM, V88, P281, DOI 10.1146/annurev-biochem-013118-110817; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Iadevaia V, 2014, SEMIN CELL DEV BIOL, V36, P113, DOI 10.1016/j.semcdb.2014.08.004; Klinge S, 2019, NAT REV MOL CELL BIO, V20, P116, DOI 10.1038/s41580-018-0078-y; Miyazawa N, 2014, GENES CELLS, V19, P273, DOI 10.1111/gtc.12129; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; TRAPMAN J, 1975, EXP CELL RES, V90, P95, DOI 10.1016/0014-4827(75)90361-4; WARNER JR, 1967, P NATL ACAD SCI USA, V58, P1984, DOI 10.1073/pnas.58.5.1984; Yelick PC, 2015, RARE DIS, V3, DOI 10.1080/21675511.2015.1025185	10	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10758	10759		10.1074/jbc.H119.009702	http://dx.doi.org/10.1074/jbc.H119.009702			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31300590	Green Published, hybrid			2022-12-28	WOS:000478717200003
J	Guengerich, FP; Wilkey, CJ; Glass, SM; Reddish, MJ				Guengerich, F. Peter; Wilkey, Clayton J.; Glass, Sarah M.; Reddish, Michael J.			Conformational selection dominates binding of steroids to human cytochrome P450 17A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; steroidogenesis; enzyme kinetics; pre-steady-state kinetics; conformational change; androgen; conformational selection; CYP17A1; induced-fit binding; P450 17A1; pregnenolone; steroid	INDUCED FIT; 17,20-LYASE ACTIVITY; NILE RED; CRYSTAL-STRUCTURES; ORTERONEL TAK-700; KINETIC-ANALYSIS; STRUCTURAL BASIS; SUBSTRATE; B(5); INHIBITOR	Cytochrome P450 (P450, CYP) enzymes are the major catalysts involved in the oxidation of steroids as well as many other compounds. Their versatility has been explained in part by flexibility of the proteins and complexity of the binding mechanisms. However, whether these proteins bind their substrates via induced fit or conformational selection is not understood. P450 17A1 has a major role in steroidogenesis, catalyzing the two-step oxidations of progesterone and pregnenolone to androstenedione and dehydroepiandrosterone, respectively, via 17 alpha-hydroxy (OH) intermediates. We examined the interaction of P450 17A1 with its steroid substrates by analyzing progress curves (UV-visible spectroscopy), revealing that the rates of binding of any of these substrates decreased with increasing substrate concentration, a hallmark of conformational selection. Further, when the concentration of 17 alpha-OH pregnenolone was held constant and the P450 concentration increased, the binding rate increased, and such opposite patterns are also diagnostic of conformational selection. Kinetic simulation modeling was also more consistent with conformational selection than with an induced-fit mechanism. Cytochrome b(5) partially enhances P450 17A1 lyase activity by altering the P450 17A1 conformation but did not measurably alter the binding of 17 alpha-OH pregnenolone or 17 alpha-OH progesterone, as judged by the apparent K-d and binding kinetics. The P450 17A1 inhibitor abiraterone also bound to P450 17A1 in a multistep manner, and modeling indicated that the selective inhibition of the two P450 17A1 steps by the drug orteronel can be rationalized only by a multiple-conformation model. In conclusion, P450 17A1 binds its steroid substrates via conformational selection.	[Guengerich, F. Peter; Wilkey, Clayton J.; Glass, Sarah M.; Reddish, Michael J.] Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg 2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg 2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Reddish, Michael/D-9150-2013	Reddish, Michael/0000-0002-0237-786X; Glass, Sarah/0000-0003-1942-7293; Wilkey, Clayton/0000-0001-6062-1093	National Institutes of Health [R01 GM118122, T32 ES007028]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM118122 (to F.P.G.) and T32 ES007028 (to F.P.G., support of S.M.G. and M.J.R.).	Agafonov RV, 2014, NAT STRUCT MOL BIOL, V21, P848, DOI 10.1038/nsmb.2891; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Benkovic SJ, 2006, SCIENCE, V312, P208, DOI 10.1126/science.1127654; Bonomo S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29468; Caron P, 2019, J CHROMATOGR B, V1104, P249, DOI 10.1016/j.jchromb.2018.12.003; Chakraborty P, 2017, BIOCHEMISTRY-US, V56, P2853, DOI 10.1021/acs.biochem.7b00340; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; CORREIA MA, 1973, MOL PHARMACOL, V9, P470; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Duggal R, 2018, FEBS LETT, V592, P2282, DOI 10.1002/1873-3468.13153; Duggal R, 2016, BIOCHEM BIOPH RES CO, V477, P202, DOI 10.1016/j.bbrc.2016.06.043; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Ershov PV, 2019, J STEROID BIOCHEM, V187, P124, DOI 10.1016/j.jsbmb.2018.11.009; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Fehl C, 2018, J MED CHEM, V61, P4946, DOI 10.1021/acs.jmedchem.8b00419; Fischer E, 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Follmer AH, 2019, J AM CHEM SOC, V141, P2678, DOI 10.1021/jacs.8b13079; Follmer AH, 2018, J AM CHEM SOC, V140, P16222, DOI 10.1021/jacs.8b09441; FRENCH JS, 1980, J BIOL CHEM, V255, P4112; Gay SC, 2009, BIOCHEMISTRY-US, V48, P4762, DOI 10.1021/bi9003765; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; Gonzalez E, 2018, J BIOL CHEM, V293, P541, DOI 10.1074/jbc.RA117.000504; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2018, ACS CATAL, V8, P10964, DOI 10.1021/acscatal.8b03401; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; GUENGERICH FP, 1979, BIOCHEMISTRY-US, V18, P5442, DOI 10.1021/bi00591a029; HALL PF, 1985, VITAM HORM, V42, P315; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson Kenneth A., 2003, P1; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Johnson KM, 2017, J BIOL CHEM, V292, P13672, DOI 10.1074/jbc.M116.773937; Kaku T, 2011, BIOORGAN MED CHEM, V19, P6383, DOI 10.1016/j.bmc.2011.08.066; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Kim D, 2014, BIOCHEMISTRY-US, V53, P6161, DOI 10.1021/bi500710e; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lampe JN, 2008, BIOCHEMISTRY-US, V47, P509, DOI 10.1021/bi7013807; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; Lee-Robichaud P, 1998, BIOCHEM J, V332, P293, DOI 10.1042/bj3320293; Liou SH, 2016, J AM CHEM SOC, V138, P10163, DOI 10.1021/jacs.6b04110; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; Nath A, 2008, ARCH BIOCHEM BIOPHYS, V474, P198, DOI 10.1016/j.abb.2008.03.017; Norris JD, 2017, J CLIN INVEST, V127, P2326, DOI 10.1172/JCI87328; Ortiz de Montellano PR, 2015, CYTOCHROME P450 STRU; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Pallan PS, 2015, J BIOL CHEM, V290, P3248, DOI 10.1074/jbc.M114.627265; Parisi G, 2019, FASEB J, V33, P1787, DOI 10.1096/fj.201800450RR; Peng HM, 2016, BIOCHEMISTRY-US, V55, P4356, DOI 10.1021/acs.biochem.6b00532; Petrunak EM, 2017, DRUG METAB DISPOS, V45, P635, DOI 10.1124/dmd.117.075317; Petrunak EM, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610998; Poulos T. L., 2015, CYTOCHROME P450 STRU, V4th, P3, DOI DOI 10.1007/978-3-319-12108-6_1; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott LJ, 2017, DRUGS, V77, P1029, DOI 10.1007/s40265-017-0752-y; Sevrioukova IF, 2013, BIOCHEMISTRY-US, V52, P4474, DOI 10.1021/bi4005396; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; Sohl CD, 2008, J BIOL CHEM, V283, P7293, DOI 10.1074/jbc.M709783200; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Wang A, 2015, J BIOL CHEM, V290, P5092, DOI 10.1074/jbc.M114.627661; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Yamaoka M, 2012, J STEROID BIOCHEM, V129, P115, DOI 10.1016/j.jsbmb.2012.01.001; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Zhou HX, 2010, BIOPHYS J, V98, pL15, DOI 10.1016/j.bpj.2009.11.029	82	20	20	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10028	10041		10.1074/jbc.RA119.008860	http://dx.doi.org/10.1074/jbc.RA119.008860			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31072872	Green Published, hybrid			2022-12-28	WOS:000474445600001
J	Xie, P; Kondeti, VK; Lin, S; Haruna, Y; Raparia, K; Kanwar, YS				Xie, Ping; Kondeti, Vinay K.; Lin, Sun; Haruna, Yoshisuke; Raparia, Kirtee; Kanwar, Yashpal S.			RETRACTION: Role of extracellular matrix renal tubulo-interstitial nephritis antigen (TINag) in cell survival utilizing integrin alpha v beta 3/focal adhesion kinase (FAK)/phosphatidylinositol 3-kinase (PI3K)/protein kinase B-serine/threonine kinase (AKT) signaling pathway (Retraction of Vol 286, Pg 34131, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Xie P, 2011, J BIOL CHEM, V286, P34131, DOI 10.1074/jbc.M111.241778	1	1	1	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10379	10379		10.1074/jbc.W119.009585	http://dx.doi.org/10.1074/jbc.W119.009585			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31253687	hybrid, Green Published			2022-12-28	WOS:000474445600026
J	Wu, D; Vonk, JJ; Salles, F; Vonk, D; Haslbeck, M; Melki, R; Bergink, S; Kampinga, HH				Wu, Di; Vonk, Jan J.; Salles, Felix; Vonk, Danara; Haslbeck, Martin; Melki, Ronald; Bergink, Steven; Kampinga, Harm H.			The N terminus of the small heat shock protein HSPB7 drives its polyQ aggregation-suppressing activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; heat shock protein (HSP); polyglutamine disease; protein aggregation; oligomerization; intrinsically disordered protein; CAG triplet expansion; heat shock protein family B (small) member 7 (HSPB7); HSPB1; N-terminus; polyglutamine aggregation	HETEROOLIGOMERIC COMPLEXES; POLYGLUTAMINE AGGREGATION; CHAPERONE ACTIVITY; FLANKING DOMAIN; HUNTINGTIN; MODULATION; DISTINCT	Heat shock protein family B (small) member 7 (HSPB7) is a unique, relatively unexplored member within the family of human small heat shock proteins (HSPBs). Unlike most HSPB family members, HSPB7 does not oligomerize and so far has not been shown to associate with any other member of the HSPB family. Intriguingly, it was found to be the most potent member within the HSPB family to prevent aggregation of proteins with expanded polyglutamine (polyQ) stretches. How HSPB7 suppresses polyQ aggregation has remained elusive so far. Here, using several experimental strategies, including in vitro aggregation assay, immunoblotting and fluorescence approaches, we show that the polyQ aggregation-inhibiting activity of HSPB7 is fully dependent on its flexible N-terminal domain (NTD). We observed that the NTD of HSPB7 is both required for association with and inhibition of polyQ aggregation. Remarkably, replacing the NTD of HSPB1, which itself cannot suppress polyQ aggregation, with the NTD of HSPB7 resulted in a hybrid protein that gained anti-polyQ aggregation activity. The hybrid NTDHSPB7-HSPB1 protein displayed a reduction in oligomer size and, unlike WT HSPB1, associated with polyQ. However, experiments with phospho-mimicking HSPB1 mutants revealed that de-oligomerization of HSPB1 alone does not suffice to gain polyQ aggregation-inhibiting activity. Together, our results reveal that the NTD of HSPB7 is both necessary and sufficient to bind to and suppress the aggregation of polyQ-containing proteins.	[Wu, Di; Vonk, Jan J.; Salles, Felix; Vonk, Danara; Bergink, Steven; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [Wu, Di] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Haslbeck, Martin] Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85748 Garching, Germany; [Melki, Ronald] CEA, Inst Francois Jacob MIRCen, F-92265 Fontenay Aux Roses, France; [Melki, Ronald] CNRS, Lab Neurodegenerat Dis, F-92265 Fontenay Aux Roses, France	University of Groningen; Nanjing Agricultural University; Technical University of Munich; CEA; Centre National de la Recherche Scientifique (CNRS)	Kampinga, HH (corresponding author), Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	h.h.kampinga@umcg.nl	Bergink, Steven/AAE-3020-2019; Haslbeck, Martin/A-4413-2013	Bergink, Steven/0000-0002-1142-869X; Vonk, Danara/0000-0002-3834-2140; Kampinga, Harm/0000-0002-8966-8466	China Scholarship Council (CSC) [201606850004]; ZonMW Top Grant [91217002]; Dutch Heart Foundation [2013T88]; Deutsche Forschungsgemeinschaft [SFB1035]; Joint Programme Neurodegenerative disease project "Protest-70" [PATHWAYS-200115]	China Scholarship Council (CSC)(China Scholarship Council); ZonMW Top Grant; Dutch Heart Foundation(Netherlands Heart Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Joint Programme Neurodegenerative disease project "Protest-70"	This work was supported by China Scholarship Council (CSC) Grant 201606850004 (to D. W.), ZonMW Top Grant 91217002 (to H.K.), Joint Programme Neurodegenerative disease project "Protest-70" PATHWAYS-200115 (to R.M. and H.H.K.), Dutch Heart Foundation Grant 2013T88 (to H. K.), and Deutsche Forschungsgemeinschaft Grant SFB1035 (to M.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Arrigo AP, 2013, FEBS LETT, V587, P1959, DOI 10.1016/j.febslet.2013.05.011; Bryantsev AL, 2007, BIOCHEM J, V407, P407, DOI 10.1042/BJ20070195; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Carra S, 2017, CELL STRESS CHAPERON, V22, P601, DOI 10.1007/s12192-017-0787-8; Carra S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0409; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Darling AL, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700193; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Eenjes E, 2016, J CELL SCI, V129, P1260, DOI 10.1242/jcs.179978; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Heldens L, 2012, CELL STRESS CHAPERON, V17, P603, DOI 10.1007/s12192-012-0335-5; Hoop CL, 2014, BIOCHEMISTRY-US, V53, P6653, DOI 10.1021/bi501010q; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kakkar V, 2016, MOL CELL, V62, P272, DOI 10.1016/j.molcel.2016.03.017; Kar K, 2017, J MOL BIOL, V429, P308, DOI 10.1016/j.jmb.2016.12.010; Kar K, 2013, J MOL BIOL, V425, P1183, DOI 10.1016/j.jmb.2013.01.016; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Kuiper EFE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI [10.3389/fnis.2017.00145, 10.3389/fnins.2017.00145]; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Mittag T, 2018, J MOL BIOL, V430, P4636, DOI 10.1016/j.jmb.2018.08.005; Monsellier E, 2015, J BIOL CHEM, V290, P2560, DOI 10.1074/jbc.M114.603332; Morelli FF, 2017, CELL REP, V20, P2100, DOI 10.1016/j.celrep.2017.08.018; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Ramirez VP, 2015, CELL STRESS CHAPERON, V20, P95, DOI 10.1007/s12192-014-0529-0; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Rothe S, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00237; Rujano MA, 2007, EXP CELL RES, V313, P3568, DOI 10.1016/j.yexcr.2007.07.034; Sudnitsyna MV, 2012, CURR PROTEIN PEPT SC, V13, P76; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vos MJ, 2011, AUTOPHAGY, V7, P101, DOI 10.4161/auto.7.1.13935; Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398; Vos MJ, 2009, BBA-MOL CELL RES, V1793, P1343, DOI 10.1016/j.bbamcr.2009.05.005; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	43	14	15	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9985	9994		10.1074/jbc.RA118.007117	http://dx.doi.org/10.1074/jbc.RA118.007117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31097540	Green Published, hybrid			2022-12-28	WOS:000473277900028
J	Ipson, BR; Green, RA; Wilson, JT; Watson, JN; Faull, KF; Fisher, AL				Ipson, Brett R.; Green, Rebecca A.; Wilson, John T.; Watson, Jacob N.; Faull, Kym F.; Fisher, Alfred L.			Tyrosine aminotransferase is involved in the oxidative stress response by metabolizing meta-tyrosine in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidative stress; tyrosine; aging; amino acid; gene expression; meta-tyrosine; ribosome; tyrosine aminotransferase; metabolism; F01D4; 5; reactive oxygen species; Nrf2; SKN-1; transcriptional regulation	INDUCED CHRONIC MODEL; ACID-INDUCED 1; DNA-DAMAGE; RAT-LIVER; CELLULAR-PROTEINS; RIBOSOMAL-SUBUNIT; GENE-EXPRESSION; LIFE-SPAN; DE-NOVO; BRAIN	Under oxidative stress conditions, hydroxyl radicals can oxidize the phenyl ring of phenylalanine, producing the abnormal tyrosine isomer meta-tyrosine (m-tyrosine). m-Tyrosine levels are commonly used as a biomarker of oxidative stress, and its accumulation has recently been reported to adversely affect cells, suggesting a direct role for m-tyrosine in oxidative stress effects. We found that the Caenorhabditis elegans ortholog of tyrosine aminotransferase (TATN-1)the first enzyme involved in the metabolic degradation of tyrosineis up-regulated in response to oxidative stress and directly activated by the oxidative stress-responsive transcription factor SKN-1. Worms deficient in tyrosine aminotransferase activity displayed increased sensitivity to multiple sources of oxidative stress. Biochemical assays revealed that m-tyrosine is a substrate for TATN-1-mediated deamination, suggesting that TATN-1 also metabolizes m-tyrosine. Consistent with a toxic effect of m-tyrosine and a protective function of TATN-1, tatn-1 mutant worms exhibited delayed development, marked reduction in fertility, and shortened lifespan when exposed to m-tyrosine. A forward genetic screen identified a mutation in the previously uncharacterized gene F01D4.5homologous with human transcription factor 20 (TCF20) and retinoic acid-induced 1 (RAI1)that suppresses the adverse phenotypes observed in m-tyrosine-treated tatn-1 mutant worms. RNA-Seq analysis of F01D4.5 mutant worms disclosed a significant reduction in the expression of specific isoforms of genes encoding ribosomal proteins, suggesting that alterations in protein synthesis or ribosome structure could diminish the adverse effects of m-tyrosine. Our findings uncover a critical role for tyrosine aminotransferase in the oxidative stress response via m-tyrosine metabolism.	[Ipson, Brett R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, San Antonio, TX 78229 USA; [Ipson, Brett R.; Wilson, John T.; Watson, Jacob N.; Fisher, Alfred L.] Univ Texas Hlth Sci Ctr San Antonio, Ctr Healthy Aging, San Antonio, TX 78229 USA; [Fisher, Alfred L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Geriatr Gerontol & Palliat Med, San Antonio, TX 78229 USA; [Green, Rebecca A.] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Faull, Kym F.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Fisher, Alfred L.] South Texas Vet Affairs Healthcare Syst, GRECC, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Ludwig Institute for Cancer Research; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Geriatric Research Education & Clinical Center	Fisher, AL (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Geriatr Gerontol & Palliat Med, 986155 Nebraska Med Ctr, Omaha, NE 68198 USA.	alfred.fisher@unmc.edu		Fisher, Alfred/0000-0001-6451-2644	NCI, National Institutes of Health (NIH) [P30 CA054174]; NIH Shared Instrument Grant [1S10OD021805-01]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP160732]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM113896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS102782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG053034, R01AG044768] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021805] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Shared Instrument Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Whole-genome sequencing and RNA-Seq data were generated in the Genome Sequencing Facility at the University of Texas Health Science Center at San Antonio, which is supported by NCI, National Institutes of Health (NIH), Grant P30 CA054174, NIH Shared Instrument Grant 1S10OD021805-01, and Cancer Prevention and Research Institute of Texas (CPRIT) Core Facility Award RP160732.	Ahmad Saheem, 2017, Front Biosci (Schol Ed), V9, P71; Ahn K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-78; Alkhatabi HA, 2016, ONCOTARGET, V7, P47875, DOI 10.18632/oncotarget.10293; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; ARONSON JN, 1965, J BACTERIOL, V90, P38, DOI 10.1128/JB.90.1.38-46.1965; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Babbs C, 2014, J MED GENET, V51, P737, DOI 10.1136/jmedgenet-2014-102582; Bai SC, 1998, J NUTR, V128, P1995, DOI 10.1093/jn/128.11.1995; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bertin C, 2007, P NATL ACAD SCI USA, V104, P16964, DOI 10.1073/pnas.0707198104; Blackwell TK, 2015, FREE RADICAL BIO MED, V88, P290, DOI 10.1016/j.freeradbiomed.2015.06.008; Boyd K.E., 1993, GENEREVIEWS; Braeckman BP, 2016, ANTIOXID REDOX SIGN, V25, P577, DOI 10.1089/ars.2016.6751; BRENNER S, 1974, GENETICS, V77, P71; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Budanov Andrei V, 2014, Subcell Biochem, V85, P337, DOI 10.1007/978-94-017-9211-0_18; Bullwinkle TJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02501; Burton EA, 2006, APPL ENVIRON MICROB, V72, P5043, DOI 10.1128/AEM.00558-06; Cao L, 2014, HUM MOL GENET, V23, P1771, DOI 10.1093/hmg/ddt568; Carmona-Mora P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045155; Carmona-Mora P, 2010, CURR GENOMICS, V11, P607, DOI 10.2174/138920210793360952; Carvalho-Silva M, 2017, METAB BRAIN DIS, V32, P1043, DOI 10.1007/s11011-017-9994-3; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; COULONDRE C, 1977, J MOL BIOL, V117, P525, DOI 10.1016/0022-2836(77)90056-0; Darvekar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078907; Darvekar S, 2012, BIOCHEM J, V442, P65, DOI 10.1042/BJ20111230; Darvekar SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085262; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Davies MJ, 1999, FREE RADICAL BIO MED, V27, P1151, DOI 10.1016/S0891-5849(99)00206-3; De Pra SDT, 2014, NEUROCHEM RES, V39, P202, DOI 10.1007/s11064-013-1207-9; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; DeLabre ML, 2002, BBA-GENE STRUCT EXPR, V1574, P255, DOI 10.1016/S0167-4781(01)00372-4; DELLWO M, 1990, EXP GERONTOL, V25, P553, DOI 10.1016/0531-5565(90)90021-S; DIAMONDSTONE TI, 1966, ANAL BIOCHEM, V16, P395, DOI 10.1016/0003-2697(66)90220-X; Dickinson DJ, 2016, GENETICS, V202, P885, DOI 10.1534/genetics.115.182162; DICKSON AJ, 1981, FEBS LETT, V127, P28, DOI 10.1016/0014-5793(81)80333-X; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dundjerski J, 2006, J APPL TOXICOL, V26, P187, DOI 10.1002/jat.1123; Elvenes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024659; Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008; Essex A, 2009, MOL BIOL CELL, V20, P1252, DOI 10.1091/mbc.E08-10-1047; Falco M, 2017, APPL CLIN GENET, V10, P85, DOI 10.2147/TACG.S128455; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Ferguson AA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004020; Ferguson AA, 2009, PLASMID, V62, P140, DOI 10.1016/j.plasmid.2009.06.001; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P14083, DOI 10.1021/bi035656u; Flibotte S, 2010, GENETICS, V185, P431, DOI 10.1534/genetics.110.116616; Fragoso YD, 2015, BRAIN STRUCT FUNCT, V220, P1195, DOI 10.1007/s00429-014-0712-1; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Gburcik V, 2005, MOL CELL BIOL, V25, P3421, DOI 10.1128/MCB.25.9.3421-3430.2005; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Goodwin AT, 2002, CLIN SCI, V103, p206S, DOI 10.1042/CS103S206S; Green RA, 2008, METHOD CELL BIOL, V85, P179, DOI 10.1016/S0091-679X(08)85009-1; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Guerra-Moreno A, 2015, J BIOL CHEM, V290, P29695, DOI 10.1074/jbc.M115.684969; Gurer-Orhan H, 2006, BIOCHEM J, V395, P277, DOI 10.1042/BJ20051964; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; HASSAN HM, 1978, J BIOL CHEM, V253, P8143; He XQ, 2009, MOL PHARMACOL, V76, P1265, DOI 10.1124/mol.109.058453; Hochbaum D., 2010, JOVE-J VIS EXP, DOI [10.3791/2090, DOI 10.3791/2090]; Huang WH, 2016, NEURON, V92, P392, DOI 10.1016/j.neuron.2016.09.019; Hwang W, 2015, AGING CELL, V14, P995, DOI 10.1111/acel.12390; Ipson BR, 2016, AGEING RES REV, V27, P93, DOI 10.1016/j.arr.2016.03.005; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; KAUR H, 1994, METHOD ENZYMOL, V233, P67; Kawasaki I, 2007, MECH DEVELOP, V124, P237, DOI 10.1016/j.mod.2006.11.004; Keith SA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005823; Kirn-Safran CB, 2007, DEV DYNAM, V236, P447, DOI 10.1002/dvdy.21046; Klipcan L, 2009, P NATL ACAD SCI USA, V106, P11045, DOI 10.1073/pnas.0905212106; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Liu DP, 2011, ANTIOXID REDOX SIGN, V15, P1669, DOI 10.1089/ars.2010.3644; Liu JJ, 2006, J CELL PHYSIOL, V207, P287, DOI 10.1002/jcp.20589; Luong TN, 1997, ANAL BIOCHEM, V253, P46, DOI 10.1006/abio.1997.2344; Macedo LGRP, 2013, NEUROCHEM RES, V38, P2625, DOI 10.1007/s11064-013-1180-3; Machuca D, 2015, MEDICINA-BUENOS AIRE, V75, P1; MAGER HIX, 1974, TETRAHEDRON, V30, P917, DOI 10.1016/S0040-4020(01)97154-6; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; MASKOS Z, 1992, ARCH BIOCHEM BIOPHYS, V296, P521, DOI 10.1016/0003-9861(92)90606-W; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Mehere P, 2010, PROTEIN CELL, V1, P1023, DOI 10.1007/s13238-010-0128-5; Mikolas E, 2013, KIDNEY BLOOD PRESS R, V38, P217, DOI 10.1159/000355770; Minevich G, 2012, GENETICS, V192, P1249, DOI 10.1534/genetics.112.144204; Molnar GA, 2016, CURR MED CHEM, V23, P667, DOI 10.2174/0929867323666160119094516; Molnar GA, 2015, WORLD J DIABETES, V6, P500, DOI 10.4239/wjd.v6.i3.500; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Movellan J, 2014, ENVIRON SCI POLLUT R, V21, P4861, DOI 10.1007/s11356-012-1302-5; Munkacsy E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006133; NATT E, 1986, HUM GENET, V72, P225, DOI 10.1007/BF00291882; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; PAN CJ, 1992, MOL ENDOCRINOL, V6, P572, DOI 10.1210/me.6.4.572; Peddibhotla S, 2015, ACS CHEM BIOL, V10, P1871, DOI 10.1021/acschembio.5b00304; Pennathur S, 2005, J BIOL CHEM, V280, P22706, DOI 10.1074/jbc.M500839200; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Popp O, 2015, BIOTECHNOL BIOENG, V112, P1187, DOI 10.1002/bit.25528; Powolny AA, 2011, EXP GERONTOL, V46, P441, DOI 10.1016/j.exger.2011.01.005; Rain-Guion M.-C., 1982, BIOCHEM EDUC, V10, P88, DOI DOI 10.1016/0307-4412(82)90082-6; Reis-Rodrigues P, 2012, AGING CELL, V11, P120, DOI 10.1111/j.1474-9726.2011.00765.x; Rekdal C, 2000, J BIOL CHEM, V275, P40288, DOI 10.1074/jbc.M006978200; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Ru M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05290-4; Ruggiero RA, 2012, CANCER RES, V72, P1043, DOI 10.1158/0008-5472.CAN-11-2964; Ruggiero RA, 2011, CANCER RES, V71, P7113, DOI 10.1158/0008-5472.CAN-11-0581; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Schafgen J, 2016, EUR J HUM GENET, V24, P1739, DOI 10.1038/ejhg.2016.90; Senchuk MM, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2086; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Sgaravatti AM, 2009, METAB BRAIN DIS, V24, P415, DOI 10.1007/s11011-009-9153-6; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Sivaraman S, 2006, FEBS J, V273, P1920, DOI 10.1111/j.1742-4658.2006.05202.x; Sjottem E, 2007, NUCLEIC ACIDS RES, V35, P6648, DOI 10.1093/nar/gkm739; SLAGBOOM PE, 1990, FEBS LETT, V269, P128, DOI 10.1016/0014-5793(90)81136-C; Smeland OB, 2017, JAMA PSYCHIAT, V74, P1065, DOI 10.1001/jamapsychiatry.2017.1986; SMITH IK, 1968, PHYTOCHEMISTRY, V7, P1065, DOI 10.1016/S0031-9422(00)88252-7; SMITH LC, 1964, ARCH BIOCHEM BIOPHYS, V105, P424, DOI 10.1016/0003-9861(64)90026-8; Sobrado VR, 2003, PROTEIN SCI, V12, P1039, DOI 10.1110/ps.0229403; Soysal P, 2017, MATURITAS, V99, P66, DOI 10.1016/j.maturitas.2017.01.006; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Steffen KK, 2012, GENETICS, V191, P107, DOI 10.1534/genetics.111.136549; Streck EL, 2017, MOL CELL BIOCHEM, V435, P207, DOI 10.1007/s11010-017-3070-5; Tabiri HY, 2002, BRIT POULTRY SCI, V43, P629, DOI 10.1080/0007166022000004561; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Teodorak BP, 2017, METAB BRAIN DIS, V32, P557, DOI 10.1007/s11011-016-9936-5; Terzian T, 2011, J PATHOL, V224, P540, DOI 10.1002/path.2891; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Walker AK, 2000, J BIOL CHEM, V275, P22166, DOI 10.1074/jbc.M001746200; Wan GQ, 2010, BIOCHEM BIOPH RES CO, V400, P575, DOI 10.1016/j.bbrc.2010.08.106; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Xiao R, 2015, CELL REP, V11, P1123, DOI 10.1016/j.celrep.2015.04.024; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Zhang WJ, 2011, BIOCHEMISTRY-US, V50, P5401, DOI 10.1021/bi200733c; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014; Zoll WL, 2002, J BIOL CHEM, V277, P37079, DOI 10.1074/jbc.M207109200	143	9	10	4	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9536	9554		10.1074/jbc.RA118.004426	http://dx.doi.org/10.1074/jbc.RA118.004426			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31043480	hybrid, Green Published			2022-12-28	WOS:000472713000020
J	Li, YC; Cooper, A; Odibo, IN; Ahmed, A; Murphy, P; Koonce, R; Dajani, NK; Lowery, CL; Roberts, DJ; Maroteaux, L; Kilic, F				Li, Yicong; Cooper, Anthonya; Odibo, Imelda N.; Ahmed, Asli; Murphy, Pamela; Koonce, Ruston; Dajani, Nafisa K.; Lowery, Curtis L.; Roberts, Drucilla J.; Maroteaux, Luc; Kilic, Fusun			Discrepancy in insulin regulation between gestational diabetes mellitus (GDM) platelets and placenta (Withdrawal of Vol 291, Pg 9657, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal													Maroteaux, Luc/H-4585-2019; Roberts, Drucilla/AAB-6379-2022	Maroteaux, Luc/0000-0002-9499-8603; 				LI YC, 2016, THE JOURNAL OF BIOLO, V291, P9657	1	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9656	9656		10.1074/jbc.W119.009465	http://dx.doi.org/10.1074/jbc.W119.009465			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31201244	Green Published, hybrid			2022-12-28	WOS:000472713000030
J	Raeeszadeh-Sarmazdeh, M; Greene, KA; Sankaran, B; Downey, GP; Radisky, DC; Radisky, ES				Raeeszadeh-Sarmazdeh, Maryam; Greene, Kerrie A.; Sankaran, Banumathi; Downey, Gregory P.; Radisky, Derek C.; Radisky, Evette S.			Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						matrix metalloproteinase (MMP); tissue inhibitor of metalloproteinase (TIMP); protease inhibitor; directed evolution; protein engineering; protein domain; protein-protein interaction; crystal structure; protein structure; metalloprotease; yeast surface display	HUMAN TISSUE INHIBITOR; YEAST SURFACE DISPLAY; HIGH-AFFINITY; ANTIBODIES; SPECIFICITY; DESIGN	Tissue inhibitors of metalloproteinases (TIMPs) are natural inhibitors of matrix metalloproteinases (MMPs), enzymes that contribute to cancer and many inflammatory and degenerative diseases. The TIMP N-terminal domain binds and inhibits an MMP catalytic domain, but the role of the TIMP C-terminal domain in MMP inhibition is poorly understood. Here, we employed yeast surface display for directed evolution of full-length human TIMP-1 to develop MMP-3-targeting ultrabinders. By simultaneously incorporating diversity into both domains, we identified TIMP-1 variants that were up to 10-fold improved in binding MMP-3 compared with WT TIMP-1, with inhibition constants (K-i) in the low picomolar range. Analysis of individual and paired mutations from the selected TIMP-1 variants revealed cooperative effects between distant residues located on the N- and C-terminal TIMP domains, positioned on opposite sides of the interaction interface with MMP-3. Crystal structures of MMP-3 complexes with TIMP-1 variants revealed conformational changes in TIMP-1 near the cooperative mutation sites. Affinity was strengthened by cinching of a reciprocal tyrosine clasp formed between the N-terminal domain of TIMP-1 and proximal MMP-3 interface and by changes in secondary structure within the TIMP-1 C-terminal domain that stabilize interdomain interactions and improve complementarity to MMP-3. Our protein engineering and structural studies provide critical insight into the cooperative function of TIMP domains and the significance of peripheral TIMP epitopes in MMP recognition. Our findings suggest new strategies to engineer TIMP proteins for therapeutic applications, and our directed evolution approach may also enable exploration of functional domain interactions in other protein systems.	[Raeeszadeh-Sarmazdeh, Maryam; Greene, Kerrie A.; Radisky, Derek C.; Radisky, Evette S.] Mayo Clin, Dept Canc Biol, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; [Downey, Gregory P.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Downey, Gregory P.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Downey, Gregory P.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Downey, Gregory P.] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Downey, Gregory P.] Univ Colorado, Dept Immunol, Aurora, CO 80045 USA; [Downey, Gregory P.] Univ Colorado, Dept Microbiol, Aurora, CO 80045 USA	Mayo Clinic; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu		Greene, Kerrie/0000-0002-2988-2436; Radisky, Evette/0000-0003-3121-109X; Downey, Gregory P/0000-0003-3253-5862	Howard Hughes Medical Institute; Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; National Institutes of Health, National Institute of General Medical Sciences [P30 GM124169]; NATIONAL CANCER INSTITUTE [R21CA205471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM124169] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Laura Lewis-Tuffin at the cell sorting facility at Mayo Clinic, Florida for help with FACS of TIMP-1 libraries; Rachel Henin and Alexandra Hockla for MMP-3 protein expression, purification, and biotinylation; and Matt Coban for advice with crystallographic data processing. We also thank Dr. Niv Papo for helpful discussions. Diffraction data were measured at beamline 8.2.2 of the Berkeley Center for Structural Biology, Advanced Light Source (ALS), Lawrence Berkeley National Laboratory. The Berkeley Center for Structural Biology is supported in part by the Howard Hughes Medical Institute. The Advanced Light Source is a Department of Energy Office of Science User Facility under Contract DE-AC02-05CH11231. The ALS-ENABLE beamlines are supported in part by the National Institutes of Health, National Institute of General Medical Sciences, Grant P30 GM124169.	Afonine P., 2005, CCP4 NEWSLETTER; Arkadash Valeria, 2018, Oncotarget, V9, P32036, DOI 10.18632/oncotarget.25885; Arkadash V, 2017, J BIOL CHEM, V292, P3481, DOI 10.1074/jbc.M116.756718; Bagowski CP, 2010, CURR GENOMICS, V11, P368, DOI 10.2174/138920210791616725; Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Batra J, 2014, ENCY INORGANIC BIOIN; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; Batra J, 2012, J BIOL CHEM, V287, P15935, DOI 10.1074/jbc.M112.341156; Bhaskara RM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00040; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; Boder ET, 2012, ARCH BIOCHEM BIOPHYS, V526, P99, DOI 10.1016/j.abb.2012.03.009; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bonsor DA, 2011, BIOCHEMISTRY-US, V50, P2394, DOI 10.1021/bi102019c; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; CHAKRABARTTY A, 1991, NATURE, V351, P586, DOI 10.1038/351586a0; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Crombez L, 2005, BIOCHEM BIOPH RES CO, V337, P908, DOI 10.1016/j.bbrc.2005.09.136; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fernandez CA, 2010, J BIOL CHEM, V285, P41886, DOI 10.1074/jbc.M110.166439; FERSHT AR, 1987, TRENDS BIOCHEM SCI, V12, P301, DOI 10.1016/0968-0004(87)90146-0; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huang J, 2008, P NATL ACAD SCI USA, V105, P6578, DOI 10.1073/pnas.0801097105; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Itoh K, 2008, P NATL ACAD SCI USA, V105, P13865, DOI 10.1073/pnas.0804512105; Jeffery G.A., 1997, INTRO HYDROGEN BONDI; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lee MH, 2005, J BIOL CHEM, V280, P15967, DOI 10.1074/jbc.M500897200; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Levin M, 2017, BBA-MOL CELL RES, V1864, P1927, DOI 10.1016/j.bbamcr.2017.06.009; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mei M, 2017, MICROBIOL RES, V196, P118, DOI 10.1016/j.micres.2016.12.002; Meng Q, 1999, J BIOL CHEM, V274, P10184, DOI 10.1074/jbc.274.15.10184; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Nagase H, 2003, BIOCHEM SOC SYMP, V70, P201, DOI 10.1042/bss0700201; Nagase H, 2002, ARTHRITIS RES THER, V4, pS51, DOI 10.1186/ar573; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Radisky ES, 2017, J CELL BIOCHEM, V118, P3531, DOI 10.1002/jcb.26185; Raeeszadeh-Sarmazdeh M, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201800353; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Shirian J, 2018, FEBS LETT, V592, P1122, DOI 10.1002/1873-3468.13016; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Williamson RA, 2001, J BIOL CHEM, V276, P32966, DOI 10.1074/jbc.M101843200; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Yuen CM, 2007, NAT METHODS, V4, P995, DOI 10.1038/nmeth1207-995	62	13	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9476	9488		10.1074/jbc.RA119.008321	http://dx.doi.org/10.1074/jbc.RA119.008321			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31040180	Green Published, hybrid			2022-12-28	WOS:000472713000016
J	Liu, TJ; De Los Santos, FG; Zhao, YY; Wu, Z; Rinke, AE; Kim, KK; Phan, SH				Liu, Tianju; De Los Santos, Francina Gonzalez; Zhao, Yuyue; Wu, Zhe; Rinke, Andrew E.; Kim, Kevin K.; Phan, Sem H.			Telomerase reverse transcriptase ameliorates lung fibrosis by protecting alveolar epithelial cells against senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						telomerase; telomerase reverse transcriptase (TERT); epithelial cell; senescence; fibrosis; inflammation; idiopathic pulmonary fibrosis (IPF); lung disease; pulmonary dysfunction	IDIOPATHIC PULMONARY-FIBROSIS; CELLULAR SENESCENCE; DEPENDENT APOPTOSIS; CATALYTIC SUBUNIT; FIBROBLAST; EXPRESSION; LENGTH; MYOFIBROBLAST; PATHOGENESIS; DEFICIENCY	Mutations in the genes encoding telomerase reverse transcriptase (TERT) and telomerase's RNA components as well as shortened telomeres are risk factors for idiopathic pulmonary fibrosis, where repetitive injury to the alveolar epithelium is considered a key factor in pathogenesis. Given the importance of TERT in stem cells, we hypothesized that TERT plays an important role in epithelial repair and that its deficiency results in exacerbation of fibrosis by impairing this repair/regenerative process. To evaluate the role of TERT in epithelial cells, we generated type II alveolar epithelial cell (AECII)-specific TERT conditional knockout (SPC-Tert cKO) mice by crossing floxed Tert mice with inducible SPC-driven Cre mice. SPC-Tert cKO mice did not develop pulmonary fibrosis spontaneously up to 9 months of TERT deficiency. However, upon bleomycin treatment, they exhibited enhanced lung injury, inflammation, and fibrosis compared with control mice, accompanied by increased pro-fibrogenic cytokine expression but without a significant effect on AECII telomere length. Moreover, selective TERT deficiency in AECII diminished their proliferation and induced cellular senescence. These findings suggest that AECII-specific TERT deficiency enhances pulmonary fibrosis by heightening susceptibility to bleomycin-induced epithelial injury and diminishing epithelial regenerative capacity because of increased cellular senescence. We confirmed evidence for increased AECII senescence in idiopathic pulmonary fibrosis lungs, suggesting potential clinical relevance of the findings from our animal model. Our results suggest that TERT has a protective role in AECII, unlike its pro-fibrotic activity, observed previously in fibroblasts, indicating that TERT's role in pulmonary fibrosis is cell type-specific.	[Liu, Tianju; De Los Santos, Francina Gonzalez; Zhao, Yuyue; Wu, Zhe; Rinke, Andrew E.; Phan, Sem H.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Kim, Kevin K.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Zhao, Yuyue] China Japan Friendship Hosp, Surg Intens Care Unit, Beijing 100029, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; China-Japan Friendship Hospital	Liu, TJ; Phan, SH (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	tianliu@umich.edu; shphan@umich.edu	Phan, Sem H/A-7033-2009	Phan, Sem H/0000-0002-3711-2159	National Institutes of Health [HL 052285, HL 112880, HL 138417]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138417, R01HL108904, R01HL112880, R01HL052285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL 052285, HL 112880, and HL 138417 (to S. H. P). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Barbas-Filho JV, 2001, J CLIN PATHOL, V54, P132, DOI 10.1136/jcp.54.2.132; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Chen RP, 2015, J BIOL CHEM, V290, P30813, DOI 10.1074/jbc.M115.681619; Chibbar R, 2010, CAN RESPIR J, V17, P269, DOI 10.1155/2010/591523; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Cui HC, 2017, AM J PHYSIOL-LUNG C, V312, pL415, DOI 10.1152/ajplung.00335.2016; Cui HC, 2017, AM J RESP CELL MOL, V56, P168, DOI 10.1165/rcmb.2016-0163OC; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Degryse AL, 2012, EXP LUNG RES, V38, P124, DOI 10.3109/01902148.2012.658148; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Erdel F, 2017, CELL REP, V18, P41, DOI 10.1016/j.celrep.2016.12.005; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Im J, 2016, J PATHOL, V240, P25, DOI 10.1002/path.4749; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kim H, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.34; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kropski JA, 2012, AM J PHYSIOL-LUNG C, V302, pL441, DOI 10.1152/ajplung.00335.2011; Lim CJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01313-w; Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7; Liu T, 2006, AM J RESP CELL MOL, V34, P625, DOI 10.1165/rcmb.2005-0252OC; Liu TJ, 2007, J CLIN INVEST, V117, P3800, DOI 10.1172/JCI32369; Liu TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142547; Liu TJ, 2013, AM J RESP CELL MOL, V49, P260, DOI 10.1165/rcmb.2012-0514OC; Liu TJ, 2011, J IMMUNOL, V187, P450, DOI 10.4049/jimmunol.1000964; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Povedano JM, 2018, ELIFE, V7, DOI 10.7554/eLife.31299; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Munoz P, 2009, MOL CELL BIOL, V29, P1608, DOI 10.1128/MCB.01339-08; Naikawadi RP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86704; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nozaki Y, 2000, AM J RESP CELL MOL, V23, P460, DOI 10.1165/ajrcmb.23.4.3958; Pardo A, 2017, AM J RESP CELL MOL, V56, P145, DOI 10.1165/rcmb.2016-0387ED; Pardo A, 2016, ANN AM THORAC SOC, V13, pS417, DOI 10.1513/AnnalsATS.201605-341AW; Patel PL, 2016, P NATL ACAD SCI USA, V113, pE5024, DOI 10.1073/pnas.1602379113; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; PHAN SH, 1985, J CLIN INVEST, V76, P241, DOI 10.1172/JCI111953; Povedano JM, 2015, CELL REP, V12, P286, DOI 10.1016/j.celrep.2015.06.028; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Snetselaar R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189467; Spagnolo P, 2015, PHARMACOL THERAPEUT, V152, P18, DOI 10.1016/j.pharmthera.2015.04.005; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Yamashita S, 2012, BIOCHEM BIOPH RES CO, V417, P630, DOI 10.1016/j.bbrc.2011.12.021; Yang J, 2013, AM J PATHOL, V183, P1559, DOI 10.1016/j.ajpath.2013.07.016	63	25	26	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8861	8871		10.1074/jbc.RA118.006615	http://dx.doi.org/10.1074/jbc.RA118.006615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31000627	Green Published, hybrid			2022-12-28	WOS:000470971100020
J	Schmitt, LR; Henderson, R; Barrett, A; Darula, Z; Issaian, A; D'Alessandro, A; Clendenen, N; Hansen, KC				Schmitt, Lauren R.; Henderson, Rachel; Barrett, Alexander; Darula, Zsuzsanna; Issaian, Aaron; D'Alessandro, Angelo; Clendenen, Nathan; Hansen, Kirk C.			Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein cross-linking; fibrin; transglutaminase; mass spectrometry (MS); thrombosis; fibrinolysis; chemical digestion; factor XIII	ACTIVATED FACTOR-XIII; PROTEIN; REGION; ROLES	The roles of factor XIIIa-specific cross-links in thrombus formation, regression, or probability for embolization are largely unknown. A molecular understanding of fibrin architecture at the level of these cross-links could inform the development of therapeutic strategies to prevent the sequelae of thromboembolism. Here, we present an MS-based method to map native factor XIIIa cross-links in the insoluble matrix component of whole-blood or plasma-fibrin clots and in in vivo thrombi. Using a chaotrope-insoluble digestion method and quantitative cross-linking MS, we identified the previously mapped fibrinogen peptides that are responsible for covalent D-dimer association, as well as dozens of novel cross-links in the C region of fibrinogen . Our findings expand the known native cross-linked species from one to over 100 and suggest distinct antiparallel registries for interprotofibril association and covalent attachment of serpins that regulate clot dissolution.	[Schmitt, Lauren R.; Barrett, Alexander; Issaian, Aaron; D'Alessandro, Angelo; Hansen, Kirk C.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Henderson, Rachel; Clendenen, Nathan] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO 80045 USA; [Darula, Zsuzsanna] Hungarian Acad Sci, Lab Prote Res, Biol Res Ctr, H-6701 Szeged, Hungary	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Hansen, KC (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	kirk.hansen@ucdenver.edu	D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490; Henderson, Rachel/0000-0002-1206-9035	NCI, National Institutes of Health (NIH) [R33CA183685]; NIH [S10OD021641]; NATIONAL CANCER INSTITUTE [R33CA183685] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021641] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NCI, National Institutes of Health (NIH) Grant R33CA183685 and NIH Grant S10OD021641. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2014, THROMB RES, V134, P931, DOI DOI 10.1016/j.thromres.2014.08.014; Barrett AS, 2017, J PROTEOME RES, V16, P4177, DOI 10.1021/acs.jproteome.7b00527; Byrnes JR, 2016, SEMIN THROMB HEMOST, V42, P445, DOI 10.1055/s-0036-1571343; Chavez JD, 2018, CELL SYST, V6, P136, DOI 10.1016/j.cels.2017.10.017; CHEN R, 1971, BIOCHEMISTRY-US, V10, P4486, DOI 10.1021/bi00800a021; Chen ZA, 2019, NAT PROTOC, V14, P171, DOI 10.1038/s41596-018-0089-3; Collet JP, 2005, BLOOD, V106, P3824, DOI 10.1182/blood-2005-05-2150; Doiphode PG, 2014, ANAL BIOCHEM, V457, P74, DOI 10.1016/j.ab.2014.04.014; Hill RC, 2015, MOL CELL PROTEOMICS, V14, P961, DOI 10.1074/mcp.M114.045260; Hoffmann BR, 2011, J BIOL CHEM, V286, P32220, DOI 10.1074/jbc.M111.255562; Lee KN, 2000, J BIOL CHEM, V275, P37382, DOI 10.1074/jbc.M003375200; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Litvinov RI, 2016, SEMIN THROMB HEMOST, V42, P333, DOI 10.1055/s-0036-1571342; Liu F, 2015, NAT METHODS, V12, P1179, DOI 10.1038/nmeth.3603; Liu WH, 2016, ELIFE, V5, DOI 10.7554/eLife.18023; Makogonenko E, 2007, BIOCHEMISTRY-US, V46, P5418, DOI 10.1021/bi7001373; Mouapi KN, 2016, BLOOD, V127, P2241, DOI 10.1182/blood-2015-09-672303; Richardson VR, 2013, CLIN SCI, V124, P123, DOI 10.1042/CS20120233; SAKATA Y, 1980, J CLIN INVEST, V65, P290, DOI 10.1172/JCI109671; Schneider M, 2018, TRENDS BIOCHEM SCI, V43, P157, DOI 10.1016/j.tibs.2017.12.006; SHEN L, 1983, J CLIN INVEST, V71, P1336, DOI 10.1172/JCI110885; Standeven KF, 2007, BLOOD, V110, P902, DOI 10.1182/blood-2007-01-066837; Thachil J, 2017, METHODS MOL BIOL, V1646, P91, DOI 10.1007/978-1-4939-7196-1_7; Tomko LA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31126-w; Tsurupa G, 2011, BIOCHEMISTRY-US, V50, P8028, DOI 10.1021/bi2008189; van Kempen THS, 2014, BIOPHYS J, V107, P504, DOI 10.1016/j.bpj.2014.05.035; VANGIEZEN JJJ, 1993, BLOOD COAGUL FIBRIN, V4, P869, DOI 10.1097/00001721-199304060-00002; Zhmurov A, 2018, STRUCTURE, V26, P857, DOI 10.1016/j.str.2018.04.005	28	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8773	8778		10.1074/jbc.AC119.007981	http://dx.doi.org/10.1074/jbc.AC119.007981			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	31028172	Green Published, hybrid			2022-12-28	WOS:000470971100013
J	Shapiro, P				Shapiro, Paul			A promiscuous kinase inhibitor reveals secrets to cancer cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Deregulated kinase signaling networks drive the growth and survival of many cancer cells. However, the genetic complexity and rapidly evolving nature of most cancer cells create challenges when identifying the most relevant kinases to inhibit to achieve optimal therapeutic benefits. A new strategy that takes advantage of a well-characterized multitargeted kinase inhibitor describes a nongenetic approach to tease out key kinases that promote proliferation of specific cancer cell types.	[Shapiro, Paul] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 North Pine St, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Shapiro, P (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 North Pine St, Baltimore, MD 21201 USA.	pshapiro@rx.umaryland.edu						Dai SX, 2016, PEERJ, V4, DOI 10.7717/peerj.1791; Druker BJ, 2009, NAT MED, V15, P1149, DOI 10.1038/nm1009-1149; Hafner M, 2016, NAT METHODS, V13, P521, DOI [10.1038/NMETH.3853, 10.1038/nmeth.3853]; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lovly CM, 2014, CLIN CANCER RES, V20, P2249, DOI 10.1158/1078-0432.CCR-13-1610; Rao S, 2019, J BIOL CHEM, V294, P8664, DOI 10.1074/jbc.RA118.006805; Rao S, 2019, CELL CHEM BIOL, V26, P818, DOI 10.1016/j.chembiol.2019.02.021; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Wu P, 2016, DRUG DISCOV TODAY, V21, P5, DOI 10.1016/j.drudis.2015.07.008; Zi FM, 2018, ONCOL LETT, V15, P683, DOI 10.3892/ol.2017.7412	10	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8674	8675		10.1074/jbc.H119.009103	http://dx.doi.org/10.1074/jbc.H119.009103			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	31127063	Green Published, hybrid			2022-12-28	WOS:000471108200033
J	Ansari, AZ				Ansari, Aseem Z.			A chemoprobe tracks its target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Small-molecule inhibitors of histone-modifying enzymes have significant clinical utility for managing diseases such as cancer. These inhibitors are usually identified and monitored through their effects on the gain or loss of specific histone marks. In cells, multiple related enzymes can place or remove a specific mark; therefore, relying on an indirect measure of inhibitor engagement can be misleading. Mascaro et al. describe a luminescence-based ELISA approach that directly monitors binding of inhibitors to the histone lysine demethylase KDM1A.	[Ansari, Aseem Z.] Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Ansari, AZ (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	azansari@wisc.edu	Ansari, Aseem/AAF-4945-2019		National Institutes of Health [GM117362, GM120625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120625, R01GM117362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM117362 and GM120625. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Haggarty SJ, 2004, COMB CHEM HIGH T SCR, V7, P669; Koschmann C, 2017, CANCER RES, V77, P227, DOI 10.1158/0008-5472.CAN-16-2301; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Mascaro C, 2019, J BIOL CHEM, V294, P8311, DOI 10.1074/jbc.RA118.006980; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Niphakis MJ, 2014, ANNU REV BIOCHEM, V83, P341, DOI 10.1146/annurev-biochem-060713-035708; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010	10	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8323	8324		10.1074/jbc.H119.008945	http://dx.doi.org/10.1074/jbc.H119.008945			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	31101661	hybrid, Green Published			2022-12-28	WOS:000470656500029
J	Spiering, MJ				Spiering, Martin J.			The mystery of metformin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ACTIVATED PROTEIN-KINASE					mspiering@asbmb.org		Spiering, Martin/0000-0002-9160-5296				El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; STERNE J, 1959, Therapie, V14, P625; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	4	13	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6689	6691		10.1074/jbc.CL119.008628	http://dx.doi.org/10.1074/jbc.CL119.008628			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	31028160	hybrid, Green Published			2022-12-28	WOS:000467394700004
J	Balty, C; Guillot, A; Fradale, L; Brewee, C; Boulay, M; Kubiak, X; Benjdia, A; Berteau, O				Balty, Clemence; Guillot, Alain; Fradale, Laura; Brewee, Clemence; Boulay, Mylene; Kubiak, Xavier; Benjdia, Alhosna; Berteau, Olivier			Ruminococcin C, an anti-clostridial sactipeptide produced by a prominent member of the human microbiota Ruminococcus gnavus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); enzyme; peptide biosynthesis; natural product biosynthesis; radical; antibiotics; microbiome; radical AdoMet enzyme; radical SAM enzyme; RiPP; ruminococcin; ruminococcin C	THIOETHER BOND FORMATION; SULFATASE-MATURATING ENZYME; H-ATOM ABSTRACTION; MECHANISTIC INVESTIGATIONS; STRUCTURAL INSIGHTS; THURINCIN H; GUT; BACTERIOCIN; PEPTIDE; BIOSYNTHESIS	The human microbiota plays a central role in human physiology. This complex ecosystem is a promising but untapped source of bioactive compounds and antibiotics that are critical for its homeostasis. However, we still have a very limited knowledge of its metabolic and biosynthetic capabilities. Here we investigated an enigmatic biosynthetic gene cluster identified previously in the human gut symbiont Ruminococcus gnavus. This gene cluster which encodes notably for peptide precursors and putative radical SAM enzymes, has been proposed to be responsible for the biosynthesis of ruminococcin C (RumC), a ribosomally synthesized and posttranslationally modified peptide (RiPP) with potent activity against the human pathogen Clostridium perfringens. By combining in vivo and in vitro approaches, including recombinant expression and purification of the respective peptides and proteins, enzymatic assays, and LC-MS analyses, we determined that RumC is a sulfur-to-alpha-carbon thioether-containing peptide (sactipeptide) with an unusual architecture. Moreover, our results support that formation of the thioether bridges follows a processive order, providing mechanistic insights into how radical SAM (AdoMet) enzymes install posttranslational modifications in RiPPs. We also found that the presence of thioether bridges and removal of the leader peptide are required for RumC's antimicrobial activity. In summary, our findings provide evidence that production of the anti-Clostridium peptide RumC depends on an R. gnavus operon encoding five potential RumC precursor peptides and two radical SAM enzymes, uncover key RumC structural features, and delineate the sequence of posttranslational modifications leading to its formation and antimicrobial activity.	[Balty, Clemence; Guillot, Alain; Fradale, Laura; Brewee, Clemence; Boulay, Mylene; Kubiak, Xavier; Benjdia, Alhosna; Berteau, Olivier] Univ Paris Saclay, AgroParisTech, INRA, ChemSyBio,Micalis Inst, F-78350 Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Benjdia, A; Berteau, O (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, ChemSyBio,Micalis Inst, F-78350 Jouy En Josas, France.	Alhosna.Benjdia@inra.fr; Olivier.Berteau@inra.fr	Berteau, Olivier/AAF-9080-2019; Benjdia, Alhosna/AAM-7415-2021	Berteau, Olivier/0000-0002-3434-5168; Benjdia, Alhosna/0000-0002-3544-2541; Balty, Clemence/0000-0002-1037-8053	European Research Council [617053]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council Consolidator Grant 617053. The authors declare that they have no conflicts of interest with the contents of this article.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Balskus EP, 2018, ACS INFECT DIS, V4, P1, DOI 10.1021/acsinfecdis.7b00248; Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00087; Benjdia A, 2017, J BIOL CHEM, V292, P10835, DOI 10.1074/jbc.M117.783464; Benjdia A, 2017, NAT CHEM, V9, P698, DOI [10.1038/NCHEM.2714, 10.1038/nchem.2714]; Benjdia A, 2016, CHEM COMMUN, V52, P6249, DOI 10.1039/c6cc01317a; Benjdia A, 2016, BIOCHEM SOC T, V44, P109, DOI 10.1042/BST20150191; Benjdia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9377; Benjdia A, 2012, NUCLEIC ACIDS RES, V40, P9308, DOI 10.1093/nar/gks603; Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; Berteau O, 2006, J BIOL CHEM, V281, P22464, DOI 10.1074/jbc.M602504200; Caruso A, 2019, J AM CHEM SOC, V141, P990, DOI 10.1021/jacs.8b11060; Chittim CL, 2018, BIOCHEMISTRY-US, V57, P2567, DOI 10.1021/acs.biochem.7b01277; Crost EH, 2011, BIOCHIMIE, V93, P1487, DOI 10.1016/j.biochi.2011.05.001; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Gomez A, 2002, J BACTERIOL, V184, P18, DOI 10.1128/JB.184.1.18-28.2002; Grell TAJ, 2015, J BIOL CHEM, V290, P3964, DOI 10.1074/jbc.R114.581249; Grove TL, 2017, J AM CHEM SOC, V139, P11734, DOI 10.1021/jacs.7b01283; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Himes PM, 2016, ACS CHEM BIOL, V11, P1737, DOI 10.1021/acschembio.6b00042; Hudson GA, 2019, J AM CHEM SOC, V141, P8228, DOI 10.1021/jacs.9b01519; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; Lee H, 2009, FEMS MICROBIOL LETT, V299, P205, DOI 10.1111/j.1574-6968.2009.01749.x; Mahanta N, 2017, BIOCHEMISTRY-US, V56, P5229, DOI 10.1021/acs.biochem.7b00771; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Ongey EL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01688; Owen CD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02109-8; Parent A, 2018, J AM CHEM SOC, V140, P2469, DOI 10.1021/jacs.7b08402; Parent A, 2016, J AM CHEM SOC, V138, P15515, DOI 10.1021/jacs.6b06697; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; Pujol A, 2011, FEMS MICROBIOL ECOL, V78, P405, DOI 10.1111/j.1574-6941.2011.01176.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RAMARE F, 1993, APPL ENVIRON MICROB, V59, P2876, DOI 10.1128/AEM.59.9.2876-2883.1993; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; Repka LM, 2017, CHEM REV, V117, P5457, DOI 10.1021/acs.chemrev.6b00591; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Scherer KM, 2015, BIOPHYS J, V108, P1114, DOI 10.1016/j.bpj.2015.01.020; Schramma KR, 2015, NAT CHEM, V7, P431, DOI [10.1038/NCHEM.2237, 10.1038/nchem.2237]; Sit CS, 2011, ANGEW CHEM INT EDIT, V50, P8718, DOI 10.1002/anie.201102527; Wieckowski BM, 2015, FEBS LETT, V589, P1802, DOI 10.1016/j.febslet.2015.05.032	46	29	29	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14512	14525		10.1074/jbc.RA119.009416	http://dx.doi.org/10.1074/jbc.RA119.009416			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31337708	Green Published, hybrid			2022-12-28	WOS:000497955000003
J	Kuatsjah, E; Verstraete, MM; Kobylarz, MJ; Liu, AKN; Murphy, MEP; Eltis, LD				Kuatsjah, Eugene; Verstraete, Meghan M.; Kobylarz, Marek J.; Liu, Alvin K. N.; Murphy, Michael E. P.; Eltis, Lindsay D.			Identification of functionally important residues and structural features in a bacterial lignostilbene dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lignin degradation; metalloenzyme; enzyme mechanism; resveratrol; X-ray crystallography; aromatic compound; bacterial catabolism; carotenoid cleavage oxygenase; lignostilbene; biomass conversion; non-heme iron oxygenase; carotenoid dioxygenase; lignostilbene dioxygenase (LSD)	CAROTENOID CLEAVAGE; BETA-DIOXYGENASE; GENERAL BASE; DOUBLE-BOND; LIGNIN; DEHYDROGENASE; PURIFICATION; MECHANISM; ISOZYMES; ENZYME	Lignostilbene-alpha,beta-dioxygenase A (LsdA) from the bacterium Sphingomonas paucimobilis TMY1009 is a nonheme iron oxygenase that catalyzes the cleavage of lignostilbene, a compound arising in lignin transformation, to two vanillin molecules. To examine LsdA's substrate specificity, we heterologously produced the dimeric enzyme with the help of chaperones. When tested on several substituted stilbenes, LsdA exhibited the greatest specificity for lignostilbene (k(cat)(app) = 1.00 +/- 0.04 x 10(6) M-1 s(-1)). These experiments further indicated that the substrate's 4-hydroxy moiety is required for catalysis and that this moiety cannot be replaced with a methoxy group. Phenylazophenol inhibited the LsdA-catalyzed cleavage of lignostilbene in a reversible, mixed fashion (K-ic = 6 +/- 1 mu M, K-iu = 24 +/- 4 mu M). An X-ray crystal structure of LsdA at 2.3 angstrom resolution revealed a seven-bladed beta-propeller fold with an iron cofactor coordinated by four histidines, in agreement with previous observations on related carotenoid cleavage oxygenases. We noted that residues at the dimer interface are also present in LsdB, another lignostilbene dioxygenase in S. paucimobilis TMY1009, rationalizing LsdA and LsdB homo- and heterodimerization in vivo. A structure of an LsdA center dot phenylazophenol complex identified Phe(59), Tyr(101), and Lys(134) as contacting the 4-hydroxyphenyl moiety of the inhibitor. Phe(59) and Tyr(101) substitutions with His and Phe, respectively, reduced LsdA activity (k(cat)(app)) similar to 15- and 10-fold. The K134M variant did not detectably cleave lignostilbene, indicating that Lys(134) plays a key catalytic role. This study expands our mechanistic understanding of LsdA and related stilbene-cleaving dioxygenases.	[Kuatsjah, Eugene; Eltis, Lindsay D.] Univ British Columbia, Life Sci Inst, Genome Sci & Technol Program, Vancouver, BC V6T 1Z3, Canada; [Verstraete, Meghan M.; Kobylarz, Marek J.; Liu, Alvin K. N.; Murphy, Michael E. P.; Eltis, Lindsay D.] Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@mail.ubc.ca	Kuatsjah, Eugene/GLN-5085-2022; Eltis, Lindsay/J-8272-2015	Liu, Alvin Ka Nok/0000-0002-5111-3713; Eltis, Lindsay/0000-0002-6774-8158; Verstraete, Meghan/0000-0003-0422-2826; Kuatsjah, Eugene/0000-0002-8793-2331	United States Department of Energy, Office of Science, and Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NSERC; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, and Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Mariko Ikehata assisted with the ICP-MS. Use of the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, was supported by the United States Department of Energy, Office of Science, and Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by NIGMS, National Institutes of Health (including Grant P41GM103393). Research described in this paper was performed using beamline 08D1-1 at the Canadian Light Source, which is supported by the NSERC, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bugg TDH, 2015, CURR OPIN CHEM BIOL, V29, P10, DOI 10.1016/j.cbpa.2015.06.009; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chong JL, 2009, PLANT SCI, V177, P143, DOI 10.1016/j.plantsci.2009.05.012; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Crestini C, 2017, GREEN CHEM, V19, P4104, DOI [10.1039/c7gc01812f, 10.1039/C7GC01812F]; dela Sena C, 2014, J BIOL CHEM, V289, P13661, DOI 10.1074/jbc.M114.557710; Diaz-Sanchez V, 2013, EUKARYOT CELL, V12, P1305, DOI 10.1128/EC.00084-13; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Han SY, 2003, J ENZYM INHIB MED CH, V18, P279, DOI 10.1080/1475636031000080207; Han SY, 2002, BIOORG MED CHEM LETT, V12, P1139, DOI 10.1016/S0960-894X(02)00126-9; Harrison PJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P105, DOI 10.1016/j.abb.2013.10.005; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jackson CA, 2017, J APPL MICROBIOL, V122, P940, DOI 10.1111/jam.13401; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kamimura N, 2017, ENV MICROBIOL REP, V9, P679, DOI 10.1111/1758-2229.12597; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P926, DOI 10.1271/bbb.57.926; Kamoda S, 2003, BIOSCI BIOTECH BIOCH, V67, P1394, DOI 10.1271/bbb.67.1394; Kamoda S, 1997, BIOSCI BIOTECH BIOCH, V61, P1575, DOI 10.1271/bbb.61.1575; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P931, DOI 10.1271/bbb.57.931; KAMODA S, 1989, AGR BIOL CHEM TOKYO, V53, P2757, DOI 10.1080/00021369.1989.10869724; Kumar VP, 2012, BIOCHEMISTRY-US, V51, P857, DOI [10.1021/bi201808, 10.1021/bi201808u]; Lei Z, 1999, BIOCHEMISTRY-US, V38, P11231, DOI 10.1021/bi990433i; Loewen PC, 2018, BMC BIOCHEM, V19, DOI 10.1186/s12858-018-0098-4; Marasco EK, 2008, CHEMBIOCHEM, V9, P1450, DOI 10.1002/cbic.200700724; McAndrew RP, 2016, P NATL ACAD SCI USA, V113, P14324, DOI 10.1073/pnas.1608917113; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nunes S, 2018, NUTR RES REV, V31, P85, DOI 10.1017/S095442241700021X; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; SEKIMOTO T, 1993, J BIOL CHEM, V268, P27039; Shiel AE, 2012, GEOCHIM COSMOCHIM AC, V76, P175, DOI 10.1016/j.gca.2011.10.005; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Sui XW, 2017, BIOCHEMISTRY-US, V56, P2836, DOI 10.1021/acs.biochem.7b00251; Sui XW, 2016, J BIOL CHEM, V291, P19401, DOI 10.1074/jbc.M116.744912; Sui XW, 2015, J BIOL CHEM, V290, P30212, DOI 10.1074/jbc.M115.696799; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012; Takahashi K, 2018, ENVIRON MICROBIOL, V20, P1739, DOI 10.1111/1462-2920.14099; Varman AM, 2016, P NATL ACAD SCI USA, V113, pE5802, DOI 10.1073/pnas.1606043113; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu RQ, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02154-18; ZABINSKI R, 1972, BIOCHEMISTRY-US, V11, P3212, DOI 10.1021/bi00767a012	46	8	8	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12911	12920		10.1074/jbc.RA119.009428	http://dx.doi.org/10.1074/jbc.RA119.009428			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31292192	hybrid, Green Published			2022-12-28	WOS:000486416000005
J	Xiaoli, AM; Song, ZY; Yang, FJ				Xiaoli, Alus M.; Song, Ziyi; Yang, Fajun			Lipogenic SREBP-1a/c transcription factors activate expression of the iron regulator hepcidin, revealing cross-talk between lipid and iron metabolisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA transcription; transcription factor; iron metabolism; transcription coregulator; inflammation; lipogenesis; Hamp; hepcidin; LPS; Mediator; SREBP	DE-NOVO LIPOGENESIS; FATTY-ACIDS; MEDIATOR COMPLEX; LIVER; CHOLESTEROL; PROTEINS; PROMOTER; STAT3; HOMEOSTASIS; PATHOLOGY	The sterol regulatory element-binding proteins (SREBPs) are a family of transcription factors best known for stimulating the expression of genes encoding key lipogenic enzymes. However, SREBP functions beyond lipid metabolism are less understood. Here, we show that hepcidin antimicrobial peptide (Hamp), encoding the hormone hepcidin essential for iron homeostasis and regulated by dietary iron and inflammation, is a target gene of the two SREBP isoforms SREBP-1a/c. We found that in tissue culture, mature, active, and nuclear forms of the SREBP-1a/c proteins induce endogenous Hamp gene expression and increase the Hamp promoter activity primarily via three regulatory sequences, including an E-box. Moreover, ChIP experiments revealed that SREBP-1a binds to the Hamp gene promoter. Overexpression of nuclear SREBP-1a under the control of the phosphoenolpyruvate carboxylase-1 (Pck1) promoter in mice increased hepatic Hamp mRNA and blood hepcidin levels, and as expected, caused fatty liver. Consistent with the known effects of Hamp up-regulation, SREBP-1a-overexpressing mice displayed signs of dysregulation in iron metabolism, including reduced serum iron and increased hepatic and splenic iron storage. Conversely, liver-specific depletion of the nuclear forms of SREBPs, as in SREBP cleavage-activating protein knockout mice, impaired lipopolysaccharide-induced up-regulation of hepatic Hamp. Together, these results indicate that the SREBP-1a/c transcription regulators activate hepcidin expression and thereby contribute to the control of mammalian iron metabolism.	Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Yang, FJ (corresponding author), Price Ctr, 1301 Morris Pk Ave,Rm 377, Bronx, NY 10461 USA.	fajun.yang@einstein.yu.edu		SONG, ZIYI/0000-0003-4306-4648	National Institutes of Health [P30 DK041296, DK020541, R01 DK110063, DK098439]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110063, P30DK041296, R01DK098439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P30 DK041296 and DK020541 and R01 DK110063 and DK098439. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aigner E, 2014, NUTRIENTS, V6, P3587, DOI 10.3390/nu6093587; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Ameer F, 2014, METABOLISM, V63, P895, DOI 10.1016/j.metabol.2014.04.003; Bayele HK, 2006, BLOOD, V108, P4237, DOI 10.1182/blood-2005-07-027037; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Camaschella C, 2018, BRIT J HAEMATOL, V182, P481, DOI 10.1111/bjh.15403; Casanovas G, 2009, J MOL MED, V87, P471, DOI 10.1007/s00109-009-0447-2; Coffey R, 2017, J BIOL CHEM, V292, P12727, DOI 10.1074/jbc.R117.781823; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Engin A, 2017, ADV EXP MED BIOL, V960, P443, DOI 10.1007/978-3-319-48382-5_19; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Feng DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126240; Frazer DM, 2017, AM J CLIN NUTR, V105, P1255, DOI 10.3945/ajcn.117.158188; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Griffin MJ, 2007, J BIOL CHEM, V282, P5453, DOI 10.1074/jbc.M610566200; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Knutson MD, 2017, J BIOL CHEM, V292, P12735, DOI 10.1074/jbc.R117.786632; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Means RT, 2013, AM J MED SCI, V345, P57, DOI 10.1097/MAJ.0b013e318253caf1; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Parrow NL, 2014, ANNU REV NUTR, V34, P77, DOI 10.1146/annurev-nutr-071813-105646; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Reichert CO, 2017, ACTA HAEMATOL-BASEL, V137, P220, DOI 10.1159/000471838; Rishi G, 2017, AM J PHYSIOL-GASTR L, V313, pG157, DOI 10.1152/ajpgi.00004.2017; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wong RHF, 2010, CURR OPIN PHARMACOL, V10, P684, DOI 10.1016/j.coph.2010.08.004; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Xiaoli, 2013, TRENDS CARDIOVAS MED, V23, P269, DOI 10.1016/j.tcm.2013.03.002; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; YEN TT, 1976, BIOCHIM BIOPHYS ACTA, V441, P213, DOI 10.1016/0005-2760(76)90164-8; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	52	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12743	12753		10.1074/jbc.RA119.009644	http://dx.doi.org/10.1074/jbc.RA119.009644			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31270208	hybrid, Green Published			2022-12-28	WOS:000484414600016
J	Burress, H; Kellner, A; Guyette, J; Tatulian, SA; Teter, K				Burress, Helen; Kellner, Alisha; Guyette, Jessica; Tatulian, Suren A.; Teter, Ken			HSC70 and HSP90 chaperones perform complementary roles in translocation of the cholera toxin A1 subunit from the endoplasmic reticulum to the cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; heat shock protein (HSP); heat shock protein 90 (Hsp90); translocation; endoplasmic reticulum-associated protein degradation (ERAD); bacterial pathogenesis	MEMBRANE TRANSLOCATION; DEGRADATION PATHWAY; PROTEIN; HSP70; CYCLOPHILIN; CELLS; P97; IDENTIFICATION; INSTABILITY; INHIBITION	Cholera toxin (CT) travels by vesicle carriers from the cell surface to the endoplasmic reticulum (ER) where the catalytic A1 subunit of CT (CTA1) dissociates from the rest of the toxin, unfolds, and moves through a membrane-spanning translocon pore to reach the cytosol. Heat shock protein 90 (HSP90) binds to the N-terminal region of CTA1 and facilitates its ER-to-cytosol export by refolding the toxin as it emerges at the cytosolic face of the ER membrane. HSP90 also refolds some endogenous cytosolic proteins as part of a foldosome complex containing heat shock cognate 71-kDa protein (HSC70) and the HSC70/HSP90-organizing protein (HOP) linker that anchors HSP90 to HSC70. We accordingly predicted that HSC70 and HOP also function in CTA1 translocation. Inactivation of HSC70 by drug treatment disrupted CTA1 translocation to the cytosol and generated a toxin-resistant phenotype. In contrast, the depletion of HOP did not disrupt CT activity against cultured cells. HSC70 and HSP90 could bind independently to disordered CTA1, even in the absence of HOP. This indicated HSP90 and HSC70 recognize distinct regions of CTA1, which was confirmed by the identification of a YYIYVI-binding motif for HSC70 that spans residues 83-88 of the 192-amino acid CTA1 polypeptide. Refolding of disordered CTA1 occurred in the presence of HSC70 alone, indicating that HSC70 and HSP90 can each independently refold CTA1. Our work suggests a novel translocation mechanism in which sequential interactions with HSP90 and HSC70 drive the N- to C-terminal extraction of CTA1 from the ER.	[Burress, Helen; Kellner, Alisha; Guyette, Jessica; Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA; [Tatulian, Suren A.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Teter, K (corresponding author), Biomol Res Annex, 12722 Res Pkwy, Orlando, FL 32826 USA.	kteter@mail.ucf.edu		Teter, Ken/0000-0003-4176-9361	National Institutes of Health NIAID [R01AI099493]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099493] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health NIAID Grant R01AI099493 (to K.T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee T, 2010, BIOCHEMISTRY-US, V49, P8839, DOI 10.1021/bi101201c; Burress H, 2014, J BIOL CHEM, V289, P33644, DOI 10.1074/jbc.M114.609800; Cano LQ, 2013, MOL CELL ENDOCRINOL, V369, P52, DOI 10.1016/j.mce.2013.01.023; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; CZAR MJ, 1994, J BIOL CHEM, V269, P11155; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Dmochewitz L, 2011, CELL MICROBIOL, V13, P359, DOI 10.1111/j.1462-5822.2010.01539.x; Ernst K, 2017, CURR TOP MICROBIOL, V406, P163, DOI 10.1007/82_2016_14; Ernst K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02882-y; Ernst K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20301; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Haug G, 2004, INFECT IMMUN, V72, P3066, DOI 10.1128/IAI.72.5.3066-3068.2004; Haug G, 2003, J BIOL CHEM, V278, P32266, DOI 10.1074/jbc.M303980200; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Heggelund JE, 2015, COMPREHENSIVE SOURCEBOOK OF BACTERIAL PROTEIN TOXINS, 4TH EDITION, P195, DOI 10.1016/B978-0-12-800188-2.00007-0; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Kaiser E, 2011, INFECT IMMUN, V79, P3913, DOI 10.1128/IAI.05372-11; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Kundel F, 2018, ACS CHEM BIOL, V13, P636, DOI 10.1021/acschembio.7b01039; Lang AE, 2014, CELL MICROBIOL, V16, P490, DOI 10.1111/cmi.12228; LENCER WI, 1993, J CLIN INVEST, V92, P2941, DOI 10.1172/JCI116917; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Massey S, 2011, INFECT IMMUN, V79, P4739, DOI 10.1128/IAI.05503-11; McConnell E, 2007, BIOCHEM BIOPH RES CO, V355, P1087, DOI 10.1016/j.bbrc.2007.02.077; Minami Y, 1999, GENES CELLS, V4, P721, DOI 10.1046/j.1365-2443.1999.00299.x; Muanprasat C, 2013, FUTURE MED CHEM, V5, P781, DOI [10.4155/FMC.13.42, 10.4155/fmc.13.42]; Murphy JR, 2011, TOXINS, V3, P294, DOI 10.3390/toxins3030294; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Ratts R, 2003, J CELL BIOL, V160, P1139, DOI 10.1083/jcb.200210028; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Schuster M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00780-x; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Tatulian Suren A, 2013, Methods Mol Biol, V974, P177, DOI 10.1007/978-1-62703-275-9_9; Taylor M., 2015, P PHYS BIOL PROT PEP, P67; Taylor M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003925; Taylor M, 2012, JOVE-J VIS EXP, DOI 10.3791/3686; Taylor M, 2011, J BIOL CHEM, V286, P22090, DOI 10.1074/jbc.M111.237966; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Tehran DA, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12647; Teter K, 2006, INFECT IMMUN, V74, P2259, DOI 10.1128/IAI.74.4.2259-2267.2006; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Teter K., 2013, MOONLIGHTING CELL ST, P323; Teter K, 2013, BIOMOLECULES, V3, P997, DOI 10.3390/biom3040997; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Williams JM, 2013, MOL BIOL CELL, V24, P785, DOI 10.1091/mbc.E12-07-0522; Winkeler A, 2003, FEBS LETT, V554, P439, DOI 10.1016/S0014-5793(03)01217-1; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	63	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					12122	12131		10.1074/jbc.RA119.008568	http://dx.doi.org/10.1074/jbc.RA119.008568			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31221799	hybrid, Green Published			2022-12-28	WOS:000484284500016
J	Potapenko, E; Negrao, NW; Huang, GZ; Docampo, R				Potapenko, Evgeniy; Negrao, Nuria W.; Huang, Guozhong; Docampo, Roberto			The acidocalcisome inositol-1,4,5-trisphosphate receptor of Trypanosoma brucei is stimulated by luminal polyphosphate hydrolysis products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inositol trisphosphate receptor (InsP3R); Trypanosoma brucei; calcium; calcium channel; organelle; acidocalcisome; DT-40 cells; orthophosphate; pyrophosphate phosphate; inositol-1; 4; 5-trisphosphate receptor; sleeping sickness	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; INTRALUMINAL LOOP PEPTIDE; CHROMOGRANIN-B; IP3 RECEPTORS; TRISPHOSPHATE; CRUZI; GROWTH; DIFFERENTIATION; PYROPHOSPHATASE; PARAMECIUM	Acidocalcisomes are acidic calcium stores rich in polyphosphate (polyP) and are present in trypanosomes and also in a diverse range of other organisms. Ca2+ is released from these organelles through a channel, inositol 1,4,5-trisphosphate receptor (TbIP3R), which is essential for growth and infectivity of the parasite Trypanosoma brucei. However, the mechanism by which TbIP3R controls Ca2+ release is unclear. In this work, we expressed TbIP3R in a chicken B lymphocyte cell line in which the genes for all three vertebrate IP(3)Rs were stably ablated (DT40-3KO). We show that IP3-mediated Ca2+ release depends on Ca2+ but not on ATP concentration and is inhibited by heparin, caffeine, and 2-aminomethoxydiphenyl borate (2-APB). Excised patch clamp recordings from nuclear membranes of DT40 cells expressing only TbIP3R disclosed that luminal inorganic orthophosphate (P-i) or pyrophosphate (PPi), and neutral or alkaline pH can stimulate IP3-generated currents. In contrast, polyP or acidic pH did not induce these currents, and nuclear membranes obtained from cells expressing rat IP3R were unresponsive to polyP or its hydrolysis products. Our results are consistent with the notion that polyP hydrolysis products within acidocalcisomes or alkalinization of their luminal pH activate TbIP3R and Ca2+ release. We conclude that TbIP3R is well-adapted to its role as the major Ca2+ release channel of acidocalcisomes in T. brucei.	[Potapenko, Evgeniy; Negrao, Nuria W.; Huang, Guozhong; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Negrao, Nuria W.; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.; Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	rdocampo@uga.edu	Docampo, Roberto/X-9424-2019	Docampo, Roberto/0000-0003-4229-8784	NIAID, National Institutes of Health [AI-108222, T32 AI060546]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060546] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grants AI-108222 (to R.D.) and T32 AI060546 (to E.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adl SM, 2019, J EUKARYOT MICROBIOL, V66, P4, DOI 10.1111/jeu.12691; Alzayady KJ, 2015, MOL BIOL EVOL, V32, P2236, DOI 10.1093/molbev/msv098; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Cai XJ, 2008, MOL BIOL EVOL, V25, P1357, DOI 10.1093/molbev/msn077; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Choe Chi-Un, 2006, Sci STKE, V2006, pre15; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; DOCAMPO R, 1995, BIOCHEM J, V310, P1005, DOI 10.1042/bj3101005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang JM, 2007, J BIOL CHEM, V282, P32501, DOI 10.1074/jbc.M704841200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Galizzi M, 2013, MOL MICROBIOL, V90, P699, DOI 10.1111/mmi.12392; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hashimoto M, 2013, MOL MICROBIOL, V87, P1133, DOI 10.1111/mmi.12155; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Huang GZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004555; Huang GZ, 2013, P NATL ACAD SCI USA, V110, P1887, DOI 10.1073/pnas.1216955110; JAYARAMAN T, 1995, P NATL ACAD SCI USA, V92, P6007, DOI 10.1073/pnas.92.13.6007; Ladenburger EM, 2006, J CELL SCI, V119, P3705, DOI 10.1242/jcs.03075; Ladenburger EM, 2009, MOL CELL BIOL, V29, P3605, DOI 10.1128/MCB.01592-08; Lander N, 2016, J BIOL CHEM, V291, P25505, DOI 10.1074/jbc.M116.749655; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Laude AJ, 2005, CELL CALCIUM, V38, P45, DOI 10.1016/j.ceca.2005.04.001; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Li FJ, 2017, AUTOPHAGY, V13, P715, DOI 10.1080/15548627.2017.1280218; LIU CM, 1978, J BIOL CHEM, V253, P5892; Mak DOD, 2000, J GEN PHYSIOL, V115, P241, DOI 10.1085/jgp.115.3.241; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; Mak Don-On Daniel, 2013, Cold Spring Harb Protoc, V2013, P787, DOI 10.1101/pdb.top066217; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Moreno B, 2000, J BIOL CHEM, V275, P28356, DOI 10.1074/jbc.M003893200; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; Rahman T, 2012, BIOCHEM SOC T, V40, P325, DOI 10.1042/BST20110772; Rahman T, 2010, METHOD CELL BIOL, V99, P199, DOI [10.1016/B978-0-12-374841-6.00008-6, 10.1016/S0091-679X(10)99008-0]; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2006, MOL BIOCHEM PARASIT, V150, P249, DOI 10.1016/j.molbiopara.2006.08.010; Rossi AM, 2012, BBA-GEN SUBJECTS, V1820, P1214, DOI 10.1016/j.bbagen.2011.10.004; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Saleem H, 2014, BRIT J PHARMACOL, V171, P3298, DOI 10.1111/bph.12685; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Traynor D, 2000, EMBO J, V19, P4846, DOI 10.1093/emboj/19.17.4846; Tu HP, 2003, BIOPHYS J, V85, P290, DOI 10.1016/S0006-3495(03)74474-9; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; Yoo SH, 2000, J BIOL CHEM, V275, P12553, DOI 10.1074/jbc.275.17.12553; Yoo SH, 2000, ADV EXP MED BIOL, V482, P83; Yoo SH, 1998, FEBS LETT, V427, P55, DOI 10.1016/S0014-5793(98)00393-7; Yoo SH, 2000, J BIOL CHEM, V275, P30293, DOI 10.1074/jbc.M001204200; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404	55	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10628	10637		10.1074/jbc.RA119.007906	http://dx.doi.org/10.1074/jbc.RA119.007906			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138655	hybrid, Green Published			2022-12-28	WOS:000478717100021
J	Uzunbas, GK; Ahmed, F; Sammons, MA				Uzunbas, Gizem Karsli; Ahmed, Faraz; Sammons, Morgan A.			Control of p53-dependent transcription and enhancer activity by the p53 family member p63	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription; transcription factor; transcription regulation; chromatin modification; chromatin regulation; chromatin; p53; p63; DNA damage response; epigenetics	SQUAMOUS-CELL CARCINOMA; REGENERATIVE PROLIFERATION; GENE; CANCER; TP53; P73; MECHANISMS; LANDSCAPE; ELEMENTS; PROGRAM	Transcriptional activation by p53 provides powerful, organism-wide tumor suppression. We hypothesized that the local chromatin environment, including differential enhancer activities, contributes to various p53-dependent transcriptional activities in different cell types during stress-induced signaling. In this work, using ChIP-sequencing, immunoblotting, quantitative PCR, and computational analyses across various mammalian cell lines, we demonstrate that the p53-induced transcriptome varies by cell type, reflects cell type-specific activities, and is considerably broader than previously anticipated. We found that these molecular events are strongly influenced by p53's engagement with differentially active cell type-specific enhancers and promoters. We also observed that p53 activity depends on the p53 family member tumor protein p63 in epithelial cell types. Notably, we demonstrate that p63 is required for epithelial enhancer identity, including enhancers used by p53 during stress-dependent signaling. Loss of p63, but not p53, caused site-specific depletion of enhancer-associated chromatin modifications, suggesting that p63 functions as an enhancer maintenance factor in epithelial cells. Additionally, a subset of epithelial-specific enhancers depends on the activity of p63 providing a direct link between lineage determination and enhancer structure. These results suggest that a broad, cell-intrinsic mechanism controls p53-dependent cellular stress response through differential regulation of cis-regulatory elements.	[Uzunbas, Gizem Karsli; Ahmed, Faraz; Sammons, Morgan A.] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany	Sammons, MA (corresponding author), SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA.	masammons@albany.edu		Sammons, Morgan/0000-0002-5329-1169	State University of New York at Albany; National Institutes of Health [R15 GM128049]	State University of New York at Albany; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by start-up funds from the State University of New York at Albany and National Institutes of Health Grant R15 GM128049. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Andrysik Z, 2017, GENOME RES, V27, P1645, DOI 10.1101/gr.220533.117; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Bao XM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0840-9; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Billant O, 2016, ONCOTARGET, V7, P69549, DOI 10.18632/oncotarget.11774; Botchkarev VA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015248; Boxer LD, 2014, GENE DEV, V28, P2013, DOI 10.1101/gad.246579.114; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Brunner HG, 2002, J MED GENET, V39, P377, DOI 10.1136/jmg.39.6.377; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Cui F, 2014, NUCLEIC ACIDS RES, V42, P836, DOI 10.1093/nar/gkt943; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Fakhouri WD, 2014, HUM MOL GENET, V23, P2711, DOI 10.1093/hmg/ddt664; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gallant-Behm CL, 2013, CELL CYCLE, V12, P409, DOI 10.4161/cc.23593; Gallant-Behm CL, 2012, GENE DEV, V26, P2325, DOI 10.1101/gad.198069.112; Hafner A., 2017, BIORXIV, DOI [10.1101/177667, DOI 10.1101/177667]; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kouwenhoven EN, 2015, EMBO REP, V16, P863, DOI 10.15252/embr.201439941; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levrero M, 2000, J CELL SCI, V113, P1661; Li LJ, 2019, CELL STEM CELL, V24, P271, DOI 10.1016/j.stem.2018.12.012; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lin-Shiao E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw0946; Lin-Shiao E, 2018, GENE DEV, V32, P181, DOI 10.1101/gad.306241.117; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marshall CB, 2016, CELL REP, V14, P2289, DOI 10.1016/j.celrep.2016.02.035; McDade SS, 2014, NUCLEIC ACIDS RES, V42, P6270, DOI 10.1093/nar/gku299; Melino G, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1033; Moll UM, 2001, BBA-REV CANCER, V1552, P47, DOI 10.1016/S0304-419X(01)00036-1; Mundt HM, 2010, BIOCHEM BIOPH RES CO, V396, P335, DOI 10.1016/j.bbrc.2010.04.093; Mungamuri SK, 2012, NAT STRUCT MOL BIOL, V19, P478, DOI 10.1038/nsmb.2271; Nemajerova A, 2016, GENE DEV, V30, P1300, DOI 10.1101/gad.279836.116; Nguyen TAT, 2018, NUCLEIC ACIDS RES, V46, P8153, DOI 10.1093/nar/gky720; Nili EL, 2010, GENOME RES, V20, P1361, DOI 10.1101/gr.103945.109; Paris R, 2008, CELL CYCLE, V7, P2427, DOI 10.4161/cc.6420; Pattison JM, 2018, NAT GENET, V50, P1658, DOI 10.1038/s41588-018-0263-0; Powell E, 2014, CANCER DISCOV, V4, P405, DOI 10.1158/2159-8290.CD-13-0136; Qu JQ, 2018, CELL REP, V25, P3490, DOI 10.1016/j.celrep.2018.11.039; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramsey MR, 2011, CANCER RES, V71, P4373, DOI 10.1158/0008-5472.CAN-11-0046; Reiter F, 2017, CURR OPIN GENET DEV, V43, P73, DOI 10.1016/j.gde.2016.12.007; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Saladi SV, 2017, CANCER CELL, V31, P35, DOI 10.1016/j.ccell.2016.12.001; Sammons MA, 2015, GENOME RES, V25, P179, DOI 10.1101/gr.181883.114; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Sethi I, 2017, NUCLEIC ACIDS RES, V45, P8208, DOI 10.1093/nar/gkx416; Sethi I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1042; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Sullivan KD, 2018, CELL DEATH DIFFER, V25, P133, DOI 10.1038/cdd.2017.174; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verfaillie A, 2016, GENOME RES, V26, P882, DOI 10.1101/gr.204149.116; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Younger ST, 2017, NUCLEIC ACIDS RES, V45, P9889, DOI 10.1093/nar/gkx577; Yu XY, 2019, GENOME RES, V29, P107, DOI 10.1101/gr.234104.117; Zaret KS, 2016, CURR OPIN GENET DEV, V37, P76, DOI 10.1016/j.gde.2015.12.003; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu JJ, 2016, P NATL ACAD SCI USA, V113, P9822, DOI 10.1073/pnas.1610387113; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	85	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10720	10736		10.1074/jbc.RA119.007965	http://dx.doi.org/10.1074/jbc.RA119.007965			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31113863	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000478717100029
J	Wang, C; Yang, ZZ; Guo, FH; Shi, S; Han, XS; Zeng, A; Lin, HF; Jing, Q				Wang, Chen; Yang, Zhen-Zhen; Guo, Fang-Hao; Shi, Shuo; Han, Xiao-Shuai; Zeng, An; Lin, Haifan; Jing, Qing			Heat shock protein DNAJA1 stabilizes PIWI proteins to support regeneration and homeostasis of planarian Schmidtea mediterranea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						regeneration; heat shock protein (HSP); stem cells; chaperone; Argonaute; DNAJA1; heat shock protein 40 (Hsp40); neoblast; PIWI proteins; planarian; PIWI-interacting RNA (piRNA)	PLURIPOTENT STEM-CELLS; PIRNA BIOGENESIS; CHAPERONE MACHINERY; SELF-RENEWAL; DROSOPHILA; EXPRESSION; GERMLINE; FAMILY; GENES; TRANSPOSONS	PIWI proteins are key regulators of germline and somatic stem cells throughout different evolutionary lineages. However, how PIWI proteins themselves are regulated remains largely unknown. To identify candidate proteins that interact with PIWI proteins and regulate their stability, here we established a yeast two-hybrid (Y2H) assay in the planarian species Schmidtea mediterranea. We show that DNAJA1, a heat shock protein 40 family member, interacts with the PIWI protein SMEDWI-2, as validated by the Y2H screen and co-immunoprecipitation assays. We found that DNAJA1 is enriched in planarian adult stem cells, the nervous system, and intestinal tissues. DNAJA1-knockdown abolished planarian regeneration and homeostasis, compromised stem cell maintenance and PIWI-interacting RNA (piRNA) biogenesis, and deregulated SMEDWI-1/2 target genes. Mechanistically, we observed that DNAJA1 is required for the stability of SMEDWI-1 and SMEDWI-2 proteins. Furthermore, we noted that human DNAJA1 binds to Piwi-like RNA-mediated gene silencing 1 (PIWIL1) and is required for PIWIL1 stability in human gastric cancer cells. In summary, our results reveal not only an evolutionarily conserved functional link between PIWI and DNAJA1 that is essential for PIWI protein stability and piRNA biogenesis, but also an important role of DNAJA1 in the control of proteins involved in stem cell regulation.	[Wang, Chen; Yang, Zhen-Zhen; Shi, Shuo; Lin, Haifan] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China; [Wang, Chen; Guo, Fang-Hao; Han, Xiao-Shuai; Zeng, An; Jing, Qing] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Lin, Haifan] Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06511 USA	ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Yale University	Lin, HF (corresponding author), ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China.; Jing, Q (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.; Lin, HF (corresponding author), Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06511 USA.	haifan.lin@yale.edu; qjing@sibs.ac.cn	Zeng, An/AAG-9158-2021; jing, qing/F-6752-2016	Zeng, An/0000-0003-3011-5709; jing, qing/0000-0001-9834-1214; Yang, Zhenzhen/0000-0002-4804-2045	National Natural Science Foundation of China [81130005, 91339205, 31229002, 31101037, 31401238, 81000117]; Ministry of Science and Technology of China [2017YFA0103700]; ShanghaiTech University; Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); ShanghaiTech University; Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences	This work was supported in part by National Natural Science Foundation of China Grants 81130005, 91339205, 31229002, 31101037, 31401238, and 81000117; Ministry of Science and Technology of China Grant 2017YFA0103700 (to Q. J.); and ShanghaiTech University (to H. L.). Publication charges were paid by the Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarado AS, 2003, CURR OPIN GENET DEV, V13, P438, DOI 10.1016/S0959-437X(03)00082-0; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Axtell MJ, 2013, RNA, V19, P740, DOI 10.1261/rna.035279.112; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.405; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; De Mulder K, 2009, DEV BIOL, V334, P198, DOI 10.1016/j.ydbio.2009.07.019; Dekker SL, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00035; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Fernandez-Taboada E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-133; Funayama N, 2010, EVOL DEV, V12, P275, DOI 10.1111/j.1525-142X.2010.00413.x; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Harris AN, 2001, DEVELOPMENT, V128, P2823; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Iyer H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006109; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kakkar V, 2012, CURR TOP MED CHEM, V12, P2479; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kim TH, 2012, THERIOGENOLOGY, V78, P1948, DOI 10.1016/j.theriogenology.2012.07.019; King RS, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-8; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Ku HY, 2014, NATL SCI REV, V1, P205, DOI 10.1093/nsr/nwu014; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu L, 2011, DEVELOPMENT, V138, P1863, DOI 10.1242/dev.059287; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Nakagawa H, 2012, DEV BIOL, V361, P167, DOI 10.1016/j.ydbio.2011.10.014; Newmark PA, 2008, COLD SH Q B, V73, P573, DOI 10.1101/sqb.2008.73.022; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Olivieri D, 2012, MOL CELL, V47, P954, DOI 10.1016/j.molcel.2012.07.021; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Parrales A, 2016, NAT CELL BIOL, V18, P1233, DOI 10.1038/ncb3427; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Petrov AI, 2017, NUCLEIC ACIDS RES, V45, pD128, DOI 10.1093/nar/gkw1008; Preall JB, 2012, RNA, V18, P1446, DOI 10.1261/rna.034405.112; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Rinkevich Y, 2010, DEV BIOL, V345, P94, DOI 10.1016/j.ydbio.2010.05.500; Rossi L, 2006, DEV GENES EVOL, V216, P335, DOI 10.1007/s00427-006-0060-0; Rouhana L, 2012, DEVELOPMENT, V139, P1083, DOI 10.1242/dev.076182; SAITO H, 1978, MOL GEN GENET, V164, P1, DOI 10.1007/BF00267592; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Sato K, 2011, GENE DEV, V25, P2361, DOI 10.1101/gad.174110.111; Shibata N, 1999, DEV BIOL, V206, P73, DOI 10.1006/dbio.1998.9130; Shibata N, 2016, DEV CELL, V37, P226, DOI 10.1016/j.devcel.2016.04.009; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Solana J, 2009, DEV BIOL, V328, P410, DOI 10.1016/j.ydbio.2009.01.043; Tan Y, 2015, ACTA BIOCH BIOPH SIN, V47, P315, DOI 10.1093/abbs/gmv018; Terada K, 2005, EMBO J, V24, P611, DOI 10.1038/sj.emboj.7600549; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; van Wolfswinkel JC, 2014, CELL STEM CELL, V15, P326, DOI 10.1016/j.stem.2014.06.007; Wagner DE, 2012, CELL STEM CELL, V10, P299, DOI 10.1016/j.stem.2012.01.016; Wang C, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.29; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Wang ZF, 2016, J BIOL CHEM, V291, P10646, DOI 10.1074/jbc.M116.723239; Watson ED, 2009, DEV DYNAM, V238, P2564, DOI 10.1002/dvdy.22088; Xiol J, 2012, MOL CELL, V47, P970, DOI 10.1016/j.molcel.2012.07.019; Zeng A, 2018, CELL, V173, P1593, DOI 10.1016/j.cell.2018.05.006; Zeng A, 2013, J CELL BIOL, V201, P409, DOI 10.1083/jcb.201207172	78	12	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9873	9887		10.1074/jbc.RA118.004445	http://dx.doi.org/10.1074/jbc.RA118.004445			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31076507	Green Published, hybrid			2022-12-28	WOS:000473277900019
J	Zhang, ZH; Li, MD				Zhang, Zhihui; Li, Min-Dian			Setting fire to fat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ADROPIN	Adropin is a liver-secreted peptide that is crucial for metabolic health. However, the molecular functions and clinical significance of adropin have not been adequately explored. Butler et al. now investigate adropin expression profiles and links to cardiometabolic disease risk in two nonhuman primate models, increasing our translational and mechanistic understanding of this fascinating hormone.	[Zhang, Zhihui] Army Med Univ, Mil Med Univ 3, Southwest Hosp, Dept Cardiol, Chongqing 400038, Peoples R China; [Li, Min-Dian] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, 677 Huntington Ave, Boston, MA 02115 USA	Army Medical University; Harvard University; Harvard T.H. Chan School of Public Health	Li, MD (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, 677 Huntington Ave, Boston, MA 02115 USA.	mindianli@hsph.harvard.edu	zhang, zh/GWV-4677-2022; Li, Min-Dian/F-1721-2015	Li, Min-Dian/0000-0002-3650-1507; Zhang, Zhihui/0000-0003-3111-2665	National Natural Science Foundation of China [81873663]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81873663. The authors declare that they have no conflicts of interest with the contents of this article.	Bremer AA, 2014, J NUTR, V144, P5, DOI 10.3945/jn.113.178061; Butler AA, 2019, J BIOL CHEM, V294, P9706, DOI 10.1074/jbc.RA119.007528; Charles KN, 2017, CELL REP, V21, P393, DOI 10.1016/j.celrep.2017.09.051; Gao S, 2015, MOL METAB, V4, P310, DOI 10.1016/j.molmet.2015.01.005; Gao S, 2014, DIABETES, V63, P3242, DOI 10.2337/db14-0388; Ghoshal S, 2018, MOL METAB, V8, P51, DOI 10.1016/j.molmet.2017.12.002; Hotamisligil GS, 2015, NAT REV ENDOCRINOL, V11, P592, DOI 10.1038/nrendo.2015.122; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Stein LM, 2016, AM J PHYSIOL-REG I, V310, pR476, DOI 10.1152/ajpregu.00511.2015	9	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9720	9721		10.1074/jbc.H119.009488	http://dx.doi.org/10.1074/jbc.H119.009488			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31227622	Green Published, hybrid			2022-12-28	WOS:000473277900007
J	Ray, S; Da Costa, R; Das, M; Nandi, D				Ray, Semanti; Da Costa, Rochelle; Das, Mrinmoy; Nandi, Dipankar			Interplay of cold shock protein E with an uncharacterized protein, YciF, lowers porin expression and enhances bile resistance in Salmonella Typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						permeability; Salmonella enterica; stress response; RNA-protein interaction; bile acid; cell stress; Cold shock protein; porins; RNA chaperone; YciF	ENTERICA SEROVAR TYPHIMURIUM; COMPLETE GENOME SEQUENCE; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; ACTIVE EFFLUX; RNA; GENES; CSPA; IDENTIFICATION	Bacterial cold shock proteins (CSPs) function as RNA chaperones. To assess CSP's roles in the intracellular human pathogen Salmonella Typhimurium, we analyzed their expression in varied stress conditions. We found that cold shock protein E (cspE or STM14_0732) is up-regulated during bile salt-induced stress and that an S. Typhimurium strain lacking cspE (cspE) displays dose-dependent sensitivity to bile salts, specifically to deoxycholate. We also found that an uncharacterized gene, yciF (STM14_2092), is up-regulated in response to bile stress in WT but not in the cspE strain. Complementation with WT CspE, but not with a F30V CspE variant, abrogated the bile sensitivity of cspE as did multicopy overexpression of yciF. Northern blotting experiments with rifampicin disclosed that the regulation of yciF expression is, most likely, due to the RNA-stabilizing activity of CspE. Importantly, electrophoretic mobility shift assays indicated that purified CspE, but not the F30V variant, directly binds yciF mRNA. We also observed that the extra-cytoplasmic stress-response (ESR) pathway is augmented in the bile-treated cspE strain, as judged by induction of RpoE regulon genes (rpoE, degP, and rybB) and downstream ESR genes (hfq, rne, and PNPase). Moreover, the transcript levels of the porin genes, ompD, ompF, and ompC, were higher in bile salts-stressed cspE and correlated with higher intracellular accumulation of the fluorescent DNA stain bisBenzimide H 33258, indicating greater cell permeability. In conclusion, our study has identified YciF, a CspE target involved in the regulation of porins and in countering bile stress in S. Typhimurium.	[Ray, Semanti; Da Costa, Rochelle; Das, Mrinmoy; Nandi, Dipankar] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Nandi, Dipankar] Indian Inst Sci, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Nandi, D (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.; Nandi, D (corresponding author), Indian Inst Sci, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	nandi@iisc.ac.in	Das, Mrinmoy/AAS-5750-2021; Nandi, Dipankar/O-1363-2019	Das, Mrinmoy/0000-0002-5785-5697; Nandi, Dipankar/0000-0002-5221-9712; Ray, Semanti/0000-0001-5321-1715	Council of Scientific and Industrial Research (CSIR) [37(1670) 16/EMR-II]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Grant 37(1670) 16/EMR-II from the Council of Scientific and Industrial Research (CSIR) (to D. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bhosale M, 2010, BIOCHEM BIOPH RES CO, V395, P76, DOI 10.1016/j.bbrc.2010.03.142; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Coldham NG, 2010, J ANTIMICROB CHEMOTH, V65, P1655, DOI 10.1093/jac/dkq169; Craig JE, 1998, MICROBIOL-UK, V144, P697, DOI 10.1099/00221287-144-3-697; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ermolenko DN, 2002, CELL MOL LIFE SCI, V59, P1902, DOI 10.1007/PL00012513; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Feng Y, 2001, J BIOL CHEM, V276, P31651, DOI 10.1074/jbc.M102855200; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Gonzalez-Escobedo G, 2013, INFECT IMMUN, V81, P2920, DOI 10.1128/IAI.00258-13; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graumann P, 1997, MOL GEN GENET, V253, P745, DOI 10.1007/s004380050379; Graumann P, 1996, ARCH MICROBIOL, V166, P293, DOI 10.1007/s002030050386; Graumann Peter L., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P203; Hanna MM, 1998, J MOL BIOL, V282, P227, DOI 10.1006/jmbi.1998.2005; Hay AJ, 2016, ADV APPL MICROBIOL, V96, P43, DOI 10.1016/bs.aambs.2016.07.019; Hindupur A, 2006, PROTEIN SCI, V15, P2605, DOI 10.1110/ps.062307706; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Horton AJ, 2000, ANTON LEEUW INT J G, V77, P13, DOI 10.1023/A:1002055719798; Hu KH, 1996, GENETICS, V143, P1521; Ibanez-Ruiz M, 2000, J BACTERIOL, V182, P5749, DOI 10.1128/JB.182.20.5749-5756.2000; Jeffreys AG, 1998, CURR MICROBIOL, V36, P29, DOI 10.1007/s002849900275; Jiang WN, 1997, J BIOL CHEM, V272, P196; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim BH, 2001, J BACTERIOL, V183, P5580, DOI 10.1128/JB.183.19.5580-5588.2001; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Leiser OP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033979; Lopez MM, 2000, BBA-PROTEIN STRUCT M, V1479, P196, DOI 10.1016/S0167-4838(00)00048-0; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; Michaux C, 2017, P NATL ACAD SCI USA, V114, P6824, DOI 10.1073/pnas.1620772114; Michaux C, 2012, J BACTERIOL, V194, P6900, DOI 10.1128/JB.01673-12; Morgan HP, 2009, ACTA CRYSTALLOGR F, V65, P1240, DOI 10.1107/S1744309109033788; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oussenko IA, 2005, J BACTERIOL, V187, P2758, DOI 10.1128/JB.187.8.2758-2767.2005; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Phadtare S, 2001, J BACTERIOL, V183, P1205, DOI 10.1128/JB.183.4.1205-1214.2001; Phadtare S, 2005, NUCLEIC ACIDS RES, V33, P5583, DOI 10.1093/nar/gki859; PICKEN RN, 1977, J GEN MICROBIOL, V102, P319, DOI 10.1099/00221287-102-2-319; Poppe C, 1998, CAN VET J, V39, P559; Prouty AM, 2004, FEMS IMMUNOL MED MIC, V41, P177, DOI 10.1016/j.femsim.2004.03.002; Prouty AM, 2004, MICROBIOL-SGM, V150, P775, DOI 10.1099/mic.0.26769-0; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; Ramos-Morales F, 2003, J BACTERIOL, V185, P5328, DOI 10.1128/JB.185.17.5328-5332.2003; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Robbe-Saule V, 2001, MOL MICROBIOL, V39, P1533, DOI 10.1046/j.1365-2958.2001.02340.x; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Santiviago CA, 2003, J BACTERIOL, V185, P5901, DOI 10.1128/JB.185.19.5901-5905.2003; Santiviago CA, 2002, MOL MICROBIOL, V46, P687, DOI 10.1046/j.1365-2958.2002.03204.x; Schaerer K, 2013, FOODBORNE PATHOG DIS, V10, P1023, DOI 10.1089/fpd.2013.1562; SCHRODER K, 1995, MOL MICROBIOL, V16, P699, DOI 10.1111/j.1365-2958.1995.tb02431.x; Shenhar Y, 2012, ENV MICROBIOL REP, V4, P532, DOI 10.1111/j.1758-2229.2012.00358.x; Shetty S, 2016, P NATL ACAD SCI USA, V113, pE6126, DOI 10.1073/pnas.1609550113; Skovierova H, 2006, MICROBIOL-SGM, V152, P1347, DOI 10.1099/mic.0.28744-0; Smirnov A, 2017, EMBO J, V36, P1029, DOI 10.15252/embj.201696127; Sulavik MC, 1997, J BACTERIOL, V179, P1857, DOI 10.1128/jb.179.6.1857-1866.1997; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tadesse DA, 2016, ANTIMICROB AGENTS CH, V60, P2567, DOI 10.1128/AAC.02536-15; Thakur M, 2016, BIOCHEMISTRY-US, V55, P5865, DOI 10.1021/acs.biochem.6b00558; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Uppal S, 2011, J BACTERIOL, V193, P6142, DOI 10.1128/JB.05728-11; Van Velkinburgh JC, 1999, INFECT IMMUN, V67, P1614; Villarreal JM, 2014, MOL MICROBIOL, V92, P1005, DOI 10.1111/mmi.12610; Vogel J, 2006, CURR OPIN MICROBIOL, V9, P605, DOI 10.1016/j.mib.2006.10.006; Yamanaka K, 1997, J BACTERIOL, V179, P5126, DOI 10.1128/jb.179.16.5126-5130.1997; YAMANAKA K, 1994, MOL MICROBIOL, V13, P301, DOI 10.1111/j.1365-2958.1994.tb00424.x	72	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9084	9099		10.1074/jbc.RA119.008209	http://dx.doi.org/10.1074/jbc.RA119.008209			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	30992363	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000471751600007
J	Huang, CQ; Xiao, X; Yang, Y; Mishra, A; Liang, YR; Zeng, XM; Yang, XY; Xu, D; Blackburn, MR; Henke, CA; Liu, L				Huang, Chaoqun; Xiao, Xiao; Yang, Ye; Mishra, Amorite; Liang, Yurong; Zeng, Xiangming; Yang, Xiaoyun; Xu, Dao; Blackburn, Michael R.; Henke, Craig A.; Liu, Lin			MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation (vol 292, pg 16420, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Liang, Yurong/DWV-1204-2022					Huang CQ, 2017, J BIOL CHEM, V292, P16420, DOI 10.1074/jbc.M117.805747	1	3	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6694	6694		10.1074/jbc.AAC119.008714	http://dx.doi.org/10.1074/jbc.AAC119.008714			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	31028163	Green Published, hybrid			2022-12-28	WOS:000467394700007
J	Tran, P; Wanrooij, PH; Lorenzon, P; Sharma, S; Thelander, L; Nilsson, AK; Olofsson, AK; Medini, P; von Hofsten, J; Stal, P; Chabes, A				Phong Tran; Wanrooij, Paulina H.; Lorenzon, Paolo; Sharma, Sushma; Thelander, Lars; Nilsson, Anna Karin; Olofsson, Anna-Karin; Medini, Paolo; von Hofsten, Jonas; Stal, Per; Chabes, Andrei			De novo dNTP production is essential for normal postnatal murine heart development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleoside; nucleotide biosynthesis; nucleoside; nucleotide metabolism; ribonucleotide reductase (RNR); heart development; cardiac muscle; cardiac function; deoxyribonucleoside kinases; desmin; dNTP metabolism; dNTP salvage; cardiomyocyte; dystrophin; laminin	RIBONUCLEOTIDE REDUCTASE; DNA-DAMAGE; REPLICATION; MOUSE; MUTAGENESIS; EXPRESSION; DEOXYRIBONUCLEOTIDE; MECHANISMS; SAMHD1; POOLS	The building blocks of DNA, dNTPs, can be produced de novo or can be salvaged from deoxyribonucleosides. However, to what extent the absence of de novo dNTP production can be compensated for by the salvage pathway is unknown. Here, we eliminated de novo dNTP synthesis in the mouse heart and skeletal muscle by inactivating ribonucleotide reductase (RNR), a key enzyme for the de novo production of dNTPs, at embryonic day 13. All other tissues had normal de novo dNTP synthesis and theoretically could supply heart and skeletal muscle with deoxyribonucleosides needed for dNTP production by salvage. We observed that the dNTP and NTP pools in WT postnatal hearts are unexpectedly asymmetric, with unusually high dGTP and GTP levels compared with those in whole mouse embryos or murine cell cultures. We found that RNR inactivation in heart led to strongly decreased dGTP and increased dCTP, dTTP, and dATP pools; aberrant DNA replication; defective expression of muscle-specific proteins; progressive heart abnormalities; disturbance of the cardiac conduction system; and lethality between the second and fourth weeks after birth. We conclude that dNTP salvage cannot substitute for de novo dNTP synthesis in the heart and that cardiomyocytes and myocytes initiate DNA replication despite an inadequate dNTP supply. We discuss the possible reasons for the observed asymmetry in dNTP and NTP pools in WT hearts.	[Phong Tran; Wanrooij, Paulina H.; Sharma, Sushma; Thelander, Lars; Nilsson, Anna Karin; Chabes, Andrei] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Lorenzon, Paolo; Olofsson, Anna-Karin; Medini, Paolo; von Hofsten, Jonas; Stal, Per] Umea Univ, Dept Integrat Med Biol IMB, S-90187 Umea, Sweden; [von Hofsten, Jonas] Umea Univ, UCMM, S-90187 Umea, Sweden; [Chabes, Andrei] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Chabes, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.; Chabes, A (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.	andrei.chabes@umu.se	Medini, Paolo/GWC-1936-2022; Medini, Paolo/R-7504-2018; Wanrooij, Paulina/R-1509-2019	Wanrooij, Paulina/0000-0002-8607-7564; Chabes, Andrei/0000-0003-1708-8259; von Hofsten, Jonas/0000-0003-3730-1790; Sharma, Sushma/0000-0003-2713-5813; Stal, Per/0000-0002-9340-5298	Swedish Cancer Society; Swedish Research Council; Swedish Society for Medical Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research	This work was supported by grants from the Swedish Cancer Society and the Swedish Research Council (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by grants from the Swedish Cancer Society and the Swedish Society for Medical Research.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alkass K, 2015, CELL, V163, P1026, DOI 10.1016/j.cell.2015.10.035; Alvino GM, 2007, MOL CELL BIOL, V27, P6396, DOI 10.1128/MCB.00719-07; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Cheddad A, 2012, IEEE T MED IMAGING, V31, P1, DOI 10.1109/TMI.2011.2161590; Chimploy K, 2013, J BIOL CHEM, V288, P13145, DOI 10.1074/jbc.M113.461111; Coquel F, 2019, CURR OPIN IMMUNOL, V56, P24, DOI 10.1016/j.coi.2018.09.017; Eriksson AU, 2013, JOVE-J VIS EXP, DOI 10.3791/50238; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Fu Y, 2018, NAT CHEM BIOL, V14, P943, DOI 10.1038/s41589-018-0113-5; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jia S, 2015, PROCEEDINGS OF THE 18TH ASIA PACIFIC SYMPOSIUM ON INTELLIGENT AND EVOLUTIONARY SYSTEMS, VOL 2, P117, DOI 10.1007/978-3-319-13356-0_10; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Kong ZQ, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky203; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Lindstrom M, 2009, HISTOCHEM CELL BIOL, V132, P141, DOI 10.1007/s00418-009-0606-0; Lmoto Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07009-z; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Mathews CK, 2015, NAT REV CANCER, V15, P528, DOI 10.1038/nrc3981; Noma T, 2001, BIOCHEM J, V358, P225, DOI 10.1042/0264-6021:3580225; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rentoft M, 2016, P NATL ACAD SCI USA, V113, P4723, DOI 10.1073/pnas.1519128113; Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029; Sambrook J., 2001, MOL CLONING LAB MANU; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Watt DL, 2016, NUCLEIC ACIDS RES, V44, P1669, DOI 10.1093/nar/gkv1298; Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968	34	9	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					15889	15897		10.1074/jbc.RA119.009492	http://dx.doi.org/10.1074/jbc.RA119.009492			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31300555	Green Published, hybrid			2022-12-28	WOS:000499478600002
J	Khan, Z; Terrien, E; Delhommel, F; Lefebvre-Omar, C; Bohl, D; Vitry, S; Bernard, C; Ramirez, J; Chaffotte, A; Ricquier, K; Vincentelli, R; Buc, H; Prehaud, C; Wolff, N; Lafon, M				Khan, Zakir; Terrien, Elouan; Delhommel, Florent; Lefebvre-Omar, Cynthia; Bohl, Delphine; Vitry, Sandrine; Bernard, Clara; Ramirez, Juan; Chaffotte, Alain; Ricquier, Kevin; Vincentelli, Renaud; Buc, Henri; Prehaud, Christophe; Wolff, Nicolas; Lafon, Monique			Structure-based optimization of a PDZ-binding motif within a viral peptide stimulates neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serine; threonine protein kinase; PDZ domain; neurite outgrowth; protein-protein interaction; viral protein; interfering peptide; neurodegenerative diseases; nuclear magnetic resonance; structure-function analysis; therapeutic drug candidate	SINGLE-DOMAIN ANTIBODIES; CELL-SURVIVAL; PTEN DELETION; EXCITOTOXICITY; GLYCOPROTEIN; SPECIFICITY; INHIBITION; SELECTION; TARGETS; STROKE	Protection of neuronal homeostasis is a major goal in the management of neurodegenerative diseases. Microtubule-associated Ser/Thr kinase 2 (MAST2) inhibits neurite outgrowth, and its inhibition therefore represents a potential therapeutic strategy. We previously reported that a viral protein (G-protein from rabies virus) capable of interfering with protein-protein interactions between the PDZ domain of MAST2 and the C-terminal moieties of its cellular partners counteracts MAST2-mediated suppression of neurite outgrowth. Here, we designed peptides derived from the native viral protein to increase the affinity of these peptides for the MAST2-PDZ domain. Our strategy involved modifying the length and flexibility of the noninteracting sequence linking the two subsites anchoring the peptide to the PDZ domain. Three peptides, Neurovita1 (NV1), NV2, and NV3, were selected, and we found that they all had increased affinities for the MAST2-PDZ domain, with K-d values decreasing from 1300 to 60 nm, while target selectivity was maintained. A parallel biological assay evaluating neurite extension and branching in cell cultures revealed that the NV peptides gradually improved neural activity, with the efficacies of these peptides for stimulating neurite outgrowth mirroring their affinities for MAST2-PDZ. We also show that NVs can be delivered into the cytoplasm of neurons as a gene or peptide. In summary, our findings indicate that virus-derived peptides targeted to MAST2-PDZ stimulate neurite outgrowth in several neuron types, opening up promising avenues for potentially using NVs in the management of neurodegenerative diseases.	[Khan, Zakir; Vitry, Sandrine; Bernard, Clara; Prehaud, Christophe; Lafon, Monique] CNRS, UMR 3569, Inst Pasteur, Unite Neuroimmunol Virale, F-75015 Paris, France; [Terrien, Elouan; Delhommel, Florent; Ramirez, Juan; Chaffotte, Alain; Ricquier, Kevin; Wolff, Nicolas] CNRS, UMR 3528, Inst Pasteur, Unite RMN Biomol, F-75015 Paris, France; [Lefebvre-Omar, Cynthia; Bohl, Delphine] Sorbonne Univ, CNRS, UMR 7225, Inst Cerveau & Moelle Epiniere ICM,INSERM,U1127, F-75013 Paris, France; [Vincentelli, Renaud] Aix Marseille Univ, CNRS, UMR 7257, AFMB, F-13009 Marseille, France; [Buc, Henri] Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris 15, France; [Khan, Zakir] Cedars Sinai Med Ctr, Dept Biomed Sci, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Wolff, Nicolas] CNRS, UMR 3571, Inst Pasteur, Unite Recepteurs Canaux, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Cedars Sinai Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lafon, M (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris 15, France.	monique.lafon@pasteur.fr	Delhommel, Florent/HCH-2439-2022	Delhommel, Florent/0000-0001-7021-087X; Vitry, Sandrine/0000-0003-4693-7694; Bohl, Delphine/0000-0001-8262-5642	ANR (Agence Nationale de la Recherche) [BSV8-0008-01 MAST-2-PTEN]; AFM (Association Francaise Contre les Myopathies) "Characterization of Pathological Defects in Motor Neurons Derived from Patients, Amyotrophic Lateral Sclerosis (ALS)"; Grand Prix de l'Academie des Sciences/Fondation Generale de Sante; Institut Carnot-Pasteur Maladies Infectieuses "Unraveling the Neuroprotective Functions and Optimization of New Neuroprotective Compound"; Investissements d'Avenir [ANR-10-IAIHU-06, ANR-11-INBS-0011]; Ministere de l'Enseignement Superieur et de la Recherche; Revive [ANR-10-LABX-73]	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); AFM (Association Francaise Contre les Myopathies) "Characterization of Pathological Defects in Motor Neurons Derived from Patients, Amyotrophic Lateral Sclerosis (ALS)"; Grand Prix de l'Academie des Sciences/Fondation Generale de Sante; Institut Carnot-Pasteur Maladies Infectieuses "Unraveling the Neuroprotective Functions and Optimization of New Neuroprotective Compound"; Investissements d'Avenir(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); Revive	This work was supported by ANR (Agence Nationale de la Recherche) Grant BSV8-0008-01 MAST-2-PTEN; AFM (Association Francaise Contre les Myopathies) "Characterization of Pathological Defects in Motor Neurons Derived from Patients, Amyotrophic Lateral Sclerosis (ALS)"; Grand Prix de l'Academie des Sciences/Fondation Generale de Sante; and Incentive Grant from Institut Carnot-Pasteur Maladies Infectieuses "Unraveling the Neuroprotective Functions and Optimization of New Neuroprotective Compound"; and the research leading to the results on IPSC was recipient of funding from the programs Investissements d'Avenir ANR-10-IAIHU-06 and ANR-11-INBS-0011-NeurATRIS: " Translational Research Infrastructure for Biotherapies in Neurosciences." Z. K., M. L., C. P., E. T., S. V., and N. W. are co-inventors of the two following patents: PCT/EP2012/072073, WO2013068430, European Patent 11 306 454.7; C. P. and M. L. are co-inventors of Institut Pasteur Patent PCT/EP2015/070669, EP14306388.1.; Recipients of Ph.D. fellowships from the Ministere de l'Enseignement Superieur et de la Recherche.; Supported by Ph.D. Fellowship ANR-10-LABX-73 from Revive.	Bach A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12157; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chopy D, 2011, J NEUROVIROL, V17, P353, DOI 10.1007/s13365-011-0041-6; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; da Costa A, 2019, JOVE-J VIS EXP, DOI 10.3791/59220; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Delhommel F, 2015, BIOCHEM J, V469, P159, DOI 10.1042/BJ20141198; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Fujii N, 2003, J AM CHEM SOC, V125, P12074, DOI 10.1021/ja035540l; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Karlsson OA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34269; Khan Z, 2014, CURR MED CHEM, V21, P2632, DOI 10.2174/0929867321666140303145312; Knafo S, 2017, TRENDS NEUROSCI, V40, P83, DOI 10.1016/j.tins.2016.11.008; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Lafon M, 2011, ADV VIRUS RES, V79, P33, DOI 10.1016/B978-0-12-387040-7.00003-2; Li TF, 2017, IMMUNOL LETT, V188, P89, DOI 10.1016/j.imlet.2017.07.001; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mo SF, 2016, BRAIN RES, V1648, P250, DOI 10.1016/j.brainres.2016.07.012; Nissen KB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117668; Prehaud C, 2003, J VIROL, V77, P10537, DOI 10.1128/JVI.77.19.10537-10547.2003; Prehaud C, 2010, Patent, Patent No. [WO/2010/116258, 2010116258]; Prehaud C., 2015, [U. S. Patent, September 9 2015], Patent No. [WO/2016/038122, 2016038122]; Prehaud C, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000510; Radio NM, 2008, TOXICOL SCI, V105, P106, DOI 10.1093/toxsci/kfn114; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seo W, 2017, MICROBES INFECT, V19, P476, DOI 10.1016/j.micinf.2017.05.006; SHOLL DA, 1953, J ANAT, V87, P387; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Terrien E., 2012, THESIS; Terrien E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002941; Terrien E, 2009, BIOMOL NMR ASSIGN, V3, P45, DOI 10.1007/s12104-008-9138-0; Thomas M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005766; Toli D, 2015, NEUROBIOL DIS, V82, P269, DOI 10.1016/j.nbd.2015.06.011; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Vincentelli R, 2015, NAT METHODS, V12, P787, DOI [10.1038/nmeth.3438, 10.1038/NMETH.3438]; Vitry S, 2009, MOL CELL NEUROSCI, V41, P8, DOI 10.1016/j.mcn.2009.01.001; Wu QJ, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0357-8; Wyatt LA, 2014, J COMP NEUROL, V522, P2741, DOI 10.1002/cne.23580; Yeyeodu S, 2011, CELL MOL NEUROBIOL, V31, P145, DOI 10.1007/s10571-010-9563-3; Zhang XC, 2012, BIOCHEM J, V444, P457, DOI 10.1042/BJ20120098; Zhang YJ, 2012, BRAIN, V135, P2736, DOI 10.1093/brain/aws196; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	59	8	8	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13755	13768		10.1074/jbc.RA119.008238	http://dx.doi.org/10.1074/jbc.RA119.008238			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31346033	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000486418600020
J	McGuire, CM; Collins, MP; Sun-Wada, G; Wade, Y; Forgac, M				McGuire, Christina M.; Collins, Michael P.; Sun-Wada, GeHong; Wade, Yoh; Forgac, Michael			Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; breast cancer; cell invasion; cell migration; plasma membrane; proton pump; metastasis; a-subunit isoforms; protein trafficking	VACUOLAR H+-ATPASE; AMINO-TERMINAL DOMAIN; CATHEPSIN-B; PLASMA-MEMBRANE; A3 ISOFORM; PROTON TRANSPORT; TUMOR-METASTASIS; EXPRESSION; PH; INVASION	The vacuolar H+-ATPase (V-ATPase) is an ATP-driven proton pump present in various intracellular membranes and at the plasma membrane of specialized cell types. Previous work has reported that plasma membrane V-ATPases are key players in breast cancer cell invasiveness. The two subunit a-isoforms known to target the V-ATPase to the plasma membrane are a3 and a4, and expression of a3 has been shown to correlate with plasma membrane localization of the V-ATPase in various invasive human breast cancer cell lines. Here we analyzed the role of subunit a-isoforms in the invasive mouse breast cancer cell line, 4T1-12B. Quantitation of mRNA levels for each isoform by quantitative RT-PCR revealed that a4 is the dominant isoform expressed in these cells. Using a CRISPR/Cas9-based approach to disrupt the genes encoding each of the four V-ATPase subunit a-isoforms, we found that ablation of only the a4-encoding gene significantly inhibits invasion and migration of 4T1-12B cells. Additionally, cells with disrupted a4 exhibited reduced V-ATPase expression at the leading edge, suggesting that the a4 isoform is primarily responsible for targeting the V-ATPase to the plasma membrane in 4T1-12B cells. These findings suggest that different subunit a-isoforms may direct V-ATPases to the plasma membrane of different invasive breast cancer cell lines. They further suggest that expression of V-ATPases at the cell surface is the primary factor that promotes an invasive cancer cell phenotype.	[McGuire, Christina M.; Collins, Michael P.; Forgac, Michael] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [McGuire, Christina M.; Forgac, Michael] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Biochem, Boston, MA 02111 USA; [Collins, Michael P.; Forgac, Michael] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA; [Sun-Wada, GeHong] Doshisha Womens Coll, Fac Pharmaceut Sci, Dept Biochem, Kyotanabe, Kyoto 6100395, Japan; [Wade, Yoh] Osaka Univ, Inst Sci & Ind Res, Div Biol Sci, Ibaraki, Osaka 5670047, Japan	Tufts University; Tufts University; Tufts University; Osaka University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	michael.forgac@tufts.edu		Collins, Michael/0000-0002-1806-6775	National Institutes of Health [R01 GM34478]; Breast Cancer Alliance; Tufts University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Alliance; Tufts University	This work was supported by National Institutes of Health Grant R01 GM34478 (to M. F.) and an Exceptional Project Award from the Breast Cancer Alliance (to M. F.) as well as the Sackler Families Collaborative Cancer Biology Award from Tufts University (to M. P. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Avnet S, 2013, BBA-MOL BASIS DIS, V1832, P1105, DOI 10.1016/j.bbadis.2013.04.003; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Capecci J, 2013, J BIOL CHEM, V288, P32731, DOI 10.1074/jbc.M113.503771; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; Cotter K, 2016, ONCOTARGET, V7, P46142, DOI 10.18632/oncotarget.10063; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Cotter K, 2015, J BIOL CHEM, V290, P3680, DOI 10.1074/jbc.M114.611210; Day CP, 2015, CELL, V163, P39, DOI 10.1016/j.cell.2015.08.068; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Feng SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084833; Feng SM, 2013, INT J BIOL SCI, V9, P853, DOI 10.7150/ijbs.6030; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Garcia-Garcia A, 2012, BIOTECH HISTOCHEM, V87, P133, DOI 10.3109/10520295.2011.574647; Gleize V, 2012, GLIA, V60, P1004, DOI 10.1002/glia.22332; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gondi CS, 2013, EXPERT OPIN THER TAR, V17, P281, DOI 10.1517/14728222.2013.740461; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hendrix A, 2013, INT J CANCER, V133, P843, DOI 10.1002/ijc.28079; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Kane PM, 2016, ADV EXP MED BIOL, V892, P33, DOI 10.1007/978-3-319-25304-6_3; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kulshrestha A, 2015, ONCOTARGET, V6, P3797, DOI 10.18632/oncotarget.2902; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liu PF, 2015, INT J CLIN ONCOL, V20, P725, DOI 10.1007/s10147-015-0782-y; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu XD, 2015, EXP THER MED, V10, P1829, DOI 10.3892/etm.2015.2758; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Marjuki H, 2011, CELL MICROBIOL, V13, P587, DOI 10.1111/j.1462-5822.2010.01556.x; Matsumoto N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24918-7; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; MILLER FR, 1983, INVAS METAST, V3, P22; MILLER FR, 1983, INVAS METAST, V3, P234; Nalla AK, 2010, CANCER GENE THER, V17, P599, DOI 10.1038/cgt.2010.16; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Ohta T, 1996, BRIT J CANCER, V73, P1511, DOI 10.1038/bjc.1996.285; Otero-Rey EM, 2008, ORAL ONCOL, V44, P193, DOI 10.1016/j.oraloncology.2007.02.011; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Perez-Sayans M, 2010, CANCER BIOL THER, V9, P1057, DOI 10.4161/cbt.9.12.11880; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Pulaski BA, 1998, CANCER RES, V58, P1486; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rojas JD, 2006, AM J PHYSIOL-HEART C, V291, pH1147, DOI 10.1152/ajpheart.00166.2006; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Schempp CM, 2014, MOL CANCER THER, V13, P926, DOI 10.1158/1535-7163.MCT-13-0484; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Soliman M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006820; Stransky L, 2016, PHYSIOL REV, V96, P1071, DOI 10.1152/physrev.00035.2015; Sun-Wada GH, 2013, HISTOL HISTOPATHOL, V28, P805, DOI 10.14670/HH-28.805; Sun-Wada GH, 2011, HYBRIDOMA, V30, P199, DOI 10.1089/hyb.2010.0087; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wiedmann RM, 2012, CANCER RES, V72, P5976, DOI 10.1158/0008-5472.CAN-12-1772; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Xu JY, 2012, CARCINOGENESIS, V33, P2432, DOI 10.1093/carcin/bgs277; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoneda Toshiyuki, 2000, Cancer, V88, P2979, DOI 10.1002/1097-0142(20000615)88:12+<2979::AID-CNCR13>3.0.CO;2-U; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zhang SW, 2015, ONCOTARGET, V6, P43508, DOI 10.18632/oncotarget.6180; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zuo J, 2008, J EXP BIOL, V211, P1102, DOI 10.1242/jeb.013672	76	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11248	11258		10.1074/jbc.RA119.007713	http://dx.doi.org/10.1074/jbc.RA119.007713			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167791	Green Published, hybrid			2022-12-28	WOS:000478717400016
J	Wang, LW; Nandadasa, S; Annis, DS; Dubail, J; Mosher, DF; Willard, BB; Apte, SS				Wang, Lauren W.; Nandadasa, Sumeda; Annis, Douglas S.; Dubail, Joanne; Mosher, Deane F.; Willard, Belinda B.; Apte, Suneel S.			A disintegrin-like and metalloproteinase domain with thrombospondin type 1 motif 9 (ADAMTS9) regulates fibronectin fibrillogenesis and turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; fibronectin; metalloprotease; proteolysis; ADAMTS; fibril; mass spectrometry (MS); primary cilium; ADAM metallopeptidase with thrombospondin type 1 motif (ADAMTS); ECM; fibrillogenesis; proteolytic enzyme	EXTRACELLULAR-MATRIX; PROTEINS; VERSICAN; DEFECTS; LOCI; METAANALYSIS; FIBRILLIN-2; SECRETION; PROTEASES; INSIGHTS	The secreted metalloprotease ADAMTS9 has dual roles in extracellular matrix (ECM) turnover and biogenesis of the primary cilium during mouse embryogenesis. Its gene locus is associated with several human traits and disorders, but ADAMTS9 has few known interacting partners or confirmed substrates. Here, using a yeast two-hybrid screen for proteins interacting with its C-terminal Gon1 domain, we identified three putative ADAMTS9-binding regions in the ECM glycoprotein fibronectin. Using solid-phase binding assays and surface plasmon resonance experiments with purified proteins, we demonstrate that ADAMTS9 and fibronectin interact. ADAMTS9 constructs, including those lacking Gon1, co-localized with fibronectin fibrils formed by cultured fibroblasts lacking fibrillin-1, which co-localizes with fibronectin and binds several ADAMTSs. We observed no fibrillar ADAMTS9 staining after blockade of fibroblast fibronectin fibrillogenesis with a peptide based on the functional upstream domain of a Staphylococcus aureus adhesin. These findings indicate that ADAMTS9 binds fibronectin dimers and fibrils directly through multiple sites in both molecules. Proteolytically active ADAMTS9, but not a catalytically inactive variant, disrupted fibronectin fibril networks formed by fibroblasts in vitro, and ADAMTS9-deficient RPE1 cells assembled a robust fibronectin fibril network, unlike WT cells. Targeted LC-MS analysis of fibronectin digested by ADAMTS9-expressing cells identified a semitryptic peptide arising from cleavage at Gly(2196)-Leu(2197). We noted that this scissile bond is in the linker between fibronectin modules III17 and I10, a region targeted also by other proteases. These findings, along with stronger fibronectin staining previously observed in Adamts9 mutant embryos, suggest that ADAMTS9 contributes to fibronectin turnover during ECM remodeling.	[Wang, Lauren W.; Nandadasa, Sumeda; Dubail, Joanne; Apte, Suneel S.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Willard, Belinda B.] Cleveland Clin, Lerner Res Inst, Prote & Metabol Core, Cleveland, OH 44195 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Dubail, Joanne] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Hop Necker Enfants Malad,AP HP,INSERM,UMR 1163, F-75015 Paris, France	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Apte, SS (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@ccf.org	Dubail, Johanne/AAB-1980-2021	Dubail, Johanne/0000-0001-9124-9765; Nandadasa, Sumeda/0000-0002-4954-6376; Apte, Suneel/0000-0001-8441-1226	Allen Distinguished Investigator Program through Paul G. Allen Frontiers Group; American Heart Association [17 DIA33820024]; National Institutes of Health [EY024943]; Mark Lauer Pediatric Research Grant; NATIONAL EYE INSTITUTE [R01EY024943] Funding Source: NIH RePORTER	Allen Distinguished Investigator Program through Paul G. Allen Frontiers Group; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mark Lauer Pediatric Research Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Allen Distinguished Investigator Program through support made by the Paul G. Allen Frontiers Group, American Heart Association Grant 17 DIA33820024 (to S.S.A.), National Institutes of Health Grant EY024943 (to S.S.A.), and a Mark Lauer Pediatric Research Grant (to S.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apte S.S., 2016, ENCY CELL BIOL, V1, P630, DOI [10.1016/b978-0-12-394447-4.10074-4, DOI 10.1016/B978-0-12-394447-4.10074-4]; Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511; Bader HL, 2012, MATRIX BIOL, V31, P398, DOI 10.1016/j.matbio.2012.09.003; Beene LC, 2013, INVEST OPHTH VIS SCI, V54, P8337, DOI 10.1167/iovs.13-13121; Bekhouche M, 2016, FASEB J, V30, P1741, DOI 10.1096/fj.15-279869; Benz BA, 2016, DEV BIOL, V416, P111, DOI 10.1016/j.ydbio.2016.05.038; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; Boesgaard TW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007236; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Choi YJ, 2019, AM J HUM GENET, V104, P45, DOI 10.1016/j.ajhg.2018.11.003; Colige A, 2019, J BIOL CHEM, V294, P8037, DOI 10.1074/jbc.RA119.007492; Doucet A, 2011, METHOD ENZYMOL, V501, P275, DOI 10.1016/B978-0-12-385950-1.00013-4; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Du W, 2013, ONCOGENE, V32, P3319, DOI 10.1038/onc.2012.359; Dubail J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33974; Dubail J, 2015, MATRIX BIOL, V44-46, P24, DOI 10.1016/j.matbio.2015.03.001; Dubail J, 2014, GENESIS, V52, P702, DOI 10.1002/dvg.22784; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Helisalmi S, 2014, ACTA OPHTHALMOL, V92, pE410, DOI 10.1111/aos.12341; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Hubmacher D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41871; Hubmacher D, 2015, MATRIX BIOL, V47, P34, DOI 10.1016/j.matbio.2015.05.004; Hubmacher D, 2015, DIS MODEL MECH, V8, P487, DOI 10.1242/dmm.017046; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Ismat A, 2013, DEVELOPMENT, V140, P1981, DOI 10.1242/dev.087908; Jungers KA, 2005, GENE EXPR PATTERNS, V5, P609, DOI 10.1016/j.modgep.2005.03.004; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Koo BH, 2007, J BIOL CHEM, V282, P16146, DOI 10.1074/jbc.M610161200; Koo BH, 2010, AM J PATHOL, V176, P1494, DOI 10.2353/ajpath.2010.090655; Koo BH, 2010, J BIOL CHEM, V285, P197, DOI 10.1074/jbc.M109.039677; Lo PHY, 2010, CANCER RES, V70, P5567, DOI 10.1158/0008-5472.CAN-09-4510; Maurer LM, 2016, CRIT REV BIOCHEM MOL, V51, P213, DOI 10.1080/10409238.2016.1184224; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; Mead TJ, 2018, CELL REP, V23, P485, DOI 10.1016/j.celrep.2018.03.034; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Nandadasa S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08520-7; Nandadasa S, 2015, CELL REP, V11, P1519, DOI 10.1016/j.celrep.2015.05.005; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Sabatier L, 2013, BIOCHEM J, V456, P283, DOI 10.1042/BJ20130699; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Schnellmann R, 2018, MOL CELL PROTEOMICS, V17, P1410, DOI 10.1074/mcp.RA118.000676; Shi F, 2011, J CELL SCI, V124, P4039, DOI 10.1242/jcs.087858; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Stanton H, 2011, BBA-MOL BASIS DIS, V1812, P1616, DOI 10.1016/j.bbadis.2011.08.009; Taylor SH, 2015, ELIFE, V4, DOI 10.7554/eLife.09345; Tharmarajah G, 2018, PIGM CELL MELANOMA R, V31, P693, DOI 10.1111/pcmr.12711; Willard BB, 2003, ANAL CHEM, V75, P2370, DOI 10.1021/ac034033j; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	61	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2019	294	25					9924	9936		10.1074/jbc.RA118.006479	http://dx.doi.org/10.1074/jbc.RA118.006479			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IF7QD	31085586	Green Published, hybrid			2022-12-28	WOS:000473277900023
J	Crummy, E; Mani, M; Thellman, JC; Martin, TFJ				Crummy, Ellen; Mani, Muralidharan; Thellman, John C.; Martin, Thomas F. J.			The priming factor CAPS1 regulates dense-core vesicle acidification by interacting with rabconnectin3/WDR7 in neuroendocrine cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; cellular regulation; intracellular trafficking; organellar pH homeostasis; H+-ATPase; CAPS; dense-core vesicle; exocytosis; rabconnectin3; WDR7	CA2+-DEPENDENT ACTIVATOR PROTEIN; VACUOLAR H+-ATPASE; GDP/GTP EXCHANGE PROTEIN; V-ATPASE; SECRETION; PH; EXOCYTOSIS; ISOFORM; RELEASE; TRAFFICKING	Vacuolar-type H+-ATPases (V-ATPases) contribute to pH regulation and play key roles in secretory and endocytic pathways. Dense-core vesicles (DCVs) in neuroendocrine cells are maintained at an acidic pH, which is part of the electrochemical driving force for neurotransmitter loading and is required for hormonal propeptide processing. Genetic loss of CAPS1 (aka calcium-dependent activator protein for secretion, CADPS), a vesicle-bound priming factor required for DCV exocytosis, dissipates the pH gradient across DCV membranes and reduces neurotransmitter loading. However, the basis for CAPS1 binding to DCVs and for its regulation of vesicle pH has not been determined. Here, MS analysis of CAPS1 immunoprecipitates from brain membrane fractions revealed that CAPS1 associates with a rabconnectin3 (Rbcn3) complex comprising Dmx-like 2 (DMXL2) and WD repeat domain 7 (WDR7) proteins. Using immunofluorescence microscopy, we found that Rbcn3/DMXL2 and Rbcn3/WDR7 colocalize with CAPS1 on DCVs in human neuroendocrine (BON) cells. The shRNA-mediated knockdown of Rbcn3/WDR7 redistributed CAPS1 from DCVs to the cytosol, indicating that Rbcn3/WDR7 is essential for optimal DCV localization of CAPS1. Moreover, cell-free experiments revealed direct binding of CAPS1 to Rbcn3/WDR7, and cell assays indicated that Rbcn3/WDR7 recruits soluble CAPS1 to membranes. As anticipated by the reported association of Rbcn3 with V-ATPase, we found that knocking down CAPS1, Rbcn3, or Rbcn3 in neuroendocrine cells impaired rates of DCV reacidification. These findings reveal a basis for CAPS1 binding to DCVs and for CAPS1 regulation of V-ATPase activity via Rbcn3/WDR7 interactions.	[Crummy, Ellen; Mani, Muralidharan; Thellman, John C.; Martin, Thomas F. J.] Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	tfmartin@wisc.edu	Martin, Thomas F/A-6962-2009	Martin, Thomas F/0000-0002-5204-0202; Mani, Muralidharan/0000-0002-1194-3616	United States Public Health Service, NIGMS, National Institutes of Health [GM119158]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119158] Funding Source: NIH RePORTER	United States Public Health Service, NIGMS, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Service, NIGMS, National Institutes of Health Grant GM119158 (to T. F. J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; Bodzeta A, 2017, CELL REP, V20, P1348, DOI 10.1016/j.celrep.2017.07.040; Brunk I, 2009, J BIOL CHEM, V284, P1050, DOI 10.1074/jbc.M805328200; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; Eckenstaler R, 2016, J CELL SCI, V129, P1378, DOI 10.1242/jcs.178251; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Einhorn Z, 2012, J NEUROSCI, V32, P11144, DOI 10.1523/JNEUROSCI.1705-12.2012; Farina M, 2015, ELIFE, V4, DOI [10.7554/eLife.05438, 10.7554/eLife.12968]; Fujita Y, 2007, J BIOL CHEM, V282, P21392, DOI 10.1074/jbc.M703699200; GRAY EG, 1962, J ANAT, V96, P79; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; Hummer BH, 2017, MOL BIOL CELL, V28, P3870, DOI 10.1091/mbc.E17-08-0491; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Imig C, 2014, NEURON, V84, P416, DOI 10.1016/j.neuron.2014.10.009; James Declan J, 2013, Front Endocrinol (Lausanne), V4, P187, DOI 10.3389/fendo.2013.00187; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; JOHNSON RG, 1976, J BIOL CHEM, V251, P2189; Kabachinski G, 2016, MOL BIOL CELL, V27, P654, DOI 10.1091/mbc.E15-07-0509; Kabachinski G, 2014, MOL BIOL CELL, V25, P508, DOI 10.1091/mbc.E12-11-0829; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawabe H, 2003, GENES CELLS, V8, P537, DOI 10.1046/j.1365-2443.2003.00655.x; Khodthong C, 2011, CELL METAB, V14, P254, DOI 10.1016/j.cmet.2011.07.002; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Lee M, 2010, J AM CHEM SOC, V132, P8828, DOI 10.1021/ja101740k; Li KW, 2012, PROTEOMICS, V12, P2428, DOI 10.1002/pmic.201100675; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Merkulova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14827; Merkulova M, 2010, BBA-BIOENERGETICS, V1797, P1398, DOI 10.1016/j.bbabio.2010.02.009; Nagano F, 2002, J BIOL CHEM, V277, P9629, DOI 10.1074/jbc.C100730200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishi T, 2003, J BIOL CHEM, V278, P46396, DOI 10.1074/jbc.M303924200; Nojiri M, 2009, J BIOL CHEM, V284, P18707, DOI 10.1074/jbc.M109.017483; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; PAREKH D, 1994, PANCREAS, V9, P83, DOI 10.1097/00006676-199401000-00013; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Petrie M, 2016, J BIOL CHEM, V291, P21257, DOI 10.1074/jbc.M116.728097; Poea-Guyon S, 2013, J CELL BIOL, V203, P283, DOI 10.1083/jcb.201303104; Ratai O, 2019, J NEUROSCI, V39, P18, DOI 10.1523/JNEUROSCI.2040-18.2018; Rizo J, 2018, PROTEIN SCI, V27, P1364, DOI 10.1002/pro.3445; Sadakata T, 2007, J HISTOCHEM CYTOCHEM, V55, P301, DOI 10.1369/jhc.6A7033.2006; Sadakata T, 2010, J BIOL CHEM, V285, P38710, DOI 10.1074/jbc.M110.137414; Sakisaka T, 2005, METHOD ENZYMOL, V403, P401, DOI 10.1016/S0076-6879(05)03035-1; Saw NMN, 2011, MOL BIOL CELL, V22, P3394, DOI 10.1091/mbc.E11-02-0155; Sethi N, 2010, J BIOL CHEM, V285, P34757, DOI 10.1074/jbc.M110.158634; Shinoda Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31540; Shinoda Y, 2011, P NATL ACAD SCI USA, V108, P373, DOI 10.1073/pnas.1012220108; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Stevens D, 2009, MOL NEUROBIOL, V39, P62, DOI 10.1007/s12035-009-8052-5; Tata B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001952; Taupenot L, 2005, J BIOL CHEM, V280, P3885, DOI 10.1074/jbc.M408197200; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Trexler AJ, 2016, MOL BIOL CELL, V27, P2423, DOI 10.1091/mbc.E16-01-0057; Tuttle AM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001852; van Keimpema L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10936-4; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Whitton B, 2018, CANCER MED-US, V7, P3800, DOI 10.1002/cam4.1594; Yaffe D, 2018, J GEN PHYSIOL, V150, P671, DOI 10.1085/jgp.201711980; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001; Zhang XM, 2017, J CELL BIOL, V216, P2151, DOI 10.1083/jcb.201702099	71	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9402	9415		10.1074/jbc.RA119.007504	http://dx.doi.org/10.1074/jbc.RA119.007504			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	31004036	Green Published, hybrid			2022-12-28	WOS:000472713000011
J	Musiek, ES; Brooks, JD; Joo, M; Brunoldi, E; Porta, A; Zanoni, G; Vidari, G; Blackwell, TS; Montine, TJ; Milne, GL; McLaughlin, B; Morrow, JD				Musiek, Erik S.; Brooks, Joshua D.; Joo, Myungsoo; Brunoldi, Enrico; Porta, Alessio; Zanoni, Giuseppe; Vidari, Giovanni; Blackwell, Timothy S.; Montine, Thomas J.; Milne, Ginger L.; McLaughlin, BethAnn; Morrow, Jason D.			Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid (vol 283, pg 19927, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Musiek ES, 2008, J BIOL CHEM, V283, P19927, DOI 10.1074/jbc.M803625200	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6657	6657		10.1074/jbc.AAC119.008639	http://dx.doi.org/10.1074/jbc.AAC119.008639			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	31003972	Green Published, hybrid			2022-12-28	WOS:000468402000038
